Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,-0.7696595305643303,-1.9613045046638253,0.0,0.0643970890234522,0.06,1/93,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.8689168794100655,-1.9457357413098522,0.0,0.0643970890234522,0.12,1/46,0.01%,CD44
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.8666030338518294,1.9024903397458095,0.0,0.9074548831864345,0.34,2/35,1.54%,CPA1;PPP1R18
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.8007361613836316,-1.8918054062418914,0.0,0.11448371381947059,0.29,11/65,3.10%,CD44;MS4A8;EHF;DUOXA1;CAPN8;CLDN4;PGC;SLCO2A1;DUOX1;SFTPA2;MUC5B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8835234324143552,-1.887481320123213,0.0,0.10017324959203674,0.33,1/41,0.01%,CD44
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.7500783737643483,-1.8578651092398604,0.0,0.14024254942885145,0.45,14/84,5.44%,CD44;PRDM1;SP140L;RAC2;RIN3;STX11;STK10;PLK3;SP110;FOS;APOBEC3G;MVP;APOL3;TMEM71
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.9676977327745996,-1.8553707381280993,0.0,0.1216389459331875,0.46,1/17,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.8892831974446603,-1.851076708412845,0.0,0.11346153780322529,0.47,2/22,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.9318674401672702,-1.850672270046675,0.0,0.10017324959203674,0.47,1/21,0.01%,CD44
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9312429731903733,1.8438939475830813,0.0,1.0,0.72,1/20,0.00%,CPA1
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.719728243099952,-1.8418131666015751,0.0,0.10414837854410171,0.52,14/151,8.18%,CD44;IRF4;PRKCD;IFI27;TRIM5;CAMK2A;PDZD2;CIITA;IRF5;EGR1;HLA-DRB1;IFIT2;OAS3;OAS1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.7279044969122277,-1.8379916859665715,0.0,0.10088877280340844,0.53,2/90,1.31%,CD44;SP140L
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.8065591719122215,1.837735358969622,0.0,1.0,0.77,1/50,0.00%,CPA1
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.7749394103295538,-1.8351947532088473,0.0,0.09692087135852906,0.56,3/80,0.64%,CD44;LRP10;IL10RB
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.8984028082290696,-1.8322865572610192,0.0,0.09480682550674907,0.58,1/25,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.9307916681929338,-1.8296596996645367,0.0,0.091917212537748,0.59,2/23,0.87%,CD44;SIRPG
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,-0.9618062222267456,-1.8279428231947312,0.0,0.08995148942958402,0.62,1/15,0.01%,CD44
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8737474520726759,-1.8271933202029507,0.0,0.08490875441610733,0.63,1/24,0.01%,CD44
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.7981522914484859,-1.8265332873870688,0.0,0.08094356328642255,0.64,6/47,3.26%,CD44;ANXA8;EHF;DUOXA1;DUOX1;TPRG1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,-0.8199511495788665,-1.8208069405208,0.023255813953488372,0.08375830533115679,0.67,6/58,2.28%,CD44;EHF;CAPN8;CLDN4;CD24;FAM3D
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.9005896271909442,-1.8204386605727563,0.0,0.08029760483171199,0.68,2/20,2.04%,CD44;CD53
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.804694727012061,-1.8180857915601358,0.0,0.07908414441476586,0.69,3/67,0.40%,CD44;ANXA8;EHF
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,-0.8153653619378144,-1.817987367446357,0.0,0.07548769879971341,0.69,7/62,2.68%,CD44;ANXA8;EHF;CD24;GPR39;ALS2CL;CLDN1
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.8300288188394945,-1.8072199657295713,0.0,0.08261040713109524,0.73,6/59,1.19%,CD44;ANXA8;EHF;CLDN4;CD24;GPR39
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.8300288188394945,-1.8072199657295713,0.0,0.08261040713109524,0.73,6/59,1.19%,CD44;ANXA8;EHF;CLDN4;CD24;GPR39
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9288146212788763,-1.8036947307496316,0.0,0.08275181488037818,0.75,1/20,0.01%,CD44
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.8428687651564286,-1.7995553160944497,0.022727272727272728,0.08616092003600781,0.75,1/23,0.08%,UGT2B15
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.859840806753181,-1.7982099369510915,0.0,0.0850041575109569,0.76,3/34,1.88%,CD44;SIRPG;CXCL13
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.9045190963305187,-1.7896695739842805,0.0,0.0868849613808482,0.79,1/21,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.9045190963305187,-1.7896695739842805,0.0,0.0868849613808482,0.79,1/21,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.9045190963305187,-1.7896695739842805,0.0,0.0868849613808482,0.79,1/21,0.01%,CD44
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.8081509997073055,-1.788977441568709,0.0,0.0848758567971937,0.79,7/60,2.82%,CD44;EHF;CLDN4;CD24;GPR39;CLDN1;C6ORF132
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.9509316358267491,-1.788351561189418,0.0,0.08276218478199227,0.79,1/16,0.01%,CD44
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Limbal Epithelium,-0.791811927339328,-1.7866296353840903,0.020833333333333332,0.08193894839901623,0.79,3/33,0.43%,ANXA8;EHF;DUOXA1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.848517646797999,-1.7816754643808441,0.0,0.08474478034683466,0.81,1/29,0.01%,CD44
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.6833649270284552,1.777418003394493,0.0,1.0,0.94,46/102,20.92%,PCDH15;LHFPL3;NXPH1;LSAMP;LRRC4C;PMP2;GFAP;CADM2;ROBO2;PCDH17;NRXN1;RAB3C;PDGFRA;NOVA1;PTPRD;SCD5;SYNPR;ANK2;MAGI2;GRM5;LRRTM3;ADGRB3;CTNNA2;NPAS3;ZNF536;GPM6B;GABRB2;RUNX1T1;SEMA6D;FAT3;DLG2;CNTN2;MAPK10;RFTN2;GRID2;SORCS1;CDR1;CSRNP3;STMN4;PLP1;KCNJ10;TRPM3;AMER2;ATP1B2;ADGRL3;CADPS
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.819909596744246,-1.7772931335424023,0.019230769230769232,0.08738056187357318,0.83,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8483868155618243,-1.7758564984588985,0.0196078431372549,0.08607323336794755,0.83,1/33,0.01%,CD44
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.8016513045180172,-1.7732779882602832,0.0,0.08708939658409726,0.83,10/66,8.18%,CD44;IRF4;PRKCD;TRIM5;CAMK2A;CIITA;IRF5;HLA-DRB1;OAS3;OAS1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9112509440037037,-1.7727002662523332,0.0,0.08506775957418994,0.83,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8629213355881729,1.772425708364091,0.0,1.0,0.94,4/32,1.92%,SGO1;ESPL1;TOP2A;NDC80
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8229245702758148,-1.7702293401211897,0.02040816326530612,0.0862495546680471,0.84,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8570717529983454,-1.7680494088555576,0.0,0.08755744560206219,0.86,1/29,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.7203304342222552,-1.762962937648708,0.0,0.08125163578020758,0.89,8/80,5.00%,CD44;PRDM1;SP140L;RAC2;RIN3;STK10;SP110;MVP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,-0.9804752812377324,-1.7603271542975376,0.0,0.08135187816247705,0.9,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.927494966304801,-1.7537959395409803,0.0,0.08692845823260333,0.93,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.8461108809186291,-1.7433740749435827,0.0,0.10017324959203676,0.95,1/14,0.61%,DDX11
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.822267544019244,-1.7425701547725259,0.0,0.0988590232854357,0.95,11/51,8.18%,CD44;IRF4;PRKCD;TRIM5;CAMK2A;CIITA;IRF5;HCK;HLA-DRB1;OAS3;OAS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.9032325080195294,-1.7419809293135895,0.018867924528301886,0.09759736603109866,0.95,1/23,0.01%,CD44
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.7776393030279122,-1.7410276529864759,0.0,0.09792847088969417,0.95,6/71,2.68%,CD44;ANXA8;EHF;CD24;GPR39;CLDN1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.8432648062948676,-1.740830762676231,0.0,0.09618283168246385,0.95,1/25,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,-0.8793526724205338,-1.739833330081983,0.0,0.0953130919298894,0.95,2/21,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.7183594252233586,-1.7384400757533378,0.0,0.09593311204316746,0.95,5/93,2.92%,CD44;PRDM1;SP140L;RAC2;NEMP2
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.970722793626249,-1.7351228438986466,0.0,0.09796163239325152,0.96,2/14,1.04%,CD44;CD24
prerank,KEGG_2021_Human__Pancreatic secretion,0.7266893371098384,1.7291436388352257,0.0,1.0,1.0,2/73,0.54%,CPA1;SLC26A3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.8179168112095412,1.72866628294405,0.0,1.0,1.0,33/58,13.34%,GAS2L3;HPSE2;ZNF804B;THEMIS;SMYD1;CDC14A;PLD5;KLHL1;RASSF3;HGF;SNTB1;ITGB8;ITGA11;RIN2;SFMBT2;RNF152;FRAS1;B3GAT2;MCTP2;PDLIM5;POSTN;RASGEF1C;SYNPR;ANKRD13A;GFRA1;LTBP1;STK32B;MAMDC2;NTNG2;GNG4;NR4A2;TRPC5;MGAT5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.7506848587854784,-1.7254652508831168,0.0,0.10950060574027487,0.98,3/66,2.04%,CD44;GYPB;CD53
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.8141360530591364,-1.723712218681891,0.0,0.11034121101679235,0.99,1/39,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,-0.7385614531820859,-1.7235940152817668,0.0,0.10868550848594136,0.99,8/65,3.34%,CD44;EHF;DUOXA1;CD24;GPX3;FAM3D;CLDN1;EPAS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,-0.984808438734063,-1.7227665352763748,0.0,0.10793485730861102,0.99,1/9,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.9269196743243462,-1.7190613270785733,0.0,0.11221789031679355,0.99,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.9260798502594885,1.7179877777367296,0.0196078431372549,1.0,1.0,3/10,1.41%,SULT2A1;HS3ST5;SULT6B1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9608007113613861,-1.7170565691470177,0.0,0.11295882828703908,0.99,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.936705346471239,-1.71556721993502,0.0,0.11367586503243801,0.99,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9414809562196416,-1.7154566359999683,0.0,0.11198506133531545,0.99,1/14,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,-0.9511568948365898,-1.7153623015754094,0.0,0.11034709525372798,0.99,1/16,0.01%,CD44
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.8834920179150142,-1.7145090414312398,0.0,0.10986033306906888,0.99,5/17,5.63%,SLC28A2;ABCC4;RNASE1;XDH;VAV3
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7666745795717129,-1.7127557467407508,0.021739130434782608,0.11177339862488084,0.99,6/47,2.82%,ANXA8;EHF;DUOXA1;CD24;ENTPD2;C6ORF132
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.6893753775859001,1.712721268967956,0.0,1.0,1.0,55/101,20.92%,LRRC3B;ZNF385D;LSAMP;NEGR1;SLC35F1;GRM3;LRRC4C;CDH20;CADM2;RORB;PCDH9;LIX1;UNC5D;NRXN1;RAB3C;NOVA1;SLC24A2;SSBP2;OLFM3;FGF12;NLGN4X;SYNPR;MAGI2;ADGRB3;CTNNA2;VWC2;SCN2B;GPM6A;GRIK3;ATP1A2;NPAS3;JAKMIP2;ZNF536;GPM6B;GABRB2;FAT3;PPP2R2B;RYR2;CNTN2;PCSK2;CNTN4;GRID2;SORCS1;HMGCLL1;PTCHD1;XKR4;STMN4;RBFOX1;TRPM3;ST8SIA1;AMER2;SLITRK5;ATP1B2;ADGRL3;CADPS
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.8380034088173935,-1.7127077015524539,0.01818181818181818,0.11021193345307242,0.99,2/25,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Keratinocyte:Skin,-0.9943698968566035,-1.7114610342408556,0.0,0.1108008737609398,0.99,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8669015460318372,-1.706893939947661,0.0,0.11645399512614625,0.99,2/17,0.08%,CYP1A2;UGT2B15
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.9653144583291011,-1.706262773772934,0.0,0.1154036722340913,0.99,1/13,0.01%,CD44
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.7112707571382451,-1.7059441429643356,0.0,0.11448371381947056,0.99,3/83,1.30%,CD44;LRP10;PRDM1
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,-0.9119181479340412,-1.7025908238496827,0.02127659574468085,0.1175644387573209,1.0,1/19,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.922668065082442,-1.7022632186968547,0.0,0.11634603450660237,1.0,1/16,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,-0.9729793322446066,-1.7011873874001968,0.0,0.11709440661771864,1.0,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7552222025151377,-1.7006093669517002,0.0,0.11629637262161219,1.0,3/64,2.29%,CD44;TERF2IP;IL11
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.813105750258087,-1.697518442371945,0.0,0.11937939894990846,1.0,6/34,2.73%,CD44;P2RY10;SIRPG;SP140;PRDM1;GPR132
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,-0.9703571881059736,-1.6960742069823354,0.0,0.12070969500932814,1.0,2/11,1.04%,CD44;CD24
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.8811365839162415,-1.6953424656342693,0.0,0.12072160848271095,1.0,3/18,3.29%,CYP1A2;PLA2G2C;CYP2E1
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,-0.9709227021187471,-1.6942746935647877,0.0,0.12046150267396824,1.0,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9696955450053015,-1.6931089726825377,0.0,0.1202078995104441,1.0,1/13,0.01%,CD44
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,-0.9471393350922357,-1.691500169900527,0.0,0.12190395452999181,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9422215706837986,1.690791879352641,0.0,1.0,1.0,1/14,0.02%,CLEC2A
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8813990645749197,-1.6904340745072803,0.0,0.12155168700497142,1.0,4/31,3.66%,CD44;CLDN4;WTIP;ZMYM6
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.7201264204317103,1.6895801375376713,0.024390243902439025,1.0,1.0,14/75,6.51%,IGF1;HEMGN;SMAD6;SMOC1;HGF;PPARG;WNT4;FBXO5;RORB;BMP2;CRIM1;ACVR2A;CCN4;WWTR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.9120460104949435,-1.6886392794325102,0.0,0.12457000487133658,1.0,1/12,0.01%,CD44
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,-0.9208737209171605,-1.6850207876871726,0.0,0.12939044738971414,1.0,1/15,0.01%,CD44
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.8075066682757777,-1.6826295796358104,0.0,0.1308144788790127,1.0,3/39,1.18%,CD44;MPL;TEK
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,-0.9338010464728224,-1.6803109519529196,0.02,0.13312059746450067,1.0,2/12,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,-0.9826623323348949,-1.67681659111137,0.0,0.13693633872803054,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.829115699593761,-1.6758007097404797,0.0,0.13684381417483593,1.0,1/33,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9118916663389176,-1.6738699999883564,0.0,0.1390044530855791,1.0,3/12,4.94%,CYP1A2;HSD11B1;CYP24A1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.919400198366535,1.6733994549070874,0.0,1.0,1.0,1/15,0.05%,SGO1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.7303530897395386,-1.673161330769087,0.0,0.13881150300610806,1.0,3/82,2.29%,CD44;TERF2IP;IL11
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,-0.9768829130136956,-1.6730057775017733,0.0,0.13744335972282593,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.9562751558493126,-1.672144116290671,0.0,0.13750489540273367,1.0,2/16,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.666197451434997,1.6701881112530603,0.017543859649122806,1.0,1.0,32/85,17.57%,PREX2;PCDH11X;COL9A1;HIF3A;LGR5;TBC1D8B;CNTNAP2;PRDM14;LIN28A;NANOGP1;APELA;IGDCC3;MAGI2;BMPR1A;CHST6;SHPRH;MIPOL1;TERF1;MGAT4C;FAT3;POU2F1;L1TD1;CDH8;VRTN;PTBP2;ORC4;SLCO1A2;GRID2;TMEM45A;LRIG2;CDKL5;PTCHD1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,-0.9596387480321239,-1.6677992978001768,0.0,0.14456646388896854,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.9841978774706046,-1.666857729223601,0.0,0.14462703208576735,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.885652118883432,-1.6664625502929196,0.0,0.14363186990377,1.0,1/23,0.01%,CD44
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,-0.9462157868230248,-1.6658947495733527,0.0,0.1434027769457431,1.0,1/12,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7837364269212195,1.6610734250447974,0.0,1.0,1.0,3/33,4.32%,GATA4;TGFBR1;DAPK2
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.8376064995804388,-1.6609496591003257,0.0,0.1522515369351722,1.0,5/36,3.78%,SLC28A2;SLC29A3;SLCO2A1;NLRP3;LCN15
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9177803828738362,-1.6591840603407602,0.0,0.15383749044491357,1.0,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.8624898784630741,1.6582580293954705,0.0,1.0,1.0,6/19,6.41%,LGALS9;IGF1;FGF10;MYC;ZFP36L2;ITGAV
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.6420343358154675,1.657326662361343,0.0,1.0,1.0,38/117,16.62%,FGF10;PDZRN4;ZNF385D;LSAMP;PRKG1;RAB27A;ANGPT1;CADM2;RSPO2;SLC17A6;ROBO2;PENK;UNC5D;NRXN1;RAB3C;PDGFRA;NOVA1;OLFM3;PTPRD;PCDH18;FGF14;PABPC5;SCN3A;MAGI2;ADGRB3;MAGEL2;TMEM196;INTS6L;ZNF536;COL11A1;RUNX1T1;SEMA6D;NREP;FRZB;PDZRN3;MAPK10;PCSK2;CNTN4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,-0.9698269268313782,-1.6537974697582385,0.0,0.16247436153167288,1.0,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9394461809847237,1.650981541993291,0.0,1.0,1.0,2/13,0.87%,CLEC2A;KLRD1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,-0.9436947338147432,-1.6501468427948514,0.0,0.16843416395689606,1.0,1/9,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,-0.9215581307208917,-1.6488842008657276,0.0,0.16945856649515692,1.0,1/12,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Stomach,-0.9863535251474826,-1.6484560771637713,0.022222222222222223,0.1688494480168294,1.0,2/6,1.04%,CD44;CD24
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8232655183559988,1.6468268746766328,0.03225806451612903,1.0,1.0,8/20,8.80%,FLT1;FGFR3;CCL5;FGFR1;FGF2;ESR1;PDGFRA;ABL2
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.7288240315367618,-1.6465624037098672,0.017241379310344827,0.17061407836202652,1.0,7/42,11.17%,NARS1;TARS3;WARS1;SARS1;DARS2;SARS2;CARS1
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,-0.8955201834765047,-1.6463964948688279,0.022222222222222223,0.169042358686562,1.0,1/11,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.9846157953178573,-1.6460906727935534,0.0,0.16852275254497068,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.7041891248023273,1.645989325569978,0.020833333333333332,1.0,1.0,17/62,14.65%,NPC1L1;SULT2A1;IL4;INSIG1;MSMO1;FDFT1;CEL;ABCA1;FDX1;CYP27A1;HMGCS1;ACAA2;MVD;SOAT2;IDI2;CH25H;SOAT1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8681656485985776,-1.6456434730115286,0.0,0.1678779459133392,1.0,2/22,2.60%,CD44;COL5A1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.6563832678018136,1.6449976928878636,0.0,1.0,1.0,37/183,10.74%,CPA1;MXRA5;MITF;CFH;HGF;LSAMP;IL4;SOCS2;ADGRL4;RIN2;ALDH1A1;ROR1;IL2RA;ST6GALNAC3;HS3ST1;CXCL12;RIOK2;POSTN;PDGFRA;UNC13B;HPGDS;NEO1;ABCA1;HS2ST1;PLSCR4;CYBRD1;ACHE;RAMP3;CYP27A1;GRIK2;ESYT3;EXT1;GSN;MEDAG;GPM6A;STK32B;PCDH7
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6836974461254349,-1.6448052143659988,0.0,0.16818139033643018,1.0,4/78,2.31%,CD44;SHCBP1;FGF1;NR4A1
prerank,CellMarker_Augmented_2021__Progenitor cell:Breast,-0.9863282408826101,-1.6437445396964547,0.0,0.16874422401515712,1.0,2/6,1.04%,CD44;CD24
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.8003015968242545,1.643588593523502,0.0,1.0,1.0,6/26,6.02%,MITF;C3;CCL5;SIRT1;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.8473347330529309,1.6423535771638382,0.022222222222222223,1.0,1.0,3/13,3.41%,SULT2A1;SULT6B1;ENPP1
prerank,KEGG_2021_Human__Shigellosis,-0.6288359580015679,-1.6420906307420928,0.0,0.1701501067775618,1.0,9/206,4.30%,CD44;SEPTIN12;HK2;CYTH4;NLRP3;PLCZ1;PRKCD;ARPC5L;ATG14
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8968827207426625,1.6408094050637883,0.018518518518518517,1.0,1.0,3/11,2.18%,IRS1;SIRT1;ZBTB7B
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.962227444803922,-1.6386401081683593,0.0,0.17595366243276583,1.0,2/11,0.35%,SLC28A2;SLC29A3
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.5930107793071556,1.6375429612984413,0.02040816326530612,1.0,1.0,51/199,14.25%,IGF1;CFH;CERCAM;SEMA5A;EBF1;GSTM2;FSTL5;LSAMP;HIF3A;NEGR1;ITGA11;INSIG1;LHFPL2;ADD3;TSHZ2;NDRG2;NLGN1;PCDH9;BGN;ZFP36L2;KANK2;COL6A2;MCTP2;CXCL12;FBLIM1;LRRN3;SYT1;POSTN;TSC22D3;CNN3;PDGFRA;FAM114A1;LIFR;SSBP2;DLC1;CYBRD1;PCDH18;RIMS2;AK1;LOXL2;RPS5;TPM2;LRRC17;PLAGL1;RAB34;FLRT2;RBMS3;PHLDA1;CCND3;TMEM98;NR2F2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.6711862066617342,1.6371678708163178,0.022727272727272728,1.0,1.0,38/100,17.87%,CGNL1;EPHA7;ESRRG;PRKG1;ERBB4;LRP4;FRAS1;LRP1B;CDH2;ZNF385B;PCLO;ALDH7A1;FREM1;CYP39A1;ADGRL2;LIFR;PTPRD;FGF12;STOX2;ANK2;MAGI1;GUCY1A2;ATP1A2;PPP1R9A;PROX1;FIGN;ID4;RUNX1T1;SEMA6D;DMD;FRZB;COBL;CPE;DST;USH2A;FLRT3;CSRNP3;FARP1
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,-0.9213672934265901,-1.633566506093685,0.0,0.18545588100147345,1.0,1/13,0.04%,CYP1A2
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.9190780915593693,-1.6332482485110493,0.0,0.18469442893531776,1.0,3/14,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.7010594335374621,-1.6313380154967554,0.0,0.1869225238910825,1.0,20/110,7.09%,CD44;PSG4;SELE;SIRPG;PSG5;SELL;TEK;PSG9;GYPB;PSG3;CD99L2;GYPE;ANGPT4;PSG2;GPC1;INPP5D;JCHAIN;PSG8;PROCR;F11R
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.6504896071856597,1.6306264753240647,0.0,1.0,1.0,18/90,12.35%,STK26;DACH1;MITF;TMEFF2;CCDC125;NAV3;TP53INP1;DLC1;FOXO3;KANK1;ARID2;MAGI2;PTPRT;TMIGD3;PTPRK;SINHCAF;FRMD5;PTEN
prerank,Reactome_2022__Methylation R-HSA-156581,-0.903384633286965,-1.6302511241509636,0.0,0.18754239961215902,1.0,1/11,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.9242639814146218,1.6292820487607302,0.0,1.0,1.0,2/13,4.04%,RAB27A;NLGN1
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,-0.9848591571117321,-1.6283043933212114,0.0,0.1910135877313993,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.901536395771774,-1.6278180234832211,0.0,0.19016879833266584,1.0,1/10,0.61%,DDX11
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6982775040928098,1.6265442069453795,0.021739130434782608,1.0,1.0,8/41,5.54%,HGF;TGFBR1;FGFR1;HIF1A;SNAI1;WNT4;BMP2;RBPJ
prerank,KEGG_2021_Human__Drug metabolism,-0.7227262217268093,-1.6247632862752739,0.020833333333333332,0.19545403278153203,1.0,8/67,5.41%,CYP1A2;UGT2B15;MPO;CYP2A6;CYP2E1;UPB1;GSTT2B;XDH
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.9271799252259507,-1.6234864209148994,0.0,0.19682952068750076,1.0,1/18,0.01%,CD44
prerank,CellMarker_Augmented_2021__Luminal progenitor:Breast,-0.9834044038433349,-1.6218460022343764,0.0,0.1990838111640058,1.0,2/5,1.04%,CD44;CD24
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6012691109245439,1.621424207666913,0.018518518518518517,1.0,1.0,41/115,17.14%,CXXC4;PDZRN4;UNC5C;ESRRG;ERBB4;PCLO;SCGN;PLCXD3;PCDH17;PTGFR;NRXN1;PLPPR1;ADGRL2;PAX6;LIFR;NOVA1;PTPRD;FGF12;STOX2;FGF14;ANK2;MAGI1;GUCY1A2;PTPRT;PAK5;TMEM196;NOL4;CNTN1;PPP1R9A;PROX1;CNTN3;SEMA3E;ID4;SEMA6D;FRZB;CPE;MAPK10;CNTN4;PXK;HMGCLL1;FLRT3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fetal Liver,-0.9860765265791938,-1.621216232335625,0.0,0.19891545276133013,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.8946156412364978,-1.6211117906377435,0.020833333333333332,0.19750805999846677,1.0,1/15,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.6610975636198173,-1.621066809273543,0.0,0.19594779091744427,1.0,9/94,5.96%,CD44;MPL;AMACR;CD24;EPAS1;IL6R;IFI27;FOXM1;DLL4
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,-0.9838031529727569,-1.6210200883206187,0.0,0.1944128920653814,1.0,1/10,0.01%,CD44
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.7064081188187814,-1.6210014032828186,0.0,0.19284504616162834,1.0,3/62,1.31%,CD44;PRDM1;SP140L
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.916736403258864,-1.6206772162945633,0.0,0.19216091364598134,1.0,3/16,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,CellMarker_Augmented_2021__Basophil:Undefined,-0.8996867549927722,-1.6198310096927269,0.0,0.1931912670703566,1.0,1/20,0.01%,CD44
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.6911993878830449,-1.6197895242866938,0.0,0.19189543763243935,1.0,6/53,3.87%,CD44;COL23A1;COL4A2;ICAM3;COL4A1;AGRN
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,-0.9857144547329438,-1.6185508993842925,0.0,0.19302486632352595,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,-0.9857144547329438,-1.6185508993842925,0.0,0.19302486632352595,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.9758527966815258,-1.6168888584888272,0.0,0.19522775621041447,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.797729006018899,1.613554525457599,0.0196078431372549,1.0,1.0,2/18,2.68%,SGO1;KASH5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.9767778889800858,1.6115938324849197,0.0,1.0,1.0,2/10,0.15%,GATA4;STK26
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.7321280903874754,1.6077032036255383,0.0,1.0,1.0,1/33,0.00%,CPA1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,-0.9835862325112991,-1.6059650207727103,0.0,0.22142985487792638,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Basal cell:Submandibular Gland,-0.7421103740415845,-1.605483445050135,0.024390243902439025,0.21759381241340606,1.0,3/32,2.25%,ANXA8;DUOXA1;DUOX1
prerank,CellMarker_Augmented_2021__Buccal Epithelial Stem cell:Oral Mucosa,-0.7421103740415845,-1.605483445050135,0.024390243902439025,0.21759381241340606,1.0,3/32,2.25%,ANXA8;DUOXA1;DUOX1
prerank,CellMarker_Augmented_2021__Basal cell:Salivary Gland,-0.7421103740415845,-1.605483445050135,0.024390243902439025,0.21759381241340606,1.0,3/32,2.25%,ANXA8;DUOXA1;DUOX1
prerank,CellMarker_Augmented_2021__Semilunar Valve cell:Heart,-0.7250388127274974,-1.6052962632559975,0.0,0.21651202358913765,1.0,6/48,3.47%,ANXA8;EHF;DUOXA1;CLDN4;C6ORF132;PTGES
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.8798350305075985,-1.6039162395786153,0.02040816326530612,0.21849763947254655,1.0,2/16,1.04%,CD44;CD24
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6924348814323751,-1.603613641700339,0.0,0.21747727387968768,1.0,10/69,3.27%,MS4A8;DUSP4;EHF;CAPN8;CLDN4;TMEM184A;FAM3D;C6ORF132;MUC5B;SPDEF
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7156191985225203,-1.6025785214469657,0.01818181818181818,0.2182864289764362,1.0,8/66,2.39%,CD44;P2RY10;SIRPG;SELL;TRAF3IP3;CD53;NR4A1;CYTH4
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,-0.8720298842214611,-1.6019471690664218,0.02040816326530612,0.21831179420340588,1.0,1/12,0.42%,NTRK1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.642377003415992,1.598949847574717,0.0,1.0,1.0,20/90,9.33%,SLC5A8;SLC7A11;SLC26A3;SLC12A7;SLC12A1;SLC1A3;SLC26A7;SLC26A6;SLC38A3;SLC12A3;SLC17A6;SLC38A4;SLC5A12;SLC7A2;SLC8A1;SLC4A7;SLC15A1;SLC7A9;SLC9A2;SLC15A2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6107379918057418,1.5964227892714848,0.0,1.0,1.0,31/139,12.26%,CRX;PCDH15;VWC2L;LSAMP;CDH20;CADM2;PCBP3;RNF152;SLC17A6;CNTNAP2;VSX2;SAG;ZDHHC22;NRXN1;RCVRN;RAB3C;FRMD3;SLC24A2;OLFM3;LIN7A;SYNPR;MAGI2;GRM5;ADGRB3;CTNNA2;QPCT;PAK5;TMEM196;HCN1;ZNF536;PROX1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.8598220828249835,1.5960236207196108,0.047619047619047616,1.0,1.0,2/14,4.06%,ESPL1;LLGL1
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.7903643344517135,1.5943199326019422,0.0,1.0,1.0,3/16,2.55%,IRS1;SOCS2;STAT5A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.8193049766475033,1.594178802702962,0.05405405405405406,1.0,1.0,4/18,4.79%,SULT2A1;SULT6B1;ENPP1;SLC35B2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.8702214630133029,-1.5935174757131698,0.022727272727272728,0.2400069286143901,1.0,2/18,1.04%,CD44;CD24
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8245233351634876,-1.5927435603036013,0.0,0.24033460489761196,1.0,3/22,6.32%,CYP1A2;HSD11B1;CYP4F2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.6299315670479169,1.592598119287931,0.022222222222222223,1.0,1.0,38/100,17.84%,PREX2;PRRX1;LSAMP;PRKG1;SLC35F1;MMP16;NLGN1;ROBO2;CXCL12;EFS;ZDHHC22;NRXN1;MEGF10;TMEM200C;PDGFRA;NOVA1;SPSB4;PTPRD;PCDH18;SNTG2;ANK2;GFRA1;MAGI2;GUCY1A2;MAGEL2;GRIK3;ZNF536;LRFN5;UBE2QL1;ID4;RUNX1T1;SEMA6D;FAT3;PDZRN3;GRID2;CDR1;GALNT16;CSRNP3
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8851895046213852,-1.5913465698512392,0.023809523809523808,0.24181661206850316,1.0,3/13,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,-0.897244714996428,-1.5913094668110208,0.0425531914893617,0.24027569657390632,1.0,2/12,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Corneal Epithelial Stem cell:Eye,-0.7645058201962349,-1.5912355894907075,0.05714285714285714,0.23870649357150026,1.0,2/25,0.43%,ANXA8;DUOXA1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9461104645564647,-1.5892621740768844,0.0,0.2410235036661628,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9461104645564647,-1.5892621740768844,0.0,0.2410235036661628,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.721356856577798,1.5876216238322458,0.05660377358490566,1.0,1.0,10/49,11.97%,IRGM;SIRT1;IL4;FYCO1;PIP4K2A;GNAI3;GPSM1;STING1;EPM2A;BNIP3L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,-0.9834406528275895,-1.5875526125961035,0.0,0.24449476807619078,1.0,1/7,0.01%,CD44
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.6685478254110115,-1.5861477784847287,0.0,0.24646873861978924,1.0,3/87,1.21%,CD44;CAPN8;COL23A1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.9275880461063284,1.5856101110893028,0.0,1.0,1.0,2/9,2.51%,NPC1L1;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.8002598412218479,1.5841983901149754,0.018518518518518517,1.0,1.0,4/28,5.62%,VAPB;TOP2A;CCL5;NR5A2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,-0.982059197082739,-1.58252064570361,0.0,0.2544189244192765,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6966889263220979,-1.5825123188017984,0.0196078431372549,0.2527227982564813,1.0,11/74,8.18%,CD44;IRF4;PRKCD;TRIM5;CAMK2A;CIITA;IRF5;HCK;HLA-DRB1;OAS3;OAS1
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,-0.8037133217645166,-1.5819028446713066,0.043478260869565216,0.25313410563891214,1.0,1/9,1.06%,ADSS1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7362172875306209,-1.5811597306923062,0.0,0.2531163360227357,1.0,1/42,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,-0.9797095980289054,-1.5810109390255842,0.0,0.251836110669056,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,-0.9213395928271574,-1.5806801730009823,0.0,0.2511300621729864,1.0,1/13,0.01%,CD44
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.5998626155660498,-1.5805462066430631,0.0,0.2501099844652789,1.0,1/157,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.8178348594918664,1.58014950366698,0.0,1.0,1.0,7/23,6.94%,IGF1;IRS1;PPP1R3B;PPP1R3A;ENPP1;PPP1R3D;DYRK2
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.8298982123375692,1.5794952312110282,0.0,1.0,1.0,3/14,2.02%,SIPA1;PRKG1;RAPGEF3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7615803936590332,1.5780220732583963,0.0,1.0,1.0,6/22,10.72%,CGNL1;NLGN1;PCLO;MARVELD3;DSP;MPP4
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7123686753852424,-1.5777034464574011,0.03508771929824561,0.256212349918094,1.0,7/40,11.17%,NARS1;TARS3;WARS1;SARS1;DARS2;SARS2;CARS1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.8095413097594815,1.576931307925732,0.0,1.0,1.0,5/26,3.80%,GATA4;TGFBR1;HES6;BMP2;PCSK5
prerank,CellMarker_Augmented_2021__Syncytiotrophoblast:Placenta,-0.7471289671938454,-1.5768018953129481,0.0196078431372549,0.25772508027432567,1.0,13/29,9.43%,PSG4;GPR78;PSG5;INHA;PSG9;CGA;PSG3;DPPA2;PSG2;PSG8;HSD3B1;DPRX;PSG6
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.9853276218322649,1.5758399412887671,0.0,1.0,1.0,1/7,0.81%,IRGM
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.8902270521620391,-1.575795056888851,0.0,0.2590828033074332,1.0,3/13,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.6732160164331413,1.5756460437415172,0.017241379310344827,1.0,1.0,10/70,8.94%,GATA4;IGF1;HGF;TGFBR1;IL4;URI1;RELA;ITGAV;PELI3;ACAA2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8367388657810205,-1.5755875276065683,0.045454545454545456,0.25638091067461904,1.0,8/17,11.61%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;FLG2;STMN1;ALOX12B
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8367388657810205,-1.5755875276065683,0.045454545454545456,0.25638091067461904,1.0,8/17,11.61%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;FLG2;STMN1;ALOX12B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,-0.7074900251274684,-1.5745124693675545,0.018518518518518517,0.2578550107067423,1.0,3/71,1.04%,CD44;CLDN4;CD24
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.8308643213034165,-1.574246002826838,0.02,0.2571025069996675,1.0,1/18,0.17%,TERT
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.6736015482384012,-1.5737123767493444,0.019230769230769232,0.25679820776223267,1.0,5/74,3.41%,CYP1A2;ACOT1;AWAT1;CYP2E1;ALOX5
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.7533549374092812,1.5732316194054856,0.0,1.0,1.0,9/22,11.63%,SMAD6;GREM2;BMP2;ACVR2A;ZFYVE16;UBE2D3;SMAD1;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.8136884639863039,1.5717717205455113,0.02,1.0,1.0,6/14,15.11%,STARD4;LDLR;NPC2;ABCA1;LRP6;STAR
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.7023662247313415,-1.5710794087306967,0.022222222222222223,0.262256708753368,1.0,4/84,1.75%,CD44;GAB3;GYPB;ICAM3
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.8852449687148015,-1.569999114902732,0.0,0.263182446655442,1.0,3/12,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.7164679700310194,-1.5689030499611698,0.041666666666666664,0.2645711729758699,1.0,4/40,5.39%,ANXA8;AHSG;TIMP4;SERPINI2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7869126357596218,1.5687849652238297,0.018518518518518517,1.0,1.0,6/20,7.75%,LGALS9;CCL5;IL4;CXCL12;MOSPD2;HMGB1
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.9893539198866182,1.5679628358266449,0.0,1.0,1.0,1/5,0.64%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.9007400212039924,-1.5665891167958286,0.0,0.27074198638668956,1.0,1/14,0.17%,TERT
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.7958335815540012,-1.5650266578740215,0.0,0.2744542603618558,1.0,3/22,3.86%,DUSP4;DUSP6;IL6R
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.9496887472873373,1.564575637121573,0.0,1.0,1.0,3/7,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.8487801450132058,1.5644880096790208,0.022222222222222223,1.0,1.0,6/18,9.05%,F2;F2R;CALCR;SNCA;RAMP3;ANK2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.7903627133562076,1.5644784798766198,0.05555555555555555,1.0,1.0,5/23,9.78%,PNP;AMPD1;SHMT2;ADA;GMPS
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9854029817975473,-1.56234444359502,0.0,0.28167904883170775,1.0,1/8,0.01%,CD44
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.8370401294760113,-1.5620666007666628,0.0,0.2808639052637232,1.0,5/18,5.42%,RAC2;NOXA1;PRKCD;RNASE1;PDZD2
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,-0.8379332508412263,-1.5614294739452745,0.0,0.2811462255676253,1.0,1/19,0.01%,CD44
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6678670881719302,1.5611859449669763,0.023255813953488372,1.0,1.0,15/42,16.53%,NPC1L1;STARD4;LDLR;NPC2;CEL;ABCA1;ABCG8;SOAT2;MSR1;ABCA8;ABCG5;LIPG;SOAT1;STAR;AKR1C1
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,-0.7741829645356599,-1.5607868245212504,0.018518518518518517,0.2815500636374189,1.0,1/11,1.06%,ADSS1
prerank,KEGG_2021_Human__AMPK signaling pathway,0.6451824280212664,1.560437837709299,0.044444444444444446,1.0,1.0,27/107,16.07%,IGF1;ADRA1A;IRS4;IRS1;SIRT1;CCNA2;PPARG;SCD;ADIPOR2;PRKAB2;FOXO3;SCD5;LEPR;PIK3CA;FOXO1;CPT1C;FASN;IGF1R;STRADA;CREB3L2;CREB1;ACACA;ACACB;PPP2R2B;CAB39L;PRKAA1;PIK3CD
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,-0.9262866223232135,-1.5600950284640327,0.0,0.2823214705678129,1.0,2/8,1.18%,CD44;TEK
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.977598604671198,-1.5599870310515809,0.0,0.28127464171163025,1.0,1/5,0.12%,ANXA8
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.7080906205090111,-1.5596187648144126,0.0,0.2808121951829014,1.0,3/59,2.29%,CD44;CD24;IL11
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9709593558437629,-1.559128522570847,0.023255813953488372,0.28080220573546993,1.0,1/6,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.8371341474448606,-1.5591138335769943,0.0,0.27764712477215003,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.8371341474448606,-1.5591138335769943,0.0,0.27764712477215003,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.8241763952989416,1.559015726336766,0.016666666666666666,1.0,1.0,4/13,8.08%,TIMELESS;SLFN11;FBXO5;GMNN
prerank,KEGG_2021_Human__Protein digestion and absorption,0.6285808757289421,1.5584383424531338,0.01818181818181818,1.0,1.0,12/80,7.70%,CPA1;COL9A1;MME;ACE2;COL9A2;COL6A5;COL6A2;SLC8A1;PRSS3;COL8A1;DPP4;SLC15A1
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.7698608187314169,-1.556838402779287,0.06382978723404255,0.28409069626919603,1.0,9/30,9.99%,CYP1A2;UGT2B15;CYP2E1;HSD11B1;CYP21A2;HSD3B2;HSD3B1;LRTOMT;DHRS11
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.7777132241757242,-1.556297183673044,0.06,0.28366520201935486,1.0,2/27,5.43%,EPN1;PTPN3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.7149996978179978,1.5555018550110193,0.019230769230769232,1.0,1.0,8/37,7.75%,LGALS9;SYK;F2R;CD244;RELA;TLR2;F3;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8960984539450794,1.5543376063976968,0.02,1.0,1.0,3/12,2.18%,IRS1;SIRT1;ZBTB7B
prerank,CellMarker_Augmented_2021__Naive T cell:Peripheral Blood,-0.8620257448478476,-1.5539582711501547,0.0,0.28862071636600645,1.0,1/6,1.10%,SELL
prerank,Reactome_2022__VEGF Binds To VEGFR Leading To Receptor Dimerization R-HSA-195399,0.9547560902318208,1.5532331055539679,0.0,1.0,1.0,2/6,0.74%,VEGFC;FLT1
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,-0.9192018010373723,-1.5529724420066402,0.025,0.2903373030758208,1.0,1/10,0.01%,CD44
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.6558132220501361,1.5528122812006737,0.018867924528301886,1.0,1.0,11/68,5.88%,CSTA;STAB1;MME;ARHGAP24;PPP1R3B;RIN2;MAFB;STEAP4;PTGS1;LTBP2;TLR2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.9240834396397253,-1.552797884084614,0.0,0.2894936533877596,1.0,2/6,2.31%,NUPR1;NR4A1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.7271822895219645,-1.55150380475616,0.0,0.2921201284687034,1.0,8/44,6.82%,CYP1A2;AWAT1;CYP2A6;CYP2E1;ALOX5;PTGES;CYP4F2;ALOXE3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6588351237430131,-1.5510997046000436,0.02,0.29193347023964994,1.0,1/86,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.9124299832230315,1.5499031951114528,0.0,1.0,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7750437413397219,-1.5490049478401535,0.023809523809523808,0.2978653884758604,1.0,2/16,4.93%,TAFA3;DRD2
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.7156340195328947,-1.5487966848277195,0.019230769230769232,0.2971525807225964,1.0,6/50,6.82%,CYP1A2;AWAT1;ALOX5;PTGES;CYP4F2;ALOXE3
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Lung,-0.686565858558734,-1.5484259231886657,0.02127659574468085,0.2952574352109957,1.0,7/53,8.71%,ANXA8;DUOXA1;CLDN4;MUC5B;MYO5B;PLEKHS1;CDH3
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Pleura,-0.686565858558734,-1.5484259231886657,0.02127659574468085,0.2952574352109957,1.0,7/53,8.71%,ANXA8;DUOXA1;CLDN4;MUC5B;MYO5B;PLEKHS1;CDH3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5480735535461616,-1.5483849113566117,0.0,0.2938917442918251,1.0,14/304,4.48%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;IL31RA;PLK3;ANGPT4;BCL2L2;PRAME
prerank,CellMarker_Augmented_2021__Stromal cell:Adipose Tissue,-0.9891304354353843,-1.5483355521474071,0.023255813953488372,0.29242796795640946,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.7664114074513526,1.547564747667158,0.018518518518518517,1.0,1.0,2/22,4.18%,MT4;GLRA1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.8715699627153584,1.5471037855130663,0.017543859649122806,1.0,1.0,2/12,4.18%,MT4;GLRA1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6104690774670708,-1.5460354170369004,0.0,0.29876820758160666,1.0,9/134,3.15%,CD44;SELE;IL10RB;LTB4R;CXCL13;XCR1;NLRP3;PTGDR;MEFV
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5976596594781617,1.5458913284705964,0.031746031746031744,1.0,1.0,6/93,9.35%,SGO1;ESPL1;NDC80;DLGAP5;CHMP6;RRS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.6984356300372718,1.5458868084566368,0.041666666666666664,1.0,1.0,6/38,7.75%,VEGFC;LGALS9;CCL5;CXCL12;MOSPD2;HMGB1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.7178894245716632,1.5458142628018814,0.0,1.0,1.0,22/34,18.59%,RBM20;LRRC3B;SEMA5A;ZNF385D;ITGA8;PCSK5;SYT6;RGS9;HS3ST4;DLC1;BCL11B;GRIK3;ANKRD18A;GRM4;SEMA3E;LUZP2;FEZF2;ABO;TLE4;VAV2;TSPAN18;RYR3
prerank,KEGG_2021_Human__Nicotine addiction,0.7145559343275898,1.545518113112035,0.038461538461538464,1.0,1.0,13/38,18.76%,GABRR1;GABRR2;GRIN3A;SLC17A6;GABRG3;GRIN3B;GABRA5;GABRG1;GABRB2;GRIN2D;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.8259156464386206,1.5454442013589644,0.0196078431372549,1.0,1.0,6/15,7.75%,FLT1;FGFR1;FGF2;PPARG;SP1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7497018545735219,-1.5453617379539912,0.06,0.2996670527211077,1.0,1/22,0.61%,DDX11
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.8258849539700471,1.5452311259244191,0.02857142857142857,1.0,1.0,3/16,4.79%,SULT2A1;SULT6B1;SLC35B2
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.9329802474418036,-1.544485809664763,0.0,0.30107298837253166,1.0,2/6,4.51%,CD200R1;C5
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,-0.8365782757159714,-1.5443979614552719,0.02,0.29978587881572905,1.0,1/14,0.42%,NTRK1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Undefined,-0.979001672343652,-1.544004689472116,0.0,0.2995340790461595,1.0,1/5,0.01%,CD44
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.8194549093220638,-1.5438513070248372,0.0,0.2985584161154975,1.0,3/15,2.36%,H1-3;H1-4;H1-2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bladder,-0.9608399046409414,-1.5434042298768353,0.023255813953488372,0.2985321843000778,1.0,2/6,1.04%,CD44;CD24
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8485408164017716,1.5432949989868652,0.01818181818181818,1.0,1.0,4/13,4.70%,IRS1;SOCS2;STAT5A;IL7R
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8485408164017716,1.5432949989868652,0.01818181818181818,1.0,1.0,4/13,4.70%,IRS1;SOCS2;STAT5A;IL7R
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9349514434416593,-1.5431871873669196,0.0,0.2950376306392326,1.0,1/10,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9349514434416593,-1.5431871873669196,0.0,0.2950376306392326,1.0,1/10,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9349514434416593,-1.5431871873669196,0.0,0.2950376306392326,1.0,1/10,0.04%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6443112048532653,-1.5419118010806998,0.041666666666666664,0.297508883777764,1.0,9/90,3.12%,CD44;RAB44;MPO;GAB3;GYPB;RAC2;ICAM3;CGA;STK10
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6649913206268134,-1.541658006326363,0.0,0.2966425294041454,1.0,8/74,3.86%,CD44;BST1;IL11;ENPP2;PRKCD;TEC;ANGPT4;IL6R
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.9062145750125952,1.541369786509251,0.0,1.0,1.0,3/9,3.61%,PPP1R3B;PPP1R3A;PPP1R3D
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.627809917367741,1.5412209576461116,0.0196078431372549,1.0,1.0,24/80,15.72%,SMAD6;GREM2;MYC;TGFBR1;GDF6;BMP2;SP1;ACVR2A;ZFYVE16;NEO1;SMAD1;SMAD2;LTBP1;INHBC;E2F4;BMPR1A;SMAD4;GREM1;ID4;ACVR1B;BAMBI;HJV;SMAD5;FBN1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.855754696615248,-1.5400722944274288,0.044444444444444446,0.29999362876774865,1.0,4/9,9.83%,EPN1;ALOX5;ADAMTS9;CREB3L1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.848101819068162,-1.5396329681839562,0.02702702702702703,0.29982167735038173,1.0,2/11,0.39%,SELP;MPL
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6397269122633269,-1.539591015881916,0.0,0.2984009664511747,1.0,7/99,3.15%,CD44;SELE;SELL;CD53;CYTH4;CD86;MEFV
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,-0.8716565578606273,-1.5391896537606216,0.04081632653061224,0.29841120211458017,1.0,2/12,3.21%,DUSP4;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.9116007055081732,1.5383752533419515,0.0,1.0,1.0,3/11,5.37%,GATA4;SOX5;SOX6
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.9041872816665707,1.537970561017623,0.020833333333333332,1.0,1.0,1/9,0.23%,REP15
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.7141185138263572,-1.5376749084187675,0.0,0.3019989554150036,1.0,2/59,1.37%,CD44;IRF4
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.910113353182841,1.5372541676154945,0.0,1.0,1.0,3/10,2.58%,FGF10;TGFBR1;ZBTB1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Pancreas,-0.9516042435675034,-1.5371149683480214,0.023809523809523808,0.30240270459550944,1.0,2/7,1.04%,CD44;CD24
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.655092807293504,1.5357283212162598,0.06382978723404255,1.0,1.0,31/99,13.70%,UNC5C;IL17RD;ERBB4;LRRC4C;EFNA5;TMEFF2;LRP1B;NLGN1;PCLO;ZNF462;EPHA5;LIFR;NOVA1;NEUROD2;FGF12;STOX2;SCD5;FAM171B;PRICKLE2;LRRIQ1;SERTAD4;OSBPL6;CADM1;PCDH7;NPAS3;CNTN1;PPP1R9A;GLRB;FIGN;SEMA3E;MLF1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,-0.9644777078855303,-1.5355449916623534,0.0,0.3052899035185882,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,-0.973840183090608,-1.5349487340201415,0.0,0.3061828945722748,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.9527366157564221,-1.534944862741534,0.0,0.3047386356356131,1.0,1/5,1.24%,RTF1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,-0.976955166776401,-1.5333564824608763,0.02564102564102564,0.3083132410314263,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8085603903759991,1.533332588672156,0.05555555555555555,1.0,1.0,7/14,11.92%,RUNX1;TGFBR1;ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8615968420833421,1.533309340719633,0.018867924528301886,1.0,1.0,1/8,0.09%,GATA4
prerank,CellMarker_Augmented_2021__Stem cell:Eye,-0.9665792744310497,-1.5318851186925107,0.022727272727272728,0.31208848854875537,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.875525284709364,1.5304968264887862,0.02,1.0,1.0,1/8,1.40%,LYPD1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6964062784649563,-1.5294493302093004,0.05454545454545454,0.3183579088363534,1.0,1/68,0.01%,CD44
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.8308540571419063,1.528484842038901,0.022222222222222223,1.0,1.0,3/12,3.79%,GATA4;TGFBR1;BMP2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7910275553307006,-1.527493120415919,0.0,0.323641748847288,1.0,5/20,7.27%,TEKT3;DNAH17;TEKT5;DRC1;RSPH9
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,-0.8773077301359657,-1.5265201004940667,0.0,0.3260741491822421,1.0,1/7,0.56%,SELE
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.3222131115936065,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.3222131115936065,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.3222131115936065,1.0,1/5,0.03%,SLC28A2
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",0.8905460484716599,1.5259365551673025,0.0,1.0,1.0,3/10,7.42%,GATA4;PAX6;DPP4
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.7194533070133261,1.5253766395984851,0.018518518518518517,1.0,1.0,18/51,14.03%,ERBB4;STAT5A;NRG1;NEDD4;GFAP;LLGL1;CXCL12;NRG3;GABRG3;ESR1;NRG2;TAB2;PIK3CA;ADAP1;SOS1;GABRB2;MXD4;WWOX
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6017309957498186,1.5243745391040475,0.0425531914893617,1.0,1.0,50/129,23.78%,RUNX1;GPRIN3;PBX3;NRTN;NEDD4;EHD1;NPY;TENM3;CNTNAP2;NLGN1;TENM1;PRMT1;MANF;LGI1;UGDH;EPHA5;POU3F2;HMGB1;EPHA8;GPM6A;PPP1R9A;MEF2C;GPM6B;HDGFL3;MYT1L;PTPRM;LRP12;RP1L1;L1CAM;SLC44A4;CNTN4;FLRT3;ARL3;MICALL1;STMN4;PLP1;WNK1;LYN;RAPGEF2;CDK16;MAP2;TDP2;STX3;RYK;TENM4;SH3GL2;PBX1;BLK;RP1;CDNF
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.6323376040224108,1.5241902787917387,0.018518518518518517,1.0,1.0,22/83,8.36%,MXRA5;FLT1;SEMA5A;PREX2;PDZRN4;ZNF385D;PRKG1;ADGRL4;VCAN;BGN;FREM1;PCDH17;CXCL12;SLC8A1;POSTN;NRXN1;PDGFRA;CASR;PTPRD;RAMP3;CYP27A1;PLXDC2
prerank,Reactome_2022__Synthesis Of Epoxy (EET) And Dihydroxyeicosatrienoic Acids (DHET) R-HSA-2142670,-0.9815572068517864,-1.5224314698388461,0.0,0.3334467671455677,1.0,1/5,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7843876450445703,-1.5224204123577316,0.06,0.33194475468094803,1.0,3/17,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.9175107162311602,1.5223719210698303,0.03773584905660377,1.0,1.0,1/8,0.48%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.9175107162311602,1.5223719210698303,0.03773584905660377,1.0,1.0,1/8,0.48%,IGF1
prerank,CellMarker_Augmented_2021__Adventitial cell:Undefined,-0.9854317201786961,-1.5211593964649701,0.023255813953488372,0.334659510968912,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,0.6027737236733736,1.5210717157180031,0.02127659574468085,1.0,1.0,21/78,11.01%,STAB1;ARHGAP24;TSHZ3;RIN2;ARHGAP31;MAFB;VCAN;KIAA0930;RAB31;SLC8A1;LMO2;TLR2;ABCA1;SIGLEC1;TFEC;CYP27A1;GPR162;ST3GAL6;TMIGD3;GSN;OSCAR
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.9023764332647963,-1.5210245634019606,0.023255813953488372,0.33358075430154327,1.0,3/7,7.27%,TEKT3;TEKT5;RSPH9
prerank,KEGG_2021_Human__Retinol metabolism,-0.7353394646150202,-1.5208999699734753,0.06382978723404255,0.33263879070879504,1.0,3/34,2.01%,CYP1A2;UGT2B15;CYP2A6
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.9468326739130067,-1.5194728781416624,0.0,0.33550440136751375,1.0,1/6,1.24%,RTF1
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.8390350797143645,1.5192181123799766,0.04838709677419355,1.0,1.0,4/13,6.51%,GATA4;KAT2B;TEAD2;WWTR1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.8466062547387719,1.5186574566264832,0.017241379310344827,1.0,1.0,3/11,3.61%,PPP1R3B;PPP1R3A;PPP1R3D
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8529090134318563,-1.516410363329016,0.022727272727272728,0.34442828769420564,1.0,1/10,1.10%,SCN5A
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7210238099632907,-1.5163445031212404,0.023809523809523808,0.34329422847346175,1.0,6/48,5.72%,CD44;HGSNAT;AGRN;GPC2;GPC1;GPC3
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,-0.8331315389680638,-1.5158991208503312,0.09615384615384616,0.3432011770177579,1.0,3/17,2.28%,CD44;CD24;BST1
prerank,CellMarker_Augmented_2021__Ito Cell (Hepatic Stellate cell):Liver,0.9267650168437594,1.5158904447265393,0.0,1.0,1.0,2/5,3.01%,LRAT;GFAP
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7953073574784484,-1.5154808117014387,0.046511627906976744,0.34310893470514703,1.0,6/15,10.52%,TERF2IP;SLX4;ERCC1;RAD50;RTEL1;PARP1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.6070509607041972,1.5154045877937767,0.03508771929824561,1.0,1.0,39/102,22.30%,SLC7A11;PCDH15;PCDH11X;GRM3;SLC17A6;ADGRV1;NAV3;FER;SLC24A2;FGF12;SYNPR;RIMS2;ANK2;MAGI2;SYT14;LRRTM3;CTNNA2;HCN1;FRMD5;MGAT4C;FAT3;CDH8;DLG2;SLCO1A2;FBXL2;GRM1;GRID2;KLHL7;UNC79;CSRNP3;RBFOX1;TRPM3;AMER2;CADPS;KCTD16;RPS6KA6;TACR3;TTLL7;AKAP6
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.8585351043272245,-1.5149470703914758,0.03571428571428571,0.3432343162428445,1.0,1/10,0.88%,APIP
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.7112543524998978,1.51451550328215,0.03225806451612903,1.0,1.0,8/25,19.07%,FGF10;ANGPT1;ANK2;PTPRK;PTPRU;GGA1;CTNNB1;SMURF1
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.7184472185704585,1.5140996690258866,0.03278688524590164,1.0,1.0,4/25,2.28%,TOP2A;MYC;CDC25A;CCNA2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Membrane,-0.9860411332559909,-1.512062184385188,0.0,0.35335126865023553,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.8446528158398768,-1.5115409941799107,0.06666666666666667,0.35346232458747484,1.0,1/7,0.61%,DDX11
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.9000179064430498,-1.5114921368767664,0.023255813953488372,0.3520435355778752,1.0,2/5,6.37%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8961769298468392,1.511291122775631,0.0,1.0,1.0,4/10,6.19%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8961769298468392,1.511291122775631,0.0,1.0,1.0,4/10,6.19%,F2;F2R;F12;HPSE
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.718282353660141,1.511277840952861,0.05357142857142857,1.0,1.0,4/21,7.73%,SYK;STAT5A;CSF3R;UBE2D3
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.9284794834430943,1.5109903027112195,0.01818181818181818,1.0,1.0,1/6,0.64%,DRD5
prerank,Reactome_2022__HDL Remodeling R-HSA-8964058,-0.868280679605725,-1.5105637903098525,0.037037037037037035,0.3538642877685869,1.0,1/7,0.33%,ALB
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6806114162691336,1.5087513225908435,0.023255813953488372,1.0,1.0,8/44,5.54%,HGF;TGFBR1;FGFR1;HIF1A;SNAI1;WNT4;BMP2;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7349172983465164,-1.508500923261681,0.06,0.3597020076149891,1.0,3/36,5.43%,EPN1;MVP;PTPN3
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.7977419958106029,-1.5084558786954756,0.037037037037037035,0.35836542274185545,1.0,6/23,16.44%,NARS1;WARS1;SARS1;CARS1;PPA1;GARS1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8634194268595067,-1.5081303871839762,0.041666666666666664,0.35782173368680115,1.0,1/11,0.33%,ALB
prerank,Reactome_2022__Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) Bind RNA R-HSA-428359,-0.9570672709484058,-1.507879366096029,0.022727272727272728,0.35725265612127155,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8416964477943435,1.5077373599429857,0.017241379310344827,1.0,1.0,3/14,2.71%,VEGFC;ITGA11;ITGA2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.8511200162001952,-1.5076690592373816,0.022222222222222223,0.35650944006594504,1.0,1/12,0.42%,NTRK1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.671892736172644,1.506184917710105,0.04081632653061224,1.0,1.0,9/53,6.82%,CPA1;TMPRSS2;GALNT7;UGDH;SDC4;TIFA;PDIA2;PRSS3;CEL
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.569239511837681,1.5054455249079752,0.0,1.0,1.0,22/221,7.59%,CPA1;CAPN13;MME;HGF;TMPRSS2;PRSS57;MMP23B;KLKB1;NAALAD2;MMP16;PCSK5;CTSF;TRHDE;ADGRV1;HGFAC;MMP15;F12;PRSS3;KLK14;F3;DPP4;HTRA2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8180691468509464,1.5054443846412688,0.07142857142857142,1.0,1.0,7/14,8.80%,FLT1;FGFR1;FGF2;ESR1;PDGFRA;BICD1;ABL2
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.8649405236719218,1.5052446796332626,0.06557377049180328,1.0,1.0,3/9,6.84%,SV2C;SYT1;VAMP1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.6415115227932832,1.5051719878947263,0.018518518518518517,1.0,1.0,36/97,19.03%,IL17RD;EPHA7;FGFR3;NYNRIN;LRP4;MYCN;FRAS1;ZNF462;EFS;UNC5D;MEGF10;CNN3;TMEM200C;ADGRL2;LIFR;PTPRD;STOX2;NLGN4X;CACHD1;ANK2;GPC4;MAGI1;VANGL2;MAGEL2;PPP1R9A;CRISPLD1;FIGN;ID4;FRZB;CPE;GPRC5B;CSRNP3;FARP1;TMEM178A;MPDZ;PLP1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9476047483341414,-1.505108231429203,0.0196078431372549,0.3647386992407147,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.6226592825731905,1.5044903689692615,0.05555555555555555,1.0,1.0,50/93,30.98%,ZNF518A;PCM1;ANKRD36;PHF3;SMG1;ZNF292;SHPRH;REV3L;KIAA0586;ZNF638;SMC5;ANKRD26;CHD9;CCP110;ZMYM4;PHIP;UBR5;RANBP2;CEP350;MACF1;ZMYM2;TTC21B;BRWD1;GCC2;SENP6;ANKRD17;CSPP1;MGA;HERC1;UBN2;TRIP11;SREK1;CEP290;AKAP9;PIKFYVE;ZNF644;ASH1L;NEK1;TTC3;MTR;KIDINS220;TNKS;NIPBL;RBM26;CLASP2;HECTD1;KANSL1L;MYO9A;RALGAPA1;HELZ
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.9026250847106622,1.5044451988632488,0.0,1.0,1.0,5/8,9.52%,ERBB4;NRG1;NRG3;NRG2;PIK3CA
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7332506866998173,1.5043998709713329,0.05263157894736842,1.0,1.0,5/26,7.57%,GATA4;CLMP;PCSK5;NPY;AGR2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5770510096966832,1.5043194720489719,0.01818181818181818,1.0,1.0,20/118,11.18%,STK26;DACH1;MITF;IL4;FGF2;TMEFF2;NAV3;TP53INP1;MARVELD3;DLC1;FOXO3;KANK1;ARID2;MAGI2;PTPRT;TMIGD3;CORO1C;BMPR1A;PTPRK;SINHCAF
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7992016895403278,1.503286047843542,0.0,1.0,1.0,5/14,13.39%,SIRT1;SNAI1;LOXL2;HP1BP3;SETD7
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7189586960035752,1.5031180085609797,0.03636363636363636,1.0,1.0,7/28,12.26%,GATA4;TGFBR1;ROBO2;BMPR1A;DAND5;SMAD4;PROX1
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.7977675523472183,1.5031026775234986,0.03571428571428571,1.0,1.0,4/14,10.29%,SOCS2;SOCS6;ABL2;FLT3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8536163402545192,-1.5019285057903302,0.0,0.37615232624258893,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.87768930045976,-1.5015416044588887,0.041666666666666664,0.37648887986001817,1.0,1/12,0.23%,RFX6
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,0.8996154326726902,1.5011882755088273,0.0,1.0,1.0,2/9,2.93%,ERBB4;NEDD4
prerank,KEGG_2021_Human__Longevity regulating pathway,0.6317658875725799,1.5006473368831794,0.04081632653061224,1.0,1.0,25/91,20.26%,IGF1;IRS4;IRS1;SIRT1;PPARG;ADIPOR2;RELA;PRKAB2;HDAC2;FOXO3;ATG101;PIK3CA;FOXO1;IGF1R;HSPA8;CREB3L2;CREB1;PRKAA1;PIK3CD;TP53;IRS2;PRKACB;AKT3;HDAC1;PIK3R3
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.8994010547308049,1.500110998239764,0.02,1.0,1.0,2/8,2.71%,ITGA8;ITGA2
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.885580918325098,1.5000559956554635,0.0,1.0,1.0,4/11,7.20%,ERBB4;NRG1;NRG3;NRG2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.7661864098344047,-1.500036339205016,0.03508771929824561,0.3808988111683154,1.0,3/27,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.8246180898227592,1.4991625932567554,0.018518518518518517,1.0,1.0,7/24,7.47%,FGF10;SMOC1;LRP4;KAT2B;RSPO2;PCSK5;CHD7
prerank,Reactome_2022__Metallothioneins Bind Metals R-HSA-5661231,0.9455297940656361,1.4990479804844037,0.02,1.0,1.0,1/6,0.15%,MT4
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.6148509280620821,1.4988815839655514,0.03636363636363636,1.0,1.0,16/84,10.39%,VEGFC;PLOD2;ITGA2;REXO2;GNG12;EVA1A;CRIM1;FBLIM1;LTBP2;ANXA5;MYOF;ITGAV;FAM114A1;EXT1;AOX1;LOXL2
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,-0.8789463716377365,-1.4987007942454986,0.01818181818181818,0.3845718223405073,1.0,1/7,0.42%,NTRK1
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.680366616230359,-1.4985233904932855,0.05263157894736842,0.38364842105660996,1.0,9/39,16.44%,NARS1;WARS1;SARS1;DARS2;SARS2;CARS1;DTD1;PPA1;GARS1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.811366285864072,1.498335821377565,0.06,1.0,1.0,3/12,7.41%,STARD4;NPC2;ABCA1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8186041637491571,1.498193335673732,0.02,1.0,1.0,1/13,1.92%,NDC80
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.598820884341165,1.4980976690843701,0.018518518518518517,1.0,1.0,17/101,12.78%,IGF1;RIT2;RAB38;CCNA2;RIN2;FGF2;RRAS;RRAD;KSR1;ARHGAP31;CDKN2A;RALA;SHOC2;RAPGEF6;RGL2;RRAGC;SOS1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8765582306220863,1.4975261391557702,0.0392156862745098,1.0,1.0,2/8,5.19%,VEGFC;CXCL12
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Thyroid,-0.9624291258010274,-1.4969977581656164,0.045454545454545456,0.388381364164383,1.0,2/5,1.04%,CD44;CD24
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.6688608728409355,1.4968843193635417,0.03571428571428571,1.0,1.0,3/46,1.70%,CPA1;TMPRSS2;ACE2
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.8661130403291248,1.4964690094165864,0.0,1.0,1.0,4/13,7.20%,ERBB4;NRG1;NRG3;NRG2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.8049711523557391,1.494987502645176,0.057692307692307696,1.0,1.0,4/14,12.35%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.8048506658934447,1.4947922901878241,0.02127659574468085,1.0,1.0,2/8,5.32%,UGDH;MAT2A
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.6750935587616068,1.4944774917255248,0.017857142857142856,1.0,1.0,6/42,2.08%,IGF1;FGF10;IRS4;IRS1;FGFR3;FGFR1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.9132731317205275,1.494448996065067,0.0,1.0,1.0,1/11,2.73%,RAB27A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7277780403390574,1.4940422168968626,0.018867924528301886,1.0,1.0,7/31,9.95%,IRGM;SIRT1;PYHIN1;FBXL3;SNCA;RNF139;GSN
prerank,Reactome_2022__Organic Anion Transporters R-HSA-428643,0.9057515005474491,1.4937287630759766,0.031746031746031744,1.0,1.0,2/9,3.91%,SLC5A8;SLC17A6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.9159703493330609,1.4933251015630296,0.015625,1.0,1.0,3/10,2.18%,PNP;RUNX1;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9646327174722884,-1.492959337880383,0.0,0.4012123297312394,1.0,2/5,3.43%,DDX11;PRKCD
prerank,CellMarker_Augmented_2021__Late Transit-Amplifying Prostate Epithelial cell:Prostate,-0.6913529795442837,-1.4928731443840286,0.061224489795918366,0.39854642873403195,1.0,8/46,7.08%,EHF;CLDN4;TMEM184A;SERINC2;SPDEF;PTGES;PHLDA2;LAMB3
prerank,CellMarker_Augmented_2021__Early Transit-Amplifying Prostate Epithelial cell:Prostate,-0.6913529795442837,-1.4928731443840286,0.061224489795918366,0.39854642873403195,1.0,8/46,7.08%,EHF;CLDN4;TMEM184A;SERINC2;SPDEF;PTGES;PHLDA2;LAMB3
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7731822906532548,1.492538301653473,0.023255813953488372,1.0,1.0,3/27,5.04%,IGF1;ESPL1;DLGAP5
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Adipose Tissue,-0.9885291212308006,-1.4924683825388176,0.02631578947368421,0.39841244630003003,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8290674599440414,1.4922780583406083,0.01818181818181818,1.0,1.0,2/13,2.55%,IGF1;STAT5A
prerank,CellMarker_Augmented_2021__Stem cell:Undefined,-0.9153774293949029,-1.492204471240269,0.0,0.39808077077107573,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),0.9564545953501925,1.4921505114416478,0.019230769230769232,1.0,1.0,2/5,3.87%,GATA4;NPY
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.6698581867436271,1.492043040096546,0.0,1.0,1.0,6/55,6.78%,FGF10;ESPL1;CDC25A;FBXO5;DLGAP5;UBE2E2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7479786041689637,1.4914000120637099,0.023255813953488372,1.0,1.0,3/18,3.79%,GATA4;SMAD6;BMP2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.7725733681886873,-1.4911956875976211,0.017857142857142856,0.40091925076699975,1.0,3/19,8.49%,ALB;NFE2L1;ALAS2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6564485459785531,1.4910229500473504,0.0425531914893617,1.0,1.0,15/59,7.90%,VEGFC;SEMA5A;SIRT1;TGFBR1;FGFR1;HIF1A;STAT5A;FGF2;BMP2;SP1;NRARP;APELA;F3;HMGB1;AGGF1
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.6004575324658994,-1.4909725977876331,0.07547169811320754,0.4002141048802211,1.0,5/92,3.34%,CD44;ANXA8;FRMD6;COL4A1;EPAS1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.801162919472511,1.4900531368990653,0.0,1.0,1.0,3/15,5.82%,SIRT1;ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7946669780301867,1.4890305633123455,0.038461538461538464,1.0,1.0,5/16,10.39%,SOX5;GDF6;BMP2;SOX6;LOXL2
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.9870354387705699,1.4890049677794468,0.0,1.0,1.0,1/5,0.81%,IRGM
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.7039756601865458,1.4883884813200603,0.07547169811320754,1.0,1.0,7/19,14.36%,NPC1L1;LDLR;NPC2;ABCG8;MSR1;ABCA8;ABCG5
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.7136408611647092,1.4882900292374222,0.06666666666666667,1.0,1.0,5/30,4.30%,GATA4;SMAD6;SNAI1;BMP2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.931736276078229,-1.4879736452690313,0.021739130434782608,0.4096159937099587,1.0,1/6,0.60%,HK2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.7997355618056362,1.4877300912753437,0.018867924528301886,1.0,1.0,3/25,1.32%,IGF1;IRS1;C3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.7103524778190443,1.486475983305011,0.057692307692307696,1.0,1.0,4/26,4.30%,GATA4;SMAD6;SNAI1;ROBO2
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.5470589294739474,1.486470832293619,0.045454545454545456,1.0,1.0,49/283,10.55%,VEGFC;IGF1;FGF10;LAMA4;FLT1;ITGA10;CHRM2;IRS1;COL9A1;ITGA8;FGFR3;HGF;SYK;ITGB8;MYC;F2R;FGFR1;ITGA11;ERBB4;IL4;CSF3R;ITGA2;FGF2;EFNA5;PIK3R6;COL9A2;ANGPT1;GNB4;GNG12;IL2RA;EFNA2;PIK3R5;COL6A5;IL7R;COL6A2;RELA;TLR2;ITGAV;PDGFRA;FOXO3;PDGFC;LAMB4;MAGI2;MAGI1;FGF17;PIK3CA;TNC;FLT3;ITGA1
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.5933207856858629,1.4863593670421515,0.0,1.0,1.0,42/141,23.20%,LHFPL3;NXPH1;GRM3;ASIC1;ZEB2;SCD;TMEFF2;CDK18;OLIG1;OLIG2;EIF3E;GPR17;KCNH8;PLPPR1;GRIK2;RGR;MTSS1;SNX22;HIP1;GSN;BIN1;NPPA;DLL3;PHLDA1;MOBP;GPR37;SGK1;GJB1;PHLDB1;FERMT1;PLP1;SHISA4;DHCR7;CSPG4;MAP2;ASPA;LRRN1;PID1;CRB1;ZDHHC9;MBP;ZCCHC24
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.6750962684865965,-1.4860447867404722,0.11538461538461539,0.4158699164843513,1.0,1/39,0.04%,CYP1A2
prerank,KEGG_2021_Human__Cellular senescence,0.586570610744832,1.4854818693986644,0.07407407407407407,1.0,1.0,34/139,17.81%,GATA4;MYC;SIRT1;TGFBR1;CDC25A;CCNA2;RRAS;CDKN2A;ZFP36L2;RELA;MAPKAPK2;MAP2K6;PPP1CC;FOXO3;MCU;PIK3CA;CCNB3;SMAD2;FOXO1;E2F4;HLA-E;CHEK2;PTEN;PPP3CA;PPP3CC;CCND3;NFATC3;HIPK1;SLC25A31;PIK3CD;TRPM7;RRAS2;CDK4;TP53
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.6171634861063863,1.4844972959688294,0.03508771929824561,1.0,1.0,25/89,12.47%,DACH1;FLT1;PREX2;ITGA8;NYNRIN;GALNT8;MYCN;ROBO2;PELI2;FREM1;AFF2;CXCL12;EFS;NRXN1;RAB3C;PDGFRA;CNRIP1;SPON1;PTPRD;AUTS2;ADGRB3;TCF4;GPM6B;BAALC;CD34
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.6171634861063863,1.4844972959688294,0.03508771929824561,1.0,1.0,25/89,12.47%,DACH1;FLT1;PREX2;ITGA8;NYNRIN;GALNT8;MYCN;ROBO2;PELI2;FREM1;AFF2;CXCL12;EFS;NRXN1;RAB3C;PDGFRA;CNRIP1;SPON1;PTPRD;AUTS2;ADGRB3;TCF4;GPM6B;BAALC;CD34
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7600956043494747,1.4844159137590305,0.037037037037037035,1.0,1.0,8/22,8.97%,ACE2;PPARG;CALCR;CBLB;CNRIP1;RAMP3;CRHBP;CHMP6
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8280328259737924,-1.4839404729756667,0.02040816326530612,0.42291041170178945,1.0,3/11,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.9023917011696484,1.4838360497027274,0.0,1.0,1.0,2/7,2.87%,IGF1;PPARG
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6340334735216534,1.4837415686652529,0.02,1.0,1.0,11/57,13.04%,VEGFC;FLT1;DOCK1;MAPKAPK2;ITGAV;MAPKAPK3;PIK3CA;PXN;NCK2;BCAR1;HSPB1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.6769791717148687,-1.4835004670300669,0.041666666666666664,0.4229352315278406,1.0,8/68,4.94%,CYP1A2;UGT2B15;AMACR;CYP2A6;CYP2E1;SLC22A24;HSD11B1;CYP24A1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.8001776926063142,1.4832668567832015,0.04918032786885246,1.0,1.0,2/9,1.66%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.8001776926063142,1.4832668567832015,0.04918032786885246,1.0,1.0,2/9,1.66%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6729457615186252,1.48294925483334,0.0,1.0,1.0,1/29,0.09%,GATA4
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,-0.8711041434705913,-1.4826502402536743,0.018518518518518517,0.4244793105299627,1.0,3/11,2.36%,H1-3;H1-4;H1-2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8969307095064761,1.4822890161335205,0.0425531914893617,1.0,1.0,4/8,7.75%,LGALS9;RUNX1;VSIR;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7840641540454742,1.482021880796431,0.017543859649122806,1.0,1.0,2/20,1.13%,IGF1;IRS1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.873191536977517,1.481403442434303,0.0,1.0,1.0,3/10,9.52%,SEMA5A;PLEKHH2;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6903177284561718,1.4813894941928774,0.0196078431372549,1.0,1.0,8/38,6.51%,IGF1;HGF;WNT4;FBXO5;BMP2;ACVR2A;CCN4;WWTR1
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.6750073405372479,1.4811120562991096,0.017543859649122806,1.0,1.0,6/43,2.08%,IGF1;FGF10;IRS4;IRS1;FGFR3;FGFR1
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.6750073405372479,1.4811120562991096,0.017543859649122806,1.0,1.0,6/43,2.08%,IGF1;FGF10;IRS4;IRS1;FGFR3;FGFR1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.6232060881276382,1.480874335198265,0.038461538461538464,1.0,1.0,24/87,12.41%,CXXC4;PLCH1;EPHA7;FGFR3;SLC35F1;ERBB4;MYCN;ADGRV1;ZDHHC22;UNC5D;NRXN1;MEGF10;TMEM200C;PCYT1B;PTPRD;STOX2;NLGN4X;PTPRT;VANGL2;C6ORF118;GRIK3;PPP1R9A;CRISPLD1;GPM6B
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,-0.7960916410535326,-1.4807070386195127,0.08163265306122448,0.4305523323811579,1.0,1/9,0.73%,AMACR
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.846526071627689,1.4804523477966274,0.0392156862745098,1.0,1.0,4/16,6.01%,FGF10;SEMA5A;ANGPT1;SCRIB
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.6873635130995855,1.4804407026433655,0.04,1.0,1.0,9/36,14.65%,SULT2A1;IL4;IDH1;ABCA1;FDX1;CYP27A1;SOAT2;CH25H;SOAT1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.7568508914682932,1.4801739206306148,0.02040816326530612,1.0,1.0,9/20,19.49%,THRSP;NPC2;PRKAB2;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6279892911616007,1.4797584615181658,0.06666666666666667,0.9988305485072908,1.0,22/64,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC26A7;SLC26A6;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;GABRG1;GABRB2;PACC1;ANO5;ANO6;SLC4A1;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.8022925854490872,-1.4794735218372175,0.02127659574468085,0.43411149624792056,1.0,2/18,1.07%,TERT;GINS3
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6068270040041857,-1.478563538333232,0.057692307692307696,0.4362779886130826,1.0,11/70,3.29%,MS4A8;EHF;DUOXA1;CAPN8;CYP2B7P;DUOX1;FAM3D;ALS2CL;SFTPA2;MUC5B;CYP2E1
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Undefined,-0.9777967852327522,-1.4783791742593566,0.025,0.4353264982949973,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.550132030040137,1.4780798240732458,0.0,1.0,1.0,43/157,20.81%,GPRIN3;NRTN;NEDD4;EHD1;NPY;CNTNAP2;NYAP2;NLGN1;PRMT1;WHRN;TNIK;ADGRV1;MANF;LGI1;NEFH;HMGB1;EPHA8;PLXNB1;GPM6A;VASH2;PPP1R9A;PTEN;GPM6B;HDGFL3;GRM7;DBN1;PTPRM;LRP12;L1CAM;SGK1;CNTN4;FLRT3;WASL;MICALL1;STMN4;PLP1;LYN;RAPGEF2;CDK16;MYO16;MAP2;CAMSAP2;DIP2A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.827379543568201,1.4777444734340783,0.03636363636363636,1.0,1.0,7/15,12.47%,LGALS9;ITGB8;HIF1A;ITGAV;LTBP1;SMAD4;CD34
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.7498557756559053,-1.4775426003764167,0.06896551724137931,0.43682149991202823,1.0,3/21,8.49%,ALB;NFE2L1;ALAS2
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.75359066752067,1.4772310685118228,0.061224489795918366,1.0,1.0,10/18,20.26%,IRS1;SOCS2;STAT5A;IL7R;SOS1;RAG2;IRS2;BRWD1;RAG1;PIK3R3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7190063590229651,1.4760206757813694,0.07142857142857142,1.0,1.0,8/28,13.60%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8608379671510055,1.475889308415795,0.018518518518518517,1.0,1.0,3/11,8.46%,GAS2L3;EPS8;GAS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6424636218131075,1.475767877670687,0.0425531914893617,1.0,1.0,10/48,10.17%,FGF10;IL4;HIF1A;INSL3;DOCK1;GLUL;PLCG2;BMPER;MARVELD3;CORO1C
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.789895259180215,1.4756208421272758,0.04081632653061224,0.997862399481545,1.0,2/14,9.57%,AASS;CTCFL
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.7498080715680776,-1.4749381782360373,0.06818181818181818,0.44551445236350573,1.0,2/17,1.10%,SELP;SELL
prerank,Reactome_2022__Biosynthesis Of Maresins R-HSA-9018682,-0.9459424052666979,-1.4746873017031992,0.020833333333333332,0.44480796327978506,1.0,3/6,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.9549200329569874,1.4745392242710864,0.0,1.0,1.0,2/6,3.42%,SLC26A3;SLC26A6
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.6710641715408743,-1.4741055374006662,0.0196078431372549,0.4454734959787124,1.0,3/39,2.39%,GOLGA8B;STX16;CYTH4
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6974124450535697,1.4739120582737288,0.05263157894736842,1.0,1.0,11/32,17.08%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2;CH25H;SC5D;SQLE
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6226496045045786,1.4736554380333293,0.0196078431372549,1.0,1.0,20/44,15.72%,SMAD6;VWC2L;GREM2;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;SMAD1;VWC2;BMPR1A;DAND5;SMAD4;GREM1;LRP2;SPART;BAMBI;SMAD5;FBN1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9808237790389012,-1.4736050467212713,0.0,0.4458937743700975,1.0,2/5,1.71%,CD44;RAC2
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6004181358479865,-1.4730157377481847,0.019230769230769232,0.4466035211498398,1.0,19/70,10.86%,MPO;CD24;SELL;DOCK8;BST1;CYTH4;NLRP3;LILRB3;MEFV;PRAM1;ARG2;HCK;SLC11A1;OAS3;TAGAP;LY86;CEACAM1;MMP9;SPI1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.8695118887092737,-1.4729097811465208,0.08163265306122448,0.44529394521031573,1.0,4/17,2.60%,MPO;GPX3;DUOX1;PXDN
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.8420571675540381,1.472604968133369,0.0,1.0,1.0,2/12,3.79%,GATA4;BMP2
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.8828430526757896,-1.4725897608923963,0.05555555555555555,0.4450501568590858,1.0,3/10,2.60%,MPO;GPX3;PXDN
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8113857362668875,1.4720432290488341,0.07142857142857142,1.0,1.0,4/11,7.75%,FGFR1;FGF2;SP1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7927575258466368,1.4719411749880529,0.06382978723404255,1.0,1.0,5/21,8.32%,F2;F2R;CALCR;SNCA;RAMP3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.694953270534747,1.4717574732951964,0.022222222222222223,0.9971026438238042,1.0,1/25,0.09%,GATA4
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.9346869179566571,1.4717416734661266,0.015873015873015872,0.9919053413439364,1.0,1/9,0.10%,TNFSF14
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8652843746071223,1.470843706521558,0.017543859649122806,0.9955455832829901,1.0,1/8,0.09%,GATA4
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.8325402168650172,1.4704351771625128,0.020833333333333332,0.995346236510929,1.0,5/14,9.52%,ERBB4;NRG1;NRG3;NRG2;PIK3CA
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.7296734799722495,1.4694344243271913,0.0,0.9995270599307892,1.0,3/21,2.12%,TNFSF14;TNFRSF18;TNFSF13B
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.692278190789765,-1.469056156371218,0.11627906976744186,0.45767179527370155,1.0,7/41,7.75%,CYP1A2;CYP2A6;CYP2E1;CYP24A1;CYP4F2;CYP21A2;ARNT2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7921656531622133,1.4689579571795341,0.04,0.9978572384776951,1.0,1/10,0.09%,GATA4
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.9542846661627423,1.468544654346068,0.0,0.9971238191262979,1.0,1/5,0.81%,IRGM
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.8479232343996781,1.4679392293457176,0.04,0.9975734596686797,1.0,1/7,0.38%,LGALS9
prerank,Reactome_2022__Defective Factor IX Causes Hemophilia B R-HSA-9668250,-0.9044192891509435,-1.4678054089400026,0.037037037037037035,0.4608179158365228,1.0,1/5,1.14%,F8
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,-0.7010083438936823,-1.4671721639363289,0.0,0.458401500850516,1.0,12/38,9.27%,P2RY10;TBC1D10C;CD24;SELL;TRAF3IP3;CD53;LTB;JCHAIN;TAGAP;TMC8;LY86;PAX5
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,-0.7010083438936823,-1.4671721639363289,0.0,0.458401500850516,1.0,12/38,9.27%,P2RY10;TBC1D10C;CD24;SELL;TRAF3IP3;CD53;LTB;JCHAIN;TAGAP;TMC8;LY86;PAX5
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,-0.7010083438936823,-1.4671721639363289,0.0,0.458401500850516,1.0,12/38,9.27%,P2RY10;TBC1D10C;CD24;SELL;TRAF3IP3;CD53;LTB;JCHAIN;TAGAP;TMC8;LY86;PAX5
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.8527565763595635,1.4671123698380863,0.0425531914893617,1.0,1.0,3/7,4.85%,ALDH1A1;GFAP;GLUL
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8758070933609082,1.467009988036144,0.0,0.9954857628801614,1.0,2/10,9.37%,SIRT1;LEPR
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.510221893648265,1.4662419364080232,0.02040816326530612,0.9965799163565309,1.0,62/348,13.34%,STK26;DACH1;MITF;IGF1;FGF10;FAM83H;FLT1;SEMA5A;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;ERBB4;IL4;FGF2;SNAI1;TMEFF2;PRR5L;BMP2;TCAF2;CXCL12;ABI3;SEMA6C;CASS4;NAV3;PDGFRA;TP53INP1;VSIR;F3;FER;DLC1;FOXO3;PDGFC;KANK1;ARID2;MAGI2;FGF17;PTPRT;TMIGD3;PLXNB1;CTNNA2;CORO1C;PTPRK;WASHC1;SINHCAF;AMOTL1;HAS2;PLXNB2;NTNG2;CARMIL1;BCAR1;FRMD5;PTEN;PPP3CA;FAM89B;FGF5;IGF1R;CPNE3;SEMA3E;MGAT5
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.7620998315093231,1.4661103710451715,0.021739130434782608,0.9926727275465819,1.0,5/18,11.92%,TNFSF14;CD40;ELF4;FLT3;MEF2C
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.7080984154147206,1.4660369729652722,0.06896551724137931,0.9881684628637913,1.0,10/29,17.08%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2;SC5D;SQLE
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.631456311386726,1.4658831983880587,0.0196078431372549,0.9844061452656861,1.0,5/67,6.55%,SGO1;ESPL1;NDC80;NDE1;EPS8
prerank,KEGG_2021_Human__Fatty acid degradation,0.6296480307998888,1.465821934967741,0.07142857142857142,0.9799252384409067,1.0,10/37,11.48%,ALDH7A1;ACADS;ALDH1B1;CYP2U1;ALDH9A1;ECI1;ACADM;ACAA2;CPT1C;ACSBG1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5822116174336371,1.4651769911340182,0.021739130434782608,0.981571223148179,1.0,42/128,20.67%,LRRC3B;LSAMP;GRM3;GRIN3A;LRRC4C;CDH20;PMP2;SLC1A3;GFAP;CADM2;HEPACAM;ZEB2;SEPTIN4;NRXN1;NTSR2;SYNPR;MAGI2;GRM5;LRRTM3;ADGRB3;CTNNA2;ATP1A2;ACSBG1;NPAS3;GPM6B;BAALC;GABRG1;SLC39A12;DLG2;GJB6;CNTN2;MAPK10;RFTN2;STMN4;TTC21B;PLP1;RBFOX1;KCNJ10;TRPM3;AMER2;DAO;ATP1B2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.7422692371562941,1.4648641966109002,0.04,0.9801436166099905,1.0,3/30,3.41%,IGF1;IRS1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.7189442329862114,1.464696645997967,0.10204081632653061,0.9774262606735112,1.0,12/33,12.26%,FGFR1;BRINP3;BMP2;ZEB1;ZC4H2;ADRA2C;NEUROD2;VWC2;TCF4;CPNE1;MEF2C;PROX1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.8148425998945159,1.4646209057173591,0.034482758620689655,0.973252776064536,1.0,4/11,10.19%,VEGFC;GAB1;PIK3CA;NUS1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9401405058760474,1.463793039381518,0.017857142857142856,0.9752680766928464,1.0,2/6,3.87%,GATA4;NPY
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7465406172565571,1.463369302143288,0.06521739130434782,0.9739599707015139,1.0,9/20,17.47%,HIF1A;BMP2;RBPJ;RELA;SMAD1;SMAD4;SMAD5;NFE2L2;VEGFA
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.7483203146014537,1.4633353288604782,0.018867924528301886,0.9696201700713883,1.0,4/27,2.54%,LGALS9;IRGM;CCL5;HIF1A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.61558054396849,1.4630313307210168,0.01818181818181818,0.9670793226265688,1.0,25/95,15.34%,DACH1;LRRC3B;PDZRN4;GPRIN3;GALNT8;MYCN;DPP10;ST6GALNAC3;PELI2;KCNH8;NRXN1;RAB3C;KHDRBS2;AUTS2;PPM1L;LRRC55;PAK5;RTN1;GRIK3;JAKMIP2;GPM6B;SEZ6L;MGAT4A;PPP2R2B;NELL2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.7456693371422498,1.4629103718250986,0.017857142857142856,0.9637788372598085,1.0,4/25,5.33%,ESPL1;FBXO5;DLGAP5;RIOK2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7664052859586383,1.4607250920250787,0.03773584905660377,0.9785148422930973,1.0,8/22,15.72%,SOX5;TGFBR1;GDF6;SOX6;WNT9A;LOXL2;GREM1;TRPS1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7557905358356811,-1.460394820994262,0.044444444444444446,0.4869949135014618,1.0,1/15,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.8248330037912822,1.4603310646540257,0.08,0.9773418113939206,1.0,1/12,0.43%,AASS
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),-0.9366626566643445,-1.46025778934623,0.046511627906976744,0.4859380658524291,1.0,1/5,3.93%,SLC17A9
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5900920446546176,1.460242390884395,0.0196078431372549,0.9735640177581926,1.0,13/108,6.94%,IGF1;IRS1;HGF;MYC;SIRT1;IL4;PRR16;FGF2;PRMT1;EIF3E;SAMD4A;TLR2;DYRK2
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.9454711344408594,1.4600771964751391,0.0,0.9704134118582113,1.0,1/6,1.94%,SIRT1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7586173330291817,1.4600448746901213,0.058823529411764705,0.96593766479366,1.0,5/14,19.73%,SOCS2;STAT5A;PXN;PRLR;LYN
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7639331926572374,-1.4600347228964405,0.08163265306122448,0.48491444016544566,1.0,9/22,9.93%,OR2M4;OR51M1;OR52A1;OR9G4;SLC24A4;DRD2;GNAL;SYT10;OR9Q1
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.7988587847106896,-1.4598615447340262,0.0847457627118644,0.4840770068933551,1.0,1/12,0.88%,APIP
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.8890289258815595,-1.459442083285588,0.020833333333333332,0.4841622185416845,1.0,3/10,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.6144147051017086,1.4594403449703321,0.038461538461538464,0.9668966953021352,1.0,22/104,11.63%,SMAD6;GREM2;ITGA8;ITGB8;MYC;TGFBR1;BMP2;ACVR2A;ZFYVE16;ITGAV;WWTR1;PPP1CC;UBE2D3;PPM1A;SMAD1;SMAD2;LTBP1;E2F4;CGN;BMPR1A;DAND5;SMAD4
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8766849651988989,-1.4592358153899978,0.0,0.4833333919652249,1.0,1/8,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6969330200557313,1.4584950441147047,0.11320754716981132,0.9707059822974232,1.0,5/22,11.34%,MYC;MRAP2;COQ10A;LEPR;SLC25A13
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.6111856487414604,1.4584680871149882,0.02040816326530612,0.9662907636695283,1.0,34/92,15.37%,PREX2;COL9A1;LSAMP;NYNRIN;ESRRG;HIF3A;LGR5;SLC35F1;MYCN;CNTNAP2;ROBO2;FREM1;LIN28A;UNC5D;NRXN1;MEGF10;RAB3C;TMEM200C;PCYT1B;IGDCC3;PTPRD;NLGN4X;MAGI2;VANGL2;SNCAIP;ATP1A2;PPP1R9A;GPM6B;SHROOM4;RUNX1T1;SEMA6D;FAT3;L1TD1;FRZB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7890380542200837,1.4581864770300306,0.018867924528301886,0.9641708133855867,1.0,6/13,11.92%,IGF1;ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.7333037088080951,1.4581054158393545,0.03773584905660377,0.960343711043381,1.0,4/17,9.33%,NPC2;PLA2G10;SLC29A2;SLC15A2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.8735169208758509,1.4578247807797793,0.05454545454545454,0.9588429532759692,1.0,1/7,0.48%,IGF1
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.897579101518211,1.4575761143397055,0.02564102564102564,0.9566143923183292,1.0,1/5,0.38%,LGALS9
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,-0.7587467830890511,-1.4575279162657362,0.07142857142857142,0.48979207246262896,1.0,7/14,11.85%,GNAL;HPCAL1;CCDC88C;GPR83;PCDH8;SERPINE2;LAMP5
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Heart,-0.8994762355454363,-1.4574027459298602,0.017857142857142856,0.488571342074642,1.0,3/7,8.66%,HRH2;TAGLN;CALD1
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.7330488789287524,1.4573355088360818,0.03571428571428571,0.9542355903777274,1.0,7/23,12.78%,ERBB4;NRG1;NRG3;NRG2;ERBIN;PIK3CA;SOS1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5848105784992499,1.4571272398642123,0.0196078431372549,0.952047677334049,1.0,20/85,10.31%,VEGFC;IL17RD;EFNA5;ROR1;GNG12;TENM3;CSRP2;ZNF462;FBLIM1;PDLIM4;WWTR1;CNN3;P3H2;ADGRL2;PCDH18;PTPN14;SERTAD4;GPR161;TNC;EFNB2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6619328294193314,-1.4569601154714718,0.0,0.48909149756954085,1.0,4/60,2.26%,SLC28A2;UGT2B15;RFX6;CLCA1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7339330952301474,1.456700269621613,0.0392156862745098,0.9517360707526378,1.0,9/35,7.44%,F2;RUNX1;CCL5;F2R;RAB27A;WNT4;ZBTB20;PLCG2;HDAC2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7949951567074371,1.4566336209565869,0.045454545454545456,0.9480662899957041,1.0,3/12,8.99%,ADRA1A;SLC8A1;MYH11
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.9051475922614224,1.4563003539073878,0.0,0.9467154681030552,1.0,3/8,2.43%,LGALS9;CCL5;IDO1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.9076587256147558,1.4559834043261852,0.0,0.9452099811163646,1.0,2/6,7.41%,F2R;ABCA1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.8150921612564476,1.4557734644983389,0.0784313725490196,0.9388811773579202,1.0,1/15,0.59%,FHDC1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.8150921612564476,1.4557734644983389,0.0784313725490196,0.9388811773579202,1.0,1/15,0.59%,FHDC1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.8562673128765026,-1.4554108182752334,0.08888888888888889,0.49466171102241524,1.0,2/5,2.61%,RAC2;NOXA1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.8145938404519125,-1.4551144546825499,0.08333333333333333,0.4942345694157632,1.0,1/8,2.60%,COL5A1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7901585372360114,1.4548521740947624,0.02,0.9432927753122756,1.0,5/14,14.05%,STK26;TNIK;RAPGEF6;RAP1A;ESPN
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.6092556902457872,-1.4547292349600929,0.02,0.4940588396297725,1.0,5/75,2.64%,CD44;SELP;GAB3;SP140L;TIE1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8138028386345825,-1.4544324709416783,0.05714285714285714,0.49390908455549704,1.0,2/21,0.33%,SLC28A2;ALB
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.8637585104275805,-1.454428431562119,0.10416666666666667,0.492230622995353,1.0,1/8,0.17%,TERT
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.9079163855081451,1.454075042238774,0.044444444444444446,0.9457565503339139,1.0,1/5,1.69%,BOK
prerank,Reactome_2022__Multifunctional Anion Exchangers R-HSA-427601,0.8953315438282767,1.4536927110442428,0.017857142857142856,0.9450482009046466,1.0,4/7,4.28%,SLC26A3;SLC26A7;SLC26A6;SLC5A12
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.8641662128112344,1.4533582288958034,0.01639344262295082,0.9431558979040697,1.0,1/8,0.70%,TIMELESS
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.8035253380909533,-1.4521007899728855,0.04878048780487805,0.5006941289746304,1.0,1/11,3.34%,EPAS1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7559195543584292,1.452061449813959,0.10204081632653061,0.9514595507768498,1.0,6/20,8.14%,CCL5;MRAP2;KLK14;BICD1;SNCA;ADA
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.836827014511238,1.4519888970037398,0.06349206349206349,0.9477862113280539,1.0,2/7,2.98%,SIRT1;SASH3
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,-0.7940937257545891,-1.451984006343288,0.03636363636363636,0.4995430201035374,1.0,1/13,0.33%,ALB
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.6742286071972804,-1.4515474349886643,0.07142857142857142,0.49966963917666113,1.0,3/45,5.43%,EPN1;PXDN;PTPN3
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8773271932653554,-1.4515391315899704,0.04,0.49801875762921477,1.0,3/10,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6357143178053601,1.4512674490548483,0.024390243902439025,0.9499117235897546,1.0,11/46,12.93%,LAMA4;ALDH1A1;RBPJ;MAP2K6;IL15;NOVA1;ARRDC3;BTN2A2;LNPEP;NR1H3;IL18R1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.7672830016554173,1.4511016050119354,0.05263157894736842,0.9473395035796498,1.0,1/16,0.40%,CSTA
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.9040864946467596,1.451033977194983,0.02040816326530612,0.9436768218010191,1.0,1/8,2.20%,SHMT2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6475837202630402,1.4507790400982958,0.05,0.9418377623029823,1.0,10/41,12.93%,LAMA4;ALDH1A1;RBPJ;MAP2K6;IL15;NOVA1;ARRDC3;LNPEP;NR1H3;IL18R1
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.9264110197993711,1.4507304190076187,0.03508771929824561,0.9381760120443088,1.0,1/5,0.53%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.8716087400384659,1.4502448090357425,0.03636363636363636,0.9384146164071798,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8910229014061093,-1.4501849345982403,0.061224489795918366,0.5021760192623557,1.0,2/6,1.23%,TAFA3;NUPR1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.7810749589459822,1.4501482204308225,0.01639344262295082,0.9354743234501112,1.0,6/13,14.59%,ABHD3;CYP4Z1;ACADM;GLYATL2;OXSM;OLAH
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Skeletal Muscle,-0.9954476615170373,-1.4497584193904522,0.0,0.5008421562695652,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Stem cell:Deciduous Tooth,-0.9954476615170373,-1.4497584193904522,0.0,0.5008421562695652,1.0,1/5,0.01%,CD44
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,-0.795450768605111,-1.4486046250892195,0.10638297872340426,0.5038195820205434,1.0,2/16,4.79%,UGT2B15;CRYL1
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Undefined,-0.958046823650841,-1.448592030409212,0.022222222222222223,0.502278149949178,1.0,2/5,1.10%,CD44;SELL
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.6519025702783597,1.448549437159048,0.047619047619047616,0.9445393734401099,1.0,13/45,17.57%,CSTA;F2;TM4SF20;HDAC2;RNF139;SPOP;SPOPL;DNAJC1;KNG1;PLAUR;ASPH;FADD;PERP
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.8355031270839202,-1.4477818004262268,0.06,0.5042530578273431,1.0,3/12,8.60%,TAFA3;SPACA3;TTBK1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8547708809812382,1.4474792382340844,0.04,0.9485196960355475,1.0,2/11,1.13%,IGF1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6742696461385057,1.4472035926998132,0.08163265306122448,0.94752899622511,1.0,11/32,25.08%,MYC;ACD;PARM1;GREM1;NEK7;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1
prerank,KEGG_2021_Human__Melanoma,0.6543660714222754,1.4471856739871853,0.03773584905660377,0.9437284862406349,1.0,14/64,13.08%,MITF;IGF1;FGF10;HGF;FGFR1;FGF2;CDKN2A;PDGFRA;PDGFC;FGF17;PIK3CA;PTEN;FGF5;IGF1R
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.7847724331706827,-1.4467919202792041,0.14583333333333334,0.5069755325223939,1.0,3/13,11.35%,NTRK1;CLTA;DNM1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8301265882092965,-1.446791174610568,0.1111111111111111,0.5052968055935118,1.0,2/7,0.56%,SELP;SELE
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryonic Stem Cell,-0.9889785074758375,-1.446749733892833,0.02631578947368421,0.5020195583995657,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Foreskin,-0.9889785074758375,-1.446749733892833,0.02631578947368421,0.5020195583995657,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.9325717145170529,-1.446500263871363,0.05555555555555555,0.5013119837312022,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.8218137181993551,-1.4464038890865756,0.06666666666666667,0.5000712221697707,1.0,4/11,4.93%,DRD4;NMUR2;ABCC4;DRD2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7842509525601665,1.44630148927549,0.043478260869565216,0.9472555359577693,1.0,4/16,11.92%,IGF1;SIX4;ADGRB3;MEF2C
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.7593558229556877,1.4462717131793321,0.04918032786885246,0.943537598635716,1.0,5/19,12.91%,RNF185;AUP1;KLHL15;RNF5;POMT2
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.835591669261285,1.4462316575591756,0.1,0.9400013741440918,1.0,3/9,7.98%,TMEM100;F2R;SPX
prerank,Reactome_2022__Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,-0.9300325121830286,-1.4461775282868425,0.04,0.4993512965354554,1.0,1/5,4.09%,RNASE1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8763273778877748,-1.4461460714216023,0.06521739130434782,0.49789264500383384,1.0,3/8,3.86%,SIGIRR;AHSG;IL6R
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7038365061439258,-1.4461017372817362,0.03508771929824561,0.4965592150373639,1.0,8/36,16.44%,NARS1;WARS1;SARS1;DARS2;SARS2;CARS1;PPA1;GARS1
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.6589677097924231,1.445567059260891,0.08928571428571429,0.9420389970678732,1.0,12/34,23.60%,CCNG1;CCNA2;CDKN2A;CHEK2;RICTOR;SGK1;TP53;MLST8;AKT3;AKT2;MDM4;PPP2R1B
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8717189817007547,1.4454030159237614,0.04411764705882353,0.9397420395547877,1.0,3/6,9.16%,ARHGAP24;ABI3;KANK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7715105123063742,1.4448856976798308,0.0,0.940264098539736,1.0,8/25,15.78%,GATA4;SIRT1;HTRA2;PYCR1;FBXO7;HSPB1;GPR37;NFE2L2
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,0.586422737804292,1.4442679032244525,0.02127659574468085,0.9417783578524125,1.0,16/83,6.66%,MXRA5;IGF1;FGF10;FLT1;SCN7A;HGF;PRRX1;ITGA11;ANGPT1;ZEB2;CPED1;FREM1;CXCL12;ZEB1;FAM20A;PDGFRA
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.5909198282125852,-1.4439711872091048,0.017543859649122806,0.5040283989265684,1.0,8/106,5.72%,CD44;XYLT2;CHST9;AGRN;GPC2;GPC1;XYLT1;GPC3
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.669620158887003,1.4435289879950894,0.1016949152542373,0.9434791748089931,1.0,10/25,21.43%,SIRT1;KAT2B;AANAT;FOXO1;ESCO1;KAT6A;NAA16;GTF2B;NAA11;NAA50
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,-0.6351465081099409,-1.4434506926550723,0.019230769230769232,0.5027009228611368,1.0,14/62,9.57%,MPL;EHF;DUOXA1;CLDN4;TMEM184A;ALS2CL;C6ORF132;STXBP2;LAMB3;F11R;MALL;ABCC3;VDR;DYTN
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,-0.6351465081099409,-1.4434506926550723,0.019230769230769232,0.5027009228611368,1.0,14/62,9.57%,MPL;EHF;DUOXA1;CLDN4;TMEM184A;ALS2CL;C6ORF132;STXBP2;LAMB3;F11R;MALL;ABCC3;VDR;DYTN
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8915033128879033,1.4432684115588632,0.03773584905660377,0.9418057080129363,1.0,4/7,5.20%,IGF1;SIRT1;CDKN2A;DIPK2A
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,0.9482461535473754,1.4431415169193627,0.0,0.9392591287668619,1.0,2/6,3.96%,FLT1;APOLD1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.822912049092709,-1.4421714133103822,0.1276595744680851,0.5063755480860808,1.0,3/7,6.12%,RAC2;NOXA1;JCHAIN
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7325310748421672,1.4418182739058452,0.06521739130434782,0.9458539954613469,1.0,2/12,3.79%,GATA4;BMP2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6060088672817827,-1.4416891132991836,0.0,0.5066314509053124,1.0,15/70,10.63%,ANXA8;CLDN4;TMEM184A;C6ORF132;PTGES;PHLDA2;CYP24A1;IER3;LAMB3;MALL;ABCC3;ADAM19;VDR;PARP1;SERPINB5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6559069000192428,1.4412692253538302,0.057692307692307696,0.9467310312313254,1.0,10/50,9.98%,LGALS9;SYK;F2R;SSC5D;CD244;RELA;TLR2;F3;HMGB1;C5AR2
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.6037972143056618,1.4412264959165397,0.04081632653061224,0.9288281868356293,1.0,38/99,19.27%,IL17RD;LSAMP;MMP16;TENM3;NLGN1;ZNF462;ZDHHC22;MEGF10;ADGRL2;LIFR;NOVA1;PTPRD;STOX2;FAM171B;PRICKLE2;ANK2;GFRA1;GUCY1A2;ADGRB3;ATP1A2;NPAS3;CNTN1;GPM6B;LRFN5;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10;CDR1;CSRNP3;MPDZ;PLP1;DZIP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.6037972143056618,1.4412264959165397,0.04081632653061224,0.9288281868356293,1.0,38/99,19.27%,IL17RD;LSAMP;MMP16;TENM3;NLGN1;ZNF462;ZDHHC22;MEGF10;ADGRL2;LIFR;NOVA1;PTPRD;STOX2;FAM171B;PRICKLE2;ANK2;GFRA1;GUCY1A2;ADGRB3;ATP1A2;NPAS3;CNTN1;GPM6B;LRFN5;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10;CDR1;CSRNP3;MPDZ;PLP1;DZIP1
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.6037972143056618,1.4412264959165397,0.04081632653061224,0.9288281868356293,1.0,38/99,19.27%,IL17RD;LSAMP;MMP16;TENM3;NLGN1;ZNF462;ZDHHC22;MEGF10;ADGRL2;LIFR;NOVA1;PTPRD;STOX2;FAM171B;PRICKLE2;ANK2;GFRA1;GUCY1A2;ADGRB3;ATP1A2;NPAS3;CNTN1;GPM6B;LRFN5;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10;CDR1;CSRNP3;MPDZ;PLP1;DZIP1
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.6037972143056618,1.4412264959165397,0.04081632653061224,0.9288281868356293,1.0,38/99,19.27%,IL17RD;LSAMP;MMP16;TENM3;NLGN1;ZNF462;ZDHHC22;MEGF10;ADGRL2;LIFR;NOVA1;PTPRD;STOX2;FAM171B;PRICKLE2;ANK2;GFRA1;GUCY1A2;ADGRB3;ATP1A2;NPAS3;CNTN1;GPM6B;LRFN5;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10;CDR1;CSRNP3;MPDZ;PLP1;DZIP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.6037972143056618,1.4412264959165397,0.04081632653061224,0.9288281868356293,1.0,38/99,19.27%,IL17RD;LSAMP;MMP16;TENM3;NLGN1;ZNF462;ZDHHC22;MEGF10;ADGRL2;LIFR;NOVA1;PTPRD;STOX2;FAM171B;PRICKLE2;ANK2;GFRA1;GUCY1A2;ADGRB3;ATP1A2;NPAS3;CNTN1;GPM6B;LRFN5;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10;CDR1;CSRNP3;MPDZ;PLP1;DZIP1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8272649123100955,-1.440948472999838,0.058823529411764705,0.5084984955481484,1.0,4/10,8.80%,CGA;DUOX1;TG;CPQ
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5737854352330007,1.4402491662134242,0.037037037037037035,0.9335212955506915,1.0,26/123,16.17%,IRGM;RIT2;CDK11A;URI1;SOCS2;CD22;NEDD4;GFAP;MLLT3;ZFYVE16;NRG3;CHPT1;ABL2;LATS1;HIP1;PAK5;SNCAIP;BCAR1;HSPA8;PICALM;STON2;RAP1A;RAB33B;HCFC1;SGK1;BAP1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.666014783860076,-1.4396444827033197,0.018518518518518517,0.5129350413671809,1.0,1/38,0.17%,TERT
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5825883792999121,-1.4395693981564475,0.06818181818181818,0.511632953695966,1.0,4/116,1.08%,CYP1A2;ACOT1;AMACR;LDHC
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.8314720500313584,1.4394836112560518,0.06521739130434782,0.9357533976254246,1.0,3/14,3.24%,CTDNEP1;C3;LDLR
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.5693518479095391,1.4394828180482495,0.02,0.9322829094390291,1.0,26/109,9.16%,PCDH15;LHFPL3;SEMA5A;COL9A1;NXPH1;LSAMP;ITGB8;SLC35F1;LRRC4C;PMP2;CADM2;BRINP3;OLIG1;OLIG2;CSRP2;RAB31;SOX6;GPR17;ANXA5;SYT1;PDGFRA;NOVA1;NEUROD2;SCD5;ALCAM;KANK1
prerank,Reactome_2022__Response To Metal Ions R-HSA-5660526,0.8878433806001127,1.4392326708061098,0.044444444444444446,0.9305377711326563,1.0,1/9,0.15%,MT4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.708631837535727,1.4390044369338264,0.0392156862745098,0.9288997125154673,1.0,5/21,6.19%,GATA4;C3;HIF1A;RORA;HPSE
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.811885364669024,1.4388819303552052,0.06896551724137931,0.9265241798333201,1.0,1/10,0.53%,FGF10
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.6741461276681727,-1.4386031253772382,0.0625,0.5149967063482788,1.0,14/46,8.25%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;GPR132;LTB;CD5;TAGAP;CD72;TNFRSF4;TMC8
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.6723108477806772,-1.4379570519337963,0.061224489795918366,0.5163206521180237,1.0,8/57,2.28%,MS4A8;EHF;CAPN8;CLDN4;PGC;TMEM184A;GPR39;FAM3D
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.7604634347323744,1.4376888769867007,0.03773584905660377,0.9322885250514131,1.0,3/15,5.23%,IGF1;CCL5;CCN4
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.8260209908101488,1.437094113713444,0.08,0.9338711589987498,1.0,2/11,7.89%,MT4;SNCA
prerank,Reactome_2022__RUNX1 And FOXP3 Control Development Of Regulatory T Lymphocytes (Tregs) R-HSA-8877330,0.9451031978534215,1.4368893137679783,0.0,0.932059588199302,1.0,3/7,4.16%,TNFRSF18;RUNX1;IL2RA
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9715736733197538,-1.4368032180221457,0.0,0.5190450095490957,1.0,1/5,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6298725156122167,1.4367858300451721,0.09090909090909091,0.9296611204072666,1.0,6/34,6.54%,NEDD4;EHD1;PRR5L;MLC1;TENM1;PCM1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.8363805727848236,1.4365423534152408,0.05454545454545454,0.9287061076406181,1.0,3/11,6.66%,F2;LDLR;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.9024127531164535,1.4362935417372336,0.0,0.9239856132444805,1.0,1/7,1.92%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.9024127531164535,1.4362935417372336,0.0,0.9239856132444805,1.0,1/7,1.92%,NDC80
prerank,CellMarker_Augmented_2021__Idiopathic Pulmonary Fibrosis cell:Lung,-0.7946985102923322,-1.4359534965961316,0.15217391304347827,0.521150550837076,1.0,3/10,9.97%,MUC5B;SPDEF;COL1A1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.6462840683684037,1.4354723361528092,0.07407407407407407,0.9281119488185365,1.0,13/43,25.08%,MYC;ACD;PARM1;GREM1;TERF1;NEK7;CTNNB1;TP53;POT1;MAPK3;MAPK15;NAF1;HMBOX1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.6346053282732304,-1.4354007052232651,0.08695652173913043,0.5221763957771232,1.0,4/68,2.39%,CD44;GAB3;CD53;CYTH4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5906156354182496,1.4352980655956638,0.0,0.9264962026777568,1.0,14/81,13.04%,LGALS9;IGF1;SYK;FZD5;IL4;MAPKAPK2;TLR2;PLCG2;VSIR;HMGB1;C5AR2;HLA-E;CD34;HSPB1
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.682785855164906,1.4351516690617643,0.03389830508474576,0.9240789073308296,1.0,11/40,14.36%,SCD;NRIP1;MOV10;HDAC3;ABCA1;ABCG8;KDM3A;TBL1X;NR1H3;FASN;ABCG5
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.9014494492381118,1.4348114851897347,0.05660377358490566,0.9241995863880891,1.0,2/7,2.43%,CCL5;IDO1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8572168425802349,1.4343893698045749,0.018867924528301886,0.9242745540640005,1.0,2/7,7.89%,ACE2;SNCA
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.782925300322284,1.4343865040065387,0.10869565217391304,0.9210416781277602,1.0,1/10,0.93%,F2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.8942021538519325,1.4343047864959004,0.0,0.9186332879606688,1.0,1/8,2.09%,SAMD9
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.6096161022169408,1.4341521131974706,0.05555555555555555,0.916730023571116,1.0,23/95,9.35%,VEGFC;GATA4;FLT1;SEMA5A;RUNX1;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PIK3R6;RRAS;SP1;APELA;GAB1;F3;ANXA3;BMPER;CD40;AGGF1;SMAD1;TMIGD2
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.7025428762076896,1.4337705945873467,0.06896551724137931,0.9167859251139364,1.0,5/27,8.59%,ERBB4;NRG1;NRG3;NRG2;ERBIN
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.752881117904283,1.4333839431089654,0.06382978723404255,0.9160482059438818,1.0,3/18,7.42%,GATA4;PAX6;DPP4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8227632786754464,-1.433185637414315,0.06,0.5314365894986646,1.0,3/12,3.41%,SELP;SELE;ALOX5
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.8741679342881237,-1.4331177949977134,0.07017543859649122,0.5302159500562633,1.0,2/6,9.92%,DBH;LRTOMT
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8351350974315341,-1.4328356585084199,0.04878048780487805,0.5301476593793946,1.0,2/10,1.92%,DDX11;KDM4D
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.6432957496676038,1.432580224756986,0.0392156862745098,0.9195753607202837,1.0,14/32,26.29%,RAB31;RAB34;GGA1;GOLPH3L;GORASP2;MACF1;BLZF1;AFDN;VAMP4;GCC2;GOLGA4;RILPL2;ARFRP1;SPTBN1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.6326272805227623,1.4317420124528528,0.05454545454545454,0.9230780213662936,1.0,21/69,13.00%,CGNL1;AASS;PREX2;PCDH11X;COL9A1;IL17RD;MYCN;FRAS1;PRDM14;SYT6;LIN28A;UNC5D;APELA;IGDCC3;NLGN4X;VANGL2;BMPR1A;CHST6;VASH2;CLDN6;TERF1
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.6058985388852763,1.4317009190863261,0.058823529411764705,0.9043254327672825,1.0,34/97,17.87%,FGFR3;NYNRIN;PRKG1;LGR5;LRP4;FRAS1;ALDH7A1;FREM1;LRIG3;CNN3;ADGRL2;NEO1;LIFR;PTPRD;PCDH18;ANK2;MAGI1;GUCY1A2;TSPAN6;EFNB2;ZNF704;PROX1;KHDRBS3;ID4;SEMA6D;LRP6;FRZB;CPE;PDZRN3;RNF128;FLRT3;CCDC3;CSRNP3;FARP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6343390394016509,1.431682137509456,0.08888888888888889,0.901388094419369,1.0,18/47,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;GABRG1;GABRB2;ANO5;ANO6;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6450319511778362,-1.4311071129886535,0.04081632653061224,0.5365765628344702,1.0,6/38,7.59%,H1-3;H1-4;H1-2;ERN2;INCENP;NCAPD3
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Breast,-0.9482579902464479,-1.430970042583897,0.0,0.5357015064465364,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6573697623573234,1.4305595585439226,0.057692307692307696,0.9077529398766704,1.0,9/33,16.69%,LRRC4C;NLGN1;NRG3;CEL;GRIK2;NLGN4X;GRIK3;PXK;GRID2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.7302989919876668,1.4302920578902214,0.0851063829787234,0.906563723789366,1.0,3/16,6.56%,SLC1A3;SLC26A6;ABCC2
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.7218021870570411,1.4301588080990968,0.06779661016949153,0.9045366138473283,1.0,12/27,14.03%,ERBB4;STAT5A;NRG1;GFAP;CXCL12;NRG3;ESR1;NRG2;TAB2;ADAP1;MXD4;WWOX
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.5363822182700877,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.5363822182700877,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.5363822182700877,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7936353051315513,1.4292236131242286,0.041666666666666664,0.908677300113804,1.0,3/13,9.73%,STK26;TNIK;RAPGEF6
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6352865363531283,1.428937643358867,0.08163265306122448,0.9092193787926305,1.0,9/54,6.66%,GATA4;IGF1;FGF10;TGFBR1;FGF2;NRG1;HPSE;MYOF;PDGFRA
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.6649599902089975,1.4286752158189093,0.0425531914893617,0.9077061165427985,1.0,9/31,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,CellMarker_Augmented_2021__Epithelial cell:Ovary,-0.8902043593103546,-1.4284434115905182,0.07272727272727272,0.5411819817731204,1.0,2/6,1.04%,CLDN4;CD24
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.8609725377055933,-1.428356768478263,0.08695652173913043,0.5398967460262721,1.0,1/10,0.60%,HK2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8208874446515056,1.4283163774492287,0.058823529411764705,0.907663551067962,1.0,1/11,0.61%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.870491857156117,1.426528723980931,0.018867924528301886,0.9182282061945611,1.0,4/8,9.95%,LGALS9;ST18;HTRA2;GSN
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),-0.9227425111479408,-1.4261368058961663,0.020833333333333332,0.5486537441190619,1.0,1/6,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.7352992894234173,-1.4260400605133805,0.1,0.547332410998064,1.0,2/11,7.24%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.75420235344833,1.4259181774333354,0.03773584905660377,0.9205144723770289,1.0,4/25,2.81%,DACH1;HGF;MYC;FGF2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.8950912879398261,-1.4257528525257408,0.020833333333333332,0.5473005005429317,1.0,1/7,0.12%,ANXA8
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.6586944200312125,-1.4257099959293336,0.12244897959183673,0.5459697646770064,1.0,8/56,5.63%,SLC28A2;UGT2B15;ALB;CYP2E1;ABCC4;RNASE1;XDH;VAV3
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.8331168012582434,1.4256363679929374,0.08695652173913043,0.9196038693274551,1.0,3/10,7.89%,FGFR3;FGFR1;SNCA
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.8056795864946503,1.4255458781392896,0.05263157894736842,0.917875457144594,1.0,5/13,12.78%,ERBB4;NRG1;NRG3;NRG2;SOS1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7234418502616189,-1.4253317373280612,0.09090909090909091,0.5441998578323095,1.0,3/22,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7234418502616189,-1.4253317373280612,0.09090909090909091,0.5441998578323095,1.0,3/22,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8112381626564594,1.4246160267854209,0.10909090909090909,0.9223574403071674,1.0,5/9,17.62%,POGLUT2;GALNT3;GALNT1;POGLUT3;GALNT16
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.8944541819506758,-1.4242128303516763,0.022222222222222223,0.5475546651741714,1.0,1/5,6.91%,PRKD2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.6750793199397657,1.424175640511113,0.04081632653061224,0.922513658304247,1.0,10/40,14.30%,SEMA5A;ERBB4;NRTN;NRG1;CDH2;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7229612592245248,-1.4233742218592655,0.06896551724137931,0.5495218263334588,1.0,3/23,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7837263467168453,-1.422683048175201,0.06382978723404255,0.5506171433901627,1.0,3/10,8.13%,RAC2;BST1;OLFM4
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.7941422023218654,1.4225000807771628,0.09259259259259259,0.9338448197839545,1.0,3/10,9.81%,LGALS9;SCRIB;BTN2A2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8834978792297007,1.4220146270823433,0.08333333333333333,0.9346947923143428,1.0,3/6,8.07%,NOX5;SLC39A8;CYBRD1
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.6677878132716983,1.4219250778337564,0.08196721311475409,0.9323377564570879,1.0,4/26,7.73%,SYK;STAT5A;CSF3R;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.9102256679754853,1.421265682721604,0.0,0.9343181977038392,1.0,3/6,6.82%,LGALS9;ZBTB7B;VSIR
prerank,CellMarker_Augmented_2021__Central Memory T cell:Peripheral Blood,-0.8636597776735269,-1.420917894670876,0.09523809523809523,0.553740085265615,1.0,1/5,1.10%,SELL
prerank,CellMarker_Augmented_2021__Effector T cell:Peripheral Blood,-0.8636597776735269,-1.420917894670876,0.09523809523809523,0.553740085265615,1.0,1/5,1.10%,SELL
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Peripheral Blood,-0.8636597776735269,-1.420917894670876,0.09523809523809523,0.553740085265615,1.0,1/5,1.10%,SELL
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6819505546352893,1.4209036813329583,0.03571428571428571,0.9343934400222406,1.0,16/29,26.67%,THRSP;PPARG;PRKAB2;SPX;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1;ACSL1;APOE;CPT2;SLC27A1;SLC27A6;CD36
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6090325815616155,1.4208533366685978,0.05454545454545454,0.9316986353734747,1.0,24/53,27.98%,FAIM;RELA;TIFA;TLR2;TICAM1;TAB2;ZNF675;TANK;TAB3;BCL3;BIRC3;ERC1;TICAM2;RIPK2;IKBKB;IRAK1BP1;TAB1;TBKBP1;BCL10;REL;TRAF6;CHUK;NFKBIA;TRADD
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.6207132249845007,1.4207494495832451,0.06896551724137931,0.9295010754543236,1.0,21/94,14.99%,RUNX1;MYC;ERBB4;KAT2B;NRIP1;PRMT1;H2BC21;CXCL12;NR5A2;MOV10;ESR1;KCTD6;KANK1;NCOA2;DAND5;H2AC6;MYB;H2AZ2;POU2F1;NCOA3;H2AX
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.5150009246182586,-1.4205784456895592,0.0,0.5539186646178297,1.0,16/375,4.09%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;SFTPA2;STK10;ALOX5;PRKCD;AHSG;CRACR2A;RNASE1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8720860598864559,1.4201181844165638,0.08620689655172414,0.931266001561184,1.0,1/6,1.34%,UHRF2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6116964444523549,1.4199773362765677,0.03508771929824561,0.9295607767656345,1.0,17/49,22.25%,REP15;SYK;NEDD4;RAB31;SNCA;RAMP3;PICALM;DNM3;CALCRL;CD81;ARRB2;SMURF1;MVB12A;LGMN;ITGB2;GRB2;MX2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8507366776831651,-1.4196554410221829,0.07692307692307693,0.5564123562186913,1.0,3/6,12.94%,APIP;BHMT2;BHMT
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.616550423050893,1.4189363385263885,0.05405405405405406,0.9348814546034949,1.0,20/83,7.90%,VEGFC;GATA4;FLT1;SEMA5A;RUNX1;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PIK3R6;RRAS;SP1;APELA;GAB1;F3;ANXA3;CD40;AGGF1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7870755532877952,1.4188376141132997,0.034482758620689655,0.9328990204544625,1.0,3/11,3.79%,TGFBR1;GDF6;BMP2
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.9121089527629189,-1.4186889707937635,0.021739130434782608,0.5589122952227575,1.0,2/5,4.05%,SLCO2A1;ABCC4
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8687304363640465,1.4184848512074075,0.10909090909090909,0.9331345960266063,1.0,1/6,0.92%,SMYD1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.80346602872181,1.4184326435951644,0.09803921568627451,0.9306987950437541,1.0,3/14,10.39%,MT4;SNCA;LOXL2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.8117462637475749,1.4183457303756524,0.04878048780487805,0.9282781232595533,1.0,5/15,7.05%,F2;F2R;F12;HPSE;F3
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.8741455392478663,1.4182873935935483,0.06382978723404255,0.9258334199073157,1.0,2/8,2.55%,IRS1;STAT5A
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7820231424559064,1.4179831050816818,0.038461538461538464,0.9255821969537905,1.0,5/19,6.46%,RGPD4;CBLB;RGPD3;RGPD2;RGPD5
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.8803037374798544,1.4178961657965805,0.06666666666666667,0.9234710740734431,1.0,1/6,2.49%,KLKB1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6597382263486099,1.4172703342470523,0.05172413793103448,0.9260895650923591,1.0,4/31,7.07%,SMOC1;C3;PBX3;PAX6
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,0.5900832164673339,1.4172085472075195,0.07272727272727272,0.923604373334885,1.0,17/81,10.39%,VEGFC;GNG12;EVA1A;DOCK1;CRIM1;LAPTM4A;FBLIM1;LTBP2;ANXA5;MYOF;TEAD2;FAM114A1;CUEDC1;NECTIN2;EXT1;MPZL1;LOXL2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.8217533571582827,-1.4171395072495383,0.0625,0.5638446271679852,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8292242550576913,1.4171260541540478,0.05263157894736842,0.9212880368935449,1.0,2/12,2.87%,IRS1;PPARG
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.891620523531963,1.4169103435080022,0.01818181818181818,0.9202882750248108,1.0,1/7,0.19%,TEX101
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.8285601350936339,1.4168257792859709,0.058823529411764705,0.9178814481321372,1.0,1/10,1.43%,CD99
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.855562075396134,1.416781009826207,0.0784313725490196,0.9154891640001446,1.0,1/6,2.55%,STAT5A
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6216615581185877,1.416506805545385,0.06,0.9148575648389343,1.0,8/49,12.35%,LRRC4C;LRP4;CDH2;ROBO2;CHODL;PLXNB1;PLXNB2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.578373579259,-1.416230316886251,0.04081632653061224,0.5661859313822527,1.0,9/99,4.67%,CD44;TNFSF18;IL11;ENPP2;IL31RA;TEC;ANGPT4;IL6R;CRLF1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7422597452323874,1.4161892233960356,0.13333333333333333,0.9151381223125125,1.0,8/14,16.70%,CDH2;SLC8A1;PIK3CA;GSN;NPPA;DMD;RYR2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.786986367355198,1.4160513014706055,0.08888888888888889,0.9138698586580618,1.0,2/12,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.7983136793723438,1.415839864827562,0.11538461538461539,0.9103056839107306,1.0,3/10,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.7983136793723438,1.415839864827562,0.11538461538461539,0.9103056839107306,1.0,3/10,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.7722758873476672,-1.4153570426005864,0.14285714285714285,0.5686774048778951,1.0,5/12,9.92%,DRD4;DRD2;PAH;DBH;LRTOMT
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.760336340686186,1.414807698762943,0.12698412698412698,0.9135329217284871,1.0,5/12,22.25%,STAT5A;IL15;PLCB1;IL2RB;GRB2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.760336340686186,1.414807698762943,0.12698412698412698,0.9135329217284871,1.0,5/12,22.25%,STAT5A;IL15;PLCB1;IL2RB;GRB2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.828139283637751,1.4146652928887564,0.06779661016949153,0.9119906704589987,1.0,2/8,7.89%,DRD5;SNCA
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.618003772009409,1.414661360053018,0.021739130434782608,0.909345414193073,1.0,18/55,12.83%,SLC26A3;CD99;TMPRSS2;ACE2;HNF4G;GOLT1A;EFNA2;FLI1;PPP1R14D;APOBEC1;AGR2;MOGAT2;DSP;MUC13;CGN;ARHGEF16;HSD11B2;BCO1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6589090519631574,1.414432992201029,0.03773584905660377,0.9081201726902369,1.0,2/25,2.60%,DACH1;ACD
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5807269084550194,-1.4144256952992786,0.058823529411764705,0.571480846370199,1.0,6/118,2.64%,CD44;SELP;MPL;TEK;HMGB3;TIE1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.7432934518599775,1.4143727200794853,0.03773584905660377,0.9058333751105654,1.0,7/22,12.78%,ERBB4;NRG1;NRG3;NRG2;ERBIN;PIK3CA;SOS1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6609477316625518,1.414195851771856,0.06382978723404255,0.9043683019511065,1.0,17/60,16.62%,FGFR1;BRINP3;BMP2;NLGN1;ZEB1;MOSMO;ZC4H2;ADRA2C;NEUROD2;BIN1;VWC2;TCF4;CPNE1;MEF2C;NREP;GPRC5B;CNTN4
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,0.8524557877122481,1.413835607635901,0.0851063829787234,0.9044139127687798,1.0,5/10,10.07%,SLC1A3;GFAP;CDH2;PAX6;TNC
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.867895429514531,-1.4137784867577141,0.022727272727272728,0.57357722884304,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,0.7540655533045998,1.4137339795110817,0.018518518518518517,0.9023769351686038,1.0,2/16,1.66%,STAB1;ITGAX
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.701680436500776,1.4134309890330015,0.02040816326530612,0.9021001999884415,1.0,8/21,15.26%,TMTC2;DPY19L1;DPY19L3;POMT2;FKRP;CRPPA;SDF2L1;TMTC3
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.849776323427964,1.4133548293379576,0.04,0.9001905949764888,1.0,4/9,10.39%,SOX5;GDF6;SOX6;LOXL2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8238606135781555,1.4127243560429472,0.038461538461538464,0.9023482764443653,1.0,4/10,6.92%,SULT2A1;ALDH1A1;ALDH1B1;ACSS2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.8239141088715132,1.4125186231883593,0.043478260869565216,0.9014600761739804,1.0,4/18,6.82%,TNFRSF18;RUNX1;IL2RA;VSIR
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7663063522758543,1.4122338908288636,0.10869565217391304,0.9013691738507794,1.0,6/18,12.19%,F2;C3;MRAP2;KLK14;KLK5;PDE6H
prerank,CellMarker_Augmented_2021__Monocyte Derived Dendritic cell:Peripheral Blood,0.844068319980271,1.412206781999836,0.09433962264150944,0.8990525231569305,1.0,1/7,1.66%,ITGAX
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.8812516831277772,1.4118495655493555,0.11764705882352941,0.8989331714519659,1.0,1/6,0.15%,STK26
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.8793296128453499,1.4116449936071924,0.05454545454545454,0.8979933021333811,1.0,2/6,10.05%,MME;HYAL3
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.5741116475089729,1.4113702759553877,0.047619047619047616,0.8975571878974424,1.0,26/95,12.58%,PDZRN4;LSAMP;LRRC4C;NDRG2;VCAN;PCDH17;SLC8A1;PARM1;NRXN1;MEGF10;TMEM200C;PDGFRA;PTPRD;SCN3A;CYP7B1;AUTS2;PTPRT;VANGL2;ADGRB3;CADM1;TCF4;RTN1;ZNF536;PROX1;BAALC;UBE2QL1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6694200763625264,1.41131078606982,0.0784313725490196,0.8954548929471148,1.0,7/34,12.35%,IGF1;PRKG1;FGF2;PPARG;BMPR1A;MEF2C;PTEN
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8964828918282616,1.4111711459363139,0.0392156862745098,0.8940724726900054,1.0,1/5,3.25%,TOX
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.7671492258075729,-1.4111009982204594,0.10869565217391304,0.5840331526700435,1.0,8/17,9.93%,OR2M4;OR51M1;OR52A1;OR9G4;SLC24A4;DRD2;SYT10;OR9Q1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5837415321527472,1.4110870806111315,0.02127659574468085,0.8921682365781354,1.0,23/61,15.60%,SMAD6;VWC2L;PPARG;BMP2;CRIM1;ACVR2A;RBPJ;ELAPOR2;BMPER;UBE2D3;SMAD1;SMAD2;VWC2;BMPR1A;DAND5;SMAD4;GREM1;FBXL15;LRP2;SPART;BAMBI;CRB2;SMAD5
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.9285233184633008,1.4109115389458136,0.0,0.8884969120892249,1.0,1/6,1.86%,RAB38
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.9285233184633008,1.4109115389458136,0.0,0.8884969120892249,1.0,1/6,1.86%,RAB38
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,0.6405906809515104,1.4108238200487617,0.10204081632653061,0.8865890224464995,1.0,7/35,9.52%,LGALS9;SYK;STAT5A;CSF2RA;IL2RA;IL15;PIK3CA
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.8280246329528148,-1.4107407407277552,0.08163265306122448,0.5837780053908808,1.0,1/8,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8680030161156956,1.4105153431035233,0.07547169811320754,0.8860882169618232,1.0,1/6,0.26%,DACH1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7681871742465639,1.4104883743926273,0.07692307692307693,0.8837797250922519,1.0,4/12,7.41%,SYK;PPARG;LDLR;ABCA1
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.6193242659578571,1.41047560302923,0.038461538461538464,0.881518672682139,1.0,13/47,14.63%,VAPB;ADD3;ARHGAP5;MOSPD2;SLC4A7;LMAN1;PLXNB1;PGRMC2;VRK2;VAMP3;DBN1;RACGAP1;LMNB1
prerank,Reactome_2022__Transcriptional Regulation Of Testis Differentiation R-HSA-9690406,0.9190705711810343,1.4103619511701446,0.0196078431372549,0.8799971709471627,1.0,2/7,3.48%,GATA4;WNT4
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8855336623311708,-1.4099270486035467,0.045454545454545456,0.5857615653206786,1.0,2/5,7.19%,COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8127836473172677,1.4097959080939244,0.08,0.8816953191507771,1.0,3/9,10.99%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5865324306246723,1.4096661377026711,0.05263157894736842,0.8801472130905466,1.0,11/54,11.85%,SMAD6;TMEM100;GDF6;BMP2;ACVR2A;ZFYVE16;SMAD1;SMAD2;BMPR1A;SMAD4;GDF9
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.8260109270086134,-1.4094565444840004,0.06976744186046512,0.586206460192886,1.0,1/11,1.23%,MAFK
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.6136493724625233,1.4088709631180754,0.06,0.8833467493688114,1.0,15/54,15.61%,SULT2A1;IL4;INSIG1;CYP39A1;MSMO1;ABCA1;FDX1;CYP27A1;CYP7B1;SOAT2;FDXR;CH25H;SOAT1;SC5D;CYP4V2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7463534929502671,1.4088104164565147,0.1,0.8814600818451566,1.0,4/17,4.48%,IL4;CD22;SAMSN1;ZFP36L2
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.9694995430443765,1.408344885439483,0.0,0.8829650777345875,1.0,1/6,0.53%,FGF10
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6842430210519541,1.4080191668288085,0.05454545454545454,0.883780666076278,1.0,4/20,6.41%,BOK;IL4;DCC;ITGAV
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7442118553507113,1.4079131681079962,0.10204081632653061,0.8823497185160702,1.0,3/11,12.66%,SIRT1;ZNF274;MYB
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.5697283948654458,1.40741505277973,0.0,0.8833319785856005,1.0,39/87,27.61%,URI1;BMI1;FBXL3;GPR180;AGGF1;CMTR2;TMEM263;MANEA;PDIK1L;ZBTB41;LIG4;NR1D2;ABCD3;SSX2IP;ZNF800;ZBTB33;PRKAA1;ZFAND1;CD2AP;GABPA;MIER3;GNPDA2;TRMT13;SUCO;STT3B;MBNL2;AP1AR;LYSMD3;VPS13A;PCNP;ZMYND11;CASD1;SOCS4;CSDE1;FBXL17;CHUK;CMPK1;TBL1XR1;TWF1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.8146303938700086,1.4069716060847204,0.07894736842105263,0.8841062339355474,1.0,3/11,5.90%,F2;KLKB1;F12
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.8980285998869802,1.4063033597673498,0.05,0.8864602162143183,1.0,2/7,5.19%,FERMT3;CXCL12
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.849524775228778,1.4062534727449452,0.061224489795918366,0.8842979789451215,1.0,2/11,3.59%,RUNX1;MAFB
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8563798904732287,1.4054212253732536,0.04081632653061224,0.88774509184063,1.0,2/7,5.20%,IGF1;DIPK2A
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.6773767185011268,1.4049792606976088,0.05,0.8891011869416161,1.0,9/36,12.78%,SYK;SOCS2;STAT5A;SOCS6;FOXO3;ABL2;PIK3CA;FLT3;SOS1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9354782466760578,1.404921446196555,0.03508771929824561,0.8871825224803296,1.0,1/6,2.90%,PIK3R6
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.7649247888269387,-1.4047371551404528,0.15,0.606270633635358,1.0,2/8,2.31%,CXCL13;NR4A1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7204397139190234,1.4045028855161574,0.02,0.888732474096946,1.0,4/19,8.33%,DRD5;GRM3;ADGRV1;GNAI3
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.6094723771011014,-1.4043645090553347,0.06666666666666667,0.6061960614777483,1.0,14/53,4.06%,OR13A1;OR1L8;OR2AK2;OR10AC1;RTP1;OR2T6;OR2M4;OR2M3;OR2M2;OR2L13;OR51M1;OR1L6;OR52A1;OR9G4
prerank,KEGG_2021_Human__Glutamatergic synapse,0.5606701207193376,1.403917984504035,0.0,0.8902411008628323,1.0,23/100,15.92%,GRM3;GRIN3A;SLC1A3;GNB4;GNG12;KCNJ3;SLC38A3;SLC17A6;GLUL;GRM8;GNAI3;GRIK2;GRM5;GRIN3B;GRIK3;GNG4;PPP3CA;GRM4;PPP3CC;GRM7;GRIN2D;PLCB1;GRM1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.8778927027837935,1.403909944996673,0.05454545454545454,0.8880368306773052,1.0,1/6,3.01%,PADI2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7574739988230832,1.4031716424881928,0.08,0.8913870193080244,1.0,3/15,8.93%,CGNL1;SCRIB;DSP
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,0.8654378792235993,1.4028172072959126,0.06153846153846154,0.8919883980146321,1.0,1/8,0.74%,FLT1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.847145696443211,1.4026357493264334,0.034482758620689655,0.8906829848462917,1.0,1/10,0.97%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.8760033334180732,1.4025645537386409,0.057692307692307696,0.8890569883685855,1.0,2/7,2.47%,SYK;IL4
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.818875767549893,-1.4025506754101378,0.10344827586206896,0.6131974128429373,1.0,1/8,0.17%,TERT
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,-0.8736760664682378,-1.402514954292731,0.0425531914893617,0.6116928431437546,1.0,2/9,3.86%,IRF4;IL6R
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7491967393281814,1.401900872202789,0.07407407407407407,0.8918147389346246,1.0,4/17,9.37%,MYC;MRAP2;PHKA1;LEPR
prerank,Reactome_2022__Urea Cycle R-HSA-70635,-0.8554844362295967,-1.4018524086100659,0.09302325581395349,0.6130705942088026,1.0,3/6,6.84%,ASS1;ARG2;CYP21A2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.79069396405713,-1.4015940791455688,0.0784313725490196,0.6121874282487297,1.0,2/8,7.78%,EGR1;CLU
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6794396209399566,1.4015707949929632,0.11627906976744186,0.8920831237526133,1.0,8/22,14.96%,ACVR2A;RBPJ;ELAPOR2;SMAD2;BMPR1A;SMAD4;FBXL15;CRB2
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.8761339888501429,1.4015015412680814,0.031746031746031744,0.8878853762796719,1.0,1/7,4.22%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.8761339888501429,1.4015015412680814,0.031746031746031744,0.8878853762796719,1.0,1/7,4.22%,THOC6
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8195865679383968,1.4014992956796912,0.10638297872340426,0.8856733806484125,1.0,3/8,10.30%,IL4;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.8564278875291763,1.401099861896059,0.0847457627118644,0.8819591724098861,1.0,1/6,2.55%,STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.8564278875291763,1.401099861896059,0.0847457627118644,0.8819591724098861,1.0,1/6,2.55%,STAT5A
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,0.8564278875291763,1.401099861896059,0.0847457627118644,0.8819591724098861,1.0,1/6,2.55%,STAT5A
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,0.5937931071588181,1.40107680162156,0.08333333333333333,0.8711009536115452,1.0,18/83,8.38%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;ITGA11;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,0.5937931071588181,1.40107680162156,0.08333333333333333,0.8711009536115452,1.0,18/83,8.38%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;ITGA11;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,0.5937931071588181,1.40107680162156,0.08333333333333333,0.8711009536115452,1.0,18/83,8.38%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;ITGA11;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,0.5937931071588181,1.40107680162156,0.08333333333333333,0.8711009536115452,1.0,18/83,8.38%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;ITGA11;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,0.5937931071588181,1.40107680162156,0.08333333333333333,0.8711009536115452,1.0,18/83,8.38%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;ITGA11;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,0.8913480669295328,1.4007804218832698,0.06896551724137931,0.8714447687742745,1.0,3/6,8.96%,RUNX1;ESR1;KCTD6
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.8307922228425866,-1.4005696326614434,0.06,0.61497544549822,1.0,2/9,1.37%,PRDM1;IRF4
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.5941550997477288,1.4005456471644353,0.06521739130434782,0.8715347940603048,1.0,14/66,15.75%,GSTM2;GSTT2;MME;PCSK5;TRHDE;NAALADL1;HPGDS;CPN1;LNPEP;ETHE1;BACE2;ANPEP;DMD;CPE
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7937433414093853,1.400513183388524,0.09615384615384616,0.8696442630536665,1.0,3/9,7.57%,BOK;PPP1R15B;AGR2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.7280726687711416,-1.4004805987094193,0.08333333333333333,0.6137970405242047,1.0,8/14,16.85%,MYH7;DSG2;ADAMTS9;HOPX;TGFB1;ID2;TGFBR3;FGFR2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6624673699464277,1.4004063427369104,0.06,0.8683274752878486,1.0,8/33,14.30%,SEMA5A;ERBB4;NRTN;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5437979586517232,1.4003555043958833,0.05555555555555555,0.8664230108835465,1.0,38/124,16.18%,MXRA5;LAMA4;MRGPRF;SEMA5A;COL9A1;PRRX1;PBX3;ADGRL4;PRG4;BMP2;BGN;COL6A2;CHODL;IL10RA;CXCL12;LTBP2;SOX6;EFS;POSTN;CCDC80;PDGFRA;PCDH18;MATN1;MEDAG;TNC;TCF4;HMCN1;HAS2;HTRA1;CREB3L2;COL11A1;CRTAC1;OLFML3;FRZB;FBN1;GAS1;PDZRN3;HAPLN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.8193330012959019,-1.399985408639644,0.1276595744680851,0.6145658267534936,1.0,1/5,2.15%,FGF1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.8278939625100751,1.3998594455968216,0.13559322033898305,0.8680844189887834,1.0,1/5,4.27%,FYCO1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5676702193112698,1.3998368155683694,0.03636363636363636,0.8661899594859815,1.0,24/92,17.87%,FZD5;CDH20;CDH7;CDH6;CDH2;NLGN1;FBLIM1;CDH12;SDK1;NRXN1;ACHE;DSCAM;GPM6A;PTEN;CDHR3;CDH10;CDH8;DNM3;RAB29;CDH24;PKP4;GJC1;FLRT3;FARP1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7013781924634205,1.3998182233953798,0.019230769230769232,0.8640875298814452,1.0,8/29,13.14%,ERBB4;NRG1;GAB1;NRG2;ERBIN;PIK3CA;SOS1;CPNE3
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8988213951998202,1.3995058864593886,0.08,0.8639153812153683,1.0,1/6,0.32%,MITF
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8832350262382159,1.3992856135529763,0.05263157894736842,0.8636822943562611,1.0,2/6,3.09%,FGF2;ANGPT1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7393908011018709,1.3991674731809036,0.1568627450980392,0.8623101737369601,1.0,3/15,6.02%,PPARG;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6982681452374702,1.399111710663052,0.05357142857142857,0.8606373429732591,1.0,6/30,12.47%,LGALS9;IGF1;IL4;VSIR;C5AR2;CD34
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.6511755255277307,1.3988467599953538,0.041666666666666664,0.8602606055024686,1.0,1/28,0.09%,GATA4
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5738549707717062,-1.3987734392723825,0.06666666666666667,0.6186734302477742,1.0,6/99,3.71%,CD44;H1-3;RNF39;CD86;LILRB3;TEC
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,0.5618222463591196,1.3985692974819626,0.0425531914893617,0.8604975191865972,1.0,21/76,13.44%,MXRA5;SCN7A;MRGPRF;ITGA8;ITGA11;ADGRL4;ACTG2;BGN;CXCL12;POSTN;PDGFRA;ABI3BP;RAMP3;PGM5;MYH11;MEDAG;SYNPO2;PPP1R12B;CD34;SHROOM4;ABCA8
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.5987257691522266,1.3980656039776473,0.041666666666666664,0.8615572458339865,1.0,21/50,27.46%,ACSS2;HDAC3;SMARCD3;NCOA2;TBL1X;MEF2C;CREB1;CHD9;HCFC1;GABPA;POLG2;TFB1M;GLUD1;NRF1;CAMK4;TFB2M;LIN9;MTERF1;SIRT5;NCOA1;TBL1XR1
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.9304713301578287,1.3979515613204032,0.0196078431372549,0.8603286030209555,1.0,1/5,0.05%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.8500791522717794,1.3979314656103958,0.057692307692307696,0.8584377419058822,1.0,3/7,7.69%,ADRA1A;ADGRV1;CD40
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8196044108943012,-1.3977863637012262,0.14583333333333334,0.6214718769941151,1.0,2/7,4.34%,PM20D1;TST
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,0.8503074386695655,1.397747420188401,0.044444444444444446,0.8576466624346151,1.0,3/10,4.16%,SYK;STAT5A;IL2RA
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.8533453362646616,1.3972493465687843,0.034482758620689655,0.8585217145254022,1.0,1/11,0.64%,DRD5
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5559443555212145,1.3972476788074886,0.037037037037037035,0.8564678348255806,1.0,31/127,16.03%,LRRC3B;NXPH1;RIT2;NGB;GRM3;KCNC2;CDH20;GFAP;CADM2;SLC17A6;NRXN1;RAB3C;OLFM3;SYNPR;GRM5;LRRTM3;ADGRB3;CTNNA2;PAK5;TMEM196;EMX1;KCND2;KCNB2;NR4A2;GABRG1;GRIN2D;SEZ6L;FEZF2;GRM1;CNTN2;CALB1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.9179909870041691,1.396674651052104,0.0625,0.8588154458318712,1.0,1/6,0.40%,PNP
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.5804522971147974,1.396541554476105,0.023255813953488372,0.8514987408622907,1.0,22/93,13.97%,LRRC3B;NXPH1;RIT2;GRM3;KCNC2;CDH20;PMP2;GFAP;CADM2;SNTG1;SLC24A2;NTSR2;SYNPR;GRM5;LRRTM3;CTNNA2;SCN2B;GPM6A;ATP1A2;GABRG1;SLC39A12;MOBP
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.5804522971147974,1.396541554476105,0.023255813953488372,0.8514987408622907,1.0,22/93,13.97%,LRRC3B;NXPH1;RIT2;GRM3;KCNC2;CDH20;PMP2;GFAP;CADM2;SNTG1;SLC24A2;NTSR2;SYNPR;GRM5;LRRTM3;CTNNA2;SCN2B;GPM6A;ATP1A2;GABRG1;SLC39A12;MOBP
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.5804522971147974,1.396541554476105,0.023255813953488372,0.8514987408622907,1.0,22/93,13.97%,LRRC3B;NXPH1;RIT2;GRM3;KCNC2;CDH20;PMP2;GFAP;CADM2;SNTG1;SLC24A2;NTSR2;SYNPR;GRM5;LRRTM3;CTNNA2;SCN2B;GPM6A;ATP1A2;GABRG1;SLC39A12;MOBP
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.5804522971147974,1.396541554476105,0.023255813953488372,0.8514987408622907,1.0,22/93,13.97%,LRRC3B;NXPH1;RIT2;GRM3;KCNC2;CDH20;PMP2;GFAP;CADM2;SNTG1;SLC24A2;NTSR2;SYNPR;GRM5;LRRTM3;CTNNA2;SCN2B;GPM6A;ATP1A2;GABRG1;SLC39A12;MOBP
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6562973780497803,-1.3962894228034752,0.09090909090909091,0.6259467049915449,1.0,2/42,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.743155257534558,1.3962835745033455,0.07575757575757576,0.851095656950799,1.0,4/16,8.00%,C3;SIRT1;ITGAV;PLA2G10
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7906709918693002,-1.3962408608397605,0.1346153846153846,0.6244830629329352,1.0,4/12,14.29%,KCNE2;KCNE1;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6351955540350714,1.396026320533479,0.043478260869565216,0.8508130914581309,1.0,8/30,13.34%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.7744259820817208,1.3959611694723038,0.08620689655172414,0.8491413211506865,1.0,1/9,0.09%,GATA4
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.7029704222715615,-1.3958588027055099,0.058823529411764705,0.624709778923003,1.0,7/39,5.24%,CYP1A2;UGT2B15;CYP2A6;CYP2E1;GSTT2B;HSD11B1;AKR7A3
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.7025143693026398,1.3958208336407734,0.08620689655172414,0.8478315789958087,1.0,2/21,1.66%,LGALS9;TMPRSS2
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,0.6215330801374386,1.3957627013787308,0.07272727272727272,0.8462334818966956,1.0,5/42,1.70%,CPA1;AP1M2;CAPN13;TMPRSS2;ACE2
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.5542886637369079,1.395431282814726,0.061224489795918366,0.8463174313633651,1.0,32/151,14.99%,RUNX1;MYC;ERBB4;KAT2B;GNB4;GNG12;NRIP1;PRMT1;H2BC21;CXCL12;FKBP5;NR5A2;MOV10;KCNH8;ESR1;FOXO3;GNAI3;KCTD6;KANK1;PIK3CA;NCOA2;DAND5;GNG4;H2AC6;MYB;XPO1;IGF1R;H2AZ2;CREB1;POU2F1;NCOA3;H2AX
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7777966816384394,-1.3952781256261648,0.11363636363636363,0.6261310258000526,1.0,2/15,1.76%,TERT;TERF2IP
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,0.8497328513907566,1.395162633789407,0.0847457627118644,0.8463716798091565,1.0,3/8,6.51%,GATA4;KAT2B;WWTR1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8198911944021198,1.3949106288238031,0.07547169811320754,0.8463964339697139,1.0,7/10,16.53%,NPC1L1;LDLR;CEL;ABCG8;SOAT2;ABCG5;AKR1C1
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.6488916732531179,-1.394695851873623,0.0625,0.627102238181485,1.0,5/39,8.84%,DUSP4;DUSP6;PTPN3;PTPN7;PEBP1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5647224217596444,1.394488670376913,0.05454545454545454,0.8474713685313641,1.0,16/104,9.33%,SLC5A8;SLC26A3;SLC12A7;SLC12A1;SLC1A3;SLC26A7;SLC26A6;SLC12A3;SLC17A6;GLRA1;SLC5A12;SLC8A1;SLC24A2;SLC15A1;SLC9A2;SLC15A2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.9005216288105311,-1.3944169581080954,0.047619047619047616,0.6264185111888089,1.0,1/9,0.17%,TERT
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.8007561854278048,1.3943833022878833,0.05263157894736842,0.8464455992770566,1.0,6/11,15.72%,GREM2;BMP2;LTBP1;DAND5;GREM1;FBN1
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.6331644575995631,1.3943345889054208,0.018518518518518517,0.8448147083581851,1.0,10/41,14.85%,ITGA8;ITGB8;TGFBR1;ITGAV;PPP1CC;SMAD2;LTBP1;SMAD4;XPO1;BAMBI
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.8863435564489004,1.3942259087870374,0.05263157894736842,0.8436548942727522,1.0,4/6,10.28%,ADRA1A;ZDHHC12;NLGN1;HAP1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.8467477699794042,-1.3936518765176515,0.06521739130434782,0.6280151052536666,1.0,2/7,1.92%,DDX11;KDM4D
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.625392596603302,1.3927606326736603,0.061224489795918366,0.850941303400837,1.0,8/44,7.07%,RUNX1;PMP2;GFAP;CALCR;BMI1;CDH2;PDGFRA;PAX6
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8635642899154021,1.3927299184286288,0.018867924528301886,0.8492247977188077,1.0,5/8,12.14%,EFS;CASS4;MCU;GSN;BCAR1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8014074036931341,1.392610394851262,0.05172413793103448,0.8480053084571356,1.0,3/11,7.26%,RPP25;RPP25L;RPP40
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.8613016723338308,1.392331814840746,0.05357142857142857,0.8478536323165585,1.0,2/5,5.20%,IGF1;DIPK2A
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,0.5763962174364065,1.3921714831096152,0.07692307692307693,0.8472443350659203,1.0,22/91,10.39%,VEGFC;MXRA5;LAMA4;MRGPRF;PRRX1;CLMP;EDIL3;ADGRL4;BGN;CRIM1;LTBP2;POSTN;CCDC80;CNN3;PDGFRA;PLSCR4;PCDH18;PRICKLE2;IGFBP6;MEDAG;TNC;LOXL2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7775713135092176,-1.392097443931593,0.0625,0.6339154040373784,1.0,2/14,1.88%,SELP;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.8564425998301552,1.3911760772055364,0.019230769230769232,0.8523251127887705,1.0,4/8,5.02%,SNAI1;WNT4;BMP2;DKKL1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.6122601865818424,1.3909694159506754,0.06,0.8517084560676099,1.0,3/46,2.01%,LGALS9;MYC;IL26
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5647248796165794,1.3909242114409741,0.09090909090909091,0.850070367905928,1.0,18/96,10.79%,LGALS9;SYK;BOK;MYC;SIRT1;F2R;EGLN3;PPARG;ST18;F3;HTRA2;HMGB1;SNCA;DLC1;HIP1;GSN;TNFRSF10B;CASP10
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6278446700830455,1.3908853354003419,0.10526315789473684,0.8485248175741024,1.0,13/67,10.54%,ADRA1A;TSHZ3;ZDHHC12;CLSTN2;NLGN1;LGI1;SYT1;NRXN1;SLC24A2;GRIK2;RIMS2;HAP1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.747771805260548,1.390873582163323,0.061224489795918366,0.8467029879169308,1.0,3/13,7.05%,VEGFC;CXCL12;F3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.6769300916453842,1.3908144498996826,0.020833333333333332,0.8452849547170104,1.0,5/31,7.22%,LGALS9;GDF6;BMP2;PRMT1;RELL1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5434737710995307,1.3901541561718431,0.04,0.8474541377408489,1.0,33/118,17.87%,F2R;FZD5;LRRC4C;LRP4;NEDD4;CDH2;NLGN1;CACNB4;SDK1;PPFIBP1;NRXN1;UNC13B;ZC4H2;SNCA;PTPRD;ACHE;NLGN4X;GPC4;DSCAM;GRM5;GPM6A;PTEN;LRFN5;SEMA3E;PPFIA3;L1CAM;DNM3;CNTN2;RAB29;PDZRN3;FLRT3;GPHN;FARP1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.8524423731994677,1.3898566470947389,0.14285714285714285,0.8475318021724495,1.0,2/8,11.30%,PEX12;ZFAND6
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.5647257486503734,-1.3898560449132757,0.05660377358490566,0.6432477550740933,1.0,6/123,2.74%,TRIP10;EPN1;SYT12;NLRP3;SYNJ2;M6PR
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.819766456987844,-1.3897634887276034,0.16363636363636364,0.6420349918907577,1.0,4/6,13.81%,NLRP3;CD86;IL18;RARA
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.8401550773570001,1.389455288068285,0.1,0.8479459636010832,1.0,2/9,2.84%,SIRT1;KAT2B
prerank,CellMarker_Augmented_2021__Neuron:Brain,0.6463520269897275,1.389258820816198,0.06818181818181818,0.8472099617748908,1.0,3/30,3.01%,NXPH1;PNOC;GFAP
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.8982084804532597,1.3891409028658581,0.015873015873015872,0.8462257119293062,1.0,1/5,4.55%,IDH1
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.5988938794651245,1.3890941360405882,0.10869565217391304,0.8446881384085136,1.0,10/78,9.30%,TNFSF14;SYK;TNFSF13B;BLNK;CXCL12;RELA;PLCG2;TICAM1;CD40;TAB2
prerank,KEGG_2021_Human__Platelet activation,0.5802115966500654,1.3890758860185983,0.02127659574468085,0.842934774218157,1.0,15/102,9.52%,F2;FERMT3;SYK;PRKG1;F2R;ITGA2;PIK3R6;PIK3R5;PTGS1;MYL12A;PLCG2;PPP1CC;GNAI3;GUCY1A2;PIK3CA
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.6150776137632716,-1.3887791233437345,0.058823529411764705,0.6444251906861865,1.0,7/67,2.86%,ANXA8;EHF;DUOXA1;NUPR1;DUOX1;ALS2CL;SPTLC3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.5718974445033145,1.388437241688347,0.057692307692307696,0.8457974769346887,1.0,8/61,10.06%,MITF;RBM20;PCBP3;HNRNPH1;AFF2;NOVA1;FASTK;METTL18
prerank,CellMarker_Augmented_2021__Kupffer cell:Liver,-0.9539798711690135,-1.3882125094462112,0.0,0.6452546785821017,1.0,1/6,0.19%,CLEC4F
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.6916872568972398,-1.3880705925322823,0.08163265306122448,0.6441403562582678,1.0,3/21,4.93%,DRD4;RHBDF1;DRD2
prerank,Reactome_2022__NOSTRIN Mediated eNOS Trafficking R-HSA-203641,-0.8841763102766088,-1.3874576774070102,0.0784313725490196,0.6454733011770347,1.0,1/5,0.59%,NOSTRIN
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.8499598429726749,1.3874141476427237,0.07142857142857142,0.8512791047034648,1.0,1/7,1.82%,CCL5
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.5765302739883501,1.3871187301731172,0.0425531914893617,0.8515681332533519,1.0,20/93,12.41%,PREX2;LRRC4C;CDH20;GALNT8;TOX;SNRPN;LRRN3;KCNH8;NRXN1;RAB3C;KHDRBS2;NLGN4X;CNKSR2;CTNNA2;MAGEL2;LRRC55;TCF4;PDE4B;JAKMIP2;GPM6B
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.5778647576199143,1.3870653335645784,0.13043478260869565,0.8499805342756479,1.0,27/95,16.15%,PREX2;SLC35F1;LRRC4C;MYCN;FREM1;SYT6;EFS;PARM1;MEGF10;TMEM200C;PTPRD;PCDH18;NLGN4X;PABPC5;GPC4;VANGL2;MAGEL2;KCND2;ATP1A2;LGI2;GPM6B;ID4;COL11A1;RUNX1T1;FRZB;GPRC5B;PDZRN3
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8489216164779216,1.3869470625372708,0.046511627906976744,0.8490603155578074,1.0,3/9,2.04%,HS3ST5;F2;F2R
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.8391671213254054,-1.3867224776756302,0.07317073170731707,0.646874191223072,1.0,2/9,1.15%,PALM3;SIGIRR
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.5825554525451222,1.3866511656641936,0.06,0.849407206381299,1.0,21/86,10.66%,VEGFC;MXRA5;MRGPRF;PRRX1;CLMP;ADGRL4;SSC5D;BGN;COL6A2;LTBP2;POSTN;CCDC80;PDGFRA;FAM114A1;PCDH18;IGFBP6;MEDAG;TNC;AOX1;LOXL2;TPM2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7511278202770998,1.3865454734109253,0.09259259259259259,0.8480812499779502,1.0,6/15,16.11%,ITGA8;ITGA2;SNAI1;SMAD2;CRB2;MESP1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.7655724199135566,1.386398217712658,0.09615384615384616,0.8470617813257804,1.0,1/9,1.94%,SIRT1
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),0.9140285740209477,1.3862857089070584,0.023809523809523808,0.8462104082960562,1.0,1/5,0.05%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.680983425224867,1.3861384388359703,0.03571428571428571,0.8453627129036094,1.0,10/31,22.07%,IRGM;FYCO1;HTRA2;LMAN1;LIG4;SORBS3;ANXA2;STX18;ANXA1;AKT2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7292025274081616,1.3860644260905055,0.04081632653061224,0.8442470433524178,1.0,3/18,8.69%,TCIRG1;ATP6V0D2;ATP6V0A4
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,0.9159017111394769,1.3859623825083194,0.03278688524590164,0.8429193372824053,1.0,1/6,1.44%,RUNX1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7178270423322854,-1.3858790672876327,0.1,0.6487161355527572,1.0,2/18,0.85%,ACTC1;MYH7
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.6412399119513585,1.3857688844344473,0.075,0.8422464388802086,1.0,13/44,13.04%,SIRT1;FGFR1;HIF1A;STAT5A;FGF2;PPARG;ANGPT1;SP1;CD40;HMGB1;NUS1;MEF2C;HSPB1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.8159195546849952,1.3856992542099642,0.05660377358490566,0.841171597643195,1.0,5/11,11.28%,SLC22A3;SLC1A3;GLUL;SLC29A2;ATP1A2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.7446426753505184,-1.3856439601159052,0.10416666666666667,0.6479398080475993,1.0,1/18,0.33%,ALB
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.750055866390746,1.3855667604557858,0.10909090909090909,0.8402360029504025,1.0,6/13,22.25%,STAT5A;IL15;SOS1;GAB2;IL2RB;GRB2
prerank,KEGG_2021_Human__Focal adhesion,0.5158617041325624,1.385398927949512,0.046511627906976744,0.8396268766369628,1.0,36/187,13.78%,VEGFC;IGF1;LAMA4;FLT1;ITGA10;COL9A1;ITGA8;HGF;ITGB8;ITGA11;ITGA2;COL9A2;DOCK1;COL6A5;COL6A2;ARHGAP5;ITGAV;MYL12A;PDGFRA;PPP1CC;ELK1;PDGFC;LAMB4;PIK3CA;TNC;ITGA1;PAK5;PXN;BCAR1;MAPK8;PTEN;PPP1R12B;SOS1;IGF1R;RAP1A;CCND3
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.7129190144535642,1.3852577221032425,0.08928571428571429,0.8388594460945048,1.0,3/18,2.16%,TOP2A;MYC;CDC25A
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6383511657924825,1.38495066026107,0.08196721311475409,0.8397008207829181,1.0,10/51,4.72%,FGF10;ITGA8;MME;TGFBR1;LRP4;GDF6;WNT4;PCSK5;ROBO2;KANK2
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.6022369536573642,1.3849273659856187,0.021739130434782608,0.8382155201890703,1.0,36/100,20.81%,IL17RD;LGR5;LRP4;FRAS1;TENM3;MEGF10;CNN3;TMEM200C;ADGRL2;NEO1;LIFR;PTPRD;STOX2;PCDH18;CACHD1;ANK2;GFRA1;MAGI1;GUCY1A2;VANGL2;CNTN1;FIGN;ID4;SEMA6D;FRZB;CPE;GPRC5B;PDZRN3;CCDC3;CSRNP3;MPDZ;PLP1;DZIP1;MAP2;SCARA3;ADGRL3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7901629079094629,1.3847985904236244,0.09803921568627451,0.8371894812906562,1.0,5/12,12.76%,AK3;EFL1;GNAI3;RAB23;ENTPD7
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.7472708829454251,1.3846346933267624,0.03636363636363636,0.8365666178742266,1.0,2/12,4.30%,SMAD6;ROBO2
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.870439197517849,1.384391347488395,0.07407407407407407,0.8362382484942594,1.0,1/5,9.78%,ACP6
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.9133323976759314,1.3842552603049227,0.03773584905660377,0.835328742260902,1.0,1/6,0.38%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6678531010940358,1.384189050044517,0.10869565217391304,0.8340002892178144,1.0,4/29,4.50%,SMAD6;PPARG;RORB;CRIM1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.5712797226730679,1.3839696333592366,0.05357142857142857,0.8338375530534577,1.0,19/86,8.38%,MXRA5;CGNL1;FLT1;TDRD10;PREX2;NYNRIN;PRKG1;ADGRL4;BGN;FREM1;PCDH17;CXCL12;POSTN;ERG;PDGFRA;ADGRL2;PLSCR4;PTPRD;PCDH18
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.8176057599455899,1.3838061724280524,0.03636363636363636,0.83309662814454,1.0,2/10,4.27%,IRGM;FYCO1
prerank,CellMarker_Augmented_2021__Epithelial cell:Cornea,-0.7133344508562789,-1.383622038339546,0.09090909090909091,0.6557352069305812,1.0,5/20,11.96%,ANXA8;ALOXE3;KRTDAP;SERPINB5;CLCA2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5138631620168257,1.383380083083186,0.0,0.8344068656799339,1.0,31/168,13.16%,LAMA4;SMAD6;HS3ST5;IL17RD;F2R;IL4;LRP4;ALDH1A1;BMP2;RBPJ;MAP2K6;TNNT1;ELAPOR2;ZNF706;RPS6KA4;IL15;NOVA1;MARVELD3;SPX;CRHBP;ARRDC3;BTN2A2;LNPEP;CORO1C;LOXL2;NR1H3;MEF2C;PTEN;TBX18;IL18R1;KLF7
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.8466437303904722,1.3830979394788636,0.03636363636363636,0.8345325298742422,1.0,3/12,8.14%,PNP;AMPD1;ADA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.6010252634886352,-1.3826804163051685,0.1,0.6583740388157604,1.0,10/81,6.21%,LRP10;SELP;ARAP3;DNASE1L1;RIN3;DUSP6;C1RL;MVP;TGFBI;SVIL
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.6148999322858271,-1.3821404738923548,0.06818181818181818,0.6590763802523687,1.0,18/60,5.71%,OR13A1;OR1L8;OR2AK2;OR10AC1;RTP1;OR2T6;OR2M4;OR2M3;OR2M2;OR2L13;OR51M1;OR1L6;OR52A1;OR9G4;ANO2;GNAL;CNGB1;OR2L8
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Undefined,0.93416315482502,1.3819141114354567,0.03636363636363636,0.8412732237424263,1.0,2/5,4.85%,SLC17A6;GLUL
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5557551469351041,-1.3818603673069834,0.05263157894736842,0.6588530353782579,1.0,2/137,0.42%,CD44;NTRK1
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.9511626281649355,-1.38163794585881,0.02040816326530612,0.6583549301135107,1.0,1/5,0.12%,ANXA8
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.869363549101379,1.3811656090630549,0.057692307692307696,0.8453765772541673,1.0,1/7,0.05%,SGO1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.7971395604469185,-1.3808715443884658,0.09803921568627451,0.6603178436020137,1.0,1/15,0.42%,NTRK1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8152622623162605,-1.3805398846223045,0.14285714285714285,0.6601662365788684,1.0,2/7,8.71%,CD24;CDH3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5972803401076845,1.3804900630738923,0.08333333333333333,0.8476922294641875,1.0,16/79,8.38%,VEGFC;LAMA4;MRGPRF;ITGA8;RSPO3;ADGRL4;GDF6;MSRB3;ACTG2;BGN;COL6A2;CXCL12;POSTN;PDGFRA;BMPER;PCDH18
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6848706748145672,1.3804106223092363,0.11538461538461539,0.8466980241689694,1.0,11/26,20.59%,TICAM1;CD40;UBE2D3;TANK;IKBKE;BIRC3;FADD;IRF3;UBE2D1;TICAM2;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.7856595746092931,1.3799974179357084,0.08771929824561403,0.8480678323606191,1.0,3/10,11.28%,RNLS;SPX;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.518082052481377,1.379917316281969,0.05555555555555555,0.8468698991133271,1.0,46/203,15.37%,IGF1;TMEM100;SMYD1;HGF;SOX5;TGFBR1;FGFR1;RIN2;PPARG;GDF6;SNAI1;RRAS;WNT4;BRINP3;FBXO5;BMP2;CDH2;ACVR2A;CCN4;SOX6;ZEB1;WWTR1;ZC4H2;ADRA2C;NEUROD2;PLA2G10;SMAD2;MEDAG;CTNNA2;EZH2;VWC2;LOXL2;TCF4;BMPR1A;CPNE1;SMAD4;MEF2C;CD34;MSR1;RAP1A;CREB1;RPS6KA1;BAMBI;CRB2;PLCB1;FRZB
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.7029095287745482,1.379741945635387,0.05454545454545454,0.8462450678075683,1.0,6/29,12.47%,LGALS9;IGF1;IL4;VSIR;C5AR2;CD34
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.8297224529535964,-1.3796574312208418,0.08333333333333333,0.6623883116700842,1.0,3/10,9.04%,NPTX2;BEGAIN;CACNG5
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6899638498988973,1.379175266750411,0.06818181818181818,0.848844555864066,1.0,8/31,13.08%,IGF1;IRS1;NYAP2;PIK3R5;PIK3C2B;PIK3CA;PTEN;IGF1R
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8874748627609998,1.3790648704179855,0.06779661016949153,0.8479610298754872,1.0,1/7,1.11%,SLC12A7
prerank,CellMarker_Augmented_2021__Endothelial cell:Ovary,-0.8897552682800813,-1.378946916548827,0.057692307692307696,0.6638890172889909,1.0,2/7,1.04%,CLDN4;CD24
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.678312049771878,1.378893751300439,0.08,0.8474404705113417,1.0,12/27,21.63%,TICAM1;CD40;UBE2D3;TANK;IKBKE;BIRC3;FADD;IRF3;UBE2D1;TICAM2;IKBKB;TNIP3
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.5927424452545782,1.3771946756075455,0.03508771929824561,0.857348126425124,1.0,27/74,22.84%,RUNX1;MYC;TGFBR1;STAT5A;CDKN2A;RELA;HDAC2;PIK3CA;SMAD4;CTBP2;SOS1;PIK3CD;GAB2;CDK4;TP53;POLK;AKT3;ABL1;HDAC1;PIK3R3;BAD;IKBKB;MAPK3;CRK;AKT2;GRB2;CDK6
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5765487435891967,1.3771184628710065,0.08333333333333333,0.8560692533913947,1.0,14/63,15.10%,DERL3;OSTC;UBE2J1;ALG6;MGAT2;GAL3ST1;SLC39A8;MAGT1;LMAN1;FUT8;ALG9;MGAT5;MGAT4C;MGAT4A
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.8638101909554313,-1.3770527811588789,0.0851063829787234,0.6715748313838866,1.0,2/7,4.85%,UMODL1;UMOD
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5867884742292935,1.3767296096318993,0.061224489795918366,0.8572703421600142,1.0,13/59,17.54%,IGF1;RAB27A;BMP2;UNC13B;SNCA;PLA2G10;ACHE;RAB9A;MYOM1;RAB27B;GOLPH3L;CD2AP;STXBP5
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,0.5656006068735924,1.3764968632459678,0.06,0.8574735718594153,1.0,21/85,10.55%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;FAM114A1;ABI3BP;PCDH18;KLF6;MEDAG;TNC;LOXL2;ITGA1
prerank,CellMarker_Augmented_2021__Colorectal Stem cell:Colorectum,0.9193168976982722,1.3763590553001155,0.04918032786885246,0.8567357986535011,1.0,2/5,2.98%,LGR5;ALDH1A1
prerank,KEGG_2021_Human__Cell cycle,0.5513025096051011,1.376248503260479,0.034482758620689655,0.8558995574118419,1.0,15/114,11.63%,ESPL1;CDC14A;CDKN2C;MYC;CDC25A;CCNA2;CDKN2A;WEE2;HDAC2;MCM7;CCNB3;SMAD2;E2F4;CHEK2;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7898153173704405,1.3762185292397011,0.09803921568627451,0.8543580417951713,1.0,3/10,3.50%,LGALS9;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8013726199966416,1.3761014872573254,0.10714285714285714,0.8533025989081081,1.0,4/12,11.01%,IGF1;IRS1;DYRK2;GCK
prerank,KEGG_2021_Human__Olfactory transduction,-0.5737361251796549,-1.3760032777349671,0.11363636363636363,0.6748742471611069,1.0,19/82,5.71%,OR13A1;OR1L8;OR2AK2;OR10AC1;OR2T6;OR2M4;OR2M3;OR2M2;OR2L13;OR51M1;OR1L6;OR52A1;OR9G4;SLC24A4;ANO2;CAMK2A;GNAL;CNGB1;OR2L8
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.5627559568680738,1.3759753674617492,0.07547169811320754,0.8525034485934782,1.0,20/87,12.03%,VEGFC;ANTXR2;F2R;CLMP;MSRB3;CRIM1;COL6A2;LTBP2;ANXA5;CCDC80;MYOF;COL8A1;CYBRD1;PDGFC;TNC;CORO1C;LOXL2;TPM2;HAS2;RAB34
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.8482938477481348,1.375775427506304,0.08163265306122448,0.8523867211966611,1.0,3/9,10.05%,MME;RELA;HYAL3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.4799783461066595,-1.3755584765233166,0.0,0.6751937212761957,1.0,20/381,6.36%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;PRKCD;IL31RA;PLK3;ANGPT4;BCL2L2;PRAME;CRLF1;SFRP1;NIBAN2;RNF213;PAX2
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,0.8540089131230962,1.375496341212527,0.14583333333333334,0.85186875239364,1.0,3/8,6.04%,UNC5C;DCC;UNC5D
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8761427095101479,1.375101319162829,0.0784313725490196,0.8528562474877588,1.0,2/8,2.08%,FGFR3;FGFR1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5953581600924954,-1.3750158948763707,0.07692307692307693,0.6758720510437888,1.0,16/72,7.72%,EHF;DUOXA1;CAPN8;PGC;ETV5;FAM3D;SFTPA2;RNASE1;CRLF1;NRN1;IFI27;MS4A4A;C2;LAMB3;SFTPA1;ADGRF5
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.8340865112000319,1.3748088018369626,0.05454545454545454,0.8533146764487078,1.0,5/11,12.78%,ERBB4;NRG1;NRG3;NRG2;SOS1
prerank,Reactome_2022__Glucuronidation R-HSA-156588,-0.7737583604140752,-1.3746150545605,0.16666666666666666,0.6760795448955732,1.0,1/8,0.08%,UGT2B15
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.7483660645587797,-1.3744107559453451,0.06818181818181818,0.6735577750247412,1.0,5/26,5.91%,ACTC1;MYH7;TMOD1;ACTN3;NEB
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.7483660645587797,-1.3744107559453451,0.06818181818181818,0.6735577750247412,1.0,5/26,5.91%,ACTC1;MYH7;TMOD1;ACTN3;NEB
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.7111361792685081,-1.3742575075039132,0.09803921568627451,0.6724490709165473,1.0,3/19,5.96%,TAFA3;SHCBP1;DLL4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.724764086809539,1.3742542512010683,0.11627906976744186,0.855243782646665,1.0,2/11,7.60%,PCBP3;NOVA1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6877768176884199,1.3739552708373501,0.11764705882352941,0.8560942120969959,1.0,4/15,8.34%,FGF2;ITPKB;IP6K3;CYP27A1
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.8900260966273885,-1.3739470686909037,0.07692307692307693,0.6720934443133099,1.0,3/5,9.52%,CYP24A1;SFRP1;VDR
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.5862353149593338,-1.3734080378679305,0.07407407407407407,0.6729114072205233,1.0,5/76,3.87%,CD44;COL4A2;TNXB;COL4A1;AGRN
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.5246015171525718,1.3723710420757342,0.041666666666666664,0.8632306272915006,1.0,25/182,9.73%,VEGFC;IGF1;FGF10;FLT1;SIPA1;FGFR3;HGF;RAPGEF3;F2R;FGFR1;FGF2;EFNA5;ANGPT1;RRAS;EFNA2;RALA;MAP2K6;PDGFRA;PDGFC;GNAI3;MAGI2;MAGI1;FGF17;PIK3CA;RAPGEF6
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.5406715049704173,1.3723653872912784,0.07547169811320754,0.8615561645213289,1.0,28/95,16.87%,LRRC3B;LSAMP;SLC35F1;GALNT8;SLC17A6;CNTNAP2;ZDHHC22;UNC5D;KCNH8;NRXN1;RAB3C;KHDRBS2;ADGRB3;CTNNA2;MAGEL2;LRRC55;PAK5;GRIK3;ZNF536;GPM6B;UBE2QL1;SEZ6L;FAT3;CRB2;NELL2;CNTN2;SORCS1;PDZD4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7288828579582963,1.3722629594962843,0.14285714285714285,0.8604330314299665,1.0,6/15,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8815531530583779,1.3718751182749083,0.09433962264150944,0.8618597236145671,1.0,1/6,1.76%,MYC
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.7056021414628925,-1.371562399623538,0.15517241379310345,0.6799241605088916,1.0,4/22,2.04%,SELP;CD24;SELL;CD53
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7221672866432931,1.3714057033115257,0.11764705882352941,0.8634534831102061,1.0,2/13,2.90%,KAT2B;AANAT
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.8641976581597348,1.3713307891362647,0.057692307692307696,0.8623332251764321,1.0,1/5,1.32%,C3
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.7592222193385096,1.3711777549363924,0.07142857142857142,0.8618315423244785,1.0,4/12,7.24%,LGALS9;SYK;IL4;FER
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7795632370772982,1.3710545143748618,0.08333333333333333,0.8608904424392706,1.0,5/10,11.92%,ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6481209274209131,1.370893153980789,0.045454545454545456,0.8603690364968255,1.0,8/29,13.34%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8062450805218464,-1.370877580525775,0.11320754716981132,0.6813194351441456,1.0,1/8,0.42%,NTRK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7251927002536703,1.3706283257059242,0.061224489795918366,0.8604114372072929,1.0,4/15,11.11%,KLRD1;NECTIN2;CADM1;HLA-E
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.7411223268316837,1.370618795196499,0.029850746268656716,0.858820333112371,1.0,4/18,4.40%,FGF10;GDF6;ROBO2;SIX4
prerank,CellMarker_Augmented_2021__Clara cell:Lung,-0.659449363566541,-1.370088139373521,0.061224489795918366,0.683289419411129,1.0,12/44,14.54%,MS4A8;DUOXA1;CYP2B7P;C7ORF57;DRC1;CCDC190;CFAP73;GAS2L2;MROH9;APOBEC4;CFAP52;ADH7
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.7019717088322197,-1.370067144063144,0.10869565217391304,0.6816808973203273,1.0,3/16,10.13%,RNASE1;PLXNA2;LIMK1
prerank,CellMarker_Augmented_2021__Mesangial cell:Kidney,0.8634810041608734,1.3700104081718811,0.05263157894736842,0.8610553641431987,1.0,2/5,12.47%,ITGA8;CD34
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,-0.5636857729368887,-1.3699172100314365,0.07272727272727272,0.6805888428164849,1.0,3/87,3.02%,CD44;COL4A1;APCDD1L
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.545601197373496,1.3696022140885842,0.09615384615384616,0.8621647055707554,1.0,25/151,8.07%,LYPD1;GRAMD2B;TSPAN12;FGFR3;HGF;HIF3A;EGLN3;HIF1A;SLC1A3;GFAP;HEPACAM;NDRG2;MAFB;MLC1;LHFPL6;ZFP36L2;LIX1;KCNH7;GLUL;NFIA;F3;ABCA1;CD40;SPON1;CYBRD1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8314412668107294,1.369436304194724,0.1206896551724138,0.8617912881030146,1.0,1/6,2.58%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5201126170013644,1.369290374113665,0.03278688524590164,0.8609112919289518,1.0,34/220,9.40%,VEGFC;IGF1;FGF10;FLT1;IRGM;F2;C3;EPHA7;FGFR3;HGF;CCL5;SIRT1;FGFR1;ERBB4;HIF1A;FGF2;EFNA5;ANGPT1;ROR1;BMP2;PELI2;TNIK;ZBTB20;ACVR2A;FAM20A;PDGFRA;EPHA5;HDAC3;EPHA3;CD40;EPHA8;FGF17;LEPR;DSCAM
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6957092246163248,1.3691852381331335,0.11764705882352941,0.859744930834998,1.0,4/14,18.72%,DNASE2B;HMGB1;ENDOG;CASP3
prerank,Reactome_2022__Synthesis Of (16-20)-Hydroxyeicosatetraenoic Acids (HETE) R-HSA-2142816,-0.9232242288230899,-1.3691370892804042,0.10869565217391304,0.6825811525205201,1.0,1/5,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.6671745561395297,1.3690141478203044,0.12280701754385964,0.859161395139228,1.0,4/26,4.61%,FGF10;MYRF;CDH2;ADGRG6
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.6528346619383594,1.3689104594186627,0.07017543859649122,0.8585079290069287,1.0,18/39,22.13%,SCD;FDFT1;HMGCS1;SMARCD3;NCOA2;TBL1X;DAND5;MVD;FASN;ACACA;CHD9;ACACB;SC5D;SQLE;DHCR7;ELOVL6;SREBF2;IDI1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6543685410642484,-1.368741626107322,0.08888888888888889,0.6826265954342364,1.0,11/45,10.96%,TEKT3;CFAP61;DNAH17;TEKT5;DNAAF1;DNHD1;RSPH9;DNAH11;CFAP73;ZBBX;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8101576478266346,1.3686932301804686,0.05,0.8580009927270681,1.0,6/16,7.44%,F2;RUNX1;F2R;WNT4;VSIR;HDAC2
prerank,CellMarker_Augmented_2021__Myeloid cell:Tonsil,0.8551554544415395,1.3683644526636762,0.09090909090909091,0.8584304669686631,1.0,1/7,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Blood,0.9409873071367422,1.368220243777157,0.018867924528301886,0.8577821077178961,1.0,3/5,4.70%,TNFRSF18;IL2RA;IL7R
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.599213604317073,-1.3678473004424316,0.058823529411764705,0.6853876717394672,1.0,3/64,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8871319583031801,1.367841960134966,0.021739130434782608,0.8579477959671411,1.0,3/7,9.63%,WNT4;BMP2;H6PD
prerank,CellMarker_Augmented_2021__Epithelial cell:Skin,-0.8563056425352916,-1.3677708865726788,0.09803921568627451,0.6808358904725852,1.0,2/7,3.86%,CD24;IL6R
prerank,CellMarker_Augmented_2021__Epithelial cell:Airway Epithelium,-0.8563056425352916,-1.3677708865726788,0.09803921568627451,0.6808358904725852,1.0,2/7,3.86%,CD24;IL6R
prerank,CellMarker_Augmented_2021__Epithelial cell:Lung,-0.8563056425352916,-1.3677708865726788,0.09803921568627451,0.6808358904725852,1.0,2/7,3.86%,CD24;IL6R
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8185788151432394,-1.3677364582952791,0.1,0.6793849788166294,1.0,2/11,1.79%,APIP;NLRP1
prerank,KEGG_2021_Human__Mitophagy,0.6044333534451365,1.367642146187467,0.038461538461538464,0.8578507804035592,1.0,9/64,12.23%,MITF;HIF1A;RRAS;TFEB;SP1;RELA;FOXO3;BNIP3L;MAPK8
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8200433039270907,1.3676129863970918,0.09433962264150944,0.8563510953466116,1.0,7/9,16.53%,NPC1L1;LDLR;CEL;ABCG8;SOAT2;ABCG5;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.8476082476339768,1.3675951896737126,0.13043478260869565,0.8549282652618798,1.0,1/5,2.47%,IL4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.6004972298108744,-1.3675207452080245,0.08,0.6786462458625346,1.0,7/76,5.65%,CD44;PRDM1;FAM3D;DUSP6;FOS;MVP;TGFBI
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6595980485530125,1.3672469314401545,0.125,0.8555955802599751,1.0,15/28,23.48%,TOX;NPY;MDGA2;ZC4H2;PROX1;NR4A2;LRP6;GRID2;CTNNB1;WNT2;MAP2;RYK;CBLN1;CEND1;SPOCK1
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.5871081043366897,1.3672261796707843,0.05555555555555555,0.8541085673518348,1.0,22/56,24.41%,IRS4;IRS1;ADIPOR2;NPY;RELA;PRKAB2;LEPR;CPT1C;ACSBG1;MAPK8;ACACB;PRKAA1;MAPK10;ACSL4;IRS2;AKT3;IKBKB;ACSL1;AKT2;NFKBIB;JAK2;ADIPOR1
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.6348668446676036,-1.3666486314087245,0.10204081632653061,0.6810168042237661,1.0,12/45,7.93%,P2RY10;SELP;SIRPG;SELL;TRAF3IP3;SCML4;PTGDR;JCHAIN;KLRB1;ARHGAP15;CD5;TAGAP
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8272756629706555,1.3665686939182728,0.16666666666666666,0.8570407230094105,1.0,1/6,1.94%,SIRT1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5758412780520432,-1.3663896854362585,0.06666666666666667,0.680637175372277,1.0,19/69,15.50%,LRP10;SIGIRR;PRKCD;STXBP2;PSD4;ST6GALNAC2;PRKD2;B3GALT4;FOXO4;DEF6;HLA-C;ARRDC2;CXCL16;NFKB2;DEDD2;RHBDF2;IFI35;SYTL1;MMP25
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.6256780166401922,-1.3662118125318148,0.05555555555555555,0.6796275123191065,1.0,7/62,7.14%,ALB;GPX3;CGA;DUOX1;ASGR2;TG;PLCB2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.8347010406556625,1.3661357498869242,0.06,0.8565704416644755,1.0,2/6,5.88%,RELA;TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.8347010406556625,1.3661357498869242,0.06,0.8565704416644755,1.0,2/6,5.88%,RELA;TLR2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7422927021123543,1.3659955658222729,0.0847457627118644,0.8557967982005732,1.0,3/17,5.37%,SOX5;BMP2;SOX6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6872434761992785,1.3656392512539195,0.061224489795918366,0.8564082033417619,1.0,5/22,6.19%,GATA4;C3;HIF1A;RORA;HPSE
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.5266391653203307,1.3656089277519237,0.05660377358490566,0.8550531517593886,1.0,45/210,14.99%,RUNX1;MYC;ERBB4;KAT2B;ALDH1A1;SCD;GNB4;GNG12;NRIP1;PRMT1;H2BC21;CXCL12;FKBP5;DHRS3;NR5A2;MOV10;KCNH8;ESR1;HDAC3;ABCA1;FOXO3;GNAI3;ABCG8;KCTD6;KDM3A;KANK1;PIK3CA;NCOA2;LDHD;TBL1X;DAND5;GNG4;NR1H3;H2AC6;MYB;FASN;XPO1;IGF1R;H2AZ2;RARB;CREB1;ABCG5;POU2F1;NCOA3;H2AX
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7058506218177738,1.3654416638936595,0.06779661016949153,0.8546833942233552,1.0,9/23,17.67%,IGF1;MYC;BMI1;PDGFRA;PDGFC;LIG4;CD74;WNT2;CDK4
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,-0.7896208063231884,-1.3653978334903625,0.021739130434782608,0.6820469468396584,1.0,4/12,2.67%,SELP;SELE;SELL;CD86
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7608876513149946,-1.3651736615480679,0.1276595744680851,0.6813106644716622,1.0,4/15,8.08%,SCN5A;KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7210529440716933,1.3648951935053855,0.1509433962264151,0.8566213815661634,1.0,4/14,10.58%,IRS1;SCD;FOXO3;FOXO1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7365290001487929,1.3648013781817483,0.08,0.8556687509381722,1.0,10/19,17.86%,ACSM2A;SCD;SLC25A1;SCD5;FASN;THEM5;ACACA;FAR2;DGAT2;ACSL4
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.666816056485344,1.364760066338892,0.0851063829787234,0.8543250431103718,1.0,8/27,19.23%,PRKAB2;PPM1A;RRAGC;STRADA;CAB39L;PRKAA1;RRAGD;MLST8
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.8596797154727069,1.3645341363827561,0.045454545454545456,0.8529012116921227,1.0,3/9,4.16%,SYK;STAT5A;IL2RA
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.8596797154727069,1.3645341363827561,0.045454545454545456,0.8529012116921227,1.0,3/9,4.16%,SYK;STAT5A;IL2RA
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,-0.6181120495394057,-1.3642729893145493,0.07317073170731707,0.6839350658080546,1.0,7/59,3.27%,MS4A8;EHF;CAPN8;CLDN4;FAM3D;MUC5B;SPDEF
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.9110426251504795,1.3640673389462845,0.03571428571428571,0.8543630478351729,1.0,3/5,6.53%,IDO1;IDO2;TDO2
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.5914863671268297,1.3640010348293103,0.06,0.8531467590834886,1.0,27/92,12.41%,LHFPL3;IL17RD;NXPH1;ITGB8;C1QL1;LRP4;PMP2;SLC1A3;PCLO;ZNF462;MEGF10;WWTR1;CNN3;TMEM200C;EPHA5;F3;SCD5;GRM5;C6ORF118;TNC;PCDH7;NPAS3;CNTN1;RPE65;NKAIN3;FRMD5;GPM6B
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.720443500405659,-1.3639556809787492,0.14,0.684246558467997,1.0,2/13,7.24%,ADSS1;LHPP
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.6056849806306818,1.3638942905131206,0.038461538461538464,0.8523258950731467,1.0,21/70,22.84%,HGF;STAT5A;CDKN2A;FHIT;PLCG2;FOXO3;PIK3CA;SOS1;RARB;PIK3CD;RET;CDK4;TP53;POLK;AKT3;PIK3R3;BAD;MAPK3;AKT2;GRB2;CDK6
prerank,Reactome_2022__Activation Of TRKA Receptors R-HSA-187015,-0.930338192581685,-1.3637394902038966,0.05660377358490566,0.6836115511664111,1.0,2/5,6.18%,NTRK1;ADCYAP1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7592370668741586,-1.3634285489002467,0.11627906976744186,0.6837708166270555,1.0,5/12,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.7501534892739071,1.3632068775254151,0.14285714285714285,0.8555944151354794,1.0,4/18,17.28%,COX19;BCS1L;COX10;SCO2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,0.9253726843735123,1.3628456178727215,0.061224489795918366,0.8563761727161677,1.0,3/6,6.15%,RUNX1;RSPO3;ESR1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5253658324716981,1.362812243876293,0.06666666666666667,0.855142186124341,1.0,26/157,7.90%,VEGFC;GATA4;FLT1;STAB1;SEMA5A;RUNX1;TSPAN12;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PPARG;PIK3R6;RRAS;SP1;GLUL;CCN6;APELA;GAB1;F3;ANXA3;BMPER;CD40;AGGF1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5473764767950658,1.3627711503641122,0.037037037037037035,0.8538670054982661,1.0,18/79,11.97%,IRGM;SIRT1;IL4;TFEB;RNF152;MID2;TP53INP1;TICAM1;HMGB1;FOXO3;GNAI3;GPSM1;STING1;EPM2A;TRIM65;FBXO7;FOXO1;BNIP3L
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6562586062023037,1.362663495500629,0.13725490196078433,0.8531434258167019,1.0,7/28,10.84%,ADRA1A;SLC35G1;MCUB;SLC8A1;SMDT1;MCU;JPH1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.6436466312629865,-1.3626579313452911,0.07142857142857142,0.6856257626336251,1.0,2/38,2.38%,ANXA8;ALS2CL
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8503426042700669,-1.362372620344923,0.20833333333333334,0.6853103694489004,1.0,1/6,0.69%,CLDN4
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),-0.8814784069870729,-1.36226837048266,0.06666666666666667,0.6841438406299933,1.0,1/5,4.93%,DRD2
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.7564424235806796,-1.36196880102872,0.09433962264150944,0.684133591702658,1.0,4/19,4.67%,IL11;IL31RA;IL6R;CRLF1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.817702979593496,1.3619454375857702,0.1320754716981132,0.8559942196844361,1.0,2/8,4.29%,IGF1;LMOD3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.859898404682287,1.3617890768853178,0.037037037037037035,0.8553148328411879,1.0,5/9,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7888751175213516,-1.3614919098155815,0.12195121951219512,0.6846059526105608,1.0,4/18,7.45%,EIF2S3B;RBM4;EIF2S2;EIF2S3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7062054582983057,1.3614070709262702,0.05555555555555555,0.8558619746599477,1.0,3/20,5.37%,MYRF;PRDM8;SOX6
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Heart,0.8649176267447213,1.3607698608634877,0.04,0.8588282987068903,1.0,1/8,0.09%,GATA4
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7666402474043095,1.3604128035412295,0.05660377358490566,0.8594349438780327,1.0,2/17,2.87%,SLC5A8;PPARG
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,-0.6172380746860848,-1.3595479665681867,0.09433962264150944,0.6922313537022134,1.0,7/62,4.60%,ANXA8;CLDN4;GPR39;SERINC2;CLDN1;PTGES;PHLDA2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6831511228382153,1.3594159691923178,0.09615384615384616,0.8639399774880193,1.0,12/32,18.72%,IGF1;SP1;RELA;LRRTM3;BIN1;HAP1;RTN1;PICALM;EFNA1;ABCA2;RTN2;CASP3
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.7646273623298068,1.3590479501270467,0.058823529411764705,0.8646253533574717,1.0,3/12,7.69%,ADRA1A;ADGRV1;CD40
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8134453801534136,1.358943086690683,0.11904761904761904,0.8634660571496194,1.0,2/7,11.62%,SOCS2;PXN
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7095631651317345,1.358524804543374,0.09615384615384616,0.8646880667017438,1.0,9/15,21.42%,EMB;CNTN6;DSCAML1;DSCAM;CNTN2;CNTN4;MYPN;BSG;ROBO3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.651692064059745,1.3583426281262456,0.09090909090909091,0.8644058467652901,1.0,13/29,23.16%,SCRIB;LIN7A;ERBIN;ANK1;SYNE4;LRRC7;DLG2;CRB2;RAP2A;DLG3;PARD3;CRB1;DLG1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.6172735290704221,1.3582193835306364,0.06779661016949153,0.8639011605866916,1.0,4/59,5.62%,VAPB;CCL5;MDFIC;NR5A2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.569209813831253,-1.3582018170726564,0.06,0.6971548030056909,1.0,6/118,4.08%,CD44;HAPLN3;INHA;RFLNB;AHSG;PHEX
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.8075331486629557,1.3579733699284695,0.07272727272727272,0.8636659467140901,1.0,3/9,10.55%,ITGA10;ITGA2;ITGA1
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,0.7021824584238158,1.357967817474093,0.10526315789473684,0.8621623028860517,1.0,4/14,13.67%,SHMT2;MTHFD2L;MTHFD2;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5423772711206422,1.3575055844037363,0.043478260869565216,0.8633758357300683,1.0,26/91,15.60%,SMAD6;IL17RD;VWC2L;SIRT1;TGFBR1;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;PPM1A;SMAD1;MAGI2;SMAD2;VWC2;BMPR1A;DAND5;SMAD4;GREM1;FAM89B;LRP2;SPART;BAMBI;VASN;SMAD5
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.5219197788948988,1.3574909556948738,0.09302325581395349,0.8619001865123894,1.0,36/192,13.08%,FGF10;ITGA10;F2;CHRM2;ITGA8;FGFR3;ITGAX;ITGB8;F2R;FGFR1;ITGA11;ITGA2;FGF2;RRAS;GNG12;DOCK1;ACTR3C;CXCL12;PIP4K2A;ITGAV;MYL12A;PDGFRA;PPP1CC;PDGFC;MYH11;FGF17;PIK3CA;GSN;ITGA1;PAK5;PXN;BCAR1;PPP1R12B;KNG1;SOS1;FGF5
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8164876524258768,1.3573847693712786,0.06,0.8611828354668373,1.0,6/10,12.35%,LRP4;NLGN1;CEL;PTPRD;NLGN4X;PTEN
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.6501567387632924,1.3572444374861308,0.10638297872340426,0.8604901129162594,1.0,4/16,5.54%,TGFBR1;SNAI1;BMP2;RBPJ
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8285328969493257,1.3571757479656203,0.0967741935483871,0.8593804344712164,1.0,3/9,11.01%,SIRT1;LEPR;GCK
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.5468463979257521,1.3571688340121681,0.07407407407407407,0.8579220894460716,1.0,20/89,12.87%,VEGFC;CFH;ARHGAP24;ADGRL4;RIN2;CRIM1;RAB31;LTBP2;PDLIM5;MYOF;FAM114A1;ABCA1;PDGFC;GSN;MEDAG;AOX1;TNS3;SMPDL3A;HTRA1;PXDC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7684193046815615,1.3566457774568947,0.05660377358490566,0.8599221606111513,1.0,4/13,11.11%,KLRD1;NECTIN2;CADM1;HLA-E
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.7138591532980223,1.3565865160479702,0.17647058823529413,0.8587094844089984,1.0,7/13,24.66%,SLC26A7;SLC26A6;SLC26A4;RACGAP1;SLC25A30;SLC25A14;SLC26A2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.7621594371130325,1.3564643311855071,0.14035087719298245,0.8579394102125661,1.0,3/16,17.28%,COX19;BCS1L;SCO2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7187785563698362,1.3564492570530546,0.1320754716981132,0.8565374566534766,1.0,2/17,0.64%,ADRA1A;DRD5
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,0.7520808790414746,1.3563898800340481,0.09090909090909091,0.8552932651176591,1.0,2/15,3.13%,CTDNEP1;LPIN3
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.6103912365049892,-1.3563578183931604,0.10204081632653061,0.7039558615342734,1.0,7/57,3.87%,ANXA8;CLDN4;TMEM184A;GPR39;MSLNL;C6ORF132;AGRN
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7823023784508696,1.3562691493049983,0.1276595744680851,0.8545549036927232,1.0,2/11,3.24%,CTDNEP1;LDLR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.8558211491806044,1.356155289681221,0.08620689655172414,0.853862628283225,1.0,2/5,13.72%,MTMR9;MTMR3
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.7463982174341215,1.3560969245536936,0.13333333333333333,0.8527598654426545,1.0,5/15,18.31%,IGF1;ACHE;BCHE;PLA2G7;UCN
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.700225213437999,-1.3559750480966264,0.18181818181818182,0.7039495409942043,1.0,3/14,7.82%,ACTC1;NEB;MYLK3
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.7420571547975205,1.3557927425282894,0.05084745762711865,0.8530709332880698,1.0,6/19,12.78%,ERBB4;NRG1;NRG3;NRG2;ERBIN;SOS1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7707577275263787,1.3557567600734588,0.09615384615384616,0.8518217313416,1.0,3/11,12.69%,TGFBR1;WNT9A;GREM1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7574478291615571,1.3555118955352015,0.08,0.8519171569879891,1.0,3/15,11.34%,BOK;RNF185;RNFT1
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8683485188805301,1.355309412226712,0.14285714285714285,0.8516237905588826,1.0,3/5,11.05%,ABHD3;ACADM;GLYATL2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6565729017232967,1.355268180949688,0.09302325581395349,0.850297290472911,1.0,7/28,8.51%,LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;ACHE;CEPT1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.8916430596248006,1.3552289304821226,0.0196078431372549,0.8491043641760819,1.0,2/5,4.82%,RUNX1;HCLS1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.604425439883686,1.3548633551786786,0.11764705882352941,0.8495473065265392,1.0,6/37,14.76%,TNFSF14;CD40;TNFRSF10B;MAPK8;MAP3K1;PIEZO1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6749762640332269,1.354150836797609,0.09259259259259259,0.8525823278917144,1.0,7/18,14.65%,NPC2;ABCA1;ABCG8;SOAT2;ABCA8;ABCG5;SOAT1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7639576442897276,1.353782738048638,0.06451612903225806,0.8536384091434737,1.0,3/11,8.97%,SYT1;UNC13B;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7876082753861327,1.3536998909261804,0.14,0.8526615268923384,1.0,3/11,11.86%,SEMA5A;CRACD;CARMIL1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.570569195251755,1.3535055322935357,0.09433962264150944,0.8523277241096124,1.0,20/86,8.38%,MXRA5;LAMA4;MRGPRF;PRRX1;PRKG1;ITGA11;ADGRL4;ANGPT1;MSRB3;SSC5D;CPED1;BGN;COL6A2;CXCL12;POSTN;CCDC80;PDGFRA;CNRIP1;CYBRD1;PCDH18
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.8584895328829437,1.352559128426844,0.14583333333333334,0.8569555639550573,1.0,1/6,2.33%,PLOD2
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.5836900727653916,-1.3524401358436111,0.061224489795918366,0.7172791972344611,1.0,13/62,9.38%,P2RY10;SIRPG;STXBP2;PCED1B;PSD4;JCHAIN;TTC22;KLRB1;F11R;CD5;CCDC88C;TMC8;DEF6
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.5836900727653916,-1.3524401358436111,0.061224489795918366,0.7172791972344611,1.0,13/62,9.38%,P2RY10;SIRPG;STXBP2;PCED1B;PSD4;JCHAIN;TTC22;KLRB1;F11R;CD5;CCDC88C;TMC8;DEF6
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.6240795371431459,-1.3523511883008892,0.10204081632653061,0.7160307907664857,1.0,6/32,7.73%,CAPN8;ERN2;MUC5B;SPDEF;IFI27;SYTL2
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.6629792906085243,1.3522996348340839,0.07142857142857142,0.8571257384565891,1.0,10/24,23.85%,STAT5A;PIK3R5;PLCG2;PIK3CA;SOS1;EPX;IRS2;LYN;GRB2;JAK2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.9128363561174944,1.3517114076709926,0.05357142857142857,0.8592686215020819,1.0,1/5,1.70%,ACE2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.8013214420430861,1.351005280987056,0.21428571428571427,0.862039774186628,1.0,2/7,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5493279311121059,-1.350912593796681,0.021739130434782608,0.7215022409461668,1.0,16/105,13.11%,TERT;DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;FLOT1;HFE;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1;WNT3A;PRMT7;CAV1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.7462016552343745,-1.3507943645299223,0.16,0.7203313969606352,1.0,1/10,1.18%,TEK
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.8652934363807332,1.3506878912461924,0.1111111111111111,0.8624754709815142,1.0,2/5,6.50%,SIX4;MEGF10
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7497713015742715,1.3505959370195832,0.19607843137254902,0.8613685717683258,1.0,5/10,19.49%,THRSP;PRKAB2;ACACA;ACACB;MID1IP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.667178263704548,-1.3505474747665682,0.10256410256410256,0.719962707660429,1.0,5/26,10.00%,DDX11;HMGB3;RECQL5;RAD50;RTEL1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5729901372393942,1.350430879252305,0.038461538461538464,0.8610241161003208,1.0,16/55,20.89%,IGF1;TLR2;UNC13B;ACHE;MCU;GCK;MYRIP;MYOM1;GOLPH3L;CD2AP;PTPN23;ACSL4;IRS2;CAPN10;BAD;GLUD1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.8080720268586757,1.3503720213769301,0.1111111111111111,0.859776048895476,1.0,1/8,2.51%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4876303247033454,1.3502667418355327,0.024390243902439025,0.8587842127155325,1.0,71/441,10.92%,TNFSF14;LGALS9;IGF1;ADRA1A;FGF10;FLT1;SEMA5A;IRS1;FGFR3;HGF;BOK;CCL5;RIT2;TNFRSF19;SIRT1;TGFBR1;IL26;F2R;FGFR1;ERBB4;FGF2;NRG1;NEDD4;ANGPT1;CALCR;ROR1;KSR1;CANT1;BMP2;NLGN1;PIK3R5;PELI2;SLC35B2;HCLS1;ADGRV1;LIN28A;SEPTIN4;MID2;RELA;PELI1;TIFA;TLR2;ESR1;HPSE;CASS4;ITGAV;PDGFRA;PLCG2;TICAM1;GAB1;HDAC3;F3;NRG2;CD40;ADRA2C;NEUROD2;HMGB1;PPM1A;PDGFC;RAMP3;EPHA8;TAB2;FGF17;TSPAN6;PIK3CA;HIP1;PLXNB1;FLT3;TNFRSF10B;CASP10;GPR62
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6556919057553929,1.3502659982006786,0.09302325581395349,0.8573552872368045,1.0,7/25,20.46%,LRP4;DCC;PTEN;KIAA0319;DIP2B;MCF2;MAP2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5483058345252183,-1.350206243024515,0.07317073170731707,0.7198552906786353,1.0,13/91,10.23%,LRP10;EHF;RAC2;FAM3D;MVP;IER3;LAMB3;OAS3;OAS1;ABCC3;VDR;MFGE8;HLA-C
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8970040773714163,1.3502053414952777,0.08333333333333333,0.8563498312794098,1.0,3/7,6.66%,SOX5;SOX6;PDGFRA
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.7831882372489121,1.3501691896738366,0.06779661016949153,0.855473118526294,1.0,4/17,3.48%,ZBTB7B;ERBB4;NRG1;WNT4
prerank,Reactome_2022__Passive Transport By Aquaporins R-HSA-432047,-0.8417567322157461,-1.3501078263441904,0.1509433962264151,0.7186961197298098,1.0,2/6,9.32%,AQP7;AQP8
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.7269425534524998,1.349890848584399,0.08620689655172414,0.8561851846951481,1.0,4/11,18.05%,MOV10;CNOT6L;PTEN;AGO3
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8368612948941405,-1.3496984257690414,0.14893617021276595,0.7192219656697525,1.0,4/7,10.96%,DNAAF1;DRC1;DNAH11;CCDC40
prerank,Reactome_2022__Hormone Ligand-Binding Receptors R-HSA-375281,0.8213591247245101,1.3493924870544476,0.16129032258064516,0.8581240024842887,1.0,2/7,8.06%,GNRH1;GNRH2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.9213661175590893,1.3493904792802671,0.038461538461538464,0.8567287541964338,1.0,2/5,4.27%,IRGM;FYCO1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6053766454243035,-1.3491687433783228,0.14814814814814814,0.7200516352995164,1.0,9/49,15.62%,DDX11;RECQL5;RAD50;XPC;RTEL1;PARP1;GTF2H2;SUPV3L1;MCM2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6259056087015603,1.3487379821152512,0.125,0.8595946528701082,1.0,13/36,17.85%,GRM3;GRIN3A;GRM8;GRIK2;GRM5;GRIN3B;GRIK3;GRM4;GRM7;PLCB1;GRM1;GRID2;FMR1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8796686649252011,-1.3485386084944835,0.1282051282051282,0.719935069737772,1.0,1/5,1.04%,CD24
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8796686649252011,-1.3485386084944835,0.1282051282051282,0.719935069737772,1.0,1/5,1.04%,CD24
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8182511279233574,1.3485000673991066,0.10344827586206896,0.8597977473940915,1.0,4/9,11.90%,PPARG;ITGAV;ABCA1;NR1H3
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7903211818832356,1.3484193861383342,0.03508771929824561,0.8587998377939124,1.0,2/10,2.18%,LGALS9;ZBTB7B
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.5437907497106702,1.3483935183565576,0.04,0.8574746153715898,1.0,29/146,14.24%,SGO1;DACH1;TOP2A;NDC80;CCNA2;PHGDH;ZEB2;FBXO5;APOLD1;DLGAP5;SYT1;CNTLN;CDCA4;ASPM;NRXN1;PAX6;GMNN;MCM7;RTN1;EMX1;SINHCAF;MEF2C;HSPB1;H2AZ2;MYT1L;PCLAF;ID4;TMEM98;RUNX1T1
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.5656102211847811,1.348263234715415,0.08,0.8570407230094105,1.0,27/97,16.15%,CADM2;TMEFF2;MMP16;LRP1B;NLGN1;PCLO;ZNF462;SYT1;ADGRL2;LIFR;STOX2;FAM171B;PRICKLE2;ANK2;MAGI1;GUCY1A2;LRRTM3;NPAS3;CNTN1;GLRB;FIGN;ID4;NBEA;DLG2;CPE;GPRC5B;MAPK10
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7668318938396697,1.3480282069227247,0.125,0.8572878512455723,1.0,5/13,11.28%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.7441651815384804,1.3479152113032973,0.09090909090909091,0.8567323166461742,1.0,1/19,1.16%,AP1M2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.6982418108966307,1.3474952369127446,0.12280701754385964,0.8578618005367236,1.0,5/25,10.26%,SMYD1;PRMT1;SMYD2;CTCFL;EZH2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.8802353181603212,1.3466756891636111,0.03773584905660377,0.8608525253642586,1.0,1/5,4.02%,TCAF2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7696175389264678,1.3463851599632146,0.14285714285714285,0.8614192255572526,1.0,2/12,7.26%,SEMA5A;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7259556573773708,1.3463535596638412,0.1111111111111111,0.860288636894397,1.0,5/24,10.28%,F2;GSTM2;F2R;SNCA;HAP1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.8105882663238584,1.3461899065649678,0.09259259259259259,0.859916287970964,1.0,3/9,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7075183106160223,1.3457052243948786,0.017543859649122806,0.8615201718135078,1.0,6/15,19.69%,SMAD6;ROBO2;NOTCH2;HEY2;JAG1;BMPR2
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,0.8179245217063777,1.3454498988205634,0.15217391304347827,0.8617568863808095,1.0,2/10,2.47%,ITGAX;IL4
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.556823480409635,1.3453674731093965,0.0392156862745098,0.8607954008003723,1.0,27/87,20.73%,IGF1;TGFBR1;CDKN2AIP;LGI1;SYT1;RIMS2;EXOSC4;DBN1;ZNF639;RPS6KA1;DERL2;L1CAM;SLC44A4;CDKL5;MACF1;H3-3A;ADAM10;SMURF1;SYT3;BRAT1;SLC25A33;CPNE9;GOLGA4;NCBP1;EDN1;ADNP2;SYT17
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8202971233321916,1.34507704093346,0.08620689655172414,0.86111357115876,1.0,2/14,1.62%,IGF1;HGF
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.5881543893072211,1.3449348073292402,0.05263157894736842,0.8609047296682433,1.0,17/63,17.39%,GATA4;IGF1;ACE2;RAB27A;PAX6;DPP4;ACHE;INHBC;MYRIP;ANPEP;BCHE;SLC30A6;CPE;PCSK2;CTNNB1;PLA2G7;EXOC6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.6459133009915586,-1.3449009227950974,0.10416666666666667,0.7351320689540248,1.0,4/34,8.85%,DUSP4;DUSP6;UBASH3B;PGP
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6380051409906893,1.3446065880172577,0.06779661016949153,0.8616054666792853,1.0,10/35,19.94%,KAT2B;ZDHHC12;GLUL;ZDHHC22;ZDHHC2;FOXO1;KAT6A;GTF2B;ZDHHC17;ZDHHC13
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8591284789448596,1.3445231125795556,0.09615384615384616,0.8608318678547227,1.0,1/5,1.32%,C3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8795969439633899,1.3442579136189803,0.09615384615384616,0.8611278134710462,1.0,3/6,9.95%,PLEKHH2;PIK3CA;GSN
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5796134551664628,-1.344076392414713,0.075,0.7373083377179184,1.0,9/75,6.91%,LRP10;UMODL1;TMEM184A;UPK1A;PRKCD;STXBP2;ABHD11;PSD4;PRKD2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7809510729274691,-1.3440341763570263,0.25,0.7358574567549935,1.0,4/7,13.81%,NLRP3;CD86;IL18;RARA
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.5589874229521975,1.343860285824065,0.058823529411764705,0.862307274032688,1.0,19/96,11.91%,IL17RD;TSPAN12;FGFR3;CKMT1A;FRAS1;PCLO;ALDH7A1;LRIG3;CYP39A1;LIFR;STOX2;DSP;MAGI1;TSPAN6;CLDN12;CGN;ARHGEF16;ZNF704;PPP1R9A
prerank,CellMarker_Augmented_2021__Macrophage:Serum,0.8559403719304464,1.3429065207760398,0.1346153846153846,0.866694071355409,1.0,1/5,1.66%,ITGAX
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8452489452602268,1.342571233544362,0.038461538461538464,0.8672598095317802,1.0,2/8,2.86%,CHRM2;HRH3
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.5654698845661981,1.3423494450628648,0.0625,0.8673636224742296,1.0,23/92,17.71%,TUBA1C;SHMT2;OSTC;PPP1R14B;SPR;SLC35B2;MANF;AHCY;MARVELD1;TK1;ALCAM;IFRD2;SLC35F2;TNFRSF10B;IRAK1;SEC61A1;ULBP3;BYSL;DOLK;MYDGF;RCC1;CDK4;RCN1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,0.6044765988005709,1.3419472701124113,0.0851063829787234,0.8687454369015404,1.0,13/57,15.10%,ZDHHC11;PRMT1;ST6GALNAC3;MAGT1;MOGAT2;GALNT1;ZDHHC2;FUT8;PRKCSH;MAN2A1;MGAT5;MGAT4C;MGAT4A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.7907147477578342,1.34165635906072,0.08333333333333333,0.8692454168497343,1.0,2/11,2.47%,SYK;IL4
prerank,CellMarker_Augmented_2021__Vaginal cell:Vagina,-0.5947397138847358,-1.341620988058369,0.0851063829787234,0.7448755635537387,1.0,5/53,2.82%,ANXA8;EHF;CLDN4;TMEM184A;C6ORF132
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.7216064575090361,-1.3415052841460313,0.14,0.7438744304120727,1.0,2/10,4.76%,APOBEC3H;APOBEC3G
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,0.7341572561866653,1.3414501698910815,0.15384615384615385,0.8690668496867101,1.0,4/11,19.49%,THRSP;PRKAB2;SLC22A5;MID1IP1
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,-0.7804720458929891,-1.341430470702497,0.13157894736842105,0.7426402746699147,1.0,1/12,0.08%,UGT2B15
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.8542165242594407,1.341379624954923,0.03773584905660377,0.8681533080011126,1.0,3/6,7.79%,HS3ST5;HS3ST3B1;HS2ST1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6901236818412035,1.3412860046589126,0.05357142857142857,0.8675602131250888,1.0,7/22,10.25%,LGALS9;SYK;TLR2;PLCG2;CD40;HMGB1;IL23R
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8431191067742263,-1.3410931790538756,0.16,0.7428173418187173,1.0,4/10,9.36%,KCNE2;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.710865452401178,-1.3409895478290752,0.13725490196078433,0.7416855138139158,1.0,4/16,8.78%,SIGIRR;TRIM5;TRIB1;LY86
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,0.7459781130954913,1.3408366012940405,0.09523809523809523,0.868851587579185,1.0,4/11,4.63%,CXXC4;TSHZ2;HS3ST3B1;PLCXD3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5332103441316849,1.3407457338245679,0.07692307692307693,0.8681999013217502,1.0,28/133,10.29%,FGF10;SEMA5A;IRS1;FGFR3;HGF;TGFBR1;IL26;FGFR1;ERBB4;FGF2;NRG1;ANGPT1;CALCR;PIK3R5;HCLS1;LIN28A;ESR1;HPSE;CASS4;PDGFRA;GAB1;F3;NRG2;RAMP3;FGF17;PIK3CA;HIP1;FLT3
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8020500617672199,1.3407221977033519,0.1111111111111111,0.8669971245490736,1.0,4/11,11.01%,IGF1;IRS1;DYRK2;GCK
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7998582087391808,-1.3406866075335269,0.14285714285714285,0.7399545631283955,1.0,3/8,4.93%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7998582087391808,-1.3406866075335269,0.14285714285714285,0.7399545631283955,1.0,3/8,4.93%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.7579680479477914,1.3405108397745937,0.16666666666666666,0.8673760203226971,1.0,5/12,17.81%,SIRT1;PPIF;PXK;VCPKMT;TP53
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.7511035779371695,-1.340244882951127,0.20930232558139536,0.7401829281749824,1.0,2/12,4.74%,TRIM56;DDX41
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4788453001130249,-1.3399944926037308,0.018867924528301886,0.739785384892657,1.0,15/386,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.528992396683976,1.33997720712908,0.07142857142857142,0.8690928581767303,1.0,39/162,18.06%,TNFRSF18;RUNX1;RSPO3;KAT2B;SEM1;LMO1;IL2RA;PRMT1;H2BC21;MOV10;LMO2;ESR1;LIFR;RYBP;YAF2;ACTL6A;KCTD6;ARID2;SMARCD3;PSMD13;ELOF1;ARID1A;H2AC6;MYB;RNF2;H2AZ2;PSME4;ARID1B;CCND3;PML;SMARCD2;CCNH;PCGF5;H2AX;PSMA1;SMARCA2;MNAT1;AGO3;CTSV
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.808561358983757,1.3399530696452375,0.10526315789473684,0.8678549929381794,1.0,2/10,3.23%,ITGAX;MYRF
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7853670416883046,-1.3398908577847426,0.11538461538461539,0.7386257255166333,1.0,2/6,16.80%,LDB1;NUP133
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9099183944605536,-1.3398650731865738,0.075,0.7371133465322108,1.0,2/5,3.29%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8390150462764976,1.3398198448452372,0.1320754716981132,0.8673669879054832,1.0,2/6,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.8093307704808272,1.3397248691391586,0.10714285714285714,0.8666648881131892,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.8499407860408582,-1.3397082000433478,0.2222222222222222,0.7363370210560606,1.0,3/5,8.08%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7714140503662953,1.3395047723790257,0.11290322580645161,0.8665325194713114,1.0,4/9,9.75%,TGFBR1;INSIG1;RORA;SMAD2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.7961748361089314,1.3390458001656989,0.11320754716981132,0.8681787351415438,1.0,4/7,19.92%,ABCD3;ABCD2;ABCD4;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5393618018639053,1.3389424711936253,0.022222222222222223,0.8675566797955622,1.0,9/80,10.07%,MAP3K11;TNFRSF19;IL26;GDF6;BMP2;PRMT1;RELL1;HMGB1;MAP4K2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7219112145253211,1.3387071702221607,0.12,0.8674819864772949,1.0,5/16,8.41%,NCAM2;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7429454023837817,1.3383845402993526,0.1346153846153846,0.8683800190677456,1.0,5/12,20.09%,PRR5L;MOV10;ZC3HAV1;CNOT8;PNPT1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.8077172018753475,-1.3383112575202494,0.13333333333333333,0.7402567734617471,1.0,1/8,0.23%,RFX6
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6758435216721396,1.3381556194834348,0.11290322580645161,0.8682071876094832,1.0,6/24,16.12%,IRGM;RELA;MAP2K6;TAB2;IRAK1;TAB3
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.5647683293987567,1.3380805059599241,0.04081632653061224,0.8672786755376676,1.0,19/98,10.88%,NXPH1;VWC2L;RIT2;NGB;GRM3;KCNC2;CADM2;RALYL;SLC17A6;ZDHHC22;NRXN1;RAB3C;OLFM3;SYNPR;GRM5;CTNNA2;PAK5;TMEM196;HCN1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5920769067465581,1.3378473500118966,0.1590909090909091,0.8673984709720479,1.0,19/62,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;SLC37A4;GABRG1;GABRB2;ANO5;ANO6;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8019991407683236,1.3376534612898592,0.12280701754385964,0.8674405766042106,1.0,3/8,11.90%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7679431709939275,1.337114565038151,0.0851063829787234,0.8694512532520698,1.0,4/10,12.75%,SHMT2;PHGDH;SRR;CBS
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.8921065525653217,1.337079535209974,0.10526315789473684,0.8682181744248056,1.0,3/5,7.36%,SEMA5A;NRARP;BMPER
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.8565997051042469,1.3369472595253553,0.04,0.8676623323291499,1.0,2/5,4.40%,FGF2;SIX4
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.7970854387332703,1.336812569940224,0.11320754716981132,0.8670889721605476,1.0,2/10,9.28%,CCL5;PAG1
prerank,CellMarker_Augmented_2021__M1 macrophage:Undefined,-0.8101842250353438,-1.336771468141745,0.10416666666666667,0.7462149845419757,1.0,2/7,7.03%,CD86;IRF5
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.47732095420318355,-1.3366198018627415,0.018518518518518517,0.7452081721882968,1.0,15/391,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5416612460444201,-1.3364644935047696,0.08,0.7443287909778804,1.0,7/89,3.34%,ANXA8;EHF;DUOXA1;CLDN4;SERINC2;CLDN1;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.8141060805933703,1.3360395994651026,0.16666666666666666,0.8705650696322423,1.0,3/6,18.53%,SNCA;PPIF;NDFIP2
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8416120822709614,1.3354881524002058,0.16,0.8727855709066421,1.0,2/5,4.00%,ACE2;CNTNAP2
prerank,KEGG_2021_Human__Oocyte meiosis,0.5052567654465117,1.3352360630084055,0.03571428571428571,0.8730676828835934,1.0,5/107,3.67%,SGO1;IGF1;ESPL1;SPDYE2B;FBXO5
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5426669443718728,1.3350067998723185,0.1276595744680851,0.8727951480647305,1.0,32/111,16.15%,LRRC3B;SLC35F1;LRRC4C;LRP4;SLC1A3;GFAP;NLGN1;OLIG2;PCDH17;EFS;MEGF10;TMEM200C;PAX6;NOVA1;PTPRD;ANK2;GUCY1A2;ADGRB3;MAGEL2;ATP1A2;NPAS3;ZNF536;GPM6B;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5492868922472606,1.3344271107854595,0.038461538461538464,0.8751928714543904,1.0,10/67,14.90%,CGNL1;TGFBR1;RAPGEF3;TMEFF2;DLC1;PPM1E;PXN;CARMIL1;SORBS3;PHLDB2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7241669574427854,-1.3340106495215136,0.14634146341463414,0.7543088687091352,1.0,1/15,0.73%,AMACR
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.48214352017142215,1.334009491098722,0.046511627906976744,0.8763648818385944,1.0,42/278,14.34%,ASB17;HERC3;NEDD4;ASB18;SPSB2;SEM1;ASB15;CBLB;UBE2J1;RNF182;TRIM50;KLHL21;ASB5;UBE2E2;FBXL3;UBE2D3;SPSB4;FBXO30;UBE2Z;RNF217;GAN;UBE3D;KCTD6;UBE2E3;KEAP1;UBA5;PSMD13;LNPEP;FBXO7;FBXL14;HECW2;UBE2U;KLHL42;RBBP6;UBA6;ASB6;UBE4A;PSME4;UBE2J2;UBA3;KLHL13;FBXL15
prerank,KEGG_2021_Human__Lysine degradation,0.590845342679341,1.333814994657992,0.10204081632653061,0.8763167254300372,1.0,11/62,11.06%,AASS;SMYD1;PLOD2;HYKK;ALDH7A1;SMYD2;ALDH1B1;ALDH9A1;COLGALT2;EZH2;CAMKMT
prerank,Reactome_2022__GRB7 Events In ERBB2 Signaling R-HSA-1306955,0.8813420431256735,1.3333989039539307,0.06976744186046512,0.8780149876914931,1.0,2/5,7.20%,NRG1;NRG2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.7309742663462065,1.3332515509626086,0.0967741935483871,0.8776802043751168,1.0,4/15,15.78%,SIRT1;HTRA2;HSPB1;NFE2L2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.580108308194377,1.3331279543627137,0.037037037037037035,0.87693009325943,1.0,24/81,15.24%,IL17RD;EPHA7;MYCN;FRAS1;CNTNAP2;SYT6;LIN28A;CXCL12;ZDHHC22;UNC5D;TMEM200C;ADAMTS19;IGDCC3;SPSB4;NLGN4X;EPHA8;VANGL2;MAGEL2;VASH2;CLDN6;GRM4;RIMS4;L1TD1;VRTN
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.9079151805344208,1.3325711257828363,0.05357142857142857,0.8785442141194004,1.0,2/5,4.68%,IL4;H2BC21
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.7289927178217055,-1.3325176801588687,0.1346153846153846,0.7599867736714908,1.0,3/18,3.15%,NLRP1;NLRP3;MEFV
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.6346140946328911,-1.3325078203029492,0.11320754716981132,0.7584087371814687,1.0,15/52,8.48%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;IRF4;TRAF3IP3;ICAM3;CD53;CYTH4;LTB;CD5;TAGAP;TMC8;PTPN7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8030547212706478,1.33245621374055,0.1320754716981132,0.8778705257172826,1.0,3/8,8.32%,CALCR;CXCL12;RAMP3
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.7167981965162327,1.3323221745278717,0.16279069767441862,0.877293048192632,1.0,2/19,5.78%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.9099762048053748,1.3321826312023057,0.02,0.8767172944814877,1.0,3/5,7.75%,RUNX1;ZBTB7B;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6077373469038249,1.3320619276376766,0.08695652173913043,0.8761432568767852,1.0,10/41,10.19%,SIRT1;FGFR1;HIF1A;STAT5A;FGF2;ANGPT1;SP1;CD40;HMGB1;NUS1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8023389806322249,1.3318722829630587,0.09836065573770492,0.8758710120041026,1.0,2/7,5.19%,LGALS9;CXCL12
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6684255428690768,1.331731493258913,0.10204081632653061,0.8753561199830843,1.0,4/30,9.35%,HELB;RPP40;PWP2;RRS1
prerank,Reactome_2022__Acrosome Reaction And Sperm:Oocyte Membrane Binding R-HSA-1300645,-0.8254461900028347,-1.331718965753819,0.16279069767441862,0.7608498523308657,1.0,3/5,13.93%,IZUMO3;IZUMO2;CD9
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.6605925562402641,1.3314842220081038,0.16666666666666666,0.8756655388611597,1.0,3/27,4.07%,ESPL1;NDC80;NDE1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.8201474523488548,-1.3312159761907183,0.22448979591836735,0.7617429660466795,1.0,2/7,6.93%,KCNE2;KCNE1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7015596213793598,1.3311683226058917,0.13333333333333333,0.8765155263666831,1.0,2/16,3.37%,MYRF;PRDM8
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.9161703211100449,1.33109946382718,0.038461538461538464,0.8756663687257,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8692517876485575,1.330710652750877,0.08771929824561403,0.8764952272136165,1.0,1/7,0.53%,FGF10
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.7143054340464984,1.330661404149243,0.14,0.8755556579416804,1.0,2/13,3.42%,NPC1L1;SLC26A6
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.7156808526351404,1.3305675509273145,0.09803921568627451,0.8748044753250998,1.0,5/23,13.56%,SYK;RAPGEF3;BCAR1;SOS1;RAP1A
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.6323310800481337,-1.3303696292564418,0.15789473684210525,0.7634070577038262,1.0,2/56,4.07%,TRIP10;OBSCN
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.7697457233133158,1.3303395218321725,0.12727272727272726,0.8747227483067932,1.0,3/13,3.30%,FGF10;NRG1;OPRK1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5112068082469333,-1.3303128938867472,0.05263157894736842,0.7619564231604938,1.0,7/134,4.32%,CD44;TEK;COL4A2;COL5A1;COL4A1;BOC;CRYM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4994413625345871,1.3300541058091475,0.022222222222222223,0.8752334981393718,1.0,19/153,8.22%,MXRA5;PCOLCE2;LAMA4;SMAD6;MRGPRF;STAB1;SMOC1;TMTC2;ADGRL4;GNG12;DOCK1;BGN;CXCL12;LTBP2;POSTN;WWTR1;FAM114A1;PLSCR4;MARVELD1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.8323407809259358,1.3300367477407988,0.0967741935483871,0.8739871250923764,1.0,3/6,6.01%,GRIP1;GRIP2;SCRIB
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.8406098270051117,-1.3299377608901393,0.14545454545454545,0.7621154204842663,1.0,2/6,2.25%,GUCY2C;GUCA1B
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.686276649087754,1.3295457202659113,0.21666666666666667,0.8759183532660341,1.0,2/13,1.94%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6075326565425115,1.3291455474772857,0.15555555555555556,0.877070032992022,1.0,6/38,7.23%,F2;SYK;ACE2;RAB27A;PLCG2;DCXR
prerank,Reactome_2022__Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors R-HSA-629587,-0.8972442106807584,-1.3289855094758578,0.0975609756097561,0.7648399694212968,1.0,2/6,6.70%,CHRNE;CHRNG
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7488091079071169,1.328796151674834,0.1896551724137931,0.8779607595500223,1.0,1/11,0.53%,FGF10
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.5510041365230203,1.3285396866104378,0.10869565217391304,0.878187478972878,1.0,27/78,15.92%,ZNF804B;PCDH15;NXPH1;VWC2L;GRM3;KCNC2;RALYL;SLC17A6;GALNTL5;LGI1;TEX26;NRXN1;GRM5;PTPRT;CTNNA2;PAK5;NOL4;CNTN5;ADAM7;GABRG1;GABRB2;GRM7;SLC9C2;MOBP;SLC25A31;LRRC72;GRM1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.7649381569671729,-1.3282631787884087,0.11627906976744186,0.7665739095472418,1.0,1/10,1.28%,INHA
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,-0.5640404961581962,-1.3278473886350575,0.1276595744680851,0.76551983324804,1.0,12/50,12.09%,EHF;CAPN8;FAM3D;TTC22;F11R;OLFM4;ABCC3;CEACAM1;SERPINB5;VSIG2;IL18;CXCL16
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,-0.5640404961581962,-1.3278473886350575,0.1276595744680851,0.76551983324804,1.0,12/50,12.09%,EHF;CAPN8;FAM3D;TTC22;F11R;OLFM4;ABCC3;CEACAM1;SERPINB5;VSIG2;IL18;CXCL16
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.5474975646591249,1.3277118026080583,0.05555555555555555,0.8827064472043366,1.0,14/73,9.02%,GATA4;CGNL1;FLT1;IRS4;PREX2;EPHA7;PRKG1;ST6GALNAC3;PCDH17;ADGRL2;QRFPR;SPSB4;PTPRD;CACHD1
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,0.7592084725616391,1.327641409502197,0.18032786885245902,0.8817898256253841,1.0,3/9,18.12%,RHOBTB3;RAB9A;HTR7
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5505943404024785,1.3276348387955539,0.034482758620689655,0.8805831846015113,1.0,18/99,14.41%,IRGM;CCNG1;CDKN2C;SIRT1;CDC25A;CCNA2;KSR1;SLC8A1;CNPPD1;SNCA;TELO2;CCNB3;EZH2;CDK12;CCND3;SERTAD1;LRP6;CCNH
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.749622132868677,1.3274350981630867,0.14035087719298245,0.8804029370914445,1.0,5/12,9.75%,CXXC4;SMAD6;FZD5;RIPPLY2;SMAD2
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.5502187395531709,1.32742202053745,0.024390243902439025,0.879183556024934,1.0,30/103,22.25%,IGF1;IRS4;IRS1;SOCS2;STAT5A;SSTR3;MAP2K6;PLCG2;GNAI3;PIK3CA;BCAR1;MAPK8;SOS1;CREB3L2;CREB1;MAP3K1;PLCB1;PIK3CD;MAPK10;IRS2;SSTR1;PRKACB;AKT3;PIK3R3;MAPK3;GNAQ;CRK;GNAI1;AKT2;GRB2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6871745686905157,1.3272996479019046,0.14285714285714285,0.8785505218421653,1.0,12/23,22.16%,SULT2A1;SULT6B1;ENPP1;MTARC2;TPST2;THAP4;GRHPR;PPA2;MINPP1;DAO;LIAS;LIPT2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7415169780138849,1.327296049290393,0.14285714285714285,0.8773191460243389,1.0,4/14,11.90%,PPARG;ITGAV;ABCA1;NR1H3
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.5634978819784116,1.3271573394933658,0.08163265306122448,0.8770719977483361,1.0,16/74,14.93%,EBF1;PPARG;MED17;RELA;MED13L;HDAC3;ZNF467;SMARCD3;NCOA2;TBL1X;ZNF638;CCND3;ANGPTL4;NR2F2;CHD9;NCOA3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.7431979669842708,1.3270623828344146,0.18,0.876390330530592,1.0,2/7,5.54%,SNAI1;RBPJ
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,0.7125351531182246,1.3267887676665058,0.14814814814814814,0.876815242734019,1.0,4/12,18.40%,PHGDH;RPIA;PRPS2;RPE
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.5498997398962874,-1.3262636500637426,0.12727272727272726,0.7710436212247789,1.0,1/152,0.01%,CD44
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6881515811043161,1.3262569007995784,0.17307692307692307,0.8787940353096113,1.0,5/17,15.86%,SHMT2;MTHFD2L;MTHFD2;SLC19A1;PM20D2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8140321110343166,1.326065082624575,0.08695652173913043,0.8785642469818362,1.0,1/7,0.09%,GATA4
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.8367346826167816,-1.3258593385736923,0.18,0.7714804128288593,1.0,2/5,13.89%,CEACAM1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.8610199019454401,1.3256444972414243,0.14893617021276595,0.8802283517603593,1.0,1/5,1.53%,TSPAN12
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.7125973212806738,1.3254800232785935,0.15555555555555556,0.8800691911759868,1.0,3/10,10.84%,BMP2;SMAD2;BMPR1A
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.8281959702573821,1.3254639229460858,0.08196721311475409,0.8789575779508485,1.0,1/5,1.86%,RAB38
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8743416057842325,1.3249862102504701,0.08928571428571429,0.880560149587723,1.0,1/5,2.00%,TGFBR1
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.8309056228010614,1.3245711027120841,0.1111111111111111,0.8808513881498373,1.0,2/8,1.70%,MME;ACE2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.8309056228010614,1.3245711027120841,0.1111111111111111,0.8808513881498373,1.0,2/8,1.70%,MME;ACE2
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.6140201959586783,1.3244028583361684,0.09615384615384616,0.880692472624376,1.0,4/35,8.54%,HELB;RIOK2;TSR3;PWP2
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,-0.5532076133988025,-1.3242868572757598,0.08163265306122448,0.7752344415264929,1.0,1/90,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,-0.5532076133988025,-1.3242868572757598,0.08163265306122448,0.7752344415264929,1.0,1/90,0.01%,CD44
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,0.8358568862795734,1.324245932776597,0.10204081632653061,0.8805340072845392,1.0,4/9,12.67%,SCD;NRIP1;NR1H3;FASN
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.8186054504423035,1.324047650158029,0.09259259259259259,0.8803225098521238,1.0,2/9,5.13%,SLC22A3;ODC1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.7929352406959489,1.3235289606757696,0.09090909090909091,0.8823902159797785,1.0,4/11,12.91%,RNF185;AUP1;RNF5;POMT2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5894698305044578,-1.3234657613468959,0.12,0.7773224464119474,1.0,8/61,5.72%,CYP1A2;ABCA4;AGRN;GPC2;SCPEP1;RBP2;GPC1;GPC3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6299692587395876,1.323422976001234,0.08620689655172414,0.8819456025608953,1.0,5/29,5.37%,RUNX1;FGFR3;SOX5;BMP2;SOX6
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.7890260240507123,1.322901764007721,0.07692307692307693,0.8835791629617524,1.0,4/12,12.08%,IRGM;FYCO1;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7253494941013655,1.3228079304983384,0.10344827586206896,0.882885957024214,1.0,5/17,15.78%,SIRT1;HIF1A;HTRA2;HSPB1;NFE2L2
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.6000253445376532,1.322741948372154,0.07142857142857142,0.8819822790801363,1.0,14/56,18.05%,RUNX1;RFNG;KAT2B;H2BC21;RBPJ;MOV10;ST3GAL6;H2AC6;H2AZ2;H2AX;SIRT6;NOTCH2;TP53;AGO3
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.613987186921632,1.3224731902761135,0.12280701754385964,0.8825659850345237,1.0,4/40,5.88%,TNFSF14;LGALS9;RELA;TLR2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5931883202597654,-1.3222735011585018,0.17647058823529413,0.7816239270888854,1.0,7/36,10.00%,H1-3;H1-4;TERF2IP;H1-2;RAD50;RAD51AP1;RTEL1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.7660832360059476,1.3222618255598297,0.1016949152542373,0.8825125833509532,1.0,6/16,14.99%,KLKB1;H2BC21;NCOA2;H2AC6;H2AZ2;H2AX
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.5533898552410509,1.3222566919501508,0.13725490196078433,0.8813135546750616,1.0,25/64,16.69%,LRAT;SCGB3A2;PCDH11X;COL9A1;CNTNAP2;PRDM14;SYT6;LIN28A;ZDHHC22;NANOGP1;APELA;PCYT1B;IGDCC3;ANKRD18CP;CHST6;VASH2;CLDN6;GRM4;TERF1;POU2F1;L1TD1;VRTN;SLCO1A2;CALB1;GRID2
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.6149302658784219,1.322082772559599,0.14,0.8813852703295307,1.0,7/34,14.62%,ENGASE;SYVN1;RNF185;RNF139;PRKCSH;RNF5;DERL2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7740716679713848,1.3219924001192582,0.11290322580645161,0.8807536595780316,1.0,5/12,11.28%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.603429988762159,1.3214768203714562,0.08,0.8832483626836086,1.0,17/40,23.74%,SLC26A7;ENPP1;SLC26A6;GLRA1;SLC26A4;PACC1;RACGAP1;ANO5;ANO6;SLC4A1;SLC34A2;ENPP3;SLC25A30;SLC25A14;BEST1;CLCN2;CLIC4
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6886704165224072,-1.3213195755957055,0.13636363636363635,0.7844588463846289,1.0,3/15,16.24%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.728852522440492,1.3212995995439243,0.16666666666666666,0.8831768540330345,1.0,1/18,0.48%,IGF1
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovarian Follicle,-0.8917569302546962,-1.321258593197805,0.06976744186046512,0.783092207414626,1.0,2/5,10.12%,GPX3;GLDC
prerank,Reactome_2022__Scavenging Of Heme From Plasma R-HSA-2168880,-0.7819393802130419,-1.3212372816537308,0.19230769230769232,0.7815545200754366,1.0,2/10,6.12%,ALB;JCHAIN
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6864329683273777,1.3207498816221648,0.15517241379310345,0.8853986881089865,1.0,7/21,11.03%,ARHGAP24;EPS8L2;NLGN1;ABI3;EPS8;KANK1;DEF8
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.5519666477945275,1.3206913103921314,0.11538461538461539,0.8844328828559419,1.0,11/58,11.85%,SMAD6;TMEM100;GDF6;BMP2;ACVR2A;ZFYVE16;SMAD1;SMAD2;BMPR1A;SMAD4;GDF9
prerank,CellMarker_Augmented_2021__Epithelial cell:Prostate,-0.8157247597798539,-1.320538442960758,0.07692307692307693,0.783196720849679,1.0,1/6,0.73%,AMACR
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6843985077762478,-1.3202924928145046,0.17391304347826086,0.7827794607684523,1.0,3/16,16.24%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.8249129222039867,1.3202462520315574,0.12698412698412698,0.8855645241622003,1.0,1/6,3.48%,WNT4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.543635861311494,1.319848827022667,0.1111111111111111,0.886971951579241,1.0,22/95,10.85%,VEGFC;EDIL3;GNG12;EVA1A;BGN;CRIM1;LTBP2;POSTN;CCDC80;ITGAV;WWTR1;CNN3;EPS8;FAM114A1;PLSCR4;ALCAM;PRICKLE2;IGFBP6;EXT1;TNC;AOX1;PTPRK
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.7214349124517402,1.3196114508901928,0.15555555555555556,0.8872091413750122,1.0,2/21,5.78%,SLC5A8;RNLS
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.7772782791190062,1.3194673097657876,0.15384615384615385,0.8866112355822097,1.0,3/7,13.86%,ADIPOR2;PRKAB2;MLXIPL
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.6932908149598804,1.3194653898904996,0.09302325581395349,0.885390007984989,1.0,9/24,15.58%,LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;ACHE;CEPT1;BCHE;SLC44A4
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.5535071760464162,1.319115595714868,0.0851063829787234,0.8862178315300197,1.0,20/102,16.06%,SULT2A1;PPARG;MED17;RORA;FDFT1;MED13L;HDAC3;ABCA1;HMGCS1;ACADM;SMARCD3;NCOA2;TBL1X;DAND5;NR1H3;ANGPTL4;CHD9;NCOA3;PEX11A;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6292957178894438,1.319082191821325,0.1,0.8852601876689399,1.0,7/38,9.16%,IRS1;SIRT1;ZBTB7B;VWA2;ENPP1;PIP4K2A;KANK1
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.7121885314938488,-1.3190354035370901,0.09302325581395349,0.7870316353793282,1.0,1/16,0.39%,MPL
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.8477160262149206,1.3190086713814775,0.12244897959183673,0.8846163696082971,1.0,2/5,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.6260624600994521,-1.3189790986843815,0.08695652173913043,0.7856882936296702,1.0,2/43,2.38%,ANXA8;ALS2CL
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7996747150853125,1.3189148035807439,0.11538461538461539,0.884077906172842,1.0,1/10,0.97%,SEMA5A
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,0.7393296674453094,1.3186460974982777,0.1320754716981132,0.8844202327088341,1.0,9/12,22.38%,CD22;CSF2RA;SIGLEC1;FLT3;CD34;KIT;CX3CR1;AXL;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.801726807369217,1.3185887775040164,0.06896551724137931,0.8834358417086516,1.0,5/15,7.44%,F2;RUNX1;F2R;WNT4;HDAC2
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.6361013993262679,1.3185464777753553,0.14,0.8825916923215039,1.0,3/27,6.90%,GSTM2;GSTT2;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.727789855020986,1.3182190529146751,0.08163265306122448,0.8832437231559156,1.0,2/12,5.82%,ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6410537044185486,1.3177956485056155,0.14893617021276595,0.8843055239214745,1.0,7/22,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL4;IL10RA
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6992870261543264,1.31768907655227,0.21153846153846154,0.8835321312274323,1.0,3/13,4.49%,INSIG1;MLC1;RORA
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.49417256036735624,1.3176489447564557,0.07894736842105263,0.8826069270340547,1.0,31/237,7.24%,IGF1;FGF10;FAM83H;FLT1;SEMA5A;TNFRSF18;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;IL4;HIF1A;SNAI1;FBXO5;BMP2;INSL3;TCAF2;DOCK1;CXCL12;CCN4;SEMA6C;CASS4;APELA;PDGFRA;PLCG2;VSIR;GAB1;F3;FER
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.824109432811258,1.3171976116187336,0.11864406779661017,0.8838189761115697,1.0,3/6,12.69%,GREM2;BMP2;GREM1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.853455111882046,1.3171886222761322,0.18333333333333332,0.8826912294052983,1.0,2/6,8.44%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5157825307513229,1.3171032897508987,0.07547169811320754,0.882009357745734,1.0,30/130,18.96%,IGF1;RIT2;RAPGEF3;CCNA2;FGF2;RRAS;KSR1;CDKN2A;EPS8L2;RALA;ARHGAP5;EPS8;SHOC2;RAPGEF6;PHACTR4;RGL2;SOS1;RAP1A;SGSM3;CNKSR1;ROPN1B;G3BP1;RRAS2;RHOG;TP53;FARP2;RHOD;RAP2A;RHOB;GNA13
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.8027678600058541,-1.31707391107127,0.2222222222222222,0.7936769992044077,1.0,3/7,9.97%,COL4A2;UBASH3B;COL1A1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6470535161568541,1.3170094793996343,0.06,0.8814653971032723,1.0,8/27,9.99%,IGF1;SGCZ;SLC8A1;MYOF;MEGF10;MYH11;ANK2;BIN1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.8087356078455792,1.3169688620131494,0.12727272727272726,0.879313196869583,1.0,2/5,10.08%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.8087356078455792,1.3169688620131494,0.12727272727272726,0.879313196869583,1.0,2/5,10.08%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6574729109712747,1.3169466000253405,0.11320754716981132,0.8782668462291051,1.0,9/27,13.84%,LGALS9;HS3ST5;TMPRSS2;MID2;NECTIN2;GSN;TRIM26;PTX3;CD74
prerank,KEGG_2021_Human__FoxO signaling pathway,0.5452948009946154,1.316697031311283,0.08620689655172414,0.8786105398636741,1.0,24/113,16.15%,IGF1;IRS4;IRS1;SIRT1;TGFBR1;PRMT1;IL7R;PRKAB2;FOXO3;PIK3CA;CCNB3;FOXO1;SMAD4;MAPK8;PTEN;SOS1;IGF1R;SETD7;FOXO6;SGK1;PRKAA1;GRM1;PIK3CD;MAPK10
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.8137436281028321,1.3163857012217317,0.07272727272727272,0.8781647285454326,1.0,2/10,3.95%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.8137436281028321,1.3163857012217317,0.07272727272727272,0.8781647285454326,1.0,2/10,3.95%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.572208170849615,1.3162304077358113,0.06896551724137931,0.8778837431093366,1.0,15/35,22.11%,ZEB2;KANK2;PRSS3;DPP4;KANK1;PIK3CA;LOXL2;PXN;ANLN;PKN2;FERMT1;KIT;ABL1;NANOS1;FAP
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5625389428984889,1.3162152357820622,0.11320754716981132,0.8767453229984944,1.0,15/79,14.41%,CCNG1;CDKN2C;CDC25A;CCNA2;CDKN2A;CNPPD1;LATS1;CCNB3;PROX1;PTEN;HEXIM2;CCND3;NR2F2;SERTAD1;CCNH
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7830213673103255,1.3161217449654887,0.18867924528301888,0.8761308849964436,1.0,2/7,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.8199845948258517,1.3160818795372413,0.13725490196078433,0.8751656540983539,1.0,2/5,1.67%,LGALS9;SYK
prerank,Reactome_2022__Mitochondrial Uncoupling R-HSA-166187,-0.8787196611082371,-1.3159690390795602,0.1206896551724138,0.7972993702648418,1.0,1/5,0.47%,PM20D1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.867667515159332,1.3159651158002137,0.07547169811320754,0.8745214308101539,1.0,1/6,1.81%,AMPD1
prerank,CellMarker_Augmented_2021__B cell:Spleen,-0.5851465985307548,-1.31596134697702,0.10909090909090909,0.7957111574736909,1.0,15/60,8.78%,P2RY10;TBC1D10C;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;LTB;DOCK2;BTK;ARHGAP15;TAGAP;TMC8;PTPN7;LY86
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.5064157298353323,1.3159480420064489,0.10638297872340426,0.8734269988438417,1.0,34/173,11.22%,GATA4;FGF10;SEMA5A;IRS1;FGFR3;HGF;SIRT1;TGFBR1;IL26;FGFR1;ERBB4;FGF2;NRG1;ANGPT1;CALCR;RRAS;PIK3R5;HCLS1;LIN28A;ESR1;HPSE;CASS4;PDGFRA;GAB1;F3;NRG2;RAMP3;MAGI2;FGF17;PIK3CA;HIP1;FLT3;BANK1;CPNE1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.7445586779956478,1.3159179487568724,0.16666666666666666,0.8723856165911439,1.0,3/12,7.59%,IRGM;PYHIN1;HTRA2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7420012623124269,1.315909955590439,0.10714285714285714,0.8712635258143193,1.0,4/10,23.85%,STAT5A;PRLR;LYN;JAK2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5035592964592767,-1.315643788037276,0.05660377358490566,0.7954474437674196,1.0,29/180,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;SPARC;COL1A1;MMP9;VIT;HRNR;ACAN
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.8128347505517435,1.315516521936538,0.16326530612244897,0.8723616929838434,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.8716426931977812,1.315363364395372,0.07142857142857142,0.8720084673948612,1.0,3/5,9.80%,ITGB8;ITGAV;LTBP1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.7231672449781783,1.315288778663072,0.18867924528301888,0.8711240982303667,1.0,1/10,3.04%,EHD1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5104807501439892,1.3152780144673117,0.08695652173913043,0.8700427939641568,1.0,21/150,7.89%,IGF1;CTDNEP1;IRS1;HGF;MYC;CCL5;SIRT1;STARD4;PRR16;HIF1A;FGF2;LDLR;ZEB2;CD244;PRMT1;EIF3E;SAMD4A;SP1;DYRK2;ELOVL5;SNCA
prerank,Reactome_2022__Phase 3 - Rapid Repolarisation R-HSA-5576890,-0.8565913955112353,-1.314821834253091,0.14893617021276595,0.7972807726548887,1.0,4/8,9.36%,KCNE2;KCNE1;KCNQ1;KCNA5
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.5703763472437346,1.314806137566167,0.11764705882352941,0.8714684596390193,1.0,6/48,14.11%,AP1M2;TBC1D8B;ACBD3;HSPA8;PICALM;SNX2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6737622623963873,1.3145716428065441,0.16129032258064516,0.8721285350729022,1.0,8/19,16.07%,TOX;NFIL3;ULBP2;CD244;ELF4;IL21R;ULBP3;PIK3CD
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.7564315329793376,1.3145048574436773,0.125,0.871364431248683,1.0,3/14,3.71%,SIRT1;SASH3;SAMSN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7723734496140992,1.3143828620010929,0.19230769230769232,0.8710483271477186,1.0,4/7,15.90%,SIRT1;PLCG2;CD74;GPRC5B
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,0.7468015491001768,1.3143746658191553,0.14545454545454545,0.8699082115362686,1.0,4/9,10.29%,ITGAX;TLR2;CD40;FLT3
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.7774080521147564,-1.314356891669189,0.125,0.7980680463609817,1.0,2/6,6.36%,CD24;PAX2
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.7750968648803634,1.3141238854256643,0.18032786885245902,0.8699902425842931,1.0,4/7,15.11%,SIRT1;STARD4;PROX1;STAR
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.751988121026768,1.3138288071468718,0.13636363636363635,0.8704669484351453,1.0,2/14,5.78%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.787105627725708,-1.3132043012414507,0.1568627450980392,0.8017603147140739,1.0,1/9,6.80%,B3GALT5
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7724205719849278,1.312995840720097,0.16326530612244897,0.8737687592089576,1.0,3/9,11.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4719447718942627,-1.3129800577349282,0.0196078431372549,0.8011130059528389,1.0,15/388,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Undefined,0.882247209403297,1.3124379529228334,0.08196721311475409,0.8759460330757946,1.0,2/5,4.13%,OLIG1;OLIG2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6766328130155737,1.3123896626517573,0.06,0.8752003099652436,1.0,6/17,15.26%,TMTC2;POMT2;FKRP;CRPPA;SDF2L1;TMTC3
prerank,Reactome_2022__Digestion R-HSA-8935690,-0.8167726821282015,-1.312091095807436,0.13513513513513514,0.8034221549730631,1.0,2/10,0.89%,GUCY2C;TREH
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.809951490213477,1.311953018756588,0.1509433962264151,0.8764534483243295,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.8680101187340923,-1.3119349311647903,0.14893617021276595,0.802444971089124,1.0,2/5,6.07%,INHA;SFRP1
prerank,CellMarker_Augmented_2021__Neutrophil:Peripheral Blood,0.8037625083933103,1.3117982958566945,0.125,0.8762484526488409,1.0,1/8,1.66%,ITGAX
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.8407046525234989,1.3117235555707045,0.11538461538461539,0.8756031906652643,1.0,3/9,12.47%,LGALS9;BMPR1A;CD34
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.7195944891948948,1.31170894070505,0.14285714285714285,0.8746008945846546,1.0,5/11,17.81%,PHGDH;SRR;CBS;CTH;PSPH
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.7680262205692245,-1.3104717786554787,0.18181818181818182,0.8080127985342274,1.0,2/11,4.09%,CD86;RNASE1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.7697431293203325,1.3100521372815552,0.08620689655172414,0.8833876581406847,1.0,1/9,7.50%,BICD1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6687868838521238,-1.3097753353873005,0.2,0.8096102376319407,1.0,8/23,14.29%,KCNE2;KCNE1;SLC11A1;KCNQ1;KCNA5;ATP4A;SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4729504024372138,1.3095425008259163,0.05,0.8849311374299255,1.0,49/378,10.31%,MITF;LGALS9;NOX5;IGF1;FGF10;RBM20;ITGAX;ITGB8;MYC;TGFBR1;IL26;ZBTB7B;IL4;PRR16;HIF1A;RAB27A;MYCN;FGF2;KAT2B;ANGPT1;CALCR;ACTG2;BMP2;SF3B1;EIF3E;SAMD4A;SP1;LIN28A;RBPJ;ZNF804A;MOV10;TLR2;PLCG2;VSIR;TICAM1;F3;PAX6;IL15;AGR2;CCDC88B;RAMP3;SMAD1;RIMS2;ANK2;TMIGD2;FGF17;CTCFL;GSN;CADM1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6459056844125872,1.3091616054966373,0.15555555555555556,0.8861458051734656,1.0,3/16,13.29%,AASS;SNCA;NOC2L
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.8695580142305335,1.3089964501437035,0.16071428571428573,0.8862056715288086,1.0,1/6,2.54%,HIF1A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5649618264558438,-1.3089657429997001,0.07017543859649122,0.8117276542843501,1.0,6/79,6.82%,SLC28A2;SLC6A6;ABCC4;SLC22A8;SLC13A3;SLC7A3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5798672169268384,1.3089421857842933,0.13043478260869565,0.8853257884557741,1.0,18/42,30.85%,PRR5L;ZFP36L2;MOV10;TOB1;ZC3HAV1;RIDA;CNOT8;PNPT1;ZFP36;NANOS1;YTHDF2;MEX3D;PUM1;PABPC1;RC3H1;YTHDF3;YTHDF1;CPEB3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6902030282011331,1.3088207420187616,0.1724137931034483,0.8850467920936302,1.0,6/18,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.7871511389812641,1.308616834525304,0.1836734693877551,0.8853178961856258,1.0,1/6,3.70%,SLC38A3
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.773676723615714,1.3084351782755181,0.13043478260869565,0.8852816898179227,1.0,3/8,14.45%,SLC35B2;SLC35D2;SLC35C1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7440557703637984,1.3084016737449733,0.09803921568627451,0.8843752548700987,1.0,4/13,13.89%,RPP25;RPP25L;RPP40;HSD17B10
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.586811015386338,-1.308382531498278,0.10204081632653061,0.812601539136763,1.0,7/39,2.96%,ANXA8;EHF;DUOXA1;NUPR1;C6ORF132;MGP;IL1RL2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5168612086852209,1.308100155961585,0.08,0.8851451686253377,1.0,46/163,17.14%,DACH1;EPHA7;PNOC;SLC35F1;EDIL3;NRG1;CADM2;CLSTN2;SLC17A6;CNTNAP2;NLGN1;ISOC1;KCNH7;RALGPS2;SYT1;ZDHHC22;FUT9;MEGF10;TMEM200C;CNRIP1;ELAVL2;LINGO2;NOVA1;OLFM3;ACHE;FAM171B;SMAD1;ANK2;ADGRB3;NHLH2;PAK5;LZTFL1;NOL4;ZNF536;MAPK8;GPM6B;TMEM170B;NBEA;RIMS4;FAT3;DNM3;CNTN2;GRID2;GNL3L;HMGCLL1;FLRT3
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.8094418354468944,1.308060919685408,0.10909090909090909,0.8842090682578705,1.0,1/10,0.15%,STK26
prerank,CellMarker_Augmented_2021__Primitive Vesicle cell:Fetal Kidney,-0.7685256342209357,-1.3080038472163527,0.17391304347826086,0.8126643428006874,1.0,3/8,12.63%,KIRREL2;CAMK2A;RFPL1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5672010607702055,-1.3078955078806054,0.19607843137254902,0.8116946216590205,1.0,13/65,10.48%,EPN1;TEK;COL4A2;ALOX5;ANGPT4;NIBAN2;NAXE;SARS1;FOXO4;ADAMTS9;CREB3L1;SPARC;SPRED1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5397682504882938,1.307364021859901,0.09433962264150944,0.887594272951091,1.0,25/93,13.44%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;PRKG1;ITGA11;ADGRL4;MSRB3;SSC5D;BGN;CXCL12;POSTN;CCDC80;PDGFRA;ABI3BP;DLC1;PCDH18;MYH11;MEDAG;HMCN1;SYNPO2;TBX18;RBMS3;ABCA8
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,-0.7414448565685942,-1.3072985667663501,0.17391304347826086,0.8128456584253239,1.0,4/14,11.22%,KCNE2;KCNE1;KCNQ1;CACNG8
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.7174810548431683,-1.30726795753121,0.20930232558139536,0.8113723344698083,1.0,1/11,1.28%,INHA
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.8662780616446206,1.3072344846551471,0.17647058823529413,0.8872346999856624,1.0,2/5,10.13%,SEC22B;TAP1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.7214900865140045,1.307193819740754,0.12727272727272726,0.8863315422482214,1.0,4/21,10.25%,ZDHHC11;IL4;STING1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.8536961759160013,1.3071429121229161,0.14545454545454545,0.8854946541499326,1.0,3/6,10.30%,NFKBIZ;IL23R;NFKBID
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.6817614425434007,1.3068662033294154,0.12727272727272726,0.8860656054687428,1.0,7/16,23.57%,SNAI1;CHD7;PAX3;NOTCH2;NUMB;CSPG4;BMP4
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6903634346160374,1.3064862668503634,0.10526315789473684,0.8869222806080073,1.0,4/14,18.05%,LIN28A;MRPL44;PRKRA;AGO3
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.8912493130829522,-1.3064576075465184,0.14814814814814814,0.8132926403518504,1.0,3/5,10.00%,SLX4;ERCC1;RTEL1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.723936201061236,1.306398185393672,0.1111111111111111,0.8862949575495546,1.0,3/15,14.62%,KCNC2;MAT2A;TMEM120A
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.602561331482239,-1.3059900199120402,0.14545454545454545,0.8139427276025227,1.0,8/39,14.15%,PARP2;PIAS3;ERCC1;XPC;PARP1;GTF2H2;POLR1A;RPA3
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,0.8655285975407612,1.305430057826819,0.12962962962962962,0.8910320885833131,1.0,3/6,4.85%,SLC1A3;GFAP;GLUL
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7325159834191425,1.3050042796164234,0.1694915254237288,0.8925944671191214,1.0,3/11,3.79%,MYC;FGF2;BMP2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.7953124976387189,1.3049981469333296,0.22641509433962265,0.8915179131556624,1.0,2/5,19.85%,PRPF39;SFSWAP
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.7625571034735217,-1.3047842973345791,0.16981132075471697,0.817544779239678,1.0,3/14,4.67%,IL11;IL31RA;CRLF1
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,0.7564401976928946,1.3046659633526516,0.16666666666666666,0.8921879535479206,1.0,1/9,3.71%,HPD
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5011405084943922,1.3042940785501793,0.045454545454545456,0.8932363166540954,1.0,54/182,21.67%,LGALS9;TNFRSF19;SIRT1;F2R;ROR1;CANT1;RORA;PELI2;SLC35B2;MID2;RELA;PELI1;TIFA;ESR1;PLCG2;TICAM1;CD40;PPM1A;TAB2;TSPAN6;TNFRSF10B;CASP10;CPNE1;ZFAND6;IRAK1;HSPB1;TANK;CD74;IKBKE;TRIM52;GPRC5B;LGALS1;TAB3;EEF1D;BIRC3;FADD;ZDHHC17;RIOK3;NDFIP2;C18ORF32;TFG;GPR89A;PIM2;ZDHHC13;SLC20A1;ATP2C1;TICAM2;RIPK2;IKBKB;CARD16;ANKRD17;TMEM101;TNIP3;CARD9
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7251802361395979,1.304217471934608,0.1864406779661017,0.8926848626075949,1.0,3/11,11.51%,TTLL2;TPGS1;TTLL9
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7323941166067985,1.3040808420262486,0.23728813559322035,0.8924032871185448,1.0,6/8,22.72%,TOX;NFIL3;PIK3CD;AXL;PTPRC;PBX1
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.5572269409120061,-1.3039640718607042,0.125,0.8201405309093568,1.0,7/68,7.75%,CYP1A2;CYP2A6;CYP2E1;CYP24A1;CYP4F2;CYP21A2;ARNT2
prerank,CellMarker_Augmented_2021__CD16+ Dendritic cell:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Immature Myeloid cell:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Suppressive monocyte:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,CellMarker_Augmented_2021__Classical monocyte:Peripheral Blood,0.8442142870943582,1.3037820731517284,0.16,0.8874836020715313,1.0,1/6,1.66%,ITGAX
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.7775050396085346,1.3037538696626183,0.17307692307692307,0.8865220471129311,1.0,2/8,13.70%,DCUN1D1;UBA3
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.576012935717401,1.303632963230729,0.05454545454545454,0.8848872061555177,1.0,16/81,8.32%,MXRA5;FLT1;PREX2;PDZRN4;ITGA8;NYNRIN;ADGRL4;MYCN;FREM1;PCDH17;CXCL12;ERG;PDGFRA;SPON1;PTPRD;RAMP3
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.576012935717401,1.303632963230729,0.05454545454545454,0.8848872061555177,1.0,16/81,8.32%,MXRA5;FLT1;PREX2;PDZRN4;ITGA8;NYNRIN;ADGRL4;MYCN;FREM1;PCDH17;CXCL12;ERG;PDGFRA;SPON1;PTPRD;RAMP3
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,-0.6140809834704803,-1.3036123384652756,0.08,0.8109538793700503,1.0,13/45,8.78%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3;ICAM3;CD53;LTB;CD5;TAGAP;TMC8;LY86
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.7394097877119006,-1.3035951391521297,0.17647058823529413,0.8094356328642255,1.0,1/8,4.30%,ATG14
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.7336097563494153,1.3035237520182592,0.11538461538461539,0.884337994144866,1.0,1/14,0.48%,IGF1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.8682967528385249,-1.3034479969895532,0.1111111111111111,0.8085274951991209,1.0,3/5,10.80%,SLC6A6;SLC6A11;SLC6A12
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5565261527453694,1.3032014787614852,0.13636363636363635,0.8852701600430223,1.0,6/65,2.93%,MME;MYC;SIRT1;CDC25A;ZBTB1;NEDD4
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.5845131660724892,1.303152123040337,0.07142857142857142,0.8844106328092208,1.0,21/59,25.22%,PKNOX1;MAFB;H2BC21;HDAC3;PAX6;PAXIP1;EZH2;H2AC6;H2AZ2;RARB;NCOA3;H2AX;KDM6A;EED;POLR2H;KMT2C;PBX1;RBBP4;EP300;PIAS2;MEIS1
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8400715934805472,1.3031026406246045,0.1346153846153846,0.8835376845081239,1.0,2/6,7.98%,RNLS;SPX
prerank,Reactome_2022__Beta Defensins R-HSA-1461957,0.8310549072576507,1.303065309331191,0.1875,0.8826513647249554,1.0,2/5,5.88%,DEFB135;TLR2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),0.8108127836537886,1.3030304393870875,0.16981132075471697,0.8817052152731392,1.0,2/5,9.65%,IL4;NECTIN2
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5289029809506296,1.3029509716222538,0.09259259259259259,0.8811020267302629,1.0,18/103,9.36%,MXRA5;LAMA4;TMEM100;PRRX1;PRKG1;LRP4;BGN;CXCL12;EFS;POSTN;PDGFRA;ADGRL2;LIFR;PCDH18;ANK2;GFRA1;MAGI1;GUCY1A2
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.5466748064015787,1.3028256607757251,0.12,0.880979716860341,1.0,31/111,16.70%,IGF1;FGFR3;MYC;FZD5;FGFR1;FGF2;WNT4;BMI1;ACVR2A;WNT9A;PAX6;LIFR;SMAD1;PIK3CA;SMAD2;INHBC;BMPR1A;SMAD4;FZD1;IGF1R;ID4;ACVR1B;SMARCAD1;DVL2;FZD4;FZD6;KAT6A;PCGF5;SMAD5;PIK3CD;CTNNB1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.689972885619502,-1.3027480730368106,0.15217391304347827,0.810268353842977,1.0,4/16,7.82%,SIGIRR;AHSG;IL6R;MYLK3
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.5515165519705055,-1.3027252074308315,0.11320754716981132,0.8088695760215772,1.0,9/66,2.73%,P2RY10;TBC1D10C;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;ZC3H12D;GPR132
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.8139961004625269,1.3027237583736724,0.125,0.8806260240481103,1.0,1/7,0.93%,F2
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6458929749466881,1.3026183354812317,0.14,0.8802269172401532,1.0,7/29,10.19%,VEGFC;FLT1;RELA;MAPKAPK2;GAB1;PIK3CA;NUS1
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.5562577067998101,1.3026150391897253,0.07407407407407407,0.8791816607155181,1.0,46/89,33.31%,ABHD3;AFTPH;CMTR2;CEPT1;GPBP1L1;SPOPL;SP3;TMEM260;PICALM;PCMTD1;RICTOR;PRKAA1;NHLRC3;DENND4C;PKN2;CD2AP;STXBP3;TRAPPC8;ZNF33A;ADAM10;TMEM87B;LMBRD1;STT3B;CPD;MON2;VPS54;TMF1;RBL2;ARFIP1;RBM39;SEL1L;STK38;PPP2R5A;CCPG1;BROX;SNX13;TMED5;TTC17;PDCD6IP;IFNGR1;COG3;ARFGEF1;FBXO38;EDEM3;UBR2;VMP1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.8535699918520336,1.3025441231832975,0.1346153846153846,0.8786621805944895,1.0,2/7,11.30%,PEX12;ZFAND6
prerank,KEGG_2021_Human__ErbB signaling pathway,0.5341488931513737,1.3024590972573764,0.09803921568627451,0.877974895619504,1.0,16/80,12.78%,MYC;ERBB4;STAT5A;NRG1;CBLB;NRG3;PLCG2;GAB1;NRG2;ELK1;ABL2;PIK3CA;PAK5;NCK2;MAPK8;SOS1
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.842485992539912,1.3024235136156925,0.09090909090909091,0.8770436617154588,1.0,6/9,13.12%,ITGA10;ITGA2;CNTN6;ITGA1;ANK1;HSPA8
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7081372627040297,1.3024151746357147,0.1568627450980392,0.8760226969446768,1.0,3/11,8.25%,FGF2;ITPKB;IP6K3
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.6194877372859958,1.302252505678418,0.16666666666666666,0.8756627214223087,1.0,4/30,8.98%,MAP3K11;KSR1;PPP1CC;SHOC2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.698209425864798,1.3021012738617326,0.13043478260869565,0.8754718707683043,1.0,6/15,12.92%,BMP2;PPP1R15B;MAGI2;ITGA1;MEF2C;MTMR9
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6859766442873346,-1.3018012207018295,0.18,0.8111766483117425,1.0,3/21,2.68%,CLDN4;DUOX1;CLDN1
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.4536690767933226,-1.3017664835541396,0.0,0.809795098096605,1.0,41/477,7.09%,CD44;PSG4;ALB;MPL;SELE;F5;SIRPG;PSG5;SELL;F8;KIF2B;TEK;MAFK;PSG9;GYPB;DOCK8;RAC2;SFTPA2;PSG3;CD99L2;GYPE;PRKCD;KIF12;AHSG;F7;ANGPT4;ABCC4;RNASE1;STXBP2;PSG2;GPC1;F13A1;VAV3;INPP5D;JCHAIN;DOCK2;PCYOX1L;SCG3;PSG8;PROCR;F11R
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7519489841671034,1.3015367068958867,0.2,0.8777258057002258,1.0,4/11,11.70%,TMEM100;F2R;SPX;ATPSCKMT
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7603812333033575,-1.3014915685476358,0.17073170731707318,0.809371018125556,1.0,5/11,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.5379136687910469,1.3013030102186194,0.1702127659574468,0.8778686069808505,1.0,6/68,4.55%,SLC7A11;MYC;PHGDH;SEM1;CDKN2A;IDH1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6872479541545858,1.301223685620145,0.09433962264150944,0.8772947795013285,1.0,3/22,7.97%,CGNL1;TMEFF2;DLC1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.6110503677192205,1.3012139464579782,0.10869565217391304,0.8762809097436371,1.0,6/24,16.70%,SIRT1;PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6835563936210399,1.3005827308593279,0.12962962962962962,0.8786294164507176,1.0,4/18,13.67%,SHMT2;MTHFD2L;MTHFD2;SLC19A1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6598876385389199,1.300494833382583,0.18518518518518517,0.8779960064564868,1.0,7/24,7.10%,F2R;LRP4;NEDD4;CACNB4;PPFIBP1;UNC13B;ZC4H2
prerank,KEGG_2021_Human__Malaria,-0.6263563312414722,-1.3004897582932768,0.061224489795918366,0.8126551478831346,1.0,3/31,1.44%,SELP;SELE;GYPB
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.6305083417454722,-1.3002418201617612,0.10810810810810811,0.8121052933308965,1.0,3/23,1.18%,SELE;F8;TEK
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8412970503711129,-1.3002361430144909,0.18,0.8105701226440706,1.0,1/6,0.36%,SELP
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.8012371466081579,1.300051732944267,0.18867924528301888,0.878506127147284,1.0,2/6,11.90%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.8012371466081579,1.300051732944267,0.18867924528301888,0.878506127147284,1.0,2/6,11.90%,PPARG;NR1H3
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5214914070995093,-1.2999870431577614,0.045454545454545456,0.8103367870974153,1.0,8/131,4.08%,CD44;TEK;COL4A2;NLRP3;COL5A1;COL4A1;SLC6A6;PHEX
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5666962036282854,-1.2999546590446178,0.07272727272727272,0.8089724292787094,1.0,6/77,6.82%,SLC28A2;SLC6A6;ABCC4;SLC22A8;SLC13A3;SLC7A3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6594144682957107,-1.2998250663605546,0.11363636363636363,0.8081511880017067,1.0,7/28,7.57%,P2RY10;KLRC1;SIRPG;SELL;LTB;KLRB1;CD5
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.844963105045412,1.2995820750426428,0.11538461538461539,0.8797966944698679,1.0,2/5,7.72%,NPC1L1;MTTP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.8288341149904369,1.2995604743911373,0.2037037037037037,0.8788929039494514,1.0,1/5,2.54%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.8025270697839139,1.2995301140861049,0.12727272727272726,0.8780365603765483,1.0,1/6,7.50%,BICD1
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.6452078147440662,1.2993236117197546,0.10344827586206896,0.8783732698546525,1.0,4/22,10.55%,LAMA4;ITGA2;ITGAV;ITGA1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.6834657571276681,1.2993228557790546,0.12903225806451613,0.8773388974176028,1.0,11/24,22.13%,MSMO1;FDFT1;HMGCS1;MVD;SOAT2;IDI2;SC5D;SQLE;DHCR7;SREBF2;IDI1
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.8264130618386808,1.2993010696629823,0.1206896551724138,0.8764724339129651,1.0,3/7,13.08%,IGF1;SOS1;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.509082560138712,1.2992357323520989,0.10638297872340426,0.875788301049019,1.0,18/125,10.58%,IGF1;IRGM;IRS1;HIF1A;TFEB;RNF152;PRR5L;ZBTB20;MID2;MOV10;TP53INP1;TICAM1;HMGB1;SNCA;FOXO3;ZC3HAV1;TRIM65;FOXO1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6214684258522445,-1.2992134010096525,0.1276595744680851,0.8094003936816767,1.0,1/24,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8227787329275513,1.2988458021515967,0.13793103448275862,0.8766662353640376,1.0,3/6,14.59%,ABHD3;OXSM;OLAH
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6388930750591203,1.2988329496519098,0.07894736842105263,0.8756687851675677,1.0,10/31,11.46%,CLSTN2;CDKN2AIP;LGI1;SYT1;SCRIB;SNCA;RAMP3;GRIK2;RIMS2;VAMP3
prerank,Reactome_2022__Presynaptic Nicotinic Acetylcholine Receptors R-HSA-622323,-0.7563169869205137,-1.2987591430477845,0.20930232558139536,0.8101893441121593,1.0,3/11,12.20%,CHRNE;CHRNG;CHRNA2
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7628635692692203,-1.2985100564715084,0.13953488372093023,0.809811784085157,1.0,5/10,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.551583191625982,1.2984846928864169,0.06896551724137931,0.8766046503702688,1.0,18/45,17.68%,ALDH7A1;ACADS;ALDH1B1;ALDH9A1;HIBCH;BCAT1;HMGCS1;ACADM;ACAA2;AOX1;HSD17B10;AGXT2;AUH;HIBADH;ACAD8;HMGCLL1;ALDH6A1;BCKDHB
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.5243886968713253,-1.2984505105553765,0.13793103448275862,0.808527879536366,1.0,17/89,9.52%,RFX6;NPAS4;CAMK1G;KIRREL2;KIF12;SLC22A8;UMOD;DLL4;PAX2;ARNT2;SPRED2;UCHL1;TTBK1;CYS1;SLC22A6;WWC1;VDR
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.6685121220633697,-1.2984407227553096,0.15789473684210525,0.807062214390751,1.0,1/20,0.33%,ALB
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.8269751242822738,1.2983765049255414,0.18181818181818182,0.8761777707634409,1.0,2/6,7.29%,FER;IL15
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.7239454919004961,-1.298314187453177,0.16981132075471697,0.8061073859563116,1.0,5/15,2.78%,SIRPG;ICAM3;CD53;CD86;LILRB3
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,0.5591806048542353,1.2978816710969068,0.05555555555555555,0.8780217345759741,1.0,23/89,10.07%,MXRA5;MRGPRF;SEMA5A;C3;PRRX1;ADGRL4;RIN2;DOCK1;BGN;CXCL12;LTBP2;POSTN;CCDC80;MYOF;PDGFRA;F3;FAM114A1;PLSCR4;CYBRD1;ALCAM;GSN;MEDAG;TNC
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6035694867987111,1.2978800211877006,0.08928571428571429,0.8770124864641546,1.0,6/41,7.47%,SMOC1;PBX3;MAFB;SIX4;PAX6;CHD7
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,-0.7096185481070196,-1.2978475783806243,0.1951219512195122,0.8063906767119363,1.0,3/13,1.10%,SELP;SELE;SELL
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7434958740067599,1.2977967890908184,0.14583333333333334,0.8762886825096218,1.0,1/12,0.64%,DRD5
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7835117895772754,1.297551170918146,0.10416666666666667,0.8765189212596243,1.0,7/11,15.94%,LRP4;NLGN1;CEL;PTPRD;NLGN4X;PTEN;CNTN2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.8059394494726815,-1.2975114945503494,0.13636363636363635,0.8063681583562153,1.0,1/7,0.22%,TAFA3
prerank,Reactome_2022__Protein Repair R-HSA-5676934,0.838609348911721,1.2973309012041316,0.14545454545454545,0.8766445783376813,1.0,2/6,10.44%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5973252778854121,1.297068747838367,0.12244897959183673,0.8769035458353405,1.0,11/25,26.29%,RAB31;RAB34;GGA1;GOLPH3L;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;ARFRP1;SPTBN1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6686797671795728,-1.2968867957770844,0.19047619047619047,0.8078534801071029,1.0,2/16,6.07%,TEK;SFRP1
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.8762899255519132,-1.296771885358941,0.24489795918367346,0.8067854246597447,1.0,1/5,4.93%,DRD2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7447851288304971,1.2966394766731177,0.14814814814814814,0.8779329440945361,1.0,3/12,8.78%,TGFBR1;PDGFRA;DSCAML1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5677577141518666,1.2966143405138715,0.043478260869565216,0.8770049674038372,1.0,17/59,21.16%,LGALS9;MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;IRAK1;ARHGEF6;TAB3;MAPK10;MAP3K8;ADORA2B;GPS1;RIPK2;IKBKB;ZFP36;MAPK3
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.8590866368437458,1.2965644013510966,0.1836734693877551,0.8762418908233122,1.0,1/5,0.89%,HS3ST5
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.8324630018909744,1.296560107749784,0.14035087719298245,0.8752441946794262,1.0,3/5,15.72%,LTBP1;DAND5;FBN1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6621394958401896,-1.2961273121998145,0.06976744186046512,0.8083567477273738,1.0,2/29,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5720385863683641,1.2957847862328224,0.08928571428571429,0.8784844509769795,1.0,26/78,19.49%,THRSP;PPARG;SCD;NPC2;RORA;SP1;FDFT1;HDAC3;HMGCS1;SMARCD3;NCOA2;TBL1X;NR1D2;MVD;FASN;ACACA;CHD9;ACACB;SC5D;RORC;SQLE;CCDC3;IRS2;PLPP1;DHCR7;MID1IP1
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,-0.7114634820581662,-1.295727355629699,0.18181818181818182,0.8086859118523103,1.0,3/12,1.10%,SELP;SELE;SELL
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.7308677105552202,-1.2956597867610806,0.22448979591836735,0.8075040484151784,1.0,3/10,13.64%,TNFSF18;SLC11A1;IFNK
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6229052179564567,-1.2956501498736475,0.13725490196078433,0.806038208092282,1.0,3/39,5.43%,EPN1;MVP;PTPN3
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,-0.7108904831789709,-1.295493421773981,0.21739130434782608,0.8052448513497245,1.0,4/9,15.27%,CLTA;DNM1;CLTB;DAB2
prerank,KEGG_2021_Human__Cholesterol metabolism,0.6340585415080517,1.2954823091381729,0.08888888888888889,0.8792996065963421,1.0,13/41,15.11%,VAPB;LDLR;NPC2;ABCA1;CYP27A1;ABCG8;SOAT2;ANGPTL4;ABCG5;LRP2;LIPG;SOAT1;STAR
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6255518244166841,1.2953447194239263,0.16071428571428573,0.8790232992781888,1.0,6/30,10.88%,SLC26A3;RAPGEF3;AANAT;SLC26A6;CRHBP;HCN1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7460629121488316,1.29507797759783,0.1702127659574468,0.8793947263551154,1.0,5/14,12.76%,AK3;EFL1;GNAI3;RAB23;ENTPD7
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,-0.8759520065338142,-1.2945398984589909,0.1276595744680851,0.8078100372471493,1.0,1/6,4.09%,RNASE1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6406008203995246,-1.294495997781107,0.17073170731707318,0.8065080481401024,1.0,3/31,1.10%,ACTC1;MYH7;SCN5A
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6666771640226042,-1.2943906453647627,0.2,0.8054449647717117,1.0,4/15,10.30%,TIE1;BTK;HCK;HES7
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.6271342117639743,1.2943872724365861,0.15555555555555556,0.8820862192512012,1.0,7/28,9.74%,SLC26A7;SLC26A6;CA13;SLC39A8;SLC4A7;CYB5R4;CA2
prerank,CellMarker_Augmented_2021__B cell:Thyroid,-0.6157046602527665,-1.2943863776738747,0.11538461538461539,0.8039831771768446,1.0,12/35,9.27%,P2RY10;TBC1D10C;SELL;SP140;TRAF3IP3;ICAM3;LTB;JCHAIN;TAGAP;CD72;TMC8;PAX5
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7694072119116235,1.2943683721007397,0.16363636363636364,0.8811473775992972,1.0,1/12,0.52%,CTDNEP1
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.7183219655465961,1.2940287186491586,0.14893617021276595,0.8819253869572555,1.0,4/15,6.57%,DERL3;PNOC;PARM1;MUC20
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5749546931892602,1.2940046338982467,0.06896551724137931,0.880988912919286,1.0,5/57,5.73%,MITF;MED17;CDKN2A;RELA;MOV10
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.833973110342723,1.29399992437212,0.125,0.879981505294141,1.0,2/7,3.50%,PPARG;CDKN2A
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.7063075390981133,1.2939669577975617,0.12280701754385964,0.8790640583358741,1.0,3/10,18.05%,MOV10;CNOT6L;AGO3
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.5172814536275083,1.293897023839657,0.10204081632653061,0.8783529591259128,1.0,34/127,20.63%,F2;SYK;RAPGEF3;F2R;GRM3;PIK3R6;RRAS;PIK3R5;PTGFR;RALA;PDGFRA;PLCG2;GAB1;GRM8;PDGFC;GRM5;PIK3CA;SOS1;GRM4;GRM7;PLCB1;DNM3;GRM1;PIK3CD;GAB2;DGKZ;RRAS2;PLPP1;KIT;GNA13;AKT3;DGKD;PIK3R3;CYTH1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.7612878368557928,-1.2938040810021882,0.21951219512195122,0.8051839732024518,1.0,2/10,1.23%,IL10RB;NUPR1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Kidney,0.9058416986059101,1.2937357391751545,0.07407407407407407,0.8783428912691819,1.0,2/5,4.70%,KLRD1;IL7R
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7451038952939779,1.293182919815814,0.17391304347826086,0.880501354131051,1.0,3/10,3.41%,MITF;LRMDA;ENPP1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.7611223018600414,1.2929058964137934,0.21818181818181817,0.8809976249620447,1.0,2/8,9.35%,RPP40;RRS1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5892766438666683,1.2927175609245403,0.15217391304347827,0.8808683833926179,1.0,15/57,20.20%,IGF1;TGFBR1;FGFR1;IL4;RELA;ITGAV;PELI3;TNFRSF10B;PML;WWOX;PHIP;FADD;TNFRSF10A;DEPTOR;FEM1B
prerank,KEGG_2021_Human__Tight junction,0.5191075020076976,1.2923058562263472,0.09433962264150944,0.8826248940543673,1.0,28/138,16.15%,GATA4;CGNL1;RUNX1;TUBA1C;NEDD4;LLGL1;ACTR3C;HCLS1;SCRIB;PRKAB2;CLDN2;MYL12A;MARVELD3;MYH11;MAGI1;RAPGEF6;MPP4;CGN;AMOTL1;MAPK8;CLDN6;RAP1A;MAP3K1;DLG2;PPP2R2B;CLDN18;PRKAA1;MAPK10
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.5488487360502359,1.2921289060275887,0.07407407407407407,0.8828562498586796,1.0,17/86,13.87%,SYK;RIT2;CD22;SEPTIN4;ZFYVE16;RALA;SYT1;ITGAV;RAB3C;RNF139;ABL2;RIMS2;HIP1;HAP1;PICALM;STON2;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.8000743804485367,1.29210922318031,0.11320754716981132,0.8819149886076609,1.0,1/7,0.53%,FGF10
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.5068176202789776,1.2920467922977923,0.06896551724137931,0.8812505046311176,1.0,29/128,21.21%,HERC3;NEDD4;CBLB;SYVN1;UBE2J1;UBE2E2;UBE2D3;UBE2Z;UBE2E3;KEAP1;FANCL;UBE2U;UBE2QL1;UBA6;UBE4A;UBE2J2;UBA3;RHOBTB1;PML;KLHL13;MAP3K1;UBR5;BIRC3;SMURF1;FZR1;UBE2D1;UBE2A;UBE2E1;HERC4
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.6467149126904473,1.2920111873520848,0.13793103448275862,0.880370987283772,1.0,9/24,21.62%,SLC7A11;SLC7A9;L1CAM;DEAF1;SLC3A2;SLC7A6;BSG;ATP1B2;SLC7A8
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6549185173517394,1.291419254078057,0.09615384615384616,0.8827957830998465,1.0,6/27,9.73%,RUNX1;KANK2;ESR1;KCTD6;LATS1;UBA5
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8080559694280358,1.2913604033179376,0.13793103448275862,0.8821037626402739,1.0,2/8,9.52%,DAPK2;PIK3CA
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6625383688192334,-1.291350636696388,0.06818181818181818,0.814816613253542,1.0,2/28,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.8019577462315091,1.2912636707335885,0.2,0.8815715857667809,1.0,1/8,0.93%,F2
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,0.8086912980707704,1.2911617978941943,0.1956521739130435,0.8811555921020691,1.0,3/10,4.62%,GREM2;RSPO2;GALNT7
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7090479265154727,1.2911179039126726,0.14814814814814814,0.8803673204717294,1.0,5/14,13.37%,PPARG;EHD1;ABCA1;NR1H3;MSR1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7494384778593338,1.2908902538083464,0.19298245614035087,0.8805558602933465,1.0,4/8,23.10%,DNAJB2;SACS;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7240091400007069,1.290795621850772,0.14545454545454545,0.8800708279993691,1.0,3/13,2.81%,SEMA5A;FGFR1;FGF2
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.8275167154979415,1.290746729219262,0.18604651162790697,0.8782466792743493,1.0,2/6,3.24%,STARD4;LDLR
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.8275167154979415,1.290746729219262,0.18604651162790697,0.8782466792743493,1.0,2/6,3.24%,STARD4;LDLR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7005759871673946,-1.2906287184786465,0.09615384615384616,0.8169492723626999,1.0,5/19,9.36%,SCN5A;KCNE2;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.4991335344267305,1.2906214931146778,0.1320754716981132,0.877908645483592,1.0,44/178,20.71%,SIPA1;CDKN2C;SIRT1;TGFBR1;CDK11A;URI1;SOCS2;ENPP1;CDKN2A;CDKN2AIP;LGI1;NRG3;NAIF1;DNAJB2;CHPT1;SERTAD2;PAK5;DACT3;SMAD4;GNG4;EXOSC4;BCAR1;ACVR1B;RAB33B;PML;ZNF639;RPS6KA1;DERL2;FRZB;SLC44A4;SGK1;BAP1;SMARCA2;DCBLD2;TP53;H3-3A;ADAM10;BRAT1;SLC25A33;FBP1;BMPR2;ST7L;NCBP1;ADNP2
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.5567285648462541,1.2905528224024798,0.05454545454545454,0.8772577137138846,1.0,16/83,13.08%,ITGA8;ITGB8;MYC;TGFBR1;ITGAV;WWTR1;PPP1CC;UBE2D3;PPM1A;SMAD2;LTBP1;E2F4;CGN;DAND5;SMAD4;XPO1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6174650145065731,-1.2904444077903199,0.14583333333333334,0.8163023995391235,1.0,6/29,9.83%,EPN1;FGF1;ALOX5;CEACAM1;ADAMTS9;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.7630072731606605,-1.2904115741473168,0.22,0.8149886592258602,1.0,5/10,16.18%,PLAAT4;ETV4;VDR;PRKCH;MED1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7669638890740553,1.2903668583738914,0.14,0.8774484889793753,1.0,2/6,14.89%,PRR5L;RICTOR
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.6790334990285384,1.2903173650671307,0.11764705882352941,0.8766430685861427,1.0,9/18,19.73%,CCL5;CXCL12;MOSPD2;HMGB1;GREM1;ANO6;PLA2G7;LGMN;LYN
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,-0.7170397268936786,-1.2902133338988224,0.19607843137254902,0.8143347830390348,1.0,3/14,8.31%,ALB;SLC51A;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.5440995235992008,1.2900713446098915,0.15517241379310345,0.8768767341726365,1.0,11/55,16.98%,IGF1;PRR5L;TENM1;PCM1;UNC13B;ACHE;MYOM1;ZFAND1;GOLPH3L;RAB29;CD2AP
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,-0.6736443555998743,-1.2897311237159101,0.2,0.8149399041631735,1.0,3/22,3.29%,UGT2B15;ALB;CYP2E1
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.6304328290851041,-1.289648831152203,0.15217391304347827,0.8138276525762455,1.0,2/27,0.89%,HK2;TREH
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.6428261163602363,-1.2895203504373807,0.14285714285714285,0.81303880332149,1.0,1/29,0.17%,TERT
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.8177491590965028,1.2894424898212093,0.18032786885245902,0.8793523952499177,1.0,1/7,2.84%,KAT2B
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.7502109266580994,1.288938044772878,0.14754098360655737,0.881127803476442,1.0,1/8,3.93%,DCC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6857389203408835,-1.2881051076759034,0.12244897959183673,0.8177499232993933,1.0,3/13,8.89%,NTRK1;TEC;TXK
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8277209206682035,1.2879014933083552,0.22580645161290322,0.886184639201634,1.0,1/6,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.5988573870787942,1.2878507798924816,0.10909090909090909,0.8854870967793307,1.0,18/40,24.14%,IGF1;MYC;BMI1;PDGFRA;PDGFC;LIG4;CD74;PEX2;CTNNB1;WNT2;CDK4;TP53;GAS6;MED25;B4GALT7;CDK6;DDR2;DHX9
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6581430614525959,1.2876449218976411,0.14814814814814814,0.8855541129301602,1.0,3/21,8.93%,MITF;MED17;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.7110771900010919,1.2876258735225994,0.10204081632653061,0.8846894743494974,1.0,4/17,10.92%,IGF1;BIN1;HAP1;RTN1
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.5937201182624039,1.2874664064251304,0.12727272727272726,0.8846303514955504,1.0,9/39,13.08%,FGF10;IRS1;FGFR3;FGFR1;FGF17;PIK3CA;FLT3;SOS1;FGF5
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,0.5449200754973711,1.287378195346845,0.08695652173913043,0.8841488957302964,1.0,14/79,10.01%,MXRA5;IGF1;LAMA4;ITGA8;PRRX1;ADGRL4;BGN;CXCL12;POSTN;PDGFRA;ABI3BP;RAMP3;MYH11;MEDAG
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.8294111806728288,-1.2873613621384645,0.12195121951219512,0.8195796385343392,1.0,2/7,9.13%,ERCC1;RAD50
prerank,KEGG_2021_Human__Calcium signaling pathway,0.49323073247248256,1.2873359382197709,0.09803921568627451,0.8833590527223604,1.0,20/199,6.74%,VEGFC;ADRA1A;FGF10;DRD5;FLT1;CHRM2;FGFR3;HGF;F2R;FGFR1;ERBB4;MCOLN3;FGF2;PDE1A;ITPKB;PHKA1;SLC8A1;PTGFR;PDGFRA;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6757623623127527,1.2872625300486695,0.1875,0.8828519861769671,1.0,4/16,9.16%,CCDC125;DLC1;ABL2;KANK1
prerank,CellMarker_Augmented_2021__Paneth cell:Intestine,0.8507864614975841,1.2872310189376717,0.13725490196078433,0.8820653465048544,1.0,1/5,2.47%,IL4
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.5747837478717871,1.287227726040613,0.10416666666666667,0.8810982032273674,1.0,15/64,21.85%,SIRT1;LIN28A;HDAC3;TELO2;PIK3CA;EPM2A;RRAGC;RICTOR;PRKAA1;DYRK3;RRAGD;MLST8;DEPTOR;GAS6;GPAT3
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7852945454875087,1.287116701575193,0.17543859649122806,0.8805673310920217,1.0,2/9,2.39%,ANTXR2;SLC22A3
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.8193747474161235,1.2870001697195974,0.15789473684210525,0.8801075793168224,1.0,3/9,14.02%,NEDD4;PTEN;PML
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.8234230454774268,1.2869594617401545,0.16666666666666666,0.8793554164137085,1.0,1/7,1.67%,SYK
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.5545894264612155,1.2869502385870986,0.043478260869565216,0.8784374305264033,1.0,20/92,10.61%,LRRC3B;IL17RD;EPHA7;SLC35F1;NLGN1;ADGRV1;SYT6;ZDHHC22;UNC5D;NRXN1;MEGF10;TMEM200C;IGDCC3;PTPRD;STOX2;NLGN4X;ANK2;VANGL2;MAGEL2;PAK5
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8115977735992983,1.2869341327706922,0.24074074074074073,0.877535417550402,1.0,2/5,13.65%,HRH3;GRM7
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.8491800269384896,-1.2868650262372014,0.2222222222222222,0.8201700696742578,1.0,1/5,3.41%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.7562732370381178,1.2865991288313467,0.14285714285714285,0.8783622918577595,1.0,7/11,19.55%,CCL5;CXCL12;MOSPD2;HMGB1;ANO6;PLA2G7;LGMN
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.702405097759429,1.2864199705890906,0.20754716981132076,0.878491781230429,1.0,1/16,0.40%,PNP
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.5695647947953909,1.286412799909151,0.11940298507462686,0.8775510042721689,1.0,13/47,14.42%,ZBTB1;ROR1;PRMT1;PDGFRA;NXT1;ALCAM;MPZL1;ITGA1;LRRC17;GPM6B;FJX1;TMEM98;SORBS3
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6656404151624816,1.2863553893608366,0.15384615384615385,0.8768760299733332,1.0,6/22,17.32%,MT4;SLC39A8;SLC39A12;SLC30A10;MT1M;SLC30A1
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,0.7766300227224523,1.2862598676074208,0.16,0.876424385255692,1.0,2/11,6.21%,ANTXR2;MAP2K6
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8328124896941349,1.2859326750397493,0.1694915254237288,0.8771371368601968,1.0,2/7,2.31%,ZBTB7B;ERBB4
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.7427080602061679,-1.285836522113716,0.21428571428571427,0.8231815442032544,1.0,1/15,0.59%,NOSTRIN
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6222820616878789,1.2854240104030639,0.1509433962264151,0.8788029277180984,1.0,10/33,16.70%,MYC;TGFBR1;URI1;ACVR2A;HTRA2;BMPR1A;CPNE3;ACVR1B;LRP2;CTNNB1
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.5636636184101218,1.2852824954776332,0.08,0.8775128477472327,1.0,27/91,16.15%,FGF10;LAMA4;TMEM100;IL17RD;ITGA8;PRRX1;PRKG1;CXCL12;POSTN;PDGFRA;EPHA3;NOVA1;PCDH18;PABPC5;ANK2;GFRA1;GUCY1A2;SGCG;MEDAG;HMCN1;RBMS3;ID4;RUNX1T1;PAX3;FBN1;GAS1;PDZRN3
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.5636636184101218,1.2852824954776332,0.08,0.8775128477472327,1.0,27/91,16.15%,FGF10;LAMA4;TMEM100;IL17RD;ITGA8;PRRX1;PRKG1;CXCL12;POSTN;PDGFRA;EPHA3;NOVA1;PCDH18;PABPC5;ANK2;GFRA1;GUCY1A2;SGCG;MEDAG;HMCN1;RBMS3;ID4;RUNX1T1;PAX3;FBN1;GAS1;PDZRN3
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7614567580128839,-1.2852151595156573,0.18181818181818182,0.8242447471172833,1.0,2/6,13.10%,BUD23;EMG1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6927475591386997,1.285012032421648,0.07272727272727272,0.8777800274148383,1.0,5/23,12.91%,RNF185;AUP1;KLHL15;RNF5;POMT2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.8325862002743172,1.2849692365199363,0.11627906976744186,0.8770135460303627,1.0,2/7,6.82%,LGALS9;VSIR
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7113225153461653,1.2848490044654928,0.18181818181818182,0.8766339992354154,1.0,3/16,8.32%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7991275101499384,-1.2846186472228402,0.1320754716981132,0.8239748247496155,1.0,1/9,0.33%,ALB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7991275101499384,-1.2846186472228402,0.1320754716981132,0.8239748247496155,1.0,1/9,0.33%,ALB
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.7100858857331288,-1.284576310854881,0.17777777777777778,0.8226627344828923,1.0,1/12,0.60%,HK2
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,0.5698636424404248,1.2843206675135685,0.09836065573770492,0.8784818598349715,1.0,7/47,6.67%,LGALS9;CFH;CAPN13;C3;PRR5L;STEAP4;CA13
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.774622339644354,-1.284264085573627,0.14285714285714285,0.8227007918729375,1.0,2/10,4.09%,DNASE1L1;REXO4
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.6086135924182815,1.2840252116574737,0.15254237288135594,0.879035136027818,1.0,12/38,24.21%,LIN28A;HDAC3;TELO2;PIK3CA;RRAGC;GPR137B;RICTOR;RRAGD;MLST8;GAS6;HTR6;PIP4P1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.6712042742540215,-1.2839366383449604,0.21818181818181817,0.8226131853403208,1.0,3/20,7.13%,DUSP4;DUSP6;PPP1CA
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.5387704330230878,1.2838046851010607,0.07407407407407407,0.8796283513585832,1.0,12/87,12.71%,CSTA;F2;SYNCRIP;TM4SF20;SAMD4A;LIN28A;TOB1;RNF139;PATL2;RIDA;DNAJC1;KNG1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.7481379208880649,1.2835199264682497,0.16326530612244897,0.8802750750909955,1.0,3/11,11.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5913798295493401,1.2834156449963665,0.1276595744680851,0.8799761552723563,1.0,14/34,20.26%,SOCS2;ITPKB;PIP4K2A;PIK3C2B;SOCS6;SMG1;IP6K3;PIK3CA;EFR3A;PI4K2B;PIK3CD;SOCS7;IP6K1;PIK3R3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6849810165587812,1.2834103113875395,0.1,0.8790490738459096,1.0,5/19,14.46%,SMAD6;ROBO2;BMPR1A;SMAD4;LRP2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.6509219603917935,1.283190574545811,0.1206896551724138,0.8791890891543545,1.0,14/32,25.19%,MYC;WWTR1;SMAD2;E2F4;DAND5;SMAD4;TGIF1;HDAC1;CDK8;MAPK3;FURIN;SERPINE1;EP300;SMAD7
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5984615295573527,1.2831079159034022,0.14545454545454545,0.8787831936052374,1.0,6/34,10.47%,NEDD4;UTRN;TCAF2;FGF12;ANK2;SCN2B
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.669900527084065,1.2828767081878947,0.17647058823529413,0.8790866990003361,1.0,4/24,7.75%,IGF1;PPARG;PYHIN1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8351459725832532,-1.2828426043267747,0.18,0.8262476088442,1.0,2/5,7.78%,EGR1;CLU
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8588459541600947,1.282751887574659,0.2127659574468085,0.878817898031883,1.0,3/6,9.74%,MYC;NGB;CA2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7706863492057274,1.2825369340083652,0.18032786885245902,0.8791750953848676,1.0,3/8,10.30%,NFKBIZ;IL23R;NFKBID
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7028664717253714,-1.2824732521695366,0.21568627450980393,0.8264543274284072,1.0,2/22,5.36%,GFRA3;GPC1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8301121388925123,-1.282336148013841,0.14583333333333334,0.8255364660345986,1.0,1/6,5.75%,KMT2B
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5946926254699509,1.2823339293690896,0.14814814814814814,0.8792327320959561,1.0,9/34,12.41%,WNT4;FBXO5;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.792818563022481,1.2822909739153239,0.13043478260869565,0.8776265050816953,1.0,4/8,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.792818563022481,1.2822909739153239,0.13043478260869565,0.8776265050816953,1.0,4/8,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.6522707721476837,1.2822616252844594,0.15789473684210525,0.8769004364840867,1.0,5/17,14.54%,RORA;SMARCD3;NCOA2;TBL1X;CHD9
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.629661695755128,1.2821918996302788,0.11764705882352941,0.876392295759765,1.0,12/31,16.79%,RUNX1;RYBP;YAF2;ACTL6A;ARID2;SMARCD3;ARID1A;RNF2;ARID1B;SMARCD2;PCGF5;SMARCA2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6502269035762507,1.2821796802497112,0.125,0.8754664771577119,1.0,11/25,21.86%,SCD;SLC25A1;ELOVL5;SCD5;ACSBG1;FASN;ACACA;TECR;ACSL4;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7571048508049378,1.2820271844441944,0.14893617021276595,0.8754062669068755,1.0,5/7,22.11%,BOK;DLC1;TP53BP2;TP53;FAP
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8310004848983521,1.281943225790806,0.11764705882352941,0.8748204762910936,1.0,2/5,14.60%,CEP120;CCP110
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8299095872256858,1.2818878184659086,0.17307692307692307,0.874182076082421,1.0,1/7,0.68%,SMAD6
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,-0.7604784729715571,-1.2818386215542572,0.2682926829268293,0.8263669813284346,1.0,1/11,0.87%,SIRPG
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.634241252725204,1.2818023325013368,0.09259259259259259,0.8736660970699232,1.0,11/36,14.99%,RUNX1;MYC;CSF3R;FLI1;H2BC21;H2AC6;MYB;H2AZ2;PML;CREB1;H2AX
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.8427445015211132,1.281685148622891,0.1568627450980392,0.87336620398358,1.0,2/6,12.66%,SIRT1;MYB
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.8244799025818703,-1.28168090367882,0.10869565217391304,0.825651566513247,1.0,4/8,15.76%,RGS8;DRD2;CAV2;VPS35
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5307216881675694,1.2813722893966921,0.12,0.8742078451783173,1.0,12/75,7.90%,VEGFC;SEMA5A;SIRT1;TGFBR1;HIF1A;STAT5A;FGF2;ANGPT1;BMP2;NRARP;F3;AGGF1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.819052177670106,-1.2812793501441262,0.11904761904761904,0.8258330397914934,1.0,1/6,2.29%,IL11
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,0.5406743894792487,1.280861475722854,0.15555555555555556,0.8759728491184419,1.0,11/89,8.31%,SGO1;TOP2A;NDC80;CCNA2;FBXO5;DLGAP5;SKA3;HMGB1;WDR76;MCM7;ASF1B
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7295408046978678,1.2807396978669188,0.13559322033898305,0.8755375230105981,1.0,4/11,19.69%,PDGFRA;PIK3CA;ERRFI1;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7263703082707192,1.280241029131397,0.25,0.8774980613614991,1.0,3/10,4.63%,DERL3;INSIG1;UBE2J1
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.9058884026842784,1.2802019530366537,0.06896551724137931,0.8767412723468795,1.0,1/5,0.53%,FGF10
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.5163260627429057,1.2801604397162463,0.07692307692307693,0.8759860866988164,1.0,21/71,19.87%,VAPB;MAP3K11;SHMT2;DOCK1;ARHGAP5;ERBIN;LMAN1;PRKCSH;ARHGEF16;PGRMC2;VRK2;VAMP3;DOCK4;PKN2;KTN1;ARHGAP21;RHOG;VAV2;STX5;MCF2;DOCK5
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6788365624850112,1.28003783486072,0.08163265306122448,0.8756059375507907,1.0,3/16,4.78%,LGALS9;IL4;IRF8
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5106870257336527,1.2797912280537755,0.06521739130434782,0.876012647980891,1.0,16/82,13.84%,GPR55;C3;ADAM28;ALDH1A1;CLIC6;TEX26;SLC8A1;FGL2;FAM20A;ABCA1;CYP27A1;ST3GAL6;APOL6;DNAJC3;MSR1;CD74
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.5086151023177035,1.2795907585599018,0.10526315789473684,0.876218865780026,1.0,29/93,19.03%,PREX2;PDZRN4;NYNRIN;ADGRL4;BGN;FREM1;PCDH17;EFS;ERG;MEGF10;PDGFRA;CNRIP1;PTPRD;PTPRT;TCF4;ATP1A2;BAALC;CD34;SHROOM4;RUNX1T1;SEMA6D;FRZB;GPRC5B;MAPK10;IL33;TMEM178A;APCDD1;KIT;PLP1
prerank,Reactome_2022__Thyroxine Biosynthesis R-HSA-209968,-0.8191383591232554,-1.279490453769606,0.1568627450980392,0.8324622734728183,1.0,1/7,2.25%,DUOX1
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.48603160395790507,1.2794631843895021,0.05357142857142857,0.8758928535819368,1.0,33/210,14.74%,ASB17;HIF3A;SOCS2;HIF1A;ASB18;SPSB2;SEM1;ASB15;KLHL21;ASB5;FBXL3;UBE2D3;SPSB4;DCUN1D1;ANKRD9;SOCS6;FBXO30;GAN;SENP8;KCTD6;KEAP1;PSMD13;FBXO7;FBXL14;COMMD2;KLHL42;DCAF5;ASB6;PSME4;UBA3;KLHL13;FBXL15;UBXN7
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.7418494120003843,1.2790941888183944,0.16981132075471697,0.8768424914034945,1.0,2/7,11.11%,VSIR;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.7762549820546267,1.2788305990820201,0.1568627450980392,0.8772196539644772,1.0,1/6,10.17%,CORO1C
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.46041300476105584,1.27863805410632,0.05172413793103448,0.8771321706509374,1.0,27/250,8.01%,GATA4;LGALS9;PNP;NOX5;C3;RUNX1;SYK;IL26;F2R;FZD5;ZBTB7B;IL4;HIF1A;LY9;CD244;RORA;RELA;TLR2;SCRIB;HPSE;PLCG2;TICAM1;F3;IL15;CD40;HMGB1;CCDC88B
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,-0.7925080006085597,-1.2786309065616226,0.12244897959183673,0.8343520574955122,1.0,1/6,1.14%,F8
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7410502502185409,1.2786088830879743,0.2127659574468085,0.8763696814806433,1.0,7/14,15.92%,GRM3;GRM8;GRM5;GRIK3;GRM4;GRM7;GRM1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.6629530529398084,1.2784967706904946,0.24528301886792453,0.8760452214811794,1.0,4/27,4.40%,GATA4;LHFPL2;WNT4;SIX4
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7267911986820053,1.2783826246854277,0.18,0.875681807917634,1.0,2/14,0.64%,ADRA1A;DRD5
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.676006703444259,1.2783823998733939,0.14814814814814814,0.8747648636161495,1.0,5/17,14.47%,C3;EHD1;PLA2G10;MSR1;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5604045440698352,-1.2782707205248585,0.125,0.8342951212938555,1.0,11/63,10.85%,DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;HFE;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.5485050470964726,1.2781819716097744,0.14,0.8751286486796188,1.0,9/56,13.08%,FGF10;FGFR3;FGFR1;STAT5A;FGF17;PIK3CA;CNTRL;SOS1;FGF5
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.7031914250562713,-1.2780308627529784,0.20930232558139536,0.8341026787459099,1.0,4/10,15.27%,CLTA;DNM1;CLTB;DAB2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5047208256898432,1.2780009338377902,0.1111111111111111,0.8752677861455131,1.0,32/93,19.30%,LAMA4;IL17RD;FGF2;TENM3;CSRP2;ALDH7A1;ZNF462;PPFIBP1;WWTR1;ADGRL2;LIFR;PCDH18;ANK2;PTPN14;MAGI1;GUCY1A2;GPR161;BMPR1A;AMOTL1;FLRT2;FIGN;RBMS3;RUNX1T1;SEMA6D;FBN1;DIXDC1;GJC1;FARP1;PHLDB1;MPDZ;DZIP1;PYGO1
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,0.8142895329701939,1.2779962870201742,0.05660377358490566,0.8743804576423223,1.0,1/10,1.16%,AP1M2
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.5219230287264657,1.2777916043078628,0.09803921568627451,0.8745726546246739,1.0,37/111,22.34%,GATA4;MYC;HIF1A;KAT2B;MED17;WNT4;ESR1;ITGAV;PLCG2;MED13L;HDAC3;HDAC2;PIK3CA;NCOA2;FOXO1;ATP1A2;NCOA3;THRB;PLCB1;TBC1D4;PIK3CD;NOTCH2;CTNNB1;PLCD1;TP53;MED30;PRKACB;AKT3;HDAC1;PIK3R3;BAD;ATP1B2;NOTCH3;MAPK3;PFKP;AKT2;PFKFB2
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.6103309694675764,1.27774254104965,0.14285714285714285,0.8739504725687873,1.0,12/43,18.05%,RUNX1;KAT2B;H2BC21;RBPJ;MOV10;H2AC6;H2AZ2;H2AX;SIRT6;NOTCH2;TP53;AGO3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7892858518000042,1.27769162281807,0.19642857142857142,0.8733033553245796,1.0,1/7,2.54%,HIF1A
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7690639102833751,1.2775679185653732,0.23636363636363636,0.8730768280137445,1.0,1/6,4.27%,FYCO1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6900014071552188,1.2772173308169663,0.16326530612244897,0.8739763209504982,1.0,9/18,13.00%,LRP4;NLGN1;PCLO;CEL;PTPRD;NLGN4X;LRRTM3;PTEN;FZD1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6034960801967615,1.2767960794066773,0.1956521739130435,0.8754230646092279,1.0,7/32,17.14%,SEMA5A;LLPH;ALCAM;AUTS2;CPNE1;CTNNB1;FLRT3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5703087232710385,1.276629141408409,0.10416666666666667,0.8754562582036085,1.0,6/50,7.75%,LGALS9;SYK;FZD5;TLR2;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7799069360320936,1.276626633065526,0.1956521739130435,0.8745499887851782,1.0,2/8,6.83%,HIF1A;TICAM1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.6558232686081665,-1.2765371752813026,0.23636363636363636,0.8393296630742662,1.0,2/33,0.59%,TERT;NOSTRIN
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7138650405136346,1.2761358542562131,0.25,0.8765260305235395,1.0,4/15,6.53%,IDO1;HPD;IDO2;TDO2
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.6082387192059517,-1.276040049159254,0.11320754716981132,0.8384631085982817,1.0,11/40,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.6082387192059517,-1.276040049159254,0.11320754716981132,0.8384631085982817,1.0,11/40,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.8044069609830995,-1.276026535216936,0.10204081632653061,0.8370396362070409,1.0,1/9,0.33%,ALB
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7700114284276045,1.2760217501826367,0.20754716981132076,0.876375699213667,1.0,3/7,11.19%,HS2ST1;EXT1;CSGALNACT1
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.5871764648532574,-1.2758736080145616,0.10909090909090909,0.8361592016923575,1.0,11/40,19.06%,KIF2B;KIF12;KIF15;KIF26A;KIF20B;KIF22;KIF4A;KIF1A;KIF26B;KIF1C;KIF18B
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.720111776362643,1.2757588536373734,0.1568627450980392,0.8766809144096442,1.0,3/13,6.81%,EGLN3;PLOD2;P3H2
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.7394478584858355,-1.2755998587055866,0.12121212121212122,0.8359899691087748,1.0,3/13,1.18%,SELP;SELE;TEK
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7409994293428092,-1.2753538516897187,0.23214285714285715,0.8356384707389253,1.0,5/11,18.46%,AQP7;AQP8;SLC5A1;UPK3A;AQP1
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,0.5891996363320677,1.275328641045848,0.1956521739130435,0.8783627943626313,1.0,14/61,6.24%,LGALS9;SELPLG;ITGAX;TRAC;SASH3;SAMSN1;IL2RA;PIK3R5;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.5943112605489954,1.275319218390343,0.16417910447761194,0.8774711782407791,1.0,8/32,17.67%,MSH4;H2BC21;TEX15;H2AC6;H2AZ2;H2AX;ARTN;CDK4
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6537110832731963,1.2752204036869674,0.10909090909090909,0.8770741277093853,1.0,3/20,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5946560013177448,1.2748252583219108,0.18181818181818182,0.8785302121496169,1.0,15/42,16.94%,TSHZ3;GRM3;CDH2;NLGN1;SYT1;NRXN1;GRM8;GRM5;GRIK3;ATP1A2;MEF2C;GRM4;GRM7;GRM1;DGKZ
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.676852857685488,1.2748208329152177,0.15789473684210525,0.8776541103713199,1.0,7/16,26.53%,TICAM1;UBE2D3;BIRC3;UBE2D1;IKBKB;TRAF6;CHUK
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.770142135620355,1.2747684500549206,0.24,0.8769737063409415,1.0,1/7,2.00%,TGFBR1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.8043276816072307,1.2746804926387918,0.18,0.876398004286398,1.0,2/6,10.59%,MYC;TCF4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6113891551495624,1.2746663189944734,0.13333333333333333,0.8755654758277847,1.0,6/34,7.29%,MYC;SIRT1;CDKN2A;CDKN2AIP;ABI3;IL15
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6032760122831702,1.274539412012121,0.1276595744680851,0.8756109696390352,1.0,12/42,12.26%,FLT1;SYK;ITGB8;TGFBR1;CDH2;RBPJ;APELA;AGGF1;EFNB2;EGFL7;HAS2;PROX1
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.45176158620412116,1.2744753565400422,0.07317073170731707,0.8749740542470495,1.0,73/334,21.36%,ASB17;HERC3;NEDD4;ASB18;SPSB2;SEM1;ASB15;CBLB;SEC22B;UBE2J1;RNF182;TRIM50;KLHL21;TLR2;ITGAV;ASB5;UBE2E2;FBXL3;UBE2D3;HMGB1;SPSB4;FBXO30;UBE2Z;RNF217;GAN;UBE3D;KCTD6;UBE2E3;KEAP1;UBA5;PSMD13;LNPEP;FBXO7;FBXL14;HLA-E;HECW2;VAMP3;UBE2U;KLHL42;RBBP6;UBA6;ASB6;UBE4A;PSME4;UBE2J2;UBA3;KLHL13;FBXL15;SEC61A1;RNF25;PSMA1;FBXO11;SEC61A2;CTSV;SMURF1;SEC14L2;FBXL20;FBXW5;HLA-F;SEC24B;RNF19B;FZR1;HSPA5;UBE2D1;UBE2A;IKBKB;TLR1;UBE2E1;PSMD4;HERC4;RNF130;CANX;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7287102764239369,1.2744598732836852,0.23076923076923078,0.8741969703757753,1.0,1/11,3.79%,BMP2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.8016814345166892,1.2743333812573794,0.19642857142857142,0.8738711383590285,1.0,2/5,7.44%,SIRT1;HDAC2
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7264677490565756,-1.2742106003870621,0.14583333333333334,0.8397662723938843,1.0,6/15,15.90%,ALOX5;ALOXE3;ALOX12B;ALOX15;PON3;LTC4S
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7628405079649205,1.2741118217965945,0.1875,0.8733112136667461,1.0,1/10,1.06%,GSTM2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7628405079649205,1.2741118217965945,0.1875,0.8733112136667461,1.0,1/10,1.06%,GSTM2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6024690606058233,1.2740184144899598,0.14545454545454545,0.8728463819673495,1.0,5/21,11.68%,FUT9;HS2ST1;EXT1;CSGALNACT1;HAS2
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.6109598156871702,1.2737159868555843,0.16666666666666666,0.8732525861932404,1.0,9/32,18.05%,MOV10;HDAC3;ABCA1;ABCG8;KDM3A;TBL1X;NR1H3;ABCG5;AGO3
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7432997324825725,-1.2734456258259201,0.13157894736842105,0.8415962145570122,1.0,4/11,16.36%,ZWILCH;SPDL1;TTK;CDK1
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,-0.5674849362796847,-1.2734258855202878,0.12962962962962962,0.840242545367394,1.0,4/55,2.68%,ANXA8;DUOXA1;SERINC2;CLDN1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7210872787507374,1.2733074746898447,0.20408163265306123,0.8749362159728571,1.0,7/11,14.28%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6959140497842726,-1.2732209877461984,0.21428571428571427,0.8397530535355645,1.0,1/7,2.93%,RIN3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.6633459944203932,1.2732005785929779,0.10909090909090909,0.8744711507301901,1.0,4/28,10.25%,ZDHHC11;IL4;STING1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.8404046142636552,1.2729472559696338,0.17647058823529413,0.8747851807032972,1.0,1/5,1.43%,CD99
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7011237703611045,1.2728500980378477,0.13793103448275862,0.874550595629034,1.0,6/11,23.85%,IL7R;PTPRT;MGAT5;PTPRC;DOT1L;JAK2
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.5796934948993174,1.2724537878832678,0.08620689655172414,0.8758059937419693,1.0,11/54,11.63%,SIRT1;KAT2B;REXO2;NPY;ABCA6;HDAC2;FOXO3;SMAD2;MAP4K2;FOXO1;SMAD4
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.6408897711818209,-1.2723736378681278,0.17647058823529413,0.8420451197608609,1.0,2/22,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.80492006708623,1.2722620850190474,0.11538461538461539,0.8760922900995168,1.0,1/5,7.75%,HMGB1
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7853667890458769,-1.272218809458892,0.2127659574468085,0.8412646512655256,1.0,2/5,9.67%,DLL4;RFX4
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.5834701167749561,-1.2721010778450932,0.1346153846153846,0.8403663521571492,1.0,8/34,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;SCML4;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.7767620303895363,1.2720823043814564,0.23529411764705882,0.8761874315242227,1.0,2/7,6.70%,CKMT1A;GAMT
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.815605871151243,-1.271984050776341,0.21568627450980393,0.839495123741956,1.0,1/5,1.10%,SCN5A
prerank,CellMarker_Augmented_2021__Exhausted T cell:Undefined,0.7660071530179402,1.2719700318332634,0.21818181818181817,0.875825455401655,1.0,2/8,4.31%,BTLA;CD244
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.7688537399453844,-1.2718098859337674,0.23809523809523808,0.838974976179327,1.0,5/9,15.40%,DRD4;CBARP;DRD2;GNB5;CALM1
prerank,Reactome_2022__Acetylcholine Binding And Downstream Events R-HSA-181431,-0.7497272683272842,-1.271734487917525,0.23255813953488372,0.8378932614237007,1.0,3/12,12.20%,CHRNE;CHRNG;CHRNA2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7195014601526417,-1.2717272927732133,0.19607843137254902,0.8365638937502199,1.0,1/17,0.17%,TERT
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.8362419178385172,1.2717069512152654,0.1836734693877551,0.8766180528165848,1.0,2/7,3.79%,WNT4;BMP2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6453454198030305,1.2716825053811003,0.14545454545454545,0.8758763652665047,1.0,6/23,9.87%,KCTD21;TULP3;ENPP1;MOSMO;KCTD6;GPR161
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.49276444884762044,-1.27166705154055,0.07547169811320754,0.8354539800223051,1.0,28/180,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;SPARC;COL1A1;MMP9;VIT;ACAN
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.8422861694327455,1.2716437115507286,0.14285714285714285,0.8752247461455509,1.0,3/6,12.26%,SIX4;CHD7;PROX1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.8520868684280322,1.2715774663303072,0.08196721311475409,0.8747387732220067,1.0,3/5,8.32%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.7812412999060503,1.2712985915063515,0.2037037037037037,0.8753019643961781,1.0,1/5,5.90%,F12
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7874716940132767,-1.2711797310353783,0.2631578947368421,0.8361246486483895,1.0,2/6,7.82%,ADCYAP1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.8094191027954031,1.2710424424153954,0.17307692307692307,0.875737866498487,1.0,2/8,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6895838687794935,1.2709253747040372,0.18,0.8753536666937145,1.0,3/19,6.94%,IGF1;PLCG2;DYRK2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.7295249755810347,1.2708993262049344,0.15789473684210525,0.8745799150989696,1.0,4/9,19.73%,BIN1;PICALM;EFNA1;LYN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5884408394613367,1.2707727842851284,0.10810810810810811,0.8743988919326374,1.0,6/46,7.75%,LGALS9;SYK;F2R;TLR2;PLCG2;HMGB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.5325817632387398,1.2707428375204213,0.0784313725490196,0.8736778985015291,1.0,25/98,14.36%,MXRA5;LRP4;GNG12;TENM3;CSRP2;ALDH7A1;LRIG3;ZNF462;EFS;ADGRL2;LIFR;STOX2;PCDH18;PRICKLE2;ANK2;MAGI1;SERTAD4;TNC;RASAL2;PCDH7;BMPR1A;FIGN;ID4;SEMA6D;DMD
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.7772493722216737,-1.2706511959935434,0.32075471698113206,0.8371978739377256,1.0,4/7,17.76%,TIE1;SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6944745617285741,1.2705767782694495,0.18461538461538463,0.8735232410154943,1.0,3/17,2.58%,SYK;IL4;ZBTB1
prerank,KEGG_2021_Human__Renin-angiotensin system,0.7126261250498426,1.2705162951601432,0.22641509433962265,0.873030288737198,1.0,4/15,13.75%,MME;ACE2;LNPEP;ANPEP
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6543744190900711,1.2704963309069695,0.16363636363636364,0.8713839771213443,1.0,3/19,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6543744190900711,1.2704963309069695,0.16363636363636364,0.8713839771213443,1.0,3/19,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7002777206443258,1.2704286573526762,0.24,0.8709571318082764,1.0,3/18,4.73%,F2;PPARG;ZBTB20
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6346518647729134,1.2699788229520537,0.13725490196078433,0.8722673982462272,1.0,4/24,12.77%,PLEKHH2;NAV3;PIK3CA;HDGFL3
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.6647644277808764,1.2699743548571572,0.15555555555555556,0.87146616092145,1.0,11/23,21.64%,DCC;DAPK2;TICAM1;TNFRSF10B;FASN;MAGED1;TANK;FADD;CASP3;TNFRSF10A;TMED7-TICAM2
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.5963204980982267,1.2699233732539918,0.1346153846153846,0.8708909040075988,1.0,7/36,10.29%,FGF10;IRS1;FGFR3;FGFR1;FGF17;PIK3CA;FLT3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6415318055366083,1.269914822070283,0.2,0.8701797889646378,1.0,6/23,8.97%,CLSTN2;CDKN2AIP;LGI1;SYT1;GRIK2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.713310034880758,1.2698338094274755,0.15555555555555556,0.8697189138337903,1.0,2/15,3.24%,CTDNEP1;LDLR
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.6219036213441076,1.2697438335517353,0.12962962962962962,0.8693086658335532,1.0,14/32,21.86%,SCD;SLC25A1;ELOVL5;SCD5;TECRL;ACSBG1;FASN;ACACA;OLAH;ELOVL4;TECR;ACSL4;ELOVL6;ACSL1
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,0.7529952069530665,1.2697075692845596,0.2553191489361702,0.8685763769021334,1.0,4/6,19.24%,TNFRSF10B;CASP10;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.7041628493055966,1.2692583101503654,0.16363636363636364,0.8700908451812187,1.0,2/19,3.72%,BOK;SYVN1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5289014127447215,1.2690360885665792,0.11538461538461539,0.8704745847674964,1.0,12/59,15.72%,SMAD6;IL17RD;SIRT1;TGFBR1;PPM1A;SMAD2;LTBP1;DAND5;FAM89B;BAMBI;VASN;FBN1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.6996833988963875,1.2690129897023996,0.16666666666666666,0.8697185471796639,1.0,6/17,14.88%,IRGM;PYHIN1;XAF1;HTRA2;IKBKE;PLSCR1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.6465801451826776,1.2688922281974326,0.21951219512195122,0.8696195259780152,1.0,6/24,12.71%,F2;F2R;F12;HPSE;CD34;KNG1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.7454044316770425,-1.2688777324409195,0.18867924528301888,0.8442341890451801,1.0,1/11,0.17%,TERT
prerank,KEGG_2021_Human__Bladder cancer,0.6116429376604164,1.2688297758237796,0.075,0.8690635116986859,1.0,4/37,4.32%,FGFR3;MYC;CDKN2A;DAPK2
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.768765219623383,1.2686195000554445,0.21153846153846154,0.8693233110055267,1.0,4/10,10.58%,SIRT1;KAT2B;FOXO3;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.49114405867881866,1.2681389442843884,0.08333333333333333,0.8709514795357518,1.0,45/139,22.04%,LGALS9;TNFRSF19;F2R;ROR1;CANT1;PELI2;SLC35B2;MID2;RELA;PELI1;TIFA;TICAM1;CD40;PPM1A;TAB2;TSPAN6;TNFRSF10B;CASP10;IRAK1;CD74;IKBKE;TRIM52;GPRC5B;LGALS1;TAB3;EEF1D;BIRC3;FADD;ZDHHC17;NDFIP2;C18ORF32;TFG;GPR89A;PIM2;ZDHHC13;SLC20A1;ATP2C1;TICAM2;RIPK2;IKBKB;CARD16;ANKRD17;TMEM101;CARD9;MIER1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8319809658033879,1.2672692504676777,0.1951219512195122,0.8745846536281988,1.0,2/5,9.38%,LLPH;AUTS2
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.8503746250953519,1.2671819470492676,0.15384615384615385,0.8741982765462198,1.0,2/5,6.72%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.7473809235712687,1.2670605109312258,0.16,0.8739725031469134,1.0,1/9,0.93%,F2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5658385767488119,1.266847920828071,0.09615384615384616,0.8741525468706665,1.0,6/62,6.78%,FGF10;CDKN2C;SLFN11;CDKN2A;KANK2;UBE2E2
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.5016884670894078,1.2664992747978918,0.07692307692307693,0.8742173374082457,1.0,24/93,12.87%,ARHGAP24;ADGRL4;RIN2;ARHGAP31;VCAN;BGN;CXCL12;LTBP2;POSTN;MYOF;TCN2;PDGFRA;ABCA1;PLSCR4;PDGFC;CYP27A1;CDK14;ALCAM;PRICKLE2;GSN;RPS6KA2;TNS3;HTRA1;PXDC1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.5016884670894078,1.2664992747978918,0.07692307692307693,0.8742173374082457,1.0,24/93,12.87%,ARHGAP24;ADGRL4;RIN2;ARHGAP31;VCAN;BGN;CXCL12;LTBP2;POSTN;MYOF;TCN2;PDGFRA;ABCA1;PLSCR4;PDGFC;CYP27A1;CDK14;ALCAM;PRICKLE2;GSN;RPS6KA2;TNS3;HTRA1;PXDC1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7927934756566847,-1.2663009807427685,0.19047619047619047,0.8541187521481646,1.0,3/10,7.45%,EIF2S3B;EIF2S2;EIF2S3
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8186556204146027,1.2662381538811247,0.14893617021276595,0.8748008134507819,1.0,2/6,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.7386687568998613,1.2661349091851009,0.1694915254237288,0.8744287136918258,1.0,5/17,7.44%,F2;RUNX1;F2R;WNT4;HDAC2
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.48036365306566703,1.2659530200911286,0.11904761904761904,0.8743140518964461,1.0,18/162,5.42%,TNFSF14;PCOLCE2;CFH;LRRC61;MYC;ERICH5;ASNSD1;RAB27A;RRAD;ENPP1;DUSP23;PRG4;HPD;EVA1A;DNAJC12;HS3ST3B1;RAB31;FKBP5
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.8149967103468918,-1.2659345418744377,0.14893617021276595,0.8544579170499559,1.0,2/5,16.26%,SLX4;MUS81
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5203766037665739,1.265664441669553,0.12244897959183673,0.8750545035959197,1.0,10/72,7.24%,IRS1;SIRT1;ZBTB7B;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;FER
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.6206567535333273,1.2655322053152445,0.16071428571428573,0.8749882616397111,1.0,1/22,0.48%,IGF1
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.5072913876268037,1.2653702826859548,0.07142857142857142,0.8749587151419601,1.0,29/156,18.48%,MYC;TGFBR1;CDC25A;CCNA2;HIF1A;H2AC25;SEM1;H2BC21;USP12;RNF146;SMAD1;KEAP1;SMAD2;PSMD13;SMAD4;PTEN;H2AC6;TANK;PSME4;CCP110;RCE1;PSMA1;RNF128;STAM2;BIRC3;IL33;FKBP8;TP53;ARRB2
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,0.7936979895245151,1.2653374968466573,0.19047619047619047,0.8743447137368384,1.0,5/7,16.86%,MAPKAPK2;RPS6KA2;CREB1;RPS6KA1;RPS6KA5
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.5321871336288153,1.265302769201118,0.19230769230769232,0.8736224074498747,1.0,19/89,12.08%,PPP1R18;ANTXR2;TSHZ3;MDFIC;ZEB2;PRDM8;GNB4;ARHGAP31;TRPV2;FLI1;COL6A2;ZEB1;CNRIP1;GYPC;CYBRD1;STK32B;QKI;RAB34;FMNL3
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7669368808328121,-1.265037656040681,0.2,0.857587092611307,1.0,2/11,8.96%,GUCA1B;SLC22A6
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.649720969986366,1.264975686817054,0.1509433962264151,0.8744328790396231,1.0,3/25,7.97%,CGNL1;TMEFF2;DLC1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6611405255299566,1.2648855422535092,0.16071428571428573,0.8740761437050667,1.0,4/24,8.90%,FBXO5;BMI1;DCUN1D1;ARRDC3
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.6699503150873686,1.2648780185803676,0.12280701754385964,0.873283398773856,1.0,5/17,20.82%,CDC14A;ANAPC16;FZR1;UBE2D1;UBE2E1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.7063525474447512,-1.26480899010007,0.21951219512195122,0.8572818198820626,1.0,5/15,16.36%,ZWILCH;SPDL1;CTCF;TTK;CDK1
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.5770704454508896,1.2647802116661178,0.1276595744680851,0.8729526923152837,1.0,16/48,10.71%,HPSE2;HS3ST5;VCAN;HS3ST3B1;BGN;B3GAT2;HS3ST1;HS3ST2;SDC4;HPSE;GPC5;HS2ST1;HS3ST4;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7025207253061729,1.2646687753248722,0.20754716981132076,0.8725984069257111,1.0,1/12,1.94%,SIRT1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.741743951818525,1.2646583167164815,0.2037037037037037,0.871809362543035,1.0,5/12,10.72%,ZDHHC12;NLGN1;PCLO;NRXN1;MPP4
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.6383282040701559,-1.2644285732868206,0.11764705882352941,0.8574490674658451,1.0,3/22,8.95%,CD24;IL6R;CEACAM1
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.7255187697944986,1.2643010877649796,0.21428571428571427,0.8727860851164724,1.0,2/11,2.12%,TNFSF14;TNFSF13B
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.6885975454770958,1.2642931568045332,0.21428571428571427,0.8720104449010555,1.0,2/11,11.34%,RNF185;RNFT1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.822792881576601,1.264270060614204,0.1568627450980392,0.8712724715761302,1.0,1/5,5.68%,SDC4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,0.545197136933781,1.2642491376848994,0.14,0.8705720571104617,1.0,18/57,14.15%,LGALS9;FLT1;TDRD10;STAB1;MYO15B;MAFB;COL6A2;CXCL12;HPGDS;SIGLEC1;CYP27A1;TMEM26;GSN;XPNPEP2;CD34;ANPEP;CH25H;ADAMDEC1
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.8158205920035406,-1.2640986275992911,0.19230769230769232,0.857556922523746,1.0,1/5,0.17%,TERT
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.7674490561088592,1.263900805208415,0.29508196721311475,0.8716545698229031,1.0,3/6,18.75%,LHFPL2;NR2F2;COL9A3
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.5948910913596106,-1.2634108216356406,0.09803921568627451,0.8591800636777939,1.0,9/40,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;LTB;KLRB1;CD5;TAGAP
prerank,Reactome_2022__PTK6 Promotes HIF1A Stabilization R-HSA-8857538,0.8398137800704761,1.263220773728327,0.09803921568627451,0.8743104591769216,1.0,1/5,2.54%,HIF1A
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.49067571930328946,1.2631984531333347,0.05,0.873573107280999,1.0,24/123,19.06%,GABRR1;NDUFC2-KCTD14;GABRR2;GNB4;GNG12;KCNJ3;SLC17A6;GABRG3;NAPEPLD;GNAI3;GRM5;GABRA5;GNG4;MAPK8;GABRG1;GABRB2;PLCB1;GRM1;MAPK10;NDUFB11;GABRE;GABRA4;GABRB1;PRKACB
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.5326377031887766,1.2629898936406392,0.10638297872340426,0.8737134059822406,1.0,20/104,16.06%,SULT2A1;PPARG;MED17;RORA;FDFT1;MED13L;HDAC3;ABCA1;HMGCS1;ACADM;SMARCD3;NCOA2;TBL1X;DAND5;NR1H3;ANGPTL4;CHD9;NCOA3;PEX11A;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.51919422290325,1.26291190368722,0.16071428571428573,0.8732178643221615,1.0,11/95,3.79%,VEGFC;IGF1;FGF10;SEMA5A;MYC;SIRT1;TGFBR1;HIF1A;STAT5A;FGF2;BMP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.6783617510197475,1.2625803329608678,0.11764705882352941,0.8739692420992714,1.0,3/19,5.23%,IGF1;CCL5;CCN4
prerank,KEGG_2021_Human__Chagas disease,0.5265790817490404,1.2625170307737505,0.13725490196078433,0.8735581828964697,1.0,27/77,22.26%,CCL3L3;C3;CCL5;TGFBR1;RELA;TLR2;TICAM1;GNAI3;PIK3CA;SMAD2;MAPK8;IRAK1;KNG1;PLCB1;PPP2R2B;PIK3CD;MAPK10;CD247;FADD;AKT3;PIK3R3;IKBKB;MAPK3;GNAQ;GNAI1;AKT2;ACE
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7732123971778063,1.2623144484071194,0.22580645161290322,0.8736501320430649,1.0,1/7,2.00%,TGFBR1
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.5814166159453877,1.2622748392433343,0.17307692307692307,0.8730729038050423,1.0,9/44,13.08%,FGF10;IRS1;FGFR3;FGFR1;FGF17;PIK3CA;FLT3;SOS1;FGF5
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.8197551909032312,-1.2622207869436242,0.3018867924528302,0.863331539019145,1.0,2/6,5.43%,TIMP4;PTPN3
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5795563992899339,1.2621046709448902,0.10204081632653061,0.8732367493730993,1.0,10/43,10.25%,LGALS9;CCL5;SLC26A6;SYNCRIP;IRF8;TLR2;CD40;SNCA;GCH1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.6573748524299323,-1.2620982365862978,0.19148936170212766,0.862504092319745,1.0,3/14,10.00%,DDX11;RAD50;RTEL1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.7052641859653555,1.2618704808747028,0.16666666666666666,0.8738653161999925,1.0,2/13,4.18%,GRIN3A;GLRA1
prerank,CellMarker_Augmented_2021__Parietal Progenitor cell:Stomach,0.8382698355492109,1.261827676214854,0.22641509433962265,0.8732776087185986,1.0,2/5,9.63%,CFH;H6PD
prerank,KEGG_2021_Human__Pathways in cancer,0.45434696595792723,1.2617211317311785,0.07142857142857142,0.8731194601196935,1.0,76/448,14.31%,VEGFC;MITF;IGF1;FGF10;LAMA4;F2;GSTM2;GSTT2;RUNX1;FGFR3;HGF;MYC;TGFBR1;F2R;FZD5;FGFR1;EGLN3;CCNA2;IL4;HIF1A;STAT5A;CSF3R;ITGA2;FGF2;PPARG;GNB4;GNG12;WNT4;CDKN2A;CSF2RA;FRAT2;BMP2;DCC;IL2RA;DAPK2;IL7R;SP1;CXCL12;RELA;RALA;ESR1;WNT9A;ITGAV;PDGFRA;PLCG2;IL15;HDAC2;ELK1;GNAI3;LAMB4;FGF17;KEAP1;PIK3CA;SMAD2;CTNNA2;IL23R;FLT3;FOXO1;SMAD4;GNG4;MAPK8;PTEN;CTBP2;KNG1;SOS1;FZD1;DLL3;FGF5;IGF1R;CCND3;DVL2;PML;RARB;RUNX1T1;LRP6;FZD4
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.5301618813055405,1.261669688863794,0.14545454545454545,0.8724978947618,1.0,27/97,17.80%,TSPAN12;BMI1;ARHGAP5;ITGAV;CNN3;EPS8;ADGRL2;SOCS6;FAM171B;ALCAM;TSPAN6;KCTD3;CLDN12;ZBTB41;ABCD3;SPIN1;LRRC1;FZD6;TMTC3;MIB1;SMAD5;MAGI3;CPE;TNFRSF21;CTNNB1;FLRT3;WASL
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8113984375700745,1.2615786601678887,0.23214285714285715,0.8722338688309029,1.0,2/5,15.15%,SLC26A6;SLC2A5
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.800390022245894,1.2613979067781953,0.25,0.8723501078089305,1.0,4/5,14.46%,TGFBR1;DSP;BMPR1A;LRP2
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.7065519857856408,-1.261389214227386,0.17647058823529413,0.8644151737380062,1.0,5/14,16.18%,PLAAT4;ETV4;VDR;PRKCH;MED1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.6859456676905286,1.2612419914389625,0.2,0.8724779846628642,1.0,5/16,15.30%,CASR;ANK2;EPB41;GRIN3B;SLC30A10
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,-0.8036965989738576,-1.2612410469860338,0.19148936170212766,0.8634952790806458,1.0,1/9,3.55%,CCT6B
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6580997325505193,1.261175787628141,0.2,0.8719541223662886,1.0,7/22,12.66%,SLC12A7;SLC12A1;SLC12A3;SCNN1B;ATP6V0A4;CYP4F12;SLC26A4
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7572568560602599,1.2610309395224082,0.27450980392156865,0.8718572790050992,1.0,2/7,2.47%,SIRT1;IL4
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7844424160350616,1.260949103420134,0.2222222222222222,0.8713940978815744,1.0,2/6,13.40%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.8050832900635172,1.2609390892119405,0.15384615384615385,0.8706128575088015,1.0,1/5,1.94%,SIRT1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.7414670518732185,1.260816968349779,0.1836734693877551,0.8703641281685538,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.7325716466624455,1.2607217972546627,0.22448979591836735,0.8700451240092368,1.0,2/11,11.63%,RAPGEF3;SMAD4
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.8190036745458615,-1.2607072296640032,0.10869565217391304,0.8643147482250095,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.8134259010660333,1.2606593339386936,0.1568627450980392,0.8694911359316334,1.0,1/7,6.30%,CHCHD4
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.773918054569571,1.2602545045273463,0.15517241379310345,0.870515095885856,1.0,4/7,14.83%,FASN;MLXIPL;ACACA;ACACB
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.7778006556908025,1.2602422117961478,0.14035087719298245,0.8697500763562769,1.0,3/7,6.01%,GRIP1;GRIP2;SCRIB
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.5754439089362239,1.2601470886439001,0.14893617021276595,0.8693623572185666,1.0,10/47,6.41%,LAMA4;COL9A1;ITGA8;ITGAX;ITGA2;LRP4;COL9A2;VCAN;BGN;ITGAV
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6925180394353467,1.2600925791451119,0.21311475409836064,0.8688228032742457,1.0,3/11,10.84%,TGFBR1;SIX4;BMPR1A
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4869462472230196,-1.2599685661272113,0.1111111111111111,0.8660390452825133,1.0,12/139,5.72%,CYP1A2;ALB;CYP2A6;ASS1;CYP2E1;HABP2;AHSG;F7;HSD11B1;FGL1;PAH;GPC3
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5742841974614573,-1.2597003806880984,0.13333333333333333,0.8655856199384261,1.0,5/47,9.57%,HK2;LDHC;PDHX;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.6550583812740733,1.2594027211271561,0.1724137931034483,0.871238757422056,1.0,2/21,4.11%,PNP;FHIT
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8109958438282971,1.259314621272123,0.19298245614035087,0.8708155957715341,1.0,1/5,2.87%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.8230631676737019,-1.2592773937678898,0.2222222222222222,0.8663049422348147,1.0,2/5,12.20%,MEFV;PYDC1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6489032707657753,-1.259102350557842,0.2,0.8656673053048317,1.0,3/13,22.67%,RCC1L;MPV17L2;UQCC2
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,0.6809784096356067,1.2586641600828716,0.17307692307692307,0.8733773450166354,1.0,7/12,20.31%,VCAN;BGN;HYAL3;BCAN;HEXB;SPAM1;CSPG4
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.6106499673462789,1.2585454407050318,0.16981132075471697,0.8731400501345872,1.0,10/20,17.68%,HIBCH;BCAT1;LDHD;HSD17B10;SOAT1;AUH;HIBADH;ACAD8;ALDH6A1;BCKDHB
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6630202637257212,1.2585260066052122,0.2,0.8724126031746012,1.0,1/13,1.82%,CCL5
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.588678906604938,-1.258461881762025,0.18,0.8669274605242987,1.0,13/45,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;IRF4;TRAF3IP3;SCML4;ZC3H12D;LTB;KLRB1;CD5;TAGAP
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6451775887076407,1.2583003169843165,0.10909090909090909,0.8726784486198762,1.0,7/18,19.54%,SLC17A6;UNC13B;GRIK2;GRIK3;CDH8;GRID2;UNC13C
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7856167066907964,1.2580823283675255,0.19607843137254902,0.8728855064693031,1.0,1/7,2.97%,SLC35G1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5116876686849994,1.2580530926696434,0.14285714285714285,0.872311740567654,1.0,26/123,12.15%,LRRC3B;NXPH1;LSAMP;RIT2;NEGR1;GRM3;LRRC4C;KCNC2;GFAP;CADM2;NPY;PENK;NRXN1;RAB3C;OLFM3;ATXN1;SYNPR;GRM5;TAC1;LRRTM3;ADGRB3;SCN2B;PAK5;TMEM196;DPF1;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6906526537674971,1.2580283496056825,0.14,0.8716226580744638,1.0,5/19,13.21%,IGF1;BIN1;HAP1;RTN1;PICALM
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.8082203937321413,1.2573841051074148,0.18181818181818182,0.8744112846571213,1.0,2/5,18.05%,MOV10;AGO3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.8741251053044526,1.2572824086529093,0.09090909090909091,0.874232648599732,1.0,2/5,5.57%,IRGM;RELA
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7048632052050765,-1.2571229599386247,0.18867924528301888,0.87126491681461,1.0,2/9,21.52%,PGP;GK5
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.596959335941781,1.2571176788097849,0.1702127659574468,0.8743560837331948,1.0,8/29,16.07%,IGF1;IRS1;SCNN1B;PIK3CA;ATP1A2;HSD11B2;SGK1;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.7546842209095945,1.2570521014200646,0.1320754716981132,0.8738183885513041,1.0,2/9,12.25%,FBXO5;BAG2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5996838854257637,1.2570488663051445,0.12280701754385964,0.8730268307861322,1.0,8/24,10.29%,FLT1;F2;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.5836150966092186,1.2569938696646878,0.18867924528301888,0.8724797702261574,1.0,20/52,22.13%,INSIG1;SCD;FDFT1;HMGCS1;SMARCD3;NCOA2;TBL1X;DAND5;MVD;FASN;ACACA;CHD9;ACACB;SC5D;SQLE;DHCR7;SEC24B;ELOVL6;SREBF2;IDI1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6463339094464857,-1.2568827745792879,0.13725490196078433,0.8710141250184055,1.0,1/21,0.17%,TERT
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.7723426458971082,-1.2568363482527944,0.2,0.8697748310064661,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.7642409952889881,-1.2565981708649654,0.26666666666666666,0.8695846617302764,1.0,1/9,0.22%,TAFA3
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8277581703190505,1.2561585454301512,0.22641509433962265,0.8758650929103726,1.0,1/5,3.06%,AK3
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.8137595626380207,1.2560491844410204,0.17543859649122806,0.8755705838994075,1.0,1/5,1.82%,CCL5
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.689418685034556,1.2554850233464623,0.11764705882352941,0.87763112176303,1.0,1/13,2.54%,HIF1A
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7463392830253817,1.25509548664979,0.2153846153846154,0.8787884599933691,1.0,4/9,18.14%,APELA;RYR2;MESP1;CITED2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6930636428497088,-1.2549044462811678,0.1875,0.8758623309968571,1.0,4/16,8.08%,SCN5A;KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.5362745255180447,1.2547311254068199,0.18181818181818182,0.8799091206217031,1.0,15/49,27.74%,ACD;TERF1;TENT4B;NEK7;CTNNB1;GNL3L;POT1;MAPK3;MAPK15;HNRNPU;NAF1;HMBOX1;HNRNPC;CCT3;TNKS
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7357327536222589,1.2544704742946418,0.1836734693877551,0.8804061899407709,1.0,2/9,2.04%,ADRA1A;F2R
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7326238760142445,1.2539432905518646,0.20754716981132076,0.8823397997405813,1.0,3/14,5.84%,TMEM100;FGF2;VEZF1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7319312532670734,1.2539232738733488,0.16326530612244897,0.8816159027310728,1.0,2/7,14.22%,LIN28A;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.6013292556014789,1.253768342646284,0.2,0.8814672559913566,1.0,11/28,23.10%,IRGM;HIF1A;CPNE1;CD74;FADD;CSF1;TICAM2;AXL;EDN1;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.6328308438661355,-1.2537638909678521,0.12244897959183673,0.8792921639904437,1.0,3/24,3.44%,CD24;DUSP6;SPAAR
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6089448505168686,1.253411711781361,0.10869565217391304,0.8826033169663228,1.0,5/28,8.92%,FERMT3;SYK;DPP4;ADA;EPHA8
prerank,"KEGG_2021_Human__Neomycin, kanamycin and gentamicin biosynthesis",-0.8328616938762088,-1.2534084356919573,0.1951219512195122,0.8793963149090063,1.0,1/5,0.60%,HK2
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.800464662848739,-1.2533295249495182,0.14285714285714285,0.8783589482626427,1.0,3/5,13.11%,RFTN1;FLOT1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.816096622631117,1.2532128486503085,0.19672131147540983,0.882774860227046,1.0,2/5,9.40%,SEMA5A;DSCAM
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.6025664756570133,1.252707016564532,0.17307692307692307,0.8842625379278853,1.0,6/25,14.62%,SYVN1;RNF185;RNF139;PRKCSH;RNF5;DERL2
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.8225638466921814,-1.2526018057455028,0.2692307692307692,0.8800251878969216,1.0,1/5,2.25%,DUOX1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8021887859930579,1.252388890353305,0.15873015873015872,0.8852099781173983,1.0,2/6,11.11%,RUNX1;HLA-E
prerank,Reactome_2022__Fertilization R-HSA-1187000,-0.6328898011787615,-1.252289769053203,0.1702127659574468,0.8801504278259217,1.0,9/17,21.65%,OVGP1;ZP3;IZUMO3;IZUMO2;CD9;ADAM21;KCNU1;CATSPER4;HVCN1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.7962007344210636,1.2522695261664671,0.14545454545454545,0.8850358935519556,1.0,2/6,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.8296760286105991,-1.2521597901239885,0.22916666666666666,0.8792303791290174,1.0,2/5,13.11%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5496690090811055,1.2521165617567085,0.17307692307692307,0.8849648706074631,1.0,18/66,16.85%,LPIN3;ABHD3;ACADS;CEL;ECI1;PECR;ACADM;ACAA2;GLYATL2;ABCD3;ABCD2;BDH2;ECHDC1;HSD17B10;AIG1;AUH;PEX2;ABCD4
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,-0.7005801130705831,-1.2520913971343985,0.2222222222222222,0.8780524378152798,1.0,1/9,1.18%,TEK
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7790825801203142,1.2520153464679527,0.10526315789473684,0.8846316400836687,1.0,5/11,14.00%,LGALS9;ST18;HTRA2;GSN;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7004326415560859,1.25186720839645,0.16,0.8846180891098621,1.0,1/16,0.48%,IGF1
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.7562658035925066,1.251832655767575,0.21568627450980393,0.8839555998518867,1.0,6/7,23.99%,LLGL1;ANK1;CNTN2;MPP3;DLG1;NRCAM
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.7841632303359389,-1.2517469286670533,0.2727272727272727,0.878078310562747,1.0,1/5,2.15%,FGF1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5811656879056007,1.2515143343668225,0.1590909090909091,0.8847275609766659,1.0,7/54,5.99%,MYC;KAT2B;SNAI1;BMP2;DLGAP5;RBPJ;NRARP
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8460858345228379,1.2514421880505593,0.16363636363636364,0.8843616520142721,1.0,1/7,0.40%,PNP
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6731204538379614,1.2513967205983028,0.2,0.8838033751574388,1.0,7/13,25.90%,FOXO3;SLC25A33;PNPT1;TFB1M;TFB2M;MTERF2;MTERF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7724013893710436,-1.251352061250829,0.2553191489361702,0.8786918931434187,1.0,2/6,13.11%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6974963983557352,1.2512188576491263,0.15217391304347827,0.8840061727710634,1.0,4/17,24.68%,PRDX6;PNPLA6;GPCPD1;GDPD3
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6835697351966626,1.2508293522621174,0.2727272727272727,0.8851153351403658,1.0,9/11,25.89%,FUT8;CSGALNACT1;GFUS;GFPT1;B4GALNT2;EXTL2;GALT;GMDS;UGP2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7413812176853732,1.2508169777042677,0.1276595744680851,0.8843880268790227,1.0,4/8,19.07%,BMI1;RNF2;PCGF5;PCGF1
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.5589935700093482,-1.2507633249852972,0.17543859649122806,0.879608258219215,1.0,2/70,0.08%,CYP1A2;UGT2B15
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.5061924417020821,-1.2504642931933105,0.06,0.879586486294082,1.0,14/157,9.57%,CYP1A2;ACOT1;AMACR;AWAT1;ALOX5;PTGES;CYP4F2;ALOXE3;HAO2;ACSM6;PCCB;MLYCD;PRXL2B;ACOT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6478563677403821,1.2504425022348813,0.1509433962264151,0.8852006971298353,1.0,7/24,11.63%,SELPLG;ST18;RELA;FER;ST3GAL6;PTPRT;SMAD4
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.5282013162121587,1.2504196562856806,0.10204081632653061,0.8845537422629703,1.0,24/85,12.87%,VEGFC;CLMP;FGF2;GNG12;EVA1A;CRIM1;CD59;LTBP2;ANXA5;PDLIM4;CCDC80;MYOF;WWTR1;FAM114A1;IGFBP6;EXT1;MEDAG;TNC;AOX1;LOXL2;TPM2;RAB34;HTRA1;PXDC1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7512072687537961,1.2503668564750896,0.2391304347826087,0.8840886427280424,1.0,6/9,19.41%,SCRIB;SNCA;RAMP3;VAMP3;RAB29;ANXA2
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7711189344535405,1.2502633136331271,0.12280701754385964,0.8837823433360773,1.0,1/11,0.87%,KLRD1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4946507400490946,1.2502170399084573,0.07894736842105263,0.8832398527615133,1.0,34/112,20.67%,GPRIN3;NRTN;NEDD4;EHD1;NPY;CNTNAP2;TTC29;NLGN1;PRMT1;MANF;LGI1;HMGB1;EPHA8;GPM6A;CARMIL1;PPP1R9A;GPM6B;HDGFL3;FAM161B;PTPRM;LRP12;ROPN1B;L1CAM;MNS1;CNTN4;FLRT3;MICALL1;STMN4;PLP1;LYN;RAPGEF2;CDK16;MAP2;ATP1B2
prerank,Reactome_2022__Defensins R-HSA-1461973,0.7751952040737673,1.2501850321497554,0.19230769230769232,0.8824955938762725,1.0,3/8,6.20%,DEFB135;TLR2;PRSS3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5004661487533448,1.250182520872499,0.11904761904761904,0.8817076513817402,1.0,21/111,13.69%,IRS4;IRS1;TCIRG1;ATP6V0D2;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;GAB1;FER;ATP6V0A4;FOXO1;GCK;BCAR1;SOS1;ATP6V0B;IGF1R;SH2B2;CPEB1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.8220499370369879,-1.2501529103619835,0.2765957446808511,0.8798010404982545,1.0,2/7,4.76%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6830719537751714,1.2499201270571327,0.22448979591836735,0.8822478030979226,1.0,8/17,23.88%,PDE4DIP;RAB33B;STX5;STX18;CAMSAP2;MAPK3;USP6NL;AKAP9
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.598540260965291,1.2499077790895399,0.16071428571428573,0.8814951852877931,1.0,10/34,17.55%,SLC12A7;SLC1A3;GLUL;IL10RA;SLC29A2;ATP1A2;SLC19A1;LRP2;SLC1A6;SLC36A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7359929070848418,1.2498574481860372,0.22413793103448276,0.8810244853198068,1.0,5/9,18.59%,GSTM2;SLC8A1;TRPM2;RYR2;RYR3
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.4825909438320347,1.2497285318061104,0.058823529411764705,0.8809807212251459,1.0,31/119,21.62%,SLC7A11;RAB38;SLC22A3;SLC38A3;LRP1B;SLC38A4;SLC7A2;ABCC2;TCN2;RAMP3;SLC7A9;ARRDC3;SLC25A48;SLC15A2;TOM1;SLC52A1;SLC22A5;LRP2;LMAN2L;SLC44A4;CALCRL;SLC3A2;SLC36A1;SLC19A2;SLC7A14;SLC7A6;EDN1;SCAMP4;SLC6A15;SLC18A2;SLC7A8
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.710304885749026,-1.2497006727798858,0.13953488372093023,0.880452996498387,1.0,2/9,4.93%,DRD4;DRD2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.6966952544884236,1.2494806191378933,0.12,0.881373957654854,1.0,9/23,16.76%,ACSM2A;SIRT1;RORA;NR1H3;PLA2G12B;MLXIPL;ANGPTL4;PNPLA8;DGAT2
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.8090239399199903,1.249450797109069,0.12727272727272726,0.8807255282790781,1.0,1/6,2.04%,F2R
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8585859087186777,1.2493398568821796,0.17543859649122806,0.8805032137040415,1.0,3/5,11.71%,KANK2;KANK1;ANLN
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5281817849154523,1.2491490852103961,0.14893617021276595,0.8807952674545243,1.0,11/86,9.05%,MT4;VAPB;DRD5;CCL5;CXCL12;SLC8A1;SLC39A8;SLC24A2;CD40;CASR;ANK2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.7297555197130929,-1.2491437375416639,0.3181818181818182,0.8801943279042747,1.0,1/9,3.43%,PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.7297555197130929,-1.2491437375416639,0.3181818181818182,0.8801943279042747,1.0,1/9,3.43%,PRKCD
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.8028992296956922,-1.2491267124619319,0.3,0.8790202651701226,1.0,1/5,3.22%,TICRR
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5216578246538566,1.249106558480517,0.09615384615384616,0.8802160543928255,1.0,17/91,12.35%,FLT1;IRGM;SIRT1;FGFR1;FGF2;PIK3R6;TENM1;PIK3R5;DIPK2A;CD40;SNCA;PDGFC;TELO2;EZH2;FLT3;PROX1;IRAK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6342834025620444,1.2490872383162315,0.16981132075471697,0.8795151771591236,1.0,6/27,12.37%,CDKN2C;SLFN11;CDKN2A;KANK2;PTEN;CDK2AP2
prerank,CellMarker_Augmented_2021__Myoblast:Muscle,-0.7899652618560539,-1.249074886114737,0.20408163265306123,0.8779949795700525,1.0,2/5,16.36%,TTN;CDK1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.6292154099628818,1.2488039797039314,0.20754716981132076,0.8800190603845263,1.0,5/27,9.71%,DRD5;LGR5;CALCR;RXFP2;TMIGD3
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7822765437457788,1.2486149059087255,0.2631578947368421,0.8802214388858601,1.0,2/8,5.24%,C3;RAB31
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.5314642036609758,1.2484051615192906,0.17777777777777778,0.8805458246100397,1.0,29/95,16.15%,MXRA5;PREX2;SLC1A3;CSRP2;CXCL12;EFS;PDLIM4;POSTN;MEGF10;TMEM200C;PDGFRA;PTPRD;PCDH18;ANK2;GPC4;VANGL2;TNC;MAGEL2;SNCAIP;LGI2;HTRA1;ID4;COL11A1;RUNX1T1;COL22A1;OLFML3;FRZB;GAS1;PDZRN3
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.8090722127864556,-1.2483511736307056,0.2857142857142857,0.8793802558200805,1.0,1/5,4.30%,ATG14
prerank,KEGG_2021_Human__Mismatch repair,-0.6257476767856109,-1.2477322346584605,0.19607843137254902,0.8807612232792842,1.0,6/22,16.63%,RFC3;LIG1;RPA3;RFC2;EXO1;RFC1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.676320847080536,1.2475917701112296,0.17543859649122806,0.8835703968062705,1.0,1/18,1.82%,CCL5
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5544474312104538,1.247460449178839,0.16326530612244897,0.8833249338329824,1.0,8/51,12.23%,STK26;SIRT1;HIF1A;PDGFRA;FER;PTPRK;PXN;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6468490505497247,1.2474299018566002,0.19444444444444445,0.8827914417089865,1.0,7/20,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL7R;IL10RA
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7735036570274713,1.2473339278191617,0.13725490196078433,0.8824916710671166,1.0,2/5,20.02%,TENT4B;ELAVL4
prerank,KEGG_2021_Human__One carbon pool by folate,0.6581318232793112,1.2473082077460014,0.24528301886792453,0.8819044729209701,1.0,3/18,11.62%,SHMT2;MTHFD2L;MTHFD2
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,-0.523668956641248,-1.2471900221697365,0.13725490196078433,0.8818379155801203,1.0,7/80,5.36%,TRIP10;SERINC2;AGRN;RHBDF1;PHLDA2;KDELR1;GPC1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6240274739589047,1.2471290892656794,0.17857142857142858,0.8821150177769996,1.0,7/21,21.89%,SAMD4A;CNOT6L;CNOT4;CNOT8;CNOT2;ZFP36;PAN3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6443035074059311,1.24690900318769,0.1836734693877551,0.8824025834142555,1.0,5/25,8.14%,SOCS2;STAT5A;FER;IL15;SOCS6
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.526850354406827,-1.2467289600826894,0.20408163265306123,0.8821901993972459,1.0,2/65,0.85%,ACTC1;MYH7
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.7916724088732972,-1.2466593640308166,0.2978723404255319,0.8810350278968796,1.0,2/6,7.55%,IRF4;HLA-DRB1
prerank,Reactome_2022__Synthesis Of 12-Eicosatetraenoic Acid Derivatives R-HSA-2142712,-0.8143637673323018,-1.2466321793627806,0.19607843137254902,0.8798281317943991,1.0,4/7,14.16%,ALOXE3;ALOX12B;ALOX15;GPX2
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.6671848028373147,-1.246608427862624,0.18,0.873135854956357,1.0,6/21,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.6671848028373147,-1.246608427862624,0.18,0.873135854956357,1.0,6/21,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.6671848028373147,-1.246608427862624,0.18,0.873135854956357,1.0,6/21,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.6671848028373147,-1.246608427862624,0.18,0.873135854956357,1.0,6/21,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.6671848028373147,-1.246608427862624,0.18,0.873135854956357,1.0,6/21,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,0.6692650725117618,1.2462187013265082,0.17307692307692307,0.8850534991288086,1.0,3/13,6.66%,FGFR3;GFAP;PDGFRA
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.7144726846997295,1.246172565436074,0.09433962264150944,0.8844219689374309,1.0,7/12,22.25%,SYK;PIK3CA;SOS1;GAB2;LYN;SLC7A8;GRB2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6982062567890633,1.2461632432310752,0.22641509433962265,0.8837364101897638,1.0,4/12,17.23%,NRG1;CDH2;HEY2;KLHL12
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.676569457403239,-1.245847041852341,0.23684210526315788,0.8746805566270327,1.0,2/11,5.12%,PLK3;GOLGA2
prerank,KEGG_2021_Human__Hepatitis B,0.4965953325828162,1.2457294376055432,0.1111111111111111,0.8850791927756968,1.0,36/134,22.25%,MYC;TGFBR1;CCNA2;STAT5A;RELA;TLR2;MAP2K6;TICAM1;ELK1;TAB2;PIK3CA;CASP10;SMAD4;MAPK8;IRAK1;SLC10A1;SOS1;CREB3L2;CREB1;NFATC3;IKBKE;MAP3K1;PIK3CD;MAPK10;FADD;TP53;CASP3;IRF3;AKT3;PIK3R3;TICAM2;BAD;IKBKB;MAPK3;AKT2;GRB2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6446095791372534,1.2456385362452902,0.21739130434782608,0.884724481272558,1.0,6/12,22.98%,ZFP36L2;AKR1C3;NR3C1;ZFP36;ANXA1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.8089298188425396,-1.2456377618026124,0.27450980392156865,0.8742402637779467,1.0,1/6,0.81%,EIF5AL1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7075406833558551,1.245590860350235,0.2033898305084746,0.884150431743347,1.0,1/14,0.52%,CTDNEP1
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,0.7619586915597287,1.2455899731875002,0.25,0.8833795944009377,1.0,1/8,1.66%,ITGAX
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.6190013537276204,1.2454915974679834,0.21568627450980393,0.8831260985713898,1.0,5/29,6.02%,C3;THRSP;ADIPOR2;ZBTB20;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8430487282722869,-1.2453729454664277,0.17391304347826086,0.8739542515934259,1.0,2/6,6.34%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7906839191359487,-1.2448845891553548,0.3018867924528302,0.8745853301435412,1.0,1/6,6.01%,ST6GALNAC2
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.6759036720047725,1.244878937066672,0.2857142857142857,0.8855056372085788,1.0,8/13,29.16%,SIKE1;TANK;IKBKE;IRF3;EP300;TRAF6;TRIM4;IFIH1
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,-0.5998921612407061,-1.2447238004031043,0.2,0.8738313605421462,1.0,6/28,7.57%,SELP;SELE;SELL;IL6R;KLRB1;CD5
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.5328441965258903,-1.244608639533856,0.12244897959183673,0.8730579342157897,1.0,6/57,2.28%,MS4A8;EHF;DUOXA1;CYP2B7P;DUOX1;FAM3D
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.7768871122766827,-1.2444112220136196,0.20454545454545456,0.8724062899924735,1.0,2/9,1.56%,TERT;DND1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,0.5089772105145021,1.2442919055758528,0.23636363636363636,0.8877385627172026,1.0,12/77,6.77%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;CXCL12;POSTN;ERG;PDGFRA;CNRIP1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5930310731805204,1.2442372044067345,0.2037037037037037,0.8871972384584819,1.0,5/29,14.30%,SEMA5A;ROBO2;SEMA6C;SEMA3E;SEMA6D
prerank,Reactome_2022__Glucocorticoid Biosynthesis R-HSA-194002,-0.760640497882025,-1.2438818679395949,0.23404255319148937,0.8732960794791489,1.0,4/6,8.26%,HSD11B1;CYP21A2;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7315052114802293,1.2437057530907596,0.16326530612244897,0.8889324931734784,1.0,3/10,9.99%,F2;BMP2;BIN1
prerank,Reactome_2022__Gamma-carboxylation Of Protein Precursors R-HSA-159740,0.7530409357755435,1.2436612002088567,0.1896551724137931,0.8883254858946322,1.0,1/8,0.23%,PROZ
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.5609204273441798,-1.2433895602101976,0.21052631578947367,0.8741182275563605,1.0,8/38,14.55%,PARP2;ERCC1;RFC3;PARP1;GTF2H2;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7705734685284598,-1.243180484669024,0.16326530612244897,0.8736300623678406,1.0,2/11,5.45%,SPTLC3;DEGS2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Skin,0.8073560226131192,1.243171301605659,0.2807017543859649,0.890275187788155,1.0,1/5,2.71%,ITGA2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.7570783326029721,1.2431235652539556,0.17307692307692307,0.8897226298774163,1.0,1/10,1.92%,NDC80
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.8060599652194094,1.2430529732248976,0.17857142857142858,0.8892473469633312,1.0,1/6,13.89%,HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.7769588663903799,-1.2430450098815053,0.21428571428571427,0.8730030711052614,1.0,1/5,3.84%,SLC6A6
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,-0.5565670706753651,-1.2429380521339122,0.13725490196078433,0.8707971281131178,1.0,12/55,8.78%,P2RY10;TBC1D10C;SELL;SP140;TRAF3IP3;CD53;CYTH4;LTB;TAGAP;TMC8;PTPN7;LY86
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,-0.5565670706753651,-1.2429380521339122,0.13725490196078433,0.8707971281131178,1.0,12/55,8.78%,P2RY10;TBC1D10C;SELL;SP140;TRAF3IP3;CD53;CYTH4;LTB;TAGAP;TMC8;PTPN7;LY86
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.5088234616843311,1.2428492971689158,0.19607843137254902,0.8894482697956348,1.0,14/78,10.38%,MXRA5;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;CXCL12;LTBP2;POSTN;PDGFRA;FAM114A1;PLSCR4;MEDAG;AOX1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.4421975297304551,1.2428452278259234,0.11538461538461539,0.8887019475247306,1.0,66/341,13.12%,LGALS9;SELPLG;IRGM;GREM2;MME;HGF;ITGAX;SYK;MYC;CCL5;SIRT1;IL26;IL4;SOCS2;HIF1A;STAT5A;CSF3R;FGF2;PYHIN1;SLC26A6;CSF2RA;IL2RA;SYNCRIP;ZFP36L2;RORA;PTPN20;IRF8;HCLS1;IL10RA;CXCL12;RELA;ZEB1;TLR2;F3;NLRP7;FER;LIFR;HTRA2;CD40;SOCS6;FOXO3;CRHBP;ERBIN;ABL2;RHOU;PTPN14;LEPR;PIK3CA;ZNF675;ST3GAL6;RO60;PTPRT;HYAL3;IL23R;FLT3;FOXO1;IL13RA2;ZFAND6;HAS2;MAPK8;NPR2;IRAK1;SOS1;IL18R1;TANK;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.8107320281214422,-1.2424158744869607,0.3125,0.8716168560866956,1.0,1/5,14.78%,USP17L2
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.8115418762902799,1.2423835263089211,0.14754098360655737,0.8905885409874345,1.0,2/7,9.52%,CXCL12;PIK3CA
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6435931055756586,1.2423426555497812,0.14893617021276595,0.8899511736939375,1.0,8/18,19.49%,THRSP;PRKAB2;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.70639617568799,1.2421381611297408,0.22448979591836735,0.8901507980610736,1.0,6/11,24.95%,BOK;DLC1;TP53BP2;TP53;FAP;FZD3
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5761908638984619,-1.2420034885537725,0.16326530612244897,0.872165938994621,1.0,9/36,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;LTB;KLRB1;CD5;TAGAP
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.46960593870519673,-1.241773922892948,0.10416666666666667,0.8716850811110306,1.0,1/177,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.7124952943774439,-1.2416459130299498,0.20930232558139536,0.8708527121004065,1.0,1/8,1.10%,SCN5A
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.49617756950894926,1.2416198472729534,0.13636363636363635,0.891944502581197,1.0,16/122,6.66%,PCDH15;LHFPL3;TMEM100;LRRC3B;NXPH1;C1QL1;SLC35F1;LRRC4C;PMP2;GFAP;OLIG1;VCAN;OLIG2;GPR17;MEGF10;PDGFRA
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7532419290105921,1.241478391246831,0.1746031746031746,0.8911265856033262,1.0,3/8,14.96%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7532419290105921,1.241478391246831,0.1746031746031746,0.8911265856033262,1.0,3/8,14.96%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7702627113358387,1.2414633178907357,0.1956521739130435,0.8904049440364367,1.0,4/9,9.70%,SELPLG;RELA;ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.6698196019005963,1.241023647844485,0.13725490196078433,0.8917923364247475,1.0,10/21,16.11%,IGF1;SMYD1;NRG1;LMOD3;EFNB2;MEF2C;PROX1;GREM1;PIEZO1;MESP1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6977867402658318,1.2410221695229964,0.27586206896551724,0.891038961277892,1.0,1/15,0.40%,PNP
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8209547645271743,1.240886964324868,0.2711864406779661,0.8909235275804411,1.0,1/5,2.87%,PPARG
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7144068389170676,1.2408137459591277,0.22950819672131148,0.8905603175325857,1.0,6/12,19.39%,RENBP;NANP;UAP1;GNPNAT1;GNPDA2;GFPT1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.514611377703557,1.2407748002828614,0.13725490196078433,0.8898530161502685,1.0,11/82,10.92%,IGF1;SYNCRIP;SAMD4A;LIN28A;TOB1;RNF139;BIN1;PATL2;HAP1;RIDA;RTN1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5534678284464963,1.2407576678104257,0.1694915254237288,0.8892007380839083,1.0,10/50,18.43%,GDAP1;IMMP2L;CHCHD4;TIMM22;FBXO7;DNAJC15;AIP;IMMP1L;MFF;TIMM10
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.6678483122074873,1.240685489845398,0.20689655172413793,0.8887538967214506,1.0,5/17,18.05%,RUNX1;MOV10;CCND3;PML;AGO3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.6435567708046113,-1.2406491014120866,0.225,0.8739315068086506,1.0,2/21,6.07%,TEK;SFRP1
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,0.46456571731440693,1.2403044623663007,0.06818181818181818,0.890317077243904,1.0,81/320,16.99%,AASS;LRRC3B;RIT2;TNFRSF19;GRM3;LRP4;PHGDH;SLC1A3;GFAP;DBX2;ADD3;NDRG2;SCD;GNG12;BRINP3;MLC1;SLC38A3;SELENBP1;ZFP36L2;CSRP2;LIX1;GLUL;LGI1;ABHD3;RAB31;LRRN3;PDLIM5;ANXA5;SYPL1;SYT1;MSMO1;CCDC80;ITGAV;CNN3;F3;DCXR;HDAC2;LIFR;ELOVL5;SPON1;RAMP3;ALCAM;HMGCS1;MAGT1;SLC15A2;TSPAN6;LRRTM3;TNC;RTN1;LRRC17;ATP1A2;ABCD3;ACSBG1;C1ORF122;PLAGL1;QKI;RAB34;GPM6B;HTRA1;BDH2;CBS;HSPB1;STON2;SLC39A12;ID4;LUZP2;SEZ6L;TTYH2;SEMA6D;SOAT1;EMC2;GPR137B;BCHE;GPRC5B;LGALS1;HAPLN1;NOTCH2;BCAN;SLC3A2;IL33;PLCD1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8020339590128187,-1.239970412291283,0.25,0.8751776602637471,1.0,4/6,18.30%,FLOT1;CAV2;CAV1;CAV3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6951882495721777,1.239936286774257,0.21739130434782608,0.8914696437265562,1.0,7/14,22.09%,SCRIB;SNCA;RAMP3;VAMP3;RAB29;ANXA2;AP1AR
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.7396267340855722,-1.239728349236019,0.2558139534883721,0.8747803642360718,1.0,4/7,8.26%,HSD11B1;CYP21A2;HSD3B2;HSD3B1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4694511454193168,1.2396861593898594,0.08163265306122448,0.8921590124603842,1.0,30/139,13.14%,SCN7A;LSAMP;CADM2;SLC17A6;NKAIN2;GDAP1;NEFH;PARM1;NRXN1;RAB3C;VAMP1;NOVA1;SCN10A;OLFM3;PTPRD;CLGN;SYNPR;ANK2;MAGI2;GRM5;TAC1;LRRTM3;ADGRB3;ZDHHC2;PAK5;TMEM196;ZNF536;LRFN5;SCN9A;CPNE3
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.598269740031188,1.2395545943444908,0.11538461538461539,0.8921934537450904,1.0,10/35,20.82%,CDKN2A;RELA;MOV10;ANAPC16;CTNNB1;TP53;AGO3;FZR1;UBE2D1;UBE2E1
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.7905029892682905,-1.239522595643722,0.28846153846153844,0.8742991941150022,1.0,1/5,3.99%,AQP7
prerank,KEGG_2021_Human__Morphine addiction,0.5079264991239177,1.2394607554543542,0.16666666666666666,0.8919065907953898,1.0,20/82,19.06%,GABRR1;GABRR2;GNB4;GNG12;PDE1A;KCNJ3;GABRG3;PDE7A;GNAI3;GABRA5;GNG4;PDE4B;GABRG1;GABRB2;ADORA1;GABRE;ARRB2;GABRA4;GABRB1;PRKACB
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7265030058841246,1.2392513007327444,0.1568627450980392,0.8921123734890974,1.0,6/13,18.33%,FGFR1;NR5A2;STOX2;SCEL;RICTOR;RAI2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6897498493873185,1.23923983349461,0.17857142857142858,0.8913984649112245,1.0,3/12,15.08%,BOK;AGR2;ATF6
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7430499027773594,-1.2391079827732916,0.20930232558139536,0.874732433937585,1.0,2/6,14.78%,KCNE1;USP17L2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,0.7846855758524222,1.239089683762014,0.22641509433962265,0.8914334339776345,1.0,1/6,1.44%,RUNX1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7552803942132231,1.2388771844714597,0.19148936170212766,0.8915857349681376,1.0,4/11,7.59%,TMPRSS2;MYRF;F12;HTRA2
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.8484848847816501,-1.2386416806029348,0.23404255319148937,0.8752915942130854,1.0,1/5,3.41%,ALOX5
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5179373427007156,1.2386003181705114,0.07317073170731707,0.8923349002907026,1.0,14/97,9.40%,GATA4;SMAD6;TSPAN12;PLOD2;LRP4;GNG12;TENM3;DOCK1;LRIG3;WWTR1;ADGRL2;LIFR;MAGI1;TSPAN6
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6334023145816531,-1.2385712536259548,0.14285714285714285,0.8745048479811999,1.0,3/33,8.69%,RFX6;HLA-DRB1;NNAT
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.6682142687933788,1.2385452528508036,0.19230769230769232,0.8918149873411532,1.0,5/13,24.21%,ELP4;CTU1;DPH3;TRMT9B;MTO1
prerank,KEGG_2021_Human__Ras signaling pathway,0.4696176208410364,1.2384478543029809,0.06976744186046512,0.8914769156134376,1.0,37/189,13.08%,VEGFC;IGF1;FGF10;FLT1;FGFR3;HGF;FGFR1;FGF2;EFNA5;ANGPT1;RRAS;KSR1;GNB4;GNG12;EFNA2;RELA;RALA;PDGFRA;PLCG2;GAB1;PLA2G10;ELK1;PDGFC;ABL2;SHOC2;FGF17;PIK3CA;FLT3;PAK5;RASAL2;RGL2;GNG4;PLA2G12B;MAPK8;SOS1;FGF5;IGF1R
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.5246143527575686,1.2383860201539754,0.13725490196078433,0.8910224195844298,1.0,20/88,10.89%,MXRA5;LAMA4;MRGPRF;SEMA5A;PRRX1;ITGA11;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;EFS;POSTN;CCDC80;PDGFRA;ABI3BP;PCDH18;MEDAG;TNC;HMCN1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7499194031595559,1.2381265506923131,0.25925925925925924,0.8918120409055367,1.0,3/7,7.10%,SOX6;MDGA2;ZC4H2
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.8083371522287339,1.2381074287766545,0.12727272727272726,0.8911562867517816,1.0,4/5,19.15%,PPARG;MEF2C;CREB1;RBFOX1
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.7558971640366685,1.2379149547208768,0.2,0.8912442693921391,1.0,4/9,12.35%,PELI2;PELI1;PELI3;IRAK1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.5316351926432912,1.2376788987526521,0.14285714285714285,0.8915441063938121,1.0,25/100,20.38%,SIPA1;CDKN2C;FGFR3;SIRT1;ENPP1;CDKN2A;CDKN2AIP;NAIF1;DNAJB2;SERTAD2;DACT3;SMAD4;GNG4;ACVR1B;PML;FRZB;MT1M;NOTCH2;SMARCA2;DCBLD2;TP53;FBP1;BMPR2;PNPT1;ST7L
prerank,KEGG_2021_Human__Notch signaling pathway,0.563767233493303,1.2375430581852216,0.19230769230769232,0.891557476794478,1.0,17/49,22.30%,RFNG;KAT2B;RBPJ;HDAC2;ATXN1;CTBP2;TLE2;DLL3;DVL2;NOTCH2;HEY2;NUMB;TLE4;JAG1;HDAC1;NOTCH3;DTX3
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6338625666125732,1.2372732743988635,0.1724137931034483,0.8921845991529657,1.0,3/20,14.22%,LIN28A;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.7599183166306701,1.237037167865605,0.23529411764705882,0.8925357598622355,1.0,3/8,3.12%,TMEM100;RIN2;RRAS
prerank,CellMarker_Augmented_2021__M2 macrophage:Undefined,-0.8162516050150845,-1.236941155887897,0.17391304347826086,0.8796390817731625,1.0,1/7,1.37%,IRF4
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5719346650654409,1.23693298836206,0.17391304347826086,0.8921890698050852,1.0,12/39,17.36%,MME;FAIM;CLSTN2;NLGN1;NRXN1;PTPRD;LIG4;LRP2;RGS14;SPEN;GRID2;NUMB
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4517959540231003,1.2368653001051104,0.06,0.8917479589101758,1.0,61/354,13.08%,VEGFC;IGF1;FGF10;FLT1;IRS4;IRS1;TCIRG1;ATP6V0D2;EPHA7;FGFR3;HGF;SYK;FGFR1;ERBB4;SOCS2;FGF2;NRG1;EFNA5;ANGPT1;ROR1;HNRNPH1;BLNK;EFNA2;DOCK1;MAPKAPK2;EFS;CLNK;CASS4;ITGAV;MUC20;PDGFRA;EPHA5;GAB1;FER;EPHA3;GALNT3;PDGFC;ATP6V0A4;MTSS1;EPHA8;SHOC2;FGF17;MAPKAPK3;PIK3CA;PTPRT;FRK;NUS1;HAP1;FLT3;EFNB2;MPZL1;FOXO1;PXN;NCK2;BCAR1;FLRT2;TIAL1;SOS1;ATP6V0B;FGF5;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5571591397515399,1.2367751750486808,0.20408163265306123,0.8915396179757381,1.0,4/39,5.23%,IGF1;CCL5;FGF2;CCN4
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.5721403980717525,1.2367565087063592,0.2222222222222222,0.8909101023591085,1.0,13/42,12.91%,C1GALT1C1;RFNG;GALNT8;GALNTL5;GALNT7;GALNT3;COLGALT2;GXYLT1;C1GALT1;GALNT12;GALNT1;B3GLCT;POMT2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6248725607343197,1.2366584998676644,0.22641509433962265,0.8905553996684472,1.0,6/22,8.97%,RAPGEF3;KSR1;ADGRG6;EPHA5;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.5404531937431052,1.2365115063906655,0.11864406779661017,0.8906957518921943,1.0,5/59,7.50%,F2;NDC80;PYHIN1;WWTR1;BICD1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.8225837766945628,1.2363645513462287,0.2631578947368421,0.8906046123849813,1.0,1/5,3.09%,ANGPT1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5549293806328458,1.236164751688486,0.17647058823529413,0.890881228028238,1.0,11/69,16.79%,SYK;RGPD4;CBLB;RGPD3;RGPD2;RGPD5;NXT1;RANBP17;PRICKLE1;KPNA4;RANBP2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7304900101548851,1.2359984309181244,0.1702127659574468,0.8908110742687076,1.0,6/11,25.01%,BACE2;SOAT1;ABCA2;ITM2B;NECAB3;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8745851586443523,-1.2359470533500323,0.11764705882352941,0.882394199840853,1.0,3/5,10.48%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6286858648660912,1.2358686768167237,0.208955223880597,0.8906466679693443,1.0,4/22,9.39%,PNP;REXO2;FHIT;AK1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5020344017704726,1.2358511871246718,0.14285714285714285,0.8900320343970766,1.0,21/113,15.60%,SMAD6;TMEM100;SIRT1;TGFBR1;GDF6;BMP2;ACVR2A;ZFYVE16;LTBP2;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9;ACVR1B;BAMBI;HJV;SMAD5
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5643069953401687,1.235713227387336,0.25,0.8899627607495975,1.0,11/32,20.58%,KLKB1;HGFAC;F12;PRSS3;VSIR;ASPH;FADD;PERP;LGMN;RIPK2;BAD
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7944152216306882,1.2353117579423532,0.12903225806451613,0.8913683731548447,1.0,4/6,15.21%,PLSCR4;PLSCR2;PLSCR1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7353752507808499,1.2352004558733178,0.2037037037037037,0.8911935993482403,1.0,1/10,3.41%,ENPP1
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.6133435018693498,1.2351269219211412,0.22641509433962265,0.8907998323408767,1.0,8/32,21.16%,IL17RD;KSR1;CNKSR2;RAP1A;CNKSR1;ARRB2;APBB1IP;MAPK3
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.5225314320493714,1.2349585625435515,0.20408163265306123,0.8907823194523938,1.0,17/69,10.92%,STAB1;CSF3R;PADI2;NDRG2;MAFB;GLUL;FGL2;LMO2;TLR2;SIGLEC1;FOXO3;CYP27A1;PLXDC2;MTSS1;RHOU;TMIGD3;RTN1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.6742595477304093,-1.2348714180660396,0.21428571428571427,0.8852571195537798,1.0,1/8,3.12%,STK10
prerank,Reactome_2022__Purine Salvage R-HSA-74217,0.7538405859095305,1.2347893716519942,0.14814814814814814,0.8908899327064322,1.0,2/11,8.14%,AMPD1;ADA
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7930418135637511,-1.2347441741664364,0.28,0.884512958057417,1.0,2/7,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7124266830348799,-1.2342374002081602,0.22448979591836735,0.885368038270713,1.0,3/14,1.10%,SELP;SELE;SELL
prerank,Reactome_2022__Muscarinic Acetylcholine Receptors R-HSA-390648,0.8381947914673001,1.2341851130772177,0.20408163265306123,0.8928826910195634,1.0,1/5,1.09%,CHRM2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5941421426471952,1.2341584740444285,0.13333333333333333,0.8922702713577231,1.0,10/39,8.23%,PCDH15;MME;PNOC;OPRK1;TRPV2;WHRN;ADGRV1;PENK;SCN10A;NTSR2
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.504073916418291,1.2338084558727158,0.09090909090909091,0.8933122969981605,1.0,30/75,15.49%,PCDH15;FGF10;SMYD1;PDZRN4;HIF3A;ERBB4;CLSTN2;LIX1;PLCXD3;FREM1;LIN28A;UNC5D;NRXN1;ADAM18;BMPER;ADAMTS19;CNTN6;SCN10A;MAGI2;MAGEL2;TECRL;FLRT2;GABRB2;COL11A1;RUNX1T1;DMD;LRP2;FAT3;CDH8;RYR2
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.769502838851408,-1.233771013320398,0.3269230769230769,0.8860317631490037,1.0,2/5,7.09%,SFRP1;EGR1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5832871003018661,1.233705422925558,0.10204081632653061,0.892981073391176,1.0,11/43,10.29%,IGF1;TNFRSF18;FGFR3;CCL5;ERBB4;IL4;HCLS1;IL15;CD40;IL23R;FLT3
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.7596204612365363,-1.2335421849276114,0.2916666666666667,0.8858030690237476,1.0,1/6,0.37%,ACTC1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.8089177726543123,1.2333579629921938,0.23076923076923078,0.8937197238136582,1.0,2/7,5.24%,C3;RAB31
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7151424912638162,1.2332545658889709,0.17857142857142858,0.8934716963719019,1.0,4/9,5.84%,TMEM100;APOLD1;ZEB1;VEZF1
prerank,CellMarker_Augmented_2021__Leukocyte:Undefined,0.7823514687663604,1.2331819902774992,0.16666666666666666,0.8930893350767809,1.0,2/5,7.69%,IL2RA;CD40
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.6715384165431919,1.2330920250639317,0.23076923076923078,0.8927800958054068,1.0,5/16,14.32%,MYC;ARID2;SMARCD3;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5328497499042415,1.2329809235697142,0.1111111111111111,0.8925644939223258,1.0,16/59,22.45%,MED17;CDKN2A;RELA;MOV10;PAXIP1;PTEN;ATF7IP;HEY2;CTNNB1;CDK4;TP53;AGO3;MED30;TRIM28;CDK8;MED25
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.8192378484906327,-1.2329785655946963,0.1875,0.8867675822803838,1.0,3/6,10.96%,DNAAF1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.8349147021440201,-1.2327843116268737,0.20930232558139536,0.8863400153944831,1.0,2/5,8.95%,CELA2A;CEACAM1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.7529803949127478,-1.232415608477436,0.2727272727272727,0.8865812385800836,1.0,2/5,14.99%,RRM2;RRM1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5162862011300915,-1.2323736117853805,0.1346153846153846,0.8853844639810202,1.0,7/116,4.02%,MS4A8;RFX6;EHF;TMEM179;NPTX2;MAPK4;IGSF21
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.7880727613833823,-1.2321465073439224,0.17391304347826086,0.8838113628996774,1.0,2/5,16.11%,F11R;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.7880727613833823,-1.2321465073439224,0.17391304347826086,0.8838113628996774,1.0,2/5,16.11%,F11R;CLDN5
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5193037446490693,1.2320945667753678,0.15217391304347827,0.8957301789943211,1.0,9/67,8.59%,ITGA10;FERMT3;SYK;ITGB8;ITGA11;ITGA2;DOCK1;ITGAV;ERBIN
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.511364009535043,1.231912007250443,0.1320754716981132,0.8957397894075934,1.0,14/89,8.38%,MXRA5;LAMA4;MRGPRF;PRRX1;PRKG1;ADGRL4;GFAP;BGN;CXCL12;POSTN;CCDC80;PDGFRA;PLSCR4;PCDH18
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5339781053568041,1.2318963888913035,0.14545454545454545,0.8950577893345496,1.0,8/50,8.97%,TVP23B;PCSK5;LTBP2;RAB3C;ABCA1;MTTP;CYB5R4;RIMS2
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.6346862409554779,1.2318799293342468,0.18181818181818182,0.8944181609147982,1.0,4/24,3.41%,PRKG1;CA8;GFAP;ENPP1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7096510857611602,1.2318064499231571,0.16279069767441862,0.8939856870802673,1.0,2/11,5.90%,RUNX1;F12
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7263243135563244,1.231302473111407,0.2641509433962264,0.8957471829982654,1.0,4/8,20.84%,RELA;RPS6KA1;RGS14;DDIT3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5870429233657743,1.2312209434755386,0.16981132075471697,0.8953863505563021,1.0,3/35,11.71%,CDC14A;ANAPC16;ANLN
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7549666690267608,1.2310689592569413,0.22641509433962265,0.8954989965049747,1.0,2/8,5.24%,C3;RAB31
prerank,Reactome_2022__Digestion Of Dietary Carbohydrate R-HSA-189085,-0.8356005557348477,-1.2310515824128914,0.11627906976744186,0.8874976597396348,1.0,1/6,0.89%,TREH
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.585810386123022,1.2309133467946134,0.25,0.8955190123376771,1.0,13/36,24.67%,FGF10;DNAJB2;PLSCR1;RYR2;TOR1AIP2;DNAJB1;POT1;ATP1B2;DNAJB11;DNAJC9;HNRNPU;DHX9;SETMAR
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.5069083665617542,1.2308151227514568,0.15,0.895138720276738,1.0,11/75,13.08%,FGF10;FGFR3;FGFR1;HNRNPH1;GALNT3;FGF17;PIK3CA;FLRT2;TIAL1;SOS1;FGF5
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8129997479415346,1.2305834221396146,0.19607843137254902,0.8955692014034462,1.0,2/6,10.44%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7364317917996656,1.2305300311033667,0.25862068965517243,0.8950050448500354,1.0,2/6,16.66%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.7027058301350618,1.2303665703712943,0.2413793103448276,0.8950049199908088,1.0,1/9,2.04%,F2R
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5387521342069976,1.230362631558777,0.12,0.894319375542908,1.0,6/59,3.25%,FGF10;HGF;MYC;SIRT1;FGF2;TOX
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.7749042015420786,1.2303362429325748,0.20754716981132076,0.8937269397319042,1.0,3/7,16.47%,ZBTB1;HMGB1;CLC
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.5845831349891832,-1.230322970311092,0.14285714285714285,0.889216212059806,1.0,10/35,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;SCML4;PTGDR;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7586113883230317,-1.230307137807768,0.16326530612244897,0.8880346168417097,1.0,3/10,10.96%,DNAAF1;CFAP73;CCDC40
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7648680327993985,-1.2303069621476195,0.21621621621621623,0.8867531816081718,1.0,2/7,5.33%,ASS1;ARG2
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.6449238151723689,1.2302152678264622,0.20634920634920634,0.8936155016953754,1.0,8/15,21.86%,ACSBG1;OXSM;FASN;ACACA;OLAH;ACACB;ACSL4;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.771086080503694,-1.2301639777140683,0.3111111111111111,0.8861352877661975,1.0,2/6,9.62%,CCBE1;ADAMTS3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6647621832956673,1.2301515223698636,0.2692307692307692,0.8931368534843364,1.0,3/15,14.62%,SYVN1;AUP1;DERL2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8255818099609725,-1.2301511510173435,0.1320754716981132,0.8836300440203965,1.0,1/6,1.07%,GINS3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8255818099609725,-1.2301511510173435,0.1320754716981132,0.8836300440203965,1.0,1/6,1.07%,GINS3
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6675806876153698,-1.2300468699549985,0.21739130434782608,0.882772912371226,1.0,2/8,23.64%,MAN2B1;MAN2B2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5955605001755035,1.2299979178943197,0.23529411764705882,0.8931076494952791,1.0,4/32,10.96%,GSTM2;GSTT2;HPGDS;ETHE1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6331539217189116,1.2299619772863064,0.15384615384615385,0.8925690529482307,1.0,2/20,2.81%,IGF1;FGF2
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.7575053589287619,1.2298849859468755,0.20754716981132076,0.8921636738597201,1.0,3/6,14.06%,FHIT;NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7677977394333121,1.229546150445792,0.2982456140350877,0.8930610097702745,1.0,1/5,3.30%,OPRK1
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.7423640156522817,1.229178537927232,0.2549019607843137,0.8938755852032684,1.0,5/9,22.25%,IRS1;SOS1;IRS2;MAPK3;GRB2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.4552448984284039,1.2289781473792645,0.13636363636363635,0.8942216739377112,1.0,45/264,13.62%,LGALS9;IGF1;FGF10;IRS1;IL17RD;FGFR3;HGF;MYC;CCL5;RIT2;FGFR1;ERBB4;NRTN;FGF2;NRG1;ANGPT1;KSR1;CSF2RA;IL2RA;ZFP36L2;TNIK;ABHD17B;SPTBN5;MAPKAPK2;ITGAV;PDGFRA;NRG2;PPP1CC;SHOC2;GFRA1;FGF17;PIK3CA;PSMD13;FLT3;RASAL2;RANBP9;RGL2;ABHD17C;MEF2C;MAPK8;SOS1;FGF5;PSME4;LYPLA1;LRRC7
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.8117994802655109,1.2288663713338073,0.22413793103448276,0.8940598164727325,1.0,4/5,17.94%,LDLR;LRP2;RNF128;CD81
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7157611570410809,1.2288176929023658,0.2037037037037037,0.8935230537248032,1.0,3/11,6.53%,IDO1;IDO2;TDO2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.6267903701364691,1.228769682072139,0.23529411764705882,0.8930276797917235,1.0,6/23,14.62%,SYVN1;RNF185;RNF139;RNF5;MAN1A2;DERL2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.7922036144844233,1.2286905946994215,0.22641509433962265,0.89266470486944,1.0,2/5,9.38%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.7577415244963814,-1.2285275977308503,0.19230769230769232,0.8874333009806203,1.0,4/7,12.70%,SCN5A;CACNA1G;KCNA5;SCN3B
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,0.507276144051074,1.2284757177171726,0.12962962962962962,0.8928889942107293,1.0,16/71,10.01%,CFH;FLT1;STAB1;HGF;ADGRL4;ZEB2;ARHGAP31;BGN;FLI1;FGL2;ERG;PDGFRA;SIGLEC1;RAMP3;MYH11;MEDAG
prerank,CellMarker_Augmented_2021__Common Myeloid progenitor:Undefined,0.8083959281521146,1.2280483612248712,0.2916666666666667,0.8940933114634944,1.0,3/6,12.47%,MME;FLT3;CD34
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7248379273501695,1.2275416646668782,0.21428571428571427,0.895972331078807,1.0,4/16,11.11%,PNP;SYK;IL23R;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6185681312842519,1.227476009794544,0.17307692307692307,0.8956081609991194,1.0,2/19,2.84%,CGNL1;LZTR1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.481001631612636,1.2273212398002704,0.046511627906976744,0.8956075555448338,1.0,30/194,12.15%,TNFSF14;NOX5;ADRA1A;ESPL1;PAWR;BOK;MYC;TNFRSF19;EGLN3;CDK11A;EFNA5;GDF6;RNF152;DCC;IL2RA;DAPK2;DUX4;SEPTIN4;TLR2;DLC1;PIK3CA;HIP1;FOXO1;PAK5;TNFRSF10B;CASP10;LIG4;PLAGL1;DPF1;RRAGC
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.7400193301354047,-1.2272636202846747,0.2972972972972973,0.8915378268156999,1.0,2/7,5.12%,PLK3;GOLGA2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.6623153761880547,1.2271677665838812,0.2413793103448276,0.8956472501473713,1.0,3/14,8.93%,IL4;CD40;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6619382318567488,1.2269947515312556,0.25925925925925924,0.8957976153180252,1.0,5/17,11.70%,ITGAX;MYRF;UNC13B;RIMS2;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.6262002641153518,-1.2269883815482399,0.24489795918367346,0.8913885949666902,1.0,4/23,11.77%,SIGIRR;TRIB1;DHX58;TYRO3
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.5390567028387021,1.226973449628412,0.13725490196078433,0.8951732212598291,1.0,19/70,18.16%,CDKN2C;CDKN2A;TNIK;H2BC21;MAPKAPK2;MOV10;MAP2K6;MAPKAPK3;EZH2;MAPK8;H2AC6;RNF2;H2AZ2;H2AX;MAPK10;CDK4;TP53;AGO3;EED
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.6684342383154824,1.2267922973979992,0.1724137931034483,0.8952031165883898,1.0,4/18,14.09%,OPRK1;FKBP5;HDAC2;CREB1
prerank,KEGG_2021_Human__Legionellosis,0.5362928181997646,1.2267596259858875,0.16363636363636364,0.8946304045916019,1.0,4/41,5.88%,C3;SEC22B;RELA;TLR2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8197624332979188,1.2267565184538536,0.2549019607843137,0.8939281539032681,1.0,2/5,15.21%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.7139014301737441,-1.2267220257102234,0.3,0.8910662668520097,1.0,4/7,8.26%,HSD11B1;CYP21A2;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.8227381281822183,1.2266755349350889,0.22413793103448276,0.8936782212764841,1.0,1/5,1.94%,SIRT1
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.5433671088300338,1.2266505865531143,0.19607843137254902,0.8930579936446253,1.0,22/83,10.66%,MXRA5;LAMA4;MRGPRF;PRRX1;PRKG1;ADGRL4;MSRB3;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;ABI3BP;PLSCR4;DLC1;PCDH18;LTBP1;MEDAG;TPM2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6309986427479015,1.2265670939506834,0.16363636363636364,0.892628955620475,1.0,6/28,8.96%,IGF1;FGFR3;STAT5A;SIX4;AGR2;LATS1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.7176172614819896,-1.226381917718753,0.22448979591836735,0.8909589024561575,1.0,2/9,17.02%,TRPV1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5969674057568618,-1.2263114379306668,0.17073170731707318,0.8899256328063131,1.0,7/37,10.10%,KCNMB2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5895561800638908,1.2262748353264048,0.21951219512195122,0.893120857088483,1.0,6/31,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL10RA
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7706570835084063,-1.2261831283923041,0.2830188679245283,0.8893018458607987,1.0,3/8,13.11%,KCNE2;KCNE1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6843252436631291,-1.226020049727401,0.2962962962962963,0.8886189329311831,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6329694827600952,1.2260044634625789,0.14814814814814814,0.8936519578881652,1.0,9/22,14.30%,FGFR3;TGFBR1;FGFR1;PDGFRA;SPEF2;DSCAML1;RAB33B;WWOX;LRP6
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6462178505807704,1.225943423202244,0.25,0.8932434430255974,1.0,1/21,0.15%,MT4
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.6666790157792697,1.2257754090395452,0.15517241379310345,0.8932946113552395,1.0,2/17,2.71%,LAMA4;ITGA2
prerank,KEGG_2021_Human__Histidine metabolism,-0.6474361182471544,-1.225766722938457,0.21739130434782608,0.8884649688624352,1.0,2/18,0.44%,UROC1;AMDHD1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,0.5557094983979616,1.225697951551408,0.19047619047619047,0.8915561047893754,1.0,6/45,4.31%,TNFSF14;CCL5;FCAR;PYHIN1;LY9;CD244
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,0.5557094983979616,1.225697951551408,0.19047619047619047,0.8915561047893754,1.0,6/45,4.31%,TNFSF14;CCL5;FCAR;PYHIN1;LY9;CD244
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,0.5557094983979616,1.225697951551408,0.19047619047619047,0.8915561047893754,1.0,6/45,4.31%,TNFSF14;CCL5;FCAR;PYHIN1;LY9;CD244
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7454571936059252,1.2256469481364365,0.18181818181818182,0.8904082970855678,1.0,2/7,5.50%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7454571936059252,1.2256469481364365,0.18181818181818182,0.8904082970855678,1.0,2/7,5.50%,GSTM2;SLC8A1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.45741138398034226,-1.225389841716466,0.08888888888888889,0.888857950284887,1.0,33/243,9.98%,CD44;CAPN8;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;TNXB;COL5A1;PXDN;COL4A1;MFAP5;AGRN;FBLN2;LOXL4;MATN4;CAPN9;COL28A1;ITGA9;LAMB3;F11R;LAMB1;COL6A3;COL11A2;CEACAM1;CAPN5;ADAM19;ADAMTS9;ADAMTS3;SPARC;COL26A1;COL1A1;MMP9
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7842579457768878,1.2253584764957173,0.16071428571428573,0.891027574098019,1.0,4/6,19.69%,SMAD6;BMPR1A;EFNA1;BMPR2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5354514403324027,-1.2252501040481343,0.23529411764705882,0.8881684517652306,1.0,8/73,3.47%,ALB;EHF;CAPN8;CLDN4;CD24;FAM3D;MUC5B;KIF12
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5883691901779025,1.22516765255346,0.22916666666666666,0.8911695216016913,1.0,11/37,10.29%,IGF1;TNFRSF18;FGFR3;CCL5;ERBB4;IL4;HCLS1;IL15;CD40;IL23R;FLT3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6218980706451449,-1.224990230471111,0.23684210526315788,0.888126786605683,1.0,3/16,8.97%,TEK;HCK;NTRK3
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,-0.70513773845974,-1.2249654263074299,0.21951219512195122,0.8869262927661942,1.0,5/8,24.94%,EIF2S2;EIF2S3;EIF2B1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5432186768945106,1.2247721194791412,0.19230769230769232,0.8920648799223234,1.0,5/57,6.24%,HGF;MYC;ACD;FGF2;PARM1
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.6251597369265827,-1.22475691851864,0.16326530612244897,0.8864336290752837,1.0,5/24,11.52%,ALB;PCSK6;MBTPS2;APOA1;APOB
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6739419112464656,1.224722839306348,0.2,0.8915518314796492,1.0,4/14,12.52%,LRRC4C;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5367938068873503,-1.224655986546243,0.16666666666666666,0.8855906173554429,1.0,17/76,17.78%,DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;JUN;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1;CAV1;DAB2;CYP2D6;CTSZ;E2F1;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.7578234745211025,-1.2245985132311017,0.21739130434782608,0.8845894041063177,1.0,2/7,16.51%,CARTPT;KCNB1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7328005266333787,-1.22455259115779,0.11904761904761904,0.8835408887086347,1.0,4/14,8.69%,DUOX1;VGF;RFC3;KCNJ11
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5632518608157738,-1.2244746998875669,0.14,0.8826854452563446,1.0,14/61,14.41%,SELE;NLRP1;BST1;IL1RL2;ALOX5;PTGES;AHSG;HCK;DHX58;TMSB4X;PIK3AP1;AKNA;ALOX15;UFL1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6208659789782566,1.2244717925982627,0.22916666666666666,0.891891045834062,1.0,7/23,21.16%,DRD5;SNCA;PDE4B;RYR2;GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.830723513415819,1.2243491651319154,0.28,0.8917350832411262,1.0,1/5,0.07%,VEGFC
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.7584646669215598,1.2242800386388193,0.22,0.8914706288714841,1.0,1/8,3.41%,ENPP1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Embryo,-0.825527214534575,-1.22403621921059,0.24074074074074073,0.8830615722466407,1.0,2/5,4.81%,TERT;CHST10
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4993726912195908,1.224001884258402,0.09090909090909091,0.8920362891354285,1.0,23/121,10.01%,MXRA5;CGNL1;DACH1;IGF1;C3;SLC12A1;ADGRL4;RIN2;CDH6;SLC12A3;DOCK1;BGN;CXCL12;RNF182;POSTN;PDGFRA;FAM114A1;CD40;PLSCR4;PRICKLE2;SMARCD3;GSN;MEDAG
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.7913226317412548,1.2239555103553943,0.20833333333333334,0.8917029255430261,1.0,3/5,20.64%,EIF3E;FMR1;NCBP1
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.5416685669765159,1.2237631463185614,0.22033898305084745,0.8917546987181595,1.0,18/55,23.15%,CDKN2C;CCNA2;CDKN2A;H2BC21;RELA;ANAPC16;RPS6KA2;H2AC6;H2AZ2;RPS6KA1;H2AX;CDK4;FZR1;UBE2D1;UBE2E1;MAPK3;CDK6;IGFBP7
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.689508975258946,1.223524254082287,0.22033898305084745,0.8921414342194496,1.0,2/17,4.30%,TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.7158138209712213,1.223292864445865,0.2631578947368421,0.8918209837872755,1.0,3/10,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.7158138209712213,1.223292864445865,0.2631578947368421,0.8918209837872755,1.0,3/10,6.53%,IDO1;IDO2;TDO2
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,-0.5260263710764802,-1.223263893201623,0.1346153846153846,0.8821037820970143,1.0,1/87,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,-0.5260263710764802,-1.223263893201623,0.1346153846153846,0.8821037820970143,1.0,1/87,0.01%,CD44
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,-0.5260263710764802,-1.223263893201623,0.1346153846153846,0.8821037820970143,1.0,1/87,0.01%,CD44
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.7056467623200811,-1.2231850668178088,0.2391304347826087,0.8811469591594773,1.0,1/11,3.07%,STX11
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7247345875125973,1.2231780570815778,0.24561403508771928,0.8916857113993936,1.0,1/9,1.31%,UNC5C
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.46740587156042535,-1.2231061565711203,0.1346153846153846,0.8802027144160993,1.0,5/180,1.18%,CD44;DUSP4;NTRK1;APIP;TEK
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Colorectum,-0.7756481780518698,-1.2225046025672663,0.24074074074074073,0.8811341308347427,1.0,2/7,7.57%,SIRPG;CD5
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7636710109706648,1.2224842486951002,0.22448979591836735,0.894055640302284,1.0,4/9,16.76%,SIRT1;MLXIPL;PRKAA1;DGAT2
prerank,CellMarker_Augmented_2021__Sertoli cell:Undefined,0.7654685847407446,1.2224818983936914,0.23636363636363636,0.8933691511276283,1.0,1/8,0.09%,GATA4
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.5750450725123146,1.2223837237888917,0.1875,0.8931545241323292,1.0,20/58,20.72%,HELB;ZNF493;PRDM14;LIN28A;SAG;NANOGP1;APELA;YWHAQP5;ZNF675;CTCFL;SPINK9;MIPOL1;TERF1;MGAT4C;VRTN;LRRC69;ZNF519;HHLA1;SUZ12P1;SYCP3
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.776077530126672,1.2219855577612837,0.2641509433962264,0.8935880512496307,1.0,4/5,22.21%,ZFP36L2;NPR2;ZFP36;PDE1B
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.776077530126672,1.2219855577612837,0.2641509433962264,0.8935880512496307,1.0,4/5,22.21%,ZFP36L2;NPR2;ZFP36;PDE1B
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.45258115585411374,-1.2219109910755146,0.07142857142857142,0.8822905922129686,1.0,8/216,3.13%,TRIP10;EPN1;RTP1;SUN3;SYNJ2;M6PR;STX11;TLCD2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.7749092156518044,1.2218886707259835,0.23333333333333334,0.8933248274225327,1.0,3/6,19.15%,SLC25A13;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5746867969140228,1.2218811310923514,0.18333333333333332,0.8926513458497366,1.0,10/38,15.86%,LDLR;ODC1;SPOP;CHMP6;SPOPL;ZDHHC2;CHEK2;MAPK8;PLAUR;PM20D2
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.6640795548508637,-1.2218404456689762,0.2553191489361702,0.8814771584069595,1.0,5/12,13.86%,SLC6A6;SLC6A11;SLC6A12;SLC22A1;SLC6A20
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.7337957934700139,1.2217598290393261,0.2962962962962963,0.8926042003435903,1.0,5/12,15.77%,LPIN3;CEPT1;SELENOI;ETNK1;ETNPPL
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7922436529753478,1.221729081900864,0.16923076923076924,0.8920689969666457,1.0,4/7,17.47%,ADIPOR2;HPSE;CD34;VEGFA
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.5011162722453956,1.2216301626738724,0.14583333333333334,0.8919248245560509,1.0,30/128,21.16%,PREX2;PPARG;NEDD4;SNAI1;SEM1;MOV10;HDAC3;HDAC2;RNF146;FRK;PSMD13;EZH2;CNOT6L;RRAGC;PTEN;RNF2;PSME4;PML;PSMA1;TP53;MAF1;AGO3;EED;RRAGD;MLST8;AKT3;HDAC1;PSMD4;SCMH1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6824029068360025,1.2216125597632341,0.19230769230769232,0.8913519843827912,1.0,7/13,21.61%,SIRT1;PLCG2;TICAM1;CD74;GPRC5B;KIT;CAMK4
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,-0.537641789119186,-1.2215449809987808,0.19047619047619047,0.8802808081278972,1.0,10/59,7.47%,EHF;CLDN4;SERINC2;FAM3D;C6ORF132;MUC5B;SPDEF;AGRN;LAMB3;PLEKHS1
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,-0.537641789119186,-1.2215449809987808,0.19047619047619047,0.8802808081278972,1.0,10/59,7.47%,EHF;CLDN4;SERINC2;FAM3D;C6ORF132;MUC5B;SPDEF;AGRN;LAMB3;PLEKHS1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.491143240714189,-1.2213010317555724,0.17307692307692307,0.8798868651530837,1.0,3/122,1.18%,CD44;NTRK1;TEK
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6522503138812794,1.2210498340764888,0.2653061224489796,0.8932832056250802,1.0,1/20,0.15%,MT4
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.47770019876508846,1.220495567341328,0.08620689655172414,0.895347698773265,1.0,18/109,12.71%,SIPA1;SEMA5A;TNFRSF18;EPHA7;CCL5;EFNA5;ANGPT1;CXCL12;ITGAV;ABL2;EPHA8;DSCAM;PLXNB1;ZDHHC2;PLXNB2;FRMD5;PPP3CA;KNG1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5653547726199576,1.2204402681446658,0.1568627450980392,0.8948707930496542,1.0,7/40,12.93%,LGALS9;FZD5;CD244;SCRIB;IL23R;PDE4B;IL18R1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5944676236798152,1.2202654635063206,0.21568627450980393,0.8949971049776942,1.0,9/28,10.25%,LGALS9;IGF1;IDO1;ICOSLG;SCRIB;HMGB1;TMIGD2;BTN2A2;IL23R
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5242400411941793,-1.2199316643035825,0.1956521739130435,0.8839758531258038,1.0,3/35,4.75%,SIRPG;TNFSF18;FGL1
prerank,Reactome_2022__Anchoring Fibril Formation R-HSA-2214320,0.7343648286291128,1.2197764355988256,0.23404255319148937,0.8967642070780171,1.0,4/7,14.44%,LAMA4;COL7A1;TLL2;TLL1
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.6525280276889784,1.219669368447096,0.20833333333333334,0.8966074946033105,1.0,2/19,3.86%,PPARG;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.7543934914608842,1.2195676194331748,0.2777777777777778,0.8964122431015057,1.0,1/6,0.50%,ADRA1A
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.6110736187063528,1.2194345312427082,0.2830188679245283,0.8963819805956701,1.0,9/26,22.07%,REXO2;TP53BP2;MAPK8;PPP3CC;TP53;AKT3;BAD;PPP1R13B;AKT2
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,0.6857057692221769,1.2193082104580348,0.24561403508771928,0.8963033638846044,1.0,4/12,17.29%,LPIN3;MOGAT2;DGAT2;AGMO
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.7406667263760125,-1.21930204479694,0.32075471698113206,0.8853053857243317,1.0,1/13,0.42%,NTRK1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7693750037305994,1.2192221224146393,0.2903225806451613,0.8960604317880205,1.0,4/7,21.69%,PYHIN1;RO60;AXL;GAS6
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.5293134457390979,-1.2191059296880522,0.17391304347826086,0.8848571702711066,1.0,9/73,7.41%,LRP10;TBC1D10C;NLRP1;PTGDR;PPM1M;APOL3;CBX7;MPPE1;B3GALT4
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.7131279168616127,1.2189671050228115,0.14814814814814814,0.8965041079792704,1.0,2/11,12.22%,CCDC125;FRMD5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.7685199920646317,1.2189403773774183,0.2916666666666667,0.895942684157505,1.0,1/7,0.64%,DRD5
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.6000318065549255,1.2188506789659157,0.1896551724137931,0.8957295377394429,1.0,13/35,17.67%,H2AC25;PRMT1;ACTL6A;ARID2;SMARCD3;ARID1A;H2AC6;H2AZ2;ARID1B;SMARCD2;H2AX;SMARCA2;CDK4
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.5409837143347458,1.218572569953635,0.24528301886792453,0.8965967453977335,1.0,15/40,22.25%,SYK;NEDD4;RAB31;SAG;SNCA;RAMP3;PICALM;DNM3;CALCRL;CD81;ARRB2;LMBRD1;ITGB2;GRB2;MX2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7154599056802996,1.2185300654346256,0.2222222222222222,0.8962388888351241,1.0,3/12,9.82%,IGF1;BMP2;IGFBP6
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.7063001377687039,1.2185262472450658,0.23636363636363636,0.8956023562235016,1.0,4/10,25.16%,GREM1;LYN;MAPK3;RNF13
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6376521564894346,1.2184675775108627,0.26785714285714285,0.8951495948531495,1.0,3/17,14.62%,SYVN1;AUP1;DERL2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4914800409607168,1.218062156308975,0.05660377358490566,0.8962837820945768,1.0,30/109,18.64%,CGNL1;FGFR3;CLIC6;ARHGEF17;MMP15;EFS;CLDN2;UNC13B;ADGRL2;NEO1;PRICKLE2;BCAM;MAGI1;PLXNB1;HTR2C;BCAR1;ID4;TMEM98;PTPRU;FRZB;COBL;CPE;GPRC5B;PDZRN3;RNF128;PRLR;FLRT3;FARP1;TMEM178A;MPDZ
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,0.6890380692954001,1.2180571582220672,0.24,0.8956198516814624,1.0,6/16,22.38%,ITGA2;ITGA1;CD34;CASP3;KIT;PTPRC
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.787337126517353,-1.2180138002907177,0.26666666666666666,0.8880024796012473,1.0,2/5,9.53%,CIITA;TAF7
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,0.7378821650733998,1.2179670721852873,0.24193548387096775,0.8953216961217433,1.0,4/10,19.35%,TICAM1;TANK;IKBKE;IRF3
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,0.5372758743059701,1.217848172882794,0.13333333333333333,0.8951774621387575,1.0,12/80,8.07%,CERCAM;FSTL5;PLOD2;MCOLN3;HTR1F;SLC38A4;SGCZ;RAB3C;DPP4;FAM110B;FGF12;PDE4DIP
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.658534863526109,-1.2176024022351757,0.18867924528301888,0.8883435717139246,1.0,3/18,9.04%,NPTX2;BEGAIN;CACNG5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5499228056504377,1.2175731295171404,0.24390243902439024,0.8957714494876148,1.0,7/32,12.20%,ARHGAP24;LZTR1;CCDC125;DLC1;ABL2;KANK1;SPRY3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6404791171896558,1.2175630051978001,0.2653061224489796,0.8951386578848287,1.0,2/14,9.38%,ARHGAP24;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7748611243151502,-1.217559225729814,0.28,0.8872975899597899,1.0,1/5,2.24%,MRLN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.7883107595560687,1.2175468550029727,0.15789473684210525,0.8944876874689198,1.0,2/6,5.19%,HCLS1;CXCL12
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.678181888282843,1.2170950244989711,0.1836734693877551,0.8958936692915138,1.0,6/12,29.42%,CEP135;KIAA0586;CEP120;CEP290;OOEP;SCFD1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5497565429404625,1.217085046895254,0.1568627450980392,0.8952717796561642,1.0,9/34,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,0.6648764388146258,1.2170821715588394,0.25862068965517243,0.8946221878686466,1.0,2/12,4.50%,SLC12A7;CRIM1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6386366678082711,-1.2170662597721822,0.275,0.8877166991873526,1.0,1/16,3.07%,STX11
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.7216377380732162,1.216720734381009,0.22807017543859648,0.8956814021761302,1.0,1/10,1.76%,MYC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,0.5368025959464021,1.2165492059235696,0.16981132075471697,0.8957379764433251,1.0,12/71,5.64%,LGALS9;SELPLG;FERMT3;STAT5A;SLFN11;IFI44;TRPV2;FLI1;IL7R;HCLS1;ABI3;FGL2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5683199738321539,1.2165249822169604,0.18181818181818182,0.8951561906715936,1.0,8/32,22.01%,RAB27A;SDC4;SNCA;RAB9A;RAB27B;STXBP5;CADPS;CADPS2
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.5679830495943848,1.2165171958730545,0.11320754716981132,0.8945181679899512,1.0,11/49,15.29%,UNC5C;TRPC4;DCC;DOCK1;UNC5D;NEO1;DSCAML1;DSCAM;MAPK8;TRPC5;HJV
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.7088192396250474,-1.216506265945826,0.2777777777777778,0.8888453236881754,1.0,1/9,0.84%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.7961692848121319,1.2163002742233722,0.24489795918367346,0.8947847584023221,1.0,2/5,9.95%,NOX5;GSN
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6289030731149599,1.2162970423292923,0.1956521739130435,0.8941099584336929,1.0,1/14,0.70%,TIMELESS
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.7895527942857068,1.2161470949872253,0.2,0.8941295126648887,1.0,2/8,4.68%,IL4;H2BC21
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.5213931613121123,1.216069099301865,0.20754716981132076,0.8937504315118068,1.0,12/67,8.38%,CSTA;RUNX1;SAMD9;CSF3R;STEAP4;DDX60L;TLR2;TET2;HPSE;NFKBIZ;MOSPD2;CYB5R4
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.7006261612439433,1.2160056618682895,0.2,0.8933245034528443,1.0,5/10,20.22%,RAPGEF3;RAP1A;SGSM3;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.7489057080437143,-1.2159828214532264,0.20930232558139536,0.8897083931399871,1.0,1/7,3.13%,TLCD2
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,0.5160687745117761,1.21594608233793,0.125,0.8929465976166933,1.0,18/74,8.32%,MXRA5;CGNL1;FLT1;TDRD10;PREX2;TSPAN12;C6;ADGRL4;BGN;FREM1;PCDH17;CXCL12;POSTN;PDGFRA;ADGRL2;CASR;PTPRD;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.7673155003961851,1.2159296347581607,0.2698412698412698,0.8923514674309212,1.0,4/7,21.28%,TMEM39A;UBQLN4;IRAK3;PHF23
prerank,Reactome_2022__Adrenoceptors R-HSA-390696,0.7819060488019748,1.215919536473982,0.27419354838709675,0.8917193823654151,1.0,2/6,7.71%,ADRA1A;ADRA2C
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.7400790802461971,-1.2157584792310268,0.3157894736842105,0.8892487519997107,1.0,1/5,4.47%,TNFRSF11A
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4698717146603456,1.2156525707284611,0.09259259259259259,0.8922228479191453,1.0,22/182,9.37%,VEGFC;FGF10;IRGM;F2;C3;HGF;SIRT1;RAPGEF3;ERBB4;FGF2;EFNA5;ANGPT1;BMP2;PELI2;TNIK;ACVR2A;FAM20A;HDAC3;CD40;DLC1;FGF17;LEPR
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6198993113486229,1.2156504216142874,0.14583333333333334,0.8915634631306335,1.0,1/14,0.09%,GATA4
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.6689631931463396,-1.2155650647962721,0.25862068965517243,0.8888291382452544,1.0,2/21,3.21%,DUSP4;DUSP6
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7156376200932786,1.2155427886533536,0.23529411764705882,0.8913204637589937,1.0,5/10,16.58%,RBPJ;SMAD4;RYR2;CPE;HEY2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.742056886782433,1.215354203918801,0.24,0.8915778188941569,1.0,2/6,14.47%,PTPRD;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.6946699442144099,-1.2152816906315873,0.2553191489361702,0.8876258821717551,1.0,2/9,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6946699442144099,-1.2152816906315873,0.2553191489361702,0.8876258821717551,1.0,2/9,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5731005649663269,1.2152487711973683,0.1836734693877551,0.8914294395998711,1.0,8/33,16.05%,SLC26A3;SLC26A6;SLC4A7;SLC9A2;CA2;SLC9C2;SLC9A9;SLC4A1
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.5768048530536759,-1.2150231034520405,0.2653061224489796,0.8873839686725461,1.0,10/40,7.74%,P2RY10;TBC1D10C;SIRPG;SELL;RAC2;ICAM3;PCED1B;LTB;CD5;ARHGDIB
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5401515952169722,1.2148725297441771,0.2033898305084746,0.8925529397260362,1.0,11/42,20.10%,SLC7A11;SLC38A3;SLC38A4;SFXN2;SLC7A9;SLC25A13;SLC3A2;SLC1A6;SLC36A1;SLC25A12;SLC7A6
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.538349724928967,1.214859774802455,0.18518518518518517,0.8919240085986657,1.0,12/47,17.36%,MME;FAIM;HES6;PCM1;PAX6;LIG4;LRP2;RGS14;SPEN;HEY2;CTNNB1;NUMB
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.7326931155348405,-1.21481958413106,0.2978723404255319,0.8868437689623847,1.0,2/11,15.90%,ALOX5;LTC4S
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7249343855059327,-1.2148126048266759,0.16216216216216217,0.8856790609238634,1.0,4/13,16.36%,ZWILCH;SPDL1;TTK;CDK1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6102189919377451,1.2144547075705734,0.1956521739130435,0.8930736796583245,1.0,9/28,17.65%,DUSP29;RORA;SGCZ;MEGF10;MEF2C;TBX18;DMD;HEY2;TMEM204
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.6577547929537466,1.2144412218330984,0.2549019607843137,0.8924265009860131,1.0,11/21,20.02%,NPY;ABCA6;HDAC2;FOXO3;SMAD2;MAP4K2;FOXO1;SMAD4;FOXO6;NR3C1;HDAC1
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,0.797443979240041,1.2143383153669185,0.3076923076923077,0.8921465595857361,1.0,1/5,4.98%,SEPTIN4
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5570131182741765,-1.2142366468463228,0.1951219512195122,0.886979499171886,1.0,1/65,0.03%,SLC28A2
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,-0.7685901148354928,-1.214049565866401,0.2765957446808511,0.8864612263514676,1.0,1/8,3.86%,IL6R
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.7929250157436627,-1.2139045664832622,0.24,0.8846721322500404,1.0,2/7,0.44%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.7929250157436627,-1.2139045664832622,0.24,0.8846721322500404,1.0,2/7,0.44%,UROC1;AMDHD1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.7257729919503814,-1.2138912998828455,0.22727272727272727,0.8835659420423662,1.0,3/11,4.35%,RFX6;HMGB3;LOXL4
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.652256936698731,1.2138546984310514,0.2549019607843137,0.8938190353202365,1.0,3/18,14.88%,PLOD2;GAMT;PLSCR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In4:Brain,0.759447718700506,1.2137852998108731,0.2857142857142857,0.8934728309498381,1.0,3/6,8.99%,FREM1;PDGFRA;MYH11
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6930150252141775,1.2137265737346408,0.21428571428571427,0.8931458827049633,1.0,2/14,2.85%,IGF1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.5467088137543499,1.2136584930663883,0.14814814814814814,0.8927164195685602,1.0,11/45,10.25%,PNP;IGF1;SYK;CCL5;IL4;ICOSLG;IL15;HMGB1;CCDC88B;TMIGD2;IL23R
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7512748692898257,1.2135912107632363,0.22413793103448276,0.89228759409086,1.0,5/9,23.10%,DNAJB2;SACS;SNCAIP;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.5781650609180713,1.2135449902282727,0.21666666666666667,0.8917939562026596,1.0,6/34,12.71%,CSTA;F2;TM4SF20;NLRP7;DNAJC1;KNG1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7889823589374265,1.212978575415021,0.24561403508771928,0.8931428632695128,1.0,2/5,6.35%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7889823589374265,1.212978575415021,0.24561403508771928,0.8931428632695128,1.0,2/5,6.35%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.57260096796854,1.2129633075152102,0.22807017543859648,0.8918962231761807,1.0,8/19,17.68%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ACAD8;ALDH6A1;BCKDHB
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.57260096796854,1.2129633075152102,0.22807017543859648,0.8918962231761807,1.0,8/19,17.68%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ACAD8;ALDH6A1;BCKDHB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.8001709632626423,1.2128563526245668,0.2558139534883721,0.8916934716898484,1.0,4/5,17.47%,HIF1A;RBPJ;NFE2L2;VEGFA
prerank,PanglaoDB_Augmented_2021__Macrophages,0.499684045777872,1.212850750598939,0.1702127659574468,0.8911000679295973,1.0,22/120,8.34%,LGALS9;STAB1;ITGAX;SYK;CCL5;TGFBR1;EGLN3;CSF3R;PPARG;SASH3;SAMSN1;PIK3R5;IL10RA;RBPJ;FGL2;TLR2;LAIR1;HPGDS;MARCHF1;SIGLEC1;TFEC;CYP27A1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5994868180779883,-1.2126949943604084,0.18867924528301888,0.8870004028819962,1.0,6/29,9.98%,DUSP4;COL4A2;LAMB3;LAMB1;NODAL;MMP9
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.7017958198797132,1.212658846738786,0.26,0.8906594577734769,1.0,3/12,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.7017958198797132,1.212658846738786,0.26,0.8906594577734769,1.0,3/12,4.62%,AASS;HYKK;ALDH7A1
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.572098097123833,-1.212644814510284,0.20833333333333334,0.8860085418678527,1.0,6/40,16.44%,TBC1D10C;RAB7B;RAB8A;SYTL1;TBC1D7;RAB11A
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7235730747456504,1.2126007358045119,0.1935483870967742,0.8901052790577166,1.0,1/12,0.40%,PNP
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.6610673894010006,-1.2124208078772654,0.24561403508771928,0.8857053099272324,1.0,3/16,4.05%,UGT2B15;CYP2E1;ABCC4
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.7819194923385375,1.2124131360060175,0.23076923076923078,0.890303674054045,1.0,1/5,14.58%,COL22A1
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.4131488278990708,1.212399948713891,0.0425531914893617,0.8896763796802987,1.0,133/775,14.30%,GATA4;CSTA;FGF10;SCN7A;ITGA10;SEMA5A;EBF1;PKNOX1;COL9A1;UNC5C;RUNX1;EPHA7;HNF4G;MYC;HIF3A;FGFR1;NRTN;CSF3R;ITGA2;KAT2B;PPARG;EFNA5;UTRN;COL9A2;RRAS;MED17;SEM1;WNT4;MAFB;TRPC4;CDH2;DCC;LLGL1;EFNA2;ROBO2;DOCK1;PRDM14;COL6A5;FLI1;ADGRG6;H2BC21;COL6A2;SPTBN5;ADGRV1;LIN28A;ACVR2A;LGI1;CXCL12;RBPJ;RELA;NR5A2;CACNB4;UNC5D;ENTHD1;MAP2K6;KLK14;ITGAV;WWTR1;MYL12A;EPHA5;POU3F2;ST8SIA4;MED13L;HDAC3;NEO1;PAX6;RPS6KA4;EPHA3;TSC22D1;ZNF467;HDAC2;CNTN6;SCN10A;FOXO3;SCD5;ALCAM;DSCAML1;ABL2;EPHA8;PAXIP1;MYH11;ANK2;KLK5;GFRA1;SCN3A;DSCAM;PIK3CA;SMARCD3;SMAD2;PSMD13;PLXNB1;MAP4K2;NCOA2;CTNNA2;RPS6KA2;EZH2;EFNB2;SCN2B;ITGA1;FOXO1;RPS5;SPINK9;TBL1X;RANBP9;DAND5;DNAAF3;SMAD4;CNTN1;MEF2C;NCK2;LGI2;ZNF638;MAPK8;ANK1;H2AC6;MYB;SOS1;SCN9A;HSPA8;H2AZ2;SEMA3E;RPL21;TRPC5;PSME4;ACVR1B;CCND3;PML;RARB;CREB1;ANGPTL4;NR2F2;RPS6KA1;SEMA6D
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.6133156171800516,1.2122957274979778,0.22641509433962265,0.8897079867270594,1.0,5/16,17.78%,STAT5A;PIK3CA;CNTRL;GAB2;ZMYM2
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.587527904374366,1.212237690390205,0.18181818181818182,0.8892487408447687,1.0,11/27,10.71%,HS3ST5;HS3ST3B1;HS3ST1;HS3ST2;SDC4;GPC5;HS2ST1;HS3ST4;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6620463748966119,-1.212174841853457,0.21052631578947367,0.885574153308325,1.0,9/18,28.53%,SPRED3;SPRED2;SPRED1;EIF5A;HIC1;RPS20;RPL37;MSX1;UBB
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5400316133728017,1.2120655736054446,0.11764705882352941,0.8892713617569463,1.0,11/39,21.70%,SLC7A11;SLC38A3;SLC38A4;SLC7A9;SLC19A1;SLC36A1;SLC7A6;SLC25A30;SLC16A7;SLC7A8;SLC25A14
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.46192767143642094,-1.2120338968977575,0.12280701754385964,0.8850062392339154,1.0,13/249,7.71%,CD44;XYLT2;CHST9;AGRN;GPC2;CRYL1;GPC1;XYLT1;GPC3;B3GALT5;GLYCTK;B3GALT4;CHST7
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4869901554730366,1.212031365432814,0.13333333333333333,0.8887761224458643,1.0,22/87,19.35%,IRS1;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;RELA;FER;CRHBP;FOXO1;GCK;NR4A2;CPEB1;SLC30A10;TBC1D4;DENND4C;IRS2;CAPN10;HDAC9;PRKACB;SLC25A33
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.617049396259275,-1.2118877048114363,0.18181818181818182,0.8842879963986693,1.0,1/25,0.23%,RFX6
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.6348655374854677,1.2118454417540463,0.16,0.8888729777399544,1.0,3/22,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.724837023550569,1.211727553258571,0.29411764705882354,0.8888127239561394,1.0,4/11,17.47%,RORB;DSCAM;TULP1;VEGFA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.623296053035278,1.2116743517459867,0.20833333333333334,0.8884204006745018,1.0,12/31,18.30%,BOK;SIRT1;FHIT;ZNF385B;DYRK2;TP53BP2;PML;PHLDA3;HIPK1;BCL3;TP53;JMY
prerank,CellMarker_Augmented_2021__Basophil:Blood,0.7517930313709424,1.2115906083511938,0.22807017543859648,0.8882222683127564,1.0,2/6,8.62%,CD22;SMAD1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5837500882597607,1.21154303580399,0.17857142857142858,0.8877848846524532,1.0,4/38,5.23%,IGF1;CCL5;PPARG;CCN4
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5799254545419972,1.2115329829550177,0.19642857142857142,0.8871732186740197,1.0,5/47,3.48%,FGF10;TGFBR1;ZBTB1;NRG1;WNT4
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.5270969092549062,1.2115327555508413,0.12727272727272726,0.8865256469815569,1.0,16/46,20.26%,IRS4;IRS1;PRKG1;NPY;PTGS1;GNAI3;PIK3CA;NPPA;NPY1R;ADORA1;ADRB1;PIK3CD;IRS2;PRKACB;AKT3;PIK3R3
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.6920367828947348,1.2114460899710662,0.27450980392156865,0.8863110888014682,1.0,2/13,7.20%,NRG1;NRG2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.4695952325333262,-1.2113569029656766,0.09803921568627451,0.885486036176193,1.0,23/190,7.68%,CD44;SPON2;TEK;COL4A2;ENTPD2;TNXB;NR4A1;COL5A1;COL4A1;MGP;MFAP5;PRKCD;FBLN2;OAF;ERCC1;PCSK6;MEOX1;TAGLN;EGR1;HCK;NOX4;LAMB1;COL6A3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5423325273863427,1.2113303528947958,0.14893617021276595,0.8861335884031122,1.0,5/50,2.91%,LGALS9;IGF1;F2R;FZD5;PYHIN1
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.6277540966361087,1.2109649346774416,0.26,0.8869752780598976,1.0,6/27,12.78%,STAT5A;PDGFRA;PIK3CA;NCK2;BCAR1;SOS1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5435300892094856,1.2109594833396302,0.14893617021276595,0.8863572542913918,1.0,8/44,11.92%,IGF1;ITGA11;UTRN;CHODL;SOX6;MKX;SGCG;MEF2C
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.6906255938608408,1.2107904426722724,0.29545454545454547,0.886565088451264,1.0,1/8,6.02%,PRKAB2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.6689673405152267,1.2107704198361755,0.20754716981132076,0.8859940588232864,1.0,7/18,16.25%,ACSM2A;RORA;NR1H3;PLA2G12B;MLXIPL;ANGPTL4;PNPLA8
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6781214245844136,1.2106235630703934,0.2909090909090909,0.8859913382308933,1.0,7/15,17.73%,GRIP1;MOV10;NTNG2;SPRY3;DVL2;FZD4;MACF1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6028459764996351,1.2105696724446198,0.26,0.8855861863462197,1.0,14/31,24.41%,IRS1;SIRT1;RORA;ZNF692;RORC;SIRT7;SDHAF3;IRS2;FBP1;PDK1;AKT2;PDK4;OGT;ADIPOR1
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7955688326942547,1.2104228903349628,0.19230769230769232,0.8855106484900903,1.0,4/5,20.24%,ENPP1;SMPDL3A;DCTPP1;ENPP3
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.4846598353357581,1.2103668509369605,0.1320754716981132,0.8850425011077359,1.0,26/87,23.34%,IGF1;SPDYE2B;CDC25A;CCNA2;GNAI3;PIK3CA;CCNB3;RPS6KA2;MAPK8;IGF1R;CPEB1;RPS6KA1;PIK3CD;MAPK10;PRKACB;AKT3;FZR1;PIK3R3;MAPK3;CDC25C;RPS6KA6;GNAI1;AKT2;SPDYE16;CPEB2;CCNB2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5491121744097168,-1.210209392984386,0.19230769230769232,0.8887631169397787,1.0,17/44,25.41%,RFC3;POLQ;SMUG1;PARP1;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3;MBD4;PNKP;POLL;PARG;APEX1;RPA2;OGG1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.547226406147822,1.210142695604565,0.16326530612244897,0.885259510711684,1.0,7/34,6.66%,GPR55;ADRA1A;FLT1;FGFR1;FGF2;ESR1;PDGFRA
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.7908844539336842,-1.2100057040105305,0.3157894736842105,0.8886098830577993,1.0,1/5,6.01%,ST6GALNAC2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.5130615213976346,1.2099816429268575,0.1875,0.8852390919072683,1.0,11/85,8.67%,CCL5;SLFN11;FGF2;CALCR;DCC;CCN4;CCN6;AGR2;SNCA;RAMP3;SLC25A24
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,0.7622049755870073,1.2099047190765362,0.2,0.8849088542135571,1.0,2/9,3.50%,RUNX1;CDKN2A
prerank,Reactome_2022__RAS Signaling Downstream Of NF1 Loss-Of-Function Variants R-HSA-6802953,-0.8392929550127995,-1.2097701304582607,0.20930232558139536,0.8882305026019873,1.0,3/6,10.48%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.7112625924250869,-1.2097467036744605,0.20754716981132076,0.8871733646346127,1.0,3/7,26.79%,POLQ;POLL;PMS2
prerank,Reactome_2022__Type I Hemidesmosome Assembly R-HSA-446107,0.7324872931825341,1.209713374496163,0.23529411764705882,0.8851254899866399,1.0,1/9,0.62%,LAMA4
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6568655687629739,-1.2096222188795518,0.21739130434782608,0.8865144293313313,1.0,2/18,4.93%,NPAS4;DRD2
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7725385078261697,-1.2093270194136496,0.24074074074074073,0.8865059919077516,1.0,3/6,13.11%,FLOT1;APOA1;CAV1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.8089715603782204,1.2092132310873427,0.25,0.8866704171495532,1.0,1/5,2.55%,STAT5A
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.5189242725124433,1.2090867398012841,0.14545454545454545,0.8866308523773824,1.0,11/66,6.24%,SELPLG;ITGAX;CCL5;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;HCLS1;IL10RA;LAIR1
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.6302548896807636,1.208993557367795,0.2545454545454545,0.8864732148647423,1.0,7/24,9.52%,IRS1;MYC;HIF1A;MYCN;HDAC3;HDAC2;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6139196120104293,1.2089176809407487,0.25,0.8861614383710309,1.0,10/24,20.58%,MME;FAIM;LMOD3;LIG4;LRP2;RGS14;SPEN;NUMB;CX3CR1;BAD
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7653747094149028,1.2087824510470395,0.2222222222222222,0.8861858422478196,1.0,2/7,2.98%,RENBP;ALDH1A1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.7718298948661422,1.2087396919794768,0.18181818181818182,0.8857387116713314,1.0,3/6,14.23%,CCL5;HMGB1;TRPM2
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.7916630652871541,-1.2087256646934597,0.2653061224489796,0.8875210940842274,1.0,3/5,18.30%,CAV2;CAV1;CAV3
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,-0.7978892302678903,-1.2086651491348235,0.2692307692307692,0.8866392275957966,1.0,1/7,0.24%,P2RY10
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.5931545800764446,1.2084382712421755,0.2,0.8861258154192321,1.0,6/23,17.47%,SEMA5A;SEMA6C;DSCAM;SEMA3E;SEMA6D;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6704953498465762,1.2081487263058166,0.24,0.8868020995363283,1.0,2/16,3.79%,RUNX1;BMP2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.6151728367790568,1.2081103323903464,0.2,0.8863645372832323,1.0,6/24,13.65%,PLEKHG2;HCLS1;CXCL12;LATS1;FCHSD2;DBN1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7007951048135017,1.2080404432016796,0.24489795918367346,0.8860451394096783,1.0,2/11,18.08%,CD59;CD55
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.6296285050812811,1.2080110298241427,0.20689655172413793,0.8855183991524176,1.0,4/22,17.81%,MYC;LIG4;PRKAA1;TP53
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.625045257627439,1.2077638254678225,0.1724137931034483,0.8860758123950317,1.0,6/30,10.12%,RUNX1;ESR1;KCTD6;LATS1;UBA5;NCOA2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7238347216926134,1.2077402622991196,0.28,0.8855407824222986,1.0,5/11,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7984416170375025,1.2076875530387094,0.2459016393442623,0.8845540977736405,1.0,1/5,3.25%,TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7984416170375025,1.2076875530387094,0.2459016393442623,0.8845540977736405,1.0,1/5,3.25%,TOX
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Bone Marrow,0.7740118990733378,1.207614126617274,0.2777777777777778,0.8842013518047821,1.0,3/7,18.93%,FLT3;CD34;KIT
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.7794940719055358,1.207045620421872,0.2222222222222222,0.8859631935606476,1.0,3/5,17.47%,TGFBR1;LRP2;VEGFA
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7587916299883283,1.2070408371533745,0.3,0.8853402551487243,1.0,2/9,4.34%,PRMT1;PRDM14
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.5578115727124341,-1.2069230550487717,0.19230769230769232,0.8923436070614492,1.0,9/54,2.73%,P2RY10;SELL;SP140;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;GPR132
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.45777051684905873,1.2069208541425511,0.09523809523809523,0.885320084420186,1.0,33/188,13.34%,IGF1;FAM83H;FLT1;SEMA5A;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;IL4;SNAI1;BMP2;TCAF2;CXCL12;SEMA6C;CASS4;PDGFRA;VSIR;F3;FER;CAVIN1;PDGFC;WASHC1;HAS2;CARMIL1;BCAR1;PPP3CA;FAM89B;IGF1R;CPNE3;SEMA3E;MGAT5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.6629065188904012,-1.2067589889576136,0.34782608695652173,0.8917944589731407,1.0,2/15,3.86%,F7;IL6R
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5496449608356148,1.2067320370346588,0.2222222222222222,0.8854974337930939,1.0,4/33,14.99%,TIMELESS;CHEK2;CDC5L;H2AX
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7616857039195878,1.206635033406408,0.32727272727272727,0.885270858610317,1.0,2/8,4.04%,INSL5;NLGN1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.7626186384239619,1.20652225638197,0.3125,0.8852687084997107,1.0,2/7,13.81%,PDLIM4;GRIN2D
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6849155749583687,-1.2064781184253848,0.28846153846153844,0.8915736808850365,1.0,3/15,1.10%,SELP;SELE;SELL
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.5171843092341497,-1.206455297094667,0.16981132075471697,0.8904485795128981,1.0,16/76,15.32%,IL10RB;SP140L;CTSO;SP110;HMGCL;APOL3;MPPE1;ARHGDIB;OAS1;CPQ;GBP2;RMDN1;GSTK1;IFI35;CTSS;FMO4
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.5834537291799943,-1.2064213884756991,0.21568627450980393,0.888262982751606,1.0,9/31,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.5834537291799943,-1.2064213884756991,0.21568627450980393,0.888262982751606,1.0,9/31,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.6159741178496446,1.2064059294759115,0.2857142857142857,0.8851859417862779,1.0,5/15,18.12%,TGFBR1;MLC1;SMAD2;LRP6;ABCA2
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7190441505968054,1.2063050236197903,0.2777777777777778,0.8849153137038801,1.0,5/8,19.69%,SNAI1;SMAD2;CRB2;MESP1;BMPR2
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,0.7155632043063286,1.2061285806405502,0.23636363636363636,0.8849939257335411,1.0,6/7,27.50%,STAT5A;EPX;IRS2;LYN;JAK2;EPOR
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7165979100445354,1.2060181307923905,0.22580645161290322,0.8846880629788316,1.0,2/10,4.97%,MYCN;LIN28A
prerank,KEGG_2021_Human__Axon guidance,0.4778176317777062,1.2059739551992017,0.13725490196078433,0.8841950545009329,1.0,34/172,14.44%,SEMA5A;UNC5C;EPHA7;LRRC4C;EFNA5;RRAS;WNT4;TRPC4;DCC;EFNA2;ROBO2;CXCL12;SEMA6C;UNC5D;MYL12A;EPHA5;PLCG2;NEO1;EPHA3;GNAI3;EPHA8;PIK3CA;PLXNB1;EFNB2;PAK5;PLXNB2;NTNG2;NCK2;PPP3CA;SEMA3E;TRPC5;PPP3CC;SEMA6D;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7639805597369831,1.2058760888090316,0.25,0.8839526728914443,1.0,1/6,1.94%,SIRT1
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.5114854187890621,1.2058753192607174,0.18032786885245902,0.8833270871356825,1.0,18/77,9.90%,IRS4;IL17RD;CDC25A;PHGDH;ROR1;FRAS1;TENM3;SIX4;CSRP2;LIN28A;TEAD2;HDAC2;IGDCC3;SPSB4;B4GALNT4;TSPAN6;GPR161;VANGL2
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.5973307359012204,1.2057976284049432,0.21818181818181817,0.8829252210918146,1.0,7/28,7.91%,CARNS1;ALDH7A1;ACADS;GADL1;ALDH1B1;ALDH9A1;HIBCH
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,-0.6113804768724418,-1.2057774542085304,0.21818181818181817,0.8894139367534891,1.0,11/40,8.48%,P2RY10;TBC1D10C;SIRPG;IRF4;CD53;LTB;CD5;TAGAP;TNFRSF4;TMC8;PTPN7
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.6998653492863249,1.2057256379266044,0.2542372881355932,0.8826575294880538,1.0,3/12,12.47%,LGR5;ALCAM;CD34
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.5090704115159589,1.2056638792690724,0.13793103448275862,0.8823012079286184,1.0,16/82,11.41%,CFH;C3;RIN2;SAMD4A;CRIM1;CD59;LTBP2;PDLIM5;SDC4;MYOF;FAM114A1;PLSCR4;DLC1;IGFBP6;GSN;TNS3
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7257991128850322,-1.2053553341733712,0.3,0.8888429529863363,1.0,4/9,22.50%,MAP1LC3B2;GABARAPL1;BECN1;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7257991128850322,-1.2053553341733712,0.3,0.8888429529863363,1.0,4/9,22.50%,MAP1LC3B2;GABARAPL1;BECN1;MAP1LC3A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7427131273940717,1.2053067642817121,0.22033898305084745,0.8832173061782499,1.0,5/9,20.02%,HDAC3;HDAC2;SMARCAD1;HDAC9;HDAC1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6548779375990736,1.2052825186626865,0.20408163265306123,0.8826744391501964,1.0,2/13,9.35%,RPP40;RRS1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.5707696315780603,1.2051732920920835,0.14814814814814814,0.8824964987436161,1.0,11/42,19.82%,NRG1;TLR2;ITGAV;EPHA3;SNCA;NR1H3;PTEN;PLSCR1;PXK;NDFIP2;MCTP1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.7264373773679957,1.205072416288591,0.2653061224489796,0.8822833060276247,1.0,1/9,3.80%,PCSK5
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.7174168779521922,1.2049568271800553,0.3333333333333333,0.8822034556663805,1.0,1/8,2.47%,IL4
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5033751203394956,1.204919019720826,0.18181818181818182,0.8817869141511565,1.0,23/104,10.22%,MXRA5;LAMA4;CFH;MRGPRF;MME;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;TLR2;POSTN;CCDC80;ITGAV;PDGFRA;ABI3BP;CYBRD1;PCDH18;MEDAG;TNC;COL5A3
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",0.7370311751766605,1.2046387436067447,0.22413793103448276,0.8822832311795649,1.0,1/9,0.23%,PROZ
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.46528942992093714,-1.2044486471591969,0.0784313725490196,0.8909235908320037,1.0,38/224,8.03%,LRP10;OR13A1;OR1L8;OR2AK2;OR10AC1;ABCA4;RTP1;OR2T6;OR2M4;OR2M3;GUCA1B;OR2M2;OTOG;OR2L13;OR51M1;OR1L6;AGRN;OR52A1;OR9G4;GPC2;ANO2;PDE6B;GPC1;GNAL;CNGB1;OR2L8;GPC3;TMIE;CDH23;TMC2;PPEF1;KCNN2;OR2L2;PLCB2;MYO15A;NMT1;GNG13;KCNQ4
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,0.6585110022991766,1.204161146208964,0.2826086956521739,0.8837701407998974,1.0,3/14,12.93%,KLRD1;DPP4;IL18R1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5456026037529698,1.2040849830102656,0.1702127659574468,0.883494890218091,1.0,11/47,14.38%,RAB27A;SEPTIN4;RALA;SYT1;RAB3C;SNCA;CHMP6;RIMS2;HAP1;RAB9A;RAB27B
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6072547142710283,1.2040020831103047,0.23529411764705882,0.8832995711661318,1.0,13/34,22.19%,CSTA;HDAC2;DSP;SCEL;CERS3;USH2A;CTNNB1;AKR1C3;CASP3;JAG1;HDAC1;ANXA1;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5643605787708602,1.2039283585570562,0.21428571428571427,0.8829808751537552,1.0,9/30,15.21%,WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5944085439365285,1.2039002281009268,0.2,0.8825743654099936,1.0,6/22,12.44%,CHRM2;MYBPH;TNNT1;ATP1A2;KCNB2;PPP1R12B
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6491368320340055,1.2037660992257881,0.27586206896551724,0.8826623352057463,1.0,6/20,15.49%,ADRA1A;SLC8A1;JPH1;GRIN2D;TRPM2;RYR2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7825526001516018,1.203461362663634,0.2982456140350877,0.8835169707667148,1.0,2/5,15.94%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.6209577935549908,1.2033449942537358,0.2,0.8833487412569246,1.0,6/24,17.32%,MT4;SLC39A8;SLC39A12;SLC30A10;MT1M;SLC30A1
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.5139856615647302,1.2030514345371008,0.1509433962264151,0.8839288618608085,1.0,13/71,10.55%,ITGA10;ITGA8;ITGB8;ITGA11;ITGA2;CDH2;SLC8A1;CACNB4;ITGAV;DSP;SGCG;CTNNA2;ITGA1
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.4188644547361116,-1.2030072836548893,0.03636363636363636,0.8951990400050268,1.0,65/775,10.25%,CD44;DUSP4;TBC1D10C;TRIM56;RAB44;MPO;SELL;SIGIRR;ATP6V1E2;DNASE1L1;HGSNAT;RAC2;ICAM3;NLRP1;CD53;ATP6V1C2;BST1;NLRP3;SFTPA2;MUC5B;STK10;MEFV;DUSP6;ALOX5;PRKCD;AHSG;TEC;CRACR2A;RNASE1;C5;FOS;DDX41;PDZD2;VAV3;MUC19;ATP6V1E1;PSMB4;AGA;DOCK2;COLEC10;BTK;HCK;ADGRG3;SLC11A1;SVIP;POLR3H;POLR3E;CLU;JUN;OLFM4;CHI3L1;ECSIT;LY86;TXK;C1S;CEACAM1;CFHR4;ATP6V1D;MASP1;MMP9;DHX58;LIMK1;MUC15;HLA-C;HRNR
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6346741294678667,1.2029525028985992,0.33962264150943394,0.883751784498877,1.0,7/18,25.45%,ACD;TERF1;TENT4B;GNL3L;POT1;HNRNPU;HNRNPC
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7686876575189396,-1.202887181970735,0.3076923076923077,0.8945886653659355,1.0,3/7,15.60%,CYP24A1;SFRP1;CDKN2D
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,0.6921518780822686,1.2028675690903807,0.30434782608695654,0.8834694851524215,1.0,3/12,9.51%,RALA;MAPKAPK2;MAPKAPK3
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.7807609981981231,1.2025657981920157,0.22,0.8842064020037547,1.0,3/5,21.36%,IL2RA;CLC;HLA-B
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6114885579205819,1.202493524410024,0.1836734693877551,0.8839417329228121,1.0,7/38,14.00%,IGF1;PPARG;PYHIN1;HMGB1;CPNE1;MAPK8;PLAUR
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5593825896839699,1.2023517002250557,0.14814814814814814,0.8839317833961112,1.0,12/45,12.52%,IL1RAPL2;CLSTN2;NLGN1;ROBO2;PDLIM5;TLR2;NRXN1;SNCA;PTPRD;GPC4;MEF2C;LRFN5
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.7378812987450196,-1.2023097515173926,0.25,0.8956119206668005,1.0,1/7,0.84%,GUCY2C
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6044452270164165,1.2023077155606055,0.24561403508771928,0.883597556343274,1.0,4/19,14.30%,SEMA5A;SEMA6C;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6712003094869269,1.2022162874313536,0.2641509433962264,0.8833776548461567,1.0,6/14,20.31%,VCAN;BGN;DSEL;CSGALNACT1;BCAN;CSPG4
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7483736141664574,1.2020765228356527,0.26785714285714285,0.8832893456432463,1.0,2/8,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6402114616447229,1.2019866315868748,0.30434782608695654,0.8831661734689474,1.0,6/16,26.55%,IL26;LYN;CARD9;RNF13;STK25;MID1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5347995641838136,-1.2018427506277074,0.17647058823529413,0.8963746959035912,1.0,9/58,4.96%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;IL6R;LTB
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.6522083577225115,1.2017900641337664,0.17307692307692307,0.8833840445720925,1.0,7/18,16.70%,PAXIP1;AUTS2;CTCFL;SMAD4;MYB;BCOR;CTNNB1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.588725074290921,1.2016170321891062,0.21739130434782608,0.8834007256799334,1.0,3/40,5.57%,STK26;SIRT1;RELA
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.7417881415675254,-1.2015030604132446,0.22727272727272727,0.8963537689808194,1.0,2/8,4.93%,DRD4;DRD2
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.5744139474895927,1.2013833461808114,0.18518518518518517,0.8840632714699482,1.0,8/38,12.39%,H2AC25;HMG20B;H2BC21;HDAC3;HDAC2;TBL1X;PHF21A;H2AC6
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.7078123390573736,1.2012975174800447,0.2641509433962264,0.883974793360042,1.0,3/9,6.01%,GRIP1;GRIP2;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6734439554518172,-1.201187194918642,0.3023255813953488,0.8964339324394296,1.0,2/12,5.43%,RNF8;RECQL5
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.550874400275951,-1.201177280068259,0.17543859649122806,0.8907351324420193,1.0,10/47,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.550874400275951,-1.201177280068259,0.17543859649122806,0.8907351324420193,1.0,10/47,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.550874400275951,-1.201177280068259,0.17543859649122806,0.8907351324420193,1.0,10/47,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.550874400275951,-1.201177280068259,0.17543859649122806,0.8907351324420193,1.0,10/47,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.550874400275951,-1.201177280068259,0.17543859649122806,0.8907351324420193,1.0,10/47,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;LTB;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,0.741712777405104,1.2010367800865962,0.2708333333333333,0.8845837289152534,1.0,1/8,6.66%,PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7243712947713181,-1.2009917160441632,0.2391304347826087,0.890311403744475,1.0,2/7,16.17%,CD200R1;ADTRP
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.7024053542178411,1.2008691297523792,0.39215686274509803,0.8846866360021324,1.0,3/10,5.28%,SIRT1;CDKN2A;ABI3
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6499660550705317,-1.2008258861603391,0.21739130434782608,0.8897977197495492,1.0,4/14,12.13%,ENTPD2;AK8;AK7;ENTPD5
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.8069135831604209,1.2007421770204905,0.16666666666666666,0.8845717983961381,1.0,3/6,19.00%,NRG1;MESP1;HDAC9
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7188724031817288,1.2006409361270525,0.3333333333333333,0.8843527421529328,1.0,6/10,25.90%,FOXO3;SLC25A33;TFB1M;TFB2M;MTERF2;MTERF1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6389533001400014,1.2002708029800975,0.1864406779661017,0.8853769578675309,1.0,5/19,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.48042035442674763,1.200233789956504,0.16129032258064516,0.8849057515841682,1.0,19/118,10.38%,TSPAN12;BOK;GNG12;RORA;EPDR1;LRIG3;FKBP5;SLC7A2;ARHGEF17;MMP15;GAMT;UNC13B;ADGRL2;BCAT1;MAGI1;KCTD3;PLXNB1;CLDN12;AOX1
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,0.5268891210697609,1.200023786059164,0.1702127659574468,0.8852771663730226,1.0,12/64,13.34%,STAB1;OIT3;RIN2;DOCK1;DIPK2A;DLC1;CRHBP;ZNF286B;EFNB2;MEF2C;CD34;MGAT5
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,0.5284672047464999,1.1998975087977384,0.2,0.885283755620627,1.0,14/71,13.05%,SGO1;LIN28A;MAP3K15;HDAC2;IGDCC3;SPSB4;ZNF286B;GINS1;ZNF114;VASH2;GNG4;CLDN6;GRM4;DLL3
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.7655537261624653,1.1997578471981138,0.24074074074074073,0.8852903358046169,1.0,1/5,5.41%,EFL1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6701497829904126,1.1996777019700344,0.26666666666666666,0.8849677423239681,1.0,3/13,9.74%,C3;SLC26A6;CA2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7575336329245133,1.1996444790411236,0.22413793103448276,0.8845157478036885,1.0,4/7,18.04%,GRIN3A;NLGN1;PTEN;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.6796929959188174,1.1996293918688046,0.24444444444444444,0.8839346186838044,1.0,4/11,27.66%,ZNF675;NPPA;HIPK3;PDCD4
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7464269423537768,-1.1995149003038648,0.3125,0.8938312319742527,1.0,2/7,10.96%,DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5848477981278679,1.1994230007371804,0.18,0.884192793845493,1.0,12/18,35.11%,INTS6L;EXOSC4;INTS6;INTS14;INTS8;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7;INTS1;INTS2
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.5564640224890639,1.1992350441862332,0.2,0.8843901457510928,1.0,10/29,18.08%,CFH;C3;CD59;C5AR2;C3AR1;CPNE1;CPNE2;AKR1C1;CD81;CD55
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,0.7718812981930994,1.1991161931805876,0.2222222222222222,0.8843023527763698,1.0,2/6,8.79%,ECI1;ACADM
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.7590153317361074,1.1989938482916043,0.20588235294117646,0.8843009465137561,1.0,1/6,2.84%,KAT2B
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7145432683864248,1.1988850226745542,0.2127659574468085,0.8841616101361064,1.0,2/7,10.21%,DCP1B;PATL2
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.49198129491009907,1.198851969243668,0.18,0.8800514067389508,1.0,18/93,9.05%,MXRA5;MRGPRF;SEMA5A;PRRX1;EDIL3;ADGRL4;FGF2;TRPC4;BGN;CXCL12;EFS;POSTN;PDGFRA;GPR176;PCDH18;PRICKLE2;PABPC5;ANK2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7278963916553319,1.1988488925188068,0.32142857142857145,0.8794613061493626,1.0,2/6,7.89%,SLC22A3;SNCA
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.6128929338635477,1.1987564289749888,0.3114754098360656,0.879163320150314,1.0,2/21,4.60%,PLD6;GDAP1
prerank,KEGG_2021_Human__Autophagy,0.485008750481082,1.1987205819688382,0.2,0.8787287440230658,1.0,31/128,21.16%,IRS4;IRS1;HIF1A;RRAS;DAPK2;HMGB1;ATG101;ATG4C;PIK3CA;RRAGC;MAPK8;PTEN;IGF1R;TANK;MTMR3;RAB33B;PRKAA1;PIK3CD;MAPK10;RRAS2;IRS2;RRAGD;STX17;PRKACB;MLST8;DEPTOR;ATG2B;AKT3;PIK3R3;BAD;MAPK3
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.6041291322445506,1.1983272235180635,0.22916666666666666,0.8797322289139365,1.0,5/31,10.26%,SMYD1;SMYD2;WDR5B;PAXIP1;EZH2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.55818202700286,1.198260892080375,0.22916666666666666,0.8793833621787736,1.0,9/33,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5970433941194171,1.1981834871446961,0.2641509433962264,0.8791375057581874,1.0,6/30,15.21%,FGF10;PLCG2;UBE2E2;EZH2;CCND3;PLCB1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6127688866281744,-1.1980702711184297,0.26666666666666666,0.8984538029490272,1.0,2/20,10.80%,MTFR2;UQCRC1
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,0.7160971859593748,1.1977891718640619,0.21818181818181817,0.8802582198795542,1.0,1/7,4.16%,IL2RA
prerank,Reactome_2022__Organic Cation Transport R-HSA-549127,0.8353907210358431,1.1977521064044512,0.14285714285714285,0.8798073071922642,1.0,2/7,2.39%,RUNX1;SLC22A3
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.7481191974048128,1.197360783137233,0.2830188679245283,0.8807981401699635,1.0,1/6,3.24%,LDLR
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6668360276230133,-1.1973445657070445,0.2857142857142857,0.9002805546578186,1.0,1/9,1.30%,PRDM1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6952302196786339,1.1967857227852645,0.2727272727272727,0.8826994512536667,1.0,2/9,10.60%,GRIN3A;GRIN3B
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.5446870076212165,1.1967135268253326,0.15384615384615385,0.8824436689229347,1.0,4/35,3.42%,RAPGEF3;KCNC2;GNB4;GNG12
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7040853143316068,1.1966708813158378,0.16666666666666666,0.8820520695253242,1.0,5/13,20.46%,NPY;LHX6;PTEN;RAPGEF2;MAP2
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.698412440578649,1.1964219310274387,0.2,0.8823923781186731,1.0,4/10,19.15%,SLC1A3;SLC25A13;SLC1A6;SLC25A12
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,-0.7438063050774043,-1.1962431052090023,0.32653061224489793,0.9036514724274048,1.0,4/9,15.90%,ALOX5;GPX2;PON3;LTC4S
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5759805372645619,-1.1962145316579582,0.1568627450980392,0.9026266513718435,1.0,16/33,25.41%,RFC3;SMUG1;PARP1;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3;MBD4;PNKP;POLL;PARG;APEX1;RPA2;OGG1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5330220830100594,1.196179391317473,0.18518518518518517,0.8829022013335311,1.0,8/48,15.59%,CNTNAP2;NYAP2;TNIK;PLXNB1;GPM6A;DBN1;SNX2;SGK1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.49636415956258995,1.1960913478865198,0.15,0.8826809436250499,1.0,15/84,9.44%,BOK;SHMT2;ZBTB1;KCNC2;EHD1;PRMT1;VSTM5;UGDH;MAT2A;TIFA;C9;SNCA;WDCP;STING1;MCU
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7488728312404024,-1.1960602272490157,0.35294117647058826,0.9020471030633569,1.0,1/5,4.61%,PDHX
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.741896012262542,1.1960300775465933,0.37254901960784315,0.8822732647949816,1.0,3/6,23.16%,NPPA;ANO6;DLG1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7205633810581511,1.1959682936390037,0.2037037037037037,0.8819763944294056,1.0,3/11,5.09%,CARNS1;UGDH;NANP
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,-0.7909568214095138,-1.1958973787940217,0.3157894736842105,0.9015412003456984,1.0,4/7,15.40%,RNASE1;CAMKK2;CAMKK1;CALM1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.45262945781607844,1.1956709734959594,0.10909090909090909,0.8826122632337012,1.0,31/106,21.29%,MCOLN3;KCNC2;PMP2;TRPM8;ZNF493;ST18;CACNB4;NRXN1;SLC24A2;SYNPR;CTNNA2;SCN2B;HCN1;PROX1;GRM4;MYT1L;MOBP;SEZ6L;CNTN2;PCSK2;RPS6KA5;XKR4;STMN4;NR3C1;UNC13C;SLC7A14;AMER2;ATP1B2;CADPS;ASPA;HTR5A
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.7194823225883804,1.1954961621975158,0.2857142857142857,0.8827475402367742,1.0,2/10,6.66%,TGFBR1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.7666063488483894,1.1954946085026188,0.27450980392156865,0.8821631587725749,1.0,1/6,2.81%,FGF2
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.6688852551450706,-1.1954529769621594,0.20454545454545456,0.9019827928136515,1.0,7/13,23.78%,DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;ATP5MC3;ATP5PB;ATP5F1B
prerank,CellMarker_Augmented_2021__T cell:Liver,0.7996860835359549,1.1953639902733089,0.21153846153846154,0.8822055093393848,1.0,2/7,4.31%,IL2RA;CD244
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.7916952469426172,-1.1951981659087274,0.2830188679245283,0.9018832568391406,1.0,3/6,9.36%,SCN5A;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.42829258003569226,1.1950436568663625,0.07142857142857142,0.8831269232619752,1.0,91/604,12.41%,VEGFC;IGF1;ADRA1A;FGF10;SMAD6;TIMELESS;FLT1;IRS1;TCIRG1;CDKN2C;RUNX1;FGFR3;ITGAX;BOK;ACE2;MYC;SIRT1;TGFBR1;F2R;FGFR1;EGLN3;ERBB4;GNRH1;IL4;STAT5A;FGF2;KAT2B;NRG1;KSR1;CDKN2A;FBXO5;BMP2;TENM1;PRMT1;CDCA7L;SIX4;ST18;IL7R;KANK2;DUX4;HCLS1;SMYD2;RELA;PTGFR;CCN6;SSTR3;TRAPPC14;DNAJB2;WNT9A;ITGAV;WWTR1;PDGFRA;TP53INP1;P3H2;POU3F2;FER;IL15;DPP4;HDAC2;LIFR;TOB1;DLC1;RNF139;PDGFC;CBFA2T3;ARID2;PTPN14;MAGI2;FGF17;TMEM115;TMIGD3;FRK;IGFBP6;RPS6KA2;EZH2;FLT3;EFNB2;ITGA1;BMPR1A;PTPRK;CNOT6L;HP1BP3;SINHCAF;HAS2;GDF9;MVD;NCK2;PROX1;PTEN;H2AC6;CTBP2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5701688186178231,-1.1948448494040824,0.20408163265306123,0.902233420208392,1.0,2/34,1.76%,TERT;TERF2IP
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.5371185497556341,1.1947859665200222,0.18,0.8835149150326668,1.0,18/85,10.66%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;ARHGEF17;POSTN;CCDC80;PDGFRA;PCDH18;MEDAG;TNC;TPM2
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.5316548704934078,1.1946905242906258,0.22916666666666666,0.882180359405378,1.0,23/80,18.04%,PLOD2;SLC22A3;PPARG;GNG12;GOLT1A;DOCK1;CRIM1;ADGRG6;SLC7A2;SDC4;LIFR;PLSCR4;DLC1;ABCG8;DSP;PTPRK;ERRFI1;THRB;GPR37;COBL;RNF128;WASL;EFNA1
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.5316548704934078,1.1946905242906258,0.22916666666666666,0.882180359405378,1.0,23/80,18.04%,PLOD2;SLC22A3;PPARG;GNG12;GOLT1A;DOCK1;CRIM1;ADGRG6;SLC7A2;SDC4;LIFR;PLSCR4;DLC1;ABCG8;DSP;PTPRK;ERRFI1;THRB;GPR37;COBL;RNF128;WASL;EFNA1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.5316548704934078,1.1946905242906258,0.22916666666666666,0.882180359405378,1.0,23/80,18.04%,PLOD2;SLC22A3;PPARG;GNG12;GOLT1A;DOCK1;CRIM1;ADGRG6;SLC7A2;SDC4;LIFR;PLSCR4;DLC1;ABCG8;DSP;PTPRK;ERRFI1;THRB;GPR37;COBL;RNF128;WASL;EFNA1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7067384105803414,1.1946272285943258,0.21052631578947367,0.8818265617862829,1.0,3/10,10.56%,SHMT2;GCAT;RIDA
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.5352672810869155,1.1946120551231771,0.16666666666666666,0.8813216912710232,1.0,6/50,11.08%,TMPRSS2;ACE2;ST6GALNAC3;CHMP6;GALNT1;PRKCSH
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.650845171498677,1.194577228996613,0.3333333333333333,0.8808679762839987,1.0,3/17,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5520792723787414,-1.1945250086462693,0.16666666666666666,0.9023313290909151,1.0,3/35,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5232290433783624,-1.194498513381781,0.1276595744680851,0.9012992190961281,1.0,6/53,13.11%,TERT;FLOT1;HFE;MMP9;WNT3A;CAV1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.542914250147701,-1.1940778638065457,0.13793103448275862,0.9020070080375747,1.0,14/51,12.12%,UROC1;ALB;HABP2;AHSG;F7;FGL1;PAH;DBH;HAO2;TTBK1;PRODH2;CDHR2;APOA1;C3P1
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.4475338302148059,-1.1940360264419558,0.1111111111111111,0.9011031002810812,1.0,24/221,10.40%,P2RY10;DUSP4;SIRPG;SP140;PRDM1;ICAM3;CXCL13;CTNNA1;RIN3;WARS1;CCDC141;PHEX;PPM1M;APOBEC3G;PMF1-BGLAP;ASB2;OAS3;UBASH3B;PTPN7;KRT86;GLDC;LIMK1;SLC2A8;GBP2
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5686052316155108,1.1935530053442298,0.23529411764705882,0.8847449688038225,1.0,7/37,13.04%,FERMT3;CD99;MEGF10;MYL12A;PDGFRA;CSRP1;HSPB1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6792365540253941,1.193542371837318,0.16981132075471697,0.8841887482647379,1.0,5/24,15.58%,LDLR;NPC2;MTTP;PITPNM1;SLC44A4
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.693436941365684,1.1935295976485916,0.2545454545454545,0.88363326885895,1.0,6/11,19.73%,PLA2G10;CD74;MFHAS1;GPR137B;PLSCR1;LYN
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.571425287597467,1.193381339272987,0.21568627450980393,0.8832624593489903,1.0,11/30,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.571425287597467,1.193381339272987,0.21568627450980393,0.8832624593489903,1.0,11/30,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5250472062504796,1.1933379176486,0.19148936170212766,0.8829433442040883,1.0,22/66,15.60%,SMAD6;VWC2L;IL4;FGF2;PPARG;NEDD4;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;SMAD1;VWC2;BMPR1A;DAND5;SMAD4;SPRY3;GREM1;LRP2;SPART;BAMBI;SMAD5
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.5674849162657642,1.1933370793880218,0.18518518518518517,0.8823650453308922,1.0,10/31,23.35%,CDKN2C;CDKN2A;MOV10;DAND5;CDK4;TP53;AGO3;MAPK3;CDK6;MDM4
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.4419782431109228,1.1933007099415507,0.09302325581395349,0.8819130477182611,1.0,46/253,15.90%,CGNL1;IGF1;SMOC1;ATP6V0D2;PPP1R18;SNTB1;ZNF493;ITPKB;STAC2;ACADS;LTBP2;RALA;POSTN;CNN3;PLCG2;FAM114A1;SCNN1B;CEP20;ANKRD9;CORO7;NUDT16L1;PLXDC2;CLGN;ATP6V0A4;MPC1;ANK2;SAV1;FAM43A;SMAP1;MEGF9;ZNF704;MAN2A1;GPR160;PPP1R12B;KHDRBS3;ATP6V0B;FAM89B;MGAT5;ID4;NCKAP5;BCOR;SC5D;TMTC3;TBC1D4;DOCK4;GPRC5B
prerank,Reactome_2022__Histidine Catabolism R-HSA-70921,-0.7872499470256599,-1.193289929314926,0.23404255319148937,0.9030063719243633,1.0,2/7,0.44%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5314199438602241,-1.1932709642103676,0.1956521739130435,0.9019696461752521,1.0,6/57,12.43%,TRMO;BUD23;CMTR1;METTL6;FTSJ3;TARBP1
prerank,Reactome_2022__GLI Proteins Bind Promoters Of Hh Responsive Genes To Promote Transcription R-HSA-5635851,-0.7729009486444337,-1.1932211310793674,0.3333333333333333,0.9010424300610883,1.0,2/6,10.65%,BOC;PTCH1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.6308624936181841,1.1932011190599352,0.3090909090909091,0.881679096579668,1.0,3/27,4.40%,GATA4;WNT4;SIX4
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.5674375776740886,1.1927504887458813,0.25,0.8830919394006215,1.0,9/32,10.30%,C1GALT1C1;GALNT8;GALNTL5;ST6GALNAC3;GALNT7;GALNT3;C1GALT1;GALNT12;GALNT1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.7050254550632099,1.1925325027701295,0.2037037037037037,0.8834922878339027,1.0,1/9,2.31%,ERBB4
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6431560752929208,1.192508342795684,0.23404255319148937,0.8830157009019435,1.0,6/19,11.28%,SLC12A1;SLC12A3;SLC8A1;SCNN1B;CYP4F12;ATP1A2
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.4088100012548492,-1.1922843719421976,0.057692307692307696,0.9035438442902198,1.0,6/620,3.43%,CD44;SNRNP27;APOBEC3H;BUD23;ENPP2;PRKCD
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4945482263536529,1.1921497991820644,0.19230769230769232,0.8840745239911667,1.0,18/85,10.07%,MXRA5;SMIM3;MME;ACTG2;GNG12;LRIG3;FBLIM1;LTBP2;SDC4;POSTN;MYOF;WWTR1;F3;FAM114A1;DSP;MYH11;IGFBP6;TNC
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.7283191300664282,1.1920441978282006,0.24193548387096775,0.8838649239766168,1.0,4/7,23.00%,TEAD2;WWTR1;CCN2;TEAD3
prerank,Reactome_2022__Transport Of Gamma-Carboxylated Protein Precursors From Endoplasmic Reticulum To Golgi Apparatus R-HSA-159763,0.7540566373803517,1.1920323158372985,0.26785714285714285,0.883355715078019,1.0,1/7,0.23%,PROZ
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7220704381728933,1.1919978925870978,0.2916666666666667,0.8829637241308195,1.0,4/8,10.84%,TGFBR1;NRG1;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.7458544144595545,1.1917493905472403,0.2909090909090909,0.883320975814562,1.0,3/8,6.92%,ALDH1A1;ALDH1B1;ACSS2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.724137712883054,1.191593841663538,0.22413793103448276,0.883278699513152,1.0,2/8,3.01%,HIF1A;PADI2
prerank,Reactome_2022__Biosynthesis Of E-series 18(S)-resolvins R-HSA-9018896,-0.7875948915896918,-1.1914451160953992,0.2830188679245283,0.9055946194707251,1.0,2/5,14.13%,ALOX5;ALOX15
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5218799308264671,1.1913735372650491,0.20408163265306123,0.8835854233662976,1.0,20/63,16.76%,SIRT1;INSIG1;EHD1;LDLR;NPC2;RORA;CYP39A1;ABCA1;MTTP;PLA2G10;ABCG8;CYP7B1;NR1H3;PLA2G12B;SOAT2;ABCG5;LIPG;SOAT1;AKR1C1;DGAT2
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.7701302415206883,1.1913421520770018,0.3125,0.8831444976465258,1.0,1/5,3.09%,SNAI1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5081235072085346,1.1913369201341966,0.2,0.8825713962919488,1.0,17/64,17.47%,MME;FAIM;ROBO2;CHODL;PTPRD;SMARCD3;PLXNB1;LIG4;PLXNB2;LRP2;CAPRIN1;RGS14;SPEN;CTNNB1;CDKL5;NUMB;VEGFA
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.5077826924013069,1.1912875023395457,0.11320754716981132,0.8821483014659942,1.0,7/60,13.39%,CDC25A;CCNA2;SEM1;CDKN2A;PSMD13;CHEK2;PSME4
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.6961602890091194,1.1909930486622435,0.2222222222222222,0.8828941384848074,1.0,2/15,3.50%,MITF;CDKN2A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6306647378230383,1.190891645188446,0.22033898305084745,0.8826701293411926,1.0,2/27,1.62%,IGF1;HGF
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5247053332813468,1.1908698631161119,0.21428571428571427,0.882189874811442,1.0,9/52,14.41%,CCNG1;CDKN2C;CDC25A;CCNA2;CNPPD1;CCNB3;CCND3;SERTAD1;CCNH
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.44942200001460947,1.1907072988979577,0.1702127659574468,0.8822147229403261,1.0,62/236,21.16%,FGF10;PREX2;IRS1;FGFR3;FGFR1;ERBB4;NRG1;PPARG;NEDD4;SNAI1;SEM1;NRG3;MOV10;PIP4K2A;ESR1;PDGFRA;HDAC3;NRG2;HDAC2;FOXO3;RNF146;FGF17;PIK3CA;FRK;PSMD13;EZH2;FLT3;FOXO1;CNOT6L;RRAGC;IRAK1;PTEN;SOS1;FGF5;RNF2;PSME4;PML;CREB1;RICTOR;FOXO6;GAB2;PSMA1;IL33;RHOG;TP53;MAF1;AGO3;EED;IRS2;RRAGD;PHLPP1;KIT;KLB;MLST8;AKT3;THEM4;HDAC1;PIK3R3;BAD;PSMD4;SCMH1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6310476962785196,1.190622852916907,0.2692307692307692,0.8819172184410239,1.0,3/18,4.40%,ITGAX;FGF2;SIX4
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6009731657992785,1.1905930224487686,0.2413793103448276,0.8814879566470237,1.0,6/21,17.85%,GRIN3A;LLPH;NLGN1;MEF2C;FOXO6;FMR1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.6761981280830787,1.1904464522468394,0.21666666666666667,0.8817278142159394,1.0,2/13,1.49%,MSH4;TOP2A
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7617971581103614,1.1904063967706437,0.2777777777777778,0.8813322317988961,1.0,2/6,14.46%,LDLR;LRP2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6593952544303833,-1.1899961975991773,0.2765957446808511,0.9101259944545551,1.0,1/14,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7758052214283772,1.18988507819141,0.18867924528301888,0.8826269808886588,1.0,1/5,3.93%,DCC
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.6892696872654084,1.1898577942451405,0.32142857142857145,0.8821489518034578,1.0,3/8,7.29%,SYK;CCL5;IL15
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.693962767967517,1.1896555139017426,0.3137254901960784,0.8823959831898862,1.0,3/10,7.89%,IRS1;CD244;SNCA
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,-0.7885423985232392,-1.1895133614394797,0.3023255813953488,0.9107448974681209,1.0,1/7,1.43%,AWAT1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7362419836437801,1.1894618890375064,0.22641509433962265,0.8825686503966993,1.0,1/6,4.75%,JADE3
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.6931791824863346,1.189430893232142,0.35714285714285715,0.8821244807882919,1.0,1/11,1.76%,MYC
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6808861925335885,1.189269125478304,0.2222222222222222,0.8821738579477281,1.0,5/11,21.43%,AANAT;METAP1D;NAA16;NAA11;NAA50
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6725817547396944,1.189058252061333,0.3,0.8825680233335748,1.0,6/10,26.96%,FZD5;RIPPLY2;MESP1;DDIT3;WLS;SHH
prerank,KEGG_2021_Human__GABAergic synapse,0.5212279093579998,1.1889108553995602,0.17777777777777778,0.8826580745837381,1.0,18/79,19.06%,GABRR1;GABRR2;GNB4;GNG12;SLC38A3;GLUL;GABRG3;GNAI3;HAP1;GABRA5;GNG4;GABRG1;GABRB2;GPHN;GABRE;GABRA4;GABRB1;PRKACB
prerank,CellMarker_Augmented_2021__Germ cell:Embryo,-0.7732126973148907,-1.1887205265227367,0.3111111111111111,0.9126374584251871,1.0,2/6,10.34%,PRDM1;DDX4
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,0.7195725692208776,1.1886440173911834,0.24528301886792453,0.8832482142139924,1.0,3/11,13.31%,FDX1;ISCA2;FDXR
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.5840143301739231,1.1886428462780374,0.19607843137254902,0.8826821253491225,1.0,4/27,6.74%,SYK;CD22;BLNK;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5181896930831598,1.1886247921740185,0.12195121951219512,0.8821331510117499,1.0,5/43,5.57%,RBM20;MYCN;LIN28A;RIOK2;RELA
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.44877553910595497,1.1886095607314349,0.11320754716981132,0.8816258102126215,1.0,39/210,16.12%,IRGM;ATP6V0D2;HGF;BOK;DEPP1;FZD5;NEDD4;GFAP;TFEB;RNF152;DAPK2;IL10RA;MID2;PIP4K2A;PRKAB2;TP53INP1;TICAM1;HTRA2;HMGB1;FOXO3;ABL2;ATG101;TAB2;LEPR;KEAP1;TRIM65;FOXO1;WASHC1;RRAGC;MAPK8;ATP6V0B;MTMR9;HSPB1;MTMR3;GPR137B;ATF6;FBXL2;PRKAA1;TAB3
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.5167968577789552,1.1885684674635204,0.21153846153846154,0.8811927371240685,1.0,23/85,14.30%,MXRA5;CGNL1;FLT1;PREX2;NYNRIN;ADGRL4;BGN;FREM1;CXCL12;EFS;PDGFRA;UNC13B;ADGRL2;PTPRD;GPC4;MAGI1;PLXNB1;CTTNBP2;PROX1;SHROOM4;ID4;RUNX1T1;SEMA6D
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6970167480901479,1.1885637667259625,0.27586206896551724,0.8806376232090001,1.0,6/12,19.39%,RENBP;UAP1;GNPNAT1;GNPDA2;GFPT1;B4GALNT2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.7307172237000378,1.1884287557053586,0.23076923076923078,0.8806958441812611,1.0,3/8,25.01%,BACE2;ITM2B;ABCA7
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.49405778013590446,1.1883464198496636,0.17073170731707318,0.8804437989853703,1.0,13/82,8.34%,MME;TMPRSS2;KLKB1;MYRF;MMP16;PCSK5;HGFAC;F12;PRSS3;VSIR;F3;HTRA2;CPN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7738236581385259,1.188106381074344,0.19148936170212766,0.8809425821224657,1.0,3/7,18.31%,CCL5;NOC2L;IRS2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.6985549984175131,-1.1878014316895242,0.2765957446808511,0.9150117902652447,1.0,2/8,10.86%,TAF7;SPI1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.8008179840784457,1.1877772748842024,0.2413793103448276,0.8811235054081312,1.0,2/5,8.79%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.8008179840784457,1.1877772748842024,0.2413793103448276,0.8811235054081312,1.0,2/5,8.79%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.6453291491393349,-1.187644000871005,0.3111111111111111,0.9145711684314234,1.0,3/6,17.38%,PAX2;FZD7;PAX8
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5608086239770137,1.187217947371643,0.24074074074074073,0.88305384344959,1.0,4/33,7.83%,SIRT1;RORA;ESR1;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.7666849415468201,1.1871154738098946,0.3,0.882809226121198,1.0,1/5,0.50%,ADRA1A
prerank,KEGG_2021_Human__Insulin resistance,0.5064888670981751,1.187106101395704,0.16981132075471697,0.8822884596787104,1.0,22/93,16.15%,IRS1;PPP1R3B;PPP1R3A;PPP1R3D;RELA;PRKAB2;PPP1CC;PIK3CA;RPS6KA2;FOXO1;NR1H3;MAPK8;PTEN;CREB3L2;MLXIPL;CREB1;RPS6KA1;ACACB;TBC1D4;PRKAA1;PIK3CD;MAPK10
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.6297100602229605,1.187104839984204,0.3220338983050847,0.8817277343920346,1.0,6/19,14.99%,SIRT1;H2BC21;H2AC6;H2AZ2;TAF1A;H2AX
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,0.6401145218746706,1.1870002844359755,0.2708333333333333,0.8816306194359614,1.0,3/18,5.86%,KLKB1;MMP16;MMP15
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7642140359023719,1.1867965518394639,0.20754716981132076,0.8820043348420773,1.0,5/6,23.43%,GREM1;IL33;LYN;ENPP3;BLK
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7296120590360439,1.1865949492479044,0.34,0.8823289069592112,1.0,4/8,21.16%,MAP2K6;CHEK2;ABL1;MAPK3
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,0.715493193616068,1.186250403838274,0.30612244897959184,0.8832366338923915,1.0,3/10,7.56%,VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5545275953626493,1.1861940067262666,0.17543859649122806,0.8828553002080248,1.0,12/38,20.53%,MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;IRAK1;ARHGEF6;TAB3;MAPK10;ADORA2B;GPS1;RIPK2
prerank,KEGG_2021_Human__Riboflavin metabolism,0.7387661112997346,1.1861206644848512,0.2727272727272727,0.8825634987059675,1.0,1/7,3.41%,ENPP1
prerank,KEGG_2021_Human__Long-term depression,0.5068920060041568,1.1860898228223744,0.1956521739130435,0.8820860118264943,1.0,15/55,21.90%,IGF1;PRKG1;GNAI3;GUCY1A2;IGF1R;PLCB1;GNAZ;GRM1;GUCY1A1;GRID2;GNA13;LYN;MAPK3;GNAQ;GNAI1
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.5350813651804672,1.1858195149795359,0.2222222222222222,0.8826843593278071,1.0,8/44,10.18%,CARNS1;CKMT1A;ALDH7A1;ODC1;ALDH1B1;GAMT;ALDH9A1;PYCR1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.5451543718106443,1.185416716655502,0.25862068965517243,0.8837020577184136,1.0,8/44,9.71%,C3;IL4;NLGN1;RAB31;BICD1;TF;SNCA;HIP1
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.5938561777652053,1.1853853645675734,0.32727272727272727,0.8832489811667809,1.0,3/17,9.52%,SYK;BLNK;PIK3CA
prerank,KEGG_2021_Human__Wnt signaling pathway,0.49400152926466756,1.1853100225510682,0.22916666666666666,0.8830304813209012,1.0,34/144,15.21%,PRICKLE3;CXXC4;RSPO3;MYC;LGR5;FZD5;ROR1;WNT4;RSPO2;FRAT2;CCN4;WNT9A;PRICKLE2;GPC4;VANGL2;TBL1X;SMAD4;MAPK8;CTBP2;PPP3CA;TLE2;FZD1;PPP3CC;CCND3;PRICKLE1;DVL2;LRP6;FZD4;NFATC3;FRAT1;FZD6;BAMBI;LGR6;PLCB1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5777113866390016,1.1851554430908715,0.17857142857142858,0.8830138531965818,1.0,8/28,18.05%,LIN28A;SMAD1;SMAD2;MRPL44;PRKRA;HNRNPA2B1;PUS10;AGO3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.5225174087475017,1.1851164954458984,0.14814814814814814,0.8825943198638451,1.0,19/57,18.93%,FGF10;TNIK;RALA;EFS;PDLIM4;CASS4;GAB1;FER;NPHS2;AUTS2;MCU;GSN;BCAR1;PTK7;RICTOR;FARP2;RAP2A;CAPN10;KIT
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6421388256063092,-1.1850719707240553,0.30612244897959184,0.9239248608884694,1.0,1/21,0.17%,TERT
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.5993135956973159,-1.185047292590552,0.22641509433962265,0.9229632596340184,1.0,1/28,0.60%,HK2
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.4712281940673501,1.1848382509197204,0.19607843137254902,0.8830128742188199,1.0,33/130,23.85%,CDKN2C;TOP2A;MYC;CDC25A;CCNA2;SEM1;CDKN2A;FBXO5;GMNN;MCM7;TK1;PSMD13;E2F4;POLE2;CCND3;DYRK1A;CCNH;ORC4;PSMA1;MNAT1;CDK4;AKT3;ABL1;LYN;HDAC1;PSMD4;AKT2;E2F6;CDK6;LIN52;PPP2R1B;RBBP4;JAK2
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6982051653337278,1.1848247318023521,0.2830188679245283,0.8825133949379356,1.0,3/9,19.70%,RNF139;GAS1;STX18
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6241038588970248,1.1847885076009768,0.3,0.8820869410680022,1.0,2/18,4.60%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4219218189034215,1.184510045898989,0.1111111111111111,0.8826657776402065,1.0,110/459,21.49%,DACH1;TIMELESS;SIRT1;TSHZ3;IL4;FOXP2;SLFN11;NRG1;PPARG;SFMBT2;MDFIC;ENPP1;WNT4;CDKN2A;RORB;BMP2;NFIL3;SYNCRIP;SIX4;SAMD4A;LIN28A;RBPJ;RELA;ZEB1;ZNF706;HDAC3;HDAC2;TOB1;GMNN;RNF139;ATXN1;CBFA2T3;YAF2;SPINDOC;NPAS1;SMAD2;PATL2;EZH2;MAGEL2;LOXL2;RIDA;FOXO1;MBTD1;PTPRK;PASD1;NR1D2;SP3;SMAD4;DPF1;PROX1;CTBP2;TLE2;ZNF281;MYB;ATF7IP;DPF3;TERF1;HSPA8;HEXIM2;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;ZNF639;BCOR;RUNX1T1;NR2F2;EPC1;KAT6A;POU2F1;CAPRIN1;PLCB1;SPEN;CNOT8;DEAF1;MESP1;BAP1;HEY2;BCL3;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3;TP53;FMR1;CITED2;EED;ZNF12;PSPC1;HDAC9;ZBTB4;NR3C1;NAB1;PAIP2B;BMPR2;TRIM28;LIMD1;HDAC1;HINFP;SFMBT1;DDIT3;PASK;ATP8B1;SCMH1;DPF2;LSM14A;TNFSF4;NANOS1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6785336825014701,1.184408646859635,0.25,0.8825289528121029,1.0,1/10,2.58%,ZBTB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8813899285529254,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8813899285529254,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8813899285529254,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5883493421615406,-1.1840819902329263,0.24074074074074073,0.9253660149231699,1.0,1/30,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6136761969265951,1.184054183265063,0.2413793103448276,0.8817029583916228,1.0,8/21,20.48%,SEMA5A;DSCAM;DBN1;L1CAM;CDKL5;VEGFA;MACF1;GOLGA4
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,-0.5566458125459578,-1.1838651784348544,0.19148936170212766,0.924879677283725,1.0,7/39,11.73%,FAM209A;NLRP13;TGM4;DNAJB13;EFCAB8;NLRP9;TOPAZ1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7504761443583035,1.1838388163465245,0.32142857142857145,0.8813755581043835,1.0,1/6,3.41%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7504761443583035,1.1838388163465245,0.32142857142857145,0.8813755581043835,1.0,1/6,3.41%,ENPP1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5219437742605691,1.1838106187592945,0.22916666666666666,0.8809682558853077,1.0,20/62,16.76%,SIRT1;INSIG1;EHD1;LDLR;NPC2;RORA;CYP39A1;ABCA1;MTTP;PLA2G10;ABCG8;CYP7B1;NR1H3;PLA2G12B;SOAT2;ABCG5;LIPG;SOAT1;AKR1C1;DGAT2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.6995485365558866,1.1837636671739329,0.22448979591836735,0.8805934386152586,1.0,3/10,10.67%,GPR33;C5AR2;C3AR1
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,-0.7193324489238375,-1.183740543895644,0.358974358974359,0.924192606315033,1.0,1/7,2.57%,TFAP2E
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,0.5710534532324737,1.1835995064108793,0.21153846153846154,0.8805944870084669,1.0,10/29,14.20%,MME;ITGAX;IL7R;TLR2;LAIR1;SIGLEC1;CD40;FLT3;CD34;CD83
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.7177931478864312,1.1835708813308348,0.2830188679245283,0.8801884532996844,1.0,2/8,10.54%,EHD1;ZDHHC2
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.6519707953534536,1.183506773809632,0.20754716981132076,0.8798706797224868,1.0,8/18,23.85%,STAT5A;PIK3CA;SOS1;KIT;LYN;PIK3R3;GRB2;JAK2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4696810314252148,1.183490588474529,0.16326530612244897,0.8793779268070103,1.0,30/150,11.83%,LRRC3B;NXPH1;RIT2;PRKG1;GRM3;HRH3;CADM2;PCBP3;PDE1A;SLC17A6;CNTNAP2;PENK;ZDHHC22;NRXN1;RAB3C;SLC24A2;OLFM3;SYNPR;GPSM1;HIVEP2;GRM5;LRRTM3;ADGRB3;CTNNA2;PAK5;TMEM196;HCN1;GRIK3;PPM1E;GNG4
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.6660070154328093,1.1834628049265403,0.20754716981132076,0.8789256310382165,1.0,5/13,24.21%,ELP4;CTU1;DPH3;TRMT9B;MTO1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.7272345574876834,1.1834210033069075,0.32075471698113206,0.8785535247779384,1.0,2/7,4.82%,RUNX1;HCLS1
prerank,KEGG_2021_Human__Breast cancer,0.4843175086917744,1.1832055422160341,0.1320754716981132,0.8790093935032178,1.0,36/128,19.45%,IGF1;FGF10;MYC;FZD5;FGFR1;FGF2;WNT4;FRAT2;SP1;ESR1;WNT9A;FGF17;PIK3CA;PTEN;SOS1;FZD1;DLL3;FGF5;IGF1R;DVL2;LRP6;FZD4;FRAT1;FZD6;NCOA3;PIK3CD;NOTCH2;HEY2;CTNNB1;WNT2;CDK4;TP53;POLK;KIT;AKT3;JAG1
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.8110812722244869,1.1831898782841612,0.32727272727272727,0.8784786687250662,1.0,2/5,7.71%,HRH3;ADRA2C
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.5962396798845317,1.1831261462913423,0.2,0.8782267493385318,1.0,1/20,2.20%,SHMT2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.5079776668586377,1.1830496916912583,0.13333333333333333,0.8780386813440122,1.0,8/67,9.98%,LGALS9;SYK;F2R;MAPKAPK2;TLR2;PLCG2;HMGB1;C5AR2
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.6478413674469063,1.1827796422892505,0.2545454545454545,0.8787477016120806,1.0,1/13,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.4967744392300036,1.1825344683123704,0.17073170731707318,0.8794241024964404,1.0,30/153,15.60%,PLD6;SIRT1;SOX5;RAPGEF3;FGFR1;LLPH;FBXO5;BMP2;NLGN1;GRIP1;SOX6;RALA;NRXN1;APELA;ELAPOR2;AGR2;NEUROD2;PAXIP1;MCU;CORO1C;BMPR1A;ACVR1B;DVL2;RPS6KA1;FZD4;PHLDB2;NCOA3;PLCB1;FOXO6;COBL
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,0.49644467978086515,1.1825337335951132,0.18181818181818182,0.8788710055766312,1.0,13/71,10.39%,VEGFC;F2;PLOD2;GNG12;EVA1A;ADGRG6;C1ORF53;WWTR1;EPS8;IGFBP6;EXT1;AOX1;LOXL2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,0.5134842760077095,1.1824646507089658,0.18867924528301888,0.8785562571138726,1.0,20/83,13.44%,MXRA5;LAMA4;CFH;MRGPRF;PRRX1;ADGRL4;BGN;CXCL12;POSTN;ERG;CCDC80;PDGFRA;ABI3BP;CYBRD1;MEDAG;ITGA1;SYNPO2;CD34;SHROOM4;ABCA8
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.5448877833255114,-1.1822389206277357,0.21568627450980393,0.9265588225887255,1.0,12/52,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.5448877833255114,-1.1822389206277357,0.21568627450980393,0.9265588225887255,1.0,12/52,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.5448877833255114,-1.1822389206277357,0.21568627450980393,0.9265588225887255,1.0,12/52,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7165734234729227,1.1819348685320032,0.3392857142857143,0.8802527703773493,1.0,1/5,5.57%,RELA
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6774140908986912,-1.1818841422775872,0.24,0.9265807173584714,1.0,2/9,7.72%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5439426710724705,1.1816662069844992,0.2549019607843137,0.8809027925470603,1.0,6/29,16.87%,SEMA5A;SEMA6C;SEMA3E;SEMA6D;KIAA0319;DIP2B
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.654909281443681,-1.1815710100172416,0.3333333333333333,0.9265938328335184,1.0,2/13,5.43%,RNF8;RECQL5
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.5378568316817715,-1.1813411311548956,0.1346153846153846,0.924224726426095,1.0,12/58,8.78%,P2RY10;TBC1D10C;SELL;TRAF3IP3;CD53;CYTH4;KCNA3;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.5378568316817715,-1.1813411311548956,0.1346153846153846,0.924224726426095,1.0,12/58,8.78%,P2RY10;TBC1D10C;SELL;TRAF3IP3;CD53;CYTH4;KCNA3;LTB;CD5;TAGAP;TMC8;LY86
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.5378568316817715,-1.1813411311548956,0.1346153846153846,0.924224726426095,1.0,12/58,8.78%,P2RY10;TBC1D10C;SELL;TRAF3IP3;CD53;CYTH4;KCNA3;LTB;CD5;TAGAP;TMC8;LY86
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.6763611327089,-1.1813096595287693,0.2926829268292683,0.9232420310224462,1.0,1/17,0.84%,GUCY2C
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,0.6392833882740133,1.1811926926282483,0.2830188679245283,0.8820817589693595,1.0,8/17,19.69%,ABCA6;ABCG8;ABCD3;ABCD2;ABCG5;ABCA9;ABCA2;ABCA10
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.6168522016524869,1.181131309692327,0.2653061224489796,0.8817578849269232,1.0,5/20,14.62%,SYVN1;RNF185;RNF139;RNF5;DERL2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5953839786929676,1.1807950798250315,0.22641509433962265,0.8826979295280744,1.0,6/19,26.04%,JADE3;MSL2;HCFC1;KANSL3;OGT;MSL3
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5449944248711169,-1.1807626693500073,0.2127659574468085,0.9242218178594123,1.0,2/49,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.638909100735921,1.1804990791221646,0.3111111111111111,0.8831869522934557,1.0,4/15,11.28%,ADRA1A;APELA;NPPA;ATP1A2
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,0.537238130471509,1.1804877050026346,0.22448979591836735,0.8826815920231003,1.0,7/42,6.49%,TMEM171;HSD17B2;LGR5;GOLT1A;SLC38A4;DAPK2;CLDN2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6462833385024387,-1.1803790766465283,0.35555555555555557,0.9246708193058087,1.0,1/14,1.92%,KDM4D
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,-0.5445484967189489,-1.1801304494374825,0.20754716981132076,0.9245303965845804,1.0,9/53,2.73%,P2RY10;TBC1D10C;SELL;SP140;IRF4;TRAF3IP3;CD53;CYTH4;GPR132
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7388620892743468,1.1801272994051926,0.2549019607843137,0.8836981166489815,1.0,5/8,23.85%,TLR2;IL33;EDN1;FCER2;JAK2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6023734398942978,1.180001209494602,0.2413793103448276,0.8836026836526799,1.0,7/23,15.66%,SLC26A6;ZBTB20;LIN28A;UNC13B;IGF1R;SLC2A5;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7618960477539911,1.1799829928987233,0.25,0.8830980106711764,1.0,1/8,2.93%,NEDD4
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,0.6931122846035115,1.179786466917769,0.3333333333333333,0.8833098991690677,1.0,4/10,18.72%,DCC;DAPK2;MAGED1;CASP3
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.7703708134205407,-1.1797802539371731,0.3148148148148148,0.9247705427745186,1.0,2/5,6.88%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7845329567751415,1.1797218351472678,0.2698412698412698,0.8829790128447197,1.0,3/5,21.28%,TMEM39A;UBQLN4;PHF23
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.510476868273581,1.17969174958366,0.18,0.8825385331363498,1.0,29/120,14.31%,RUNX1;PBX3;TGFBR1;FZD5;WNT4;RORB;OLIG1;TENM3;TENM1;OLIG2;MANF;UGDH;FUT9;WNT9A;EPHA5;POU3F2;PAX6;NEUROD2;PTPRD;LHX6;NLGN4X;INSM2;EMX1;MEF2C;NR4A2;FZD1;MYT1L;LRP6;FZD4
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,0.4952503061280368,1.1795462095143974,0.1320754716981132,0.8814242986146326,1.0,8/85,6.08%,SGO1;TOP2A;NDC80;CDC25A;CCNA2;DLGAP5;SKA3;ASPM
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,0.4952503061280368,1.1795462095143974,0.1320754716981132,0.8814242986146326,1.0,8/85,6.08%,SGO1;TOP2A;NDC80;CDC25A;CCNA2;DLGAP5;SKA3;ASPM
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,0.4952503061280368,1.1795462095143974,0.1320754716981132,0.8814242986146326,1.0,8/85,6.08%,SGO1;TOP2A;NDC80;CDC25A;CCNA2;DLGAP5;SKA3;ASPM
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.48857278659877185,1.17951614682454,0.14634146341463414,0.8809545293993514,1.0,13/77,7.75%,SEMA5A;SIRT1;FGFR1;HIF1A;STAT5A;RIN2;FGF2;ANGPT1;RRAS;SP1;ANXA3;CD40;HMGB1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7526525588720158,-1.1793366487727808,0.23529411764705882,0.9254071429871966,1.0,2/9,14.60%,TICRR;CDC6
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.43830948584022617,1.1791713431554474,0.10416666666666667,0.8817151488263194,1.0,71/290,18.48%,MITF;LGALS9;IGF1;FGF10;ITGAX;ITGB8;MYC;TGFBR1;ZBTB7B;IL4;HIF1A;RAB27A;MYCN;FGF2;ANGPT1;CALCR;ACTG2;BMP2;SP1;RBPJ;ZNF804A;MOV10;TLR2;SCRIB;PLCG2;VSIR;TICAM1;F3;PAX6;AGR2;SNCA;RAMP3;SMAD1;RESF1;RIMS2;ANK2;MAGI2;FGF17;CTCFL;GSN;VAMP3;MEF2C;MAPK8;CD34;GREM1;ATF7IP;FGF5;RBMS3;MYOM1;CD74;PLSCR1;HCFC1;PRKAA1;NFE2L2;PIK3CD;TBC1D5;RAB29;UBR5;HEY2;IL33;CSF1;VEGFA;FAM98A;GABPA;TP53;FMR1;MAZ;AGO3;CITED2;AFDN;ARRB2
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.7764146020006937,1.1791466588873893,0.2727272727272727,0.8812927522374261,1.0,1/5,13.89%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6408920401519486,1.1790681789951845,0.25925925925925924,0.8810429954214386,1.0,2/18,2.71%,RUNX1;CD22
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.6408422540123782,-1.17889418602644,0.21052631578947367,0.9259042770381339,1.0,1/17,0.60%,HK2
prerank,Reactome_2022__Removal Of Aminoterminal Propeptides From Gamma-Carboxylated Proteins R-HSA-159782,0.7380042493975245,1.178851194955498,0.22413793103448276,0.8814112157624788,1.0,1/8,0.23%,PROZ
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4961822136794813,-1.1787712844348117,0.17391304347826086,0.9251947603501753,1.0,10/92,11.75%,ANKK1;FBXO43;PLK3;BUB1;SFRP1;ENTR1;PLK4;CAV2;IHO1;KIF20B
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5447597008982824,1.178710596573641,0.21428571428571427,0.8814351755935191,1.0,9/35,18.37%,EFNA5;EPHA3;BICD1;KLHL42;CDK2AP2;PHLDB2;PRKAA1;MACF1;PHLDB1
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.4677413907386063,1.178568034993809,0.1702127659574468,0.8804461832029825,1.0,35/98,20.92%,LRRC3B;LSAMP;SLC35F1;LRRC4C;CDH20;CADM2;ZDHHC22;NRXN1;MEGF10;RAB3C;LRRTM3;ADGRB3;CTNNA2;PAK5;RTN1;GRIK3;ATP1A2;NPAS3;JAKMIP2;ZNF536;GPM6B;UBE2QL1;SEZ6L;FAT3;CNTN2;SORCS1;PDZD4;STMN4;PLP1;RBFOX1;AMER2;ELAVL4;ATP1B2;ADGRL3;CADPS
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.4677413907386063,1.178568034993809,0.1702127659574468,0.8804461832029825,1.0,35/98,20.92%,LRRC3B;LSAMP;SLC35F1;LRRC4C;CDH20;CADM2;ZDHHC22;NRXN1;MEGF10;RAB3C;LRRTM3;ADGRB3;CTNNA2;PAK5;RTN1;GRIK3;ATP1A2;NPAS3;JAKMIP2;ZNF536;GPM6B;UBE2QL1;SEZ6L;FAT3;CNTN2;SORCS1;PDZD4;STMN4;PLP1;RBFOX1;AMER2;ELAVL4;ATP1B2;ADGRL3;CADPS
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.4677413907386063,1.178568034993809,0.1702127659574468,0.8804461832029825,1.0,35/98,20.92%,LRRC3B;LSAMP;SLC35F1;LRRC4C;CDH20;CADM2;ZDHHC22;NRXN1;MEGF10;RAB3C;LRRTM3;ADGRB3;CTNNA2;PAK5;RTN1;GRIK3;ATP1A2;NPAS3;JAKMIP2;ZNF536;GPM6B;UBE2QL1;SEZ6L;FAT3;CNTN2;SORCS1;PDZD4;STMN4;PLP1;RBFOX1;AMER2;ELAVL4;ATP1B2;ADGRL3;CADPS
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7314900937552075,1.178433244688735,0.3103448275862069,0.880486269362609,1.0,4/9,14.46%,SIRT1;LEPR;GCK;LRP2
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.4793502904261657,1.1784046422432293,0.1111111111111111,0.8801056686651844,1.0,24/97,12.41%,NXPH1;SLC35F1;ERBB4;CADM2;LRP1B;SLC17A6;PCLO;SYT1;ZDHHC22;MEGF10;POU3F2;PAX6;FGF12;STOX2;GRM5;LRRTM3;ADGRB3;PAK5;GRIK3;NOL4;PPM1E;NPAS3;CNTN1;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.6530319320619169,1.178316550230075,0.2692307692307692,0.879959081187477,1.0,6/15,28.90%,TELO2;GPR137B;RRAGD;PIP4P1;SIK3;PIH1D1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7336432778813999,1.1783155662817273,0.19607843137254902,0.8794158965694602,1.0,1/6,3.69%,RORB
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Lymph Node,0.8008489286132187,1.1780599548493904,0.38596491228070173,0.8798297272473589,1.0,2/5,12.47%,PROX1;CD34
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.5019796635425411,1.1779609577767622,0.18,0.8797302032370478,1.0,14/76,17.52%,MT4;MYC;COX19;SLC39A8;TF;ANKRD9;CYBRD1;SMAD4;SLC39A12;HJV;SLC30A10;MT1M;SLC30A1;FRRS1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.6141475343916956,1.1779334682407245,0.2,0.8792658195014996,1.0,4/21,4.30%,PIK3R6;GNB4;GNG12;PIK3R5
prerank,Reactome_2022__Androgen Biosynthesis R-HSA-193048,-0.7543033082440918,-1.177797859150007,0.34146341463414637,0.9277033636669118,1.0,3/6,14.42%,HSD3B2;HSD3B1;HSD17B12
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7834399360980437,1.1777000269354307,0.2777777777777778,0.8796556957242886,1.0,4/5,21.16%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6640492030918902,1.1775166740154943,0.35,0.8798356794340679,1.0,3/11,16.44%,MLC1;CRHBP;DYRK3
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6502897737124695,-1.1773655601942106,0.3333333333333333,0.9283247964679968,1.0,3/16,9.08%,WTIP;NEK8;WWC1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6224911929505413,1.1773454192334447,0.23076923076923078,0.8799456804699126,1.0,5/27,4.16%,TNFRSF18;RUNX1;IL4;ZBTB1;IL2RA
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,0.5079999946911093,1.1773025085416842,0.2037037037037037,0.8790117590325055,1.0,13/75,8.32%,MXRA5;CGNL1;TDRD10;PREX2;NYNRIN;ADGRL4;NDRG2;BGN;FREM1;CXCL12;ERG;PTPRD;RAMP3
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,0.5079999946911093,1.1773025085416842,0.2037037037037037,0.8790117590325055,1.0,13/75,8.32%,MXRA5;CGNL1;TDRD10;PREX2;NYNRIN;ADGRL4;NDRG2;BGN;FREM1;CXCL12;ERG;PTPRD;RAMP3
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.7761349071356588,1.1771809918225082,0.2608695652173913,0.8789054278375673,1.0,2/6,11.92%,FGFR3;MEF2C
prerank,CellMarker_Augmented_2021__Natural Killer cell:Kidney,0.7857085394127052,1.1770667183418972,0.32653061224489793,0.878814691576665,1.0,1/5,0.87%,KLRD1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6046513922050372,1.1769484553819252,0.2727272727272727,0.8786777016261589,1.0,6/19,16.66%,MYC;ZNF706;LOXL2;ZC3H13;NCOA3;CNOT2
prerank,Reactome_2022__Peptide Hormone Biosynthesis R-HSA-209952,-0.7891310490421526,-1.1768925096226837,0.3137254901960784,0.9288074683824852,1.0,1/5,1.28%,INHA
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.49218871593689334,1.1767946247432475,0.17647058823529413,0.8788188988211765,1.0,25/94,19.00%,RBM20;TGFBR1;ERBB4;KAT2B;BMP2;PCSK5;PDLIM5;PDLIM4;APELA;FGF12;TAB2;PIK3CA;MEF2C;PTEN;DVL2;BCOR;CRB2;FBN1;HEY2;NXN;FLRT3;KDM6A;CITED2;PDLIM7;HDAC9
prerank,Reactome_2022__FGFRL1 Modulation Of FGFR1 Signaling R-HSA-5658623,0.6754082097793127,1.1766340489611193,0.3157894736842105,0.8790062312555541,1.0,3/10,13.08%,FGF10;FGF17;FGF5
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.5571010129939898,-1.1764614967381906,0.24074074074074073,0.9291176013914607,1.0,9/40,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6461952800344879,1.1763114178227647,0.33962264150943394,0.8799029584385262,1.0,4/13,10.55%,PPP1R14D;PPP1R15B;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.7848728976176482,1.176289436535309,0.26785714285714285,0.8794495859504822,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.73928605474543,1.1761845741978307,0.2692307692307692,0.879250995593512,1.0,2/9,8.79%,ACADS;ACADM
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6609867077809195,1.1761739125509652,0.30434782608695654,0.8787369819249349,1.0,6/11,22.92%,IRS1;AKR1C1;DGAT2;AKR1C3;PID1;PDK4
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6598399130703185,1.1761602533699336,0.2972972972972973,0.8782620682121322,1.0,7/13,14.28%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7465018702588203,1.1760861292096352,0.2222222222222222,0.8779722885984677,1.0,1/6,4.04%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5268197826534847,-1.1759206181835793,0.19148936170212766,0.9299576436409057,1.0,8/38,10.10%,KCNMB2;STAC;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6349807059858179,1.1759198149156331,0.1956521739130435,0.8780517464734324,1.0,9/22,23.79%,ROBO2;TLR2;DLC1;CORO1C;PTEN;PHLDB2;IKBKB;ACE;SLIT1
prerank,Reactome_2022__Synthesis Of 15-Eicosatetraenoic Acid Derivatives R-HSA-2142770,-0.7929797580531981,-1.1756891093866735,0.3409090909090909,0.9296929009116549,1.0,2/6,14.16%,ALOX15;GPX2
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.48746634218981383,1.1756245661839173,0.16326530612244897,0.8786610552608308,1.0,4/81,3.21%,TNFSF14;TNFRSF18;TNFSF13B;SEM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.6487135666460051,1.1755689526159472,0.20833333333333334,0.8783869135472155,1.0,5/18,14.62%,SYVN1;RNF185;RNF139;RNF5;DERL2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.7174722258663169,1.1755368926836522,0.2641509433962264,0.8780363950125321,1.0,2/7,9.05%,SLC22A3;SLC29A2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6625678615925426,-1.1751057738699449,0.2765957446808511,0.9305985594771985,1.0,2/12,9.08%,WTIP;WWC1
prerank,KEGG_2021_Human__Nitrogen metabolism,0.6531358775847252,1.1750255149881113,0.29545454545454547,0.879602899621482,1.0,4/16,9.74%,CA8;GLUL;CA13;CA2
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.5407360153790254,-1.1749549199716416,0.24528301886792453,0.9288769003624856,1.0,7/61,5.06%,MPL;TBC1D10C;LILRB3;STK10;PRAM1;SLX4;FMNL1
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.5407360153790254,-1.1749549199716416,0.24528301886792453,0.9288769003624856,1.0,7/61,5.06%,MPL;TBC1D10C;LILRB3;STK10;PRAM1;SLX4;FMNL1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Brain,0.7690883540010621,1.1748670569612183,0.26666666666666666,0.879688786456718,1.0,1/7,3.01%,GFAP
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6888737929863017,-1.1748566542973662,0.3829787234042553,0.9281467616141398,1.0,3/9,17.78%,FLOT1;HTR2B;PDGFB
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.4578374225660038,1.1747805921930845,0.2,0.8795065714236555,1.0,34/128,12.41%,NXPH1;EPHA7;LSAMP;SOX5;SLC35F1;GRM3;LRRC4C;CADM2;SLC17A6;ROBO2;PCLO;ZDHHC22;FUT9;NRXN1;RAB3C;POU3F2;PAX6;EPHA3;NOVA1;OLFM3;LHX6;SYNPR;HIVEP2;ANK2;LRRTM3;ADGRB3;CTNNA2;PAK5;GRIK3;NOL4;NPAS3;ZNF536;PROX1;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6158760051237967,1.1745373289744174,0.25,0.879875552087771,1.0,1/21,0.81%,IRGM
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7066609530087442,1.1742127763501378,0.2830188679245283,0.8807411906047682,1.0,1/8,1.70%,ACE2
prerank,KEGG_2021_Human__p53 signaling pathway,0.5018122518525708,1.174140568038832,0.21311475409836064,0.8804822374519412,1.0,22/68,26.42%,IGF1;CCNG1;CDKN2A;TNFRSF10B;CHEK2;PTEN;CCND3;PERP;CDK4;TP53;GORAB;CASP3;TNFRSF10A;CDK6;GTSE1;CCNB2;MDM4;SERPINE1;SESN2;BID;CD82;GADD45G
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.4908092903790531,-1.1740545361486476,0.22,0.9302396600858065,1.0,14/70,18.74%,UVSSA;ERCC1;RFC3;PRPF19;GTF2H2;COPS7A;LIG1;XRCC1;RPA3;RFC2;RFC1;COPS7B;LIG3;COPS6
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.50923682008176,1.174018433422543,0.17647058823529413,0.8803992838914316,1.0,14/84,6.66%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7036582240403939,1.1739455539003578,0.23636363636363636,0.8801255837567334,1.0,2/7,7.41%,RIT2;ABCA1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.6423031669174253,-1.1739322267114818,0.3,0.9296793934134364,1.0,1/15,1.28%,INHA
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4875481276226175,1.1736266556599981,0.18867924528301888,0.8808821652844105,1.0,16/76,12.19%,C3;CCL5;FRMPD1;TULP3;CALCR;MRAP2;KCTD8;SAG;CNGA1;KLK14;RAMP3;KLK5;PDE6A;CAMKMT;GNG4;PDE6H
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6536302133313593,1.173491189911351,0.15254237288135594,0.8809744871950846,1.0,6/16,19.44%,PDGFRA;FER;PDGFC;BCAR1;RGS14;ABL1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,0.5017662014077171,1.1733762365333684,0.23529411764705882,0.8808914366360862,1.0,18/58,16.03%,SCGB3A2;PCDH11X;COL9A1;PRDM14;SYT6;LIN28A;NANOGP1;APELA;IGDCC3;CHST6;VASH2;CLDN6;GRM4;TERF1;POU2F1;L1TD1;VRTN;CALB1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7005242770195721,1.1731005770341698,0.28,0.8814786444607805,1.0,5/9,20.81%,SIRT1;KLF15;PRKAA1;DIP2B;DIP2A
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.6232909658374491,1.1730318441835104,0.2,0.8812507839277549,1.0,3/21,10.17%,FGF2;PRR5L;CORO1C
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6960343878995816,1.1729397689634113,0.2807017543859649,0.8811753232269267,1.0,2/6,20.02%,TENT4B;ELAVL4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.531604843060726,-1.1728579978436193,0.2549019607843137,0.9325963372860531,1.0,8/61,13.03%,EPN1;RHBDF1;MVP;PTPN3;CEACAM1;MMP9;WDR54;DAB2IP
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.4827188455048161,-1.1726718831401297,0.23076923076923078,0.9323563814734058,1.0,8/78,7.08%,EHF;CLDN4;GPR39;CLDN1;RHBDF1;DSG2;MYO5B;LAMB3
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.4256445463076543,1.1725852189927233,0.14893617021276595,0.882095770045519,1.0,70/288,16.07%,DERL3;SLC7A11;CD99;EMB;ITGAX;EGLN3;ANKRD36B;PPP1R14B;LY9;MDFIC;ARL6IP6;SLC12A3;BLNK;NPC2;DAPK2;CDCA7L;CRIM1;UBE2J1;IRF8;AHCY;SNRPN;MAPKAPK2;PPFIBP1;MAP2K6;LAIR1;PLAC8;MYO1E;VAMP1;LRRC36;GAB1;ANKRD36;STAMBPL1;CD40;ADA;CCDC50;ABHD15;LMAN1;KANK1;TMIGD2;TEX2;COBLL1;SERTAD2;UBA5;RNASET2;TCF4;TPM2;RNF5;CEP135;FCHSD2;FMNL3;GPM6B;MYB;SCN9A;MAGED1;PAPLN;CREB3L2;ZBTB33;TPST2;PCMTD1;DENND5B;PTK7;CD83;SGSM3;MGAT4A;TBC1D4;SEC61A1;S100PBP;ASPH;TNFRSF21;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6855465151392537,1.1725592461220555,0.2545454545454545,0.8816780228065908,1.0,5/7,30.85%,CPEB1;FMR1;CPEB2;CPEB4;CPEB3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6258341869383737,1.1725523136287774,0.20689655172413793,0.8811848539375636,1.0,9/20,19.73%,SP1;RELA;LRRTM3;RANBP9;PICALM;EFNA1;ABCA2;CASP3;LYN
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,0.6643747779897561,1.172476604735619,0.2962962962962963,0.8810413233465458,1.0,3/12,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7120725990920604,-1.1723015357846227,0.2549019607843137,0.9326667448085324,1.0,4/9,11.81%,IRF4;SLC11A1;GBP2;GBP6
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.4892023640109041,1.172265838227851,0.23214285714285715,0.8813302168492131,1.0,6/76,9.76%,CDC14A;CCNA2;SEM1;FBXO5;ANAPC16;PSMD13
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7983092144224391,-1.1721322765477113,0.2857142857142857,0.9322921087010605,1.0,1/5,7.65%,POLR3H
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5280343350470267,1.1720643410107194,0.2,0.8816187629153167,1.0,17/51,28.25%,SAMD4A;DCP1B;PATL2;CNOT6L;CNOT4;EXOSC4;CNOT8;CNOT2;EXOSC1;ZFP36;PAN3;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;RC3H1
prerank,KEGG_2021_Human__Thermogenesis,0.4631180079681575,1.171997075918752,0.24390243902439024,0.8814600818451565,1.0,33/183,19.23%,PRKG1;NDUFC2-KCTD14;FGFR1;PPARG;COX19;PRKAB2;ACTL6A;KDM3A;SMARCD3;RPS6KA2;CPT1C;NPPA;DPF1;ARID1A;SOS1;DPF3;CREB3L2;ARID1B;CREB1;RPS6KA1;SMARCD2;COX6A1;PRKAA1;SIRT6;NDUFAF6;COX10;SMARCA2;BMP8B;NDUFB11;ACSL4;KLB;PRKACB;MLST8
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,0.5032342946385046,1.1719178582810623,0.23529411764705882,0.8811956156708044,1.0,16/66,15.93%,EBF1;KLKB1;PDE1A;NKAIN2;ZFP36L2;B3GAT2;CACNB4;KLHL6;OXR1;STK32B;CD34;NPL;PLCXD2;TRPM2;COBL;PADI4
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.4975959014087475,1.1719150466325754,0.21568627450980393,0.8806818170299988,1.0,13/90,8.38%,MXRA5;LAMA4;PRRX1;GNG12;DOCK1;BGN;KANK2;LRIG3;POSTN;CCDC80;WWTR1;FAM114A1;PCDH18
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5356335951884788,1.1717910897323016,0.22,0.8806298321504296,1.0,5/35,7.72%,TVP23B;LTBP2;RAB3C;ABCA1;MTTP
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6178195214475849,1.1717333591351418,0.2727272727272727,0.8803436711487904,1.0,4/20,15.03%,TSHZ3;SLC24A2;GRIN2D;RGS14
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6475955638910261,1.171650675041974,0.23076923076923078,0.8802164356492077,1.0,3/19,7.17%,RENBP;UGDH;UAP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5432128231720339,-1.1713929025896006,0.1891891891891892,0.9337915419349327,1.0,2/25,1.10%,MYH7;SCN5A
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.5880748702407345,1.1713147124778556,0.2542372881355932,0.8810251842433301,1.0,9/27,21.01%,KAT2B;RBPJ;HDAC3;HDAC2;TBL1X;NOTCH2;HDAC9;HDAC1;NOTCH3
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5689468308894902,1.1710689563656165,0.2765957446808511,0.8814482966678261,1.0,9/32,11.53%,RAPGEF3;KSR1;ADGRG6;EPHA5;PDE7A;RIMS2;NUDT4;NPPA;HTR2C
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.7118649581059188,-1.171057997165984,0.40384615384615385,0.9338125717690782,1.0,2/5,9.36%,SCN5A;KCNA5
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.7343776586582702,-1.1708532218369987,0.38636363636363635,0.9324419344055132,1.0,1/5,2.19%,CTNNA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.7343776586582702,-1.1708532218369987,0.38636363636363635,0.9324419344055132,1.0,1/5,2.19%,CTNNA1
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.44818682359876066,1.1708510325497588,0.19230769230769232,0.8817578329406995,1.0,44/206,19.05%,PADI6;KAT2B;H2AC25;PADI2;HMG20B;PRMT1;H2BC21;JADE3;SMYD2;RELA;HDAC3;HDAC2;MSL2;ACTL6A;KDM3A;ARID2;SMARCD3;NCOA2;EZH2;TBL1X;PHF21A;ARID1A;H2AC6;ATF7IP;H2AZ2;SETD7;ARID1B;SMARCD2;PAX3;EPC1;KAT6A;H2AX;HCFC1;PADI4;SMARCA2;RUVBL2;CDK4;SUPT3H;KDM6A;EED;KMT5B;NSD1;KDM5B;BRWD1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.7796758276860638,1.170784031006772,0.25,0.881464319437072,1.0,3/5,11.63%,BMP2;SOX6;SMAD4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7582105180236716,1.1707010157730489,0.32727272727272727,0.8813367945284154,1.0,1/8,0.40%,PNP
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.640754991818132,1.1705241804468114,0.375,0.881585646964254,1.0,7/17,17.47%,NRG1;BMP2;SLC8A1;MYH11;MEF2C;MESP1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.7728329896860833,1.1704151571057846,0.3148148148148148,0.8815258819498029,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5763198609389111,-1.1701927987251979,0.32142857142857145,0.9339929393132775,1.0,6/26,6.18%,H1-3;H1-4;TERF2IP;H1-2;ERCC1;NIBAN2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.48050623435626916,1.1701455632310673,0.16279069767441862,0.8819171198767255,1.0,22/92,19.47%,GSTM2;ANGPT1;VCAN;BGN;SLC35B2;CHSY3;UGDH;MAT2A;HPGDS;DSEL;ST3GAL6;SLC35D2;CSGALNACT1;CHST6;CBS;CTH;BCAN;B4GALT3;MPST;GSTA4;PRELP;CHST15
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6972873207422248,1.1701262975992228,0.3137254901960784,0.8814591429640448,1.0,2/9,17.61%,ADRB1;CPS1
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.39571320322713643,1.1699770740624833,0.10256410256410256,0.881579717890097,1.0,189/836,18.74%,PCOLCE2;TEX101;DACH1;CXXC4;IRGM;MAP3K11;COL9A1;GABRR1;TSPAN12;EMB;PLD6;BOK;RAB38;RASEF;CA8;ERICH5;C19ORF38;NRG1;EFNA5;DBX2;NDRG2;TBC1D12;GNG12;NAALAD2;SPR;ZNF518A;CNTNAP2;NRIP1;CTSF;MLLT3;PELI2;CSRP2;ZGLP1;ADGRG6;ZBTB20;GLUL;ACVR2A;ODC1;ZFYVE16;RALGPS2;SMYD2;PENK;PELI1;TEX15;SYPL1;CACNB4;NRXN1;NFIA;BBX;EPS8;NBPF8;UBE2E2;ACSS2;ELAVL2;MED13L;NEO1;PAX6;CCDC106;UAP1;TSC22D1;SLC25A1;CEP85L;SSBP2;TOB1;INPP1;AGGF1;NBPF10;ADA;LHX6;CLGN;NPW;PTOV1;SMAD1;KLF6;ARRDC3;UBE2E3;DENND1B;SLC35F2;GPC4;LRRIQ1;RAP1GDS1;MTX2;SGCG;CTCFL;SMARCD3;GMPS;LTBP1;GPR161;OXR1;FBXO7;CADM1;TCF4;STK32B;RASAL2;JPH1;CNOT6L;PASD1;TOP1MT;CRACD;BANK1;PHF21A;ANKRD50;SMAD4;EGFL7;SSX2IP;GNG4;REV3L;PPP1R9A;BNIP3L;EYA2;NCK2;C6ORF62;CNTRL;SYCP2;ZNF800;PPP3CA;LZIC;CCDC82;ABHD10;MAN1A2;HSPB1;TANK;MXD4;MYT1L;MYOM1;ZBTB33;TASOR2;SPIN1;ZNF652;MLF1;PTPRM;MTMR3;BEND4;ECHDC1;ANGPTL4;SPAG6;RUNX1T1;DYRK1A;CSNK1G3;MFHAS1;CSMD3;IFT57;RICTOR;C9ORF43;ERRFI1;ZNF280B;MGAT4A;SLC25A31;PTBP2;NELL2;TBC1D4;RYR2;TAF2;COBL;TRPS1;HSF2;USP31;ASPH;PDZRN3;NDUFAF6;HEY2;GLCCI1;ELOVL4;KTN1;DGAT2;SMS;RAB28;STX8;FBXO11;AGMO;FKBP8;ARHGAP21;MXI1;ZMYM2;FMR1;FARP1;B4GALT3;TLE4;EFNA1;CD55;RHOD;ARHGAP20;RRAGD;MB21D2;RHOB;PHLPP1;MPDZ;IMPDH1;PER3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7631785313349659,1.1698593766659615,0.3137254901960784,0.881550107131187,1.0,2/5,11.19%,DSEL;CSGALNACT1
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.7731116715100793,1.169740992730547,0.2807017543859649,0.8814230622264957,1.0,4/5,20.11%,CALCR;RAMP3;CALCRL;IAPP
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.7550479166810317,1.169569424682204,0.3050847457627119,0.8815434435472923,1.0,3/6,12.35%,ZDHHC12;NRXN1;PTEN
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.787569262528766,1.1693970654171295,0.2222222222222222,0.8817086142190238,1.0,2/6,11.28%,TSHZ3;ATP1A2
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,0.6825623627876065,1.1693602879634277,0.2641509433962264,0.8814020786175182,1.0,3/14,6.53%,IDO1;IDO2;TDO2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4557465203069731,1.169114092875878,0.11627906976744186,0.8818812906574663,1.0,23/122,13.46%,PLEKHH2;NXPH1;SLC35F1;SLC1A3;GFAP;IFI44;SLC17A6;ZDHHC22;MEGF10;TMEM200C;POU3F2;STOX2;MAGEL2;NHLH1;PAK5;GRIK3;NPAS3;ZNF536;GPM6B;DLL3;IGF1R;MGAT5;ID4
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,0.49366097246066337,1.1690296859870661,0.18181818181818182,0.8816273441277723,1.0,19/80,14.24%,MXRA5;LAMA4;ITGA8;PRRX1;ADGRL4;BGN;CXCL12;POSTN;ERG;PDGFRA;ABI3BP;PCDH18;MEDAG;TCF4;SYNPO2;CD34;SHROOM4;ABCA8;RUNX1T1
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.5490292506128867,1.1689522305824485,0.22,0.8813886406171345,1.0,9/37,22.07%,PRKAB2;PPM1A;RRAGC;STRADA;CAB39L;PRKAA1;RRAGD;MLST8;AKT2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.6087427707569744,1.16867522847853,0.3275862068965517,0.8820760723982674,1.0,4/22,9.15%,INSIG1;MDFIC;RAB23;LMAN1
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.6266331798465234,1.168627769668876,0.2564102564102564,0.8816956053695183,1.0,11/16,34.15%,MAPKAPK2;EXOSC4;EXOSC1;ZFP36;EXOSC5;DIS3;EXOSC2;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5756604519466179,1.1684826880595174,0.2807017543859649,0.8817332206937488,1.0,12/23,26.28%,TGFBR1;ROBO2;BMPR1A;SMAD4;PROX1;HEY2;CITED2;BMPR2;BMP4;SMAD7;SLIT2;ZFPM2
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,-0.7531690690452866,-1.1683716848794317,0.30612244897959184,0.9400028908502118,1.0,1/9,0.24%,P2RY10
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.6109096167472602,1.168250288164807,0.2777777777777778,0.8821285502057239,1.0,3/32,4.40%,GATA4;WNT4;SIX4
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.5324952532691996,1.16811129670539,0.2222222222222222,0.882240354197187,1.0,8/60,13.39%,PREX2;NEDD4;SEM1;RNF146;FRK;PSMD13;PTEN;PSME4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5459616254719238,1.1680896453737237,0.16666666666666666,0.8818309110468426,1.0,13/54,12.02%,PNP;FGF10;CCL5;TNFSF13B;IL4;SASH3;IL15;CD40;CCDC88B;IL23R;HLA-E;MEF2C;NCK2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7301457154692004,1.1678907705040849,0.32786885245901637,0.8820990009722524,1.0,2/9,7.82%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7395705868126345,1.1678308745386425,0.25,0.8817942243706661,1.0,2/5,16.44%,ZFAND1;DYRK3
prerank,Reactome_2022__N-glycan Trimming And Elongation In cis-Golgi R-HSA-964739,0.7613869452521778,1.1677396068101005,0.2857142857142857,0.8816012771640486,1.0,2/5,12.90%,MANEA;MAN1A2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6153685900204688,1.167737157441108,0.2631578947368421,0.8810817714026085,1.0,7/19,17.81%,SIRT1;DYRK2;PML;PHLDA3;HIPK1;BCL3;TP53
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.5212307076124895,1.1676314880210756,0.23636363636363636,0.8809711194185279,1.0,13/49,18.16%,CDC25A;CDKN2A;H2BC21;FOXO3;EZH2;H2AC6;TANK;H2AZ2;LMNB1;H2AX;FADD;TP53;EED
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6053332998043508,1.1675651531856055,0.2549019607843137,0.8806454695784645,1.0,8/23,17.05%,SIRT1;ABHD17B;HDAC3;ABHD17C;ABHD10;LYPLA1;SIRT6;SIRT7
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7195467406750213,1.1675429528686023,0.3333333333333333,0.8802015813025021,1.0,2/9,9.37%,INSL5;LEPR
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.648154372488702,1.167472728689159,0.3,0.8799212236894004,1.0,3/10,12.35%,RELA;FUT9;IRAK1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.4379490153752794,1.1673688168143734,0.14,0.879737462278297,1.0,23/201,9.39%,PCOLCE2;CARNS1;FSTL5;CCDC74B;FAIM;NRG1;EFNA5;ASIC1;CLSTN2;CYB561;PCLO;STOM;H2BC21;ABHD3;MEIG1;GADL1;CNPPD1;FGF12;CLGN;SPEF2;MANEA;LRRIQ1;AK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.480683169887239,1.1673291089490556,0.17391304347826086,0.8793466946438132,1.0,20/108,16.06%,FGFR3;TNFRSF19;LRP4;GFAP;SLC38A3;DOCK1;ARHGEF17;LIFR;ALCAM;PLXNB1;FAM43B;BCAR1;ID4;SLC19A1;PTPRU;KAZN;GPR37;CPE;GPRC5B;TNFRSF21
prerank,Reactome_2022__RUNX1 Regulates Expression Of Components Of Tight Junctions R-HSA-8935964,0.837968688276788,1.1671859870857442,0.3148148148148148,0.8793410007285606,1.0,1/5,1.44%,RUNX1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6968216808206756,1.1670842406431208,0.29310344827586204,0.8791948634860295,1.0,5/10,17.42%,SMAD1;SMAD2;MRPL44;HNRNPA2B1;PUS10
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.7094884479151663,1.1670433079195952,0.24,0.8788124888420146,1.0,4/11,23.62%,ASF1A;ASF1B;H3-3A;RBBP4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7022259872902478,1.1670291636956385,0.3673469387755102,0.878349344314462,1.0,7/8,29.80%,MAPKAPK2;CX3CR1;ZFP36;SIRPA;CD47;FOXP1;CD274
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),0.695231065376284,1.1668836140105563,0.2553191489361702,0.8779335427550965,1.0,4/5,30.06%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),0.695231065376284,1.1668836140105563,0.2553191489361702,0.8779335427550965,1.0,4/5,30.06%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),-0.7319402394680721,-1.1668472517608945,0.36363636363636365,0.9444236110751407,1.0,1/5,3.86%,IL6R
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.5582396397332341,-1.1668165599506994,0.17073170731707318,0.9434110776741768,1.0,3/51,2.40%,ALB;MAFK;NLRP3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7642595362396297,-1.1667570089094597,0.3181818181818182,0.9425513704938305,1.0,4/7,14.04%,OVGP1;CHI3L1;AMDHD2;CHIT1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7060956255136547,-1.1666437356980703,0.3902439024390244,0.9418439545531664,1.0,1/5,7.50%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.5510709037092832,1.1666094092249837,0.25,0.8783635542070902,1.0,6/20,21.16%,RPS6KA4;PAXIP1;SMAD4;RPS6KA5;RUVBL2;MAPK3
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,-0.5110012653865795,-1.166429886972749,0.24074074074074073,0.9414967831495316,1.0,6/53,5.49%,RFX6;TMEM179;INSRR;CLCA1;FAM163A;VGF
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,-0.6926580826851743,-1.1660750336496177,0.24489795918367346,0.9418001384603056,1.0,2/8,16.57%,GNAL;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.741813363628213,1.1660576579909012,0.32,0.8801705393384368,1.0,1/6,4.97%,LIN28A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.62496342465191,-1.1660164784719105,0.30434782608695654,0.9409296630284568,1.0,2/12,10.52%,PARP2;PARP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.8124699074991308,1.1659499932906892,0.3023255813953488,0.8800097913143631,1.0,2/6,17.85%,EIF3E;FMR1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6993135104485915,1.1658262462470967,0.32727272727272727,0.8799669523018225,1.0,2/7,10.93%,TOP2A;LIG4
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7254762872230432,-1.1658118196609486,0.35294117647058826,0.9405598320538515,1.0,2/6,7.64%,RFTN1;FLOT1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7936706546598029,-1.1657755096555131,0.35,0.9395766048907709,1.0,2/5,17.91%,SSU72;CTDP1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.47485944265972463,1.1656677413050875,0.18604651162790697,0.8800712290879459,1.0,14/125,9.65%,CTDNEP1;FAM83H;TULP3;EHD1;SIX4;CNTLN;TOR1B;BANP;BICD1;WASHC2A;AUP1;ANK2;BBS9;TULP1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.70520612332731,-1.1656339911140294,0.3023255813953488,0.9389604654070989,1.0,4/10,13.62%,PDXDC1;ENPP2;FUCA1;CYP1B1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6707804933645638,-1.165568535821929,0.3125,0.9382132478738296,1.0,2/12,11.67%,AGBL1;FOLH1B
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.5322183658258116,1.1654718179117773,0.23809523809523808,0.880285619312607,1.0,12/45,20.74%,RUNX1;KAT2B;PRMT1;H2BC21;MOV10;H2AC6;H2AZ2;H2AX;AGO3;HDAC1;KMT2C;GP1BA
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7447131215538131,1.1654432567482886,0.32142857142857145,0.8798974926001591,1.0,2/6,7.82%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7176380981817491,1.1653198342953999,0.37254901960784315,0.8798401379060088,1.0,3/9,11.43%,NEDD4;ATP1A2;HECW2
prerank,CellMarker_Augmented_2021__B cell:Brain,-0.5751014525861183,-1.1652770878155876,0.24489795918367346,0.9360232016995901,1.0,13/40,9.27%,P2RY10;TBC1D10C;SELL;SP140;IRF4;TRAF3IP3;CD53;CD86;LTB;JCHAIN;TAGAP;LY86;PAX5
prerank,CellMarker_Augmented_2021__B cell:Synovium,-0.5751014525861183,-1.1652770878155876,0.24489795918367346,0.9360232016995901,1.0,13/40,9.27%,P2RY10;TBC1D10C;SELL;SP140;IRF4;TRAF3IP3;CD53;CD86;LTB;JCHAIN;TAGAP;LY86;PAX5
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,-0.5751014525861183,-1.1652770878155876,0.24489795918367346,0.9360232016995901,1.0,13/40,9.27%,P2RY10;TBC1D10C;SELL;SP140;IRF4;TRAF3IP3;CD53;CD86;LTB;JCHAIN;TAGAP;LY86;PAX5
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.7716460716966024,1.1652679527605165,0.3137254901960784,0.8795554287112858,1.0,4/5,21.89%,SIRT1;CD74;ANXA1;PIBF1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5878286734403001,1.1649931002783271,0.22448979591836735,0.8800482324095708,1.0,7/15,19.45%,SNAI1;BMP2;RBPJ;BMPR1A;NOTCH2;HEY2;JAG1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.726640164909469,-1.1649486543023815,0.4117647058823529,0.9362390406859425,1.0,1/6,10.00%,DHX58
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.47812334932112616,1.1648138236512926,0.20930232558139536,0.8801960640209506,1.0,16/71,23.14%,RBM20;HNRNPH1;AFF2;KHDRBS2;FASTK;QKI;KHDRBS3;DYRK1A;PTBP2;RBM12B;FUS;RRP1B;MBNL2;SRSF3;HSPA1A;HNRNPF
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.48197616315878694,1.164605311298249,0.2222222222222222,0.8804975148523809,1.0,12/88,12.40%,NEDD4;GFAP;SEC22B;ODC1;ASB5;BANP;CHMP6;ZDHHC2;FOXO1;CHEK2;HECW2;TIPARP
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5798618615257667,1.1645866443490451,0.32075471698113206,0.880037426156363,1.0,4/23,14.62%,SYVN1;AUP1;LMAN1;DERL2
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.8251972768415445,-1.1645560186323616,0.2978723404255319,0.9365120200023564,1.0,1/5,3.41%,ALOX5
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,-0.7263002318312082,-1.1643762278732233,0.2765957446808511,0.9361181949971107,1.0,3/8,7.15%,RNASE1;DOCK2;HCK
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.49223920150447986,-1.164365245245209,0.23529411764705882,0.9350927222045564,1.0,7/57,3.88%,KLRC1;SELP;SELE;SELL;CD86;IL6R;CD200R1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.47817424483746157,1.164238027019469,0.21739130434782608,0.8809676989146695,1.0,17/99,11.92%,SMAD6;SIRT1;SOX5;TGFBR1;WNT4;ZFP36L2;LTBP2;SOX6;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5774975155942178,1.1641543084483965,0.18,0.8808368499491165,1.0,10/31,27.74%,ACD;NEK7;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.7441999675032006,1.163938219564276,0.24561403508771928,0.8811372302940229,1.0,1/5,0.49%,PCDH15
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6729560020022477,1.1639032751591407,0.33962264150943394,0.8807508588864089,1.0,2/9,4.63%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7635356852835874,1.16376524817538,0.33962264150943394,0.8807809174297723,1.0,2/7,15.01%,SPSB4;MARCHF7
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.6300252519382793,1.1637301924557801,0.2653061224489796,0.8803514371190413,1.0,8/14,30.72%,REXO2;PPP3CC;AKT3;BAD;AKT2;BID;YWHAH;YWHAZ
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.558067886037392,-1.1636916456850754,0.23404255319148937,0.9365312638382637,1.0,7/29,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6493339341770847,-1.1635499449142237,0.29508196721311475,0.9360650048606884,1.0,2/15,3.18%,PDXDC1;ENPP2
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,0.7064832396527585,1.1634626193591324,0.3170731707317073,0.8804556234153288,1.0,5/9,19.24%,TNFRSF10B;FASN;TANK;FADD;TNFRSF10A
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,0.7064832396527585,1.1634626193591324,0.3170731707317073,0.8804556234153288,1.0,5/9,19.24%,TNFRSF10B;FASN;TANK;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6864219588526588,-1.1634170048915713,0.2553191489361702,0.9355179451929735,1.0,3/12,13.11%,KCNE2;KCNQ1;CAV1
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.46343023176413506,1.1634041302643792,0.1509433962264151,0.8801654157769189,1.0,15/65,14.66%,SIRT1;HIF1A;NFIL3;NRIP1;RORA;FBXL3;HDAC3;PPP1CC;SMARCD3;NCOA2;TBL1X;MEF2C;CREB1;CHD9;KLF15
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.4794034971252949,1.1631227300012137,0.2,0.880697829639824,1.0,19/71,19.33%,VAPB;STOM;ARHGEF17;ARHGAP5;CAVIN1;DLC1;ERBIN;LMAN1;ABCD3;VAMP3;ANLN;FMNL3;RACGAP1;PKN2;ARHGAP21;VAV2;ARHGEF40;STX5;MCF2
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.6074903341013703,1.1630966496763242,0.3157894736842105,0.8802332730389157,1.0,7/18,26.08%,PRSS3;TCN2;LRP2;ABCD4;LMBRD1;MMAB;MTR
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.5509714675594799,1.1630356260713748,0.22413793103448276,0.8799727696297263,1.0,3/33,3.41%,PNP;SIRT1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.4070761558718218,1.1629231919016745,0.11363636363636363,0.8798360594122205,1.0,104/486,18.54%,VEGFC;IGF1;FGF10;FLT1;TNFRSF18;IRS1;TCIRG1;FGFR3;ITGAX;MYC;CCL5;SIRT1;TGFBR1;F2R;FGFR1;ERBB4;IL4;RAB27A;SLFN11;FGF2;NRG1;CALCR;MYRF;CDKN2AIP;FBXO5;MLC1;PRMT1;CDCA7L;IL7R;HCLS1;LGI1;CXCL12;RELA;PTGFR;TLR2;ITGAV;WWTR1;PDGFRA;POU3F2;FER;IL15;DPP4;HDAC2;LIFR;PDGFC;RAMP3;FGF17;TULP1;EZH2;FLT3;EFNB2;CNOT6L;SINHCAF;HAS2;GDF9;MVD;EXOSC4;FRMD5;MAPK8;PROX1;PTEN;SMC5;PPP3CA;FASN;GREM1;FGF5;IGF1R;MLXIPL;DVL2;ZNF639;ACACA;SERTAD1;RPS6KA1;LRP6;DERL2;ACACB;BAMBI;MARCHF7;HCFC1;RYR2;SLC44A4;PRKAA1;PHIP;CNOT8;GAB2;PRLR;CSF1;VEGFA;WNT2;FAM98A;CDK4;AKR1C3;RHOG;FMR1;MAZ;CD81;NOXO1;CITED2;RHOD;IRS2;IER5;CAPN10;IL2RB;H3-3A
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,-0.7364912193138032,-1.1629027892436485,0.32608695652173914,0.9362478116156304,1.0,2/9,2.40%,SLCO2A1;NLRP3
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7197537557144534,-1.1628941523495513,0.35,0.9351953717213515,1.0,1/6,8.95%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.5830552321444553,1.1628140599620742,0.24615384615384617,0.8796632061764045,1.0,6/22,15.49%,MYBPH;SCN10A;ANK2;ATP1A2;DMD;RYR2
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,0.7206903000939184,1.1627145791609637,0.26785714285714285,0.8795050638136803,1.0,6/7,27.50%,PLCG2;EPX;IRS2;LYN;JAK2;EPOR
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.4613903615195303,1.1626254733953079,0.16,0.8793906139279357,1.0,15/92,15.21%,RAPGEF3;KCNC2;GNB4;GNG12;ADIPOR2;PRKAB2;ADRA2C;GNG4;FASN;RAP1A;KCNG2;MLXIPL;ACACA;ACACB;PLCB1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5709022785505399,1.1626242473027208,0.28,0.8789066691356442,1.0,7/31,14.94%,UNC5C;EPHA7;SEMA6C;ITGAV;SEMA3E;SEMA6D;LGR6
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7542248982989754,-1.1626181492507701,0.3508771929824561,0.9351978118982907,1.0,3/7,15.90%,ALOX5;ALOX15;LTC4S
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.6135510065829548,1.1625975700255535,0.24074074074074073,0.8784594976708272,1.0,6/12,23.85%,PIK3R5;PIK3CA;EPX;IRS2;LYN;JAK2
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.5983522352805034,1.162467823886653,0.2727272727272727,0.8785268268872692,1.0,7/18,25.06%,REXO2;PRMT1;E2F4;TP53;CDC25C;EP300;RBL2
prerank,KEGG_2021_Human__Apelin signaling pathway,0.46011771268380836,1.1624057314467797,0.19230769230769232,0.8782178537267109,1.0,30/112,22.07%,TGFBR1;PIK3R6;RRAS;GNB4;GNG12;PIK3R5;SLC8A1;PRKAB2;GNAI3;SMAD2;SMAD4;GNG4;MEF2C;PLCB1;RYR2;PRKAA1;RRAS2;RYR3;GNA13;PRKACB;CCN2;AKT3;JAG1;NOTCH3;NRF1;MAPK3;GNAQ;CAMK4;GNAI1;AKT2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5886408235456242,-1.162291695407162,0.32142857142857145,0.9353224885232386,1.0,4/24,10.93%,ERCC1;XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6809700731405206,1.1621270837902977,0.3137254901960784,0.8787552558567431,1.0,1/9,0.68%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.7605829121998137,1.1621245423820639,0.33962264150943394,0.8782586092307038,1.0,4/6,21.61%,PLCG2;TICAM1;KIT;CAMK4
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.4699386722558868,1.162105634472307,0.1896551724137931,0.8778203130995679,1.0,22/119,10.01%,GATA4;MXRA5;IGF1;MRGPRF;ESRRG;SLC22A3;ADGRL4;ALDH1A1;MAFB;INSL3;BGN;CXCL12;NR5A2;EFS;POSTN;PDGFRA;FAM114A1;LIFR;PLSCR4;PRICKLE2;TAC1;MEDAG
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5579505495644785,1.1620934780798398,0.25,0.8773825190258556,1.0,6/25,24.84%,FAIM;TNFRSF10B;FADD;TNFRSF10A;SERPINE1;ARHGEF2
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.45420146332600175,1.1620040345648952,0.17647058823529413,0.8772482305445914,1.0,29/95,18.00%,SCN7A;ITGA10;FGFR1;ITGA2;LLGL1;SPTBN5;ITGAV;RPS6KA4;CNTN6;SCN10A;ALCAM;ANK2;SCN3A;RPS6KA2;SCN2B;ITGA1;RANBP9;CNTN1;ANK1;SCN9A;HSPA8;RPS6KA1;L1CAM;DNM3;CNTN2;RPS6KA5;KCNQ3;NUMB;VAV2
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.6047159179295701,1.1618788929085142,0.3333333333333333,0.8771789880801238,1.0,5/22,14.80%,LIN28A;VSIR;SMAD2;ACVR1B;L1TD1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7422707157866141,1.161549077009698,0.32142857142857145,0.8781114783492644,1.0,2/6,14.46%,NLGN1;LRP2
prerank,Reactome_2022__Interaction With Cumulus Cells And Zona Pellucida R-HSA-2534343,-0.7295136433460234,-1.1614751165978041,0.37209302325581395,0.937123761805952,1.0,2/5,5.48%,OVGP1;ZP3
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7572303079557932,-1.161402951910487,0.3617021276595745,0.9362377292431063,1.0,3/5,20.56%,PRKCD;PRKCH;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6595856945785171,1.1609284591198858,0.34782608695652173,0.8798423274551902,1.0,4/11,11.03%,EPS8L2;NLGN1;EPS8;DEF8
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7303119571840455,1.1609150343922907,0.37735849056603776,0.8793974308206378,1.0,2/5,13.67%,ABCC2;SLC19A1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6516750925402179,1.1607907432635391,0.2982456140350877,0.8793343135328974,1.0,5/11,20.31%,VCAN;BGN;BCAN;HEXB;CSPG4
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5785835578664016,1.1603660154657698,0.29508196721311475,0.8804935168624413,1.0,6/25,13.39%,SMYD1;SMYD2;METTL21C;METTL18;ATPSCKMT;SETD7
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.5579301669099773,-1.160328451518995,0.25925925925925924,0.9378951699534305,1.0,10/46,8.11%,P2RY10;TBC1D10C;SIRPG;TRAF3IP3;CD53;CYTH4;LTB;CD5;TAGAP;TNFRSF4
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.5579301669099773,-1.160328451518995,0.25925925925925924,0.9378951699534305,1.0,10/46,8.11%,P2RY10;TBC1D10C;SIRPG;TRAF3IP3;CD53;CYTH4;LTB;CD5;TAGAP;TNFRSF4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6059365643688412,-1.160315458276893,0.2711864406779661,0.9358379884115785,1.0,4/18,14.15%,ERCC1;PARP1;GTF2H2;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6059365643688412,-1.160315458276893,0.2711864406779661,0.9358379884115785,1.0,4/18,14.15%,ERCC1;PARP1;GTF2H2;RPA3
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,0.6987630017928503,1.1599701181514472,0.3114754098360656,0.8815076864362587,1.0,2/8,15.16%,STAT5A;IL21R
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,-0.6532687176347984,-1.1598851000764128,0.3023255813953488,0.9363409509082292,1.0,4/13,15.81%,ARSL;SUMF1;ARSI;ARSG
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6323478083721736,-1.1598597872462575,0.3404255319148936,0.9353406638584412,1.0,4/15,11.23%,RFTN1;NAXE;FLOT1;MYADM
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.4391354329453301,-1.1598430603750405,0.16666666666666666,0.9343668325814161,1.0,32/251,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;LOXL4;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;FLOT1;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;CREB3L1;SPARC;COL26A1;COL1A1;MMP9;VIT;ACAN
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7483283744811907,-1.1597148861452233,0.35,0.9337336177585916,1.0,2/7,8.13%,SLC6A6;OLFM4
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5573057905134872,1.1595265740209975,0.3442622950819672,0.8826643303472484,1.0,2/34,1.62%,IGF1;HGF
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.5689518833625374,1.1593988035182323,0.32,0.8826425609011308,1.0,19/46,25.19%,MYC;WWTR1;UBE2D3;PPM1A;SMAD2;E2F4;DAND5;SMAD4;TGIF1;HDAC1;UBE2D1;CDK8;MAPK3;SKIL;FURIN;USP9X;SERPINE1;EP300;SMAD7
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.6865537821605782,1.1591432879843582,0.2826086956521739,0.8832018559299579,1.0,1/8,1.52%,MME
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6007612810730214,-1.159087024314306,0.22,0.9350415473329003,1.0,3/25,9.57%,HK2;ENO2;GAPDHS
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,0.7091802893049508,1.158990888801048,0.32,0.8833805444670877,1.0,1/7,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5835381371257319,1.1589828007464247,0.21428571428571427,0.8829284945727401,1.0,8/19,21.16%,RPS6KA4;PAXIP1;PRKAA1;RPS6KA5;DIP2B;RUVBL2;DIP2A;MAPK3
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.4882107970941648,1.1588164620708747,0.21818181818181817,0.8830784909644757,1.0,12/74,9.05%,VAPB;DRD5;CCL5;TMTC2;CXCL12;SLC8A1;FAM20A;SLC24A2;CD40;CASR;SNCA;ANK2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6957795591478031,1.158796561710362,0.2857142857142857,0.8826485971027371,1.0,1/12,0.40%,PNP
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.47229597201681456,1.1585957809834577,0.14545454545454545,0.8827985820896408,1.0,19/87,14.82%,CRX;SV2C;CDH7;AANAT;SAG;GABRG3;CNGA1;RCVRN;SLC24A2;RGR;SLC2A11;PDE6A;HCN1;PDE6H;MYT1L;MGAT4C;ADRB1;RP1L1;TMEM145
prerank,KEGG_2021_Human__Phosphonate and phosphinate metabolism,0.7642581815808058,1.1584325958663033,0.35714285714285715,0.8829055034292166,1.0,4/6,11.29%,CHPT1;PCYT1B;CEPT1;SELENOI
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.6067377825904201,-1.1584175344897174,0.2857142857142857,0.9364349731927174,1.0,6/17,21.15%,KIF2B;STMN1;STMN3;KATNB1;KIF18B;KIF24
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.6715963952530972,-1.1583487805102595,0.3541666666666667,0.9356489885536152,1.0,3/6,20.56%,PRKCD;PRKCH;PRKCA
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7213073614356521,1.1581918063066807,0.3673469387755102,0.8834767197008772,1.0,1/7,3.23%,MYRF
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6222307242306053,1.1581588875259723,0.23255813953488372,0.883097560188725,1.0,4/21,14.98%,CBLB;CHMP6;NCK2;ERRFI1
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.6355431166409848,1.158052989045804,0.23529411764705882,0.8830399848334336,1.0,8/17,23.24%,MAPKAPK2;MAP2K6;TAB2;MAPKAPK3;IRAK1;TAB3;RIPK2;TAB1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.64892484086418,-1.1577756592361823,0.32075471698113206,0.9367337898469951,1.0,1/13,0.37%,ACTC1
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7482180067205015,1.157768044573868,0.29310344827586204,0.8836030224575199,1.0,2/5,8.14%,PNP;ADA
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.466592362564514,1.15772015131308,0.17647058823529413,0.8832458209747301,1.0,24/97,16.15%,LAMA4;MRGPRF;PRRX1;PRKG1;EDIL3;SLC1A3;OLIG2;BGN;EFS;PDGFRA;CNRIP1;PCDH18;ANK2;TNC;COL5A3;BAALC;HTRA1;ID4;COL11A1;RUNX1T1;SEMA6D;FBN1;GAS1;PDZRN3
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.505059349368184,-1.15735417868429,0.1956521739130435,0.9371030421362235,1.0,7/55,3.88%,KLRC1;SELP;SELE;SELL;CD86;IL6R;CD200R1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.651500899135981,1.1573511902354294,0.2962962962962963,0.8840218457610203,1.0,2/14,8.93%,IL4;PAXIP1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5903612950160912,-1.1572903145499258,0.2727272727272727,0.9363829766714876,1.0,6/23,15.19%,ABCA4;RFT1;ABCB1;ABCB4;ATP9B;ATP8B4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.700947850932107,1.1571960951750042,0.3404255319148936,0.8841418944266074,1.0,6/13,15.29%,TGFBR1;GDF6;ACVR2A;SMAD2;ACVR1B;HJV
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.5094491917604704,-1.1571905740397674,0.28888888888888886,0.9358004297283861,1.0,5/62,2.64%,SELP;SELE;SELL;TEK;TIE1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6537648112511425,1.156972199908853,0.26785714285714285,0.8843756734950047,1.0,1/12,2.87%,PPARG
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7304602328752714,1.156632967841922,0.3508771929824561,0.8851497468552909,1.0,1/5,14.88%,PLSCR1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.5008498987367542,1.156285131901989,0.26,0.885594064293438,1.0,18/89,10.38%,VEGFC;MRGPRF;PRRX1;ADGRL4;BGN;CRIM1;CD59;LTBP2;POSTN;CCDC80;MYOF;FAM114A1;PLSCR4;ALCAM;IGFBP6;MEDAG;TNC;AOX1
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.5008498987367542,1.156285131901989,0.26,0.885594064293438,1.0,18/89,10.38%,VEGFC;MRGPRF;PRRX1;ADGRL4;BGN;CRIM1;CD59;LTBP2;POSTN;CCDC80;MYOF;FAM114A1;PLSCR4;ALCAM;IGFBP6;MEDAG;TNC;AOX1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6925573444971126,1.1562349996894385,0.32,0.8852868538804248,1.0,3/11,7.56%,VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5676213278894114,1.1559460828711292,0.23809523809523808,0.8857251311506734,1.0,10/25,28.64%,KAT2B;KAT6A;RUVBL2;ATAT1;NAA50;CPA4;EP300;MSL3;KAT6B;PHF20L1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,-0.49068628505819917,-1.1557721223455926,0.22413793103448276,0.9398509181868939,1.0,33/95,27.02%,CA11;ENO2;CELF3;INA;MAGEE1;USP11;STMN3;TUBB4A;ADGRB2;FBXL16;CCDC184;KIF1A;RAB3A;CACNB1;SV2A;CCDC136;BRSK2;GNG3;SALL2;TMEM151A;TCEAL2;NEFL;SLC22A17;TMEM59L;STX1B;CLIP3;CHN1;NLGN2;TUBG2;SNCB;STXBP1;TTC9B;PRRT1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6174863788177849,1.155618343266534,0.37037037037037035,0.8863260448117364,1.0,6/14,20.58%,ASPH;FADD;PERP;LGMN;RIPK2;BAD
prerank,PanglaoDB_Augmented_2021__Podocytes,0.4476291757280746,1.155600875002445,0.17307692307692307,0.8858842575651347,1.0,35/168,15.80%,DACH1;PLEKHH2;ARHGAP24;PLOD2;GNG12;MAFB;DOCK1;LRIG3;ARHGEF17;WWTR1;MYO1E;UNC13B;ADGRL2;DPP4;LIFR;TOB1;PLSCR4;PRICKLE2;NPHS2;KANK1;BCAM;MAGI2;MAGI1;LOXL2;RASAL2;QKI;BCAR1;HTRA1;SEMA3E;NR2F2;FZD4;EMC2;CRB2;CPE;DST
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5997264020110591,1.1555748478370684,0.24074074074074073,0.8855138131937077,1.0,5/18,10.93%,TGFBR1;BMP2;CHD7;FUT8;LIG4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.48418619730665496,1.1553968858306547,0.1896551724137931,0.8857385588517531,1.0,14/85,15.14%,SMAD6;IL17RD;SIRT1;TGFBR1;ZEB2;PPM1A;LATS1;SMAD2;DAND5;SMAD4;FAM89B;NREP;BAMBI;VASN
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.4815092460760538,-1.155367211784136,0.2127659574468085,0.9402549330436494,1.0,18/73,19.68%,KIF2B;ARF3;KIF12;KDELR1;COPG2;KIF15;KIF26A;KIF20B;COPG1;KIF22;PTGES2;ARFGAP3;KIF4A;KIF1A;KIF26B;KIF1C;KIF18B;NAPG
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.4717571894769409,1.1551355347531629,0.19230769230769232,0.8862178120618909,1.0,28/140,15.33%,GATA4;ADRA1A;IRS4;IRS1;PRKG1;PIK3R6;PIK3R5;SLC8A1;CNGA1;PPP1CC;ADRA2C;GNAI3;GUCY1A2;NPPA;ATP1A2;MEF2C;NPR2;PPP3CA;KNG1;CREB3L2;PPP3CC;CREB1;ADORA1;NFATC3;ADRB1;SLC25A31;PLCB1;PPIF
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6780126973428293,1.1550389962667047,0.2903225806451613,0.8860529122695331,1.0,3/10,20.95%,PSMD13;PSMG2;PSMD4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5669360419112327,1.1549352274697129,0.2727272727272727,0.8859588847149917,1.0,6/39,10.84%,F2;GSTM2;F2R;SNCA;ANK2;JPH1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.646080080669522,1.154915166358569,0.288135593220339,0.8855046595779686,1.0,3/11,10.94%,ALDH9A1;ACADM;CPT1C
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.47740698333941023,1.1548991044176198,0.19148936170212766,0.8850580041834205,1.0,22/66,28.99%,VAPB;TOR1B;LMAN1;UBE2J2;LMAN2L;SEC61A1;REEP6;TOR1AIP2;STX5;STX18;TMCC1;MAPK15;EIF2AK3;BNIP1;TMEM33;LPCAT3;ALDH3A2;VAPA;APP;REEP4;ZBED3;SEC31A
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6773071200940989,1.154851561062707,0.3137254901960784,0.884731815469467,1.0,1/17,2.73%,RAB27A
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6913716348000746,1.154804366385355,0.29310344827586204,0.8843777802066887,1.0,5/11,19.39%,RENBP;UAP1;GNPNAT1;GNPDA2;GFPT1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5574973422733448,1.1547149447858351,0.20454545454545456,0.8841580711918786,1.0,10/26,21.70%,SLC26A7;SLC26A6;SLC35B2;SLC26A4;RACGAP1;SLC44A4;SLC36A1;SLC19A2;SLC25A30;SLC25A14
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.5591369041314352,-1.1546080287593758,0.2708333333333333,0.9388681036759912,1.0,7/28,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.5591369041314352,-1.1546080287593758,0.2708333333333333,0.9388681036759912,1.0,7/28,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.5591369041314352,-1.1546080287593758,0.2708333333333333,0.9388681036759912,1.0,7/28,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.5591369041314352,-1.1546080287593758,0.2708333333333333,0.9388681036759912,1.0,7/28,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7718537543727302,1.1545649744758948,0.34782608695652173,0.8843472189353669,1.0,4/5,18.32%,ETHE1;CBS;CTH;MPST
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.5827813700462586,1.154259534133065,0.35185185185185186,0.8849515792861875,1.0,5/22,9.57%,DEFB135;LEAP2;TLR2;PRSS3;RO60
prerank,KEGG_2021_Human__RNA degradation,0.49203014075951257,1.1542211055440197,0.26,0.8845982120173985,1.0,26/72,28.57%,DCP1B;TOB1;PABPC1L2A;PABPC5;ZCCHC7;CNOT6L;CNOT4;EXOSC4;LSM8;TENT4B;CNOT8;MPHOSPH6;CNOT2;EXOSC1;PNPT1;C1D;PFKP;PAN3;LSM2;TOB2;PATL1;EXOSC5;DIS3;EXOSC2;PABPC1;BTG3
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.569079982507047,1.154064847524968,0.2698412698412698,0.8846531662090473,1.0,5/20,25.21%,TIMM22;TIMM10;BAD;MAIP1;TIMM9
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.7082444070899785,1.1540599215479754,0.30434782608695654,0.8841738320840498,1.0,2/6,19.93%,TBCA;TBCE
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7802594593070701,1.1540238344850282,0.24561403508771928,0.8838285146419346,1.0,1/5,3.91%,SLC17A6
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.70964206002252,1.1537979142598154,0.3333333333333333,0.8841365787368667,1.0,1/5,3.86%,ADIPOR2
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.5743906275657097,-1.1537949881704128,0.3,0.9405798525005851,1.0,11/35,19.61%,SLX4;ERCC1;FANCG;FANCC;FAN1;POLR1A;RPA3;CENPS-CORT;MUS81;FANCA;FANCB
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6237553267546052,1.1537602362921828,0.2777777777777778,0.8837425436488282,1.0,3/14,7.04%,BMP2;SOX6;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5180930895924408,1.1537203051920664,0.2833333333333333,0.8834050563574118,1.0,11/36,16.70%,TGFBR1;SNAI1;BMP2;WWTR1;SMAD2;EZH2;LOXL2;SMAD4;BAMBI;CRB2;CTNNB1
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.5427070359286641,-1.153588999225248,0.2857142857142857,0.940298924959518,1.0,1/40,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5949333417628714,1.1534082202373672,0.23404255319148937,0.8842105345842362,1.0,8/24,22.81%,FZD5;PLCG2;HLA-E;CD55;KIT;HLA-F;TNFSF4;RAET1G
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.7794212469007631,1.1533985770867907,0.33962264150943394,0.8827726590131468,1.0,2/5,13.68%,ENPP1;SLC52A1
prerank,Reactome_2022__Vitamin B2 (Riboflavin) Metabolism R-HSA-196843,0.7794212469007631,1.1533985770867907,0.33962264150943394,0.8827726590131468,1.0,2/5,13.68%,ENPP1;SLC52A1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.7794212469007631,1.1533985770867907,0.33962264150943394,0.8827726590131468,1.0,2/5,13.68%,ENPP1;SLC52A1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.4932890845432103,1.1533861449678595,0.18181818181818182,0.8823107508561902,1.0,12/78,4.12%,ADRA1A;SMYD1;PREX2;COL9A1;FAM110D;HIF3A;SLC35F1;PPP1R3A;CADM2;ASB15;LRP1B;KBTBD12
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.4875235786967122,1.1533728899275715,0.16326530612244897,0.8818912969735424,1.0,25/103,20.46%,SIPA1;CDKN2C;SIRT1;ENPP1;CDKN2A;CDKN2AIP;DCC;NAIF1;DNAJB2;SERTAD2;DACT3;SMAD4;GNG4;ACVR1B;PML;KIAA0319;FRZB;SMARCA2;DIP2B;DCBLD2;TP53;FBP1;BMPR2;ST7L;MAP2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.6336805619562793,-1.1533318120356693,0.34615384615384615,0.9402006657743109,1.0,1/18,0.42%,NTRK1
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,0.49863917153476284,1.153253481846854,0.25,0.8812562780639699,1.0,15/66,14.15%,C3;ITGAX;CSF2RA;DDX60L;XAF1;FGL2;TLR2;LAIR1;ABCA6;SIGLEC1;TFEC;APOL6;MSR1;NPL;ADAMDEC1
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,0.49863917153476284,1.153253481846854,0.25,0.8812562780639699,1.0,15/66,14.15%,C3;ITGAX;CSF2RA;DDX60L;XAF1;FGL2;TLR2;LAIR1;ABCA6;SIGLEC1;TFEC;APOL6;MSR1;NPL;ADAMDEC1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.6702169146816452,1.1532159189852667,0.3898305084745763,0.8808869557509513,1.0,1/9,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6204499903093015,1.1532113642695803,0.2807017543859649,0.8804413189410535,1.0,8/17,26.88%,ODC1;CHMP6;ZDHHC2;CHEK2;FAP;FURIN;HGS;ZDHHC7
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6469585455809574,1.152967536116472,0.3333333333333333,0.8807629833913813,1.0,2/11,5.82%,F2R;NAPEPLD
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5827661135181933,-1.152874703235146,0.3076923076923077,0.9409565077898241,1.0,7/25,16.47%,RPF2;DDX18;LAS1L;FTSJ3;NSA2;NHP2;RRP15
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5499754256142653,1.1528665386469055,0.25862068965517243,0.8805756916492649,1.0,3/23,14.58%,RAPGEF3;RAP1A;COL22A1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5727591724712533,1.152487337307986,0.3148148148148148,0.8815445116368895,1.0,3/18,17.26%,ESR1;LRWD1;RUVBL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5528137008493733,-1.1524538183303443,0.2549019607843137,0.9414974458857992,1.0,8/36,16.63%,ERCC1;RFC3;PARP1;GTF2H2;FAN1;RPA3;RFC2;RFC1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.601691238715698,1.152438890941239,0.3,0.8812526036355655,1.0,1/18,0.38%,LGALS9
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.7109786455284055,1.1523377228656193,0.29545454545454547,0.8812879308428964,1.0,2/9,3.79%,NRG1;BMP2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.4721722477031223,1.1523165839753158,0.2765957446808511,0.8808783064687341,1.0,25/91,15.32%,C1GALT1C1;TMTC2;PLOD2;GALNT8;POGLUT2;GALNT7;TET2;MUC20;GALNT3;GXYLT1;C1GALT1;GALNT12;GALNT1;MUC13;MUC7;B3GLCT;POMT2;FKRP;SLC35C1;CRPPA;B3GALNT2;POGLUT3;SDF2L1;TMTC3;POMK
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6394631748059929,-1.1518583614720228,0.3148148148148148,0.9426761920578705,1.0,3/11,13.98%,CXCL13;P2RY12;CDH17
prerank,Reactome_2022__p75NTR Negatively Regulates Cell Cycle Via SC1 R-HSA-193670,0.7876370238773875,1.1518499098106867,0.35185185185185186,0.8821991676071232,1.0,2/5,7.44%,HDAC3;HDAC2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6162894894233258,1.1518230761539339,0.30952380952380953,0.8818311571460462,1.0,3/12,7.50%,PCM1;CCDC120;BICD1
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,0.6045991266027546,1.1516327190914724,0.34375,0.8820881767647628,1.0,2/13,2.08%,FGF10;FGFR1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6166745931582532,-1.1514831888879096,0.37209302325581395,0.9429145966948355,1.0,4/14,7.66%,PXDN;COL4A1;LAMB3;LAMB1
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.5352275764075792,1.151212825369307,0.24,0.8833160172788885,1.0,12/51,23.78%,CTDNEP1;LPIN3;VRK2;LMNB1;NEK7;RANBP2;BANF1;CNEP1R1;NUP153;LEMD3;CCNB2;LMNA
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.5922281276401602,-1.1511052601502627,0.2916666666666667,0.9430973759917896,1.0,1/20,0.42%,NTRK1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6311294144138332,1.151101941413714,0.3181818181818182,0.8832738338606012,1.0,4/15,16.11%,NRG1;BMP2;MEF2C;MESP1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.504800679498275,1.150984197805821,0.18518518518518517,0.8832801986265614,1.0,6/60,3.50%,MAP3K11;CDKN2C;MYC;CDC25A;CCNA2;CDKN2A
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6608570919849075,1.1509360563579687,0.25,0.8830372556061891,1.0,2/13,5.05%,FGD4;VSTM5
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Undefined,0.7604493321342102,1.150928788822159,0.34615384615384615,0.8820679501664457,1.0,3/6,12.47%,MME;FLT3;CD34
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Undefined,0.7604493321342102,1.150928788822159,0.34615384615384615,0.8820679501664457,1.0,3/6,12.47%,MME;FLT3;CD34
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6190290536642327,1.150713122710421,0.3076923076923077,0.8824897800049707,1.0,4/19,7.22%,GDF6;BMP2;PRMT1;RELL1
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,-0.6991311066275355,-1.1506888274611522,0.35555555555555557,0.9434841887792522,1.0,2/8,6.86%,KCNN3;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.764506969647341,1.1505821371103118,0.25,0.8824343686577882,1.0,3/6,17.47%,APELA;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.7216327388955343,1.1505258452917295,0.3673469387755102,0.8821580244565114,1.0,3/9,5.28%,SIRT1;CDKN2A;ABI3
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,0.7535616856028682,1.1504987144964898,0.2727272727272727,0.8817439375868432,1.0,3/7,6.92%,ALDH1A1;ALDH1B1;ACSS2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.6204177626625749,1.1504712161013155,0.40425531914893614,0.8813372025035919,1.0,2/11,10.84%,BMP2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5328815557540111,1.1501952312179475,0.2916666666666667,0.8819926986221909,1.0,11/38,18.35%,NEDD4;DCC;TNIK;ADGRB3;HECW2;DBN1;CSMD3;KIAA0319;COBL;CDKL5;RAP2A
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.5492888085793896,1.1500630863768286,0.2909090909090909,0.882020401883346,1.0,1/35,0.15%,STK26
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7840719705511674,1.1499452651628483,0.29508196721311475,0.8819723158838405,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5171843921987334,1.1498498320903148,0.25,0.881917398989717,1.0,15/69,21.28%,ANGPT1;BMI1;SEPTIN4;HDAC3;SPSB4;DCUN1D1;ARRDC3;PAXIP1;PRICKLE1;MARCHF7;BIRC3;NDFIP2;UBE2D1;RIPK2;PHF23
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5104479224005448,1.149561390374242,0.25,0.8824817115921937,1.0,10/52,19.28%,VAPB;CCL5;NR5A2;ZC3HAV1;TMEM39A;PROX1;PLSCR1;PKN2;OASL;BANF1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.551751109050965,-1.149078240510936,0.27450980392156865,0.9474798313739284,1.0,7/30,7.93%,P2RY10;SIRPG;TRAF3IP3;SCML4;KLRB1;CD5;TAGAP
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.551751109050965,-1.149078240510936,0.27450980392156865,0.9474798313739284,1.0,7/30,7.93%,P2RY10;SIRPG;TRAF3IP3;SCML4;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.7935461319607005,1.1490231968687874,0.34,0.8842143128920616,1.0,2/5,11.50%,HAP1;CEP135
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,0.49285641717329537,1.148990453565805,0.2549019607843137,0.883780294608211,1.0,14/48,7.42%,KLRD1;RUNX1;MME;ITGAX;ITGA2;LY9;TOX;NFIL3;CD244;IL7R;LAIR1;LRRC36;IL15;DPP4
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,-0.5275592313052427,-1.148691794592348,0.27450980392156865,0.9477978766360303,1.0,10/55,2.73%,TBC1D10C;SIRPG;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;CD101;CD86;GPR132
prerank,KEGG_2021_Human__MAPK signaling pathway,0.42185284601008516,1.1486643144848403,0.17073170731707318,0.8846036691661403,1.0,47/261,14.49%,VEGFC;IGF1;FGF10;FLT1;MAP3K11;FGFR3;HGF;MYC;TGFBR1;FGFR1;ERBB4;FGF2;EFNA5;ANGPT1;RRAS;GNG12;EFNA2;RELA;MAPKAPK2;CACNB4;MAP2K6;PDGFRA;RPS6KA4;PPM1A;ELK1;PDGFC;TAB2;FGF17;MAPKAPK3;MAP4K2;RPS6KA2;FLT3;MEF2C;MAPK8;IRAK1;PPP3CA;SOS1;HSPB1;FGF5;IGF1R;HSPA8;PPP3CC;RAP1A;DUSP2;RPS6KA1;NFATC3;MAP3K1
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,0.7060903394459672,1.1486437060755543,0.3064516129032258,0.8836885997279137,1.0,3/7,11.63%,TGFBR1;SMAD2;SMAD4
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,0.7060903394459672,1.1486437060755543,0.3064516129032258,0.8836885997279137,1.0,3/7,11.63%,TGFBR1;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.718766717871397,-1.1482776931285055,0.36363636363636365,0.9483422519208605,1.0,3/6,25.95%,TGFB1;FGFR2;TGFB2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5753691803644079,1.1481555142018838,0.2727272727272727,0.8851072569599763,1.0,6/24,23.20%,FKBP5;P3H2;PPIF;PPIL6;CWC27;NKTR
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4156794484638957,1.1479968522490007,0.14285714285714285,0.8852564785081609,1.0,83/381,17.56%,SEMA5A;CHRM2;LSAMP;TGFBR1;FZD5;ERBB4;NRTN;IL1RAPL2;FGF2;NRG1;EFNA5;ZEB2;POU6F2;CDH2;NLGN1;VCAN;TENM1;THOC6;ROBO2;CRIM1;ADGRG6;ADGRV1;LGI1;SOX6;SDK1;NRXN1;NAV3;WWTR1;POU3F2;ST8SIA4;PAX6;ZC4H2;CHD7;NEUROD2;CNTN6;FGF12;ACHE;ATXN1;PDGFC;SCD5;SNTG2;DSCAML1;ACTL6A;GFRA1;FGF17;DSCAM;NPAS1;ROGDI;GSN;HAP1;NHLH2;NHLH1;GPM6A;LIG4;EMX1;DPF1;MEF2C;GLRB;PROX1;PTEN;GPM6B;DPF3;FGF5;TRPC5;MYT1L;ACVR1B;MOBP;APBA1;DYRK1A;ADORA1;L1CAM;DNM3;GJB1;RAB29;MESP1;HAPLN1;NOTCH2;CNTN4;BCAN;ARTN;FLRT3;VEGFA;WNT2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.4891994525093957,1.1477924341404109,0.23809523809523808,0.8856110303597322,1.0,15/65,18.20%,CCL5;GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA;MEF2C;POLR3G;PLSCR1;GPRC5B;PLA2G7;IL33;RIOK3
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.7345344019407776,-1.1477260723059342,0.3673469387755102,0.9489245369433944,1.0,1/6,2.27%,DRD4
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5403016307933454,1.147615057390878,0.27419354838709675,0.8857255860107319,1.0,4/22,9.75%,TGFBR1;GRIN3A;GLRA1;SMAD2
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,0.51036690078331,1.1474926670477335,0.2608695652173913,0.8857784364653688,1.0,9/56,5.64%,CCL3L3;GPRIN3;TNFSF13B;SASH3;PIK3R5;CD244;IRF8;IL10RA;FGL2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6766082856919846,1.1473458507584684,0.2826086956521739,0.8857765207663089,1.0,4/11,21.56%,HIF1A;HAP1;ACTR10;TRAK2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7504674638409157,1.1472421919954594,0.32,0.8857130931209366,1.0,2/6,11.50%,HAP1;CEP135
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,0.4111480365990694,1.1471404156861265,0.14814814814814814,0.8856019159227083,1.0,79/410,14.32%,SELPLG;IGF1;STAB1;TCIRG1;C3;RUNX1;PPP1R18;ITGAX;SYK;CSF3R;RIN2;LHFPL2;ADAM28;SASH3;SFMBT2;GNB4;SAMSN1;BLNK;NPC2;NRIP1;CPED1;FLI1;ZFP36L2;CSRP2;STOM;PTGS1;ZBTB20;IRF8;HCLS1;RGS10;GPSM3;GLUL;IL10RA;RAB31;ABI3;DHRS3;ANXA5;SYT1;RBMS1;LAIR1;TSC22D3;CNN3;MYL12A;P3H2;HPGDS;TSC22D1;GYPC;SOCS6;TFEC;PLXDC2;KLF6;STING1;PAG1;TMIGD2;TMIGD3;RAPGEF6;TMC6;GSN;BIN1;RNASET2;GALNT1;GPM6A;TCF4;C3AR1;RTN1;HLA-E;EGFL7;FMNL3;HTRA1;NR4A2;MAGED1;IRAG2;NPL;DBN1;CH25H;CD74;CD83;RPS6KA1;C12ORF75
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,0.6052246533521258,1.1470447563307098,0.27450980392156865,0.8854157568251895,1.0,4/12,5.88%,MME;ITGAX;CSF3R;TLR2
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.5055703683462077,-1.146975126063863,0.2222222222222222,0.9505757108627997,1.0,15/61,8.48%,P2RY10;TBC1D10C;SELL;SP140;DOCK8;TRAF3IP3;CD53;CYTH4;GPR132;LTB;DOCK2;ARHGAP15;CD5;TAGAP;PTPN7
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4511664584913911,1.1469535105643673,0.19148936170212766,0.8852639182574035,1.0,17/143,4.55%,IGF1;ADRA1A;FGF10;FLT1;EPHA7;FGFR3;SYK;RIT2;F2R;FGFR1;FGF2;RRAS;ROR1;KSR1;BMP2;PELI2;TNIK
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5891493352210883,1.1468326701089655,0.2553191489361702,0.8853509474270007,1.0,9/27,18.30%,BOK;FHIT;ZNF385B;PAXIP1;TP53BP2;GREM1;BCL3;TP53;JMY
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5616148618695369,1.1467903375760733,0.30612244897959184,0.8850152651087219,1.0,6/23,13.67%,SLC1A3;SLC26A7;SLC26A6;ABCC2;SLC25A13;SLC19A1
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,0.6459133553269288,1.1466648303173006,0.31666666666666665,0.8850001437346141,1.0,7/13,27.50%,SOS1;EPX;IRS2;LYN;GRB2;JAK2;EPOR
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.7246770196653431,1.1464459309849953,0.39215686274509803,0.8848746748350083,1.0,2/7,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.7246770196653431,1.1464459309849953,0.39215686274509803,0.8848746748350083,1.0,2/7,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5664679323407478,-1.1463795960018195,0.2631578947368421,0.951591251031878,1.0,4/34,4.85%,SELP;SELE;IGSF21;UMOD
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.7451714758932855,1.1463465595507294,0.4,0.8847576283954567,1.0,1/6,2.04%,F2R
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4785912891429225,-1.146275469274532,0.23404255319148937,0.9508820228159132,1.0,7/80,2.82%,EHF;CLDN4;TMEM184A;GPR39;SERINC2;CLDN1;C6ORF132
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,0.6509655194134627,1.1462056958683113,0.2962962962962963,0.8848650430747502,1.0,7/14,27.64%,RELA;IRAK1;RIPK2;IKBKB;TRAF6;NFKB1;NFKBIA
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6260122474835267,-1.1459764961163201,0.3333333333333333,0.9508439245435952,1.0,2/15,5.60%,PNPLA1;PNPLA4
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7490717268499512,1.1456755726484842,0.3541666666666667,0.8862768592953586,1.0,2/6,9.47%,TCAF2;GRM5
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.47943454669896035,1.1455318665993797,0.20689655172413793,0.8863629675735792,1.0,11/64,13.08%,FGF10;FGFR3;FGFR1;FGF2;HNRNPH1;GALNT3;SHOC2;FGF17;FLRT2;TIAL1;FGF5
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.636526100999355,1.1454508747367629,0.30612244897959184,0.8862793070216103,1.0,3/16,5.54%,KAT2B;DLGAP5;RBPJ
prerank,Reactome_2022__Fibronectin Matrix Formation R-HSA-1566977,-0.7543344204975934,-1.145432869451067,0.375,0.9518480842058239,1.0,1/5,8.95%,CEACAM1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.5678793638643859,1.14531919221595,0.23404255319148937,0.886263570431722,1.0,1/23,0.05%,SGO1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.48821923813986007,1.1452445832229685,0.18867924528301888,0.8860580180010275,1.0,6/65,2.08%,FGF10;IRS1;TCIRG1;ATP6V0D2;FGFR3;FGFR1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6732247808256092,1.1452134513975867,0.36538461538461536,0.88565617978731,1.0,3/9,7.44%,SIRT1;IL4;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6640170551775291,1.1451606991773933,0.32786885245901637,0.8853969949950634,1.0,4/8,23.10%,RAP1GDS1;MCU;MICU1;BCAP31
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.7578206181864502,1.1451070866481772,0.3508771929824561,0.8851245509597961,1.0,2/5,12.75%,DCTPP1;CBS
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.7610652802930222,1.1450815744789231,0.32786885245901637,0.8847103305139769,1.0,1/5,7.89%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.7529045896476029,1.145020749270495,0.2641509433962264,0.8844317856270505,1.0,4/6,16.07%,SIRT1;CDKN2A;MEF2C;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.4690853520416596,1.1449726595350413,0.20408163265306123,0.8841129918658661,1.0,32/111,19.62%,MT4;SYT15;ITPKB;NLGN1;GLRA1;ADGRV1;SYT6;SYT1;PLCG2;TF;NEUROD2;SNCA;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;MEF2C;MAPK8;CPNE3;TRPM2;DLG2;PPIF;CPNE2;PRKAA1;MT1M;AKR1C3;RYR3;SLFN14;SYT3;LGMN;FBP1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.48534429434119336,1.1448598248614275,0.22641509433962265,0.8841255009180206,1.0,21/120,12.43%,GATA4;RBM20;TGFBR1;ERBB4;KAT2B;BMP2;PCSK5;SGCZ;PDLIM5;PDLIM4;APELA;CHD7;FGF12;DLC1;TAB2;SGCG;DAND5;SCUBE1;MEF2C;PTEN;FLRT2
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,0.6610726179080109,1.1448426959169677,0.3050847457627119,0.8837262044207357,1.0,6/12,27.64%,RELA;IRAK1;IKBKB;TRAF6;NFKB1;NFKBIA
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.574287646151683,1.1448084738085142,0.2909090909090909,0.8833340825128718,1.0,7/28,8.30%,UTRN;ADGRG6;ADGRV1;WWTR1;POU3F2;HDAC2;SCD5
prerank,Reactome_2022__Biosynthesis Of EPA-derived SPMs R-HSA-9018679,-0.7732933574220395,-1.1445748807635425,0.32,0.9538211859906258,1.0,2/6,14.13%,ALOX5;ALOX15
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.6455208479379654,1.1445352592790656,0.3333333333333333,0.8838122874693872,1.0,5/14,15.77%,LPIN3;CEPT1;SELENOI;ETNK1;ETNPPL
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.756971125797468,1.1444976134289289,0.2982456140350877,0.8834946773803756,1.0,3/5,21.36%,ABCD2;CD74;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7078911448473735,1.144470875643077,0.29310344827586204,0.8831302529887817,1.0,2/7,4.49%,NLGN1;RORA
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5482620287566246,1.1443982799856358,0.22033898305084745,0.8830018610492882,1.0,7/34,10.25%,LGALS9;SYK;TLR2;PLCG2;CD40;HMGB1;IL23R
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.5430486542805194,1.1443430236352974,0.26785714285714285,0.8827053795650925,1.0,5/24,9.80%,ITGA8;ITGB8;BMP2;ITGAV;LTBP1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.7355496788955485,1.144332135550243,0.3684210526315789,0.8822747049976968,1.0,2/7,11.90%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.661563465741525,1.1439546854798488,0.3269230769230769,0.8832560863014631,1.0,5/12,21.17%,ELOVL5;TECRL;ELOVL4;TECR;ELOVL6
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7147237557974075,1.1434738509292246,0.38181818181818183,0.8845588999930314,1.0,5/7,26.90%,ANGPT1;VEGFA;SH3GL2;TJP2;TJP1
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.5844787693958295,1.1434384592871287,0.288135593220339,0.8842152177132485,1.0,4/27,2.71%,TNFSF14;CCL5;CSF3R;ITGA2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.547781161229134,1.143432045193121,0.22448979591836735,0.8837712341895338,1.0,4/27,7.89%,SYK;IL4;PLCG2;SNCA
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7231509488322421,-1.143427448226837,0.3170731707317073,0.9556924921030708,1.0,3/6,11.69%,IL18BP;ALOX5;IL18
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7231509488322421,-1.143427448226837,0.3170731707317073,0.9556924921030708,1.0,3/6,11.69%,IL18BP;ALOX5;IL18
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5761693296395951,1.1433765207800817,0.3,0.8834887051246322,1.0,5/33,10.25%,PNP;IL4;ZBTB1;VSIR;IL23R
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,0.7048659863695509,1.143344107010524,0.37254901960784315,0.8831528445372706,1.0,4/8,20.21%,TCN2;LRP2;ABCD4;LMBRD1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.7412017409008548,-1.1433090950994569,0.3333333333333333,0.9552079996658099,1.0,1/5,3.83%,CRACR2A
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7330524326845607,1.1432172878248499,0.3148148148148148,0.8831724647279636,1.0,3/6,25.01%,BACE2;ITM2B;ABCA7
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.4584213000521848,1.1431972469380087,0.18181818181818182,0.8823013497364537,1.0,23/93,16.15%,MXRA5;SEMA5A;ITGB8;EDIL3;ADGRL4;EFS;POSTN;CNN3;PDGFRA;F3;PTPRD;PRICKLE2;FGF14;TNC;ATP1A2;BAALC;SHROOM4;CNTN3;ID4;SEMA6D;FRZB;GPRC5B;MAPK10
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.4584213000521848,1.1431972469380087,0.18181818181818182,0.8823013497364537,1.0,23/93,16.15%,MXRA5;SEMA5A;ITGB8;EDIL3;ADGRL4;EFS;POSTN;CNN3;PDGFRA;F3;PTPRD;PRICKLE2;FGF14;TNC;ATP1A2;BAALC;SHROOM4;CNTN3;ID4;SEMA6D;FRZB;GPRC5B;MAPK10
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.7239871441908525,1.1430401851805185,0.33962264150943394,0.8824150475252613,1.0,2/7,7.07%,CDH2;PAX6
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.8067022515541229,1.1430320721645972,0.2830188679245283,0.8819602952878944,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5783650358718441,-1.1430114749447147,0.2765957446808511,0.9553279148931375,1.0,6/29,9.36%,SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.6060938320617107,1.1429696685111392,0.3333333333333333,0.8812258944456856,1.0,6/17,26.08%,PRSS3;TCN2;ABCD4;LMBRD1;MMAB;MTR
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.6060938320617107,1.1429696685111392,0.3333333333333333,0.8812258944456856,1.0,6/17,26.08%,PRSS3;TCN2;ABCD4;LMBRD1;MMAB;MTR
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6804776633273544,1.1427579417159828,0.3157894736842105,0.8815468646950374,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.6966861914692464,-1.1425548267480683,0.43137254901960786,0.955965282303148,1.0,1/5,4.39%,CBARP
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.617069204515485,1.142535219000402,0.3191489361702128,0.8817674140650021,1.0,3/17,6.41%,ITGA2;SDC4;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7389566882349763,1.1424774620120144,0.29545454545454547,0.8814875895714436,1.0,2/7,7.98%,F2R;SPX
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.517089714346018,1.1423711983536822,0.2711864406779661,0.8815013216146033,1.0,11/58,10.29%,FLT1;MAP3K11;FGFR1;FGF2;PIK3R6;TENM1;PIK3R5;CD40;PDGFC;EZH2;FLT3
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5325475686703303,1.1423060993412402,0.24074074074074073,0.8812685639930041,1.0,9/34,15.21%,WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.4685495995127438,1.1423050333466922,0.20930232558139536,0.880809681254521,1.0,16/112,10.31%,LGALS9;NOX5;ACE2;IL26;ICOSLG;IRF8;CCN4;MAPKAPK2;RPS6KA4;IL15;CCDC88B;STING1;TMIGD2;BTN2A2;C5AR2;CADM1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6592391818007554,1.1422863873785387,0.3333333333333333,0.8804045187303096,1.0,3/12,3.12%,TMEM100;RIN2;RRAS
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.617480696556992,1.1421985791179745,0.2857142857142857,0.8802924253812939,1.0,3/12,18.40%,RPIA;H6PD;RPE
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.7278148425749877,-1.1421643564272783,0.3888888888888889,0.9564469006548043,1.0,6/8,24.60%,DARS2;SARS2;GARS1;AARS2;TARS2;WARS2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.6844789013941897,-1.1421618504011166,0.36538461538461536,0.9554239570464624,1.0,1/7,5.62%,SENP3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.5597206108865562,1.1421039859996085,0.25,0.8802203348946007,1.0,5/36,10.58%,MYC;HDAC3;MARVELD3;ZNF675;FOXO1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6947307494620252,1.1417734838512115,0.2833333333333333,0.8809721680486358,1.0,4/12,8.96%,ERBB4;WNT4;SCRIB;LATS1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6742666762808107,-1.1417573026161383,0.3469387755102041,0.9555816338908824,1.0,2/11,12.20%,MEFV;PYDC1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5518990246066083,1.1417492876289599,0.3275862068965517,0.8806208972439484,1.0,2/20,2.47%,CCL5;IL4
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.7652967594804212,1.141479473647663,0.3559322033898305,0.8810730655582526,1.0,1/5,5.79%,NEFH
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6388203964829037,1.1414056219344713,0.30357142857142855,0.8808614136930543,1.0,8/14,20.02%,SIRT1;HDAC3;HDAC2;SMARCAD1;SIRT6;SIRT7;HDAC9;HDAC1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Undefined,0.7461435589046503,1.1412598090552133,0.2698412698412698,0.8810013719941244,1.0,2/5,10.59%,IRF8;TCF4
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.3946269813510734,1.1409636119544253,0.09259259259259259,0.8815917828747987,1.0,198/1022,19.47%,GATA4;ZNF804B;SMAD6;CCNG1;TNFRSF18;RUNX1;ZNF300;RSPO3;HNF4G;MYC;ESRRG;ZNF792;SIRT1;CCNA2;KAT2B;PPARG;REXO2;MED17;SEM1;RRAD;OPRK1;ZNF493;CDKN2A;LMO1;RORB;BMP2;NPY;IL2RA;COX19;PRMT1;ZNF582;RORA;H2BC21;RBM14-RBM4;SMYD2;FKBP5;RBPJ;RELA;NR5A2;MOV10;LMO2;PIP4K2A;PRKAB2;ESR1;MAP2K6;TEAD2;ZNF599;WWTR1;ZNF543;GAMT;ABCA6;ZNF706;TP53INP1;ZNF595;DYRK2;HDAC3;BANP;HDAC2;LIFR;UBE2D3;PPM1A;ZNF274;RYBP;FOXO3;SMAD1;YAF2;ZNF41;ZNF195;ACTL6A;ZNF202;ZNF561;KCTD6;ARID2;TAF3;ANAPC16;ZNF675;SMARCD3;SMAD2;PSMD13;ZNF771;ZNF426;MAP4K2;EZH2;ZNF669;ZNF692;FOXO1;TNFRSF10B;E2F4;CASP10;TBL1X;ZNF114;CNOT6L;NPPA;NR1D2;DAND5;CHEK2;SMAD4;PLAGL1;ZNF704;ELOF1;CNOT4;NR1H3;MEF2C;BNIP3L;TP53BP2;RRAGC;ARID1A;ZNF347;IRAK1;PTEN;ZNF175;H2AC6;ZNF778;CDK12;MYB;FASN;ZNF212;NR4A2;RNF2;H2AZ2;NOC2L;PSME4;ARID1B;CCND3;MOBP;PML;WWOX;RARB;CREB1;SMARCD2;ZNF263;CCNH;EPC1;KAT6A;PCGF5;TAF5;ZNF442;RICTOR;HIPK1;H2AX;THRB;COX6A1;FOXO6;ZNF257;ZFP30;TAF2;SGK1;PRKAA1;ZNF607;CNOT8;ZNF682;PSMA1;NOTCH2;ZNF776;ZNF584;HEY2;CNOT2;CTNNB1;SMARCA2;NELFB;RORC;MNAT1;ARTN;ZNF786;SCO2;VEGFA;TGIF1;PERP;CDK4;TP53;AGO3;CTSV;MED30;CITED2;EED;ZNF12;ZNF30;JMY;ZNF234;RRAGD;ZNF33A;ZNF738;KDM5B;KIT;HDAC9;SMURF1;RBFOX1;ZNF782;MLST8;TNFRSF10A;NR3C1;CCN2;ZNF519;ZNF311;AKT3;ABL1;JAG1;POLR2H
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,0.4405287301803464,1.1409137031804315,0.17777777777777778,0.8813007162737876,1.0,36/191,14.25%,LAMA4;CCNG1;TSPAN12;F2R;FGFR1;RFWD3;COL6A2;DLGAP5;PCDH17;RCBTB2;LRRN3;ZBTB44;ZEB1;ZBTB2;ADGRL2;LIFR;CEP152;SSBP2;HMGB1;WDR76;GYPC;BCAT1;SMAD1;ZNF195;GPR161;BIN1;HLA-E;HNRNPD;DNAJC1;PTEN;FLRT2;CD34;HSPB1;ZNF652;WWOX;NR2F2
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.47125715989418065,1.1408548889422037,0.2,0.8810231944276561,1.0,28/148,20.02%,MITF;UHRF2;TOP2A;PPARG;CDKN2A;NRIP1;RORA;RELA;NR5A2;ESR1;HDAC2;NCOA2;SP3;NR1H3;SMC5;NR4A2;RNF2;PML;IKBKE;THRB;RANBP2;TP53;SMC3;NSMCE2;NR3C1;SATB2;TRIM28;HDAC1
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.6888987376526345,1.140826870639814,0.3333333333333333,0.8806467234702533,1.0,3/10,13.31%,TRPC4;DCC;TRPC5
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6126121485662086,1.140760025209625,0.36363636363636365,0.8804690243613512,1.0,2/13,4.63%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.729634187498137,1.1407527273481846,0.358974358974359,0.8800337569968079,1.0,3/6,17.81%,PHGDH;SRR;PSPH
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.6554554705177758,1.140686433489365,0.3392857142857143,0.8797839034980758,1.0,5/11,26.18%,TIFA;TAB2;TAB3;TAB1;TRAF6
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.7557622648753682,1.1406797826290913,0.2982456140350877,0.878875861232679,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.7557622648753682,1.1406797826290913,0.2982456140350877,0.878875861232679,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5976453544411678,-1.1404502598927542,0.3191489361702128,0.9593858318839182,1.0,4/19,6.93%,SCN5A;KCNE2;CACNA1G;KCNE1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.6484133514189659,-1.140419018465368,0.3191489361702128,0.9584936818797968,1.0,6/10,22.43%,P2RY11;P2RY12;TRPV1;CIB2;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6256972834082901,1.14018141341688,0.29508196721311475,0.8802560348648689,1.0,10/17,23.74%,SCRIB;ERBIN;LRRC7;DLG2;CRB2;DLG3;PARD3;CRB1;DLG1;CLIC4
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6621489129507643,-1.1401274919021909,0.28846153846153844,0.9586091710461745,1.0,1/10,6.80%,B3GALT5
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.6149993428361336,1.1399088825737351,0.36065573770491804,0.8806064424959246,1.0,6/11,18.50%,GABRG3;GABRA5;GABRG1;GABRB2;GABRE;GABRA4
prerank,Reactome_2022__Chylomicron Assembly R-HSA-8963888,-0.7142066656097394,-1.139889711903199,0.34210526315789475,0.9583793049891332,1.0,2/6,11.52%,APOA1;APOB
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.4829243566810703,1.1398187356690133,0.1346153846153846,0.8804557681308354,1.0,13/74,16.35%,TGFBR1;H2AC25;SEM1;INO80E;SENP8;ACTL6A;INO80D;PSMD13;NFRKB;H2AC6;PSME4;HCFC1;PSMA1
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.5776249784329096,1.1397763401198928,0.3076923076923077,0.8801735527771593,1.0,4/16,14.65%,LDLR;NPC2;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6063232129995346,1.1396164652301848,0.32727272727272727,0.8803720804281507,1.0,2/19,3.67%,CDC25A;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.7280211980694615,-1.1396055678538068,0.30434782608695654,0.9584333825298665,1.0,5/5,27.22%,WNT7A;WNT5A;MAPT;NLGN2;DVL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5759826956292683,1.1394968652891384,0.27450980392156865,0.8803862155026593,1.0,3/28,7.38%,RBM20;PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5068541857785691,1.1394839720519947,0.2826086956521739,0.8799598365171186,1.0,12/43,20.67%,ACE2;SLC8A1;ANK2;NPPA;ATP1A2;NPR2;RYR2;ASPH;RYR3;CORIN;TRPC1;ATP1B2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.522520988558633,1.1393784897677262,0.20754716981132076,0.8797770361236575,1.0,14/69,16.97%,RUNX1;SEM1;LMO1;H2BC21;LMO2;PSMD13;H2AC6;MYB;H2AZ2;PSME4;CCNH;H2AX;PSMA1;MNAT1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.6602398993113607,-1.1392549656812336,0.32608695652173914,0.9578531878725737,1.0,2/5,10.65%,PAX2;PTCH1
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),-0.6602398993113607,-1.1392549656812336,0.32608695652173914,0.9578531878725737,1.0,2/5,10.65%,PAX2;PTCH1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4362897233167821,1.1391745127503767,0.17391304347826086,0.8799950598800071,1.0,23/118,15.32%,C1GALT1C1;PLOD2;GALNTL5;GALNT7;TET2;FUT9;ALG6;MGAT2;GAL3ST1;ST8SIA4;SLC39A8;MAGT1;ST3GAL6;NUS1;GALNT1;FUT8;ALG9;POMT2;MGAT5;MGAT4C;B3GALNT2;MGAT4A;POMK
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.536563251802199,-1.1391106881237645,0.24444444444444444,0.9572814754999339,1.0,2/46,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5583400975932263,-1.1390537214169822,0.2857142857142857,0.9565126494703526,1.0,13/25,23.78%,AFG3L2;APOO;SPG7;DNAJC11;LETM1;DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;SAMM50;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.41966240351942985,1.138985668569913,0.16666666666666666,0.8801012626841352,1.0,73/384,16.91%,DACH1;TIMELESS;SIRT1;TSHZ3;IL4;FOXP2;NRG1;PPARG;SFMBT2;MDFIC;WNT4;CDKN2A;RORB;BMP2;NFIL3;SIX4;RBPJ;RELA;ZEB1;ZNF706;HDAC3;HDAC2;GMNN;ATXN1;CBFA2T3;YAF2;SPINDOC;NPAS1;SMAD2;EZH2;MAGEL2;LOXL2;FOXO1;MBTD1;PTPRK;PASD1;NR1D2;SP3;SMAD4;DPF1;PROX1;CTBP2;TLE2;ZNF281;MYB;ATF7IP;DPF3;HSPA8;HEXIM2;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;ZNF639;BCOR;RUNX1T1;NR2F2;EPC1;KAT6A;POU2F1;PLCB1;SPEN;DEAF1;MESP1;BAP1;HEY2;BCL3;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4098939121515392,1.138747030114791,0.17647058823529413,0.8804829138361293,1.0,55/302,20.95%,DERL3;CDC20B;SIRT1;NEDD4;SPSB2;FBXO5;SYVN1;UBE2J1;PELI1;DNAJB2;RNF185;FBXL3;UBE2D3;SPSB4;ANKRD9;SPOP;UBE3D;AUP1;SPOPL;ANAPC16;PSMD13;KLHL15;FBXL14;TBL1X;HECW2;RNF5;UBE2U;KLHL42;UBE4A;PSME4;UBE2J2;PML;FBXL15;DERL2;RMND5A;FBXL2;NFE2L2;PSMA1;NHLRC3;DNAJB9;CTNNB1;ARRB2;SMURF1;FBXL20;TMUB2;FBXW5;FEM1B;FZR1;HSPA5;UBE2D1;UBE2A;UBE2E1;STT3B;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.731318905535216,-1.1386973074886086,0.3877551020408163,0.9568046486972844,1.0,3/5,24.94%,CGAS;PDE10A;THBS1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.693495496195512,-1.138695068478668,0.3404255319148936,0.9557867714114362,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.722625410333071,-1.138622043283022,0.4186046511627907,0.9551360427929952,1.0,1/5,3.88%,CD200R1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.651912880774141,-1.138470934127627,0.32653061224489793,0.9546234199444945,1.0,3/8,10.48%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5413913206422092,1.1383559552723603,0.24074074074074073,0.8815068041254975,1.0,13/45,23.00%,PBX3;PCSK5;RBPJ;APELA;TEAD2;BMPR1A;RARB;COBL;HEY2;KIT;ERCC3;PBX1;TEAD3
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7396339846604666,1.1383420623029878,0.35185185185185186,0.8810877268692001,1.0,1/5,7.27%,DCP1B
prerank,"Reactome_2022__Defective CHST14 Causes EDS, Musculocontractural Type R-HSA-3595174",0.7263111061430786,1.1381543690179972,0.4,0.8812979521070613,1.0,2/7,4.37%,VCAN;BGN
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4099907255988381,1.1380835563791445,0.17391304347826086,0.8811282159043808,1.0,47/278,12.07%,TIMELESS;NXPH1;LYPD1;RIT2;PNOC;SLC35F1;NXPH4;GRM3;KCNC2;CADM2;PCBP3;PDE1A;RORB;NPY;SLC17A6;RORA;RGS10;VSX2;DHRS3;SYT1;ZDHHC22;KCNQ5;PARM1;NRXN1;RAB3C;ADGRL2;PAX6;OLFM3;FGF12;LHX6;RAMP3;SYNPR;HIVEP2;GRM5;LRRTM3;ADGRB3;CTNNA2;OXR1;PCF11;HAP1;SCN2B;PAK5;TMEM196;GABRA5;NOL4;GNG4;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.43046450923669394,1.137846771403608,0.16666666666666666,0.8815017991700694,1.0,96/421,16.79%,GATA4;MITF;IGF1;RUNX1;MYC;ESRRG;TGFBR1;F2R;ERBB4;RFPL2;IL4;HIF1A;MYCN;FGF2;PPARG;PYHIN1;GDF6;SNAI1;TFEB;MED17;MYRF;MDFIC;WNT4;MAFB;RORB;BMP2;NFIL3;MLLT3;SIX4;FLI1;RORA;FANK1;SP1;RELA;NR5A2;ESR1;TEAD2;TP53INP1;PAX6;HDAC2;PPM1A;ELF4;ELK1;RYBP;FOXO3;YAF2;KLF6;KDM3A;CTCFL;SMARCD3;SMAD2;FOXO1;TCF4;TBL1X;NR1D2;HNRNPD;CHEK2;SP3;SMAD4;NPAS3;NR1H3;MEF2C;ARID1A;ZNF281;MYB;ATF7IP;FZD1;PICALM;CREB3L2;ZXDC;SPIN1;ARID1B;CD74;MLXIPL;PML;CREB1;NR2F2;RPS6KA1;LRP6;FZD4;DYRK1A;PAX3;EPC1;KAT6A;BAMBI;PLCB1;HCFC1;SMAD5;PHIP;DEAF1;MESP1;NAA16;HEY2;BCL3;CTNNB1;SMARCA2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4550988492360374,-1.1377878220640405,0.21153846153846154,0.9564033796453464,1.0,15/80,13.11%,DUSP4;SPRY4;DUSP6;PRKCD;FOXM1;SPRED3;SPRED2;UCHL1;PEBP1;CAMK2N1;SPRED1;GBP1;DUSP9;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6994062256926623,1.1377312460965756,0.3103448275862069,0.8815021863023619,1.0,4/7,28.57%,PICALM;EFNA1;LYN;EPHA4
prerank,CellMarker_Augmented_2021__Dendritic cell:Liver,0.7603793714272502,1.1375368975002458,0.2857142857142857,0.8818294283246692,1.0,1/5,1.66%,ITGAX
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6486751405657334,1.1375227839937616,0.3333333333333333,0.8814310884760812,1.0,3/12,14.98%,CBLB;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6798711873762255,1.1375087471580492,0.25,0.8810201007516426,1.0,5/12,17.24%,SIRT1;PLCG2;CD74;GPRC5B;IRAK3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6458509501113289,-1.1374531304311242,0.2826086956521739,0.9567697449684939,1.0,2/10,7.72%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5848858223712478,1.1373748667495767,0.23076923076923078,0.8810598982361645,1.0,3/24,9.38%,SEMA5A;ALCAM;AUTS2
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.6568367132743875,-1.1373580157889067,0.27450980392156865,0.9561131588990507,1.0,1/9,3.86%,IL6R
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.6831961874122676,-1.1373473172567705,0.30434782608695654,0.9541468023066514,1.0,3/8,14.55%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.6831961874122676,-1.1373473172567705,0.30434782608695654,0.9541468023066514,1.0,3/8,14.55%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.750792727081545,1.1372289869282421,0.2982456140350877,0.8811453195226228,1.0,1/6,10.31%,CADM1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.627858042453816,1.1372211603449862,0.35,0.8807611982711814,1.0,6/15,11.63%,HIF3A;PRDM14;LIN28A;TSC22D1;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6826808121461347,1.1372149955781081,0.36666666666666664,0.8803123059970207,1.0,3/8,24.21%,HSD17B10;TRMT5;MTO1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.47761574536582,1.1370216307508754,0.34,0.8804175215721158,1.0,23/72,25.26%,ZEB2;PDE4DIP;LMAN1;PLXNB1;RAB33B;SIRT7;CENPV;MFF;STX5;STX18;CAMSAP2;SAR1A;MAPK3;USP6NL;MAPK15;TBC1D25;CLIC4;AKAP9;MIEF2;EP300;SPATA4;TMEM33;PAK2
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.4971887558225224,1.136929458956087,0.25,0.8802817550125067,1.0,8/67,16.79%,IRS1;H2AC25;H2BC21;CHMP6;H2AC6;PCSK2;UBAP1;RANBP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,-0.674478974433298,-1.1369052499939134,0.36585365853658536,0.954634765551598,1.0,1/9,1.04%,CD24
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.4661882770350161,1.1368182848433803,0.22033898305084745,0.8802111959560267,1.0,28/153,20.02%,MITF;UHRF2;TOP2A;PPARG;CDKN2A;NRIP1;RORA;RELA;NR5A2;ESR1;HDAC2;NCOA2;SP3;NR1H3;SMC5;NR4A2;RNF2;PML;IKBKE;THRB;RANBP2;TP53;SMC3;NSMCE2;NR3C1;SATB2;TRIM28;HDAC1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6635498084637117,-1.1368171105340557,0.34146341463414637,0.9538927195646945,1.0,1/9,0.37%,ACTC1
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.5487128063234735,-1.1368084633668611,0.2708333333333333,0.9529112174349853,1.0,12/43,14.16%,GPX3;PLA2G2C;CYP2E1;ALOX5;PTGES;CYP4F2;PRXL2B;PLB1;ALOX12B;PTGES2;ALOX15;GPX2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5310275919289701,1.1367464556452036,0.2857142857142857,0.8801081928427315,1.0,6/26,9.44%,TRPC4;MCUB;SLC8A1;SMDT1;CASR;MCU
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5760748055302023,1.1365580746918176,0.32142857142857145,0.880219796654494,1.0,10/23,29.16%,TIFA;MAP2K6;TAB2;IRAK1;TAB3;RIPK2;TAB1;TRAF6;CYLD;IFIH1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5512022119296689,1.136480367916439,0.2619047619047619,0.8800974052862479,1.0,5/32,5.54%,SMAD6;LRP4;ENPP1;BMP2;RBPJ
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.6701595268807546,-1.136293359873068,0.3333333333333333,0.9538955182347607,1.0,4/12,7.02%,F5;F8;F13A1;PROCR
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,0.6664379228588252,1.1362911716844093,0.38636363636363635,0.8803517527666898,1.0,1/10,1.70%,ACE2
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.45046725082319855,1.1362080273708342,0.28846153846153844,0.8801190898463696,1.0,24/82,27.46%,PRKAB2;ACSS2;HDAC3;MTX2;SMARCD3;NCOA2;TBL1X;MEF2C;CREB1;CHD9;HCFC1;GABPA;POLG2;TFB1M;GLUD1;NRF1;CAMK4;TFB2M;LIN9;MTERF1;APOOL;SIRT5;NCOA1;TBL1XR1
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.5513232078395978,-1.1360958088719193,0.21052631578947367,0.9534647431532562,1.0,3/39,4.14%,ALB;AMACR;SLC51A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.49691278703340674,1.1360102737808218,0.23529411764705882,0.8803342445219804,1.0,2/45,2.37%,ESPL1;SNX18
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.518107112133968,1.1357930495878135,0.2413793103448276,0.8806788438948824,1.0,3/33,1.22%,REP15;TCIRG1;ATP6V0D2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4835182615689986,1.1357907283063853,0.2222222222222222,0.8802325326846764,1.0,21/94,14.47%,IL17RD;C1QL1;LRP4;GNG12;CDH2;TENM3;SIX4;CNN3;ADGRL2;LIFR;ADRA2C;MAGI1;SERTAD4;GPR161;GLRB;BCAR1;FIGN;ID4;FJX1;NR2F2;PTPRU
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.46398102779334593,1.1357696967823965,0.18181818181818182,0.8799291662346936,1.0,20/112,16.15%,VEGFC;INSL5;TGFBR1;GNB4;GNG12;INSL3;RELA;RXFP2;GNAI3;PIK3CA;SMAD2;GNG4;MAPK8;SOS1;CREB3L2;CREB1;PLCB1;RXFP1;PIK3CD;MAPK10
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.5412962528905356,1.1357493887563184,0.2765957446808511,0.8795613782810934,1.0,11/42,18.47%,KLKB1;REXO2;H2BC21;MYH11;NCOA2;H2AC6;PPP1R12B;H2AZ2;H2AX;PKN2;RHOB
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5481708113616152,-1.1356781418234498,0.26785714285714285,0.9538532564773741,1.0,3/26,6.62%,KCNMB2;SCPEP1;PER2
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7322698805708664,1.1356683209742542,0.4067796610169492,0.8793815976361128,1.0,3/6,25.10%,SMURF1;FNBP1L;HGS
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7154325376288271,1.1353323363093026,0.38596491228070173,0.8797270950890714,1.0,2/7,12.14%,HGF;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7154325376288271,1.1353323363093026,0.38596491228070173,0.8797270950890714,1.0,2/7,12.14%,HGF;BCAR1
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.4834336971894507,1.1350990243918135,0.23404255319148937,0.880148289764051,1.0,11/55,7.44%,CFH;F2;C3;ITGAX;C6;F2R;KLKB1;CD59;F12;F3;C9
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6451614337978593,1.1350954972495853,0.3050847457627119,0.8797103075869632,1.0,3/10,25.21%,TIMM22;TIMM10;TIMM9
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.47122585668713096,1.1350676863359312,0.24444444444444444,0.8793502150385928,1.0,31/107,21.40%,NXPH1;LSAMP;RIT2;GRM3;KCNC2;SLC17A6;FUT9;NRXN1;OLFM3;SYNPR;MAGI2;GRM5;LRRTM3;CTNNA2;PAK5;TMEM196;NOL4;GABRG1;DLG2;GRM1;CNTN2;SLC1A6;UNC79;CSRNP3;STMN4;RBFOX1;TRPM3;AMER2;CADPS;HTR5A;KCTD16
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.37325527844349327,1.1350489423880865,0.057692307692307696,0.8789646905684823,1.0,186/1190,14.74%,TEX101;PROZ;MITF;ASB17;SEMA5A;C3;UHRF2;LYPD1;TOP2A;RENBP;LSAMP;C1GALT1C1;TUBA1C;MYC;RAB38;HIF3A;TGFBR1;CDC25A;NEGR1;CCNA2;SOCS2;HIF1A;GALNT8;RAB27A;KAT2B;PPARG;H2AC25;ASB18;SPSB2;ENGASE;SEM1;ASB15;CDKN2A;RNF152;SYVN1;SEC22B;CDH2;EVA1A;NRIP1;VCAN;ULBP2;GALNTL5;ST6GALNAC3;RORA;PEX12;H2BC21;SPTBN5;CD59;NANP;RAB31;PENK;RELA;NR5A2;KLHL21;ADAMTS17;ADAMTS16;LY6D;MDGA2;ESR1;RNF185;ALG6;MUC20;FAM20A;RAB3C;ASB5;FBXL3;PIGQ;ST8SIA4;UAP1;RAB39A;STAMBPL1;ADAMTS19;HDAC2;GALNT3;USP12;TF;UBE2D3;TTLL2;SPSB4;SPON1;DCUN1D1;INO80E;ANKRD9;TPGS1;SOCS6;RNF139;FBXO30;UBE2Z;RNF146;GAN;SMAD1;MAGT1;SENP8;ACTL6A;MOGAT2;KCTD6;MANEA;ANK2;UBE2E3;INO80D;RAB23;LMAN1;C1GALT1;KEAP1;ST3GAL6;BET1;TMEM115;SMAD2;PSMD13;LTBP1;GALNT12;NCOA2;NUS1;FBXO7;GALNT1;XPNPEP2;FBXL14;COL7A1;MUC13;FUT8;PIGF;COMMD2;PTP4A2;DCTN3;MUC7;CAMKMT;PRKCSH;NFRKB;TRIM26;SP3;CNTN5;RNF5;TTLL9;SHPRH;KLHL42;VASH2;SMAD4;EGFL7;DYNC1I2;B3GLCT;DMTF1;NTNG2;MVD;NR1H3;MAN2A1;RAB34;ALG9;ANK1;PTEN;H2AC6;SMC5;PPP3CA;UBA6;KNG1;NR4A2;DNAJC3;MAN1A2;POMT2;RAB9A;DCAF5;TANK;HSPA8;RNF2;RAB30;ASB6;CNTN3;MGAT5;PSME4;UBE2J2;NPL;UBA3;TPST2;RAB33B;MGAT4C;PLAUR;PML;KLHL13;FBXL15;RAB27B;SLC35C1;IKBKE;CCP110;B3GALNT2;DERL2;LMAN2L;UBXN7
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.6071486073378762,1.1350391535373818,0.3157894736842105,0.8785666668497025,1.0,2/20,3.50%,SIRT1;CDKN2A
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.4961946092689621,1.1349767888539894,0.2391304347826087,0.8784074606304499,1.0,14/82,17.79%,KAT2B;H2AC25;H2BC21;JADE3;MSL2;ACTL6A;NCOA2;H2AC6;PAX3;EPC1;KAT6A;HCFC1;RUVBL2;SUPT3H
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.49475257866165884,1.134955055779307,0.1956521739130435,0.877568143438998,1.0,19/89,10.66%,VEGFC;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;LTBP2;POSTN;CCDC80;PDGFRA;PLSCR4;CYBRD1;IGFBP6;MEDAG;COL5A3;LOXL2;TPM2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.49475257866165884,1.134955055779307,0.1956521739130435,0.877568143438998,1.0,19/89,10.66%,VEGFC;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;LTBP2;POSTN;CCDC80;PDGFRA;PLSCR4;CYBRD1;IGFBP6;MEDAG;COL5A3;LOXL2;TPM2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.6208838380137934,1.1348063197777258,0.25862068965517243,0.8777506747207224,1.0,2/15,2.71%,FGF10;CD22
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6632409584076979,1.1347593328980339,0.3584905660377358,0.8774893236934586,1.0,4/8,31.51%,PRIMPOL;POLG2;POLG;DNA2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.6214849439684863,1.1346048596177827,0.2903225806451613,0.8775303128416839,1.0,7/14,21.27%,SCD;SLC25A1;SCD5;FASN;ACACA;DIP2A;ACSS1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6269173590557715,1.134585885850658,0.36363636363636365,0.8771151687985543,1.0,5/18,20.02%,SMYD1;HDAC3;PIEZO1;HDAC9;HDAC1
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.49303684582321744,-1.1344361283871296,0.2545454545454545,0.9574285587131076,1.0,12/58,8.48%,P2RY10;SELL;SP140;TRAF3IP3;CD53;CYTH4;APOBEC3G;LTB;ARHGAP15;CD5;TAGAP;PTPN7
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6965401774119293,1.134068821667078,0.36,0.8782734825236003,1.0,5/7,25.72%,PLCG2;FAM3A;CX3CR1;CARD9;BCL10
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.6255540213289698,1.1338946180027356,0.2916666666666667,0.8785963701624939,1.0,8/20,26.53%,TICAM1;UBE2D3;BIRC3;UBE2D1;IKBKB;TMED7-TICAM2;TRAF6;CHUK
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4803683940295247,1.1338195577649373,0.15384615384615385,0.8784058079393936,1.0,9/57,10.85%,MYC;CDC25A;ZBTB1;NEDD4;SAG;CNGA1;RGR;PDE6A;PTPRK
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5030663801189219,-1.1337501702211894,0.2553191489361702,0.9587186869519393,1.0,23/102,14.54%,MS4A8;CFAP61;PVALB;AK8;VWA3A;RGS22;DNAAF1;DRC1;TMEM107;AK7;ANGPTL2;ZBBX;CCDC40;GAS2L2;RSPH1;S100B;CFAP221;APOBEC4;RIIAD1;DNAH2;CFAP52;HDC;ADH7
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.6444796094960353,1.1336704709691554,0.3584905660377358,0.8784590481812616,1.0,1/7,3.79%,BMP2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.6914937147276222,-1.1335705036865327,0.32558139534883723,0.9584343601694759,1.0,2/7,2.27%,NPAS4;DRD4
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.6901311959446773,1.1334446674454548,0.38181818181818183,0.8788133864920653,1.0,1/5,3.69%,MLC1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6670352393173397,1.1334210990106832,0.425,0.8780167518184643,1.0,4/8,24.27%,UQCC3;BCS1L;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6670352393173397,1.1334210990106832,0.425,0.8780167518184643,1.0,4/8,24.27%,UQCC3;BCS1L;SLC25A33;UQCRFS1
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.4536042836341209,-1.1334207473649351,0.26785714285714285,0.9579711860336536,1.0,9/171,5.96%,CYP1A2;UGT2B15;CYP2A6;CYP2E1;GSTT2B;HSD11B1;FOS;PAQR7;DLL4
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.7133050511356203,1.1332319401546171,0.3793103448275862,0.8782940022109427,1.0,3/9,19.15%,NXF5;HNRNPA2B1;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.6917739426371199,1.1330779897861323,0.3076923076923077,0.8783919255501363,1.0,3/9,14.47%,C3;PLA2G10;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5993138149844855,1.133048851028926,0.3220338983050847,0.8780679272414604,1.0,3/18,11.43%,NEDD4;TCAF2;HECW2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5640300495374838,1.1330010197448241,0.2962962962962963,0.877795361429982,1.0,8/27,14.24%,SIRT1;ENPP1;ZFP36L2;RORA;WWTR1;FOXO1;ANKRD26;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.7162261770456261,1.1330001578553592,0.3617021276595745,0.877363452472869,1.0,2/5,7.75%,C3;HMGB1
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.6746982766256006,1.132921986475232,0.35185185185185186,0.877219150158746,1.0,4/9,24.90%,ESR1;VEGFA;KIT;EGFR
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.7481595398789217,1.1328769826111762,0.3220338983050847,0.8768900229171659,1.0,1/5,7.84%,ZNF274
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7058986076153141,1.1327845054465675,0.2982456140350877,0.8767269808023607,1.0,3/7,18.40%,RPIA;DCXR;RPE
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.6936165556948506,1.1327384318696876,0.34,0.8764494100543062,1.0,3/7,12.83%,LRAT;RPE65;BCO1
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,0.4844561160217695,1.1327044805422877,0.26229508196721313,0.8761784884631695,1.0,17/61,13.00%,PLCH1;COL9A1;TMPRSS2;FZD5;MYCN;PRDM14;SYT6;LIN28A;UNC5D;APELA;IGDCC3;MARVELD3;VANGL2;CGN;CHST6;CLDN6;TERF1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5305635124587238,-1.132430605366651,0.3023255813953488,0.9605040186054224,1.0,7/40,18.05%,ABRAXAS1;TICRR;CDC6;BRCA1;CDK1;BLM;MRNIP
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.5208110824998389,1.1324031632810594,0.2413793103448276,0.8767417111088915,1.0,7/47,12.78%,ERBB4;NRG1;NRG3;NRG2;ERBIN;PIK3CA;SOS1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.6384179426221592,-1.1322837123304494,0.23404255319148937,0.959935196336382,1.0,3/15,5.63%,ABCA4;PDE6B;CNGB1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6339383932231923,-1.1322383996383785,0.3404255319148936,0.9591439581101816,1.0,2/15,2.62%,MYH7;STAC
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.5258600587732023,1.1322128366806186,0.3,0.8769671679456092,1.0,23/47,29.57%,RELA;STING1;SIKE1;CASP10;MAPK8;TANK;IKBKE;MAP3K1;MAPK10;FADD;IRF3;IKBKB;NFKBIB;TBKBP1;IL12A;TRAF6;CHUK;NFKB1;NFKBIA;TRADD;CYLD;IFIH1;ATG12
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.4582612468644987,1.132185739885618,0.23728813559322035,0.8766455231892497,1.0,20/161,15.48%,SWSAP1;IGF1;IRGM;PYHIN1;SYVN1;TELO2;ANK2;HIP1;TBL1X;CHEK2;ZNF207;BAG2;PTEN;ATF7IP;MTMR9;CREB1;PRKRA;CCNH;MARCHF7;HCFC1
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,-0.6516670098108641,-1.132037865458332,0.3469387755102041,0.9588308856818276,1.0,4/11,15.40%,CTNNA1;RNASE1;IQGAP3;CALM1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5897322154284852,1.1319212717399207,0.27906976744186046,0.8771758792677075,1.0,8/26,21.36%,CSTA;DSP;SCEL;CERS3;AKR1C3;CASP3;JAG1;ANXA1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.4432030654379293,1.131920353944168,0.22448979591836735,0.8767401069193086,1.0,56/154,24.53%,SCN7A;FSTL5;LSAMP;LRRC4C;EFNA5;CADM2;TOX;CYB561;PCLO;LIX1;PCDH17;NRXN1;NOVA1;OLFM3;ANK2;SCN3A;GUCY1A2;PIK3CA;TAC1;ADGRB3;FBXO7;ZDHHC2;PAK5;TMEM196;CNTN1;ZNF536;TSHZ1;TAFA1;CPE;CNTN2;MAPK10;HMGCLL1;RET;STXBP5;CSRNP3;STMN4;RBFOX1;GAL;SLC7A14;ELAVL4;HIVEP3;MAP2;ADGRL3;GOLGA7B;KCTD16;AKAP6;PPFIA2;CLVS2;PARVA;SNAP91;DCLK1;SNX21;SCRT1;ASXL3;CYTH3;RGS7BP
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6513992839280938,-1.1319158623173677,0.29411764705882354,0.9582655765102204,1.0,5/10,19.02%,XDH;DAB2IP;ADAMTS12;PIK3CB;DCN
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5388386171993951,-1.13172547635625,0.2682926829268293,0.9578128936107302,1.0,4/45,7.09%,CLDN4;CTNNA1;CLDN1;F11R
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5404432003959191,-1.131714475541629,0.2692307692307692,0.9568712688505491,1.0,7/34,16.63%,ERCC1;RFC3;PARP1;GTF2H2;RPA3;RFC2;RFC1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6167016696443636,1.1316663014864567,0.4222222222222222,0.8772127364706704,1.0,4/10,14.66%,SIRT1;SNCA;NOC2L;KLF15
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,-0.6736834223469043,-1.1315906768636381,0.27906976744186046,0.9562949183111891,1.0,1/6,4.76%,APOBEC3G
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6687383443828856,1.131570971627614,0.3559322033898305,0.8771327712370613,1.0,4/6,29.45%,LHX6;PEX13;HTR6;FGF13
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5061515304360897,1.1315123638539304,0.3148148148148148,0.8768562535067711,1.0,19/51,17.13%,EMB;CDH2;TENM3;ROBO2;SDK1;CNTN6;DSCAML1;DSCAM;NECTIN2;PTPRT;CADM1;IGSF11;HMCN1;PLXNB2;PTPRM;L1CAM;CNTN2;CNTN4;MYPN
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.710275398470856,1.1314430419140633,0.32,0.8766751110964631,1.0,2/10,10.27%,HIF1A;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4084782539677936,1.1313983945884725,0.16279069767441862,0.8763674184015576,1.0,41/366,7.51%,VEGFC;IGF1;FGF10;FLT1;IRS1;TCIRG1;FGFR3;ITGAX;MYC;CCL5;SIRT1;TGFBR1;F2R;FGFR1;ERBB4;IL4;FGF2;NRG1;TOX;FBXO5;BMP2;BMI1;PRMT1;CDCA7L;IL7R;HCLS1;CCN4;RBPJ;RELA;PTGFR;HPSE;ITGAV;MEGF10;WWTR1;PDGFRA;POU3F2;FER;IL15;DPP4;HDAC2;LIFR
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4417635822390511,-1.13138051344087,0.2,0.9560382651651712,1.0,12/126,7.93%,TRIP10;ARAP3;RAC2;RASGRF2;OBSCN;STARD8;VAV3;FOXM1;ARHGAP15;ARHGDIB;ARHGAP12;TAGAP
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.7257313688145882,1.1313777851846851,0.37037037037037035,0.8755377315525125,1.0,2/5,22.21%,FER;PDE1B
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.7257313688145882,1.1313777851846851,0.37037037037037035,0.8755377315525125,1.0,2/5,22.21%,FER;PDE1B
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.40467404918925576,1.1313267802449771,0.2549019607843137,0.8752816898505702,1.0,79/446,13.56%,VEGFC;IGF1;FGF10;LAMA4;FLT1;IRS4;IRS1;TCIRG1;ATP6V0D2;COL9A1;FGFR3;MYC;RIT2;FGFR1;ERBB4;HIF1A;STAT5A;ITGA2;MYCN;NRG1;NEDD4;GFAP;COL9A2;RRAD;HNRNPH1;PCSK5;LLGL1;DOCK1;COL6A5;COL6A2;CXCL12;HGFAC;NRG3;RALA;MAPKAPK2;GABRG3;KCNH8;ESR1;ITGAV;MUC20;PDGFRA;HDAC3;F3;NRG2;FER;HDAC2;GALNT3;TF;SOCS6;PDGFC;ERBIN;ATP6V0A4;PAG1;TAB2;FGF17;MAPKAPK3;PIK3CA;RPS6KA2;FLT3;BCL11B;PTPRK;RANBP9;ADAP1;TNS3;MEF2C;NCK2;BCAR1;FLRT2;TIAL1;SOS1;ATP6V0B;HSPB1;FGF5;IGF1R;GABRB2;MXD4;ID4;SH2B2;RAP1A
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,-0.5438665586205622,-1.131303770524108,0.2727272727272727,0.9553233792531157,1.0,10/36,10.18%,SELP;PTGDR;BEND2;F13A1;IFIT1B;ALAS2;P2RY12;MAX;DYTN;CMTM2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.6913962294554417,1.131209404666932,0.42857142857142855,0.8752915090443945,1.0,2/8,10.93%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.590653069896496,1.1311984829308286,0.34,0.8748588671341636,1.0,6/25,13.89%,IDO1;HPD;IDO2;TDO2;CBS;HSD17B10
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6591610490593388,1.1310868532851241,0.3333333333333333,0.8748436181696679,1.0,2/14,8.94%,BOK;ACAA2
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.5370676586697947,-1.1310766893797204,0.24528301886792453,0.9550682600382445,1.0,7/28,7.57%,P2RY10;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;CD5
prerank,Reactome_2022__Creation Of C4 And C2 Activators R-HSA-166786,-0.7282011165766806,-1.1310728969823372,0.45652173913043476,0.9540974057598021,1.0,3/7,9.85%,COLEC10;C1S;MASP1
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,0.7797582717872826,1.1310361204569106,0.3,0.874575808531905,1.0,1/6,1.54%,EMB
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.5427067950607215,-1.1310043081517858,0.34,0.953371978665184,1.0,5/29,2.28%,P2RY10;SIRPG;SELL;TRAF3IP3;SCML4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6388864278412756,1.130699077447762,0.34615384615384615,0.8751855290320625,1.0,5/18,7.75%,LGALS9;SYK;IL4;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7050420613358557,1.1306882809844183,0.3333333333333333,0.874341430303777,1.0,2/7,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7050420613358557,1.1306882809844183,0.3333333333333333,0.874341430303777,1.0,2/7,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7122107073765691,-1.1306485590006765,0.3695652173913043,0.9536354825256916,1.0,2/6,8.91%,ZP3;C1S
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.633710966827848,1.1305904858661466,0.2857142857142857,0.8742193480897313,1.0,7/14,15.72%,GPR55;IL4;MAFB;ZNF675;LRRC17;GPR137B;FBN1
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.7359789350934631,-1.1305439264970771,0.4,0.9529929981581045,1.0,1/5,3.29%,CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6239286817301232,1.1301362637843289,0.3090909090909091,0.8754200982463617,1.0,6/17,20.73%,SYT1;RIMS2;SMURF1;SYT3;CPNE9;SYT17
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.43158388148136934,1.130119573305479,0.20967741935483872,0.8750268937918477,1.0,39/230,14.30%,VEGFC;FGF10;IRGM;F2;C3;EPHA7;HGF;SIRT1;ERBB4;FGF2;EFNA5;ANGPT1;PRR5L;BMP2;PELI2;TNIK;ACVR2A;WWTR1;FAM20A;PPP1R15B;HDAC3;FER;BMPER;CD40;FGF17;LEPR;GRM5;CORO1C;AKTIP;PLXNB2;PTEN;HSPB1;FGF5;CCND3;CD74;DVL2;PLAUR;PML;LRP6
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6658780698192759,1.1297547496522489,0.3448275862068966,0.8760561488774793,1.0,4/12,15.78%,HGF;PYCR1;GPR37;NFE2L2
prerank,Reactome_2022__Transport Of Fatty Acids R-HSA-804914,-0.6987265648582746,-1.1296809452779273,0.3829787234042553,0.9550580270346931,1.0,1/6,3.78%,LCN15
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.48197043572504517,1.1296637570186698,0.2558139534883721,0.8759397438841556,1.0,13/70,16.85%,DERL3;SEM1;RNF185;ABCC2;ABCA1;ABCG8;PSMD13;RNF5;PSME4;ABCG5;DERL2;PSMA1;ABCD4
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5431372012162806,1.1296296899593965,0.23636363636363636,0.875584584919912,1.0,9/45,10.39%,VEGFC;SEMA5A;RSPO3;FGF2;ANGPT1;NRARP;BMPER;EFNB2;LOXL2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.6391300217587953,1.1295587824048317,0.28,0.8753177409499592,1.0,5/8,31.25%,NECTIN2;PLSCR1;LYN;MILR1;CRLF2
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.5206981385866317,1.129532946765843,0.32727272727272727,0.8749506862412083,1.0,6/36,5.19%,TNFSF14;CCL3L3;CCL5;IL2RA;IL10RA;CXCL12
prerank,Reactome_2022__Conjugation Of Salicylate With Glycine R-HSA-177128,0.713488805149427,1.1294310313969185,0.34615384615384615,0.8748727236397548,1.0,2/6,11.05%,ACSM2A;GLYATL2
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6839678707356859,-1.1293771572270281,0.43636363636363634,0.9542878029817214,1.0,2/7,13.04%,DGAT2L6;DGAT1
prerank,Reactome_2022__Acyl Chain Remodeling Of DAG And TAG R-HSA-1482883,-0.6839678707356859,-1.1293771572270281,0.43636363636363634,0.9542878029817214,1.0,2/7,13.04%,DGAT2L6;DGAT1
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.6072865863440051,1.1291082151025325,0.34615384615384615,0.8755978516559558,1.0,9/19,22.21%,PRKG1;PDE1A;GUCY1A2;GUCY1A1;KCNMB4;PDE9A;KCNMB1;NANOS1;PDE1B
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.42738230958103457,1.1288183345045726,0.23076923076923078,0.8762219314648231,1.0,33/164,16.07%,PLD6;FGF2;PIK3R6;LPIN3;PIK3R5;ABHD3;PIP4K2A;SLC44A5;PIK3C2B;PLCG2;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;INPP4B;CPNE7;PIK3CA;ACP6;CPNE1;SELENOI;ABHD8;PTEN;MTMR9;CPNE3;MTMR3;PI4K2B;PLSCR1;PITPNM1;ETNK1;SLC44A4;ETNPPL;PIK3CD
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5483379995565923,1.1287427966026262,0.2807017543859649,0.8760619781234419,1.0,9/28,19.15%,SLC1A3;SLC38A3;SLC7A2;SLC7A9;SLC25A13;SLC3A2;SLC1A6;SLC36A1;SLC25A12
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.759650428265581,-1.128717365358952,0.39215686274509803,0.9557953192558695,1.0,1/5,7.82%,OAS3
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.599313359441872,1.1285004257721079,0.4339622641509434,0.8763719976498549,1.0,7/18,26.81%,TP53INP1;BNIP3L;TP53BP2;TP53;PPP1R13B;BID;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6876045591894311,-1.1284560832318817,0.43137254901960786,0.9558789562438256,1.0,4/8,23.40%,CYP4F2;ALOX12B;AQP1;ABCB11
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,-0.6884789665894813,-1.128339560770281,0.391304347826087,0.955186906239931,1.0,2/9,3.43%,ENPP2;PRKCD
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,0.6605249616877656,1.1283210570198312,0.36363636363636365,0.8765189212596244,1.0,6/12,29.16%,SIKE1;IKBKE;IRF3;EP300;TRIM4;IFIH1
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,0.46509460464227453,1.128202771686541,0.19230769230769232,0.8764967339317501,1.0,15/92,10.07%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;BGN;COL6A2;CXCL12;POSTN;CCDC80;PDGFRA;CNRIP1;PCDH18;MEDAG;TNC
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.6345976629930221,1.1281125469906406,0.32653061224489793,0.8763557263129652,1.0,2/10,10.21%,DCP1B;PATL2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6784640800098303,1.1280100609690384,0.37037037037037035,0.8763086349223058,1.0,3/11,7.89%,HIF1A;TF;SNCA
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4370183009252592,1.1279816519389771,0.2631578947368421,0.8759554060604581,1.0,21/121,10.13%,DRD5;CHRM2;LGR5;ADGRL4;HTR1F;CALCR;OPRK1;INSL3;ADGRG6;ADGRG4;PTGFR;RXFP2;ADGRL2;ABCA1;GRM8;GPR12;GPR26;RAMP3;GNAI3;GPR161;ADGRB3
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,-0.5167915708842883,-1.127935087480455,0.3,0.9546101815714605,1.0,10/48,8.25%,SIRPG;SELL;TRAF3IP3;CD53;CYTH4;KLRB1;HCK;CD5;TAGAP;TMC8
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,-0.5167915708842883,-1.127935087480455,0.3,0.9546101815714605,1.0,10/48,8.25%,SIRPG;SELL;TRAF3IP3;CD53;CYTH4;KLRB1;HCK;CD5;TAGAP;TMC8
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.5347259885728393,-1.1276391045021468,0.3191489361702128,0.954731154696319,1.0,10/36,13.11%,SCN5A;KCNE2;CACNA1G;DSG2;KCNE1;KCNQ1;KCNA5;CTNNA3;SCN3B;CAV1
prerank,Reactome_2022__Defective CHST3 Causes SEDCJD R-HSA-3595172,0.7100763495824217,1.127557352835108,0.3541666666666667,0.8769890415928364,1.0,2/8,4.37%,VCAN;BGN
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6819002632812523,1.1275237932582975,0.41379310344827586,0.876679522900064,1.0,5/7,31.55%,MOGAT2;DGAT2;PLA2G15;PNPLA2;MOGAT1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5054853894439872,1.1274472113558718,0.30434782608695654,0.876501337562893,1.0,6/53,7.75%,LGALS9;SYK;FZD5;TLR2;PLCG2;HMGB1
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.45617071121184344,1.1274464115275888,0.19230769230769232,0.8760676407110559,1.0,19/90,19.70%,VEGFC;FLT1;DOCK1;MAPKAPK2;ITGAV;MAPKAPK3;PIK3CA;NCK2;BCAR1;HSPB1;RICTOR;PKN2;CTNNB1;VEGFA;VAV2;PRKACB;MLST8;AKT3;THEM4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.737829830959355,1.1274038254080543,0.38,0.875790202956553,1.0,2/5,12.69%,RBPJ;GREM1
prerank,KEGG_2021_Human__Thiamine metabolism,-0.653850609063392,-1.127334167936393,0.3695652173913043,0.9548373086659052,1.0,2/11,8.48%,AK8;AK7
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6901237330799409,1.1272843194282332,0.3050847457627119,0.8757809348003753,1.0,3/13,14.44%,PPARG;RELA;NFATC3
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.6091225530018137,1.1271963083438121,0.35185185185185186,0.8757218594386438,1.0,4/19,7.20%,ERBB4;NRG1;NRG3;NRG2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.701339275364036,1.1271418157568465,0.37037037037037035,0.8755072431631427,1.0,3/8,22.30%,LRRC55;NPPA;AKAP6
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.5263484831183511,-1.1270719923216552,0.32,0.954703040491349,1.0,5/34,5.72%,LRP10;AGRN;GPC2;GPC1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6097252234947079,1.1270206831585934,0.4523809523809524,0.8754794657000199,1.0,7/19,14.10%,SMAD6;LRP4;ENPP1;RBPJ;MEF2C;GREM1;BCOR
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.7267273822551672,1.1268972937032609,0.25,0.8755574187429056,1.0,1/5,15.61%,CTU1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.7068358176541241,1.1268139953123149,0.2777777777777778,0.8754302077189536,1.0,2/11,4.31%,PADI2;PRMT1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6150951351246545,1.126650943699908,0.35294117647058826,0.8755143199003013,1.0,8/10,29.59%,SLC8A1;MYH11;VEGFA;JAG1;ALPK3;ALPK2;CXADR;NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.618766049437153,1.1266201738256731,0.30357142857142855,0.8751885789450559,1.0,4/11,20.78%,INSIG1;CD81;GCC2;SAR1A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.6740923662449589,-1.126616114271681,0.3695652173913043,0.9553325608414776,1.0,1/9,0.96%,MPO
prerank,Reactome_2022__Activated NTRK3 Signals Thru PI3K R-HSA-9603381,0.7515163882962068,1.126614178058381,0.3333333333333333,0.8747762805901509,1.0,2/5,9.52%,IRS1;PIK3CA
prerank,PanglaoDB_Augmented_2021__Microglia,0.47836027809161513,1.126544630923358,0.24074074074074073,0.874544261397644,1.0,16/94,9.04%,LGALS9;TCIRG1;ITGAX;TGFBR1;CSF3R;SASH3;MAFB;PIK3R5;PTGS1;IL10RA;FGL2;LAIR1;HPGDS;SIGLEC1;CD40;STING1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5806392377632678,1.126431618007788,0.32727272727272727,0.8744922553382746,1.0,3/21,8.14%,SOCS2;STAT5A;SOCS6
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.5797312953607027,1.1263389101594816,0.3333333333333333,0.8743969254007383,1.0,1/18,2.55%,STAT5A
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.3895577416848617,1.1263375544924916,0.14583333333333334,0.8739734397076886,1.0,103/506,18.80%,SCN7A;ITGA10;SEMA5A;COL9A1;UNC5C;EPHA7;FGFR1;NRTN;ITGA2;EFNA5;UTRN;COL9A2;RRAS;SEM1;TRPC4;DCC;LLGL1;EFNA2;ROBO2;DOCK1;COL6A5;ADGRG6;COL6A2;SPTBN5;ADGRV1;CXCL12;CACNB4;UNC5D;ENTHD1;ITGAV;WWTR1;MYL12A;EPHA5;POU3F2;ST8SIA4;NEO1;RPS6KA4;EPHA3;HDAC2;CNTN6;SCN10A;SCD5;ALCAM;DSCAML1;ABL2;EPHA8;MYH11;ANK2;GFRA1;SCN3A;DSCAM;PIK3CA;PSMD13;PLXNB1;RPS6KA2;EFNB2;SCN2B;ITGA1;RPS5;RANBP9;DNAAF3;CNTN1;NCK2;MAPK8;ANK1;SOS1;SCN9A;HSPA8;SEMA3E;RPL21;TRPC5;PSME4;CREB1;RPS6KA1;SEMA6D;L1CAM;HJV;DNM3;NELL2;CNTN2;GJB1;GAB2;PSMA1;LIMK2;RPL18A;PKN2;RPS6KA5;ARTN;FLRT3;RPL7;KCNQ3;RET;NUMB;WASL;FARP2;VAV2;EFNA1;RPS3A;IRS2;RHOB;COL9A3;ADAM10;PDLIM7
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.7042883202422962,1.1262965520237869,0.3488372093023256,0.8736432251698695,1.0,1/5,4.40%,SIX4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.7182679883544882,1.1262837668477133,0.37254901960784315,0.8732885856290551,1.0,1/6,13.09%,TANK
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5501647440063202,-1.1262684000174732,0.28205128205128205,0.9555903290306925,1.0,6/30,18.05%,ABRAXAS1;TICRR;BRCA1;CDK1;BLM;MRNIP
prerank,Reactome_2022__FGFR1b Ligand Binding And Activation R-HSA-190370,0.7161434414750922,1.1262138926877387,0.3898305084745763,0.8730703480313493,1.0,2/5,2.08%,FGF10;FGFR1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.5290647465854923,1.1261066680709089,0.2692307692307692,0.8730315803387338,1.0,11/37,17.59%,SCRIB;ARHGAP5;VANGL2;RASAL2;MUC13;PICALM;ANKRD26;DST;PKP4;KTN1;ARHGAP21
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5223002228023746,1.1260336289010688,0.28,0.872863108329675,1.0,9/44,12.26%,TGFBR1;FGFR1;BMP2;PCSK5;SIX4;CHD7;FUT8;LIG4;PROX1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6380825079234432,-1.1259864735566028,0.3829787234042553,0.9556516400155983,1.0,2/12,3.48%,TAFA3;IL31RA
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.6380937287788495,1.1258846996318206,0.35714285714285715,0.8728985823105617,1.0,2/8,18.05%,PEX11A;MFF
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),-0.7013624588878989,-1.1258569195386112,0.34146341463414637,0.9550748729377109,1.0,3/5,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.7300212581276356,-1.1258481543014212,0.4166666666666667,0.9541299243784026,1.0,1/5,0.85%,MYH7
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.6855586437183068,1.125835754973699,0.35714285714285715,0.8726377581180466,1.0,4/8,26.67%,SPX;ACSL1;SLC27A1;CD36
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.4979258990097198,-1.1257521350910837,0.2857142857142857,0.9525999020728447,1.0,11/68,10.18%,ARAP3;TEK;ZDHHC19;TP53I11;WDR86;NHSL2;OLFM1;ADGRG3;RNF175;CA4;CMTM2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.4979258990097198,-1.1257521350910837,0.2857142857142857,0.9525999020728447,1.0,11/68,10.18%,ARAP3;TEK;ZDHHC19;TP53I11;WDR86;NHSL2;OLFM1;ADGRG3;RNF175;CA4;CMTM2
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.5977934025277324,1.1257021074869997,0.37254901960784315,0.8727349990116559,1.0,3/16,16.70%,FRAT2;FRAT1;CTNNB1
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.5548250587691341,1.1255341808363277,0.25925925925925924,0.8728198125266566,1.0,2/29,2.08%,FGF10;FGFR1
prerank,CellMarker_Augmented_2021__Stem cell:Hair Follicle,0.7955207179230205,1.1254790750849932,0.35185185185185186,0.8725285939782199,1.0,1/5,1.93%,LGR5
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6370066864614743,1.1254688596222537,0.3617021276595745,0.872126778516929,1.0,4/16,15.69%,SLC8A1;SLC9A2;SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6493487779014219,1.1253470035607451,0.3888888888888889,0.8720701520509487,1.0,3/12,7.56%,VCAN;BGN;DSEL
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,0.6972799738677865,1.125322288937092,0.35714285714285715,0.8717243394867515,1.0,2/8,7.17%,RENBP;UAP1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.6830937190822276,1.1250852685963857,0.3333333333333333,0.8721477480697778,1.0,2/6,13.65%,NEUROD2;DBN1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.541206298071339,1.1249732882770724,0.23728813559322035,0.8720481577645465,1.0,6/38,8.18%,MYC;RFWD3;FBXO5;SMYD2;WDR76;SMG1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5048250135211295,-1.1248443442070069,0.25925925925925924,0.9549527291547046,1.0,8/56,9.14%,SELE;XCR1;NMUR2;P2RY11;BTK;CAMKK2;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6324919230906912,1.1246679734290392,0.3673469387755102,0.872649202635159,1.0,7/12,32.22%,SCRIB;SYNE4;RAP2A;ZDHHC7;MYO9A;OPHN1;RAB10
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.6507710267692974,1.12460359726093,0.35555555555555557,0.8724819021864375,1.0,5/10,12.69%,BMP2;SOX6;EFNB2;MEF2C;GREM1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.45966895128811175,1.1245582980474242,0.25,0.872204261201964,1.0,31/127,18.76%,SLC26A3;DRD5;CCL5;RAPGEF3;URI1;INSIG1;AANAT;SLC26A6;NRIP1;RORA;ESR1;RAMP3;CRHBP;STING1;HCN1;ATP1A2;MEF2C;TIPARP;GABRB2;RAP1A;TRPM2;NCOA3;CTNNB1;RORC;RUVBL2;LCOR;RIOK3;SSTR1;RYR3;CASP3;GABRB1
prerank,Reactome_2022__Calcitonin-like Ligand Receptors R-HSA-419812,0.7455946627619809,1.1244458890256428,0.3157894736842105,0.8722091509497224,1.0,4/6,20.11%,CALCR;RAMP3;CALCRL;IAPP
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.48374619416573766,1.1243407884694232,0.17857142857142858,0.8722140359386025,1.0,11/93,9.15%,RUNX1;SYK;TGFBR1;RAPGEF3;LRP4;NRG1;NRXN1;NEUROD2;SNCA;FRMPD4;LMAN1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7462863736478716,1.1243049728392602,0.3508771929824561,0.8719246701044754,1.0,2/5,24.89%,TANK;OTUD4
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.654759097683983,1.1240882046389986,0.23404255319148937,0.8722728088382974,1.0,1/11,2.61%,KCNC2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.679195702940308,1.1240728402847076,0.37735849056603776,0.8718918331198676,1.0,5/15,7.07%,ROBO2;TLR2;PCM1;ELAPOR2;PAX6
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.5056609533088147,-1.124063776232388,0.32,0.9567021389789012,1.0,10/44,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;SCML4;ZC3H12D;LTB;KLRB1;CD5;TAGAP
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.582733203373518,1.1240405814272025,0.3090909090909091,0.8716030453820598,1.0,5/18,13.08%,FGF10;FGFR1;FGF17;PIK3CA;FGF5
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.41498513003231235,-1.1240095135518466,0.25,0.9559404515269426,1.0,12/306,4.30%,CD44;NTRK1;TEK;INHA;TERF2IP;FGF1;IL11;ENPP2;TEC;ANGPT4;IL6R;ATG14
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.4672240998701692,1.1239842814360932,0.27586206896551724,0.8713512473606311,1.0,17/74,10.66%,LAMA4;CFH;MRGPRF;ADGRL4;MSRB3;SSC5D;BGN;COL6A2;LTBP2;POSTN;ERG;ABI3BP;PLSCR4;CYBRD1;GSN;MEDAG;TPM2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.41711308690216264,1.123970972883403,0.2127659574468085,0.8709651580801387,1.0,42/258,10.39%,NOX5;ADRA1A;ITGAX;SYK;ESRRG;SIRT1;SOX5;TGFBR1;IL26;F2R;ZBTB7B;IL4;FGF2;TRPM8;SNAI1;SCD;TRPV2;FBXO5;BMP2;ADIPOR2;NLGN1;SIX4;SOX6;PRKAB2;APELA;PLAC8;WWTR1;HDAC3;IL15;ABCA1;CCDC88B;ACHE;PDGFC;PAXIP1;KDM3A;TMIGD2;LEPR;SMAD2;EZH2;HAP1;CADM1;LOXL2
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,0.6975354067740285,1.1237379746482914,0.40816326530612246,0.8713801531470556,1.0,2/8,4.37%,VCAN;BGN
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5000610352762299,1.123706555529656,0.1836734693877551,0.8711349386575435,1.0,18/64,16.58%,FGFR3;RAPGEF3;GRIN3A;BMP2;DCC;ELAPOR2;ZNF706;NEUROD2;KANK1;HYAL3;LOXL2;SINHCAF;SPRY3;GREM1;KLF7;KIAA0319;ANP32B;HEY2
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6092290915133676,-1.1236940101011728,0.3333333333333333,0.9561088931671102,1.0,3/11,13.61%,NLRP1;IRF5;NOD1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5206004490459191,-1.1236682197634225,0.23636363636363636,0.9552414651513426,1.0,11/51,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.48569461336795017,1.1236648812923185,0.19148936170212766,0.8708288981159656,1.0,12/89,10.93%,TOP2A;MYC;NDC80;SIRT1;PADI2;RFWD3;HDAC3;HDAC2;LATS1;LRWD1;EZH2;LIG4
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.7047063635774824,-1.1236448784684254,0.40816326530612246,0.9543470430869573,1.0,1/8,0.37%,ACTC1
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,0.6732456177058846,1.1236273642222705,0.3448275862068966,0.8705109471632473,1.0,2/8,24.21%,HSD17B10;MTO1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.7587358785619451,1.1235761363209464,0.3148148148148148,0.8703580162894737,1.0,2/5,16.47%,TNFRSF21;CLC
prerank,Reactome_2022__Methionine Salvage Pathway R-HSA-1237112,-0.6977088693730877,-1.1235729674434374,0.45,0.9537414857454177,1.0,1/5,0.88%,APIP
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5808185851050174,-1.1234660403823573,0.34615384615384615,0.9531084636606199,1.0,2/14,2.46%,DND1;ZC3H12D
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.6281998642002988,-1.1230648229348112,0.34146341463414637,0.953551068063537,1.0,4/10,21.69%,ALAS2;MED1;NCKAP1L;G6PD
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.577374896464333,1.122828208439155,0.29310344827586204,0.8725893573165479,1.0,6/22,13.37%,PPARG;ITGAV;ABCA1;PLA2G10;NR1H3;MSR1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5041617582391823,1.1228269649454214,0.23214285714285715,0.8721674088845766,1.0,11/42,24.86%,FZD5;HTRA2;INF2;SIRT7;MFF;IAPP;MARCHF5;PID1;SREBF2;MIEF2;EP300
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3852132233263651,1.122752814221995,0.1568627450980392,0.8719529830521069,1.0,130/857,14.02%,CRX;GATA4;MITF;LGALS9;IGF1;FGF10;RBM20;RUNX1;ITGAX;ACE2;ITGB8;MYC;ESRRG;SIRT1;TGFBR1;ZBTB7B;TULP3;CDK11A;IL4;HIF1A;RAB27A;MYCN;FGF2;ICOSLG;ANGPT1;CALCR;TFEB;SFMBT2;PCBP3;PRDM8;ACTG2;HNRNPH1;WNT4;HES6;MAFB;HMG20B;POU6F2;RORB;BMP2;BMI1;NFIL3;PRDM14;RORA;SP1;AFF2;HCLS1;ZNF462;CCN4;SOX6;SLC8A1;RBPJ;RELA;NR5A2;ZNF804A;MOV10;TLR2;ESR1;NFKBIZ;TEAD2;NFIA;WWTR1;ABCC2;PLCG2;VSIR;TICAM1;ELAVL2;SLC39A8;F3;PAX6;RPS6KA4;CHD7;AGR2;NOVA1;CIAO3;SSBP2;TOB1;ZNF274;RYBP;ATXN1;RAMP3;SMAD1;YAF2;ZNF195;GPBP1L1;RIMS2;ANK2;FGF17;ZNF675;RO60;CTCFL;BTN2A2;GSN;FASTK;METTL18;NCOA2;EZH2;NFKBID;BMPR1A;ZNF114;NR1D2;HP1BP3;CPNE1;TRIM26;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;MAPK8;PROX1;TIPARP;CD34;ZNF117;ZNF281;MYB;ZNF212;MAGED1;FGF5;PICALM;RBMS3;MSR1;MYOM1;SPIN1;MLF1;ACVR1B;CD74;MLXIPL;DVL2;PML
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,-0.6537959351400319,-1.122746657694011,0.3181818181818182,0.95359209425928,1.0,3/8,14.23%,OAS3;OAS1;OAS2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7150078652662066,-1.1227435201218257,0.36585365853658536,0.9526466028885052,1.0,2/5,17.02%,GOLGA2;CHP1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.38355120384905356,1.1224232000007448,0.13725490196078433,0.8726764190643136,1.0,210/1135,19.47%,GATA4;ZNF804B;SMAD6;CCNG1;TNFRSF18;RUNX1;ZNF300;RSPO3;HNF4G;MYC;ESRRG;ZNF792;SIRT1;CCNA2;U2AF1;KAT2B;PPARG;REXO2;MED17;SEM1;RRAD;OPRK1;ZNF493;CDKN2A;LMO1;RORB;BMP2;NPY;MLLT3;IL2RA;THOC6;COX19;PRMT1;ZNF582;RORA;H2BC21;RBM14-RBM4;SMYD2;FKBP5;RBPJ;RELA;NR5A2;MOV10;LMO2;PIP4K2A;PRKAB2;ESR1;MAP2K6;TEAD2;ZNF599;WWTR1;ZNF543;GAMT;ABCA6;ZNF706;TP53INP1;ZNF595;DYRK2;HDAC3;BANP;HDAC2;LIFR;PAPOLA;UBE2D3;PPM1A;ZNF274;RYBP;FOXO3;SMAD1;YAF2;ZNF41;ZNF195;ACTL6A;ZNF202;ZNF561;KCTD6;ARID2;TAF3;ANAPC16;ZNF675;SMARCD3;SMAD2;PSMD13;ZNF771;ZNF426;MAP4K2;PCF11;EZH2;ZNF669;ZNF692;FOXO1;TNFRSF10B;E2F4;CASP10;TBL1X;ZNF114;CNOT6L;NPPA;NR1D2;DAND5;CHEK2;SMAD4;PLAGL1;ZNF704;ELOF1;CNOT4;NR1H3;MEF2C;BNIP3L;TP53BP2;RRAGC;ARID1A;ZNF347;IRAK1;PTEN;ZNF175;H2AC6;ZNF778;CDK12;INTS6;MYB;FASN;ZNF212;NR4A2;RNF2;H2AZ2;NOC2L;PSME4;ARID1B;CCND3;MOBP;PML;WWOX;RARB;CREB1;SMARCD2;ZNF263;CCNH;EPC1;KAT6A;POU2F1;PCGF5;TAF5;ZNF442;RICTOR;HIPK1;H2AX;THRB;COX6A1;FOXO6;ZNF257;ZFP30;ELL2;TAF2;SGK1;PRKAA1;ZNF607;CNOT8;ZNF682;PSMA1;SRSF11;NOTCH2;ZNF776;ZNF584;HEY2;CNOT2;CTNNB1;SMARCA2;NELFB;RORC;MNAT1;ARTN;ZNF786;SCO2;GTF2B;VEGFA;TGIF1;PERP;CDK4;TP53;AGO3;CTSV;MED30;CITED2;EED;ZNF12;ZNF30;JMY;ZNF234;RRAGD;ZNF33A;ZNF738;INTS11;KDM5B;KIT;HDAC9;CSTF3;SMURF1;RBFOX1;ZNF782;MLST8;TNFRSF10A;NR3C1;CCN2;ZNF519;ZNF311;AKT3;ABL1;JAG1;POLR2H
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.7713610525013161,1.1223330597115224,0.43636363636363634,0.8726384406016017,1.0,2/5,12.84%,ZBTB7B;ITK
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.7312556786768893,1.1222401321121886,0.32608695652173914,0.8725214225328813,1.0,2/7,11.08%,PLD6;PRKCSH
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.5558454044500499,1.1221609070972356,0.26785714285714285,0.8723801979402633,1.0,7/27,13.08%,FGF10;FGFR1;FGF17;PIK3CA;FLRT2;SOS1;FGF5
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.49644020471688677,1.12180763302624,0.27906976744186046,0.8731749558047335,1.0,17/64,16.62%,TEX101;LYPD1;LSAMP;NEGR1;ULBP2;LY6D;MDGA2;PIGQ;XPNPEP2;PIGF;CNTN5;NTNG2;CNTN3;PLAUR;GPAA1;PIGP;CNTN4
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.4449443169457033,1.1217991610294036,0.21818181818181817,0.8727723705827228,1.0,29/144,10.79%,MITF;IGF1;FLT1;CDKN2C;RUNX1;TMPRSS2;MYC;PBX3;CCNA2;MYCN;PPARG;BMI1;MLLT3;SIX4;FLI1;SP1;RELA;ZEB1;LMO2;ERG;NFKBIZ;HDAC2;CD40;CDK14;SMAD1;FLT3;FOXO1;BCL11B;FUT8
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6915912975025725,1.1217627915856978,0.34615384615384615,0.8724794524566856,1.0,2/6,21.16%,IL33;MAPK3
prerank,Reactome_2022__Insulin Processing R-HSA-264876,0.5564231102071877,1.1217048626577764,0.32608695652173914,0.8722657022925295,1.0,6/24,17.39%,RAB27A;MYRIP;SLC30A6;CPE;PCSK2;EXOC6
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7240677645277306,1.121255964748042,0.4375,0.8735199425956682,1.0,7/7,27.62%,PLA2G10;ABCG8;ABCG5;ABCA2;SREBF2;SHH;NFKB1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.7109442634733051,1.1211686538368686,0.2608695652173913,0.8733362091272364,1.0,1/7,0.30%,GPR55
prerank,Reactome_2022__SOS-mediated Signaling R-HSA-112412,0.7628773547163832,1.121148744824472,0.2909090909090909,0.8729829892865439,1.0,4/6,22.25%,IRS1;SOS1;IRS2;GRB2
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,0.7433191800354649,1.1211402716528573,0.39215686274509803,0.8726119394696614,1.0,3/6,16.08%,STAT5A;FLT3;GAB2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.6159683821205133,-1.1211272686029197,0.35,0.9574300407971141,1.0,4/14,10.55%,P2RY11;P2RY12;KCNJ11;TRPV1
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.5612510611402105,1.1210316230482598,0.25,0.8726105140727277,1.0,6/26,7.69%,TNFSF13B;IL4;ICOSLG;CXCL12;IL15;CD40
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,0.493228618559448,1.120926917298192,0.26,0.8725062286998178,1.0,14/75,10.70%,PNP;SIPA1;TCIRG1;FERMT3;SHMT2;C19ORF38;THOC6;GPSM3;RPIA;ELF4;MAPKAPK3;NFKBID;ARHGAP45;E2F4
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.6910228135331656,-1.1209178837358278,0.40476190476190477,0.957310132638099,1.0,2/7,15.60%,CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6499954145026559,1.1206306560289605,0.3269230769230769,0.8731035840255065,1.0,2/8,17.08%,AUP1;SQLE
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6611001360880912,1.1206206381197754,0.3157894736842105,0.8726969190356086,1.0,8/12,23.73%,ZBTB1;TICAM1;IL23R;HLA-E;HLA-F;AXL;GAS6;IL12A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6185027735940545,-1.1204687569852112,0.25,0.9578176151586906,1.0,2/16,5.43%,SCN5A;PTPN3
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6768868240085852,1.1204294465562439,0.4406779661016949,0.8728948404955695,1.0,3/7,26.60%,MEGF10;ANXA1;THBS4
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7447535602412819,1.1204112064422522,0.38596491228070173,0.8721311684646978,1.0,1/5,5.82%,NAPEPLD
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7447535602412819,1.1204112064422522,0.38596491228070173,0.8721311684646978,1.0,1/5,5.82%,NAPEPLD
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.547032525489249,1.120090419476195,0.2608695652173913,0.8727574400105051,1.0,7/22,17.47%,ITGB8;APELA;AGGF1;EGFL7;HAS2;HEY2;VEGFA
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.6561437466781752,-1.1198071224656296,0.41509433962264153,0.95898621372061,1.0,2/8,12.13%,ENTPD2;ENTPD5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5753780440090515,1.1197854976848847,0.36065573770491804,0.8734253250669433,1.0,4/23,12.35%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.678317348635964,1.1196782787304764,0.3898305084745763,0.8733029664524533,1.0,3/9,10.13%,C3;EPHA8;ADGRB3
prerank,KEGG_2021_Human__Mineral absorption,0.5126550788730554,1.1194129842507943,0.3333333333333333,0.8737771638521176,1.0,10/42,17.33%,SLC26A3;SLC26A6;SLC8A1;TF;CYBRD1;ATP1A2;MT1M;TRPM7;SLC30A1;SLC34A2
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.4609881873478625,-1.119352361725233,0.24444444444444444,0.95952658402892,1.0,2/71,1.76%,TERT;TERF2IP
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.5439263378229426,-1.1191263784244432,0.2608695652173913,0.9594761251355864,1.0,10/40,7.93%,P2RY10;TBC1D10C;SIRPG;TRAF3IP3;SCML4;LTB;KLRB1;ARHGAP15;CD5;TAGAP
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.436897448602952,1.1190971973401416,0.2127659574468085,0.8743773650483082,1.0,16/104,12.96%,GATA4;SCN7A;KCNK2;KAT2B;SLC8A1;WWTR1;SCN10A;FGF12;FGF14;SCN3A;SCN2B;NPPA;KCND2;ATP1A2;KCNIP4;SCN9A
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.4578330758869097,1.1190574239457862,0.22807017543859648,0.8740801794875809,1.0,13/81,7.08%,MXRA5;MRGPRF;SEMA5A;NYNRIN;ADGRL4;ACTG2;BGN;CXCL12;FBLIM1;EFS;POSTN;PDGFRA;FAM114A1
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,-0.5956981048820407,-1.1190514725015428,0.3191489361702128,0.9587585125707225,1.0,1/15,0.23%,RFX6
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.5546079159611539,-1.119028934034008,0.3191489361702128,0.9578934028311723,1.0,4/28,2.28%,P2RY10;SIRPG;TRAF3IP3;SCML4
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.4836982046245413,1.118944408815813,0.2727272727272727,0.8732864877874857,1.0,20/95,13.49%,LYPD1;EDIL3;FGF2;MMP16;TRPC4;CDH2;TENM3;NLGN1;CNN3;TMEM200C;ADGRL2;PTPRD;GPR176;PCDH18;FAM171B;ANK2;GLRB;KHDRBS3;FIGN;COL11A1
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.4836982046245413,1.118944408815813,0.2727272727272727,0.8732864877874857,1.0,20/95,13.49%,LYPD1;EDIL3;FGF2;MMP16;TRPC4;CDH2;TENM3;NLGN1;CNN3;TMEM200C;ADGRL2;PTPRD;GPR176;PCDH18;FAM171B;ANK2;GLRB;KHDRBS3;FIGN;COL11A1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.4836982046245413,1.118944408815813,0.2727272727272727,0.8732864877874857,1.0,20/95,13.49%,LYPD1;EDIL3;FGF2;MMP16;TRPC4;CDH2;TENM3;NLGN1;CNN3;TMEM200C;ADGRL2;PTPRD;GPR176;PCDH18;FAM171B;ANK2;GLRB;KHDRBS3;FIGN;COL11A1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4809028121013391,1.1189234658825982,0.24,0.872948336945154,1.0,12/77,11.85%,SMAD6;SIRT1;TGFBR1;LTBP2;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5971615003611584,-1.1188541520195339,0.2926829268292683,0.957639263568116,1.0,2/19,10.85%,FGF1;GTF2F1
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,0.6042021775157496,1.118774925974423,0.40350877192982454,0.8729347537369692,1.0,2/13,2.08%,FGF10;FGFR1
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,-0.6521712969647573,-1.1185663349098063,0.35555555555555557,0.9575130199099786,1.0,3/7,17.89%,DUSP6;DUSP9;DUSP16
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6863884614250093,1.1184644783817062,0.34615384615384615,0.873653389124887,1.0,2/10,4.84%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7451592381609992,1.1183730356687789,0.28,0.8735375031720491,1.0,4/5,25.46%,SETD2;SETMAR;ASH1L;SETD5
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.47478350862964347,-1.118255749932254,0.24561403508771928,0.957599137369161,1.0,13/60,8.48%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP;PTPN7
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.670165188616378,1.1181987336636985,0.3888888888888889,0.8736855503942129,1.0,2/7,17.90%,GAL3ST1;B4GALT3
prerank,KEGG_2021_Human__Alzheimer disease,0.4046280038396888,1.118194136708829,0.2545454545454545,0.8732701031519902,1.0,56/299,21.16%,IRS4;IRS1;MME;TUBA1C;NDUFC2-KCTD14;FZD5;SEM1;WNT4;FRAT2;RELA;WNT9A;SNCA;ATG101;MCU;GRM5;PIK3CA;PSMD13;BACE2;KLC2;MAPK8;PPP3CA;FZD1;PPP3CC;GRIN2D;HSD17B10;DVL2;LRP6;FZD4;FRAT1;FZD6;ATF6;SLC25A31;PLCB1;COX6A1;PPIF;PIK3CD;MAPK10;PSMA1;CTNNB1;FADD;CSF1;WNT2;NDUFB11;IRS2;RYR3;CASP3;ADAM10;TUBB1;ATG2B;AKT3;PIK3R3;BAD;IKBKB;DDIT3;PSMD4;MAPK3
prerank,KEGG_2021_Human__Viral carcinogenesis,0.4550196575944089,1.118142609068217,0.21568627450980393,0.8730407493678742,1.0,38/158,21.36%,ATP6V0D2;C3;SYK;CCNA2;STAT5A;KAT2B;CDKN2A;H2BC8;H2BC21;RBPJ;RELA;MAPKAPK2;SCRIB;HDAC3;HDAC2;PIK3CA;GSN;HLA-E;PXN;CREB3L2;CCND3;CREB1;PIK3CD;GTF2B;CDK4;TP53;RASA2;CASP3;HDAC9;PRKACB;IRF3;LYN;HLA-F;HDAC1;PIK3R3;BAD;MAPK3;HLA-B
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6694014005612736,-1.1180843242708736,0.3953488372093023,0.9572188998881426,1.0,3/9,8.31%,SLCO2A1;ABCC4;ABCC3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.42459227721356274,1.1179186721219765,0.18181818181818182,0.8733983816321693,1.0,29/152,16.88%,SMAD6;IL17RD;SIRT1;TGFBR1;PPARG;ENPP1;RORB;ZFP36L2;RORA;CRIM1;ADGRV1;WNT9A;ITGAV;WWTR1;ABCA1;FOXO1;SINHCAF;NR1H3;PTEN;MYB;GREM1;ANKRD26;RUNX1T1;BAMBI;VASN;ANP32B;USH2A;CNTN4;NELFB
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4572152461685494,1.1178782083875778,0.20408163265306123,0.873133277225462,1.0,20/115,10.66%,MXRA5;FGF10;LAMA4;MRGPRF;HGF;PRRX1;ADGRL4;PPARG;GFAP;BGN;COL6A2;CXCL12;SLC8A1;POSTN;PDGFRA;PLSCR4;PCDH18;IGFBP6;MEDAG;TPM2
prerank,KEGG_2021_Human__Primary immunodeficiency,0.5602453018839152,1.1178027726626927,0.2857142857142857,0.8729461871658778,1.0,10/26,19.66%,BLNK;IL7R;RFXAP;CD40;ADA;TAP1;RFX5;RAG2;ZAP70;RAG1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.8016815684127478,-1.1177811523286922,0.38181818181818183,0.9573545326430838,1.0,1/5,3.41%,ALOX5
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6203129650408497,1.1177357534165127,0.34782608695652173,0.8727473167932154,1.0,5/12,23.32%,UBA5;UBA6;UBA3;SENP6;SAE1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.4828942477557334,-1.1176454665131033,0.2553191489361702,0.9569047904906868,1.0,10/60,5.54%,MS4A8;EHF;CAPN8;CLDN4;CLCA1;FAM3D;MUC5B;SPDEF;SLC9A8;CAPN9
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.511025245589621,1.1175418630218323,0.33962264150943394,0.8729669601919341,1.0,7/43,18.93%,SIRT1;ZBTB1;PRIMPOL;REV1;PCLAF;FAAP20;POLK
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6567497046342704,1.1175007914104194,0.38,0.8726726966093242,1.0,2/9,6.81%,EGLN3;P3H2
prerank,Reactome_2022__Abacavir Transmembrane Transport R-HSA-2161517,0.7183237328301801,1.1174003282939307,0.36,0.8725996170668862,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6128433183144766,1.1173870219657542,0.3333333333333333,0.8722103247104042,1.0,3/12,18.35%,SCRIB;SYNE4;RAP2A
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.514643540360488,-1.1173421931132739,0.24324324324324326,0.9568644016324831,1.0,4/41,2.36%,H1-3;H1-4;TERF2IP;H1-2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6554927093486768,1.1173399924010214,0.37735849056603776,0.8719585903310784,1.0,2/9,17.47%,PHKA1;GBE1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.5402203983832513,1.117256582534358,0.29411764705882354,0.8717905612636628,1.0,10/40,12.55%,ITGA8;MME;TGFBR1;LRP4;WNT4;PCSK5;C1GALT1;HAS2;PROX1;TBX18
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.4313077181035041,1.1172337571187825,0.21818181818181817,0.8714558357125098,1.0,37/224,17.81%,MYC;TGFBR1;CDC25A;CCNA2;HIF1A;KAT2B;H2AC25;SEM1;H2BC21;ESR1;STAMBPL1;USP12;INO80E;RNF146;SMAD1;SENP8;ACTL6A;INO80D;KEAP1;SMAD2;PSMD13;NFRKB;SMAD4;PTEN;H2AC6;TANK;PSME4;CCP110;HCFC1;RCE1;PSMA1;RNF128;STAM2;BIRC3;IL33;FKBP8;TP53
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5225363288951056,-1.117102302549185,0.2777777777777778,0.9566974509253803,1.0,2/16,4.75%,ASS1;FGL1
prerank,KEGG_2021_Human__Ferroptosis,0.4955044952542638,1.1168604021695092,0.2857142857142857,0.8722650369759126,1.0,3/35,7.63%,SLC7A11;SLC39A8;TF
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5042409219210383,-1.1167899897874944,0.30612244897959184,0.9567979193948349,1.0,11/57,8.78%,P2RY10;CD24;PRDM1;IRF4;CD53;ANGPT4;KCNA3;MS4A4A;JCHAIN;TAGAP;LY86
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.48651280071072966,1.1167103726444076,0.2641509433962264,0.8723590548629157,1.0,6/49,3.95%,SMAD6;SIRT1;PPARG;GDF6;MAFB;STEAP4
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7045229391782916,-1.1165363294449298,0.4,0.9567366888696335,1.0,2/6,11.71%,SLC19A3;ACP3
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.600846249252552,1.1164706387110819,0.3090909090909091,0.8726969618462554,1.0,6/21,19.62%,HRH3;NEDD4;SNCA;GPM6B;PXK;WNK1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.5743140965535887,1.116324334523593,0.27450980392156865,0.8724622243654483,1.0,2/17,6.90%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.5743140965535887,1.116324334523593,0.27450980392156865,0.8724622243654483,1.0,2/17,6.90%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6012828609262242,1.1162798295738532,0.38461538461538464,0.8721756671361054,1.0,1/15,2.25%,NXF1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.7094586719200876,1.1162687008572116,0.38181818181818183,0.8718121669726833,1.0,1/7,1.97%,STARD4
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.46261216866566,1.1161399268624383,0.25,0.8717577158354635,1.0,20/88,10.29%,IGF1;FLT1;HGF;CCL5;SIRT1;F2R;FGFR1;FGF2;NEDD4;ROR1;PIK3R5;HCLS1;DIPK2A;PIP4K2A;PDGFRA;GAB1;PDGFC;PIK3CA;PLXNB1;FLT3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4295513956307629,1.1161223344882127,0.19148936170212766,0.8713947547264798,1.0,51/186,18.31%,SEMA5A;UNC5C;EPHA7;EMB;NRTN;EFNA5;DCC;EFNA2;ROBO2;SPTBN5;LGI1;CXCL12;SEMA6C;UNC5D;NRXN1;EPHA5;GAB1;EPHA3;CNTN6;PLA2G10;ALCAM;DSCAML1;EPHA8;GFRA1;DSCAM;PIK3CA;PLXNB1;EFNB2;RANBP9;PLXNB2;SOS1;KLF7;SEMA3E;PTPRM;SEMA6D;LGR6;L1CAM;CNTN2;PIK3CD;GAB2;NOTCH2;CNTN4;RPS6KA5;ARTN;MYPN;RET;VEGFA;RHOG;EFNA1;LAMA5;IRS2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6156200549505276,1.1159104890574822,0.3508771929824561,0.8717735199364373,1.0,5/14,26.05%,INTS6L;INTS6;ERI1;INTS14;INTS8
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.48154383617619906,-1.1158805519258639,0.25,0.9580925949601391,1.0,13/57,12.45%,EHF;CLDN4;GPR39;CLDN1;DSG2;MYO5B;LAMB3;MALL;FOXQ1;SERPINB5;MISP;CLCA2;MAL2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5760468738266257,1.115713567391685,0.3157894736842105,0.8717892943164877,1.0,4/15,23.96%,JADE3;HCFC1;KANSL3;OGT
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5760468738266257,1.115713567391685,0.3157894736842105,0.8717892943164877,1.0,4/15,23.96%,JADE3;HCFC1;KANSL3;OGT
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.6275689688580939,1.1154296510062978,0.37037037037037035,0.8724457078097441,1.0,2/14,3.61%,PRKG1;PDE1A
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.4859754356590288,1.1153553182669171,0.3018867924528302,0.8723319132087122,1.0,15/73,18.16%,IRS1;H2AC25;H2BC21;KCNH8;HDAC3;EZH2;TBL1X;DYNC1I2;H2AC6;PML;CREB1;USH2A;PCSK2;RANBP2;EED
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.7145939424065567,-1.1151847333400802,0.3877551020408163,0.9592916676337175,1.0,1/5,4.05%,ABCC4
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4791252669514503,1.1151644150847866,0.25,0.8725318346694397,1.0,14/64,13.52%,IRS4;IRS1;TCIRG1;ATP6V0D2;GAB1;FER;ATP6V0A4;PIK3CA;FOXO1;BCAR1;SOS1;ATP6V0B;IGF1R;SH2B2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.4612614091040612,1.1150183305639247,0.2545454545454545,0.8726132809336365,1.0,27/121,13.04%,MITF;LAMA4;TYR;PRRX1;RAB38;PPARG;ENPP1;GNG12;BMI1;DOCK1;POSTN;PPFIBP1;CCDC80;ITGAV;WWTR1;EPS8;FAM114A1;PRICKLE2;PTPN14;TNC;LOXL2;RASAL2;HMCN1;KLC2;HTRA1;PXDC1;HSPB1
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.7113003019446636,1.1149306116213114,0.34615384615384615,0.872523214273907,1.0,1/6,6.63%,TCN2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.7236439583113148,1.1148469590861692,0.4,0.8724155055669136,1.0,2/7,21.62%,TRPM7;SLC7A8
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,-0.6440790525799732,-1.1147939226559211,0.36538461538461536,0.9598652864878557,1.0,4/10,15.40%,CAMK2A;CAMKK2;CAMKK1;CALM1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.7314758363423572,1.1147621436493593,0.3620689655172414,0.8723492402515434,1.0,2/6,20.81%,TSR3;RPUSD2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.664075779544989,1.1147221130346006,0.3469387755102041,0.8721059380880715,1.0,5/15,17.23%,NRG1;CDH2;MEF2C;LRP6;KLHL12
prerank,Reactome_2022__Amino Acid Conjugation R-HSA-156587,0.7028896483024534,1.1146287887959014,0.3877551020408163,0.872033979213743,1.0,2/7,11.05%,ACSM2A;GLYATL2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.7136228692739146,1.1146277507949405,0.3728813559322034,0.8716259146469607,1.0,3/8,14.31%,GRIP1;DVL2;FZD4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7272492481400193,1.114587236959467,0.3888888888888889,0.8713479221148405,1.0,1/6,0.09%,GATA4
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.574362808056467,-1.1144049958415982,0.24489795918367346,0.9601719981493941,1.0,2/24,5.60%,PNPLA1;PNPLA4
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.357514994186866,1.1143677033406068,0.0625,0.8716063849960402,1.0,352/2043,15.03%,SGO1;VEGFC;GPR55;IGF1;ADRA1A;FGF10;CXXC4;VAPB;LAMA4;DRD5;SMAD6;FLT1;INSL5;MAP3K11;IRS4;PREX2;CHRM2;CDC14A;IRS1;TCIRG1;ATP6V0D2;COL9A1;C3;IL17RD;RUNX1;GREM2;ITGA8;ARHGAP24;RHOBTB3;FGFR3;SYK;ITGB8;RSPO3;MYC;CCL5;RIT2;PRKG1;NDC80;LGR5;PNOC;TGFBR1;RAPGEF3;F2R;FGFR1;SHMT2;RFNG;ERBB4;TULP3;GNRH1;GRM3;KLKB1;HIF1A;NRTN;STAT5A;ITGA2;MYCN;PLEKHG2;UTS2R;KAT2B;NRG1;HRH3;PPARG;PIK3R6;NEDD4;ALDH1A1;GFAP;HTR1F;COL9A2;SNAI1;ANGPT1;CALCR;REXO2;SEM1;ADD3;FGD4;RRAD;OPRK1;KSR1;SCD;GNB4;GNG12;HNRNPH1;WNT4;ARHGAP31;PDE1A;RSPO2;CSF2RA;SYVN1;FRAT2;BMP2;PCSK5;NPY;INSL3;NRIP1;LLGL1;NDE1;IL2RA;PIK3R5;PRMT1;DOCK1;COL6A5;RORA;STOM;ABHD17B;H2BC21;COL6A2;SPTBN5;RGS10;GPSM3;MOB1A;ACVR2A;SYDE2;DLGAP5;ZFYVE16;CXCL12;HGFAC;NRG3;SOX6;FKBP5;PENK;ARHGEF17;DHRS3;RBPJ;RELA;PTGFR;NR5A2;RALA;GPR17;RXFP2;MAPKAPK2;MOV10;GABRG3;SSTR3;PIP4K2A;SCRIB;PRKAB2;KCNH8;NHS;ESR1;ARHGAP5;WNT9A;NPFFR2;PLPPR1;ITGAV;WWTR1;MUC20;MOSPD2;PDGFRA;PLCG2;HDAC3;F3;GPC5;NRG2;FER;SLC4A7;ABCA1;HDAC2;PPP1CC;GALNT3;GRM8;TF;KHDRBS2;ADRA2C;UBE2D3;QRFPR;CASR;PPM1A;CAVIN1;DLC1;GNRH2;GPR176;SOCS6;FOXO3;NTSR2;PDE7A;PDGFC;RAMP3;CRHBP;GNAI3;RNF146;SPOP;ERBIN;NPW;SMAD1;ATP6V0A4;GPSM1;RGR;ABCG8;ABL2;RHOU;KCTD6;LATS1;KDM3A;SHOC2;MYH11;LMAN1;KANK1;GFRA1;PAG1;TAB2;RAP1GDS1;FGF17;KCTD3;SPOPL;GRM5;SAV1;TEX2;MAPKAPK3;PIK3CA;ST3GAL6;CNKSR2;CENPO;TAC1;FRK;SMAD2;PSMD13;LTBP1;GPR161;VANGL2;PLXNB1;C5AR2;NCOA2;RPS6KA2;EZH2;FLT3;ARHGAP45;FOXO1;RASAL2;MUC13;BCL11B;C3AR1;PDE6A;TNFRSF10B;E2F4;PCDH7;ARHGAP25;CGN;CASP10;LDHD;BMPR1A;PTPRK;TBL1X;CNOT6L;RANBP9;PRKCSH;UTS2;ARHGEF16;DAND5;PGRMC2;RGL2;VRK2;ADAP1;ABCD3;TNS3;ABHD17C;AMOTL1;VAMP3;HTR2C;SMAD4;DYNC1I2;ANLN;GNG4;CNTN1;NR1H3;MEF2C;PDE4B;NCK2;FMNL3;BCAR1;RRAGC;RBBP6;MAPK8;PRPF38B;IRAK1;PTEN;H2AC6;CTBP2;FLRT2;PPP1R12B;KHDRBS3;PPP3CA;TLE2;TIAL1;MYB;FASN;KNG1;SOS1;ATP6V0B;GRM4;RAB9A;MAGED1;FZD1;HSPB1;XPO1;FGF5;IGF1R;TANK;RNF2;RGSL1;STRADA;H2AZ2;PICALM;GABRB2;ANKRD26;MXD4;PSME4;ID4;LYPLA1;SH2B2;PPP3CC;RAP1A;LRRC7;GRM7;DBN1;ACVR1B;LRRC1;CCND3;RACGAP1;GRIN2D;RHOBTB1;NPY1R;PRICKLE1;DVL2;PML;WWOX;RARB;DUSP2;CREB1;NBEA;CNKSR1;RPS6KA1;LRP6;FZD4;ABCG5;ADORA1;PTPRU;FRAT1;ADRB1;CCP110;DERL2;LMNB1;FZD6;ARHGEF6;POU2F1;CENPP;BAMBI;IFT57;RICTOR;NCOA3;LGR6;H2AX;RGS14
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.6903070637804789,1.1143137501094973,0.3728813559322034,0.8713816669382719,1.0,2/7,10.87%,HDAC3;TBL1X
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.46800843623123484,1.1141490587661682,0.30612244897959184,0.8714514964929875,1.0,15/66,19.03%,CDC20B;INSIG1;SLFN11;CDKN2A;DPY19L1;ACTL6A;CDK2AP2;PAQR4;LAYN;BAMBI;POGLUT3;PRPS2;MAZ;CASP3;CHORDC1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4228630536200386,1.1140669174632252,0.23404255319148937,0.8712623645999645,1.0,68/396,14.02%,CRX;GATA4;MITF;ESRRG;TGFBR1;CCNA2;TULP3;CDK11A;HIF1A;TFEB;PRDM8;HES6;MAFB;POU6F2;FBXO5;RORB;BMP2;NFIL3;RORA;SP1;HCLS1;SOX6;RELA;NR5A2;ESR1;TEAD2;NFIA;WWTR1;ELAVL2;SLC39A8;RPS6KA4;CHD7;SSBP2;ZNF274;GMNN;RYBP;FOXO3;ATXN1;YAF2;ZNF195;GPBP1L1;GRM5;ZNF675;METTL18;NCOA2;EZH2;ZNF114;NR1D2;HP1BP3;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;RBBP6;ZNF117;ZNF281;MYB;ZNF212;MAGED1;SPIN1;MLF1;ACVR1B;ESCO1;MLXIPL;DVL2;PML
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6511276884581725,1.1136258761361593,0.45454545454545453,0.8722378986857322,1.0,4/8,28.60%,FOXO1;BAD;GSK3A;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5732955006790188,1.113559451490049,0.3392857142857143,0.8719956697783411,1.0,4/25,15.21%,FGF10;UBE2E2;CCND3;PLCB1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4661972860678357,1.1135168200006298,0.29545454545454547,0.8717007847392094,1.0,37/115,18.64%,SCN7A;PRKG1;EDIL3;LRP4;PRDX6;VCAN;PENK;EFS;MEGF10;TMEM200C;ADGRL2;LIFR;PTPRD;STOX2;PCDH18;PRICKLE2;PABPC5;ANK2;GFRA1;GUCY1A2;MAGEL2;LRFN5;ID4;COL11A1;RUNX1T1;SEMA6D;FRZB;CPE;GPRC5B;PDZRN3;MAPK10;CCDC3;VAT1L;CSRNP3;COL25A1;TMEM178A;MPDZ
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5283231126473598,1.1133536903619312,0.3137254901960784,0.871776175931609,1.0,6/32,14.30%,SEMA5A;SEMA6C;PLXNB1;PLXNB2;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.5713292386282864,1.1132995541422186,0.32608695652173914,0.8715638520590097,1.0,3/28,4.07%,NDC80;LLGL1;NDE1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6105669402682727,-1.1131394238516197,0.38095238095238093,0.9633988988736382,1.0,1/13,3.43%,PRKCD
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.5515072568854709,1.112969601612238,0.34,0.8723433451860491,1.0,9/27,28.95%,UBE2Z;UBE2E3;UBA6;UBE2D1;UBE2A;UBE2E1;USP9X;UBE2Q2;OTULIN
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.39268252878554694,-1.1129543849624897,0.09302325581395349,0.9630733003635243,1.0,44/646,7.93%,CD44;EPN1;HK2;LTB4R;SELL;RAC2;ICAM3;CD53;BST1;NLRP3;CD86;LILRB3;RIN3;WARS1;STX11;TLCD2;MEFV;DUSP6;VSTM1;ALOX5;PTGES;PLK3;PRAM1;IL6R;SLC24A4;SCPEP1;PHLDA2;STXBP2;FMNL1;DNAAF1;ASGR2;TGFBI;IER3;ITPRIP;BATF3;NIBAN2;TRIB1;DOCK2;HCK;SLC11A1;HLA-DRB1;ARHGDIB;BRI3;WBP4
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.5015691345815569,1.1126641924218887,0.3018867924528302,0.8728699247681109,1.0,9/62,13.56%,LAMA4;ITGA2;HGFAC;MUC20;PIK3CA;RANBP9;TNS3;SOS1;RAP1A
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.4264392146556974,1.1126319135832754,0.3076923076923077,0.8725284219847241,1.0,44/211,14.30%,DRD5;CHRM2;SLC12A7;GABRR1;RIT2;PNOC;GABRR2;GRM3;SLC1A3;HRH3;HTR1F;OPRK1;NPY;NLGN1;GLRA1;PENK;SYPL1;GABRG3;SYT1;CACNB4;NRXN1;UNC13B;CEL;NOVA1;SNCA;GPR176;GRIK2;NLGN4X;GRM5;RPS6KA2;HAP1;SCN2B;UTS2;KCND2;GABRA5;HTR2C;GLRB;GRM4;GABRG1;GABRB2;GRM7;APBA1;RPS6KA1;LRP6
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6030310299168111,1.112597270737244,0.32727272727272727,0.8722458305941825,1.0,6/23,14.00%,RBPJ;AGR2;HIP1;HAP1;PDE6H;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7489064406881272,1.1125913654161543,0.42857142857142855,0.8718580818904363,1.0,4/5,23.85%,TLR2;IL33;FCER2;JAK2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.5080983413576178,1.1125402216215823,0.3137254901960784,0.8716404577378706,1.0,16/57,17.89%,LGALS9;RUNX1;SIRT1;IL4;PPARG;EFNA2;IL15;CBFA2T3;OSCAR;PML;PIK3CD;GAB2;CSF1;VEGFA;CDK4;FARP2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.590457578170156,1.1124353221231464,0.3275862068965517,0.871551762614682,1.0,3/23,5.88%,MYRF;PRDM8;TLR2
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7026685108399857,-1.1123913195683994,0.4222222222222222,0.9640594317114994,1.0,4/6,20.56%,LY86;BMP6;LY96;PRKCA
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.45681604098469447,1.1122154396290411,0.24489795918367346,0.8719661217068312,1.0,15/80,10.22%,MXRA5;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;PDGFRA;CNRIP1;PCDH18;MEDAG;COL5A3
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.48021892128801485,1.1119442874903427,0.2765957446808511,0.8724970123772272,1.0,10/72,9.19%,RPP25;NXF1;REXO2;RPP25L;RIOK2;EFL1;RPP40;NXT1;PWP2;AK6
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.49072338939371973,1.1119419797498524,0.3137254901960784,0.8721100460386809,1.0,6/52,9.71%,IRS1;STAT5A;PPFIBP1;WDCP;PIK3CA;HIP1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6711254034904804,1.1118683615382132,0.37254901960784315,0.8715531827361452,1.0,2/6,17.90%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6711254034904804,1.1118683615382132,0.37254901960784315,0.8715531827361452,1.0,2/6,17.90%,GAL3ST1;B4GALT3
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.4955691487757993,1.111830996808859,0.2653061224489796,0.8713072301428392,1.0,8/54,16.35%,DERL3;SEM1;RNF185;PSMD13;RNF5;PSME4;DERL2;PSMA1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.7207292390634473,1.111827683597357,0.38,0.8709040338308806,1.0,2/5,16.86%,RPS6KA4;RPS6KA5
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5782321371994013,1.1117980998445374,0.29411764705882354,0.8705886541208124,1.0,5/18,13.52%,GPR33;C5AR2;C3AR1;BCAR1;SH2B2
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.5571212618825602,1.1114237515132441,0.32075471698113206,0.8713806731013726,1.0,8/25,14.28%,GRIN3A;LLGL1;LIN7A;GRIN3B;LRRC7;GRIN2D;APBA1;NBEA
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.45596522360407754,1.1111319287050276,0.24,0.8718923991244072,1.0,23/99,14.93%,MME;CCL5;TGFBR1;URI1;SOCS2;ROBO2;PTPN20;HCLS1;ACVR2A;HTRA2;RAMP3;STING1;PTPN14;NCOA2;FLT3;BMPR1A;MAPK8;TIPARP;IL18R1;CPNE3;ACVR1B;LRP2;NCOA3
prerank,Reactome_2022__Lipophagy R-HSA-9613354,0.66654048940064,1.1110474297447033,0.43636363636363634,0.8718098597725872,1.0,2/7,13.12%,PRKAB2;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.6962540457130295,1.1107762545474797,0.33962264150943394,0.8723558279939357,1.0,4/9,22.07%,IRS1;ABCD2;IRS2;AKT2
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,0.7003732844614535,1.110438007145948,0.390625,0.8726905061270936,1.0,2/6,9.75%,TGFBR1;SMAD2
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,0.7003732844614535,1.110438007145948,0.390625,0.8726905061270936,1.0,2/6,9.75%,TGFBR1;SMAD2
prerank,KEGG_2021_Human__TNF signaling pathway,0.47308025326511455,1.1104368326922562,0.3125,0.8722939699509374,1.0,31/89,22.07%,VEGFC;CCL5;RELA;MAP2K6;RPS6KA4;IL15;TAB2;PIK3CA;CASP10;MAPK8;IL18R1;CREB3L2;CREB1;PIK3CD;TAB3;MAPK10;BCL3;MAP3K8;BIRC3;FADD;RPS6KA5;CSF1;CASP3;AKT3;JAG1;PIK3R3;IKBKB;EDN1;MAPK3;VEGFD;AKT2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5779258843381228,-1.110405631798531,0.3170731707317073,0.9701644757575132,1.0,3/19,8.85%,NUPR1;ACTN3;PGP
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6430892382566462,1.1103159168506391,0.38596491228070173,0.8722346680581541,1.0,3/11,12.14%,HGF;MUC20;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6118925935797309,1.110175286664319,0.26666666666666666,0.8723089451726502,1.0,7/16,18.72%,SP1;RELA;LRRTM3;PICALM;EFNA1;ABCA2;CASP3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.7622186427137825,1.1101095159728525,0.40350877192982454,0.8721162280899709,1.0,1/5,4.30%,ROBO2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6100322045923944,-1.1100549981874535,0.41304347826086957,0.9703343907987946,1.0,5/19,17.81%,BUD23;FTSJ3;EMG1;MRM1;NSUN4
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.450271937948308,1.1099999302662897,0.24390243902439024,0.8720860901860327,1.0,16/138,11.68%,TNFSF14;TNFRSF18;CCL5;SIRT1;TNFSF13B;ZFP36L2;ST18;RELA;CD40;FOXO3;CRHBP;ERBIN;PSMD13;HYAL3;ZFAND6;HAS2
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.5079347563891957,-1.1099442167645595,0.21428571428571427,0.9697738498614337,1.0,12/57,8.48%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;ARHGAP15;CD5;TAGAP;PTPN7
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.6639229309405045,-1.1097806249873718,0.3541666666666667,0.9693394402443849,1.0,2/7,10.52%,PARP2;PARP1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.5771439896581647,1.1097248472462622,0.27450980392156865,0.8726878962290272,1.0,6/23,18.16%,H2BC21;EZH2;H2AC6;H2AZ2;H2AX;EED
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5659878876808832,1.10970314907307,0.3673469387755102,0.8723735813804916,1.0,8/16,24.54%,SHMT2;SRR;CBS;CTH;PSPH;DAO;GLYAT;BAAT
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5660057820774808,1.1097006164823056,0.37037037037037035,0.8719726744037541,1.0,7/26,13.99%,MOB1A;TEAD2;WWTR1;LATS1;SAV1;AMOTL1;DVL2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7026748586004365,1.1094330008537483,0.35714285714285715,0.8724115998203889,1.0,4/8,19.45%,SCUBE1;CD34;MESP1;JAG1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,0.5832033672229584,1.1093984565667767,0.3076923076923077,0.8720862712716078,1.0,2/18,10.80%,LDLR;LDHD
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.44411249829568494,1.1093782533334693,0.23529411764705882,0.8717438890454356,1.0,19/171,7.51%,SEMA5A;RUNX1;TSPAN12;RSPO3;SIRT1;FRMPD1;RFNG;TULP3;VWA2;SOCS2;MDFIC;CDKN2AIP;LLGL1;RORA;DHRS3;KCTD8;ESR1;WWTR1;LIFR
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6186132439044618,1.109319104657348,0.37254901960784315,0.8715926084641775,1.0,2/13,8.45%,YAE1;ISCA2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6689469968645523,-1.1091904996038215,0.3673469387755102,0.9706478357483617,1.0,1/13,0.17%,TERT
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",0.6478295301857655,1.1091816771091738,0.37735849056603776,0.8715917151375336,1.0,2/7,18.72%,SEPTIN4;CASP3
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.6330236080541387,1.1091305127489046,0.39622641509433965,0.871336672417996,1.0,5/13,21.92%,INPP1;INPP4B;MTMR9;IMPA1;INPP5J
prerank,Reactome_2022__HDL Clearance R-HSA-8964011,-0.7195100053619491,-1.1089192063361548,0.37777777777777777,0.9705462226185276,1.0,3/5,23.43%,APOA1;CUBN;HDLBP
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.631734818578481,1.108730392018,0.3333333333333333,0.8718371866877404,1.0,3/11,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.631734818578481,1.108730392018,0.3333333333333333,0.8718371866877404,1.0,3/11,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.6325915487731937,-1.1087125745282478,0.35714285714285715,0.9703963196546798,1.0,2/8,8.48%,AK8;AK7
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.7167334907253674,1.1085978299776504,0.33962264150943394,0.8717958055875372,1.0,1/5,3.71%,SAMSN1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4169435162977999,1.1085240389790953,0.19230769230769232,0.8716276197669437,1.0,28/157,13.96%,RIT2;LRRC4C;RETREG3;ROR1;TOX;CDH2;DCC;TENM3;ABI3;PDLIM5;ZNF804A;FUT9;EPHA3;HDAC2;ABL2;KANK1;MAGI2;CTNNA2;FBXO7;EFNB2;PLXNB2;NTNG2;PTEN;FZD1;RAP1A;LRRC7;DBN1;PTK7
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.634062208328194,-1.1081592346324611,0.37037037037037035,0.9714507785803044,1.0,4/14,14.29%,KCNE2;KCNE1;KCNQ1;ATP1B1
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.5066271228032363,1.108156505137569,0.23529411764705882,0.8723874203746843,1.0,13/63,10.29%,FGF10;IRS1;FGFR3;FGFR1;ERBB4;NRG1;NRG3;ESR1;PDGFRA;NRG2;FGF17;PIK3CA;FLT3
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.6254456408603539,1.108087776909766,0.3148148148148148,0.8722191178981739,1.0,1/10,2.55%,STAT5A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.46000778145374877,1.1080519440804188,0.288135593220339,0.8719588464697428,1.0,36/128,20.47%,HNF4G;ESRRG;KAT2B;PPARG;MED17;RORB;RORA;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;HDAC3;TAF3;TBL1X;NPPA;NR1D2;NR1H3;NR4A2;RARB;CCNH;TAF5;THRB;TAF2;NOTCH2;RORC;MNAT1;GTF2B;MAZ;HDAC9;NR3C1;CCN2;POLR2H;NR6A1;HDAC1;TAF4
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.7381970002322941,-1.1077991511236511,0.3829787234042553,0.9716252149008147,1.0,1/5,13.93%,CD9
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5968081530854709,1.1077108527176482,0.30357142857142855,0.872596599146225,1.0,2/15,4.49%,SIRT1;RORA
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.4796676556203613,1.1074435976897263,0.32786885245901637,0.8731532358637971,1.0,14/57,15.59%,PPARG;OPRK1;FKBP5;MOV10;GAMT;HDAC3;HDAC2;TBL1X;MEF2C;IRAK1;PTEN;MOBP;CREB1;SGK1
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,-0.6916966798789416,-1.1072179923899965,0.4444444444444444,0.972807677298508,1.0,2/7,5.69%,ARG2;IER3
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5886666177892038,1.1071747180815599,0.3404255319148936,0.8736058684781612,1.0,6/14,26.13%,PAXIP1;NECTIN2;KMT5B;TNFSF4;SHLD2;SHLD1
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.40934250640982195,1.1071339434377057,0.24444444444444444,0.873339692259529,1.0,43/199,15.67%,GPR55;INSL5;CHRM2;C3;CCL5;PNOC;GRM3;HTR1F;OPRK1;GNB4;GNG12;PDE1A;NPY;RGS10;GPSM3;CXCL12;PENK;GPR17;SSTR3;GRM8;ADRA2C;CASR;GNAI3;NPW;GPSM1;RGR;C3AR1;GNG4;PDE4B;PPP3CA;KNG1;GRM4;RGSL1;PPP3CC;GRM7;NPY1R;CREB1;NBEA;ADORA1;RGS14;PLCB1;GPR37;GNAZ
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,0.7004959523725225,1.1071053073680115,0.36065573770491804,0.8730795032298129,1.0,3/9,12.78%,MUC20;RANBP9;SOS1
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.557523717722534,-1.1070855007409701,0.2978723404255319,0.9705015261073683,1.0,4/25,2.28%,P2RY10;SIRPG;TRAF3IP3;SCML4
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.557523717722534,-1.1070855007409701,0.2978723404255319,0.9705015261073683,1.0,4/25,2.28%,P2RY10;SIRPG;TRAF3IP3;SCML4
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.557523717722534,-1.1070855007409701,0.2978723404255319,0.9705015261073683,1.0,4/25,2.28%,P2RY10;SIRPG;TRAF3IP3;SCML4
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7218273782880229,1.1070071675922313,0.3541666666666667,0.8729918092248743,1.0,1/7,2.33%,PLOD2
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7504568334475451,1.106934237067352,0.28,0.8728812378191311,1.0,3/6,9.55%,FGF10;OPRK1;EPB41
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.6727476561082876,1.1066819928111913,0.3673469387755102,0.8734132779872469,1.0,2/9,8.30%,SCD;SCD5
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),0.7148136540947393,1.1066814862445165,0.4339622641509434,0.8730216448034693,1.0,3/5,28.09%,ANXA1;TNFSF4;CD80
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6995427092807749,-1.1066243218709595,0.43478260869565216,0.9702865910978364,1.0,1/5,6.56%,PEX7
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6995427092807749,-1.1066243218709595,0.43478260869565216,0.9702865910978364,1.0,1/5,6.56%,PEX7
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6161185240772452,1.1065165904103804,0.3269230769230769,0.8731404701600767,1.0,2/14,9.22%,TIMELESS;ARID2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.7312992253820121,1.1064848765117898,0.40425531914893614,0.8728524368831134,1.0,2/5,25.72%,NAA16;NAA30
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4696830301147794,1.1064649612620556,0.2826086956521739,0.8724902237088211,1.0,15/77,11.28%,SLC5A8;SCN7A;SLC12A1;ASIC1;SLC12A3;SLC5A12;SLC8A1;SCNN1B;SLC24A2;SCN10A;SCN3A;SCN2B;HCN1;SLC6A16;ATP1A2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6128853459310308,-1.1064113276854775,0.4,0.9701382320478038,1.0,1/11,1.00%,NPAS4
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5234501962035971,1.1063215300932463,0.26785714285714285,0.8725805101211974,1.0,5/29,8.59%,IRS1;STAT5A;CALCR;RAMP3;ERBIN
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5713432132408444,1.1062402346761264,0.35185185185185186,0.872499082155838,1.0,6/24,11.92%,NEDD4;ABHD17B;PDLIM5;CTNNA2;ABHD17C;MEF2C
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.6163312766299377,1.1062186254018997,0.37735849056603776,0.8721603962748428,1.0,5/14,20.02%,MYC;CTBP2;TLE2;TLE4;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5829930887343348,1.1061382961991197,0.39622641509433965,0.8720220737831044,1.0,4/20,13.44%,SIRT1;PPARG;NR1H3;ABCA8
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,0.5013054082330657,1.1059605895155704,0.2692307692307692,0.87227809440471,1.0,11/54,6.24%,SELPLG;ITGAX;TRAC;SASH3;SAMSN1;IL2RA;PIK3R5;HCLS1;IL10RA;FGL2;LAIR1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.6443920439321472,-1.1056760877079201,0.37209302325581395,0.9715337118699535,1.0,1/5,0.25%,KLRC1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.46505471312611385,1.1056686539849936,0.2916666666666667,0.8728194185881506,1.0,9/65,14.31%,SIPA1;SEMA5A;ANGPT1;DSCAM;PLXNB1;PLXNB2;KNG1;ADAMDEC1;FZD4
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.6036380655317699,1.105593536280316,0.3898305084745763,0.8726524449392292,1.0,7/15,25.06%,CCNA2;E2F4;HDAC1;LIN52;RBBP4;LIN9;RBL2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.40873014531541485,1.1055272421728488,0.17391304347826086,0.8724570947611442,1.0,58/272,19.00%,LGALS9;IGF1;RUNX1;ITGB8;SIRT1;HIF1A;MYCN;FGF2;KAT2B;SFMBT2;WNT4;BMP2;BMI1;SYNCRIP;ZFP36L2;SAMD4A;LIN28A;MOV10;ESR1;ABCC2;RPS6KA4;TOB1;NUDT16L1;RNF139;BTN2A2;PATL2;EZH2;RIDA;BMPR1A;CPNE1;MEF2C;TIPARP;CD34;ZNF281;PICALM;RBMS3;MSR1;DXO;EPC1;CAPRIN1;PTBP2;PRKAA1;CNOT8;NOTCH2;HEY2;RPS6KA5;VEGFA;CCDC3;CENPV;FMR1;AGO3;CITED2;EED;NDFIP2;H3-3A;SLFN14;ADAM10;HDAC9
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5735451100785408,-1.1053934900980358,0.27906976744186046,0.9715694915789229,1.0,1/20,0.60%,HK2
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.5315197827247443,-1.1052807948407404,0.25,0.9710231982839843,1.0,6/29,7.19%,MPO;ATP6V1E2;RAC2;ATP6V1C2;ATP6V1E1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5476044084070746,1.105256098075129,0.3793103448275862,0.8730261179162202,1.0,5/28,11.11%,KLRD1;NECTIN2;IL23R;CADM1;HLA-E
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.6581438966666373,1.1052511078058735,0.3448275862068966,0.8726426629013728,1.0,5/10,26.18%,TICAM1;TAB2;TAB3;TAB1;TRAF6
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,0.6206020177314102,1.105179241867594,0.35294117647058826,0.8725159557219779,1.0,6/12,29.16%,CASP10;FADD;IKBKB;CHUK;TRIM4;IFIH1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.6536928954027263,-1.1050499837409207,0.36,0.9708541806609811,1.0,1/11,0.17%,TERT
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6255014917048888,1.1048998792853677,0.30612244897959184,0.8730272286145739,1.0,3/15,6.35%,TSHZ3;NLGN1;NRXN1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.4545869497248801,1.1048773813663078,0.1836734693877551,0.8727182972108021,1.0,11/69,12.78%,ADRA1A;PLEKHG2;FGD4;GNB4;GNG12;ARHGEF17;PLXNB1;ARHGEF16;GNG4;PRPF38B;SOS1
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8714285333755313,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8714285333755313,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8714285333755313,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8714285333755313,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.6559801591001753,-1.1047488945073862,0.36363636363636365,0.9710545236582135,1.0,1/6,3.52%,TRPV5
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5689129171869542,1.1045040693943577,0.36,0.871933234048635,1.0,7/24,18.05%,PEX12;ABCD3;ABCD2;PEX11A;PEX2;ABCD4;MFF
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7314781839531965,-1.1044764862644285,0.42857142857142855,0.9709950388822438,1.0,2/5,14.45%,TRAIP;TEX264
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.6956420669652403,-1.1044680795460184,0.375,0.9700830421475872,1.0,3/5,14.23%,OAS3;OAS1;OAS2
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.5796658893381226,1.1044623104142186,0.38461538461538464,0.87167672581756,1.0,11/16,34.23%,EXOSC4;EXOSC1;EXOSC5;DIS3;EXOSC2;YWHAZ;DCP2;EXOSC8;EXOSC9;EXOSC7;MAPK14
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.41133098907607285,1.104213551301657,0.19642857142857142,0.8720503418374416,1.0,37/229,17.81%,MYC;TGFBR1;CDC25A;SHMT2;CCNA2;HIF1A;KAT2B;ESR1;STAMBPL1;USP12;INO80E;SMAD1;SENP8;ACTL6A;INO80D;KEAP1;SMAD2;PSMD13;NFRKB;SMAD4;PTEN;PSME4;CCP110;HCFC1;RCE1;USP45;USP31;BAP1;PSMA1;RNF128;STAM2;MINDY2;BIRC3;IL33;USP38;SUPT3H;TP53
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5875391765034476,1.1040624864276283,0.36363636363636365,0.872185390839367,1.0,4/26,3.44%,TEX101;ASB17;CRISP1;GCNA
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.637839837198086,1.1040054453288937,0.38596491228070173,0.8719971506462738,1.0,5/15,16.88%,IRS1;PIK3CA;SOS1;PTPRU;NELFB
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5334739902191036,1.1038348043510675,0.3220338983050847,0.872120767999413,1.0,9/33,16.83%,NEDD4;UTRN;FGF12;FGF14;SCN2B;HECW2;NETO1;DMD;GLRX
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5866470418216805,1.1036152499148086,0.40425531914893614,0.8725614869290785,1.0,5/10,19.45%,SNAI1;RBPJ;NOTCH2;HEY2;JAG1
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,0.4755096080766628,1.10343783029174,0.2777777777777778,0.8728149649515926,1.0,21/77,13.44%,FLT1;TDRD10;STAB1;PREX2;ITGA8;HIF3A;ADGRL4;ARHGAP31;ST6GALNAC3;CXCL12;ERG;PDGFRA;ABCA6;RAMP3;MYH11;TCF4;SYNPO2;HECW2;CD34;SHROOM4;ABCA8
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4387567554730716,1.1033209926857603,0.27906976744186046,0.8728022223463,1.0,32/131,21.22%,LRP4;DCC;CNTNAP2;NYAP2;NLGN1;LLGL1;TNIK;NEFH;ALCAM;DSCAML1;PLXNB1;CTNNA2;GPM6A;CPNE1;NTNG2;PTEN;KLF7;DBN1;LRP2;SGK1;CNTN4;CTNNB1;FLRT3;ZDHHC17;WASL;FARP1;SLITRK5;MYO16;MAP2;PARD3;DIP2A;SLITRK6
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.4785611689308839,1.1031633855017313,0.2222222222222222,0.8729139426522212,1.0,14/86,10.07%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;CXCL12;POSTN;CCDC80;PDGFRA;PCDH18;MEDAG;TNC
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.5915624483137796,1.1030419482728084,0.3333333333333333,0.8729690192429991,1.0,5/20,17.38%,SLC1A3;SYT1;UNC13B;PPFIA3;SLC1A6
prerank,Reactome_2022__Nectin/Necl Trans Heterodimerization R-HSA-420597,0.6785954555717237,1.1029345472543624,0.4,0.8729618765092622,1.0,2/6,10.31%,NECTIN2;CADM1
prerank,KEGG_2021_Human__Cocaine addiction,0.5435712179013871,1.10292251904463,0.24444444444444444,0.8725931863629904,1.0,10/44,14.09%,GRM3;GRIN3A;RELA;RGS9;GNAI3;GPSM1;GRIN3B;CREB3L2;GRIN2D;CREB1
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.6451256163502668,1.102670528824185,0.3157894736842105,0.8730210179579967,1.0,6/9,21.51%,TNFRSF10B;TP53BP2;FASN;TP53;TNFRSF10A;PPP1R13B
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6931517305556387,1.1026542019108594,0.4,0.8726582757646529,1.0,4/6,27.64%,FOXO1;DNAJC3;EIF2AK3;NFKBIA
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6856586696702068,1.1024813069107768,0.32653061224489793,0.8728487441392249,1.0,3/6,9.99%,MYOF;ANK2;BIN1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6851044911685908,1.1023370617060522,0.3902439024390244,0.8729206195483925,1.0,2/6,13.16%,SIRT1;KLF7
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7803233034797747,1.102291831369391,0.3888888888888889,0.8726880517942293,1.0,2/5,16.84%,SLC15A2;BIRC3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.41581604883475615,1.1022581090455144,0.2916666666666667,0.8723937165814255,1.0,66/359,15.48%,CRX;GATA4;MITF;ESRRG;TGFBR1;TULP3;CDK11A;HIF1A;TFEB;PRDM8;HES6;MAFB;POU6F2;RORB;BMP2;NFIL3;RORA;SP1;HCLS1;SOX6;RELA;NR5A2;ESR1;TEAD2;NFIA;WWTR1;ELAVL2;SLC39A8;RPS6KA4;CHD7;SSBP2;ZNF274;RYBP;ATXN1;YAF2;ZNF195;GPBP1L1;ZNF675;NCOA2;EZH2;ZNF114;NR1D2;HP1BP3;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;ZNF117;ZNF281;MYB;ZNF212;MAGED1;SPIN1;MLF1;ACVR1B;MLXIPL;DVL2;PML;ZNF263;TAF5;ZNF280B;ZNF502;ZNF257;HCFC1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5719132458808133,-1.102203228736554,0.3023255813953488,0.9768595461917324,1.0,2/17,6.42%,FGF1;MBTPS2
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.5696717716896483,1.1021875198259972,0.3728813559322034,0.8721953817489516,1.0,1/16,4.93%,GRIP2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.7016182454812151,-1.1021585580949265,0.41304347826086957,0.9760730574459631,1.0,5/5,29.86%,P2RY12;CD9;P2RX4;TGFB2;AZU1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.5043443014379224,1.1020833702468675,0.2571428571428571,0.8721548386944606,1.0,5/33,7.75%,LGALS9;SYK;HIF1A;TLR2;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.7057792706494928,1.101962584897332,0.37735849056603776,0.8721368381606331,1.0,1/5,6.71%,PPP1R15B
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,-0.6603266238735814,-1.1015036806669405,0.37777777777777777,0.9774169495263201,1.0,1/9,1.07%,GINS3
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.51509138692307,1.1014452959549355,0.34,0.8734461341245799,1.0,16/74,22.07%,REXO2;COX19;MOV10;PRKAB2;RRAGC;PTEN;COX6A1;PRKAA1;SCO2;TP53;AGO3;RRAGD;MLST8;AKT3;TACO1;AKT2
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.441072655414347,1.1011494126971868,0.2711864406779661,0.8741527550766341,1.0,10/89,9.76%,RUNX1;MYC;KAT2B;SEM1;CDKN2A;RBPJ;TEAD2;WWTR1;FOXO3;PSMD13
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.7401264901389162,1.101123328515649,0.46808510638297873,0.8730632189053154,1.0,3/5,24.66%,SLC35B2;PAPSS2;SLC26A2
prerank,Reactome_2022__Transport And Synthesis Of PAPS R-HSA-174362,0.7401264901389162,1.101123328515649,0.46808510638297873,0.8730632189053154,1.0,3/5,24.66%,SLC35B2;PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.7401264901389162,1.101123328515649,0.46808510638297873,0.8730632189053154,1.0,3/5,24.66%,SLC35B2;PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7113067562462447,1.101070834737343,0.45454545454545453,0.8728316231360963,1.0,1/5,9.71%,HIP1
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.44646213822396563,-1.101068434088066,0.3125,0.9780787798825247,1.0,15/96,16.69%,TERT;TERF2IP;CENPH;CHTF18;RFC3;ITGB3BP;RTEL1;POLR1A;SMARCA5;RPA3;RFC2;CENPS-CORT;NHP2;H2BC15;DAXX
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.7153325641446966,1.100962310591489,0.36,0.8728694680049113,1.0,2/6,24.32%,LIG4;ERCC8
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5046012830733894,1.1008711182047133,0.24489795918367346,0.8728119677356081,1.0,13/52,18.20%,LGALS9;CCL5;SIRT1;SASH3;IL15;IL23R;MYB;POLR3G;CD74;PLSCR1;FADD;CD81;RIOK3
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.5393549468579508,-1.100828990444551,0.26785714285714285,0.9778160986370423,1.0,6/30,1.74%,P2RY10;TBC1D10C;SIRPG;SELL;SP140;TRAF3IP3
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,-0.4786180521147705,-1.100788695581327,0.3023255813953488,0.9769842096806017,1.0,15/55,8.78%,P2RY10;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;ALOX5;LTB;INPP5D;BTK;HCK;ARHGDIB;TAGAP;LY86
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.7284408503158203,1.100606771688478,0.4,0.8733261331332912,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7505094396825106,1.1005828019652137,0.4262295081967213,0.8730556212256452,1.0,2/5,16.46%,IMMP2L;IMMP1L
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,0.6670967828849059,1.1003621110903046,0.38181818181818183,0.8733508572381612,1.0,6/14,21.16%,H2BC21;H2AC6;H2AZ2;H2AX;DPEP2;MAPK3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.4186689254614673,1.1001744559363655,0.32142857142857145,0.8735562854741528,1.0,65/290,21.13%,PKNOX1;PRRX1;HNF4G;ESRRG;SOX5;ZBTB7B;ZBTB1;KAT2B;PPARG;MED17;RORB;MLLT3;RORA;SP1;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;ELP4;HDAC3;TSC22D1;PAPOLA;TAF3;PCF11;TBL1X;NPPA;NR1D2;ELOF1;NR1H3;CDK12;INTS6;NR4A2;RARB;TAF1A;CCNH;POU2F1;TAF5;THRB;ELL2;TAF2;DEAF1;EAF2;NOTCH2;NELFB;RORC;MNAT1;GTF2B;MAZ;ARRB2;INTS11;HDAC9;CSTF3;NR3C1;ETV7;CCN2;NFIC;POLR2H;NR6A1;HDAC1;TAF4;WDR33;NCBP1;NOTCH3;SETD2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4490436378688364,1.1001741511761036,0.29411764705882354,0.8731685552098499,1.0,22/129,17.39%,HEMGN;SMOC1;RUNX1;TGFBR1;FGFR1;MAFB;NLGN1;MEGF10;MOSMO;EPHA3;BIN1;NR1D2;SINHCAF;GREM1;RPS6KA1;NREP;PHLDB2;TRPS1;ANP32B;HEY2;RORC;CSF1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6271971578729254,1.1000750442054505,0.32142857142857145,0.8730831171473743,1.0,4/12,21.17%,ELOVL5;ELOVL4;TECR;ELOVL6
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.37388361092185124,1.0999678037211886,0.16981132075471697,0.8729921657084377,1.0,224/1265,19.47%,GATA4;ZNF804B;SMAD6;CCNG1;TNFRSF18;RUNX1;PLD6;ZNF300;RSPO3;HNF4G;MYC;ESRRG;ZNF792;SIRT1;CCNA2;U2AF1;KAT2B;PPARG;REXO2;MED17;SEM1;RRAD;OPRK1;ZNF493;CDKN2A;LMO1;RORB;BMP2;NPY;SF3B1;MLLT3;IL2RA;THOC6;COX19;PRMT1;ZNF582;RORA;H2BC21;RBM14-RBM4;SMYD2;FKBP5;RBPJ;RELA;NR5A2;MOV10;LMO2;PIP4K2A;TET2;PRKAB2;ESR1;MAP2K6;TEAD2;NFIA;ZNF599;WWTR1;MYO1E;ZNF543;GAMT;ABCA6;ZNF706;TP53INP1;ZNF595;DYRK2;HDAC3;BANP;TDRD9;HDAC2;LIFR;PAPOLA;UBE2D3;PPM1A;ZNF274;CAVIN1;RYBP;FOXO3;SMAD1;YAF2;ZNF41;ZNF195;ACTL6A;ZNF202;ZNF561;KCTD6;ARID2;TAF3;ANAPC16;ZNF675;SMARCD3;SMAD2;PSMD13;ZNF771;ZNF426;MAP4K2;PCF11;EZH2;ZNF669;ZNF692;FOXO1;TNFRSF10B;E2F4;CASP10;TBL1X;ZNF114;CNOT6L;NPPA;NR1D2;DAND5;CHEK2;SMAD4;PLAGL1;ZNF704;ELOF1;CNOT4;NR1H3;MEF2C;BNIP3L;TP53BP2;RRAGC;ARID1A;ZNF347;IRAK1;PTEN;ZNF175;H2AC6;ZNF778;CDK12;INTS6;MYB;FASN;ZNF212;NR4A2;GTF3C4;RNF2;H2AZ2;NOC2L;PSME4;POLR3G;ARID1B;CCND3;MOBP;PML;WWOX;RARB;CREB1;PRKRA;TAF1A;SMARCD2;ZNF263;CCNH;EPC1;KAT6A;POU2F1;PCGF5;TAF5;ZNF442;RICTOR;HIPK1;H2AX;THRB;COX6A1;FOXO6;ZNF257;ZFP30;ELL2;TAF2;SGK1;PRKAA1;ZNF607;CNOT8;ZNF682;PSMA1;SRSF11;NOTCH2;ZNF776;ZNF584;HEY2;CNOT2;CTNNB1;RANBP2;SMARCA2;NELFB;POLR1H;RORC;MNAT1;ARTN;ZNF786;SCO2;PIWIL1;GTF2B;VEGFA;TGIF1;PERP;CDK4;TP53;AGO3;CTSV;MED30;CITED2;EED;ZNF12;ZNF30;JMY;ZNF234;RRAGD;ZNF33A;ZNF738;INTS11;KDM5B;KIT;HDAC9;CSTF3;SMURF1;RBFOX1;ZNF782;MLST8;TNFRSF10A;NR3C1;CCN2;ZNF519;ZNF311;AKT3;ABL1;JAG1;POLR2H
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7159492837878425,1.099924174321183,0.36538461538461536,0.8727281079581122,1.0,2/7,8.18%,ERBB4;LHX6
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.541215016890619,1.099838578867366,0.35294117647058826,0.8726094734052392,1.0,3/27,11.28%,NOX5;ATP6V0A4;ATP1A2
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6784183070094489,1.0998166275423265,0.39622641509433965,0.8723346555697565,1.0,4/5,25.72%,PLCG2;CX3CR1;CARD9;BCL10
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,0.6654251362575822,1.0994719211128485,0.4318181818181818,0.873075505695197,1.0,7/13,21.64%,TICAM1;TNFRSF10B;FASN;TANK;FADD;TNFRSF10A;TMED7-TICAM2
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6047045652427243,-1.0993733470327407,0.3877551020408163,0.9807275531622971,1.0,2/13,2.68%,CLDN4;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.49985477302195325,-1.0992506501575454,0.3148148148148148,0.9800975651394411,1.0,9/43,13.03%,DUSP4;DUSP6;SPRED3;SPRED2;CAMK2N1;SPRED1;GBP1;DUSP9;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.7009298246681044,1.0992389325956362,0.3617021276595745,0.8733193661019695,1.0,3/5,26.67%,TLR2;TLR1;CD36
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.6057768673165091,1.0989705591697545,0.4230769230769231,0.8737971322854095,1.0,2/17,2.04%,CHRM2;F2R
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.44253277624190784,1.0988723935330638,0.3191489361702128,0.8737395777895323,1.0,23/111,17.24%,CCL5;HIF1A;PELI2;ST18;RELA;PELI1;NLRP7;RPS6KA4;PELI3;CD40;TAB2;PSMD13;HYAL3;HAS2;IRAK1;TANK;PSME4;PLCB1;TAB3;PSMA1;MAP3K8;RPS6KA5;IRAK3
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.4251447685471441,1.0986384700182636,0.288135593220339,0.8742055972543937,1.0,41/148,17.81%,GSTM2;GSTT2;HGF;MYC;TGFBR1;FZD5;WNT4;CDKN2A;FRAT2;WNT9A;PLCG2;GAB1;ELK1;ACTL6A;ARID2;KEAP1;PIK3CA;SMARCD3;SMAD2;SMAD4;DPF1;ARID1A;PTEN;SOS1;DPF3;FZD1;IGF1R;ARID1B;DVL2;LRP6;FZD4;SMARCD2;FRAT1;FZD6;NFE2L2;PIK3CD;CTNNB1;SMARCA2;WNT2;CDK4;TP53
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5480485409121951,1.0986316580906172,0.3333333333333333,0.8734392362590451,1.0,3/23,5.89%,ZDHHC11;ZDHHC12;ZDHHC22
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5480485409121951,1.0986316580906172,0.3333333333333333,0.8734392362590451,1.0,3/23,5.89%,ZDHHC11;ZDHHC12;ZDHHC22
prerank,KEGG_2021_Human__Taurine and hypotaurine metabolism,0.6461471085845203,1.0985430082787955,0.4,0.8733318831107459,1.0,1/9,5.80%,GADL1
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.41093528647416816,1.0983123909160106,0.21739130434782608,0.8737527836062492,1.0,65/272,21.16%,FGF10;PREX2;IRS1;FGFR3;FGFR1;ERBB4;NRG1;PPARG;NEDD4;SNAI1;SEM1;PDE1A;NRG3;MOV10;PIP4K2A;ESR1;PDGFRA;HDAC3;NRG2;HDAC2;FOXO3;RNF146;FGF17;PIK3CA;FRK;PSMD13;EZH2;FLT3;FOXO1;CNOT6L;RRAGC;IRAK1;PTEN;SOS1;FGF5;RNF2;PSME4;PML;CREB1;NBEA;RICTOR;FOXO6;GAB2;PSMA1;IL33;RHOG;TP53;MAF1;AGO3;EED;IRS2;RRAGD;PHLPP1;KIT;KLB;PRKACB;MLST8;AKT3;THEM4;HDAC1;PIK3R3;BAD;PSMD4;SCMH1;MAPK3
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6177958091651575,1.09791878562697,0.3684210526315789,0.8747345816958793,1.0,1/14,1.13%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6365670775109276,1.0973691335990765,0.37037037037037035,0.8761210050949192,1.0,1/10,2.47%,IL4
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,0.481024077047796,1.0973664517039416,0.3,0.8757406009252934,1.0,14/64,8.27%,LGALS9;STAB1;TCIRG1;FERMT3;ITGAX;SH3TC1;STAT5A;PIK3R6;TRPV2;PTGS1;HCLS1;LAIR1;SIGLEC1;TFEC
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4195667594458834,1.0973431495904291,0.16666666666666666,0.8753882806431886,1.0,52/223,18.31%,SEMA5A;UNC5C;EPHA7;EMB;NRTN;EFNA5;DCC;LLGL1;EFNA2;ROBO2;SPTBN5;LGI1;CXCL12;NEFH;SEMA6C;UNC5D;NRXN1;EPHA5;GAB1;EPHA3;CNTN6;PLA2G10;DSCAML1;EPHA8;GFRA1;AUTS2;DSCAM;PIK3CA;CTNNA2;EFNB2;RANBP9;NTNG2;PTEN;SOS1;KLF7;SEMA3E;SEMA6D;LGR6;L1CAM;CNTN2;PIK3CD;GAB2;NOTCH2;CNTN4;RPS6KA5;ARTN;MYPN;RET;ZDHHC17;EFNA1;LAMA5;IRS2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7543502788124997,1.0973237324706924,0.3548387096774194,0.8750529125004752,1.0,2/5,11.90%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.6866171783517284,-1.0973118516740028,0.391304347826087,0.9854878196092635,1.0,4/7,12.70%,SCN5A;KCNQ1;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6815598880575351,1.09728152989289,0.37735849056603776,0.8748287372909648,1.0,2/10,5.09%,RENBP;NANP
prerank,CellMarker_Augmented_2021__Natural Killer cell:Blood,-0.6819580026631412,-1.0972446744870168,0.42857142857142855,0.984793716969387,1.0,1/5,0.25%,KLRC1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.47817270432777603,1.0972208430481318,0.2830188679245283,0.8746213866067631,1.0,2/53,2.54%,SHMT2;HIF1A
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.45242499948303405,1.0970606296356797,0.29411764705882354,0.8747299992121839,1.0,39/98,29.30%,SEM1;PELI2;RELA;PELI1;TIFA;MAP2K6;PELI3;HMGB1;TAB2;PSMD13;IRAK1;TANK;PSME4;TAB3;PSMA1;MAP3K8;IRAK3;TP53;RIPK2;IKBKB;PSMD4;IL1RAP;TAB1;NFKBIB;IKBIP;N4BP1;USP18;TRAF6;PSMB5;CHUK;NLRC5;PSMB1;NFKB1;NFKBIA;MAP2K4;PSMC5;APP;BTRC;LRRC14
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.38721122600634333,1.096903191440581,0.19148936170212766,0.8748883546274409,1.0,115/582,15.45%,DERL3;IGF1;EBF1;ACSM2A;ARHGAP24;PAWR;SYK;MYC;SAC3D1;PNOC;SHMT2;NXPH4;LRRC4C;CD22;PHGDH;ADAM28;LY9;TFEB;ASB15;BTLA;SYVN1;BLNK;IL2RA;PCDH9;PRMT1;CDCA7L;SELENBP1;UBE2J1;JADE3;IRF8;SLC35B2;ODC1;RALGPS2;NPIPB15;SYPL1;CACNB4;TIFA;TIMD4;PLAC8;SMDT1;TP53INP1;CHPT1;CHD7;BICD1;SCAF4;KHDRBS2;CD40;CDK14;CBFA2T3;CEPT1;CCDC50;PTOV1;SLC7A9;MTSS1;MTHFD2L;ATG101;ANK2;ANKRD13A;IFRD2;SLC35F2;ZCCHC7;C1GALT1;SAV1;COBLL1;SERTAD2;SNX22;CA2;LRWD1;PYCR1;NUS1;RNASET2;NFKBID;SLC2A11;MPZL1;XPNPEP2;EIF1AY;GPM6A;TCF4;FUT8;LDHD;PTPRK;BANK1;HLA-E;SHPRH;EGFL7;MEF2C;CEP120;FCHSD2;RRAGC;GPR160;ACBD3;CCSER1;ABHD10;SLC37A4;RAB30;MGAT5;IRAG2;LYPLA1;SH2B2;TXNDC11;CD74;PCMTD1;DENND5B;SPATS2;SNX2;CD83;SGSM3;CNKSR1;CSNK1G3;IFT57;NCOA3;COL19A1;SC5D;ORC4;RNF25
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,-0.4852555970335089,-1.0968940747637694,0.2765957446808511,0.9850527048326367,1.0,16/68,13.11%,EHF;CLDN4;GPR39;CLDN1;C6ORF132;DSG2;XDH;LAMB3;MALL;CDH3;SERPINB5;CAV2;MISP;BNC1;MAL2;CAV1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.4819677185695041,1.0967525198699033,0.3684210526315789,0.8749635436784051,1.0,12/47,20.74%,RUNX1;KAT2B;PRMT1;MOV10;CNOT4;MEF2C;AGO3;H3-3A;HDAC1;KMT2C;FAXDC2;GP1BA
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5008607667207275,1.0967446153752416,0.3469387755102041,0.8746015817014512,1.0,14/43,22.89%,LLGL1;RAB31;RAB34;GGA1;GOLPH3L;EXOC6;ARL3;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;COMMD1;EXOC6B
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.7228281955262865,-1.0967185466760152,0.4,0.9847447205250301,1.0,3/6,14.23%,OAS3;OAS1;OAS2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5431885039678782,1.0964825475207698,0.37254901960784315,0.875196678237709,1.0,4/31,5.89%,ZDHHC11;ZDHHC12;GLUL;ZDHHC22
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.708790127051196,1.0964331327930312,0.2916666666666667,0.8750118233093562,1.0,2/5,20.46%,ABL1;MAP2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.48723203383733793,1.0963877581862866,0.38,0.874766350568364,1.0,7/44,13.80%,CCNA2;SLFN11;FBXO5;GMNN;RBBP6;TERF1;ESCO1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.5408253239354816,1.0963418884059593,0.3404255319148936,0.8745708001787658,1.0,5/19,11.46%,IL4;CD22;SASH3;HLA-E;VAMP3
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5911181374800041,1.096313054086445,0.3584905660377358,0.8742981326363681,1.0,4/14,15.49%,ADRA1A;NPPA;ADRB1;RYR2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.46002654609425253,1.0962795893211155,0.27586206896551724,0.8740422584193723,1.0,30/114,22.13%,PPARG;LDLR;SCD;SP1;ODC1;PRKAB2;FDFT1;HDAC3;HMGCS1;SMARCD3;PSMD13;NCOA2;TBL1X;NR1D2;MVD;FASN;PSME4;ACACA;CHD9;ACACB;SC5D;PSMA1;SQLE;IRS2;PLPP1;DHCR7;PSMD4;ELOVL6;SREBF2;IDI1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.7352941889845148,1.0961204762643095,0.4727272727272727,0.8742444172755086,1.0,1/5,5.79%,DMC1
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,0.6239874705985408,1.0960911817380006,0.3275862068965517,0.8739501969008073,1.0,4/12,21.86%,ELOVL5;SYCP2;ACOX1;ACSL1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5746582379766838,1.0959022540814312,0.34545454545454546,0.8741907958636845,1.0,5/18,13.44%,SLC22A3;ABCC2;SLC15A2;ABCC11;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6304914526745932,1.0957972054627645,0.3728813559322034,0.8741667745817846,1.0,3/13,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5216574800490243,1.095721900430121,0.30612244897959184,0.8740436638816964,1.0,8/36,15.48%,IRGM;GFAP;LATS1;METTL18;SNCAIP;HSPA8;RAP1A;HCFC1
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.4342039835703329,1.0957059880586022,0.2962962962962963,0.8737115189893456,1.0,40/147,21.36%,C3;SYK;MYC;HIF1A;FGF2;PIK3R6;GNB4;GNG12;PIK3R5;RELA;MAPKAPK2;MAP2K6;PLCG2;TICAM1;PIK3CA;HLA-E;GNG4;MAPK8;PPP3CA;PPP3CC;CREB1;NFATC3;IKBKE;PIK3CD;MAPK10;CTNNB1;FADD;VEGFA;CDK4;TP53;CASP3;IRF3;AKT3;LYN;HLA-F;PIK3R3;IKBKB;ZFP36;MAPK3;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5421807753087947,1.0956889104202372,0.3333333333333333,0.873396168034104,1.0,4/30,4.72%,CDKN2C;SLFN11;CDKN2A;KANK2
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.4674496400112767,1.095556504244467,0.23076923076923078,0.8734110278574689,1.0,16/93,10.07%,MXRA5;IL17RD;PRRX1;FGFR1;LRP4;TENM3;BGN;LRIG3;EFS;POSTN;CNN3;ADGRL2;PCDH18;ANK2;MAGI1;TNC
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.5894114726741947,1.095465050026304,0.36363636363636365,0.8733159441481116,1.0,5/17,13.08%,FGF10;FGFR1;FGF17;SOS1;FGF5
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5718065367196801,-1.09530046497301,0.34782608695652173,0.9883383326039181,1.0,4/26,7.86%,LDB1;RNF8;RECQL5;BTBD18
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.49294846204791753,1.0952898770368393,0.2619047619047619,0.8734352145055133,1.0,18/62,10.29%,IGF1;FLT1;HGF;CCL5;SIRT1;F2R;FGFR1;FGF2;NEDD4;ROR1;PIK3R5;HCLS1;PDGFRA;GAB1;PDGFC;PIK3CA;PLXNB1;FLT3
prerank,KEGG_2021_Human__Glutathione metabolism,0.4998211938217785,1.0950477554356282,0.3,0.8738619182841626,1.0,6/43,6.90%,GSTM2;GSTT2;PRDX6;IDH1;ODC1;HPGDS
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.7524815425461799,1.0949245525565494,0.5,0.8738545919796004,1.0,1/5,3.12%,ASIC1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.6820196032770279,-1.094855217313772,0.42857142857142855,0.9887817277295947,1.0,1/5,6.90%,RAB7B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,0.4725609894073025,1.0945543056761287,0.31746031746031744,0.8743226005896763,1.0,11/72,6.83%,STAB1;TCIRG1;ADGRL4;RRAS;ARHGAP31;SSC5D;TRPV2;BGN;PTGS1;LTBP2;TICAM1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,0.4725609894073025,1.0945543056761287,0.31746031746031744,0.8743226005896763,1.0,11/72,6.83%,STAB1;TCIRG1;ADGRL4;RRAS;ARHGAP31;SSC5D;TRPV2;BGN;PTGS1;LTBP2;TICAM1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.6410764612851343,-1.0944349221005805,0.42,0.9892780881434843,1.0,3/8,7.66%,PXDN;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7094578326221921,1.0943115403174135,0.4339622641509434,0.874742693780573,1.0,2/5,10.16%,FRMPD4;CTNNA2
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,0.5773698556131402,1.0943093304982587,0.35,0.8743623708702336,1.0,5/16,18.47%,SLC1A3;NAV3;BIN1;CD83;RHOB
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.6091247385520262,1.0942376326759498,0.4418604651162791,0.8738326679771485,1.0,4/15,14.90%,DLC1;CORO1C;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.6091247385520262,1.0942376326759498,0.4418604651162791,0.8738326679771485,1.0,4/15,14.90%,DLC1;CORO1C;PTEN;PHLDB2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,0.4750383745111408,1.0942102972166075,0.26785714285714285,0.8731507166857707,1.0,13/60,15.24%,LRAT;SCGB3A2;PCDH11X;PRDM14;LIN28A;NANOGP1;APELA;CTCFL;VASH2;TERF1;MGAT4C;L1TD1;VRTN
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,0.4750383745111408,1.0942102972166075,0.26785714285714285,0.8731507166857707,1.0,13/60,15.24%,LRAT;SCGB3A2;PCDH11X;PRDM14;LIN28A;NANOGP1;APELA;CTCFL;VASH2;TERF1;MGAT4C;L1TD1;VRTN
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.7217867785751106,-1.0941841150506426,0.425,0.9891486933391545,1.0,2/6,6.37%,BFSP1;WNT7A
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,0.45405100416464345,1.0940824210017321,0.28,0.8732038745802655,1.0,11/85,7.08%,VEGFC;ITGA2;GNG12;LRIG3;FBLIM1;PDLIM4;ITGAV;WWTR1;P3H2;F3;FAM114A1
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.5089183992708026,1.0940417405918976,0.2127659574468085,0.8729399849299398,1.0,5/38,4.16%,SYK;STAT5A;CSF2RA;BLNK;IL2RA
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4957026679642971,1.0940279634204382,0.32,0.8726053028039858,1.0,11/46,12.69%,SMAD6;TGFBR1;GDF6;BMP2;ACVR2A;BMPER;INHBC;BMPR1A;SMAD4;GDF9;GREM1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.5206710504931948,1.093985217951693,0.35,0.8723801268154396,1.0,15/52,23.10%,GDAP1;TIMM22;SLC25A24;MTX2;FBXO7;SLC25A13;BCS1L;AIP;SLC25A31;PPIF;MFF;TIMM10;BAD;MAIP1;BCAP31
prerank,Reactome_2022__Regulation Of Gene Expression In Early Pancreatic Precursor Cells R-HSA-210747,0.7624769483378431,1.0939813160953766,0.42857142857142855,0.872007767964521,1.0,2/5,5.62%,FGF10;NR5A2
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.7399555064628355,1.0934440279459134,0.3333333333333333,0.8733925885992959,1.0,2/5,11.19%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4497893738296516,1.093333307788575,0.2391304347826087,0.8733364294794396,1.0,16/114,9.44%,VAPB;DRD5;F2;CCL5;SLC35G1;TRPC4;SCGN;CXCL12;MCUB;SLC8A1;SMDT1;SLC24A2;CD40;CASR;ANK2;MCU
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4266854384763458,1.0932565351727814,0.1774193548387097,0.8732039999260277,1.0,26/149,13.08%,STK26;FLT1;MAP3K11;FGFR3;FGFR1;ERBB4;DAPK2;TNIK;STK33;RIOK2;MAPKAPK2;PDGFRA;FER;MAP3K9;MEX3B;SMG1;EPHA8;MAPKAPK3;MAP3K21;FLT3;VRK2;CHEK2;IRAK1;CDK12;ITK;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6473063106636369,1.0931825011769725,0.3617021276595745,0.873098929888106,1.0,1/8,2.47%,IL4
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.37775809970706004,1.0931767506938368,0.1836734693877551,0.8727542982158403,1.0,95/481,18.80%,SCN7A;ITGA10;SEMA5A;COL9A1;UNC5C;EPHA7;FGFR1;NRTN;ITGA2;EFNA5;COL9A2;RRAS;SEM1;TRPC4;DCC;LLGL1;EFNA2;ROBO2;DOCK1;COL6A5;COL6A2;SPTBN5;CXCL12;CACNB4;UNC5D;ENTHD1;ITGAV;MYL12A;EPHA5;ST8SIA4;NEO1;RPS6KA4;EPHA3;CNTN6;SCN10A;ALCAM;DSCAML1;ABL2;EPHA8;MYH11;ANK2;GFRA1;SCN3A;DSCAM;PIK3CA;PSMD13;PLXNB1;RPS6KA2;EFNB2;SCN2B;ITGA1;RPS5;RANBP9;DNAAF3;CNTN1;NCK2;MAPK8;ANK1;SOS1;SCN9A;HSPA8;SEMA3E;RPL21;TRPC5;PSME4;CREB1;RPS6KA1;SEMA6D;L1CAM;HJV;DNM3;NELL2;CNTN2;GAB2;PSMA1;LIMK2;RPL18A;PKN2;RPS6KA5;ARTN;FLRT3;RPL7;KCNQ3;RET;NUMB;WASL;FARP2;VAV2;EFNA1;RPS3A;IRS2;RHOB;COL9A3;ADAM10;PDLIM7
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.58112998401807,1.093102447090089,0.45161290322580644,0.8721965343320586,1.0,2/13,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.58112998401807,1.093102447090089,0.45161290322580644,0.8721965343320586,1.0,2/13,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.5254401303030167,1.0930897859959428,0.35294117647058826,0.8718418591597863,1.0,11/33,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.36597461086926947,-1.09303496083151,0.1694915254237288,0.9922346971953118,1.0,74/874,11.22%,NPIPA2;SLC28A2;UGT2B15;SLC29A3;ANKK1;IL10RB;F5;LRRC2;MAFK;STX16;TTC12;UVSSA;SHCBP1;GUCA1B;ZC3H12D;LILRB3;MFAP5;TLCD2;MEFV;CCBE1;IL6R;ZNF773;ATG14;OVGP1;VWA3A;PIPOX;GOLGA2;DNAAF1;POLR1G;BCL2L15;NEK8;ZNF454;FSD2;SUGP2;BEST4;TRIM72;DYNLT5;CDH23;TIGD1;ZNF816-ZNF321P;GOLGA8A;PRKD2;TBC1D32;PIGO;WDR93;NOX4;MYLK3;CCDC88C;DNAH11;ISG20L2;FAM184B;ENO2;METTL6;BHMT2;PGP;PIWIL2;PDPR;XPC;S1PR3;VSTM4;POFUT2;RABGGTA;SPRYD7;ZBBX;DCAF16;ZNF737;RNPC3;GTF2F1;GTF2H2;CCDC40;TASL;DOC2A;FBXL18;CACNG8
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,-0.7364330268659045,-1.0929226557357883,0.45652173913043476,0.9917339475777697,1.0,3/9,14.98%,HGSNAT;SGSH;IDUA
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.5803598816328388,1.092828563982942,0.26229508196721313,0.8721997694474544,1.0,2/17,1.82%,IGF1;CCL5
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3811539258029174,-1.0927844130388993,0.23076923076923078,0.9912676339712796,1.0,32/602,8.13%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;DUSP6;SPDEF;IL31RA;PLK3;ANGPT4;RASGRF2;OBSCN;BCL2L2;PRAME;OLFM1;ACTN3;VAV3;SFRP1;NIBAN2;BEX2;PAX2;IRF5;HCK;IFIT2;CLU;JUN;WNT10B;OLFM4
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5168179324449697,1.0927665017253436,0.3269230769230769,0.872041055274243,1.0,4/41,2.55%,IRS1;SIRT1;ZBTB7B;STAT5A
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.5373578447173478,-1.0926165499853842,0.3404255319148936,0.9908088861826819,1.0,2/27,1.14%,F5;F8
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.4673395915477686,-1.0926097584403505,0.2807017543859649,0.9899230193663264,1.0,9/82,5.36%,DUSP4;ETV5;GPR39;FRMD6;SPRY4;ETV4;RHBDF1;PHLDA2;GPC1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6579811298731781,1.092523940283494,0.45098039215686275,0.8725235200465353,1.0,3/6,27.68%,GALK1;GALT;GALM
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.4723071655619398,1.0920906573157507,0.2916666666666667,0.8733802542430021,1.0,27/98,16.18%,PRRX1;PRKG1;EDIL3;MMP16;TRPC4;CDH2;TENM3;NLGN1;BGN;EFS;POSTN;MEGF10;PDGFRA;ADGRL2;PCDH18;PRICKLE2;PABPC5;ANK2;MAGEL2;LRFN5;COL11A1;RUNX1T1;FAT3;FRZB;FBN1;PDZRN3;HAPLN1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5290708262967713,-1.0920667719581219,0.32142857142857145,0.9906555819665462,1.0,2/33,1.90%,DNASE1L1;ENTPD2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.6078471687000668,1.091920448509524,0.3269230769230769,0.8735251980802139,1.0,1/11,1.52%,MME
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6617989770944438,1.091854601650577,0.46551724137931033,0.8733227822745041,1.0,1/9,5.82%,PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5361332571436837,1.0915413115151054,0.3584905660377358,0.8739231757451114,1.0,5/27,14.53%,SIRT1;PPARG;NR1H3;ABCA8;LIPG
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.515457081066891,1.091337938039694,0.3157894736842105,0.874089382553146,1.0,16/56,16.70%,CDH20;CDH7;CDH6;CDH2;CDH12;CLDN12;CDHR3;CDH10;CDH8;GJB6;GJB1;CDH24;PKP4;GJC1;PKN2;CTNNB1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6626802172902541,-1.091323779557156,0.4423076923076923,0.9922077606346642,1.0,1/5,25.59%,ABHD12B
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6723913689253646,1.0912585001645028,0.44642857142857145,0.8740224489331845,1.0,4/8,19.09%,VAMP1;SNCA;VAMP3;VAMP4
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.70091184689038,1.0912115466983496,0.36,0.873744340326336,1.0,2/5,17.05%,PRIMPOL;SIRT7
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.7128305855390702,1.0911387139421644,0.4576271186440678,0.8736397151810982,1.0,3/5,19.62%,RYR3;SLFN14;FBP1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.656706371551907,-1.0909132623527493,0.40384615384615385,0.9927234385246252,1.0,1/9,1.07%,GINS3
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.5928541364251532,-1.090881511307699,0.4,0.9918923862071832,1.0,3/16,11.69%,IL18BP;HLA-DRB1;IL18
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.583697366176222,1.0908195923906243,0.36363636363636365,0.8742549183210372,1.0,5/16,21.85%,LPIN3;MOGAT2;DGAT2;AGMO;GPAT3
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.549751545878283,1.0907971125855147,0.3333333333333333,0.8739283848197826,1.0,8/25,14.91%,LRP4;NLGN1;SCRIB;NRXN1;MAGI2;SAV1;LRRC7;DLG2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6701211028318063,1.0907694480788723,0.36,0.8736291661049821,1.0,1/9,1.94%,SIRT1
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.4370514234391741,1.0907487836122534,0.22641509433962265,0.8733193947989898,1.0,39/169,21.01%,RUNX1;MYC;RFNG;HIF1A;KAT2B;SEM1;H2BC21;DLGAP5;RBPJ;MOV10;HDAC3;HDAC2;ST3GAL6;PSMD13;TBL1X;CNTN1;H2AC6;TLE2;H2AZ2;CREB1;NBEA;H2AX;MIB1;SIRT6;PSMA1;NOTCH2;HEY2;NUMB;TP53;TLE4;AGO3;ARRB2;ADAM10;HDAC9;JAG1;HDAC1;PSMD4;CDK8;NOTCH3
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,0.6471874273106445,1.090712277123719,0.4,0.8731071302497093,1.0,6/11,22.07%,BANP;TP53BP2;TP53;AKT3;PPP1R13B;AKT2
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.45166402731594324,1.0905697550474351,0.3018867924528302,0.873213646073912,1.0,27/89,15.80%,IDO1;ADAM28;NDRG2;ENPP1;BTLA;RGS10;CD59;DHRS3;CLNK;IDO2;ACSS2;DPP4;ELOVL5;CD40;GYPC;PDE4DIP;DENND1B;SNX22;FLT3;CADM1;CSRP1;CPNE3;ANPEP;DUSP2;INF2;SLC9A9;DST
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.6197669846550865,1.0905202672891239,0.35,0.8729638249925177,1.0,5/15,21.64%,TICAM1;TANK;IKBKE;IRF3;TMED7-TICAM2
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6929153392312131,1.0904857750753645,0.375,0.8727357992032206,1.0,5/6,27.67%,SNCA;ANXA2;ANXA1;AKT2;C2CD5
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.62709274532749,-1.0903800954892797,0.3333333333333333,0.9927335435317671,1.0,2/13,3.15%,NLRP3;MEFV
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.3536242578803623,1.090333850717324,0.08163265306122448,0.8728746954398493,1.0,268/1610,17.91%,GATA4;TEX101;PROZ;MITF;IGF1;ASB17;SEMA5A;C3;UHRF2;LYPD1;TOP2A;RENBP;LSAMP;C1GALT1C1;ACE2;TUBA1C;MYC;RAB38;HIF3A;TGFBR1;CDC25A;NEGR1;CCNA2;KLKB1;SOCS2;HIF1A;GALNT8;RAB27A;KAT2B;PPARG;H2AC25;ASB18;SPSB2;ENGASE;SEM1;ASB15;MSRB3;GNB4;GNG12;CDKN2A;RNF152;CSF2RA;SYVN1;SEC22B;CDH2;EVA1A;NRIP1;VCAN;ULBP2;EIF3E;GALNTL5;ST6GALNAC3;RORA;PEX12;H2BC21;SPTBN5;CD59;NANP;RAB31;PENK;RELA;NR5A2;KLHL21;ADAMTS17;ADAMTS16;LY6D;MDGA2;ESR1;RNF185;ALG6;MUC20;FAM20A;RAB3C;ASB5;FBXL3;PIGQ;ST8SIA4;HDAC3;PAX6;UAP1;RAB39A;STAMBPL1;ADAMTS19;DPP4;HDAC2;GALNT3;USP12;TF;ADRA2C;UBE2D3;TTLL2;SPSB4;SPON1;DCUN1D1;SNCA;INO80E;ANKRD9;TPGS1;SOCS6;ACHE;RNF139;FBXO30;UBE2Z;RNF146;GAN;SMAD1;MAGT1;SENP8;ACTL6A;MOGAT2;KCTD6;MANEA;ANK2;UBE2E3;INO80D;RAB23;LMAN1;C1GALT1;KEAP1;ST3GAL6;BET1;TMEM115;SMAD2;PSMD13;LTBP1;IGFBP6;MRPL54;GALNT12;GSN;NCOA2;NUS1;FBXO7;GALNT1;XPNPEP2;MSRB1;FBXL14;COL7A1;ZDHHC2;INHBC;MUC13;RPS5;FUT8;PIGF;COMMD2;PTP4A2;DCTN3;MUC7;NPPA;CAMKMT;PRKCSH;NFRKB;SNCAIP;TRIM26;SP3;CNTN5;RNF5;TTLL9;SHPRH;KLHL42;VASH2;SMAD4;EGFL7;DYNC1I2;B3GLCT;DMTF1;MRPL44;NTNG2;GNG4;MVD;NR1H3;MAN2A1;RAB34;ALG9;ANK1;PTEN;H2AC6;SMC5;PPP3CA;MYRIP;FARS2;UBA6;KNG1;NR4A2;DNAJC3;MAN1A2;POMT2;RAB9A;DCAF5;TANK;HSPA8;RNF2;RAB30;ASB6;CNTN3;RPL21;MGAT5;PSME4;UBE2J2;NPL;UBA3;ANPEP;TPST2;RAB33B;MGAT4C;PLAUR;PML;KLHL13;FBXL15;RAB27B;EIF3H;SLC35C1;IKBKE;CCP110;B3GALNT2;DERL2;LMAN2L;UBXN7;H2AX;MGAT4A;GFUS;THRB;BCHE;POMK;SEC61A1;HCFC1;RCE1;SLC30A6;GGA1;FBN1;CPE;NFE2L2;GPAA1;PIGP;CALB1;LGALS1;RAB29;COG5;DOLK;PSMA1;PEX2;EEF1D;RPL18A;RNF128;PCSK2;CNTN4;KTN1;CTNNB1;STAM2;RANBP2;BIRC3;PLA2G7;IL33;ADAMTS6;RPL7;FBXO11;SLC34A2;EXOC6;CSF1;FKBP8;VCPKMT;GALNT5;MRPL58;ERAL1;RCN1;AGBL2;TP53;B4GALT3;SEC61A2
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.6549569442601385,1.0903074591816084,0.42857142857142855,0.872571432533577,1.0,6/10,28.99%,ZNF692;SIRT7;SDHAF3;FBP1;OGT;PDK2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.4160068389880336,1.0902665401196052,0.2631578947368421,0.8723169248159371,1.0,56/266,14.91%,DRD5;CHRM2;SLC12A7;GABRR1;RIT2;PNOC;GABRR2;GRM3;SLC1A3;HRH3;HTR1F;OPRK1;NPY;SLC17A6;NLGN1;GLRA1;PENK;SYPL1;GABRG3;SYT1;CACNB4;PDLIM4;NRXN1;UNC13B;CEL;NOVA1;SNCA;GPR176;CRHBP;GRIK2;NLGN4X;LIN7A;GRM5;RPS6KA2;HAP1;SCN2B;GRIK3;UTS2;KCND2;GABRA5;HTR2C;GLRB;FCHSD2;PTEN;GRM4;HSPA8;GABRG1;GABRB2;GRM7;GRIN2D;APBA1;RPS6KA1;LRP6;PPFIA3;CDH8;DLG2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.5917833568979065,-1.0902029280769046,0.375,0.9924426638916849,1.0,3/10,16.04%,KDM4D;HR;KDM4B
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.47028009038166846,1.0899775531472722,0.21568627450980393,0.8728328509622987,1.0,17/87,13.08%,FGF10;IRS1;FGFR3;FGFR1;ERBB4;NRG1;NRG3;PIP4K2A;ESR1;PDGFRA;NRG2;FGF17;PIK3CA;FLT3;IRAK1;SOS1;FGF5
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.4954300250789766,-1.0899724423658037,0.35185185185185186,0.9923383471656825,1.0,6/41,8.08%,KCNMB2;SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.5159359630192583,-1.0898082099649016,0.3829787234042553,0.9920284612726364,1.0,10/50,5.11%,P2RY10;SIRPG;SELL;GAB3;TRAF3IP3;CD53;CYTH4;STX11;LTB;APOL3
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,-0.6768792115024709,-1.0897341646496277,0.4146341463414634,0.9913212684703808,1.0,2/6,17.01%,ARNT2;AHR
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6785576586777285,1.089707443041612,0.3584905660377358,0.8732944980600764,1.0,4/7,31.89%,SFXN2;SLC38A5;SLC38A2;SLC7A10
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6143056236021137,1.0896664142913144,0.35714285714285715,0.8730400076172555,1.0,1/15,1.32%,C3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5585634980726324,1.089244751933667,0.35714285714285715,0.874125163120617,1.0,4/24,8.16%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6180954989530355,1.0891583247180805,0.4,0.8740748590419203,1.0,5/7,34.71%,CORO1C;TMCC1;SH3GLB1;SLC25A46;SPAST
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,0.4949596089423286,1.0888826523619484,0.38181818181818183,0.8746964283592531,1.0,7/48,5.64%,SELPLG;ITGAX;CSF3R;SASH3;CD244;HCLS1;FGL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6490163673872947,1.08887270599381,0.4406779661016949,0.8743665613055425,1.0,1/9,0.09%,GATA4
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4831616480857042,1.0888390354698478,0.3191489361702128,0.8741014161157595,1.0,10/47,14.50%,HEMGN;FERMT3;PRSS57;GPSM3;BORCS6;HYAL3;MSRB1;CCND3;RNF166;FRAT1
prerank,Reactome_2022__Estrogen Biosynthesis R-HSA-193144,0.7170779465788899,1.088832679982464,0.2830188679245283,0.8737613478977654,1.0,1/5,1.12%,HSD17B2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5092464396273612,1.088500510222225,0.3333333333333333,0.8743551647815748,1.0,11/58,15.78%,SIRT1;URI1;SNAI1;SYVN1;CXCL12;HTRA2;HSPB1;NOC2L;PLAUR;PPIF;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.6375661053820034,1.08834771122619,0.3673469387755102,0.874460424313131,1.0,6/7,24.67%,PLSCR1;ITGB2;ITGAM;HNRNPU;DHX9;SETMAR
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.5680834383435778,-1.088283732368453,0.38636363636363635,0.9954385417462647,1.0,4/28,9.08%,LDHC;PDHX;LDHAL6A;PDPR
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.40965067842466996,1.088229492368856,0.2682926829268293,0.8743618790634263,1.0,50/233,13.90%,ADRA1A;DRD5;INSL5;F2;CHRM2;C3;GABRR1;F2R;GNRH1;GABRR2;GRM3;GRIN3A;UTS2R;HRH3;HTR1F;CALCR;OPRK1;NPY;INSL3;GLRA1;PENK;PTGFR;RXFP2;GABRG3;SSTR3;PRSS3;NPFFR2;GRM8;ADRA2C;GNRH2;NTSR2;GRIK2;NPW;LEPR;GRM5;TAC1;GRIN3B;C3AR1;GRIK3;UTS2;GABRA5;HTR2C;GLRB;KNG1;GRM4;GABRG1;GABRB2;GRM7;GRIN2D;NPY1R
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.46667836179479294,1.0880749341933675,0.35294117647058826,0.8743973838101524,1.0,36/68,28.22%,CCL3L3;CCL5;RELA;TLR2;MAP2K6;TICAM1;CD40;TAB2;PIK3CA;MAPK8;IRAK1;IKBKE;PIK3CD;MAPK10;MAP3K8;FADD;IRF3;AKT3;PIK3R3;TICAM2;IKBKB;TLR1;MAPK3;AKT2;TAB1;IL12A;LBP;TRAF6;CHUK;TLR5;NFKB1;NFKBIA;SPP1;CD80;MAP2K4;CTSK
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6078500645234668,1.0879975652937206,0.4032258064516129,0.8742882363721408,1.0,6/13,22.70%,SLC8A1;ATP1A2;RYR2;GJC1;ATP1B2;GJA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5620600010247951,-1.0879351162992075,0.3695652173913043,0.9956826511914708,1.0,8/23,24.08%,XPC;PARP1;COPS7A;COPS7B;COPS6;COPS3;COPS8;COPS5
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6878348897825989,1.0878348662084394,0.36,0.8744201159506403,1.0,3/5,25.65%,BCL11B;GAS6;JAM2
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.6843542978901919,-1.087643203380417,0.4423076923076923,0.9958403408248759,1.0,3/5,27.31%,RRM1;GNL3;CASP8
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,0.6502069926640492,1.0876329921984895,0.4107142857142857,0.8746268090329457,1.0,1/7,0.98%,EBF1
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.5451902098614956,1.0876267323483992,0.40816326530612246,0.8742716238933446,1.0,5/21,11.65%,SSTR3;RAB3IP;BBS9;LZTFL1;BBIP1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.4179407778527253,1.0875902261618677,0.32608695652173914,0.874023685750419,1.0,43/247,14.31%,SLC26A3;DRD5;IRGM;IRS1;RAPGEF3;INSIG1;KCNC2;AANAT;SLC26A6;BRINP3;RORB;NRIP1;GLRA1;RORA;RELA;TLR2;ESR1;WNT9A;PDGFRA;TICAM1;NLRP7;FER;EPHA3;HTRA2;HMGB1;RAMP3;CRHBP;ABL2;FOXO1;PTPRK;HCN1;PXN;NR1H3;MEF2C;PDE4B;RRAGC;MAPK8;IRAK1;RAP1A;CPEB1;PTK7;CREB1;FZD4
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,0.5594369598598915,1.0875377739630427,0.34615384615384615,0.8738026829664871,1.0,5/31,3.05%,ADRA1A;DRD5;CHRM2;HRH3;HTR1F
prerank,Reactome_2022__Uptake Of Dietary Cobalamins Into Enterocytes R-HSA-9758881,0.6887916068374812,1.0869588753005401,0.4,0.8751526351543989,1.0,3/7,20.21%,PRSS3;ABCD4;LMBRD1
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,0.5084560289064174,1.0869397664074048,0.3137254901960784,0.874829872114248,1.0,8/42,4.78%,PNOC;C19ORF38;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;IRF8
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,0.6701354576212596,1.0868657976341265,0.4126984126984127,0.8747422642151508,1.0,2/7,21.86%,ELOVL5;ACSL1
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.50466016325827,1.0867899562920174,0.3333333333333333,0.8746707383803766,1.0,11/48,11.00%,C1GALT1C1;GALNT8;GALNTL5;ST6GALNAC3;MUC20;GALNT3;C1GALT1;GALNT12;GALNT1;MUC13;MUC7
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5563158222401765,1.0865146055059418,0.38,0.8751326433776359,1.0,10/19,16.58%,GATA4;SMAD1;BMPR1A;NPPA;SMAD4;TBX18;GJB6;SMAD5;NOTCH2;HEY2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4593818713642555,1.0864822156969536,0.2708333333333333,0.8748797437319488,1.0,11/95,14.02%,CTDNEP1;SYK;SIX4;TOR1B;BANP;NXT1;TAF3;RRS1;RANBP17;PRICKLE1;PML
prerank,Reactome_2022__Conjugation Of Benzoate With Glycine R-HSA-177135,0.6995203082329216,1.0864048189018078,0.4230769230769231,0.874722983418223,1.0,3/5,23.74%,GLYATL2;GLYATL3;GLYAT
prerank,Reactome_2022__Ligand-receptor Interactions R-HSA-5632681,-0.6337437517373501,-1.0863938197258403,0.391304347826087,0.9989377930726278,1.0,2/6,10.65%,BOC;PTCH1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5512259079113879,1.0863601307577826,0.3333333333333333,0.8745716825553304,1.0,3/23,10.28%,NDE1;FYCO1;HAP1
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,0.6292401465032014,1.0862975831535084,0.42105263157894735,0.8743938860868209,1.0,4/15,14.99%,H2BC21;H2AC6;H2AZ2;H2AX
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,0.48991972448813714,1.0862310185623907,0.25925925925925924,0.8738738174374502,1.0,11/58,7.66%,SELPLG;ITGAX;CSF3R;PIK3R6;SASH3;PIK3R5;HCLS1;IL10RA;FGL2;LAIR1;SIGLEC1
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,0.48991972448813714,1.0862310185623907,0.25925925925925924,0.8738738174374502,1.0,11/58,7.66%,SELPLG;ITGAX;CSF3R;PIK3R6;SASH3;PIK3R5;HCLS1;IL10RA;FGL2;LAIR1;SIGLEC1
prerank,PanglaoDB_Augmented_2021__Neurons,0.3927041481879313,1.0861624593058952,0.20754716981132076,0.8738082174227181,1.0,40/267,12.26%,IGF1;NXPH1;RIT2;RESP18;GRM3;CADM2;PDE1A;NPY;SLC17A6;CNTNAP2;PCLO;RORA;B3GAT2;CHODL;NEFH;CACNB4;ZDHHC22;NWD2;NRXN1;RAB3C;CNRIP1;SACS;OLFM3;SYNPR;GPR162;ZCCHC7;GRM5;TAC1;LRRTM3;ADGRB3;CTNNA2;HAP1;SCN2B;PAK5;TMEM196;GPATCH8;CTTNBP2;NOL4;PPP1R9A;PROX1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6408896043491772,1.0859248267871835,0.36666666666666664,0.8740456680121835,1.0,9/11,35.60%,RANBP9;PICALM;ABCA2;ABCA7;APOE;TMED10;FLOT2;PRNP;ROCK1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7577911808027968,1.0856920657411218,0.42592592592592593,0.8744157550265762,1.0,2/5,6.35%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.6911577879049733,-1.085650061171947,0.3684210526315789,1.0,1.0,4/6,28.75%,SVIP;USP14;AQP11;UBXN1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5203476984464896,-1.0853473758782626,0.34615384615384615,1.0,1.0,3/26,12.01%,RTP1;RTP5;OTOF
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5420227410392655,1.0850576619156105,0.3333333333333333,0.8761983163257321,1.0,8/37,7.89%,SLC12A7;TMTC2;SLC12A1;SLC12A3;SLC8A1;FAM20A;SCNN1B;SNCA
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.509335101129651,1.0849882772484079,0.41509433962264153,0.8760734488133942,1.0,7/43,10.60%,CCL5;F2R;CASR;ANK2;GRAMD2A;EPB41;GRIN3B
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6306366490469797,-1.0849235495521465,0.38095238095238093,1.0,1.0,1/12,2.28%,BST1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.42574218600635483,1.0849181138002286,0.3,0.8759911404822687,1.0,10/85,7.31%,FGF10;HIF1A;RIN2;FGF2;ANGPT1;RRAS;INSL3;DOCK1;PLCG2;ANXA3
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.5924493752417247,-1.0848196526737484,0.3684210526315789,1.0,1.0,2/19,4.77%,IL10RB;STXBP2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6278984437592989,1.0846922776200665,0.36538461538461536,0.8763120449710192,1.0,3/8,17.62%,GALNT3;GALNT1;GALNT16
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6492599397447849,1.0846125486700195,0.4528301886792453,0.8762244032282234,1.0,2/10,18.53%,TERF1;NDFIP2
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.3725324025067655,1.084514919173127,0.17777777777777778,0.8761633354903506,1.0,84/591,14.44%,ASB17;KLRD1;SIPA1;AP1M2;C3;CD99;SYK;PRKG1;RAPGEF3;HERC3;CD22;NEDD4;ASB18;SPSB2;ICOSLG;SEM1;ASB15;CBLB;BTLA;SEC22B;BLNK;CTSF;UBE2J1;RNF182;TRIM50;RELA;KLHL21;TLR2;LAIR1;ITGAV;ASB5;PLCG2;UBE2E2;FBXL3;SIGLEC1;CD40;UBE2D3;HMGB1;SPSB4;FBXO30;UBE2Z;RNF217;GAN;UBE3D;KCTD6;UBE2E3;PAG1;TAB2;KEAP1;PIK3CA;KLRG1;NECTIN2;UBA5;PSMD13;BTN2A2;LNPEP;FBXO7;FBXL14;DCTN3;OSCAR;HLA-E;HECW2;VAMP3;UBE2U;KLHL42;DYNC1I2;RBBP6;PTEN;PPP3CA;UBA6;SOS1;ITK;ASB6;UBE4A;PSME4;UBE2J2;RAP1A;UBA3;RACGAP1;CD74;PRICKLE1;KLHL13;FBXL15;NFATC3
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.5118118163309757,-1.0844943256852824,0.2682926829268293,1.0,1.0,3/28,9.04%,AMACR;HAO2;MLYCD
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.5842336198770225,1.0844889823489439,0.3829787234042553,0.8759168950050743,1.0,7/15,15.92%,GRM3;GRM8;CASR;GRM5;GRM4;GRM7;GRM1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6262182703455582,1.084453513538013,0.35714285714285715,0.8756812528227639,1.0,1/10,1.44%,RUNX1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.6689114576119916,1.0842890812009396,0.4666666666666667,0.8757528246710842,1.0,3/6,29.45%,PEX13;HTR6;FGF13
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.5054521037653945,1.0840597774231433,0.34,0.876110058995766,1.0,22/40,29.30%,RELA;TIFA;HMGB1;TAB2;IRAK1;TANK;TAB3;TP53;RIPK2;IKBKB;TAB1;NFKBIB;IKBIP;N4BP1;USP18;TRAF6;CHUK;NLRC5;NFKB1;NFKBIA;APP;LRRC14
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5829923864596859,1.0838030835054226,0.4,0.876541038638102,1.0,7/19,29.93%,FKBP5;PPIF;PPIL6;CWC27;NKTR;PPIL1;PPIB
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.683860504099447,1.0835884547275492,0.3770491803278688,0.8768289152852705,1.0,3/7,20.65%,ELAPOR2;KLF7;MAFF
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3536531695116371,1.0835156825377743,0.15384615384615385,0.876699074776552,1.0,161/908,17.25%,STK26;CSTA;CTDNEP1;ASB17;DUSP29;MAP3K11;HS3ST5;C3;SYK;PRKG1;RAB38;HIF3A;SIRT1;TGFBR1;FGFR1;EGLN3;PLOD2;CDK11A;SOCS2;HIF1A;ASB18;SPSB2;ENGASE;ASB15;CDK18;BMP2;CDH2;EVA1A;VCAN;DAPK2;GALNTL5;TNIK;PTAR1;ACVR2A;PENK;METAP1D;MAPKAPK2;KLHL21;MMP15;ERG;FUT9;FAM20A;ASB5;UBE2E2;CEL;FBXL3;DYRK2;PPP4R1;ST8SIA4;RPS6KA4;FER;PPP1CC;TF;UBE2D3;SPSB4;PPM1A;DCUN1D1;MAP3K9;PTPRD;ANKRD9;MEX3B;SOCS6;FBXO30;IP6K3;CDK14;GAN;SENP8;ZC3HAV1;ABL2;DSP;KCTD6;LATS1;PTPN14;KEAP1;ST3GAL6;PTPRT;FRK;PSMD13;MAP3K21;LTBP1;FASTK;PPM1L;TNC;MAP4K2;NUS1;FBXO7;NIM1K;LOXL2;FBXL14;QPCT;PAK5;BMPR1A;PTPRK;PTP4A2;PRKCSH;VRK2;CHEK2;PPM1E;KLHL42;MAN2A1;MAPK8;IRAK1;PTEN;TIPARP;CDK12;PPP3CA;KNG1;DNAJC3;DCAF5;STRADA;ASB6;PSME4;PPP3CC;UBA3;PTPRM;MTMR3;ACVR1B;DUSP2;CREB1;KLHL13;DYRK1A;FBXL15;PTPRU;IKBKE;CSNK1G3;MAP3K1;B3GALNT2;UBXN7;NEK7;HIPK1;MGAT4A;FBXL2;RCE1;SGK1;PRKAA1;FBN1;CPE;GPAA1;PADI4;PIK3CD;LGALS1;MAPK10;CTH;BAP1;SIRT6;PSMA1;DYRK3;LIMK2;PKN2;CD247;PXK;KTN1;TGM6;GLRX;RPS6KA5;SIRT7;CDKL5;FBXO11;IRAK3;RET;PPEF2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4608003203589088,1.0833249264809997,0.3170731707317073,0.8769707970190408,1.0,17/83,10.13%,ADRA1A;DRD5;LGR5;ADGRL4;CALCR;ADGRG6;ADGRG4;PTGFR;RXFP2;ADGRL2;ABCA1;GPR12;ADRA2C;GPR26;RAMP3;GPR161;ADGRB3
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.5121474903448561,1.0832678482908362,0.36538461538461536,0.8767987652572555,1.0,8/35,20.82%,PEX12;UBE2D3;UBE3D;FANCL;MARCHF7;KLHL12;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4618306774557835,1.0831932653860308,0.3541666666666667,0.8766215997113325,1.0,8/96,9.76%,TNFSF14;TNFRSF18;TNFSF13B;ST18;RELA;CD40;FOXO3;PSMD13
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3816784890376502,1.0831753078726243,0.1956521739130435,0.8763232424157544,1.0,86/461,17.45%,UHRF2;MKRN3;HIF3A;SIRT1;HIF1A;LZTR1;NEDD4;SPSB2;RNF152;RFWD3;SYVN1;PELI2;PEX12;UBE2J1;RNF182;TRIM50;PELI1;KLHL21;KLHL8;RNF185;ASB5;UBE2E2;FBXL3;MARCHF1;PELI3;NEUROD2;UBE2D3;MSL2;SPSB4;ANKRD9;RNF139;FBXO30;UBE2Z;RNF146;SPOP;RNF217;GAN;UBE3D;UBE2E3;KEAP1;ANAPC16;PSMD13;LNPEP;FBXO7;FBXL14;AKTIP;TRIM26;RNFT1;HECW2;FANCL;UBE2U;SHPRH;KLHL42;CNOT4;RBBP6;ARIH1;UBE2QL1;UBA6;UBE4A;PSME4;UBE2J2;TSPAN17;KLHL24;RNF166;KLHL13;FBXL15;RMND5A;MARCHF7;MIB1;TRIM52;RNF25;FBXL2;NFE2L2;PDZRN3;MARCHF3;PSMA1;PEX2;NHLRC3;UBR5;RNF208;RNF26;CTNNB1;FBXO11;KLHL7;KLHL12;RNF38
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5766732454332049,1.0831148258968266,0.4528301886792453,0.8757536327363485,1.0,2/14,7.81%,ZFP36L2;TOB1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5766732454332049,1.0831148258968266,0.4528301886792453,0.8757536327363485,1.0,2/14,7.81%,ZFP36L2;TOB1
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.3869821573922441,1.0830160140903193,0.24,0.8757352715365929,1.0,55/461,14.99%,SGO1;CTDNEP1;ESPL1;CDC14A;CDKN2C;TOP2A;TUBA1C;MYC;NDC80;CDC25A;CCNA2;CDK11A;LPIN3;SEM1;CDKN2A;FBXO5;NDE1;H2BC21;CEP70;PCM1;PPP1CC;CEP152;GMNN;MCM7;TK1;CHMP6;ANAPC16;CENPO;PSMD13;GINS1;E2F4;DCTN3;POLE2;VRK2;CEP135;DYNC1I2;CNTRL;H2AC6;PPP1R12B;XPO1;H2AZ2;PSME4;PHLDA1;SLC19A1;NEDD1;CCND3;ESCO1;RAB33B;DYRK1A;CCNH;CCP110;LMNB1;NEK7;CENPP;H2AX
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6214202437069742,1.0830038269092763,0.3888888888888889,0.875406182321705,1.0,5/15,19.28%,NXT1;ANP32A;XPO1;RGS14;BANF1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5669373596680294,1.0828051723235725,0.39622641509433965,0.8757038597917361,1.0,1/18,0.53%,FGF10
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.41782206289005364,1.0826742691397764,0.24444444444444444,0.8758013160189189,1.0,36/182,21.23%,KCTD21;NEDD4;SPSB2;SYVN1;KLHL8;RNF185;SPSB4;RNF146;RNF217;KCTD6;KEAP1;ANAPC16;PSMD13;KLHL15;FBXO7;FBXL14;RNF5;CNOT4;UBQLN4;RBBP6;ARIH1;UBA6;UBE4A;RNF166;MIB1;RNF128;FBXO11;NDFIP2;SMURF1;RNF19B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;RNF130
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,0.6813485683048855,1.0823434564631063,0.43478260869565216,0.8760853713366091,1.0,3/7,22.38%,IL2RA;ITGB2;PTPRC
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,0.6813485683048855,1.0823434564631063,0.43478260869565216,0.8760853713366091,1.0,3/7,22.38%,IL2RA;ITGB2;PTPRC
prerank,Reactome_2022__Synthesis Of PI R-HSA-1483226,0.7116166555317066,1.0822437011368398,0.36,0.8760143591894624,1.0,2/5,15.22%,CHEK2;PITPNM1
prerank,KEGG_2021_Human__Viral myocarditis,-0.4830420376563891,-1.0821425799703974,0.3,1.0,1.0,9/46,15.16%,MYH7;RAC2;CD86;HLA-DRB1;HLA-C;CAV1;CCND1;RAC1;HLA-DQA1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4104883668934734,1.082095944411924,0.28888888888888886,0.8760957625010806,1.0,42/264,15.37%,MAP3K11;TOP2A;EPHA7;PAWR;BOK;SIRT1;TGFBR1;PLEKHG2;FGD4;BMP2;DAPK2;FANK1;SEPTIN4;DKKL1;ARHGEF17;SCRIB;UNC13B;HTRA2;HMGB1;SNCA;DLC1;RYBP;FOXO3;UBE2Z;LATS1;BIN1;RPS6KA2;FOXO1;TNFRSF10B;ARHGEF16;BNIP3L;TP53BP2;MAPK8;KNG1;SOS1;PHLDA1;RBM5;ARHGEF6;PHLDA3;ATF6;ANO6;FRZB
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.5770838255713249,-1.0820905998221575,0.36065573770491804,1.0,1.0,3/26,5.33%,PM20D1;SPTLC3;ARG2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.711790858132454,-1.0820675974391993,0.5116279069767442,1.0,1.0,4/5,24.56%,SF3A3;SF3A1;SLU7;SF3A2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7144714449504083,1.0820314156286628,0.38181818181818183,0.8758620094754995,1.0,2/6,9.43%,VAPB;GRAMD2A
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,-0.5131804086355523,-1.0819230188585967,0.37254901960784315,1.0,1.0,4/26,3.86%,KLRC1;SELL;CD86;IL6R
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.48942510824851826,1.0818690270653393,0.38596491228070173,0.8760798899150816,1.0,9/54,13.27%,RIT2;CD22;ZFYVE16;EPHA3;SNCA;ABL2;HIP1;PICALM;STON2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5664201501331754,-1.0816386341013142,0.3111111111111111,1.0,1.0,3/24,4.93%,NPAS4;DRD4;DRD2
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.660660105052948,1.0815400028268962,0.45098039215686275,0.8767121100310241,1.0,3/5,27.93%,SIRT7;FBLL1;TRMT112
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.4548766170539542,1.0815390788013206,0.3064516129032258,0.8763577592070779,1.0,15/73,8.38%,LAMA4;FLT1;TMEM100;TDRD10;RSPO3;PRKG1;ADGRL4;BGN;CXCL12;POSTN;ERG;PDGFRA;PLSCR4;RAMP3;PCDH18
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.45848073795156924,1.0814024316860793,0.2549019607843137,0.8764598213138715,1.0,4/65,4.68%,TIMELESS;CCNA2;RRAD;H2BC21
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5948593518801212,1.0813994303722487,0.3389830508474576,0.8761006295129278,1.0,3/16,11.01%,WNT4;DKKL1;GCK
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5677741187358529,1.0811680035579152,0.37037037037037035,0.8765589234270739,1.0,7/22,10.29%,FLT1;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.557290351950444,-1.0811671118124648,0.2926829268292683,1.0,1.0,4/15,5.48%,TNFSF18;RAC2;BST1;ZP3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.488920335888975,1.081103787503572,0.36,0.8764408542366512,1.0,13/55,20.74%,RUNX1;KAT2B;MAFB;PRMT1;MOV10;CNOT4;MEF2C;AGO3;H3-3A;LYN;HDAC1;KMT2C;GP1BA
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.6040497516187319,1.0810285934071815,0.4230769230769231,0.87630194699731,1.0,6/15,22.25%,SOCS6;SOS1;SH2B2;KIT;LYN;GRB2
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6468962241465237,1.08101476740124,0.45098039215686275,0.8759852719924951,1.0,6/8,35.31%,GAL3ST1;B4GALT3;UGT8;GALC;B3GALT2;FA2H
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.624445430054477,1.0806446201219533,0.4107142857142857,0.8767723232529698,1.0,3/14,12.20%,PADI2;ESR1;ARID1A
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6692111371202942,1.0806309436899462,0.4186046511627907,0.8764609433596431,1.0,1/8,3.69%,RORB
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.4596305676683984,1.0806158587953973,0.32075471698113206,0.8761654977034309,1.0,19/97,19.74%,IRS1;H2AC25;H2BC21;KCNH8;HDAC3;CHMP6;EZH2;TBL1X;DYNC1I2;H2AC6;PML;CREB1;USH2A;PCSK2;UBAP1;RANBP2;EED;MVB12A;TRIM28
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6247590672785608,1.0803293882847471,0.34,0.8767216757183854,1.0,2/19,2.87%,IRGM;PPARG
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.4781437458229907,1.080315010942718,0.3111111111111111,0.8764211458115141,1.0,10/51,13.26%,GABRR1;GABRR2;GNB4;GNG12;KCNJ3;GABRG3;GNAI3;GABRA5;GNG4;GABRB2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7054058128557977,1.0803104894156779,0.46808510638297873,0.8760791139334047,1.0,2/6,5.37%,BMP2;SOX6
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.5300858110822846,-1.0802204790476666,0.32558139534883723,1.0,1.0,3/26,5.63%,CTNNA1;RNASE1;VAV3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6483523216070981,-1.080114203182446,0.5333333333333333,1.0,1.0,4/8,19.02%,XDH;DAB2IP;PIK3CB;DCN
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6304803189351759,-1.0801034028803187,0.36363636363636365,1.0,1.0,2/8,8.48%,AK8;AK7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5765444547659165,-1.0800341430959197,0.35185185185185186,1.0,1.0,3/20,10.93%,XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.455818892879445,1.0800166993209022,0.22448979591836735,0.8765407365381477,1.0,20/85,11.68%,HS3ST5;ANGPT1;VCAN;HS3ST3B1;BGN;HS3ST1;CHSY3;UGDH;HS3ST2;SDC4;GPC5;DSEL;HS2ST1;GPC4;ST3GAL6;EXT1;SLC35D2;CSGALNACT1;CHST6;HAS2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6923085983346108,1.0800032438694809,0.5192307692307693,0.8762041527415747,1.0,3/9,7.36%,WHRN;ADGRV1;SLC4A7
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.7111949927043657,-1.0799371018606208,0.4,1.0,1.0,2/5,15.15%,WNT7A;OSR1
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.7111949927043657,-1.0799371018606208,0.4,1.0,1.0,2/5,15.15%,WNT7A;OSR1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6550736942578804,1.079844039319908,0.3620689655172414,0.8762639883870846,1.0,7/8,33.79%,GLRX;BAD;AKT2;STOML2;ANK3;MTLN;VCP
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3803740848699399,-1.0797594468069784,0.2708333333333333,1.0,1.0,34/436,8.18%,CD44;IL10RB;IRF4;TNFSF18;CXCL13;DUOX1;IL11;CD86;IL1RL2;IL18BP;ALOX5;PRKCD;IL31RA;TEC;IL6R;TNFRSF11A;CRLF1;FOS;LTB;IFI27;TRIM5;CAMK2A;F13A1;CIITA;INPP5D;PSMB4;IRF5;EGR1;HCK;HLA-DRB1;IFIT2;OAS3;TNFRSF4;OAS1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6776291017223339,1.0795658693968444,0.41509433962264153,0.8767145416150783,1.0,2/8,21.54%,HEXB;NAGA
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.556013277561911,1.079555182150048,0.3333333333333333,0.8763783032508661,1.0,6/17,22.25%,PDGFRA;KANK1;PIK3CA;SOS1;GOLGA4;GRB2
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.5837831641641327,-1.0795337341097704,0.3877551020408163,1.0,1.0,5/15,10.34%,APOBEC3H;APOBEC3G;BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6268614348632382,1.0794943169119295,0.4074074074074074,0.8761985203505349,1.0,1/10,1.43%,CD99
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6112452555712062,1.0794334744631675,0.4117647058823529,0.8756313346966458,1.0,3/9,21.16%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6112452555712062,1.0794334744631675,0.4117647058823529,0.8756313346966458,1.0,3/9,21.16%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.536736524884227,1.079394668473057,0.40384615384615385,0.8753948881728691,1.0,8/28,11.09%,FLT1;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3;WASHC1
prerank,KEGG_2021_Human__Fat digestion and absorption,0.550783557668703,1.0792539234465985,0.3829787234042553,0.875454884814276,1.0,7/28,8.86%,NPC1L1;CEL;ABCA1;MTTP;PLA2G10;ABCG8;MOGAT2
prerank,Reactome_2022__Tandem Pore Domain Potassium Channels R-HSA-1296346,0.6472002133076061,1.0791693923499863,0.3829787234042553,0.875379756956741,1.0,1/8,2.62%,KCNK2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,0.49764787890224804,1.0791560700443648,0.2916666666666667,0.8750502314039221,1.0,10/53,7.66%,LGALS9;ITGAX;SYK;CSF3R;SASH3;IRF8;IL10RA;FGL2;TLR2;SIGLEC1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5658476995332357,1.0791455728498929,0.3695652173913043,0.8747261682033067,1.0,3/19,4.83%,CHRM2;LYPD1;RGS10
prerank,Reactome_2022__mRNA Editing R-HSA-75072,-0.6420021642822071,-1.079057893732504,0.42592592592592593,1.0,1.0,1/7,1.33%,APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6125146380867382,-1.0787747548319258,0.5,1.0,1.0,2/7,18.75%,SFRP1;STK17A
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.4592279637699399,1.078741566447643,0.3076923076923077,0.8756839998225071,1.0,18/94,13.08%,FGF10;IRS1;FGFR3;FGFR1;ERBB4;NRG1;NRG3;PIP4K2A;ESR1;PDGFRA;NRG2;FGF17;PIK3CA;FLT3;IRAK1;PTEN;SOS1;FGF5
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.47862226028698485,1.078597415308841,0.2857142857142857,0.875712634186086,1.0,9/51,12.02%,PNP;CCL5;IDO1;IL4;SDC4;IL15;CCDC88B;IL23R;NCK2
prerank,Reactome_2022__Eicosanoid Ligand-Binding Receptors R-HSA-391903,-0.6795287892229782,-1.0785786070632168,0.4716981132075472,1.0,1.0,2/9,2.57%,LTB4R;PTGDR
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.6965157732079205,1.078330394554703,0.4339622641509434,0.876145636651156,1.0,1/6,1.43%,CD99
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6316254428347521,-1.0782939118317034,0.391304347826087,1.0,1.0,1/16,0.36%,SELP
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5302766290238453,1.0782294769641454,0.34782608695652173,0.8760911396223566,1.0,6/31,17.85%,ZBTB7B;RPS6KA4;PAXIP1;RPS6KA5;RUVBL2;FMR1
prerank,KEGG_2021_Human__mTOR signaling pathway,0.4299177800639338,1.078024495646013,0.3469387755102041,0.876508089834858,1.0,39/138,22.25%,IGF1;IRS1;FZD5;LPIN3;WNT4;RNF152;WNT9A;TELO2;PIK3CA;RPS6KA2;RRAGC;PTEN;SOS1;FZD1;IGF1R;STRADA;DVL2;RPS6KA1;LRP6;FZD4;FZD6;RICTOR;SGK1;CAB39L;PRKAA1;PIK3CD;SLC3A2;WNT2;RRAGD;MLST8;DEPTOR;AKT3;PIK3R3;IKBKB;MAPK3;RPS6KA6;AKT2;CLIP1;GRB2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.6594257251797477,1.0779840856798868,0.46153846153846156,0.875933093096283,1.0,2/6,14.91%,CRHBP;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.6594257251797477,1.0779840856798868,0.46153846153846156,0.875933093096283,1.0,2/6,14.91%,CRHBP;DLG2
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,0.6879609100135984,1.0779431776438406,0.36,0.8756821658581192,1.0,1/5,14.02%,PI4K2B
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.48196086533571825,1.0779395634905833,0.37777777777777777,0.8753280096719008,1.0,13/59,16.86%,ERBB4;NRG1;GAB1;NRG2;ERBIN;PIK3CA;NCK2;BCAR1;SOS1;CPNE3;SLC30A10;FAM83A;RPS6KA5
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.5700050688187398,1.0779301865123765,0.2857142857142857,0.875020670619715,1.0,1/16,1.69%,BOK
prerank,PanglaoDB_Augmented_2021__Pericytes,0.42876552074463886,1.077888797847903,0.28,0.8748117661468424,1.0,24/124,13.75%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;ANGPT1;GNB4;STEAP4;BGN;LHFPL6;COL6A2;CXCL12;POSTN;PDGFRA;PLSCR4;PCDH18;INPP4B;MEDAG;SYNPO2;NR1H3;HTRA1;TBX18;ABCA8;ANPEP
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.6759430003810187,-1.077563505288049,0.4444444444444444,1.0,1.0,2/5,27.07%,VPS25;VPS36
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.6759430003810187,-1.077563505288049,0.4444444444444444,1.0,1.0,2/5,27.07%,VPS25;VPS36
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.5424503760103987,-1.0775216428579781,0.3103448275862069,1.0,1.0,7/20,20.15%,DUOX1;P2RY12;CCDC25;TGFB1;NTN1;PDGFB;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5344981631365062,1.077423945333547,0.423728813559322,0.8758995446084181,1.0,4/25,9.16%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.61293644004691,-1.0773601144669513,0.37037037037037035,1.0,1.0,3/14,12.02%,SLC5A10;SLC2A8;SLC5A1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5290699691175735,-1.0772674773785205,0.32558139534883723,1.0,1.0,7/43,10.10%,KCNMB2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.49637642460720327,1.0770319211440307,0.3469387755102041,0.87685218681515,1.0,15/47,20.06%,PLCH1;FGF2;ITPKB;PLCG2;INPP1;IP6K3;INPP4B;NUDT4;PTEN;NUDT4B;PLCB1;PLCD1;IMPA1;IP6K1;MINPP1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6800005012131103,1.0769810963802382,0.41818181818181815,0.8766118220461913,1.0,4/5,17.50%,HIBCH;BCAT1;HIBADH;ALDH6A1
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.4793460839873662,1.0769558298083741,0.3333333333333333,0.8763200636338004,1.0,10/35,18.08%,CFH;C3;CD59;C5AR2;C3AR1;CPNE1;CPNE2;AKR1C1;CD81;CD55
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.45581159696197415,1.0768867103695112,0.30612244897959184,0.8761780949833197,1.0,19/86,13.44%,FLT1;STAB1;PREX2;ITGA8;ADGRL4;ZEB2;ZBTB20;ZEB1;ERG;STARD9;RAMP3;MYH11;TCF4;ATP1A2;MEF2C;PPP1R12B;CD34;SHROOM4;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.43937143899411446,1.0766637811178603,0.23529411764705882,0.8766032728940532,1.0,18/86,22.90%,EIF3E;SYNCRIP;SAMD4A;LIN28A;C8ORF88;TOB1;RNF139;PATL2;RIDA;CPEB1;CAPRIN1;CNOT8;FMR1;PAIP2B;LSM14A;NANOS1;EIF2AK3;CPEB2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.4760581700434131,1.0766304900034795,0.2833333333333333,0.8763479448188248,1.0,5/49,2.58%,LGALS9;PNP;CCL5;IL4;ZBTB1
prerank,KEGG_2021_Human__Measles,0.4733898902858226,1.0766256848346372,0.3137254901960784,0.8759949638606005,1.0,33/93,23.73%,STAT5A;CBLB;IL2RA;RELA;TLR2;TAB2;PIK3CA;MAPK8;IRAK1;RAB9A;HSPA8;CCND3;EIF3H;IKBKE;PIK3CD;MAPK10;FADD;CDK4;TP53;IL2RB;CASP3;IRF3;AKT3;PIK3R3;BAD;IKBKB;AKT2;MX2;EIF2AK3;CDK6;HSPA1A;NFKBIB;IL12A
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.6690444232260613,1.0765416256062144,0.4444444444444444,0.875873954006914,1.0,3/8,24.84%,PELI1;BIRC3;ARHGEF2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.5252491046592639,1.076533095564168,0.3584905660377358,0.875557479677125,1.0,11/28,18.34%,SOCS2;NRIP1;ESR1;LOC400499;RAMP3;CRHBP;NCOA3;CTNNB1;RUVBL2;LCOR;SSTR1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5965470500809601,1.0764253293108375,0.45098039215686275,0.8755293446090252,1.0,6/17,18.72%,GSTM2;SLC8A1;CRHBP;RYR2;RYR3;CASP3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.45593509713646635,1.0762721098540444,0.2857142857142857,0.8756503563917697,1.0,12/46,26.04%,JADE3;MSL2;ACTL6A;EPC1;HCFC1;RUVBL2;KANSL3;OGT;ING3;EP300;ZZZ3;MSL3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6510181741839487,-1.0759822502267133,0.4444444444444444,1.0,1.0,1/9,1.23%,NUPR1
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.38468694281648735,-1.0758039224264078,0.23404255319148937,1.0,1.0,38/534,8.18%,CD44;DUSP4;IL10RB;SIGIRR;IRF4;TNFSF18;IL11;CD86;IL1RL2;DUSP6;IL18BP;ALOX5;PRKCD;IL31RA;TEC;IL6R;TNFRSF11A;CRLF1;FOS;STXBP2;LTB;IFI27;TRIM5;CAMK2A;PDZD2;F13A1;CIITA;INPP5D;PSMB4;IRF5;EGR1;HCK;HLA-DRB1;IFIT2;OAS3;JUN;TNFRSF4;OAS1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.44712696512322564,1.0756567792649085,0.2727272727272727,0.8772773205437645,1.0,12/62,22.18%,U2AF1;THOC6;LIN28A;PAPOLA;PCF11;TENT4B;SRSF11;CSTF3;PNPT1;WDR33;NCBP1;SRSF3
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6240833993524706,-1.0756496705826477,0.4583333333333333,1.0,1.0,2/12,4.76%,APOBEC3H;APOBEC3G
prerank,Reactome_2022__RSK Activation R-HSA-444257,0.6896373393533436,1.0756246565789878,0.4772727272727273,0.876996756247034,1.0,4/7,21.74%,RPS6KA2;RPS6KA1;MAPK3;RPS6KA6
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,-0.6701067786854937,-1.0753287804483316,0.45454545454545453,1.0,1.0,3/5,30.38%,SMPD3;RACK1;TNFRSF1A
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.45606486263712204,-1.0751011340266423,0.2916666666666667,1.0,1.0,7/75,3.47%,EHF;CLDN4;TMEM184A;GPR39;SERINC2;CLDN1;KIF12
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.6258016478799276,1.0750288653071352,0.4406779661016949,0.8786988845280037,1.0,3/13,9.39%,PNP;AK3;AK1
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.6319573351383043,1.0747489381132662,0.3617021276595745,0.8792291140771396,1.0,2/8,1.49%,ESPL1;TOP2A
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.5928418089541018,1.0746334562403932,0.38596491228070173,0.8791995527777726,1.0,7/19,16.70%,FZD5;FRAT2;FZD1;DVL2;LRP6;FRAT1;CTNNB1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42601519964833257,1.0745369524584312,0.21153846153846154,0.8791289783739065,1.0,24/125,15.32%,EPHA7;PBX3;PHGDH;CDH2;CNTNAP2;ROBO2;AFF2;SOX6;ADGRL2;ATXN1;PCDH18;SPEF2;DSCAML1;ROGDI;CTNNA2;HAP1;EMX1;PLXNB2;PROX1;PTEN;SHROOM4;GRIN2D;PITPNM1;POMK
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6059042255557373,1.0745020832003616,0.4406779661016949,0.8788482314749194,1.0,2/16,3.09%,RUNX1;SNAI1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6098757845112582,1.0745012760965955,0.3125,0.8784908308114485,1.0,5/13,16.70%,PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.3994745290629119,-1.0743861663335528,0.2641509433962264,1.0,1.0,25/168,17.20%,GOLGA8B;KIF2B;STX16;CYTH4;M6PR;ARF3;KIF12;KDELR1;COPG2;KIF15;RABEPK;KIF26A;KIF20B;COPG1;KIF22;PTGES2;BET1L;DCTN2;DCTN1;ARFGAP3;KIF4A;KIF1A;DYNC1LI2;PAFAH1B1;KIF26B
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.6920679400107428,-1.074338230461303,0.4186046511627907,1.0,1.0,1/6,5.33%,ARG2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6092138902006152,1.0743194678050456,0.40384615384615385,0.8785999492314549,1.0,5/14,23.02%,RAPGEF3;ANP32B;TP53;GAS6;GTSE1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.42969705196007213,1.0743118194631225,0.3137254901960784,0.8782736677568649,1.0,23/105,11.66%,STAB1;HIF1A;ITGA2;RIN2;MAFB;PTGS1;TLR2;ESR1;ITGAV;TCN2;ABCA1;GRM8;SIGLEC1;CASR;CYP27A1;TMIGD3;CA2;GSN;EFNB2;C3AR1;OSCAR;SMAD4;EGFL7
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.46801412770852757,1.074137319819609,0.3333333333333333,0.8784646933933307,1.0,19/48,28.88%,ALG6;MGAT2;FUT8;MAN2A1;ALG9;MAN1A2;MGAT5;MGAT4C;MGAT4A;DOLK;B4GALT3;STT3B;DPM1;TUSC3;ST6GAL2;ALG5;B4GALT1;ALG2;DPAGT1
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.5789980949817584,1.0741327293741316,0.3076923076923077,0.87813361463037,1.0,10/22,26.66%,SYT1;UNC13B;LIN7A;APBA1;PPFIA3;SLC18A2;PPFIA2;SYN2;TSPOAP1;CASK
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.5329778996410822,1.0739249122771395,0.26,0.8785137997568889,1.0,10/41,14.46%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;RIMS2;GRM4;HSPA8;PPFIA3
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.44880679300070486,1.0738099471187457,0.3137254901960784,0.8785255405615257,1.0,6/58,15.21%,MAP3K11;TNFRSF19;HMGB1;MAP4K2;MFHAS1;PLCB1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5111047417838793,1.073746412168373,0.37777777777777777,0.8783890550308449,1.0,10/38,10.54%,FERMT3;EPHA7;EFNA5;TENM3;FUT9;MEGF10;DPP4;ADA;MAGI1;ZDHHC2
prerank,Reactome_2022__Serotonin Receptors R-HSA-390666,0.6268870732355271,1.0736645513768908,0.49122807017543857,0.8782986598250365,1.0,7/10,24.08%,HTR1F;HTR2C;HTR7;HTR1E;HTR2A;HTR5A;HTR6
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.646985957881596,1.0735346143841522,0.4782608695652174,0.8783053667469639,1.0,3/12,16.44%,AFF2;PML;DYRK3
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6579322303429862,1.0735017041791435,0.4230769230769231,0.8777013439159662,1.0,2/5,20.35%,TICAM1;TICAM2
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.6579322303429862,1.0735017041791435,0.4230769230769231,0.8777013439159662,1.0,2/5,20.35%,TICAM1;TICAM2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.47644865256927155,1.0734859014389988,0.35185185185185186,0.8773818471277809,1.0,8/77,5.96%,SELPLG;FLT1;RUNX1;RRAS;TOX;BMI1;ZFP36L2;TET2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5294096879196166,1.073373073547034,0.32075471698113206,0.8773481259205236,1.0,9/34,20.25%,NEDD4;PADI2;ESR1;KDM3A;ARID1A;UBR5;PLPP1;NR3C1;TRIP4
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.4490582600986004,1.073360116749905,0.3018867924528302,0.8770494161811652,1.0,14/95,9.97%,MXRA5;NYNRIN;LRP4;GNG12;DOCK1;LRIG3;ARHGEF17;EFS;TEAD2;ADGRL2;BCAM;GPC4;MAGI1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.4991396068718672,1.0733271358122414,0.29411764705882354,0.8768375526828053,1.0,6/48,8.80%,TGFBR1;ERBB4;NRG1;NRG2;ZSWIM5;ABL2
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.5769583521239284,1.0730375233487741,0.3559322033898305,0.8773438802443393,1.0,3/19,10.27%,FZD5;HTRA2;FBXO7
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.621048008687582,1.0730061870715484,0.36538461538461536,0.8771015272559423,1.0,3/13,14.33%,MME;BACE2;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4574476635857035,1.0729988533801238,0.2857142857142857,0.8767830465345269,1.0,15/80,9.37%,SYK;ESRRG;ZBTB7B;IL4;TRPM8;SCD;TRPV2;ADIPOR2;PRKAB2;PLAC8;HDAC3;ACHE;PDGFC;KDM3A;LEPR
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.6981503292406953,-1.0729415195198977,0.5,1.0,1.0,1/5,11.25%,GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.6981503292406953,-1.0729415195198977,0.5,1.0,1.0,1/5,11.25%,GAS2L2
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,0.37196622498871856,1.0729250139327862,0.23809523809523808,0.8766174080902586,1.0,162/770,17.49%,SLC7A11;PCDH15;PADI6;F2;SLC12A7;UNC5C;LYPD1;EMB;FSTL5;PLD6;BOK;ACE2;NGB;THRSP;ERICH5;C19ORF38;ERBB4;INSIG1;RAB27A;SLC35G1;REXO2;GNB4;GNG12;NAALAD2;DUSP23;CNTNAP2;NDE1;ANKRD46;CTSF;MLLT3;LMOD3;SAMD4A;CSRP2;FANK1;GDAP1;ADGRG6;SPTBN5;GLUL;MCTP2;CD59;KIAA0930;WEE2;SMYD2;TRIM50;SLC8A1;MOV10;ADAMTS17;KCNH8;MDGA2;NRXN1;MYOF;SMDT1;MYO1E;CNN3;EPS8;MUC20;CNRIP1;UBE2E2;TP53INP1;ELAVL2;WDSUB1;NLRP7;TDRD9;TSC22D1;FRMD3;CHD7;UBE2D3;TOB1;WDR76;AGGF1;MARVELD3;ADA;FOXO3;GRIK2;CBFA2T3;CRYZ;CCDC50;SLC7A9;INPP4B;CPNE4;ESYT3;AK1;COBLL1;BBS9;UBA5;LRWD1;ADARB2;HAP1;CADM1;LOXL2;TCF4;TXNDC16;SMAP1;COMMD2;BMPR1A;PTPRK;CPT1C;NR1D2;LRRC17;CSGALNACT1;ABCD3;ELOF1;GNG4;GDF9;CRISPLD1;QKI;EYA2;NCK2;MAPK8;BAALC;PPP3CA;TLE2;ZNF281;BCO1;SAMD12;SPINK2;SEMA3E;FDXR;POLR3G;ZBTB33;NPL;ECHDC1;PRICKLE1;DENND5B;MGAT4C;APBA1;WWOX;RUNX1T1;CCNH;CRPPA;AFF1;PCGF5;BEND7;MGAT4A;THRB;MAP3K7CL;ANKRD45;FAR2;TAFA1;FBXL2;ELL2;SGK1;MRO;ASPH;MESP1;COG5;PKP4;HEY2;CNTN4;ELOVL4;PXK;TMEM243;SMS;SMARCA2;GLRX;STX8;PRADC1;SQLE;KLHL7;NUMB;RNF38;RRAS2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5993792398474991,1.072903774268441,0.41379310344827586,0.8763451367036583,1.0,2/11,12.07%,GSN;FCHSD2
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.49404875980657537,1.0726886597307026,0.3541666666666667,0.8766727694573786,1.0,9/35,18.75%,ZNF385B;CACNB4;ADAMTS16;BCAM;HCN1;BANK1;GABRB2;CCDC146;COL9A3
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.5256182682226104,-1.0726714029611049,0.36363636363636365,1.0,1.0,5/37,5.72%,LRP10;AGRN;GPC2;GPC1;GPC3
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,-0.6874664047994599,-1.0726271777115772,0.44680851063829785,1.0,1.0,2/6,13.77%,APOB;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.512759450535689,1.0724234366746503,0.3125,0.8772287391867073,1.0,3/32,2.91%,LGALS9;FZD5;PYHIN1
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,0.5523538071469078,1.0724021700238775,0.3695652173913043,0.8769159267697723,1.0,3/15,10.05%,HPSE2;HPSE;HYAL3
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5597795814606156,-1.0722265815657304,0.4,1.0,1.0,3/18,11.90%,GINS3;RFC3;LIG1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4595479157481271,1.0721363433239315,0.28,0.8773495283727083,1.0,8/74,13.17%,NXF1;U2AF1;THOC6;WASHC4;ATXN1;RANBP17;XPO1;STRADA
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.4829711538732886,1.0719030560956262,0.36363636363636365,0.8778030764156486,1.0,14/46,21.00%,MYC;HIF1A;KAT2B;RBPJ;HDAC3;HDAC2;TBL1X;TLE2;NBEA;HEY2;TLE4;HDAC9;HDAC1;CDK8
prerank,Reactome_2022__Formation Of Editosome R-HSA-75094,-0.6442371397793322,-1.071814319554059,0.40384615384615385,1.0,1.0,1/5,1.33%,APOBEC3H
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4569963080761278,1.0718024283877448,0.25,0.8777490747199527,1.0,13/96,6.66%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3860916107466596,1.0717948876819972,0.2653061224489796,0.8774162770873931,1.0,63/322,21.23%,KCTD21;SIRT1;NEDD4;SPSB2;SYVN1;PELI1;KLHL8;RNF185;UBE2D3;SPSB4;ANKRD9;RNF146;SPOP;RNF217;UBE3D;KCTD6;SPOPL;KEAP1;ANAPC16;PSMD13;KLHL15;FBXO7;FBXL14;TBL1X;HECW2;RNF5;UBE2U;KLHL42;CNOT4;UBQLN4;RBBP6;ARIH1;UBA6;UBE4A;PSME4;RNF166;PML;RMND5A;MIB1;NFE2L2;PSMA1;NHLRC3;RNF128;CTNNB1;UBAP1;FBXO11;UBAP1L;PTPN23;ARRB2;NDFIP2;SMURF1;MVB12A;FBXW5;RNF19B;FEM1B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;DDIT3;PSMD4;RNF130
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.672060834253748,1.0717815586179615,0.4,0.877098950389855,1.0,9/11,26.96%,MANF;NR4A2;LRP6;CTNNB1;VEGFA;WNT2;RYK;CDNF;SHH
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,-0.5733696016615677,-1.071754783141942,0.375,1.0,1.0,4/15,19.62%,XDH;NT5C;NUDT16;ADPRM
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5293728452041531,1.0717543444533744,0.45,0.8768376018249059,1.0,4/26,9.16%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.43058862773301904,1.0711580219507664,0.2830188679245283,0.8782525467319451,1.0,28/90,28.65%,MAP3K11;TNFRSF19;HDAC3;HMGB1;MARVELD3;ZNF675;MAP4K2;IGF1R;MFHAS1;PLCB1;RAP2A;PHLPP1;CCN2;CARD9;ANKRD6;ZNF622;MAPK8IP2;ZMYND11;EGFR;FKTN;TRAF6;GADD45G;TRAF5;MAP4K4;SIRPA;CYLD;DUSP15;APP
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,0.45821680083419425,1.0709293192465745,0.39285714285714285,0.8786692075913807,1.0,12/74,6.66%,MXRA5;MRGPRF;ITGA8;PRRX1;ADGRL4;ACTG2;SSC5D;BGN;COL6A2;CXCL12;POSTN;PDGFRA
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.4312906804664929,-1.0708877234746685,0.3125,1.0,1.0,10/85,8.18%,SELP;MPO;NLRP1;CXCL13;PRKCD;IL6R;JCHAIN;SLC11A1;OAS3;OAS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.624824912013836,-1.0708743286271905,0.39655172413793105,1.0,1.0,7/12,15.15%,XDH;SPRED3;SPRED2;MMP9;SPRED1;CAV1;OSR1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.677787229097498,1.07072142623906,0.38596491228070173,0.8790905935484983,1.0,1/6,2.39%,SLC22A3
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.5729664396096893,1.0706955005768328,0.43636363636363634,0.8788187500682252,1.0,3/23,4.06%,ERBB4;NRG1;LLGL1
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.7250296171087646,-1.0705454280494275,0.46,1.0,1.0,2/5,11.67%,AGBL1;FOLH1B
prerank,CellMarker_Augmented_2021__Cancer cell:Kidney,-0.6799604176283369,-1.0703538942174573,0.3953488372093023,1.0,1.0,1/5,12.00%,PODXL
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.5922167140529107,-1.0702794264907443,0.4375,1.0,1.0,4/16,20.56%,PRKCD;ITPR3;CALM1;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.6241937929240299,-1.0701651241956833,0.4230769230769231,1.0,1.0,2/15,5.72%,TERT;FOXM1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.6692628549192732,1.0701187520687083,0.3695652173913043,0.8803165747397573,1.0,4/6,28.90%,LRWD1;RUVBL2;NIPBL;PIH1D1
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.6607560715847077,1.069970562638475,0.4727272727272727,0.8803678845347856,1.0,6/8,30.46%,ABL2;ABL1;SLIT2;TMPRSS4;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.665667966568624,1.0696905321648573,0.48214285714285715,0.8809697687768017,1.0,3/8,12.35%,NLGN1;NRXN1;PTEN
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4843938670965667,-1.0696426949772184,0.3137254901960784,1.0,1.0,2/38,4.30%,MAP1LC3B2;ATG14
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.49972320238034545,-1.069621368159148,0.3090909090909091,1.0,1.0,12/56,8.25%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP;TMC8
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6748402649833012,1.0695762272762683,0.49019607843137253,0.8810207757618832,1.0,2/8,14.41%,CDK12;CCNH
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.622582785856551,-1.069476811548008,0.32,1.0,1.0,3/12,14.90%,RAC2;RAC1;NTN1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.6614239170389897,1.0694234936512532,0.41304347826086957,0.881122216622204,1.0,1/5,1.94%,SIRT1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.5225842180289949,1.069352705826105,0.35,0.8809662581935025,1.0,6/27,25.70%,CHMP6;UBAP1;MVB12A;VTA1;SGIP1;VPS37D
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.4270366308134984,1.0692335555829982,0.2857142857142857,0.8809718144499847,1.0,27/175,11.26%,ZDHHC11;IRGM;KLRD1;C3;SYK;SHMT2;IL4;PPP1R14B;PPARG;H2BC21;MID2;RELA;TIFA;TLR2;F12;PLCG2;FER;CD40;HMGB1;SNCA;GCH1;STING1;FRK;IL23R;MSRB1;HLA-E;TRIM26
prerank,KEGG_2021_Human__Galactose metabolism,-0.567775102690777,-1.0692024194386476,0.40816326530612246,1.0,1.0,1/26,0.60%,HK2
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.4805025303163151,-1.0691629236911568,0.32653061224489793,1.0,1.0,5/64,2.82%,EHF;CLDN4;CD24;CLDN1;C6ORF132
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,0.4701320154409163,1.0690230036992703,0.3333333333333333,0.8808871650283707,1.0,8/84,6.08%,ESPL1;TOP2A;NDC80;CDC25A;CCNA2;DLGAP5;SKA3;ASPM
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,0.4701320154409163,1.0690230036992703,0.3333333333333333,0.8808871650283707,1.0,8/84,6.08%,ESPL1;TOP2A;NDC80;CDC25A;CCNA2;DLGAP5;SKA3;ASPM
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4888068089715878,1.0689015458006357,0.3269230769230769,0.8809280079374129,1.0,15/64,17.69%,URI1;SOCS2;ROBO2;LMO2;LOC400499;RAMP3;CRHBP;NCOA2;GCK;ATP1A2;MEF2C;NCOA3;THRB;AKR1C1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5742046562325457,1.068784060112314,0.3787878787878788,0.8809234998491653,1.0,3/16,9.37%,RUNX1;IL15;LEPR
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,0.4020094160382422,1.0683398400217643,0.23809523809523808,0.8819860682407734,1.0,39/211,17.65%,CWH43;LRRC46;CCDC74B;ERICH5;RRAD;DNAI4;CD59;UGDH;SMYD2;SPAG16;DNAJB2;PLAC8;ALDH9A1;ISCA2;GPR162;ZNHIT2;AMZ2;AK1;BBS9;TSPAN19;LRWD1;ENDOG;MSRB1;DNAAF3;LRRC45;MLF1;SPAG6;KLHL13;C12ORF75;IFT57;HIPK1;PITPNM1;MORN5;CCDC181;FAM81B;PPIL6;RUVBL2;ALDH3B1;ARL3
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.668640813343419,1.068261175254767,0.375,0.8819207651327023,1.0,3/8,16.93%,CHPT1;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4881982832294167,1.0682154315723094,0.26,0.881704633774387,1.0,7/37,18.96%,FGF2;ITPKB;IP6K3;GPHN;CPS1;MOCOS;IP6K1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5304982756678963,-1.0681602268958905,0.33962264150943394,1.0,1.0,10/40,17.78%,RAC2;BST1;FBLN2;VIT;MYADM;ALOX15;RAC1;FZD7;PIK3CB;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5071078715557988,1.0681564915307706,0.4107142857142857,0.8815138115357122,1.0,11/40,13.40%,TENM1;LMOD3;FER;GSN;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2;SPIRE2
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.72615540140246,-1.0679951346057888,0.4489795918367347,1.0,1.0,1/5,0.69%,PGC
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6671863852148332,1.0679405049284079,0.4262295081967213,0.8810326410697512,1.0,1/7,5.88%,TLR2
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,0.6671863852148332,1.0679405049284079,0.4262295081967213,0.8810326410697512,1.0,1/7,5.88%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6671863852148332,1.0679405049284079,0.4262295081967213,0.8810326410697512,1.0,1/7,5.88%,TLR2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.595699424978753,1.0679377006320632,0.4117647058823529,0.8806817718379433,1.0,4/14,20.35%,TICAM1;PPIF;TRPM7;TICAM2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.4112645379676729,1.0678890915618435,0.32727272727272727,0.8804716672795838,1.0,27/151,10.84%,TNFSF14;CCL3L3;TNFRSF18;CCL5;TNFRSF19;TGFBR1;IL26;TNFSF13B;IL4;CSF3R;GDF6;CSF2RA;BMP2;IL2RA;IL7R;ACVR2A;IL10RA;CXCL12;IL15;LIFR;CD40;LEPR;IL23R;INHBC;IL13RA2;TNFRSF10B;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6003666412453151,1.0672603326798822,0.40816326530612246,0.8820070669570056,1.0,5/19,14.25%,CDKN2A;LATS1;PTEN;HEXIM2;NR2F2
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,0.5265209946698244,1.067214061454062,0.3684210526315789,0.8818166557455731,1.0,2/16,5.53%,ALDH1A1;DHRS3
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,-0.5896654506844102,-1.0671613176702686,0.34146341463414637,1.0,1.0,2/13,1.04%,P2RY10;CD24
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.6456013034469164,1.0671197167738908,0.4107142857142857,0.8817216115652597,1.0,2/10,6.74%,SYK;PLCG2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.44656455987085025,1.066929927847028,0.28,0.8819272043050638,1.0,20/101,18.53%,MITF;LLGL1;TEAD2;CD40;LIN7A;SLC7A9;MATN1;MAGI1;RANBP9;VAMP3;PICALM;CD74;PML;GPAA1;CD247;MNAT1;CD2AP;WASL;TP53;IL2RB
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.6927890554951746,1.0669256262490945,0.4406779661016949,0.881586830795244,1.0,3/7,5.01%,CFH;IL4;CD59
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6949660843974024,1.0667856973002072,0.4666666666666667,0.8817372546132067,1.0,2/6,16.60%,AKTIP;RNF26
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.4485873429413076,1.0667453851693285,0.32,0.8815123047309096,1.0,11/82,11.53%,VAPB;DRD5;CCL5;CXCL12;SLC8A1;SLC24A2;CD40;CASR;ANK2;ATP1A2;HTR2C
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.6478629125604853,1.0666190550266224,0.4230769230769231,0.8815376036192382,1.0,7/10,26.87%,MEF2C;TBX18;HEY2;TMEM204;BMP4;MRTFA;MRTFB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.34801729299966855,1.0665160987887214,0.1875,0.8814328974941091,1.0,348/1744,19.50%,CRX;GATA4;DACH1;MITF;AASS;IGF1;SMAD6;EBF1;PKNOX1;TPRX1;ZSCAN4;RUNX1;HGF;PRRX1;ZNF300;DMRT3;HNF4G;MYC;ESRRG;HIF3A;ZNF792;SIRT1;PBX3;SOX5;IL26;FZD5;ZBTB7B;TSHZ3;IL4;URI1;ZBTB40;HIF1A;STAT5A;ZBTB1;FOXP2;MYCN;FGF2;KAT2B;PPARG;DBX2;SNAI1;LPIN3;TFEB;MED17;TOX;ZEB2;TSHZ2;ZNF493;HES6;CDKN2A;MAFB;LMO1;POU6F2;RORB;BMP2;BMI1;OLIG1;NFIL3;ZNF518A;NRIP1;OLIG2;PRDM14;SIX4;ZNF582;FLI1;RORA;ST18;ZGLP1;KANK2;ZBTB20;IRF8;SP1;DUX4;HCLS1;ACVR2A;ZNF462;SOX6;VSX2;LCORL;SMYD2;RBPJ;RELA;NR5A2;MOV10;ZEB1;LMO2;VEZF1;TLR2;TET2;ZBTB2;ESR1;ZBTB26;ERG;ZNF283;TEAD2;NFIA;PLAC8;ZNF599;WWTR1;BBX;ELP4;ZNF543;ZSCAN20;ZNF595;POU3F2;MED13L;HDAC3;PAX6;RFXAP;RPS6KA4;ZNF467;MKX;HDAC2;ZSCAN23;NCOA5;MYPOP;CD40;SSBP2;NEUROD2;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;ELF4;DUXA;ELK1;FOXO3;LHX6;ATXN1;TFEC;PTOV1;SMAD1;ZNF230;ZNF41;HIVEP2;KLF6;ACTL6A;ZNF202;ZNF561;KDM3A;INSM2;STING1;RIPPLY2;TAF3;AUTS2;ZNF675;CTCFL;SMARCD3;NPAS1;FRK;SMAD2;ZNF771;ZNF426;ZNF165;NCOA2;EZH2;ZNF669;LOXL2;ZNF692;NHLH2;NHLH1;ZNF239;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;ZBTB41;BMPR1A;TBL1X;PASD1;NR1D2;ZNF292;EMX1;PHF21A;SP3;SLTM;SMAD4;PLAGL1;ZNF704;DMTF1;DPF1;NPAS3;NR1H3;MEF2C;NCK2;ZNF536;ARID1A;ZNF347;PROX1;CDC5L;PTEN;ZNF175;CTBP2;ZNF778;CDK12;TBX18;PPP3CA;TIAL1;ZNF281;MYB;GREM1;HDGFL3;ZNF212;NR4A2;DPF3;ZBTB10;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;CREB3L2;ZXDC;ZBTB33;ZNF652;ARID1B;ZNF182;MLXIPL;TSHZ1;DVL2;WWOX;RARB;CREB1;ZNF639;BCOR;VGLL3;NR2F2;RPS6KA1;LRP6;SMARCD2;ZNF263;RFX5;CCNH;NFATC3;PAX3;ZNF780B;KLF15;EPC1;KAT6A;POU2F1;PCGF5;PLSCR1;ZNF442;GABPB1;NCOA3;ETV3;ATF6;THRB;VRTN;HJV;FOXO6;HCFC1;ZFP30;SPEN;SMAD5;PHIP;TRPS1;ZNF607;NFE2L2;HSF2;DEAF1;POGZ;MESP1;SIRT6;EAF2;PEX2;ZNF623;MYDGF;ZNF776;ZNF584;HEY2;CNOT2;CTNNB1;SMARCA2;ZNF672;FADD;RPS6KA5;RORC;MNAT1;IL33;CHD1;SIRT7;THAP3;ZNF276;ZNF786;RUVBL2;ZNF654;NUFIP1;VEGFA;TGIF1;WNT2;CDK4;MXI1;LCOR;SUPT3H;GABPA;WASL;TP53;CSRNP3;MAZ;ZNF784;MIER3;CD81;EFNA1;AGO3;MED30;ABCA2;CITED2;EED;TEF;ZNF12;ZNF30;JMY;ZNF234;TTC21B;IER5;NSD1;ZNF33A;FUS;PER3;ZNF518B;CSRNP2;KDM5B;KIT;HDAC9;DNAJB1;ZBTB4;BRWD1;PCGF1;ZNF251;ZNF322;ZXDA;ZNF782;NR3C1;ETV7;IRF3;ARNT;NFIC;ZNF311;ABL1;JAG1;TFCP2L1;ZSCAN2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.49910044363703465,1.066300214185049,0.32,0.881663102786591,1.0,19/57,20.60%,IL4;TOX;NFIL3;BLNK;LY6D;PLCG2;CHD7;KLF6;LEPR;FLT3;PIK3CD;DNAJB9;RAG2;ZAP70;KIT;HDAC9;GPR89A;RAG1;AXL
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.3657445525495025,1.0662352886125346,0.32727272727272727,0.8815234617160687,1.0,79/414,15.55%,PNP;LAMA4;TIMELESS;MAP3K11;SLC12A7;TCIRG1;ITGA8;TUBA1C;F2R;EGLN3;SH3TC1;EDIL3;LHFPL2;EFNA5;UTRN;ANGPT1;ADD3;POGLUT2;MMP16;PELI2;CSRP2;COL6A2;LRIG3;PCDH17;FBLIM1;RAB31;FKBP5;RALA;PELI1;ZEB1;LMO2;PIP4K2A;RBMS1;RNF185;NAV3;WWTR1;GAB1;GYPC;FDX1;SMAD1;MTSS1;KLF6;STING1;ST3GAL6;RAPGEF6;GPR161;MAP4K2;RPS6KA2;EFNB2;LOXL2;HLA-E;CTTNBP2;CHEK2;AMOTL1;PXN;EGFL7;MEF2C;MAN2A1;PDE4B;FMNL3;CSRP1;FLRT2;PXDC1;HSPB1;STON2;PTPRM;RACGAP1;TPST2;RARB;ANGPTL4;NR2F2;FZD4;INF2;PHLDB2;OLFML3;H1-10;BCHE;CPNE2;DOCK4
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6478869230539314,-1.0660476534603505,0.44680851063829785,1.0,1.0,4/7,13.36%,GPX3;PRKCD;RNF112;XRCC1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.5597802830794498,-1.0660121874595163,0.40425531914893614,1.0,1.0,4/15,17.00%,CRLF1;OAS1;OAS2;STAT1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5049185221501472,-1.0658865840000034,0.3191489361702128,1.0,1.0,7/46,6.82%,PM20D1;SPTLC3;ASS1;PNPLA1;ARG2;DEGS2;ALOXE3
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.6840179391814927,-1.0657200923844585,0.4489795918367347,1.0,1.0,2/5,8.19%,CARTPT;UBASH3B
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.37469308924823824,-1.0656417125428925,0.21818181818181817,1.0,1.0,20/571,3.47%,TRIP10;EPN1;ALB;GOLGA8B;TBC1D10C;F5;F8;KIF2B;STX16;COL4A2;SYT12;ALS2CL;CYTH4;NLRP3;SYNJ2;M6PR;COL4A1;RIN3;ARF3;KIF12
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8809725041843536,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.689835818259749,1.065630866153138,0.47058823529411764,0.8806393702910104,1.0,2/5,24.40%,BBIP1;ARL13B
prerank,Reactome_2022__Chylomicron Clearance R-HSA-8964026,0.6981421753060695,1.0655029922713897,0.48148148148148145,0.8807047156517459,1.0,1/5,3.24%,LDLR
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.6682569460070582,1.0654073256396692,0.4583333333333333,0.8806008343830987,1.0,2/5,21.16%,MAPK8;MAPK3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6003688930872636,1.0651905616326536,0.42857142857142855,0.880974517284454,1.0,6/13,23.87%,RORB;TULP1;CRB2;VEGFA;RP1;CEP290
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5936251496125102,-1.065084746286554,0.3488372093023256,1.0,1.0,1/11,2.68%,CLDN1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.5031262527003849,1.064995239274152,0.3170731707317073,0.8811390893188815,1.0,7/31,17.26%,RAPGEF3;RPS6KA4;SNCA;PAXIP1;NOC2L;RPS6KA5;RUVBL2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.6101753359417007,1.0649313025595006,0.36538461538461536,0.8809407325018502,1.0,2/7,21.36%,PPP3CA;ANXA1
prerank,KEGG_2021_Human__Steroid biosynthesis,0.5795009044437122,1.0648698861115573,0.4,0.8808120825331649,1.0,9/17,19.26%,MSMO1;FDFT1;CEL;SOAT2;SOAT1;SC5D;CYP2R1;SQLE;DHCR7
prerank,CellMarker_Augmented_2021__B cell:Blood,0.6833737054985525,1.0646489149659044,0.5348837209302325,0.8811453657890869,1.0,2/5,2.12%,MME;TNFSF13B
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5307553290390441,1.0644825673267289,0.4888888888888889,0.8812103317039685,1.0,4/21,12.41%,EFNA5;EPHA3;CORO1C;GPM6B
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.6751604725688551,1.064396905681654,0.4423076923076923,0.8811114996844837,1.0,2/5,13.36%,POU3F2;MYT1L
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.520749695986342,1.0642464948992434,0.40816326530612246,0.8812855493519227,1.0,2/24,3.23%,ITGAX;MYRF
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.45984953398997686,1.0641750311631177,0.3888888888888889,0.881152058664492,1.0,11/54,20.18%,LPIN3;ALDH7A1;ALDH1B1;CEL;ALDH9A1;MOGAT2;LIPG;DGAT2;DGKZ;PLPP1;DGKD
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.43120547273657783,1.0639721834314317,0.38461538461538464,0.881340824007046,1.0,21/100,11.16%,INSL5;C3;CCL5;PNOC;F2R;UTS2R;OPRK1;NPY;INSL3;CXCL12;PENK;RXFP2;SSTR3;NPFFR2;QRFPR;NTSR2;NPW;TAC1;C5AR2;C3AR1;UTS2
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6623098754381248,-1.0639625607919536,0.37777777777777777,1.0,1.0,2/6,16.27%,RAC1;PIK3CB
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,0.647496372142278,1.063896049037212,0.4426229508196721,0.8812470503113896,1.0,2/9,4.30%,DCC;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.5720326006633798,1.0637651601035452,0.39655172413793105,0.8812920140100869,1.0,1/13,5.68%,SDC4
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.5545262521767163,1.0635815289906685,0.4032258064516129,0.8814656509663467,1.0,2/17,8.97%,SDC4;CHMP6
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.6425453323945307,1.0635394685594124,0.45614035087719296,0.8812878161451994,1.0,5/7,19.69%,GSN;HIPK1;RYR2;CAPN10;BMPR2
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.573381860194612,1.0635142983990804,0.49019607843137253,0.8810309778032259,1.0,10/20,24.52%,IL1RAPL2;PPFIBP1;PTPRD;PPFIA3;SLITRK5;SLITRK6;IL1RAP;PPFIA2;IL1RAPL1;PPFIBP2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.4483662029771554,1.0634830620380786,0.3137254901960784,0.8807792854858613,1.0,16/69,20.67%,ACE2;SLC8A1;APELA;SCN10A;ANK2;TMIGD3;NPPA;ATP1A2;NPR2;KCNG2;RYR2;ASPH;RYR3;CORIN;TRPC1;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.6856773712009832,1.0634434578335505,0.52,0.880552503397852,1.0,3/6,19.69%,NPPA;ADRB1;BMPR2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6282582099492535,1.063255970495808,0.39285714285714285,0.8808446649667705,1.0,4/9,20.16%,CPNE7;CPNE1;CPNE3;HDHD5
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6242665733509097,1.0631957884217622,0.3870967741935484,0.8806526058274309,1.0,4/8,22.98%,MAGI2;DAND5;FSTL3;LEMD3
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,0.6095176964504154,1.0631617881738409,0.4423076923076923,0.8804458868753791,1.0,1/13,0.09%,GATA4
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.34496102465747713,1.0628319798708106,0.18,0.8811226632662505,1.0,284/1778,15.83%,CRX;GATA4;DACH1;MITF;IGF1;SMAD6;TIMELESS;EBF1;PKNOX1;TPRX1;ZSCAN4;RUNX1;PRRX1;ZNF300;DMRT3;HNF4G;MYC;ESRRG;HIF3A;ZNF792;SIRT1;PBX3;SOX5;TGFBR1;F2R;ZBTB7B;ERBB4;TSHZ3;TULP3;CDK11A;RFPL2;IL4;URI1;ZBTB40;HIF1A;STAT5A;ZBTB1;FOXP2;MYCN;FGF2;NRG1;PPARG;PYHIN1;GDF6;DBX2;SNAI1;TFEB;SFMBT2;MED17;MYRF;TOX;MDFIC;ZEB2;TSHZ2;ZNF493;PRDM8;WNT4;HES6;CDKN2A;CDK18;MAFB;POU6F2;FBXO5;RORB;BMP2;OLIG1;NFIL3;ZNF518A;TENM1;OLIG2;MLLT3;PRDM14;SIX4;ZNF582;FLI1;RORA;FANK1;ST18;ZGLP1;ZBTB20;IRF8;SP1;DUX4;HCLS1;SOX6;VSX2;LCORL;RBPJ;RELA;NR5A2;ZEB1;VEZF1;ZBTB2;ESR1;ZBTB26;ERG;ZNF283;TEAD2;NFIA;ZNF599;WWTR1;BBX;ELP4;ZNF543;ZSCAN20;ZNF706;TP53INP1;ZNF595;POU3F2;ELAVL2;MED13L;HDAC3;SLC39A8;PAX6;RFXAP;RPS6KA4;ZNF467;MKX;HDAC2;CHD7;ZSCAN23;MYPOP;SSBP2;NEUROD2;HMGB1;PPM1A;ZNF274;ELF4;DUXA;ELK1;GMNN;RYBP;FOXO3;LHX6;ATXN1;TFEC;CDK14;CBFA2T3;SMAD1;YAF2;ZNF230;ZNF41;ZNF195;HIVEP2;GPBP1L1;KLF6;ACTL6A;ZNF202;ZNF561;KDM3A;ZNF675;CTCFL;SPINDOC;SMARCD3;NPAS1;SMAD2;ZNF771;ZNF426;ZNF165;NCOA2;EZH2;MAGEL2;ZNF669;LOXL2;ZNF692;NHLH2;NHLH1;ZNF239;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;ZBTB41;MBTD1;PTPRK;TBL1X;ZNF114;PASD1;NR1D2;HP1BP3;ZNF292;EMX1;HNRNPD;CHEK2;SP3;SLTM;SMAD4;PLAGL1;ZNF704;DMTF1;DPF1;NPAS3;NR1H3;MEF2C;ZNF536;ARID1A;ZNF347;PROX1;CDC5L;ZNF175;CTBP2;ZNF778;ZNF117;TBX18;TLE2;TIAL1;ZNF281;MYB;ATF7IP;HDGFL3;ZNF212;NR4A2;DPF3;MAGED1;ZBTB10;FZD1;HSPA8;KLF7;PICALM;HEXIM2;MXD4;MYT1L;ZNF20;POLR3G;ID4;CREB3L2;ZXDC;ZBTB33;SPIN1;ZNF652;ARID1B;MLF1;ACVR1B;CD74;ZNF182;MLXIPL;TSHZ1;PRICKLE1;DVL2;PML;CREB1;ZNF639;BCOR;VGLL3;RUNX1T1;NR2F2;RPS6KA1;LRP6;FZD4;SMARCD2;DYRK1A;ZNF263;RFX5;CCNH;NFATC3;PAX3;ZNF780B;KLF15;EPC1;KAT6A;POU2F1;BAMBI;PCGF5;TAF5;ZNF442;ETV3;ZNF280B;RGS14;ATF6;ZNF502;PLCB1;VRTN;FOXO6;ZNF257;HCFC1;ZFP30;SPEN;SMAD5;PHIP;TRPS1;ZNF607;NFE2L2;HSF2
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.5346496601287868,-1.0628110826256416,0.3783783783783784,1.0,1.0,2/20,2.67%,IL10RB;CD86
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.550396359573165,1.0626636159619405,0.41818181818181815,0.8812661575132622,1.0,2/22,3.67%,CDC25A;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5284505970614514,-1.0625431776302885,0.37254901960784315,1.0,1.0,6/29,10.00%,TRIM56;IRF5;FLOT1;OAS3;OAS1;DHX58
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.605720418735182,1.0623752007198952,0.4745762711864407,0.8818385332138563,1.0,3/12,21.86%,ELOVL5;ACOX1;ACSL1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.369178633014146,1.062254269964813,0.21951219512195122,0.8818140481022657,1.0,202/966,17.86%,CRX;GATA4;MITF;IGF1;RUNX1;HGF;ZNF300;HNF4G;MYC;ESRRG;SIRT1;TGFBR1;IL26;F2R;FZD5;ERBB4;RFPL2;IL4;HIF1A;MYCN;FGF2;KAT2B;PPARG;PYHIN1;GDF6;PADI2;SNAI1;LPIN3;TFEB;MED17;MYRF;MDFIC;ZEB2;WNT4;MAFB;LMO1;RORB;BMP2;NFIL3;NRIP1;MLLT3;SIX4;FLI1;RORA;FANK1;ST18;ZGLP1;IRF8;SP1;DUX4;HCLS1;ACVR2A;ZNF462;RBPJ;RELA;NR5A2;LMO2;VEZF1;TLR2;TET2;CDCA4;ESR1;ERG;TEAD2;NFIA;ASF1A;PLAC8;WWTR1;TP53INP1;POU3F2;HDAC3;PAX6;RFXAP;RPS6KA4;HDAC2;CD40;SSBP2;HMGB1;PPM1A;ELF4;ELK1;RYBP;FOXO3;TFEC;PTOV1;SMAD1;YAF2;KLF6;KDM3A;STING1;AUTS2;CTCFL;SERTAD2;SMARCD3;SMAD2;NCOA2;NHLH2;NHLH1;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;BMPR1A;TBL1X;NR1D2;HNRNPD;CHEK2;SP3;SMAD4;PLAGL1;ELOF1;DPF1;NPAS3;NR1H3;MEF2C;NCK2;ARID1A;PROX1;CDC5L;ZNF175;CTBP2;PPP3CA;ZNF281;MYB;GREM1;ATF7IP;NR4A2;DPF3;FZD1;KLF7;PICALM;CREB3L2;ZXDC;SPIN1;ARID1B;CD74;MLXIPL;DVL2;PML;WWOX;RARB;CREB1;ZNF639;NR2F2;SERTAD1;RPS6KA1;LRP6;FZD4;SMARCD2;DYRK1A;ZNF263;RFX5;NFATC3;PAX3;KLF15;EPC1;KAT6A;POU2F1;BAMBI;PCGF5;PLSCR1;GABPB1;NCOA3;ATF6;H1-10;THRB;PLCB1;HJV;HCFC1;SMAD5;PHIP;NFE2L2;HSF2;DEAF1;POGZ;MESP1;EAF2;NAA16;MYDGF;HEY2;BCL3;CTNNB1;SMARCA2;FADD;RPS6KA5;RORC;IL33;SIRT7;THAP3;RET;RUVBL2;NUFIP1;VEGFA;WNT2;RHOG;SUPT3H;GABPA;WASL;TP53;CSRNP3;MAZ
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.6582136358566902,-1.062114884801402,0.46938775510204084,1.0,1.0,1/5,1.18%,TEK
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.5525255071486423,1.0620386684428893,0.3709677419354839,0.8820556459197654,1.0,1/20,1.94%,SIRT1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5752460865115344,1.0619321713045975,0.391304347826087,0.8820803469191398,1.0,4/12,20.56%,PCM1;BICD1;GCC2;SAXO2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5499505230171204,1.0615007637033067,0.39285714285714285,0.8831586057964332,1.0,6/24,17.39%,RUNX1;HCLS1;IL23R;CD74;FADD;CSF1
prerank,CellMarker_Augmented_2021__Effector T cell:Undefined,0.6622768575434774,1.0613834928870873,0.42,0.8832025421719504,1.0,3/8,9.58%,BTLA;IL2RA;KLRG1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.46539355888088574,1.0613197806652146,0.32608695652173914,0.8830496676674829,1.0,2/42,2.50%,CSTA;URI1
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),-0.7208745028209455,-1.0613033564823453,0.4186046511627907,1.0,1.0,2/6,4.76%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.47458746630759113,1.0611600088911863,0.3469387755102041,0.8832804770773581,1.0,17/72,14.58%,PCDH15;LHFPL3;CDC14A;ROR1;EPS8L2;WHRN;ALDH7A1;ADGRV1;CCDC50;ATP6V0A4;TBL1X;TPRN;SLC26A4;COL11A1;GRM7;LRP2;PAX3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5611092489822853,1.0609762216261622,0.34782608695652173,0.8835651777983362,1.0,2/10,6.77%,PCM1;CCDC120
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.41677706174713114,1.0608655810952563,0.36,0.8835450095586179,1.0,37/146,19.16%,LRRC3B;FGFR3;CDH20;PMP2;SLC1A3;AANAT;GFAP;CADM2;NRXN1;CD40;NTSR2;SYNPR;GRM5;PLXNB1;LRRTM3;ADGRB3;SRR;ATP1A2;ACSBG1;GPM6B;BAALC;HTRA1;GABRG1;SLC39A12;LUZP2;NFATC3;GJB6;GPRC5B;CNTN2;BYSL;PLA2G7;SLC1A6;TMEM178A;GSTA4;PLP1;RBFOX1;KCNJ10
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5609625628675369,1.0607716316538085,0.38596491228070173,0.8834953865629425,1.0,5/22,19.17%,NEDD4;UBAP1;UBAP1L;PTPN23;MVB12A
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.47172816223245706,1.0607140206531493,0.43103448275862066,0.8833770645744239,1.0,10/49,14.30%,SEMA5A;ERBB4;NRTN;SEMA6C;CORO1C;PHACTR4;AMOTL1;SEMA3E;SGPL1;SEMA6D
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.5996971426330953,1.060695073740735,0.44,0.8831066891990693,1.0,6/12,22.07%,REXO2;FOXO3;FOXO1;FOXO6;AKT3;AKT2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.45262668710927617,1.0604874713861199,0.3617021276595745,0.8835135537134998,1.0,25/63,20.73%,SYT15;ITPKB;NLGN1;ADGRV1;SYT6;SYT1;PLCG2;NEUROD2;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;MEF2C;CPNE3;TRPM2;PPIF;CPNE2;PRKAA1;AKR1C3;RYR3;SYT3;LGMN;CPNE9;SYT17
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5291908772521166,1.0604774092612337,0.375,0.8832090069300914,1.0,5/25,12.35%,ZNF804A;CTNNA2;FBXO7;NTNG2;PTEN
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.5611737693701965,-1.0603472967080694,0.3448275862068966,1.0,1.0,4/29,7.96%,DUSP4;DUSP6;FOS;JUN
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,0.66769110517325,1.0602663799997856,0.46551724137931033,0.8834831559143956,1.0,3/9,24.90%,SOS1;GRB2;EGFR
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.48539606994847406,-1.0602440358888192,0.43636363636363634,1.0,1.0,4/36,1.74%,P2RY10;SIRPG;SELL;TRAF3IP3
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.45999426736540777,1.0602098781858391,0.32142857142857145,0.883306265247829,1.0,19/80,12.75%,PLCH1;CAPN13;FGFR3;TMPRSS2;FZD5;CKMT1A;MYCN;GOLT1A;FRAS1;EFNA2;MMP15;MARVELD3;MAGI1;TSPAN6;VANGL2;CGN;ARHGEF16;HSD11B2;CLDN6
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.4613066758062907,1.0601675300425717,0.375,0.8831197153124105,1.0,15/61,21.70%,SLC1A3;SLC7A2;SLC39A8;SLC25A1;SFXN2;SLC25A13;SLC19A1;SLC44A4;SLC3A2;SLC1A6;SLC25A12;SLC25A30;SLC16A7;SLC7A8;SLC25A14
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.42797393836966974,1.0600553966409485,0.3111111111111111,0.8830753082523434,1.0,26/140,13.82%,GAS2L3;CGNL1;RHOBTB3;KASH5;LMOD3;EFS;CASS4;MYO1E;EPS8;CORO7;GAS2;MCU;HIP1;GSN;CORO1C;TPM2;ARHGAP25;LMOD2;CARMIL1;PPP1R9A;BCAR1;PROX1;SHROOM4;SPIRE2;DBN1;RHOBTB1
prerank,CellMarker_Augmented_2021__Foxp3+IL-17+ T cell:Undefined,-0.7139106258010929,-1.060035904873299,0.5208333333333334,1.0,1.0,3/5,8.11%,SIRPG;CD5;TNFRSF4
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.6486754825267432,1.059634005918418,0.41818181818181815,0.8839951676788155,1.0,1/7,3.41%,ENPP1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.6624302809937225,1.05951829965871,0.391304347826087,0.8840776648900621,1.0,1/6,2.22%,EGLN3
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.659122048304324,1.0594165525204544,0.49056603773584906,0.8840525009156681,1.0,2/6,8.18%,ROBO2;LHX6
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.5997893795440394,1.0593190175422598,0.4482758620689655,0.8840469119948529,1.0,6/14,26.18%,TICAM1;TAB2;TAB3;TMED7-TICAM2;TAB1;TRAF6
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,0.7336389457589338,1.0592797481791891,0.3793103448275862,0.8837920910599174,1.0,1/5,12.47%,CD34
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.49603365437206326,-1.0592726299013278,0.34545454545454546,1.0,1.0,5/28,12.25%,ACOT1;ACSM6;MLYCD;ACOT2;ACSM4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.49603365437206326,-1.0592726299013278,0.34545454545454546,1.0,1.0,5/28,12.25%,ACOT1;ACSM6;MLYCD;ACOT2;ACSM4
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.474384331520603,1.0592390299998689,0.3392857142857143,0.883566778218833,1.0,3/45,1.22%,REP15;TCIRG1;ATP6V0D2
prerank,KEGG_2021_Human__Bile secretion,-0.5030957253659032,-1.0592124149896118,0.3793103448275862,1.0,1.0,14/58,14.29%,UGT2B15;ABCC4;SLC51A;SLC22A8;KCNN2;ABCC3;AQP8;SLC5A1;SLC22A1;SLC4A4;ABCB1;ABCB4;SLC2A1;ATP1B1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.48735733466179665,-1.0591328413490695,0.23404255319148937,1.0,1.0,7/60,2.39%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6402811028115604,1.0591223963823388,0.43636363636363634,0.8836004495885303,1.0,2/9,11.43%,NEDD4;HECW2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.6430596286068313,-1.059102714718143,0.42857142857142855,1.0,1.0,1/6,6.07%,SFRP1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.446802241516749,1.059067104530073,0.3888888888888889,0.8834144359680144,1.0,28/98,26.18%,TGFBR1;ANGPT1;SEPTIN4;IVNS1ABP;DNAJB2;HDAC3;DCUN1D1;PAXIP1;SPOPL;WASHC1;BAG2;PRICKLE1;NXN;GNL3L;BIRC3;SIRT7;ARRB2;NDFIP2;UBE2D1;RIPK2;PHF23;COMMD1;HSPA1A;OGT;N4BP1;SMAD7;BCL10;TRAF6
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.5271709086315726,1.0590087557778407,0.40384615384615385,0.8832432046345188,1.0,5/29,8.77%,SLC7A11;SLC38A3;SLC38A4;SLC7A2;SLC7A9
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.622202886432322,1.0589401572265882,0.35294117647058826,0.8830818608949689,1.0,1/12,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6428446926607095,-1.0588983221476798,0.4090909090909091,1.0,1.0,5/7,34.09%,AQP1;SCTR;AQP11;AQP4;CLN3
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.651581673712632,-1.0587651441563957,0.475,1.0,1.0,1/8,3.29%,CYP2E1
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,0.679184403668349,1.058734046560414,0.43137254901960786,0.8832911909391105,1.0,1/6,10.29%,FLT3
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.5350108615345319,1.0586372959314412,0.44,0.88323230235892,1.0,10/16,34.15%,MAPKAPK2;EXOSC4;EXOSC1;EXOSC5;DIS3;EXOSC2;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.45096017860665893,1.0586329566336137,0.38461538461538464,0.882905506192617,1.0,6/87,4.55%,SLC7A11;MYC;PHGDH;SEM1;CDKN2A;IDH1
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.5103542987995828,-1.0585748913266664,0.32727272727272727,1.0,1.0,8/42,10.18%,TBC1D10C;RAB44;ICAM3;PRAM1;LTB;ADGRG3;ALAS2;CMTM2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.47448962354232954,1.058495733799156,0.35185185185185186,0.8829734319490021,1.0,13/48,15.21%,ENPP1;WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;GREM1;BCOR;ANKH;ANO6
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6253243387580243,1.0583511539238122,0.43636363636363634,0.8830461733440631,1.0,3/8,16.07%,PIK3C2B;PIK3CA;PIK3CD
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5396413058950854,1.0583285320375202,0.375,0.8827782223507503,1.0,5/19,17.85%,NLGN1;RIMS2;RAP1A;RIMS4;FMR1
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.45060781617045087,1.0583010378370101,0.32142857142857145,0.8824910207753492,1.0,7/62,13.08%,FGF10;HNRNPH1;FGF17;PIK3CA;TIAL1;SOS1;FGF5
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4968796256332692,1.058278995451539,0.3392857142857143,0.8821845908986266,1.0,12/44,19.44%,BOK;SIRT1;DYRK2;HTRA2;CHEK2;PML;IKBKE;PHLDA3;HIPK1;BCL3;TP53;ABL1
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,-0.4718595868743527,-1.0582576364743657,0.2962962962962963,1.0,1.0,12/55,7.93%,DOCK8;TRAF3IP3;CD53;CYTH4;LILRB3;MEFV;PRAM1;BTK;HCK;SLC11A1;ARHGAP15;TAGAP
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6240927472250475,1.0581786329926328,0.4444444444444444,0.882131148658639,1.0,1/9,2.87%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5994966055921129,-1.058025752096917,0.3404255319148936,1.0,1.0,1/17,0.69%,CLDN4
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6329827916927951,1.0579039678866338,0.39215686274509803,0.8826413600538149,1.0,1/9,1.61%,FGFR3
prerank,CellMarker_Augmented_2021__Epithelial cell:Breast,0.6902814452252266,1.057871208569451,0.42592592592592593,0.8823595107746153,1.0,2/5,18.93%,ALCAM;KIT
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.6455813206109264,1.0578679871846828,0.41379310344827586,0.8820293287905299,1.0,3/8,18.93%,CLMP;COBL;KIT
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.48187016375535946,-1.0578484848509357,0.34146341463414637,1.0,1.0,5/40,5.23%,SCN5A;DRD4;CRACR2A;DRD2;CAMK2A
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.5012084655892947,-1.0578382607595804,0.3125,1.0,1.0,10/47,10.40%,IRF4;IFI27;IRF5;EGR1;IFIT2;OAS3;OAS1;IFIT3;HLA-C;GBP2
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.663221963788762,1.0577928404871753,0.36538461538461536,0.8818741132313812,1.0,3/6,23.21%,NLGN4X;PTEN;CBLN1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4260710252598044,1.0577337839070156,0.275,0.8817384221492516,1.0,26/101,16.94%,GRM3;LRRC4C;CLSTN2;CDH2;NLGN1;MCTP2;LGI1;NRG3;SYT1;CEL;GRM8;GRIK2;NLGN4X;RIMS2;GRM5;GRIK3;SNCAIP;ATP1A2;MEF2C;PTEN;GRM4;GRM7;GRM1;PXK;GRID2;DGKZ
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5534221100894005,1.0576839577876391,0.38,0.8815446429184622,1.0,6/18,11.19%,HS3ST5;HS3ST3B1;UGDH;HS2ST1;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.4954101868754845,-1.057494040138763,0.30434782608695654,1.0,1.0,10/42,10.40%,IRF4;IFI27;IRF5;EGR1;IFIT2;OAS3;OAS1;IFIT3;HLA-C;GBP2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.4954101868754845,-1.057494040138763,0.30434782608695654,1.0,1.0,10/42,10.40%,IRF4;IFI27;IRF5;EGR1;IFIT2;OAS3;OAS1;IFIT3;HLA-C;GBP2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.5948779211063016,1.0574116132920246,0.46808510638297873,0.8819569521738242,1.0,2/8,7.72%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.6787926626701792,1.0573561147903843,0.45161290322580644,0.8817680835806669,1.0,4/6,30.35%,IL23R;CARD9;SMAD7;IL23A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.42999750955743493,1.0572765804206756,0.36538461538461536,0.8816229542640605,1.0,16/104,12.82%,ATP6V0D2;SIRT1;IL4;NEDD4;PRKAB2;SMG1;GNAI3;GPSM1;ATG101;STING1;PIK3CA;EPM2A;BNIP3L;RRAGC;MAPK8;ATP6V0B
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.5188845266775766,1.057135237839277,0.3333333333333333,0.8817248748133356,1.0,4/26,10.70%,CDC25A;FBXO5;TK1;E2F4
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6713043208364157,1.0570018788682427,0.44642857142857145,0.8817783163912049,1.0,3/5,25.79%,HMGB1;TNFSF4;STOML2
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.6975063684255094,1.0569235225022238,0.3673469387755102,0.8817107616603361,1.0,1/5,19.54%,TIMP1
prerank,CellMarker_Augmented_2021__T cell:Lymph Node,-0.6575300151934523,-1.0568982192413168,0.4594594594594595,1.0,1.0,1/5,7.57%,CD5
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5609916224881649,1.0568592136871742,0.46,0.8815513680379177,1.0,2/18,3.79%,WNT4;BMP2
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.7103930288705409,1.0568461146581152,0.45454545454545453,0.8812615652118357,1.0,3/5,22.13%,MVD;IDI2;IDI1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6865708345307411,1.0568390182918632,0.4782608695652174,0.88094298875285,1.0,2/6,2.87%,SIRT1;PPARG
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.45289312904548784,1.0567991872685676,0.4074074074074074,0.8807695803100565,1.0,10/58,20.95%,CCNA2;SEM1;CDKN2A;PSMD13;CHEK2;PSME4;PSMA1;TP53;CARD16;PSMD4
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,0.5735190496401821,1.0566340038700466,0.375,0.880828093989489,1.0,7/13,32.51%,TCN2;ABCD4;LMBRD1;MMAB;MTR;CD320;MMUT
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.429227857649383,1.0565205827029087,0.3,0.8807465771485685,1.0,7/71,11.83%,PRKG1;GNB4;GNG12;PDE1A;SLC8A1;GUCY1A2;GNG4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6272103730042302,-1.056506235867154,0.46511627906976744,1.0,1.0,5/12,11.48%,NUPR1;ALOX5;MBTPS2;CLU;WFS1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.47774487294609747,1.0561663834060286,0.34615384615384615,0.8814033852159374,1.0,7/45,13.08%,FGF10;FGFR1;FGF17;PIK3CA;FLRT2;SOS1;FGF5
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,0.6861004348411063,1.0561418640617892,0.41818181818181815,0.8811094810732596,1.0,3/7,25.03%,PLBD1;GPCPD1;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.4333026194633829,1.0561275437250055,0.3829787234042553,0.8808447311190095,1.0,27/151,13.37%,LGALS9;IGF1;RUNX1;ITGB8;SIRT1;HIF1A;MYCN;FGF2;SFMBT2;LDLR;WNT4;BMP2;APOBEC1;MOV10;ESR1;ABCC2;ANKRD13D;ANKRD13A;BMPR1A;CPNE1;MEF2C;TIPARP;CD34;ZNF281;PICALM;RBMS3;MSR1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.4183480808444966,1.0560710028127853,0.38636363636363635,0.880700676385033,1.0,9/94,7.89%,F2;CCL5;GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5022005930348785,1.0560189651046445,0.38181818181818183,0.8805519139176556,1.0,4/35,3.42%,SLC26A3;RAPGEF3;AANAT;SLC26A6
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6160409156278401,1.05562772613083,0.4186046511627907,0.8813857344437682,1.0,5/12,25.80%,PGRMC2;DGAT2;RORC;ARID5B;SOX8
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.5559338608633395,1.0556039873023928,0.4482758620689655,0.8811597969672876,1.0,6/22,12.78%,KLRD1;SYK;PLCG2;PIK3CA;HLA-E;SOS1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6616971536978318,1.05552457560467,0.4523809523809524,0.8809869678586728,1.0,2/9,11.92%,FGFR3;MEF2C
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.6280354557887051,-1.0553926605144455,0.3673469387755102,1.0,1.0,4/7,19.64%,DRD2;TRPV1;RYR1;HTR1B
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.6893553489694513,1.055096685361904,0.4642857142857143,0.8818725832034753,1.0,2/6,19.35%,ABCC11;SLC25A33
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.7270590014292395,1.0549778632250773,0.5,0.8819544738561448,1.0,1/5,5.22%,ACADS
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5418807372542664,-1.0549744923120514,0.42857142857142855,1.0,1.0,2/19,2.97%,COL5A1;MFAP5
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4549341622382079,-1.0549511737658672,0.3076923076923077,1.0,1.0,14/63,16.63%,DNASE1L1;REXO4;RNASE1;ERCC1;RFC3;RAD50;PARP1;GTF2H2;IHO1;FAN1;RPA3;RFC2;MUS81;RFC1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6470772514973024,-1.0549076375481135,0.5476190476190477,1.0,1.0,2/9,13.71%,DRD2;SHANK1
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,-0.6639802480961152,-1.0547432962908843,0.5102040816326531,1.0,1.0,2/7,12.13%,ENTPD2;ENTPD5
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5141343945441625,-1.0547132077278791,0.42,1.0,1.0,4/21,7.66%,TNXB;PXDN;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.5783371649567682,1.0546760124488794,0.37735849056603776,0.8825842820464724,1.0,4/9,32.07%,SYNE4;RAP2A;MYO9A;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7241257884820047,-1.0546585568731908,0.5,1.0,1.0,2/7,9.55%,PRDM7;RAD51AP1
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.472407606489153,-1.0546547422956694,0.36666666666666664,1.0,1.0,8/58,8.76%,DUSP4;DUSP6;FOS;VGF;TRIB1;EGR1;EGR4;CHD4
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.4807444047827674,1.0544305546725843,0.3953488372093023,0.8829589445110182,1.0,10/28,24.26%,CDKN2A;DLC1;CORO1C;PTEN;SEMA3E;PHLDB2;JAG1;NEXMIF;ADAM15;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5278373910513251,1.054361221439522,0.3333333333333333,0.882838594037497,1.0,4/23,9.40%,CCL5;CD244;SNCA;DSCAM
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5514035015191988,-1.0541078924891718,0.39215686274509803,1.0,1.0,1/14,1.30%,PRDM1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6690636826332816,1.0541041705309053,0.45614035087719296,0.8832320795585216,1.0,2/8,7.24%,CDH2;FER
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4727436998742201,1.0540728521350686,0.43902439024390244,0.8829725306480681,1.0,10/65,10.79%,BOK;F2R;EGLN3;PPARG;F3;SNCA;DLC1;HIP1;TNFRSF10B;CASP10
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.42712758764093833,-1.0538576652662135,0.3018867924528302,1.0,1.0,7/142,5.24%,CYP1A2;UGT2B15;CYP2A6;CYP2E1;GSTT2B;CYP24A1;AKR7A3
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,0.5561501653158455,1.053846749377073,0.42592592592592593,0.8833032956025804,1.0,7/19,14.94%,RSPO3;LGR5;RSPO2;LRP6;FZD4;FZD6;LGR6
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.7193647417040144,1.0538434667343326,0.4897959183673469,0.8829863667078218,1.0,1/5,3.32%,MRAP2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.44363219579741375,1.0536296214123393,0.3269230769230769,0.883259346250961,1.0,12/65,12.26%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;MEGF9;VAMP3;PXN;NTNG2;MEF2C;PROX1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.45509222664395954,-1.0534480631589702,0.32075471698113206,1.0,1.0,4/64,5.37%,H1-3;H1-4;H1-2;RNF8
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.4649567365409338,1.053301266257761,0.34782608695652173,0.8838340280996901,1.0,9/47,5.74%,NXPH2;PNOC;NXPH4;UTS2R;OPRK1;NPY;GLRA1;PENK;SSTR3
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.5260333697420337,1.053228254039741,0.36,0.8836992940266225,1.0,5/37,6.41%,LAMA4;ITGA2;SDC4;NRXN1;ITGAV
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4337160952812563,-1.0531877409259198,0.3137254901960784,1.0,1.0,14/130,6.32%,SLC28A2;EHF;TREH;SPON2;CLCA1;GFRA2;AQP7;SLC51A;RBP2;ABHD11;DEGS2;GULP1;BEST4;CYP4F2
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.5200392496523188,-1.0531140692912344,0.3888888888888889,1.0,1.0,6/24,14.55%,PARP2;RFC3;PARP1;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.40515843774153515,1.0530501550411044,0.2727272727272727,0.8837753598130128,1.0,31/197,15.57%,CCNG1;CDKN2C;MYC;CDC25A;CCNA2;CDKN2A;NDE1;CEP70;PCM1;EPS8;FBXL3;CEP152;CDK14;BCAT1;LATS1;CCNB3;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;ACVR1B;CCND3;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.5281300535607081,1.0527871871134296,0.44,0.8842678159724672,1.0,6/21,25.33%,ADD3;MAGT1;ANKH;MRS2;TUSC3;NIPAL1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5205907788968099,1.0526920221608251,0.29411764705882354,0.8842526942439146,1.0,4/31,3.91%,SLC26A3;SLC22A3;SLC26A7;SLC17A6
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.6033749278104867,1.052466899857451,0.49019607843137253,0.8846441498008343,1.0,1/7,2.98%,ALDH1A1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,-0.577835654148189,-1.0524608181801451,0.39215686274509803,1.0,1.0,1/19,1.04%,CD24
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.600415446680938,1.0523580451485528,0.45,0.8846336780911257,1.0,6/13,22.25%,PYHIN1;RO60;AXL;GAS6;KLHL20;MX2
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.4021452655410061,1.0523482148639758,0.2692307692307692,0.8843316648572307,1.0,22/121,15.57%,CDC25A;CCNA2;NDE1;CEP70;PCM1;FBXL3;CEP152;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6583049650369194,1.0523118521563266,0.47368421052631576,0.8841254343478818,1.0,2/7,13.08%,RRS1;XPO1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6624640560125519,1.0522632605244573,0.5178571428571429,0.8839909982916146,1.0,4/7,24.40%,BBIP1;RAB29;ARL3;ARL13B
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.6029801618471596,1.0522324837959178,0.43636363636363634,0.8837373123758799,1.0,5/15,16.08%,STAT5A;PIK3CA;FLT3;SOS1;GAB2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5023707406992021,-1.0519803114749093,0.39622641509433965,1.0,1.0,8/52,12.82%,TERT;ALOX5;CLU;UBASH3B;KIF26A;APOA1;WFS1;IGFBP3
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5267797347047429,-1.0519133620100276,0.4634146341463415,1.0,1.0,7/27,21.15%,KIF2B;STMN1;STMN3;DSTN;KATNB1;KIF18B;KIF24
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.44896815393603073,1.0518181643219502,0.4,0.8846912004862827,1.0,10/50,15.10%,HIF1A;ENGASE;ST6GALNAC3;HPSE;ST8SIA4;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.6478212247060828,-1.0518136450422517,0.48936170212765956,1.0,1.0,1/6,12.89%,TCF7
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.4236400609782436,1.0518079003311862,0.3333333333333333,0.8843849665876373,1.0,26/147,10.66%,MXRA5;LAMA4;MRGPRF;SMOC1;ITGA8;PRRX1;PRKG1;ADGRL4;KAT2B;ANGPT1;RRAD;MSRB3;ACTG2;BGN;CXCL12;ZBTB44;POSTN;CCDC80;PDGFRA;PLSCR4;PDE4DIP;PCDH18;MYH11;MEDAG;ITGA1;TPM2
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,0.4327357230624507,1.051777002336394,0.3,0.8841171136152696,1.0,36/94,19.30%,CLMP;FGF2;ROR1;TRPC4;TENM3;ALDH7A1;FBLIM1;PPFIBP1;CCDC80;NAV3;WWTR1;BMPER;COL8A1;DSEL;GPR176;ABL2;PTPN14;GPR161;TNC;LOXL2;RASAL2;HAS2;FLRT2;FGF5;RBMS3;VGLL3;LRP12;FBXL2;FBN1;GJC1;FMN2;DCBLD2;FARP1;PHLDB1;DZIP1;PYGO1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.62265089038933,1.0517686475304704,0.5178571428571429,0.8838065616434867,1.0,2/13,7.07%,IGF1;PAX6
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.5707368695156292,1.0516933144243334,0.42592592592592593,0.8836582559724405,1.0,9/16,28.15%,TAB2;MAPK8;IRAK1;TAB3;MAPK10;RIPK2;TAB1;TRAF6;MAP2K4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5563157325201232,1.0515887089441887,0.38181818181818183,0.8837815672302922,1.0,6/21,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.6593100639070568,1.0515330257006552,0.45098039215686275,0.8836000529553342,1.0,4/6,27.62%,RELA;PNPT1;ZSWIM8;NFKB1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5473814348785125,1.051472243695392,0.3673469387755102,0.8834805511611635,1.0,6/17,19.07%,BMI1;RYBP;RNF2;BCOR;PCGF5;PCGF1
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.44484434198073036,1.0514672913259406,0.4,0.883156552115836,1.0,21/90,23.78%,CTDNEP1;LPIN3;H2BC21;VRK2;H2AC6;H2AZ2;RAB33B;LMNB1;NEK7;H2AX;RANBP2;GORASP2;BLZF1;BANF1;CNEP1R1;MAPK3;NUP153;LEMD3;CCNB2;PPP2R1B;LMNA
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6512789651815283,-1.0513496520563324,0.41304347826086957,1.0,1.0,6/7,33.41%,PINK1;TOMM7;MFN2;PRKN;OPTN;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.6384258463350767,1.0513495990674369,0.47540983606557374,0.8832180378786879,1.0,1/7,6.65%,ELAPOR2
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6490325915921902,-1.051291496960324,0.42857142857142855,1.0,1.0,1/5,11.32%,AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6490325915921902,-1.051291496960324,0.42857142857142855,1.0,1.0,1/5,11.32%,AR
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.49180601613180713,1.051245171719636,0.32608695652173914,0.8831939005965295,1.0,4/65,8.33%,NXF1;U2AF1;THOC6;NXT1
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.7004685904912102,1.051227407304945,0.42857142857142855,0.8829226532812876,1.0,2/5,20.15%,SLC30A4;SLC30A2
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5314333487011271,1.0510607877704452,0.37777777777777777,0.8831124258977924,1.0,4/26,9.81%,LGALS9;SDC4;SCRIB;BTN2A2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5820164162559501,1.0510442502171509,0.375,0.8828224181489228,1.0,5/12,31.08%,ABL2;ABL1;EDN1;PDP1;PDP2
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6454306414082059,1.0510299984561753,0.5909090909090909,0.8821956047016548,1.0,6/7,34.15%,EXOSC4;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6454306414082059,1.0510299984561753,0.5909090909090909,0.8821956047016548,1.0,6/7,34.15%,EXOSC4;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,-0.45688807872034853,-1.0508482651427657,0.39215686274509803,1.0,1.0,12/67,8.45%,SELP;SELE;TEK;VWFP1;TNXB;TIE1;RNASE1;ANO2;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5525751660936045,-1.05072873564796,0.47368421052631576,1.0,1.0,1/15,4.15%,CMTR1
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.49127452550175793,1.050682958315667,0.4107142857142857,0.8828122823095396,1.0,12/46,15.19%,HNF4G;ESRRG;PPARG;RORB;RORA;NR5A2;ESR1;NR1D2;NR1H3;NR4A2;RARB;THRB
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.46080182033488226,-1.050266305363392,0.3559322033898305,1.0,1.0,10/69,9.14%,SELP;SELE;XCR1;NMUR2;P2RY11;BTK;GPR143;CAMKK2;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6036692354571452,1.0501029294126905,0.4727272727272727,0.8841682070550043,1.0,1/10,1.59%,PLD6
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6259157167827578,-1.0500953091596923,0.375,1.0,1.0,2/6,14.60%,DNAAF1;AHI1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3976041436708872,1.0500451846164314,0.35714285714285715,0.8839636667669789,1.0,33/169,16.03%,GRM3;PMP2;GFAP;HEPACAM;MYRF;NDRG2;OLIG1;OLIG2;ST18;DPY19L1;NRXN1;GAMT;TF;NTSR2;SYNPR;DSCAML1;GRM5;PTPRT;LRRTM3;GPR62;ATP1A2;ANLN;FAM163B;GPM6B;FASN;GABRG1;SLC39A12;MOBP;DLG2;GPR37;GPRC5B;CNTN2;GJB1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5209928294195084,1.0499474457847788,0.3584905660377358,0.8838966872841635,1.0,9/21,30.46%,NAV3;HDGFL3;MID1IP1;CAMSAP2;ARHGEF2;CIB1;FGF13;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5682247360326517,-1.0498606618747661,0.45454545454545453,1.0,1.0,2/10,13.62%,PRKCD;CYP1B1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4241926538732166,1.0497464454433494,0.34615384615384615,0.8840997325069057,1.0,44/225,17.26%,FGF10;SEMA5A;LGR5;LRP4;ZEB2;BMP2;MLLT3;DKKL1;NRARP;WWTR1;GPC5;PPM1A;CDK14;RNF146;LATS1;KANK1;PSMD13;IGFBP6;SCEL;TBL1X;DACT3;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;PTK7;DVL2;TMEM170B;LRP6;FZD4;PTPRU;CSNK1G3;FRAT1;FZD6;BAMBI;LGR6;FRZB;GPRC5B;PSMA1;UBR5;CTNNB1;KLHL12;RUVBL2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.40833428553563533,1.049451599514007,0.35135135135135137,0.8846198442557633,1.0,30/127,12.58%,CXXC4;LSAMP;LRRC4C;EFNA5;CADM2;MAFB;NPY;SLC17A6;ROBO2;SCGN;PCDH17;UNC5D;NRXN1;PLPPR1;RAB3C;PAX6;NOVA1;CD40;CASR;FGF12;RIPPLY2;PTPRT;ADGRB3;PAK5;TMEM196;NOL4;KCNB2;CNTN1;PROX1;UBE2QL1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.442135012110868,1.0492501013996762,0.36363636363636365,0.8847988012518294,1.0,10/73,20.95%,CDC20B;FBXO5;ANAPC16;PSMD13;PSME4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,CellMarker_Augmented_2021__Basophil:Lung,0.49537798104910447,1.049197051236236,0.4358974358974359,0.884584946034057,1.0,11/53,8.62%,FRMD4B;STAB1;IDO1;MAFB;FGL2;TLR2;HPGDS;SIGLEC1;TFEC;PLXDC2;SMAD1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.48023174377561867,-1.04910119190556,0.39285714285714285,1.0,1.0,3/46,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.48893149228097854,1.0487331592490443,0.34615384615384615,0.8855299257210797,1.0,13/44,16.70%,CDH20;CDH7;CDH6;CADM2;CDH2;CDH12;NECTIN2;CADM1;CDHR3;CDH10;CDH8;CDH24;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4764765922833063,1.0487011510428934,0.34146341463414637,0.8853254117133803,1.0,6/50,7.75%,SYK;MYC;SIRT1;F2R;HTRA2;HMGB1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.6126061769551785,1.0486796912967604,0.4827586206896552,0.8850926966512193,1.0,5/10,31.18%,TAB2;TAB3;TAB1;TRAF6;MAP3K7
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Ovary,0.681082738835612,1.0486038485919145,0.49019607843137253,0.8849735312109419,1.0,1/5,12.26%,PROX1
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.46414574875298914,1.048592548577833,0.4117647058823529,0.8846608450471974,1.0,12/40,15.78%,SIRT1;NRIP1;RORA;HDAC3;SMARCD3;NCOA2;TBL1X;MEF2C;XPO1;CREB1;CHD9;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6466881834249687,1.0484963577088129,0.4727272727272727,0.8844852854878016,1.0,3/9,20.10%,TERF1;TP53;POT1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.4491819688425544,1.0482828196311458,0.3333333333333333,0.8848477845896429,1.0,10/75,6.41%,IGF1;ITGA10;ITGA8;ITGB8;ITGA11;ITGA2;SLC8A1;CACNB4;PRKAB2;ITGAV
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.6207788400086217,1.0480519421862775,0.46153846153846156,0.8851486927413422,1.0,1/11,0.30%,ZDHHC11
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5812948966367364,1.0478117303122327,0.5344827586206896,0.8854635211339056,1.0,4/11,19.87%,PRKG1;MEF2C;DOCK4;DOCK5
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.4500074659130681,-1.047730528768521,0.38181818181818183,1.0,1.0,7/54,9.36%,RFX6;CELA2A;ALOX5;PER2;HFE;KCNJ11;KCNA5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,0.6599319373268611,1.0474456996634252,0.4745762711864407,0.8861127630217408,1.0,4/7,26.72%,ALCAM;CD34;PTPRC;NT5E
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,0.7043003736128474,1.047326265223244,0.41818181818181815,0.886125452988174,1.0,3/6,22.38%,ALCAM;CD34;PTPRC
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.42062920497703027,1.0471903516142127,0.3469387755102041,0.8861805220579201,1.0,47/154,21.92%,IRGM;IRS1;URI1;INSIG1;BRINP3;RORB;NRIP1;RORA;RELA;ESR1;WNT9A;TICAM1;NLRP7;EPHA3;HTRA2;HMGB1;RAMP3;CRHBP;ABL2;ATP1A2;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1;PTK7;CREB1;FZD4;NCOA3;RORC;RET;RUVBL2;WNT2;LCOR;SSTR1;NR3C1;LYN;CX3CR1;TICAM2;AXL;ADNP2;ZFP36;CARD16;TNFSF4;TNIP3;GNAI1;PID1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.38194972173745856,1.0471724527076272,0.375,0.8858871517920615,1.0,86/381,21.16%,FGF10;MAP3K11;IRS1;FGFR3;MYC;TGFBR1;FGFR1;ERBB4;STAT5A;KAT2B;NRG1;SEM1;KSR1;SYVN1;NRG3;RBPJ;ESR1;PPFIBP1;PDGFRA;HDAC3;NRG2;HDAC2;PPP1CC;AGGF1;FOXO3;WDCP;ERBIN;ZC3HAV1;SHOC2;KANK1;FGF17;PIK3CA;CNKSR2;HIP1;SMAD2;PSMD13;FLT3;FOXO1;TBL1X;SMAD4;QKI;CNTRL;PTEN;CTBP2;SOS1;FGF5;PSME4;RAP1A;CREB1;CNKSR1;LRP6;FZD4;DERL2;FZD6;RICTOR;MIB1;FOXO6;GAB2;PSMA1;HEY2;CTNNB1;RANBP2;RHOG;ZMYM2;IRS2;ARRB2;ADAM10;KIT;KLB;HDAC9;TFG;MLST8;AKT3;JAG1;POLR2H;GCC2;LYN;HDAC1;PIK3R3;GOLGA4;BAD;NCBP1;APBB1IP;PSMD4;CDK8;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.41172735711538333,-1.0468391811865463,0.3076923076923077,1.0,1.0,6/205,2.29%,CD44;NTRK1;CD24;TEK;FGF1;IL11
prerank,Reactome_2022__Phenylalanine Metabolism R-HSA-8964208,-0.6094104184875997,-1.0467309319822549,0.425,1.0,1.0,1/6,5.40%,PAH
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.6094104184875997,-1.0467309319822549,0.425,1.0,1.0,1/6,5.40%,PAH
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4544169222701401,1.046672086648244,0.3684210526315789,0.8868976528229877,1.0,19/73,16.56%,F2R;CDH20;CDH7;CDH6;CADM2;CDH2;CDH12;SDK1;MARVELD3;NLGN4X;DSP;NECTIN2;CADM1;CDHR3;CDH10;CDH8;CDH24;PKP4;GJC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.640676781509538,-1.0466379017514913,0.4318181818181818,1.0,1.0,5/7,29.73%,PINK1;MAPT;HAX1;PRKN;ATP5IF1
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.5400005120637034,1.046621213157911,0.37777777777777777,0.8867124389702625,1.0,13/27,28.53%,MAP2K6;TAB2;IRAK1;TAB3;BIRC3;RIPK2;IKBKB;CARD9;TAB1;TRAF6;CHUK;CASP2;CYLD
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,-0.3691183501728866,-1.0464563561975013,0.3076923076923077,1.0,1.0,20/539,5.12%,TRIP10;EPN1;GOLGA8B;TBC1D10C;F5;F8;KIF2B;STX16;SYT12;ALS2CL;CYTH4;NLRP3;SYNJ2;M6PR;RIN3;ARF3;KIF12;RNASE1;KDELR1;GOLGA2
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.539137437978463,1.046376173281874,0.38181818181818183,0.8871951628466379,1.0,1/22,0.38%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.6980713059641621,-1.0463625828679575,0.45,1.0,1.0,1/5,11.08%,TASL
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.6980713059641621,-1.0463625828679575,0.45,1.0,1.0,1/5,11.08%,TASL
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,0.6390198977739978,1.0463529637327926,0.47058823529411764,0.8869582645393043,1.0,2/7,8.98%,PPP1CC;SHOC2
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.63678536602274,-1.046309557446456,0.5,1.0,1.0,2/7,3.43%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.5170938919475473,1.0462020187051662,0.43137254901960786,0.8871350818622873,1.0,7/28,20.83%,MAP3K11;ZNF675;NPPA;DVL2;PPEF2;EDN1;HIPK3
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6230855795044756,1.046116594547692,0.4444444444444444,0.8870299140800517,1.0,7/12,22.38%,ZFP36L2;LIG4;FADD;RAG2;RAG1;MR1;PTPRC
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5147400695807638,1.046088780318302,0.4230769230769231,0.8867745589111353,1.0,9/40,14.46%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;GRM4;HSPA8;PPFIA3
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.49374552177961945,-1.0460430329549804,0.375,1.0,1.0,6/39,10.00%,TRIM56;IRF5;FLOT1;OAS3;OAS1;DHX58
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.6279533871390397,-1.0460394503778692,0.40476190476190477,1.0,1.0,2/7,11.97%,ADCK1;VAT1
prerank,KEGG_2021_Human__Fatty acid elongation,-0.5661316792019652,-1.0458566312809114,0.4444444444444444,1.0,1.0,1/25,0.44%,ACOT1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6205609429687624,-1.0458485063264717,0.45,1.0,1.0,5/14,17.00%,DUOX1;VGF;KCNJ11;RYR1;STAT1
prerank,Reactome_2022__Disease R-HSA-1643685,0.3420718123008941,1.0457484978278662,0.3,0.88753331002151,1.0,234/1448,17.03%,ZDHHC11;DERL3;FGF10;SLC26A3;LRAT;DRD5;MAP3K11;SV2C;SEMA5A;IRS1;AP1M2;C3;ANTXR2;FGFR3;TMPRSS2;SYK;C1GALT1C1;ACE2;MYC;TGFBR1;SLC12A1;FGFR1;CDC25A;ERBB4;KLKB1;STAT5A;SLC1A3;KAT2B;NRG1;H2AC25;CALCR;REXO2;SEM1;RRAD;KSR1;GNB4;GNG12;CDKN2A;HMG20B;CSF2RA;SYVN1;SLC12A3;BLNK;INSL3;VCAN;PRMT1;DOCK1;BGN;ST6GALNAC3;IDH1;H2BC21;AHCY;NRG3;RBPJ;RELA;RXFP2;SDC4;SYT1;NAPEPLD;ADAMTS17;TLR2;F12;ADAMTS16;KCNH8;ESR1;PPFIBP1;MAP2K6;RNF185;ALG6;CYP2U1;MYO1E;ABCC2;MUC20;TCN2;RPIA;PDGFRA;PLCG2;TICAM1;VAMP1;HDAC3;GPC5;NRG2;DCXR;ADAMTS19;ABCA1;HDAC2;PPP1CC;GALNT3;HMGB1;SPON1;AGGF1;GPR176;ADA;FOXO3;FDX1;RAMP3;GNAI3;CYP27A1;WDCP;ERBIN;MAGT1;SLC7A9;ZC3HAV1;ABCG8;MOGAT2;CHMP6;SHOC2;STING1;KANK1;GPC4;TAF3;TAB2;CYP7B1;C1GALT1;FGF17;SIKE1;KEAP1;ANAPC16;PIK3CA;CNKSR2;HIP1;SMAD2;PSMD13;EXT1;GALNT12;MAP4K2;NUS1;EZH2;FLT3;GALNT1;ZDHHC2;FOXO1;MUC13;RPS5;C3AR1;FUT8;TBL1X;LIG4;MUC7;PRKCSH;HLA-E;ATP1A2;PHF21A;RNF5;CHST6;SMAD4;EGFL7;DYNC1I2;B3GLCT;GNG4;MAN2A1;QKI;GALK1;ALG9;CNTRL;MAPK8;IRAK1;PTEN;H2AC6;CTBP2;SLC26A4;PGM1;SOS1;DNAJC3;POMT2;SLC37A4;XPO1;FGF5;TANK;H2AZ2;RPL21;FDXR;MGAT5;PSME4;RAP1A;PACS1;CCND3;TPST2;MGAT4C;DVL2;PML;CREB1;ACACA;SLC22A5;CNKSR1;LRP6;FZD4;ABCG5;CCNH;SLC35C1;IKBKE;ADRB1;DERL2;LMNB1;FZD6;TAF5;RICTOR;H2AX;MGAT4A;MIB1;FOXO6;TAF2;GNAZ;SLC9A9;RXFP1;NFE2L2;SLC4A1;GAB2;TAB3;USH2A;DOLK;PSMA1;CYP2R1;RPL18A;NOTCH2;CALCRL;KPNA4;HEY2;PCSK2;PKN2;CD247;CTNNB1;UBAP1;STAM2;RANBP2;BCAN;ABCD4;FADD;NELFB;SLC3A2;RCC1;MNAT1;ARTN;ADAMTS6
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6850070365563159,1.0456832666490397,0.5098039215686274,0.8873999575910697,1.0,2/7,20.86%,BCL3;CARD16
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.5585397364606866,1.0455079382476529,0.5272727272727272,0.8875997343187995,1.0,2/14,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5773736739169816,1.0454364196358696,0.43137254901960786,0.8874523899465551,1.0,8/15,30.19%,CORO7;AP1AR;KLHL20;MON2;VPS13A;EPS15;GBF1;KIF16B
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.6593167407968202,-1.0454017046451933,0.4523809523809524,1.0,1.0,5/5,34.09%,AQP1;SCTR;AQP11;AQP4;CLN3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.4773310419968445,-1.0453681392067944,0.39215686274509803,1.0,1.0,2/36,2.46%,DND1;ZC3H12D
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.5452545290071729,1.0453441435991522,0.40384615384615385,0.8873895224837718,1.0,8/29,12.47%,LGALS9;SYK;IL4;PLCG2;VSIR;HMGB1;IL23R;CD34
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.37208798537110516,1.0453203140983987,0.3148148148148148,0.8870971205498948,1.0,107/446,21.16%,STK26;FLT1;MAP3K11;FGFR3;SYK;PRKG1;TGFBR1;FGFR1;CCNA2;ERBB4;CDK11A;GDF6;CDK18;BMP2;DAPK2;TNIK;ACVR2A;STK33;ABI3;RIOK2;MAPKAPK2;TLR2;ERG;MAP2K6;FAM20A;PDGFRA;DYRK2;PPP4R1;RPS6KA4;FER;EPHA3;MAP3K9;MEX3B;SMG1;IP6K3;CDK14;ABL2;EPHA8;LATS1;MAPKAPK3;FRK;SMAD2;MAP3K21;FASTK;MAP4K2;RPS6KA2;FLT3;NIM1K;PAK5;STK32B;BMPR1A;VRK2;CHEK2;MAPK8;IRAK1;CDK12;IGF1R;STRADA;ACVR1B;CREB1;RPS6KA1;DYRK1A;CCNH;IKBKE;CSNK1G3;MAP3K1;NEK7;RICTOR;HIPK1;SGK1;PRKAA1;PIK3CD;MAPK10;DYRK3;LIMK2;PKN2;PXK;RPS6KA5;CDKL5;IRAK3;RET;CDK4;MAST1;STK38L;ZAP70;ADAM10;KIT;PRKACB;AKT3;ABL1;FAM20B;WNK1;BMPR2;LYN;PIM2;ERC1;EPHB4;CDK16;PDK1;IKBKB;HIPK3;PASK;STK36;STK32C;CDK8;CILK1;MAPK3
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.5857828745858705,1.0452276262081794,0.5,0.887039115422439,1.0,9/15,30.31%,RFNG;ST3GAL6;NOTCH2;NOTCH3;FURIN;SEL1L;B4GALT1;NOTCH1;ATP2A3
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.40846481113680566,1.045138111579368,0.3684210526315789,0.8869062437903574,1.0,24/132,17.38%,GRIN3A;SEM1;RORA;SP1;RBPJ;ATXN8OS;ATXN1;FGF14;ATG101;MCU;PIK3CA;PSMD13;GRIN3B;MAPK8;GRIN2D;SLC25A31;PLCB1;PPIF;GRM1;PIK3CD;MAPK10;PSMA1;GTF2B;SLC1A6
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,-0.6686756881650863,-1.045028668126257,0.46153846153846156,1.0,1.0,2/5,28.26%,PMS2;MSH3
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6847112333787287,1.0448768962619088,0.4375,0.8873912455445016,1.0,2/5,20.82%,UBE2E2;UBE2E1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.6714132439630798,-1.0448371957962677,0.52,1.0,1.0,1/7,5.75%,KMT2B
prerank,Reactome_2022__FLT3 Signaling Thru SRC Family Kinases R-HSA-9706374,0.690332473954117,1.0447161411529389,0.3673469387755102,0.8875016173034532,1.0,2/5,10.29%,SYK;FLT3
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.5771394091581638,-1.0446625059671264,0.4222222222222222,1.0,1.0,2/17,2.67%,KLRC1;CD86
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.641288569604634,-1.0446523001700194,0.5,1.0,1.0,3/10,5.62%,XYLT2;CHST9;XYLT1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.594262952642299,-1.0446332768472502,0.4528301886792453,1.0,1.0,1/14,1.22%,ABCA4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4483062599997799,1.044473212069544,0.37037037037037035,0.8879299185538672,1.0,12/81,11.21%,SIPA1;ARHGAP24;TBC1D3L;TBC1D8B;TBC1D12;CCDC125;SYDE2;SCRIB;CORO1C;ARHGAP45;ARHGAP25;ARHGEF16
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.6746352157780912,1.0443293228570776,0.46,0.8880914325694804,1.0,1/5,4.40%,SIX4
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Peripheral Blood,-0.6286422316102096,-1.044253380413117,0.42105263157894735,1.0,1.0,1/6,6.95%,KLRB1
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,0.576983954958492,1.0442412496860152,0.5,0.8879817829400812,1.0,1/14,2.62%,KCNK2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5133647033327331,-1.0441827502900192,0.41818181818181815,1.0,1.0,6/29,9.98%,RTF1;COL4A2;LAMB3;LAMB1;NODAL;MMP9
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.5331322764539992,1.0439924758737824,0.4423076923076923,0.8884327871670831,1.0,6/26,16.70%,FRAT2;FZD1;DVL2;LRP6;FRAT1;CTNNB1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.664509854677807,1.043945996036567,0.4358974358974359,0.8881923405104226,1.0,2/8,19.23%,SMG1;MLST8
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.6480947566826538,-1.043922367205074,0.48,1.0,1.0,1/5,12.89%,TCF7
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,0.5005649314078544,1.0436588203110284,0.40384615384615385,0.8888063118987298,1.0,7/31,13.67%,GNG12;CDCA7L;CSRP2;GDI2;CNOT6L;ARIH1;ZNF652
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.5883541984947739,-1.0436068694628136,0.4146341463414634,1.0,1.0,6/10,24.08%,COPS7A;COPS7B;COPS6;COPS3;COPS8;COPS5
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6819521856120028,1.0435388462143091,0.4489795918367347,0.8888645449649181,1.0,4/6,29.10%,NOC2L;IRS2;BCL10;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.4979235996904533,-1.0435251600800168,0.40816326530612246,1.0,1.0,3/23,14.25%,RAC2;CLRN1;RAC1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.5037640623423753,-1.0435091640052265,0.391304347826087,1.0,1.0,8/38,17.41%,CLDN4;CLDN1;F11R;CLDN15;CLDN16;CLDN5;MARVELD2;CLDN20
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6734360263869388,1.043471466327507,0.4107142857142857,0.8883980322205173,1.0,1/5,18.57%,KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6734360263869388,1.043471466327507,0.4107142857142857,0.8883980322205173,1.0,1/5,18.57%,KMT5B
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6050038145687103,1.0434541994727422,0.46296296296296297,0.8881114323049026,1.0,4/10,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 24-Hydroxycholesterol R-HSA-193775,-0.563521072158119,-1.0434068972359678,0.41818181818181815,1.0,1.0,1/13,0.73%,AMACR
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.6696471272443048,-1.0433879146164904,0.4791666666666667,1.0,1.0,2/5,15.76%,CAV2;VPS35
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.46246037182403193,1.0431996424857273,0.40384615384615385,0.8884447377592387,1.0,4/42,13.43%,CTDNEP1;CHMP6;BIN1;IRAG2
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.640215845310163,1.0430918388969905,0.45098039215686275,0.88848902396241,1.0,4/12,23.80%,LIG4;BANF1;LRIG1;SGIP1
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.743363029459058,1.0430651514820242,0.4915254237288136,0.8882399553095802,1.0,2/5,12.47%,RAB27A;CD34
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.6668131822988489,-1.042722150488578,0.5128205128205128,1.0,1.0,2/8,1.23%,TEK;NUPR1
prerank,Reactome_2022__Glycerophospholipid Catabolism R-HSA-6814848,0.6431640106352097,1.04267229736555,0.42857142857142855,0.8891546175091767,1.0,3/7,29.17%,PNPLA6;GDPD3;GDPD5
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.48017205047743133,1.0426363992218413,0.38596491228070173,0.8889287493893775,1.0,3/35,3.50%,CCNG1;CCNA2;CDKN2A
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5359619078627245,-1.0425012849347282,0.4375,1.0,1.0,3/20,4.62%,KCNMB2;SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.6380379878425086,-1.0423745891541043,0.58,1.0,1.0,3/7,8.19%,SFRP1;CARTPT;UBASH3B
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.4670387794177763,1.0423735960621667,0.3333333333333333,0.889516929699093,1.0,16/57,21.16%,PPARG;SNAI1;HDAC3;HDAC2;EZH2;RRAGC;PTEN;RNF2;TP53;MAF1;EED;RRAGD;MLST8;HDAC1;SCMH1;MAPK3
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,0.6715769139229397,1.0420890301764185,0.5,0.8900860799384299,1.0,3/8,24.90%,SOS1;GRB2;EGFR
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,0.4417577184234242,1.0419320980249445,0.37037037037037035,0.8899548701577902,1.0,14/77,10.22%,CFH;C3;ADGRL4;RIN2;RRAS;BGN;TEX26;SDC4;POSTN;MYOF;PLSCR4;CYP27A1;GSN;COL5A3
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,0.4417577184234242,1.0419320980249445,0.37037037037037035,0.8899548701577902,1.0,14/77,10.22%,CFH;C3;ADGRL4;RIN2;RRAS;BGN;TEX26;SDC4;POSTN;MYOF;PLSCR4;CYP27A1;GSN;COL5A3
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.5202935174662071,1.0419107677954342,0.3170731707317073,0.8897012599037557,1.0,3/26,3.42%,F2R;GNB4;GNG12
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.4382483832684004,1.041636499135553,0.3269230769230769,0.8901488068383733,1.0,19/74,21.22%,SEMA5A;DCC;LLGL1;NEFH;DSCAML1;CTNNA2;VASH2;NTNG2;KLF7;GRM7;NREP;L1CAM;CNTN4;ZDHHC17;PLP1;SLITRK5;CAMSAP2;PARD3;SLITRK6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6162003545514627,1.041461042971705,0.5094339622641509,0.8900362991355765,1.0,1/9,1.70%,ACE2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6162003545514627,1.041461042971705,0.5094339622641509,0.8900362991355765,1.0,1/9,1.70%,ACE2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.3960456119667851,1.0414080868601616,0.3877551020408163,0.8898340398574526,1.0,22/112,20.95%,PRR5L;ZFP36L2;SAMD4A;MAPKAPK2;MOV10;ZC3HAV1;PSMD13;HNRNPD;EXOSC4;ANP32A;HSPB1;XPO1;HSPA8;PSME4;CNOT8;PSMA1;FMR1;EXOSC1;CSDC2;PNPT1;ZFP36;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5801569753163632,1.0413737564539975,0.44642857142857145,0.8896365647126867,1.0,3/14,6.66%,F2;PRKG1;PDGFRA
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.5114011255037128,1.0413623888530767,0.375,0.8893604626449567,1.0,5/26,14.85%,TGFBR1;PPP1CC;SMAD2;XPO1;BAMBI
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,0.6589713512280925,1.0413325558787838,0.4915254237288136,0.8891123552278701,1.0,1/7,1.76%,MYC
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.48547462810205483,1.0412980018389637,0.44680851063829785,0.8888736906083304,1.0,7/35,18.54%,H2BC21;ASF1A;ASF1B;H2AX;ANP32B;PADI4;H3-3A
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.5578760458739997,1.0412091524415277,0.4666666666666667,0.8887740577664501,1.0,5/19,13.08%,FGF10;FGFR1;FGF17;SOS1;FGF5
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.6707391595123274,1.0410606759848744,0.44642857142857145,0.8889752433418096,1.0,1/6,3.87%,CDH2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4637574593458377,-1.0409548339618084,0.38461538461538464,1.0,1.0,11/82,12.99%,NTRK1;PM20D1;CD200R1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5622634825486836,-1.0407749570223763,0.37209302325581395,1.0,1.0,3/17,3.71%,SELP;CELA2A;TEC
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.570027425306023,-1.040708832307511,0.43137254901960786,1.0,1.0,2/19,6.35%,NTRK1;SHC3
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.4532915632505917,1.0406700700646794,0.375,0.8897960516675467,1.0,4/74,3.21%,MYC;CDC25A;CCNA2;SEM1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4615388798430377,1.0406424847404978,0.37735849056603776,0.889515875346481,1.0,13/62,9.16%,GPR55;RIT2;F2R;GPR174;EPS8L2;CCDC125;KANK2;GPR17;EPS8;ABCA1;DLC1;ABL2;KANK1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.6403099859225013,-1.0406353077434158,0.4318181818181818,1.0,1.0,1/12,0.37%,ACTC1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6974576490384803,1.040548155762973,0.49019607843137253,0.8894485054774424,1.0,1/5,6.73%,UNC13B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5692013444466001,1.040475505060614,0.4339622641509434,0.8893165040758227,1.0,7/21,23.57%,RUNX1;KLF7;ERRFI1;CTSV;MAFF;ZFP36;BMP4
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.648060616851086,1.0404069252731243,0.45652173913043476,0.8891707442948223,1.0,5/10,13.84%,NRG1;SPX;VAMP3;NR1H3;CD74
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4720110843146733,1.0403251618851106,0.39622641509433965,0.8890620247482236,1.0,12/56,17.56%,HSD17B2;BRINP3;RORB;WNT9A;EPHA3;HTRA2;ABL2;PTK7;CREB1;FZD4;RET;WNT2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5701439757022777,1.0403127524263505,0.47540983606557374,0.8887687851859979,1.0,5/18,11.09%,TGFBR1;HIF1A;DNAJB2;DCUN1D1;WASHC1
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.5591099015656623,1.0401025928324337,0.4423076923076923,0.8889601569648304,1.0,3/21,8.37%,AMPD1;ADA;TK1
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.5997538616068754,1.0400603315464816,0.49019607843137253,0.8887317318583411,1.0,6/15,26.18%,TICAM1;TAB2;TAB3;TMED7-TICAM2;TAB1;TRAF6
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex5:Brain,0.6450115689028311,1.0400427564819525,0.4897959183673469,0.8885034738514176,1.0,3/9,14.44%,IL1RAPL2;RNF182;TLL1
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,0.6519999700840617,1.0399257027789883,0.4897959183673469,0.8885334442753869,1.0,3/7,23.99%,CNTN1;ANK1;NRCAM
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5294480607186461,1.0399130833537693,0.35185185185185186,0.8882271141276902,1.0,4/23,19.23%,PRR5L;SMG1;RICTOR;MLST8
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.6661651675612374,-1.03989351008926,0.5283018867924528,1.0,1.0,1/5,21.52%,GK5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4572046662464505,1.0398390266375563,0.42,0.88810059790839,1.0,19/62,18.37%,IL17RD;TGFBR1;SNAI1;BMP2;WWTR1;EPHA3;SMAD2;EZH2;LOXL2;SMAD4;PTEN;GREM1;BAMBI;PHLDB2;CRB2;VASN;CTNNB1;EFNA1;PHLDB1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.4681870972324969,1.0397047373567272,0.32142857142857145,0.8881951273262567,1.0,8/60,12.35%,TNFSF14;LGALS9;RELA;TLR2;PPM1A;TSPAN6;CPNE1;IRAK1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.5348685538530594,1.0396003004201335,0.43137254901960786,0.8881469408623388,1.0,7/22,19.69%,TGFBR1;BMPR1A;LRP2;HEY2;VEGFA;JAG1;BMPR2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.5725679024443708,1.0395666420342269,0.40816326530612246,0.887896396957173,1.0,10/22,18.40%,GPR55;IL4;MAFB;ZNF675;IL23R;LRRC17;GPR137B;FBN1;CSF1;TMEM178A
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,-0.6729656359822672,-1.0395410576915687,0.4897959183673469,1.0,1.0,1/7,4.09%,RNASE1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5102057195577049,1.0394939166551853,0.4576271186440678,0.887774784175338,1.0,5/33,5.99%,FGF10;MYC;FGF2;BMP2;NRARP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6115561632000872,1.0394344184364552,0.4528301886792453,0.8875981023727271,1.0,1/10,1.94%,SIRT1
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.48508101398892817,-1.0394267476324726,0.38,1.0,1.0,11/53,7.93%,P2RY10;SIRPG;SELL;TRAF3IP3;CD53;SCML4;CYTH4;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.5687308198220543,-1.0393456522825637,0.4074074074074074,1.0,1.0,1/14,1.90%,ENTPD2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6215909037919841,1.039308094537915,0.46,0.887628315453673,1.0,1/10,2.87%,PPARG
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.6451903110314381,1.0391851871598414,0.4634146341463415,0.8877319965428357,1.0,2/10,3.71%,TYR;HPD
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6900335857739793,1.0391030987048873,0.4807692307692308,0.8876703097617717,1.0,1/5,3.02%,ICOSLG
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.46259996259230873,-1.038889299411207,0.3877551020408163,1.0,1.0,14/73,8.91%,PALMD;SELE;TEK;SLCO2A1;RERGL;TIE1;MGP;EPAS1;RNASE1;IFI27;ADGRF5;ADIRF;CLEC14A;C1S
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.45276617249905404,1.0386100775197435,0.38095238095238093,0.8886275994058307,1.0,7/58,10.80%,CWH43;ZDHHC12;GLUL;ZDHHC22;PIGQ;ZDHHC2;PIGF
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.38931606515731887,1.0385987428062502,0.391304347826087,0.8883362259733238,1.0,37/131,23.32%,RAPGEF3;FZD5;PRR5L;TCAF2;TENM1;HCLS1;PCM1;HDAC3;HTRA2;UBE2D3;RHOU;ZDHHC2;TP53BP2;MAPK8;UBE2J2;PPP3CC;ZFAND1;ANP32B;RAB29;BAP1;UBR5;TP53;CD81;MFF;TRIM28;ITGB2;BAD;SAR1A;ZIC1;PPP1R13B;MYO1C;GAS6;SREBF2;AKT2;ITGAM;GTSE1;SAE1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5729364745324885,1.0384823156707241,0.5102040816326531,0.8883523561542925,1.0,12/18,38.65%,RIDA;DXO;YTHDF2;MEX3D;PUM1;YTHDF3;YTHDF1;CELF1;METTL16;ROCK1;GIGYF2;FTO
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.5536721044774308,-1.038409701600533,0.4117647058823529,1.0,1.0,2/17,0.87%,P2RY10;SIRPG
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6701355853864177,-1.0383667092128357,0.5,1.0,1.0,2/5,10.43%,HMGCL;MCCC2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.5923899628939607,-1.038275040764587,0.42592592592592593,1.0,1.0,1/9,0.91%,TRIM56
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.6031897286535409,1.0380636355327288,0.39655172413793105,0.8892441661781461,1.0,3/10,12.78%,PDGFRA;PIK3CA;SOS1
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.5930058528772487,1.0380487701221428,0.4666666666666667,0.8889574695069373,1.0,2/12,11.31%,REXO2;CHEK2
prerank,Reactome_2022__FGFR4 Ligand Binding And Activation R-HSA-190322,-0.5605856281515091,-1.0379992340023139,0.4883720930232558,1.0,1.0,3/10,15.11%,FGF1;FGF20;FGFR4
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4757593212413351,1.037927676890599,0.35555555555555557,0.8890191706680461,1.0,14/47,10.71%,HPSE2;HS3ST5;HS3ST3B1;B3GAT2;HS3ST1;UGDH;HS3ST2;SDC4;HPSE;GPC5;HS2ST1;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5687291455559316,1.0379026407397254,0.4074074074074074,0.8887831416310451,1.0,2/13,11.51%,RENBP;CHST6
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.682297647502092,1.0378548247716681,0.49206349206349204,0.8886205338431474,1.0,1/6,16.47%,CLC
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5303430338999513,1.0377589502168703,0.43137254901960786,0.8885129615295081,1.0,7/26,20.65%,HIF1A;HDAC2;ADRA2C;GREM1;NCOA3;HDAC1;EDN1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.5791672592302085,1.03727572531065,0.40816326530612246,0.8896040616791071,1.0,2/14,9.65%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.43330472300300876,1.0371960535136309,0.4222222222222222,0.8895145030726405,1.0,22/95,20.02%,MYC;SIRT1;ZBTB1;KAT2B;ESR1;HDAC2;ACTL6A;SMARCD3;ARID1A;MYB;ARID1B;SMARCAD1;SMARCD2;HCFC1;PADI4;SMARCA2;RUVBL2;KDM6A;KDM5B;NPM3;SATB2;HDAC1
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.6587680093984919,-1.0371597840028186,0.5192307692307693,1.0,1.0,1/5,1.10%,SCN5A
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,-0.5589838750492153,-1.0370936757257345,0.46511627906976744,1.0,1.0,3/11,15.11%,FGF1;FGF20;FGFR4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.4925075502447042,1.0368366405207312,0.39622641509433965,0.8903347317661447,1.0,8/27,17.47%,LHFPL2;GLRA1;APELA;PLA2G10;HYAL3;ACVR1B;PLCB1;VEGFA
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4406216433760608,1.036821807967576,0.35555555555555557,0.8900621807178202,1.0,18/67,28.64%,KAT2B;JADE3;ACTL6A;EPC1;KAT6A;TAF5;RUVBL2;SUPT3H;NAA50;CPA4;ING3;EP300;ZZZ3;MSL3;KAT6B;BRPF1;ATF2;PHF20L1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4474287240826562,1.0366077171554784,0.45454545454545453,0.8903699829452177,1.0,10/64,6.15%,GPR55;ADRA1A;DRD5;CHRM2;F2R;GPR174;OPRK1;GPR17;GPR33;ESR1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.6378372742725685,1.0365369928932948,0.43636363636363634,0.8902894096261598,1.0,1/7,1.82%,CCL5
prerank,CellMarker_Augmented_2021__Pericyte:Adipose Tissue,0.6666771873641266,1.0363487240300469,0.5409836065573771,0.8904827854375958,1.0,3/6,22.38%,CD34;CSPG4;PTPRC
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.6523375774357466,-1.0363291396119227,0.47058823529411764,1.0,1.0,2/5,22.70%,ACOT4;SUCLG2
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.4295910876827034,1.036298097877093,0.38461538461538464,0.890297276174703,1.0,17/72,20.38%,PCDH11X;PRSS57;LIN28A;GABRG3;PCYT1B;BCAT1;CTCFL;ACSBG1;MYB;ZNF280B;STAR;SLC1A6;ZNF519;NR6A1;ASIC4;PDCD6IPP2;SUZ12P1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.6113984458064471,1.0362680288618862,0.45901639344262296,0.8900526011492155,1.0,3/11,22.25%,ITGAV;CTNNB1;GRB2
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.5429415827333681,1.036266169820223,0.44,0.8897488245786754,1.0,5/26,6.84%,SV2C;ANTXR2;SYT1;MAP2K6;VAMP1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5021766065137879,-1.0361922649848667,0.32,1.0,1.0,3/27,4.85%,UMODL1;CXCL13;UMOD
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.5795769312531814,-1.0361900280458163,0.4423076923076923,1.0,1.0,3/19,9.26%,NUPR1;FLOT1;CDC37
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.41248771972153614,-1.0361431108503714,0.35294117647058826,1.0,1.0,13/91,12.10%,SIGIRR;TEK;NLRP3;MEFV;ALOX5;PRKCD;DRD2;TRIB1;DHX58;CCN3;APOA1;TYRO3;FFAR4
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.3727514019873476,1.0360791499521549,0.30434782608695654,0.8900059315446942,1.0,47/303,12.98%,ADRA1A;SMAD6;CDKN2C;MYC;IL26;F2R;ERBB4;GNRH1;KAT2B;PPARG;CDKN2A;BMP2;TENM1;ST18;KANK2;DUX4;SMYD2;CCN6;SSTR3;DNAJB2;WNT9A;TP53INP1;P3H2;TOB1;MARVELD3;DLC1;RNF139;CBFA2T3;MTSS1;ARID2;PTPN14;MAGI2;TMEM115;TMIGD3;FRK;IGFBP6;PLXNB1;RPS6KA2;ITGA1;PTPRK;NCK2;PROX1;PTEN;H2AC6;CTBP2;GREM1;MAGED1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.45436712670152557,1.0360090981228924,0.35714285714285715,0.8899165514328766,1.0,18/76,25.06%,MYC;CDC25A;CCNA2;SEM1;PSMD13;E2F4;CCNH;PSMA1;MNAT1;CDK4;AKT3;FZR1;PSMD4;AKT2;LIN52;RBBP4;LIN9;RBL2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.42270713868060494,1.0355564085699562,0.32727272727272727,0.8909249783000577,1.0,15/91,9.37%,SYK;ESRRG;ZBTB7B;IL4;TRPM8;SCD;TRPV2;ADIPOR2;PRKAB2;PLAC8;HDAC3;ACHE;PDGFC;KDM3A;LEPR
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6522175697472071,1.0354531936646163,0.5098039215686274,0.8909127368783485,1.0,3/8,20.89%,GLUL;CPS1;GLUD1
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.4907702302978249,1.0352980124716777,0.4117647058823529,0.8910370540280267,1.0,4/35,4.06%,CSTA;CSF3R;RAB27A;VCAN
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,0.608050242646187,1.0350684808943027,0.42857142857142855,0.8914069821986761,1.0,5/7,38.37%,POLE2;POLA1;PRIM1;POLE4;POLE
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,-0.4285999653297699,-1.035041733996893,0.4375,1.0,1.0,9/84,13.01%,CD24;ZDHHC19;FAM3D;WDR86;ADGRG3;KCNQ1;VSIG2;UBXN10;SLC25A29
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5306877084512497,1.0349047995187706,0.38461538461538464,0.8914173219464321,1.0,3/21,11.67%,TUBA1C;CCDC88B;DYNC1I2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6023102892632686,-1.0348635528650378,0.5,1.0,1.0,4/8,16.97%,IL11;ZFPM1;MED1;ZNF385A
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6027662463697303,1.034601018804167,0.5333333333333333,0.8919368881752348,1.0,3/12,3.04%,RAPGEF3;IL4;EHD1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.4432757893427409,-1.0345588659937341,0.41509433962264153,1.0,1.0,17/86,9.27%,P2RY10;TBC1D10C;SELL;SP140;TRAF3IP3;CD53;CYTH4;CD86;ALOX5;LTB;ZBTB32;BTK;TAGAP;CD72;TMC8;LY86;PAX5
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6245574905761777,-1.0341454133196715,0.45098039215686275,1.0,1.0,3/8,26.73%,DCN;RACK1;SRC
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.4793987386632101,1.0341078477623649,0.48,0.8929242241451485,1.0,9/46,12.49%,ERBB4;HIF1A;NRG1;DOCK1;NRG3;NRG2;KHDRBS2;BCAR1;KHDRBS3
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.5703788423356946,1.034085833674887,0.4482758620689655,0.8926704854560781,1.0,5/17,18.14%,WNT4;PRKCSH;PROX1;COBL;CITED2
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.4522283945377946,-1.0340771984512604,0.37209302325581395,1.0,1.0,9/63,16.46%,UVSSA;ERCC1;RFC3;PRPF19;GTF2H2;POLR1A;RPA3;RFC2;ISY1-RAB43
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.44054630166273473,1.0340137515336982,0.4,0.8925486423124713,1.0,20/69,21.00%,MYC;HIF1A;KAT2B;RBPJ;HDAC3;HDAC2;TBL1X;CNTN1;TLE2;NBEA;MIB1;HEY2;NUMB;TLE4;ARRB2;ADAM10;HDAC9;JAG1;HDAC1;CDK8
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6343883312292646,1.0338667608209984,0.41509433962264153,0.8926947575798508,1.0,5/9,18.12%,IGF1;SOAT1;PLCB1;IL33;ABCA2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6368666821839073,1.0338220490566603,0.5333333333333333,0.8925230694501716,1.0,2/5,25.11%,VPS13A;VPS13D
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6139267114470607,-1.0337875828377323,0.4489795918367347,1.0,1.0,2/11,10.78%,SLCO2A1;SLCO2B1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.4217317275406865,1.0335159410836259,0.3409090909090909,0.8930501892913616,1.0,27/137,12.81%,MXRA5;LAMA4;MRGPRF;ITGA8;PAWR;PRRX1;ADGRL4;BGN;CRIM1;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;FAM114A1;ABI3BP;PLSCR4;DLC1;PCDH18;MEDAG;NCOA2;TPM2;HMCN1;MEF2C;HTRA1;TBX18;NR4A2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.38279724138649185,1.0334935577760733,0.27450980392156865,0.8928013970824435,1.0,37/256,14.80%,FGF10;SIPA1;CDC14A;UHRF2;CDKN2C;MYC;SIRT1;TGFBR1;CDC25A;CDK11A;KAT2B;CDKN2A;FBXO5;BMP2;DLGAP5;MAP2K6;TP53INP1;FBXL3;HTRA2;GMNN;INSM2;MAGI2;BIN1;RPS6KA2;PTPRK;PHACTR4;PLAGL1;TP53BP2;PROX1;PCLAF;MLF1;MLXIPL;PML;LRP6;SPATA22;BOP1;NEK7
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5995924876448793,1.0334536662765035,0.38461538461538464,0.8925890530407096,1.0,4/8,22.43%,NFE2L2;HSPA5;DDIT3;EIF2AK3
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,-0.5456534799538278,-1.0334383213163199,0.4489795918367347,1.0,1.0,1/16,1.04%,CD24
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.5880855492181386,-1.0334316385419176,0.4117647058823529,1.0,1.0,3/14,11.15%,RPF2;DDX18;FTSJ3
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5632327285547406,1.0333847295769116,0.4727272727272727,0.8924357779341281,1.0,1/17,0.86%,MAP3K11
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.5301873161555242,1.0333640821102028,0.4074074074074074,0.8922055964182944,1.0,7/18,22.80%,STAT5A;PIK3CA;SOS1;GAB2;ZMYM2;GRB2;TRIP11
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.5711360604623777,1.0332640908929975,0.509090909090909,0.8921884320584479,1.0,4/16,14.30%,SEMA5A;ITGA1;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.4797178303779535,1.0332621444523047,0.38636363636363635,0.891881543476578,1.0,7/43,15.37%,ZBTB7B;PPARG;BMP2;NAPEPLD;MEDAG;CREB1;FRZB
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.6110021356565548,1.033196307502275,0.49056603773584906,0.8917739976376564,1.0,1/10,5.50%,SLC8A1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5054613946900638,1.033179784429528,0.4074074074074074,0.8914991453055691,1.0,6/29,15.66%,ZBTB20;LIN28A;UNC13B;IGF1R;MLXIPL;PRKAA1
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.6960163752705897,1.0331033817419222,0.5217391304347826,0.8910720893842883,1.0,1/5,4.53%,WHRN
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.6960163752705897,1.0331033817419222,0.5217391304347826,0.8910720893842883,1.0,1/5,4.53%,WHRN
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,0.47613574641904843,1.0330479606187137,0.3617021276595745,0.8908881647202307,1.0,11/54,6.24%,ITGAX;CSF3R;PIK3R6;SASH3;SAMSN1;PIK3R5;CD244;IRF8;HCLS1;IL10RA;LAIR1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.43781348304714895,1.0329635973432045,0.36,0.8908218242463088,1.0,14/114,11.30%,ZDHHC11;AP1M2;ZDHHC12;NLGN1;PEX12;GDAP1;LTBP2;ZDHHC22;TIMM22;RAB3IP;FBXO7;HAP1;ZDHHC2;ZFAND6
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6717561631827749,1.0328767174783162,0.5094339622641509,0.8903687803685588,1.0,2/7,8.31%,ASF1A;ASF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6717561631827749,1.0328767174783162,0.5094339622641509,0.8903687803685588,1.0,2/7,8.31%,ASF1A;ASF1B
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5289442459667932,-1.0328153788311385,0.4489795918367347,1.0,1.0,1/19,0.17%,TERT
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.5582195609574753,-1.0327991807409176,0.4090909090909091,1.0,1.0,4/14,20.19%,EIF2S2;EIF2S3;ATF5;EIF2AK1
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.5662388477286837,1.0326994824505324,0.39215686274509803,0.8905463745771158,1.0,8/21,21.86%,ELOVL5;TECRL;ACSBG1;ELOVL4;TECR;ACSL4;ELOVL6;ACSL1
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.6498454789721593,1.0326073625260537,0.47368421052631576,0.8905073169923509,1.0,3/6,22.17%,PLAUR;GPAA1;PIGT
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.4081753485924025,1.0323589654249414,0.4489795918367347,0.89087412585451,1.0,23/110,20.24%,SLC5A8;SHMT2;ENPP1;RNLS;PRSS3;TCN2;MTHFD2L;AOX1;MTHFD2;PANK1;FASN;SLC19A1;SLC52A1;ACACA;LRP2;ACACB;NMRK2;ABCD4;GPHN;SLC19A2;MOCOS;LMBRD1;ENPP3
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.4315133613160319,-1.0318913820614675,0.3958333333333333,1.0,1.0,4/65,5.36%,ANXA8;CLDN1;LOXL4;GPC1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.4541079314655955,1.031652702592538,0.4074074074074074,0.8924983217176071,1.0,6/45,9.12%,SLC7A11;SLC38A3;SLC38A4;SLC7A2;SLC7A9;SLC25A48
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6039040759692136,1.0314019912481398,0.35185185185185186,0.892850638179844,1.0,7/12,23.87%,RORB;TULP1;RP1L1;VEGFA;ARL3;RP1;CEP290
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.40417520209544644,1.0313571195340427,0.37037037037037035,0.8926261291386537,1.0,18/91,12.91%,SEMA5A;C1GALT1C1;GALNT8;GALNTL5;ST6GALNAC3;ADAMTS17;ADAMTS16;MUC20;ADAMTS19;GALNT3;SPON1;C1GALT1;GALNT12;GALNT1;MUC13;MUC7;B3GLCT;POMT2
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,-0.4715801233307385,-1.0312130873487837,0.5227272727272727,1.0,1.0,11/49,8.78%,DOCK8;TRAF3IP3;CD53;CYTH4;CD86;ALOX5;BTK;HCK;TAGAP;TMC8;LY86
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.6378663124578966,1.0310726923347124,0.4909090909090909,0.8931987889455933,1.0,3/9,12.51%,MYRF;PTEN;ABCD2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.42442415797535354,1.0310414478474426,0.42592592592592593,0.8929608121355401,1.0,31/82,31.46%,AP1M2;LLGL1;CORO7;ACBD3;HSPA8;SORCS1;EXOC6;ARL3;RP2;KLHL20;MON2;SH3GL2;COMMD1;EXOC6B;VPS13A;CLVS2;HGS;PUM1;EXOC4;EPS15;MYO5A;FTL;GBF1;APP;SCFD1;VAMP8;KIF16B;ARRB1;AP4B1;DNAJC6;AP1G2
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,-0.4376132656347268,-1.030999977696781,0.43636363636363634,1.0,1.0,13/91,13.18%,TMEM179;RGS8;ST8SIA2;ZCCHC12;DRD2;SEMA5B;TTBK1;CACNG5;PCDH8;CELF3;LRRTM1;INA;C2CD4C
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),-0.7074331253920416,-1.0309835215766459,0.5306122448979592,1.0,1.0,3/5,16.85%,PAX2;PODXL;FGFR2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.4412183835325063,-1.0309426281012177,0.375,1.0,1.0,12/75,9.52%,CLEC4F;MPO;CD53;CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;HFE;LY86;VDR
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-0.5747460242451052,-1.0305662547791505,0.475,1.0,1.0,3/5,22.46%,PAX2;PAX8;SMO
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,0.5099146621634778,1.0303039868635353,0.3870967741935484,0.8948423438276164,1.0,5/18,16.35%,PEX12;GDAP1;ABCD3;ABCD2;PEX2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6223541644653632,1.030292091851807,0.41935483870967744,0.8945544717492732,1.0,1/7,10.17%,ADARB2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.39870280021482046,1.0302840511485447,0.28846153846153844,0.8942443228403681,1.0,22/122,15.57%,CDC25A;CCNA2;NDE1;CEP70;PCM1;FBXL3;CEP152;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.49034266779829494,-1.0302106004878764,0.34,1.0,1.0,4/24,13.11%,SCN5A;DSG2;CTNNA3;CAV1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,0.5904519019849991,1.0299006097386643,0.4074074074074074,0.8950581059246449,1.0,1/12,2.28%,CCNA2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.47275526339338303,1.0298321189115396,0.38596491228070173,0.8949501944366434,1.0,7/31,18.04%,NLGN1;ABI3;PDLIM5;PTEN;DBN1;CAPRIN1;EFNA1
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.48281567288855404,-1.0297902439688211,0.43478260869565216,1.0,1.0,12/57,8.45%,SELP;SELE;TEK;TIE1;MGP;RNASE1;IFI27;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.558128618405034,-1.0296612414202169,0.475,1.0,1.0,4/21,10.48%,CLDN4;CLDN1;F11R;CLDN15
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5379160128972441,1.0295872461371902,0.3541666666666667,0.8953678816685824,1.0,3/12,13.29%,SIRT1;SNCA;NOC2L
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.5137180683712562,1.0295516437438395,0.45614035087719296,0.8951431956904068,1.0,13/43,25.06%,CDKN2C;CDKN2A;E2F4;CCND3;CCNH;MNAT1;CDK4;ABL1;LYN;CDK6;PPP2R1B;JAK2;RBL2
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6328798270056033,1.0295395444779651,0.4716981132075472,0.8948603200225519,1.0,3/6,23.08%,PCLO;ERC1;ERC2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.6493859726608091,1.0295061667751897,0.4375,0.8946673826075348,1.0,3/6,21.62%,SLC3A2;SLC6A15;SLC7A8
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.487494535081524,-1.0295011177599185,0.391304347826087,1.0,1.0,5/35,15.98%,IFT27;DYNLT5;KIF17;DYNLRB1;TRAF3IP1
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.43412504329185403,-1.029333864699925,0.4166666666666667,1.0,1.0,25/95,23.78%,PM20D1;NDUFC1;TMEM126B;ECSIT;UQCRC1;NDUFAF3;UCP3;NDUFS5;TMEM186;COX6C;DMAC2L;ETFDH;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;ATP5F1A;ATP5F1E;ATP5ME;UQCRH;NDUFA1;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.6344153579971903,1.0293312845051559,0.4909090909090909,0.8949410480535255,1.0,1/6,9.15%,LMAN1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6133806854642692,1.0293273305184079,0.5087719298245614,0.8946361279439843,1.0,3/8,25.62%,ACHE;LIMD1;TNN
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.4177257128975015,1.0292786907905014,0.36538461538461536,0.8944345119813977,1.0,13/87,8.86%,SLC26A3;LAMA4;SEMA5A;LSAMP;BGN;SCGN;FREM1;ADGRG4;PDGFRA;MTTP;PTPRD;FGF14;MOGAT2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5620836437042264,-1.0291736773351892,0.38636363636363635,1.0,1.0,7/14,23.78%,DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;ATP5MC3;ATP5PB;ATP5F1B
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.4165870706181993,1.0289672497843037,0.40384615384615385,0.8949319914609829,1.0,26/84,19.40%,PLOD2;ITGA2;GNG12;EPS8L2;EVA1A;ADGRG6;LRIG3;SDC4;WWTR1;FAM114A1;DSP;BCAM;MAGI1;TSPAN6;PTPRK;ARHGEF16;BCAR1;NR2F2;ERRFI1;TMEM54;RNF128;PERP;LAMA5;RHOD;FERMT1;LURAP1L
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5077433778954135,1.0288910585699302,0.43137254901960786,0.8947796812229504,1.0,2/19,2.93%,HIF1A;NEDD4
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.42156925501710624,-1.0287719301736509,0.36538461538461536,1.0,1.0,10/98,8.72%,MS4A8;TERT;FAM3D;CAPN9;MYO5B;ITGA9;KCNQ1;OLFM4;HEPH;ZBTB7C
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.42044257661001005,1.0287537241014733,0.32142857142857145,0.8948423885844206,1.0,26/117,13.00%,MXRA5;MRGPRF;ADGRL4;GNG12;FRAS1;DOCK1;BGN;LRIG3;CXCL12;SDC4;POSTN;CCDC80;WWTR1;F3;FAM114A1;DPP4;PLSCR4;PRICKLE2;DSP;COBLL1;MEDAG;AOX1;HAS2;HTRA1;PXDC1;FZD1
prerank,Reactome_2022__MET Receptor Activation R-HSA-6806942,0.6734046258226704,1.028709510482433,0.4583333333333333,0.8946320343843062,1.0,2/6,12.78%,HGFAC;SOS1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.4882178282823091,-1.0286875423871638,0.4146341463414634,1.0,1.0,7/34,17.93%,DDX11;TRAIP;RTEL1;NUCKS1;ZRANB3;ZGRF1;BLM
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5908889112145684,1.0286636407576168,0.43548387096774194,0.8944263036305689,1.0,1/14,3.72%,SYVN1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4236756651071274,1.0286064306913774,0.37254901960784315,0.8942699165255166,1.0,24/109,14.77%,RIT2;RETREG3;ROR1;TOX;TENM3;ROBO2;GRIP1;CHODL;ZNF804A;FUT9;EPHA3;PTPRD;ABL2;MAGI2;PLXNB1;PLXNB2;CARMIL1;FZD1;RAP1A;LRRC7;PTK7;DVL2;FZD4;CAPRIN1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.6621923239307109,1.028455813212853,0.48,0.8943103611111907,1.0,2/5,7.61%,HIF1A;CIAO3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.5706206107242693,1.0283929691094642,0.4807692307692308,0.8941585953737885,1.0,1/12,2.62%,KCNK2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5779929150964942,1.0282131531398864,0.5,0.8943688254800801,1.0,7/14,21.27%,TDO2;HMGCS1;MVD;ACACA;ACACB;DIP2A;ACSS1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.6241088575045421,-1.028134322674604,0.4772727272727273,1.0,1.0,1/6,3.27%,ASS1
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,0.38884199220179255,1.0279473224835334,0.3090909090909091,0.8948558093151212,1.0,28/231,8.27%,STK26;STAB1;FERMT3;ITGAX;TNFSF13B;CSF3R;SLFN11;SFMBT2;MAFB;SAMSN1;FLI1;IRF8;HCLS1;GPSM3;KIAA0930;ABI3;METAP1D;FGL2;PELI1;LMO2;TLR2;PLCG2;HPGDS;ABCA1;SIGLEC1;CD40;CORO7;TFEC
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.6460465386971954,1.0277425321275862,0.43636363636363634,0.89511475400389,1.0,3/7,23.75%,RP1L1;ARL3;RP1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.5155111868319797,1.0276596629280512,0.37037037037037035,0.8950209375195445,1.0,8/26,22.80%,STAT5A;PIK3CA;FLT3;SOS1;GAB2;ZMYM2;GRB2;TRIP11
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4457103922298043,-1.0275449806231494,0.38461538461538464,1.0,1.0,16/100,8.62%,SELE;NLRP1;GUCA1B;BST1;IL1RL2;ALOX5;SPAAR;PTGES;AHSG;PDE6B;TRIM5;CNGB1;PPEF1;HCK;NMT1;P2RY12
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.43893356936827665,1.0275075482035263,0.3958333333333333,0.8951814889698865,1.0,18/89,10.66%,LAMA4;MRGPRF;PRRX1;EDIL3;ADGRL4;SSC5D;BGN;CRIM1;LTBP2;POSTN;CCDC80;PDGFRA;PLSCR4;IGFBP6;MEDAG;TNC;LOXL2;TPM2
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.46363281546532653,1.0274417148939496,0.42592592592592593,0.8950877152661507,1.0,14/47,20.06%,PLCH1;ITPKB;PLCG2;INPP1;IP6K3;INPP4B;NUDT4;PTEN;MTMR9;PLCB1;PLCD1;IMPA1;IP6K1;MINPP1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,0.45430226842016724,1.0273349031454897,0.39622641509433965,0.8950653402847765,1.0,10/47,8.03%,HEMGN;TRPC2;STAB1;CSF3R;ZEB2;FLI1;PTGS1;LMO2;ERG;GYPC
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.42132960778743017,-1.0272521025123604,0.3469387755102041,1.0,1.0,14/67,15.98%,TEK;NLRP3;MEFV;ALOX5;PRKCD;DHX58;CCN3;APOA1;TYRO3;FFAR4;MAPK7;TNFAIP6;VPS35;TRAF3IP1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5826586951599226,-1.0272378977953174,0.5098039215686274,1.0,1.0,2/10,10.52%,PARP2;PARP1
prerank,KEGG_2021_Human__Circadian rhythm,0.49667429165688276,1.0271878564901418,0.423728813559322,0.8951900521391245,1.0,8/28,18.74%,RORB;RORA;PRKAB2;FBXL3;CREB1;PRKAA1;RORC;PER3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.500417572347093,1.027028374406164,0.4222222222222222,0.8953057655827986,1.0,14/30,34.15%,DCP1B;EXOSC4;CNOT8;EXOSC1;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;LSM3;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4766444313857049,1.027019517914386,0.48214285714285715,0.8950072173123371,1.0,9/40,20.22%,SNAI1;WNT4;DKKL1;GCK;PROX1;CD34;AKR1C3;ABCA2;RAPGEF2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.4702046019375084,1.0269803612745096,0.35294117647058826,0.8947934674726005,1.0,7/39,18.20%,RIOK2;TSR3;PWP2;RPS5;RIOK1;ERAL1;RIOK3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.41993997290540125,1.0269732657467692,0.3695652173913043,0.8944953109375385,1.0,21/97,14.03%,CDH20;PMP2;SLC1A3;GFAP;NDRG2;GLUL;SLC8A1;NRXN1;NTSR2;RAMP3;CYP27A1;PLXDC2;SYNPR;GRM5;PTPRT;TMIGD3;RTN1;ATP1A2;BAALC;SLC39A12;SEZ6L
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.4681029554646936,1.0269599861551133,0.4583333333333333,0.8942062625539622,1.0,2/26,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.4703525034066384,1.0269366004440468,0.48,0.8939529962512329,1.0,5/51,9.14%,IRGM;TP53INP1;ATG101;STING1;RAB23
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.5406798874027146,-1.0267497549950189,0.4772727272727273,1.0,1.0,5/19,13.00%,SIGIRR;IL18BP;PTPN7;PTPN5;SMAD3
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.4076738176787843,-1.0265961382127702,0.36,1.0,1.0,36/141,23.78%,PM20D1;LDHC;PDHX;NDUFC1;LDHAL6A;TMEM126B;ECSIT;PDPR;UQCRC1;NDUFAF3;UCP3;NDUFS5;TMEM186;COX6C;D2HGDH;VDAC1;DMAC2L;ACO2;ETFDH;NDUFA10;COX7C;LDHB;COX7A2L;NNT;NDUFA5;PCDHB11;NDUFS1;ATP5F1A;ATP5F1E;ATP5ME;UQCRH;SUCLG2;NDUFA1;ATP5MC3;ATP5PB;ATP5F1B
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.49021481320532256,1.0265240036082164,0.37254901960784315,0.8947224180411968,1.0,4/28,4.30%,PIK3R6;GNB4;GNG12;PIK3R5
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,0.6153466063036785,1.0264109785305184,0.5208333333333334,0.8947713488823773,1.0,2/11,17.54%,PLA2G10;PLBD1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4211811905825349,1.0263396340227453,0.3541666666666667,0.8946958535751891,1.0,27/103,15.75%,CXXC4;TSPAN12;FGFR3;HNF4G;C1QL1;CKMT1A;LRP4;EFNA2;PCLO;LRIG3;SLC7A2;MMP15;NRARP;MAGI1;PLXNB1;EFNB2;ONECUT2;CGN;JPH1;ARHGEF16;BCAR1;FAM222A;ID4;NR2F2;TMEM54;COBL;CPE
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,-0.5036700774125786,-1.0261418038636638,0.3877551020408163,1.0,1.0,11/41,9.97%,COL23A1;COL24A1;COL4A2;COL27A1;COL5A1;COL4A1;COL28A1;COL6A3;COL11A2;COL26A1;COL1A1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.641176331986403,1.0261324575252206,0.4807692307692308,0.8950112189144102,1.0,2/7,10.58%,MYC;FOXO1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.683571584369286,1.0260600423435877,0.49122807017543857,0.8948469037127864,1.0,3/6,19.20%,RENBP;NPL;GNPDA2
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.434398887342026,1.025889650853725,0.4074074074074074,0.8950288577906892,1.0,12/81,10.66%,IGF1;ITGA10;ITGA8;ITGB8;ITGA11;ITGA2;SLC8A1;CACNB4;ITGAV;SGCG;ITGA1;TPM2
prerank,KEGG_2021_Human__Toxoplasmosis,0.4248791232278882,1.025818252987748,0.32142857142857145,0.8949045787917848,1.0,13/93,9.30%,LAMA4;IRGM;PIK3R6;LDLR;PIK3R5;IL10RA;RELA;TLR2;MAP2K6;CD40;GNAI3;LAMB4;TAB2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4859711441284571,1.0257341479361646,0.38,0.8948956905737206,1.0,5/27,8.98%,IGF1;FGF10;ITGAV;ERBIN;SHOC2
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.6704224614198606,-1.0257319464724615,0.48936170212765956,1.0,1.0,3/6,16.18%,HSD3B2;HSD3B1;MED1
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,-0.6006527141922534,-1.0257212679374534,0.46938775510204084,1.0,1.0,3/11,7.96%,NOXA1;RNASE1;JUN
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.44471425000483555,1.0256702186756865,0.4,0.8947626794767247,1.0,23/103,21.16%,SMAD6;RUNX1;SEM1;BMP2;RBM14-RBM4;ESR1;WWTR1;HDAC3;SMAD1;PSMD13;SMAD4;PSME4;PSMA1;HEY2;CDK4;SMURF1;NR3C1;AKT3;ABL1;SATB2;HIVEP3;PSMD4;MAPK3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.49620164964061203,1.0254948867446547,0.4444444444444444,0.8950064499992633,1.0,5/37,8.96%,F2;PYHIN1;GLUL;WWTR1;LATS1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3537498263856139,1.0252275772224673,0.2857142857142857,0.895440542026497,1.0,153/787,18.28%,DACH1;MITF;AASS;TIMELESS;RUNX1;MYC;SIRT1;ZBTB7B;TSHZ3;IL4;URI1;ZBTB1;FOXP2;NRG1;PPARG;SNAI1;SFMBT2;MDFIC;ZEB2;WNT4;CDKN2A;RORB;BMP2;BMI1;NFIL3;NRIP1;SIX4;ZNF582;ZGLP1;KANK2;IRF8;VSX2;SMYD2;RBPJ;RELA;ZEB1;ZBTB2;ESR1;ZNF599;ZNF706;HDAC3;PAX6;HDAC2;NCOA5;MYPOP;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;GMNN;FOXO3;ATXN1;TFEC;CBFA2T3;YAF2;ZNF202;INSM2;RIPPLY2;TAF3;ZNF675;SPINDOC;NPAS1;FRK;SMAD2;EZH2;MAGEL2;ZNF669;LOXL2;ZNF692;ZNF239;FOXO1;MBTD1;PTPRK;TBL1X;PASD1;NR1D2;PHF21A;SP3;SMAD4;DPF1;NR1H3;MEF2C;ZNF536;PROX1;ZNF175;CTBP2;ZNF778;TLE2;ZNF281;MYB;ATF7IP;NR4A2;DPF3;HSPA8;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;WWOX;RARB;CREB1;ZNF639;BCOR;RUNX1T1;NR2F2;ZNF263;EPC1;KAT6A;POU2F1;THRB;PLCB1;HJV;HCFC1;SPEN;TRPS1;DEAF1;MESP1;BAP1;SIRT6;PEX2;HEY2;BCL3;CNOT2;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3;RORC;IL33;SIRT7;VEGFA;TGIF1;MXI1;LCOR;TP53;MAZ;MIER3;MAF1;EFNA1;CITED2;EED;ZNF12;PSPC1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6652081823489322,1.0251801833702732,0.5,0.8952011954483965,1.0,4/8,23.37%,PROX1;GRID2;CBLN1;CEND1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.61896539547652,-1.0251383467191713,0.42105263157894735,1.0,1.0,2/9,18.29%,CLTA;AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.61896539547652,-1.0251383467191713,0.42105263157894735,1.0,1.0,2/9,18.29%,CLTA;AP2A2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5307545274629316,1.0250062666709285,0.40384615384615385,0.8953515890238086,1.0,9/20,22.38%,F2R;FGF2;PLCG2;HTR2C;TRPM2;RYR2;RYR3;HTR2A;PTPRC
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.42584698987479996,-1.0249473255190473,0.3617021276595745,1.0,1.0,28/102,13.28%,ALB;ASS1;CYP2E1;HABP2;F7;UPB1;HSD11B1;SLC22A8;SLC9A8;CRYL1;PAH;TGFBI;CYP4F2;SLC13A3;NOX4;GNG13;HAO2;SLC22A6;CACNG5;PRODH2;APOB;SMLR1;SLC5A1;C3P1;SLC22A1;SLC36A2;BHMT;SLC4A4
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.6475197277769331,1.0249383603904745,0.4444444444444444,0.8952363529679687,1.0,1/6,11.68%,HAS2
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.3734101256841433,1.0248973576065024,0.42857142857142855,0.895041568562292,1.0,43/264,9.98%,GPR55;ADRA1A;DRD5;INSL5;CHRM2;C3;CCL5;PNOC;F2R;GNRH1;GRM3;UTS2R;HRH3;HTR1F;CALCR;OPRK1;GNB4;GNG12;WNT4;NPY;INSL3;CXCL12;PENK;PTGFR;GPR17;RXFP2;SSTR3;WNT9A;NPFFR2;PLPPR1;GRM8;ADRA2C;QRFPR;CASR;GNRH2;NTSR2;RAMP3;CRHBP;NPW;RGR;GRM5;TAC1;C5AR2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.48899484098427504,1.024731448519953,0.3018867924528302,0.8952405050803872,1.0,12/37,26.61%,SIX4;ROGDI;HAP1;MESP1;WNT2;ANXA1;TRAK2;RYK;CDK6;SPOCK1;BTBD2;CHAC1
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.5219279925578477,-1.024589277954825,0.43137254901960786,1.0,1.0,3/35,6.35%,GFRA3;GFRA2;SHC3
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.6312092182988359,1.0245422062662173,0.5094339622641509,0.8954702472481749,1.0,1/12,4.15%,MLLT3
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5492410705453302,-1.024523504273436,0.48,1.0,1.0,5/15,9.36%,KCNE2;KCNN2;KCNE1;KCNQ1;KCNA5
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.5003593076804901,-1.0243698068788583,0.42,1.0,1.0,5/27,14.55%,GINS3;RFC3;POLR1A;RPA3;RFC2
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.39976015677424415,1.0243145311438604,0.28888888888888886,0.8957351818549596,1.0,50/177,22.25%,CCL3L3;MYC;CCL5;GNB4;GNG12;CDKN2A;SP1;IL10RA;CXCL12;RELA;MAP2K6;ITGAV;PDGFRA;ELK1;GNAI3;STING1;PIK3CA;TAP1;HLA-E;PXN;GNG4;BCAR1;PPP3CA;SOS1;CREB3L2;PPP3CC;CREB1;NFATC3;PLCB1;PIK3CD;CTNNB1;FADD;VEGFA;CDK4;TP53;CASP3;GNA13;PRKACB;IRF3;AKT3;HLA-F;PIK3R3;IKBKB;MAPK3;HLA-B;GNAQ;CRK;GNAI1;AKT2;GRB2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.4590490975519332,-1.0239786300644669,0.32653061224489793,1.0,1.0,13/64,8.11%,P2RY10;SIRPG;SELL;SP140;TRAF3IP3;CD53;CYTH4;LTB;CNGB1;KLRB1;CD5;TAGAP;TNFRSF4
prerank,KEGG_2021_Human__Tuberculosis,0.41605195483695673,1.0239687677515366,0.35185185185185186,0.8963224187940317,1.0,20/122,14.40%,TCIRG1;ATP6V0D2;C3;ITGAX;SYK;KSR1;IL10RA;RELA;TLR2;RFXAP;ATP6V0A4;CASP10;MAPK8;IRAK1;PPP3CA;ATP6V0B;PPP3CC;CD74;CREB1;RFX5
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5505901189251861,-1.0239228958588693,0.46938775510204084,1.0,1.0,1/18,1.79%,NLRP1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5871555071320483,1.0239119298056696,0.45901639344262296,0.8961673399653,1.0,3/12,14.07%,PCSK5;PDGFRA;RARB
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.4761718651855098,-1.0237628281180982,0.46153846153846156,1.0,1.0,3/32,4.71%,CD24;IL11;FOS
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5974150726603036,1.0237225838882202,0.46296296296296297,0.8963522901176767,1.0,2/13,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4752544154896001,1.0235309191469073,0.4067796610169492,0.8965724147868774,1.0,3/36,5.54%,KAT2B;ROBO2;RBPJ
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.6671006181374217,1.0234164739714395,0.5576923076923077,0.8965762238412699,1.0,2/5,22.25%,PIK3CA;GRB2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.436014551797666,-1.0233178093569975,0.3898305084745763,1.0,1.0,13/72,8.25%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP;TMC8
prerank,Reactome_2022__Maturation Of Spike Protein R-HSA-9683686,0.6718197228384453,1.023190026549797,0.45098039215686275,0.8968799045208902,1.0,2/5,21.31%,PRKCSH;CANX
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.43045527530974015,1.0231632999473923,0.41304347826086957,0.8966235093183909,1.0,9/79,8.96%,CDKN2C;MYC;CDC25A;CDKN2A;CDK18;FBXO5;CDK14;BCAT1;LATS1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.45900967873747506,1.0229876043097572,0.3333333333333333,0.89678594247065,1.0,21/64,16.69%,SCGB3A2;PCDH11X;IL17RD;PRDM14;LIN28A;NANOGP1;APELA;IGDCC3;ANKRD18CP;CHST6;VASH2;CLDN6;GRM4;TERF1;POU2F1;L1TD1;VRTN;CALB1;NMRK2;GJC1;GRID2
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.4429967676445135,1.0228202789357383,0.39215686274509803,0.8968998038624089,1.0,13/56,15.92%,NLGN1;LLGL1;PDLIM5;SYT1;NRXN1;NLGN4X;LIN7A;GRM5;EPB41;LRRTM3;GRIN2D;APBA1;GRM1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.685180556026515,1.0227930061945592,0.4666666666666667,0.8966656892282141,1.0,3/6,13.71%,ROBO2;ALCAM;PTPRM
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.4804172503182761,1.0225798416517915,0.3877551020408163,0.896973210519521,1.0,10/49,11.51%,HS3ST5;HS3ST3B1;HS3ST1;CHSY3;HS3ST2;HS2ST1;EXT1;FUT8;CSGALNACT1;CHST6
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,0.5302543327899139,1.022510684661602,0.46808510638297873,0.8968492506771271,1.0,4/11,12.23%,DCC;DSCAML1;DSCAM;MAPK8
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4298563275239051,1.0221557869564808,0.4090909090909091,0.8975392185233445,1.0,13/65,13.81%,SULT2A1;ACSM2A;SULT6B1;AMPD1;AK3;ENPP1;EFL1;GNAI3;RAB23;OXSM;ENTPD7;THEM5;TPST2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.466781090495509,1.0220436535934676,0.37037037037037035,0.8976042447708262,1.0,8/33,12.82%,TCIRG1;ATP6V0D2;RAB38;RAB31;RAB39A;ATP6V0A4;RAB34;ATP6V0B
prerank,CellMarker_Augmented_2021__Spermatogonium:Testis,0.6925661356067558,1.0219711869968806,0.49019607843137253,0.8974582141733065,1.0,4/5,24.77%,KIT;NR6A1;SYCP3;SYCE3
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.5042809995186235,-1.0218552017929308,0.3829787234042553,1.0,1.0,1/26,0.44%,ACOT1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.6652713884878168,1.0218076333248962,0.48,0.8972850695919931,1.0,1/7,19.37%,ATG2B
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.6652713884878168,1.0218076333248962,0.48,0.8972850695919931,1.0,1/7,19.37%,ATG2B
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.515050221152143,-1.0218041694352114,0.3684210526315789,1.0,1.0,4/19,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.40897703364376997,-1.021728931652506,0.39285714285714285,1.0,1.0,15/123,8.82%,SELP;SELE;TRIM56;SIGIRR;IL1RL2;MEFV;IL18BP;IL6R;TNFRSF11A;TIMP4;CIITA;SLC11A1;CHI3L1;PTPN7;LAMP3
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.6711792251177249,1.0216467064071861,0.4838709677419355,0.8971516757730355,1.0,2/6,21.69%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.6711792251177249,1.0216467064071861,0.4838709677419355,0.8971516757730355,1.0,2/6,21.69%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.694547633957697,1.021248254237579,0.5208333333333334,0.8979451787031815,1.0,3/5,23.01%,HMGB1;CD74;MBP
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",0.4681697977259566,1.0211531525796818,0.4444444444444444,0.8978739115690816,1.0,13/35,20.56%,SHMT2;PHGDH;ALDH7A1;GCAT;GAMT;SRR;CBS;AGXT2;CTH;PSPH;GRHPR;BPGM;DAO
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.6445474826458517,1.0210148791453255,0.5087719298245614,0.8979298696248047,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6136279319956399,1.0209330235280925,0.49019607843137253,0.897898111952877,1.0,1/9,1.44%,GREM2
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.47258707369758124,1.020794460969757,0.36538461538461536,0.8979364934172676,1.0,6/35,17.80%,MAP3K11;NCK2;CCP110;DST;PKN2;WASL
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.42356149662999076,1.020573934115288,0.3333333333333333,0.898207030202971,1.0,16/87,14.46%,IL1RAPL2;NLGN1;LLGL1;PDLIM5;SYT1;PPFIBP1;NRXN1;PTPRD;NLGN4X;LIN7A;GRM5;EPB41;LRRTM3;GRIN2D;APBA1;PPFIA3
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4516099780127538,-1.0202713290080025,0.525,1.0,1.0,7/53,13.17%,CELA2A;TPP1;CEACAM1;ADAMTS9;PRPF19;DAB2IP;DENND3
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.42727311173856014,1.0202621236566647,0.4583333333333333,0.8987532730168944,1.0,12/53,16.70%,MYC;PRKG1;GNB4;GNG12;MOV10;PDE6A;GNG4;PPP3CA;FZD4;FZD6;PLCB1;CTNNB1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6040709248462472,1.0202591119219209,0.43103448275862066,0.8984454752631701,1.0,2/7,16.70%,CDH2;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.6524085962214615,1.0202036858152852,0.49122807017543857,0.8982954355084387,1.0,1/8,3.67%,FBXO5
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5877362679152209,-1.0201289836511134,0.43478260869565216,1.0,1.0,3/14,12.27%,KCNE2;KCNE1;KCNS1
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.42104116039722944,1.0198118904204747,0.40425531914893614,0.8990466902100166,1.0,9/67,15.21%,RAPGEF3;KCNC2;GNB4;GNG12;ADRA2C;GNG4;RAP1A;KCNG2;PLCB1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7166642000358027,-1.0196792114098039,0.543859649122807,1.0,1.0,2/6,15.90%,ALOX5;LTC4S
prerank,Reactome_2022__Synthesis Of Lipoxins (LX) R-HSA-2142700,-0.7166642000358027,-1.0196792114098039,0.543859649122807,1.0,1.0,2/6,15.90%,ALOX5;LTC4S
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.6672613040062925,1.0194573680109713,0.5306122448979592,0.8997187061086106,1.0,2/7,15.33%,ATPSCKMT;PPIF
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.45498128911456576,1.0194321266864288,0.38,0.899467832315517,1.0,6/51,12.73%,PNP;ENPP1;CANT1;TK1;DCTPP1;NT5C3A
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5807751790109165,1.0193898318435548,0.48,0.8992520937748295,1.0,3/9,17.47%,TENM3;LRP6;VEGFA
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,-0.5879841181274844,-1.0192072367160692,0.47619047619047616,1.0,1.0,1/10,0.25%,KLRC1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.41404726470617936,1.0190859484961081,0.41379310344827586,0.8997267506601646,1.0,42/156,21.16%,HNF4G;ESRRG;KAT2B;PPARG;MED17;RORB;RORA;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;HDAC3;CAVIN1;TAF3;TBL1X;NPPA;NR1D2;NR1H3;NR4A2;RARB;TAF1A;CCNH;TAF5;THRB;TAF2;NOTCH2;POLR1H;RORC;MNAT1;GTF2B;MAZ;HDAC9;NR3C1;CCN2;POLR2H;NR6A1;HDAC1;TAF4;TFB1M;NOTCH3;MAPK3
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5426303615058827,1.0189204054868866,0.4339622641509434,0.8998997465694689,1.0,1/17,0.48%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.6412170831654469,-1.018913556406364,0.5111111111111111,1.0,1.0,3/6,25.81%,HFE;TNFRSF14;TARM1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.5461594506818948,-1.0187263464154361,0.4318181818181818,1.0,1.0,3/11,12.00%,CD24;NPHS1;PODXL
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.4556380845021564,-1.018647034226262,0.4117647058823529,1.0,1.0,8/53,10.10%,KCNMB2;KCNE2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.49176892514569454,1.0185820026050483,0.41509433962264153,0.9005615718840861,1.0,5/22,18.09%,MED17;ESR1;PAXIP1;TP53;MED30
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.580551344833891,1.0185412112263812,0.47368421052631576,0.9003588457515451,1.0,2/9,7.41%,SMAD6;ABCA1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.684500253083298,-1.018439532466841,0.5116279069767442,1.0,1.0,2/5,26.76%,ATP6V0A2;ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.6412244851448934,1.0182667329564843,0.5370370370370371,0.9008411875453505,1.0,6/7,35.40%,DDR2;CLASP2;MELTF;CLASP1;CARMIL2;PDPN
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.49316000140967065,1.0182149790600823,0.4603174603174603,0.9006777547335716,1.0,2/18,9.65%,HS3ST5;NECTIN2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.4061333871610757,1.018156645456362,0.3953488372093023,0.9005580307651225,1.0,20/102,12.15%,LGR5;SLC35F1;LRRC4C;LRP4;CADM2;PCLO;VSX2;SAG;NEFH;ZDHHC22;UNC5D;MEGF10;TMEM200C;PAX6;STOX2;ANK2;PAK5;GRIK3;NOL4;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5454063638928193,1.01806704402994,0.4772727272727273,0.9005255510044264,1.0,8/12,28.62%,FER;CD55;ENPP3;RPS19;LGALS3;APPL1;RC3H1;CD47
prerank,CellMarker_Augmented_2021__Hepatocyte:Liver,-0.6057813286993996,-1.017950989209942,0.48,1.0,1.0,1/10,0.33%,ALB
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5982747309299365,-1.0178993210678688,0.5434782608695652,1.0,1.0,1/12,0.65%,KCNMB2
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.4320029398939692,1.0177803604366715,0.391304347826087,0.8995178712538027,1.0,18/94,12.14%,LAMA4;PLOD2;EDIL3;LRP4;FGF2;GNG12;TENM3;BGN;PPFIBP1;WWTR1;CNN3;ADGRL2;LIFR;PTPN14;MAGI1;LOXL2;AMOTL1;BCAR1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6285388129452194,1.017723894851553,0.5178571428571429,0.8994032253175274,1.0,2/9,1.81%,PNP;AMPD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.5842977134687226,1.0177166223130258,0.5208333333333334,0.8991148165157699,1.0,2/9,2.47%,LGALS9;IL4
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.623033676763613,1.0176140389441657,0.5,0.8991220359596565,1.0,4/8,16.97%,IL4;HMGB1;TMEM98;RORC
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.468047591426551,1.0174757530713685,0.42592592592592593,0.8992117684366077,1.0,9/33,17.78%,FGFR1;STAT5A;FGF17;PIK3CA;CNTRL;SOS1;FGF5;GAB2;ZMYM2
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.618386087461319,-1.0172558268795706,0.5111111111111111,1.0,1.0,2/8,10.89%,MFAP5;KDM2B
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.7010581519191493,-1.0171474342674156,0.5510204081632653,1.0,1.0,1/6,3.27%,ASS1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.365432803450498,1.017081138031201,0.4528301886792453,0.8999049155195517,1.0,84/362,21.16%,STK26;MAP3K11;EPHA7;SYK;PRKG1;TGFBR1;FGFR1;CDK11A;CDK18;BMP2;DAPK2;TNIK;ACVR2A;MAPKAPK2;ERG;FAM20A;DYRK2;PPP4R1;RPS6KA4;FER;MAP3K9;MEX3B;IP6K3;CDK14;LATS1;PIK3CA;FRK;MAP3K21;FASTK;MAP4K2;NIM1K;PAK5;BMPR1A;VRK2;CHEK2;MAPK8;IRAK1;CDK12;STRADA;ACVR1B;CREB1;DYRK1A;IKBKE;MAP3K1;NEK7;HIPK1;POMK;SGK1;PRKAA1;PIK3CD;MAPK10;DYRK3;LIMK2;PKN2;PXK;RPS6KA5;DGKZ;CDKL5;IRAK3;RET;CDK4;MAST1;STK38L;ZAP70;ADAM10;PRKACB;AKT3;ABL1;FAM20B;WNK1;BMPR2;LYN;PIM2;LIMD1;DGKD;CDK16;PDK1;IKBKB;HIPK3;PASK;STK36;CDK8;CILK1;MAPK3
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,0.45494138290624747,1.0170145421449497,0.4444444444444444,0.899807693944706,1.0,10/58,6.24%,CCL3L3;ITGAX;PIK3R6;SASH3;SAMSN1;IL2RA;PIK3R5;IRF8;IL10RA;LAIR1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.4135718540946118,1.0169255035134892,0.39215686274509803,0.8997018621678164,1.0,20/83,21.36%,SEM1;SEC22B;TLR2;ITGAV;HMGB1;PSMD13;LNPEP;HLA-E;VAMP3;PSME4;SEC61A1;PSMA1;SEC61A2;CTSV;SEC14L2;HLA-F;IKBKB;TLR1;PSMD4;HLA-B
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5986174142208148,1.0168897631124443,0.4528301886792453,0.8995050246519813,1.0,2/11,2.02%,SIRT1;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5806257713539298,1.0168524940755728,0.5,0.8993169937254547,1.0,3/13,15.78%,RNF185;RNFT1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6508267949401981,-1.0167521812196836,0.46808510638297873,1.0,1.0,3/6,21.11%,FOXO4;FGFR2;MYOCD
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.43146512033674994,1.0167362431086462,0.3541666666666667,0.8993761353726473,1.0,16/71,15.08%,TGFBR1;GDF6;ZEB2;BMP2;ACVR2A;RBPJ;ELAPOR2;SMAD2;INHBC;BMPR1A;SMAD4;GDF9;ACVR1B;FBXL15;CRB2;KIAA0319
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.41740783241358637,1.0165564099158344,0.3409090909090909,0.899569547029492,1.0,22/105,15.37%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;BGN;CXCL12;POSTN;PDGFRA;FAM114A1;PLSCR4;MYH11;MEDAG;TPM2;SYNPO2;HTRA1;INTS6;ABCA8;TMEM98;FZD4;OLFML3;FRZB
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.4819340580354022,1.0164131389846767,0.4576271186440678,0.8996285612414274,1.0,5/31,14.65%,LDLR;NPC2;NR1H3;SOAT2;SOAT1
prerank,CellMarker_Augmented_2021__Stem cell:Blood Vessel,0.6211367623928474,1.0164039915064373,0.48,0.8993454944873994,1.0,2/8,18.93%,CD34;KIT
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4170536901814892,1.016342159525192,0.3584905660377358,0.8992141070036519,1.0,13/75,19.45%,RUNX1;LMO1;ZFP36L2;LMO2;PDGFRA;PSMD13;BMPR1A;MYB;PSME4;PSMA1;NELFB;ABL1;JAG1
prerank,Reactome_2022__Arachidonate Production From DAG R-HSA-426048,-0.6403605583785306,-1.0162769127526858,0.5370370370370371,1.0,1.0,2/5,33.31%,DAGLA;DAGLB
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5878662882884576,-1.0161709029459682,0.46808510638297873,1.0,1.0,1/11,1.47%,DOCK8
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5451988969232823,1.016123090619974,0.4,0.8994808617990112,1.0,3/21,3.50%,CDKN2C;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.6421521561586755,1.016013953078744,0.5178571428571429,0.899505224091945,1.0,3/5,27.95%,FOXO1;LMNA;TRPC3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.478554892560767,1.0159147163828957,0.49056603773584906,0.8994560670348485,1.0,6/24,24.45%,RALA;MCU;INF2;MFF;MARCHF5;MIEF2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.5683098828442212,1.0158393615117447,0.4745762711864407,0.8993637216765419,1.0,6/18,24.86%,SMYD2;CHEK2;TP53;JMY;MDM4;EP300
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4472255141079644,1.0157132119732197,0.3469387755102041,0.8994313062710477,1.0,3/39,3.40%,PADI2;NDRG2;GNB4
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,0.5760052871009158,1.0155627693010976,0.44680851063829785,0.8995377176959886,1.0,6/13,21.72%,CYP27A1;CYP7B1;NCOA2;AKR1C1;AKR1C3;HSD3B7
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.47442195031087975,-1.0155362716035874,0.4,1.0,1.0,10/44,17.44%,FXYD6-FXYD2;CAMK2A;ATP4A;ATP13A5;ATP1B1;ATP9B;ATP8B4;CALM1;FXYD7;CUTC
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5328906888455768,1.0155358393493752,0.40384615384615385,0.8993288597663285,1.0,7/27,22.17%,AGR2;HIP1;HAP1;PDE6H;PLAUR;DGKD;ARAP1
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.41995065853443625,1.015503766752006,0.39622641509433965,0.8991115123283707,1.0,11/97,14.44%,SYK;CD22;SEM1;BLNK;RELA;PLCG2;PSMD13;PPP3CA;SOS1;PSME4;NFATC3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5995339755510334,-1.0154171789896522,0.42592592592592593,1.0,1.0,4/7,26.06%,CAV1;CALM1;TRDN;CALM3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.570313115115946,-1.015414287695206,0.4782608695652174,1.0,1.0,1/9,5.37%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.5880606284924498,-1.0154030475169744,0.46153846153846156,1.0,1.0,3/6,17.53%,NODAL;ARHGDIB;ACVR1C
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5001799549466681,-1.0153829008461541,0.4634146341463415,1.0,1.0,6/28,10.96%,TTC12;DNAH17;DNAAF1;DRC1;CFAP73;CCDC40
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.3825816242433717,1.0153772406033528,0.43103448275862066,0.8991402574879472,1.0,5/155,4.07%,SGO1;ESPL1;NDC80;SEM1;NDE1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.4669411865421318,1.0153216065395405,0.4090909090909091,0.8990050765653882,1.0,17/75,14.58%,PCDH15;LHFPL3;CDC14A;ROR1;EPS8L2;WHRN;ALDH7A1;ADGRV1;CCDC50;ATP6V0A4;TBL1X;TPRN;SLC26A4;COL11A1;GRM7;LRP2;PAX3
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.5086123487987287,1.0151481541507283,0.46153846153846156,0.8991588821446459,1.0,2/31,5.78%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5135850936905205,1.0151370949489218,0.42857142857142855,0.8989160279102133,1.0,4/27,7.89%,SLC17A6;NLGN1;PCLO;SNCA
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.4375575605277369,1.0149609516117193,0.37777777777777777,0.8991214655981982,1.0,9/64,13.68%,SHMT2;ENPP1;PRSS3;TCN2;MTHFD2L;AOX1;MTHFD2;SLC19A1;SLC52A1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.46748400049987243,1.0149444299768986,0.41818181818181815,0.8988357158492657,1.0,7/45,14.42%,TGFBR1;RAPGEF3;SYNPO2;PPM1E;PXN;CARMIL1;SORBS3
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.43467234569206387,1.0148512027437004,0.43137254901960786,0.898791295017988,1.0,20/81,21.16%,PELI2;ST18;RELA;PELI1;RPS6KA4;PELI3;TAB2;PSMD13;IRAK1;PSME4;PLCB1;TAB3;PSMA1;MAP3K8;RPS6KA5;IRAK3;RIPK2;IKBKB;PSMD4;MAPK3
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,-0.5945447695197252,-1.014723336163645,0.5434782608695652,1.0,1.0,2/15,4.61%,RFX6;PDHX
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.6394852066759801,1.014605394408831,0.4838709677419355,0.8991127859850111,1.0,3/10,12.47%,TBC1D8B;MYO1E;CD34
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.4293608202699963,1.0145827458499714,0.4,0.8988531499844995,1.0,15/63,19.44%,BOK;DEPP1;DAPK2;PIP4K2A;ABL2;KEAP1;RRAGC;HSPB1;MTMR3;GPR137B;FBXL2;VPS29;RMC1;RRAGD;ABL1
prerank,Reactome_2022__M Phase R-HSA-68886,0.36979395599176956,1.01442262317678,0.36538461538461536,0.899079766303784,1.0,34/331,14.99%,SGO1;CTDNEP1;ESPL1;TUBA1C;NDC80;LPIN3;SEM1;FBXO5;NDE1;H2BC21;CEP70;PCM1;PPP1CC;CEP152;CHMP6;ANAPC16;CENPO;PSMD13;DCTN3;VRK2;CEP135;DYNC1I2;CNTRL;H2AC6;XPO1;H2AZ2;PSME4;NEDD1;RAB33B;CCP110;LMNB1;NEK7;CENPP;H2AX
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.4211756296983845,1.0142565867481863,0.4339622641509434,0.8992417267604609,1.0,18/83,20.28%,EPHA7;EFNA5;EFNA2;MYL12A;EPHA5;EPHA3;EPHA8;MYH11;EFNB2;NCK2;LIMK2;PKN2;WASL;VAV2;EFNA1;ADAM10;LYN;EPHB4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.45690447334116574,1.013979786745898,0.40816326530612246,0.8996958825793807,1.0,17/55,19.97%,ADIPOR2;ACADS;ECI1;PECR;ACADM;ACAA2;ABCD3;ABCD2;BDH2;ECHDC1;HSD17B10;AUH;CYP4V2;PEX2;ABCD4;ACOX1;ECI2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.4760008479775726,1.0139531117918734,0.5087719298245614,0.8994621847608238,1.0,8/42,18.93%,ZBTB1;PRIMPOL;POLE2;REV3L;REV1;PCLAF;FAAP20;POLK
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6455707549729471,1.0139387640076518,0.49019607843137253,0.8992243505603968,1.0,4/6,23.85%,IL4;PRLR;PIBF1;JAK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6510301314014458,1.0139191760743362,0.45614035087719296,0.8989609130986872,1.0,5/6,33.79%,BAD;AKT2;STOML2;MTLN;VCP
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.49680059103672397,1.0138863686364383,0.4230769230769231,0.898740582678996,1.0,4/30,7.21%,F2;HIF1A;TICAM1;NLRP7
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.47196175130393586,-1.013838600730397,0.48936170212765956,1.0,1.0,11/75,7.80%,LRP10;ABCA4;GUCA1B;AGRN;GPC2;PDE6B;GPC1;CNGB1;GPC3;PPEF1;NMT1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.41591726133784795,1.0138288155012385,0.375,0.8985976456476723,1.0,22/82,20.47%,MCOLN3;TRPM8;SLC35G1;TRPV2;TRPC4;MCUB;SLC8A1;ITGAV;SMDT1;SLC24A2;MCU;TRPC5;GRIN2D;TRPM2;ANO6;TRPM7;TRPV3;RYR3;MICU1;TRPM3;ATP2C1;TRPC1
prerank,Reactome_2022__FGFR2b Ligand Binding And Activation R-HSA-190377,0.6214580283529498,1.0137691137091795,0.5294117647058824,0.8984376465720622,1.0,1/7,0.53%,FGF10
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.5924610713034707,-1.013554083174612,0.5306122448979592,1.0,1.0,3/11,17.00%,CDC37;IFNGR2;STAT1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.40020486825579377,1.0135190856804481,0.3695652173913043,0.8987194592088403,1.0,24/115,16.07%,CWH43;SOCS2;FGF2;PIK3R6;ITPKB;PIK3R5;PIP4K2A;PIK3C2B;PLCG2;PIGQ;SOCS6;SMG1;IP6K3;INPP4B;PIK3CA;EFR3A;PIGF;PTEN;MTMR9;MTMR3;PI4K2B;PITPNM1;PIGP;PIK3CD
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.49111878112813834,1.0132275659891454,0.4444444444444444,0.8991254007694315,1.0,9/21,23.85%,CSF2RA;IL2RA;PIK3CA;SOS1;GAB2;IL2RB;PIK3R3;GRB2;JAK2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.4163463962708305,-1.0131270482035246,0.4166666666666667,1.0,1.0,21/111,9.27%,P2RY10;TBC1D10C;CD24;SELL;SP140;IRF4;TRAF3IP3;CD53;BST1;CYTH4;CD86;LTB;JCHAIN;CD5;TAGAP;CD72;POU2AF1;TMC8;LY86;IFIT3;PAX5
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6472389070361552,1.0131223777291825,0.5370370370370371,0.8990425237485309,1.0,5/8,31.84%,SLC39A8;SLC39A14;ABCB7;SLC25A28;SLC11A2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5772017484657379,1.0130844373065455,0.5102040816326531,0.8989125790231965,1.0,2/16,5.19%,SNAI1;CXCL12
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5059067514969382,1.0129190029299462,0.38095238095238093,0.8991210439318909,1.0,14/28,34.15%,DCP1B;EXOSC4;CNOT8;EXOSC1;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;LSM3;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4643278667668071,1.0125453876705834,0.38461538461538464,0.8999287203475074,1.0,10/45,11.83%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;MEGF9;VAMP3;PXN;NTNG2
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5951071769476437,1.0125161894837367,0.45,0.8997001753561487,1.0,2/10,6.35%,PCDH15;NRXN1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryo,0.6543521973700297,1.0123359803930356,0.4406779661016949,0.8999637770705172,1.0,2/5,13.75%,CD34;ANPEP
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.3658003741785078,-1.0123220347897735,0.34782608695652173,1.0,1.0,38/362,11.03%,P2RY10;DUSP4;GOLGA8B;IL10RB;F5;SIRPG;PRDM1;IRF4;ICAM3;ATP6V1C2;CTNNA1;ZC3H12D;DDX24;CCDC141;PDE4A;TSPYL2;VAV3;GOLGA8A;TPP1;ZBTB32;IRF5;ASB2;CCNG2;RPS27L;OAS3;TNFRSF4;OAS1;LRPAP1;CEACAM1;VDR;ARPP19;GOT2;GBP2;MCCC2;HDAC7;ICA1;SERPINE2;BEX3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4867410771654199,-1.0121178310000376,0.43478260869565216,1.0,1.0,6/24,19.06%,KIF2B;STMN1;STMN3;TRPV4;KATNB1;KIF18B
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6757251238064494,-1.012057362444639,0.52,1.0,1.0,1/6,2.14%,TNXB
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4122196161059064,1.01174303732079,0.41509433962264153,0.9013305976949604,1.0,34/100,20.92%,LSAMP;SLC35F1;ROBO2;PCDH17;ZDHHC22;UNC5D;NRXN1;RAB3C;TMEM200C;NOVA1;PTPRD;ANK2;MAGI2;GUCY1A2;ADGRB3;CTNNA2;MAGEL2;CPT1C;ATP1A2;CNTN1;GPM6B;RUNX1T1;FAT3;CNTN2;GJC1;GRID2;FMN2;CSRNP3;PLP1;RBFOX1;TRPM3;ATP1B2;ADGRL3;CADPS
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5270947163615057,1.0116446471520002,0.4166666666666667,0.9012856469978793,1.0,9/18,32.07%,SYNE4;RAP2A;FERMT1;CYTH1;PARD3;CYTH3;CLASP1;MYO9A;OPHN1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.4032008962205078,1.0115658768404852,0.4318181818181818,0.901197988434047,1.0,23/121,20.84%,MAP3K11;IRS1;NDUFC2-KCTD14;PPARG;ADIPOR2;RELA;PRKAB2;LEPR;PIK3CA;NR1H3;MAPK8;MLXIPL;COX6A1;PRKAA1;PIK3CD;MAPK10;NDUFB11;IRS2;CASP3;AKT3;PIK3R3;IKBKB;DDIT3
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.549680555575239,1.011495440558568,0.4375,0.9011659303236735,1.0,3/14,17.93%,EXOSC4;TENT4B;ERI1
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.409862197148408,1.0109715518656957,0.40476190476190477,0.9023511114640063,1.0,29/86,21.23%,SEMA5A;CAPN13;SOCS2;MRAP2;WNT4;ROBO2;CYP2U1;CASR;SCD5;ALCAM;GPSM1;MTSS1;LRRTM3;CADM1;GPM6A;GREM1;FAM222A;SGCB;ZNF776;CNTN4;ELOVL4;VAT1L;CTSV;RASA4B;LGMN;IAPP;GCC1;TDRP;RNF130
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.5006407502143123,1.0109327921154212,0.4444444444444444,0.9021265573140662,1.0,9/40,16.95%,KAT2B;SF3B1;H2BC21;MYO1E;H2AC6;H2AZ2;TAF1A;H2AX;POLR1H
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.6265085306385715,1.0107716341793602,0.5964912280701754,0.902252135027292,1.0,1/7,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5287074391522137,-1.0106445943804236,0.47058823529411764,1.0,1.0,4/27,6.93%,SCN5A;KCNE2;KCNN2;KCNE1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.5736191501961543,1.0106381448987714,0.5333333333333333,0.9023392283072663,1.0,2/9,7.72%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.4829513196046643,1.010471546636364,0.4339622641509434,0.9024177323261076,1.0,9/31,20.22%,NEDD4;TNIK;PTPRD;ADGRB3;HECW2;CAPRIN1;CDKL5;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5064999129536394,-1.0104595022488132,0.5,1.0,1.0,12/21,25.95%,HSD3B2;HSD3B1;CAV1;ABCB4;TGFB1;TGFBR3;SLIT3;UBE3A;CATSPER4;YAP1;THBS1;TGFB2
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.5632761820233039,1.0101677996138363,0.5,0.9029524006807735,1.0,1/12,5.83%,CACNB4
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.4880476976635275,1.0101455019604952,0.375,0.9027152360679994,1.0,4/34,2.19%,SELPLG;CFH;C3;FCAR
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4200988053068177,-1.0098603284730576,0.42857142857142855,1.0,1.0,13/80,16.41%,KIF2B;ARF3;KDELR1;COPG2;KIF15;KIF26A;RAB6C;COPG1;KIF22;ERGIC1;ATP9B;ARFGAP3;KIF4A
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4021442047121134,-1.0098277986037738,0.4146341463414634,1.0,1.0,30/135,15.24%,EHF;CLDN4;F5;CD24;TMEM184A;FAM3D;CLDN1;C6ORF132;INCENP;MYO5B;LAMB3;PLEKHS1;SLC46A2;CDH3;CEACAM1;KIF15;SERPINB5;VSIG2;APOA1;MISP;KIF20B;MAL2;ALOX15;GPX2;EMILIN2;STAP2;BRCA1;SDR16C5;EXO1;TMC4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5198660512731041,1.0097179019439981,0.41818181818181815,0.9034965705761864,1.0,8/21,28.53%,MAP2K6;TAB2;IRAK1;TAB3;RIPK2;TAB1;TRAF6;CYLD
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6083058650689664,1.0094266560400236,0.5777777777777777,0.903957922599637,1.0,4/11,20.80%,F2R;PLPP1;DGKD;PARD3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.43670562392515355,1.0094248328825859,0.3877551020408163,0.9036567893622872,1.0,21/119,16.51%,FGF10;SEMA5A;LGR5;ZEB2;NRARP;GPC5;PPM1A;RNF146;KANK1;PSMD13;SCEL;TBL1X;PSME4;PTK7;CSNK1G3;FRAT1;BAMBI;LGR6;GPRC5B;PSMA1;UBR5
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.4894493486408993,1.009376381575614,0.43636363636363634,0.9034537593628611,1.0,11/27,18.08%,MYC;TSHZ2;FHIT;IL7R;LRRN3;FAM117B;RPS5;NELL2;C1ORF162;TMEM204;CD55
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.625200173035781,-1.009352316910949,0.5,1.0,1.0,1/6,4.32%,CRYM
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.46953479984504404,-1.0092320206232834,0.36363636363636365,1.0,1.0,9/46,7.93%,P2RY10;SIRPG;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6276170523679597,1.0092172222339142,0.44642857142857145,0.9035912726664532,1.0,1/6,2.87%,PPARG
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5415891415281063,1.0092126554171306,0.4772727272727273,0.9032948217070953,1.0,5/23,11.92%,SIX4;SGCZ;PGM5;SGCG;MEF2C
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.4459643580020626,-1.0089880820059542,0.42857142857142855,1.0,1.0,8/81,5.09%,CLDN4;GPR39;SERINC2;CLDN1;ASS1;AGRN;RHBDF1;DSG2
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,0.5631805952507593,1.0088229379069573,0.48,0.9040020915143915,1.0,8/13,27.64%,RELA;TICAM1;IKBKB;NFKBIB;DHX9;CHUK;NFKB1;NFKBIA
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.680842871030413,1.0087928719599142,0.5636363636363636,0.9037822158683106,1.0,1/7,2.93%,NEDD4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5247556964546518,1.0087620903330394,0.44,0.9035794858430894,1.0,6/23,13.40%,SNX18;DOCK1;GSN;ARHGAP25;MSR1;SPIRE2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.5824553393710027,1.008748080099074,0.4666666666666667,0.9032961822415992,1.0,3/12,20.35%,TICAM1;TRPM7;TICAM2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.5479951268191001,-1.008684891079824,0.375,1.0,1.0,4/16,9.92%,DRD4;DRD2;DBH;LRTOMT
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,0.41416925043985203,1.008614651777899,0.391304347826087,0.9033740199847736,1.0,13/84,10.22%,MXRA5;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;POSTN;PDGFRA;PCDH18;MEDAG;COL5A3
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,0.6153567443550985,1.0085414865419116,0.44,0.9032989836568532,1.0,3/10,13.31%,STARD4;FDX1;FDXR
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.44041680693089535,-1.008481788179062,0.4,1.0,1.0,12/69,7.93%,GAB3;DOCK8;TRAF3IP3;CD53;TESPA1;KCNA3;DOCK2;BTK;PLCB2;HCK;ARHGAP15;TAGAP
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,-0.6014945164154172,-1.0083789315187113,0.5102040816326531,1.0,1.0,1/9,3.86%,IL6R
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.6316505208203866,1.0081872618815404,0.4482758620689655,0.9040175540834556,1.0,3/8,29.02%,PRKRA;AGO3;DICER1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.5485365969491828,-1.0080001162225571,0.4318181818181818,1.0,1.0,7/15,23.78%,DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;ATP5MC3;ATP5PB;ATP5F1B
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.5457297823731989,1.0079473153843241,0.4444444444444444,0.9043877813850218,1.0,6/20,13.99%,MOB1A;WWTR1;LATS1;SAV1;AMOTL1;DVL2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.44628020776732313,1.0079417086090972,0.37254901960784315,0.904100441673983,1.0,11/51,15.46%,CHRM2;HRH3;HTR1F;OPRK1;INSL3;GRM8;GNAI3;GRM4;GRM7;NPY1R;GPR37
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4864044821429767,1.0079206849707472,0.42,0.903851449268635,1.0,4/30,4.73%,IGF1;IL4;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4182985865161375,-1.007917166077844,0.391304347826087,1.0,1.0,3/80,1.92%,TERT;DDX11;KDM4D
prerank,KEGG_2021_Human__PPAR signaling pathway,0.46387615509653646,1.007831421270613,0.46296296296296297,0.903839947188536,1.0,12/60,17.86%,PPARG;SCD;SCD5;CYP27A1;HMGCS1;ACADM;CPT1C;ACSBG1;NR1H3;ANGPTL4;ME3;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5882283467463449,-1.0077189783516585,0.4523809523809524,1.0,1.0,3/10,8.95%,KLRC1;HFE;CEACAM1
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.5096601387507881,1.00755009838913,0.3958333333333333,0.9042859931181645,1.0,13/22,29.16%,RELA;HMGB1;TANK;MAP3K1;IKBKB;NFKBIB;TRAF6;CHUK;TRIM4;NFKB1;NFKBIA;APP;IFIH1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.6540755800534453,-1.0073656037329404,0.48,1.0,1.0,1/11,2.86%,SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.6540755800534453,-1.0073656037329404,0.48,1.0,1.0,1/11,2.86%,SPTLC3
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.4070600321190194,1.0070331979955807,0.4222222222222222,0.9053839386025498,1.0,11/114,11.11%,MYC;CDC25A;CCNA2;SEM1;FBXO5;GMNN;MCM7;TK1;PSMD13;E2F4;POLE2
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.6751962195517134,-1.0069102733433648,0.543859649122807,1.0,1.0,1/5,8.99%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.6751962195517134,-1.0069102733433648,0.543859649122807,1.0,1.0,1/5,8.99%,KIF17
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.6188478073545678,1.0068198232106156,0.4444444444444444,0.9056259516113191,1.0,4/11,21.82%,BCAR1;RAP1A;APBB1IP;CRK
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,0.4253534166657955,1.006757242114721,0.4339622641509434,0.9054911348383705,1.0,8/65,5.74%,PNOC;LINGO3;CD22;MLC1;OLIG1;IRF8;IL10RA;SSTR3
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.6124106812136131,1.00647418144464,0.5531914893617021,0.9060291050746809,1.0,1/7,11.68%,HAS2
prerank,Reactome_2022__Activated NTRK2 Signals Thru RAS R-HSA-9026519,0.6635987033787744,1.0062954570542066,0.5409836065573771,0.9062029879337166,1.0,2/6,22.25%,SOS1;GRB2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.6442628522798317,1.0061264446052087,0.515625,0.9063344745612323,1.0,3/9,12.47%,TBC1D8B;MYO1E;CD34
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.5289957545144359,-1.0060816981200293,0.45454545454545453,1.0,1.0,3/18,13.00%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.38830019679706373,1.0060658236082136,0.4444444444444444,0.9062038275683595,1.0,36/225,12.97%,C3;EPHA7;PBX3;PHGDH;IL1RAPL2;MYRF;POU6F2;CDH2;CNTNAP2;VCAN;THOC6;ROBO2;AFF2;SOX6;ADGRL2;PAX6;CHD7;CNTN6;ATXN1;PDGFC;PCDH18;SNTG2;DSCAML1;NPAS1;ROGDI;GSN;HAP1;NHLH2;NHLH1;LIG4;EMX1;PLXNB2;PROX1;PTEN;NR4A2;SHROOM4
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,0.5422540229483266,1.0060215437693831,0.44642857142857145,0.9059929908447274,1.0,5/18,9.21%,HPSE2;SDC4;HPSE;GPC5;GPC4
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5484778759092631,1.005997471677705,0.48214285714285715,0.9057400583680808,1.0,4/15,11.00%,F2;H2BC21;FAM3A;MUC7
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6574437926736665,-1.005943257826877,0.5609756097560976,1.0,1.0,1/8,0.43%,DUOXA1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.6840782405011903,1.0058062636813394,0.5,0.9060361932518047,1.0,3/5,23.21%,PROX1;GRID2;CBLN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.5464893688875057,1.0057618153857322,0.45098039215686275,0.905884716777706,1.0,1/16,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6604533344437667,1.0056558986967374,0.391304347826087,0.9055609777380174,1.0,4/5,30.46%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6604533344437667,1.0056558986967374,0.391304347826087,0.9055609777380174,1.0,4/5,30.46%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.4648194354674585,-1.005446296529381,0.40816326530612246,1.0,1.0,7/54,2.67%,TBC1D10C;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;CD86
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.46243116177832433,1.0053601708891051,0.3958333333333333,0.9060423084407586,1.0,6/62,6.55%,PCDH15;EPS8L2;PCLO;WHRN;MYO1E;EPS8
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6500394899548961,-1.0052555072284135,0.52,1.0,1.0,3/8,11.67%,AGBL1;AGBL3;FOLH1B
prerank,Reactome_2022__RUNX3 Regulates Immune Response And Cell Migration R-HSA-8949275,0.6536386864767673,1.0052236026133858,0.4838709677419355,0.9059753371812392,1.0,5/5,34.65%,RORC;ITGAL;CBFB;ITGA4;CXXC1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.45881568093705377,1.0051620007468285,0.48214285714285715,0.9058578448458217,1.0,12/40,25.05%,LDLR;ITGAV;BANP;PTX3;IRAK3;FMN2;IAPP;EDN1;MDM4;CRYAB;EGFR;APOE
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.43149692574778237,1.0049865090362142,0.46938775510204084,0.9060310875530929,1.0,16/57,20.71%,TGFBR1;CDKN2AIP;LGI1;AGR2;EXOSC4;ZNF639;RPS6KA1;DERL2;PLCB1;SLC44A4;H3-3A;ADAM10;BRAT1;SLC25A33;NCBP1;ADNP2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.524477356572068,1.004838361496817,0.5166666666666667,0.9060947283470445,1.0,1/14,2.84%,KAT2B
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.45606450106960816,1.0048287857315938,0.4489795918367347,0.905813139493295,1.0,8/36,13.21%,LRP4;NLGN1;NRXN1;CEL;PTPRD;NLGN4X;PTEN;PICALM
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.5861134587426108,1.004608517239461,0.42857142857142855,0.9060072645636552,1.0,7/13,24.16%,ACVR2A;SMAD2;SMAD4;ACVR1B;MAPK3;FSTL3;FOXH1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3901948118167497,1.0046061699408988,0.4576271186440678,0.9057048589346287,1.0,30/215,12.81%,GATA4;CXXC4;IRS1;KCTD21;CCL5;TULP3;FGF2;NEDD4;ENPP1;BMP2;DCC;KANK2;PIP4K2A;NRARP;KLK14;MOSMO;SNCA;CRHBP;NLGN4X;KCTD6;KANK1;PTPRT;EZH2;PHACTR4;GPR108;DACT3;EGFL7;SPRY3;PTEN;NR4A2
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.5408229572111116,1.004586746178073,0.4,0.9054531197359622,1.0,1/14,0.10%,TNFSF14
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.5549072648342674,1.0045639380082196,0.43333333333333335,0.9052183644060662,1.0,3/12,3.79%,MYC;FGF2;BMP2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,-0.4390620478280429,-1.0045573583976168,0.4807692307692308,1.0,1.0,5/91,4.91%,EPN1;GPX3;PVALB;RNASE1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.4828771912137925,1.0045348634947913,0.4444444444444444,0.9049753604701588,1.0,3/36,2.91%,LGALS9;FZD5;PYHIN1
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,-0.44854135980822385,-1.0044969262286025,0.46,1.0,1.0,10/35,8.95%,CD24;CD86;ALOX5;VAV3;JCHAIN;TTC22;HCK;CCDC88C;POU2AF1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5002525981806727,1.0043958190288405,0.425531914893617,0.905093820018144,1.0,4/27,11.41%,ABHD17B;ABI3;PDLIM5;ABHD17C
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.49434158629986424,1.004194734617945,0.4067796610169492,0.9053885913831111,1.0,9/19,31.40%,CTNNB1;STAM2;FZR1;SH3GL1;GRB2;SH3GL2;HGS;EPS15;CBLL1
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.6103481166319962,1.0041849593624281,0.5636363636363636,0.9050995913926878,1.0,2/8,4.40%,WNT4;SIX4
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.44660217698680654,1.0041280352111908,0.42857142857142855,0.9049786631977196,1.0,11/49,18.96%,EPS8L2;ARHGAP5;EPS8;RHOU;PHACTR4;CNKSR1;ROPN1B;RHOG;RHOD;RHOB;GNA13
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6102869344168209,1.0041276778962829,0.5,0.9046774053204901,1.0,3/7,23.48%,MVD;IDI2;PDSS2
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.5334199847103938,1.0040229551478885,0.4897959183673469,0.9045776690532036,1.0,8/22,23.60%,CDC25A;CCNA2;XPO1;CCNH;MNAT1;CDC25C;CCNB2;PPP2R1B
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.41145728332664544,1.0039359630826052,0.3541666666666667,0.904494770321749,1.0,20/126,11.39%,GATA4;MITF;RBM20;SMYD1;PRKG1;PPP1R3A;FGF2;RRAD;PDE1A;ADIPOR2;PDLIM5;ASB5;MTTP;IP6K3;SGCG;SYPL2;NPPA;LMOD2;ATP1A2;SYNPO2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.4215211673080898,1.0038169551131118,0.35,0.9045083289293304,1.0,20/115,15.40%,TEX101;ASB17;LRRC46;GCNA;C2ORF78;GALNTL5;DKKL1;MEIG1;TEX15;DMC1;PRNT;UBE3D;POTEA;SPINK2;SPATA3;MARCHF11;MLF1;SPAG6;SLC25A31;MORN5
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4857804649681085,1.0037498481579084,0.49056603773584906,0.9043375182286798,1.0,8/29,16.58%,GATA4;RBPJ;BMPR1A;MEF2C;PROX1;CPE;MESP1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6224908606606704,1.003696968069864,0.4888888888888889,0.9042128958171246,1.0,1/7,16.51%,UBR5
prerank,Reactome_2022__Zinc Efflux And Compartmentalization By SLC30 Family R-HSA-435368,0.6527982223089073,1.0035593806521903,0.5306122448979592,0.904272594005825,1.0,4/7,24.60%,SLC30A6;SLC30A1;SLC30A2;SLC30A7
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.6449451957910493,1.0035273171707517,0.5344827586206896,0.9040518017995265,1.0,1/5,18.26%,HEXB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5859885362509887,1.0035012187170393,0.47540983606557374,0.9038018651058783,1.0,4/12,10.25%,ZBTB7B;LY9;IL15;IL23R
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.5815613391988351,-1.0034910792890375,0.47058823529411764,1.0,1.0,2/7,16.81%,SFRP1;TGFBR3
prerank,CellMarker_Augmented_2021__B cell:Lymph Node,-0.6581123755324907,-1.0031995369147766,0.5098039215686274,1.0,1.0,3/6,15.92%,POU2AF1;PAX5;CD27
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5144561817859129,1.0031592348049532,0.4375,0.9043050439387331,1.0,13/23,23.57%,IL4;PPARG;IRF8;LY6D;FLT3;TRPM2;VEGFA;LYN;AXL;GAS6;PDE1B;BLK;BMP4
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5772509375235918,1.0029594851088206,0.46511627906976744,0.9046029872640116,1.0,3/10,7.89%,THRSP;CCN6;SNCA
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.583268042767098,1.0028291681614014,0.4782608695652174,0.9046540965099332,1.0,2/12,1.82%,FLT1;CCL5
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.5045365893251985,-1.0027395423748902,0.45652173913043476,1.0,1.0,2/15,5.22%,DNAH17;DNAAF1
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,0.41996797297826277,1.0026948175650636,0.3958333333333333,0.90472606632672,1.0,11/74,10.01%,MXRA5;SEMA5A;ANTXR2;IDO1;SNRPN;POSTN;TCN2;DPP4;CASR;PABPC1P4;MEDAG
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.5085412096682905,1.0026586947412384,0.43859649122807015,0.9045473379856385,1.0,11/23,28.53%,TAB2;TANK;TAB3;BIRC3;IKBKB;TAB1;OTUD7B;USP2;CHUK;TRADD;CYLD
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.4951854798791725,1.002590050060445,0.4897959183673469,0.9043896087025101,1.0,4/24,11.83%,GNB4;GNG12;ADRA2C;GNG4
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.46132671386451435,1.002494213931165,0.4117647058823529,0.9043614008502989,1.0,12/51,11.92%,LLGL1;MCTP2;SEPTIN4;RALA;SYT1;RAB3C;RIMS2;HAP1;SNCAIP;DNAJC1;VAMP3;MEF2C
prerank,Reactome_2022__Phosphorylation Of Emi1 R-HSA-176417,0.6747038735279959,1.0022711560585165,0.4909090909090909,0.9046169999976618,1.0,1/5,3.67%,FBXO5
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.35391488752992073,1.0020341959055719,0.391304347826087,0.9049141496919123,1.0,64/355,15.92%,GABRR1;ERBB4;GABRR2;GRIN3A;KCNC2;KCNK2;IL1RAPL2;SLC1A3;NRG1;GNB4;GNG12;KCNJ3;NLGN1;LLGL1;GLRA1;KCNH7;GLUL;GRIP2;PDLIM5;GABRG3;SYT1;CACNB4;KCNH4;KCNQ5;PRKAB2;KCNH8;PPFIBP1;KCNH5;NRXN1;UNC13B;PTPRD;ACHE;GNAI3;NLGN4X;LIN7A;GRM5;EPB41;LRRTM3;RPS6KA2;GRIN3B;HCN1;GRIK3;KCND2;GABRA5;PPM1E;KCNB2;GNG4;GLRB;HSPA8;GABRB2;LRRC7;KCNG2;GRIN2D;APBA1;CREB1;NBEA;RPS6KA1;PPFIA3;PLCB1;KCNF1;BCHE;PRKAA1;KCNAB3;GRM1
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.6592558630668413,1.0020125052543605,0.5245901639344263,0.9046605841031613,1.0,3/5,23.57%,BMPR1A;BMPR2;BMP4
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.6362204754870522,1.0019777308821889,0.5263157894736842,0.9044822321604489,1.0,1/5,6.50%,MEGF10
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.34960145334449716,1.0019639013792654,0.4230769230769231,0.904237312778311,1.0,152/735,18.14%,CRX;GATA4;MITF;IGF1;RUNX1;HGF;ZNF300;HNF4G;MYC;SIRT1;IL26;FZD5;IL4;HIF1A;MYCN;FGF2;KAT2B;PPARG;LPIN3;TFEB;MED17;ZEB2;LMO1;RORB;BMP2;NRIP1;RORA;ST18;ZGLP1;IRF8;SP1;DUX4;HCLS1;ACVR2A;DLGAP5;ZNF462;RBPJ;RELA;NR5A2;LMO2;VEZF1;TLR2;TET2;ESR1;ERG;NFIA;PLAC8;WWTR1;POU3F2;HDAC3;PAX6;RFXAP;RPS6KA4;HDAC2;CD40;SSBP2;HMGB1;ELF4;ELK1;FOXO3;TFEC;PTOV1;SMAD1;KLF6;PAXIP1;STING1;AUTS2;CTCFL;SMARCD3;SMAD2;NCOA2;NHLH2;NHLH1;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;BMPR1A;TBL1X;NR1D2;SP3;SMAD4;PLAGL1;DPF1;NR1H3;MEF2C;NCK2;PROX1;CDC5L;ZNF175;CTBP2;CDK12;PPP3CA;MYB;GREM1;NR4A2;DPF3;KLF7;MLXIPL;DVL2;WWOX;RARB;CREB1;ZNF639;NR2F2;RPS6KA1;LRP6;SMARCD2;ZNF263;RFX5;NFATC3;PAX3;KLF15;EPC1;KAT6A;POU2F1;PCGF5;PLSCR1;GABPB1;NCOA3;ATF6;THRB;HJV;HCFC1;SMAD5;PHIP;NFE2L2;HSF2;POGZ;MESP1;EAF2;MYDGF;HEY2;CTNNB1;SMARCA2;FADD;RPS6KA5;IL33;SIRT7;THAP3;RUVBL2;NUFIP1;VEGFA;WNT2;GABPA;WASL;TP53;CSRNP3;CD81;MED30;CITED2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In BCR Signaling R-HSA-8939245,0.6497096817717372,1.001880212818944,0.5272727272727272,0.9041425478690186,1.0,2/6,11.74%,RUNX1;ELOF1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5321803291257334,1.0018733886133182,0.4117647058823529,0.9038604168750687,1.0,6/12,31.30%,PATL2;LIMD1;LSM14A;PATL1;RC3H1;LSM3
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.3697049933503526,1.0018586820585422,0.375,0.9036034545306906,1.0,40/225,15.66%,GABRR1;ERBB4;GABRR2;GRIN3A;SLC1A3;NRG1;GNB4;GNG12;KCNJ3;LLGL1;GLRA1;GLUL;GRIP2;GABRG3;SYT1;CACNB4;PRKAB2;UNC13B;ACHE;GNAI3;LIN7A;RPS6KA2;GRIN3B;GRIK3;GABRA5;PPM1E;GNG4;GLRB;HSPA8;GABRB2;LRRC7;GRIN2D;APBA1;CREB1;NBEA;RPS6KA1;PPFIA3;PLCB1;BCHE;PRKAA1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.43088439105410803,-1.0013406302882717,0.34375,1.0,1.0,13/64,12.91%,EHF;CLDN4;FAM3D;CYP24A1;ST6GALNAC2;LAMB3;F11R;ABCC3;VDR;SERPINB5;IL18;CXCL16;CRH
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.41423190324176185,1.0013380124339166,0.3448275862068966,0.9046453093654726,1.0,20/128,9.95%,GATA4;C3;BOK;PADI2;MAFB;SELENBP1;BGN;MEIG1;CXCL12;ARHGEF17;SDC4;EPS8;GAMT;FAM114A1;TF;PLSCR4;ABCG8;BCAM;NECTIN2;GSN
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5812559895796366,1.0012390685202295,0.42592592592592593,0.9045879835197155,1.0,4/9,8.14%,FERMT3;CCL5;DPP4;ADA
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.47683392183662404,1.0012344593466156,0.45098039215686275,0.904301918383284,1.0,11/51,12.78%,COL9A1;STAT5A;COL9A2;COL6A5;COL6A2;PDGFRA;PDGFC;PIK3CA;NCK2;BCAR1;SOS1
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.4983449026917434,1.0011865855438205,0.5,0.9041116808784234,1.0,8/21,17.90%,B3GAT2;FUT9;POMT2;FKRP;CRPPA;B3GALNT2;POMK;B4GALT3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4252401855437965,1.0010941054030171,0.40384615384615385,0.9040878424754031,1.0,22/68,25.01%,RAPGEF3;TMEFF2;DNAJB2;SACS;EPHA3;CRACD;CARMIL1;HSPA8;IRAK3;VEGFA;WASL;RIOK3;DNAJB1;MCTP1;IAPP;HSPA5;FAP;WASHC2C;HSPA1A;CRYAB;EP300;ABCA7
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.5091190843595894,1.00091285675685,0.4583333333333333,0.9042634823443678,1.0,5/27,13.56%,LAMA4;ITGA2;TNS3;SOS1;RAP1A
prerank,Reactome_2022__Crosslinking Of Collagen Fibrils R-HSA-2243919,-0.600810003261025,-1.0007187966876783,0.5185185185185185,1.0,1.0,2/10,4.35%,PXDN;LOXL4
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,0.4669102127523001,1.0006838786758445,0.48148148148148145,0.9046051704407655,1.0,12/37,15.42%,EFNA2;MAMDC4;PRSS3;MUC20;SLC15A1;MOGAT2;SLC35D2;ANPEP;MLXIPL;CNKSR1;SLC41A2;TMEM45B
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.540180028817732,-1.000616346344523,0.5,1.0,1.0,3/17,13.00%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.523782091335742,1.0005887224771008,0.4444444444444444,0.9046227203165227,1.0,6/23,13.27%,NLGN1;SYT1;CEL;SNCA;NLGN4X;STON2
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.5091180638784282,1.0005146108601666,0.5084745762711864,0.9045198690852195,1.0,5/23,23.14%,HNRNPH1;TIAL1;POLR2H;NCBP1;HNRNPF
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6460165617962819,1.0005061013113958,0.4925373134328358,0.9042510857171671,1.0,2/7,8.96%,ERBB4;LATS1
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.37215755183619664,1.000465683495475,0.4423076923076923,0.9040405601263876,1.0,7/211,4.07%,SGO1;ESPL1;TUBA1C;NDC80;SEM1;FBXO5;NDE1
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,0.4317916211210108,1.0004063145767432,0.45098039215686275,0.9039462965206101,1.0,19/86,12.53%,LAMA4;PRRX1;ADGRL4;MSRB3;ARHGAP31;SSC5D;CDH2;BGN;COL6A2;LTBP2;POSTN;PDGFRA;CNRIP1;CYBRD1;PCDH18;MEDAG;STK32B;CD34;HTRA1
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.42585524892776316,1.0001097304441446,0.3076923076923077,0.9045278768472094,1.0,16/86,20.64%,NXF1;CPSF4L;PPP1CC;PAPOLA;SMG1;NXT1;PABPC1L2A;PABPC5;PCF11;NXF5;PPP2R2B;FUS;CSTF3;MSI2;WDR33;NCBP1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4545981081970354,1.000078918513037,0.4528301886792453,0.904292600695883,1.0,13/45,20.06%,PLCH1;ITPKB;PLCG2;INPP1;IP6K3;INPP4B;NUDT4;PTEN;PLCB1;PLCD1;IMPA1;IP6K1;MINPP1
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.4520913513986981,1.0000291498822178,0.46153846153846156,0.9038680722504091,1.0,13/74,7.05%,MXRA5;SEMA5A;ITGB8;VWA2;CLIC6;HS3ST1;FBLIM1;EFS;PDLIM4;POSTN;PRSS3;TCN2;F3
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.4520913513986981,1.0000291498822178,0.46153846153846156,0.9038680722504091,1.0,13/74,7.05%,MXRA5;SEMA5A;ITGB8;VWA2;CLIC6;HS3ST1;FBLIM1;EFS;PDLIM4;POSTN;PRSS3;TCN2;F3
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.5257811239066429,0.999864733729451,0.4807692307692308,0.9040514305200816,1.0,3/15,10.05%,IGF1;WEE2;HYAL3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.5266361551099134,0.9998278112242593,0.5272727272727272,0.9038662890260504,1.0,8/18,31.61%,ANAPC16;FZR1;UBE2D1;UBE2E1;ANAPC15;CDC27;ANAPC7;RB1
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.6326207488943578,0.99980665753822,0.5357142857142857,0.903610927604979,1.0,2/5,11.92%,MTSS1;MEF2C
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6481027080355752,-0.9996954521949442,0.5490196078431373,1.0,1.0,3/6,16.14%,SPI1;AKNA;TRPV4
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.5085101729857644,0.9996561912687046,0.4583333333333333,0.9036866439411713,1.0,2/30,6.55%,PAWR;EPS8
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.49165347691967054,0.9996222041261075,0.46,0.9035183444324544,1.0,4/30,12.35%,LRP4;PCM1;PAX6;PTEN
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.47196725889143193,-0.9995379639375389,0.5,1.0,1.0,11/50,16.26%,SLX4;RNF8;ERCC1;FANCG;FANCC;RAD51AP1;RAD51AP2;FAN1;NUCKS1;RPA3;MUS81
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.532094720053465,0.999467997636857,0.47058823529411764,0.9036891157281476,1.0,7/21,9.93%,HS3ST5;HS3ST3B1;UGDH;HPSE;HS2ST1;HS3ST4;EXT1
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,0.6234233030318663,0.9993879524927153,0.48214285714285715,0.9035953073171442,1.0,4/7,26.72%,CD34;PTPRC;ITGAM;NT5E
prerank,KEGG_2021_Human__Human papillomavirus infection,0.37818294748813924,0.9990207690435692,0.38,0.9043360130673217,1.0,75/281,21.16%,LAMA4;ITGA10;TCIRG1;ATP6V0D2;COL9A1;ITGA8;ITGB8;FZD5;ITGA11;CCNA2;RFNG;ITGA2;COL9A2;WNT4;HES6;LLGL1;COL6A5;COL6A2;RBPJ;RELA;SCRIB;WNT9A;ITGAV;TICAM1;HDAC2;LAMB4;ATP6V0A4;MAGI1;PIK3CA;TNC;ITGA1;FOXO1;HLA-E;PXN;PTEN;SOS1;ATP6V0B;FZD1;CREB3L2;CCND3;DVL2;CREB1;FZD4;IKBKE;FZD6;DLG2;PPP2R2B;PIK3CD;NOTCH2;HEY2;CTNNB1;FADD;VEGFA;WNT2;CDK4;TP53;LAMA5;CASP3;COL9A3;PRKACB;OASL;IRF3;AKT3;JAG1;ITGA7;HLA-F;HDAC1;DLG3;PIK3R3;BAD;IKBKB;THBS2;PARD3;NOTCH3;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5573234714799344,-0.9988440332810599,0.45652173913043476,1.0,1.0,1/9,4.36%,PIAS3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5595426544875841,0.9988414429160749,0.5208333333333334,0.9045476445916915,1.0,5/14,24.14%,LIN28A;CPEB1;FMR1;CPEB2;DHX9
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5580446321606571,-0.9986657396486913,0.48936170212765956,1.0,1.0,4/13,16.94%,PRPF19;USP4;SRSF10;PRPF6
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.5158588097344383,-0.9986516137297097,0.5531914893617021,1.0,1.0,5/32,12.13%,ENTPD2;UPB1;XDH;NT5C;ENTPD5
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.6297350059291654,-0.9986268991254448,0.5434782608695652,1.0,1.0,3/8,14.33%,CDHR2;PODXL;USH1C
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.4725158004751644,0.9984704212268287,0.45161290322580644,0.905151321003436,1.0,5/31,7.89%,ACE2;NEDD4;KCNJ3;SCN10A;SNCA
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,0.4746188751319711,0.9982262750064568,0.42857142857142855,0.9055441303899412,1.0,9/43,11.01%,STAB1;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.618195581040025,-0.998198936597606,0.5,1.0,1.0,1/10,0.91%,FBXO43
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.521128494506236,-0.9981864506982892,0.42857142857142855,1.0,1.0,1/19,0.25%,KLRC1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,0.5877837399172008,0.9981819421899374,0.509090909090909,0.9053467296798503,1.0,4/11,26.18%,IRAK1;RIPK2;IKBKB;TRAF6
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.6142391361679337,0.9979655555727426,0.5660377358490566,0.9056814793189509,1.0,1/7,1.12%,HSD17B2
prerank,KEGG_2021_Human__Leishmaniasis,0.44115864231533786,0.997858532260618,0.48936170212765956,0.9057439021205641,1.0,6/54,9.30%,C3;IL4;RELA;TLR2;ELK1;TAB2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4983751368945202,0.9977100024860307,0.532258064516129,0.9057939196031005,1.0,2/27,4.49%,SIRT1;RORA
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,-0.45937754790194085,-0.9974854867919523,0.5,1.0,1.0,9/38,8.78%,CLEC4F;XCR1;CD86;MS4A4A;F13A1;HCK;HLA-DRB1;SLC46A2;LY86
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.41868493709691734,0.9974300088457241,0.4642857142857143,0.9062600395732164,1.0,11/56,8.69%,CCL3L3;FLT1;TCIRG1;ATP6V0D2;CCL5;TNFSF13B;ANGPT1;CXCL12;TLR2;IL15;ATP6V0A4
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.6966799064077365,-0.9973368611754172,0.5652173913043478,1.0,1.0,2/5,2.97%,TEK;MFAP5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.41139860309730825,0.997030825338975,0.40476190476190477,0.9070430027928315,1.0,21/124,11.45%,EPHA7;SIRT1;SLC35F1;ERBB4;POU6F2;EFNA2;SCGN;ZDHHC22;UNC5D;TMEM200C;POU3F2;ELAVL2;IGDCC3;SPSB4;B4GALNT4;GRM5;EZH2;MAGEL2;PAK5;NOL4;PPM1E
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4231230308534479,0.9969781105100308,0.5,0.9068578517240311,1.0,10/79,13.39%,CDKN2C;SLFN11;CDKN2A;FBXO5;ZFP36L2;KANK2;PSMD13;PTEN;CDK2AP2;PSME4
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.37586198793345366,0.9965889799002438,0.39285714285714285,0.9075824827100699,1.0,57/238,25.32%,MYC;TGFBR1;CDC25A;CCNA2;HIF1A;KAT2B;ESR1;STAMBPL1;USP12;INO80E;SMAD1;SENP8;ACTL6A;INO80D;KEAP1;SMAD2;PSMD13;NFRKB;SMAD4;PTEN;PSME4;CCP110;HCFC1;RCE1;USP45;USP31;BAP1;PSMA1;RNF128;STAM2;BIRC3;IL33;USP38;TP53;ARRB2;SENP6;JOSD2;GPS1;UBE2D1;PSMD4;ACTR5;TNIP3;OTULINL;BRCC3;USP9X;TAB1;BARD1;MDM4;OGT;POLB;EP300;OTUD4;OTUD7B;HGS;USP18;SMAD7;ASXL1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6156468739766908,0.9963926604064367,0.5272727272727272,0.907792294313966,1.0,2/8,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.711959994358384,0.9962616794691358,0.5128205128205128,0.9078292050350074,1.0,1/5,3.71%,HPD
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3782001289273357,0.9961873583033299,0.3958333333333333,0.9077016082770236,1.0,20/154,11.26%,IGF1;MYC;HIF1A;TFEB;LDLR;PCBP3;HMG20B;BMI1;PRDM14;AFF2;ZNF462;SLC8A1;NFKBIZ;NOVA1;CIAO3;TOB1;RO60;NFKBID;TRIM26;HNRNPD
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.4371208057318659,-0.9959822825121483,0.4074074074074074,1.0,1.0,7/62,2.39%,P2RY10;SIRPG;SELL;SP140;TRAF3IP3;CD53;CYTH4
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.4659887679312703,0.9959102340815866,0.47368421052631576,0.9081660418386382,1.0,10/46,17.81%,CCNA2;REXO2;PRMT1;E2F4;CNOT6L;PLAGL1;CNOT4;CNOT8;CNOT2;TP53
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.44333234035479707,-0.9958959590762293,0.46296296296296297,1.0,1.0,4/50,2.36%,H1-3;H1-4;TERF2IP;H1-2
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.3858619987971958,0.995550139711987,0.4444444444444444,0.9088602991287676,1.0,30/184,8.75%,GPR55;ADRA1A;DRD5;INSL5;CHRM2;C3;CCL5;PNOC;F2R;GNRH1;UTS2R;HRH3;HTR1F;OPRK1;NPY;INSL3;CXCL12;PENK;PTGFR;GPR17;RXFP2;SSTR3;NPFFR2;PLPPR1;ADRA2C;QRFPR;GNRH2;NTSR2;NPW;RGR
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5029763371895638,0.9953244867354749,0.43137254901960786,0.9091925942160045,1.0,7/30,14.09%,CTDNEP1;LDLR;ZBTB20;ELOVL5;NR1H3;MLXIPL;CREB1
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.44667599669243385,0.99522698628263,0.3793103448275862,0.9091961347272507,1.0,12/54,20.02%,KAT2B;SF3B1;H2BC21;MYO1E;HDAC2;H2AC6;H2AZ2;TAF1A;H2AX;POLR1H;POLR2H;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.609283323796067,0.9951731171313445,0.5208333333333334,0.9090149304883295,1.0,4/6,28.25%,TNFRSF21;LYN;BLK;RC3H1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.6606790010325161,0.9951095915557912,0.6078431372549019,0.908883092869079,1.0,3/5,25.78%,DOCK4;DOCK5;CHRM3
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4557034055376601,0.9949513237651467,0.4489795918367347,0.9090631474108318,1.0,3/49,1.94%,FGF10;MYC;SIRT1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.42536593634002556,-0.9948681150695834,0.5178571428571429,1.0,1.0,4/88,2.74%,EPN1;SYT12;NLRP3;M6PR
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5631133446763725,0.9948096831606866,0.5106382978723404,0.9091856654508915,1.0,1/13,3.27%,CYB561
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.592489301215172,0.9947921963739927,0.5555555555555556,0.9089308995871934,1.0,2/13,3.87%,NRG1;CDH2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6549464981480492,0.9946684221290542,0.5192307692307693,0.9089837028405833,1.0,4/5,28.92%,PXN;NCK2;MAPK8IP2;NCK1
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.6712224628992989,0.9944398142936812,0.5964912280701754,0.9094216254560195,1.0,2/5,28.01%,SLC44A4;SLC44A2
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.46614827338209136,-0.9943723708396712,0.4375,1.0,1.0,9/50,17.17%,NUPR1;KCNE2;RHBDF1;LAMP3;DDRGK1;DAB2IP;UFL1;PSME3;GLMN
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.4960843694325539,0.9943676633308808,0.4117647058823529,0.9093390653184976,1.0,3/20,2.04%,ADRA1A;ACE2;F2R
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.407458106737598,0.9941183578409373,0.39285714285714285,0.9096905988667998,1.0,17/73,21.36%,SEM1;SEC22B;TLR2;HMGB1;PSMD13;HLA-E;VAMP3;PSME4;SEC61A1;PSMA1;SEC61A2;SEC14L2;HLA-F;IKBKB;TLR1;PSMD4;HLA-B
prerank,Reactome_2022__Organic Cation/Anion/Zwitterion Transport R-HSA-549132,0.6330809181884123,0.9941123449448881,0.5555555555555556,0.9094156157883179,1.0,2/10,2.39%,RUNX1;SLC22A3
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.6519867462585829,0.9939659368974216,0.6101694915254238,0.9091566269898784,1.0,2/5,14.96%,RORB;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.6519867462585829,0.9939659368974216,0.6101694915254238,0.9091566269898784,1.0,2/5,14.96%,RORB;CRB2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.4289441338296814,0.9938805132808431,0.47368421052631576,0.9091397172222015,1.0,18/82,7.97%,MXRA5;LAMA4;CFH;ADGRL4;ITGA2;DOCK1;BGN;CRIM1;FBLIM1;POSTN;ERG;PPFIBP1;CCDC80;WWTR1;FAM114A1;ABI3BP;PLSCR4;DLC1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4774490493193386,0.9938278850938044,0.46153846153846156,0.9090083522804394,1.0,12/37,18.59%,F2R;FGF2;TRPV2;SLC8A1;PLCG2;SLC24A2;HTR2C;GRIN2D;TRPM2;RYR2;TRPV3;RYR3
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.507107226917856,-0.9937564381707819,0.46808510638297873,1.0,1.0,9/26,12.36%,TTC12;DNAJB13;DNAAF1;DRC1;RSPH9;CCDC40;CFAP74;RSPH1;CFAP46
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.4125371504491074,0.9937205490531686,0.42857142857142855,0.9090487160714086,1.0,12/84,14.62%,DERL3;SYVN1;UBE2J1;DNAJB2;RNF185;RNF139;AUP1;RNF5;POMT2;UBE4A;UBE2J2;DERL2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5079675322122444,0.9936763014348621,0.4888888888888889,0.9088439281183786,1.0,8/32,18.93%,TFEB;BORCS6;DEF8;RAB34;KLC2;PIK3CD;FAM98A;KIT
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.445439965171446,0.9934019219538069,0.46808510638297873,0.9091783744044114,1.0,8/66,6.66%,IGF1;PLCH1;IRS1;FGFR1;NYAP2;PIK3R5;PIK3C2B;PDGFRA
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4758082827784811,-0.9933075629610564,0.4117647058823529,1.0,1.0,2/42,1.06%,GUCY2C;ADSS1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.64743549595452,0.9932917285719998,0.5925925925925926,0.9089201263457247,1.0,3/6,14.65%,PPARG;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.64743549595452,0.9932917285719998,0.5925925925925926,0.9089201263457247,1.0,3/6,14.65%,PPARG;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.3839826880862994,0.9931929209495304,0.3877551020408163,0.9089196520034912,1.0,20/170,14.60%,CDC14A;FBXO5;NDE1;ZFP36L2;RIOK2;CEP70;KCNH5;PCM1;CEP152;ANAPC16;PSMD13;DCTN3;HECW2;CEP135;DYNC1I2;ANLN;CNTRL;PSME4;NEDD1;CCP110
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.570276559903823,0.9931188367226186,0.484375,0.9088457592884059,1.0,1/12,1.65%,RENBP
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,0.48544406868329487,0.9930589333948879,0.4583333333333333,0.908714829441263,1.0,9/49,6.24%,LGALS9;FERMT3;ITGAX;CSF3R;PIK3R6;SASH3;SAMSN1;CD244;LAIR1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5180583588500872,-0.9929325496732972,0.4444444444444444,1.0,1.0,4/31,1.75%,P2RY10;SIRPG;SPON2;ICAM3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4908825908897906,0.9928586172548954,0.5,0.908918230817705,1.0,11/34,27.74%,ACD;NEK7;HNRNPA2B1;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3957593895847664,0.9927925630623999,0.5185185185185185,0.9088444102330209,1.0,21/97,16.53%,NPC1L1;SLC10A3;LDLR;NPC2;ABCC2;ABCA6;ABCA1;MTTP;ABCG8;SLC10A5;NCOA2;ABCD3;ABCD2;SLC10A1;ABCC11;ABCA8;ABCG5;PITPNM1;SLCO1A2;ABCA9;AKR1C1
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.41531063411216523,0.9927700495074239,0.4528301886792453,0.9086158427574149,1.0,11/70,20.95%,CCNA2;SEM1;FBXO5;ANAPC16;PSMD13;PSME4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3765168755472381,0.9926208474679749,0.5106382978723404,0.9087742844705505,1.0,51/246,19.44%,MAP3K11;TOP2A;PAWR;SYK;BOK;SIRT1;PLEKHG2;FGD4;BMP2;DAPK2;FANK1;SEPTIN4;DKKL1;ARHGEF17;SCRIB;UNC13B;HTRA2;HMGB1;SNCA;RYBP;FOXO3;UBE2Z;LATS1;BIN1;RPS6KA2;FOXO1;TNFRSF10B;ARHGEF16;BNIP3L;MAPK8;KNG1;SOS1;PHLDA1;RBM5;ARHGEF6;PHLDA3;ATF6;ANO6;FRZB;CTNNB1;FADD;TP53;CSRNP3;VAV2;JMY;RHOB;CASP3;GNA13;TNFRSF10A;MCF2;ABL1
prerank,Reactome_2022__Reelin Signaling Pathway R-HSA-8866376,0.6986784105518842,0.9925652127166456,0.5087719298245614,0.9085988091400637,1.0,1/5,11.50%,DNAAF3
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.618374751544249,0.9925521369178006,0.5740740740740741,0.9083298464119803,1.0,1/7,3.24%,LDLR
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.6397931978595001,0.9924488095381659,0.5,0.9083295639835667,1.0,1/6,3.97%,NPC2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.47386597964992444,0.9924322389462359,0.4418604651162791,0.9080771295971384,1.0,9/36,18.37%,EFNA5;SKA3;EPHA3;BICD1;CDK2AP2;PHLDB2;PRKAA1;STMN4;PHLDB1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.5583158015404096,-0.9923717550248661,0.5681818181818182,1.0,1.0,3/16,9.92%,BFSP1;WNT7A;LRTOMT
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Triglyceride Lipolysis In Adipose R-HSA-9031528,0.669584034774014,0.9923569342403006,0.5769230769230769,0.9079915500528352,1.0,1/5,11.90%,NR1H3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5837543616382801,0.992346611161999,0.5576923076923077,0.9077353231293736,1.0,1/12,1.13%,IRS1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6182097973172023,-0.9921860244746066,0.576271186440678,1.0,1.0,1/8,2.09%,PLAAT4
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.39059781096660656,0.9920181955957319,0.4107142857142857,0.908312183943797,1.0,5/120,5.04%,SGO1;ESPL1;NDC80;NDE1;DLGAP5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6046583024290143,0.9918975838431213,0.53125,0.9083362780267836,1.0,7/9,31.01%,ZSWIM5;VEGFA;ZSWIM8;ZSWIM4;TUBB2B;YTHDF1;ZSWIM6
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.4948647752002498,0.9918854335170216,0.49122807017543857,0.9080639460107381,1.0,3/21,8.16%,CDC25A;CDKN2A;FOXO3
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.45794556758054733,0.9917188643355582,0.5111111111111111,0.9082382916336299,1.0,9/55,8.60%,ADAM28;CDKN2A;BLNK;STEAP4;MID2;TOR1B;HTRA2;SLC15A1;GAN
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.5082691755981872,0.9914339149711973,0.49019607843137253,0.908814247614904,1.0,5/36,14.29%,MAP3K11;KSR1;CNKSR2;RAP1A;CNKSR1
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,-0.4053589168746148,-0.9914295809689613,0.38,1.0,1.0,14/85,10.32%,ACTC1;MYH7;TEK;COL4A2;COL4A1;MAPK4;ST8SIA2;PTH1R;SFRP1;HEPH;SEMA5B;CTNNA3;ADAMTS9;ANGPTL2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4385646189668638,0.9913679407123159,0.38333333333333336,0.9087002281473572,1.0,13/63,13.65%,PLEKHG2;TENM1;HCLS1;FER;LATS1;KANK1;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2;DBN1
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.6693573648695135,0.9910684873150365,0.5892857142857143,0.9091945610110761,1.0,2/5,18.40%,RPIA;RPE
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.6051037643693999,-0.9910248939707909,0.5476190476190477,1.0,1.0,2/8,12.10%,CRYM;FFAR4
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.39475509779478074,-0.990946019886813,0.4444444444444444,1.0,1.0,15/124,9.49%,DUSP4;NTRK1;DUSP6;RNASE1;FOS;VGF;PCSK6;ADCYAP1;TRIB1;SHC3;EGR1;EGR4;CHD4;NTRK3;CLTA
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.38345654447710087,-0.9908185357413698,0.47368421052631576,1.0,1.0,14/123,12.10%,RFX6;GFRA3;TMEM179;ENPP2;ADCYAP1;SCG3;TRPA1;TTBK1;VWA5B2;GLP2R;CELF3;LRRTM1;INA;FFAR4
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.45464807368169247,0.9907769637666632,0.5,0.909668306429974,1.0,8/75,12.02%,EPHA7;EFNA5;EFNA2;EPHA5;EPHA3;EPHA8;EFNB2;NCK2
prerank,PanglaoDB_Augmented_2021__Platelets,0.39691531442233713,0.9906036751174196,0.4117647058823529,0.9098094352011333,1.0,17/136,6.48%,TNFSF14;SELPLG;NOX5;FERMT3;ITGAX;CCL5;F2R;CSF3R;ITGA2;PIK3R6;SASH3;ANGPT1;CD244;PTGS1;HCLS1;FGL2;CYP2U1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.6186454326232538,-0.990568497516419,0.5306122448979592,1.0,1.0,1/6,2.67%,CD86
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.513100910137841,0.9903616471036082,0.54,0.9100396014597343,1.0,10/32,28.53%,HDAC3;MARVELD3;ZNF675;NPPA;HIPK3;ZMYND11;FKTN;PDCD4;SIRPA;CYLD
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5652218279978528,0.9901546799234765,0.5098039215686274,0.9102412699314372,1.0,2/11,6.00%,INSIG1;PDIA2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4606320027771362,0.9901093583417536,0.4318181818181818,0.910078427660793,1.0,2/42,1.94%,FGF10;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.5933349017378989,0.9900664781630396,0.5,0.9098873583202169,1.0,5/10,19.49%,ELOVL5;NR1H3;ABCD2;MLXIPL;MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.6207091427183815,-0.9898731342666799,0.5294117647058824,1.0,1.0,1/5,6.12%,JCHAIN
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,-0.5970040869967469,-0.9897901264840414,0.5,1.0,1.0,1/6,7.84%,TAFAZZIN
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4146088205477549,0.9896811708015594,0.45098039215686275,0.9106351022794634,1.0,27/88,17.85%,F2;ACE2;CCL5;STARD4;IL4;PPARG;ANGPT1;SCRIB;DCXR;SNCA;PLA2G10;RAMP3;MAGI2;VAMP3;NR1H3;FASN;GREM1;ACACA;ACACB;TBC1D5;RAB29;AKR1C1;CSF1;VEGFA;AKR1C3;TP53;FMR1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4179224925916802,0.9894612648523985,0.47368421052631576,0.9110426046303547,1.0,10/76,9.16%,IGF1;FGF10;LZTR1;EPS8L2;KANK2;EPS8;DLC1;ERBIN;SHOC2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5108336510368556,-0.9893428734891068,0.48936170212765956,1.0,1.0,2/13,1.88%,DOCK8;CXCL13
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.42388970403141807,0.9891731575827303,0.48214285714285715,0.9115064542882455,1.0,10/52,18.05%,PLD6;BOK;RALA;HTRA2;MCU;FBXO7;PLAUR;PPIF;TP53;MFF
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.6630091240314776,0.988968567006788,0.48,0.9117274751770629,1.0,1/7,1.06%,GSTM2
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),-0.6391502679720669,-0.9887726999826124,0.6,1.0,1.0,1/5,4.27%,RFTN1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4787495311201909,0.988626891001672,0.4423076923076923,0.9122958709943918,1.0,11/26,23.57%,FLT1;MLLT3;FLT3;MLF1;TP53;PRRC2C;KIT;ACE;PTPRC;FSTL3;BMP4
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.48562430891283426,0.9885552427170038,0.46774193548387094,0.9121569731260224,1.0,5/29,13.44%,SIRT1;PPARG;PLA2G10;NR1H3;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6690888430281571,-0.9885032394877165,0.5961538461538461,1.0,1.0,4/5,32.38%,BAIAP3;STX1B;PRKN;GPER1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.5005120019985836,0.9884430346941354,0.4727272727272727,0.9121393133214353,1.0,5/23,11.19%,IGF1;CANT1;HPSE;HS3ST4;CSGALNACT1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.4370939747556878,0.9883375046814291,0.5306122448979592,0.9121579979050632,1.0,13/57,23.88%,KSR1;AGGF1;ZC3HAV1;CNKSR2;QKI;RAP1A;CNKSR1;ARRB2;APBB1IP;MAPK3;LMNA;JAK2;AKAP9
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.5444754155254025,-0.9883291854630071,0.5106382978723404,1.0,1.0,1/11,4.67%,CRLF1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.6091017827736024,0.9882729709932457,0.5,0.9120394561900448,1.0,1/6,3.05%,HTR1F
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.49419220800005853,0.988204221000771,0.509090909090909,0.9119371280613284,1.0,8/21,27.99%,SOS1;STAM2;SH3GL1;GRB2;SH3GL2;LRIG1;HGS;EPS15
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.6420656887472946,0.9880271073677207,0.5102040816326531,0.9120808865242783,1.0,3/8,23.80%,LIG4;BANF1;SGIP1
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.3970820565876062,0.987958143224194,0.47368421052631576,0.9120148971947691,1.0,20/74,18.60%,THEMIS;GPRIN3;TRAC;ZEB2;RORA;RCBTB2;LRRN3;JAKMIP2;ABCD2;ITK;RSRP1;RBM5;ARHGEF6;NELL2;C1ORF162;CD247;TIGIT;SAMD3;ZMAT1;ZAP70
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.6238534181362378,0.9875921564288302,0.48936170212765956,0.9126905718712726,1.0,3/10,23.80%,LIG4;BANF1;SGIP1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5747609791477721,-0.9874945609946368,0.5370370370370371,1.0,1.0,2/9,12.21%,RAB7B;MTURN
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.47463840469378293,0.9874639117353994,0.42857142857142855,0.9127171029107947,1.0,8/52,11.48%,RNF152;SYVN1;PELI1;UBE2E2;UBE2D3;RNF146;UBE2E3;RNF5
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.6087140467332608,0.9872178316981148,0.5535714285714286,0.9130094634743953,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5818647626833309,0.9869844206138214,0.5892857142857143,0.9133378774371241,1.0,5/12,21.36%,FGF2;VEGFA;HDAC9;AKT3;ANXA1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.44537984389211593,-0.9869359728981018,0.4074074074074074,1.0,1.0,5/40,10.00%,DDX11;TERF2IP;FOXM1;RAD51AP1;RTEL1
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.6106984997452,0.9869320965422713,0.5681818181818182,0.9131749823250125,1.0,4/11,22.25%,SOS1;RAP1A;APBB1IP;GRB2
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.5152486770894938,-0.9868591819404333,0.4423076923076923,1.0,1.0,10/26,15.56%,GUCA1B;PDE6B;CNGB1;PPEF1;NMT1;GNGT1;GNB5;CHURC1-FNTB;CALM1;METAP2
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.40705113214637995,0.986824424357708,0.4,0.9131691318655033,1.0,22/89,16.51%,ITGA2;GNG12;DOCK1;CRIM1;SDC4;PDLIM4;MYOF;ITGAV;WWTR1;EPS8;F3;FAM114A1;TNC;RASAL2;HTRA1;PXDC1;SERPINB7;ERRFI1;TMEM54;ASPH;TNFRSF21;KRT17
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,0.5178018898286789,0.986795697089153,0.47368421052631576,0.9129701890915336,1.0,1/20,0.19%,TEX101
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.40196574004564406,0.9867762861507591,0.4666666666666667,0.9127472439708127,1.0,21/112,12.58%,LRRC3B;NXPH1;KCNC2;GFAP;CADM2;SLC17A6;NKAIN2;PARM1;OLFM3;NTSR2;SYNPR;ANK2;GRM5;PTPRT;LRRTM3;ADGRB3;PAK5;TMEM196;ZNF536;LRFN5;UBE2QL1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.3983590860575695,-0.9867604589620238,0.40540540540540543,1.0,1.0,5/80,5.69%,LRP10;C1RL;MVP;TGFBI;IER3
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.4840548811168045,0.9867440939471622,0.5102040816326531,0.9125324816157473,1.0,7/28,16.05%,SLC26A6;SLC4A7;SLC9A2;CA2;SLC9C2;SLC9A9;SLC4A1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.40742824685003287,0.9866826519243838,0.4666666666666667,0.9124263688480241,1.0,21/87,12.87%,MXRA5;MRGPRF;ADGRL4;DOCK1;BGN;CRIM1;FBLIM1;LTBP2;ARHGEF17;POSTN;MYOF;TCN2;FAM114A1;PLSCR4;NECTIN2;MEDAG;AOX1;TPM2;TNS3;HTRA1;PXDC1
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,0.6805166349191173,0.9866619564484922,0.5957446808510638,0.9121837217685479,1.0,3/5,30.16%,RAP1GDS1;TRAK2;RHOT1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.545391880863134,0.9865662234366716,0.5081967213114754,0.9121500834132464,1.0,3/16,10.13%,C3;EPHA8;ADGRB3
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,0.5719951671335377,0.9865605635054251,0.5,0.9118835880825206,1.0,6/11,38.81%,PARP8;GSK3A;PARP14;PARP9;GSK3B;PARP6
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4248550724236018,-0.9865240045812926,0.4375,1.0,1.0,12/81,8.00%,EHF;CLDN4;TMEM184A;FAM3D;CLDN1;C6ORF132;SPDEF;PTH1R;MYO5B;LAMB3;SYTL2;ANKRD30A
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.4635120478835824,-0.9862955053279965,0.4883720930232558,1.0,1.0,2/31,3.27%,ADSS1;ASS1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.4323862253725312,0.9862909291001063,0.39215686274509803,0.9122474394962568,1.0,11/55,19.33%,LRP4;DCC;NLGN1;HDAC2;KANK1;EFNB2;PTEN;KIAA0319;RAB29;EFNA1;MCF2
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.5708093988832466,0.9862469966546233,0.5357142857142857,0.9121175108627878,1.0,7/10,39.03%,BDH2;GGCT;CHAC1;CHAC2;CNDP2;MGST2;GCLC
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.3700683950097054,0.9862231898146832,0.39622641509433965,0.9118713369065893,1.0,35/160,29.84%,EIF3E;SAMD4A;DCP1B;SMG1;PATL2;RPS5;CNOT6L;CNOT4;EXOSC4;RPL21;DXO;TENT4B;CNOT8;RPL18A;CNOT2;RPL7;ERI1;RPS3A;NCBP1;ZFP36;RPL23A;PAN3;PATL1;RPL9;CSDE1;EXOSC5;RPS29;RPS19;PABPC1;RC3H1;PPP2R2A;RPS15A;SMG9;RPS23;TUT4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.42269746977393796,0.9861908563559116,0.40816326530612246,0.9116694299845617,1.0,17/58,19.20%,RENBP;ALLC;TRHDE;NAALADL1;GADL1;PLA2G10;LNPEP;RIDA;CYP3A4;NPL;ANPEP;SGPL1;CTH;PNPLA8;PLA2G7;MPST;GNPDA2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.5669248402887743,0.9861410978376509,0.5,0.9115157566167245,1.0,1/10,1.82%,CCL5
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6253749952641336,-0.9861124819124417,0.5192307692307693,1.0,1.0,2/7,15.40%,ATG14;CALM1
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.4345304329393847,0.9860726532493056,0.42857142857142855,0.9114022558235069,1.0,16/71,15.66%,ERBB4;GRIN3A;NRG1;LLGL1;PRKAB2;LIN7A;RPS6KA2;GRIN3B;PPM1E;LRRC7;GRIN2D;APBA1;CREB1;NBEA;RPS6KA1;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5086554707307025,0.9860370759453205,0.5370370370370371,0.9112207215976237,1.0,4/25,9.05%,CCL5;F2R;CXCL12;ANK2
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5197103568444595,0.9860221047514398,0.3584905660377358,0.9109712187945874,1.0,5/23,13.56%,RUNX1;SNAI1;PDLIM5;MEF2C;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5475489372796033,-0.9859479040050412,0.4772727272727273,1.0,1.0,1/12,1.23%,NUPR1
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,-0.49549189394253146,-0.9859084309417019,0.5208333333333334,1.0,1.0,8/36,7.16%,RAB44;MPO;NLRP3;MEFV;VSTM1;PRAM1;HCK;ADGRG3
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.5266581425809342,0.9858574952799282,0.5333333333333333,0.9111542704167054,1.0,1/11,1.94%,SIRT1
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,-0.40829458159710447,-0.9858389622284452,0.4897959183673469,1.0,1.0,1/84,0.09%,LRP10
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.619163576754745,0.9858008546156138,0.5208333333333334,0.9104867725401464,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.619163576754745,0.9858008546156138,0.5208333333333334,0.9104867725401464,1.0,1/5,2.98%,ALDH1A1
prerank,Reactome_2022__Fructose Catabolism R-HSA-70350,0.619163576754745,0.9858008546156138,0.5208333333333334,0.9104867725401464,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.5808338060115641,-0.9857565064812417,0.5384615384615384,1.0,1.0,3/10,12.99%,CD200R1;P2RY12;PTK2B
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.48949633910598606,-0.9856917966863311,0.4444444444444444,1.0,1.0,5/24,16.04%,KDM4D;KDM2B;HR;KDM1B;KDM4B
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6218960485067112,0.9856005542246752,0.6122448979591837,0.9106897384833265,1.0,2/6,34.42%,NDUFV1;COA6
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,0.5931515471957457,0.9854507359690413,0.5,0.9107166937402287,1.0,3/7,34.70%,BAD;BID;BCL2L1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.47120866164125885,0.9854455627139764,0.49056603773584906,0.9104439281937597,1.0,6/29,22.61%,STK33;CHEK2;CDC5L;H2AX;HINFP;DOT1L
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.5362716737803825,0.985442418675694,0.4745762711864407,0.9101553564257111,1.0,5/10,36.55%,SMC3;NIPBL;PMEPA1;PDS5A;STAG2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6421930190217316,-0.9854304911211491,0.5,1.0,1.0,1/5,20.56%,PRKCA
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.5168630143427801,-0.985245277582094,0.4897959183673469,1.0,1.0,1/15,1.36%,INSRR
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.49980219521092883,0.9850242922302423,0.47368421052631576,0.9108413857078316,1.0,4/24,3.78%,MCOLN3;TRPM8;TRPV2;TRPC4
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,0.4386223706814378,0.9847153577593375,0.4482758620689655,0.911395236060581,1.0,8/55,8.27%,LGALS9;ITGAX;SASH3;IL10RA;FGL2;LAIR1;SIGLEC1;TFEC
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.564918493386076,0.9847089062536212,0.4883720930232558,0.9111186101530676,1.0,2/11,2.47%,LGALS9;IL4
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5963855950832097,0.984683420894494,0.46296296296296297,0.9108940258006002,1.0,2/10,14.07%,PPARG;RARB
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.4484778156292714,0.9845492786292739,0.46153846153846156,0.9109447874708408,1.0,9/37,21.37%,ADD3;ARHGAP5;SLC4A7;VAMP3;LMNB1;ARHGAP21;FARP1;FAM169A;ARHGAP32
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.432222554184885,0.9843960752216863,0.4666666666666667,0.9111191202318858,1.0,15/67,16.99%,PRDX6;ABHD3;PIGQ;PLA2G10;IP6K3;CPNE7;ACP6;PIGF;CPNE1;CPNE3;PNPLA6;PLCB1;PIGP;PLA2G7;PLCD1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5261133336227619,-0.9843507630540956,0.5319148936170213,1.0,1.0,1/18,0.37%,ACTC1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.6230295023654502,0.9843331380358362,0.5,0.910654580516671,1.0,2/8,8.34%,CEL;CYP27A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.6230295023654502,0.9843331380358362,0.5,0.910654580516671,1.0,2/8,8.34%,CEL;CYP27A1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.3907632582761301,0.9842429703425224,0.45098039215686275,0.9102822176039455,1.0,15/98,9.87%,LRP4;GNG12;MMP16;TENM3;DOCK1;ARHGEF17;TEAD2;UNC13B;ADGRL2;LIFR;GPR176;PCDH18;ANK2;MAGI1;GPR161
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.3907632582761301,0.9842429703425224,0.45098039215686275,0.9102822176039455,1.0,15/98,9.87%,LRP4;GNG12;MMP16;TENM3;DOCK1;ARHGEF17;TEAD2;UNC13B;ADGRL2;LIFR;GPR176;PCDH18;ANK2;MAGI1;GPR161
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.48818380560204677,-0.9842072486921455,0.5,1.0,1.0,4/37,5.96%,ACTC1;F5;SCPEP1;DLL4
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.6057316914696664,0.9840697224878822,0.5,0.9105480450987489,1.0,2/9,16.02%,DLGAP5;POGZ
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5177724217999117,0.9839825509773608,0.44642857142857145,0.9104276790225759,1.0,9/22,21.86%,ELOVL5;ACSBG1;THEM5;FAR2;DGAT2;TECR;ACSL4;ELOVL6;ACSL1
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.5550440707345562,0.983798289279324,0.5178571428571429,0.9107012495614701,1.0,3/12,18.72%,GAS2;GSN;CASP3
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.49959807816306684,0.9837883576769942,0.5490196078431373,0.9104496656582948,1.0,7/28,25.70%,RAB27A;CHMP6;STAM2;MVB12A;VTA1;HGS;VPS37D
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6308631860572094,0.9836573810523933,0.5714285714285714,0.9105004073737848,1.0,1/5,6.83%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.5490840254354085,0.9836360747761721,0.5185185185185185,0.9102450708594299,1.0,2/16,1.05%,LGALS9;TNFRSF18
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3773548596015197,-0.9836240128898743,0.46,1.0,1.0,15/162,13.00%,TERT;HK2;MTFR2;PTCD2;BIK;FANCG;AFG3L2;IFIT2;ADCK1;PARP1;CAV2;DNM1;NIPSNAP2;TIMM44;SPG7
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.44826954103628625,0.9835984612963442,0.49206349206349204,0.9100455225650143,1.0,6/42,8.93%,SYK;TNFSF13B;IL4;SASH3;CD40;PAXIP1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.417722508027079,-0.9835408892339248,0.5833333333333334,1.0,1.0,16/91,9.02%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;FMNL1;BATF3;KLRB1;CD5;TAGAP;TNFRSF4;TXK;IFIT3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.426268206597822,0.9832879666587645,0.4339622641509434,0.9105809424410294,1.0,13/64,20.95%,HIF3A;EGLN3;HIF1A;RBPJ;PSMD13;PSME4;NFE2L2;PSMA1;VEGFA;CITED2;ARNT;LIMD1;PSMD4
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4670738516846384,-0.983268597708676,0.4375,1.0,1.0,10/41,19.84%,CLDN4;CLDN1;F11R;CLDN15;CLDN16;CLDN5;MARVELD2;CLDN20;PATJ;LSR
prerank,KEGG_2021_Human__Melanogenesis,0.4188865738177591,0.9831934177487722,0.45614035087719296,0.9105402488494424,1.0,13/85,15.21%,MITF;TYR;FZD5;WNT4;WNT9A;GNAI3;FZD1;CREB3L2;DVL2;CREB1;FZD4;FZD6;PLCB1
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.41334595693168763,-0.9831762270594475,0.4489795918367347,1.0,1.0,2/119,0.60%,TRIP10;HK2
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.5216569604785742,0.9827874034725511,0.52,0.9113609881954261,1.0,9/17,27.64%,RELA;TICAM1;IRF3;IKBKB;NFKBIB;DHX9;CHUK;NFKB1;NFKBIA
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.4213312761110413,0.9827725399290156,0.47058823529411764,0.9111137194335391,1.0,13/77,20.95%,MYC;SEM1;FRAT2;PSMD13;CTBP2;TLE2;PSME4;FRAT1;PSMA1;CTNNB1;TLE4;HDAC1;PSMD4
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.549837552636391,0.9826185270272655,0.509090909090909,0.9112474498475326,1.0,8/15,35.11%,INTS6L;INTS6;INTS11;INTS14;INTS8;INTS3;INTS1;INTS2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6105472395096057,0.9824711222562503,0.5087719298245614,0.9113652326148917,1.0,2/9,8.34%,CEL;CYP27A1
prerank,Reactome_2022__Pre-NOTCH Processing In Endoplasmic Reticulum R-HSA-1912399,0.6354106559477093,0.9824619318109216,0.56,0.911090443494891,1.0,4/6,33.96%,NOTCH2;NOTCH3;NOTCH1;NOTCH4
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.32411740345557555,-0.9822164002625087,0.5079365079365079,1.0,1.0,113/1769,9.17%,CD44;CYP1A2;UGT2B15;LRP10;UROC1;ALB;AMDHD1;ACOT1;PM20D1;NOSTRIN;AMACR;APIP;ADSS1;LDHC;AWAT1;ENTPD2;SERINC2;CYP2A6;PLAAT4;XYLT2;DUOX1;BST1;DGAT2L6;AK8;SYNJ2;TYRP1;SPTLC3;SFTPA2;ARF3;CHST9;PLCZ1;ENPP2;ASS1;CYP2E1;PLEKHA4;ALOX5;PTGES;AGRN;UPB1;SLC51A;GPC2;CRYM;GSTT2B;HMGCL;PDHX;HSD11B1;SLC19A3;PIPOX;CRYL1;ASPG;CYP24A1;AKR7A3;ARG2;NDUFC1;GPC1;PAH;XDH;DEGS2;DDHD2;PNPLA4;XYLT1;GPC3;PLEKHA2;AKR1B15;INPP5D;AGPAT4;PSMB4;CYP4F2;MBTPS2;B3GALT5;ALOXE3;CYP21A2;SIN3B;PRKD2;DBH;NAXE;PPP1CA;PLCB2;LHPP;GLYCTK;PTS;PXMP2;B3GALT4;LDHAL6A;ARSL;CHST7;RPS27L;RRM2;ARNT2;DMGDH;TAFAZZIN;GNG13;HSD3B2;TMEM126B;HSD3B1;HAO2;ABCC3;SARS1;AK7;ALAS2;ACSM6;OAZ3;ENO2;KCNJ11;ECSIT;BHMT2;PGP;PCCB;MLYCD;PDPR;PRODH2;STARD6;PRXL2B
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.5895092823610164,0.9821215303747746,0.5517241379310345,0.9116917335975382,1.0,1/7,8.92%,RHOU
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.5708636747138682,0.9820296410328956,0.5357142857142857,0.9116507803592945,1.0,3/11,13.65%,LATS1;KEAP1;DBN1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.6031040007934398,0.9820086077097463,0.5102040816326531,0.911411808549166,1.0,3/7,14.93%,MLLT3;CDK2AP2;NCOA3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5776992415209998,0.9819736882667123,0.5,0.91124426044762,1.0,4/13,10.42%,SPR;GCH1;CYB5B;MTARC2
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.49878764876916537,0.9818521410101335,0.5636363636363636,0.9112272367235501,1.0,6/27,11.63%,SMAD6;RBM14-RBM4;WWTR1;HDAC3;SMAD1;SMAD4
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.4689754711255913,-0.9818278885293918,0.5,1.0,1.0,10/43,22.79%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5;TMEM186;NDUFA10;NDUFA5;NDUFS1;NDUFA1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.444820773794823,0.9818228026935679,0.4523809523809524,0.9109846658299122,1.0,28/89,19.44%,FGF10;IRS1;FGFR3;FGFR1;ERBB4;NRG1;NRG3;ESR1;PDGFRA;NRG2;FOXO3;FGF17;PIK3CA;FLT3;FOXO1;PTEN;SOS1;FGF5;CREB1;RICTOR;FOXO6;GAB2;RHOG;IRS2;KIT;KLB;MLST8;AKT3
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4347238398798604,0.981778848607424,0.5,0.9108015859100506,1.0,14/47,26.20%,STK33;PAXIP1;CHEK2;CDC5L;H2AX;BCL3;TP53;ABL1;HINFP;GRB2;DOT1L;MDM4;SESN2;BID
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3918036047224824,0.9817626123495471,0.40816326530612246,0.9105553461279775,1.0,27/106,22.04%,PADI6;SIRT1;CCNA2;PADI2;PRMT1;RPS6KA4;HDAC2;CTCFL;EZH2;TBL1X;UBE2U;EYA2;KAT6A;PADI4;RPS6KA5;SIRT7;RUVBL2;SUPT3H;MIER3;NSD1;HDAC9;TBL1Y;HDAC1;UBE2A;NAA50;BRMS1L;MIER1
prerank,Reactome_2022__Signaling To P38 Via RIT And RIN R-HSA-187706,-0.675956026706934,-0.9817452374554996,0.6444444444444445,1.0,1.0,1/5,0.42%,NTRK1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.41821051524718406,0.9816221032589478,0.47058823529411764,0.9105820476077038,1.0,23/76,20.60%,LGALS9;MAPKAPK2;TLR2;PLCG2;TICAM1;UBE2D3;HMGB1;TAB2;MAPKAPK3;IRAK1;MAP3K1;TAB3;BIRC3;FADD;IRAK3;LGMN;UBE2D1;TICAM2;ITGB2;RIPK2;SCARA3;IKBKB;TLR1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.6010859084375343,-0.9813077134764124,0.5869565217391305,1.0,1.0,3/6,23.71%,XRCC1;FANCB;RAD21L1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.5109391072510637,0.9813074188400156,0.5111111111111111,0.9110474256449572,1.0,6/16,23.85%,IL4;SNCA;CX3CR1;ITGB2;ITGAM;JAK2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5539470857037511,-0.9810612817466036,0.44680851063829785,1.0,1.0,6/9,37.31%,ATP5F1A;ATP5MC3;ATP5PB;ATP5F1C;VPS9D1;ATP5PD
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.33587899078832445,0.9810483151549388,0.42105263157894735,0.9113307680715177,1.0,82/470,14.76%,GPR55;ADRA1A;DRD5;INSL5;CHRM2;C3;CCL5;PNOC;F2R;GNRH1;GRM3;PLEKHG2;UTS2R;HRH3;PIK3R6;HTR1F;CALCR;FGD4;OPRK1;GNB4;GNG12;WNT4;PDE1A;NPY;INSL3;PIK3R5;RGS10;GPSM3;CXCL12;PENK;ARHGEF17;PTGFR;GPR17;RXFP2;SSTR3;WNT9A;NPFFR2;PLPPR1;GRM8;ADRA2C;QRFPR;CASR;GNRH2;GPR176;NTSR2;PDE7A;RAMP3;CRHBP;GNAI3;NPW;GPSM1;RGR;GRM5;PIK3CA;TAC1;PLXNB1;C5AR2;RPS6KA2;C3AR1;UTS2;ARHGEF16;HTR2C;GNG4;PDE4B;PRPF38B;PPP3CA;KNG1;SOS1;GRM4;FZD1;RGSL1;PPP3CC;GRM7;NPY1R;CREB1;NBEA;RPS6KA1;FZD4;ADORA1;ADRB1;FZD6;ARHGEF6
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.5167276793555158,0.9808665398661208,0.5208333333333334,0.9114677934606321,1.0,10/18,29.30%,TANK;TP53;IKBKB;IKBIP;N4BP1;USP18;TRAF6;CHUK;NLRC5;LRRC14
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.6459952812851292,0.9805735243097345,0.5254237288135594,0.9120193231272741,1.0,1/6,1.67%,SYK
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.5783002642814654,0.9805509286834285,0.5208333333333334,0.9117929008840973,1.0,3/7,26.08%,CBS;CTH;MTR
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.4209633241737505,0.9805346007240836,0.42857142857142855,0.9115626744156364,1.0,16/95,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;FMR1;WDR33;NCBP1;ZFP36;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4645786092227199,-0.9802835230278919,0.5102040816326531,1.0,1.0,2/44,0.61%,NTRK1;DDX11
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5479936679510654,0.9802457135286583,0.5370370370370371,0.9120347611180094,1.0,3/12,11.92%,PRKG1;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.5806754197173707,0.9801912483499792,0.5416666666666666,0.9118795302232479,1.0,5/9,21.29%,HTR1F;HTR2C;HTR1E;HTR2A;HTR5A
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,-0.4302971799909433,-0.9800628886704507,0.4782608695652174,1.0,1.0,7/64,2.63%,MS4A8;EHF;DUOXA1;CAPN8;SLCO2A1;FAM3D;ERN2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4978400173235932,-0.9798775783452001,0.5,1.0,1.0,3/17,10.52%,SLX4;RTEL1;PARP1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.39682918537738604,-0.9797404514114004,0.45614035087719296,1.0,1.0,5/179,3.13%,ANXA8;GOLGA8B;SUN3;ALS2CL;TLCD2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.490957552440821,0.9797189102304129,0.5576923076923077,0.9126784335644889,1.0,11/24,27.57%,TLR2;TAB2;IRAK1;MAP3K1;TAB3;IRAK3;TLR1;TAB1;TRAF6;CD36;TLR5
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5556551233632191,0.9796167014612812,0.5666666666666667,0.9127359162256163,1.0,2/13,12.22%,CCDC125;FRMD5
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.6441151089416826,0.9795139174308403,0.5409836065573771,0.9128367011609435,1.0,2/5,16.52%,FBN1;NOTCH2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5395024332321092,0.9794888615948211,0.5614035087719298,0.9126262732108433,1.0,6/15,12.47%,NOX5;SEMA5A;NRARP;BMPER;LOXL2;CD34
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.4128413008446445,0.9793790755628539,0.4666666666666667,0.9126404071596571,1.0,11/71,22.18%,U2AF1;CPSF4L;THOC6;PAPOLA;PCF11;TENT4B;SRSF11;CSTF3;WDR33;NCBP1;SRSF3
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.5197766194241105,0.9791836542371503,0.5098039215686274,0.9128749564659288,1.0,4/21,7.75%,RELA;TLR2;TICAM1;HMGB1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.6154055177990541,0.9791169649941445,0.5686274509803921,0.912735542174693,1.0,3/6,11.63%,SMAD1;SMAD2;SMAD4
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,0.6416626100483138,0.9791044773072605,0.5636363636363636,0.9124664031665788,1.0,3/5,27.83%,ACADM;HADHB;HADH
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5667739554711506,-0.9789837451461362,0.4827586206896552,1.0,1.0,1/12,3.41%,ALOX5
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5587597669706357,0.9789542493982283,0.5102040816326531,0.9125080965895137,1.0,12/16,39.29%,TMEM98;TNFRSF21;TENM4;HES5;PTPRZ1;TNFRSF1B;NOTCH1;NF1;DRD3;PTN;SLC45A3;HES1
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.5330699972702142,0.9789144882023532,0.5294117647058824,0.9123571334781336,1.0,7/28,21.16%,KSR1;CNKSR2;RAP1A;CNKSR1;ARRB2;APBB1IP;MAPK3
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.38991726826841683,0.9789077676267235,0.4074074074074074,0.9120962242504403,1.0,24/142,15.66%,CCNG1;CCNA2;RRAD;CDKN2A;SMYD2;PIP4K2A;PRKAB2;MAP2K6;TP53INP1;DYRK2;BANP;HDAC2;TAF3;CHEK2;TP53BP2;NOC2L;PML;KAT6A;TAF5;RICTOR;HIPK1;TAF2;SGK1;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.35188811333736647,0.9789043726595642,0.425531914893617,0.9118158337628448,1.0,109/567,18.16%,DACH1;MITF;AASS;RUNX1;MYC;SIRT1;ZBTB7B;IL4;URI1;ZBTB1;FOXP2;PPARG;NEDD4;SNAI1;ZEB2;BMP2;BMI1;NFIL3;NRIP1;ZNF582;ZGLP1;KANK2;IRF8;VSX2;SMYD2;RBPJ;RELA;ZEB1;ZBTB2;ESR1;ZNF599;HDAC3;PAX6;HDAC2;NCOA5;MYPOP;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;FOXO3;ATXN1;TFEC;ZNF202;INSM2;RIPPLY2;TAF3;ZNF675;FRK;SMAD2;EZH2;ZNF669;LOXL2;ZNF692;ZNF239;TBL1X;NR1D2;PHF21A;SMAD4;NR1H3;MEF2C;ZNF536;PROX1;ZNF175;CTBP2;ZNF778;ZNF281;MYB;NR4A2;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;WWOX;RARB;BCOR;NR2F2;ZNF263;NFATC3;EPC1;THRB;HJV;HCFC1;SPEN;TRPS1;DEAF1;SIRT6;PEX2;HEY2;CNOT2;SMARCA2;RORC;IL33;SIRT7;VEGFA;TGIF1;MXI1;LCOR;TP53;MAZ;MIER3;EFNA1;CITED2;EED
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.445929255140911,-0.9788975736984162,0.4716981132075472,1.0,1.0,8/44,12.94%,APIP;LDHC;TST;LDHAL6A;BHMT2;GOT2;BCAT2;BHMT
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6394400662835805,0.9788478185888297,0.5192307692307693,0.9116455897078497,1.0,3/5,22.12%,CRACD;CARMIL1;WASHC2C
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.4138313240074033,0.9786933596151884,0.5,0.9118170429961443,1.0,16/98,10.47%,GRM3;KCNC2;GFAP;SYT1;NAV3;EPHA5;GRIK2;FAM171B;FRMPD4;SYNPR;FGF14;ANK2;MAGI2;GRM5;LRRTM3;SCN2B
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.460959842500843,0.9786785867275597,0.4,0.9115644772151908,1.0,8/30,21.98%,GLUL;SLC39A8;PYCR1;CPS1;RIMKLA;GLUD1;RIMKLB;OAT
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4297339460251639,-0.9786722395475529,0.42,1.0,1.0,16/67,18.77%,TRIM56;DDX41;IRF5;FLOT1;POLR3H;POLR3E;OAS3;OAS1;DHX58;NFKB2;OAS2;CGAS;POLR1C;STAT1;POLR3A;IRF1
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.4984410113350404,0.9785991753805251,0.43636363636363634,0.9115004154982738,1.0,4/19,13.08%,FGF10;FGF17;PIK3CA;FGF5
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.39067543351559675,0.9784237458407581,0.46938775510204084,0.9116246818378645,1.0,25/112,17.54%,PLD6;LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;CPNE7;ACP6;PRKCSH;CPNE1;SELENOI;CHEK2;CPNE3;PITPNM1;BCHE;ETNK1;SLC44A4;ETNPPL;PNPLA8;GPD2;DGAT2;PLBD1
prerank,Reactome_2022__Tyrosine Catabolism R-HSA-8963684,0.6874586769326693,0.978194071518478,0.5714285714285714,0.911984157844529,1.0,1/5,3.71%,HPD
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5305238015623539,-0.97807813162394,0.4489795918367347,1.0,1.0,4/16,15.40%,SPRED3;SPRED2;SPRED1;CALM1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,0.4992895443472173,0.977746219775901,0.48148148148148145,0.9127628748567062,1.0,4/18,18.72%,HMGB1;CHMP6;TP53;CASP3
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.5593406510011095,0.9777255318950736,0.44680851063829785,0.9125535167677706,1.0,4/10,11.34%,NAALAD2;GOLT1A;GADL1;SLC25A13
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6431847974684635,0.9776276257065322,0.5689655172413793,0.9125205895206662,1.0,6/9,34.75%,ABCD2;SLC30A10;SLC18A2;ABCB7;PPARA;TRAP1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5613612779989207,0.9775967275512084,0.5306122448979592,0.912315353414813,1.0,2/13,13.08%,RRS1;XPO1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.4683444944091014,0.9775794221328438,0.4727272727272727,0.9120945833891198,1.0,8/31,20.75%,PLEKHG2;HCLS1;LATS1;FCHSD2;DBN1;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5684940542447767,0.9775669452866692,0.45652173913043476,0.9118465514875698,1.0,4/10,28.99%,ATP6V0A4;SLC26A4;PDK4;PDK2
prerank,KEGG_2021_Human__Osteoclast differentiation,0.402429143659634,0.9774864855222337,0.41509433962264153,0.9118021458344222,1.0,19/92,16.15%,MITF;SYK;TGFBR1;PPARG;CALCR;BLNK;RELA;MAP2K6;PLCG2;TAB2;PIK3CA;OSCAR;MAPK8;PPP3CA;PPP3CC;CREB1;PIK3CD;GAB2;MAPK10
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,-0.5949925809267596,-0.9772499089665877,0.5106382978723404,1.0,1.0,2/7,25.46%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.35710784881067575,0.9772035944331158,0.3829787234042553,0.9122037030541338,1.0,57/353,17.45%,UHRF2;MKRN3;HIF3A;SIRT1;HIF1A;LZTR1;NEDD4;SPSB2;RNF152;RFWD3;SYVN1;PEX12;RNF182;TRIM50;KLHL21;KLHL8;ASB5;FBXL3;NEUROD2;UBE2D3;MSL2;SPSB4;DCUN1D1;ANKRD9;RNF139;UBE2Z;GAN;UBE2E3;KEAP1;ANAPC16;UBA5;FBXO7;TRIM26;HECW2;SHPRH;CNOT4;ARIH1;UBA6;UBE2J2;UBA3;TSPAN17;KLHL24;KLHL13;FBXL15;MIB1;TRIM52;RNF25;FBXL2;NFE2L2;PDZRN3;MARCHF3;PEX2;RNF26;RANBP2;FBXO11;KLHL7;RNF38
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.4566321599505665,0.9769565415573815,0.45652173913043476,0.912491606604679,1.0,12/34,23.83%,MLC1;NEFH;RNF139;HAP1;ATPSCKMT;GAS1;REEP6;TTC21B;CAPN10;MAP2;MX2;CRYAB
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.6281093077770007,-0.9767002083097898,0.631578947368421,1.0,1.0,2/8,8.13%,BST1;OLFM4
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.6041557500406566,0.9764637003865573,0.5454545454545454,0.9134790938589528,1.0,2/9,2.54%,HIF3A;HIF1A
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.39452803700403444,0.976382750286798,0.42857142857142855,0.9133717078769783,1.0,18/79,16.33%,CCDC74B;C1QL1;CDC25A;ASIC1;LMO1;TENM3;EFNA2;HDAC2;CAMK2N2;ONECUT2;JPH1;MANEAL;DNAAF3;FAM222A;FJX1;FOXO6;ULBP3;CDH24
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.5828982490600979,0.9763630754916515,0.5689655172413793,0.9131276482652504,1.0,2/9,7.24%,SYK;FER
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.598502471149759,0.9763364408467459,0.5932203389830508,0.9129110794807717,1.0,1/7,10.16%,CTNNA2
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.3826938486340991,0.9763179077201732,0.46551724137931033,0.9126946448776961,1.0,32/124,21.12%,PLEKHG2;FGD4;ARHGEF17;RELA;HDAC3;HDAC2;TAB2;TNFRSF10B;CASP10;ARHGEF16;MAPK8;PRPF38B;IRAK1;FASN;SOS1;MAGED1;TANK;ARHGEF6;TAB3;BIRC3;FADD;VAV2;ARHGEF40;CASP3;GNA13;TNFRSF10A;MCF2;HDAC1;RIPK2;BAD;IKBKB;ARHGEF4
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5274717334925845,0.9762585181823208,0.4782608695652174,0.9125681186952531,1.0,3/18,4.83%,CHRM2;HRH3;RGS10
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5040909120346047,-0.9761882802563148,0.4897959183673469,1.0,1.0,2/17,6.30%,ENC1;PSMB4
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6199968359500769,0.9760069601640542,0.5333333333333333,0.9130308765992029,1.0,2/7,28.30%,ATG2B;ATG9A
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.57553139473413,0.9755974073067476,0.5517241379310345,0.9138288183248792,1.0,1/10,5.88%,TLR2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5198995571686241,0.9755427202167789,0.5,0.9136708617849941,1.0,6/22,25.05%,PIK3CA;HSPA8;ABL1;MAP2;CAMSAP2;APOE
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.586491335636213,0.9755262928985309,0.5208333333333334,0.9134155428609373,1.0,2/11,8.04%,COX19;ANKRD9
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.3722702601569234,0.9753872670959167,0.35714285714285715,0.9134799521129713,1.0,32/163,16.64%,GATA4;SCN7A;KCNK2;KAT2B;ACTG2;SLC8A1;ENTHD1;TNNT1;WWTR1;MYL12A;SCN10A;FGF12;FGF14;MYH11;SCN3A;GUCY1A2;SCN2B;ITGA1;TPM2;NPPA;KCND2;ATP1A2;KCNIP4;SCN9A;DMD;SORBS3;HIPK1;RYR2;ASPH;GUCY1A1;TMOD4;PKN2
prerank,Reactome_2022__EGFR Interacts With Phospholipase C-gamma R-HSA-212718,0.6428804679578103,0.9752943593937774,0.5769230769230769,0.9134625056742995,1.0,1/5,24.90%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5598262168730458,-0.9752561968443804,0.5384615384615384,1.0,1.0,4/14,12.82%,IL11;UBASH3B;KIF26A;IGFBP3
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.4881727573924228,0.9751329641774701,0.48214285714285715,0.9135969668235767,1.0,5/25,13.08%,FGF10;FGF17;PIK3CA;SOS1;FGF5
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.49586780008430204,0.975056390738349,0.5254237288135594,0.9135405591484895,1.0,9/26,21.42%,FZD5;ZBTB1;IL23R;HLA-E;FADD;CD55;HLA-F;HLA-B;TNFSF4
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.4994617216805592,0.9749570053620149,0.5686274509803921,0.9135114330038719,1.0,13/29,25.19%,WWTR1;UBE2D3;PPM1A;SMAD2;SMAD4;TGIF1;HDAC1;UBE2D1;MAPK3;SKIL;USP9X;SERPINE1;SMAD7
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6606279713237251,0.9745787095028391,0.5932203389830508,0.9141438258650627,1.0,1/5,12.50%,TPRKB
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,-0.4609611812202983,-0.9745471393533125,0.5476190476190477,1.0,1.0,4/60,2.28%,EHF;CLDN4;CD24;FAM3D
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.5405839751009436,0.9745021474150345,0.5185185185185185,0.9140717417096691,1.0,3/11,9.65%,EFNA2;LIN28A;NECTIN2
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.5765469889027995,-0.9744868104203783,0.5098039215686274,1.0,1.0,2/12,8.08%,CLDN4;KCNQ1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4222819001404077,0.9743349394615747,0.46511627906976744,0.9141941410996389,1.0,18/75,15.69%,SCN7A;SLC12A1;ASIC1;SLC12A3;SLC8A1;SCNN1B;SLC24A2;SCN10A;SLC9A2;SCN3A;SCN2B;HCN1;SLC6A16;ATP1A2;SCN9A;SLC9C2;ANO6;SLC9A9
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.36112729852201014,0.9742760168260187,0.4791666666666667,0.9140404466765547,1.0,67/319,23.29%,ZDHHC11;TMPRSS2;SYK;ACE2;REXO2;HMG20B;BLNK;PRMT1;ST6GALNAC3;SDC4;TLR2;PLCG2;GPC5;HDAC2;MAGT1;MOGAT2;CHMP6;STING1;GPC4;TAB2;SIKE1;KEAP1;GALNT1;ZDHHC2;RPS5;FUT8;PRKCSH;HLA-E;ATP1A2;PHF21A;MAN2A1;IRAK1;SOS1;MGAT5;MGAT4C;IKBKE;MGAT4A;NFE2L2;TAB3;RANBP2;G3BP1;VEGFA;RPS3A;NR3C1;IRF3;AKT3;HLA-F;HDAC1;SEC24B;RIPK2;IKBKB;TLR1;ATP1B2;CANX;HLA-B;BRMS1L;NUP153;AKT2;GRB2;GJA1;ZDHHC9;FURIN;TUSC3;GEMIN6;VPS18;TAB1;PARP8
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.4413069118327032,0.974274032276798,0.4807692307692308,0.9137663691660435,1.0,6/56,9.76%,HIF3A;EGLN3;HIF1A;SEM1;UBE2D3;PSMD13
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6075911739654828,0.9742467336479615,0.5555555555555556,0.913581819884891,1.0,3/6,17.31%,SPIRE2;ESPN;FMN2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.6006647243575065,0.9739875656242468,0.6140350877192983,0.9139061867345113,1.0,1/8,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.41677008278993144,0.973917568092675,0.39655172413793105,0.9137527704174213,1.0,10/71,14.62%,DERL3;SYVN1;UBE2J1;DNAJB2;RNF185;AUP1;RNF5;UBE4A;UBE2J2;DERL2
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.424290158932837,0.9738524863289291,0.41509433962264153,0.9136382645509249,1.0,18/89,14.47%,IL17RD;NYNRIN;LRP4;FRAS1;LRIG3;FBLIM1;TEAD2;CNN3;PTPN14;MAGI1;TSPAN6;SERTAD4;GPR161;MAGED1;DBN1;PTK7;TMEM98;PTPRU
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.40501123395567695,0.9737663081247087,0.5686274509803921,0.9135626331955661,1.0,8/62,7.98%,VEGFC;LHFPL2;MSRB3;PTGS1;RAB31;ERG;SNCA;SPX
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5565407224834659,0.9737059456920235,0.5102040816326531,0.9134404979258273,1.0,4/10,17.81%,ESR1;HMGB1;ATF7IP;TP53
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,0.5722680784056706,0.9736327942911739,0.46938775510204084,0.9132796576930415,1.0,2/10,6.70%,CKMT1A;GAMT
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.6067978625090322,-0.9731573065016571,0.5217391304347826,1.0,1.0,2/6,9.98%,HFE;MMP9
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.45258244356738436,0.9731228567373809,0.41509433962264153,0.9143323608974498,1.0,7/45,10.31%,EPHA7;EFNA5;EFNA2;EPHA5;EPHA3;EPHA8;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5211496961799403,0.9731115338016657,0.5098039215686274,0.9141015840400321,1.0,5/21,14.25%,CDKN2A;LATS1;PTEN;HEXIM2;NR2F2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.47735155311938354,0.9730441120537356,0.4909090909090909,0.9140259265049278,1.0,9/49,14.50%,MYC;FZD5;FRAT2;LIX1;FZD1;HSPA8;DVL2;LRP6;FRAT1
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.44903265467073733,0.9729087004527727,0.4528301886792453,0.9141207382620843,1.0,6/45,16.35%,CDC25A;SEM1;PSMD13;CHEK2;PSME4;PSMA1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5995620494916981,0.972852403980621,0.559322033898305,0.9139599361125021,1.0,5/9,28.90%,RUVBL2;NUFIP1;NAF1;SHQ1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.42859586272014005,0.9726774890232731,0.48333333333333334,0.9141205146226168,1.0,7/48,11.21%,DPP10;STAC2;EPHA3;AGR2;RAMP3;EPB41;ARHGEF16
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4102660620996391,0.9726727933491464,0.4745762711864407,0.9138437209552607,1.0,13/44,22.04%,SIRT1;HDAC3;HDAC2;TBL1X;SMARCAD1;SIRT6;SIRT7;MIER3;HDAC9;TBL1Y;HDAC1;BRMS1L;MIER1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.45104403735280096,-0.9725891472422319,0.5384615384615384,1.0,1.0,5/51,7.78%,NTRK1;SLC6A6;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.5840559418878567,0.972537771797336,0.5,0.9138843133747567,1.0,4/9,18.93%,WHRN;ADGRV1;COL11A1;KIT
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.39090159942364555,-0.9725140348966327,0.5106382978723404,1.0,1.0,20/106,17.97%,KIF2B;ARF3;KIF12;KDELR1;COPG2;KIF15;KIF26A;KIF20B;COPG1;KIF22;PTGES2;DCTN2;DCTN1;ARFGAP3;KIF4A;KIF1A;DYNC1LI2;PAFAH1B1;KIF26B;KIF1C
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.37230971315224715,0.9725069784795741,0.5283018867924528,0.9136735061969175,1.0,43/177,20.59%,RAB38;FRMPD1;EHD1;MRAP2;NLGN1;DPP10;TNIK;ZDHHC22;SCRIB;NRXN1;RAB3C;ARL5A;RAMP3;LIN7A;ANK2;MAGI2;SAV1;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;LRRC7;PACS1;TSPAN17;LRP6;DLG2;SYNE3;CPE;RAB29;DENND4C;ARL3;CD81;RAP2A;SMURF1;DLG3;RAPGEF2;BSG;ITGB2;IKBKB
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.40169094170616804,0.9724939586943753,0.48214285714285715,0.9134241671828552,1.0,9/87,6.51%,FGF10;STAB1;PRRX1;PPARG;GNG12;KANK2;LRIG3;TEAD2;WWTR1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4753290999699225,0.9722471073007845,0.46,0.9138436141564299,1.0,5/29,5.08%,IGF1;CANT1;HS3ST3B1;B3GAT2;UGDH
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5935173143463008,0.9722425530344369,0.5079365079365079,0.913567329645666,1.0,1/10,2.84%,KAT2B
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.4914285809985593,-0.9721490425906765,0.5384615384615384,1.0,1.0,3/23,8.08%,KCNMB2;PER2;KCNQ1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.4245213111029808,-0.9719071285084999,0.5217391304347826,1.0,1.0,12/84,9.02%,TRIM56;APOBEC3H;NLRP1;RNASE1;APOBEC3G;IFI27;TRIM5;IFIT1B;IFIT2;OAS3;OAS1;IFIT3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.4019900879566786,0.9718114205079306,0.42592592592592593,0.9144229451661582,1.0,21/65,17.87%,FZD5;CDH2;NLGN1;SDK1;NRXN1;ACHE;NLGN4X;DSCAM;PLXNB1;LRRTM3;GPM6A;PLXNB2;LGI2;PTEN;FZD1;GABRB2;DNM3;RAB29;GRID2;FLRT3;FARP1
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.46614034532867327,0.9717957631565945,0.5,0.9141814048644659,1.0,8/27,17.78%,FGFR1;STAT5A;FGF17;PIK3CA;CNTRL;FGF5;GAB2;ZMYM2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.6165240816299908,0.9717691267533178,0.5192307692307693,0.9139747542843667,1.0,2/6,13.37%,EHD1;MSR1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5681635966871653,0.9716523573059466,0.5625,0.9140267841954266,1.0,5/10,23.88%,ANK2;LRRC55;GAL;ATP1B2;AKAP9
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.49962204445851466,0.9716461809731366,0.4528301886792453,0.9137624399578943,1.0,5/15,30.85%,TOB1;TENT4B;ZFP36;PABPC1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.522242982835897,0.9716197245211711,0.5094339622641509,0.9135252540645432,1.0,3/20,7.07%,IGF1;PCM1;PAX6
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.44640047539187433,-0.9712714023754745,0.46938775510204084,1.0,1.0,5/30,9.71%,CD86;FGL1;HLA-DRB1;CEACAM1;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.5667182858237085,0.9711835727299905,0.509090909090909,0.9142829252232585,1.0,1/11,1.82%,CCL5
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.4103425997344208,0.9711457187720228,0.5652173913043478,0.9141343739805312,1.0,15/73,15.08%,PCDH15;TYR;POU6F2;WHRN;ADGRV1;DHRS3;PAX6;GRM8;CRYZ;TULP1;CRYGS;RPE65;COL11A1;RPGR;ATF6
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.631407642292189,0.9710577637302522,0.5306122448979592,0.9140668289877013,1.0,3/6,11.63%,HIF1A;BMPR1A;SMAD4
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.3976708545959038,-0.9709326928743667,0.47540983606557374,1.0,1.0,12/108,9.49%,DUSP4;NTRK1;DUSP6;FOS;VGF;ADCYAP1;TRIB1;SHC3;EGR1;EGR4;CHD4;CLTA
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.5056735232780956,0.9709291684815442,0.4791666666666667,0.914080215972535,1.0,2/23,4.07%,NDC80;NDE1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5588181672970864,0.9708267721343863,0.576271186440678,0.9141321023849497,1.0,3/10,9.44%,MCUB;SMDT1;MCU
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5357428115726335,0.9708058141405314,0.5192307692307693,0.9139221853472013,1.0,5/13,22.98%,ZFP36L2;NR3C1;ZFP36;ANXA1;HNRNPU
prerank,Reactome_2022__Acetylcholine Inhibits Contraction Of Outer Hair Cells R-HSA-9667769,-0.6077249781252544,-0.9707032928105501,0.5,1.0,1.0,1/5,6.86%,KCNN2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.49897313685920286,-0.9705626097103306,0.46938775510204084,1.0,1.0,5/20,10.34%,APOBEC3H;APOBEC3G;BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.5421039102564895,-0.9701041429048273,0.5409836065573771,1.0,1.0,1/9,3.41%,ALOX5
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,0.5484134474027154,0.9700818760095151,0.5192307692307693,0.9154326354037606,1.0,3/11,23.63%,HIP1;EIF2AK3;BCL11A
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.4908305013947207,0.9699548529312386,0.45652173913043476,0.9155109921158218,1.0,4/21,10.41%,TOP2A;DNASE2B;HMGB1;ENDOG
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.4356292438225662,0.9699201331366183,0.5272727272727272,0.9153316149565403,1.0,5/53,9.14%,IRGM;TP53INP1;ATG101;STING1;RAB23
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.36365994308698757,0.9698897719787074,0.4423076923076923,0.9151177432560508,1.0,27/191,16.70%,SIRT1;NEDD4;SPSB2;SYVN1;PELI1;RNF185;UBE2D3;SPSB4;ANKRD9;SOCS6;RNF139;SPOP;UBE3D;SPOPL;PSMD13;TBL1X;HECW2;RNF5;UBE2U;KLHL42;PSME4;PML;RMND5A;NFE2L2;PSMA1;NHLRC3;CTNNB1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5571406795982661,-0.969871685725631,0.5714285714285714,1.0,1.0,2/6,6.36%,FGF1;PAX2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.45722177088704113,0.9697118051937528,0.5423728813559322,0.9152999046046496,1.0,11/33,19.73%,TNFSF13B;IL4;CD22;SASH3;CD40;MEF2C;CD74;TNFRSF21;CD81;IRS2;LYN
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,-0.5192045375230046,-0.9696913970919423,0.49019607843137253,1.0,1.0,4/15,16.77%,BOC;SMOX;PTCH1;EVC
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6149150617517627,-0.9696830924455321,0.5652173913043478,1.0,1.0,6/6,38.53%,GRN;ATP6AP2;CLN3;PPT1;CLN6;TMEM9
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5836634802094851,0.9695639618641944,0.5294117647058824,0.9154204741961123,1.0,3/8,17.47%,TGFBR1;LRP2;VEGFA
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,0.5786245540344293,0.9691269050551116,0.5357142857142857,0.9161978448264,1.0,3/8,21.51%,TP53BP2;TP53;PPP1R13B
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.4912181652073356,-0.9690225436859097,0.45098039215686275,1.0,1.0,4/35,9.57%,ACOT1;ACSM6;PCCB;ACOT2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.47774859208148573,0.9686969876597566,0.43137254901960786,0.9169478603312854,1.0,5/18,24.45%,RALA;MCU;MFF;MARCHF5;MIEF2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.5668478845639713,0.9686705050969402,0.5098039215686274,0.916737661080742,1.0,3/7,9.30%,MYO1E;NPHS2;MAGI2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6350376029837794,0.9686329556868857,0.5185185185185185,0.9166043470918873,1.0,2/5,24.30%,DTYMK;DUT
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.3595700956107514,0.9686189513761754,0.5535714285714286,0.9163368299756135,1.0,56/323,19.47%,CCNG1;CCNA2;REXO2;RRAD;CDKN2A;COX19;PRMT1;SMYD2;MOV10;PIP4K2A;PRKAB2;MAP2K6;TP53INP1;DYRK2;BANP;HDAC2;TAF3;TNFRSF10B;E2F4;CASP10;CNOT6L;CHEK2;PLAGL1;CNOT4;BNIP3L;TP53BP2;RRAGC;PTEN;CDK12;FASN;NOC2L;PML;CCNH;KAT6A;TAF5;RICTOR;HIPK1;COX6A1;TAF2;SGK1;PRKAA1;CNOT8;CNOT2;NELFB;MNAT1;ARTN;SCO2;PERP;TP53;AGO3;JMY;RRAGD;MLST8;TNFRSF10A;AKT3;POLR2H
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5189791388969595,-0.9685771842064816,0.5,1.0,1.0,1/18,1.71%,RAC2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5230169075293336,0.9683996078428478,0.5454545454545454,0.9165489164928651,1.0,4/16,8.78%,PCSK5;WNT9A;PDGFRA;DSCAML1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6224390955770752,0.9682431694789665,0.5,0.9167110272895177,1.0,1/6,16.17%,BAP1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.4234807880990511,0.9682407772605383,0.4883720930232558,0.9164437218128886,1.0,12/61,14.09%,GNB4;GNG12;PRMT1;KCNH8;ESR1;FOXO3;GNAI3;PIK3CA;GNG4;XPO1;IGF1R;CREB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.4454447048428601,0.9682221573603034,0.43103448275862066,0.9162417233571487,1.0,7/48,11.21%,DPP10;STAC2;EPHA3;AGR2;RAMP3;ZDHHC2;ARHGEF16
prerank,Reactome_2022__Opsins R-HSA-419771,0.6050263274239448,0.9679156803811054,0.5813953488372093,0.9167906968909488,1.0,3/6,24.80%,RGR;OPN5;OPN1SW
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.530278606564399,0.9678826883330033,0.5344827586206896,0.9166116939569652,1.0,6/12,36.55%,SMC3;NIPBL;PLK1;PMEPA1;PDS5A;STAG2
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.47948790801629987,-0.9678650263813449,0.46296296296296297,1.0,1.0,12/40,13.96%,SELP;GYPB;IFIT1B;BTK;ADGRG3;SLC11A1;ALAS2;CMTM2;SPI1;TSPAN32;CLEC1B;CMTM5
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.41349703257795495,0.9678390928906065,0.4897959183673469,0.9164366283091031,1.0,4/67,4.98%,NOX5;ESPL1;SNX18;SEPTIN4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5664529753538258,-0.967746435137194,0.5208333333333334,1.0,1.0,4/11,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.46546704942983674,-0.9677242852823718,0.3953488372093023,1.0,1.0,4/22,7.09%,SELP;SELE;UMOD;F11R
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6199668762888868,-0.967703802841805,0.5849056603773585,1.0,1.0,3/5,22.20%,PER2;E2F1;E2F3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.42029660996813534,-0.9676025354863123,0.5306122448979592,1.0,1.0,8/47,12.20%,PALM3;SIGIRR;OAS3;OAS1;RNF113A;TRAIP;APOA1;PYDC1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.46236992290642875,0.9674217425481709,0.45454545454545453,0.917268268146493,1.0,13/39,20.71%,BRINP3;RORB;WNT9A;EPHA3;HTRA2;ABL2;PTK7;CREB1;FZD4;RET;WNT2;LYN;ADNP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.5135166810741068,-0.9674146917959103,0.5384615384615384,1.0,1.0,1/16,4.48%,EML3
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.429664729413824,-0.9673836235729487,0.4642857142857143,1.0,1.0,11/66,7.93%,SELP;GAB3;TRAF3IP3;CD53;CYTH4;APOL3;CIITA;DOCK2;HCK;ARHGAP15;TAGAP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.6235395254411076,0.9673165069133856,0.6037735849056604,0.9172499841315759,1.0,4/7,23.73%,VSIR;DDIT3;TNFSF4;IL12A
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,-0.44974694823892136,-0.96729204062023,0.5555555555555556,1.0,1.0,13/52,8.49%,CD24;GYPB;DOCK8;TRAF3IP3;CD53;ALOX5;IFIT1B;KLRB1;BTK;HCK;ARHGAP15;TAGAP;ALAS2
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.5303081389000777,0.9672673978863959,0.559322033898305,0.9170940094114802,1.0,6/17,26.16%,UBAP1;MVB12A;FURIN;SGIP1;VPS37D;NMT2
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,0.44858518926787094,0.9672277350992659,0.4406779661016949,0.9166332573587911,1.0,6/44,7.66%,STAB1;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,0.44858518926787094,0.9672277350992659,0.4406779661016949,0.9166332573587911,1.0,6/44,7.66%,STAB1;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.49132777553529094,-0.9672230904883203,0.5106382978723404,1.0,1.0,7/23,19.80%,CD86;HLA-DRB1;HLA-C;ICA1;HLA-DQA1;HLA-DMA;HLA-DPA1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6096335978926145,0.9670560622284886,0.5172413793103449,0.916771872461115,1.0,2/8,12.75%,SHMT2;CBS
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4309381930330841,-0.9670149221177334,0.4222222222222222,1.0,1.0,3/61,1.15%,CD24;PALM3;SIGIRR
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5755917458127096,-0.9669900954670843,0.5416666666666666,1.0,1.0,1/8,2.29%,IL11
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.5170357806325839,-0.9669214492921383,0.5,1.0,1.0,2/17,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5464207290384957,-0.9668783641217953,0.5641025641025641,1.0,1.0,3/15,13.30%,SARS1;DARS2;DTD1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5309664033466195,-0.9668415926221409,0.5294117647058824,1.0,1.0,4/16,12.82%,IL11;UBASH3B;KIF26A;IGFBP3
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.589201587052654,-0.9667072333323421,0.5581395348837209,1.0,1.0,2/5,29.70%,BNIPL;ATCAY
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,0.5152106745879955,0.9666829204916393,0.54,0.917380314236746,1.0,6/26,12.78%,KLRD1;SYK;PLCG2;PIK3CA;HLA-E;SOS1
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.4601340040578989,0.9666302325986919,0.5384615384615384,0.9172398133662478,1.0,6/34,10.39%,ITGA8;ITGB8;BMP2;ITGAV;LTBP1;LOXL2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.5823549604286481,0.9666151327619915,0.5357142857142857,0.9170077632805663,1.0,2/8,13.84%,CD244;CD74
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5637250206390322,0.9665015439286069,0.5416666666666666,0.9169896024567409,1.0,2/10,11.06%,BIN1;NPPA
prerank,KEGG_2021_Human__Th17 cell differentiation,0.4405161414743084,0.9664202417476665,0.58,0.9169256632015249,1.0,19/83,16.97%,RUNX1;TGFBR1;IL4;HIF1A;STAT5A;IL2RA;RORA;RELA;SMAD2;IL23R;SMAD4;MAPK8;PPP3CA;PPP3CC;NFATC3;IL21R;MAPK10;CD247;RORC
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4268798449049388,0.9663276679874954,0.4888888888888889,0.9168655772812226,1.0,13/66,15.37%,SIRT1;PPARG;ENPP1;BMP2;ZFP36L2;RORA;WWTR1;MEDAG;FOXO1;ANKRD26;CREB1;RUNX1T1;FRZB
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.5890163138702487,0.9662683808923163,0.5961538461538461,0.9167635794793331,1.0,1/8,9.70%,PTPRT
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.6252019759098804,0.9661733083891542,0.5769230769230769,0.9167417021664126,1.0,3/6,22.25%,PIK3CA;SOS1;GRB2
prerank,Reactome_2022__Suppression Of Apoptosis R-HSA-9635465,-0.6509789428167239,-0.9661175015191802,0.675,1.0,1.0,1/5,6.23%,RNF213
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.477270046958843,0.9660943521415499,0.5111111111111111,0.9166626705305297,1.0,2/24,0.50%,GPR55;ADRA1A
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.4439684864289453,-0.9660776474117222,0.43137254901960786,1.0,1.0,9/46,7.93%,SIRPG;SELL;TRAF3IP3;CD53;CYTH4;KLRB1;HCK;CD5;TAGAP
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.46443907323852246,-0.9660283180829796,0.47058823529411764,1.0,1.0,9/35,13.89%,TERT;FOS;EGR1;JUN;SPI1;ATOH8;FOSL1;SMAD3;TGFB1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.42151122027312427,0.9659806374038009,0.46,0.9166598870397968,1.0,14/90,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,Reactome_2022__Sensory Perception Of Salty Taste R-HSA-9730628,0.6626578906656839,0.9655036212316636,0.6153846153846154,0.9177197790520345,1.0,2/5,20.41%,SCNN1B;SCNN1D
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.6301713437301584,-0.9654755212451688,0.58,1.0,1.0,1/5,4.34%,TST
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,0.4436817620618028,0.9653117627126728,0.5,0.9179337176884867,1.0,10/56,6.24%,SELPLG;FERMT3;ITGAX;PIK3R6;SASH3;PIK3R5;CD244;HCLS1;IL10RA;LAIR1
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.6162281117235013,0.9651509338186842,0.5576923076923077,0.9180295235497519,1.0,2/5,26.67%,STMP1;CD36
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.5419889972120893,0.9649956160729002,0.5555555555555556,0.9181252715572358,1.0,7/17,26.26%,SYT1;UNC13B;PPFIA3;SLC18A2;PPFIA2;SYN2;TSPOAP1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.41106103363885993,-0.9646612094003694,0.5957446808510638,1.0,1.0,7/62,10.77%,PLA2G2C;PLAAT4;ENPP2;AGPAT4;PLCB2;PGP;PLB1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6008470721405311,0.9645842331215781,0.543859649122807,0.9189704025688563,1.0,4/7,34.47%,IGF1R;INSR;PICK1;PRNP
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,0.5485508102471152,0.9645685209203114,0.5172413793103449,0.9187235280721107,1.0,6/11,21.98%,GLUL;PYCR1;RIMKLA;GLUD1;RIMKLB;OAT
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.5761367198985264,0.9645567554344543,0.5660377358490566,0.9184653966006624,1.0,2/7,23.75%,GALK1;GALT
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3902968495026578,-0.9643311990745409,0.5,1.0,1.0,23/141,12.54%,SELE;TEK;NLRP1;BST1;NLRP3;IL1RL2;MEFV;ALOX5;PRKCD;PTGES;AHSG;CD200R1;ZP3;HCK;MMP9;CCN3;TMSB4X;APOA1;IL18;TYRO3;FFAR4;PIK3AP1;AKNA
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.34520628644261153,-0.9642561181222138,0.5357142857142857,1.0,1.0,33/393,9.53%,TRIP10;NTRK1;ARAP3;CD24;TEK;PRDM1;RAC2;FGF1;BST1;PAK6;PLK3;RASGRF2;OBSCN;STARD8;RPF2;NEK8;VAV3;IER3;PRKD2;GPR143;ARHGAP15;ARHGDIB;ARHGAP12;TAGAP;RFC3;LBH;CHD4;CEACAM1;NTRK3;WWC1;RAD50;TAF11;TAF7
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.41368223211756733,0.964118822354992,0.5294117647058824,0.9193856769738048,1.0,12/43,22.04%,SIRT1;HDAC3;HDAC2;TBL1X;SIRT6;SIRT7;MIER3;HDAC9;TBL1Y;HDAC1;BRMS1L;MIER1
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.4602825489797936,0.9640741400498231,0.5555555555555556,0.9192148941713524,1.0,13/37,28.92%,ARHGAP31;RHOU;NCK2;ARHGEF6;DST;PKN2;STAM2;GRB2;USP9X;HGS;SPTBN1;SRGAP2;NCK1
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,0.5531116028593653,0.9640641527164574,0.4827586206896552,0.9189568480007827,1.0,3/10,16.08%,STAT5A;FLT3;GAB2
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.44572255382344156,0.9640205627842844,0.509090909090909,0.9187749051424234,1.0,5/38,13.08%,FGF10;FGF17;PIK3CA;SOS1;FGF5
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.3417593242039376,0.9640111577669396,0.54,0.9185209431951714,1.0,74/346,17.81%,LGALS9;IRS1;ITGAX;SYK;MYC;CCL5;IL26;IL4;SOCS2;HIF1A;STAT5A;CSF3R;SEM1;CSF2RA;BLNK;IL2RA;RORA;PELI2;PTPN20;IL7R;IL10RA;RELA;RALA;PELI1;MAPKAPK2;ZEB1;TIFA;KCNH8;MAP2K6;IL15;PELI3;LIFR;HMGB1;FOXO3;RHOU;PTPN14;TAB2;MAPKAPK3;PIK3CA;PSMD13;RPS6KA2;IL23R;FOXO1;IL13RA2;MEF2C;MAPK8;IRAK1;SOS1;IL18R1;TANK;HSPA8;PSME4;CREB1;RPS6KA1;LMNB1;POU2F1;IL21R;GAB2;TAB3;MAPK10;PSMA1;HNRNPA2B1;PKN2;MAP3K8;RPS6KA5;RORC;RAG2;IL33;IRAK3;CSF1;VEGFA;TXLNA;PTPN23;TP53
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,-0.5166991432544524,-0.9638308668280667,0.5660377358490566,1.0,1.0,3/14,15.19%,POLR1A;RPA3;EXO1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.45130789009169253,0.9637191331770749,0.4444444444444444,0.9189882039315398,1.0,7/36,23.18%,ATXN1;NXT1;ANP32A;XPO1;RGS14;NCBP1;GEMIN6
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.5930626943943678,0.963652503585606,0.5,0.9188709132867253,1.0,2/5,14.38%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.36241588503358135,0.9636220291526963,0.5,0.9186550799215197,1.0,34/143,19.93%,NRG1;ANGPT1;DNAI4;DLGAP5;IMMP2L;CHCHD4;VAMP1;SNCA;PDE4DIP;SMAD1;HIP1;SMAD2;PSMD13;BIN1;TCF4;VAMP3;DNAAF3;PXN;SMAD4;ANLN;NCK2;PICALM;PSMG2;DMD;HIGD1C;POGZ;HIGD1B;PRLR;GTF2B;DNAAF2;TBCA;VAMP4;MID1IP1;TBCE
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.42492270834717805,-0.9635999300843775,0.5192307692307693,1.0,1.0,11/54,11.61%,CLDN4;COL5A1;CLDN1;ALOXE3;FLG;COL1A1;HRNR;FLG2;STMN1;WNT10A;ALOX12B
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.43956172751954614,0.9635976398161635,0.5576923076923077,0.918443168098665,1.0,6/57,10.25%,PNP;NRIP1;RORA;DPP4;TMIGD2;IL23R
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.5900124773309687,0.9635966153171666,0.6136363636363636,0.9181707351278215,1.0,1/10,3.95%,STEAP4
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.6035090154283294,0.9635653937961024,0.55,0.9179818327483538,1.0,3/6,25.79%,HLA-E;ANXA1;STOML2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.5282917281736766,0.9632841405271217,0.5,0.9183726476612004,1.0,1/24,0.40%,PNP
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.4924494673710497,0.9630682947280734,0.49019607843137253,0.918713995131018,1.0,4/16,14.76%,GNB4;GNG12;GNG4;ARHGEF6
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.6098555042688193,-0.9629319864753999,0.6086956521739131,1.0,1.0,4/8,20.90%,DRD2;HTR2B;HTR1D;EDN3
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.3701030080711562,0.9628028420419747,0.4489795918367347,0.919149787120561,1.0,51/246,23.29%,ZDHHC11;TMPRSS2;ACE2;REXO2;PRMT1;ST6GALNAC3;SDC4;TLR2;GPC5;MAGT1;MOGAT2;CHMP6;STING1;GPC4;TAB2;SIKE1;GALNT1;ZDHHC2;RPS5;FUT8;PRKCSH;HLA-E;MAN2A1;IRAK1;MGAT5;MGAT4C;IKBKE;MGAT4A;TAB3;RANBP2;G3BP1;RPS3A;IRF3;AKT3;HLA-F;SEC24B;RIPK2;IKBKB;TLR1;CANX;HLA-B;NUP153;AKT2;GJA1;ZDHHC9;FURIN;TUSC3;GEMIN6;VPS18;TAB1;PARP8
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4656389431176088,0.962629652136787,0.48,0.9192787447775024,1.0,7/29,21.51%,BOK;TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,-0.5994372748997072,-0.962613004613433,0.5490196078431373,1.0,1.0,1/8,0.42%,NTRK1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.4838254265532232,0.9624700650522195,0.49056603773584906,0.9194038412950388,1.0,6/23,8.14%,TNFRSF18;STAT5A;ITGA2;IL2RA;DPP4;ADA
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.50750166940044,-0.9624180956045195,0.5192307692307693,1.0,1.0,10/27,15.56%,GUCA1B;PDE6B;CNGB1;PPEF1;NMT1;GNGT1;GNB5;CHURC1-FNTB;CALM1;METAP2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5074892394074721,-0.9623601670120876,0.5283018867924528,1.0,1.0,1/27,0.17%,TERT
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.5783856245819298,-0.9622211411787962,0.48214285714285715,1.0,1.0,1/10,4.09%,RNASE1
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.3973570823753974,0.9620853568850073,0.48936170212765956,0.9201643353319029,1.0,18/96,12.22%,NXPH1;FSTL5;GRM3;SLC17A6;SYT1;ZDHHC22;POU3F2;ELAVL2;OLFM3;FAM171B;RIMS2;SYT14;CAMK2N2;CTNNA2;PAK5;NOL4;DPF1;FRMD5
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5568395783138337,-0.9619728810824714,0.5892857142857143,1.0,1.0,6/9,26.12%,MEOX1;PTCH1;SMO;PPP2R3A;SFRP2;MTHFD1
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.46957692234464743,0.9619160850699432,0.5263157894736842,0.9203458126826449,1.0,3/22,1.22%,SLC12A7;TCIRG1;ATP6V0D2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.6200073473823458,0.9618327957299312,0.5862068965517241,0.920296582505672,1.0,1/6,10.16%,CTNNA2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5195886010950747,0.9616381908777426,0.5344827586206896,0.9205988448877607,1.0,1/13,1.76%,MYC
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.39354658993866704,0.9615919273116302,0.5,0.920481563663831,1.0,15/70,17.16%,PLOD2;MMP15;ST8SIA4;UBE2D3;ABL2;ST3GAL6;LOXL2;QPCT;UBA3;CSNK1G3;FBXL2;CPE;PADI4;BAP1;FBXO11
prerank,CellMarker_Augmented_2021__Myeloid Conventional Dendritic cell:Bone Marrow,0.5964579224433411,0.961273248652394,0.5217391304347826,0.9210328653437916,1.0,4/8,10.31%,ITGAX;BTLA;DPP4;CADM1
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.4188837007811849,0.9611999317952502,0.46,0.9209155243661148,1.0,15/59,10.37%,MXRA5;STAB1;C3;SLC16A5;ACE2;NYNRIN;IDO1;ALDH1A1;VCAN;TCN2;ABCA1;CYP27A1;MOGAT2;GSN;XPNPEP2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3964769883320941,0.961050051202552,0.5348837209302325,0.920968112703786,1.0,20/106,14.83%,SHMT2;ZBTB1;KCNC2;EHD1;ASIC1;STEAP4;PRMT1;VSTM5;TIFA;TDO2;ALDH9A1;C9;TK1;CRYZ;HCN1;HSD17B10;TRPM2;ACACA;TMEM120A;ACACB
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),0.6298381754518787,0.9609203891539101,0.5531914893617021,0.9210697252462178,1.0,5/5,37.03%,LIPG;ANXA2;GPIHBP1;LDLRAP1;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.6619906333917563,0.9608888433916492,0.5869565217391305,0.9205675428913651,1.0,1/5,5.20%,DIPK2A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.6619906333917563,0.9608888433916492,0.5869565217391305,0.9205675428913651,1.0,1/5,5.20%,DIPK2A
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.33227954640678753,0.9605276428673423,0.5294117647058824,0.9212686345242013,1.0,63/582,14.99%,SGO1;CTDNEP1;ESPL1;MSH4;CDC14A;CDKN2C;TOP2A;TUBA1C;MYC;NDC80;CDC25A;CCNA2;CDK11A;ACD;LPIN3;REXO2;SEM1;RRAD;CDKN2A;FBXO5;NDE1;H2BC21;CEP70;TEX15;PCM1;PPP1CC;CEP152;GMNN;MCM7;TK1;CHMP6;ANAPC16;CENPO;PSMD13;GINS1;E2F4;DCTN3;POLE2;VRK2;CHEK2;CEP135;DYNC1I2;CNTRL;SYCP2;H2AC6;PPP1R12B;TERF1;XPO1;H2AZ2;PSME4;PHLDA1;SLC19A1;NEDD1;CCND3;ESCO1;RAB33B;DYRK1A;CCNH;CCP110;LMNB1;NEK7;CENPP;H2AX
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.526387799279223,0.9604741357756617,0.5686274509803921,0.9211288195741621,1.0,4/15,17.69%,CD40;GSN;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.5159155238753661,0.9604554291130264,0.5,0.9209137307314518,1.0,4/15,12.69%,BMP2;HPSE;PLXNB1;GREM1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.39529239823860074,0.960423924684553,0.509090909090909,0.9207100706986094,1.0,21/85,12.14%,TSPAN12;CKMT1A;EFNA5;GNG12;FRAS1;TENM3;PCLO;LRIG3;ADGRL2;HDAC2;LRRIQ1;TSPAN6;SERTAD4;VANGL2;EFNB2;ONECUT2;PCDH7;JPH1;ARHGEF16;KCNB2;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5843528507767441,0.960198859633397,0.509090909090909,0.9209998289704767,1.0,1/6,9.65%,NECTIN2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.4623615018221884,0.9599770430021358,0.4888888888888889,0.921236711173896,1.0,4/24,14.30%,TIMELESS;KLK14;TBX18;LRP6
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.5126303531884885,0.9598351634194274,0.5396825396825397,0.9213379704433055,1.0,7/25,15.19%,PPARG;RORA;NR5A2;ESR1;NR1H3;NR4A2;THRB
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.44540313675010784,0.9595231491662077,0.4888888888888889,0.9219244996073924,1.0,11/42,10.71%,HS3ST5;HS3ST3B1;HS3ST1;UGDH;HS3ST2;SDC4;GPC5;HS2ST1;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5556953891588925,0.9594806533159214,0.5471698113207547,0.921792303254684,1.0,5/19,10.25%,ZBTB7B;LY9;VSIR;IL15;IL23R
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4383007689618178,-0.9593737403043859,0.5961538461538461,1.0,1.0,7/35,15.40%,PRKCD;PPP6R1;ARPP19;PTPA;TGFB1;ANKLE2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.5997454016418096,0.9593676814683613,0.54,0.9218030660053131,1.0,1/6,7.89%,SNCA
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,0.6195853731688392,0.9592207901151795,0.5689655172413793,0.9218777233742695,1.0,3/7,21.64%,TICAM1;FADD;TMED7-TICAM2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5021848627886346,-0.9590538851339809,0.4791666666666667,1.0,1.0,2/18,1.88%,DOCK8;CXCL13
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.4784346358880761,0.9590083802096822,0.49122807017543857,0.9221251933631713,1.0,9/34,23.10%,FKBP5;DCTN3;DYNC1I2;HSPA8;DNAJB1;NR3C1;ACTR10;STIP1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.641396375046853,0.9589504208670384,0.5961538461538461,0.921996851446141,1.0,4/6,31.45%,ANGPTL4;HDAC9;RGS2;PLIN5
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5005452813709224,0.9589078386415958,0.509090909090909,0.9217934755252217,1.0,2/13,2.81%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.35194905540416843,0.9588579422313533,0.5652173913043478,0.9216840809128959,1.0,71/464,12.71%,ADRA1A;SMAD6;SIPA1;SEMA5A;CDKN2C;MYC;SIRT1;F2R;ERBB4;GNRH1;FGF2;KAT2B;ANGPT1;ENPP1;CDKN2A;CDKN2AIP;FBXO5;BMP2;TENM1;ST18;KANK2;DUX4;CCN4;SMYD2;NAIF1;TEX15;CCN6;SSTR3;TLR2;DNAJB2;WNT9A;TP53INP1;P3H2;TDRD9;AGR2;HTRA2;TOB1;DLC1;GMNN;RNF139;CBFA2T3;ARID2;PTPN14;MAGI2;DSCAM;SERTAD2;TMEM115;TMIGD3;FRK;BTN2A2;IGFBP6;PLXNB1;RPS6KA2;ITGA1;PTPRK;SINHCAF;VAMP3;DACT3;SMAD4;PLXNB2;GNG4;NR1H3;BNIP3L;TP53BP2;NCK2;PROX1;PTEN;H2AC6;CTBP2;CD34;KNG1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4913093999031658,0.9587229974620552,0.559322033898305,0.9217736757024669,1.0,5/21,14.37%,IL4;LATS1;SMAD2;SMAD4;NREP
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,-0.5971732176584612,-0.9586711648050434,0.5609756097560976,1.0,1.0,1/8,2.60%,PXDN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.44810849537030684,-0.9585796543210785,0.5094339622641509,1.0,1.0,2/58,3.43%,TERT;PRKCD
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,0.5929897304572807,0.9584803606182943,0.5849056603773585,0.9221108603858582,1.0,4/6,35.87%,MMAB;MTR;MMUT;MMADHC
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,0.5516597418688156,0.9582367806498342,0.5769230769230769,0.922380325399558,1.0,6/15,31.21%,HDAC2;SERTAD1;KDM5B;DHX9;LBHD1;YRDC
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4299452592427395,0.9581642071259128,0.5471698113207547,0.9222858861245579,1.0,9/40,16.86%,GAB1;ERBIN;PIK3CA;NCK2;BCAR1;SOS1;SLC30A10;FAM83A;RPS6KA5
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.659386739791857,0.9581509566014287,0.6557377049180327,0.9220265548556859,1.0,1/5,16.05%,SLC4A1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.4708279220408671,0.9577918011345654,0.6101694915254238,0.9225618917854224,1.0,9/32,19.57%,TULP3;EHD1;BBS9;TULP1;ROPN1B;RAB29;ARL3;TTC21B;IFT140
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,-0.5526872222850518,-0.9577860903946596,0.5853658536585366,1.0,1.0,3/9,19.37%,ARPP19;CDK1;ENSA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4833559338875608,-0.9575082436875841,0.52,1.0,1.0,3/25,6.07%,PRKCD;MVP;SFRP1
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.45116419382282535,-0.9573134402355076,0.5769230769230769,1.0,1.0,16/59,12.02%,SELP;CD24;FAM3D;RNASE1;MS4A4A;F13A1;VAV3;ITGA9;HLA-DRB1;OLFM4;CEACAM1;PIP5K1B;CYYR1;UBXN10;P2RY14;SLC5A1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3940164765910685,0.9573095936428354,0.4318181818181818,0.923464076589855,1.0,32/122,20.02%,MYC;SIRT1;ZBTB1;KAT2B;PADI2;SNAI1;ESR1;HDAC3;HDAC2;ACTL6A;SMARCD3;LRWD1;EZH2;LOXL2;HP1BP3;ARID1A;MYB;SETD7;SMARCAD1;SMARCD2;HCFC1;PADI4;HMGN4;SMARCA2;CHD1;RUVBL2;KDM6A;KDM5B;BRWD1;NPM3;SATB2;HDAC1
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.48909618037581565,0.957308724378059,0.45901639344262296,0.9231933899519513,1.0,6/15,27.99%,STAM2;SH3GL1;GRB2;SH3GL2;HGS;EPS15
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3673934151508718,0.9572674845607327,0.5106382978723404,0.9230202176974185,1.0,36/160,20.78%,PROZ;VAPB;F2;GOLT1A;SEC22B;SPTBN5;CD59;ANK2;LMAN1;TRAPPC3L;BET1;TMEM115;COL7A1;DCTN3;DYNC1I2;ANK1;LMAN2L;MIA2;RAB29;COG5;VTI1A;KLHL12;CD55;TMED1;TMED3;TRAPPC8;STX17;VAMP4;TFG;STX5;TRAPPC1;ACTR10;SEC24B;TICAM2;TRAPPC2;SAR1A
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,0.4251430810625623,0.9572073846611511,0.5319148936170213,0.9228621213278535,1.0,10/50,6.24%,LGALS9;TRPC2;FERMT3;PRSS57;STAT5A;PIK3R6;SAMSN1;CD244;HCLS1;LAIR1
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,0.39814356124253886,0.957130982358037,0.5416666666666666,0.9227377981332107,1.0,15/88,17.14%,NDC80;F2R;CHCHD4;RELL1;BCAT1;DSP;CACHD1;TSPAN6;GUF1;CPNE3;RPL21;LYPLA1;PSMA1;SLCO4C1;RPL7
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.511452602261547,0.9570814886727083,0.5102040816326531,0.9226210308087005,1.0,4/21,3.59%,GPR55;MYC;IL4;MAFB
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.6199700483489697,0.9570771003887544,0.5370370370370371,0.922350995944972,1.0,3/5,34.81%,ANXA2;NR1H4;LDLRAP1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.4444087198296673,0.9570362578640547,0.5294117647058824,0.9221372034931072,1.0,2/25,8.97%,TUBA1C;CHMP6
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4279624805786052,0.9568971139570959,0.46296296296296297,0.9222636689679714,1.0,19/46,26.23%,FGFR1;CEP85L;AUTS2;GPM6A;MEF2C;NR4A2;LRP12;KIAA0319;CDKL5;VEGFA;RAPGEF2;ADGRL3;ASTN2;PEX13;USP9X;SPOCK1;NRCAM;DNER;SDCCAG8
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.34805943173687004,0.9568876571993822,0.509090909090909,0.9219977168218465,1.0,10/238,4.68%,SGO1;NDC80;CDC25A;CCNA2;REXO2;SEM1;RRAD;CDKN2A;NDE1;H2BC21
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.4219012602425549,0.9568808499357785,0.574468085106383,0.9217431287908446,1.0,26/73,27.64%,HIF1A;RELA;TLR2;MAP2K6;TICAM1;PIK3CA;PTEN;PPP3CA;PPP3CC;NFATC3;PIK3CD;CD247;ZAP70;AKT3;PIK3R3;TICAM2;IKBKB;MAPK3;AKT2;NFKBIB;JAK2;EGFR;TRAF6;CHUK;NFKB1;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5103583706955613,0.9568178347076529,0.48936170212765956,0.9216193950050606,1.0,2/16,12.00%,CEP135;CEP120
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.41974024044949204,0.956769417266946,0.48,0.9214770681408854,1.0,19/70,21.16%,IL4;STAT5A;IL2RA;RBPJ;RELA;MAPK8;PPP3CA;DLL3;PPP3CC;NFATC3;MAPK10;NOTCH2;CD247;IL2RB;ZAP70;JAG1;IKBKB;NOTCH3;MAPK3
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.4365030159103363,0.9567598223029856,0.5660377358490566,0.9212228604512438,1.0,19/59,24.65%,KAT2B;H2BC21;HDAC2;CAVIN1;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;POLR2H;HDAC1;DPEP2;MAPK3;ERCC3;RBBP4;POLR1D;TAF1B
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.5952112542526357,0.9566892807324991,0.5370370370370371,0.9211329701616398,1.0,4/6,39.96%,DLG1;CYLD;DUSP10;DUSP1
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,-0.47451135731035154,-0.9564609072175599,0.5666666666666667,1.0,1.0,7/32,8.13%,MS4A8;CLCA1;FAM3D;RBP2;MEP1B;TINAG;OLFM4
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.46753678275542837,0.9564561924583749,0.5272727272727272,0.921401209385154,1.0,8/28,25.46%,TET2;METTL21C;ATPSCKMT;VCPKMT;KMT5B;SETD2;OGT;SETD5
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.5359022545482443,0.9563699008649911,0.5172413793103449,0.921072372622006,1.0,6/9,45.07%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.5359022545482443,0.9563699008649911,0.5172413793103449,0.921072372622006,1.0,6/9,45.07%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.4293845105752695,-0.9562857161148721,0.49019607843137253,1.0,1.0,11/65,8.48%,P2RY10;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;DOCK2;ARHGAP15;TAGAP;TMC8;PTPN7
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.4293845105752695,-0.9562857161148721,0.49019607843137253,1.0,1.0,11/65,8.48%,P2RY10;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;DOCK2;ARHGAP15;TAGAP;TMC8;PTPN7
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5191320398656519,-0.9562625106196575,0.4090909090909091,1.0,1.0,5/18,20.54%,TIMP4;PTPN3;PACSIN3;ADAM8;ADAM9
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.5872394163177135,-0.9561993613076365,0.5111111111111111,1.0,1.0,1/12,3.41%,ALOX5
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.3571938321133975,0.9561903995386638,0.6078431372549019,0.9212956719872528,1.0,6/210,4.07%,SGO1;ESPL1;TUBA1C;NDC80;SEM1;NDE1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.4617364161966992,0.9561033752666317,0.5208333333333334,0.9212394229924491,1.0,5/29,16.87%,FGFR3;DCC;PTEN;KIAA0319;DIP2B
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.479664332773749,-0.9559509214596662,0.46153846153846156,1.0,1.0,4/22,16.04%,KDM4D;KDM2B;KDM1B;KDM4B
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.44802277904386445,0.9558650781212006,0.58,0.9215742745303396,1.0,9/28,22.70%,RPS6KA4;RPS6KA2;RPS6KA1;L1CAM;DNM3;RPS6KA5;NUMB;RPS6KA6;SH3GL2
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.4846802223806031,0.95584322722643,0.5645161290322581,0.9213318089604206,1.0,8/27,18.47%,FGF10;SCRIB;MTSS1;MEF2C;RYR2;MESP1;CTNNB1;RHOB
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.38847131614767993,-0.9555218514750476,0.5192307692307693,1.0,1.0,12/128,8.13%,GFRA3;NTRK1;FGF1;MAPK4;TST;NRN1;CAMK2A;LGI4;MPZ;TAGLN;ARNT2;TCEAL6
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5046255311776379,0.9554915437300179,0.5208333333333334,0.9218488257000609,1.0,3/14,14.88%,TLR2;HMGB1;PLSCR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.41190571182625924,0.9553826277893712,0.5833333333333334,0.9218631816958408,1.0,18/91,12.53%,PLOD2;EDIL3;GNG12;DOCK1;CRIM1;LRIG3;ARHGEF17;PPFIBP1;ITGAV;WWTR1;CNN3;ADGRL2;FAM114A1;GPR176;ALCAM;TNC;BCAR1;HTRA1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.5707133984958498,0.9552575423491539,0.5185185185185185,0.9219482102267006,1.0,3/8,19.73%,PICALM;EFNA1;LYN
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5195492830750428,-0.955245209576494,0.5116279069767442,1.0,1.0,1/13,2.27%,DRD4
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.6163400321883785,0.9552219413310569,0.6226415094339622,0.9217617048300618,1.0,2/7,11.43%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.5419965723353477,-0.9550846709327993,0.5098039215686274,1.0,1.0,5/12,12.70%,SCN5A;KCNN2;KCNQ1;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.5206369815349883,-0.9550429477467118,0.5869565217391305,1.0,1.0,4/21,4.93%,DRD4;STAC;CBARP;DRD2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.48523967798869516,0.9550111990030424,0.5172413793103449,0.9219954274675808,1.0,8/20,23.10%,MCUB;SMDT1;RAP1GDS1;MCU;MICU1;PDZD8;MAIP1;BCAP31
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.3927007742273309,-0.9549368081537702,0.5454545454545454,1.0,1.0,20/98,18.74%,UVSSA;SLX4;ERCC1;FANCC;RFC3;XPC;PRPF19;PARP1;GTF2H2;FAN1;COPS7A;LIG1;XRCC1;RPA3;RFC2;RFC1;COPS7B;LIG3;PNKP;COPS6
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5547950331157735,0.9544170944264774,0.5833333333333334,0.9231173183815082,1.0,4/13,19.74%,APOBEC1;RESF1;ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5145415896229557,-0.9543940573388525,0.6041666666666666,1.0,1.0,2/16,8.18%,OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.5829129206038767,0.9541294981229507,0.6363636363636364,0.9235437182075515,1.0,2/8,7.24%,SYK;FER
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.35575846940674044,0.9539965306536365,0.5,0.9235575492907228,1.0,44/234,15.78%,NOX5;SCN7A;SLC12A1;MCOLN3;KCNC2;KCNK2;TRPM8;SLC1A3;ASIC1;TRPV2;TRPC4;SLC12A3;KCNH7;SLC8A1;KCNH4;KCNQ5;KCNH8;KCNH5;ITGAV;SLC39A8;SCNN1B;SLC24A2;SCN10A;ATP6V0A4;SLC9A2;SCN3A;LRRC55;SCN2B;HCN1;SLC6A16;KCND2;ATP1A2;KCNB2;SCN9A;TRPC5;KCNG2;SLC9C2;TRPM2;ANO6;KCNF1;SLC30A10;SLC30A6;SLC9A9;KCNAB3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4631974478902235,0.9539528802140926,0.5476190476190477,0.9233931253402198,1.0,1/24,0.92%,MSH4
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.6502375219192502,0.9538821050287096,0.6458333333333334,0.9233030459107141,1.0,3/5,22.38%,LRRC17;TP53;PTPRC
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.4985489242983424,-0.9538632493652379,0.5098039215686274,1.0,1.0,1/17,4.71%,LDB1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.334696029261515,0.953692463565778,0.4722222222222222,0.923506211423009,1.0,72/423,14.52%,GPR55;ADRA1A;DRD5;INSL5;CHRM2;C3;CCL5;PNOC;F2R;GNRH1;GRM3;PLEKHG2;UTS2R;PIK3R6;HTR1F;CALCR;FGD4;OPRK1;GNB4;GNG12;PDE1A;NPY;INSL3;PIK3R5;RGS10;GPSM3;CXCL12;PENK;ARHGEF17;PTGFR;GPR17;RXFP2;SSTR3;NPFFR2;GRM8;ADRA2C;QRFPR;CASR;GNRH2;GPR176;NTSR2;PDE7A;RAMP3;GNAI3;NPW;GPSM1;RGR;GRM5;PIK3CA;TAC1;PLXNB1;RPS6KA2;C3AR1;UTS2;ARHGEF16;HTR2C;GNG4;PDE4B;PRPF38B;PPP3CA;KNG1;SOS1;GRM4;RGSL1;PPP3CC;GRM7;NPY1R;CREB1;NBEA;RPS6KA1;ADORA1;ADRB1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.4492461029217563,0.9535189415889948,0.52,0.9236758655454242,1.0,8/33,20.47%,TRPC4;SLC39A8;TF;TRPC5;SLC30A10;SLC30A1;ATP2C1;TRPC1
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.4158070335357174,0.9535179570907495,0.5192307692307693,0.9234040362736333,1.0,11/61,18.47%,SEMA5A;RRAS;MYH11;PLXNB1;ITGA1;SEMA3E;SEMA6D;LIMK2;PKN2;FARP2;RHOB
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.44097248688534596,-0.9533614501276476,0.5208333333333334,1.0,1.0,12/51,12.15%,SELL;CD53;CYTH4;PTGDR;F13A1;HCK;SLC11A1;TAGAP;LY86;SPI1;P2RY14;PARVG
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5976676484746702,-0.9533413582058055,0.5714285714285714,1.0,1.0,4/9,18.26%,TAF11;TAF7;TBP;TAF7L
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.5538843230314788,0.9532085475118567,0.5490196078431373,0.923899925874365,1.0,1/12,3.14%,REXO2
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.35412889065745945,0.9526420138087827,0.5510204081632653,0.9250590630894262,1.0,49/280,14.29%,FGF10;MAP3K11;CDC14A;IRS1;IL17RD;FGFR3;MYC;FGFR1;ERBB4;NRTN;NRG1;ANGPT1;SEM1;KSR1;CSF2RA;LLGL1;IL2RA;ABHD17B;SPTBN5;NRG3;MOV10;PDGFRA;NRG2;PPP1CC;FOXO3;SHOC2;GFRA1;FGF17;PIK3CA;CNKSR2;PSMD13;FLT3;FOXO1;RASAL2;RANBP9;RGL2;ABHD17C;SOS1;HSPB1;XPO1;FGF5;PSME4;LYPLA1;RAP1A;LRRC7;CCND3;GRIN2D;DUSP2;CNKSR1
prerank,CellMarker_Augmented_2021__Lung Epithelial cell:Lung,0.6161780676746966,0.9523875920420424,0.5185185185185185,0.9253466477655784,1.0,2/6,30.48%,SLC34A2;SFTPC
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.40685204311592804,0.9523548701359845,0.58,0.9251746750828711,1.0,10/82,12.78%,SYK;ACE2;HMG20B;BLNK;PLCG2;HDAC2;KEAP1;ATP1A2;PHF21A;SOS1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.41913976524645113,-0.9522660125193032,0.5263157894736842,1.0,1.0,11/67,6.58%,ALB;CLDN4;CLDN1;KIF12;HABP2;AHSG;FGL1;DSG2;PAH;FOXM1;MYO5B
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.558487213933198,0.9520842574993464,0.5441176470588235,0.9255435371905916,1.0,2/8,11.93%,ENGASE;MAN2A1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.5779482334054725,-0.9520559755085873,0.4909090909090909,1.0,1.0,1/7,6.91%,PRKD2
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,0.5157775231497893,0.9519879902602907,0.5111111111111111,0.9255049001417073,1.0,3/10,18.96%,IP6K3;NUDT4;IP6K1
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.5660640446156544,0.9519516967110586,0.5614035087719298,0.9252997191786103,1.0,4/7,39.68%,AGO3;TNRC6B;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.5781036404844416,-0.9519486508869718,0.5882352941176471,1.0,1.0,1/6,2.64%,TIE1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.4748758071407823,0.9518425854515977,0.5,0.9253425850578186,1.0,2/19,6.44%,CTDNEP1;TOR1B
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5354715359597128,0.9517218202872658,0.5862068965517241,0.9253669292370033,1.0,6/16,21.86%,ELOVL5;ACSBG1;TECR;ACSL4;ELOVL6;ACSL1
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.4481488372670693,0.9516954057256216,0.4791666666666667,0.9251582711535277,1.0,12/39,17.16%,KCNC2;KCNH7;KCNH4;KCNQ5;KCNH8;KCNH5;KCND2;KCNB2;KCNG2;KCNF1;KCNAB3;KCNQ3
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.5158670691865345,0.9516891102225726,0.5833333333333334,0.924901672705016,1.0,5/18,12.46%,ENPP1;GADL1;ALDH1B1;BCAT1;PANK1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.6215762888361374,0.9516311345035479,0.5686274509803921,0.9247819787076875,1.0,1/5,6.14%,DNAJB2
prerank,KEGG_2021_Human__Thyroid cancer,-0.44513716050449526,-0.9515936072890107,0.5531914893617021,1.0,1.0,1/37,0.42%,NTRK1
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.6359660926353742,0.951505260147185,0.6538461538461539,0.9248360184453558,1.0,2/5,4.15%,RSPO3;MLLT3
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.443152927579351,-0.9514412880969002,0.4489795918367347,1.0,1.0,10/60,8.45%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5303615210133964,-0.9514391931750689,0.5121951219512195,1.0,1.0,3/14,16.11%,F11R;S1PR3;CLDN5
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.4682338406059545,0.9514075125235477,0.48148148148148145,0.9248161487808084,1.0,10/26,20.31%,VCAN;BGN;CHSY3;UGDH;DSEL;CSGALNACT1;BCAN;HEXB;CHST15;CSPG4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.40901498078881265,0.9513200325212658,0.49206349206349204,0.9247925979557818,1.0,26/85,24.90%,MYC;CDC25A;ZBTB1;NEDD4;RELA;PRIMPOL;PTPRK;REV1;MAPK8;NOC2L;PCLAF;BCL3;RUVBL2;TP53;FMR1;POLK;UBE2A;SCARA3;TMEM161A;ERCC3;MAP4K3;IL12A;ERCC8;N4BP1;EP300;EGFR
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.5025489608347726,-0.9511890427672921,0.509090909090909,1.0,1.0,5/24,7.02%,F5;F8;F7;F13A1;PROCR
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5746495067304401,-0.9509718720798263,0.5,1.0,1.0,2/6,21.54%,BRCA1;DNMT1
prerank,CellMarker_Augmented_2021__Immune cell:Breast,-0.6220705856068445,-0.9508415510357231,0.6590909090909091,1.0,1.0,1/5,2.67%,CD86
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Testis,0.5757104789946096,0.9508047523394504,0.6037735849056604,0.9251869128857011,1.0,4/8,16.41%,FRG1FP;PASD1;OR8A1;GTF2IP6
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Testis,0.5757104789946096,0.9508047523394504,0.6037735849056604,0.9251869128857011,1.0,4/8,16.41%,FRG1FP;PASD1;OR8A1;GTF2IP6
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Gonad,0.5757104789946096,0.9508047523394504,0.6037735849056604,0.9251869128857011,1.0,4/8,16.41%,FRG1FP;PASD1;OR8A1;GTF2IP6
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,-0.41952087864879267,-0.9507407232777295,0.45098039215686275,1.0,1.0,7/66,5.40%,ALB;CYP2E1;AHSG;F7;HEPN1;FGL1;PAH
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.582968557806006,0.9507369083224291,0.6181818181818182,0.9248667954418404,1.0,3/9,14.44%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.582968557806006,0.9507369083224291,0.6181818181818182,0.9248667954418404,1.0,3/9,14.44%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3974011465181688,0.9504876875959904,0.6041666666666666,0.9251971581887757,1.0,21/90,10.58%,LGALS9;SMAD6;HSD17B2;F2R;SOCS2;PPARG;SCD;PELI1;MAPKAPK2;ESR1;LOC400499;FER;SNCA;FOXO3;ERBIN;GCH1;TAB2;MAPKAPK3;IL23R;SRR;FOXO1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4093634408778221,-0.9504741951187008,0.5208333333333334,1.0,1.0,15/82,9.97%,COL23A1;COL24A1;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;LOXL4;COL28A1;LAMB3;COL6A3;COL11A2;ADAMTS3;COL26A1;COL1A1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5850510662766392,-0.9504383001826401,0.5609756097560976,1.0,1.0,1/8,4.91%,OLFM1
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.38125557307391483,0.9504311636918237,0.52,0.9250335048271074,1.0,23/86,21.12%,PLEKHG2;FGD4;ARHGEF17;RELA;HDAC3;HDAC2;ARHGEF16;MAPK8;PRPF38B;IRAK1;SOS1;MAGED1;ARHGEF6;VAV2;ARHGEF40;CASP3;GNA13;MCF2;HDAC1;RIPK2;BAD;IKBKB;ARHGEF4
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.5027949158285782,0.9504099539171599,0.5535714285714286,0.9247999479418738,1.0,6/24,18.16%,H2BC21;EZH2;H2AC6;H2AZ2;H2AX;EED
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,-0.3964523576332796,-0.9503895608377073,0.5416666666666666,1.0,1.0,8/67,4.60%,INHA;COL4A2;IL11;ETV4;LY6K;HSF2BP;CBARP;PHLDA2
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,-0.5342118545604246,-0.9503859524920136,0.5660377358490566,1.0,1.0,4/16,13.89%,SLC5A10;SLC2A8;SLC5A1;SLC2A1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5144706588281166,0.9502936526831685,0.6078431372549019,0.9247985623414322,1.0,3/17,15.58%,SLC22A3;SLC22A5;SLC44A4
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.4732114000270716,-0.9502227498020449,0.41304347826086957,1.0,1.0,1/17,0.61%,DDX11
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3853064117219078,0.9500394257165105,0.62,0.9251248769557552,1.0,26/102,15.94%,PMP2;ALDH1A1;GFAP;NDRG2;FREM1;PCDH17;DHRS3;EFS;NRXN1;MEGF10;PTPRD;RAMP3;ANK2;PTPRT;GRIK3;ATP1A2;CNTN1;ZNF536;GPM6B;INTS6;ID4;CRTAC1;L1CAM;FRZB;GPRC5B;CNTN2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5062412750872562,0.9498208491301613,0.5283018867924528,0.9254252343827132,1.0,6/17,25.74%,ANO6;AFDN;ADAM10;BAD;NUP153;AHCTF1
prerank,KEGG_2021_Human__Cholinergic synapse,0.41124633457925924,0.9495684900402203,0.5714285714285714,0.9257290962841793,1.0,24/102,22.07%,CHRM2;PIK3R6;GNB4;GNG12;KCNJ3;PIK3R5;KCNQ5;ACHE;GNAI3;PIK3CA;GNG4;CREB3L2;CREB1;PLCB1;PIK3CD;KCNQ3;PRKACB;AKT3;PIK3R3;MAPK3;GNAQ;CAMK4;GNAI1;AKT2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.3907467595317909,-0.9493368466364163,0.4666666666666667,1.0,1.0,19/90,12.15%,P2RY10;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;CUX2;JCHAIN;BTK;IRF5;HCK;TAGAP;LY86;CARD6;SPI1;ZFAT;LAMP5;PARVG
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.41034848550679676,0.9492844098848785,0.4489795918367347,0.9260474959662567,1.0,14/93,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5373243915562687,0.9490925379361514,0.5416666666666666,0.9262333119772054,1.0,3/12,23.84%,HAP1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.608395259867349,0.9490575639473617,0.6271186440677966,0.926132241245017,1.0,2/7,10.25%,ZBTB1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.45828380402164465,0.9490417949697525,0.48,0.9259025844060675,1.0,6/39,14.42%,TGFBR1;RAPGEF3;PPM1E;PXN;CARMIL1;SORBS3
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.320988459514451,0.9487481345455744,0.65,0.9263418207454654,1.0,148/794,21.90%,ZDHHC11;DRD5;SV2C;IRS1;AP1M2;C3;ANTXR2;TMPRSS2;SYK;ACE2;H2AC25;CALCR;REXO2;SEM1;GNB4;GNG12;HMG20B;BLNK;INSL3;PRMT1;DOCK1;ST6GALNAC3;H2BC21;RELA;RXFP2;SDC4;SYT1;TLR2;KCNH8;MAP2K6;MYO1E;PLCG2;VAMP1;HDAC3;GPC5;HDAC2;GPR176;RAMP3;GNAI3;MAGT1;MOGAT2;CHMP6;STING1;GPC4;TAF3;TAB2;SIKE1;KEAP1;PSMD13;EZH2;GALNT1;ZDHHC2;RPS5;C3AR1;FUT8;TBL1X;LIG4;PRKCSH;HLA-E;ATP1A2;PHF21A;DYNC1I2;GNG4;MAN2A1;MAPK8;IRAK1;H2AC6;SOS1;DNAJC3;XPO1;RPL21;MGAT5;PSME4;PACS1;MGAT4C;DVL2;PML;CREB1;CCNH;IKBKE;ADRB1;TAF5;MGAT4A;TAF2;GNAZ;RXFP1;NFE2L2;TAB3;USH2A;PSMA1;RPL18A;CALCRL;KPNA4;PCSK2;PKN2;CD247;CTNNB1;UBAP1;STAM2;RANBP2;NELFB;RCC1;MNAT1;RPL7;G3BP1;GTF2B;VEGFA;WASL;NOXO1;VAV2;RPS3A;HTR7;EED;ADORA2B;PRKACB;MVB12A;BANF1;NR3C1;IRF3;AKT3;ABL1;POLR2H;LYN;TRIM28;HLA-F;HDAC1;SEC24B;IAPP;FZR1;TAF4;RIPK2;IKBKB;TLR1;NCBP1;ATP1B2;DPEP2;RPL23A;PSMD4;VTA1;MAPK3;CANX;HLA-B;SH3GL1;BRMS1L;NUP153;CRK;WIPF1;GNAI1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5207447910119787,0.9485853057533714,0.6,0.92644651886956,1.0,4/12,13.00%,NLGN1;NLGN4X;LRRTM3;FZD1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.4149811607201733,0.948473415175231,0.5769230769230769,0.9264409851761792,1.0,12/64,8.80%,FLT1;FGFR3;SYK;FGFR1;ERBB4;IL4;ABI3;PDGFRA;FER;EPHA3;IL15;ABL2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.480275165400256,0.9484017418584962,0.5106382978723404,0.9263546863171744,1.0,5/28,7.89%,SYT15;HRH3;SYT6;SYT1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.5915402496239053,-0.948334750048042,0.5306122448979592,1.0,1.0,1/5,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.4752271502798956,0.9482205177712509,0.5531914893617021,0.9265400340979464,1.0,3/27,9.22%,TIMELESS;PAXIP1;ARID2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.506900188782795,0.9481526906894215,0.47058823529411764,0.9264977864847427,1.0,9/21,22.38%,F2R;FGF2;PLCG2;HTR2C;TRPM2;RYR2;RYR3;HTR2A;PTPRC
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.5298567518848442,0.9480742108486045,0.6363636363636364,0.9264078783577592,1.0,14/22,36.59%,EXOSC4;ATF6;EXOSC1;DDIT3;ATF3;EXOSC5;DIS3;EXOSC2;DCP2;EXOSC8;EXOSC9;EXOSC7;NFYC;CEBPB
prerank,KEGG_2021_Human__Insulin secretion,-0.4366230735171298,-0.9479057505646307,0.5319148936170213,1.0,1.0,11/73,14.29%,KCNMB2;KCNN3;CAMK2A;ADCYAP1;KCNN2;PLCB2;KCNJ11;CREB3L1;ITPR3;SLC2A1;ATP1B1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.43970787541236794,0.9478610992841563,0.5686274509803921,0.9266737232713766,1.0,7/39,18.31%,ZBTB20;LIN28A;UNC13B;GCK;IGF1R;PRKAA1;IRS2
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.4172507875258507,0.9477563948995591,0.5185185185185185,0.9267047926606604,1.0,26/60,30.12%,RELA;UBE2D3;HMGB1;SIKE1;CASP10;TANK;IKBKE;MAP3K1;FADD;IRF3;UBE2D1;IKBKB;NFKBIB;EP300;TRAF6;CHUK;NLRC5;TRIM4;NFKB1;NFKBIA;CYLD;APP;IFIH1;PCBP2;ATG12;HERC5
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5090836131284237,0.9476907331871655,0.5185185185185185,0.92662956231163,1.0,1/14,0.92%,SMYD1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.575645227161783,0.9473946246161276,0.6122448979591837,0.9271149401275619,1.0,4/8,19.62%,SNCA;RYR3;SLFN14;FBP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4507406904299464,0.947379980165549,0.5961538461538461,0.926878473088989,1.0,7/27,17.76%,IL4;MARVELD3;CORO1C;PTEN;PTPRM;NR2F2;PTPN23
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.5273213711189779,0.9473425795455791,0.5,0.9266750986693806,1.0,7/14,24.90%,RPS6KA2;SOS1;CREB1;RPS6KA1;MAPK3;GRB2;EGFR
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.5081215342357918,0.9472379147180207,0.5161290322580645,0.9266621950110676,1.0,5/15,26.16%,UBAP1;MVB12A;SGIP1;VPS37D;NMT2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4795301819829879,0.9471093398565342,0.5471698113207547,0.9267590857803516,1.0,5/23,13.86%,ADIPOR2;PRKAB2;ELOVL5;NR1H3;MLXIPL
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,-0.49617495394375766,-0.9470933062541935,0.4772727272727273,1.0,1.0,4/11,13.36%,PARP2;RAD50;PARP1;XRCC1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.41490297235348383,0.9469839090314144,0.47368421052631576,0.9268705543083118,1.0,13/57,20.47%,HIF1A;NEDD4;SNCA;LOXL2;SLC25A13;PPP3CA;PLSCR1;SLC30A4;GPHN;SLC25A12;SLC30A2;ZACN;TRPC1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6093081509999282,0.946971443938987,0.5614035087719298,0.9266418161731345,1.0,2/5,24.00%,FBXO7;LANCL1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.4252128310636199,0.9468369792952963,0.5192307692307693,0.9266910955951467,1.0,10/55,7.00%,COL9A1;FGFR1;NRTN;COL9A2;COL6A5;COL6A2;SPTBN5;CACNB4;ENTHD1;ST8SIA4
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5832305884652331,-0.9467655614940185,0.5625,1.0,1.0,1/7,5.37%,RNF8
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,-0.6112828804911294,-0.9466843445002748,0.559322033898305,1.0,1.0,2/5,28.44%,SUMO2;SENP2
prerank,KEGG_2021_Human__Gastric acid secretion,-0.42079735791609557,-0.9465919231556041,0.5454545454545454,1.0,1.0,11/62,11.78%,HRH2;KCNE2;KCNJ1;KCNJ16;CAMK2A;PLCB2;MYLK3;KCNQ1;KCNJ15;ATP4A;ITPR3
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6116757699190866,0.9465327684631102,0.6071428571428571,0.9271570528031805,1.0,3/7,26.67%,SLC15A2;BIRC3;CD36
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.40796705181189885,0.9464965612096472,0.5769230769230769,0.9269868987087739,1.0,9/60,12.93%,LGALS9;FZD5;CD244;SCRIB;VSIR;HMGB1;IL23R;PDE4B;IL18R1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.648958529027742,0.9463258574812791,0.5740740740740741,0.9271200588554869,1.0,2/5,23.10%,RAP1GDS1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.4036473566900748,0.9463182484715702,0.5769230769230769,0.9268696669810639,1.0,10/69,14.33%,PLEKHH2;LDLR;NAV3;SNCA;KANK1;PIK3CA;SMAD4;HDGFL3;HSPA8;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.44155778193212103,0.9462603538447653,0.5957446808510638,0.9267545102646318,1.0,4/41,7.04%,RAPGEF3;NEDD4;HCLS1;HDAC3
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5372380575808251,0.9462594602739403,0.6153846153846154,0.9264861191524788,1.0,4/13,18.27%,PCM1;CEP120;SYNE3;SUN2
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6053060312405423,0.9460121252402125,0.5625,0.9268090164796408,1.0,2/5,29.59%,FLRT3;NOTCH1
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.42675894668551806,-0.9459945622585685,0.45652173913043476,1.0,1.0,10/62,8.45%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4699014746435191,0.9458941898630453,0.5535714285714286,0.9269201479262756,1.0,10/23,25.02%,HIF1A;RBPJ;ATF6;NFE2L2;VEGFA;TP53;HSPA5;DDIT3;ATF3;SESN2
prerank,CellMarker_Augmented_2021__Nephron Epithelial cell:Kidney,0.4972705009836388,0.945885721414041,0.5161290322580645,0.926677469868516,1.0,3/14,5.50%,ATP6V0D2;SLC12A1;SLC8A1
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,0.5352066364976328,0.9458569755404337,0.5964912280701754,0.9264713902361423,1.0,4/10,29.89%,CASP10;TP53;CASP2;CRADD
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.4668218495163751,0.9458339974397066,0.5660377358490566,0.9262836535359507,1.0,7/32,13.21%,C3;IL4;BICD1;TF;HIP1;SMAP1;PICALM
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.409537190237418,0.9457225151300783,0.5370370370370371,0.9263110033740682,1.0,23/85,18.96%,C1GALT1C1;GOLT1A;SPR;IDH1;UGDH;C1ORF53;ALDH1B1;ALDH9A1;CRYZ;MTX2;CLDN12;RIDA;ABCD3;SLC37A4;LMAN2L;TCAIM;PEX11A;RNF128;HIBADH;REEP6;NDFIP2;PLPP1;GNPNAT1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5188183425425205,0.9456348235417914,0.5208333333333334,0.9262181302291984,1.0,6/21,15.30%,RAB27A;CCN6;PLCG2;SNCA;ABCD2;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.441146070025925,-0.9455733272395294,0.5,1.0,1.0,5/37,10.52%,DDX11;KDM4D;FOXM1;RAD51AP1;PARP1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4096278379007681,-0.9454102266803098,0.4772727272727273,1.0,1.0,14/81,7.93%,P2RY10;KLRC1;SIRPG;SELL;SPON2;TRAF3IP3;CD53;CYTH4;HSD11B1;LTB;DOCK2;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.48725510834915337,0.9453171561466036,0.6181818181818182,0.9266861154816429,1.0,5/30,13.04%,FERMT3;MYL12A;PDGFRA;CSRP1;HSPB1
prerank,CellMarker_Augmented_2021__Stem cell:Bone,0.6118483152968678,0.9452652104696707,0.6153846153846154,0.9265604228029152,1.0,3/7,26.72%,CD34;PTPRC;NT5E
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5287517238149193,0.9451757834878382,0.5434782608695652,0.9265257898661637,1.0,8/11,29.59%,ZFP36L2;NELFB;JAG1;HNRNPU;YTHDF2;HES5;N4BP2L2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4332411793597051,0.9450194991171583,0.576271186440678,0.9266294374685446,1.0,4/37,6.74%,PNP;RUNX1;NAV3;PLCG2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5731218412187064,0.94491599890834,0.6037735849056604,0.9265911672189977,1.0,3/8,7.75%,CCL5;EPS8;HMGB1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4352405649554332,0.9446998871101149,0.576271186440678,0.9269238253090389,1.0,11/50,22.12%,EHD1;VPS26C;SNX31;DENND1B;WASHC1;ANKRD50;VPS29;PTPN23;MICALL1;VPS50;WASHC2C
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.42950294013913515,-0.9446475135538378,0.5471698113207547,1.0,1.0,7/61,5.59%,SELP;GAB3;TIE1;RNASE1;APOL3;MS4A4A;F13A1
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.42950294013913515,-0.9446475135538378,0.5471698113207547,1.0,1.0,7/61,5.59%,SELP;GAB3;TIE1;RNASE1;APOL3;MS4A4A;F13A1
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.42950294013913515,-0.9446475135538378,0.5471698113207547,1.0,1.0,7/61,5.59%,SELP;GAB3;TIE1;RNASE1;APOL3;MS4A4A;F13A1
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.42950294013913515,-0.9446475135538378,0.5471698113207547,1.0,1.0,7/61,5.59%,SELP;GAB3;TIE1;RNASE1;APOL3;MS4A4A;F13A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.6061084653331661,-0.944644526703446,0.6153846153846154,1.0,1.0,2/6,29.20%,TRDN;EHD3
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.42100180092949785,0.9444533208337857,0.46,0.927289009082443,1.0,4/74,8.33%,NXF1;U2AF1;THOC6;NXT1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.48492561152921476,-0.9444503243314896,0.5714285714285714,1.0,1.0,5/31,14.25%,RAC2;ENPP2;CLRN1;RREB1;RAC1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.37179202066686096,0.9444018978027501,0.5254237288135594,0.9271560915428104,1.0,39/149,17.55%,IL17RD;PAWR;MYC;FZD5;LRP4;ROR1;GNG12;FRAS1;TENM3;DOCK1;ALDH7A1;LRIG3;CD59;FBLIM1;TEAD2;ADGRL2;LIFR;SMAD1;DSP;PTPN14;MAGI1;TSPAN6;SMAD2;SMAD4;CLDN6;FZD1;PTK7;PML;LRP6;L1TD1;ANO6;SMAD5;GJB1;GJC1;BCL3;NXN;CTNNB1;PIWIL1;DCBLD2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.628242177100971,0.9443666524184111,0.5818181818181818,0.9269687527677835,1.0,4/6,12.03%,MAPKAPK2;MAPKAPK3;CARMIL1;RAB34
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.633794598564328,-0.9443462203136309,0.5121951219512195,1.0,1.0,4/5,29.73%,PINK1;HAX1;PRKN;ATP5IF1
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.475721885594601,0.9442303775966323,0.5192307692307693,0.926995818471189,1.0,4/32,11.08%,PLD6;PLA2G10;ACP6;PRKCSH
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.5689423215861115,-0.9442033810927756,0.6078431372549019,1.0,1.0,1/8,3.18%,ENPP2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5304958067020269,0.9441473891080662,0.5471698113207547,0.9268957801604902,1.0,5/11,37.49%,TERF1;CCT3;CCT7;DKC1;CCT4
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.3614447128561504,0.9441414291754794,0.48,0.9266505974013037,1.0,37/161,23.12%,DERL3;SYVN1;UBE2J1;DNAJB2;RNF185;UBE2D3;LMAN1;PRKCSH;DNAJC1;RNF5;UBQLN4;MAPK8;BAG2;DNAJC3;MAN1A2;HSPA8;UBE2J2;DERL2;ATF6;SEC61A1;NFE2L2;MAPK10;SEC61A2;DNAJB1;SEC24B;HSPA5;UBE2D1;DNAJC5B;SAR1A;STT3B;DDIT3;DNAJB11;CANX;EIF2AK3;BCAP31;HSPA1A;TUSC3
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,0.6085144672932213,0.9441187917940289,0.5483870967741935,0.9264345878888415,1.0,1/7,1.76%,MYC
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4619757765871626,0.9437753321872613,0.5964912280701754,0.9270277382637983,1.0,5/25,8.69%,TCIRG1;ATP6V0D2;RAB38;RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.5874477930895926,-0.943772838578178,0.543859649122807,1.0,1.0,2/7,12.81%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.46574091691106856,0.9437300508153333,0.5087719298245614,0.926866148313588,1.0,3/21,6.74%,PNP;RUNX1;PLCG2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5354280148467763,0.9436795982161752,0.6,0.9264526264628067,1.0,5/18,12.52%,IL1RAPL2;SNCA;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5354280148467763,0.9436795982161752,0.6,0.9264526264628067,1.0,5/18,12.52%,IL1RAPL2;SNCA;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5704454601307734,0.9435862301975048,0.5384615384615384,0.9264435404123983,1.0,1/8,2.54%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.4866578855872971,0.943561325114231,0.5283018867924528,0.9262569449368482,1.0,2/16,4.04%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5175991743867547,-0.9435436230624715,0.625,1.0,1.0,7/18,22.46%,SFRP1;PDCL;TXNDC15;DCDC2;EVC;TTC23;SMO
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.44199899484589955,-0.943499989588792,0.54,1.0,1.0,20/59,17.76%,NUPR1;ALOX5;XDH;SFRP1;CEACAM1;VDR;SPARC;CAV2;ATOH8;WDR77;DAB2IP;CAV1;TGFB1;CDKN1C;SCG2;MED1;TGFBR3;FGFR2;STAT1;RGCC
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5811676865253395,-0.9434403282868253,0.5714285714285714,1.0,1.0,4/5,41.43%,MAPT;DNM1L;CLUH;ARMC1
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.3567279883973404,0.9434150236003432,0.5208333333333334,0.9263348413044536,1.0,41/237,14.29%,FGF10;MAP3K11;IRS1;IL17RD;FGFR3;FGFR1;ERBB4;NRTN;NRG1;ANGPT1;SEM1;KSR1;CSF2RA;LLGL1;IL2RA;ABHD17B;SPTBN5;NRG3;PDGFRA;NRG2;PPP1CC;SHOC2;GFRA1;FGF17;PIK3CA;CNKSR2;PSMD13;FLT3;RASAL2;RANBP9;RGL2;ABHD17C;SOS1;FGF5;PSME4;LYPLA1;RAP1A;LRRC7;GRIN2D;DUSP2;CNKSR1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,-0.5587425788192328,-0.943311204422117,0.5849056603773585,1.0,1.0,3/8,15.40%,CAMKK2;CAMKK1;CALM1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4694194952817191,-0.9432024140203962,0.5869565217391305,1.0,1.0,4/35,14.01%,CENPH;RNF8;ITGB3BP;SMARCA5
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.4138607279167734,0.942862932182131,0.5454545454545454,0.9273794108691524,1.0,14/63,20.95%,HIF3A;EGLN3;HIF1A;SEM1;UBE2D3;PSMD13;PSME4;EPX;PSMA1;VEGFA;CITED2;LIMD1;UBE2D1;PSMD4
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.39015257570569695,-0.9428009536073506,0.5892857142857143,1.0,1.0,3/97,2.09%,ACOT1;PM20D1;PLAAT4
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5821046167800124,0.9427081807826997,0.6271186440677966,0.9275619093052865,1.0,2/9,6.36%,FGF2;APELA
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.33550694583962054,0.9426655181695127,0.5454545454545454,0.9274403416028648,1.0,26/317,9.14%,REP15;TCIRG1;ATP6V0D2;TVP23B;RAB38;TBC1D3L;ACD;TBC1D8B;PPARG;EHD1;TBC1D12;LRP1B;IL10RA;RAB31;LTBP2;RAB3C;VPS26C;ABCA1;TF;MTTP;ARL5A;SNX31;RAMP3;ATP6V0A4;ARRDC3;RAB23
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.46601764659231776,0.9425781830219052,0.58,0.9273622542724106,1.0,4/20,11.08%,SYK;PLCG2;PIK3CA;PRKCSH
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,-0.4093029963438314,-0.9425438433946508,0.4716981132075472,1.0,1.0,9/72,12.30%,ACTC1;ST8SIA2;BEX1;GPC3;SLC7A3;SEMA5B;COL26A1;LRRTM1;RTL1
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,-0.4093029963438314,-0.9425438433946508,0.4716981132075472,1.0,1.0,9/72,12.30%,ACTC1;ST8SIA2;BEX1;GPC3;SLC7A3;SEMA5B;COL26A1;LRRTM1;RTL1
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.47785434156928314,0.9424386154182731,0.5636363636363636,0.9274758868263202,1.0,10/18,39.49%,ANAPC16;UBE2D1;UBE2E1;ANAPC15;CDC27;ANAPC7;BUB3;ANAPC4;ANAPC5;UBE2S
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5384377571387022,-0.9423429765320587,0.5869565217391305,1.0,1.0,3/16,11.75%,FBXO43;CAV2;KIF20B
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.5630826486735806,0.9423167324758105,0.6153846153846154,0.9274882209331995,1.0,6/12,39.36%,TIPARP;PARP8;PARP14;PARP9;PARP6;PARP3
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.5564271753461256,-0.942304142690262,0.6,1.0,1.0,3/15,10.52%,NUPR1;ACTN3;PARP1
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.4597195496614937,0.9422613240446961,0.5370370370370371,0.9273921148710106,1.0,6/29,19.73%,SYK;PLCG2;CREB1;CD247;PRKACB;LYN
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5375783164245771,-0.9421970789164203,0.56,1.0,1.0,1/11,2.45%,DGAT2L6
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5414039943211303,0.9421877216034792,0.5625,0.9272671567135722,1.0,4/14,10.42%,SPR;GCH1;CYB5B;MTARC2
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,0.5032125707649454,0.9421850053941294,0.6716417910447762,0.927005000331609,1.0,4/18,13.08%,FGF10;FGF17;SOS1;FGF5
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.40816353836900415,0.942171152181933,0.49019607843137253,0.9267827188073109,1.0,14/96,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,KEGG_2021_Human__Butanoate metabolism,0.4502993271393583,0.9421449813751995,0.5510204081632653,0.9265786161037719,1.0,4/24,12.64%,ACSM2A;ACADS;HMGCS1;BDH2
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.43859539416980603,0.9419903809428004,0.5344827586206896,0.9267499934603729,1.0,13/40,26.91%,UHRF2;NRIP1;NCOA2;RNF2;TRIM28;SCMH1;PHC3;ING3;EP300;PIAS2;PHC2;MRTFA;NCOA1
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.6197658657290677,0.9416784404990305,0.6545454545454545,0.9273145695315778,1.0,1/5,4.39%,SYNCRIP
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.5532122672544835,-0.9416552678364806,0.5576923076923077,1.0,1.0,3/8,17.32%,WNT7A;ARF1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4860214827214909,-0.9416005837471212,0.5660377358490566,1.0,1.0,9/25,13.89%,TERT;FOS;EGR1;JUN;SPI1;ATOH8;FOSL1;SMAD3;TGFB1
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.4779700290925483,0.9415306387040786,0.5769230769230769,0.9274279230333281,1.0,11/26,18.43%,CDH6;CADM2;CDH2;CDH12;NECTIN2;CADM1;CDH10;CDH8;CDH24;CTNNB1;AFDN
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.46218194357538395,-0.9414864728004012,0.5094339622641509,1.0,1.0,5/22,10.39%,PDHX;PXMP2;PRODH2;GLDC;GOT2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.41754932352060714,0.9414456692074261,0.5283018867924528,0.9273536911876378,1.0,15/60,21.60%,UHRF2;RNF185;UBE2D3;RNF146;UBE3D;RNFT1;CNOT4;KLHL24;MARCHF7;TRIM52;RNF208;RAG1;RNF19B;UBE2A;MARCHF5
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5326278535892475,0.9414299948927394,0.5925925925925926,0.9268881940010265,1.0,4/14,14.32%,ARID2;SMARCD3;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5326278535892475,0.9414299948927394,0.5925925925925926,0.9268881940010265,1.0,4/14,14.32%,ARID2;SMARCD3;ARID1A;SMARCD2
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,0.4155648226892008,0.9414108300447757,0.5660377358490566,0.9266808665129498,1.0,9/58,11.11%,SELPLG;RCBTB2;OR52K3P;FGL2;ANXA5;TLR2;C3AR1;OSCAR;HLA-E
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.5158718555522424,0.9413950691696206,0.5769230769230769,0.9264628514097955,1.0,2/10,7.75%,TLR2;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3993575602646386,0.9413764645840134,0.5531914893617021,0.9262485618981409,1.0,14/74,18.72%,PRR16;EIF3E;SAMD4A;SP1;RELA;LRRTM3;HNRNPD;PLXNB2;PICALM;BCL3;FMR1;EFNA1;ABCA2;CASP3
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.38656531485168766,0.9413243537151763,0.45614035087719296,0.9261243943745271,1.0,13/88,13.01%,RASEF;TBC1D8B;NEDD4;FRAS1;FER;GAN;MORC4;FRK;SPINK9;BMPR1A;SHPRH;MIPOL1;EPB41L4A
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.6231848794066839,-0.9410169965543573,0.627906976744186,1.0,1.0,2/5,21.11%,LRPAP1;MYOCD
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.48842925950609084,-0.9409870713072134,0.5714285714285714,1.0,1.0,1/16,0.64%,IL10RB
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.4497130113663646,-0.9409230731314694,0.56,1.0,1.0,1/22,4.15%,CMTR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3821046982942427,0.9408672352089733,0.4716981132075472,0.9268712448479884,1.0,32/143,20.95%,LRP4;BMP2;MLLT3;DKKL1;WWTR1;LATS1;PSMD13;IGFBP6;DACT3;TBX18;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;DVL2;TMEM170B;LRP6;FZD4;PTPRU;FZD6;FRZB;MESP1;PSMA1;KLHL12;RUVBL2;TLE4;LIMD1;AMER2;HDAC1;DDIT3;PSMD4
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.5326519484348338,-0.9407286279568384,0.5476190476190477,1.0,1.0,1/19,2.67%,CD86
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.45525374188520934,-0.9407214967659272,0.4418604651162791,1.0,1.0,5/30,7.78%,HK2;BIK;CAMK2A;IFIT2;CLU
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,0.46209293843373855,0.940636396650232,0.559322033898305,0.9271031652822617,1.0,7/29,25.70%,CHMP6;UBAP1;STAM2;MVB12A;VTA1;HGS;VPS37D
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,-0.3980977873263561,-0.9406224722168371,0.5737704918032787,1.0,1.0,6/88,3.23%,RAB44;MPO;SELL;SPON2;SHCBP1;TCF19
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.41058698166683144,0.9405782327250172,0.5319148936170213,0.9269752632721017,1.0,3/56,3.15%,STK26;SIRT1;TFEB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6141307650540894,0.9404945844815715,0.6458333333333334,0.9269660981023071,1.0,1/7,5.50%,SLC8A1
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.4287059877643599,-0.940429718612522,0.48148148148148145,1.0,1.0,5/52,9.57%,HK2;LDHC;LDHAL6A;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.5877851734399108,0.9404130507709019,0.6363636363636364,0.9269389639165736,1.0,3/6,33.56%,VPS18;NDP;ULK3
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.44731610671520294,-0.9403755659287143,0.475,1.0,1.0,3/43,2.62%,MYH7;SCN5A;STAC
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,0.41413591098821373,0.9402352719256978,0.4230769230769231,0.9270879425710286,1.0,11/46,19.24%,PELI1;HMGB1;CHMP6;TNFRSF10B;FASN;TANK;BIRC3;FADD;TP53;CASP3;TNFRSF10A
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,0.4154919222554192,0.9402173293456018,0.45454545454545453,0.9268667779581321,1.0,5/54,2.92%,KLRD1;FCAR;CSF3R;PYHIN1;LY9
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.48468756863151796,0.9401946160056512,0.5454545454545454,0.926649331176319,1.0,5/26,14.99%,H2BC21;HDAC2;H2AC6;H2AZ2;H2AX
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.5371201648165994,0.9401519445080044,0.5357142857142857,0.9264786880737476,1.0,4/10,23.85%,TSR3;NOP10;RPUSD2;NAF1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.5804683653382314,0.9400912511453855,0.5555555555555556,0.9263655778469704,1.0,1/5,21.16%,MAPK3
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.6276334848397881,0.939990954601097,0.6,0.9263960803258375,1.0,4/5,26.96%,DAND5;CITED2;FOXH1;SHH
prerank,KEGG_2021_Human__Influenza A,0.39773011396015584,0.9399843325917427,0.5357142857142857,0.9261395505791147,1.0,36/118,24.06%,TMPRSS2;CCL5;NXF1;CPSF4L;RELA;PRSS3;TICAM1;NXT1;PIK3CA;TNFRSF10B;DNAJC3;XPO1;CCND3;PML;IKBKE;NXF5;SLC25A31;PIK3CD;FADD;IL33;CDK4;CASP3;DNAJB1;TNFRSF10A;IRF3;AKT3;PIK3R3;IKBKB;MAPK3;AKT2;MX2;CDK6;NFKBIB;IL12A;JAK2;CALCOCO2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.34364047921667046,0.939820533996252,0.6274509803921569,0.9262884599571768,1.0,45/299,15.10%,ASB17;C3;RAB38;HIF3A;SOCS2;HIF1A;ASB18;SPSB2;ASB15;CDH2;EVA1A;VCAN;PENK;KLHL21;ASB5;FBXL3;TF;SPSB4;DCUN1D1;ANKRD9;SOCS6;FBXO30;GAN;SENP8;KCTD6;KEAP1;PSMD13;LTBP1;TNC;FBXO7;FBXL14;PTP4A2;PRKCSH;KLHL42;KNG1;DNAJC3;DCAF5;ASB6;PSME4;UBA3;ESCO1;KLHL13;FBXL15;UBXN7;MGAT4A
prerank,CellMarker_Augmented_2021__Monocyte:Lung,0.4418676937409606,0.9396804661899509,0.3888888888888889,0.9264014281633476,1.0,8/47,10.67%,STAB1;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1;TFEC;C3AR1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.3542898514727815,0.9396447188745157,0.6590909090909091,0.9262419006414817,1.0,44/238,18.53%,MITF;PAWR;ACD;NLGN1;LLGL1;PCLO;FBLIM1;SPAG16;NEFH;TEAD2;EPS8;HORMAD1;CD40;NLGN4X;LIN7A;SLC7A9;RHOU;MATN1;MAGI1;GSN;LRRTM3;RANBP9;VAMP3;HAS2;SYCP2;GPM6B;FZD1;PICALM;NOC2L;CD74;PML;ESPN;RP1L1;GPAA1;CD247;MNAT1;CD2AP;GORASP2;RHOG;WASL;TP53;TOGARAM1;RHOD;IL2RB
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.4908329333229239,0.9396034457671532,0.4827586206896552,0.9260752966268537,1.0,5/20,16.35%,PEX12;GDAP1;ABCD3;ABCD2;PEX2
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.6182834655839294,-0.9394071150759439,0.6304347826086957,1.0,1.0,1/5,10.14%,SLC2A8
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.6467320123535135,-0.9393749271009771,0.62,1.0,1.0,2/5,25.04%,SLF1;XRCC4
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.4889148882302722,-0.939335763600658,0.5370370370370371,1.0,1.0,1/22,0.73%,AMACR
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4433896538118434,-0.9389375375997985,0.5576923076923077,1.0,1.0,8/29,20.41%,MAP1LC3B2;ATG14;RUBCNL;CALM1;TECPR1;LIX1L;GABARAPL1;CHMP3
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5546150017010176,-0.938817903127705,0.5217391304347826,1.0,1.0,4/12,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.5792567300557151,0.9387996434360032,0.5660377358490566,0.9277000806821967,1.0,1/6,2.54%,HIF1A
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.42723046930535624,-0.938690186223323,0.5625,1.0,1.0,5/47,5.09%,H1-3;H1-4;H1-2;PRKCD;DSG2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.49724521902677365,-0.93867991746755,0.574468085106383,1.0,1.0,5/21,7.80%,GUCA1B;PDE6B;CNGB1;PPEF1;NMT1
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.41710857387930506,0.9386411152266788,0.5111111111111111,0.9279128032582706,1.0,9/51,22.18%,U2AF1;THOC6;PAPOLA;PCF11;SRSF11;CSTF3;WDR33;NCBP1;SRSF3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5348631570799299,0.9385944335174825,0.6333333333333333,0.9277852526100951,1.0,3/13,4.04%,ADRA1A;ZDHHC12;NLGN1
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.42406211366407914,0.938557459642614,0.46938775510204084,0.9276434562763533,1.0,21/56,24.47%,RENBP;ST6GALNAC3;NANP;ST8SIA4;UAP1;ST3GAL6;NUS1;EGFL7;MVD;NPL;SLC35C1;GFUS;DOLK;GNPNAT1;GFPT1;ST8SIA1;DPM1;GMDS;ST6GALNAC4;CTSA;ST6GAL2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3809919336788034,0.9385055085570516,0.48936170212765956,0.9275267900882609,1.0,18/81,15.60%,RIT2;RETREG3;ROR1;TOX;TENM3;ZNF804A;FUT9;EPHA3;ABL2;MAGI2;PLXNB2;FZD1;RAP1A;LRRC7;DBN1;PTK7;CAPRIN1;COBL
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.409261530869192,0.9384119362629652,0.48936170212765956,0.9274781626720154,1.0,11/51,13.09%,LGALS9;CCL5;HIF1A;RELA;NLRP7;CD40;SNCA;HYAL3;HAS2;IRAK1;TANK
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,0.4363492989619224,0.9382505747407514,0.5555555555555556,0.9270750849172686,1.0,8/53,7.66%,STAB1;ITGAX;CSF3R;IL10RA;FGL2;TLR2;LAIR1;SIGLEC1
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,0.4363492989619224,0.9382505747407514,0.5555555555555556,0.9270750849172686,1.0,8/53,7.66%,STAB1;ITGAX;CSF3R;IL10RA;FGL2;TLR2;LAIR1;SIGLEC1
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,0.4363492989619224,0.9382505747407514,0.5555555555555556,0.9270750849172686,1.0,8/53,7.66%,STAB1;ITGAX;CSF3R;IL10RA;FGL2;TLR2;LAIR1;SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),-0.5914061744898913,-0.9382479449320565,0.5208333333333334,1.0,1.0,1/6,0.91%,FBXO43
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,0.6415759426087589,0.9381793851996234,0.6111111111111112,0.9270194938306938,1.0,1/5,11.90%,NR1H3
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.45750758238571404,0.9381673170836565,0.5185185185185185,0.926792457523044,1.0,1/29,0.53%,FGF10
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.44663474361594424,0.9380412901223417,0.5416666666666666,0.926836977779854,1.0,12/36,29.16%,ESR1;PTEN;RNF128;TP53;UBE2D1;RIPK2;TNIP3;OTUD7B;TRAF6;YOD1;TRIM4;IFIH1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.4778512940948664,-0.9379771737794191,0.5625,1.0,1.0,5/30,8.08%,SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.33539058933656857,0.937962947278697,0.5272727272727272,0.926799353429998,1.0,55/397,17.72%,VAPB;TUBA1C;NDUFC2-KCTD14;FZD5;SEM1;WNT4;FRAT2;UBE2J1;RELA;NEFH;MAP2K6;WNT9A;HTRA2;SNCA;ATXN1;ATG101;MCU;GRM5;HIP1;PSMD13;HAP1;DCTN3;DNAH8;SNCAIP;KLC2;MAPK8;PPP3CA;FZD1;TANK;UBE2J2;PPP3CC;GRIN2D;HSD17B10;DVL2;LRP6;FZD4;FRAT1;FZD6;IFT57;ATF6;SLC25A31;PLCB1;COX6A1;PPIF;GPR37;RYR2;DNAH14;GRM1;MAPK10;PSMA1;CTNNB1;FADD;CSF1;WNT2;NDUFB11
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.45032881293020244,0.9373030584855515,0.48,0.9281359681528519,1.0,10/25,30.46%,NAV3;HDGFL3;MID1IP1;CAMSAP2;ARHGEF2;CIB1;MAP1B;FGF13;CLASP2;CLASP1
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.4249066757978259,-0.9371388118606555,0.5106382978723404,1.0,1.0,9/58,8.45%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.502818512184527,-0.9371171136682268,0.5576923076923077,1.0,1.0,4/15,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.40659204168139285,0.937109259574998,0.6170212765957447,0.9283906049983401,1.0,9/54,9.38%,GPR55;IGF1;FGF10;F2R;GPR174;GPR17;ERBIN;SHOC2;AUTS2
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,0.5760504260501006,0.9370455351088943,0.6136363636363636,0.9282669558210764,1.0,5/9,23.16%,LLGL1;GRIK3;MPP3;GRIK1;DLG1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.5704973673610775,0.9368402267900068,0.6607142857142857,0.928485747827345,1.0,2/6,7.29%,CCL5;IL15
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.49363604424617996,-0.9368350384541322,0.49019607843137253,1.0,1.0,2/21,4.09%,DNASE1L1;REXO4
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.39705434704051445,0.9365300030390447,0.5294117647058824,0.9290074714657918,1.0,10/63,20.95%,CCNA2;SEM1;ANAPC16;PSMD13;PSME4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.31051017641512774,0.9365257050691069,0.7317073170731707,0.928766129205837,1.0,219/930,20.72%,TEX101;AASS;MSH4;CDKN2C;PAWR;PBX3;C19ORF38;URI1;KASH5;AK3;SLC26A7;LEAP2;NPC2;CTSF;ADGRG6;JADE3;ACVR2A;SYDE2;ZFYVE16;RNF182;RALGPS2;LCORL;SPAG16;TEX15;SYPL1;DMC1;VEZF1;CNTLN;KLHL8;ARHGAP5;ITGAV;SMDT1;TUBE1;PCM1;AFTPH;NBPF8;ZNF595;LRRC36;ACSS2;FBXL3;ANKRD36;MED13L;HORMAD1;ADGRL2;WDSUB1;PAX6;UAP1;SLC35G2;TDRD9;RAB3IP;HDAC2;NCOA5;DSEL;SCAF4;NBPF10;SMG1;ASF1B;CLGN;LATS1;TMEM263;UBE2E3;DENND1B;ARID2;ZCCHC7;MTX2;AK1;SPOPL;C16ORF95;CCNB3;CTCFL;CNKSR2;SCEL;NSRP1;PRPF39;OXR1;PCF11;EZH2;PDIK1L;SRR;IL13RA2;LZTFL1;RANBP17;SYNGR4;PHF21A;RNFT1;CCDC158;DNAJC1;FANCL;ANKRD50;SMAD4;BBIP1;CETN3;CEP120;CNTRL;ACBD3;SYCP2;ZNF800;TIPARP;PPP1R12B;CDK12;INTS6;UBA6;LZIC;CCDC82;TERF1;TANK;GABRB2;TASOR2;ZNF652;MLF1;RSRP1;DENND5B;TMEM98;TBCCD1;SPAG6;SPATA22;CHD9;B3GALNT2;EMC2;CSMD3;CENPP;IFT57;RICTOR;C9ORF43;HIPK1;ZNF280B;RWDD2B;SLC25A31;PTBP2;ORC4;RBM41;SPESP1;PHIP;CCDC181;DNAH14;SLC35F5;HSF2;GPAA1;S100PBP;PIGP;CCDC152;KRCC1;MAPK10;BTBD10;EAF2;MNS1;NHLRC3;DNAJB9;LIMK2;NOTCH2;MYDGF;PPIL6;GLCCI1;CTNNB1;DGAT2;VPS29;RAB28;FBXO11;URGCP;SIMC1;CEP350;ARHGAP21;ZDHHC17;MXI1;LCOR;MACF1;TXLNA;ZMYM2;KDM6A;FMR1;SOCS7;FARP2;AGO3;TSC22D2;CD55;ZMAT1;ARHGAP20;PHLDB1;RASA2;TRAPPC8;NDFIP2;FAM229B;SMC3;PHLPP1;RP2;GKAP1;KDM5B;POLK;RAVER2;PHTF1;CSTF3;TEX14;BRWD1;PRKACB;GNPDA2;SNX16;DZIP1;NR3C1;FBXL20;FAM169A;GPR89A;WNK1;SENP6;BMPR2;STX18;ZDHHC13;KIAA1586;JOSD2;SEC24B;RNF19B;POT1;COLEC11;PIK3R3;SUCO;RAB5B;HINFP;C1D;ADNP2;SYCP3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.4405186289837883,0.9365109204138637,0.4339622641509434,0.9285320500967468,1.0,13/38,28.70%,CCN6;PYCR1;SPART;SLC25A33;ABL1;PPA2;HEBP2;BAD;PID1;AKT2;STOML2;PRELID1;OPRD1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.5874112453465121,0.9365043884187897,0.5961538461538461,0.9282767293025105,1.0,1/5,18.03%,MAF1
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.40963445826010436,0.9363383751709616,0.5238095238095238,0.92843822818241,1.0,21/93,16.15%,NYNRIN;FGFR1;CDH2;BGN;FREM1;CXCL12;EFS;PDGFRA;PTPRD;PCDH18;NLGN4X;PABPC5;ANK2;MAGEL2;FAM43B;COL11A1;RUNX1T1;NREP;OLFML3;FRZB;PDZRN3
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,0.4161003675254518,0.936258189362149,0.5510204081632653,0.9283931371413131,1.0,10/53,8.27%,ITGAX;PIK3R6;SASH3;SAMSN1;PIK3R5;IRF8;HCLS1;IL10RA;CD40;TFEC
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.37895883134566344,-0.9359642765733888,0.48148148148148145,1.0,1.0,7/95,3.52%,EHF;CLDN4;SLCO2A1;FAM3D;KCNJ1;PTGES;TRPV5
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.45233389553355796,0.9358896708957664,0.5,0.9289246808557236,1.0,5/33,8.16%,HIF1A;MAFB;PRMT1;ACVR2A;FOXO3
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,0.5790445663755017,0.935883062567595,0.62,0.9286730958583428,1.0,3/7,28.10%,RAP1GDS1;TRAK2;MFN1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3694612601512726,0.9356764798440816,0.5714285714285714,0.9288805455309319,1.0,19/120,11.81%,SLC12A7;SLC12A1;KCNC2;KCNK2;SLC1A3;KCNJ3;SLC12A3;KCNH7;KCNH4;KCNQ5;KCNH8;KCNH5;SLC24A2;SLC9A2;LRRC55;HCN1;KCND2;ATP1A2;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.40388361910689496,-0.9356222631252069,0.5192307692307693,1.0,1.0,15/51,25.87%,GPR132;PSMB4;RFPL1;PSMC4;PSMD8;SKP1;ATF5;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.40589016022778834,0.9353547699723692,0.603448275862069,0.9293368193862958,1.0,14/81,10.97%,MXRA5;FGF10;GNG12;BGN;LRIG3;EFS;PDLIM4;POSTN;ADGRL2;F3;SERTAD4;TNC;PCDH7;MAMDC2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5090900431427638,0.935232808742758,0.559322033898305,0.9293484232689532,1.0,5/15,26.71%,IGF1R;IRAK3;MTRF1;TBC1D25;INSR
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.5314842271305613,-0.9352257580853214,0.5909090909090909,1.0,1.0,1/11,1.43%,GATD3
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4200609232808824,-0.9349963836858985,0.6481481481481481,1.0,1.0,8/49,7.19%,SELP;SELE;CD24;PALM3;TNFRSF11A;TRIB1;IRF5;SLC11A1
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,0.42064123669162223,0.934986580285477,0.6666666666666666,0.9295910499646711,1.0,10/62,6.90%,LGALS9;STAB1;ADAM28;SASH3;SAMSN1;HCLS1;IL10RA;FGL2;LAIR1;HPGDS
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.3502380444835654,0.9348124023678482,0.6875,0.9298086667833939,1.0,20/166,14.60%,CDC25A;CCNA2;CDK11A;SEM1;NDE1;CEP70;PCM1;CEP152;PSMD13;DCTN3;CEP135;DYNC1I2;CNTRL;PPP1R12B;XPO1;PSME4;PHLDA1;NEDD1;CCNH;CCP110
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4157472898701812,0.9347478289853753,0.6166666666666667,0.9297171113311226,1.0,17/67,16.93%,ACSM2A;SCD;FDFT1;ACSS2;SCD5;ABCD3;OXSM;MVD;FDXR;IDI2;ACACA;LIPG;OLAH;STAR;PRKAA1;ELOVL4;PRLR
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.5946075677263388,0.9346345427434751,0.6122448979591837,0.9297214923939536,1.0,6/7,39.29%,TMEM98;HES5;NOTCH1;NF1;DRD3;HES1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.4808524089783554,-0.9345987746309122,0.5,1.0,1.0,2/14,7.09%,PIAS3;EGR1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3897669494958726,0.9343359616304474,0.5777777777777777,0.9302051605395592,1.0,27/85,21.86%,SLC7A11;SLC26A7;SLC10A3;SLC26A6;SLC38A3;SLC38A4;SLC7A2;ABCC2;SLC7A9;SLC10A5;SLC25A48;NCOA2;SLC10A1;ABCC11;SLC19A1;SLCO1A2;AKR1C1;SLC3A2;SLC36A1;SLC7A14;SLC7A6;SLC25A30;ATP8B1;SLC6A15;SLC7A8;SLC25A14;ACSL1
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",-0.5109989503030723,-0.9342587610430638,0.5319148936170213,1.0,1.0,4/12,5.72%,AGRN;GPC2;GPC1;GPC3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3696743006676421,0.9342569023833163,0.5681818181818182,0.9301029228998668,1.0,28/137,18.97%,VAPB;GSTM2;LPIN3;PCSK5;ABHD3;NANP;SLC44A5;HPGDS;CHPT1;ELOVL5;PCYT1B;ACHE;CEPT1;GCH1;PPM1L;CERS3;SGPL1;DMD;CERS5;SLC44A4;ELOVL4;GPHN;ALDH3B1;CPS1;PLPP1;MOCOS;SAMD8;GSTA4
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6105197819844717,0.9340809503243098,0.6727272727272727,0.9302810580469918,1.0,3/5,13.74%,ACVR2A;SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5440095447946541,0.9339665409556174,0.6181818181818182,0.9302817281582296,1.0,5/10,32.79%,CPEB1;NCBP1;CPEB3;CDC73;NUDT21
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.37623356023105975,0.9338765821158889,0.559322033898305,0.9301937404638037,1.0,3/87,4.07%,SGO1;NDC80;NDE1
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,0.6288505662980226,0.9337838090610194,0.5925925925925926,0.930151891164867,1.0,1/7,1.67%,SYK
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5775005360544021,-0.9337288545753123,0.58,1.0,1.0,3/6,15.24%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5775005360544021,-0.9337288545753123,0.58,1.0,1.0,3/6,15.24%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5250842644074891,0.9336567113051986,0.5208333333333334,0.930202217270809,1.0,9/15,39.04%,INTS6;ZCCHC8;INTS11;INTS8;INTS3;INTS1;INTS2;INTS7;INTS5
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,0.4123927142339813,0.9336410292969853,0.5490196078431373,0.9299796805047746,1.0,10/91,7.46%,MXRA5;LAMA4;PLEKHH2;PRRX1;LTBP2;POSTN;CCDC80;NFIA;LPP;ABI3BP
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5013766498002109,0.9335329117596254,0.5272727272727272,0.9299839766888146,1.0,7/20,25.09%,TTLL2;TPGS1;TTLL9;NAA11;TTLL7;TTLL8;AGBL4
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.3936189417261791,0.9335140983373306,0.5471698113207547,0.9297616262993227,1.0,27/88,19.65%,LAMA4;TMEM100;ITGA8;PRRX1;PRKG1;GNG12;BGN;PDGFRA;BMPER;LIFR;GUCY1A2;PCDH7;RBMS3;RUNX1T1;NR2F2;SEMA6D;FZD4;FBN1;PDZRN3;CCDC3;WNT2;ARHGAP20;PHLDB1;BNC2;PYGO1;SVEP1;ENOX1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.38815691382314793,0.9333931338637205,0.52,0.929251010831751,1.0,23/93,16.06%,PLOD2;HIF1A;ITGA2;GNG12;DOCK1;CRIM1;SDC4;MYOF;ITGAV;MYO1E;EPS8;F3;FAM114A1;PDGFC;ALCAM;EXT1;RASAL2;PXDC1;SLC41A2;FZD6;TMTC3;ASPH;TNFRSF21
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.38815691382314793,0.9333931338637205,0.52,0.929251010831751,1.0,23/93,16.06%,PLOD2;HIF1A;ITGA2;GNG12;DOCK1;CRIM1;SDC4;MYOF;ITGAV;MYO1E;EPS8;F3;FAM114A1;PDGFC;ALCAM;EXT1;RASAL2;PXDC1;SLC41A2;FZD6;TMTC3;ASPH;TNFRSF21
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.38815691382314793,0.9333931338637205,0.52,0.929251010831751,1.0,23/93,16.06%,PLOD2;HIF1A;ITGA2;GNG12;DOCK1;CRIM1;SDC4;MYOF;ITGAV;MYO1E;EPS8;F3;FAM114A1;PDGFC;ALCAM;EXT1;RASAL2;PXDC1;SLC41A2;FZD6;TMTC3;ASPH;TNFRSF21
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.43002910706032316,-0.933237146027222,0.5490196078431373,1.0,1.0,8/56,7.15%,SELP;GAB3;TRAF3IP3;CD53;CYTH4;PRAM1;BTK;HCK
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.48880902200473975,-0.9330826378881438,0.5714285714285714,1.0,1.0,1/20,2.09%,PLAAT4
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.6006151195740728,0.9330106567075095,0.7037037037037037,0.9298356291477055,1.0,1/9,3.12%,ASIC1
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.4008861961619294,-0.9329181134566853,0.5192307692307693,1.0,1.0,4/65,4.64%,ACTC1;STK10;STARD8;DHDDS
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4872188392986452,0.9328345635170731,0.5932203389830508,0.9300450666327611,1.0,1/13,3.24%,LDLR
prerank,KEGG_2021_Human__Glioma,0.4146359608502154,0.9327338603831825,0.5,0.9300210532011571,1.0,19/68,22.84%,IGF1;CDKN2A;PDGFRA;PLCG2;PIK3CA;PTEN;SOS1;IGF1R;PIK3CD;CDK4;TP53;POLK;AKT3;PIK3R3;MAPK3;CAMK4;AKT2;GRB2;CDK6
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.48752220366494337,0.9327333981207562,0.5283018867924528,0.929760250886743,1.0,6/26,13.60%,ERBB4;FDFT1;PDE4DIP;LHX6;MEF2C;PHLDA1
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.4307165067637129,0.9326997563653887,0.5689655172413793,0.9296091293533775,1.0,6/35,13.08%,FGFR3;GALNT3;FGF17;PIK3CA;SOS1;FGF5
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3369370526478302,0.9326683978841889,0.6410256410256411,0.9294298334709965,1.0,42/250,19.57%,STK26;FHDC1;CDC14A;EHD1;FGD4;TNIK;VSTM5;SPAG16;SSTR3;TRAPPC14;PCM1;RAB3IP;CEP20;MTSS1;RAB23;BBS9;RAPGEF6;GSN;LZTFL1;BBIP1;SSX2IP;CARMIL1;KIAA0586;RABL2B;RAP1A;ARHGEF6;RPGR;ANO6;DNM3;DZIP1L;CD2AP;EXOC6;CEP19;ARL3;PTPN23;RHOD;RAP2A;RP2;KIT;DZIP1;ATAT1;IFT140
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5944309271115686,-0.9325750416815157,0.6153846153846154,1.0,1.0,2/6,18.88%,RNF213;SERPINB9
prerank,CellMarker_Augmented_2021__Schwann cell:Undefined,0.5660994683893276,0.9325578193388315,0.5964912280701754,0.9294378018682764,1.0,1/6,3.01%,GFAP
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5044365696585,0.9324561190629032,0.4727272727272727,0.9294175225744785,1.0,2/14,11.43%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6343391256911998,0.9323964512648479,0.65,0.9292949016109252,1.0,3/5,33.89%,ABCA2;APOE;LAPTM5
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.4088347214264765,0.9322532843336098,0.5517241379310345,0.9278149897978933,1.0,18/76,10.77%,PLCH1;CAPN13;TMPRSS2;ACE2;NYNRIN;ESRRG;VWA2;MYCN;FRAS1;FREM1;UNC5D;TMEM200C;SVOPL;PTPRD;TSPAN6;PTPRT;VANGL2;CGN
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,0.4093478429801705,0.9319334652066708,0.5416666666666666,0.9283727451207405,1.0,14/80,5.64%,SELPLG;TRAC;SASH3;ZEB2;ARHGAP31;TRPV2;SAMSN1;FLI1;IL7R;HCLS1;XAF1;IL10RA;ABI3;FGL2
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.49635356656441054,0.9319004936718654,0.5538461538461539,0.9281979161307801,1.0,1/13,8.97%,CHMP6
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.3903588035356081,-0.9318453495845542,0.5882352941176471,1.0,1.0,14/88,15.27%,ADSS1;ENTPD2;AK8;UPB1;XDH;RRM2;AK7;NT5C;ENTPD5;CTPS1;PUDP;TK2;RRM1;UPP1
prerank,Reactome_2022__Diseases Associated With Visual Transduction R-HSA-2474795,0.5292263603417265,0.9318034747949805,0.6415094339622641,0.928213240958292,1.0,2/8,5.82%,LRAT;NAPEPLD
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.6072603675166895,0.9316616221015143,0.6,0.9282989287537636,1.0,1/6,3.01%,PADI2
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.3782651677559886,0.9316459403375014,0.6122448979591837,0.9280715028346023,1.0,17/84,14.09%,REXO2;CLSTN2;MCTP2;TIFA;CNN3;RPIA;ABI3BP;GRM8;PPM1A;RAPGEF6;IGSF11;PTPRK;UBE2U;DNAJC3;IRAG2;PCMTD1;CREB1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4577881559390329,0.9315960133346276,0.5192307692307693,0.9279286025328796,1.0,5/31,16.19%,SIRT1;RNF152;EPM2A;PRKAA1;KPTN
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5187530013549371,0.9315887759862247,0.6136363636363636,0.9276978911570974,1.0,3/14,12.35%,CCL5;TICAM1;IRAK1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.5209362736178312,0.9315675886709907,0.5230769230769231,0.9274848817118709,1.0,2/12,3.48%,TGFBR1;WNT4
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.49877063526537435,0.931564589709257,0.5471698113207547,0.9272263133032532,1.0,1/22,1.94%,SIRT1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.47562046378347794,0.9313513638446387,0.5740740740740741,0.927442102487387,1.0,5/24,14.99%,H2BC21;H2AC6;H2AZ2;RAB33B;H2AX
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6157654349321805,0.9313358859713501,0.64,0.9272082720827679,1.0,4/7,28.65%,ABL1;APOE;EPHA4;APP
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5718949322191467,0.9312251287679026,0.5789473684210527,0.927174683862921,1.0,5/9,38.09%,AGO3;DHX9;DICER1;TARBP2;CLP1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4353378444892301,0.9309940151367393,0.5454545454545454,0.9273762681185418,1.0,12/39,21.62%,TRPM8;SLC7A2;SFXN2;ATP1A2;TRPM2;SLC22A5;SLC44A4;TRPM7;SLC3A2;TRPM3;KCNJ8;SLC7A8
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.41555429953989004,0.9308821253157662,0.5964912280701754,0.9273917747597817,1.0,15/57,18.31%,SIRT1;PPARG;ZBTB20;TLCD3B;ABCA1;NR1D2;ABHD8;NR1H3;MLXIPL;LIPG;PRKAA1;PNPLA8;DGAT2;ABCA2;IRS2
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,0.607617795780328,0.9307537625176818,0.5740740740740741,0.9274669054387253,1.0,5/7,37.36%,AKT3;AKT2;CBFB;ITGA5;ITGBL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.49655421983962356,0.9305058347510818,0.5625,0.927553936058123,1.0,3/18,9.95%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.49655421983962356,0.9305058347510818,0.5625,0.927553936058123,1.0,3/18,9.95%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.40942497126242994,0.9304980107578581,0.5714285714285714,0.92730300534178,1.0,13/35,26.24%,LRP4;CTNNA2;PTEN;KLF7;WASL;FARP1;MAP2;DIP2A;MAPK8IP2;MEF2A;DOCK10;PHACTR1;MAP6
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.5689034582718253,0.9304892718424098,0.6538461538461539,0.927080245373779,1.0,4/8,30.16%,RAP1GDS1;TRAK2;MFN1;RHOT1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5185610512093178,0.930424934220187,0.5714285714285714,0.9269662000420504,1.0,4/18,7.72%,RIT2;CD22;PLCG2;NEUROD2
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.5417876343617947,0.9302787676617015,0.6,0.9270343198042271,1.0,3/14,14.46%,SYT1;UNC13B;PPFIA3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5142417508011221,-0.9302371332135861,0.5777777777777777,1.0,1.0,4/16,9.83%,SPRY4;GPC1;PRKD2;CREB3L1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.626856288331199,0.9302291373086302,0.6326530612244898,0.9268888417380082,1.0,4/5,35.24%,GPAA1;PIGT;PIGU;PIGK
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5408502544922453,-0.9301181708995508,0.6590909090909091,1.0,1.0,4/16,14.60%,KIF2B;BUB1;IHO1;CDC6
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5000983536434221,0.9300814291302965,0.5531914893617021,0.9270024452933965,1.0,4/11,22.43%,NFE2L2;HSPA5;DDIT3;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5103437492991207,0.9298892802165889,0.5217391304347826,0.9271474771256553,1.0,3/22,14.36%,GSTM2;JPH1;DMD
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.42990506788285854,0.9297177006413134,0.5370370370370371,0.9272854323151849,1.0,12/47,23.10%,SYK;PELI3;ZNF675;CPNE1;HIPK1;BIRC3;FADD;CCDC3;IKBKB;CARD16;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.42973039917082384,0.9295152610459364,0.6111111111111112,0.9274967499993179,1.0,5/32,8.69%,TCIRG1;ATP6V0D2;RAB38;RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.4886108764253845,0.9294563312990903,0.5961538461538461,0.9273723221967334,1.0,2/10,10.84%,BMP2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6000434045191002,-0.9290602458616898,0.62,1.0,1.0,1/6,16.37%,SHANK3
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.6174933524801226,0.9289700552232649,0.6,0.9282510737752652,1.0,1/5,11.46%,VAMP3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3604805377210579,0.9289362894372287,0.5681818181818182,0.9280566220555596,1.0,20/165,14.22%,U2AF1;HNRNPH1;SF3B1;SYNCRIP;LIN28A;APOBEC1;IVNS1ABP;SNRPN;RBMS1;BICD1;NOVA1;ATXN1;SNRNP48;ADARB2;HNRNPD;MRPL44;RRAGC;CDK12;RBM5;TENT4B
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4599049031959212,0.9288305370887404,0.5319148936170213,0.9280578984805095,1.0,8/34,15.29%,NLGN1;SYT1;CEL;SNCA;NLGN4X;PICALM;STON2;DNM3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5293178436049758,0.9287897167901974,0.6,0.9278985305732661,1.0,3/15,12.51%,F2;NLRP7;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4795348451871144,0.9285134501326154,0.5106382978723404,0.9283257868940696,1.0,10/19,30.84%,NCK2;PTEN;MLXIPL;DMD;INPP5J;SMAD7;NLRP2B;NCK1;PDE4D;DDIT4
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.58413745727452,0.9283523695181446,0.5689655172413793,0.9284386779097986,1.0,2/8,7.57%,PDGFRA;AGR2
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.5867870508154092,0.9283459125626322,0.6,0.9281851244386288,1.0,4/7,24.88%,ROBO2;PRKACB;ROBO3;PRKAR2A
prerank,KEGG_2021_Human__Hippo signaling pathway,0.3752047772904269,0.9281213201082671,0.5873015873015873,0.9284619460556597,1.0,33/149,17.56%,MYC;TGFBR1;FZD5;GDF6;WNT4;BMP2;LLGL1;MOB1A;SCRIB;WNT9A;TEAD2;WWTR1;PPP1CC;SMAD1;LATS1;SAV1;SMAD2;CTNNA2;BMPR1A;SMAD4;TP53BP2;FZD1;CCND3;DVL2;FZD4;FZD6;DLG2;CRB2;PPP2R2B;CTNNB1;BIRC3;BMP8B;WNT2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5479532061693094,0.9281075710273358,0.5576923076923077,0.9282329384115804,1.0,5/9,27.86%,CSGALNACT1;GFPT1;B4GALNT2;EXTL2;FN3K
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5481176829193706,-0.9279686066841883,0.5769230769230769,1.0,1.0,3/12,5.63%,ABCA4;PDE6B;CNGB1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5494808111478713,-0.9278368374682915,0.54,1.0,1.0,2/9,10.00%,SLX4;RTEL1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4887821208036325,0.9277041610499673,0.6274509803921569,0.928987238183205,1.0,5/23,14.72%,SIRT1;CDKN2A;SMC5;PML;KAT6A
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.4527012081216553,0.9274095163558642,0.5384615384615384,0.9294518248953118,1.0,1/34,2.25%,NXF1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.41373503949825235,0.9270850517507988,0.5423728813559322,0.9299440309458011,1.0,13/72,17.74%,MRAP2;DPP10;STAC2;ABI3;EPHA3;AGR2;RAMP3;ZDHHC2;ARHGEF16;PICALM;STX8;NUMB;RHOG
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.5595096850616409,0.927062975913735,0.6,0.9297253175432418,1.0,2/12,6.74%,SYK;PLCG2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.6016464022054541,0.927062579178907,0.5740740740740741,0.9294684163778528,1.0,2/5,16.58%,MESP1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4494353047576328,-0.9268394188374952,0.5319148936170213,1.0,1.0,4/32,4.93%,DRD4;IL11;RHBDF1;DRD2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.40624351866355646,0.9266185003320956,0.58,0.9303223005926979,1.0,4/68,3.52%,TCIRG1;ATP6V0D2;TFEB;RNF152
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,0.3918581495909016,0.9266145379345635,0.6078431372549019,0.9300723378143207,1.0,18/78,11.86%,GATA4;IGF1;RSPO3;ALDH1A1;CALCR;ADD3;BMP2;CDH2;MAP2K6;PDGFRA;DPP4;MTTP;CPN1;CACHD1;GPR161;CADM1;AMOTL1;CARMIL1
prerank,KEGG_2021_Human__Inflammatory bowel disease,0.44596692102169966,0.926554002042248,0.532258064516129,0.9299443032046638,1.0,9/39,16.97%,IL4;RORA;RELA;TLR2;SMAD2;IL23R;IL18R1;IL21R;RORC
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5386713341213188,0.9265148454449662,0.6041666666666666,0.9297989454840488,1.0,9/14,27.95%,TRPC4;SLC39A8;TRPC5;SLC30A10;ATP2C1;TRPC1;SLC39A14;TMEM165;TRPC3
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.495156178859303,0.9264664478065684,0.5925925925925926,0.9296954015592319,1.0,6/24,19.62%,SIRT1;ZNF692;GCK;SIRT7;SDHAF3;FBP1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.494959794998277,0.9264533005522019,0.609375,0.9294597948940474,1.0,3/26,7.71%,IGF1;NRG1;ADRA2C
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.4244270726310838,0.9264443663952728,0.5918367346938775,0.9292312699424368,1.0,7/45,14.46%,SLC1A3;SYT1;UNC13B;LIN7A;HSPA8;APBA1;PPFIA3
prerank,KEGG_2021_Human__Pancreatic cancer,0.3940175355437471,0.9264439290192427,0.62,0.9289750716325547,1.0,22/74,22.84%,TGFBR1;CDKN2A;RELA;RALA;PIK3CA;SMAD2;SMAD4;MAPK8;ARHGEF6;PIK3CD;MAPK10;VEGFA;CDK4;TP53;POLK;AKT3;PIK3R3;BAD;IKBKB;MAPK3;AKT2;CDK6
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.5220073193631757,0.926363527441746,0.5660377358490566,0.9288753429198643,1.0,4/11,23.41%,MOV10;NTNG2;MACF1;FAM110C
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,0.4452967446094025,0.9262773921570526,0.5636363636363636,0.9288555483153148,1.0,2/29,7.30%,PLD6;TDRD9
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4540368936042067,0.9261248565810317,0.5,0.9289954788984358,1.0,4/32,8.16%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,Reactome_2022__Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,0.6303161446790999,0.9260424682749893,0.6363636363636364,0.9289062402433065,1.0,3/5,27.98%,TANK;FADD;TRADD
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5512905298633872,0.9259894395781275,0.6744186046511628,0.9287615285255678,1.0,6/9,34.15%,EXOSC4;DXO;EXOSC5;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.5930429183627962,0.9256869906999557,0.5806451612903226,0.9292274725940181,1.0,2/6,6.55%,CXCL12;EPS8
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.39045601461996354,0.9256361993246849,0.5961538461538461,0.9291278390853217,1.0,19/81,19.66%,CDC14A;MYC;SEM1;MOV10;FOXO3;PSMD13;FOXO1;HSPB1;XPO1;PSME4;CCND3;NCOA3;PSMA1;PKN2;RAG2;AGO3;DNAJB1;PRKACB;RAG1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.34512783169306815,0.925478920070097,0.6595744680851063,0.9292293622725221,1.0,68/399,19.44%,TNFSF14;C3;SYK;ZNF300;CCL5;ZNF792;NXF1;ZNF582;RELA;TLR2;ZNF283;ZNF599;ZNF543;ZNF595;TICAM1;PPP1CC;ZNF230;ZNF41;ZNF195;ZNF561;STING1;TAB2;PIK3CA;ZNF675;NECTIN2;ZNF426;TAP1;ZNF669;ZNF114;HLA-E;ZNF347;IRAK1;ZNF175;ZNF778;ZNF212;ZNF20;CD74;ZNF182;PML;IKBKE;ZNF780B;POU2F1;ZNF442;NXF5;ZNF257;HCFC1;ZFP30;ZNF607;PIK3CD;ZNF682;ZNF623;ZNF584;BIRC3;FADD;ZNF786;TP53;ZNF12;ZNF30;ZNF234;ZNF559-ZNF177;ZNF33A;CASP3;ZNF251;ZNF782;IRF3;ZNF519;ZNF311;AKT3
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,-0.34125363636538825,-0.9253774556363872,0.6481481481481481,1.0,1.0,57/356,14.13%,MS4A8;TEKT3;KCNMB2;CFAP61;ATP6V1C2;MRLN;AK8;TTC23L;HHLA2;WARS1;CHST9;DCDC1;CFAP92;MORN3;VWA3A;RGS22;C7ORF57;DNAAF1;SPAG8;ST6GALNAC2;DYNLT5;SLC13A3;KCNE1;DRC1;PLCB2;CFAP20DC;RSPH9;TSPAN15;PLEKHS1;CCDC88C;DNAH11;POLQ;KIF17;ECT2L;MORN2;SYT10;CFAP57;ZBBX;TTC21A;ANKMY1;GAS2L2;WDR54;UBXN10;RSPH1;CFAP46;CFAP221;CES4A;P4HTM;SLC25A29;RIIAD1;SGMS2;CFAP52;B9D1;DCDC2;ANKUB1;ZNF440;IL5RA
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,0.39748247493800276,0.9253498873454983,0.5535714285714286,0.9292441716127804,1.0,15/63,10.67%,CFH;STAB1;HGF;ADGRL4;ALDH1A1;FLI1;PTGS1;FGL2;ERG;SIGLEC1;TFEC;CYP27A1;GSN;XPNPEP2;C3AR1
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,-0.5403010177281566,-0.9252931884471604,0.5686274509803921,1.0,1.0,2/15,3.75%,TEK;ANGPT4
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.506042412102127,0.9252650726287603,0.6458333333333334,0.9292381806068893,1.0,3/17,12.08%,HELB;KLHL15;UBQLN4
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.6042010187064598,-0.925218309701544,0.673469387755102,1.0,1.0,2/6,12.71%,TMEM107;NPHP4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4575375203746472,0.9251867382885524,0.5185185185185185,0.9290901518990181,1.0,10/19,24.81%,SLC39A8;SLC39A12;TRPM2;SLC30A10;SLC30A6;SLC30A4;SLC30A1;SLC30A2;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5873469852801579,-0.9251454444664965,0.5434782608695652,1.0,1.0,3/9,17.99%,PCCB;MCCC2;BTD
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.57523641664786,0.9251367929228451,0.603448275862069,0.9289699122479677,1.0,3/7,35.70%,AGO3;DICER1;TARBP2
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.39151483921704494,0.9250213331199081,0.5581395348837209,0.9289570765036955,1.0,25/93,22.25%,SLC22A3;HIF1A;SP1;SLC44A5;PDGFRA;CHPT1;PCYT1B;PDGFC;PIK3CA;MAPK8;SOS1;LYPLA1;SLC22A5;SLC44A4;PIK3CD;MAPK10;DGKZ;PLPP1;AKT3;DGKD;PIK3R3;GPCPD1;MAPK3;AKT2;GRB2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.44485042034978,-0.9249796843818588,0.5490196078431373,1.0,1.0,3/45,3.15%,NLRP1;NLRP3;MEFV
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.498460187105937,-0.924673008242597,0.6037735849056604,1.0,1.0,1/17,1.18%,TEK
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.3341384574472612,0.9246560831692814,0.6521739130434783,0.9295084820938654,1.0,40/247,15.21%,CXXC4;RSPO3;MYC;PRKG1;LGR5;SEM1;GNB4;GNG12;WNT4;RSPO2;FRAT2;RORA;H2BC21;SOX6;MOV10;SCRIB;WNT9A;RNF146;PSMD13;VANGL2;PDE6A;GNG4;H2AC6;CTBP2;PPP3CA;TLE2;FZD1;XPO1;H2AZ2;PSME4;PRICKLE1;DVL2;LRP6;FZD4;FRAT1;FZD6;NCOA3;LGR6;H2AX;PLCB1
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.34553483573768895,0.9244263127562857,0.6875,0.9297861967244863,1.0,20/168,14.60%,CDC25A;CCNA2;CDK11A;SEM1;NDE1;CEP70;PCM1;CEP152;PSMD13;DCTN3;CEP135;DYNC1I2;CNTRL;PPP1R12B;XPO1;PSME4;PHLDA1;NEDD1;CCNH;CCP110
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5702962048443847,0.924219749078428,0.6166666666666667,0.9300430009325086,1.0,2/11,2.31%,ZBTB7B;ERBB4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5040093818167719,-0.9241482682392167,0.6326530612244898,1.0,1.0,4/18,13.89%,SLC5A10;SLC2A8;SLC5A1;SLC2A1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4558535462254196,-0.9240433351898366,0.5357142857142857,1.0,1.0,7/30,13.48%,KCNE2;DRD2;KCNN2;KCNE1;KCNA5;PTK2B;KCNIP3
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4699036346657983,-0.923967840410901,0.45098039215686275,1.0,1.0,1/26,0.42%,NTRK1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3675346478583893,0.9237854220352774,0.6153846153846154,0.9308219294375306,1.0,27/150,10.38%,MXRA5;CFH;MRGPRF;C3;RSPO3;C6;ADGRL4;PPARG;STEAP4;BGN;COL6A2;CXCL12;LTBP2;TLR2;POSTN;PDGFRA;FAM114A1;CAVIN1;PLSCR4;CYP27A1;TMEM26;H6PD;GSN;MEDAG;COL5A3;MPZL1;AOX1
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Adipose Tissue,0.6173740477086651,0.9235878812986053,0.603448275862069,0.9310126111210071,1.0,3/5,26.72%,CD34;PTPRC;NT5E
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6133519132029176,0.9235565775534905,0.6363636363636364,0.9308091115295485,1.0,2/5,32.80%,NAGA;GALC
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5832595183287945,-0.9235490544949506,0.5918367346938775,1.0,1.0,1/6,5.37%,RNF8
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.48530847129870175,0.9234639681130702,0.5396825396825397,0.9308338106334848,1.0,7/19,15.61%,CYP39A1;FDX1;CYP27A1;CYP7B1;NCOA2;FDXR;CYP4V2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.43551774029213486,-0.9234448500973578,0.5106382978723404,1.0,1.0,3/32,12.43%,TRMO;METTL6;TARBP1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4704060623167071,0.9231203618467227,0.5535714285714286,0.931328365013685,1.0,5/27,20.15%,SLC4A7;SLC4A1;SLC30A4;WNK1;SLC30A2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.3861257772866295,-0.9229822473662678,0.6,1.0,1.0,16/90,8.78%,P2RY10;TBC1D10C;SELL;SP140;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;LTB;PSG2;STAG3;TAGAP;CD72;TMC8;LY86
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.6361916437840077,0.9229140602402188,0.6851851851851852,0.9315670544796523,1.0,3/5,28.41%,NEXMIF;TNN;SRGAP2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.5684491891635178,-0.92291389268938,0.625,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,0.39632259326759783,0.9228633009877683,0.5192307692307693,0.9314154213691996,1.0,16/65,18.27%,CCL5;ZEB2;CD244;GLUL;ABI3;ARL5A;KLRG1;PATL2;PXN;C12ORF75;LGR6;RAB29;SAMD3;AKR1C3;ABCA2;SUN2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.40193408720893425,-0.9228198946212373,0.5272727272727272,1.0,1.0,10/53,11.54%,CLDN4;TMEM184A;GPR39;DSG2;ALOXE3;LAMB3;WWC1;KRT86;SERPINB5;MISP
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.5547599375553343,0.9227489312758307,0.6111111111111112,0.9314571877407244,1.0,3/7,31.10%,TAP1;B2M;IDE
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.3385584623929834,0.9227154104774891,0.5454545454545454,0.9312539007508348,1.0,44/301,21.20%,VAPB;TUBA1C;NDUFC2-KCTD14;NXF1;ERBB4;NRG1;SEM1;NRG3;NEFH;MAP2K6;NRG2;NXT1;ATG101;MCU;PSMD13;HAP1;DCTN3;DNAH8;UBQLN4;KLC2;PPP3CA;TANK;PPP3CC;GRIN2D;ATF6;NXF5;COX6A1;DNAH14;PSMA1;HNRNPA2B1;RANBP2;NDUFB11;TP53;FUS;CASP3;TUBB1;ATG2B;ACTR10;HSPA5;BAD;NCBP1;DDIT3;PSMD4;NUP210L
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,0.5747341569440813,0.92269566803693,0.5454545454545454,0.9307855741714777,1.0,2/6,18.91%,GPHN;MOCOS
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5747341569440813,0.92269566803693,0.5454545454545454,0.9307855741714777,1.0,2/6,18.91%,GPHN;MOCOS
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.3730382359352132,0.9226660309061333,0.58,0.9306033275960354,1.0,11/86,12.23%,VEGFC;TGFBR1;STAT5A;RELA;PLCG2;F3;PIK3CA;SMAD2;FOXO1;SMAD4;MAPK8
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.5277297368103773,-0.9222873001614037,0.5365853658536586,1.0,1.0,4/10,15.08%,DUSP6;WWC1;DUSP9;LATS2
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.4120678048815295,0.9221283873854347,0.5660377358490566,0.9315691508586367,1.0,15/72,17.50%,PLCH1;ITPKB;PIP4K2A;PIK3C2B;PLCG2;INPP1;INPP4B;PIK3CA;PTEN;MTMR3;PI4K2B;PLCB1;PIK3CD;PLCD1;ALDH6A1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.5755897872094597,0.9218487412299167,0.5471698113207547,0.9319657874234455,1.0,2/6,19.54%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.500238936336703,-0.9218323449355476,0.6086956521739131,1.0,1.0,7/13,20.15%,TMIE;PAX2;USH1C;OSR1;FGFR2;PAX8;TWIST1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.46869864569244385,-0.9216973485912403,0.5555555555555556,1.0,1.0,7/31,12.79%,SELE;RIN3;FLOT1;LRPAP1;ARF1;WDR54;WNT3A
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4587356885668691,0.9216970785983025,0.5294117647058824,0.9320521145631278,1.0,5/26,7.93%,CLSTN2;NLGN1;VSTM5;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.48878564205334385,-0.9216949298367993,0.5925925925925926,1.0,1.0,5/18,21.43%,SLX4;RAD50;BRCA1;BLM;UBE2V2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4160095674337783,0.921663177508001,0.5686274509803921,0.9318559429496238,1.0,7/54,12.40%,NEDD4;SEC22B;ASB5;VSIR;FOXO1;HECW2;TIPARP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.44986987950797425,0.9215550279979945,0.5777777777777777,0.9318251708621722,1.0,4/31,12.08%,HELB;NUDT16L1;KLHL15;UBQLN4
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.41669736147783293,-0.9215324982148642,0.5853658536585366,1.0,1.0,12/76,7.93%,SELP;MPL;SPON2;CYTH4;LILRB3;PLK3;PRAM1;PDE6B;F13A1;HCK;SLC11A1;TAGAP
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,0.6055968636049924,0.9214371524095958,0.631578947368421,0.9318253994315284,1.0,3/5,24.86%,CTNNB1;IRF3;EP300
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,0.5200352874144328,0.9213586621820147,0.5306122448979592,0.9317223765922371,1.0,5/9,39.17%,NCBP1;LSM11;LSM10;SNRPG;SNRPB
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.38220571088922756,0.9210485703012347,0.6,0.9322009001119845,1.0,19/94,20.73%,SIRT1;KAT2B;SF3B1;H2BC21;TET2;MYO1E;HDAC2;EZH2;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;EED;POLR2H;HDAC1;DPEP2
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,-0.4288793122144742,-0.9210454667174437,0.6170212765957447,1.0,1.0,9/49,8.78%,CD53;CYTH4;CD86;LILRB3;ALOX5;MS4A4A;HCK;SLC11A1;LY86
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),0.5818032153734591,0.9208852073395363,0.5740740740740741,0.9323042208719438,1.0,2/6,11.11%,IL23R;HLA-E
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.382322717257784,0.9206690558157002,0.5882352941176471,0.9324865797709202,1.0,6/64,14.11%,AP1M2;TBC1D8B;ACBD3;HSPA8;PICALM;SNX2
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,0.47006519638935745,0.9206579304983088,0.6349206349206349,0.9322528467268651,1.0,4/20,13.08%,FGF10;FGF17;SOS1;FGF5
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.5449860612091192,0.9206430065917524,0.625,0.9320295522119134,1.0,5/11,27.62%,EXOSC4;TENT4B;EXOSC5;FBLL1;EXOSC2
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.36674287102423525,0.9206349101692302,0.5348837209302325,0.9317926351312179,1.0,26/160,14.99%,CXXC4;RSPO3;MYC;LGR5;SEM1;WNT4;RSPO2;FRAT2;H2BC21;SOX6;WNT9A;RNF146;PSMD13;H2AC6;TLE2;FZD1;XPO1;H2AZ2;PSME4;DVL2;LRP6;FZD4;FRAT1;FZD6;LGR6;H2AX
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6010802091759949,-0.9204607491987198,0.6153846153846154,1.0,1.0,1/6,1.79%,NLRP1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.48562397473086966,-0.9203918994849056,0.5319148936170213,1.0,1.0,1/17,1.00%,NPAS4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.4967847386395439,-0.9202613462030494,0.5833333333333334,1.0,1.0,3/11,13.89%,HFE;APOA1;TGFB1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.5792067839120677,0.9201457555902434,0.6111111111111112,0.9327512769956201,1.0,1/8,5.82%,PIP4K2A
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.41649868783196176,0.9200023507774416,0.5636363636363636,0.932782160523325,1.0,18/58,24.65%,KAT2B;H2BC21;HDAC2;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;POLR2H;HDAC1;DPEP2;MAPK3;ERCC3;RBBP4;POLR1D;TAF1B
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5865001881518456,0.9198465851106596,0.6226415094339622,0.9328061606821542,1.0,4/6,40.65%,TOR1AIP2;PLK1;NUTF2;NUP54
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.41338537158977845,-0.9196449355770604,0.62,1.0,1.0,12/62,8.11%,P2RY10;SIRPG;SELL;IRF4;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP;TNFRSF4
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,0.5063625151435256,0.9195226464522553,0.6206896551724138,0.9333690246172988,1.0,1/13,0.53%,FGF10
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.45232903255256857,0.9195208236029153,0.5967741935483871,0.9331183397589887,1.0,6/28,11.95%,ADRA1A;SLC8A1;SCN10A;ANK2;NPPA;PDE4B
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,0.42443560342260733,0.919387287315389,0.5714285714285714,0.9328505876837723,1.0,14/51,16.10%,SCGB3A2;PRDM14;LIN28A;NANOGP1;APELA;NLRP7;CHEK2;VASH2;CLDN6;TERF1;L1TD1;VRTN;CALB1;NMRK2
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,0.42443560342260733,0.919387287315389,0.5714285714285714,0.9328505876837723,1.0,14/51,16.10%,SCGB3A2;PRDM14;LIN28A;NANOGP1;APELA;NLRP7;CHEK2;VASH2;CLDN6;TERF1;L1TD1;VRTN;CALB1;NMRK2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.33019923514238175,0.919255266787874,0.6808510638297872,0.9329259656099324,1.0,56/287,20.95%,MKRN3;NEDD4;RNF152;SYVN1;PELI2;UBE2J1;PELI1;UBE2E2;FBXL3;MARCHF1;PELI3;UBE2D3;FBXO30;RNF146;SPOP;RNF217;UBE3D;UBE2E3;PSMD13;LNPEP;FBXO7;MAGEL2;FBXL14;AKTIP;HECW2;RNF5;UBE2U;SHPRH;KLHL42;RBBP6;ARIH1;UBE2QL1;UBE4A;PSME4;UBE2J2;RNF166;FBXL15;RMND5A;PSMA1;NHLRC3;UBR5;RNF26;CTNNB1;FBXO11;ZNF738;SMURF1;FBXL20;MARCHF8;FBXW5;RNF19B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),-0.5894494945115285,-0.9191750834731112,0.5777777777777777,1.0,1.0,2/5,11.52%,APOA1;APOB
prerank,Reactome_2022__Chylomicron Remodeling R-HSA-8963901,-0.5894494945115285,-0.9191750834731112,0.5777777777777777,1.0,1.0,2/5,11.52%,APOA1;APOB
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5090371445698635,-0.9191094625881294,0.6274509803921569,1.0,1.0,3/18,5.97%,PLK3;ZWILCH;BUB1
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.37916006301230065,-0.9190709555134846,0.6545454545454545,1.0,1.0,6/100,4.08%,DUSP4;SIRPG;CXCL13;WARS1;SLC6A6;PHEX
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.5309761817464828,0.9190694870335543,0.639344262295082,0.933028723890866,1.0,5/12,20.21%,UGDH;APELA;SMAD2;MESP1;LMBRD1
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.46175023984702535,-0.9190260485085554,0.5333333333333333,1.0,1.0,9/35,11.52%,ALB;COL4A2;COL4A1;JCHAIN;SPARC;MASP1;COL1A1;APOA1;APOB
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.39812797967119495,0.9188535044428033,0.5555555555555556,0.9332753492640498,1.0,12/65,12.35%,IRGM;FZD5;RELA;TLR2;TICAM1;NLRP7;HMGB1;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.4810341388139744,0.918818433947414,0.48214285714285715,0.9330764857933905,1.0,3/15,9.44%,MCUB;SMDT1;MCU
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.46337000385264665,0.9187526438790738,0.5416666666666666,0.9329496527759569,1.0,2/19,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5623803363338167,0.9185847802789795,0.6666666666666666,0.9331241957949071,1.0,4/6,34.72%,CD34;DDAH1;HYOU1;ENO1
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.4130428989505664,-0.9184462109825808,0.5614035087719298,1.0,1.0,8/43,16.63%,ERCC1;RFC3;XPC;GTF2H2;LIG1;RPA3;RFC2;RFC1
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.48950874552100343,-0.9184436229102342,0.5961538461538461,1.0,1.0,3/15,15.19%,POLR1A;RPA3;EXO1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.41003492050489254,0.9183438857834033,0.6326530612244898,0.9334321415774881,1.0,11/50,11.00%,C1GALT1C1;GALNT8;GALNT7;MUC20;GALNT3;GXYLT1;C1GALT1;GALNT12;GALNT1;MUC13;MUC7
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.3651334599174483,0.9182519781270568,0.6346153846153846,0.9333463803286668,1.0,24/127,16.70%,MYC;PRKG1;SEM1;GNB4;GNG12;WNT4;RORA;MOV10;SCRIB;PSMD13;VANGL2;PDE6A;GNG4;PPP3CA;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;NCOA3;PLCB1;PSMA1;CTNNB1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.5015567627485951,-0.9182161452887969,0.5882352941176471,1.0,1.0,3/16,17.31%,ARF3;VAC14;PIK3C2G
prerank,PanglaoDB_Augmented_2021__Myocytes,0.38471136492630725,0.9180767977277188,0.5510204081632653,0.9334727773331684,1.0,20/115,11.62%,GATA4;SMYD1;PRRX1;PRKG1;IL4;PPP1R3A;DOCK1;SIX4;CHODL;TNNT1;ASB5;IP6K3;SGCG;SYPL2;TPM2;NPPA;WASHC1;LMOD2;SYNPO2;PXN
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.43500740382432374,0.9180283039276295,0.6363636363636364,0.9333220672718372,1.0,4/38,6.69%,TIMELESS;SLFN11;RFWD3;PRIMPOL
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4579925521079468,-0.918021063599419,0.5434782608695652,1.0,1.0,1/24,4.71%,LDB1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34582345919565266,0.9179614025019147,0.6190476190476191,0.9332535021864107,1.0,23/215,9.16%,IGF1;IRS1;C3;RSPO3;SIRT1;TGFBR1;ZBTB7B;HIF1A;KAT2B;CDKN2AIP;RSPO2;BMP2;NLGN1;IL7R;RBPJ;TLR2;KLK14;NRXN1;ITGAV;F3;RIMS2;KLK5;KANK1
prerank,Reactome_2022__Fructose Metabolism R-HSA-5652084,0.5497277083743666,0.917955426427103,0.6222222222222222,0.9330106372875623,1.0,1/7,2.98%,ALDH1A1
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.38919364174171556,0.9179374154284977,0.5272727272727272,0.9320609816851908,1.0,18/93,15.90%,FGFR3;LRP4;ARHGEF17;MMP15;EFS;TEAD2;CNN3;ADGRL2;SPSB4;VANGL2;PLXNB1;ID4;PTPRU;L1CAM;FRZB;CPE;GAS1;GPRC5B
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.38919364174171556,0.9179374154284977,0.5272727272727272,0.9320609816851908,1.0,18/93,15.90%,FGFR3;LRP4;ARHGEF17;MMP15;EFS;TEAD2;CNN3;ADGRL2;SPSB4;VANGL2;PLXNB1;ID4;PTPRU;L1CAM;FRZB;CPE;GAS1;GPRC5B
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.38919364174171556,0.9179374154284977,0.5272727272727272,0.9320609816851908,1.0,18/93,15.90%,FGFR3;LRP4;ARHGEF17;MMP15;EFS;TEAD2;CNN3;ADGRL2;SPSB4;VANGL2;PLXNB1;ID4;PTPRU;L1CAM;FRZB;CPE;GAS1;GPRC5B
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.38919364174171556,0.9179374154284977,0.5272727272727272,0.9320609816851908,1.0,18/93,15.90%,FGFR3;LRP4;ARHGEF17;MMP15;EFS;TEAD2;CNN3;ADGRL2;SPSB4;VANGL2;PLXNB1;ID4;PTPRU;L1CAM;FRZB;CPE;GAS1;GPRC5B
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.5710234329729711,0.9178472373029712,0.6153846153846154,0.9320509032348812,1.0,2/6,7.89%,CD244;SNCA
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3547585222216131,0.9177120825105077,0.6170212765957447,0.9320544815181426,1.0,15/109,13.08%,FGF10;ERBB4;FGF2;NRG1;CCDC125;ABI3;NRG2;CAVIN1;ABL2;FGF17;PLXNB1;AMOTL1;PLXNB2;FRMD5;FGF5
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,0.46643809139568876,0.91768918232478,0.6326530612244898,0.9318601679554014,1.0,10/27,17.16%,SCN7A;SPTBN5;SCN10A;ANK2;SCN3A;SCN2B;ANK1;SCN9A;L1CAM;KCNQ3
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,0.39647284291541884,0.9173712296550213,0.6428571428571429,0.9323174551438316,1.0,12/67,8.99%,LAMA4;CFH;FLT1;TDRD10;STAB1;PREX2;ADGRL4;BGN;ERG;ABI3BP;RAMP3;MYH11
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.4618785819474116,0.9173600143825957,0.6037735849056604,0.9320890750911168,1.0,6/34,9.21%,TMPRSS2;ACE2;SDC4;GPC5;CHMP6;GPC4
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.44033206798567315,-0.9172186544358638,0.5918367346938775,1.0,1.0,8/24,27.20%,NCAPD3;TTN;CDK1;AKAP8L;NCAPD2;NCAPG2;NCAPH;SMC2
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.5581781001745141,0.9172081169691253,0.6166666666666667,0.932259686367935,1.0,4/6,34.54%,COLGALT1;RB1;EFEMP2;AEBP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.40114257485210614,0.9170029005103844,0.6086956521739131,0.9324779202348197,1.0,12/59,14.68%,ESPL1;FBXO5;BMI1;DUX4;ZFYVE19;RYBP;YAF2;EZH2;TERF1;RNF2;CCP110;EPC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.6045434725956758,0.9169825431751403,0.6851851851851852,0.9320147544618632,1.0,2/5,23.73%,NECTIN2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.6045434725956758,0.9169825431751403,0.6851851851851852,0.9320147544618632,1.0,2/5,23.73%,NECTIN2;IL12A
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3680268230845753,0.9168101117246655,0.5094339622641509,0.9321375252401412,1.0,16/86,15.79%,NOX5;PRR5L;PRDX6;HTRA2;SNCA;FOXO3;SLC25A24;KEAP1;PIK3CA;PYCR1;FOXO1;VRK2;ERMP1;PRKAA1;NFE2L2;ZFAND1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.6140986761542546,-0.916756345129208,0.6222222222222222,1.0,1.0,2/5,6.18%,DRD2;ADCYAP1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.6334164418721046,0.9167031958691134,0.6507936507936508,0.9321478804692518,1.0,4/5,30.35%,IL23R;CSF1;TRAF6;IL23A
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.34842578951314235,0.9166323724738213,0.5625,0.932069736440569,1.0,41/242,14.29%,FGF10;MAP3K11;IRS1;IL17RD;FGFR3;FGFR1;ERBB4;NRTN;NRG1;ANGPT1;SEM1;KSR1;CSF2RA;LLGL1;IL2RA;ABHD17B;SPTBN5;NRG3;PDGFRA;NRG2;PPP1CC;SHOC2;GFRA1;FGF17;PIK3CA;CNKSR2;PSMD13;FLT3;RASAL2;RANBP9;RGL2;ABHD17C;SOS1;FGF5;PSME4;LYPLA1;RAP1A;LRRC7;GRIN2D;DUSP2;CNKSR1
prerank,KEGG_2021_Human__Small cell lung cancer,0.41646986991224166,0.9166052912083027,0.6226415094339622,0.9318793460475765,1.0,20/87,20.59%,LAMA4;MYC;ITGA2;FHIT;RELA;ITGAV;LAMB4;PIK3CA;PTEN;RARB;PIK3CD;BIRC3;CDK4;TP53;LAMA5;CASP3;POLK;AKT3;PIK3R3;IKBKB
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.5403280978199684,0.9165823245155476,0.5686274509803921,0.931682254899037,1.0,4/11,20.67%,DMD;GLRX;WNK1;ATP1B2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,0.5571802512115204,0.9165622311198646,0.5932203389830508,0.9314988735029188,1.0,3/8,22.38%,CD34;KIT;PTPRC
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.38818462210163557,0.9164701384856898,0.660377358490566,0.9314583880994228,1.0,9/63,20.95%,CCNA2;SEM1;ANAPC16;PSMD13;PSME4;PSMA1;UBE2D1;UBE2E1;PSMD4
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.3952459723906638,0.9164528345199809,0.6122448979591837,0.931261569936696,1.0,11/86,19.47%,PLD6;H2BC21;TDRD9;H2AC6;H2AZ2;PRKRA;H2AX;RANBP2;PIWIL1;AGO3;POLR2H
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.3786862183015239,0.9163165177496644,0.5714285714285714,0.931285734178715,1.0,11/101,8.15%,MXRA5;MRGPRF;PRRX1;PRKG1;GNG12;BGN;POSTN;WWTR1;ASB5;FAM114A1;ACHE
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3545867872404099,0.9162928117509711,0.5283018867924528,0.9310856714742635,1.0,29/127,20.59%,EHD1;MRAP2;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;LIN7A;ANK2;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;PACS1;TSPAN17;LRP6;RAB29;DENND4C;ARL3;CD81;RAP2A;SMURF1;RAPGEF2;BSG;IKBKB
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.38811193964780716,0.9162578031373073,0.6111111111111112,0.930909490447451,1.0,9/64,20.95%,CCNA2;SEM1;ANAPC16;PSMD13;PSME4;PSMA1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.5559086004491052,0.9161021833205378,0.5714285714285714,0.9310016370137286,1.0,1/5,7.01%,HORMAD1
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,0.5059349150006331,0.9160837129591597,0.6153846153846154,0.9308391512620823,1.0,1/14,0.53%,FGF10
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.46377642440990496,0.9160509887924092,0.5961538461538461,0.9306937206186008,1.0,14/35,22.38%,ZFP36L2;CHD7;LEPR;LIG4;PIK3CD;FADD;RAG2;ZAP70;KIT;GPR89A;RAG1;ANXA1;MR1;PTPRC
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.4976443624848659,-0.9158315397918988,0.6346153846153846,1.0,1.0,1/18,0.88%,APIP
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.4437702528042944,-0.9157891567146617,0.5405405405405406,1.0,1.0,4/30,7.13%,RIN3;VAV3;NEB;PPP1CA
prerank,KEGG_2021_Human__VEGF signaling pathway,0.3928758251693062,0.9156421841198067,0.6326530612244898,0.9314440168749768,1.0,15/49,22.07%,MAPKAPK2;PLCG2;MAPKAPK3;PIK3CA;PXN;PPP3CA;HSPB1;PPP3CC;PIK3CD;VEGFA;AKT3;PIK3R3;BAD;MAPK3;AKT2
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.4201559027083449,-0.9156043151809248,0.6274509803921569,1.0,1.0,22/83,21.22%,CAMK1G;NR4A1;CACNA1G;CAMK2A;CYP21A2;PRKD2;PLCB2;HSD3B2;HSD3B1;CREB3L1;ITPR3;ATP1B1;CALM1;ADCY1;ATP2B2;CACNA1H;KCNJ5;CACNA1S;PRKD3;DAGLA;PRKCA;KCNK3
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,-0.49122231471022526,-0.915439042264482,0.6153846153846154,1.0,1.0,3/14,15.19%,POLR1A;RPA3;EXO1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4598506849017761,-0.9153160164057629,0.5227272727272727,1.0,1.0,1/19,0.56%,SELE
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.43955675883884876,0.9153003615219705,0.5869565217391305,0.931956490635225,1.0,6/48,6.66%,IGF1;PLCH1;IRS1;FGFR1;PIK3C2B;PDGFRA
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.38754493350741126,0.9151582360008832,0.6166666666666667,0.9320685762672133,1.0,11/99,12.57%,LZTR1;SCRIB;CCDC106;PELI3;PTOV1;SCYL1;ENDOG;ABHD8;UBQLN4;KLC2;TPRN
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.41266235078941627,-0.915143878477307,0.5263157894736842,1.0,1.0,3/59,4.71%,DUSP4;DUSP6;FOS
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5638140723588125,0.9151061942615896,0.6415094339622641,0.9319195815456051,1.0,3/7,29.07%,PIBF1;INPP5F;PARP14
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.6170553892140542,0.9150802452752282,0.6136363636363636,0.9317367773561291,1.0,1/5,9.40%,DSCAM
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.5480818928672597,-0.9149877258561245,0.6410256410256411,1.0,1.0,2/9,8.87%,PER2;PIWIL2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.47209235624702683,-0.914809028469536,0.5319148936170213,1.0,1.0,6/23,18.46%,CYP4F2;MYO5B;WFS1;RAB11A;ADCY1;AQP1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.49321625058654955,0.9147592961925474,0.48148148148148145,0.9321503679666986,1.0,1/12,5.30%,MID2
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.3943466039450122,0.9146637387252754,0.4418604651162791,0.932099698387189,1.0,12/55,14.38%,RAB38;RAB27A;RAB31;RAB3C;RAB39A;RAB23;PTP4A2;RAB34;RAB9A;RAB30;RAB33B;RAB27B
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.4097244457485602,0.9145637888974324,0.5892857142857143,0.9320896907689071,1.0,6/46,12.03%,KCTD21;TULP3;RORA;MOSMO;KCTD6;RAB34
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,0.3900723424444421,0.9144143651437097,0.6271186440677966,0.9322455691236053,1.0,15/70,8.32%,FLT1;TDRD10;STAB1;PREX2;HGF;ADGRL4;ZEB2;CDH2;BGN;ZEB1;ERG;PDGFRA;CNRIP1;RAMP3;CRHBP
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,0.3213497490379233,0.9143619866056288,0.675,0.9321576862968064,1.0,67/472,14.87%,SMIM3;IGF1;MAP3K11;SIPA1;ARHGAP24;NYNRIN;FCAR;NEGR1;SASH3;CADM2;MAFB;CSF2RA;PCSK5;ITPKB;TENM1;PCDH9;IL7R;RAB31;MDGA2;LAIR1;TSC22D3;PIK3C2B;ANKRD13D;ARPP21;DYRK2;MED13L;TSC22D1;MYPOP;SPON1;ZNF274;CCDC88B;ELK1;UBE2Z;PDE7A;HMGCS1;ZNF230;PAG1;AUTS2;IGFBP6;LRWD1;EXT1;RPS6KA2;RNASET2;EFNB2;TCF4;TPM2;FAM106A;ADAP1;TNS3;HECW2;DPF1;MVD;MEF2C;FCHSD2;FMNL3;RRAGC;CSMD1;MAN1A2;IGF1R;KLF7;WWOX;DUSP2;AFF1;SPECC1;PIEZO1;ZC3H13;TAF5
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.40572830530909954,0.914239321453476,0.6481481481481481,0.9321781226772746,1.0,9/50,20.95%,SEM1;CDKN2A;PSMD13;CHEK2;PSME4;PSMA1;TP53;CARD16;PSMD4
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.45579834563877486,0.9142343874627107,0.58,0.9319414710501946,1.0,1/33,2.25%,NXF1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41837170495790277,0.9139403976517682,0.5925925925925926,0.9324049552139422,1.0,12/32,30.46%,NAV3;SNCA;HDGFL3;DYRK1A;MID1IP1;MAP2;CAMSAP2;ARHGEF2;CIB1;FGF13;CLASP2;CLASP1
prerank,Reactome_2022__Immune System R-HSA-168256,-0.3014694632381239,-0.913832524822796,0.8947368421052632,1.0,1.0,98/1484,9.02%,CD44;KLRC1;DUSP4;IL10RB;TBC1D10C;TRIM56;RAB44;MPO;SELL;KIF2B;SIGIRR;ATP6V1E2;IRF4;DNASE1L1;CTSO;HGSNAT;TNFSF18;RAC2;ICAM3;NLRP1;CD53;ATP6V1C2;BST1;IL11;NLRP3;CD101;CD86;SFTPA2;IL1RL2;MUC5B;STK10;MEFV;DUSP6;IL18BP;ALOX5;PRKCD;IL31RA;AHSG;TEC;CRACR2A;IL6R;CD200R1;RNASE1;ATG14;TNFRSF11A;C5;CRLF1;FOS;DDX41;STXBP2;LTB;IFI27;TRIM5;CAMK2A;XDH;PDZD2;F13A1;VAV3;CIITA;MUC19;INPP5D;ATP6V1E1;RNF213;KLHL25;PSMB4;AGA;DOCK2;COLEC10;KLRB1;BTK;FBXW12;IRF5;EGR1;HCK;ADGRG3;ASB2;SLC11A1;ARIH2;SVIP;HLA-DRB1;IFIT2;POLR3H;POLR3E;CLU;OAS3;JUN;TNFRSF4;OLFM4;OAS1;CHI3L1;PTPN7;ECSIT;LY86;TRAIP;TXK;C1S;CEACAM1;IFIT3
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5178883359922861,0.9138009832599902,0.5471698113207547,0.9325368744923186,1.0,5/13,21.70%,SLC25A13;SLC1A6;SLC25A12;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.4057850179585254,0.9137888074062521,0.5625,0.9323036969180973,1.0,4/69,3.52%,TCIRG1;ATP6V0D2;TFEB;RNF152
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5362096863528163,-0.9136999900234639,0.5918367346938775,1.0,1.0,4/12,18.26%,TAF11;TAF7;TBP;TAF7L
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.5348336420306613,0.9136855165037892,0.6,0.9322429715951913,1.0,2/6,15.49%,ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.6191259126221162,-0.9135149862438124,0.6041666666666666,1.0,1.0,2/5,12.91%,FFAR4;CRH
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.496252761630042,0.9133183460441409,0.5849056603773585,0.9328004637149933,1.0,8/16,18.34%,NRIP1;ESR1;RAMP3;CRHBP;NCOA3;RUVBL2;LCOR;SSTR1
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.4658087430152389,-0.9133103811067912,0.46153846153846156,1.0,1.0,4/17,15.11%,FGF1;FGF20;FRS3;FGFR4
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,0.42295869265450253,0.9132650898888858,0.56,0.9326754718923574,1.0,8/53,5.09%,CCL3L3;ITGAX;PIK3R6;SASH3;SAMSN1;PIK3R5;IRF8;IL10RA
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.5910408429737924,0.9131152177812423,0.6140350877192983,0.9327598745155798,1.0,1/6,0.40%,PNP
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.4224734228973872,-0.9129521758988977,0.6326530612244898,1.0,1.0,5/61,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.4537939767909416,0.9129321590975088,0.6078431372549019,0.9330231252419353,1.0,7/24,35.70%,PRKRA;AGO3;POLR2H;DICER1;XPO5;POLR2E;TARBP2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5669325569543984,0.912693627531874,0.5625,0.9333402260725089,1.0,4/9,21.16%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5575023900020875,0.912665314798635,0.6730769230769231,0.9331578734426409,1.0,7/11,41.30%,PKD1;CPSF6;PKD2;CBR4;NUDT21;GRIN1;CPSF7
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.3875591626878597,0.9125831703787161,0.5636363636363636,0.933083542751942,1.0,22/85,24.76%,U2AF1;PCBP3;ZFP36L2;NUDT16L1;PCF11;RIDA;DXO;SRSF11;HNRNPA2B1;TP53;AGO3;SLFN14;CSTF3;PNPT1;NCBP1;ZFP36;HIPK3;LSM2;HSPA1A;DHX15;AURKAIP1;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4822384820669225,0.9125521446182467,0.5689655172413793,0.932877754222735,1.0,4/25,12.35%,BMI1;DCUN1D1;ARRDC3;PTEN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5305898043040285,0.9123583480974367,0.6274509803921569,0.9331237672294967,1.0,4/14,13.86%,PPARG;ELOVL5;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.514146082606407,-0.9123449465963354,0.5526315789473685,1.0,1.0,1/8,6.07%,SFRP1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.449621355720027,0.9123230734540703,0.59375,0.932961887088834,1.0,7/26,21.62%,SLC1A3;SLC7A2;SLC25A13;SLC3A2;SLC1A6;SLC25A12;SLC7A8
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.46762007940290934,0.9123094567590684,0.6111111111111112,0.9327596651357549,1.0,9/20,30.52%,BICD1;G3BP1;PRRC2C;LSM14A;YTHDF2;CSDE1;RPS23;YTHDF3;YTHDF1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.45715330806692867,0.9119480785893279,0.6,0.9334096879916289,1.0,4/23,13.75%,TRHDE;NAALADL1;LNPEP;ANPEP
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.38430390052349994,-0.9119119464859509,0.5869565217391305,1.0,1.0,14/87,11.54%,ALB;F5;AHSG;VGF;GPC3;MXRA8;SCG3;LAMB1;NOTUM;MFGE8;APOA1;WFS1;APOB;PRSS23
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.38309292309068343,0.9118528867668084,0.5576923076923077,0.9334061209959674,1.0,28/90,26.94%,TCAF2;DPP10;STAC2;EPHA3;AGR2;RAMP3;ARHGEF16;TP53BP2;MAPK8;PPP3CC;RHOG;TP53;CD81;MFF;ITGB2;BAD;PPP1R13B;MYO1C;STX3;AKT2;ITGAM;DLG1;MIEF2;EGFR;BID;SPTBN1;CIB1;LGALS3
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.3750212484045273,0.9118252040840208,0.6071428571428571,0.933234239398751,1.0,10/67,14.60%,NDE1;CEP70;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.43534580593757,0.9117836965061683,0.5689655172413793,0.9330658150253635,1.0,2/38,5.30%,MDFIC;MID2
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,-0.48244711795907486,-0.9117424106401778,0.58,1.0,1.0,1/16,0.40%,EHF
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.583027108657796,0.9115959860211909,0.6470588235294118,0.9332541210559903,1.0,5/6,25.65%,GLRA1;TMEM98;TNFRSF21;EIF2AK3;JAM2
prerank,Reactome_2022__Defective ST3GAL3 Causes MCT12 And EIEE15 R-HSA-3656243,-0.5495657628325606,-0.9115651213215721,0.52,1.0,1.0,2/5,13.84%,ACAN;ST3GAL3
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.5361822102684757,0.9114959689927693,0.6557377049180327,0.9331698721478269,1.0,1/6,9.90%,VANGL2
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.5302586275283585,0.9114934929120794,0.5636363636363636,0.9329242567977459,1.0,3/9,16.05%,SLC4A7;AHCYL2;SLC4A1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.4071273308840216,0.9114402621582036,0.6071428571428571,0.9327796276925377,1.0,7/48,8.30%,GSTM2;SCD;PTGS1;CYP4Z1;ELOVL5;PLA2G10;SCD5
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.38633427388265973,0.9113811502632188,0.46938775510204084,0.9326720461069822,1.0,7/64,7.40%,IGF1;TGFBR1;FAIM;IL4;RELA;ITGAV;PELI3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5429675604393873,0.9113243906574807,0.5689655172413793,0.9325544417389786,1.0,4/9,22.86%,GPM6B;PICALM;LEPROTL1;COMMD1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3359681011109129,0.9112844079040442,0.6470588235294118,0.9324100268401602,1.0,58/317,19.74%,TIMELESS;HELB;TOP2A;BOK;MYC;SIRT1;ZBTB40;ZBTB1;SLFN11;CDKN2AIP;RFWD3;STK33;MAPKAPK2;MAP2K6;ASF1A;UBE2E2;DYRK2;HTRA2;WDR76;MCM7;AKTIP;FOXO1;POLE2;CHEK2;PAXX;FANCL;UBE2U;SHPRH;UBQLN4;RBBP6;SMC5;UBA6;TANK;PSME4;SETD7;PCLAF;PML;IKBKE;H2AX;USP45;UBR5;BCL3;MNAT1;SIRT7;FMN2;TP53;FMR1;RAD51B;FAAP20;KMT5B;POLK;ZBTB4;BRAT1;IRF3;ABL1;MACROD2;LYN;TRIM28
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5518907656875467,0.9112799656363662,0.6181818181818182,0.9321649411788769,1.0,1/6,15.01%,MARCHF7
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4921438870804667,0.9111833847246898,0.5535714285714286,0.9321919324794763,1.0,4/17,19.31%,URI1;ATP1A2;AKR1C3;NR3C1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.3720527291677744,0.9111631012304914,0.6296296296296297,0.9319906695309117,1.0,27/102,17.03%,CGNL1;F2;OIT3;C6;CALCR;OPRK1;GHRLOS;CLDN2;MTTP;SLC7A9;ABCG8;MOGAT2;GRAMD2A;SLC6A16;PLA2G12B;PROX1;CYP3A4;ABCA8;NPY1R;FZD4;COL22A1;AGXT2;OLFML3;FRZB;GJB1;RNF128;ADAMTS6
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.3819056557030224,0.9111363707436665,0.6086956521739131,0.9317794470258414,1.0,10/73,14.29%,MAP3K11;KSR1;PPP1CC;AGGF1;ZC3HAV1;SHOC2;CNKSR2;QKI;RAP1A;CNKSR1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.36060437725611616,-0.9109502016133936,0.6808510638297872,1.0,1.0,11/103,7.78%,ALB;SELP;F5;F8;AHSG;ABCC4;STXBP2;F13A1;PCYOX1L;SCG3;CLU
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.4660883323262118,-0.9108359309630092,0.5116279069767442,1.0,1.0,2/15,2.33%,CXCL13;XCR1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.44194670324465035,0.9107303411357142,0.5925925925925926,0.9324103621295331,1.0,3/25,6.92%,SHMT2;GLUL;ACSS2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.36810979516461567,0.9107027627297892,0.5957446808510638,0.9322393858280131,1.0,16/106,12.60%,CAPN13;FGFR3;TMPRSS2;NDRG2;BMI1;PLPPR1;PIK3C2B;NEO1;ZSWIM5;DSCAML1;PTPRT;PLXNB1;CGN;ZNF704;PPP1R9A;MYRIP
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.46847961248451886,-0.9106882258736572,0.5882352941176471,1.0,1.0,2/19,10.70%,EPOP;ATXN7L3
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,0.5533299073966904,0.9106333286948829,0.5869565217391305,0.9321690874072942,1.0,3/7,19.87%,KCND2;KCNIP4;KCND1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6153789548665244,0.9105308394435754,0.6862745098039216,0.9322027385446107,1.0,3/5,34.08%,VPS41;PLEKHM1;ARL8B
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5150214299529152,0.9104218066148406,0.5961538461538461,0.932172700619679,1.0,5/13,21.70%,SLC37A4;SLC34A2;SLC20A1;SLC25A30;SLC25A14
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.382479624652821,0.910416672845736,0.6111111111111112,0.9319349648194434,1.0,10/64,14.60%,NDE1;CEP70;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3840587346360771,-0.9103880969017358,0.5892857142857143,1.0,1.0,9/86,9.36%,RFX6;CELA2A;FAM3D;ALOX5;SFRP1;PER2;KCNJ11;NNAT;KCNA5
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.4218059630073213,-0.9103831131595079,0.5217391304347826,1.0,1.0,8/56,5.17%,SELP;SELE;TEK;TIE1;MGP;RNASE1;APOL3;MS4A4A
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5117029261153416,0.9100282429568008,0.5964912280701754,0.9324944966254083,1.0,2/13,5.22%,EIF3E;C8ORF88
prerank,CellMarker_Augmented_2021__Memory B cell:Undefined,0.6132703674475262,0.9099250913231828,0.7073170731707317,0.9324744504581352,1.0,2/5,5.88%,RBPJ;TLR2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.4385762774885789,-0.9097160980639911,0.5652173913043478,1.0,1.0,4/31,14.35%,EML3;ANKRD53;GPSM2;DCTN1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.35183310512240257,0.9096342329635145,0.64,0.932990023547015,1.0,18/107,12.61%,NOX5;HIF1A;PRR5L;PRDX6;PDGFRA;FER;HTRA2;SNCA;FOXO3;SLC25A24;KEAP1;PYCR1;FOXO1;PTPRK;VRK2;PXN;MAPK8;ERMP1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.39839490820792794,0.9096228604932419,0.5818181818181818,0.9327590165572842,1.0,14/59,12.91%,SEMA5A;C1GALT1C1;ADAMTS17;ADAMTS16;MUC20;ADAMTS19;GALNT3;SPON1;C1GALT1;GALNT12;MUC13;MUC7;B3GLCT;POMT2
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.358278354724129,0.9095430533613301,0.6101694915254238,0.9326887294868804,1.0,3/102,4.07%,SGO1;NDC80;NDE1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.383076863628901,0.9093279300356296,0.5961538461538461,0.9330332459036389,1.0,14/83,12.52%,FLT1;FGFR1;FGF2;PIK3R6;KSR1;TENM1;PIK3R5;CD40;PDGFC;EZH2;FLT3;SPRY3;IRAK1;CDK12
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.43518391637782944,-0.909262172791852,0.5714285714285714,1.0,1.0,4/33,9.57%,ACOT1;ACSM6;MLYCD;ACOT2
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.5238954066432675,-0.9092223818217721,0.6304347826086957,1.0,1.0,4/12,19.80%,HLA-DRB1;PDCD1LG2;HLA-DQA1;HLA-DPA1
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.5847949357231288,0.9089574090903482,0.625,0.9336350675871988,1.0,2/6,5.28%,VSTM5;ABI3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.5385802086971687,0.908912563531855,0.6521739130434783,0.9334743399939797,1.0,2/11,17.05%,EPS8;SIRT7
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.4420360470918927,0.9088612197441802,0.5370370370370371,0.9333437776926153,1.0,13/28,24.86%,PIP4K2A;MAP2K6;HDAC2;PML;KAT6A;TP53;AKT3;HDAC1;AKT2;RBBP4;PIP4P1;ING3;EP300
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.4481732315052037,0.9087917093051291,0.5714285714285714,0.9333035008381749,1.0,6/31,11.70%,GSTM2;STAC2;ANK2;HAP1;LRRC55;ATPSCKMT
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.4056699234044434,0.9087915226771145,0.6086956521739131,0.9330561370690686,1.0,5/63,6.41%,FGFR3;BOK;IL4;DCC;ITGAV
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.36413608686623833,0.9087462192289432,0.5384615384615384,0.9329090915111086,1.0,31/186,16.15%,ESPL1;CDKN2C;MYC;TGFBR1;CCNA2;STAT5A;KAT2B;CDKN2A;IL2RA;RELA;IL15;CD40;ELK1;PIK3CA;SMAD2;HLA-E;CHEK2;SMAD4;MAPK8;PTEN;PPP3CA;XPO1;CREB3L2;PPP3CC;CCND3;CREB1;NFATC3;MAP3K1;SLC25A31;PIK3CD;MAPK10
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.47702902488149057,0.9084410889936467,0.52,0.9333964742179233,1.0,4/20,5.08%,VCAN;BGN;CHSY3;UGDH
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3976905855979697,0.908386505319416,0.58,0.9333128346490541,1.0,10/58,17.38%,GLUL;RIOK2;DDX31;RRS1;XPO1;NOC2L;BOP1;BYSL;RPL7;RIOK1
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.6121610564367829,0.9083324631854893,0.6,0.9331891963506661,1.0,1/5,6.41%,ITGAV
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5920065665412759,0.9082130183489283,0.6491228070175439,0.9331923928321294,1.0,3/6,29.45%,BMPR2;EIF2AK3;SULF1
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.3552520418533128,0.9080223801819184,0.6363636363636364,0.9334123725128292,1.0,29/167,14.29%,GABRR1;ERBB4;GABRR2;GRIN3A;NRG1;GNB4;GNG12;KCNJ3;LLGL1;GLRA1;GRIP2;GABRG3;PRKAB2;GNAI3;LIN7A;RPS6KA2;GRIN3B;GRIK3;GABRA5;PPM1E;GNG4;GLRB;GABRB2;LRRC7;GRIN2D;APBA1;CREB1;NBEA;RPS6KA1
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.4213753174228479,0.9079829107357448,0.5614035087719298,0.9332587975786296,1.0,7/58,11.37%,COX19;CHCHD4;TIMM22;MTX2;LDHD;SLC25A13;BCS1L
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.5451536243036148,0.907882701915643,0.7,0.9332353060116861,1.0,7/10,35.18%,EXOSC4;DXO;EXOSC5;EXOSC8;EXOSC9;EXOSC7;PCID2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.42713432926835837,0.9078106043823339,0.5714285714285714,0.9332484844404118,1.0,5/34,8.97%,PCLO;SYT1;UNC13B;SNCA;RIMS2
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.4706433092566034,0.9077487748047443,0.5555555555555556,0.9331717020079024,1.0,1/18,1.76%,TUBA1C
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.42595432336813865,-0.9076647630794006,0.6590909090909091,1.0,1.0,4/51,11.53%,UVSSA;PRPF19;GTF2H2;COPS7A
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.344341619532149,0.9074166963316007,0.68,0.9336745098324132,1.0,35/190,16.76%,PLD6;PIK3R6;LPIN3;PIK3R5;ABHD3;PIP4K2A;SLC44A5;PIK3C2B;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;INPP4B;CPNE7;PIK3CA;ACP6;PRKCSH;CPNE1;SELENOI;CHEK2;PTEN;MTMR9;CPNE3;PNPLA6;MTMR3;PI4K2B;PITPNM1;BCHE;ETNK1;SLC44A4;ETNPPL;PNPLA8;GPD2;DGAT2
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.3682849551787342,0.9072310368536244,0.6101694915254238,0.9338107667928511,1.0,3/91,4.07%,SGO1;NDC80;NDE1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.44832587343651614,0.9072279994434834,0.6071428571428571,0.9335674473985699,1.0,5/32,15.49%,SOCS2;SLC8A1;ANK2;TBX18;RYR2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.5059271522678982,0.907145356390624,0.5,0.9334773494145936,1.0,1/10,3.24%,LDLR
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4758686998580982,0.9071333970748215,0.62,0.9332508826487147,1.0,6/18,18.08%,FZD5;IL4;DENND1B;IL18R1;CD81;CD55
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.434807297507979,0.9071115084796444,0.5208333333333334,0.933041167171765,1.0,1/25,0.47%,NOX5
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5489767085402282,-0.9070311966735213,0.6415094339622641,1.0,1.0,2/7,16.21%,CTPS1;PRPS1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.5584889061199038,-0.9068217926433447,0.5869565217391305,1.0,1.0,1/7,0.91%,FBXO43
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.4220916912491444,0.9066624362442824,0.6,0.9338757606670717,1.0,16/43,27.62%,SMYD2;RELA;EZH2;ATF7IP;SETD7;EED;KMT5B;NSD1;KMT2C;SETD2;PRDM16;DOT1L;RBBP4;ASH1L;SMYD3;NFKB1
prerank,CellMarker_Augmented_2021__Hematopoietic Precursor cell:Fetal Liver,0.5603106201158886,0.9065019945521279,0.6229508196721312,0.9339685291513363,1.0,3/7,22.38%,CD34;KIT;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.517793010383513,-0.9063825467247835,0.6538461538461539,1.0,1.0,2/12,2.67%,NLRP3;CD86
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.37597743048543164,0.9063732004583721,0.6415094339622641,0.9339947743397532,1.0,11/76,14.60%,CDK11A;NDE1;CEP70;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.45586858421809995,-0.9063655935958221,0.6666666666666666,1.0,1.0,3/31,9.57%,ACOT1;CYP4F2;ACOT2
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.34288056707086867,0.90606513233355,0.6382978723404256,0.9344928492660843,1.0,51/174,24.59%,FGFR1;SOCS2;TBC1D8B;PCDH9;KLHL21;SYT1;POSTN;DDX31;ABI3BP;STARD9;DLC1;TPGS1;PCDH18;GFRA1;TRIM65;CA2;COL5A3;XPNPEP2;AOX1;CERS3;PI15;ABHD8;FLRT2;SLC37A4;SH3TC2;PTBP2;GPR37;FBN1;GAS1;FRRS1;TMEM144;SVEP1;METTL25;NCBP1;THBS2;ADGRL3;FECH;P3H3;ASPA;ELOVL6;ROBO3;ACKR1;TENM4;ARHGAP10;FURIN;GALT;IKBIP;SNX21;ADAM33;SHQ1;SLC16A2
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.4014644135882923,0.9057284053673634,0.5625,0.9350338471947144,1.0,11/70,14.05%,PCDH15;EPS8L2;PCLO;WHRN;MYO1E;EPS8;GSN;OTOGL;CTBP2;TPRN;ESPN
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.4637252496237558,-0.9057135012996974,0.5555555555555556,1.0,1.0,5/22,10.23%,CGA;CD86;TG;HLA-DRB1;HLA-C
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.580521377830893,0.9057121827375928,0.6530612244897959,0.9348273145552773,1.0,4/6,40.65%,TTPA;GLTP;PLEKHA8;CERT1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4998994736818132,-0.9055537346986328,0.6444444444444445,1.0,1.0,1/17,2.09%,PLAAT4
prerank,KEGG_2021_Human__Amphetamine addiction,0.4171170907202115,0.905475436906908,0.5686274509803921,0.9351753668085351,1.0,10/57,14.09%,SIRT1;GRIN3A;HDAC2;PPP1CC;GRIN3B;PPP3CA;CREB3L2;PPP3CC;GRIN2D;CREB1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5230037127126459,-0.9053868838093111,0.5609756097560976,1.0,1.0,2/7,17.02%,GOLGA2;CHP1
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.6095403063854388,0.9052363415176569,0.6607142857142857,0.9353904620677774,1.0,2/5,32.76%,MAPK3;BRAF
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,-0.45246110562028546,-0.9050529739865868,0.58,1.0,1.0,11/31,10.86%,CD24;CD53;CD86;ALOX5;JCHAIN;BTK;HCK;POU2AF1;LY86;PAX5;SPI1
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,-0.45246110562028546,-0.9050529739865868,0.58,1.0,1.0,11/31,10.86%,CD24;CD53;CD86;ALOX5;JCHAIN;BTK;HCK;POU2AF1;LY86;PAX5;SPI1
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.41343881226164536,-0.9049432781349386,0.5849056603773585,1.0,1.0,8/55,6.12%,SELP;GAB3;CD53;APOL3;MS4A4A;F13A1;CIITA;JCHAIN
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,0.42219498937744687,0.9048252097821025,0.66,0.9361363988795638,1.0,11/51,14.15%,STAB1;ITGAX;IL10RA;FGL2;TLR2;LAIR1;SIGLEC1;TFEC;C3AR1;MSR1;ADAMDEC1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.43900579929779504,0.9047595378514051,0.6296296296296297,0.9360591796490763,1.0,3/34,8.29%,EPHA7;ENPP1;PDGFC
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.4491437237744721,0.9046577893252458,0.6,0.9360417020394458,1.0,1/19,1.82%,CCL5
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.49935244452689354,0.9045798623458203,0.7142857142857143,0.9359744958990487,1.0,2/14,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4578186237705645,0.9044524996374581,0.5918367346938775,0.9359669946858155,1.0,3/19,2.90%,LGALS9;KLRD1;PIK3R6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.40442951435555596,0.9042397326505732,0.6037735849056604,0.9361484013834287,1.0,11/53,10.29%,FLT1;FGFR3;SYK;FGFR1;ERBB4;ABI3;PDGFRA;FER;EPHA3;ABL2;FLT3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4407296372304328,-0.9039908958120343,0.5882352941176471,1.0,1.0,7/24,17.51%,RFC3;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3
prerank,"Reactome_2022__Metabolism Of Ingested SeMet, Sec, MeSec Into H2Se R-HSA-2408508",0.6188848850884188,0.9038568757672272,0.711864406779661,0.9368101315544967,1.0,1/5,5.11%,AHCY
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6249327657366317,0.9036303980497251,0.6666666666666666,0.9370475314795709,1.0,2/7,4.15%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5895282918147476,0.9033884036512482,0.7222222222222222,0.9373742169488763,1.0,3/7,20.60%,MFHAS1;LYN;TLR1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.5794109127545162,0.9033247025884213,0.72,0.9372703498632327,1.0,2/7,12.66%,ZBTB7B;MYB
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4395041918541209,0.903197292515733,0.5769230769230769,0.9372823786903304,1.0,4/24,14.36%,CACNB4;ANK2;JPH1;DMD
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5154296633996953,0.9031864593244722,0.5660377358490566,0.9370859414947341,1.0,3/12,3.79%,SIRT1;WNT4;BMP2
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.5496079070613337,0.9030949590845135,0.6610169491525424,0.9370318520934408,1.0,2/7,23.83%,ANO6;PMP22
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5293590983373945,0.9030581393372584,0.6326530612244898,0.9369017266800206,1.0,2/9,14.30%,MLC1;LRP6
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.405156657482,-0.9030495226742085,0.5789473684210527,1.0,1.0,12/51,9.98%,COL24A1;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;LOXL4;LAMB3;COL6A3;COL11A2;COL1A1;MMP9
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.39768632517726055,-0.9029552466599962,0.5777777777777777,1.0,1.0,19/75,17.48%,EHF;UPK1A;TST;ACTL8;PAX2;TAGLN;TPP1;ZNF703;CDHR2;E2F7;GSTK1;UPK3A;AKR1C2;FZD7;DAB2;VDAC1;CDK1;FGFR2;UPK2
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.5813808058537926,0.9028415577622829,0.6666666666666666,0.9370890724352977,1.0,2/7,14.44%,PPP3CA;NFATC3
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.4937102418927313,0.9028275452242951,0.6792452830188679,0.9368697541158431,1.0,1/17,0.40%,CSTA
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.3943093333663103,-0.9026450668317462,0.7073170731707317,1.0,1.0,4/50,6.74%,DDX11;ERN2;TSPYL2;TPP1
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.4377573312185609,-0.9025597246577763,0.5625,1.0,1.0,6/34,16.27%,HK2;PLCB2;SLC5A1;G6PC3;ATP1B1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.36339053584714315,-0.9024688014208894,0.7272727272727273,1.0,1.0,12/120,7.78%,NTRK1;TNFSF18;TERF2IP;NLRP3;TNFRSF11A;TRIM5;CAMK2A;RAB7B;PRKD2;BTK;FLOT1;CLU
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5316526662340675,0.9024182379349688,0.6153846153846154,0.9375824328936927,1.0,2/11,4.30%,BMP2;ROBO2
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,-0.4736520452194418,-0.9023514044463705,0.6304347826086957,1.0,1.0,4/14,18.07%,TSPAN15;ICA1;SPINK4;CHKB
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.5385914046386644,0.902325364675232,0.5925925925925926,0.9375381952815842,1.0,4/10,29.72%,RRAGD;SESN2;SESN1;GCN1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.39841765404908785,-0.9023025309539767,0.5909090909090909,1.0,1.0,10/58,7.69%,ARAP3;CD24;TEK;OR52A1;DPPA2;RBPMS;B3GALT5;SLC7A3;C1ORF94;NODAL
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5285437228258743,0.9022822699270866,0.5434782608695652,0.9374114104928816,1.0,3/13,12.71%,HS3ST5;CD34;KNG1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.5459064974400891,-0.9022782827577807,0.6,1.0,1.0,1/8,3.15%,MEFV
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.3658404093116264,0.9022331460396782,0.6226415094339622,0.9372615784915168,1.0,3/99,4.07%,SGO1;NDC80;NDE1
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.458898376826599,0.9021776238254072,0.5806451612903226,0.9371316314834125,1.0,5/18,13.08%,FGFR3;FGF17;PIK3CA;SOS1;FGF5
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.4214902388825901,0.9021631086100371,0.5882352941176471,0.9369093463692011,1.0,11/33,16.53%,SLC10A3;NPC2;ABCC2;ABCG8;SLC10A5;NCOA2;SLC10A1;ABCC11;ABCG5;SLCO1A2;AKR1C1
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.3733018353365344,-0.9021438911775472,0.6041666666666666,1.0,1.0,14/102,14.55%,UVSSA;PARP2;PIAS3;ERCC1;RFC3;XPC;PRPF19;PARP1;GTF2H2;COPS7A;POLR1A;XRCC1;RPA3;RFC2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.4676792333759852,0.9020236856990401,0.5510204081632653,0.9369808203215254,1.0,6/21,17.85%,LLPH;NLGN1;DBN1;CAPRIN1;FOXO6;FMR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.5920415677792605,0.9019865021356879,0.7037037037037037,0.9365531661143558,1.0,4/5,24.67%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.5920415677792605,0.9019865021356879,0.7037037037037037,0.9365531661143558,1.0,4/5,24.67%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5285364100584193,0.9017609509911543,0.6666666666666666,0.9368455605326398,1.0,11/16,31.41%,FZD5;CLC;CD55;HLA-F;TNFSF4;SMAD7;TRAF6;B2M;TNFRSF1B;MAP3K7;TRPM4
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.5430150049932462,-0.9016805600553823,0.6,1.0,1.0,2/6,9.42%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.5430150049932462,-0.9016805600553823,0.6,1.0,1.0,2/6,9.42%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.4936855788814468,0.9016451537053098,0.6078431372549019,0.9368642419246396,1.0,2/14,11.70%,IL4;ATPSCKMT
prerank,KEGG_2021_Human__Long-term potentiation,0.40955934860392157,0.9015474125544591,0.6590909090909091,0.9368137176424663,1.0,16/59,21.74%,RAPGEF3;PPP1CC;GRM5;RPS6KA2;PPP3CA;PPP3CC;RAP1A;GRIN2D;RPS6KA1;PLCB1;GRM1;PRKACB;MAPK3;GNAQ;CAMK4;RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.4840324933811439,-0.9012474908492274,0.6,1.0,1.0,2/14,6.07%,INHA;SFRP1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6100695780715955,0.9012257872376251,0.6296296296296297,0.9373495841539263,1.0,4/5,38.38%,PDE4B;PDE4D;CHGA;CAMK2D
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.482842207420216,0.9012230445539662,0.574468085106383,0.9371079468285777,1.0,4/16,5.54%,TGFBR1;NRG1;ADGRG6;RBPJ
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.40859679767696055,-0.9010917379259491,0.5849056603773585,1.0,1.0,3/62,4.71%,DUSP4;DUSP6;FOS
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,-0.5568403084151046,-0.9010523116796098,0.6304347826086957,1.0,1.0,1/7,18.29%,AP2A2
prerank,Reactome_2022__Erythrocytes Take Up Carbon Dioxide And Release Oxygen R-HSA-1237044,0.5501717035163696,0.9009049136816571,0.6415094339622641,0.9375150505333669,1.0,5/7,23.56%,CYB5R4;CA2;SLC4A1;CYB5R1;CYB5R2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3543246090979095,0.9007620141526937,0.6825396825396826,0.9375796150968632,1.0,16/133,8.92%,FLT1;EPHA7;FGFR3;MYC;FGFR1;ERBB4;ACD;ROR1;BMI1;PARM1;PDGFRA;EPHA5;EPHA3;DCUN1D1;ARRDC3;EPHA8
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.6142464818964501,-0.9005752844584238,0.6666666666666666,1.0,1.0,2/5,17.38%,PAX2;PAX8
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.4904034104599162,0.9004580544421714,0.65625,0.9379962552884555,1.0,7/14,34.43%,PUF60;RBM17;DHX9;SRSF9;CELF4;CDK13;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.42061571240868284,0.9004351359619296,0.6,0.9377974699335433,1.0,8/40,17.73%,ROBO2;CHODL;PLXNB1;PLXNB2;DBN1;L1CAM;CDKL5;MACF1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,-0.41544112123583915,-0.900394998172351,0.5454545454545454,1.0,1.0,4/42,3.68%,F5;HAPLN3;CD101;CCDC141
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4112115935013335,-0.9003393121318319,0.5660377358490566,1.0,1.0,9/62,9.08%,CLDN4;C6ORF132;PTGES;CRABP2;LYPD6;RHBDF1;ALOXE3;CDH3;WWC1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.458818641738038,0.9002922896005188,0.5961538461538461,0.9379145346347267,1.0,11/36,19.66%,IL4;SYVN1;BLNK;PLCG2;KLF6;FLT3;DNAJB9;RAG2;KIT;HDAC9;RAG1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.39878956819594463,-0.9002760152753089,0.5254237288135594,1.0,1.0,9/49,8.49%,GAB3;GYPB;GYPE;BEND2;ABCC13;IFIT1B;BTK;ARHGAP15;ALAS2
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.39878956819594463,-0.9002760152753089,0.5254237288135594,1.0,1.0,9/49,8.49%,GAB3;GYPB;GYPE;BEND2;ABCC13;IFIT1B;BTK;ARHGAP15;ALAS2
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.4892490689773066,0.9002456539050199,0.5319148936170213,0.9377882139738758,1.0,4/10,16.24%,LMOD3;PGM5;LMOD2;TMOD4
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.5846366652089414,0.9001710317775701,0.6274509803921569,0.9377178434491944,1.0,4/5,37.07%,CITED2;ASXL2;LMO3;PTGIS
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.52520243020112,-0.8999163931397651,0.5348837209302325,1.0,1.0,1/21,0.59%,NOSTRIN
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.49499413910426715,0.8998142534810142,0.5660377358490566,0.9381667689005344,1.0,1/10,2.93%,NEDD4
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.46938474973439576,-0.899780283737981,0.6382978723404256,1.0,1.0,5/15,19.66%,ADAMTS9;EDEM2;ADAMTS12;FBXO2;FBXO44
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.5115179593970595,0.8997609828884923,0.631578947368421,0.9380339100873447,1.0,3/11,5.90%,IL4;KLKB1;F12
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5788598700935743,-0.89975583814504,0.7291666666666666,1.0,1.0,1/7,5.40%,PAH
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4739949501793837,0.8996025145972498,0.5849056603773585,0.9380883505965809,1.0,8/22,23.29%,RAPGEF3;PTPN14;ANP32B;SIRT7;TP53;GAS6;GTSE1;BARD1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.4170506010030385,-0.8995905716274639,0.6274509803921569,1.0,1.0,9/47,8.11%,TBC1D10C;SELL;TRAF3IP3;CD53;CYTH4;LTB;CD5;TAGAP;TNFRSF4
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5152027931908987,-0.8994071057994176,0.5333333333333333,1.0,1.0,4/14,15.15%,CD24;CEACAM1;CAV1;OSR1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5025276418565878,0.8993596625501558,0.6296296296296297,0.9383824861402656,1.0,3/15,19.45%,CADM1;CD55;JAG1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.5389842945108377,0.8992717931685287,0.6545454545454545,0.9383284676032577,1.0,1/7,4.29%,LMOD3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.45188735552049203,-0.89905412282524,0.575,1.0,1.0,6/29,14.93%,CD24;SFRP1;AR;CAV1;RARA;BRCA1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.541770766459041,0.8989535183128686,0.5882352941176471,0.9387635208119968,1.0,1/7,13.89%,HSD17B10
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.39025395593841344,0.8987849876780276,0.5777777777777777,0.9388767783865896,1.0,11/92,8.38%,MXRA5;MRGPRF;GNG12;DOCK1;BGN;FBLIM1;POSTN;ITGAV;ADGRL2;GPR176;PCDH18
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.41413530771459817,0.8987591764309076,0.6304347826086957,0.9386881743788764,1.0,14/37,27.64%,CCL5;RELA;STING1;POLR3G;IKBKE;IL33;IRF3;POLR2H;IKBKB;NFKBIB;POLR1D;CHUK;NFKB1;NFKBIA
prerank,Reactome_2022__CREB3 Factors Activate Genes R-HSA-8874211,-0.5510972661895845,-0.8987202848800963,0.6304347826086957,1.0,1.0,2/8,9.83%,MBTPS2;CREB3L1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5298120190640787,-0.8986746161635754,0.6111111111111112,1.0,1.0,1/17,2.86%,SPTLC3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.44921041308617715,0.8986580967768136,0.6,0.9386734878393811,1.0,2/18,4.48%,CALCR;ZFP36L2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.36719903961852707,0.8986542302281847,0.5909090909090909,0.9384489685241953,1.0,34/95,20.73%,SYT15;NEDD4;ITPKB;NLGN1;ADGRV1;SYT6;SYT1;PLCG2;NEUROD2;CASR;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;SLC25A13;MEF2C;PPP3CA;CPNE3;TRPM2;PPIF;CPNE2;RYR2;PRKAA1;AKR1C3;RYR3;SLC25A12;SYT3;LGMN;KCNMB4;CPNE9;TRPC1;KCNMB1;SYT17
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.4290674387864548,0.8986363771351349,0.5961538461538461,0.9382376776092195,1.0,12/35,29.79%,RALA;LMNB1;HNRNPA2B1;PKN2;ANXA2;HNRNPF;IL12A;JAK2;AURKAIP1;PDCD4;GSTO1;IL12RB2
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,0.5305994782340564,0.8985683597079253,0.6666666666666666,0.9380953146512796,1.0,1/8,5.57%,RELA
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.37021787777256565,-0.8985278871664477,0.7058823529411765,1.0,1.0,15/76,14.70%,SLC29A3;SLCO2A1;NLRP3;SLC24A4;SLC39A4;HEPH;SLC3A1;SLC24A5;SLC5A1;TAC4;SLC36A2;SLC4A4;SLC6A20;SLC2A1;POM121C
prerank,KEGG_2021_Human__Colorectal cancer,0.3667788098091593,0.8984313100939905,0.6078431372549019,0.938182359681126,1.0,21/81,22.25%,MYC;TGFBR1;DCC;RALA;PIK3CA;SMAD2;SMAD4;MAPK8;SOS1;PIK3CD;MAPK10;CTNNB1;TP53;CASP3;POLK;AKT3;PIK3R3;BAD;MAPK3;AKT2;GRB2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.5931011503955269,-0.8984187249237195,0.6086956521739131,1.0,1.0,1/5,3.49%,CCBE1
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.4116867099015117,-0.8984011187568975,0.6122448979591837,1.0,1.0,3/63,1.08%,NTRK1;HK2;LDHC
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.4694217045565908,0.8983568932011051,0.5789473684210527,0.9381186934500326,1.0,5/16,10.25%,IGF1;ICOSLG;HMGB1;TMIGD2;IL23R
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.5641902002986957,-0.8981982800657158,0.56,1.0,1.0,1/6,1.18%,TEK
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.40672520069727713,-0.8981868562367109,0.6041666666666666,1.0,1.0,6/68,6.81%,GOLGA8B;ABRAXAS1;HAUS7;GOLGA2;GOLGA8A;TUBGCP2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.56437012811949,0.8980024488634651,0.6557377049180327,0.9386117248390966,1.0,3/7,30.87%,AXL;APPL1;APPL2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5784870394991857,0.8977931221944816,0.6326530612244898,0.9386315444332752,1.0,3/6,32.25%,CDC27;ANAPC7;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5784870394991857,0.8977931221944816,0.6326530612244898,0.9386315444332752,1.0,3/6,32.25%,CDC27;ANAPC7;TACC3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.38741092234567154,0.897776733931814,0.5636363636363636,0.9384238620334967,1.0,14/74,20.95%,HIF3A;EGLN3;HIF1A;PSMD13;PSME4;NFE2L2;PSMA1;VEGFA;TP53;DNAJB1;ARNT;LIMD1;DDIT3;PSMD4
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,-0.4030736242272126,-0.8976948287696559,0.5957446808510638,1.0,1.0,4/64,2.82%,EHF;CLDN4;TMEM184A;C6ORF132
prerank,KEGG_2021_Human__Prostate cancer,0.3960725986905212,0.897659806244906,0.6078431372549019,0.9384354509931174,1.0,15/88,14.09%,IGF1;TMPRSS2;FGFR1;RELA;ZEB1;ERG;PDGFRA;PDGFC;PIK3CA;FOXO1;PTEN;SOS1;IGF1R;CREB3L2;CREB1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5275455888721795,-0.8974860227117523,0.6481481481481481,1.0,1.0,1/12,5.96%,DLL4
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.371299242352466,0.8974404889109308,0.6326530612244898,0.9386759513759811,1.0,5/96,4.68%,TIMELESS;CCNA2;SEM1;RRAD;H2BC21
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,0.4790565211846639,0.8973970460763445,0.6065573770491803,0.9385141906884923,1.0,3/12,25.89%,PGM1;GBE1;UGP2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.38179862351455635,-0.8973188540120973,0.5365853658536586,1.0,1.0,8/44,12.44%,KDM4D;WARS1;ATG14;SPRED3;CCDC88C;SPRED2;SPRED1;ASPSCR1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.505345645327101,0.8971848557202667,0.6078431372549019,0.9387512773575319,1.0,5/17,26.94%,CXCL12;CTNNB1;SLC30A1;GRM6;LGALS3
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,0.40603259935435804,0.8971656458534033,0.6363636363636364,0.9385536362590777,1.0,11/41,21.32%,DDX31;SLX4IP;POMT2;H2AX;SGK1;ZFAND1;RPE;CASP3;KIAA1586;UBE2D1;C2CD2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.437559275639515,0.8969712731001034,0.5769230769230769,0.9388297920990927,1.0,7/27,17.80%,CORO7;GSN;MSRB1;SPIRE2;COBL;WASHC5;WASL
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.40718567335222516,-0.8969168910674785,0.64,1.0,1.0,12/49,19.61%,SLX4;ERCC1;FANCG;FANCC;FAN1;RPA3;BRCA1;CENPS-CORT;MUS81;BLM;FANCA;FANCB
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.4707560600837295,-0.8968007213374775,0.6595744680851063,1.0,1.0,3/16,10.39%,ASS1;ARG2;GOT2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3322187133927149,0.8966323201228332,0.6976744186046512,0.9393344256513174,1.0,23/170,17.85%,SHMT2;PRR16;EIF3E;SYNCRIP;SAMD4A;LIN28A;TOB1;FOXO3;RNF139;GRM5;METTL18;PATL2;RIDA;HNRNPD;PLXNB2;HSPB1;RPS6KA1;EIF3H;CAPRIN1;CNOT8;BCL3;MTRF1;FMR1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.47502804341565086,-0.896444990928933,0.6730769230769231,1.0,1.0,2/15,7.24%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5341624783618113,0.896417829024309,0.7096774193548387,0.9395253418171815,1.0,2/10,20.58%,BNIP3L;BAD
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,-0.5905082736053905,-0.8963943137606725,0.6,1.0,1.0,2/8,11.88%,TFAP2E;YEATS4
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.5803116369255665,0.8962993961358022,0.6727272727272727,0.939513771239954,1.0,1/5,10.38%,AOX1
prerank,CellMarker_Augmented_2021__Endothelial cell:Antecubital Vein,0.6613336221932409,0.8961289836693063,0.7551020408163265,0.9396294821756422,1.0,3/5,22.81%,CD34;PTPRC;ITGAM
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.3753680829071241,-0.8960973375870931,0.6440677966101694,1.0,1.0,25/159,12.62%,P2RY10;LTB4R;GPR39;MRLN;XCR1;NLRP3;GPR132;NMUR2;PRKCD;CD200R1;RGS4;BTK;GPR143;PLCB2;GNG13;GPRC6A;TRHR;NMU;GNGT1;PROKR2;MCHR2;ITPR3;FFAR4;GNB3;ADRA1D
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.48752177641033245,-0.8959060538407972,0.7142857142857143,1.0,1.0,4/15,10.34%,HSF2BP;BTBD18;MOV10L1;DDX4
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.39547844011175864,0.8958177936728807,0.7843137254901961,0.9367580325181147,1.0,11/64,8.99%,FLT1;TDRD10;STAB1;PREX2;ITGA8;ADGRL4;BGN;ERG;HPGDS;RAMP3;MYH11
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.3514807124584771,-0.895672741579294,0.7,1.0,1.0,26/188,13.84%,RFX6;TMEM52;CD24;SIGIRR;DOCK8;DDX24;CRABP2;PDE6B;TSPYL2;ABHD14A;TXLNB;CFAP97;NOL12;NNAT;ATP6V1D;NMU;MEIS2;SERPINE2;TCEAL4;USP11;KLHL35;CFAP221;DUSP9;DTD1;UROS;CCND1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5286757636355562,0.8955853267569532,0.5849056603773585,0.9370007270601663,1.0,4/9,24.11%,SNCA;RAB33B;ANXA1;IL1RAPL1
prerank,CellMarker_Augmented_2021__B cell:Peripheral Blood,-0.5346542498517236,-0.8954494959336999,0.6304347826086957,1.0,1.0,2/9,7.57%,CD24;CD5
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.5546449852021156,0.8954425717715226,0.6551724137931034,0.9371100803980676,1.0,2/8,7.27%,MYC;ZFYVE19
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4558986417312091,-0.8953363020295964,0.5714285714285714,1.0,1.0,3/27,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4558986417312091,-0.8953363020295964,0.5714285714285714,1.0,1.0,3/27,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.4773989396042364,0.8952587748315928,0.7049180327868853,0.9372875924045911,1.0,8/20,32.98%,AKTIP;STX8;PTPN23;SNX16;WDR81;HOOK1;KIF16B;RAB7A
prerank,KEGG_2021_Human__Endometrial cancer,0.39102129988149775,0.8951622858925515,0.5849056603773585,0.9372604205546855,1.0,17/57,22.25%,MYC;ELK1;FOXO3;PIK3CA;CTNNA2;PTEN;SOS1;PIK3CD;CTNNB1;TP53;POLK;AKT3;PIK3R3;BAD;MAPK3;AKT2;GRB2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5283487317094943,0.8951605103371799,0.6363636363636364,0.9370189830429507,1.0,4/10,24.16%,KANK2;CNOT2;VPS18;FOXH1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.4022719524355621,-0.8950897888813776,0.5294117647058824,1.0,1.0,12/58,13.03%,TEK;COL4A2;ALOX5;ANGPT4;NIBAN2;NAXE;SARS1;FOXO4;SPARC;SPRED1;ADAMTS1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.47891128425944335,0.89505930181457,0.6779661016949152,0.936995140189467,1.0,4/17,9.44%,CD99;DAPK2;MOSPD2;MCU
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.39710874967035653,0.8950489945652663,0.62,0.9367668752615543,1.0,12/60,11.59%,MITF;LGALS9;ITGAX;CSF2RA;DDX60L;FGL2;TLR2;LAIR1;TFEC;C3AR1;HLA-E;APOL6
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.5207252732495599,0.8949270130937146,0.7241379310344828,0.9367917718917647,1.0,5/13,21.12%,H2BC21;TF;HLA-E;WFDC11;WFDC9
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.44292366792555127,0.894545035749358,0.6428571428571429,0.9373745066831567,1.0,1/29,0.53%,FGF10
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.3977002033874767,-0.8944914259483138,0.5116279069767442,1.0,1.0,6/64,5.09%,CLDN4;GPR39;SERINC2;C6ORF132;SPDEF;DSG2
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5127944132856033,-0.8944245364267472,0.6956521739130435,1.0,1.0,3/11,11.63%,RIN3;LRPAP1;WDR54
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.5734035587179186,0.8944069743871329,0.6981132075471698,0.9374640838835248,1.0,1/5,7.75%,HMGB1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5452780548414619,0.8943385409416239,0.6842105263157895,0.9373526326278373,1.0,3/10,7.89%,CBLB;F3;SNCA
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.5725805756994339,0.8942105624594512,0.6545454545454545,0.937364389760988,1.0,3/6,22.07%,IRS2;ACSL1;AKT2
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.3954980047843054,0.8941049781794029,0.6190476190476191,0.9373729008647533,1.0,9/59,22.18%,U2AF1;THOC6;PAPOLA;PCF11;SRSF11;CSTF3;WDR33;NCBP1;SRSF3
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.4841131552172277,-0.8940406268301386,0.6136363636363636,1.0,1.0,6/19,16.44%,CNGB1;PRKD2;EXOC3;PTGES2;RAB8A;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.35321244056183,0.8940395740413617,0.6851851851851852,0.937303667948146,1.0,34/162,20.95%,CXXC4;LRP4;BMP2;MLLT3;DKKL1;WWTR1;LATS1;PSMD13;IGFBP6;DACT3;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;DVL2;WWOX;TMEM170B;LRP6;FZD4;PTPRU;FZD6;FRZB;PSMA1;NXN;KLHL12;RUVBL2;TLE4;APCDD1;LIMD1;AMER2;HDAC1;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4218095373069801,-0.8940051350581885,0.6046511627906976,1.0,1.0,2/36,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.4129549996037725,0.8938327444702229,0.5882352941176471,0.9375453492941497,1.0,6/41,24.86%,HIF1A;GCK;RANBP2;NUP153;OGT;EP300
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.4839419507347851,0.8937471678193463,0.723404255319149,0.9375149575021081,1.0,2/14,4.33%,DCC;DOCK1
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",-0.534125609995853,-0.8936429541373586,0.625,1.0,1.0,2/13,4.09%,PXDN;RNASE1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.5569994137100127,-0.8936184690427694,0.7,1.0,1.0,2/7,18.88%,RNF213;SERPINB9
prerank,CellMarker_Augmented_2021__Monocyte:Blood,0.5764906670095098,0.8935378655503952,0.6956521739130435,0.9377467504884871,1.0,2/5,4.31%,SELPLG;CD244
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.39116202888700463,0.8935261950122162,0.6595744680851063,0.9375318805449352,1.0,7/76,4.40%,IGF1;FGF10;MYC;IL26;FGF2;ANGPT1;SIX4
prerank,KEGG_2021_Human__Base excision repair,-0.4313140374253572,-0.8934215129805018,0.7142857142857143,1.0,1.0,7/30,18.22%,PARP2;SMUG1;PARP1;LIG1;XRCC1;LIG3;MBD4
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.5048848932424009,-0.8932921437804476,0.6444444444444445,1.0,1.0,1/10,3.49%,CCBE1
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.3690705456572554,0.89303291991738,0.5833333333333334,0.938345849275398,1.0,13/78,20.95%,CCNA2;SEM1;GMNN;MCM7;ANAPC16;PSMD13;PSME4;ORC4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5289944425506614,0.8929777804200508,0.6037735849056604,0.9382182583214008,1.0,3/9,19.80%,PTAR1;RCE1;PGGT1B
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6072679095296678,0.8926748102400233,0.7142857142857143,0.938659799801908,1.0,5/5,39.29%,DICER1;NOTCH1;SKI;RNF10;HES1
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.3594964251415659,-0.8926570587972676,0.6590909090909091,1.0,1.0,4/95,2.85%,MS4A8;TREH;CD24;HHLA2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.574448653986958,0.8925947545068184,0.673469387755102,0.9385903788792467,1.0,1/5,8.96%,KDM3A
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5763026947341551,0.8922153816146999,0.6862745098039216,0.9392965960213204,1.0,1/5,3.94%,TENM3
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.3944507194779261,0.8921709143052664,0.6206896551724138,0.9391753538745928,1.0,16/62,20.72%,MSH4;ACD;H2BC21;TEX15;SYCP2;H2AC6;TERF1;H2AZ2;LMNB1;H2AX;ARTN;CDK4;SUN2;SMC3;POT1;SYCP3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5147538559994432,0.8920414683996285,0.56,0.9392221349381664,1.0,1/12,2.18%,ZBTB7B
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.44876920094465844,-0.8918859271975067,0.6326530612244898,1.0,1.0,5/27,19.97%,PRKCD;ITPR3;PRKCH;DGKA;DAGLA
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.37951262335083275,0.8918335699772109,0.6296296296296297,0.9394303516768838,1.0,19/106,10.62%,MYC;IL4;SOCS2;STAT5A;CSF3R;GFAP;CSF2RA;IL2RA;IL7R;IL10RA;PDGFRA;IL15;LIFR;SOCS6;LEPR;PIK3CA;IL23R;AOX1;IL13RA2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.40187304235856935,0.8916927510047999,0.6444444444444445,0.9394835001892687,1.0,15/40,16.58%,GATA4;NRG1;BMP2;SGCZ;SMAD1;SGCG;BMPR1A;NPPA;SMAD4;TBX18;GJB6;SMAD5;MESP1;NOTCH2;HEY2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.5623898907843276,0.8912904428794094,0.6181818181818182,0.9401853568327342,1.0,1/8,5.30%,MID2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.37743325278689255,0.8911299175287068,0.660377358490566,0.9403350862204767,1.0,9/66,20.95%,CCNA2;SEM1;ANAPC16;PSMD13;PSME4;PSMA1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5135935413198747,0.8910176641619011,0.5294117647058824,0.9403395740518418,1.0,2/14,8.04%,COX19;ANKRD9
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.3656213638109857,0.8909101273048978,0.6470588235294118,0.9403247092179233,1.0,15/82,20.95%,SEM1;H2BC21;GMNN;MCM7;ANAPC16;PSMD13;H2AC6;H2AZ2;H2AX;ORC4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.46919382624012534,0.8907414850206195,0.6491228070175439,0.940432372972224,1.0,6/21,17.97%,RUNX1;NLRP7;RNF139;BAG2;GAS1;ASTL
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.3768113513477032,0.8907296648507705,0.5961538461538461,0.9402144170661721,1.0,7/66,8.69%,TCIRG1;ATP6V0D2;SLC1A3;SLC17A6;SYT1;UNC13B;ATP6V0A4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.36471164326579175,-0.8906909292809699,0.6730769230769231,1.0,1.0,7/98,6.62%,RFX6;CELA2A;DRD4;ALOX5;RHBDF1;DRD2;PER2
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.4365512914760772,0.8905862841486327,0.6333333333333333,0.9403123862013246,1.0,8/28,20.21%,NEDD4;ZFYVE16;KPTN;RNF128;CD81;SNX16;GCC2;LMBRD1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5222281345115201,0.890485654514854,0.6470588235294118,0.9402943217526671,1.0,4/9,27.68%,GALK1;GALK2;GALT;GALM
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.536274536481246,0.8904640499757167,0.6226415094339622,0.9400797891686145,1.0,6/9,39.03%,GGCT;CHAC1;CHAC2;CNDP2;MGST2;GCLC
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,0.505834808705353,0.8904325542053072,0.7115384615384616,0.9399201082059003,1.0,1/14,0.53%,FGF10
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.4460646602807154,0.8902194366181595,0.64,0.9401371663356779,1.0,7/20,20.98%,PRDX6;SMPDL3A;PNPLA6;LIPG;PLBD2;PLBD1;GPCPD1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.5015783144116934,0.8901983917100228,0.5806451612903226,0.939951804490534,1.0,1/11,4.55%,IDH1
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.5360986570126892,-0.890188527885037,0.5961538461538461,1.0,1.0,2/7,11.52%,APOA1;APOB
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.3956673777619205,-0.8901614360372824,0.5869565217391305,1.0,1.0,3/47,7.55%,KLRC1;CIITA;HLA-DRB1
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.36318294450053534,0.8901179284429316,0.5961538461538461,0.9398888080386432,1.0,28/125,12.91%,SEMA5A;C1GALT1C1;VCAN;BGN;SDC4;ADAMTS17;ADAMTS16;ALG6;MUC20;GPC5;ADAMTS19;GALNT3;SPON1;MOGAT2;GPC4;C1GALT1;EXT1;GALNT12;NUS1;MUC13;MUC7;CHST6;EGFL7;B3GLCT;GALK1;ALG9;PGM1;POMT2
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.44350591350640634,0.890075267521102,0.6111111111111112,0.9397164715233013,1.0,11/23,39.49%,ANAPC16;UBE2D1;UBE2E1;ANAPC15;CDC27;ANAPC7;BUB3;ANAPC4;ANAPC5;RPS27A;UBE2S
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.45282702362604865,-0.889713063381819,0.6190476190476191,1.0,1.0,5/25,14.99%,AK8;RRM2;AK7;CTPS1;RRM1
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.49075063343939157,0.8894635782162482,0.7090909090909091,0.9409303229212295,1.0,3/15,12.78%,ERBIN;PIK3CA;SOS1
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.4955145319083919,0.8893787644754841,0.6101694915254238,0.940905707324302,1.0,2/15,10.77%,TGFBR1;CGN
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.5297001089801419,-0.8892997077465461,0.6363636363636364,1.0,1.0,1/6,16.14%,TRPV4
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4190712524356532,0.8892769684049092,0.5952380952380952,0.9408553893327913,1.0,3/29,8.42%,CDK18;FBXO5;CDK14
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.43697881734865057,-0.8892541388261539,0.6458333333333334,1.0,1.0,6/39,10.37%,EIF5AL1;F8;F7;ARSL;DPH6;SUMF1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.34931168270258095,0.8887865680190297,0.6842105263157895,0.9419169850310551,1.0,28/123,20.59%,EHD1;MRAP2;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;ANK2;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;PACS1;TSPAN17;LRP6;DENND4C;GORASP2;CD81;RAP2A;AFDN;SMURF1;RAPGEF2;BSG;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5117074252488623,0.888638078640291,0.6923076923076923,0.9419788804629005,1.0,3/14,19.44%,FBXO5;BAG2;ABL1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.4238585337194682,0.8886312865616212,0.6808510638297872,0.9417580961509234,1.0,8/44,20.55%,ZBTB1;PRIMPOL;REV1;PCLAF;FAAP20;POLK;UBE2A;WDR33
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,-0.5352173742238191,-0.8883907734347603,0.6818181818181818,1.0,1.0,1/15,0.73%,AMACR
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.5524877086282121,-0.8883167981742827,0.62,1.0,1.0,1/7,3.80%,SLX4
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.335090939577023,0.8883065755301902,0.5918367346938775,0.942250286987596,1.0,37/132,22.25%,CCL3L3;CCL5;PIK3R6;GNB4;GNG12;PIK3R5;CXCL12;RELA;PLCG2;FOXO3;GNAI3;PIK3CA;PXN;GNG4;BCAR1;SOS1;ITK;RAP1A;PLCB1;PIK3CD;VAV2;ARRB2;PRKACB;AKT3;LYN;CX3CR1;PIK3R3;BAD;IKBKB;PARD3;MAPK3;CCL25;GNAQ;CRK;GNAI1;AKT2;GRB2
prerank,KEGG_2021_Human__Gap junction,0.3773307873072482,0.8881952346142256,0.6326530612244898,0.9422863680260112,1.0,21/82,22.70%,TUBA1C;PRKG1;PDGFRA;PDGFC;GNAI3;GUCY1A2;GRM5;HTR2C;SOS1;ADRB1;PLCB1;GRM1;GUCY1A1;PRKACB;TUBB1;HTR2A;MAPK3;GNAQ;GNAI1;GRB2;GJA1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.4639241622423196,-0.8881850894290829,0.5454545454545454,1.0,1.0,2/12,4.76%,APOBEC3H;APOBEC3G
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.4319779655317148,0.8881744754428013,0.6274509803921569,0.9420688835371607,1.0,6/33,19.76%,BICD1;GALNT1;DCTN3;DYNC1I2;PAFAH1B3;ACTR10
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,-0.4763585256195034,-0.8881351203068091,0.6037735849056604,1.0,1.0,2/16,10.77%,PLA2G2C;PLB1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.37687087493325777,-0.8879331964686635,0.6595744680851063,1.0,1.0,7/64,14.78%,TBC1D10C;PODXL;CAV1;RAB17;DCDC2;RAC1;USP17L2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5319567708733384,0.8878580977832485,0.7111111111111111,0.9424836119703305,1.0,4/9,22.81%,TICAM1;ITGB2;CAMK4;ITGAM
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.4431327031012445,0.8877262509688486,0.6607142857142857,0.9425003591303128,1.0,6/22,20.65%,PRR16;PTEN;VAV2;RAP1GAP2;DEPTOR;EDN1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.35994279982455224,-0.8876350545092782,0.6296296296296297,1.0,1.0,23/118,12.44%,P2RY10;CD53;XCR1;CYTH4;CD86;GPR132;ASS1;BATF3;RAB7B;HCK;SLC11A1;HLA-DRB1;HFE;TAGAP;LY86;LAMP3;ADAM19;PDCD1LG2;HLA-C;SPI1;CXCL16;PARVG;S100B
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5065780889404418,0.8872457141355472,0.5510204081632653,0.9434182669157697,1.0,3/10,21.30%,ADA;PRPS2;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.4225920673144162,-0.8871848797061705,0.5434782608695652,1.0,1.0,4/23,5.48%,TNFSF18;F7;IL6R;ZP3
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4332924515153533,-0.8868982077036531,0.6170212765957447,1.0,1.0,6/38,7.41%,SPTLC3;PNPLA1;ST8SIA2;DEGS2;ALOXE3;B3GALT4
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.3687288485546059,0.8868427248490813,0.5918367346938775,0.9439317275221,1.0,27/91,20.89%,MCOLN3;TRPM8;ASIC1;TRPV2;TRPC4;STOM;TSC22D3;SCNN1B;TRPC5;SLC9C2;TTYH2;TRPM2;ANO5;ANO6;RYR2;SGK1;ASPH;TRPM7;UNC79;TRPV3;RYR3;WNK1;TRPM3;ASIC4;SCNN1D;TRPC1;OSTM1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.3334053617250567,0.8867600317740064,0.7454545454545455,0.9438871914628878,1.0,41/207,13.31%,SEMA5A;C1GALT1C1;CSF2RA;VCAN;BGN;IDH1;AHCY;SDC4;ADAMTS17;ADAMTS16;ALG6;CYP2U1;MUC20;TCN2;RPIA;GPC5;DCXR;ADAMTS19;GALNT3;SPON1;ADA;FDX1;CYP27A1;MOGAT2;GPC4;CYP7B1;C1GALT1;EXT1;GALNT12;NUS1;MUC13;MUC7;CHST6;EGFL7;B3GLCT;GALK1;ALG9;PGM1;POMT2;SLC37A4;FDXR
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.44652338042124384,0.8867001622842349,0.5909090909090909,0.9437593594542649,1.0,2/20,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5170861379879245,0.8866736991365285,0.625,0.9435963512187813,1.0,2/10,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.4570209194905758,0.886670636147664,0.7021276595744681,0.9433597583823964,1.0,1/17,1.76%,MYC
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.4916937393219602,0.8865834618976389,0.6428571428571429,0.9433794552790435,1.0,2/15,11.51%,RENBP;CHST6
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4730628470683168,0.8865621608631444,0.6415094339622641,0.9431654468627558,1.0,9/13,40.58%,TOB1;ZFP36;PABPC1;CPEB3;TNRC6B;BTG2;TNRC6C;TNRC6A;CNOT7
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.4559291739478273,0.8865345830992315,0.6097560975609756,0.9430219579735898,1.0,2/20,3.42%,GNB4;GNG12
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.5224060785266741,0.8864794543766884,0.5666666666666667,0.942923337461778,1.0,3/9,22.25%,SOS1;CRK;GRB2
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.31703012028268923,-0.8863989929634304,0.7169811320754716,1.0,1.0,23/410,7.93%,TRIP10;ACTC1;ARAP3;DOCK8;RAC2;PRAG1;NOXA1;STK10;RASGRF2;OBSCN;RNASE1;STARD8;DHDDS;FMNL1;DSG2;VAV3;MPZ;DOCK2;ARHGAP15;FLOT1;ARHGDIB;ARHGAP12;TAGAP
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.3952223333780855,-0.8863913718504385,0.64,1.0,1.0,4/56,7.71%,TRIM56;DDX41;POLR3H;POLR3E
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.36215095924182317,-0.8862755006373851,0.6938775510204082,1.0,1.0,23/122,18.09%,F5;F8;ARF3;KDELR1;GOLGA2;PPP6R1;COPG2;TRAPPC2L;CFAP73;COPG1;PTGES2;BET1L;DCTN2;DCTN1;CSNK1D;SEC16A;TRAPPC6A;ARFGAP3;CTSZ;DYNC1LI2;TRAPPC4;SEC24C;SEC13
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.4507478872308911,0.8862302688656224,0.6458333333333334,0.9433301881601228,1.0,5/34,8.97%,SYT15;RAB27A;SYT6;SYT1;RIMS2
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.37806923044463536,0.8862106279486134,0.6666666666666666,0.9431323997390153,1.0,13/86,7.92%,PLOD2;ITGA2;GNG12;DOCK1;CRIM1;ADGRG6;CD59;SDC4;MYOF;WWTR1;EPS8;FAM114A1;PLSCR4
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.35720646150395147,0.8861931078035705,0.5925925925925926,0.9429187254418602,1.0,11/94,8.58%,NEGR1;FGF2;GFAP;CDH2;PCDH9;ZEB1;DPY19L1;NAV3;EPHA5;SACS;FRMPD4
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3619020557536873,-0.8860619466396737,0.625,1.0,1.0,11/87,9.13%,NTRK1;TEK;INSRR;DRD4;TIE1;TSPYL2;LDB1;CAMKK2;HLA-DRB1;NTRK3;RAD50
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,-0.5129620615584883,-0.8860197753157087,0.5238095238095238,1.0,1.0,1/10,2.15%,FGF1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.351315949759148,0.885918064951737,0.6727272727272727,0.9432964998529938,1.0,7/134,5.00%,STK26;TCIRG1;ATP6V0D2;SIRT1;TFEB;RNF152;TBL2
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5088761177037051,0.8858493408415397,0.6296296296296297,0.9432203041233802,1.0,2/8,7.75%,IL4;HMGB1
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,0.5495630812735152,0.8855689281712465,0.6226415094339622,0.9436233690776951,1.0,5/7,27.64%,RELA;IKBKB;CHUK;NFKB1;NFKBIA
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,0.5114407205085139,0.8855667846991102,0.62,0.9433874289284214,1.0,1/11,1.32%,C3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3987982200068542,0.8850576186036067,0.6557377049180327,0.9442947720870127,1.0,8/41,19.70%,SDC4;PIP4K2A;CNOT6L;CEP120;CCP110;CNOT2;G3BP1;STX18
prerank,KEGG_2021_Human__Sulfur relay system,-0.5657897849999161,-0.8849636202760389,0.5581395348837209,1.0,1.0,1/8,4.34%,TST
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.44460728763978397,0.8847044538905999,0.6153846153846154,0.9448185692750801,1.0,7/32,18.36%,RNF152;TELO2;RRAGC;GPR137B;KPTN;DYRK3;RRAGD
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,0.40012934925840804,0.8845688419888454,0.6724137931034483,0.9448314487620949,1.0,12/34,12.93%,KLRD1;MME;ITGAX;LY9;CD244;IL7R;LAIR1;LRRC36;KLRG1;FLT3;CD34;IL18R1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.5199141358196506,-0.884524698353302,0.6744186046511628,1.0,1.0,3/10,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4289172945329368,0.8845128506037481,0.5849056603773585,0.944710309403329,1.0,5/27,20.22%,RAPGEF3;RAPGEF6;RAP1A;AFDN;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3427557889282582,0.884422326780998,0.6792452830188679,0.9446657904545304,1.0,32/172,20.18%,CGNL1;SIRT1;URI1;CD22;RORA;RELA;ESR1;PPM1A;MAGI2;TSPAN6;EPM2A;ARHGAP25;BANK1;CPNE1;SPRY3;PTEN;TANK;NOC2L;PLAUR;PHLDA3;PPIF;PRKAA1;CD2AP;PPEF2;RIOK3;ARRB2;PHLPP1;DEPTOR;THEM4;LYN;LIMD1;DGKD
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.3740056615537086,-0.8843986439323486,0.6744186046511628,1.0,1.0,9/69,4.09%,SELE;TEK;COL4A2;SLCO2A1;TIE1;COL4A1;MGP;EPAS1;RNASE1
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.38238803252676784,0.8842889794828834,0.5925925925925926,0.9446499964293896,1.0,18/73,18.09%,ITGAX;MYC;IL4;HIF1A;RORA;ZEB1;FOXO3;RHOU;IL23R;FOXO1;IL13RA2;SOS1;HSPA8;POU2F1;RORC;VEGFA;TP53;LAMA5
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.4675476753479557,0.8840995170579191,0.6379310344827587,0.9448191345850273,1.0,9/27,25.19%,FBXO5;TERF1;TP53;IRS2;ABL1;POT1;ZFP36;HNRNPU;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3601034253415896,-0.884022645648926,0.6585365853658537,1.0,1.0,7/82,5.41%,NUPR1;INHA;TERF2IP;WARS1;ATG14;ACTN3;XDH
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3841239834951719,0.8838490961162909,0.6,0.945131626566077,1.0,20/75,20.47%,CCL5;GRIN3A;TRPC4;SLC8A1;SLC39A8;RAMP3;MAGT1;TRPC5;TRPM2;LRP2;RYR2;CALCRL;TRPM7;SLC3A2;SLC30A1;NDFIP2;RYR3;MRS2;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5076028874285216,0.8837968435649928,0.6785714285714286,0.9449691368908547,1.0,3/12,13.00%,SLFN11;GMNN;TERF1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.5563794937207293,-0.8837867836301774,0.6590909090909091,1.0,1.0,3/10,17.73%,SLC5A1;SLC2A1;HNF1A
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.5526821686461623,-0.8837485648516654,0.6222222222222222,1.0,1.0,1/6,2.45%,DGAT2L6
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.561800732691847,-0.8835855123032483,0.6388888888888888,1.0,1.0,1/6,1.88%,CXCL13
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,0.399261560157567,0.8833875860123763,0.5306122448979592,0.9453387611966397,1.0,11/64,6.24%,LGALS9;ITGAX;PIK3R6;SASH3;SAMSN1;FLI1;IRF8;HCLS1;IL10RA;FGL2;LAIR1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,0.399261560157567,0.8833875860123763,0.5306122448979592,0.9453387611966397,1.0,11/64,6.24%,LGALS9;ITGAX;PIK3R6;SASH3;SAMSN1;FLI1;IRF8;HCLS1;IL10RA;FGL2;LAIR1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.4709007398628507,-0.8832551045356276,0.6444444444444445,1.0,1.0,2/11,11.45%,TLCD2;APOA1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,0.3834322545942867,0.8831805299602455,0.65,0.9455011430269528,1.0,10/70,8.32%,MXRA5;TDRD10;STAB1;ADGRL4;BGN;POSTN;ERG;PDGFRA;PLSCR4;RAMP3
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.39082750370778196,0.8831408657776894,0.6551724137931034,0.9453482747365178,1.0,6/57,13.39%,RUNX1;LMO1;LMO2;PSMD13;MYB;PSME4
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.40440805341031405,0.8830768482274113,0.6122448979591837,0.9452400416221436,1.0,10/49,19.49%,CORO7;GSN;MSRB1;ZNF207;HDGFL3;SPIRE2;COBL;WASHC5;WASL;MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.46804658619854145,0.8827274951666193,0.6346153846153846,0.9457396077035992,1.0,9/23,27.67%,TCAF2;MFF;ITGB2;MYO1C;AKT2;ITGAM;MIEF2;CIB1;C2CD5
prerank,CellMarker_Augmented_2021__Activated T cell:Undefined,0.5762374180180043,0.8825619469581671,0.6885245901639344,0.9458921811053507,1.0,2/8,9.58%,IL2RA;KLRG1
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.37403413349872605,0.882504051586766,0.660377358490566,0.9457902532831951,1.0,9/67,20.95%,CCNA2;SEM1;ANAPC16;PSMD13;PSME4;PSMA1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.44101021231800097,-0.8825015100998881,0.6,1.0,1.0,2/23,5.43%,SCN5A;PTPN3
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4764209129884967,0.88230721080931,0.5833333333333334,0.946028583442972,1.0,10/24,25.42%,NLGN1;TENM1;RALA;GPM6A;WASL;FMR1;ARAP1;FNBP1L;PLPPR5;DOCK11
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.5833009856484129,0.8817064362990512,0.6341463414634146,0.9469629283844317,1.0,2/6,12.35%,ZFP36L2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4209317560336521,-0.8815441503852659,0.5454545454545454,1.0,1.0,7/33,10.61%,DRD4;FAM3D;RHBDF1;DRD2;SFRP1;KCNJ11;CCN3
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.36359243884323444,0.8814440516307326,0.6415094339622641,0.9472548669267932,1.0,19/81,12.47%,FLT1;EBF1;TOP2A;NDC80;F2R;CCNA2;APOLD1;BGN;DLGAP5;ASPM;ERG;RAMP3;TK1;HIP1;CASP10;HMCN1;EGFL7;ANLN;CD34
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.4969907393199589,0.881324928117406,0.6730769230769231,0.9472702509289647,1.0,3/14,12.09%,LLGL1;LGI1;LGI2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.4590676739836203,0.8812101710007368,0.6078431372549019,0.9472665694048582,1.0,7/26,25.12%,H2BC21;TLR2;HLA-E;STAB2;MR1;IL12A;LBP
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.41567979220710405,0.8809880706488286,0.56,0.9474947008780507,1.0,4/38,3.91%,SLC12A7;SLC12A1;KCNJ3;SLC12A3
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.5224764966934056,0.8809830763989268,0.5769230769230769,0.9472687360063374,1.0,2/11,8.79%,ACADS;ACADM
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4397457561689815,0.8807709855080069,0.6428571428571429,0.9474808825563951,1.0,9/38,18.58%,PRMT1;METTL21C;CTCFL;EZH2;CAMKMT;ATPSCKMT;VCPKMT;FAM98A;NSD1
prerank,KEGG_2021_Human__Coronavirus disease,0.3270023790785676,0.8807380263425802,0.8043478260869565,0.947280419716006,1.0,17/169,12.35%,F2;C3;TMPRSS2;SYK;ACE2;C6;RELA;TLR2;PLCG2;C9;STING1;TAB2;PIK3CA;RPS5;C3AR1;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.4740601519923988,0.8806500737649158,0.6206896551724138,0.9472386726893329,1.0,3/12,13.83%,GFAP;DSP;KLHL24
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.48771731535717383,-0.8805019663059352,0.6,1.0,1.0,6/16,11.52%,COL4A2;COL4A1;MASP1;COL1A1;APOA1;APOB
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.43606306284321283,0.8801847248612861,0.6428571428571429,0.9480944811046773,1.0,6/25,15.21%,GNB4;GNG12;LLGL1;GRIK3;GNG4;PLCB1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.42807080033630984,-0.880167840692171,0.6041666666666666,1.0,1.0,3/34,4.93%,NPAS4;DRD4;DRD2
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.3958503752034347,0.879976794412254,0.6122448979591837,0.9482840115260283,1.0,15/70,16.31%,RENBP;ST6GALNAC3;NANP;ALG6;ST8SIA4;UAP1;ST3GAL6;NUS1;EGFL7;MVD;ALG9;NPL;SLC35C1;GFUS;DOLK
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.5259101331643612,0.8799156862367332,0.5909090909090909,0.9481691357841268,1.0,2/9,12.44%,ATP1A2;PPP1R12B
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.5604004439476713,-0.8799070978506159,0.6274509803921569,1.0,1.0,1/5,4.35%,LOXL4
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3171738237781349,-0.87960926696314,0.75,1.0,1.0,9/290,3.12%,DUOXA1;SEPTIN12;TBC1D10C;RTP1;STX16;IFT27;ARL5C;STX11;ARF3
prerank,KEGG_2021_Human__Cell adhesion molecules,0.36679990653316935,0.8796076850685796,0.6530612244897959,0.9486184189256455,1.0,32/116,12.75%,SELPLG;CD99;ITGA8;ITGB8;NEGR1;LRRC4C;CD22;NCAM2;ICOSLG;CDH2;CNTNAP2;NLGN1;VCAN;SDC4;NRXN1;ITGAV;CLDN2;VSIR;NEO1;SIGLEC1;CD40;NLGN4X;ALCAM;NECTIN2;CADM1;IGSF11;MPZL1;HLA-E;NTNG2;CNTN1;CD34;CLDN6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.451606338058443,0.8795297326791209,0.6129032258064516,0.9485383682929877,1.0,3/23,8.01%,FGF10;TICAM1;CCDC88B
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,0.4100398321530273,0.8793497442298942,0.6226415094339622,0.9486420737356834,1.0,8/53,8.27%,STAB1;ITGAX;CSF3R;FGL2;TLR2;LAIR1;SIGLEC1;TFEC
prerank,Reactome_2022__E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,-0.5334732577966996,-0.8793147470432154,0.6666666666666666,1.0,1.0,3/7,18.84%,ORC6;CDK1;SLC25A15
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.422472567387177,-0.8792192671182196,0.5964912280701754,1.0,1.0,6/25,5.72%,XYLT2;AGRN;GPC2;GPC1;XYLT1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4445855987237426,0.8790043906031062,0.6382978723404256,0.9491415668906021,1.0,3/20,7.75%,LGALS9;VSIR;HMGB1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5176760115655665,0.8789606079839007,0.6041666666666666,0.9490139563240756,1.0,2/12,7.89%,PCSK5;SNCA
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.44323116406103835,-0.8788372491267827,0.64,1.0,1.0,3/34,4.07%,ACTC1;TMOD1;OBSCN
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),0.5606515935231839,0.8787633761129631,0.6078431372549019,0.94919026214765,1.0,1/5,1.49%,TOP2A
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,0.38279079883638645,0.8787163430931156,0.603448275862069,0.9490278957652534,1.0,7/53,5.09%,ITGAX;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;IL10RA
prerank,Reactome_2022__Tachykinin Receptors Bind Tachykinins R-HSA-380095,0.5636452802519455,0.8786213463597898,0.7142857142857143,0.9489478629104462,1.0,2/5,21.95%,TAC1;TACR3
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.45544251823853055,0.8784347050867091,0.6379310344827587,0.9490860996488041,1.0,3/19,7.30%,PLD6;TEX15;TDRD9
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.5141137343468158,-0.8782761580482223,0.5319148936170213,1.0,1.0,2/5,2.15%,CXCL13;FGF1
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.36941817780319836,0.8782655692972706,0.7547169811320755,0.9492116192186587,1.0,12/86,16.35%,SYK;SEM1;RELA;PLCG2;TAB2;PSMD13;PPP3CA;PSME4;UBA3;NFATC3;TAB3;PSMA1
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.41206438475900076,0.8779879462584972,0.6326530612244898,0.9495615180972673,1.0,22/53,34.15%,DCP1B;CNOT6L;CNOT4;EXOSC4;CNOT8;CNOT2;EXOSC1;PAN3;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;PABPC1;EIF4E;TUT4;LSM3;DCP2;SKIC3;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4506374188760898,0.8779599867344179,0.625,0.9493961018241782,1.0,4/26,11.92%,FGF2;PPARG;HMGB1;MEF2C
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),-0.5725464976242659,-0.8778619737597928,0.6304347826086957,1.0,1.0,2/5,14.54%,CYP24A1;ADH7
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5508570933347883,-0.8777864947176786,0.6875,1.0,1.0,1/5,9.44%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5508570933347883,-0.8777864947176786,0.6875,1.0,1.0,1/5,9.44%,NRDE2
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5673645022551466,-0.8774778213030499,0.6829268292682927,1.0,1.0,2/8,11.22%,CACNG5;CACNG8
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5673645022551466,-0.8774778213030499,0.6829268292682927,1.0,1.0,2/8,11.22%,CACNG5;CACNG8
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.5023691387473864,0.8774490621475385,0.6862745098039216,0.9502702682803713,1.0,4/13,19.74%,RESF1;ATF7IP;SIRT6;TRIM28
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,0.37626191123717534,0.8772706627764129,0.6739130434782609,0.9504237942696464,1.0,13/76,6.41%,HEMGN;ITGAX;KAT2B;ZEB2;SAMSN1;DDX60L;CPED1;FLI1;PTGS1;XAF1;FGL2;TET2;ITGAV
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.5990128938221178,0.8772560618706708,0.7213114754098361,0.95020460044504,1.0,1/5,4.47%,FLI1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5295929883245387,-0.8767073601734535,0.6129032258064516,1.0,1.0,1/8,1.04%,CD24
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5200572515586139,0.8766172564035992,0.7291666666666666,0.9513494265820488,1.0,4/13,20.81%,PUS7L;PUS10;NOP10;RPUSD2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5630248259912408,-0.8764731885649861,0.5588235294117647,1.0,1.0,2/7,18.88%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.40345718316670043,0.87621464707273,0.5614035087719298,0.9519381513666751,1.0,4/41,11.60%,PLD6;PLA2G10;ACP6;ABHD8
prerank,Reactome_2022__Alpha-oxidation Of Phytanate R-HSA-389599,0.6024556859132403,0.8759335897566741,0.6949152542372882,0.9522867543453595,1.0,1/5,7.25%,PECR
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.4420715122241719,-0.8755303297236966,0.6440677966101694,1.0,1.0,2/31,1.10%,SELP;SELL
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,-0.4800419212124142,-0.8755109663319032,0.5909090909090909,1.0,1.0,2/14,0.89%,GUCY2C;TREH
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.43273633187521365,0.8750593139924193,0.6610169491525424,0.9539286625085712,1.0,2/30,4.93%,LLGL1;GRIP2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.38192167086846796,0.8749490154101879,0.7368421052631579,0.9539454187851167,1.0,9/49,17.52%,MYC;NEO1;TF;CYBRD1;SMAD4;BDH2;PICALM;HJV;FRRS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3760847029281055,0.8747206030128752,0.7297297297297297,0.9540977564250224,1.0,3/77,1.92%,IGF1;CDC14A;NDC80
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,-0.39895589881277826,-0.8745973318173371,0.7,1.0,1.0,11/67,8.45%,SELP;SELE;TEK;GPX3;TIE1;RNASE1;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.36588202508891,0.8745514075862659,0.6346153846153846,0.9542626277029713,1.0,11/76,19.35%,COX19;IMMP2L;SDHAF1;CHCHD4;UQCC3;BCS1L;NDUFAF6;SCO2;NDUFB11;SDHAF3;SLC25A33
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.5062493149872166,0.8742867840342998,0.6545454545454545,0.9546322752650712,1.0,4/12,25.33%,MAGT1;MRS2;TUSC3;NIPAL1
prerank,CellMarker_Augmented_2021__Eosinophil:Bronchoalveolar System,-0.41258270683927334,-0.874180039316471,0.6842105263157895,1.0,1.0,14/47,11.56%,UROC1;ALB;AHSG;F7;MST1P2;FGL1;PAH;HAO2;NOTUM;PRODH2;ITIH3;APOA1;APOB;SMLR1
prerank,KEGG_2021_Human__Basal cell carcinoma,0.40318988122708294,0.8739338561398639,0.65,0.9551624331389548,1.0,12/55,18.93%,FZD5;WNT4;BMP2;WNT9A;FZD1;DVL2;FZD4;FZD6;CTNNB1;WNT2;TP53;POLK
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.338377608219228,-0.8739270330658143,0.7358490566037735,1.0,1.0,11/204,4.69%,SLC28A2;SLC29A3;SLCO2A1;NLRP3;SLC5A10;LCN15;SLC6A6;SLC24A4;SLC39A4;SLC22A8;SLC9A8
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.3726807745687158,-0.8737463564662394,0.7115384615384616,1.0,1.0,4/58,6.07%,TERT;EPAS1;ANGPT4;SFRP1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.5153083623773029,0.8735760728762443,0.6515151515151515,0.9556702753177475,1.0,5/8,36.30%,CTNNB1;GRB2;CBLL1;CBL;CDH1
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.4260019984905384,0.8734575679384823,0.6296296296296297,0.9557117657696769,1.0,7/26,19.24%,PELI1;TNFRSF10B;FASN;TANK;BIRC3;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.41397227332889686,-0.8733591988766157,0.5641025641025641,1.0,1.0,12/31,26.33%,FGF1;TRPV1;TRPV4;DAXX;SLU7;RBBP7;MAPT;STUB1;BAG3;THBS1;DHX36;CLPB
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.34783969328899833,0.8732954667004709,0.6875,0.9558319485823861,1.0,22/161,11.21%,SIPA1;ARHGAP24;CCL5;RAPGEF3;F2R;TBC1D3L;SNX18;TBC1D8B;TBC1D12;CCDC125;RGS10;SYDE2;SCRIB;CD40;RAP1GDS1;RAPGEF6;PLXNB1;CORO1C;EZH2;ARHGAP45;ARHGAP25;ARHGEF16
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4981282378962074,0.873169294344037,0.6415094339622641,0.9558356050845903,1.0,5/13,12.59%,AK3;ENPP1;AK1;SMPDL3A;DCTPP1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4888025883463368,0.8728269107300992,0.6415094339622641,0.9563553597776193,1.0,3/11,23.29%,PAPOLA;NCBP1;BARD1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.37070229010693306,0.8727837383212259,0.6521739130434783,0.9562582064930994,1.0,28/85,23.36%,IL4;CBLB;RELA;PIK3CA;PAK5;NCK2;MAPK8;PPP3CA;SOS1;ITK;PPP3CC;NFATC3;PIK3CD;MAPK10;CD247;MAP3K8;CDK4;VAV2;ZAP70;AKT3;PIK3R3;IKBKB;MAPK3;AKT2;GRB2;PTPRC;DLG1;NFKBIB
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.49714307820483783,0.8726029722645386,0.6833333333333333,0.956387569103203,1.0,2/12,2.47%,IGF1;IL4
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.43881201114751534,-0.8725540385586154,0.7209302325581395,1.0,1.0,1/29,0.39%,MPL
prerank,KEGG_2021_Human__RNA polymerase,-0.4131393821128148,-0.8724622674973569,0.6326530612244898,1.0,1.0,6/29,20.35%,POLR3H;POLR3E;POLR1A;POLR1C;POLR3A;POLR3F
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.4616733140787121,-0.8724066067588822,0.6851851851851852,1.0,1.0,5/23,8.41%,MPPE1;PIGG;PIGO;PIGH;PIGL
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5229886682346843,-0.8723898271134881,0.5909090909090909,1.0,1.0,1/8,0.61%,DDX11
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.43547456789480693,0.8723446350379561,0.6538461538461539,0.9566740969520772,1.0,8/20,24.90%,KCNH8;FOXO3;XPO1;CREB1;AKT3;MAPK3;AKT2;EGFR
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5169551446985877,0.8722771963595221,0.7142857142857143,0.9565675054292303,1.0,4/13,20.97%,GLUL;PM20D2;GLUD1;ASPA
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.40373181168358124,0.8722380027270431,0.625,0.9564326798222555,1.0,7/41,14.02%,PYHIN1;RNF139;LATS1;UBQLN4;PTEN;XPO1;PML
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.359417724358386,0.8722266679975683,0.6842105263157895,0.9562130808595138,1.0,17/117,9.97%,MXRA5;GNG12;DOCK1;LRIG3;FBLIM1;SDC4;WWTR1;F3;FAM114A1;SCNN1B;MEX3B;DSP;BCAM;GRAMD2A;SERTAD4;IGFBP6;PLXNB1
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),-0.5466679303866667,-0.8720957396021005,0.6904761904761905,1.0,1.0,3/7,14.10%,CYP24A1;CYP4F2;CYP26B1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.49699870439465016,-0.871872275026012,0.6818181818181818,1.0,1.0,2/12,3.88%,TAFA3;CD200R1
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,0.5171209463836933,0.8717543806773926,0.6458333333333334,0.9569862929266602,1.0,1/7,4.86%,LRIG3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.5083808495343703,0.8716842287400483,0.6491228070175439,0.956882870531688,1.0,5/12,27.45%,SSC5D;BCL3;ANXA1;OTUD7B;MAPKBP1
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,-0.4733351268332361,-0.8714570151072324,0.6226415094339622,1.0,1.0,1/13,2.60%,PXDN
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.41514603497739344,0.8713526297006648,0.673469387755102,0.9573666601030998,1.0,6/38,19.93%,KAT2B;JADE3;KAT6A;TAF5;SUPT3H;PHF14
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,0.5038384020229641,0.8713401289879417,0.625,0.9571596037495105,1.0,4/11,19.15%,CSRP2;NEUROD2;PPP2R2B;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.5166543670438684,0.8712804111452058,0.6481481481481481,0.9570499387938495,1.0,2/10,11.03%,SYK;DEF8
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.34680211591480625,0.8712386216380604,0.74,0.9569246406865055,1.0,18/154,10.75%,NXPH1;SLC35F1;HRH3;POU6F2;SLC17A6;DPP10;GRIP1;KCTD8;ZDHHC22;OLFM3;FGF12;CDK14;CPNE4;ADGRB3;MAGEL2;NHLH2;PAK5;TMEM196
prerank,Reactome_2022__CDC6 Association With ORC:origin Complex R-HSA-68689,-0.5751154371838574,-0.8712065265904227,0.6521739130434783,1.0,1.0,3/6,18.84%,ORC6;CDC6;SLC25A15
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.44640873535913733,0.8708522715370954,0.65,0.9574361691658214,1.0,7/21,16.43%,AHCY;CYP2U1;FDX1;CYP27A1;CYP7B1;FDXR;CYP2R1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5098429134681779,0.8707183066236246,0.6595744680851063,0.9574582287962038,1.0,3/11,17.69%,CD40;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9569038791830433,1.0,2/5,29.81%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9569038791830433,1.0,2/5,29.81%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9569038791830433,1.0,2/5,29.81%,APOE;ERLIN1
prerank,KEGG_2021_Human__Purine metabolism,0.35953290658575815,0.8705610022111372,0.6956521739130435,0.9568383288035383,1.0,20/118,12.77%,PNP;AMPD1;AK3;ALLC;ENPP1;CANT1;PDE1A;FHIT;ADA;PDE7A;AK6;GUCY1A2;AK1;GMPS;PDE6A;PDE4B;PDE6H;NPR2;NT5C3A;PGM1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.45005911589197595,0.8704579724561645,0.603448275862069,0.9568323207604148,1.0,8/29,21.61%,MOV10;HDAC3;HDAC2;TBL1X;CREB1;AGO3;HDAC1;CAMK4
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.47128352563015086,0.8702257046278292,0.6530612244897959,0.9570235885033472,1.0,1/13,3.73%,CPSF4L
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.5448445733016982,-0.8700482068526086,0.7083333333333334,1.0,1.0,1/6,7.88%,HFE
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.4468501677321201,0.8700190066865774,0.6666666666666666,0.957158411572588,1.0,8/26,16.25%,LPIN3;NAPEPLD;PLA2G10;CEPT1;SELENOI;ETNK1;ETNPPL;PNPLA8
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4438881048285335,-0.8697809651607962,0.6086956521739131,1.0,1.0,8/24,24.36%,LIMK1;SHANK1;RAC1;SHANK3;SYNPO2L;SYNPO;PFN2;FHOD1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.364300602945646,0.8697400648951028,0.6140350877192983,0.9574465258799785,1.0,26/98,20.47%,CCL5;GRIN3A;MCOLN3;TRPM8;TRPV2;TRPC4;SLC8A1;ITGAV;SLC24A2;CASR;RAMP3;ANK2;TRPC5;TRPM2;ANO6;RYR2;CALCRL;TRPM7;SLC3A2;TRPV3;CACNA1I;RYR3;MICU1;TRPM3;ATP2C1;TRPC1
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.3683150983395862,0.8696629990596582,0.6896551724137931,0.9573715352038171,1.0,13/69,8.32%,CFH;FLT1;TDRD10;PREX2;ADGRL4;BGN;CXCL12;GPR17;ERG;HPGDS;PLSCR4;DLC1;RAMP3
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,-0.39196690314204696,-0.8695551869213374,0.6829268292682927,1.0,1.0,11/61,8.48%,RAB44;MPO;RAC2;BST1;NLRP3;GPR132;RIN3;SLC17A9;DOCK2;PLCB2;PTPN7
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.5766270659033562,0.8692770016939987,0.7407407407407407,0.9576219764494398,1.0,2/5,10.25%,CCL5;IL23R
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.5766270659033562,0.8692770016939987,0.7407407407407407,0.9576219764494398,1.0,2/5,10.25%,CCL5;IL23R
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.36999582890093813,0.8692572915918997,0.6071428571428571,0.9574188052671122,1.0,14/94,14.23%,SLC26A3;RAPGEF3;AANAT;SLC26A6;GLRA1;RELA;CRHBP;HCN1;MEF2C;RRAGC;GABRB2;RAP1A;CPEB1;TRPM2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.5400404613543803,-0.8691221436474404,0.64,1.0,1.0,1/5,15.45%,PRDX1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.538824145602063,-0.868833475823751,0.5681818181818182,1.0,1.0,1/5,12.10%,CPSF3
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.39395284839261185,-0.8688217225507708,0.7272727272727273,1.0,1.0,2/44,4.70%,DDX11;TSPYL2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.34645904660950777,0.8687362724850544,0.6976744186046512,0.958287911013739,1.0,23/100,12.35%,LGALS9;SMAD6;IRGM;F2R;RELA;PELI1;MAPKAPK2;TICAM1;NLRP7;FER;HMGB1;SNCA;ERBIN;GCH1;TAB2;MAPKAPK3;IL23R;SRR;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.37316725629618325,-0.8687342330015753,0.6842105263157895,1.0,1.0,6/67,7.82%,ACTC1;FRMD6;TMOD1;OBSCN;F11R;MYLK3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.5785012735426878,-0.8685658057065972,0.7045454545454546,1.0,1.0,1/7,8.18%,OAS1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.5785012735426878,-0.8685658057065972,0.7045454545454546,1.0,1.0,1/7,8.18%,OAS1
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,0.3980800775146518,0.8684890665279064,0.6136363636363636,0.9585659413128436,1.0,12/61,6.24%,SELPLG;TRAC;PYHIN1;SASH3;SAMSN1;IL2RA;PIK3R5;CD244;IL7R;HCLS1;IL10RA;LAIR1
prerank,KEGG_2021_Human__Peroxisome,-0.3865116895195204,-0.8684399985826825,0.6136363636363636,1.0,1.0,8/74,9.04%,AMACR;HMGCL;PIPOX;XDH;PEX7;PXMP2;HAO2;MLYCD
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.4682956264999195,0.8683157989495196,0.6612903225806451,0.9587750985476021,1.0,5/17,11.00%,SYK;MUC20;PLCG2;MUC13;MUC7
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.4401415951672688,0.868305799047351,0.5961538461538461,0.9585531016706934,1.0,4/28,13.44%,IVNS1ABP;RO60;GTF3C4;POLR3G
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.42765577688690737,0.868285514503975,0.725,0.9583593198220683,1.0,3/31,8.16%,CDC25A;RRAD;MCM7
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.47316181345161573,0.8681086711582681,0.6666666666666666,0.958562128795667,1.0,4/24,8.97%,SYT15;SYT6;SYT1;RIMS2
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.29414629555792465,0.8680910239969933,0.9333333333333333,0.9583746831572105,1.0,100/599,15.69%,SLC5A8;DERL3;SLC7A11;SLC26A3;SLC12A7;TCIRG1;ATP6V0D2;RUNX1;EMB;NGB;SLC12A1;SLC22A3;MCOLN3;TRPM8;SLC1A3;SLC26A7;ASIC1;SEM1;LDLR;ADD3;GNB4;SLC26A6;GNG12;TRPV2;SLC38A3;TRPC4;PCSK5;SLC12A3;SLC17A6;NPC2;SLC38A4;SLC5A12;STOM;SLC35B2;MCUB;SLC7A2;SLC8A1;SLC44A5;RNF185;TSC22D3;SMDT1;ABCC2;ABCA6;SLC39A8;SLC4A7;ABCA1;SCNN1B;TF;SLC15A1;CYBRD1;CYB5R4;ATP6V0A4;MAGT1;SLC7A9;ABCG8;SLC9A2;SLC29A2;SLC15A2;MCU;CA2;PSMD13;SLC2A11;SLC35D2;ATP1A2;ABCD3;RNF5;GNG4;NR1H3;SLC5A11;AHCYL2;ABCD2;SLC26A4;SOAT2;ATP6V0B;ABCC11;TRPC5;PSME4;ABCA8;SLC9C2;ATP13A1;TTYH2;ANGPTL4;TRPM2;SLC22A5;ABCG5;SLC41A2;SLC35C1;LIPG;ANKH;DERL2;SOAT1;ANO5;ANO6;SLC30A10;RYR2;SLCO1A2;SLC44A4;SGK1;SLC30A6;SLC9A9
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.5078010534101541,0.867902259633348,0.65,0.9585773879017221,1.0,1/11,4.30%,ROBO2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.4108558900726901,0.8678058271022654,0.6730769230769231,0.9585428959994883,1.0,2/30,7.32%,SHMT2;STAMBPL1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.44728002748314805,-0.8674124005757792,0.6041666666666666,1.0,1.0,4/17,15.40%,EEF1AKMT2;EEF1AKMT1;KIN;CALM1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.4842745580790467,0.8672385707318427,0.7068965517241379,0.9594253825077507,1.0,3/10,18.92%,ODC1;SMS;SAT1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.5622994481681447,-0.8671582664863037,0.65,1.0,1.0,3/5,20.38%,TGFB1;SOX15;USP19
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,0.39699590502037013,0.8670163280960658,0.6481481481481481,0.959465138466763,1.0,8/52,6.24%,ITGAX;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;IL10RA;LAIR1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,0.39699590502037013,0.8670163280960658,0.6481481481481481,0.959465138466763,1.0,8/52,6.24%,ITGAX;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;IL10RA;LAIR1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3139319546625298,-0.8669088916685197,0.7924528301886793,1.0,1.0,37/302,11.65%,ACTC1;KIF2B;COL23A1;COL24A1;COL4A2;RAC2;COL27A1;TNXB;COL5A1;PXDN;COL4A1;PLK3;TMOD1;LOXL4;BFSP1;TGFBI;COL28A1;MYO5B;TUBGCP2;LAMB3;TSPAN15;MYO15A;COL6A3;ARHGAP12;CCDC88C;COL11A2;TRIOBP;ADAMTS3;COL26A1;COL1A1;MFGE8;MYO7B;STMN1;RND1;CLRN1;APOA1;P4HA3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.37636446621360664,-0.8668497120802868,0.7254901960784313,1.0,1.0,4/53,5.27%,H1-3;H1-4;H1-2;POLR1G
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.43154088531432305,0.8668209428308814,0.6727272727272727,0.9596299237108882,1.0,1/27,1.94%,SIRT1
prerank,KEGG_2021_Human__Gastric cancer,0.34917526780172115,0.8668086229669147,0.6981132075471698,0.9594113801550301,1.0,24/127,14.69%,FGF10;HGF;MYC;TGFBR1;FZD5;FGF2;WNT4;FRAT2;WNT9A;GAB1;FGF17;PIK3CA;SMAD2;CTNNA2;SMAD4;SOS1;FZD1;FGF5;DVL2;RARB;LRP6;FZD4;FRAT1;FZD6
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,0.5515075207220258,0.866668593555608,0.6964285714285714,0.9594514947580415,1.0,2/8,22.38%,CD34;PTPRC
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.38452430749553196,0.8665381877696602,0.660377358490566,0.9594947038287668,1.0,21/62,22.81%,RUNX1;MYC;CCNA2;STAT5A;RELA;PIK3CA;FLT3;SOS1;PML;RUNX1T1;PIK3CD;KIT;AKT3;PIM2;PIK3R3;BAD;IKBKB;MAPK3;AKT2;GRB2;ITGAM
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.5319049831264849,0.8663194380330482,0.6774193548387096,0.9596997947335235,1.0,1/8,0.53%,FGF10
prerank,Reactome_2022__Defective C1GALT1C1 Causes TNPS R-HSA-5083632,0.4723853558627231,0.8663060194237545,0.703125,0.9594970135889827,1.0,5/14,11.00%,C1GALT1C1;MUC20;C1GALT1;MUC13;MUC7
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3346839330255808,0.8662580051416412,0.6578947368421053,0.959369020227985,1.0,36/113,18.61%,DEPP1;RESP18;EDIL3;ALDH1A1;MAFB;SCGN;PCDH17;PLPPR1;RAB3C;PAX6;DPP4;PTPRD;FGF14;MAGI1;PTPRT;MAGEL2;TMEM196;NOL4;KCNB2;PROX1;CNTN3;ID4;TMEM98;RUNX1T1;SEMA6D;FRZB;CPE;PDZRN3;MAPK10;PCSK2;CNTN4;HMGCLL1;CSRNP3;RAI2;SSTR1;PRRG2
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.3583078412064772,0.8661781774807474,0.7592592592592593,0.9592753134449209,1.0,14/77,12.42%,EPHA7;MYCN;HRH3;SYT6;ZDHHC22;UNC5D;ADAMTS19;IGDCC3;SPSB4;NLGN4X;VANGL2;MAGEL2;GRIK3;DCAF12L2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.4540692111851778,0.8659703833334166,0.6170212765957447,0.9594615933394358,1.0,3/11,28.30%,TRAPPC8;STX17;ATG9A
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,-0.4143237907055252,-0.8659474652770572,0.6545454545454545,1.0,1.0,11/44,10.18%,MPL;GYPB;MEFV;VSTM1;PRAM1;BEND2;IFIT1B;ADGRG3;ALAS2;DYTN;CMTM2
prerank,CellMarker_Augmented_2021__Platelet:Plasma,-0.4143237907055252,-0.8659474652770572,0.6545454545454545,1.0,1.0,11/44,10.18%,MPL;GYPB;MEFV;VSTM1;PRAM1;BEND2;IFIT1B;ADGRG3;ALAS2;DYTN;CMTM2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5851948423669002,-0.8656857223809369,0.6666666666666666,1.0,1.0,2/6,17.78%,TGFB1;PDGFB
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.5354752187300045,0.8656589954833264,0.6666666666666666,0.9598063750801059,1.0,3/9,15.11%,FDX1;FDXR;STAR
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.38343481656914497,-0.8655679047763047,0.7391304347826086,1.0,1.0,12/63,8.78%,EHF;CD53;CYTH4;CD86;CLDN1;ALOX5;MS4A4A;CIITA;HCK;HLA-DRB1;TAGAP;LY86
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5405623971025679,0.8655156761024768,0.6981132075471698,0.959927144870439,1.0,6/9,22.18%,NR4A2;FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.39123301199566163,0.8653645923974393,0.5769230769230769,0.9599732595434738,1.0,9/51,14.05%,PCDH15;EPS8L2;WHRN;MYO1E;EPS8;GSN;OTOGL;TPRN;ESPN
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.44099185339637126,0.8651452055723647,0.7017543859649122,0.9602990158276126,1.0,6/24,13.84%,TNFSF13B;IL4;SASH3;CD40;MEF2C;CD74
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37382058469017687,0.8650623339166051,0.6538461538461539,0.9601958985503326,1.0,13/62,21.36%,SEC22B;ITGAV;PSMD13;LNPEP;TAP1;HLA-E;VAMP3;PSME4;PSMA1;HLA-F;IKBKB;PSMD4;HLA-B
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.45044993496888663,0.8649693148037251,0.6607142857142857,0.9601860076002786,1.0,2/16,15.62%,CHMP6;CNTROB
prerank,Reactome_2022__Regulation Of Signaling By NODAL R-HSA-1433617,0.5122532562547895,0.864900568488165,0.6666666666666666,0.960101599483641,1.0,3/8,13.74%,ACVR2A;DAND5;ACVR1B
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.4275372791249571,-0.8648858897893732,0.6842105263157895,1.0,1.0,3/26,15.11%,FGF1;FGF20;FGFR4
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.3729074485840256,-0.8648611279599634,0.7333333333333333,1.0,1.0,10/75,14.55%,UVSSA;ERCC1;RFC3;PRPF19;GTF2H2;COPS7A;POLR1A;XRCC1;RPA3;RFC2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3411484380046006,0.8648221537277575,0.7555555555555555,0.9600234415877724,1.0,9/97,13.45%,TIMELESS;HELB;RBMS1;MCM7;TOP1MT;POLE2;REV3L;REV1;PCLAF
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.4746040387370797,-0.8647845244057171,0.6428571428571429,1.0,1.0,4/17,21.00%,DAB2IP;VPS35;AMER1;RGP1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.4124675627197607,0.8647340716359083,0.6875,0.959985668409059,1.0,6/41,24.86%,HIF1A;GCK;RANBP2;NUP153;OGT;EP300
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.39387792453854614,0.8646957567795134,0.6923076923076923,0.9598486244930096,1.0,12/79,12.26%,SEMA5A;TENM1;NAV3;FER;BIN1;CRACD;LMOD2;SYNPO2;CARMIL1;NCK2;FCHSD2;PROX1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4788266029197318,0.8644538498893133,0.7358490566037735,0.9601180137134675,1.0,4/19,17.36%,MRAP2;ABI3;PICALM;NUMB
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4629065805251407,0.8644498831905867,0.6458333333333334,0.9598848654669937,1.0,4/19,14.60%,HAP1;CEP135;CEP120;CCP110
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3958042205957674,0.8644402524188262,0.6585365853658537,0.9596611334361721,1.0,3/45,1.94%,FGF10;TIMELESS;SIRT1
prerank,KEGG_2021_Human__Asthma,0.5210378413389701,0.8642370083930422,0.6825396825396826,0.9598559762627131,1.0,2/11,7.69%,IL4;CD40
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.450771402092161,0.8641267834502822,0.6875,0.9598616856669888,1.0,5/17,15.21%,GNB4;GNG12;GRIK3;GNG4;PLCB1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.5355853024937945,-0.8639982460793221,0.7608695652173914,1.0,1.0,1/5,14.25%,RAC1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.39836415908593226,0.8639766708728718,0.6140350877192983,0.9600161066010864,1.0,4/42,11.60%,PLD6;PLA2G10;ACP6;ABHD8
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5206231522769706,-0.8639620009515883,0.6086956521739131,1.0,1.0,1/9,0.61%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5063761655798649,0.8638829488488639,0.6923076923076923,0.959981506944236,1.0,3/11,26.08%,PIP4K2A;ANXA2;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.46178711270721795,-0.8637418435633447,0.6326530612244898,1.0,1.0,3/23,2.29%,TEK;NUPR1;IL11
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.33996023062027286,0.8636132288985154,0.7547169811320755,0.9603030439715141,1.0,22/118,20.64%,PCBP3;HNRNPH1;SYNCRIP;APOBEC1;RBMS1;BICD1;NOVA1;PAPOLA;ATXN1;ADARB2;RNASET2;HNRNPD;MRPL44;LSM8;RBM5;HNRNPA2B1;NUFIP1;AGO3;POLR2H;ELAVL4;PNPT1;NCBP1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.545808348168251,0.8633239690499356,0.717391304347826,0.9606213271019367,1.0,2/12,17.54%,PLA2G10;PLBD1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.3812158646319983,0.8630541038683165,0.6481481481481481,0.9609611201081079,1.0,9/66,11.77%,PRKG1;EFNA5;FGD4;EPHA5;EPHA3;RAPGEF6;PLXNB1;ADAP1;PLXNB2
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.3942148255284437,0.8630486928167688,0.603448275862069,0.960725185632265,1.0,8/38,17.49%,ARHGAP5;VANGL2;RASAL2;MUC13;ANKRD26;DST;PKP4;RRAS2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.37815514635066066,0.8630397763950626,0.6956521739130435,0.9605017415906708,1.0,13/59,17.54%,LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;NR1H3;SLC44A4;PNPLA8;PLA2G7;PLBD1
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.39536521108676437,0.8630279982192621,0.6981132075471698,0.9602938716811757,1.0,10/54,16.35%,SEM1;SCRIB;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;PSMA1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,-0.5236730689332098,-0.8629731582674066,0.5909090909090909,1.0,1.0,1/10,1.04%,CD24
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4764533636489834,-0.8629655319716726,0.58,1.0,1.0,3/10,20.00%,SCARF1;PTPRS;GRN
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.43587193318438255,0.8629275678432184,0.6481481481481481,0.9602932767772704,1.0,3/21,13.81%,LLGL1;PTPRD;GRIN2D
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.48435765970679034,-0.8629037347556786,0.5833333333333334,1.0,1.0,3/8,26.95%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.5249194816394763,0.8628532448468251,0.6842105263157895,0.9602123063886111,1.0,1/7,8.17%,NUDT16L1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.5797030101643501,-0.8628421454764377,0.7272727272727273,1.0,1.0,3/5,24.94%,SERPINE2;CTSZ;THBS1
prerank,Reactome_2022__Cross-presentation Of Particulate Exogenous Antigens (Phagosomes) R-HSA-1236973,0.571411757060922,0.8628176468246139,0.7547169811320755,0.9600417477899207,1.0,1/5,6.41%,ITGAV
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.35625061719313283,0.8626789874420414,0.7083333333333334,0.9600195861118781,1.0,6/100,4.86%,TIMELESS;CCNA2;SEM1;RRAD;H2BC21;LRIG3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4772301231424183,-0.8625190833827096,0.6938775510204082,1.0,1.0,4/21,10.52%,TERF2IP;PARP2;SMUG1;PARP1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.5095495171133709,0.8625128512840579,0.7,0.9601549795479561,1.0,1/11,1.44%,RUNX1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.40620175354286775,0.8624197228913778,0.7169811320754716,0.9600864757946705,1.0,9/33,18.05%,FZD5;MOV10;PDE6A;PPP3CA;FZD4;FZD6;PLCB1;CTNNB1;AGO3
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.39179059638842,-0.8623523942712301,0.6938775510204082,1.0,1.0,10/64,8.45%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.44362548331636176,0.8623217278064643,0.6065573770491803,0.960024180784059,1.0,4/21,21.11%,CHMP6;LEPROTL1;MVB12A;VTA1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.49324954937603016,-0.8622627333120483,0.5869565217391305,1.0,1.0,1/10,3.60%,WTIP
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.4434285082610164,-0.8622465553842552,0.603448275862069,1.0,1.0,1/25,0.73%,AMACR
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.42425449444368424,0.8621893949557153,0.6538461538461539,0.9601502131143052,1.0,2/33,3.28%,SEM1;RRAD
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.49635057229433,0.8620469157281021,0.7307692307692307,0.9602237204089452,1.0,2/12,5.04%,NDC80;DLGAP5
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In7:Brain,-0.5934631887635744,-0.8619376329951955,0.6727272727272727,1.0,1.0,1/6,1.39%,COL24A1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.48075818214666866,0.8616936150924204,0.6140350877192983,0.9607630753246612,1.0,3/13,15.27%,PPP1R15B;PPP3CA;PPP2R2B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4864587357776398,0.861652552324306,0.6530612244897959,0.9606173924039463,1.0,5/13,18.93%,WHRN;ADGRV1;COL11A1;TMEM120A;KIT
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.4306556458660303,0.8615779746234463,0.6382978723404256,0.960521121767682,1.0,4/18,17.47%,EPHA5;RPS6KA4;RPS6KA5;VEGFA
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.3442366679744977,0.8610839156262439,0.7678571428571429,0.9613128188598956,1.0,11/81,14.60%,NDE1;CEP70;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;PPP1R12B;NEDD1;CCP110
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,0.37924586281582184,0.8610470677485649,0.7142857142857143,0.9611486145561925,1.0,8/68,4.37%,LAMA4;CFH;FLT1;TDRD10;STAB1;ADGRL4;ZEB2;BGN
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.39600111881970007,0.8609050385423898,0.6481481481481481,0.9612402592090373,1.0,9/45,20.50%,EFNA5;EPHA5;FER;GSN;REEP6;LYN;CDK16;MAP2;ADGRE2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.4190379807619835,0.8608889122464023,0.5555555555555556,0.9610268601675074,1.0,8/32,14.00%,F2;KLKB1;F12;PDGFRA;F3;CD34;KNG1;PLAUR
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.44210679092851557,-0.8608642598077932,0.6666666666666666,1.0,1.0,1/17,1.87%,MTFR2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.46293044467572164,0.8607216191571094,0.7142857142857143,0.961106169606497,1.0,6/17,24.57%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.4082808294427165,-0.8606178746140418,0.6,1.0,1.0,6/33,10.10%,KCNE2;KCNJ1;KCNJ16;KCNQ1;KCNJ11;KCNJ15
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.5436272778175681,-0.8605967378180681,0.6744186046511628,1.0,1.0,1/6,4.42%,RPF2
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.48014444325194344,0.8605454990889044,0.7222222222222222,0.9612193124981157,1.0,5/19,15.40%,H2BC21;H2AC6;H2AZ2;H2AX;ORC4
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,0.4013365165906875,0.860484043623459,0.6666666666666666,0.9611446092176572,1.0,9/59,5.09%,SELPLG;FERMT3;ITGAX;PIK3R6;SASH3;PIK3R5;CD244;HCLS1;IL10RA
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.35354668116556975,-0.8604331685363461,0.6875,1.0,1.0,2/89,2.93%,LRP10;RIN3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.4535380191977595,0.8602672142175245,0.6415094339622641,0.9613961879033166,1.0,5/20,12.31%,SIX4;CSRP2;TNNT1;LMOD2;CSRP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.46852082596187483,0.8601946950973127,0.6949152542372882,0.9613091697720226,1.0,5/15,13.84%,IL4;DAPK2;MOSPD2;MCU;CD74
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.4741636409047434,0.8600729122731182,0.68,0.9612775672514342,1.0,5/12,26.88%,SCRIB;VANGL2;LAMA5;LAMA3;ZDHHC7
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.3832598048485096,-0.8600085083540974,0.6808510638297872,1.0,1.0,7/80,3.47%,CLDN4;CD24;SLCO2A1;ENTPD2;FAM3D;ALS2CL;KIF12
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.39094997565378337,0.8598878135859466,0.7307692307692307,0.9613813036686174,1.0,9/33,20.31%,VCAN;BGN;GADL1;CTH;BCAN;HEXB;MPST;PRELP;CSPG4
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5590198879762,-0.8598486170837566,0.6,1.0,1.0,1/5,18.73%,AMER1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.4374247608297835,0.8598004810144144,0.6666666666666666,0.9613251006968924,1.0,3/26,6.74%,PLCH1;ITPKB;PLCG2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3263596018322057,-0.8597374486181178,0.8064516129032258,1.0,1.0,22/252,10.52%,TERT;HMGB3;DNASE1L1;TERF2IP;PARP2;TICRR;SLX4;REXO4;RECQL5;ORC6;ERCC1;FANCG;FANCC;RPAIN;RFC3;POLQ;RAD50;XPC;RAD51AP1;RTEL1;SMUG1;PARP1
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.3373290035094558,0.8597015990155484,0.76,0.9612904433803505,1.0,16/95,20.95%,SEM1;H2BC21;GMNN;MCM7;ANAPC16;PSMD13;POLE2;H2AC6;H2AZ2;H2AX;ORC4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.49435922397690824,-0.8596965097977103,0.68,1.0,1.0,4/12,23.93%,TRPV1;CTSS;CHP1;GPR65
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.40818998570618986,0.8594583922710676,0.7346938775510204,0.9615662047078235,1.0,4/32,9.14%,MDFIC;HCLS1;HDAC3;RAB23
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5256245466915225,0.8594431644733977,0.6349206349206349,0.9613594435317364,1.0,3/7,27.36%,PECR;PEX13;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3732464303083841,0.8593926461731943,0.6779661016949152,0.9612172906576921,1.0,6/61,13.39%,RUNX1;LMO1;LMO2;PSMD13;MYB;PSME4
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.5259883840635113,0.8593600302218621,0.6964285714285714,0.961047567716725,1.0,4/6,38.84%,PIH1D1;NOP58;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3540729149437964,0.8590207307892029,0.7692307692307693,0.9615441803751454,1.0,31/125,14.47%,FLT1;EPHA7;FGFR3;SYK;FGFR1;ERBB4;ROR1;BLNK;ACVR2A;EFS;CLNK;CASS4;PDGFRA;EPHA5;FER;EPHA3;LIFR;PTPRD;MTSS1;EPHA8;PTPRT;FRK;FLT3;MPZL1;NPPA;BCAR1;NPR2;IGF1R;ACVR1B;CNKSR1;PTPRU
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.41990818780878475,-0.8589939966498089,0.7333333333333333,1.0,1.0,10/26,23.78%,APOO;DNAJC11;DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;SAMM50;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.5341461415094217,-0.8589814928129539,0.6274509803921569,1.0,1.0,1/6,6.32%,CYP4F2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.389685683073759,0.8587680487044218,0.6206896551724138,0.9618655872352613,1.0,15/76,24.86%,SIRT1;MAPKAPK2;BAG2;CD34;HSPA8;RANBP2;IER5;DNAJB1;CHORDC1;MLST8;MAPK3;NUP153;HSPA1A;CRYAB;EP300
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5371265858543638,0.8587509098688981,0.6842105263157895,0.9616712800605207,1.0,2/9,7.86%,HIF1A;DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.5069740076707859,-0.8586939404443836,0.6274509803921569,1.0,1.0,2/9,3.69%,F8;F7
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,0.5324914157634953,0.8586569262306425,0.65,0.9613657665687281,1.0,3/8,30.35%,IL23R;JAK2;IL23A
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.5324914157634953,0.8586569262306425,0.65,0.9613657665687281,1.0,3/8,30.35%,IL23R;JAK2;IL23A
prerank,KEGG_2021_Human__Necroptosis,0.3690459237913971,0.8586368328839242,0.6724137931034483,0.961174789389665,1.0,16/103,16.99%,STAT5A;GLUL;TICAM1;HMGB1;CHMP6;TNFRSF10B;MAPK8;H2AC6;H2AZ2;H2AX;SLC25A31;MAPK10;TRPM7;BIRC3;FADD;IL33
prerank,KEGG_2021_Human__Prion disease,0.3322653444539919,0.8583921724163788,0.8,0.9614744345315553,1.0,38/212,21.16%,TUBA1C;CCL5;C6;NDUFC2-KCTD14;GRIN3A;NCAM2;SEM1;C9;MCU;PIK3CA;PSMD13;GRIN3B;KLC2;MAPK8;PPP3CA;HSPA8;CREB3L2;PPP3CC;GRIN2D;CREB1;SLC25A31;COX6A1;PPIF;RYR2;PIK3CD;MAPK10;PSMA1;NDUFB11;RYR3;CASP3;PRKACB;TUBB1;PIK3R3;HSPA5;BAD;DDIT3;PSMD4;MAPK3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.3550318030601849,0.858166073988841,0.723404255319149,0.9616482663387913,1.0,23/173,8.32%,VEGFC;LAMA4;CFH;FLT1;TMEM100;TDRD10;STAB1;OIT3;ADGRL4;BMP2;APOLD1;BGN;FLI1;CXCL12;POSTN;ERG;PLAC8;PDGFRA;DPP4;LIFR;PLSCR4;RAMP3;CRHBP
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.4047493878011365,-0.8580457568635205,0.6,1.0,1.0,3/28,7.19%,DND1;TENT5B;SLC11A1
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.43783285563169927,0.8576901589787774,0.6730769230769231,0.9624318129053739,1.0,6/18,13.74%,ACVR2A;FOXO3;SMAD2;DAND5;SMAD4;ACVR1B
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3711652323993402,0.8575809255033024,0.7272727272727273,0.9624153859559906,1.0,20/72,23.99%,LRP4;DCC;LLGL1;NEFH;DSCAML1;CTNNA2;NTNG2;MEF2C;KLF7;CNTN4;ZDHHC17;FARP1;SLITRK5;MAP2;PARD3;SLITRK6;RYK;MAPK8IP2;MEF2A;NRCAM
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,0.574014901477707,0.8575796421756909,0.75,0.9621845689825006,1.0,3/6,27.83%,ACADM;HADHB;HADH
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,0.35945483458638916,0.8575493540496711,0.8048780487804879,0.9620365404480633,1.0,14/81,10.34%,FRMD4B;TMEM171;TMPRSS2;MYC;SLC12A3;NPC2;SLC7A2;TET2;MYOF;PLAC8;ATP6V0A4;HIP1;OSBPL6;NIM1K
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.47253859517402474,0.857398003779549,0.75,0.9620998163392085,1.0,4/16,12.96%,MME;OPRK1;RETREG1;SCN9A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4647958607875751,0.8573211543483201,0.7636363636363637,0.9620345164086828,1.0,5/19,17.36%,MRAP2;ABI3;LZTFL1;PICALM;NUMB
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,0.37483522938056585,0.8573057530003506,0.723404255319149,0.961843794156731,1.0,12/68,6.24%,STAB1;ITGAX;CSF3R;SASH3;ZEB2;SAMSN1;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,-0.5191045959692357,-0.8572216812275583,0.6,1.0,1.0,2/7,10.43%,PCCB;MCCC2
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,-0.5191045959692357,-0.8572216812275583,0.6,1.0,1.0,2/7,10.43%,PCCB;MCCC2
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.5792524867616344,0.8571873510448145,0.7272727272727273,0.9618397702997316,1.0,2/5,17.91%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.35550597371673825,-0.8571791626564923,0.6666666666666666,1.0,1.0,12/104,9.14%,ACTC1;MYH7;LTB4R;CHRNE;TMOD1;ACTN3;NEB;TRIM72;CHRNG;MYOM3;CALD1;TPCN2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3365100722770828,0.8571011072686152,0.74,0.9617592891621225,1.0,8/71,11.19%,IGF1;CANT1;GALNTL5;FUT9;ST8SIA4;ST3GAL6;NUS1;CSGALNACT1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.4341730704093133,0.8569598168513173,0.6896551724137931,0.9618072674238667,1.0,3/19,9.44%,MCUB;SMDT1;MCU
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.3866679551084674,-0.856857700878468,0.6904761904761905,1.0,1.0,2/46,4.70%,DDX11;TSPYL2
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.4945474300341877,0.8568256863649194,0.6666666666666666,0.9618521655263658,1.0,3/10,22.25%,PIK3CA;SOS1;GRB2
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.3881063931344626,0.8568090362908025,0.6458333333333334,0.9616831117376662,1.0,5/37,15.67%,GNB4;GNG12;GNAI3;GNG4;GNAZ
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.48214778826873206,-0.8567996256476839,0.5686274509803921,1.0,1.0,2/11,12.61%,IFI27;NUCKS1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.39569099934799157,0.8564489776754555,0.68,0.9622443813860949,1.0,8/63,14.43%,CCL5;EIF3E;C8ORF88;PPP1R15B;NCK2;DNAJC3;HSPB1;EIF3H
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.3031059648256542,0.8563943512236565,0.8571428571428571,0.9621058611146421,1.0,56/355,18.49%,IGF1;F2;C3;PLOD2;MSRB3;CSF2RA;PCSK5;CDH2;EVA1A;VCAN;MRPL28;PENK;MMP15;ST8SIA4;MRPS12;HTRA2;TF;UBE2D3;FDX1;ABL2;ST3GAL6;LTBP1;IGFBP6;TNC;LOXL2;MSRB1;QPCT;ZDHHC2;RPS5;PRKCSH;CHEK2;RNF5;KNG1;DNAJC3;RPL21;FDXR;UBA3;CSNK1G3;MGAT4A;ZAR1L;FBXL2;FBN1;CPE;PADI4;LGALS1;BAP1;RPL18A;KTN1;RPL7;FBXO11;SLC34A2;CSF1;RCN1;RPS3A;MRPL18;ADORA2B
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.527692824789228,0.8563013078536654,0.7045454545454546,0.9620773491984441,1.0,6/11,25.47%,MYRF;PTEN;ABCA2;PLP1;TENM4;HES5
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,-0.292238351769222,-0.8562192707002405,0.9423076923076923,1.0,1.0,35/580,7.93%,TRIP10;ACTC1;ARAP3;KIF2B;DOCK8;RAC2;CTNNA1;ERCC6L;CENPH;PRAG1;NOXA1;STK10;PRKCD;RASGRF2;ZWILCH;OBSCN;RNASE1;STARD8;INCENP;DHDDS;FMNL1;DSG2;PDZD2;VAV3;PMF1-BGLAP;BUB1;MPZ;SPC25;DOCK2;BTK;ARHGAP15;FLOT1;ARHGDIB;ARHGAP12;TAGAP
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),-0.5280667558448473,-0.8561758735526799,0.7073170731707317,1.0,1.0,3/6,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.4344125912238211,0.8561654635633348,0.5892857142857143,0.962109914759164,1.0,6/25,12.84%,TCIRG1;RELA;VEZF1;RAB23;KLRG1;ITK
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.4393336011525527,0.8560183018277462,0.62,0.962163831651729,1.0,2/21,6.63%,LRAT;TCN2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.377856378620172,0.8559640299517812,0.7818181818181819,0.9620590337946363,1.0,16/76,17.85%,EPS8L2;NLGN1;TENM1;RALA;EPS8;AUTS2;PIK3CA;GPM6A;DEF8;WASHC1;ANLN;CEP120;CCP110;FAM98A;WASL;FMR1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.36844572354558336,-0.8557203819690973,0.717391304347826,1.0,1.0,14/105,10.67%,KLRC1;SELL;IRF4;ICAM3;CXCL13;CD200R1;FGL1;KLRB1;HLA-DRB1;COL1A1;DHX58;SPPL2B;HLA-C;MADCAM1
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.35912631934411915,0.8554554546848695,0.7142857142857143,0.9628390667796033,1.0,5/77,7.04%,TUBA1C;GNB4;GNG12;FBXL3;HDAC3
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.3851903653775644,-0.8554458935136323,0.6521739130434783,1.0,1.0,6/57,11.52%,ALB;PCSK6;MBTPS2;CLTA;APOA1;APOB
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4726216777374995,-0.8554450027886498,0.7045454545454546,1.0,1.0,2/15,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.37637338188413694,0.8553877518200765,0.7450980392156863,0.9627128046389375,1.0,12/72,12.17%,SYT15;NEDD4;KCNJ3;NKAIN2;SYT6;SYT1;TF;SCN10A;SNCA;CA2;VAMP3;NKAIN3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.5554090542202037,0.8552873324536424,0.7540983606557377,0.9626902862402961,1.0,3/7,28.90%,RUVBL2;NUFIP1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5637914335649261,0.855262720406508,0.64,0.9624970486337008,1.0,2/6,23.10%,CPNE1;HSPA1A
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.4508312601282988,0.8549804514833718,0.7017543859649122,0.9628129229164897,1.0,6/21,16.43%,LRAT;CYP4F12;RPE65;CYP3A4;LRP2;CYP2R1
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.3875096623180788,-0.8548798136702344,0.6666666666666666,1.0,1.0,12/73,14.79%,SEPTIN12;CTNNA1;ARPC5L;SHC3;CTNNA3;CLTA;CAV2;DNM1;CAV1;RAC1;CLTB;ARPC5
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4094653327556643,-0.8544745687459786,0.65,1.0,1.0,6/27,14.74%,NUPR1;KCNE2;CLU;DDRGK1;DAB2IP;CCDC22
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.43187189169867163,-0.8544623961693799,0.6458333333333334,1.0,1.0,7/30,24.52%,NDUFC1;NDUFS5;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4100742336880483,0.8543810009044088,0.6785714285714286,0.9638447546852155,1.0,1/35,0.81%,IRGM
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4467917092704725,0.8542479229064214,0.7272727272727273,0.9638890083447132,1.0,6/19,15.10%,ST8SIA4;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4963429844936976,0.8542420316146369,0.7166666666666667,0.9636652097975378,1.0,3/10,7.75%,RUNX1;ZBTB7B;HMGB1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,-0.3924513989717174,-0.8540377522229066,0.7659574468085106,1.0,1.0,9/37,12.88%,KIF2B;RTP1;OR52A1;DPPA2;TRIM77;GPRC6A;DDX4;TOPAZ1;TRIM60
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.5075487075975598,0.8540096488208648,0.6666666666666666,0.9638921895841736,1.0,2/8,7.89%,GFAP;SNCA
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.3026591207304272,-0.8539893716605718,0.9122807017543859,1.0,1.0,47/648,9.57%,CYP1A2;ALB;ACOT1;AMACR;AWAT1;PLAAT4;DGAT2L6;SYNJ2;SPTLC3;SFTPA2;ARF3;CYP2E1;PLEKHA4;ALOX5;PTGES;SLC51A;HMGCL;HSD11B1;CYP24A1;DEGS2;DDHD2;PNPLA4;PLEKHA2;AKR1B15;INPP5D;AGPAT4;CYP4F2;MBTPS2;ALOXE3;CYP21A2;SIN3B;PRKD2;PPP1CA;ARSL;ARNT2;TAFAZZIN;HSD3B2;HSD3B1;HAO2;ABCC3;ACSM6;PCCB;MLYCD;STARD6;PRXL2B;VDR;ACOT2
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.4051374929869753,-0.8539664032649273,0.6382978723404256,1.0,1.0,4/47,9.08%,LDHC;PDHX;LDHAL6A;PDPR
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4321205221659461,-0.8538946138672855,0.6585365853658537,1.0,1.0,2/20,2.28%,RAC2;BST1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.370826386216709,0.8538894394956577,0.6818181818181818,0.9639090007180008,1.0,15/94,13.85%,LYPD1;C1QL1;SCD;TENM3;GPR176;GPSM1;B4GALNT4;GPR161;CAMK2N2;PYCR1;ANLN;BCAR1;FRMD5;DBN1;FJX1
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.4124791829734587,-0.8538623637516802,0.7021276595744681,1.0,1.0,7/52,7.15%,SELP;GAB3;CD53;CYTH4;MS4A4A;F13A1;HCK
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.47706132852604566,-0.853841172727231,0.6666666666666666,1.0,1.0,3/10,10.61%,RIN3;C5;CCN3
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.42446603107659736,-0.8537132418359562,0.6730769230769231,1.0,1.0,2/25,2.61%,P2RY10;PRAG1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5432313944264417,0.8537046477715323,0.7804878048780488,0.964090158033939,1.0,3/12,11.53%,KCNC2;NPPA;HTR2C
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3663402303349309,0.8535446178694017,0.6666666666666666,0.9642103706092892,1.0,8/80,13.94%,SYK;PEX12;GDAP1;NXT1;RANBP17;ABCD3;ABCD2;PRICKLE1
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.4673515961447341,0.8534046018345139,0.6727272727272727,0.9642514298015107,1.0,6/13,31.99%,AKT3;BAD;AKT2;CHUK;GSK3A;CDKN1B
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.46270467239574986,0.853257717680492,0.5964912280701754,0.964304634756713,1.0,6/11,30.46%,PHLDB2;CRB2;PHLDB1;TENM4;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.33083333336866644,0.8532326359450115,0.78,0.9641236831393416,1.0,20/153,13.52%,THEMIS;SYK;ICOSLG;BLNK;RELA;NFKBIZ;PLCG2;DENND1B;PAG1;TAB2;PIK3CA;PSMD13;BTN2A2;NFKBID;MEF2C;PDE4B;BCAR1;ITK;PSME4;SH2B2
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),0.5632166296098122,0.8531990586238195,0.6825396825396826,0.9639580184499625,1.0,2/5,29.45%,RET;SULF1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.45614899059507064,0.8529777348651923,0.6666666666666666,0.9642483128481207,1.0,5/20,14.93%,LPIN3;CEL;LDHD;CYP4F12;AGXT2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4130793556249158,0.8529703516788978,0.6792452830188679,0.9640310441372657,1.0,2/21,3.79%,URI1;BMP2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.5391014634117337,0.8529663483293717,0.6724137931034483,0.9638047669707077,1.0,1/6,17.42%,PUS10
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4293383654782674,-0.8528172517878811,0.7083333333333334,1.0,1.0,3/27,9.26%,OAS3;OAS1;CDC37
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.46949498669396983,0.8523677560724233,0.6888888888888889,0.9648176938746053,1.0,4/16,29.57%,ATG2B;ATG3;ATG9A;ATG12
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4605191951284966,-0.8521630672729138,0.6444444444444445,1.0,1.0,2/16,5.07%,IL10RB;ACTN3
prerank,KEGG_2021_Human__Taste transduction,-0.393001554591598,-0.8521431009546528,0.7333333333333333,1.0,1.0,8/52,12.35%,HTR3B;ENTPD2;PLCB2;GNG13;TAS2R5;GABRA6;ITPR3;GNB3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.33301472765513457,0.8519843444232086,0.8,0.9653170037895151,1.0,36/148,17.86%,RUNX1;FZD5;FGFR1;WNT4;HES6;OLIG1;OLIG2;SIX4;FUT9;WNT9A;POU3F2;CEP85L;NEUROD2;PTPRD;LHX6;NLGN4X;INSM2;AUTS2;GPM6A;EMX1;PLXNB2;MEF2C;NR4A2;FZD1;MYT1L;RACGAP1;FZD4;LRP12;KIAA0319;TAFA1;HEY2;CTNNB1;ARTN;CDKL5;WNT2;ACSL4
prerank,KEGG_2021_Human__Renal cell carcinoma,0.3689019091783822,0.8518167664955258,0.6938775510204082,0.9653486008463699,1.0,18/64,22.25%,HGF;EGLN3;HIF1A;GAB1;PIK3CA;PAK5;SOS1;RAP1A;PIK3CD;VEGFA;ARNT;AKT3;PIK3R3;BAD;MAPK3;CRK;AKT2;GRB2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.36453866993475015,-0.8518116033746149,0.75,1.0,1.0,9/91,6.82%,TERT;HK2;ERCC6L;CENPH;ZNF296;TICRR;DPPA2;BUB1;SLC7A3
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,-0.5411190878006545,-0.8517921396923085,0.6578947368421053,1.0,1.0,4/8,25.41%,SMUG1;MBD4;APEX1;OGG1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5393466377120238,-0.8515890069299746,0.7045454545454546,1.0,1.0,1/7,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.4165120670013486,0.8514026576822626,0.6363636363636364,0.9660023174589575,1.0,1/28,0.92%,SMYD1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.4241340777477397,-0.8513938189737351,0.6296296296296297,1.0,1.0,4/20,17.81%,BUD23;FTSJ3;NHP2;NSUN4
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,-0.37604456659530866,-0.8512767633952391,0.6792452830188679,1.0,1.0,6/84,3.81%,MS4A8;DUOXA1;CAMK1G;FAM3D;ANKRD65;BOC
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.40349622942555213,0.8512249666558158,0.7222222222222222,0.9661217224487684,1.0,9/36,9.17%,COL9A1;NRTN;COL9A2;COL6A5;COL6A2;CACNB4;ENTHD1;ST8SIA4;GFRA1
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.3534132026867652,-0.8510016267961461,0.7407407407407407,1.0,1.0,3/71,2.68%,ANXA8;FRMD6;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.5343930981947154,0.8509696028023943,0.7241379310344828,0.9663563369961491,1.0,2/10,7.44%,TMEFF2;HDAC2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.4314509937858557,-0.8509602350880542,0.7111111111111111,1.0,1.0,3/26,7.19%,SELP;IL6R;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.5727243456678157,0.8509239625110917,0.7755102040816326,0.9662208598412936,1.0,2/5,39.76%,NCK1;DDX3X
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.3836771290745906,-0.8509052188658661,0.6097560975609756,1.0,1.0,10/64,8.45%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1;ITGA9;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3145941410356742,0.8507144616701966,0.9111111111111111,0.9664007637590651,1.0,65/327,26.62%,NXF1;U2AF1;HNRNPH1;THOC6;MRPL28;SYNCRIP;APOBEC1;RBMS1;BICD1;MRPS12;NOVA1;SMG1;ATXN1;NXT1;ADARB2;RPS5;HNRNPD;MRPL44;RRAGC;NR4A2;RPL21;MLF1;TSPAN17;RBM5;EPC1;NXF5;THRB;ZAR1L;SRSF11;HNRNPA2B1;RPL18A;BCL3;RANBP2;RPL7;NUFIP1;RPS3A;MRPL18;POLR2H;ELAVL4;WDR33;NCBP1;RPL23A;DNAJB11;XAB2;NUP153;SRSF3;DDX19B;MRPL11;MRPS15;HNRNPU;HNRNPF;NFKBIB;MEF2A;TAF1B;MRPL10;THAP1;MRPL41;RBM39;MRPL52;SRSF9;RPL9;MRPS33;TESC;RPS29;RPS19
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5543542503101893,-0.8506768620793879,0.6923076923076923,1.0,1.0,4/5,26.06%,MAPK7;CALM1;RACK1;CALM3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.3985727422766169,0.8504219198781744,0.7017543859649122,0.9667685127164977,1.0,6/35,22.91%,MRPS12;FOXO3;SLC25A33;MRPS34;TFB2M;MRPS15
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.3441122218734588,0.8501484810963201,0.7678571428571429,0.9671179022754736,1.0,19/152,9.68%,CCNG1;SEMA5A;HIF3A;RPP25;ALDH1A1;GOLT1A;VCAN;ISOC1;RPP25L;ZGLP1;ZBTB20;DIPK2A;LRRN3;TSC22D3;PDGFRA;HORMAD1;SLC35F2;AK1;TAC1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5149030327980135,-0.8499863478028642,0.7,1.0,1.0,2/11,5.97%,ZWILCH;BUB1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.57586647161763,0.8498809213737611,0.7391304347826086,0.966923484673484,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.57586647161763,0.8498809213737611,0.7391304347826086,0.966923484673484,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.57586647161763,0.8498809213737611,0.7391304347826086,0.966923484673484,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.3075372690976453,-0.8498586515258871,0.8771929824561403,1.0,1.0,24/260,8.31%,CLEC4F;NLRP1;NR4A1;WARS1;STX11;STK10;MEFV;DUSP6;ALOX5;PRAM1;ERICH1;SCPEP1;STXBP2;MS4A4A;SVIL;CDH23;TAGLN;KIAA0513;HCK;SLC11A1;CAMKK2;IFIT2;OAS1;ABCC3
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.4057526326333037,0.8498304991448269,0.6808510638297872,0.9667941541130304,1.0,5/29,9.52%,SYK;PIK3R6;PIK3R5;PLCG2;PIK3CA
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4574909453650882,-0.8497343161205175,0.6,1.0,1.0,1/11,4.93%,DRD2
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,0.44025199032084833,0.8496738255358444,0.6888888888888889,0.9668676803835292,1.0,2/13,12.77%,PHKA1;PGM1
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.36862603498771707,0.849577446555877,0.7333333333333333,0.9668049986457367,1.0,21/57,23.85%,SOCS2;STAT5A;RELA;ESR1;SOCS6;FOXO3;PIK3CA;GCK;MAPK8;SOS1;PIK3CD;MAPK10;PRLR;SOCS7;AKT3;PIK3R3;MAPK3;AKT2;GRB2;GALT;JAK2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.44457212760335363,-0.8494064334823314,0.7021276595744681,1.0,1.0,8/36,19.64%,PRPF19;WDR77;PRMT7;USP4;SRSF10;PRPF6;COIL;SNRPD2
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,0.3845091602561629,0.8493968726775407,0.7307692307692307,0.9667099715010542,1.0,9/52,10.76%,ITGAX;CSF3R;SASH3;HCLS1;IL10RA;FGL2;LAIR1;C3AR1;ARHGAP25
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,0.3845091602561629,0.8493968726775407,0.7307692307692307,0.9667099715010542,1.0,9/52,10.76%,ITGAX;CSF3R;SASH3;HCLS1;IL10RA;FGL2;LAIR1;C3AR1;ARHGAP25
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3718300314519722,0.8493771410434037,0.7017543859649122,0.9665082741471535,1.0,3/45,7.07%,SMOC1;PBX3;PAX6
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.46760318997215083,0.8493146114289127,0.6545454545454545,0.9664034145663694,1.0,2/22,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4843496430558049,0.8492747960747308,0.6862745098039216,0.966274425824628,1.0,6/11,29.59%,FOXO1;SMAD4;LMNA;RGS2;GSK3A;NOTCH1
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,0.5081822723244309,0.8490624886489503,0.7307692307692307,0.9665201906055362,1.0,1/11,8.97%,CHMP6
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.41684075728726394,-0.8490134702684319,0.62,1.0,1.0,4/30,13.78%,IFT27;GPC2;PTCH1;B9D1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.5453234533029611,0.8489715574311493,0.6511627906976745,0.96646978126039,1.0,1/5,13.08%,XPO1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.4996487901388673,-0.8489670566216989,0.6744186046511628,1.0,1.0,1/11,3.93%,SLC17A9
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4727523480407336,0.8488102955685707,0.6730769230769231,0.9665492672041469,1.0,1/12,3.73%,CPSF4L
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.44934122179780145,0.8487985133624891,0.6538461538461539,0.9663358201445067,1.0,2/15,5.82%,LRAT;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4010659632177521,0.8487193130276828,0.7083333333333334,0.9662371901904474,1.0,8/37,11.85%,TGFBR1;GDF6;BMP2;ACVR2A;INHBC;BMPR1A;SMAD4;GDF9
prerank,KEGG_2021_Human__Cushing syndrome,0.3397253730982384,0.8486824987591765,0.7636363636363637,0.9660812637802261,1.0,27/135,19.38%,CDKN2C;FZD5;KCNK2;LDLR;WNT4;CDKN2A;SP1;WNT9A;GNAI3;WDR5B;FZD1;CREB3L2;RAP1A;DVL2;CREB1;FZD4;FZD6;AIP;STAR;PLCB1;CTNNB1;WNT2;CDK4;ARMC5;CACNA1I;PRKACB;ARNT
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.36613358286422015,0.8486300015534836,0.7115384615384616,0.965955585694942,1.0,17/65,23.23%,RNF152;PEX12;UBE2D3;UBE2Z;UBE2E3;SHPRH;UBA6;UBE2J2;PEX2;UBE2D1;RNF144A;UBE2A;UBE2E1;HLA-B;HLTF;PEX13;USP9X
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.37288338893232886,0.848559946078656,0.7209302325581395,0.965854100926203,1.0,19/78,15.47%,SULT2A1;HSD17B2;ACSM2A;OIT3;C6;SLC26A7;SLC15A1;SLC7A9;ABCG8;FRK;CYP4F12;PLA2G12B;KNG1;SLC10A1;CYP3A4;ABCG5;AGXT2;TMEM45B;MIA2
prerank,CellMarker_Augmented_2021__Myotube:Muscle,-0.36190437822647403,-0.8482481434441959,0.72,1.0,1.0,14/61,12.46%,MYH7;AGBL1;CCDC141;SMTNL1;DHRS7C;NEB;TRIM72;CHRNG;MYOM3;TXLNB;SRPK3;MYO18B;KY;TNNC2
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4447851865778062,0.8481626130316648,0.675,0.9664282313619269,1.0,1/24,2.50%,URI1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.4373840487910766,0.848041689255987,0.6842105263157895,0.9664352293121984,1.0,6/27,16.35%,PEX12;GDAP1;ZFAND6;ABCD3;ABCD2;PEX2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.4388068803070102,0.84795910638091,0.7678571428571429,0.9663879632785669,1.0,9/18,24.81%,SLC39A8;TRPM2;SLC30A10;SLC30A6;SLC30A4;SLC30A1;SLC30A2;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.38854307995694437,-0.8478783647172818,0.6326530612244898,1.0,1.0,3/33,7.19%,DND1;TENT5B;SLC11A1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.33346481347085594,0.8478645091474789,0.7884615384615384,0.9663135960186489,1.0,12/95,6.72%,SLC12A7;MYCN;HRH3;GOLT1A;EFNA2;SCGN;HGFAC;SYT1;SEMA6C;MMP15;PLPPR1;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.394403883817299,0.8478438642475761,0.711864406779661,0.9661097036601455,1.0,5/35,9.15%,FZD5;HTRA2;UBE2D3;RHOU;LMAN1
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,0.4310256489933734,0.8477268047790641,0.6666666666666666,0.9661137587317974,1.0,14/38,29.15%,SHMT2;FDFT1;ASF1B;ARHGEF16;ACVR1B;DHCR7;DPF2;DUSP7;BNIP1;SDCCAG8;STARD7;STK38;FTL;YPEL1
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,-0.4789102816338922,-0.8477147336954066,0.7272727272727273,1.0,1.0,2/12,3.86%,CD24;IL6R
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,0.3892685241048152,0.8473727457000869,0.6923076923076923,0.9666388184193424,1.0,12/66,11.88%,FAM83H;AP1M2;CAPN13;TMPRSS2;CKMT1A;GOLT1A;AGR2;MARVELD3;DSP;CGN;ARHGEF16;HSD11B2
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4025509440119788,-0.847272108209628,0.6666666666666666,1.0,1.0,5/45,10.52%,GPC2;GPC1;GPC3;HFE;PARP1
prerank,KEGG_2021_Human__Salmonella infection,0.3232086985334536,0.847205426424756,0.7916666666666666,0.9667029627351374,1.0,43/220,20.63%,TUBA1C;MYC;SNX18;RRAS;FYCO1;ACTR3C;RELA;RALA;TLR2;MAP2K6;MYL12A;PIK3C2B;TAB2;PIK3CA;TNFRSF10B;DCTN3;DYNC1I2;KLC2;MAPK8;ACBD3;IRAK1;RAB9A;PIK3CD;TAB3;MAPK10;KPNA4;CTNNB1;BIRC3;FADD;RHOG;WASL;RHOB;CASP3;TUBB1;TNFRSF10A;ANXA2;AKT3;GCC2;ACTR10;RAB5B;RIPK2;IKBKB;CYTH1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.46075808501428184,0.8470185458091232,0.6444444444444445,0.9668573812120732,1.0,4/17,12.25%,KLKB1;F12;GSN;BAG2
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,0.5008402747524141,0.8470146433757128,0.7450980392156863,0.966638555228063,1.0,2/13,2.55%,IL4;STAT5A
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.4881870026676691,0.8469595477445929,0.6727272727272727,0.966531156466207,1.0,2/14,8.44%,SHMT2;CBFA2T3
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.34287229001517683,0.8468702845340167,0.746268656716418,0.966511041107408,1.0,14/108,19.17%,TCIRG1;LIX1;PIP4K2A;PRKAB2;CHMP6;ATG101;MTMR3;TMEM74;PRKAA1;TBC1D5;STAM2;MTERF3;STX17;MVB12A
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.37482744949972274,-0.8467874755659872,0.6923076923076923,1.0,1.0,9/54,8.48%,DOCK8;TRAF3IP3;CD53;CYTH4;KLRB1;ARHGAP15;TAGAP;TMC8;PTPN7
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.4282475858644194,-0.8467105962117891,0.7272727272727273,1.0,1.0,3/30,14.79%,RNASE1;LIMK1;ARPC5
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.37750160807966227,0.8464144696454561,0.7755102040816326,0.9670984073328746,1.0,22/70,29.15%,SEM1;RELA;TAB2;PSMD13;PSME4;TAB3;PSMA1;LYN;UBE2D1;IKBKB;PSMD4;RASGRP4;TAB1;BCL10;TRAF6;PSMB5;CHUK;PSMB1;NFKB1;NFKBIA;PSMC5;BTRC
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5365734220041091,0.8461716268942295,0.7068965517241379,0.9672886261303134,1.0,3/8,15.78%,PYCR1;GPR37;NFE2L2
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.34171453318697537,0.8461256274137894,0.7358490566037735,0.9671090343236406,1.0,30/132,18.16%,CDKN2C;CCNA2;ACD;CDKN2A;TNIK;H2BC21;RELA;MAPKAPK2;MOV10;MAP2K6;ASF1A;ANAPC16;MAPKAPK3;RPS6KA2;EZH2;DAND5;MAPK8;H2AC6;TERF1;RNF2;H2AZ2;RPS6KA1;LMNB1;H2AX;MAPK10;ARTN;CDK4;TP53;AGO3;EED
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.32486377624533097,0.8460215828684944,0.8541666666666666,0.9671068311784428,1.0,24/145,26.62%,CARNS1;PCSK5;MRPL28;MRPS12;RPS5;RPL21;DMD;ZAR1L;RPL18A;RPL7;RPS3A;MRPL18;RPL23A;MRPL11;FURIN;MRPS15;GGTLC2;MRPL10;MRPL41;MRPL52;RPL9;MRPS33;RPS29;RPS19
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.4755115738927354,-0.846000442881431,0.7358490566037735,1.0,1.0,1/16,1.75%,ICAM3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4266072258441912,-0.8458721874887191,0.6428571428571429,1.0,1.0,7/26,21.41%,ERN2;DAB2IP;DNAJC10;QRICH1;BRSK2;MAP3K5;BAK1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.38339776917606266,0.8456962847877787,0.6875,0.9675703141150446,1.0,3/46,4.98%,BOK;TGFBR1;SEPTIN4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.45979065561325183,0.8456447752151014,0.7272727272727273,0.9674598687593857,1.0,7/13,29.42%,PPIF;ZFAND1;CPEB2;MKNK2;ATF3;GSTO2;GSTO1
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.3742573758780322,0.8455616188342739,0.6666666666666666,0.9673885148765136,1.0,11/74,10.85%,RUNX1;FGFR3;TNFRSF19;VWA2;ITGA2;LRIG3;PRICKLE2;PLXNB1;C6ORF118;TNC;PTPRK
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.4290236707504988,-0.8453834598163881,0.6170212765957447,1.0,1.0,2/16,9.13%,TERF2IP;RAD50
prerank,Reactome_2022__Scavenging By Class B Receptors R-HSA-3000471,0.5734383000688035,0.845290589188705,0.7450980392156863,0.9677255040507604,1.0,1/5,3.59%,SSC5D
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,0.3750205752757401,0.8452844856569602,0.68,0.9675040430162479,1.0,7/56,5.09%,ITGAX;SASH3;SAMSN1;PIK3R5;IRF8;HCLS1;IL10RA
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.5147115527181588,0.8452668538960828,0.6842105263157895,0.9673036933394447,1.0,1/8,5.30%,MID2
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.41897903159818717,-0.8451199786333397,0.58,1.0,1.0,3/32,4.61%,RFX6;GATD3;PDHX
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,0.35487890320269283,0.8450757722146344,0.7777777777777778,0.9674484538279455,1.0,20/66,21.59%,CD22;ZEB1;PLAC8;MYO1E;SIGLEC1;MYH11;HIP1;BIN1;ENTPD7;SCN9A;CCND3;SLC41A2;CEP95;LGMN;STX18;PIM2;CX3CR1;SLC20A1;AXL;GNAQ
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.45215575528098045,0.8450130975656419,0.6274509803921569,0.9673531922496885,1.0,1/14,2.16%,CDC25A
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.3559747775799477,0.8448821927672008,0.76,0.9674468941608305,1.0,18/96,14.30%,LRP4;FRAS1;CDH2;TENM3;CSRP2;ALDH7A1;LRIG3;TEAD2;CNN3;ADGRL2;LIFR;PCDH18;MAGI1;GPR161;BCAR1;FIGN;TMEM98;LRP6
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.34569343305309574,0.8448545280753061,0.8076923076923077,0.9672707326067478,1.0,16/153,8.97%,VEGFC;IGF1;FERMT3;HGF;SYT15;LHFPL2;PCLO;SYT6;MANF;RAB31;ANXA5;SYT1;TF;SNCA;CRHBP;RIMS2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.37590003228495306,0.8448193647936691,0.6923076923076923,0.9671066439381072,1.0,14/75,19.07%,FZD5;PRICKLE2;MAGI2;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PSMA1;ARRB2;SMURF1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.5182449669042624,-0.8446885921418477,0.6666666666666666,1.0,1.0,3/8,16.62%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5017832080918676,0.8446567695151128,0.6938775510204082,0.9672452860640001,1.0,1/9,5.50%,SLC8A1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.48124201659435856,-0.8445856565574738,0.7111111111111111,1.0,1.0,5/11,31.36%,ALOX12B;ATG10;WIPI1;WDR45B;PORCN
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3792019357066165,0.8445777884355433,0.7647058823529411,0.9671921278934622,1.0,6/34,12.49%,CDK11A;PAPOLA;KHDRBS2;SLTM;QKI;KHDRBS3
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.4406141322058714,-0.8444854486827758,0.6739130434782609,1.0,1.0,5/16,15.27%,CLTA;GJD2;DNM1;CLTB;DAB2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5293319411737646,-0.844334685502391,0.6046511627906976,1.0,1.0,3/8,8.08%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.5364721634548765,-0.8440687483814497,0.6964285714285714,1.0,1.0,1/6,1.52%,SOX30
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.3778222669314411,-0.843983996032775,0.75,1.0,1.0,7/69,5.59%,SELP;SELE;TEK;TIE1;RNASE1;MS4A4A;F13A1
prerank,KEGG_2021_Human__Salivary secretion,0.3730069282587635,0.84386026151402,0.7254901960784313,0.9684388848121707,1.0,9/63,16.19%,ADRA1A;PRKG1;PRB2;GUCY1A2;MUC7;ATP1A2;ADRB1;PLCB1;GUCY1A1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.5456628584725544,-0.8438218837307696,0.6875,1.0,1.0,1/5,10.45%,RABGGTA
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.4085857271907,-0.8437562456838124,0.6326530612244898,1.0,1.0,1/33,0.42%,NTRK1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.32411147491310527,0.8437525367779053,0.8333333333333334,0.9683944515971389,1.0,39/161,22.43%,TGFBR1;POGLUT2;MAPKAPK2;DYRK2;RPS6KA4;GALNT3;SMG1;LATS1;MAPKAPK3;RPS6KA2;GALNT1;STK32B;VRK2;MAPK8;RPS6KA1;DYRK1A;IKBKE;CSNK1G3;RICTOR;HIPK1;POGLUT3;SGK1;DYRK3;PKN2;RPS6KA5;GALNT16;MAST1;STK38L;AKT3;WNK1;NAA11;IKBKB;HIPK3;STK32C;CAMK4;GAS6;RPS6KA6;AKT2;EIF2AK3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.482438583194558,-0.8436349875610836,0.5833333333333334,1.0,1.0,2/9,19.39%,ZFPM1;TPO
prerank,CellMarker_Augmented_2021__Germ cell:Ovary,-0.46235534565559044,-0.8435912360432852,0.5909090909090909,1.0,1.0,2/10,10.34%,GPC3;DDX4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.4926496117761493,0.8433233607513257,0.6808510638297872,0.9689817133502231,1.0,2/8,11.77%,PLXNB1;PLXNB2
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.46685762526800334,0.843064548909192,0.6792452830188679,0.9692005566875036,1.0,4/18,15.58%,ABHD17B;ABHD17C;LYPLA1;RCE1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3937875668498384,0.8428824331274957,0.6346153846153846,0.9694163038171113,1.0,15/39,29.79%,RALA;LMNB1;AIP;PLCB1;HNRNPA2B1;ANXA2;HNRNPF;IL12A;JAK2;PAK2;PDCD4;SIRPA;CD47;GSTO1;IL12RB2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.5215885953218797,-0.8428508486951221,0.7333333333333333,1.0,1.0,2/8,12.81%,ZNF703;RREB1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.5267638733751574,0.8428074155589984,0.7291666666666666,0.9693387733728765,1.0,1/8,9.43%,GRAMD2A
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.47106853375797614,0.8427298293674178,0.75,0.9692911884581463,1.0,8/16,33.55%,INPP4B;PI4K2B;PIKFYVE;INPP5F;MTM1;MTMR10;PIK3R4;INPP4A
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5420843359936596,0.8426110368694997,0.7,0.9692525966133954,1.0,2/6,32.26%,WASL;SH3GLB1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,0.4657241418452478,0.8425487892603,0.6557377049180327,0.9691721707133952,1.0,5/16,10.25%,IL26;RORA;NFKBIZ;LRRC36;IL23R
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.4122242011532127,0.8424927275967558,0.7068965517241379,0.9690678729925382,1.0,9/27,29.42%,RALA;LMNB1;HNRNPA2B1;PKN2;ANXA2;HNRNPF;AURKAIP1;PDCD4;GSTO1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.35246347396018735,0.8424517040606693,0.6964285714285714,0.9689128280964057,1.0,20/103,17.54%,FGF2;PIK3R6;PIK3R5;PIP4K2A;PIK3C2B;PLCG2;PLA2G10;IP6K3;INPP4B;PIK3CA;PTEN;MTMR9;MTMR3;PI4K2B;MTMR11;PLCB1;PITPNM1;PIK3CD;PLCD1;PLBD1
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,-0.3933197332530295,-0.8422183669697726,0.6428571428571429,1.0,1.0,8/31,10.94%,ABCA4;CLCA1;ERN2;SPDEF;RNASE1;ZBTB24;CFHR4;SPINK4
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.39446593974527566,-0.8422126417982466,0.6730769230769231,1.0,1.0,8/45,10.18%,SELL;FOS;DRC1;ADGRG3;NFE4;MMP9;KCNJ15;CMTM2
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.45342280618908803,0.8421783865783087,0.6410256410256411,0.9692298546429813,1.0,4/18,11.83%,GNB4;GNG12;GNAI3;GNG4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.4133578581615057,0.8421107149715723,0.75,0.9691495103651542,1.0,6/28,14.25%,FGF2;PPARG;HMGB1;MEF2C;PTPRM;NR2F2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,-0.4824255373211258,-0.8418607045460653,0.6666666666666666,1.0,1.0,3/10,9.66%,PCED1B;PAH;SYT10
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.37421623358487405,0.8418583806874923,0.7543859649122807,0.9693886968793886,1.0,7/56,21.77%,H2BC21;H2AC6;H2AZ2;H2AX;RANBP2;POLR2H;NUP153
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.3775243654308807,0.8418039404418584,0.74,0.9692337228870217,1.0,7/65,10.60%,ZDHHC11;FRMPD1;ZDHHC12;ZDHHC22;RAB3IP;ZDHHC2;GRIN3B
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4154871699314104,0.841778479062255,0.7321428571428571,0.9690609152947778,1.0,5/30,8.41%,NLGN1;SYT1;CEL;SNCA;NLGN4X
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.33519661531822403,0.8417479317786988,0.7169811320754716,0.968929962621048,1.0,23/111,16.55%,RAB38;SLC22A3;LRP1B;TCN2;ABCA6;ABCA1;RAMP3;ABCG8;ARRDC3;TAP1;TOM1;ABCD3;ABCD2;ABCC11;ABCA8;SLC19A1;SLC22A5;ABCG5;LRP2;LMAN2L;SLCO1A2;ABCA9;CALCRL
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,-0.3972013556548886,-0.8417469994747716,0.7627118644067796,1.0,1.0,5/46,4.83%,MPL;RAB44;MEFV;PRAM1;BEND2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4653915975583594,0.8416887977962643,0.68,0.9687960888503487,1.0,4/12,21.70%,SLC37A4;SLC20A1;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5304217804070454,-0.8413551861576242,0.6862745098039216,1.0,1.0,1/5,7.13%,PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.34343589500906596,0.8413114292754321,0.8253968253968254,0.9693541907156664,1.0,13/101,10.29%,FLT1;F2;EPHA7;FGFR3;FGFR1;ERBB4;ROR1;PDGFRA;EPHA5;EPHA3;EPHA8;TAB2;FLT3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.43519831331993064,0.8411760235251109,0.6885245901639344,0.9693753270234501,1.0,7/20,19.96%,TOX;SMARCD3;PROX1;LRP2;CTNNB1;VEGFA;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.38975816544091313,0.8411094653636548,0.7857142857142857,0.9692593287251197,1.0,9/53,12.92%,HGF;IL10RA;SNCA;SMG1;TAB2;LEPR;PIK3CA;WASHC1;MTMR9
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.39074620820601186,0.8410674911793847,0.6875,0.9691135826368042,1.0,13/40,23.10%,ZFP36L2;NUDT16L1;RNASET2;RIDA;HNRNPD;DXO;AGO3;SLFN14;PNPT1;NCBP1;ZFP36;LSM2;HSPA1A
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.5186217460720818,0.8409489628587098,0.66,0.9691049652326997,1.0,3/10,7.07%,TGFBR1;POU3F2;PAX6
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.3909853337761633,-0.8407946839673978,0.7333333333333333,1.0,1.0,6/38,7.19%,SIRPG;AHSG;SPACA3;C2;DOCK2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.39460712701758904,0.8407818954031729,0.782608695652174,0.969179759872095,1.0,2/44,3.67%,IGF1;FBXO5
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.360219603685869,0.8407620035641539,0.7169811320754716,0.9689894636198982,1.0,15/51,21.12%,PLEKHG2;FGD4;ARHGEF17;ARHGEF16;MAPK8;PRPF38B;SOS1;MAGED1;ARHGEF6;VAV2;ARHGEF40;GNA13;MCF2;BAD;ARHGEF4
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,-0.3761884335436675,-0.84075670702472,0.7222222222222222,1.0,1.0,8/55,7.93%,TRAF3IP3;CD53;CYTH4;MEFV;PRAM1;HCK;SLC11A1;TAGAP
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.39446864053490827,-0.840642880438051,0.6739130434782609,1.0,1.0,12/32,21.14%,MBTPS2;AFG3L2;ADAM19;SPPL2B;MYH9;TGFB1;APH1B;MBTPS1;ADAM9;APH1A;RBMX;PRTN3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5156000682575897,0.8406146826380324,0.6190476190476191,0.9690582953091981,1.0,1/7,5.22%,ACADS
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.3782297509338651,0.8405443641974912,0.7317073170731707,0.9689871874506802,1.0,11/68,15.17%,LRP4;FBLIM1;SDK1;PPFIBP1;SNCA;MARVELD3;NLGN4X;GRM5;SEMA3E;PPFIA3;L1CAM
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3166567230344915,0.8405138144170288,0.8723404255319149,0.9688238558552903,1.0,22/142,14.47%,CTDNEP1;DUSP29;DUSP23;PLPPR1;PPP4R1;PPP1CC;PPM1A;PTPRD;PTPN14;DUSP18;PTPRT;ACP6;PPM1L;PTPRK;PPM1E;PTEN;PPP3CA;PPP3CC;PTPRM;MTMR3;DUSP2;PTPRU
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.40903037215825117,0.8402580427640135,0.6935483870967742,0.9691128530488327,1.0,8/31,20.10%,ACD;H2BC21;H2AC6;TERF1;H2AZ2;H2AX;POLR2H;POT1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.41654027548800865,0.8402331149962216,0.6666666666666666,0.9689317210657453,1.0,4/29,11.63%,PLEKHH2;KANK1;PIK3CA;SMAD4
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.3521108663815967,-0.8401992393818468,0.7241379310344828,1.0,1.0,15/96,17.61%,DDX11;INCENP;NEMP1;CHD4;PDCD11;DARS2;FTSJ3;SNRNP200;UCP3;TTF2;CHAF1A;MCM2;HNRNPL;ILF3;DHX38
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3469904280186551,-0.8401743710333137,0.7407407407407407,1.0,1.0,10/109,7.75%,GFRA3;COL4A2;GFRA2;COL4A1;BOC;OLFML2A;GULP1;SFRP1;MPZ;ARNT2
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.3826251480214627,0.8400660738876906,0.7446808510638298,0.9689766936856145,1.0,23/77,22.07%,SYK;RRAS;KSR1;CBLB;RELA;MAPKAPK2;PLCG2;PIK3CA;MAPK8;PPP3CA;PPP3CC;NFATC3;IKBKE;PIK3CD;MAPK10;BCL3;RRAS2;AKT3;PIK3R3;IKBKB;MAPK3;CARD9;AKT2
prerank,KEGG_2021_Human__Lysosome,0.3323736467836485,0.8399256018989494,0.6792452830188679,0.9690216450869794,1.0,9/113,10.05%,AP1M2;TCIRG1;ATP6V0D2;NPC2;CTSF;LAPTM4A;DNASE2B;ATP6V0A4;HYAL3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.34764283100972093,-0.8397322503223543,0.6909090909090909,1.0,1.0,6/89,5.49%,TMEM179;RGS8;ST8SIA2;ZCCHC12;DRD2;VGF
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.4464326778478708,-0.8395398897922237,0.7068965517241379,1.0,1.0,2/11,2.67%,NLRP3;CD86
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.3378684700754441,0.8394358912282829,0.7142857142857143,0.9697918733440037,1.0,28/137,19.33%,MAP3K11;PREX2;ARHGAP24;PLEKHG2;FGD4;ARHGAP31;STOM;SCRIB;ARHGAP5;DLC1;KCTD3;ARHGAP45;PRKCSH;ARHGEF16;VAMP3;FMNL3;RACGAP1;ARHGEF6;PKN2;KTN1;ARHGAP21;WASL;FARP1;VAV2;ARHGAP20;ARAP2;GNA13;MCF2
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3890561866490885,0.8393501017370893,0.7647058823529411,0.9696820760623311,1.0,8/46,24.86%,HIF1A;GCK;RANBP2;PNPT1;NUP153;PRDM16;OGT;EP300
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4758173600556165,0.8393354587981448,0.6964285714285714,0.9694921099955025,1.0,4/9,23.73%,CSF1;LYN;MAPK3;IL12A
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.5603305601008256,0.8393290461750058,0.7368421052631579,0.9692725291588628,1.0,2/6,8.55%,ALDH1A1;BCAT1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.5011035668622459,0.8391033314902173,0.6666666666666666,0.9695163298982307,1.0,1/10,1.67%,SYK
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.4973519337064246,0.8390028808715485,0.6938775510204082,0.9695195241958877,1.0,2/6,27.85%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4409436662746974,0.8384831561838942,0.7049180327868853,0.9703241667797796,1.0,8/18,23.73%,NECTIN2;IL23R;HLA-E;FADD;HLA-F;HLA-B;MR1;IL12A
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5697877014627549,-0.8382885049368334,0.7857142857142857,1.0,1.0,1/8,3.27%,ASS1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.38955164364746636,0.838236230505699,0.6842105263157895,0.9705052273776904,1.0,16/60,17.56%,FZD5;WNT4;FRAT2;WNT9A;PTEN;NR4A2;FZD1;DVL2;LRP6;FZD4;FRAT1;FZD6;FRZB;DIXDC1;CTNNB1;WNT2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.4884070577005099,-0.8381717730099979,0.6808510638297872,1.0,1.0,2/10,5.97%,DDX11;BUB1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.37430755127754417,-0.8379918409003866,0.74,1.0,1.0,10/61,8.63%,SELP;SELE;TEK;TIE1;RNASE1;STARD8;MS4A4A;ADGRF5;CLEC14A;ETS2
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.4708842821121174,0.8379108455027531,0.7555555555555555,0.9709354252737468,1.0,1/13,4.99%,PHKA1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5539862502502584,0.8377507599616553,0.7368421052631579,0.97099760731636,1.0,2/6,10.70%,CEP152;E2F4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.47865972655209504,-0.8377502886632769,0.673469387755102,1.0,1.0,1/11,6.14%,RBM4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.47865972655209504,-0.8377502886632769,0.673469387755102,1.0,1.0,1/11,6.14%,RBM4
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5136093783128285,0.8376761992591142,0.7272727272727273,0.9708818277667988,1.0,2/9,4.15%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3754890222017778,0.8374814657047975,0.717391304347826,0.9710299735578724,1.0,7/37,14.68%,BMI1;DUX4;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4227242142701677,-0.8374409438801342,0.6666666666666666,1.0,1.0,3/29,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.3758789125970572,0.8374106636806237,0.6666666666666666,0.9709735237340269,1.0,17/42,21.98%,NAALAD2;GLUL;GADL1;PYCR1;SRR;SLC25A13;CBS;THAP4;CPS1;RIMKLA;SLC25A12;GPT;GLUD1;ASPA;FOLH1;RIMKLB;OAT
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,0.3877344097979887,0.8373629965124266,0.6938775510204082,0.970822270152418,1.0,9/55,6.24%,SELPLG;ITGAX;SASH3;SAMSN1;PIK3R5;CD244;HCLS1;IL10RA;LAIR1
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.3837817176183572,0.8372595716955656,0.7307692307692307,0.97079256044692,1.0,9/46,17.95%,REXO2;RALA;PRKAB2;MYO1E;LNPEP;TBC1D4;RALGAPA2;EXOC6;STXBP3
prerank,KEGG_2021_Human__Protein export,0.41980033465976635,0.8372430439085055,0.6610169491525424,0.9706117999487441,1.0,5/23,20.31%,IMMP2L;SEC61A1;IMMP1L;SEC61A2;HSPA5
prerank,Reactome_2022__Beta Oxidation Of butanoyl-CoA To acetyl-CoA R-HSA-77352,0.5429585442103427,0.8371694358013709,0.7241379310344828,0.9705170037791113,1.0,1/5,5.22%,ACADS
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.42375185736102866,-0.8370915587557249,0.6363636363636364,1.0,1.0,1/25,1.91%,ARL5C
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,0.3655438532423622,0.8369776068637791,0.76,0.9705140229475503,1.0,9/64,11.01%,STAB1;TCIRG1;ANTXR2;PTGS1;TLR2;SIGLEC1;CYP27A1;C3AR1;OSCAR
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,0.3655438532423622,0.8369776068637791,0.76,0.9705140229475503,1.0,9/64,11.01%,STAB1;TCIRG1;ANTXR2;PTGS1;TLR2;SIGLEC1;CYP27A1;C3AR1;OSCAR
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.4077779589470556,-0.8367077178914994,0.6938775510204082,1.0,1.0,5/18,15.27%,CLTA;GJD2;DNM1;CLTB;DAB2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.44675433933822495,0.8365846163247161,0.7457627118644068,0.9711088269178144,1.0,5/22,16.45%,ARHGAP24;ABI3;KANK1;CCP110;LIMK2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3440070986988548,0.8363166737792381,0.7818181818181819,0.9713956595799702,1.0,17/70,13.86%,IRS1;ACSM2A;SIRT1;HIF1A;PPARG;ADIPOR2;PAX6;CYB5R4;LEPR;MCU;FOXO1;GCK;BACE2;IGF1R;KLF7;HKDC1;MLXIPL
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.388277403981967,0.8363068493622721,0.7368421052631579,0.9711913490098633,1.0,9/39,13.57%,SIRT1;HIF1A;ZBTB20;LIN28A;UNC13B;FOXO1;GCK;IGF1R;HKDC1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.42498216500349617,-0.8362943701413345,0.7142857142857143,1.0,1.0,7/19,21.14%,ADAM19;SPPL2B;MYH9;ADAM9;APH1A;RBMX;PRTN3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4758670130707987,0.8361643121566978,0.6792452830188679,0.9712118806885838,1.0,1/12,3.09%,ANGPT1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,0.5220323384644412,0.8361484744045469,0.7205882352941176,0.9710047525862197,1.0,4/9,22.81%,CD34;KIT;PTPRC;ITGAM
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.3021764431105253,0.8360801880188617,0.9056603773584906,0.9709336885312851,1.0,92/636,18.38%,MT4;SLC7A11;NOX5;TCIRG1;ATP6V0D2;CDKN2C;MYC;HIF3A;SIRT1;EGLN3;CCNA2;HIF1A;ACD;PHGDH;SEM1;CDKN2A;SYVN1;NRIP1;COX19;RORA;TNIK;IDH1;H2BC21;FKBP5;RELA;MAPKAPK2;MOV10;MAP2K6;ASF1A;HDAC3;UBE2D3;KEAP1;ANAPC16;MAPKAPK3;SMARCD3;PSMD13;NCOA2;RPS6KA2;EZH2;RPS5;DCTN3;TBL1X;DAND5;DYNC1I2;MEF2C;EXOSC4;RRAGC;MAPK8;BAG2;CSRP1;H2AC6;DNAJC3;ATP6V0B;TERF1;XPO1;HSPA8;RNF2;H2AZ2;RPL21;PSME4;CREB3L2;CREB1;RPS6KA1;CHD9;LMNB1;UBXN7;H2AX;ATF6;COX6A1;NFE2L2;EPX;TNFRSF21;MAPK10;KPTN;MT1M;PSMA1;DNAJB9;RPL18A;MYDGF;RANBP2;ARTN;RPL7;SCO2;VEGFA;CDK4;TP53;AGO3;RPS3A;CITED2;EED;RRAGD;MRPL18
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.44472275370668635,0.8360769500367814,0.6721311475409836,0.9707060370216647,1.0,2/18,7.52%,GSTM2;ELOVL5
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.5122903600751734,0.8357875283896777,0.7540983606557377,0.9710368769258706,1.0,4/8,35.03%,EZH2;DOT1L;DPY30;SIRT2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4790253789624595,0.8355860925625856,0.6909090909090909,0.9711105877783637,1.0,3/12,12.31%,CSRP2;PGM5;CSRP1
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.28393045956725954,-0.8354686146806085,0.9629629629629629,1.0,1.0,35/595,7.93%,TRIP10;ACTC1;ARAP3;KIF2B;DOCK8;RAC2;CTNNA1;ERCC6L;CENPH;PRAG1;NOXA1;STK10;PRKCD;RASGRF2;ZWILCH;OBSCN;RNASE1;STARD8;INCENP;DHDDS;FMNL1;DSG2;PDZD2;VAV3;PMF1-BGLAP;BUB1;MPZ;SPC25;DOCK2;BTK;ARHGAP15;FLOT1;ARHGDIB;ARHGAP12;TAGAP
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,0.3554672937329269,0.8353144496657765,0.7659574468085106,0.9713673520659645,1.0,3/94,2.28%,TIMELESS;CDC25A;CCNA2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4128006465802418,-0.835161019517256,0.7358490566037735,1.0,1.0,3/24,9.71%,CD86;HLA-DRB1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,0.38823582126542183,0.835152714942323,0.7454545454545455,0.9714557126732893,1.0,6/49,5.09%,SELPLG;ITGAX;SASH3;PIK3R5;CD244;IL10RA
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.46308293761801167,0.8347564994723213,0.7230769230769231,0.9721579748281526,1.0,2/12,13.67%,SLC7A9;SLC19A1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.45479260378744385,0.8346745903423364,0.7254901960784313,0.9720838062745291,1.0,8/20,16.99%,IL4;PLA2G10;NR1H3;LRFN5;CD74;MFHAS1;GPR137B;IL33
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,-0.522536838559982,-0.8346323392016801,0.6530612244897959,1.0,1.0,2/10,7.96%,FOS;JUN
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.3450814924620098,-0.8346283628995274,0.6875,1.0,1.0,19/112,10.15%,UROC1;EHF;PVALB;SPTLC3;KCNJ1;KCNJ16;AQP7;SLC22A8;UMOD;PDZD2;PTPN3;COL28A1;MYO5B;ADGRF5;ZBTB7C;SLC22A6;SLC3A1;VDR;MUC15
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.34958960762614283,0.83447378437369,0.8444444444444444,0.9722132408576472,1.0,13/79,17.81%,NDE1;CEP70;KCNH5;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110;DYRK3;TP53
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.35467071630041175,0.8344376788567595,0.7450980392156863,0.9720417580633535,1.0,14/81,17.81%,CCNA2;RRAD;PRKAB2;TP53INP1;DYRK2;TAF3;CHEK2;NOC2L;TAF5;HIPK1;TAF2;PRKAA1;ARTN;TP53
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.5054143671915212,-0.8342868853287265,0.6727272727272727,1.0,1.0,1/10,1.95%,BUD23
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.42675121500244506,0.8342525404814517,0.6666666666666666,0.9721681930299532,1.0,10/25,24.90%,MYCN;LIN28A;TP53;FMR1;LIMD1;ZFP36;BMP4;DHX9;PUM2;EGFR
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.4851451433523075,-0.8342502584400318,0.7115384615384616,1.0,1.0,4/14,17.38%,BTK;APOA1;WNT5A;TRIL
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.46967165594011706,-0.8341188929292923,0.6415094339622641,1.0,1.0,2/13,6.96%,DUOX1;DBH
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.4345338979529212,0.8340713399671996,0.7192982456140351,0.9722621386841741,1.0,8/24,29.84%,CNOT6L;CNOT4;CNOT8;CNOT2;PAN3;PABPC1;EIF4E;TUT4
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.3951555617514473,-0.8338292765662322,0.75,1.0,1.0,2/32,6.96%,RNASE1;BTK
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.41066252174454215,0.8336915399244741,0.7049180327868853,0.9727922714373755,1.0,6/20,15.08%,TGFBR1;WWTR1;BMPR1A;SMAD4;FAM89B;KIAA0319
prerank,Reactome_2022__Prostanoid Ligand Receptors R-HSA-391908,-0.5761766020291728,-0.8336900360460674,0.7659574468085106,1.0,1.0,1/5,2.57%,PTGDR
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,0.47250324402691435,0.833578259669294,0.6595744680851063,0.97280940998127,1.0,5/10,39.17%,NCBP1;LSM11;LSM10;SNRPG;SNRPB
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.4367967109832537,0.8334100328382802,0.660377358490566,0.9729001937388196,1.0,2/25,1.82%,SYK;CCL5
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.4729596477534698,0.8334068297995775,0.7192982456140351,0.9726757729270191,1.0,6/17,26.26%,SYT1;UNC13B;PPFIA3;SLC18A2;PPFIA2;TSPOAP1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4951527943296921,0.8333460920506083,0.7037037037037037,0.9725751365833221,1.0,1/11,1.67%,SYK
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4739400614301296,0.8332780447243316,0.6666666666666666,0.9724980997708188,1.0,6/15,24.57%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.41366203784428135,-0.833237227059194,0.7307692307692307,1.0,1.0,2/18,5.75%,EEF1AKMT2;KMT2B
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.46505753481651185,0.8330185146551974,0.7555555555555555,0.9727743041724527,1.0,2/12,11.28%,SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5199941816884985,0.832732000296582,0.7450980392156863,0.973094519942721,1.0,4/6,33.34%,HEY2;VEGFA;NOTCH1;EFEMP2
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.4035029603896863,-0.8326808768185243,0.7755102040816326,1.0,1.0,10/36,18.27%,PARP2;RFC3;SMUG1;PARP1;POLR1A;XRCC1;RPA3;RFC2;MBD4;PNKP
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.5465968967616018,-0.8325991590009348,0.7,1.0,1.0,2/5,14.10%,PRAME;CYP26B1
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,-0.5424307754251376,-0.8324942444078982,0.6792452830188679,1.0,1.0,3/7,19.07%,MYH9;RHBDF2;PLK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.4030895883268668,0.8323585686638002,0.6666666666666666,0.9735381503372467,1.0,4/26,7.69%,SEMA5A;IL4;ANGPT1;CD40
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.39820511124581703,-0.8322818308568682,0.6444444444444445,1.0,1.0,7/43,7.19%,HRH2;PTGDR;LILRB3;MS4A4A;F13A1;HCK;SLC11A1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.40548476077285833,0.8321088571711903,0.7213114754098361,0.9738080360121925,1.0,4/29,16.35%,PEX12;CHCHD4;DNAJC15;PEX2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.47329038768900716,-0.8319255640287542,0.68,1.0,1.0,1/14,1.04%,CD24
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3862218679172494,0.8317473144872171,0.7111111111111111,0.9744424338649582,1.0,3/43,7.83%,SMAD6;HMGB1;PPM1A
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.44365138467118753,-0.831730261469439,0.6470588235294118,1.0,1.0,6/19,10.93%,NLRP3;ADGRG3;CCN3;HDAC7;SPI1;TMSB4X
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,0.3588160808982999,0.8315982757338671,0.7916666666666666,0.9744709072845955,1.0,8/68,5.65%,GPRIN3;ADAM28;SASH3;SAMSN1;PIK3R5;IRF8;IL10RA;PELI1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.503690369731028,0.8315780196277437,0.7272727272727273,0.9742730445264701,1.0,7/10,30.57%,ROBO2;BMP4;NPNT;SLIT2;SALL1;PKD1;PKD2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.5499795599035271,-0.8314814138850192,0.68,1.0,1.0,2/8,10.96%,DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.33942765586418067,0.8313185670695692,0.7333333333333333,0.9746042171923323,1.0,11/78,8.55%,AASS;CARNS1;SHMT2;IDO1;HYKK;ALDH7A1;GLUL;IDO2;TDO2;HIBCH;BCAT1
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.4834474339835212,-0.8312123006718725,0.6481481481481481,1.0,1.0,1/7,7.03%,IRF5
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.3705281543064581,-0.8311733548347505,0.7209302325581395,1.0,1.0,3/59,9.83%,TBC1D10C;ENTR1;TCHP
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.48263767423541704,0.8309670642158918,0.6595744680851063,0.9749998690040313,1.0,2/7,27.85%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.36595580711517733,-0.8308778931758719,0.7551020408163265,1.0,1.0,9/58,12.20%,WARS1;TRIB1;TRIB2;UBASH3B;CEACAM1;CAMK2N1;TAF7;SPRED1;PYDC1
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.3921116073090758,-0.8308147360446371,0.6428571428571429,1.0,1.0,7/56,9.57%,AMACR;HMGCL;PIPOX;PEX7;HAO2;MLYCD;ACOT2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3945157485799667,0.8306426951614928,0.7872340425531915,0.9751945061456374,1.0,6/24,20.55%,PAPOLA;PCF11;TENT4B;CSTF3;PNPT1;WDR33
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3945157485799667,0.8306426951614928,0.7872340425531915,0.9751945061456374,1.0,6/24,20.55%,PAPOLA;PCF11;TENT4B;CSTF3;PNPT1;WDR33
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.34688888143670976,0.8306280056823019,0.6538461538461539,0.9749937694473501,1.0,23/142,15.66%,CCNG1;SMYD2;PIP4K2A;PRKAB2;MAP2K6;TP53INP1;DYRK2;BANP;HDAC2;TAF3;RRS1;CHEK2;TP53BP2;NOC2L;PML;BOP1;KAT6A;TAF5;RICTOR;HIPK1;TAF2;SGK1;PRKAA1
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.32567218460714764,0.8306239745417263,0.8571428571428571,0.9747725801857388,1.0,20/156,13.55%,STK26;REXO2;SEM1;CDKN2A;DCC;DAPK2;SEPTIN4;TICAM1;HMGB1;GAS2;PSMD13;GSN;TNFRSF10B;TP53BP2;MAPK8;FASN;MAGED1;TANK;PSME4;PPP3CC
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.35455154885459483,0.8305142355812034,0.8163265306122449,0.9747451688103775,1.0,13/84,10.51%,PCOLCE2;LAMA4;COL9A1;PLOD2;COL9A2;COL6A5;COL6A2;P3H2;COL8A1;COLGALT2;COL5A3;LOXL2;COL7A1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.43534666975779873,-0.8305077728409688,0.6122448979591837,1.0,1.0,5/18,11.02%,CELA2A;PRKCD;F11R;CEACAM1;SERPINE2
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.4985200350093951,-0.8304840352024052,0.625,1.0,1.0,3/6,10.34%,BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.37870517367666545,-0.8304114539062967,0.6923076923076923,1.0,1.0,5/45,7.35%,APIP;TRPV5;UPB1;GOLGA2;TRPA1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.36022392498802414,0.830347917494513,0.6888888888888889,0.9748145850989389,1.0,13/71,14.23%,SLC12A7;SLC12A1;TRPV2;KCNJ3;SLC12A3;SLC8A1;SLC39A8;SLC24A2;SLC9A2;ATP1A2;SLC39A12;SLC9C2;TRPM2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.38397781852415525,0.8301474473356064,0.7090909090909091,0.9750276910848685,1.0,7/29,17.05%,PRR5L;TENM1;PCM1;PTPN14;ZFAND1;RAB29;SIRT7
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.3359928176274563,0.8298870078201782,0.6888888888888889,0.9753257380780833,1.0,5/105,4.33%,GATA4;EHD1;AK3;HMG20B;DOCK1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.4279927944525411,-0.8298567715697663,0.7045454545454546,1.0,1.0,2/21,12.64%,EML3;GPSM2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5559393646936084,0.8298075427898335,0.7692307692307693,0.9752425205214631,1.0,4/6,35.74%,CDK6;HES5;EIF2B5;MT3
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5113431967249221,-0.8296492941898421,0.6923076923076923,1.0,1.0,3/6,29.25%,CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.45517745027771933,-0.8295636769693152,0.7777777777777778,1.0,1.0,1/10,3.27%,ASS1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.4003363878054089,0.8294068116388846,0.7115384615384616,0.9757602081146538,1.0,7/29,19.06%,LPIN3;PPP1CC;MOGAT2;GPD2;DGAT2;AGMO;PRKACB
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4294509734259352,0.8293566020446743,0.7068965517241379,0.9756476244954051,1.0,10/30,22.91%,CCL5;SP1;NAPEPLD;ZNF639;CHD1;CX3CR1;HDAC1;RRP1B;CARD9;LRRC19
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,-0.37508601656509943,-0.8293195371970764,0.68,1.0,1.0,10/54,8.78%,CD53;CYTH4;CD86;LILRB3;MEFV;PRAM1;HCK;SLC11A1;TAGAP;LY86
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,-0.37508601656509943,-0.8293195371970764,0.68,1.0,1.0,10/54,8.78%,CD53;CYTH4;CD86;LILRB3;MEFV;PRAM1;HCK;SLC11A1;TAGAP;LY86
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3418523320804674,0.8292074135459655,0.7948717948717948,0.9757284529659193,1.0,9/92,12.52%,U2AF1;SF3B1;SYNCRIP;IVNS1ABP;SNRPN;NOVA1;SNRNP48;RRAGC;CDK12
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3589396911821269,0.8291469344913442,0.72,0.975624716091388,1.0,22/83,19.44%,RHOBTB3;RAPGEF3;EFNA5;ABI3;EPS8;PDGFRA;EPHA5;EPHA3;DLC1;ABL2;PIK3CA;GPM6B;SEMA3E;RHOBTB1;TRPM2;RICTOR;NOTCH2;RHOG;RHOD;RHOB;MLST8;ABL1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.5152858704883622,-0.8290682556599224,0.7659574468085106,1.0,1.0,2/8,7.77%,DLL4;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.5360839902022547,0.8289244126320121,0.8333333333333334,0.9757494373017085,1.0,3/5,21.01%,GRM5;GABRE;ATP8B1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.46104979105347643,0.8287797595278061,0.7441860465116279,0.9758448240537566,1.0,5/13,27.66%,MAPKAPK2;ELAVL4;ZFP36;HNRNPC;ANGEL2
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.3222816021401524,0.8287727904565424,0.8297872340425532,0.9756269805321772,1.0,20/123,19.57%,TULP3;SEM1;SYVN1;GPC5;SPOP;SPOPL;PSMD13;GPR161;PSME4;DERL2;IFT57;GAS1;PSMA1;NUMB;TTC21B;ARRB2;PRKACB;SMURF1;DZIP1;IFT140
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,0.5114108257610208,0.8287663017398313,0.7049180327868853,0.9754238696289548,1.0,2/10,12.47%,TNC;CD34
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5096351275331487,0.8285850019135559,0.7222222222222222,0.9755368192054417,1.0,4/8,25.12%,NR1H3;TICAM2;NINJ1;LBP
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.5482840791062871,0.8284038247375526,0.7111111111111111,0.9756877404972735,1.0,2/5,7.89%,CD244;SNCA
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.34081989019984216,0.8282343456309914,0.7777777777777778,0.9757625611200256,1.0,24/96,24.05%,RIT2;SLC35F1;GRM3;HRH3;ZDHHC22;NRXN1;CTNNA2;PAK5;GABRA5;MYT1L;SEZ6L;CNTN2;PDZD4;STMN4;RBFOX1;LHFPL4;AMER2;ATP1B2;HTR5A;VSTM2B;CEND1;CLVS2;SNAP91;SCRT1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3437440823936902,0.8281407296578414,0.8,0.9757204039550215,1.0,14/70,19.73%,SIRT1;CDKN2A;SLC8A1;LATS1;SPRY3;PTEN;HEXIM2;NR2F2;LRP6;RGS14;IRAK3;PKIA;ABL1;LYN
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.3892430956642232,0.827784207029136,0.7959183673469388,0.9761868507515274,1.0,9/35,20.84%,SIRT1;MAGI2;BANK1;PTEN;PHLDA3;ARRB2;PHLPP1;THEM4;DDIT3
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.45755438885712285,0.8274191525831565,0.782608695652174,0.9767027590103936,1.0,2/25,2.81%,FGF10;FGF2
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.3894406707016521,-0.8271731322864401,0.7288135593220338,1.0,1.0,9/49,13.04%,ACTC1;PIPOX;YBEY;WFDC1;GBP2;VSNL1;CFAP221;ADRA1D;TMEM51
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.404593676010944,-0.8267841119976203,0.6470588235294118,1.0,1.0,10/37,16.57%,NLRP3;AQP7;MYO5B;GNG13;AQP8;GNGT1;GNB3;GNB5;RAB11A;ADCY1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5464495178685385,-0.8265778217621638,0.7333333333333333,1.0,1.0,1/5,12.61%,NUCKS1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.35364302847735984,0.8265666751656989,0.74,0.9781270282190154,1.0,7/62,8.27%,LGALS9;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1;TFEC
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.38856683580428014,-0.8264139256557901,0.6904761904761905,1.0,1.0,6/35,9.23%,CELA2A;KRTAP5-7;DSG2;PCSK6;FLG;KRT86
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.42475359922880374,0.8261386323386313,0.7254901960784313,0.9786743772534322,1.0,9/20,23.48%,HMGCS1;NUS1;MVD;IDI2;RCE1;ZMPSTE24;IDI1;PCYOX1;PDSS2
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.4314431740919412,0.826028389127337,0.6949152542372882,0.9786257538904679,1.0,3/18,13.84%,PTGS1;NR4A2;CLEC17A
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4952205801718878,0.8260079648273125,0.6842105263157895,0.9784340968894583,1.0,3/8,14.24%,SLC22A3;SLC25A48;SLC22A5
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,-0.3635676726629512,-0.825804190467711,0.7058823529411765,1.0,1.0,9/74,8.00%,EHF;CLDN4;CTNNA1;EPAS1;RHBDF1;LAMB3;MALL;TSPAN15;ADIRF
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4818960944920202,0.8256851063124426,0.7083333333333334,0.9788788352204655,1.0,5/10,24.02%,SMPDL3A;ABCA8;ABCA2;SAMD8;SGMS1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.42899820089023843,0.8256746505482461,0.7666666666666667,0.9786813720496439,1.0,1/25,3.29%,MDFIC
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5115316639287041,0.8256653814433077,0.78,0.9782400509239967,1.0,3/8,15.49%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5115316639287041,0.8256653814433077,0.78,0.9782400509239967,1.0,3/8,15.49%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.38162065831488695,0.8255271954875797,0.7115384615384616,0.9782819957720179,1.0,13/37,29.79%,RALA;LMNB1;AIP;PLCB1;HNRNPA2B1;ANXA2;HNRNPF;IL12A;JAK2;PAK2;PDCD4;GSTO1;IL12RB2
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.35535940802845395,-0.825442271183182,0.8070175438596491,1.0,1.0,17/78,14.85%,MS4A8;CHST9;PTPN3;CAPN9;MYO5B;PLEKHS1;AK7;ZBTB7C;ZBBX;CCDC40;MROH9;RSPH1;APOBEC4;CFAP52;ATP1B1;ADH7;TACC2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5608566211893924,0.8253156284579735,0.7192982456140351,0.9784726097508649,1.0,4/5,30.87%,PTPRC;APPL1;CD47;APPL2
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.40576152016355527,0.8251919863786465,0.7843137254901961,0.978415378648371,1.0,2/37,3.28%,SEM1;RRAD
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.5218450332339558,-0.8250165807680555,0.6666666666666666,1.0,1.0,1/5,11.71%,ACP3
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",-0.45586460346192337,-0.8249608586912843,0.7555555555555555,1.0,1.0,4/10,17.77%,PTS;CALM1;PRKG2;TACR1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.40611688647352934,0.8247986965948589,0.6981132075471698,0.9788477450463718,1.0,11/29,26.77%,CCL5;HLA-E;POLR3G;PLSCR1;FADD;RIOK3;DHX9;LBP;SH2D1B;RPS19;NLRC5
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.45582225729007053,0.8247130168505086,0.7391304347826086,0.9787904536865755,1.0,1/13,4.99%,PHKA1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.5327588770636591,-0.8245198157449959,0.7209302325581395,1.0,1.0,2/7,8.97%,F7;NTRK3
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.4619227256397323,-0.824415776032389,0.7037037037037037,1.0,1.0,4/16,8.41%,PIGG;PIGO;PIGH;PIGL
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,0.42898236600801154,0.824408568995901,0.75,0.9791176739673061,1.0,4/19,6.24%,LGALS9;CSF2RA;CD244;LAIR1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.44311607888475046,0.8243975903337595,0.7555555555555555,0.9789205662331275,1.0,2/14,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.4673843119642642,0.8243070278608449,0.6530612244897959,0.9788400063892791,1.0,3/10,12.52%,IL4;NR1H3;LRFN5
prerank,CellMarker_Augmented_2021__Hepatocyte:Embryoid Body,-0.3769597983050191,-0.8243042428745485,0.7959183673469388,1.0,1.0,12/51,11.56%,ALB;HABP2;AHSG;F7;FGL1;PAH;HAO2;PRODH2;ITIH3;APOA1;APOB;SMLR1
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,-0.45919893915798915,-0.8243039245315726,0.7169811320754716,1.0,1.0,3/9,20.69%,DLL4;APH1B;APH1A
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4306771233732917,-0.8242325149818069,0.5818181818181818,1.0,1.0,4/33,3.41%,CLDN4;DUOX1;CLDN1;ALOX5
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.35800862639576175,0.8240607674774566,0.6274509803921569,0.9791320595351194,1.0,11/66,19.62%,IGF1;HIF1A;ZBTB20;CBFA2T3;GCK;MLXIPL;PRKAA1;RANBP2;PFKFB4;ARNT;FBP1
prerank,CellMarker_Augmented_2021__B cell:Lymphoid Tissue,-0.5540808083070263,-0.8240353189898092,0.74,1.0,1.0,2/5,9.27%,CD86;PAX5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4862082213031601,0.8239977864433928,0.7169811320754716,0.9790194772220717,1.0,2/14,1.82%,SYK;CCL5
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.34497298770348983,0.8238873298078551,0.7391304347826086,0.9790000478282398,1.0,14/89,11.83%,KCNC2;KCNK2;GNB4;GNG12;KCNJ3;KCNH7;KCNH4;KCNQ5;KCNH8;KCNH5;HCN1;KCND2;KCNB2;GNG4
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,-0.4803547608396239,-0.8238845225978791,0.6842105263157895,1.0,1.0,1/7,5.96%,DLL4
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.33573831345327465,0.8238560740990665,0.7857142857142857,0.9788468256849854,1.0,19/111,15.68%,TSPAN12;LRRC4C;FGF2;EFNA5;NEDD4;CDH2;TNIK;ABI3;PDLIM5;BMPER;ADGRB3;HECW2;VASH2;MEF2C;INF2;PHLDB2;CRB2;ZMYM4;PHIP
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.3742482453710353,-0.8238335050504884,0.7,1.0,1.0,8/58,8.45%,SELP;SELE;TIE1;RNASE1;MS4A4A;F13A1;ADGRF5;CLEC14A
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.3937005000621327,0.8237181400394245,0.7115384615384616,0.9789263191965132,1.0,6/27,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;HEXB;PRELP
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.39463187918112,0.823643584056587,0.7777777777777778,0.9788487769180958,1.0,4/25,11.46%,SASH3;CD244;HLA-E;VAMP3
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.3442056741093063,0.8236335117049944,0.7547169811320755,0.978634654543386,1.0,18/96,19.44%,IGF1;IL4;NRG1;ANGPT1;TNIK;ADRA2C;PAK5;TNFRSF10B;IRAK1;STRADA;RICTOR;PRLR;VEGFA;BORA;PRKACB;MLST8;TNFRSF10A;ABL1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4708211698911783,0.8235948447385667,0.7636363636363637,0.978470033765518,1.0,4/15,17.67%,JAGN1;CBFA2T3;PML;CDK4
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9778430406962682,1.0,1/7,18.08%,CD55
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9778430406962682,1.0,1/7,18.08%,CD55
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9778430406962682,1.0,1/7,18.08%,CD55
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.35750175774964793,0.8235103143761299,0.8253968253968254,0.9777687585128094,1.0,12/67,12.26%,SEMA5A;TENM1;HCLS1;FER;BIN1;CRACD;LMOD2;SYNPO2;CARMIL1;NCK2;FCHSD2;PROX1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.49588539383990227,-0.8234214716382575,0.6862745098039216,1.0,1.0,3/9,16.62%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.43478675537922534,0.8233864070569967,0.703125,0.9777728835485033,1.0,1/18,2.71%,CD22
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.422678044600779,-0.8232329062465749,0.6923076923076923,1.0,1.0,1/21,1.43%,GATD3
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.36818794979398106,-0.8232271753991867,0.6981132075471698,1.0,1.0,2/44,2.74%,STX16;M6PR
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.4117082375263865,-0.822994199382535,0.7333333333333333,1.0,1.0,2/31,4.09%,CD86;RNASE1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4400591446751447,-0.8228999165440458,0.6346153846153846,1.0,1.0,4/20,19.37%,ARPP19;PTPA;PPP1R1B;ENSA
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.34363853161476354,-0.8227591632338555,0.7954545454545454,1.0,1.0,7/82,11.48%,DDX11;TSPYL2;EIF2S2;MBTPS2;EIF2S3;CREB3L1;WFS1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.48058227270428877,0.8227279606059764,0.6521739130434783,0.9788565638792449,1.0,2/6,9.30%,MYO1E;MAGI2
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,-0.44602915716525093,-0.8227150473551388,0.7391304347826086,1.0,1.0,3/14,6.36%,TEK;CLDN1;PAX2
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.37701617124938236,-0.8226567988629702,0.7435897435897436,1.0,1.0,4/54,3.88%,KLRC1;SELL;ICAM3;CD200R1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5104257568106145,-0.822488364666526,0.6176470588235294,1.0,1.0,1/5,20.63%,RNF20
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.39283935252128266,0.8224012539568899,0.7647058823529411,0.9792956417121766,1.0,3/25,11.92%,LMOD3;SIX4;MEF2C
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.48193704734447873,0.8223958020772744,0.7627118644067796,0.9790760586139895,1.0,2/12,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.49905363530431374,0.8223667569611105,0.6481481481481481,0.9789087771464955,1.0,5/7,21.65%,GAB1;HSPB1;PIK3CD;VEGFA;MYO1C
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5133076446362571,-0.8223268021349938,0.6428571428571429,1.0,1.0,3/9,26.72%,TASL;GRN;ATP6AP2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.3966557437681477,0.8220708795604601,0.717391304347826,0.9792199678828747,1.0,6/42,19.95%,ST6GALNAC3;ESYT3;ESYT2;ABCA2;HEXB;ST8SIA1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.4207096832226288,0.8220526133389503,0.6885245901639344,0.9790295406778721,1.0,6/25,16.85%,PEX12;GDAP1;ABCD3;ABCD2;PEX2;ABCD4
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.44893501605179514,0.8218796584178307,0.7647058823529411,0.9791434943786078,1.0,9/14,34.15%,EXOSC4;EXOSC1;EXOSC5;DIS3;EXOSC2;SKIC3;EXOSC8;EXOSC9;EXOSC7
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.318530147606457,0.8216818542295181,0.8372093023255814,0.9792979588042214,1.0,11/106,8.33%,DRD5;SYK;CALCR;GNB4;GNG12;INSL3;RXFP2;PLCG2;GPR176;RAMP3;GNAI3
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.36107705264051126,0.8216525632603486,0.6666666666666666,0.9791366119695096,1.0,6/60,8.69%,TCIRG1;ATP6V0D2;CCL5;RELA;PLCG2;ATP6V0A4
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,-0.362641581811184,-0.8216522319556697,0.673469387755102,1.0,1.0,6/66,4.21%,CLDN4;GPR39;SERINC2;CLDN1;C6ORF132;RHBDF1
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,CellMarker_Augmented_2021__Macrophage:Eye,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,CellMarker_Augmented_2021__Macrophage:Artery,0.38634802507702126,0.8215081638858183,0.7755102040816326,0.9780283434709686,1.0,10/58,11.11%,LGALS9;SELPLG;TCIRG1;ITGAX;TLR2;SIGLEC1;TFEC;C3AR1;OSCAR;HLA-E
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.4580074955844784,-0.8212663450010594,0.7058823529411765,1.0,1.0,1/11,11.38%,AP3S2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.4580074955844784,-0.8212663450010594,0.7058823529411765,1.0,1.0,1/11,11.38%,AP3S2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3728550141132459,0.8211512194572204,0.8113207547169812,0.9784806610540079,1.0,21/66,29.13%,ANGPT1;SEPTIN4;HDAC3;DCUN1D1;PAXIP1;TANK;PRICKLE1;BIRC3;NDFIP2;UBE2D1;RIPK2;PHF23;COMMD1;SAE1;SMAD7;BCL10;TRAF6;GSK3A;CENPX;MUL1;HDAC4
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.5156999564433458,-0.8211171284795006,0.7073170731707317,1.0,1.0,4/8,29.25%,CDC7;NUGGC;DBF4B;DBF4
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.3331567273870762,0.8210570724203585,0.78,0.978522194667914,1.0,17/80,20.26%,VAPB;DOCK1;NHS;ERBIN;LMAN1;PIK3CA;PGRMC2;VRK2;VAMP3;RACGAP1;DOCK4;PKN2;ARHGAP21;VAV2;MCF2;SLITRK5;PIK3R3
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.511675910992375,0.8208999796599723,0.7391304347826086,0.9786591029960939,1.0,5/11,28.65%,HMGB1;PRKCSH;MAPK3;LGALS3;APP
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.4208832782470703,0.8208476700626941,0.76,0.9785329533190723,1.0,8/33,23.85%,KSR1;CNKSR2;RAP1A;CNKSR1;ARRB2;APBB1IP;MAPK3;JAK2
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.36189720972400347,0.8206651459584774,0.7868852459016393,0.9786640176180463,1.0,12/43,19.96%,SEMA5A;HGF;CXCL12;PDGFRA;ARHGEF16;BCAR1;DOCK4;VEGFA;RHOG;ARRB2;KIT;CX3CR1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.5303761670071683,-0.8206131999735613,0.75,1.0,1.0,1/6,16.14%,TRPV4
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.36063079173883045,0.8204895699400205,0.7647058823529411,0.9787892443720542,1.0,11/64,10.51%,PCOLCE2;COL9A1;PLOD2;COL9A2;COL6A5;COL6A2;P3H2;COL8A1;COLGALT2;COL5A3;COL7A1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.4988824646654315,0.8204254448749039,0.8113207547169812,0.9786775919470665,1.0,4/8,20.46%,NEFH;HAP1;TTC21B;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.46927660779035435,0.8203381485315479,0.723404255319149,0.9786555003574104,1.0,3/14,16.44%,PLCG2;EZH2;DYRK3
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.38457774407955947,0.8203306616463386,0.7551020408163265,0.9784428935456422,1.0,1/31,1.16%,AP1M2
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,0.5164060621616847,0.8202505946952872,0.7169811320754716,0.9783718023454588,1.0,4/7,29.51%,SYCP2;ACOX1;AGPS;HSD17B4
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.509975122216787,0.8201811953505108,0.7358490566037735,0.9782545768828426,1.0,2/6,14.30%,BMP2;LRP6
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.3262871417665118,0.8201352023321731,0.7833333333333333,0.9781258660209927,1.0,3/112,4.07%,SGO1;NDC80;NDE1
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,-0.39074299319236494,-0.8200914903407354,0.75,1.0,1.0,5/36,7.16%,CD24;LILRB3;ALOX5;HCK;ADGRG3
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.3971667273724414,0.8200547002916498,0.75,0.9780952736450075,1.0,4/28,11.83%,GNB4;GNG12;GNAI3;GNG4
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.4886161879023807,-0.8198947576303882,0.717391304347826,1.0,1.0,1/9,5.40%,PAH
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.4162331496175228,-0.8196705388846335,0.6904761904761905,1.0,1.0,5/23,17.93%,RAD50;RAD51AP1;BRCA1;EXO1;BLM
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.3934352546467734,-0.819612761676991,0.6444444444444445,1.0,1.0,12/35,19.37%,ASS1;ZNF703;MYADM;APOA1;PODXL;AKNA;TGFB1;MAPK7;ADTRP;BMP6;RGCC;GTPBP4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.46368046979819133,0.819586996234617,0.6904761904761905,0.9787365380558132,1.0,3/15,3.09%,SEMA5A;IL4;ANGPT1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.5338957810172754,-0.819529267814192,0.6938775510204082,1.0,1.0,2/6,17.13%,CFAP73;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.49762293401153784,0.8194497378582718,0.7735849056603774,0.9785569487916933,1.0,3/6,39.96%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.49762293401153784,0.8194497378582718,0.7735849056603774,0.9785569487916933,1.0,3/6,39.96%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4500719038813451,0.8194250828151725,0.75,0.9783850939156085,1.0,1/14,4.99%,PHKA1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5262828408723856,0.8193993987274951,0.7307692307692307,0.9782075559834469,1.0,2/6,7.95%,GLRA1;FGF12
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3322398042447644,0.8193875044588925,0.8571428571428571,0.9780099381371065,1.0,17/77,16.90%,SLC22A3;SLC26A7;SLC26A6;SLC35B2;CA13;SLC39A8;SLC4A7;CYB5R4;SLC25A24;CA2;ABCC11;SLC19A1;SLC52A1;SLCO1A2;SLC44A4;SLC4A1;SLCO4C1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.39095468537598377,0.8193552147342642,0.6296296296296297,0.9778296875459542,1.0,9/26,26.63%,SIGLEC1;FCHSD2;PICALM;LMBRD1;CANX;SNAP91;SGIP1;FNBP1L;INPP5F
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4593897548055206,-0.8193546266713153,0.7659574468085106,1.0,1.0,2/12,3.88%,DOCK8;CD200R1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.5064169270116359,0.8193365179737429,0.7017543859649122,0.977649519298608,1.0,1/5,17.82%,KDM6A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3610038914181184,0.8191824458218815,0.7708333333333334,0.977662271242963,1.0,3/39,5.70%,TENT5A;SYNCRIP;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.43060052492304923,0.8190858156579311,0.6181818181818182,0.9776318545561414,1.0,2/14,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.5191928670795025,-0.8190506617315645,0.675,1.0,1.0,2/7,9.42%,DSG2;CTNNA3
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.3753094480403733,0.8189394024298712,0.7659574468085106,0.9776618658935846,1.0,10/50,14.02%,PIK3R6;PIK3R5;PIP4K2A;PIK3C2B;INPP4B;PIK3CA;PTEN;MTMR9;MTMR3;PI4K2B
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.49649398723000715,-0.8189324604366883,0.7450980392156863,1.0,1.0,3/7,12.87%,HMGCL;MCCC2;BCAT2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.4269190394416985,0.8187958270076419,0.7758620689655172,0.9776947397406968,1.0,5/21,13.08%,FGFR3;FGF17;PIK3CA;SOS1;FGF5
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.4726477989593733,0.8186624295134957,0.7636363636363637,0.9777736074032353,1.0,3/11,13.39%,SMYD2;METTL18;SETD7
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.3551261877647014,-0.8185861688076879,0.6818181818181818,1.0,1.0,9/63,16.46%,UVSSA;RFC3;PRPF19;GTF2H2;POLR1A;XRCC1;RPA3;RFC2;ISY1-RAB43
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3808572960626908,-0.818407882443268,0.7115384615384616,1.0,1.0,9/59,12.99%,NTRK1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3109501661165768,0.8182749738111453,0.8571428571428571,0.9782721737681314,1.0,15/136,14.60%,CDC25A;FBXO5;NDE1;CEP70;KCNH5;PCM1;CEP152;PSMD13;DCTN3;CEP135;DYNC1I2;CNTRL;PSME4;NEDD1;CCP110
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.544345353031412,-0.8182325871673368,0.6829268292682927,1.0,1.0,1/5,1.56%,DND1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.544345353031412,-0.8182325871673368,0.6829268292682927,1.0,1.0,1/5,1.56%,DND1
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.4252688181023785,0.8182320236452192,0.8695652173913043,0.9781238088576144,1.0,3/24,3.64%,GNB4;GNG12;KCNJ3
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",0.4521776512732686,0.8182172693121531,0.7692307692307693,0.9779237870864097,1.0,1/10,4.49%,RORA
prerank,Reactome_2022__Defective CSF2RA Causes SMDP4 R-HSA-5688890,-0.5230347084278462,-0.8182061459309874,0.675,1.0,1.0,2/6,7.64%,SFTPA2;SFTPA1
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.4782594823286599,0.8181751454158215,0.7090909090909091,0.9777669504403946,1.0,4/12,21.61%,HDAC3;TBL1X;HDAC1;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.46821181308007437,-0.8180498864479903,0.6888888888888889,1.0,1.0,4/11,12.99%,RFLNB;AHSG;RFLNA;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5308559459595935,0.8180246512085626,0.8333333333333334,0.9778227335839341,1.0,2/8,11.09%,PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.3629102377071178,0.8176808774823267,0.7358490566037735,0.9781800114047035,1.0,9/78,12.51%,ZDHHC11;ZDHHC12;PEX12;GDAP1;ZDHHC22;RAB3IP;ZDHHC2;ABCD3;ABCD2
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.4249792393579125,-0.817621149944488,0.7413793103448276,1.0,1.0,4/18,18.84%,ORC6;CDK1;E2F1;SLC25A15
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.45535070727398463,-0.8176127392863509,0.78,1.0,1.0,2/12,5.96%,COL4A1;DLL4
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.3952124570818565,-0.817387295744952,0.6666666666666666,1.0,1.0,6/38,9.57%,ACOT1;CGA;ALOX5;HSD3B2;HSD3B1;ACOT2
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.3234443534956563,-0.8172623130275596,0.8333333333333334,1.0,1.0,26/150,18.09%,F5;F8;ARF3;ST8SIA2;CHST10;KDELR1;GOLGA2;PPP6R1;COPG2;TRAPPC2L;CFAP73;COPG1;FUCA1;PTGES2;BET1L;DCTN2;DCTN1;CSNK1D;SEC16A;TRAPPC6A;ARFGAP3;CTSZ;DYNC1LI2;TRAPPC4;SEC24C;SEC13
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.35783006408763934,-0.8169330336794878,0.782608695652174,1.0,1.0,11/74,7.93%,SELP;CD53;CD86;APOL3;MS4A4A;F13A1;CIITA;JCHAIN;DOCK2;ARHGAP15;TAGAP
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.4316705658431702,0.8169244621306954,0.7021276595744681,0.9793266420629506,1.0,5/15,32.10%,DCP1B;LSM2;PATL1;LSM3;DCP2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.4334263456979496,0.8168829799800352,0.8157894736842105,0.9791552772437145,1.0,9/22,21.69%,MYC;CRHBP;PPM1E;MEF2C;PDE4B;TP53;RAP2A;FBP1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.43616275479039623,0.8168286005161398,0.7894736842105263,0.97903277465362,1.0,2/16,4.31%,MAFB;PRMT1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.48832176478290734,0.816793079163562,0.6862745098039216,0.9788615547460723,1.0,6/12,25.19%,ACVR2A;MAGI2;ACVR1B;FSTL3;LEMD3;SMAD7
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,-0.3499530515126515,-0.816570622057616,0.7704918032786885,1.0,1.0,11/82,8.00%,NTRK1;CALB2;ALOX5;TMOD1;TSPYL2;BEX1;ADCYAP1;BTK;EGR1;CLU;ADIRF
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,0.37243123048446386,0.8165217772790466,0.74,0.9789122235329129,1.0,5/47,5.64%,ITGAX;CSF3R;SASH3;PIK3R5;FGL2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,0.37243123048446386,0.8165217772790466,0.74,0.9789122235329129,1.0,5/47,5.64%,ITGAX;CSF3R;SASH3;PIK3R5;FGL2
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.34006504209256266,0.8163812376474401,0.7884615384615384,0.979007783296648,1.0,5/82,7.04%,TUBA1C;GNB4;GNG12;FBXL3;HDAC3
prerank,KEGG_2021_Human__cAMP signaling pathway,0.3161413286935532,0.8161453346685615,0.8409090909090909,0.9792695505207057,1.0,40/177,20.67%,DRD5;CHRM2;RAPGEF3;F2R;GRIN3A;HTR1F;RRAS;NPY;RELA;CNGA1;PPP1CC;GNAI3;PIK3CA;GRIN3B;NPPA;ATP1A2;PDE4B;MAPK8;CREB3L2;RAP1A;GRIN2D;NPY1R;CREB1;ADORA1;ADRB1;RYR2;PIK3CD;MAPK10;RRAS2;VAV2;SSTR1;HTR1E;AFDN;PRKACB;AKT3;ACOX1;PIK3R3;BAD;EDN1;ATP1B2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.4954598534349543,0.8161010704243892,0.7358490566037735,0.9791156658937258,1.0,2/7,20.82%,DCP1B;ZFP36
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.37507760409613833,0.8158295984009417,0.78,0.9794603772515046,1.0,10/62,20.95%,SEM1;BMP2;ESR1;PSMD13;PSME4;PSMA1;SMURF1;NR3C1;HIVEP3;PSMD4
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.36863582428927705,-0.8158157250244717,0.75,1.0,1.0,7/69,5.17%,SELP;SELE;TEK;TIE1;MGP;RNASE1;MS4A4A
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.5356351972996268,-0.8157371724608795,0.6363636363636364,1.0,1.0,1/5,6.54%,SLC13A3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4067016707339399,0.8153399221834573,0.7241379310344828,0.9801458003916812,1.0,8/26,16.07%,SYK;BLNK;PLCG2;MEF2C;BCAR1;ITK;SH2B2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.5319980489023026,0.8153396207377216,0.7090909090909091,0.9799230905983635,1.0,1/6,7.29%,IL15
prerank,CellMarker_Augmented_2021__Macrophage:Lung,0.4651774810790737,0.8152917331189414,0.7111111111111111,0.9797921024545239,1.0,1/11,1.66%,ITGAX
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3518734919362155,0.8151825121215657,0.7547169811320755,0.9797756733790598,1.0,12/60,21.36%,SEC22B;ITGAV;PSMD13;TAP1;HLA-E;VAMP3;PSME4;PSMA1;HLA-F;IKBKB;PSMD4;HLA-B
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.49644027295279025,0.8151115041065785,0.6862745098039216,0.97966481106942,1.0,1/7,8.58%,LIN7A
prerank,Reactome_2022__S Phase R-HSA-69242,0.3240703280538025,0.8149972642494846,0.851063829787234,0.9796770302459377,1.0,25/144,20.95%,MYC;CDC25A;CCNA2;SEM1;GMNN;MCM7;ANAPC16;PSMD13;GINS1;E2F4;POLE2;PSME4;SLC19A1;ESCO1;CCNH;ORC4;PSMA1;MNAT1;CDK4;SMC3;AKT3;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3871430981222195,0.8149278916660204,0.82,0.9795834038890937,1.0,8/43,12.35%,MAPKAPK2;TIFA;TLR2;PLCG2;HMGB1;TAB2;MAPKAPK3;IRAK1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.3944789690614005,0.8148958073771218,0.7272727272727273,0.979412602962592,1.0,6/28,16.94%,CWH43;PIGQ;PIGF;GPAA1;PIGP;PGAP4
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.41887189210730363,0.8147863389153237,0.66,0.979401997100594,1.0,4/24,7.89%,SYT15;SYT6;SYT1;SNCA
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.3166663262888251,0.8147682797703703,0.9423076923076923,0.9792170218280775,1.0,28/179,16.86%,STK26;REXO2;SEM1;CDKN2A;DCC;DAPK2;SEPTIN4;PELI1;TICAM1;HMGB1;GAS2;CHMP6;PSMD13;GSN;TNFRSF10B;TP53BP2;MAPK8;FASN;MAGED1;TANK;PSME4;PPP3CC;LMNB1;PSMA1;PKN2;CTNNB1;BIRC3;FADD
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.3959871476202516,0.8147367421595001,0.7142857142857143,0.979049278118103,1.0,5/27,12.35%,NLGN1;NRXN1;NLGN4X;RIMS2;PTEN
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.554889487370867,0.8147128636118095,0.7758620689655172,0.9788616093814024,1.0,4/5,35.74%,CDK6;EIF2B5;NF1;MT3
prerank,Reactome_2022__Translation R-HSA-72766,-0.3108281130825833,-0.8146679938198592,0.9166666666666666,1.0,1.0,54/259,25.45%,NARS1;WARS1;EIF2S2;MRPS25;EIF2S3;RPS27L;SARS1;RPN1;EIF3J;MRPL21;DARS2;SARS2;CARS1;MRPL45;RPL38;MRPL23;DTD1;SRP68;PPA1;RPL12;MRPS21;EIF4EBP1;GARS1;MRPS22;RPL37A;MRPL40;RPS8;EIF2B1;RPS27;RPL4;EIF4H;EIF3L;SRPRA;MRPS18C;MRPL16;RPL5;MRPS23;AARS2;MRPL9;SRP14;RPL26L1;RARS1;TARS2;EIF2B2;MRPS35;MRPL19;RPS20;WARS2;MTFMT;EIF2B4;RPL22;RPL34;RPL31;RPL37
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.4499949732922204,-0.8146663687941416,0.6590909090909091,1.0,1.0,4/18,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.47545599541713085,-0.8144092977613174,0.7169811320754716,1.0,1.0,2/10,13.93%,GPC1;CD9
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.42820977671287186,-0.8143098426205672,0.7021276595744681,1.0,1.0,5/29,14.25%,ASS1;CLU;SMAD3;CAV1;RAC1
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.4070005769383455,-0.8143080947064801,0.7843137254901961,1.0,1.0,2/26,3.69%,NLRP3;F7
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.341383623606739,0.8141758205168887,0.8301886792452831,0.979611006934817,1.0,19/112,16.79%,CDKN2C;CCL5;SIRT1;IL4;HIF1A;CDKN2A;FER;MCM7;DSCAM;GRM5;CORO1C;GCK;PLXNB2;HSPB1;PML;ROPN1B;PHIP;BTBD10;RANBP2
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.37763086456302425,-0.8141053451267276,0.7391304347826086,1.0,1.0,8/37,18.27%,PRKCD;CAMK2A;CAMKK2;CAMKK1;ITPR3;CALM1;ADCY1;PDE1C
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.4725280471086163,0.8140608216758792,0.7017543859649122,0.9796146481440989,1.0,2/7,0.87%,LGALS9;KLRD1
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.35929798796020274,0.8140525041339154,0.7708333333333334,0.9793984253149065,1.0,20/84,22.40%,RAB38;RAB27A;RIN2;RAB31;RAB39A;RAB3IP;DENND1B;GDI2;RAB9A;DENND5B;RAB27B;DENND4C;TRAPPC8;TRAPPC1;AKT3;RAB5B;TRAPPC2;DENND4A;AKT2;DENND6A
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3496674612576568,-0.8136683442074693,0.8297872340425532,1.0,1.0,12/91,9.02%,TRIM56;APOBEC3H;NLRP1;RNASE1;APOBEC3G;IFI27;TRIM5;IFIT1B;IFIT2;OAS3;OAS1;IFIT3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5091048972117154,-0.8136112907146595,0.7254901960784313,1.0,1.0,1/7,7.82%,OAS3
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,-0.3551967151309211,-0.8135831229950273,0.7954545454545454,1.0,1.0,13/76,10.85%,NPAS4;HCRTR2;RGS8;KIRREL2;ST8SIA2;DRD2;ADCYAP1;SEMA5B;TTBK1;CACNG5;PCDH8;CELF3;LRRTM1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.5620536159444611,-0.8134696816245536,0.7307692307692307,1.0,1.0,3/7,11.69%,IL18BP;HLA-DRB1;IL18
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.34788217606374744,0.8134569797494259,0.8085106382978723,0.9802071409503904,1.0,14/94,17.85%,PRR16;EIF3E;SAMD4A;HDAC2;PLA2G10;HNRNPD;PLXNB2;NR1H3;ASPH;BCL3;FADD;CSF1;PERP;FMR1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4467391795749791,0.8132823582778913,0.7068965517241379,0.9803219531297998,1.0,6/17,29.24%,PLA2G10;PNPLA8;PLA2G15;SLC27A1;LPGAT1;CDS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.46796246319000534,0.8132287740722047,0.7674418604651163,0.9802055865978794,1.0,4/20,10.28%,GSTM2;STAC2;ANK2;HAP1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.34966262189336006,0.8132286319824437,0.8148148148148148,0.979983720236042,1.0,13/65,22.18%,NXF1;U2AF1;THOC6;NXF5;SRSF11;HNRNPA2B1;FMR1;RBFOX1;PNPT1;NCBP1;ZFP36;NUP153;SRSF3
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.5340677724129586,-0.8130582061601315,0.7090909090909091,1.0,1.0,3/5,41.79%,LYPLA2;ABHD2;ABHD12
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.3954343968698871,-0.8127350042132346,0.7446808510638298,1.0,1.0,6/28,19.84%,CLDN1;F11R;MFSD2A;CLDN5;SLC1A1;LSR
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.49906930337358263,0.8124837263717272,0.7049180327868853,0.9810083328812341,1.0,1/9,0.09%,GATA4
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,0.3474607913607601,0.8124613535476339,0.78,0.9808034941724975,1.0,14/78,12.14%,AP1M2;TMPRSS2;LPIN3;WNT4;LRIG3;AGR2;DSP;BCAM;MAGI1;TSPAN6;CGN;ARHGEF16;HSD11B2;BCAR1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.466676457303292,0.8123749931797634,0.66,0.9807840523830764,1.0,3/6,36.66%,ACE;N4BP2L2;EIF2AK2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.5111406405270102,0.812341355703438,0.7058823529411765,0.9806591623580022,1.0,2/6,18.76%,GABRB2;GABRB1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3072788534104677,0.8122271090499043,0.86,0.9806397619919123,1.0,9/123,8.32%,STAB1;SCGB3A2;SYK;NEDD4;LDLR;LRP1B;RAB31;SNCA;RAMP3
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.4395117326214655,-0.8122137465089234,0.723404255319149,1.0,1.0,5/19,17.26%,NEMP1;TMEM43;DCTN1;EMD;AKAP8L
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.3939423179003839,0.8122067877620004,0.68,0.9804522852103885,1.0,1/22,1.76%,TUBA1C
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.32877677941016864,-0.8121342005309495,0.8163265306122449,1.0,1.0,23/146,12.91%,TEK;GPR39;CGA;HRH2;NLRP3;PTGDR;MEFV;ALOX5;PRKCD;CD200R1;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R;CCN3;APOA1;TYRO3;FFAR4;MYH9;CRH
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.4552299714057147,0.8120157511271352,0.6923076923076923,0.9805725049889423,1.0,1/14,1.44%,RUNX1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.3455995668035271,-0.812004878009574,0.8823529411764706,1.0,1.0,20/89,19.80%,KIF2B;CTSO;HLA-DRB1;KIF15;CLTA;KIF26A;DNM1;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA;CTSB;HLA-DPA1
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.31003246112904204,0.8119928191774687,0.86,0.9803794328912138,1.0,17/219,8.33%,VEGFC;IGF1;FERMT3;SYK;RAPGEF3;F2R;LHFPL2;PIK3R6;GNB4;GNG12;PIK3R5;MANF;ANXA5;PLCG2;TF;ADRA2C;GNAI3
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.5203646611011605,0.8118936205169496,0.6909090909090909,0.9803629602122654,1.0,2/5,17.76%,VEGFA;PTPN23
prerank,KEGG_2021_Human__Adherens junction,0.35763453385002075,0.8118503849317014,0.7543859649122807,0.980209871233234,1.0,14/68,18.43%,TGFBR1;FGFR1;SNAI1;FER;NECTIN2;CTNNA2;SMAD4;SSX2IP;IGF1R;PTPRM;CTNNB1;WASL;FARP2;AFDN
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3747169466512698,0.8117507211633685,0.7659574468085106,0.9801336848866602,1.0,8/39,11.48%,NEDD4;RNF152;PELI1;UBE2E2;PELI3;UBE2E3;MAGEL2;RNF5
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.46075101278761593,0.8116530570303683,0.7115384615384616,0.9801115887508162,1.0,5/18,13.40%,LMOD3;MAGEL2;WASHC1;LMOD2;SPIRE2
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,0.5469138867503331,0.8116513872286073,0.7090909090909091,0.9798960833324767,1.0,1/5,5.57%,RELA
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.4824775456082275,0.8115817522115606,0.6666666666666666,0.9797745192120381,1.0,1/9,0.47%,NOX5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.36696419323284357,-0.8115787423852524,0.8837209302325582,1.0,1.0,2/62,3.60%,DND1;WTIP
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.47034935604038536,0.8115726306397736,0.8,0.9795677164105514,1.0,3/11,9.73%,NRXN1;GCH1;UBA5
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,0.3914101363701087,0.8114942917338545,0.631578947368421,0.9794747059427078,1.0,3/29,11.08%,ST6GALNAC3;GALNT1;PRKCSH
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.5271001882867715,0.8114643541086816,0.7592592592592593,0.9792936405209889,1.0,3/6,28.68%,TENM4;PTPRZ1;TNFRSF1B
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5142948008210836,-0.811390783507628,0.7254901960784313,1.0,1.0,3/6,26.50%,AQP1;RHBG;RHCE
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.449773002204458,-0.8113286818310127,0.7441860465116279,1.0,1.0,4/16,15.90%,ALOX5;CYP4F2;ALOX15;LTC4S
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.4467408345440097,0.8113039591440955,0.74,0.9793371111214385,1.0,4/11,19.66%,HMGB1;LIG4;RAG2;RAG1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.44345518139866774,0.8112940317403351,0.7454545454545455,0.9791305933366966,1.0,6/18,20.73%,SYT1;RIMS2;SMURF1;SYT3;CPNE9;SYT17
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.4007083077190899,-0.8112714205077285,0.6888888888888889,1.0,1.0,6/30,14.55%,TERF2IP;CHTF18;RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.4659757003458424,0.8112593266647818,0.8166666666666667,0.9789696072500793,1.0,3/10,22.12%,WASHC2A;MICALL1;WASHC2C
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.3778365895978441,-0.8112462027117052,0.78,1.0,1.0,9/62,8.48%,P2RY10;TRAF3IP3;CD53;CYTH4;CD86;DOCK2;ARHGAP15;TAGAP;PTPN7
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3527500538602783,-0.8112062635966703,0.8222222222222222,1.0,1.0,15/78,20.35%,TRIM56;DDX41;IRF5;POLR3H;POLR3E;DHX58;NFKB2;CGAS;POLR1C;TRAF3IP1;POLR3A;IRF1;NLRP4;NLRX1;POLR3F
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3633646001214255,0.8111580211970292,0.7391304347826086,0.9789307825047724,1.0,7/38,14.68%,BMI1;DUX4;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.33736543407099673,0.8108762484658291,0.7857142857142857,0.9793546727767412,1.0,6/104,5.67%,VEGFC;IGF1;FERMT3;LHFPL2;MANF;ANXA5
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.3163751051671216,0.8108088093172768,0.8653846153846154,0.9792732088698264,1.0,18/173,14.84%,SGO1;NDC80;NDE1;CEP70;PCM1;PPP1CC;CEP152;CENPO;DCTN3;CEP135;DYNC1I2;CNTRL;XPO1;NEDD1;RAB33B;CCP110;NEK7;CENPP
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5596430682166763,0.8107156916424727,0.75,0.9792059684271249,1.0,4/6,25.05%,NLGN1;GPHN;LHFPL4;APOE
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4244235149579193,-0.8106267732606987,0.7307692307692307,1.0,1.0,1/29,0.73%,AMACR
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.5360311389222266,-0.8105858124786635,0.6666666666666666,1.0,1.0,3/5,26.08%,RFPL1;RNF34;RFFL
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.28508559135075484,-0.8105436254423934,1.0,1.0,1.0,52/579,13.27%,TRIP10;ETV5;FRMD6;PRDM1;COL4A2;ZNF296;PXDN;COL4A1;ETV4;PABIR3;STK10;ASS1;TEC;SLC6A6;IL6R;ENC1;NR2C2AP;VSIG10;SCPEP1;PCED1B;TPP1;SLC7A3;F11R;PPP1CA;EIF2S3;RBM3;ENO2;CALD1;CDH3;CAPN5;SNX8;ZNF208;SLC38A7;GLDC;DOCK6;SUMF1;TMSB4X;SARS2;MYADM;WDR54;INA;VAT1;PODXL;GPATCH2;TXN;NDUFS5;CTPS1;RPL38;TMEM51;EMG1;ZNF486;TUBB
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.40839581119882934,0.8105413757379248,0.7948717948717948,0.9792181863688765,1.0,3/26,5.88%,LGALS9;HIF1A;TLR2
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.3985599929147712,0.8101695644028442,0.7073170731707317,0.9796841716308793,1.0,3/25,10.80%,CWH43;PIGQ;PIGF
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.331037442616397,-0.8100081207452876,0.8928571428571429,1.0,1.0,5/115,6.72%,GOLGA8B;STX16;PLK3;GOLGA2;GOLGA8A
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.3645471453193281,0.8098297239798489,0.8113207547169812,0.9800790611737303,1.0,13/54,21.00%,MYC;KAT2B;RBPJ;HDAC3;HDAC2;TBL1X;MIB1;HEY2;ADAM10;HDAC9;JAG1;HDAC1;CDK8
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.3359522133380763,-0.8097247214717178,0.725,1.0,1.0,10/112,7.30%,INSRR;CTNNA1;ASS1;EPAS1;AGRN;RHBDF1;GPC1;NFE2L1;MYO5B;TSPAN15
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3404260558304764,0.8096997317337362,0.7674418604651163,0.980068396059493,1.0,18/111,11.28%,ADRA1A;F2;F2R;SLC35G1;CALCR;TRPC4;SCGN;SLC8A1;PTGFR;GPR33;ESR1;PDGFRA;HMGB1;ABL2;TAC1;C5AR2;C3AR1;ATP1A2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.41917375149409375,-0.8094411357422554,0.6938775510204082,1.0,1.0,3/19,9.75%,WTIP;NRDE2;MOV10L1
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.4510970132682769,0.8093138448100387,0.7543859649122807,0.9805253732743612,1.0,6/18,14.99%,ACD;H2BC21;H2AC6;TERF1;H2AZ2;H2AX
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,0.35673802597573984,0.8092372050317765,0.8269230769230769,0.9804211061359933,1.0,14/78,11.21%,AP1M2;FGFR3;TMPRSS2;CKMT1A;VWA2;GNG12;LRIG3;AGR2;DSP;BCAM;MAGI1;TSPAN6;CGN;ARHGEF16
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.50853776651171,0.8090629374504021,0.7551020408163265,0.9805576817573554,1.0,3/7,21.09%,SGSM3;DENND4C;DENND4A
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.36193712610910833,0.8090348382408987,0.75,0.9803684865345981,1.0,2/54,7.26%,RPP25;RPP40
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.4058423971552203,0.8089971497456477,0.7090909090909091,0.9802218506223572,1.0,5/24,13.31%,HSD17B2;STARD4;FDX1;HSD11B2;FDXR
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3482767911584553,0.8088518723485797,0.8333333333333334,0.9802819424044236,1.0,12/62,20.83%,TGFBR1;DYRK2;GALNT3;GALNT1;MAPK8;ACVR1B;DYRK1A;HIPK1;DYRK3;GALNT16;WNK1;HIPK3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5152357115782857,-0.8085083020012094,0.6590909090909091,1.0,1.0,1/5,2.82%,COL4A1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.41256081814322254,0.8083182445020134,0.7358490566037735,0.981058085263883,1.0,4/21,5.63%,GPR55;F2R;GPR174;GPR17
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5158963670491157,0.808313855203824,0.7833333333333333,0.9808547990391416,1.0,1/6,11.97%,BNIP3L
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.551827486034249,-0.808245480174075,0.7435897435897436,1.0,1.0,2/5,18.56%,HLA-DRB1;HLA-DMA
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.3155834856397332,0.8081584445014676,0.8666666666666667,0.980897733814692,1.0,27/146,17.33%,DERL3;SLC26A3;SLC12A1;SLC1A3;SEM1;SLC12A3;RNF185;ABCC2;ABCA1;SLC7A9;ABCG8;PSMD13;MAP4K2;RNF5;SLC26A4;PSME4;SLC22A5;ABCG5;SLC35C1;DERL2;SLC9A9;SLC4A1;PSMA1;RANBP2;ABCD4;SLC3A2;SLC34A2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.4956708740148449,-0.8080329688695216,0.6888888888888889,1.0,1.0,1/10,3.22%,TICRR
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,0.4777087733982312,0.8078473564265395,0.7413793103448276,0.9812574348863389,1.0,4/10,13.08%,FGFR3;GALNT3;FGF17;FGF5
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,0.2501546171479384,0.8076940916066467,1.0,0.9813228825214257,1.0,668/4122,19.64%,TNFSF14;STK26;GPR55;SELPLG;CTDNEP1;CFH;CCL3L3;THEMIS;TMEM171;CCNG1;MAP3K11;KLRD1;SIPA1;TNFRSF18;CDC14A;TCIRG1;FERMT3;UHRF2;HELB;CD99;EMB;PPP1R18;GPRIN3;MYC;CCL5;MMP23B;IL26;SAMD9;FAIM;SHMT2;ASNSD1;NXF1;ANKRD36B;NXPH4;CDK11A;URI1;INSIG1;SOCS2;ZBTB1;ACD;OSTC;U2AF1;RAB27A;CCDC102A;KAT2B;PYHIN1;LY9;SASH3;ZDHHC12;EHD1;AK3;UTRN;SLC10A3;LLPH;MED17;ADD3;TOX;MDFIC;ZNF493;CBLB;ENPP1;HNRNPH1;CDKN2A;CDKN2AIP;PRR5L;TRPV2;HMG20B;MLC1;SAMSN1;PRDX6;ADIPOR2;TCAF2;SF3B1;FHIT;MLLT3;IL2RA;COX19;ISOC1;MRPL28;LMOD3;PCDH9;CD244;PRMT1;EIF3E;SYNCRIP;FLI1;ZFP36L2;RORA;STOM;TNIK;UBE2J1;PTAR1;ABHD17B;IL7R;NAALADL1;ZBTB20;LAPTM4A;IRF8;HCLS1;GPSM3;XAF1;MCTP2;MANF;MOB1A;JAGN1;ABHD3;ODC1;ABI3;IVNS1ABP;SNRPN;RALGPS2;SMYD2;DHRS3;METAP1D;RELA;RALA;SDC4;ZBTB44;SYPL1;PIP4K2A;RBMS1;TIFA;KCNQ5;TET2;POSTN;CDCA4;DNAJB2;COQ10A;NFKBIZ;TSC22D3;ALG6;FDFT1;TOR1B;ASF1A;PLAC8;SMDT1;PCM1;BBX;MYL12A;RPIA;MGAT2;PPP1R15B;PLCG2;ZNF706;TICAM1;TSR3;FBXL3;PIGQ;ANKRD36;ST8SIA4;HDAC3;WDSUB1;SLC39A8;NEO1;BANP;PHF3;PUS7L;UAP1;RFXAP;DCXR;PECR;STAMBPL1;LINGO2;RGS9;TRA2A;DPP4;PPP1CC;GALNT3;MRPS12;ELOVL5;CNPPD1;PAPOLA;UBE2D3;TSSC4;HMGB1;SPON1;PPM1A;ZNF274;INPP1;ARL5A;DCUN1D1;AGGF1;PWWP2A;INO80E;CCDC88B;GYPC;CORO7;RYBP;TPGS1;ADA;SLX4IP;NUDT16L1;SMG1;RNF139;PDE7A;FDX1;SCD5;NXT1;GNAI3;CMTR2;CRYZ;SPOP;HMGCS1;CCDC50;GAN;RESF1;YAF2;GCH1;CYB5B;MAGT1;ZNF195;ZC3HAV1;ACADM;GPBP1L1;MTSS1;KLF6;AUP1;TELO2;ACAA2;CHMP6;SHOC2;MPC1;ATG101;TMEM263;ABHD15;ANKRD13A;UBE2E3;DENND1B;AMZ2;INO80D;ARID2;TAF3;GXYLT1;DUSP18;ZCCHC7;RAP1GDS1;C1GALT1;RRS1;TMIGD2;AUTS2;KLHL6;NUDT4;SIKE1;KEAP1;ANAPC16;MAPKAPK3;EPB41;GTPBP6;RO60;KLRG1;TRIM65;HIP1;UBA5;CA2;SMAD2;PSMD13;GMPS;LNPEP;IGFBP6;EFR3A;LRWD1;TMC6;MRPL54;EXT1;GSN;BIN1;GDI2;NSRP1;FASTK;PRPF39;TAP1;OXR1;IL23R;EZH2;FBXO7;NFKBID;EIF1AY;NT5DC1;CMC1;SMN2;FAM43A;AKTIP;LZTFL1;BCL11B;RPS5;SMAP1;E2F4;ARHGAP25;MPLKIP;FUT8;CASP10;COMMD2;PTPRK;PTP4A2;DCTN3;CNOT6L;GPATCH8;ETHE1;GPR108;CAMKMT;NR1D2;CCDC97;PRKCSH;HLA-E;HP1BP3;ZNF292;CPNE1;PGRMC2;C4ORF33;TRIM26;HNRNPD;ZFAND6;RNFT1;PUF60;SP3;DNAJC1;FANCL;RNF5;HPS3;CEP135;SHPRH;SLTM;APOL6;PXN;LRRC45;DYNC1I2;ARL14EP;B3GLCT;DMTF1;MRPL44;ZNF207;CNOT4;REV3L;KIAA0586;MVD;YIPF5;PPP1R9A;PDE4B;C6ORF62;RBBP6;ARIH1;CNTRL;ARID1A;ZNF638;MAPK8;BAG2;ACBD3;PRPF38B;KCNIP4;CDC5L;PTEN;CDK2AP2;ZNF800;TIPARP;CTBP2;BAALC;CDK12;SMC5;PPP3CA;ERMP1;FARS2;INTS6;UBA6;TIAL1;SOAT2;NT5C3A;ATF7IP;PGM1;NR4A2;DNAJC3;ITK;ANP32A;FAM222A;MAN1A2;MTMR9;IL18R1;FAM89B;RAB9A;ZBTB10;TERF1;DCAF5;TANK;HSPA8;RABL2B;CPNE3;H2AZ2;SAMD12;HECA;NOC2L;RPL21;MXD4;PSME4;SPIRE2;UBE2J2;IRAG2;LYPLA1;TASOR2;PPP3CC;PNPLA6;RAP1A;PHLDA1;FKRP;PACS1;UBA3;TSPAN17;NEDD1;RSRP1;TXNDC11;CCND3;SMARCAD1;ESCO1;TPST2;KLHL24;PSMG2;CD74;HSD17B10;PCMTD1;RNF166;LSM8;DVL2;PML;PI4K2B;DUSP2;CREB1;ZNF639;RBM5;CD83;DNAJC15;SGSM3;SERTAD1;RPS6KA1;C12ORF75;SMARCD2;ZNF263;CCNH;EIF3H;NFATC3;TRABD;IKBKE;CSNK1G3;CHD9;ANKH;OLAH;BOP1;B3GALNT2;DERL2;LMNB1;EPC1;KAT6A;ARHGEF6;NEK7;CERS5;ZC3H13;RPGR;AIP;BAMBI;PLSCR1;RICTOR;PHLDB2;GABPB1;RMND5A;ETV3;H2AX;RGS14;MGAT4A;GFUS;SDF2L1;GJB6;IL21R;OLFML3;H1-10;PLCB1;PITPNM1;COX6A1;SC5D;ORC4;CNNM2;SEC61A1;ETNK1;ELL2;RCE1;PRKAA1;GGA1;CLDND1;NFE2L2;ZFAND1;GPAA1;ANP32B;S100PBP;PIGP;PIK3CD;LGALS1;TBC1D5;RAB29;CCDC152;BTBD10;BAP1;KPTN;PNPLA8;LEPROTL1;PSMA1;PEX2;EEF1D;NHLRC3;DNAJB9;DENND4C;CYP2R1;SRSF11;IMMP1L;HNRNPA2B1;RPL18A;UBR5;MYDGF;KPNA4;GLCCI1;BCL3;VTI1A;CD247;CNOT2;KTN1;OLA1;TMEM243;TRPM7;MAP3K8;UBAP1;SMARCA2;GLRX;BIRC3;RPS6KA5;ACAD8;NELFB;SLC3A2;SLCO4C1;FOXN3;DGKZ;RCC1;POLR1H;AGMAT;RORC;MNAT1;CD2AP;PLCD1;CHD1;STX8;GORASP2;TECR;SIRT7;TIGIT;ZNF276;ZNF786;CCDC146;RPL7;SAMD3;GPHN;G3BP1;SIMC1;TCP11L2;GTF2B;RIOK1;FKBP8;NUFIP1;RRAS2;STXBP5;VCPKMT;PERP;ZMYND8;USP38;TMEM204;AKR1C3;RCN1;NDUFB11;MACF1;RHOG;ARMC5;LENG1;ZMYM2;SUPT3H;TP53;TMX1;KDM6A;MAZ;ZNF784;SOCS7;CD81;STXBP3;TLE4;ZBED5;MAF1;MFF;AGO3;TMEM218;TSC22D2;RPS3A;CD55;MED30;MICALL1;TMED1;RIOK3;PRRC2C;SUN2;PSPC1;JMY;IRS2;MPST;FAAP20;C9ORF85;MOB2;RPE;TMED3;RASA2;IER5;TIMM10;ARRB2;IL2RB;H3-3A;TOR1AIP2;SMC3;NSD1;ZAP70;FUS;RBM10;ARAP2;CASP3;TBCA;IMPA1;ADAM10;NSMCE2;STX17;KIT;GNPNAT1;IP6K1;EXOSC1;DDX3Y;PHTF1;DNAJB1;BRWD1;PRKACB;NBEAL1;RSAD1;SLC25A12;TFG;GNPDA2;RBM17;TNFRSF10A;BRAT1;DTYMK;BANF1;SLC35E2B;NR3C1;STX5;IRF3;CHCHD7;ANXA2;TRAPPC1;JAG1;FAM20B;POLR2H;MRPS9;EWSR1;CUTA;FAM169A;UNC13C;PRRT3;PPA2;GCC2;PPP1R10;WNK1;PAIP2B
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4014034749898382,-0.8075567041510737,0.7,1.0,1.0,8/22,28.53%,RFC3;RPA3;RFC2;RFC1;POLDIP2;RPA2;RPA1;UBB
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.32630552674354923,-0.8075517662765324,0.8775510204081632,1.0,1.0,5/83,7.74%,ARAP3;NOXA1;DSG2;ARHGAP15;ARHGDIB
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.4023111579153685,-0.807513978721837,0.7045454545454546,1.0,1.0,4/26,14.15%,CRYBA4;POLR1A;DEDD2;RPA3
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.5255549002672903,-0.8075050454287535,0.717391304347826,1.0,1.0,2/5,16.33%,HTR2B;HTR1D
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.3637755216154406,0.807489365423145,0.7254901960784313,0.9814646344826514,1.0,15/38,20.18%,C3;IL4;ANGPT1;BICD1;TF;MAGI2;HIP1;GREM1;TBC1D5;VEGFA;WASL;FMR1;ARRB2;ANXA2;DGKD
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.39891060024204517,-0.8074675857421036,0.7115384615384616,1.0,1.0,3/33,2.68%,CLDN4;DUOX1;CLDN1
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.3615642640898815,-0.8074263705252787,0.8235294117647058,1.0,1.0,11/66,7.93%,SELP;GAB3;DOCK8;CD53;CYTH4;MS4A4A;F13A1;HCK;ARHGAP15;ARHGDIB;TAGAP
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.4006945324877049,-0.8073855758396468,0.7454545454545455,1.0,1.0,6/32,21.52%,DGAT2L6;DGAT1;CAV1;CAV3;DGKA;GK5
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,-0.43165833092984796,-0.8073840321256953,0.76,1.0,1.0,3/18,11.12%,MGP;GPC3;PLAC9
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.41883953419110526,0.8071728554888473,0.7758620689655172,0.981773088699694,1.0,2/18,6.41%,FGFR1;ITGAV
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.4889730245857041,0.8071294951264398,0.7,0.9816320855679765,1.0,1/7,5.56%,METAP1D
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,0.4920321143585023,0.8068450682987818,0.7358490566037735,0.9819290628695972,1.0,5/8,26.72%,CD34;ANPEP;PTPRC;ITGAM;NT5E
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.37088842347949785,0.8067572119733748,0.6909090909090909,0.9818558793239747,1.0,4/28,16.17%,SIRT1;ZC3HAV1;TIPARP;SIRT6
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.347300925029227,0.8067209696345099,0.7317073170731707,0.9816923603729466,1.0,11/69,12.35%,IRGM;CCL5;RELA;TICAM1;NLRP7;HMGB1;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5101794388961829,0.806617651030624,0.8181818181818182,0.9816813768610518,1.0,5/8,39.72%,ALDH6A1;DPYSL5;DPYSL3;DPYS;DPYD
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.45469210815805083,-0.8065962871802408,0.6808510638297872,1.0,1.0,1/13,1.71%,RAC2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.36520357864538516,0.8063815877263398,0.8235294117647058,0.9819442041781193,1.0,1/26,1.11%,CDC14A
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,0.47563413364973167,0.8058677184391814,0.6538461538461539,0.9826104754207791,1.0,7/9,39.03%,GGCT;CHAC1;GGT5;CHAC2;PRNP;CNDP2;GCLC
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,0.40919087250238506,0.8058275234383832,0.6785714285714286,0.9824695057869798,1.0,4/19,7.69%,ITGAX;TLR2;SIGLEC1;CD40
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.48907666698809843,0.8058243972028982,0.8125,0.9822580781044252,1.0,2/8,9.99%,BMP2;BIN1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.5248491785822245,0.8057302203226204,0.7884615384615384,0.9821792951382377,1.0,2/7,24.14%,AGO3;DHX9
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,-0.3877290535883654,-0.8056178528632179,0.813953488372093,1.0,1.0,7/38,8.08%,ICAM3;PRKCD;PRAM1;ASGR2;HCK;ADGRG3;KCNQ1
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,-0.4159033103035639,-0.8055627986762983,0.717391304347826,1.0,1.0,1/16,2.15%,FGF1
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.30430470316005237,0.8055622046344293,0.8409090909090909,0.9822358874490205,1.0,42/166,22.07%,AP1M2;GNB4;GNG12;WEE2;RELA;TLR2;MAP2K6;PLCG2;GNAI3;STING1;TAB2;PIK3CA;CCNB3;TAP1;PAK5;HLA-E;PXN;GNG4;MAPK8;IRAK1;PPP3CA;PPP3CC;NFATC3;PIK3CD;MAPK10;LIMK2;CD247;FADD;CASP3;IRF3;AKT3;HLA-F;PIK3R3;BAD;IKBKB;MAPK3;CDC25C;HLA-B;GNAQ;CRK;GNAI1;AKT2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.3216889520786218,-0.8055045072392542,0.8125,1.0,1.0,6/111,6.30%,TERT;EPAS1;PLK3;ANGPT4;SFRP1;PSMB4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.30466578175272724,0.8054088594526362,0.9375,0.9822980923510506,1.0,22/131,15.27%,CTDNEP1;DUSP29;PPP1R15B;PPP4R1;PPP1CC;PPM1A;PTPRD;PTPN14;DUSP18;PTPRT;PPM1L;PTPRK;PPM1E;EYA2;PTEN;PPP3CA;PPP3CC;PTPRM;MTMR3;DUSP2;PTPRU;PPP2R2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4917521295658616,0.805160198666341,0.6785714285714286,0.9825209138391089,1.0,4/8,25.10%,PTPRT;BCL3;ADIPOR1;HGS
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.5209427437945502,0.8049976586860347,0.7692307692307693,0.9826112041344429,1.0,2/5,19.34%,PTEN;DEPTOR
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.3277956969170164,0.8049259002256677,0.8269230769230769,0.9825183449699049,1.0,24/98,21.16%,SYK;RELA;PLCG2;FER;TAB2;PIK3CA;PSMD13;MAPK8;PPP3CA;SOS1;ITK;PSME4;NFATC3;MAP3K1;GAB2;TAB3;MAPK10;PSMA1;VAV2;KIT;LYN;IKBKB;PSMD4;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.44785570491784943,0.8047270591686517,0.7592592592592593,0.9826114119196128,1.0,3/14,8.62%,FGF2;BMPER;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3414496479703882,0.8046189975737418,0.7678571428571429,0.9825383048307794,1.0,8/78,7.89%,GATA4;FGF2;KANK2;CCN4;CCN6;AGR2;HTRA2;SNCA
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.4195033999432115,-0.8046071263675353,0.6956521739130435,1.0,1.0,1/20,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.4195033999432115,-0.8046071263675353,0.6956521739130435,1.0,1.0,1/20,1.76%,TERF2IP
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.4567749795252337,-0.8045355441437496,0.6333333333333333,1.0,1.0,3/15,15.11%,FGF1;FGF20;FGFR4
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.33275341621676635,-0.8044554400625415,0.8490566037735849,1.0,1.0,14/95,12.99%,WARS1;TSPYL2;ADCYAP1;TRIB1;TRIB2;CAMKK2;UBASH3B;CEACAM1;CAMK2N1;TAF7;CAMKK1;SPRED1;PYDC1;PTK2B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.39102207401258166,0.8044532305442504,0.8421052631578947,0.9826031739930843,1.0,2/43,1.35%,TIMELESS;HELB
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,-0.2761405315845354,-0.8042696942395415,1.0,1.0,1.0,30/392,8.33%,NOSTRIN;HK2;F8;INHA;HMGN5;DDX24;PABIR3;STK10;ASS1;IL6R;RNASE1;CMTR1;PRAME;TSPYL2;APOBEC3G;STXBP2;PCED1B;MVP;GPC1;BEX1;BEX2;TTC8;MYOM3;F11R;SVIP;ARNT2;CLU;MYLK3;IQCK;UCHL1
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.33426730615184397,0.8042647299694526,0.7068965517241379,0.9826989741965151,1.0,6/109,5.67%,VEGFC;IGF1;FERMT3;LHFPL2;MANF;ANXA5
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.4917906516803371,0.8041853698200508,0.7833333333333333,0.9826315243613272,1.0,4/7,21.36%,LNPEP;HLA-E;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.41424189086000207,-0.8041422922241902,0.7291666666666666,1.0,1.0,6/36,10.00%,HMGB3;RECQL5;ERCC1;RPAIN;RAD50;RTEL1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.43366385184179596,-0.8040136968489248,0.7674418604651163,1.0,1.0,3/16,15.89%,CHRNE;CHRNA2;COLQ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3990030726216445,0.8038689706864592,0.7368421052631579,0.9830254842285787,1.0,9/23,15.49%,TGFBR1;NRG1;RBPJ;DSP;BMPR1A;SMAD4;PROX1;LRP2;RYR2
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,-0.3809152142535662,-0.8038228547218484,0.7857142857142857,1.0,1.0,8/40,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,-0.3809152142535662,-0.8038228547218484,0.7857142857142857,1.0,1.0,8/40,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,-0.3809152142535662,-0.8038228547218484,0.7857142857142857,1.0,1.0,8/40,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,-0.3809152142535662,-0.8038228547218484,0.7857142857142857,1.0,1.0,8/40,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.39788000004130775,0.8037940991246513,0.72,0.9829326776715073,1.0,7/26,21.60%,RPIA;H6PD;PGM1;PRPS2;RPE;FBP1;PFKP
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.34283118528681916,-0.8037698886917528,0.8666666666666667,1.0,1.0,10/105,7.09%,CLDN4;SIRPG;CTNNA1;PXDN;CLDN1;KIRREL2;CDH4;ACTN3;LAMB3;F11R
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.4443828793163644,-0.8037552557831559,0.717391304347826,1.0,1.0,1/11,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4443828793163644,-0.8037552557831559,0.717391304347826,1.0,1.0,1/11,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.3852410569503703,-0.803705865324647,0.725,1.0,1.0,2/31,4.93%,SCN5A;DRD2
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.3548807881708185,0.8036997577298347,0.7555555555555555,0.9829045893282092,1.0,7/59,16.35%,CCNA2;SEM1;MCM7;PSMD13;PSME4;ORC4;PSMA1
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.4818036599494812,0.803504251207154,0.7666666666666667,0.9827894238345503,1.0,3/7,27.26%,PIK3CD;KIT;MILR1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.4818036599494812,0.803504251207154,0.7666666666666667,0.9827894238345503,1.0,3/7,27.26%,PIK3CD;KIT;MILR1
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.35737801454990104,-0.8034935175304405,0.7755102040816326,1.0,1.0,7/50,11.78%,PRKCD;CAMK2A;GNAL;PLCB2;CAMKK2;CAMKK1;ITPR3
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.29417575796575807,-0.8030753218158605,0.9545454545454546,1.0,1.0,13/370,6.72%,TERT;GOLGA8B;CFAP61;ARAP3;MTFR2;PTCD2;PAK6;WTIP;ZMYM6;GOLGA2;PEX7;FANCG;GOLGA8A
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.38889264921397226,0.8030119761823259,0.782608695652174,0.983368379452997,1.0,6/34,18.60%,STOM;SLC4A7;VAMP3;DBN1;PKN2;ZAP70
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.39554850775994566,-0.802915588521977,0.7407407407407407,1.0,1.0,4/26,14.15%,XPC;PARP1;GTF2H2;RPA3
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.33014621652389947,0.8028780183034007,0.8,0.9834273143805334,1.0,15/78,12.14%,AP1M2;PAWR;LPIN3;GNG12;GOLT1A;EPS8L2;ADGRG6;LRIG3;MMP15;DSP;BCAM;TSPAN6;CGN;ARHGEF16;BCAR1
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.35077703249298964,-0.8028534259528917,0.82,1.0,1.0,5/57,10.93%,FOS;FANCC;JUN;GTF2F1;GTF2H2
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,0.3657743697405035,0.8026519891790742,0.8461538461538461,0.9829441933000599,1.0,11/57,6.24%,STAB1;ITGAX;CSF3R;SASH3;SAMSN1;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,0.3657743697405035,0.8026519891790742,0.8461538461538461,0.9829441933000599,1.0,11/57,6.24%,STAB1;ITGAX;CSF3R;SASH3;SAMSN1;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,0.3657743697405035,0.8026519891790742,0.8461538461538461,0.9829441933000599,1.0,11/57,6.24%,STAB1;ITGAX;CSF3R;SASH3;SAMSN1;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,0.3657743697405035,0.8026519891790742,0.8461538461538461,0.9829441933000599,1.0,11/57,6.24%,STAB1;ITGAX;CSF3R;SASH3;SAMSN1;FLI1;HCLS1;IL10RA;ABI3;FGL2;LAIR1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.31648483270785205,-0.8025328709639159,0.92,1.0,1.0,26/150,16.48%,KDM4D;PARP2;ABRAXAS1;SLX4;RNF8;RECQL5;ERCC1;EYA1;MEIOB;POLQ;RAD50;RAD51AP1;PRPF19;RAD51AP2;PARP1;FAN1;AP5S1;CYREN;NUCKS1;XRCC1;SMARCA5;RPA3;BRCA1;TNKS1BP1;KDM4B;APTX
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3139078593033679,0.8024778708847894,0.88,0.9830199954624619,1.0,5/90,4.97%,CCL5;PRR16;EIF3E;SAMD4A;LIN28A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.5298717074669632,0.8023378740778025,0.7543859649122807,0.9830677061278095,1.0,2/6,20.60%,MFHAS1;TLR1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.485855094795843,-0.8022574639938592,0.675,1.0,1.0,2/9,13.11%,SVIP;CAV1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3793763667642851,-0.8022055210851574,0.7708333333333334,1.0,1.0,5/50,12.69%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3793763667642851,-0.8022055210851574,0.7708333333333334,1.0,1.0,5/50,12.69%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.3761752038306614,-0.8019049225391908,0.6739130434782609,1.0,1.0,1/44,0.60%,HK2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.45135777730098164,0.801894449414446,0.75,0.9836175174489753,1.0,8/16,26.94%,SAMSN1;PAG1;BANK1;TIGIT;PIBF1;IL4I1;GPNMB;LGALS3
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.33207834061119057,0.8015934532714853,0.8947368421052632,0.9838417590621358,1.0,18/85,21.85%,LPIN3;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;SELENOI;PLA2G12B;LYPLA1;PNPLA6;ETNK1;ETNPPL;GPD2;DGKZ;PLPP1;DGKD;GPCPD1;GPAT3
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3650169795562226,0.80152237184813,0.7058823529411765,0.9837462560594407,1.0,16/57,19.66%,IL4;CD22;BLNK;PLCG2;CD40;KLF6;FLT3;BANK1;MEF2C;PIK3CD;DNAJB9;RAG2;ZAP70;KIT;HDAC9;RAG1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.34423483763350476,0.8014705824025956,0.803921568627451,0.9836031398061346,1.0,14/55,14.22%,IRS1;ACSM2A;PPARG;ADIPOR2;PAX6;CYB5R4;LEPR;MCU;GCK;BACE2;IGF1R;KLF7;MLXIPL;TENT4B
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.4342948818349795,0.8011389527663564,0.7857142857142857,0.9840038022944544,1.0,2/16,2.61%,TIMELESS;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.34707573657571156,-0.8010247709444088,0.8333333333333334,1.0,1.0,12/78,15.27%,NUPR1;KCNE2;TRIB1;TRIB2;ARIH2;CLU;DDA1;DDRGK1;RFPL1;DAB2IP;CSNK1D;DAB2
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.38882948256587,0.8009991639778414,0.8333333333333334,0.9840708448205149,1.0,3/22,17.47%,PHKA1;PGM1;GBE1
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.31901017401406384,0.8009986135001894,0.851063829787234,0.9838521138036621,1.0,22/133,16.19%,PIK3R6;KCNJ3;PIK3R5;CACNB4;PRKAB2;PPP1CC;ELK1;GNAI3;GUCY1A2;NPPA;MEF2C;NPR2;PPP1R12B;PPP3CA;PPP3CC;TRPM2;NFATC3;PLCB1;RYR2;PRKAA1;PPP1R12C;GUCY1A1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.5068973656820991,-0.8009078021495032,0.7755102040816326,1.0,1.0,4/7,16.77%,CBLN2;DCTN1;CHCHD10;RAB3A
prerank,Reactome_2022__Reversible Hydration Of Carbon Dioxide R-HSA-1475029,0.4791334129652213,0.8008763910672994,0.7209302325581395,0.9838183319212437,1.0,2/11,9.74%,CA13;CA2
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.3076478764953195,-0.8007156256596966,0.9183673469387755,1.0,1.0,12/136,7.93%,ACTC1;ARAP3;STK10;RASGRF2;OBSCN;STARD8;DHDDS;VAV3;DOCK2;FLOT1;ARHGDIB;TAGAP
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.3796786415457498,-0.8005208769421713,0.75,1.0,1.0,8/31,17.93%,SLX4;RAD50;RAD51AP1;RTEL1;BRCA1;EXO1;MUS81;BLM
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4881053469347483,0.8001842181667206,0.8113207547169812,0.9846806176633368,1.0,5/9,22.18%,FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.4103575247220989,-0.7999750231101993,0.7777777777777778,1.0,1.0,1/15,4.12%,FCHSD1
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.5440362789119293,0.7997515301484164,0.74,0.9851505843966162,1.0,3/5,18.07%,HRH3;GRM7;GABRE
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.38006407766097905,0.7996957107739778,0.7818181818181819,0.9850577593283495,1.0,8/38,22.07%,SOX6;TLE2;XPO1;CTNNB1;TLE4;PYGO1;HDAC1;AKT2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.5230216534245871,0.7995208341823701,0.8035714285714286,0.9851748479264807,1.0,2/5,38.65%,TDG;FTO
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3937671307745254,0.7994612253494803,0.782608695652174,0.9850820586820999,1.0,3/31,10.57%,TFEB;ABCA1;AKTIP
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.37638428704017657,-0.7993569046227343,0.8974358974358975,1.0,1.0,4/30,10.00%,SLX4;ERCC1;RAD50;RTEL1
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.3110403539971389,0.7992627370213125,0.9565217391304348,0.9852130752038153,1.0,11/103,8.33%,DRD5;CALCR;GNB4;GNG12;PDE1A;INSL3;RXFP2;GPR176;PDE7A;RAMP3;GNAI3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2802124863056024,0.7991670809036566,1.0,0.9851370972732747,1.0,35/372,11.87%,FHDC1;IRGM;CDC14A;SAC3D1;RAB38;KASH5;EHD1;LMOD3;DLGAP5;SPAG16;SSTR3;TRAPPC14;PCM1;TP53INP1;HDAC3;RAB3IP;BICD1;CEP20;STARD9;PGM5;AUP1;CHMP6;ATG101;STING1;RAB23;BBS9;GSN;PATL2;LZTFL1;E2F4;LMOD2;BBIP1;SSX2IP;ANLN;KIAA0586
prerank,CellMarker_Augmented_2021__Placenta cell:Placenta,-0.3698938469925067,-0.7991319494289816,0.7659574468085106,1.0,1.0,5/42,7.98%,RFX6;CLCA1;KIF12;MUC3A;TINAG
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.4547995262243254,0.7990404017882835,0.7169811320754716,0.985103090295823,1.0,3/13,12.69%,TGFBR1;WNT9A;GREM1
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.3964252324353923,0.7989734526327777,0.7192982456140351,0.9849824473176133,1.0,4/20,12.10%,ALG6;MOGAT2;EGFL7;ALG9
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.4945545792037114,0.7989217262488553,0.7,0.98462397563209,1.0,1/8,1.06%,GSTM2
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.4945545792037114,0.7989217262488553,0.7,0.98462397563209,1.0,1/8,1.06%,GSTM2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.508678108939755,-0.7985369075231848,0.75,1.0,1.0,2/7,14.74%,TMSB4X;CCDC22
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",-0.5172603430032803,-0.7985218815914411,0.6078431372549019,1.0,1.0,1/5,1.14%,F8
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",-0.5172603430032803,-0.7985218815914411,0.6078431372549019,1.0,1.0,1/5,1.14%,F8
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.4081345630532875,0.7983983855800192,0.6888888888888889,0.9852269935393106,1.0,6/41,13.79%,HELB;MYC;IL7R;SMG1;HNRNPD;SMARCAD1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.4549426697609285,-0.7982181369961069,0.6923076923076923,1.0,1.0,3/10,24.67%,AR;ZNF143;MTOR
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.48405453830584755,0.7980209530051275,0.74,0.9856929009883031,1.0,3/6,19.24%,TNFRSF10B;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.4781287194097173,0.7978797006374729,0.6739130434782609,0.9857593316891284,1.0,3/7,17.85%,RAP1A;SLC30A1;FMR1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.32897836769787997,0.7977914678293994,0.92,0.9856470781320947,1.0,8/89,6.53%,FGF10;TIMELESS;PPARG;WNT4;BMP2;KANK2;APELA;CNN3
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.450168003992203,-0.7975489479468147,0.7755102040816326,1.0,1.0,2/15,4.05%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3302751758498724,0.797258457949271,0.8604651162790697,0.9863525973253005,1.0,13/72,15.08%,TYR;POU6F2;ADGRV1;DHRS3;PAX6;GRM8;CRYZ;TULP1;CRYGS;RPE65;COL11A1;RPGR;ATF6
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.34205486655228823,-0.7971792626934565,0.8846153846153846,1.0,1.0,8/67,4.34%,CLDN4;SERINC2;CTNNA1;CLDN1;ASS1;KIF12;RHBDF1;TST
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.4245191465651968,0.7970871868964474,0.6862745098039216,0.986421628103966,1.0,7/17,20.89%,EFNA2;OSCAR;GAB2;CSF1;FARP2;ANXA2;OSTM1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.38755003416098377,-0.7970338428210623,0.8070175438596491,1.0,1.0,7/52,6.36%,RAC2;BST1;NOXA1;ALOX5;XDH;FOXM1;PAX2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In5:Brain,0.45587733705343636,0.7969844137912327,0.6896551724137931,0.9863762535698005,1.0,2/7,3.58%,TOX;TMEM255A
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.377383395444196,-0.7969770583398158,0.78,1.0,1.0,2/37,4.91%,ACTC1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.49820655791898794,-0.7968453753823959,0.7777777777777778,1.0,1.0,1/5,8.62%,P2RY12
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.4917743999504418,0.7968231545132615,0.7115384615384616,0.9864368815297155,1.0,4/7,34.65%,THEM5;HADHB;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.46829070459004796,-0.7965951016610032,0.6595744680851063,1.0,1.0,3/11,9.83%,SPRY4;GPC1;CREB3L1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Undefined,0.5100906087648652,0.7965547124289989,0.7291666666666666,0.9866619978981906,1.0,3/6,22.38%,IRF8;CD81;PTPRC
prerank,Reactome_2022__Myogenesis R-HSA-525793,-0.4043892066085304,-0.7965371042526398,0.7307692307692307,1.0,1.0,3/22,4.37%,CTNNA1;BOC;CDH4
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.37767062973408105,-0.7961622477418296,0.7413793103448276,1.0,1.0,6/31,12.91%,DRD2;ADCYAP1;HFE;NNAT;FFAR4;CRH
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4344518652307049,0.7961127079085749,0.7884615384615384,0.9872215479257176,1.0,4/20,7.89%,TMTC2;SLC8A1;FAM20A;SNCA
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.31159116553306343,-0.796106036913183,0.9245283018867925,1.0,1.0,35/195,25.45%,NARS1;WARS1;TMA7;ZC3H15;SARS1;DARS2;SARS2;CARS1;RPL38;MRPL23;PPA1;RPL12;MRPS21;GARS1;ABCF1;RPL37A;RPS8;RPS27;RPL4;MRPS18C;MRPL16;RPL5;MRPL9;RPL26L1;RARS1;COPS5;GATC;DRG1;RPS20;WARS2;RPL22;RPL34;RPL31;GTPBP2;RPL37
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.3896536766286249,0.7961058258556213,0.6981132075471698,0.9867961601442284,1.0,5/23,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;PRELP
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.3896536766286249,0.7961058258556213,0.6981132075471698,0.9867961601442284,1.0,5/23,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;PRELP
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.509699082048238,0.7958394309403228,0.6949152542372882,0.9870377136250328,1.0,1/5,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5030878249252088,-0.7956883903545456,0.7272727272727273,1.0,1.0,2/8,15.64%,RNF8;GPR183
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.42690526016358044,-0.7955805875551935,0.72,1.0,1.0,5/12,16.97%,CACNA1G;ZP3;SYT10;KCNB1;CACNA1H
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.48604106853247775,0.7953215637246374,0.7457627118644068,0.9875883300534504,1.0,1/8,7.89%,SNCA
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.31132216904964854,0.7951267246744473,0.9787234042553191,0.9876207494688125,1.0,23/150,14.81%,CCL5;PRKG1;RAPGEF3;F2R;SNX18;EFNA5;FGD4;RGS10;EPHA5;EPHA3;CD40;GPSM1;RAP1GDS1;RAPGEF6;PLXNB1;EZH2;ADAP1;PLXNB2;PICALM;RAP1A;SGSM3;ADRB1;GPR137B
prerank,Reactome_2022__Dopamine Receptors R-HSA-390651,0.5451644627977864,0.795038139217231,0.7222222222222222,0.9875445753563292,1.0,1/5,0.64%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3400271452752321,-0.7950178333246029,0.8043478260869565,1.0,1.0,11/57,20.56%,NUPR1;MEIS2;RARA;CCND1;EIF4EBP1;FGFR2;RGCC;PDGFB;NUDT16;USP19;PRKCA
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.5728368254737013,-0.7949817222293879,0.8260869565217391,1.0,1.0,1/5,3.49%,CCBE1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.29240063425374024,-0.7949794383191604,0.9565217391304348,1.0,1.0,17/231,6.96%,KIF2B;RAC2;CTNNA1;ERCC6L;CENPH;NOXA1;PRKCD;ZWILCH;RNASE1;INCENP;DHDDS;FMNL1;PDZD2;PMF1-BGLAP;BUB1;SPC25;BTK
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.4405409126742841,-0.7949045267149312,0.6904761904761905,1.0,1.0,3/14,8.41%,SYCE2;STAG3;SYCE1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.4405409126742841,-0.7949045267149312,0.6904761904761905,1.0,1.0,3/14,8.41%,SYCE2;STAG3;SYCE1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4470362853382389,0.7948891099244676,0.7735849056603774,0.987549155442059,1.0,2/10,0.87%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.40973720449248796,-0.7948651677989946,0.7708333333333334,1.0,1.0,2/20,6.91%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.37399903568443765,-0.7948091789339935,0.8604651162790697,1.0,1.0,5/27,12.59%,GPC2;GPC1;GPC3;AR;GBP1
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.3668786558717892,0.7947999174286424,0.803921568627451,0.9874897278922866,1.0,2/53,3.21%,CCNA2;SEM1
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.4332055777184681,0.7946343543045802,0.8214285714285714,0.9874998825403519,1.0,4/15,13.08%,FGFR3;FGF17;PIK3CA;FGF5
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.3952815539149308,0.7945283940083321,0.7962962962962963,0.9874432737211126,1.0,7/30,12.96%,SCN7A;SCN10A;FGF12;FGF14;SCN3A;SCN2B;SCN9A
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.40166088571615266,0.7944832715134316,0.7413793103448276,0.9873032595656667,1.0,4/21,12.19%,PRIMPOL;POLE2;REV3L;REV1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.492666829446384,0.7943233506473021,0.7555555555555555,0.9871540663820377,1.0,3/6,16.58%,RBPJ;BMPR1A;HEY2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.492666829446384,0.7943233506473021,0.7555555555555555,0.9871540663820377,1.0,3/6,16.58%,RBPJ;BMPR1A;HEY2
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.32620253139519256,-0.794268859025994,0.8333333333333334,1.0,1.0,8/75,14.53%,RTF1;GTF2E1;TAF11;TAF7;GTF2F1;GTF2H2;TBP;SKIC8
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.3813401612091031,-0.7942659091158198,0.7346938775510204,1.0,1.0,9/43,11.70%,SIRPG;AHSG;SPACA3;DOCK2;HCK;SLC11A1;OLFM4;APOA1;FER1L5
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,0.5391324287858504,0.7942067424934188,0.75,0.9871837380463281,1.0,3/6,24.90%,SOS1;GRB2;EGFR
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.44076161457580965,0.7941922980402409,0.7543859649122807,0.9869799977381656,1.0,4/12,23.79%,LMAN1;SNX2;STX5;SNX1
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.33476020404068296,0.7941409283987754,0.8269230769230769,0.9868596856164576,1.0,20/92,15.80%,LAMA4;PRRX1;EDIL3;ADGRL4;BGN;POSTN;CNN3;ADGRL2;DLC1;PCDH18;TNC;LOXL2;HMCN1;MAMDC2;HTRA1;PTPRM;FZD4;FRZB;FBN1;DST
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.4233329968957932,-0.7941044082016813,0.76,1.0,1.0,4/21,15.40%,RNASE1;LIMK1;MYH9;CALM1
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.4233935538244769,-0.793999340360421,0.74,1.0,1.0,4/21,10.47%,KIRREL2;ACTN3;NPHS1;KIRREL3
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.4577781618211994,0.7937149460549586,0.7368421052631579,0.987355994586435,1.0,6/16,14.99%,ACD;H2BC21;H2AC6;TERF1;H2AZ2;H2AX
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3079222863693674,0.7936425170624283,0.9230769230769231,0.9872578664144404,1.0,37/151,24.60%,TGFBR1;MAPKAPK2;DYRK2;RPS6KA4;SMG1;LATS1;MAPKAPK3;RPS6KA2;STK32B;VRK2;MAPK8;RPS6KA1;DYRK1A;IKBKE;CSNK1G3;RICTOR;HIPK1;SGK1;DYRK3;PKN2;RPS6KA5;MAST1;STK38L;AKT3;WNK1;IKBKB;HIPK3;STK32C;CAMK4;GAS6;RPS6KA6;AKT2;EIF2AK3;MKNK2;STK32A;PIKFYVE;SGK2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.35923066328094755,0.7935447825077361,0.8333333333333334,0.9871819903518507,1.0,10/52,18.94%,VAPB;ELOVL5;PPM1L;CERS3;SGPL1;CERS5;ELOVL4;ALDH3B1;PLPP1;SAMD8
prerank,KEGG_2021_Human__Phagosome,0.32213416191811306,0.7935308686280268,0.8936170212765957,0.9870006787531331,1.0,16/117,13.37%,TCIRG1;ATP6V0D2;C3;TUBA1C;FCAR;ITGA2;SEC22B;TLR2;ITGAV;ATP6V0A4;TAP1;HLA-E;VAMP3;DYNC1I2;ATP6V0B;MSR1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.3309426258417332,0.7934982462823555,0.8870967741935484,0.986827771655369,1.0,22/85,17.56%,FZD5;WNT4;WNT9A;PLCG2;GPC4;PTEN;NR4A2;FZD1;DVL2;LRP6;FZD4;CSNK1G3;FRAT1;FZD6;FRZB;CPE;DIXDC1;NXN;CTNNB1;VPS29;KLHL12;WNT2
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.48497330201598754,-0.793438979176252,0.6904761904761905,1.0,1.0,3/8,29.79%,PDE3A;UBE2B;RNF157
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.40520762549162814,-0.7933146965874215,0.7,1.0,1.0,1/27,1.92%,KDM4D
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.41235440083095765,-0.7932588922956669,0.7105263157894737,1.0,1.0,4/24,11.48%,ALOX5;CLU;CREB3L1;WFS1
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.39004747915356003,0.7932096769733562,0.84,0.9870877278772392,1.0,6/27,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;HEXB;PRELP
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3364218954686601,-0.793209217648374,0.7755102040816326,1.0,1.0,12/82,13.11%,WARS1;MVP;TRIB1;TRIB2;UBASH3B;CEACAM1;CAMK2N1;TAF7;SPRED1;PYDC1;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.4163350068498992,0.7931864540778292,0.7678571428571429,0.9868926883949498,1.0,2/18,7.21%,IGF1;NLRP7
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3107535674588259,0.7928084252756876,0.9591836734693877,0.9872440267933387,1.0,11/90,14.60%,NDE1;CEP70;PCM1;RAB3IP;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4846562306626412,-0.7928043704779436,0.7567567567567568,1.0,1.0,4/9,29.25%,E2F7;CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.4594233086108408,0.7927882059588993,0.78,0.9870656734131861,1.0,4/8,16.69%,NLGN1;PLXNB2;PTEN;GRID2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4682677495723556,-0.792724825605288,0.8392857142857143,1.0,1.0,2/13,6.91%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.456652481977172,-0.7921534394946758,0.8292682926829268,1.0,1.0,1/12,1.10%,SCN5A
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5035616845483277,0.7920442099652654,0.7115384615384616,0.9881042346550235,1.0,2/7,18.48%,SAG;ARRB2
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,0.40847197178381894,0.7920360403686022,0.7719298245614035,0.987911914432012,1.0,3/21,9.44%,MCUB;SMDT1;MCU
prerank,Reactome_2022__Miscellaneous Substrates R-HSA-211958,0.4897632860038133,0.7920357721667891,0.7368421052631579,0.9876947432043944,1.0,2/8,9.42%,CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.4790221210902643,-0.7918926501681302,0.7111111111111111,1.0,1.0,3/8,15.64%,POU2AF1;PTK2B;GPR183
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,0.46200842772396955,0.7915535602279247,0.7291666666666666,0.9882532699009191,1.0,4/9,10.84%,LGR5;BMI1;ALCAM;BMPR1A
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.3364803122601033,-0.791507512945971,0.7959183673469388,1.0,1.0,16/109,10.10%,KCNMB2;KCNE2;KCNJ1;KCNJ16;SLC24A4;KCNN3;SLC9A8;KCNA3;KCNN2;KCNE1;KCNV1;KCNQ4;KCNQ1;KCNJ11;KCNA5;KCNJ15
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.43189784085787164,0.7914567996556411,0.7333333333333333,0.9882105913144298,1.0,4/20,18.12%,RORA;STAR;RORC;ABCA2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.44807068330533256,-0.7913068990819551,0.7142857142857143,1.0,1.0,1/9,3.18%,ENPP2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5154616787881426,0.7912311049830478,0.7903225806451613,0.9884005099864841,1.0,4/7,35.49%,RPUSD2;TRUB2;PUS3;DKC1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4574548126951198,-0.7911473804386452,0.7659574468085106,1.0,1.0,4/12,8.18%,SIGIRR;MEFV;OAS3;OAS1
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.36716376678734913,0.7910748005353988,0.8076923076923077,0.9884547042351884,1.0,7/48,16.35%,SEM1;PSMD13;HNRNPD;HSPB1;HSPA8;PSME4;PSMA1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.48435282949266056,-0.790933514758797,0.75,1.0,1.0,2/10,10.00%,TERF2IP;RTEL1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.40986647809816223,0.7907902680857919,0.7962962962962963,0.9887136752899482,1.0,2/18,8.16%,CDC25A;FOXO3
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4603805210697136,0.7906377967686958,0.734375,0.9887871457684021,1.0,3/13,21.11%,CHMP6;LEPROTL1;VTA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.4535628186384224,0.7905852542491228,0.8,0.9886614060132861,1.0,1/12,2.47%,IL4
prerank,CellMarker_Augmented_2021__Neuroepithelial cell:Undefined,0.5253884756431251,0.7905723074543187,0.7254901960784313,0.9884610460910243,1.0,4/5,40.21%,NOTCH1;CDH1;HES1;OCLN
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.38283915054759665,0.7905170916680158,0.8214285714285714,0.9883299027595808,1.0,10/49,13.19%,C3;C6;H2BC8;H2BC21;C9;CD40;RO60;H3C6;H2AC6;H2AZ2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.45286196050525795,-0.7903309781312668,0.82,1.0,1.0,1/10,2.64%,TIE1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.502697175565903,-0.7902261728234595,0.7551020408163265,1.0,1.0,3/6,6.47%,COL5A1;WNT7A;PLET1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.4311968203353125,-0.7902190983071342,0.6976744186046512,1.0,1.0,2/10,9.56%,TESPA1;CLPTM1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.38536486575273365,0.7901664804404185,0.7692307692307693,0.9887074924079149,1.0,2/29,2.87%,FLT1;PPARG
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.37260628891647923,0.7901644095056518,0.7777777777777778,0.988496198457845,1.0,9/46,24.31%,ST6GALNAC3;ESYT3;ST3GAL6;ESYT2;ABCA2;HEXB;NAGA;ST6GALNAC4;CTSA
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.48026672335132664,-0.7901169943373189,0.6595744680851063,1.0,1.0,5/10,18.10%,DNAAF1;RSPH9;CCDC40;SPATA6;BBOF1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.3297634343025862,0.79011496078031,0.8260869565217391,0.9883678970070575,1.0,17/94,16.35%,DERL3;SEM1;RNF185;ABCC2;ABCA6;ABCG8;PSMD13;ABCD3;RNF5;ABCD2;ABCC11;PSME4;ABCA8;ABCG5;DERL2;ABCA9;PSMA1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.43924808945292393,0.7901032270592605,0.7288135593220338,0.9879484979069494,1.0,1/14,2.73%,RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.43924808945292393,0.7901032270592605,0.7288135593220338,0.9879484979069494,1.0,1/14,2.73%,RAB27A
prerank,Reactome_2022__Activation Of Phototransduction Cascade R-HSA-2485179,-0.47760208473626936,-0.7900758562694898,0.6964285714285714,1.0,1.0,3/8,11.16%,PDE6B;CNGB1;GNGT1
prerank,CellMarker_Augmented_2021__Monocyte:Liver,-0.36962339762167484,-0.7898180524450318,0.8181818181818182,1.0,1.0,8/41,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.34736151210762256,-0.7894855103759915,0.8936170212765957,1.0,1.0,3/55,10.93%,RTF1;GTF2F1;GTF2H2
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.36563868187038007,-0.789421124808377,0.8043478260869565,1.0,1.0,9/45,18.27%,PRKCD;CAMK2A;PLCB2;CAMKK2;CAMKK1;ITPR3;CALM1;ADCY1;PDE1C
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.38500661468382946,0.7893008984033338,0.7321428571428571,0.9891624955504678,1.0,1/24,1.76%,TUBA1C
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.33200985157768537,-0.789268104826823,0.8148148148148148,1.0,1.0,10/84,6.85%,TMEM52;HMGB3;H19;AGRN;PHLDA2;MBNL3;KDELR1;DSG2;BATF3;LAS1L
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.37498845294892363,0.7892563706233826,0.7450980392156863,0.9890120733085207,1.0,15/44,19.39%,RENBP;UGDH;NANP;UAP1;CYB5R4;GCK;GALK1;PGM1;HKDC1;NPL;GFUS;HEXB;GNPNAT1;GNPDA2;GFPT1
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.4090647649572584,-0.789189770586773,0.7692307692307693,1.0,1.0,5/27,14.99%,AK8;RRM2;AK7;CTPS1;RRM1
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,0.3445935512578789,0.7888960748375402,0.7592592592592593,0.9894137774032655,1.0,12/67,11.88%,AP1M2;TMPRSS2;HNF4G;CKMT1A;GOLT1A;AGR2;MARVELD3;DSP;MUC13;CGN;ARHGEF16;HSD11B2
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NUDT Proteins R-HSA-2393930,-0.45972229166228223,-0.7888935756463495,0.7358490566037735,1.0,1.0,5/7,33.92%,NUDT16;ADPRM;NUDT9;NUDT1;NUDT15
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.3603306467587867,0.7886991897759981,0.8333333333333334,0.9895420954956957,1.0,6/46,7.93%,ACE2;CLSTN2;CNTNAP2;NLGN1;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.4714463212246063,0.7886974645517623,0.7407407407407407,0.9893282297874095,1.0,2/6,27.98%,FADD;TRADD
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.37182264356146333,0.7886791018378663,0.8387096774193549,0.9891392841035959,1.0,9/41,22.07%,PEX12;CHCHD4;DNAJC15;SEC61A1;PEX2;SEC61A2;RTN2;HSPA5;AKT2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.400256899537318,-0.7886789485164184,0.7804878048780488,1.0,1.0,1/16,3.88%,CD200R1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.5245680555339005,0.7882480079293691,0.7884615384615384,0.9897005661623216,1.0,3/6,27.62%,EXOSC4;EXOSC5;EXOSC2
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.33876250188161444,0.7881637203403807,0.86,0.9896632722521737,1.0,15/65,17.15%,KLRD1;ZEB2;PIK3R5;GLUL;VEZF1;MTSS1;PATL2;ARHGAP25;PXN;TPST2;RNF166;C12ORF75;LGALS1;SLCO4C1;SAMD3
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.34810748595668867,0.7881605064047129,0.875,0.9894523238286909,1.0,6/64,3.84%,KLRD1;GPRIN3;CSF3R;ZEB2;MLC1;OLIG1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3425667984617078,-0.7881255983244096,0.8846153846153846,1.0,1.0,10/103,6.94%,P2RY10;CD24;CXCL13;XCR1;PTGDR;PLCZ1;NMUR2;DRD2;ADCYAP1;JPH2
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.5035482273471132,-0.7881137916147722,0.7209302325581395,1.0,1.0,2/5,15.64%,CXCL16;GPR183
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4178568032036335,0.7880614067611118,0.7636363636363637,0.9894316369752716,1.0,2/26,4.72%,SIRT1;KANK2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.5137440266235339,0.7879138733786599,0.8070175438596491,0.9894826015024507,1.0,1/7,13.08%,XPO1
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.31941181652786155,0.7876597941022511,0.8163265306122449,0.9897015909506452,1.0,15/66,18.31%,CALCR;GNB4;GNG12;WNT4;WNT9A;RAMP3;CRHBP;GNG4;FZD1;FZD4;FZD6;CALCRL;WNT2;CD55;UCN
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.4101001895999958,0.7876026100715278,0.8333333333333334,0.9896009893533787,1.0,1/20,0.47%,NOX5
prerank,Reactome_2022__Interleukin-18 Signaling R-HSA-9012546,-0.47844406041883714,-0.787483559517032,0.7321428571428571,1.0,1.0,2/5,3.41%,IL18BP;ALOX5
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.47519909266455385,0.7874396142301379,0.803921568627451,0.9896766664902233,1.0,2/6,14.01%,HSPA8;APBA1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.46043691227087646,0.7874320018141135,0.7407407407407407,0.9894714977470356,1.0,1/9,3.59%,SSC5D
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.4146761495016582,0.7873902516953099,0.7647058823529411,0.9893297253258624,1.0,3/21,18.03%,TENM1;POLR3G;MAF1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.32039195153808875,-0.7873778822826412,0.8245614035087719,1.0,1.0,11/141,6.38%,SELP;SELE;CLDN4;SELL;CLDN1;IGSF21;CDH4;UMOD;DSG2;MPZ;CDH23
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.4533529120958833,0.7872760284380647,0.8,0.9892953375349444,1.0,1/15,1.13%,IRS1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.46416810668212655,0.7871912636233507,0.7659574468085106,0.9891976856869565,1.0,2/9,16.40%,METAP1D;NAA16
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.45120519401135784,-0.7871330884236201,0.7454545454545455,1.0,1.0,4/13,16.77%,TRIM72;FER1L5;MYH9;RAB3A
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,0.4680829135533504,0.786819214015811,0.7291666666666666,0.9896749651294413,1.0,6/9,24.86%,PIP4K2A;MAP2K6;TP53;PIP4P1;ING3;EP300
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.36338384391441697,-0.786296836742145,0.7608695652173914,1.0,1.0,6/61,7.55%,APIP;TRPV5;UPB1;GOLGA2;TRPA1;HLA-DRB1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.3900816499976346,0.7862811762909612,0.8301886792452831,0.9903747914156311,1.0,5/38,12.97%,HRH3;CHD7;MAGT1;GRM5;SHROOM4
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.34596838765832516,0.7862125004637864,0.8235294117647058,0.9902907153097649,1.0,12/75,23.10%,SIRT1;MAPKAPK2;BAG2;HSPA8;TNFRSF21;RANBP2;MRPL18;DNAJB1;HSPA5;MAPK3;NUP153;HSPA1A
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.5294706899215008,0.7861070447733518,0.7555555555555555,0.9900209873184851,1.0,3/5,43.06%,DKC1;CCT4;TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.5294706899215008,0.7861070447733518,0.7555555555555555,0.9900209873184851,1.0,3/5,43.06%,DKC1;CCT4;TCP1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,-0.3695045543947891,-0.7859903557600033,0.8297872340425532,1.0,1.0,10/47,12.15%,CYTH4;NLRP3;LILRB3;PRAM1;MS4A4A;HCK;SLC11A1;LY86;SPI1;PARVG
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.4563712339325622,0.7858451765592309,0.703125,0.9901843331957009,1.0,3/11,15.60%,CARMIL1;SPIRE2;COBL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.4579998231269174,-0.7856005623788397,0.74,1.0,1.0,2/13,14.93%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.4934388510181313,-0.7854760143305968,0.75,1.0,1.0,2/7,8.31%,ABCC4;ABCC3
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.3297645542269995,0.7854620681778627,0.9347826086956522,0.9904904553132278,1.0,9/95,4.13%,LINGO3;TSHZ3;GALNT8;ZEB2;KSR1;MLC1;OLIG1;ITPKB;OLIG2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.36128973304070305,-0.7852421865308329,0.875,1.0,1.0,9/51,12.15%,CD53;CYTH4;CD86;LILRB3;HCK;TAGAP;LY86;SPI1;PARVG
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.4045725265151168,0.7851823614134484,0.7894736842105263,0.9907305287915528,1.0,3/19,12.35%,FBXO5;BAG2;PTEN
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3564257538599602,0.7849470898354991,0.8653846153846154,0.9909842270091509,1.0,6/51,11.97%,TCIRG1;CTSF;HTRA2;CHEK2;RNF5;BNIP3L
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.335303507303567,0.784840652014093,0.8301886792452831,0.990968778130088,1.0,11/66,15.63%,RUNX1;EMB;SLC22A3;SLC44A5;SLC39A8;SLC5A11;SLC22A5;SLC41A2;SLC30A10;SLC44A4;SLC30A6
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.4004682248833886,0.7848161036951904,0.7547169811320755,0.9907968895984194,1.0,1/17,1.82%,CCL5
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.3001971590915049,-0.7847688957542438,0.9811320754716981,1.0,1.0,9/159,7.96%,SELP;SELE;CYP2A6;NLRP3;FOS;CAMK2A;VAV3;PLCB2;JUN
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.36836367831453526,0.7846963582988085,0.8727272727272727,0.990770511930981,1.0,10/29,28.54%,GPM6B;PICALM;LEPROTL1;CTNNB1;ABCA2;STX3;COMMD1;ABCA7;TMEM35A;GBF1
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.339090845569015,0.7846351467156957,0.8518518518518519,0.9904215598477308,1.0,11/70,11.50%,FAM83H;AP1M2;TSPAN12;GNG12;EPS8L2;SDC4;ATP6V0A4;DSP;BCAM;ARHGEF16;DNAAF3
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.339090845569015,0.7846351467156957,0.8518518518518519,0.9904215598477308,1.0,11/70,11.50%,FAM83H;AP1M2;TSPAN12;GNG12;EPS8L2;SDC4;ATP6V0A4;DSP;BCAM;ARHGEF16;DNAAF3
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.435028990171885,-0.7845299567849398,0.6923076923076923,1.0,1.0,2/12,5.41%,ADSS1;XDH
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.3795797860361664,0.784390546035159,0.803921568627451,0.9906064369771072,1.0,1/27,1.76%,TUBA1C
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.4140723090475107,0.7842993004905007,0.8076923076923077,0.9905389983704971,1.0,7/25,12.96%,SCN7A;SLC8A1;SCN10A;SCN3A;SCN2B;ATP1A2;SCN9A
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.4796781949208231,-0.7842049784652002,0.7727272727272727,1.0,1.0,6/11,31.07%,AKAP8L;MYOCD;PARG;MTHFR;AKAP8;NNMT
prerank,CellMarker_Augmented_2021__Cancer cell:Peripheral Blood,0.48842316089486987,0.7841492202749324,0.7592592592592593,0.9906141258707842,1.0,2/5,24.04%,ABCB5;EPCAM
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.3367805613322561,-0.7837754215908159,0.85,1.0,1.0,5/65,10.85%,DNASE1L1;DDX24;RECQL5;RAD50;GTF2F1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.3181543214462999,0.7837610973563486,0.875,0.9909934157302607,1.0,22/103,19.05%,SIPA1;RHOBTB3;FGD4;PCLO;TNIK;RHOU;NECTIN2;BIN1;PAK5;RANBP9;FMNL3;ANK1;RHOBTB1;ZMYM4;SYNE3;PHIP;DST;MAST1;RHOG;RHOD;RHOB;BRWD1
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.29566283472853805,0.7836363077887987,0.9761904761904762,0.9909368965795731,1.0,13/255,6.39%,PNP;SCGB3A2;TUBA1C;F2R;PPP1R3B;MYCN;FRAT2;NPC2;STOM;LIN28A;FBLIM1;ACADS;TEAD2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.4313875179740094,0.7834824295259947,0.6949152542372882,0.9909872348729253,1.0,1/13,0.59%,FHDC1
prerank,Reactome_2022__Diseases Associated With Surfactant Metabolism R-HSA-5687613,-0.48245399842794956,-0.7832695637416458,0.7105263157894737,1.0,1.0,2/8,7.64%,SFTPA2;SFTPA1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.45126593810056315,-0.7832566926757588,0.78,1.0,1.0,2/14,4.05%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.44647782419452514,0.7832026761856288,0.7647058823529411,0.9912484319030922,1.0,2/11,0.87%,LGALS9;KLRD1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.37368520872557137,0.7831284152709194,0.7962962962962963,0.9911535605865689,1.0,10/38,21.51%,TP53INP1;TNFRSF10B;CASP10;BNIP3L;TP53BP2;FASN;PERP;TP53;TNFRSF10A;PPP1R13B
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.47963603782072006,-0.7830178764321195,0.72,1.0,1.0,1/6,15.45%,PRDX1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.49709474946855403,-0.7830065966386673,0.7674418604651163,1.0,1.0,1/5,12.00%,PODXL
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4263577215320955,0.782960244213347,0.7755102040816326,0.9912147690974038,1.0,2/15,9.95%,KANK1;GSN
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3482624409310938,0.7828789448979944,0.85,0.9911199462945481,1.0,7/57,7.89%,GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.4852199414341801,-0.7826374069028496,0.8,1.0,1.0,1/15,2.63%,ERN2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.5254544893915797,0.7824622584712353,0.75,0.9915177042241223,1.0,2/5,24.93%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.4472775922403061,0.782402028870366,0.7636363636363637,0.9913927637242821,1.0,8/18,27.17%,TAF3;PML;BCL3;SUN2;HNRNPU;BARD1;RANGAP1;ARL2BP
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.48436701361228773,-0.7817426390155998,0.6976744186046512,1.0,1.0,2/7,5.23%,PRKCD;CAMK2A
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.33083297625916197,0.7816999850286765,0.875,0.9923646698908366,1.0,7/81,8.34%,MME;AANAT;MMP16;PCSK5;F12;F3;CPN1
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4216516855002633,0.7816777095831889,0.75,0.9921931124967852,1.0,3/17,11.28%,SLC38A3;CA2;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.446955371646922,0.7816527171168921,0.7333333333333333,0.9917928203075622,1.0,3/18,18.14%,ZEB2;SMAD4;CITED2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.446955371646922,0.7816527171168921,0.7333333333333333,0.9917928203075622,1.0,3/18,18.14%,ZEB2;SMAD4;CITED2
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.3254496212672257,0.7813180574674852,0.8666666666666667,0.9921188628289099,1.0,12/89,20.95%,TULP3;SEM1;PSMD13;GPR161;PSME4;IFT57;PSMA1;NUMB;TTC21B;PRKACB;IFT140;PSMD4
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.3856461681726189,-0.7812421179621781,0.7021276595744681,1.0,1.0,2/29,5.96%,GATD3;DLL4
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.46738409925607244,0.7810924081259626,0.7419354838709677,0.9922726367381113,1.0,4/9,25.05%,ABCA1;PRKACB;ABCA7;APOE
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4142880515778975,0.7810522285560004,0.7884615384615384,0.9921258694785465,1.0,5/14,19.45%,RBPJ;BMPR1A;PROX1;HEY2;JAG1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.43995439059965696,0.7809700993908972,0.7115384615384616,0.9920556336720171,1.0,6/13,40.52%,TMEM33;REEP4;RAB10;REEP3;ATL2;REEP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.3907726762298,-0.7809385617166207,0.8333333333333334,1.0,1.0,2/19,13.50%,CLU;HOPX
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.3790210485812655,-0.780791159749341,0.8163265306122449,1.0,1.0,9/35,17.93%,ERCC1;RFC3;RAD50;POLR1A;RPA3;RFC2;BRCA1;EXO1;BLM
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.4987480360404596,0.7806967681689592,0.75,0.9922530077866208,1.0,2/6,8.67%,SYK;GCH1
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.4759876003965112,0.7806476386577009,0.7959183673469388,0.9921199892017262,1.0,2/10,7.75%,TLR2;HMGB1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.31912139231315234,0.7805048908934425,0.9019607843137255,0.9921671567753613,1.0,23/98,21.16%,SYK;RELA;PLCG2;FER;TAB2;PIK3CA;PSMD13;MAPK8;PPP3CA;SOS1;ITK;PSME4;NFATC3;MAP3K1;GAB2;TAB3;MAPK10;PSMA1;VAV2;LYN;IKBKB;PSMD4;MAPK3
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.3224594718500958,0.7804945260850359,0.9074074074074074,0.9919659986336522,1.0,10/75,14.60%,NDE1;CEP70;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.36187293499457623,0.7804823107145339,0.8,0.991770383651331,1.0,7/32,19.96%,HES6;FOXO1;NOTCH2;HEY2;CTNNB1;HDAC9;CX3CR1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.45706870061470406,0.780398620773709,0.6808510638297872,0.9916948610715011,1.0,2/9,11.92%,CD40;MEF2C
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.4586098760474301,-0.7801706276487964,0.7368421052631579,1.0,1.0,2/10,11.70%,SPACA3;FER1L5
prerank,"Reactome_2022__POU5F1 (OCT4), SOX2, NANOG Activate Genes Related To Proliferation R-HSA-2892247",0.5054592649210561,0.7799599237092653,0.7169811320754716,0.9922001920344201,1.0,3/6,29.45%,NR6A1;SALL1;FGF13
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.36958630365232714,-0.7798602533551232,0.7916666666666666,1.0,1.0,7/45,9.77%,ATP6V1E2;ATP6V1C2;KDELR1;ATP6V1E1;KCNQ1;ARF1;ATP6V1D
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.46926004756672113,-0.779775124484061,0.717391304347826,1.0,1.0,4/7,16.72%,CTCF;PRMT7;KDM1B;DIRAS3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.34976401700756166,0.7797210020909621,0.8333333333333334,0.9923508894546874,1.0,7/47,18.17%,SHMT2;IDH1;MTHFD2L;MTHFD2;SLC19A1;ME3;SDHAF3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.387273246018512,0.7796488941295083,0.8653846153846154,0.9922780160102338,1.0,4/42,4.98%,BOK;URI1;DAPK2;SEPTIN4
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.46560701670671234,0.7796393838397306,0.7692307692307693,0.9918599135736055,1.0,4/10,33.09%,RRAGD;SESN2;SESN1;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.46560701670671234,0.7796393838397306,0.7692307692307693,0.9918599135736055,1.0,4/10,33.09%,RRAGD;SESN2;SESN1;UBR2
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,-0.3875559116995313,-0.779546429151014,0.7884615384615384,1.0,1.0,12/44,13.42%,RAB44;MPO;NLRP3;PRAM1;BTK;HCK;ADGRG3;LY86;SPI1;PARVG;TSPAN32;CLEC1B
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,-0.3875559116995313,-0.779546429151014,0.7884615384615384,1.0,1.0,12/44,13.42%,RAB44;MPO;NLRP3;PRAM1;BTK;HCK;ADGRG3;LY86;SPI1;PARVG;TSPAN32;CLEC1B
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.3363124818269725,-0.7791759972243153,0.84,1.0,1.0,8/56,13.71%,NPTX2;CAMK2A;BEGAIN;CACNG5;CACNG8;CRH;PTK2B;SHANK1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,0.5145291683819715,0.7791648097367038,0.7719298245614035,0.9924164171221143,1.0,1/6,14.38%,RAB27B
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.3853555524490691,0.7790438739748005,0.8461538461538461,0.9923762723826395,1.0,11/38,20.26%,STAT5A;FER;SOCS6;PIK3CA;SOS1;SH2B2;PTPRU;GAB2;KIT;LYN;PIK3R3
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.3650395975598744,-0.7790229435532716,0.847457627118644,1.0,1.0,4/34,11.77%,OAS3;OAS1;DHX58;TYRO3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4311023796636943,0.778922745387266,0.7555555555555555,0.9923334222531095,1.0,2/13,7.26%,NYNRIN;RPP40
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.2883218129964592,-0.7789030434309782,1.0,1.0,1.0,32/283,18.48%,TERT;INHA;WARS1;TICRR;RECQL5;ORC6;SARS1;ALAS2;RFC3;RAD50;RPL38;MRPL23;PTMA;RPA3;RFC2;CDC6;KIN;BRCA1;EXO1;MCM2;RPL12;MRPS21;CDK1;E2F1;PAX8;ABCF1;CDC7;RPL37A;RPS8;BLM;POLR3A;RPS27
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.41260328566779847,0.7788125067954951,0.7843137254901961,0.9923668107459332,1.0,3/19,5.03%,VCAN;BGN;CHSY3
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.5204275971278589,0.7786496112738232,0.7818181818181819,0.9923947417010601,1.0,2/5,14.53%,NR1H3;LIPG
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.49031925750404914,-0.7785526575650036,0.8536585365853658,1.0,1.0,1/9,4.40%,CUX2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.4798372115326708,0.7784729390599001,0.7647058823529411,0.9924934058555049,1.0,3/7,12.69%,EFNB2;MEF2C;GREM1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4642531406649567,-0.7784352005362997,0.75,1.0,1.0,4/10,11.18%,PHLDA2;NODAL;ADAM19;E2F7
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.48215831822816735,0.7782768447194814,0.75,0.992592027418042,1.0,3/5,19.69%,BMPR1A;HEY2;BMPR2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.46142618482944087,0.7780727555962268,0.8541666666666666,0.9926742876332785,1.0,4/11,24.08%,NOC2L;TP53;RBBP4;HIRIP3
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.484076034349176,0.7779530271240042,0.7872340425531915,0.9926395863075584,1.0,1/8,5.90%,F12
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.43681745341173334,0.7779044316238589,0.7636363636363637,0.9922658083537672,1.0,1/15,2.73%,RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.43681745341173334,0.7779044316238589,0.7636363636363637,0.9922658083537672,1.0,1/15,2.73%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3487578916780161,0.7777887083083661,0.8431372549019608,0.9922855665761587,1.0,13/48,21.95%,FZD5;HTRA2;UBE2D3;RHOU;TP53BP2;MAPK8;UBE2J2;PPP3CC;BAP1;TP53;BAD;PPP1R13B;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.35886903594760783,-0.7777209975563365,0.8518518518518519,1.0,1.0,3/41,8.33%,SPRY4;PRKCD;UCHL1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.5492610888873354,-0.7776029206714594,0.8936170212765957,1.0,1.0,1/5,8.97%,NTRK3
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3988096630050739,-0.777534611221559,0.7317073170731707,1.0,1.0,3/23,11.23%,PRKCD;TMSB4X;MYADM
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.4174393103894491,-0.7775051582610402,0.7272727272727273,1.0,1.0,3/23,8.56%,TERF2IP;CHTF18;RFC3
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.3967925292563249,-0.7773936614380033,0.7755102040816326,1.0,1.0,2/30,3.07%,STX16;STX11
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.31559085222769884,0.7772823852716807,0.84,0.9929166110657442,1.0,12/128,12.23%,TIMELESS;CCNA2;SEM1;RRAD;H2BC21;LRIG3;PAXIP1;LIG4;POLE2;CHEK2;EYA2;MAPK8
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.4943746157705128,-0.7772227322067753,0.7857142857142857,1.0,1.0,4/6,26.78%,CDHR2;SMO;YAP1;PTPRJ
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.44140460299292883,0.7771997833127566,0.7857142857142857,0.9928384344259052,1.0,2/15,5.19%,CCL5;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.448712230092075,-0.7771383902538695,0.7560975609756098,1.0,1.0,3/11,18.30%,CBARP;PACSIN3;CAV3
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.3066093822626424,-0.7771136926894321,0.8979591836734694,1.0,1.0,10/164,7.30%,LRP10;BST1;ENPP2;AGRN;GPC2;SLC19A3;GPC1;GPC3;NAXE;PTS
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.40175932959924754,0.7769944906182839,0.8275862068965517,0.9929558215086404,1.0,8/18,33.35%,ANAPC16;UBE2D1;UBE2E1;ANAPC15;CDC27;CCNB1;ANAPC7;PLK1
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.359584000281611,-0.7766819176682629,0.8260869565217391,1.0,1.0,19/85,12.59%,HAPLN3;SPON2;COL5A1;GFRA2;MGP;SPTLC3;BOC;ZNF469;SFRP1;IFIT2;C1S;IFIT3;PIEZO2;SPARC;COL1A1;PAMR1;PDGFRL;ADAMTS1;GBP1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.3721993703611317,0.7764897374761099,0.8888888888888888,0.9936107497707372,1.0,4/33,9.40%,SEMA5A;FGF2;F3;DSCAM
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.36593496615693594,-0.7763943205991669,0.7894736842105263,1.0,1.0,7/38,16.81%,INHA;ALAS2;ZFPM1;UFL1;ID2;MED1;TGFBR3
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.3507114147817366,0.776393295788063,0.8703703703703703,0.9935949082186071,1.0,2/48,1.22%,TCIRG1;ATP6V0D2
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.35399449733324206,-0.7763728032284222,0.8363636363636363,1.0,1.0,11/45,18.29%,TRPV5;PTH1R;PLCB2;CLTA;VDR;DNM1;ATP1B1;CLTB;RAB11A;ATP2B2;AP2A2
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.41274255836478957,-0.7763655800909817,0.7209302325581395,1.0,1.0,1/12,4.74%,DDX41
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.34680366608599067,0.7763073198139728,0.7931034482758621,0.9935465062019148,1.0,9/59,12.07%,TENM1;NAV3;FER;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3586672212365065,0.776292415973019,0.896551724137931,0.9933651705666788,1.0,14/46,25.19%,FBXO5;IVNS1ABP;SPOPL;BAG2;MARCHF7;NXN;GNL3L;SIRT7;ARRB2;ABL1;HSPA1A;OGT;N4BP1;SMAD7
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.39261322509449087,-0.7762378541631214,0.8,1.0,1.0,4/29,12.59%,TESPA1;PRKD2;CEACAM1;GBP1
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.3680777104513844,0.776227302621902,0.84,0.9932761472501634,1.0,3/37,2.53%,IRS4;IRS1;SOCS2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.32338393238928176,0.776107827733006,0.8431372549019608,0.9932278450757389,1.0,26/139,16.51%,FGF10;SEMA5A;RSPO3;LGR5;ZEB2;RSPO2;BMP2;TLR2;NRARP;GPC5;PPM1A;RNF146;KANK1;PSMD13;SCEL;TBL1X;PSME4;SPIN1;PTK7;CSNK1G3;FRAT1;BAMBI;LGR6;GPRC5B;PSMA1;UBR5
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.4031127265361302,-0.7760937276239079,0.7659574468085106,1.0,1.0,1/19,6.23%,RNF213
prerank,Reactome_2022__Melanin Biosynthesis R-HSA-5662702,0.5511348485149807,0.7759971057229627,0.8604651162790697,0.9931985449203891,1.0,1/5,1.48%,TYR
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3323719164873699,-0.7759853386784717,0.875,1.0,1.0,7/94,7.13%,TERT;SOX30;ATP6V1C2;RSPO4;GPC3;SFRP1;PPP1CA
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.38393521571337014,0.7758080883592648,0.7735849056603774,0.9932288998481289,1.0,5/33,13.72%,TBC1D12;SEC22B;PIP4K2A;TMEM39A;MTMR3
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,0.354471449812434,0.775506637510102,0.8148148148148148,0.9934760768175215,1.0,12/45,13.75%,MME;ITGAX;IL2RA;CD244;TLR2;ITGAV;SIGLEC1;CD40;FLT3;CD34;IL18R1;ANPEP
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.2962031723804493,-0.7754161159967649,0.9629629629629629,1.0,1.0,31/346,12.82%,TRIP10;SLC29A3;KCNMB2;XYLT2;PLEKHA4;PRKCD;PDHX;IFI27;RBPMS;TGFBI;ZNF275;PTS;CAMKK2;LAMB1;CFAP97;HSD3B2;PTPN7;PCCB;RABEPK;PEPD;WFDC1;CCDC86;CAV2;CTNNAL1;PRSS23;CCDC25;GPATCH2;TXN;MTCH2;SAMD13;CTPS1
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.47696257511749607,-0.7753919366918314,0.74,1.0,1.0,1/6,6.96%,BTK
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.34630947616399077,-0.7753520571165418,0.8837209302325582,1.0,1.0,4/62,12.43%,TRMO;DUS2;METTL6;TARBP1
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.41241162908498896,0.7751761705649542,0.673469387755102,0.9937556657685506,1.0,7/29,18.93%,MYC;ESR1;WWOX;VEGFA;CITED2;KDM5B;KIT
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.4757074252277457,0.7748926481025389,0.75,0.9939403099475569,1.0,4/9,32.36%,NELL2;CD81;NOTCH1;CSPG5
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.3952535509841848,-0.7748055162610366,0.7843137254901961,1.0,1.0,5/21,15.93%,PDE4A;PPP1CA;PDE4C;CALM1;PPP1R1B
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.43573334905562844,0.7746441250658461,0.7254901960784313,0.9938706465753925,1.0,3/14,7.66%,TRPV2;SLC8A1;SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.43573334905562844,0.7746441250658461,0.7254901960784313,0.9938706465753925,1.0,3/14,7.66%,TRPV2;SLC8A1;SLC24A2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3677875382548641,0.774554439046386,0.7321428571428571,0.9937843943166395,1.0,6/36,18.15%,PLD6;TDRD9;PRKRA;TENT4B;PIWIL1;ZCCHC8
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.3856311932804465,-0.7745356238926736,0.76,1.0,1.0,1/32,0.42%,NTRK1
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.4241413959193081,-0.774316877453147,0.8125,1.0,1.0,4/17,20.35%,POLR3H;POLR3E;POLR3A;POLR3F
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3728359291664472,0.7738982854519082,0.8214285714285714,0.9945968851419092,1.0,5/22,12.35%,SLC24A2;ACHE;NLGN4X;GRIK3;PTEN
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.4607406010228807,0.7738619829150156,0.75,0.9944320294055243,1.0,1/10,5.50%,SLC8A1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.3937816750938109,-0.7736086154938397,0.7674418604651163,1.0,1.0,3/14,18.89%,DDX41;CGAS;NLRP4
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.44916368292219,0.7736062021246246,0.7321428571428571,0.9946649946433724,1.0,2/9,2.71%,ITGA11;ITGA2
prerank,CellMarker_Augmented_2021__Osteoclast:Bone,0.500332074850541,0.7735408496326459,0.8431372549019608,0.9945515939108104,1.0,1/6,3.11%,CALCR
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.43783321421787186,0.7733243417578233,0.7586206896551724,0.994673543990548,1.0,2/12,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.3965363632990498,0.7732917002381523,0.7407407407407407,0.9945304456204901,1.0,10/21,32.81%,MOGAT2;DGAT2;DGKZ;DGKD;PLA2G15;DGKE;PNPLA2;DGKI;MOGAT1;DGKH
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.45176029028081277,0.7731811951088846,0.7678571428571429,0.9942768675959547,1.0,1/9,11.09%,WASHC1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.45176029028081277,0.7731811951088846,0.7678571428571429,0.9942768675959547,1.0,1/9,11.09%,WASHC1
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.355382897425351,0.773094530314723,0.8604651162790697,0.9941879923760661,1.0,15/58,21.74%,ERBB4;NRG1;LLGL1;PRKAB2;RPS6KA2;LRRC7;GRIN2D;CREB1;RPS6KA1;PRKAA1;PRKACB;MPP3;MAPK3;CAMK4;RPS6KA6
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.40992252925406375,0.773094132196868,0.8113207547169812,0.9939748759789867,1.0,1/18,1.49%,EPHA7
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.28845469938354296,0.7729818311585511,0.9782608695652174,0.9939401264648294,1.0,57/260,20.04%,RENBP;ENGASE;SYVN1;SEC22B;ST6GALNAC3;SPTBN5;CD59;NANP;RNF185;ALG6;ST8SIA4;UAP1;RNF139;MAGT1;MOGAT2;MANEA;ANK2;LMAN1;ST3GAL6;BET1;TMEM115;NUS1;COL7A1;FUT8;DCTN3;PRKCSH;RNF5;EGFL7;DYNC1I2;MVD;MAN2A1;ALG9;ANK1;MAN1A2;MGAT5;NPL;MGAT4C;SLC35C1;DERL2;LMAN2L;MGAT4A;GFUS;COG5;DOLK;B4GALT3;CD55;TMED3;STX17;GNPNAT1;TFG;STX5;GFPT1;B4GALNT2;TRAPPC1;ACTR10;ST8SIA1;SEC24B
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.31204077402241226,0.772947784894396,0.8958333333333334,0.9937811658208224,1.0,25/124,17.81%,IL4;SEM1;PELI2;PTPN20;RELA;PELI1;TIFA;MAP2K6;PELI3;HMGB1;PTPN14;TAB2;PSMD13;MAPK8;IRAK1;IL18R1;TANK;PSME4;TAB3;PSMA1;MAP3K8;IL33;IRAK3;PTPN23;TP53
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),-0.5100382932694836,-0.7729288327679107,0.7727272727272727,1.0,1.0,2/5,13.89%,SLC5A1;SLC2A1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3713481917804338,0.7728840986167432,0.7931034482758621,0.9936735730393113,1.0,5/27,18.54%,BMI1;EZH2;EPC1;EED;H3-3A
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.33252834853229485,-0.7728039953014417,0.7872340425531915,1.0,1.0,5/65,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3256959567700868,0.7727172252664424,0.8823529411764706,0.9936901991542657,1.0,4/67,13.94%,SYK;NXT1;RANBP17;PRICKLE1
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,-0.4619738472615085,-0.7724991001103555,0.7872340425531915,1.0,1.0,1/11,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.4773404193008846,0.7721835508723919,0.7413793103448276,0.994427405984335,1.0,1/6,5.88%,TLR2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.42079413667595844,0.7721591122830433,0.8409090909090909,0.9942360981090127,1.0,4/16,15.21%,GNB4;GNG12;GNG4;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.38677559316486293,0.7720825838179355,0.8297872340425532,0.9941338954214497,1.0,7/34,22.26%,CASS4;GRM5;GPRC5B;EFNA1;DLG3;GAS6;ACE
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.406665340872874,0.7720502785458625,0.8333333333333334,0.9939993712968749,1.0,9/23,26.63%,PRDX6;PLA2G10;PNPLA6;PNPLA8;PLA2G7;GPCPD1;GDPD3;PLA2G15;INPP5F
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,0.43616335187466887,0.7718703821198303,0.782608695652174,0.9940752333878973,1.0,4/14,13.08%,FGFR3;FGF17;SOS1;FGF5
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.39350733945935634,-0.7717862749198721,0.7833333333333333,1.0,1.0,6/28,15.19%,ABCA4;ABCB1;ABCB4;MFSD2A;ATP9B;ATP8B4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.37971678657882874,-0.7716415265354153,0.7857142857142857,1.0,1.0,2/25,6.78%,NUPR1;LZTS1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.43413741902867226,0.7715279301509299,0.7547169811320755,0.9943532588541362,1.0,1/11,4.61%,ADGRG6
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,-0.33003436628064003,-0.7714086757117081,0.9310344827586207,1.0,1.0,7/94,12.16%,TMEM179;ZCCHC12;BEX1;LZTS1;ENO2;INA;USP11
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.48235609989054823,0.7712279693361248,0.8043478260869565,0.9945691719439955,1.0,2/9,7.75%,TLR2;HMGB1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.42173667910116097,0.7710544764209291,0.7916666666666666,0.9946098312538557,1.0,5/16,27.11%,SLC8A1;ATP1A2;ATP1B2;ATP12A;KCNJ2
prerank,Reactome_2022__Gap Junction Assembly R-HSA-190861,0.47681591722065103,0.771016426358993,0.8070175438596491,0.994451101234538,1.0,4/7,22.70%,GJB7;GJB6;GJB1;GJA1
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.3219364993117085,-0.7707713144103359,0.8444444444444444,1.0,1.0,7/107,7.14%,SELP;MPO;RAC2;H4C5;C5;H4C3;PLCB2
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.3158110257059851,0.7707302052851512,0.875,0.9946506931399743,1.0,8/93,7.63%,IGF1;FLT1;EGLN3;HIF1A;ANGPT1;RELA;PLCG2;TF
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.3718705451483669,0.7702886296899718,0.7924528301886793,0.9951679813149429,1.0,2/38,3.28%,SEM1;RRAD
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.2765675852985746,0.7701369920021105,1.0,0.995178860580561,1.0,89/627,18.38%,SLC7A11;NOX5;TCIRG1;ATP6V0D2;CDKN2C;MYC;HIF3A;SIRT1;EGLN3;CCNA2;HIF1A;ACD;PHGDH;SEM1;CDKN2A;SYVN1;NRIP1;COX19;RORA;TNIK;IDH1;H2BC21;FKBP5;RELA;MAPKAPK2;MOV10;MAP2K6;ASF1A;HDAC3;UBE2D3;KEAP1;ANAPC16;MAPKAPK3;SMARCD3;PSMD13;NCOA2;RPS6KA2;EZH2;RPS5;DCTN3;TBL1X;DAND5;DYNC1I2;MEF2C;EXOSC4;RRAGC;MAPK8;BAG2;H2AC6;DNAJC3;ATP6V0B;TERF1;XPO1;HSPA8;RNF2;H2AZ2;RPL21;PSME4;CREB3L2;CREB1;RPS6KA1;CHD9;LMNB1;UBXN7;H2AX;ATF6;COX6A1;NFE2L2;EPX;TNFRSF21;MAPK10;KPTN;PSMA1;DNAJB9;RPL18A;MYDGF;RANBP2;ARTN;RPL7;SCO2;VEGFA;CDK4;TP53;AGO3;RPS3A;CITED2;EED;RRAGD;MRPL18
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.3503517718140081,0.7700181028987895,0.8333333333333334,0.9951116697009816,1.0,11/37,18.26%,MGAT2;B4GALNT4;FUT8;MAN2A1;ALG9;MAN1A2;MGAT4C;MGAT4A;HEXD;B4GALT3;HEXB
prerank,CellMarker_Augmented_2021__B cell:Undefined,-0.34292771021161644,-0.7699046139031075,0.78,1.0,1.0,5/53,3.86%,CD24;SELL;BST1;CD86;IL6R
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.40145570941091624,-0.7697339578411916,0.75,1.0,1.0,1/16,1.76%,TERF2IP
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.38620827544090836,0.7696097618571303,0.819672131147541,0.9956312193961209,1.0,2/22,1.22%,TCIRG1;ATP6V0D2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.3803374925830748,0.7693486106181612,0.7966101694915254,0.9958249647691538,1.0,2/23,3.67%,ENPP1;FBXO5
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.41865827251201154,0.7690658351009397,0.782608695652174,0.9960428391431797,1.0,4/16,19.76%,HAP1;DLG2;DST;ACTR10
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4525395565034501,-0.769026812744194,0.7551020408163265,1.0,1.0,4/10,12.94%,DMGDH;SMOX;LRTOMT;BHMT
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,0.45828541428286396,0.7690113650373294,0.7719298245614035,0.9958921431512624,1.0,4/8,22.81%,CD40;CX3CR1;PTPRC;ITGAM
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.3571418819503494,0.7689311141709376,0.8461538461538461,0.9958006703880535,1.0,5/29,14.91%,NLGN1;CRHBP;MEF2C;LRRC7;DLG2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.41082954428704604,-0.7688200174274553,0.75,1.0,1.0,7/23,16.45%,DRD4;CBARP;DRD2;MMP9;GNB5;CALM1;CLIC2
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.4442931413840358,-0.76875666148235,0.84,1.0,1.0,1/12,1.14%,F8
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.3910985324410766,-0.7686950191483118,0.75,1.0,1.0,4/22,15.11%,FGF1;FGF20;FRS3;FGFR4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.3561636422945744,0.7686515963753955,0.88,0.995975395024569,1.0,6/49,6.24%,IGF1;FCAR;STEAP4;DAPK2;IDO2;LAIR1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.49521875929069903,-0.7686452474099434,0.725,1.0,1.0,1/6,6.54%,SLC13A3
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.44995738589772355,0.7683927301955492,0.7346938775510204,0.9962145546177468,1.0,1/7,1.48%,TYR
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.4711504334591354,-0.7683475862092788,0.7407407407407407,1.0,1.0,1/6,5.96%,DLL4
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.3748104396060479,0.7682850530143222,0.8333333333333334,0.9961902546707276,1.0,7/28,19.24%,PELI1;TNFRSF10B;FASN;TANK;BIRC3;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.4527985688639181,-0.768209970833918,0.7317073170731707,1.0,1.0,1/9,5.40%,PAH
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.40237278654595476,0.7679965731408461,0.7586206896551724,0.9964588207362257,1.0,5/22,17.62%,PRMT1;METTL21C;CAMKMT;VCPKMT;FAM98A
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.3139927442963412,0.7679924577052585,0.9148936170212766,0.9962518190864712,1.0,18/91,19.06%,FGFR1;MMP16;MAFB;SP1;MMP15;CASR;GNAI3;MEF2C;PDE4B;NR4A2;CREB3L2;CREB1;LRP6;PLCB1;SLC34A2;ARRB2;GNA13;PRKACB
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3823720437849889,0.7677359225716511,0.7441860465116279,0.9964370038526045,1.0,3/32,15.80%,HIF1A;HAP1;DST
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.46373694458011533,-0.7675080438984154,0.7083333333333334,1.0,1.0,1/8,4.39%,CBARP
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.43212614445148273,0.767426284940928,0.7457627118644068,0.9964313123167576,1.0,3/12,10.17%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.43212614445148273,0.767426284940928,0.7457627118644068,0.9964313123167576,1.0,3/12,10.17%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.3524229461238243,0.7669733185867493,0.8,0.9969196199486217,1.0,13/46,16.53%,LRAT;ALDH1A1;DHRS3;SDC4;NAPEPLD;GPC5;PECR;GPC4;RPE65;BCO1;LRP2;CYP4V2;AKR1C1
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,-0.4617334308650096,-0.7668797980386439,0.7446808510638298,1.0,1.0,2/8,25.46%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.4837458201930882,0.7668541855485423,0.7755102040816326,0.9968925227893934,1.0,2/7,13.29%,ABI3;RBMS3
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.4090409906592984,0.766852648139561,0.6923076923076923,0.9966803277015286,1.0,7/21,23.16%,LLGL1;PPM1E;LRRC7;GRIN2D;MPP3;CAMK4;DLG1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.34376335421871484,-0.7662652413885718,0.8936170212765957,1.0,1.0,1/45,1.32%,HSPB3
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.33754354852359475,0.7662214617640687,0.8596491228070176,0.9971706354674196,1.0,9/66,9.92%,MYC;PPP1R14B;HES6;FRAT2;AHCY;ODC1;HDAC2;ADA;FAM117B
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.33754354852359475,0.7662214617640687,0.8596491228070176,0.9971706354674196,1.0,9/66,9.92%,MYC;PPP1R14B;HES6;FRAT2;AHCY;ODC1;HDAC2;ADA;FAM117B
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.42870294113102236,-0.7661950641272073,0.7307692307692307,1.0,1.0,2/10,9.13%,ERCC1;RAD50
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.3937657902633719,0.766178179126658,0.8085106382978723,0.9970067752430694,1.0,9/24,20.65%,PTGS1;HPGDS;CYP2S1;CD74;PNPLA8;AKR1C1;AKR1C3;ACOX1;EDN1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.4390117689738058,-0.7655159202265268,0.7551020408163265,1.0,1.0,2/9,13.87%,APOA1;ABCB4
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.31078143718267925,-0.7653910673086969,0.9629629629629629,1.0,1.0,10/127,9.83%,ACTC1;MYH7;SCN5A;CAMK2A;KCNE1;PPP1CA;PLCB2;KCNQ1;CACNG5;CREB3L1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.49113905387286944,0.7652956610139263,0.7560975609756098,0.9981564119013507,1.0,4/7,31.73%,SMS;MTR;ADI1;MSRA
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.4883979676644377,-0.7652567942027847,0.8181818181818182,1.0,1.0,2/7,12.32%,STAC;NIPSNAP2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3864221035422472,-0.7650582904236353,0.7777777777777778,1.0,1.0,8/30,18.94%,RAC2;P2RY12;KIF17;PARVG;RAC1;PARVB;RHOQ;NCKAP1L
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3925235419201536,0.7650443692484973,0.7543859649122807,0.9983193587851047,1.0,7/25,23.45%,DMC1;HORMAD1;GDF9;FMN2;NANOS1;USP9X;TOB2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.4735710802169474,-0.764994430203259,0.7441860465116279,1.0,1.0,2/7,14.90%,P2RY12;NTN1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.3136553321695391,0.7646758641460918,0.9411764705882353,0.9986537131240169,1.0,11/82,12.71%,IGF1;TRPM8;ASIC1;TRPV2;MAP2K6;PLCG2;PPP1CC;PIK3CA;HTR2C;MAPK8;KNG1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.40471644988224803,-0.7646439201529317,0.8269230769230769,1.0,1.0,6/16,12.91%,FAM3D;SFRP1;KCNJ11;CCN3;FFAR4;CRH
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.40485954088983833,-0.7642743474969643,0.7045454545454546,1.0,1.0,5/17,12.16%,NLRP3;MEFV;IL18;ENTPD5;TXN
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,0.3244727735523696,0.7642029969088734,0.8727272727272727,0.9991727593979718,1.0,5/79,5.04%,TOP2A;CDC25A;CCNA2;CKMT1A;DLGAP5
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.28327037998107085,-0.764191494744217,1.0,1.0,1.0,30/318,10.84%,UROC1;AMDHD1;APIP;SERINC2;DUOX1;TYRP1;ASS1;CRYM;PDHX;PIPOX;ASPG;ARG2;PAH;PSMB4;CYP21A2;DBH;PXMP2;RPS27L;DMGDH;SARS1;OAZ3;BHMT2;PRODH2;SMOX;SLC6A11;GLDC;GOT2;MCCC2;SLC6A12;VSIG2
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.295730585559355,0.7641704348900431,0.9464285714285714,0.9990140042006677,1.0,16/121,16.35%,CCNA2;SEM1;H2BC21;GMNN;MCM7;ANAPC16;PSMD13;GINS1;POLE2;H2AC6;H2AZ2;PSME4;SLC19A1;H2AX;ORC4;PSMA1
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,0.47119199373019166,0.764085671520526,0.7719298245614035,0.9989115464011381,1.0,2/8,20.21%,CTNNB1;FZR1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4014213454549401,-0.7637365299206186,0.8048780487804879,1.0,1.0,5/26,9.16%,PDE6B;RBM4;PER2;PPP1CA;RBM4B
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.3311304542461198,-0.7636260481415397,0.94,1.0,1.0,8/47,16.04%,ABRAXAS1;RNF8;EYA1;RAD50;SMARCA5;BRCA1;H2BC15;KDM4B
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",0.42235598862388124,0.7635788091539867,0.7884615384615384,0.9994596546904684,1.0,4/10,23.60%,PFKFB4;PRKACB;PFKFB2;PPP2R1B
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.42129960504250874,0.7634679943682092,0.7547169811320755,0.9994320871832192,1.0,2/9,21.01%,VANGL2;ATP8B1
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.3156449945333561,0.7634242448706192,0.9166666666666666,0.9992948190375835,1.0,14/155,10.87%,SLC7A11;NOX5;MYC;PHGDH;SEM1;CDKN2A;COX19;IDH1;HDAC3;KEAP1;SMARCD3;PSMD13;NCOA2;TBL1X
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.4369620643454899,-0.7632996677516403,0.8333333333333334,1.0,1.0,3/12,14.54%,SCPEP1;CYP26B1;ADH7
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.35918804509302527,0.7632849597205593,0.8478260869565217,0.9993127790513319,1.0,2/46,3.28%,SEM1;RRAD
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.343574600453184,-0.7632446347042137,0.9183673469387755,1.0,1.0,10/77,12.99%,NTRK1;NUPR1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3389821249216493,0.7631810151930619,0.8490566037735849,0.9992799107159994,1.0,13/77,19.07%,FZD5;PRICKLE2;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PSMA1;ARRB2;SMURF1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.49604476665567887,-0.763110795954102,0.7391304347826086,1.0,1.0,2/5,15.64%,P2RY12;GPR183
prerank,KEGG_2021_Human__Propanoate metabolism,-0.37779494213701903,-0.7630971467457518,0.7755102040816326,1.0,1.0,4/32,9.04%,LDHC;LDHAL6A;PCCB;MLYCD
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.29351060109711213,-0.7629557628373471,0.9591836734693877,1.0,1.0,15/243,8.56%,TERT;F5;F8;HGSNAT;CLDN1;MEFV;GOLGA2;JCHAIN;TUBGCP2;RSPH9;FANCC;AFG3L2;PPP6R1;HFE;TRAPPC2L
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,0.4669079397108847,0.762774872794021,0.7358490566037735,0.9997016716071033,1.0,1/10,8.00%,PLA2G10
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,0.42073148442912334,0.7627480590859912,0.7580645161290323,0.9995350527078978,1.0,5/17,10.58%,EBF1;CD22;ICOSLG;CD40;FOXO1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3567467866987129,-0.7625934871690448,0.8163265306122449,1.0,1.0,1/34,3.26%,MAP1LC3B2
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.358365797603404,0.7625307846148942,0.8235294117647058,0.9996705617541429,1.0,5/33,7.82%,SEMA5A;ADAMTS17;ADAMTS16;ADAMTS19;SPON1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5095620606419446,-0.7624616368624068,0.76,1.0,1.0,1/5,12.61%,NUCKS1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.413443482903801,0.7623327346696527,0.8245614035087719,0.999787305788004,1.0,2/16,14.30%,PCSK5;LRP6
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.4355128952044697,0.762301926810228,0.723404255319149,0.999612758884216,1.0,1/8,12.90%,GTF3C4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3868371666932242,-0.7622310653931285,0.8181818181818182,1.0,1.0,6/24,16.18%,PLAAT4;ETV4;VDR;PRKCH;ZFP36L1;MED1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.45824748416148486,0.7621653400339181,0.8,0.9995718546459685,1.0,3/13,11.32%,STING1;UBA5;RETREG1
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.29657763078772165,0.7620914015228228,0.9215686274509803,0.9994561851369512,1.0,24/103,21.59%,ADRA1A;PRKG1;ACTG2;PPP1CC;PLA2G10;RAMP3;MYH11;GUCY1A2;NPPA;PLA2G12B;NPR2;PPP1R12B;PLCB1;PPP1R12C;GUCY1A1;CALCRL;ADORA2B;GNA13;PRKACB;KCNMB4;KCNMB1;EDN1;MAPK3;GNAQ
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4143507648526439,-0.7620739703141218,0.7391304347826086,1.0,1.0,3/15,6.96%,INHA;SFRP1;BTK
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.34497308671155225,-0.7620105593543455,0.8461538461538461,1.0,1.0,6/57,16.34%,BUD23;PDCD11;UTP11;EMG1;NHP2;UTP15
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.4307052291130207,0.7619370144789606,0.7903225806451613,0.9995034493740603,1.0,1/11,9.95%,GSN
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5042716385224896,0.7618240450134998,0.7560975609756098,0.9994706033104279,1.0,2/9,3.04%,IL4;EHD1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3421512108239265,-0.7617910292809644,0.8867924528301887,1.0,1.0,2/41,3.41%,CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),0.4855194709943053,0.761712604635678,0.8269230769230769,0.9994057418320551,1.0,1/6,7.71%,ADRA2C
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,-0.35414363822597994,-0.7616924937507091,0.825,1.0,1.0,7/65,6.58%,CLDN4;GPR39;C6ORF132;SPDEF;RHBDF1;DSG2;MYO5B
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,-0.35414363822597994,-0.7616924937507091,0.825,1.0,1.0,7/65,6.58%,CLDN4;GPR39;C6ORF132;SPDEF;RHBDF1;DSG2;MYO5B
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),0.3735885432881362,0.7614088001416105,0.8148148148148148,0.9997438581791407,1.0,1/26,4.55%,IDH1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3757290085867463,-0.761202228642807,0.7291666666666666,1.0,1.0,8/24,21.69%,RRM2;B3GNT5;RRM1;ALG8;ALG11;ST8SIA6;GK5;G6PD
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.30465712235011155,0.7606979005935641,0.8936170212765957,1.0,1.0,3/94,1.96%,TCIRG1;ATP6V0D2;NDUFC2-KCTD14
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.44243270401326407,-0.7603340352960274,0.6944444444444444,1.0,1.0,3/7,20.62%,LETM1;CLDN16;TESMIN
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.33248916669245504,0.7598314601577109,0.9038461538461539,1.0,1.0,6/46,11.86%,EFNA5;DOCK1;CASS4;KANK1;CORO1C;CARMIL1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.3353507906090143,0.7598126769474145,0.8775510204081632,1.0,1.0,32/92,28.80%,CDH2;LLGL1;SCRIB;GPR176;PTOV1;GPSM1;PRKCSH;KLC2;FASN;DBN1;FJX1;BOP1;CDH24;ABL1;TRIM28;CDK16;GPS1;P3H3;SH3GL1;PLOD3;TMEM184B;NAT14;STK25;SLC4A2;NR2F6;RANGAP1;SCARF2;MEX3D;FAM171A2;ZNF205;THOP1;GLIS2
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.39526687688447054,-0.7597173534551234,0.8536585365853658,1.0,1.0,5/27,9.16%,PDE6B;RBM4;PER2;PPP1CA;RBM4B
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.36821897446201945,0.7594602683128261,0.86,1.0,1.0,2/40,3.28%,SEM1;RRAD
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.3165575917724973,0.7594180621456101,0.9215686274509803,1.0,1.0,28/97,26.90%,LRP4;GNG12;ARHGEF17;LIFR;B4GALNT4;MAGI1;PLXNB1;PCDH7;BCAR1;PTPRU;GPR37;CPE;GPRC5B;LAMA5;MAP2;SCARA3;CAMSAP2;CDR2L;DDR1;FAT1;COL4A5;ARHGAP39;EGFR;EPN2;DNER;MAP6;MID1;TJP1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.4496644036398806,-0.7592482171882248,0.7446808510638298,1.0,1.0,4/5,33.41%,MAPT;BAG3;PRKN;HDAC6
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.4902238389903051,-0.7592017425737119,0.7608695652173914,1.0,1.0,2/6,13.11%,CAMK2A;CAV1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.4750509961182138,-0.7590472576030676,0.85,1.0,1.0,2/7,14.78%,DHX58;USP17L2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.39559840822337006,0.7590005171892874,0.711864406779661,1.0,1.0,6/19,18.12%,OSBPL6;NUS1;NR1H3;ABCA8;LIPG;ABCA2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.4556823545402674,0.758974147638803,0.7924528301886793,1.0,1.0,1/6,2.81%,FGF2
prerank,KEGG_2021_Human__African trypanosomiasis,0.37992976286445546,0.7589690458966858,0.864406779661017,1.0,1.0,3/23,6.21%,LAMA4;IDO1;IDO2
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.35458024912840236,0.7586307428017077,0.8222222222222222,1.0,1.0,9/39,16.68%,SCRIB;ARHGAP5;VANGL2;MUC13;ANKRD26;LRRC1;DST;PKP4;KTN1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.47426167822700305,-0.7584157902087418,0.7555555555555555,1.0,1.0,2/10,4.93%,SCPEP1;DRD2
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.4101045384109935,-0.7583455965982617,0.7777777777777778,1.0,1.0,1/16,1.14%,F8
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.39233738022333225,0.7581653456509065,0.7818181818181819,1.0,1.0,6/31,13.57%,ST6GALNAC3;NANP;ST8SIA4;ST3GAL6;EGFL7;NPL
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.3654513563408914,-0.757946350219478,0.8095238095238095,1.0,1.0,8/43,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3290006109326449,-0.7578309490653143,0.8461538461538461,1.0,1.0,11/85,9.53%,GPR39;CGA;HRH2;PTGDR;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.41879447570109285,0.7576142273141632,0.82,1.0,1.0,6/14,15.60%,CCNA2;PRDM14;SMAD1;SMAD4;POU2F1;SMAD5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.4113159480978179,0.757590626968552,0.746031746031746,1.0,1.0,2/20,7.38%,PRDX6;TRA2A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.3458757349533182,-0.7575620172700485,0.7727272727272727,1.0,1.0,8/49,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.40309716123448186,0.7572689215622737,0.8363636363636363,1.0,1.0,5/24,17.36%,MRAP2;ABI3;LZTFL1;PICALM;NUMB
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.33804069768723544,-0.7571614010304731,0.8125,1.0,1.0,4/64,3.43%,RAC2;BST1;PEAK3;PRKCD
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.3063224406215597,-0.7568956109423691,0.9615384615384616,1.0,1.0,17/96,12.98%,ALB;F5;AHSG;VGF;GPC3;MXRA8;SCG3;LAMB1;NOTUM;PAPPA2;MFGE8;APOA1;WFS1;APOB;PRSS23;IGFBP3;PAPPA
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.42989463112985193,0.7568030821054476,0.7959183673469388,1.0,1.0,2/16,9.99%,BMP2;BIN1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.27851322480861557,0.756711549590796,1.0,1.0,1.0,54/298,22.30%,AP1M2;SYK;RAB38;TBC1D3L;ACD;TBC1D8B;EHD1;TBC1D12;NLGN1;RAB31;LTBP2;VPS26C;ARL5A;SNX31;NXT1;RAB23;LMAN1;HAP1;RANBP17;BCS1L;XPO1;RABL2B;STRADA;CD74;PRICKLE1;SGSM3;RPGR;TBC1D4;GGA1;TBC1D5;RAB29;VPS29;RAB28;STX8;STXBP3;TMED1;TMED3;RTN2;STX17;SMURF1;STX5;GRTP1;PPP1R10;TICAM2;RAB5B;EVI5L;SAR1A;TRAK2;MYO1C;STX3;NUP153;AKT2;USP6NL;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.3494351183651223,0.7566334244779446,0.7931034482758621,1.0,1.0,3/37,3.12%,RIN2;UTRN;RRAS
prerank,CellMarker_Augmented_2021__Dendritic cell:Peripheral Blood,0.47231531434163704,0.7565999864446079,0.7313432835820896,1.0,1.0,1/7,1.66%,ITGAX
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.3565083454924315,-0.7565744021677863,0.851063829787234,1.0,1.0,10/35,16.85%,EPOP;SFRP1;MEOX1;PAX2;WNT7A;FOXO4;UFL1;OSR1;HTR2B;FGFR2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3382705337068167,-0.7565668752754396,0.8888888888888888,1.0,1.0,11/49,20.69%,AHSG;TIMP4;SERPINI2;SERPINB5;SERPINE2;APH1B;PSME3;VTN;SERPINB9;SERPINA10;APH1A
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4276834275746799,0.7565527130289122,0.7924528301886793,1.0,1.0,3/13,18.74%,GRIK2;PPFIA3;SHISA8
prerank,KEGG_2021_Human__ABC transporters,-0.3592077150372561,-0.756510254062671,0.8367346938775511,1.0,1.0,3/42,4.05%,ABCA4;ABCC12;ABCC4
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.33129736073182725,-0.7564895509009488,0.94,1.0,1.0,8/46,16.04%,ABRAXAS1;RNF8;EYA1;RAD50;SMARCA5;BRCA1;H2BC15;KDM4B
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.39524869788836453,-0.7563600079139627,0.813953488372093,1.0,1.0,5/22,12.94%,APIP;BHMT2;GOT2;VSIG2;BHMT
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.45330549954237187,-0.7561543893799241,0.7804878048780488,1.0,1.0,2/8,10.93%,DDRGK1;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.47816643625856353,-0.7561394777516548,0.7413793103448276,1.0,1.0,1/5,2.24%,MRLN
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.35049670032463515,0.7558591464409681,0.7872340425531915,1.0,1.0,9/55,8.32%,STAB1;ITGAX;CSF3R;HCLS1;ABI3;FGL2;SIGLEC1;TFEC;RAMP3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.4621397723011785,0.7557736312667652,0.6896551724137931,1.0,1.0,4/6,31.68%,DMD;KCNJ2;C12ORF57;SLC8A3
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.5050396228879792,0.7554810199464341,0.8571428571428571,1.0,1.0,1/5,18.40%,RPE
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.37730483722972796,0.7552153456921143,0.875,1.0,1.0,3/24,8.93%,ITGAX;ITGAV;DSP
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.4635925921382916,0.7551644898785538,0.7547169811320755,1.0,1.0,2/6,8.94%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.27492079349732823,0.7551455642602939,1.0,1.0,1.0,13/138,13.39%,TENT5A;ZFP36L2;SAMD4A;MAPKAPK2;PSMD13;RIDA;HNRNPD;EXOSC4;ANP32A;HSPB1;XPO1;HSPA8;PSME4
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),0.4794447986625992,0.7550957022253506,0.8076923076923077,1.0,1.0,1/5,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.2972809895082455,0.7550369191211674,0.8775510204081632,1.0,1.0,17/110,18.54%,H2BC21;DMC1;ASF1A;GMNN;MCM7;PSMD13;TCF4;PSME4;CCNH;H2AX;ORC4;ANP32B;PADI4;PSMA1;MNAT1;CENPV;H3-3A
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.3210133330786329,-0.7548222332162506,0.9322033898305084,1.0,1.0,7/97,8.73%,DUSP4;SIGIRR;DUSP6;FOS;BTK;JUN;ECSIT
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),-0.5090272593318602,-0.7547723502520659,0.825,1.0,1.0,1/5,5.07%,ACTN3
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.3270298072885205,-0.754622199723236,0.8269230769230769,1.0,1.0,1/68,0.76%,TBC1D10C
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.30686997943225586,0.7541325334402709,0.9629629629629629,1.0,1.0,28/116,22.25%,SYK;SEM1;RELA;PLCG2;TAB2;PIK3CA;PSMD13;MAPK8;PPP3CA;SOS1;ITK;PSME4;NFATC3;MAP3K1;GAB2;TAB3;MAPK10;PSMA1;PKN2;VAV2;LYN;UBE2D1;IKBKB;PSMD4;MAPK3;SLC7A8;RASGRP4;GRB2
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.4469266566172252,0.7540863118808053,0.8727272727272727,1.0,1.0,3/9,20.84%,ATF6;HSPA5;DDIT3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.33547877832205913,0.7540647981893269,0.9074074074074074,1.0,1.0,14/60,22.25%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.33547877832205913,0.7540647981893269,0.9074074074074074,1.0,1.0,14/60,22.25%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.38937157290078156,0.7540357363034558,0.7446808510638298,1.0,1.0,5/26,5.08%,VCAN;BGN;B3GAT2;CHSY3;UGDH
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),-0.4862656663700319,-0.7540207365610007,0.72,1.0,1.0,2/6,10.39%,PRODH2;GOT2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.46556102328123106,0.7539168803775738,0.819672131147541,1.0,1.0,4/8,23.64%,PICALM;DNM3;MX2;SNAP91
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.3585100809539201,-0.7536734495712077,0.8,1.0,1.0,8/28,14.63%,ATP6V1E2;ATP6V1C2;ATP6V1E1;HFE;ATP6V1D;ATP6V0A2;ATP6V1F;STEAP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.4664677453126146,0.7536139977473831,0.7735849056603774,1.0,1.0,2/7,5.19%,CCL5;CXCL12
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.47297526858432093,0.7534701487339802,0.7454545454545455,1.0,1.0,1/5,6.69%,PRIMPOL
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.4070256855608804,0.753452666641422,0.7719298245614035,1.0,1.0,4/13,15.08%,TGFBR1;BMPR1A;SMAD4;KIAA0319
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.29872310563920845,-0.7534215150152985,0.8936170212765957,1.0,1.0,22/140,13.11%,TERF2IP;WARS1;PRKCD;ATG14;MVP;XDH;SFRP1;TRIB1;TRIB2;SPRED3;SPRED2;UBASH3B;CEACAM1;NTRK3;CAMK2N1;TAF7;SPRED1;MYADM;PYDC1;IGFBP3;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.42999401735196524,0.7528826993100811,0.8,1.0,1.0,2/10,7.75%,F2R;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.32124419937425097,-0.7526516308991802,0.8125,1.0,1.0,8/75,8.71%,SIRPG;AHSG;GPC3;SPACA3;DOCK2;SLC11A1;FLOT1;CDH3
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.29163703861887935,0.7525584891832103,0.9622641509433962,1.0,1.0,36/154,21.01%,TCIRG1;ATP6V0D2;MCOLN3;TRPM8;ASIC1;TRPV2;TRPC4;STOM;TSC22D3;SCNN1B;ATP6V0A4;ATP1A2;ATP6V0B;TRPC5;SLC9C2;ATP13A1;TTYH2;TRPM2;ANO5;ANO6;RYR2;SGK1;ASPH;TRPM7;UNC79;TRPV3;RYR3;WNK1;TRPM3;ASIC4;ATP2C1;SCNN1D;TRPC1;ATP1B2;OSTM1;ATP8B1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.42426813930900764,-0.7525310363765132,0.75,1.0,1.0,2/10,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.45665460160439797,0.7523436337701759,0.7924528301886793,1.0,1.0,2/8,26.69%,FCHSD2;WASF2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.4699703498869638,-0.7522712196357496,0.8,1.0,1.0,2/11,7.56%,TST;NOX4
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.2999315639964199,0.7522273354128804,0.9565217391304348,1.0,1.0,11/92,14.60%,NDE1;CEP70;PCM1;RAB3IP;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,KEGG_2021_Human__Circadian entrainment,0.31035395649264913,0.7521981295872887,0.8863636363636364,1.0,1.0,17/84,19.06%,PRKG1;GNB4;GNG12;KCNJ3;GNAI3;GUCY1A2;GNG4;GRIN2D;CREB1;PLCB1;RYR2;GUCY1A1;RPS6KA5;CACNA1I;RYR3;PER3;PRKACB
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.34401390634369944,0.7520552756232712,0.8113207547169812,1.0,1.0,3/48,9.76%,SEM1;CDKN2A;PSMD13
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.5058210857834902,0.7515666220035834,0.8269230769230769,1.0,1.0,2/5,14.36%,ABCG8;ABCG5
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.33971353921354364,0.7515046674759068,0.8333333333333334,1.0,1.0,15/51,25.06%,PRMT1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;CNOT2;TP53;CDC25C;GTSE1;MDM4;EP300;RBL2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.4756711359533232,-0.7514712105544177,0.75,1.0,1.0,1/6,8.19%,UBASH3B
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3798757525165519,0.751207276596577,0.7169811320754716,1.0,1.0,5/25,9.21%,HPSE2;SDC4;HPSE;GPC5;GPC4
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.3045557217183801,-0.7510920966604464,0.9166666666666666,1.0,1.0,15/81,15.78%,STAC;KCNE2;CAMK2A;KCNE1;JPH2;CACNG5;MMP9;CACNG8;KCNS1;CRH;PTK2B;SHANK1;CTSS;CALM1;SHISA7
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,-0.45620112787183326,-0.7510012387429585,0.8367346938775511,1.0,1.0,2/12,14.15%,POLR1A;RPA3
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.3553064322168085,0.7509999722607501,0.8620689655172413,1.0,1.0,14/47,23.23%,H2BC21;SNCA;GSN;NPPA;SNCAIP;H2AC6;H2AX;GGA1;CALB1;ADAM10;IAPP;ITM2B;FURIN;USP9X
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.48645857501708994,0.7508482221683833,0.7777777777777778,1.0,1.0,2/6,10.93%,FLT3;LIG4
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.4344690550482655,0.7508404363581104,0.8169014084507042,1.0,1.0,3/11,22.23%,PEX12;PEX2;PEX13
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,0.4616587575732237,0.7501747689766571,0.7755102040816326,1.0,1.0,2/9,10.30%,ST6GALNAC3;GALNT1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.4263766046787086,0.7501591542311181,0.803921568627451,1.0,1.0,3/8,18.78%,PTEN;PHLDB2;FERMT1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4069110312221245,-0.7500587844476608,0.8333333333333334,1.0,1.0,4/15,16.37%,WNT7A;SHANK1;EPHB1;SHANK3
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.322084733421716,-0.7500077844528893,0.9038461538461539,1.0,1.0,12/76,14.55%,PARP2;PIAS3;ERCC1;RFC3;XPC;PARP1;GTF2H2;COPS7A;POLR1A;XRCC1;RPA3;RFC2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.4520153929287568,0.7497561024624275,0.8070175438596491,1.0,1.0,3/12,20.89%,GLUL;DAO;GLUD1
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,-0.4527975407226166,-0.7496324694115709,0.8461538461538461,1.0,1.0,2/11,9.52%,CYP24A1;VDR
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.44420562895864457,0.7494994345804888,0.7254901960784313,1.0,1.0,2/8,15.22%,SPX;NENF
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.457922827238399,0.749369188762186,0.7818181818181819,1.0,1.0,1/7,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.457922827238399,0.749369188762186,0.7818181818181819,1.0,1.0,1/7,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.5037589340298595,0.7492877532619527,0.8392857142857143,1.0,1.0,3/6,17.00%,PLXNB2;RACGAP1;ARTN
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.37333993952235245,-0.7489845343348811,0.8392857142857143,1.0,1.0,1/32,0.73%,AMACR
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.42542322771192914,0.7488475462110085,0.8048780487804879,1.0,1.0,6/14,19.92%,PTGS1;HPGDS;CYP2S1;AKR1C1;AKR1C3;ACOX1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3499599146137534,0.7487936576537063,0.82,1.0,1.0,3/30,10.55%,PPP1R15B;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.5012322953666526,0.7486819804600489,0.8,1.0,1.0,4/5,34.12%,CHAC1;DPEP1;GGT5;CHAC2
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.32564498040546963,0.748578068718154,0.8113207547169812,1.0,1.0,7/56,16.35%,SEM1;SYVN1;GPC5;PSMD13;PSME4;DERL2;PSMA1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3632552893866856,0.7485648840902249,0.803921568627451,1.0,1.0,6/21,21.51%,TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3632552893866856,0.7485648840902249,0.803921568627451,1.0,1.0,6/21,21.51%,TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.3365352660229524,0.7484857600181061,0.8,1.0,1.0,6/49,16.35%,SEM1;SYVN1;PSMD13;PSME4;DERL2;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.5022203741434115,-0.7481695729707363,0.7924528301886793,1.0,1.0,3/6,7.64%,ACTN3;NIBAN2;FLOT1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.32682037017503673,0.748093003704126,0.88,1.0,1.0,12/42,24.76%,ZFP36L2;NUDT16L1;RIDA;EXOSC4;DXO;AGO3;SLFN14;PNPT1;ZFP36;LSM2;HSPA1A;YTHDF2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.29648881342473127,0.7480021618895675,0.9803921568627451,1.0,1.0,20/134,16.65%,THEMIS;ICOSLG;RELA;NFKBIZ;PLCG2;DENND1B;PAG1;TAB2;PIK3CA;PSMD13;BTN2A2;NFKBID;PDE4B;BCAR1;ITK;PSME4;TNFRSF21;PIK3CD;PSMA1;CD247
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.3161400276289024,0.7479059335548359,0.9230769230769231,1.0,1.0,12/68,13.09%,CCL5;SIRT1;ZFP36L2;RELA;CD40;CRHBP;ERBIN;GCH1;HYAL3;ZFAND6;HAS2;TANK
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.3191708152765307,0.7478382730191143,0.9615384615384616,1.0,1.0,14/74,11.21%,ACE2;HNF4G;CKMT1A;GOLT1A;EFNA2;PPP1R14D;APOBEC1;MMP15;AGR2;DSP;TSPAN6;MUC13;CGN;ARHGEF16
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.3966789143016446,-0.7476726911762817,0.8095238095238095,1.0,1.0,7/19,24.60%,DARS2;SARS2;DTD1;GARS1;AARS2;TARS2;WARS2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.4608895024610636,0.7476295750477127,0.8367346938775511,1.0,1.0,5/11,33.65%,NR1H3;SGK1;SGK2;STK39;PON1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3431693108755693,0.7476243404084715,0.8297872340425532,1.0,1.0,7/40,17.61%,SIRT1;LPIN3;MOGAT2;LIPG;DGAT2;AGMO;CPS1
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.28578654554736704,-0.7474601333299252,0.9607843137254902,1.0,1.0,18/131,16.17%,ACTC1;HMGB3;BEX2;RPS27L;CEBPZ;NTRK3;BEX4;TMSB4X;NLRP9;TXN;NDUFS5;ZNF486;ATP6V1F;RPA3;SPATA6;EID1;MRPS21;ADTRP
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.37384978066328467,0.747390718541884,0.9,1.0,1.0,5/41,14.96%,CSTA;NLRP7;KNG1;SERPINB7;CRB2
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.42342727494681043,-0.7472989937009402,0.7317073170731707,1.0,1.0,5/11,24.71%,MLYCD;DECR2;EHHADH;ACOT4;ACAA1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.3679634548988069,0.7472919408230834,0.7727272727272727,1.0,1.0,3/31,10.28%,NDE1;BICD1;HAP1
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.3075255493535505,0.7472129845583076,0.8461538461538461,1.0,1.0,16/66,21.12%,PLEKHG2;FGD4;ARHGEF17;ARHGEF16;MAPK8;PRPF38B;SOS1;MAGED1;ARHGEF6;VAV2;ARHGEF40;CASP3;GNA13;MCF2;BAD;ARHGEF4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.32585462090461625,-0.7470765083884604,0.88,1.0,1.0,11/86,9.53%,GPR39;CGA;HRH2;PTGDR;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.36318897814873263,-0.7469606373316324,0.7924528301886793,1.0,1.0,2/32,6.74%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.49114805960602204,0.7469146670110831,0.8444444444444444,1.0,1.0,1/6,6.56%,ABCC2
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.30477370550637817,-0.7465654329498939,0.9333333333333333,1.0,1.0,11/94,10.48%,CLDN4;RAC2;CTNNA1;CLDN1;CD99L2;VAV3;F11R;TXK;CTNNA3;MMP9;CLDN15
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.3512108020260167,-0.7464789405074745,0.8163265306122449,1.0,1.0,8/45,7.71%,XYLT2;CHST9;AGRN;GPC2;GPC1;XYLT1;GPC3;CHST7
prerank,KEGG_2021_Human__RNA transport,0.3046606887036906,0.7464179865329889,0.9148936170212766,1.0,1.0,11/154,10.49%,RPP25;NXF1;THOC6;EIF3E;RPP25L;RPP40;NXT1;PABPC1L2A;PABPC5;EIF1AY;SMN2
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.45414843901015545,-0.7463524620758131,0.7804878048780488,1.0,1.0,2/9,6.32%,CYP24A1;CYP4F2
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.32100503215274173,-0.7461337166915015,0.9347826086956522,1.0,1.0,5/82,5.63%,CTNNA1;PXDN;PRKCD;RNASE1;VAV3
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.3659304175659611,0.7460353252877019,0.8333333333333334,1.0,1.0,12/40,24.65%,H2BC21;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;POLR2H;ERCC3;POLR1D;TAF1B
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.3211802989074324,0.7460311619610676,0.82,1.0,1.0,13/56,14.53%,ACSM2A;CYP39A1;GAMT;CYP27A1;CYP7B1;OSBPL6;SRR;ABCD3;OXSM;CH25H;HSD17B10;ACACA;LIPG
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.4418980121118916,-0.7460247967734926,0.7843137254901961,1.0,1.0,1/12,7.83%,CCDC88C
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.39342450270323504,0.7459950203312408,0.8301886792452831,1.0,1.0,2/19,3.06%,AMPD1;AK3
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.4426284744987016,-0.7459587401697085,0.7804878048780488,1.0,1.0,2/9,11.03%,IFI27;CAV2
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,0.4489413086332681,0.7457282708166976,0.8076923076923077,1.0,1.0,6/11,28.53%,TANK;FADD;OTUD7B;USP2;TRADD;CYLD
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.38240954489615564,0.7455166598120314,0.813953488372093,1.0,1.0,4/20,11.56%,TSPAN12;FGF2;BMPER;VASH2
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,-0.3768058918956371,-0.7453294396528795,0.8043478260869565,1.0,1.0,1/16,2.60%,PXDN
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.4657608331114754,-0.7450893343044435,0.813953488372093,1.0,1.0,2/15,9.08%,PDHX;PDPR
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.49129123331565194,-0.7449229622814569,0.8076923076923077,1.0,1.0,1/5,12.82%,CTPS1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.37035557205281217,-0.7447797312780076,0.8048780487804879,1.0,1.0,7/17,20.69%,MBTPS2;SPPL2B;TGFB1;APH1B;MBTPS1;ADAM9;APH1A
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.36087012059155693,-0.744580526037746,0.86,1.0,1.0,9/42,16.45%,FXYD6-FXYD2;CAMK2A;KCNJ11;ITPR3;ATP1B1;RYR1;CALM1;FXYD7;CLIC2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.4728628650533055,-0.7442506046816129,0.8181818181818182,1.0,1.0,1/8,1.76%,TERF2IP
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.34551547008791644,0.7440369710636086,0.8775510204081632,1.0,1.0,5/36,11.83%,GNB4;GNG12;KCNJ3;GNAI3;GNG4
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3334927564272984,0.7439549101708303,0.8620689655172413,1.0,1.0,11/59,17.81%,RFWD3;PRMT1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;CNOT2;TP53
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.34500306286530774,0.7437629252685416,0.8490566037735849,1.0,1.0,5/34,7.82%,SEMA5A;ADAMTS17;ADAMTS16;ADAMTS19;SPON1
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.3558269902094848,0.7437471357831509,0.8367346938775511,1.0,1.0,7/47,20.95%,SEM1;FBXO5;PSMD13;PSME4;PSMA1;FZR1;PSMD4
prerank,Reactome_2022__Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,-0.44043539420175926,-0.743698486562941,0.8775510204081632,1.0,1.0,1/9,5.09%,DSG2
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.3335661424006929,-0.7435989885424957,0.9090909090909091,1.0,1.0,20/90,12.55%,CFAP61;INSRR;ATP6V1C2;KCNJ16;DCDC1;SLC22A8;UMOD;RGS22;DNAAF1;PDZD2;COL28A1;WDR93;ADGRF5;ZBTB7C;SLC22A6;MUC15;CCDC40;P2RY14;ATP13A5;CFAP221
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.38027223380661396,0.7435551622342662,0.7884615384615384,1.0,1.0,7/21,30.92%,ANAPC16;UBE2D1;UBE2E1;ANAPC15;CDC27;CCNB1;ANAPC7
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.3845983382374398,0.7434975559007044,0.7843137254901961,1.0,1.0,3/21,7.32%,KAT2B;H2AC25;STAMBPL1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.4126445297495104,0.743331352104467,0.7619047619047619,1.0,1.0,4/11,13.61%,MID2;GSN;TRIM26;PTX3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.42600382039791623,-0.7433277923247923,0.7291666666666666,1.0,1.0,1/12,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.3530834290610866,0.7431624953389591,0.7843137254901961,1.0,1.0,3/39,4.06%,RHOBTB3;NLGN1;LLGL1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,-0.4307790360814341,-0.7431070204118954,0.7692307692307693,1.0,1.0,1/14,1.43%,GATD3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.37929264043820893,-0.743073467056902,0.813953488372093,1.0,1.0,7/28,16.18%,SOX30;PAQR7;AR;CAV1;TGFB1;ADTRP;MED1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.304611609769768,0.7430193596920827,0.9285714285714286,1.0,1.0,21/111,19.07%,FZD5;WNT4;MOV10;PRICKLE2;PSMD13;VANGL2;PDE6A;PPP3CA;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PLCB1;FRZB;PSMA1;CTNNB1;AGO3;ARRB2;SMURF1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.2882515360162082,0.7425894357373766,1.0,1.0,1.0,19/153,16.15%,IRS1;NDUFC2-KCTD14;TGFBR1;SP1;RELA;PPP1CC;MPC1;PIK3CA;SMAD2;MAPK8;PTEN;SLC25A31;PLCB1;COX6A1;PPIF;TBC1D4;RYR2;PIK3CD;MAPK10
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,0.431279640233902,0.7425112610471659,0.7894736842105263,1.0,1.0,2/11,7.69%,ITGAX;CD40
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,0.431279640233902,0.7425112610471659,0.7894736842105263,1.0,1.0,2/11,7.69%,ITGAX;CD40
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,0.431279640233902,0.7425112610471659,0.7894736842105263,1.0,1.0,2/11,7.69%,ITGAX;CD40
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,0.431279640233902,0.7425112610471659,0.7894736842105263,1.0,1.0,2/11,7.69%,ITGAX;CD40
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,0.431279640233902,0.7425112610471659,0.7894736842105263,1.0,1.0,2/11,7.69%,ITGAX;CD40
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.3489285015940761,0.7423131839399503,0.8461538461538461,1.0,1.0,4/30,9.20%,SCN7A;CACNB4;SCN10A;SCN3A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4701163823682111,0.7422935523230855,0.84375,1.0,1.0,3/8,30.16%,BNIP3L;ATF2;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.5064143631847468,0.7422293768794597,0.8,1.0,1.0,2/8,3.04%,IL4;EHD1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.3921121261708974,-0.7421952134923843,0.8653846153846154,1.0,1.0,3/31,4.59%,AWAT1;ALOX5;HMGCL
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.3994785572070805,0.742005445584006,0.8148148148148148,1.0,1.0,4/21,19.55%,NEDD4;SMURF1;MVB12A;LGMN
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.28546024162526557,0.7419273988846717,1.0,1.0,1.0,13/111,12.81%,NXPH1;HRH3;SLC17A6;TENM1;ZDHHC22;NRXN1;OLFM3;PAK5;TMEM196;GRIK3;NOL4;KCNB2;NR4A2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.43994137691196733,-0.7417428780637764,0.782608695652174,1.0,1.0,2/6,12.94%,BHMT2;BHMT
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryo,-0.35221604563333614,-0.7416892543490672,0.875,1.0,1.0,11/45,12.12%,ALB;HABP2;AHSG;FGL1;PAH;HAO2;PRODH2;APOA1;APOB;SMLR1;C3P1
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryonic Stem Cell,-0.35221604563333614,-0.7416892543490672,0.875,1.0,1.0,11/45,12.12%,ALB;HABP2;AHSG;FGL1;PAH;HAO2;PRODH2;APOA1;APOB;SMLR1;C3P1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.38534964967747887,0.7416818839539724,0.851063829787234,1.0,1.0,4/18,12.35%,NLGN1;NRXN1;RIMS2;PTEN
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.34831691451348434,-0.7413395530788393,0.8444444444444444,1.0,1.0,7/58,12.24%,ABRAXAS1;RNF8;ERCC1;POLQ;RAD50;PRPF19;CYREN
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.3035735629094953,0.7413180958065042,0.9487179487179487,1.0,1.0,9/81,8.33%,DRD5;CALCR;GNB4;GNG12;INSL3;RXFP2;GPR176;RAMP3;GNAI3
prerank,Reactome_2022__Fatty Acids R-HSA-211935,-0.45521340325670245,-0.7412958000004808,0.7674418604651163,1.0,1.0,1/7,6.32%,CYP4F2
prerank,KEGG_2021_Human__Tyrosine metabolism,0.36714474124707486,0.7412826894810305,0.7727272727272727,1.0,1.0,2/25,3.71%,TYR;HPD
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.37067476216450695,0.7412403833004984,0.8490566037735849,1.0,1.0,11/27,22.25%,SYK;PLCG2;MAPK8;SOS1;MAP3K1;MAPK10;PKN2;VAV2;LYN;MAPK3;GRB2
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.39084085386427303,0.7412044510760171,0.8596491228070176,1.0,1.0,1/26,1.16%,AP1M2
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.30718225039005476,0.7410541482981734,0.9642857142857143,1.0,1.0,19/91,20.26%,ITPKB;PIP4K2A;PIK3C2B;PLCG2;INPP1;IP6K3;INPP4B;PIK3CA;PTEN;MTMR3;PI4K2B;PLCB1;PIK3CD;DGKZ;PLCD1;IMPA1;IP6K1;DGKD;PIK3R3
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3635524132560084,0.7407754915978226,0.8571428571428571,1.0,1.0,5/37,5.74%,CHRM2;HRH3;HTR1F;NPY;SSTR3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.4169749780674202,-0.740770030468694,0.7142857142857143,1.0,1.0,1/12,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.32056242088963216,-0.7407696151009081,0.8333333333333334,1.0,1.0,15/56,26.31%,GPR132;PSMB4;RFPL1;PSMC4;PSMD8;SKP1;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NABP2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.30947305403464037,0.7407062135703719,0.8913043478260869,1.0,1.0,14/70,15.34%,C1QL1;TENM3;EFNA2;VSX2;POU3F2;SPSB4;EPHA8;ONECUT2;BCAR1;DLL3;FJX1;NR2F2;RIMS4;FOXO6
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.3017550222047296,0.740688235827689,0.8490566037735849,1.0,1.0,11/79,14.02%,PIK3R6;PIK3R5;PIP4K2A;PIK3C2B;INPP4B;PIK3CA;PTEN;MTMR9;PNPLA6;MTMR3;PI4K2B
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.43691299658308125,-0.7406424161838593,0.8,1.0,1.0,3/22,5.91%,TMOD1;ACTN3;NEB
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.3091281830050273,0.7406046762959342,0.926829268292683,1.0,1.0,13/99,15.75%,LRP4;TENM3;PCLO;SYT1;MAGI1;CAMK2N2;CLDN12;RASAL2;ONECUT2;BCAR1;SPIRE2;MAGI3;CPE
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.4495133331464742,0.740557069032796,0.7547169811320755,1.0,1.0,1/7,6.69%,PRIMPOL
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.3020187367342618,0.740497269220325,0.8928571428571429,1.0,1.0,22/96,23.63%,SIRT1;PLOD2;KAT2B;METTL21C;LOXL2;ATPSCKMT;ESCO1;CTH;RANBP2;SIRT7;VCPKMT;NSMCE2;HDAC9;SENP6;TRIM28;KIAA1586;P3H3;NUP153;LIPT2;PLOD3;SAE1;BCL11A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.368008716392793,0.7404092051810485,0.86,1.0,1.0,3/22,14.98%,CBLB;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.44269433788433554,-0.7402121087372525,0.8085106382978723,1.0,1.0,2/11,8.18%,RFTN1;OAS1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.28570234768351904,-0.7402008393883734,1.0,1.0,1.0,40/269,16.48%,PARP2;ABRAXAS1;TICRR;SLX4;REXO4;RNF8;RECQL5;ERCC1;FANCG;EYA1;FANCC;RPAIN;RFC3;POLQ;TRAIP;RAD50;XPC;RAD51AP1;SMUG1;RAD51AP2;PARP1;GTF2H2;FAN1;LIG1;NUCKS1;XRCC1;SMARCA5;RPA3;TEX264;RFC2;ZRANB3;BRCA1;EXO1;TNP1;CDKN2D;TNKS1BP1;KDM4B;MUS81;CDK1;APTX
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.3319428646707211,0.740117761928866,0.8333333333333334,1.0,1.0,15/67,14.25%,SIPA1;CDKN2A;BRINP3;BMP2;SCRIB;HTRA2;GMNN;LATS1;RPS6KA2;PTPRK;TP53BP2;PTEN;HEXIM2;HECA;NR2F2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.2828901323821263,0.7399797093885501,1.0,1.0,1.0,35/152,20.49%,SLC5A8;SCN7A;SLC22A3;TRPM8;ASIC1;KCNJ3;SLC12A3;SLC5A12;SLC8A1;KCNH4;SCNN1B;SCN3A;ATP1A2;KCNB2;SCN9A;KCNG2;TRPM2;LRP2;PIEZO1;ANO6;KCNF1;SGK1;KCNAB3;TRPM7;SLC3A2;SLC5A4;SLC36A1;NDFIP2;KCNJ10;TRPM3;SLC7A6;KCNMB4;KCNJ8;SCNN1D;KCNMB1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.4521035584053743,0.739798381423016,0.8,1.0,1.0,1/5,3.59%,MAFB
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3360591324595573,0.7397411313032242,0.8793103448275862,1.0,1.0,5/32,15.40%,GMNN;MCM7;LRWD1;POLE2;ORC4
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.33173610792817076,0.7397399492122455,0.88,1.0,1.0,5/51,8.69%,TCIRG1;ATP6V0D2;TF;CYBRD1;ATP6V0A4
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),0.5037488437861984,0.7397240845761642,0.8571428571428571,1.0,1.0,4/5,49.50%,ATP2B4;CHRNB2;CHRNA7;CHRNA3
prerank,CellMarker_Augmented_2021__CD4+ T cell:Peripheral Blood,0.4586815348612661,0.7393511534818761,0.75,1.0,1.0,1/5,4.16%,IL2RA
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.3377944929023641,0.7392492331309254,0.8813559322033898,1.0,1.0,7/46,17.64%,EFL1;PWP2;RRS1;RPS5;BOP1;MTERF3;ERAL1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46057717858897457,0.7392490916959267,0.7843137254901961,1.0,1.0,1/10,8.00%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.41288389190605657,-0.7391723528228386,0.8,1.0,1.0,2/14,8.95%,CIITA;CEACAM1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.4378589142506626,0.7390966614731976,0.76,1.0,1.0,1/7,8.67%,GCH1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5142885693369071,0.7389371785484682,0.8392857142857143,1.0,1.0,1/6,5.96%,TET2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.4602573734683539,-0.7388680302456453,0.7551020408163265,1.0,1.0,2/5,18.46%,RCSD1;AQP1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.3861158369730799,0.7388221396010981,0.9387755102040817,1.0,1.0,3/29,5.86%,COL9A1;COL9A2;MMP15
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.3638718235017302,0.7386727498923711,0.8793103448275862,1.0,1.0,6/28,16.17%,FZD5;HTRA2;UBE2D3;RHOU;UBE2J2;BAP1
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.38309551488355187,0.7384947776580101,0.8723404255319149,1.0,1.0,4/19,18.47%,MYH11;PPP1R12B;LIMK2;RHOB
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4322552573795333,0.738428861108866,0.7868852459016393,1.0,1.0,2/15,7.38%,PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3026137352035302,0.7383318556111786,1.0,1.0,1.0,30/151,19.44%,STK26;SIRT1;DAPK2;FANK1;KANK2;SEPTIN4;TP53INP1;HIP1;FLT3;TNFRSF10B;CASP10;BNIP3L;TP53BP2;BCAR1;ANP32A;MAGED1;IFT57;SGK1;GAS1;ANP32B;LGALS1;BCL3;BIRC3;FBXO11;PERP;TP53;PHLPP1;TNFRSF10A;IRF3;ABL1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.36316388807922423,0.7383228439171171,0.8666666666666667,1.0,1.0,7/31,21.16%,ABL2;PHACTR4;MAPK8;ABL1;MID1IP1;POT1;MAPK3
prerank,KEGG_2021_Human__Apoptosis,-0.2970333287802869,-0.7383118089033696,0.9433962264150944,1.0,1.0,4/121,4.71%,NTRK1;CTSO;PARP2;FOS
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.29687812375902206,0.7382526330604541,1.0,1.0,1.0,24/122,16.16%,EDIL3;LRP4;ASIC1;TENM3;BGN;ARHGEF17;ADGRL2;LIFR;PRICKLE2;ANK2;GFRA1;MAGI1;GUCY1A2;BCAR1;HTRA1;CBS;FIGN;ID4;SEMA6D;FRZB;CPE;GPRC5B;PDZRN3;CTH
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.3416433445536329,0.7382484847554549,0.8703703703703703,1.0,1.0,1/41,2.25%,NXF1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.36988568450080295,0.7382002173288151,0.8363636363636363,1.0,1.0,6/23,27.39%,RBBP6;DBN1;RHOBTB1;GPS1;HNRNPC;STK38
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.4704935545481112,0.738125049952817,0.8,1.0,1.0,4/7,23.64%,PICALM;DNM3;MX2;SNAP91
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.290351507344731,-0.7381026911968163,0.9803921568627451,1.0,1.0,9/182,7.24%,DUSP4;HK2;PLA2G2C;PLAAT4;PLCZ1;INPP5D;PPP1CA;PLCB2;LHPP
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.31561999848119915,0.7379941781171803,0.9285714285714286,1.0,1.0,14/78,16.35%,SEM1;WNT4;RORA;SCRIB;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;NCOA3;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.4273344332511093,0.7379280704675072,0.8367346938775511,1.0,1.0,3/11,28.49%,STX3;ABCA7;TMEM35A
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.4380549446098104,0.7377192323809361,0.7755102040816326,1.0,1.0,4/9,18.32%,GADL1;CBS;CTH;MPST
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.4822528780563299,0.737705938268236,0.8214285714285714,1.0,1.0,2/6,29.33%,SCARA3;SDF4
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,-0.3574610381654083,-0.7375435122746266,0.8163265306122449,1.0,1.0,5/20,13.84%,MUC5B;MUC19;ST6GALNAC2;MUC15;ST3GAL3
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.33795891826613184,0.7373509612223633,0.8524590163934426,1.0,1.0,1/41,1.49%,TOP2A
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.36695805164564693,-0.7373355269885462,0.8604651162790697,1.0,1.0,7/33,18.27%,PRKCD;CAMK2A;CAMKK2;CAMKK1;CALM1;ADCY1;PDE1C
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.31462122618327965,-0.7372683777972575,0.9444444444444444,1.0,1.0,13/77,13.89%,TERF2IP;WARS1;ATG14;XDH;NTRK3;ARPP19;BEX4;PTPA;MYADM;IGFBP3;DAB2IP;XRCC1;TGFB1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.3208767054045542,-0.7372488898908318,0.8653846153846154,1.0,1.0,16/53,27.67%,RPF2;LAS1L;NSA2;EBNA1BP2;NHP2;RRP15;MRTO4;BRIX1;RPL5;RPL26L1;EIF6;SURF6;RPL35A;WDR12;SNU13;NPM1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.46195466126379586,0.7368667435599809,0.8723404255319149,1.0,1.0,3/11,19.74%,RESF1;ATF7IP;TRIM28
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.34250154816059114,0.7368359308243185,0.8448275862068966,1.0,1.0,13/41,28.95%,TAB2;TANK;TAB3;BIRC3;FADD;IKBKB;TAB1;OTUD7B;USP2;CHUK;TRADD;CYLD;OTULIN
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.30692547747994764,0.7365458877310009,0.9230769230769231,1.0,1.0,11/115,7.51%,RUNX1;CALCR;GNG12;BMI1;DOCK1;LRIG3;ARHGEF17;SCRIB;WWTR1;ASB5;LIFR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.4740557771565801,0.7365347761595068,0.8275862068965517,1.0,1.0,1/7,7.57%,AGR2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.3984686632105695,-0.7365236149096577,0.75,1.0,1.0,1/18,1.23%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.3926120934789932,0.7362993944706752,0.7719298245614035,1.0,1.0,3/12,20.46%,SNCA;DYRK1A;MAP2
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.323865248380861,0.7362124955947844,0.8269230769230769,1.0,1.0,6/50,16.35%,SEM1;SYVN1;PSMD13;PSME4;DERL2;PSMA1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.45546966439767494,0.735904897027832,0.7884615384615384,1.0,1.0,2/5,20.82%,GSN;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.40246115928705073,-0.7358433193238323,0.7619047619047619,1.0,1.0,3/23,4.93%,DRD4;CBARP;DRD2
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.3866280532164277,-0.7358272820664811,0.8367346938775511,1.0,1.0,3/17,13.11%,PNPLA4;PPP1CA;CAV1
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,0.32786369610315474,0.735676335426557,0.9137931034482759,1.0,1.0,9/57,11.11%,LGALS9;TNFSF13B;IFI44;TLR2;SIGLEC1;TFEC;TAP1;C3AR1;HLA-E
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.28588444423295645,0.7356229460590373,0.9791666666666666,1.0,1.0,15/176,8.33%,DRD5;C3;SYK;CALCR;GNB4;GNG12;INSL3;DOCK1;RELA;RXFP2;MYO1E;PLCG2;GPR176;RAMP3;GNAI3
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,-0.44754249237049887,-0.7355724979673531,0.8636363636363636,1.0,1.0,3/10,15.40%,SLC24A4;SLC24A5;CALM1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.3749107076012486,0.7355478233590562,0.8043478260869565,1.0,1.0,8/23,34.80%,BAP1;MINDY2;OTUD4;OTUD7B;YOD1;USP8;MINDY1;USP33
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.42582287016804155,0.7354664572907695,0.82,1.0,1.0,5/15,24.86%,FOXO3;FOXO1;CITED2;DDIT3;EP300
prerank,Reactome_2022__Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,0.5018945623438669,0.7353752834450635,0.8,1.0,1.0,3/5,22.84%,CCND3;CDK4;CDK6
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.3580624228827217,0.7353361501016293,0.8135593220338984,1.0,1.0,3/25,13.08%,FGFR3;FGF17;FGF5
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3779612997035072,-0.735110033313675,0.8947368421052632,1.0,1.0,3/21,12.95%,BIK;MMP9;PDCD5
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.4044405822918241,0.735090426508512,0.7678571428571429,1.0,1.0,2/19,8.67%,IDH1;GCH1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.32670248868873636,0.735059351544801,0.8653846153846154,1.0,1.0,3/71,3.60%,SWSAP1;SEM1;RFWD3
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.35662378009550555,-0.7347497278193855,0.8444444444444444,1.0,1.0,7/32,20.23%,STX11;DNM1;FER1L5;OTOF;CHP1;NAPG;GCA
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.474052817680994,0.7346894584122206,0.78,1.0,1.0,1/5,20.58%,BAD
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.4198903497827233,-0.734592996404306,0.7209302325581395,1.0,1.0,3/8,20.15%,DAB2IP;PIK3IP1;TWIST1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.45391695147551636,0.7345771230882517,0.873015873015873,1.0,1.0,4/8,33.19%,SNAPC1;ICE2;ZC3H8;SNAPC3
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.32696882550760986,-0.7345039434503584,0.9019607843137255,1.0,1.0,4/75,6.35%,KLRC1;RAC2;VAV3;SHC3
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.3294253422592923,0.7344305324336369,0.8823529411764706,1.0,1.0,6/53,16.35%,SEM1;RELA;PSMD13;PSME4;UBA3;PSMA1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.4393676528978428,0.7341636074962423,0.8305084745762712,1.0,1.0,1/12,1.94%,SIRT1
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.31494026303996725,0.7341249447179635,0.9215686274509803,1.0,1.0,24/95,22.25%,KCNJ3;SP1;FKBP5;ESR1;GNAI3;PIK3CA;NCOA2;SOS1;HSPA8;CREB3L2;CREB1;NCOA3;PLCB1;GRM1;PIK3CD;KRT17;PRKACB;AKT3;PIK3R3;MAPK3;GNAQ;GNAI1;AKT2;GRB2
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),-0.5002510211471856,-0.7339829158908928,0.85,1.0,1.0,1/5,4.93%,DRD2
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,-0.31110630786077986,-0.7339239395003975,0.86,1.0,1.0,13/90,16.36%,SHCBP1;TICRR;ZWILCH;PARPBP;POLQ;RAD51AP1;DARS2;TTK;CDC6;RRM1;ARHGAP11A;EXO1;CDK1
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,-0.31110630786077986,-0.7339239395003975,0.86,1.0,1.0,13/90,16.36%,SHCBP1;TICRR;ZWILCH;PARPBP;POLQ;RAD51AP1;DARS2;TTK;CDC6;RRM1;ARHGAP11A;EXO1;CDK1
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,-0.31110630786077986,-0.7339239395003975,0.86,1.0,1.0,13/90,16.36%,SHCBP1;TICRR;ZWILCH;PARPBP;POLQ;RAD51AP1;DARS2;TTK;CDC6;RRM1;ARHGAP11A;EXO1;CDK1
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,-0.31110630786077986,-0.7339239395003975,0.86,1.0,1.0,13/90,16.36%,SHCBP1;TICRR;ZWILCH;PARPBP;POLQ;RAD51AP1;DARS2;TTK;CDC6;RRM1;ARHGAP11A;EXO1;CDK1
prerank,Reactome_2022__Sensing Of DNA Double Strand Breaks R-HSA-5693548,-0.4979830262033579,-0.7338939734344513,0.8780487804878049,1.0,1.0,1/6,9.13%,RAD50
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.3685241774858382,-0.7338160541754257,0.8409090909090909,1.0,1.0,7/31,18.27%,PRKCD;CAMK2A;CAMKK2;CAMKK1;CALM1;ADCY1;PDE1C
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,-0.42224859610626636,-0.733777967692261,0.8478260869565217,1.0,1.0,2/10,9.34%,NR4A1;FOXO4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.34774008432570225,0.7336718707653886,0.9130434782608695,1.0,1.0,9/31,20.30%,MCTP2;RIMS2;SNCAIP;MEF2C;RIMS4;SLC30A1;FMR1;MCTP1;KCNMB4
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.38906137686935854,0.7336373221293906,0.8909090909090909,1.0,1.0,6/18,21.36%,CYB5R4;RIMS2;GAL;CDK16;EDN1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.47510668457810473,0.7336052524987416,0.7924528301886793,1.0,1.0,3/7,15.21%,GLRA1;PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.31452531480874574,0.7335491612074821,0.9245283018867925,1.0,1.0,12/94,12.40%,NEDD4;SEC22B;PRMT1;ASB5;PLA2G10;IL23R;FOXO1;RANBP9;HECW2;NR1H3;MAPK8;TIPARP
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.3976104270965679,0.7334607252814282,0.8163265306122449,1.0,1.0,2/16,5.01%,CFH;CD59
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.30457688323771814,-0.7334250631453998,0.9565217391304348,1.0,1.0,14/74,18.32%,WARS1;SLX4;BIK;ERCC1;FLOT1;CLU;LIMK1;SMAD3;DAB2IP;TGFB1;SYNPO2L;SMPD3;RGCC;SLF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3528089354448801,0.73334326624452,0.9302325581395349,1.0,1.0,9/32,27.98%,FAIM;TNFRSF10B;FADD;TNFRSF10A;FEM1B;SERPINE1;ARHGEF2;LGALS3;TRADD
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.5086416949010403,0.7330974809822417,0.9148936170212766,1.0,1.0,2/5,18.48%,SAG;ARRB2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.30898104882951843,0.732998739249893,0.9130434782608695,1.0,1.0,16/79,22.98%,PRDX6;TRA2A;NOVA1;KHDRBS2;NSRP1;PUF60;QKI;KHDRBS3;RBM5;FMR1;RBFOX1;SFSWAP;NCBP1;MBNL2;SRSF3;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.38282664856491333,0.7327894260343519,0.8070175438596491,1.0,1.0,2/21,7.21%,IGF1;NLRP7
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.3250896017130525,0.7327008356519332,0.8269230769230769,1.0,1.0,19/74,16.70%,LAMA4;CDH6;CADM2;CDH2;FBLIM1;CDH12;SDK1;CLDN2;NECTIN2;CLDN12;CADM1;CLDN6;CDH10;ARHGEF6;CDH8;CLDN18;DST;CDH24;CTNNB1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.37051619545145353,0.7326581307014006,0.8214285714285714,1.0,1.0,2/19,8.20%,SLC1A3;SFXN2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.4983931050875232,0.7324644695980094,0.8307692307692308,1.0,1.0,2/5,19.96%,PLCG2;CX3CR1
prerank,Reactome_2022__Orexin And Neuropeptides FF And QRFP Bind To Their Respective Receptors R-HSA-389397,0.44052582028305,0.7324226770871372,0.8076923076923077,1.0,1.0,2/6,7.77%,NPFFR2;QRFPR
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4553274232635811,0.7323104105922289,0.8360655737704918,1.0,1.0,1/8,6.50%,MEGF10
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.35879376141912983,0.7318774992052852,0.9,1.0,1.0,9/33,22.43%,TBL2;FOXO3;NIM1K;MTMR3;PRKAA1;KPTN;TP53;HSPA5;EIF2AK3
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.34746136413192197,-0.7317929578736853,0.8571428571428571,1.0,1.0,4/30,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4053368536585569,-0.7317601653337761,0.7916666666666666,1.0,1.0,1/8,1.88%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4053368536585569,-0.7317601653337761,0.7916666666666666,1.0,1.0,1/8,1.88%,CXCL13
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.45138829397512414,0.731566985854183,0.8333333333333334,1.0,1.0,1/9,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.35140025008325365,-0.7314909215817357,0.9272727272727272,1.0,1.0,7/46,14.94%,SPTLC3;PNPLA1;DEGS2;ALOXE3;ALOX12B;SGMS2;ASAH2B
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.45946998359917557,-0.7313626194139117,0.74,1.0,1.0,1/6,5.09%,DSG2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.4064922282481579,0.7313354225876965,0.7924528301886793,1.0,1.0,4/10,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.43084268934669756,-0.7311194906351096,0.813953488372093,1.0,1.0,2/10,25.46%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.43084268934669756,-0.7311194906351096,0.813953488372093,1.0,1.0,2/10,25.46%,ASCC2;ASCC1
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.44172623121527227,0.7311110011494109,0.7872340425531915,1.0,1.0,2/6,19.06%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.41100450431266633,-0.7308637452711867,0.7954545454545454,1.0,1.0,6/13,17.27%,PAH;DBH;SMOX;HDC;TPH1;SAT2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.4638708213308322,-0.7307665118506572,0.8245614035087719,1.0,1.0,2/7,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.4638708213308322,-0.7307665118506572,0.8245614035087719,1.0,1.0,2/7,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.4215551923084832,0.7306330106113622,0.8793103448275862,1.0,1.0,5/11,15.78%,HDAC3;MTSS1;HAS2;MEF2C;NFE2L2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.37158552304281717,0.7305897157301594,0.8113207547169812,1.0,1.0,1/22,1.86%,RAB38
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.2846617685158896,0.7305350915783424,0.9767441860465116,1.0,1.0,10/116,8.32%,DRD5;SYK;CALCR;SAMSN1;INSL3;RXFP2;PLCG2;FER;GPR176;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.28460165074364563,0.7304812662852517,0.9811320754716981,1.0,1.0,11/130,10.61%,IRGM;CCL5;TNIK;CASS4;SNCA;TELO2;TAB2;GRM5;IL23R;EZH2;PAK5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.3325681385958627,0.7304465293331343,0.8372093023255814,1.0,1.0,8/64,9.32%,TNFRSF18;SYK;CCL5;CXCL12;ITGAV;MEGF10;AGR2;MAGI1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.39758256731065933,0.7301625765277676,0.7592592592592593,1.0,1.0,1/13,1.94%,SIRT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3319582706313042,-0.7299611377709733,0.8695652173913043,1.0,1.0,6/40,17.49%,ABRAXAS1;GOLGA2;MISP;KIF4A;RAB11A;BCCIP
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.36084753820188764,-0.7296693475743229,0.7872340425531915,1.0,1.0,1/24,2.66%,SYNJ2
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.3091812916228619,-0.7295498885665852,0.9607843137254902,1.0,1.0,17/79,16.57%,PRKCD;PDE4A;CAMK2A;GNAL;PPP1CA;PLCB2;CAMKK2;GNG13;CAMKK1;GNGT1;ITPR3;GNB3;GNB5;PDE4C;CALM1;PPP1R1B;ADCY1
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.30205795690789505,0.7294284849213315,0.88,1.0,1.0,19/88,14.90%,ITGA2;DOCK1;CRIM1;ADGRG6;MYOF;ITGAV;CNN3;F3;LPP;DSP;CACHD1;PTPN14;TSPAN6;PTPRK;BACE2;PTPRM;LRRC1;FZD6;PHLDB2
prerank,Reactome_2022__Negative Regulation Of TCF-dependent Signaling By WNT Ligand Antagonists R-HSA-3772470,0.4337071869634621,0.7293168468157958,0.8604651162790697,1.0,1.0,2/12,6.30%,WNT4;WNT9A
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.3428694040459935,0.7292003207881146,0.9298245614035088,1.0,1.0,5/67,5.99%,RFNG;KAT2B;LLGL1;RBPJ;NRARP
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.34904805637364816,0.7291003798824907,0.9183673469387755,1.0,1.0,7/40,18.94%,VAPB;PPM1L;CERS3;SGPL1;ALDH3B1;PLPP1;SAMD8
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.3504255694378565,0.728878377218792,0.88,1.0,1.0,3/35,10.57%,TFEB;ABCA1;AKTIP
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.38370160834502887,0.7286871755562828,0.8333333333333334,1.0,1.0,3/15,12.67%,ENPP1;PANK1;FASN
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3376332409474481,0.7285720777039721,0.8695652173913043,1.0,1.0,5/51,8.00%,LDLR;NPC2;ABCA1;MTTP;PLA2G10
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,-0.3138724627288822,-0.7284106547940364,0.9411764705882353,1.0,1.0,10/96,9.02%,NLRP1;HRH2;GFRA2;TMEM132E;NHSL2;CDH23;RTP5;SIN3B;SEMA5B;RNF175
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.395630314547636,0.7283686117260377,0.76,1.0,1.0,5/19,9.21%,VCAN;BGN;SDC4;GPC5;GPC4
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.41517943293712745,-0.7282493761785713,0.7755102040816326,1.0,1.0,1/12,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.43988957108981175,0.7282017896289577,0.7857142857142857,1.0,1.0,1/7,2.18%,ZBTB7B
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.31590033190622885,0.7281529815719405,0.9411764705882353,1.0,1.0,15/83,15.66%,SIRT1;PRMT1;PHKA1;PRKAB2;FOXO1;CPT1C;GCK;PPP3CA;CREB3L2;PPP3CC;CREB1;ACACA;ACACB;PLCB1;PRKAA1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.37996585594935856,0.7281394657764163,0.7954545454545454,1.0,1.0,4/17,17.05%,CAVIN1;GTF3C4;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.4706586552551892,-0.7280464645551215,0.7659574468085106,1.0,1.0,2/6,20.14%,SLC6A20;SLC6A7
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.3348588669377953,0.7279290355733967,0.9047619047619048,1.0,1.0,17/55,22.25%,SYK;IL4;MAP2K6;PLCG2;PIK3CA;MAPK8;SOS1;PIK3CD;GAB2;MAPK10;VAV2;AKT3;LYN;PIK3R3;MAPK3;AKT2;GRB2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.4464816259634984,0.7277308953268994,0.8909090909090909,1.0,1.0,3/10,19.56%,MYOM1;PRKACB;GAL
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.4708373705440066,-0.7276931855249518,0.85,1.0,1.0,2/7,9.27%,FLOT1;ADAM19
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.37864985722432126,0.7275880491739034,0.88,1.0,1.0,1/16,2.81%,FGF2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.4861557636336251,0.727413380844403,0.8461538461538461,1.0,1.0,1/7,7.47%,CHD7
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2805794802586746,0.7272643363655619,0.9811320754716981,1.0,1.0,35/198,20.83%,PKNOX1;SOX5;ZBTB7B;MLLT3;IVNS1ABP;TSC22D1;FOXO3;TAF3;RO60;RRAGC;NR4A2;GTF3C4;POLR3G;MLF1;TAF1A;CCNH;EPC1;TAF5;THRB;TAF2;DEAF1;EAF2;BCL3;NELFB;MNAT1;GTF2B;TP53;ARRB2;ETV7;SLC25A33;NFIC;POLR2H;TAF4;NCBP1;HIPK3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.42054897989253054,-0.727145883809203,0.8181818181818182,1.0,1.0,3/10,11.45%,LOXL4;SUMF1;APOA1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3425814553338161,-0.7270297967686005,0.86,1.0,1.0,3/28,11.27%,SCN5A;LAMB1;WNT10A
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4006080671431322,0.7268209465549358,0.8245614035087719,1.0,1.0,5/16,16.31%,ALG6;NUS1;MVD;ALG9;DOLK
prerank,KEGG_2021_Human__Endocytosis,-0.265302775501851,-0.7266888987154708,1.0,1.0,1.0,25/229,15.85%,EPN1;ARAP3;CYTH4;ARF3;ARPC5L;AGAP9;PSD4;WASHC3;ARF1;CLTA;HLA-C;PIP5K1B;CAV2;DNM1;SMAD3;CAV1;RAB8A;VPS25;CLTB;ARPC5;FGFR4;DAB2;GIT2;VPS35;ARFGAP3
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,-0.3105498502539583,-0.7265630219719719,0.8571428571428571,1.0,1.0,2/66,3.82%,CLDN4;BIK
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,-0.3105498502539583,-0.7265630219719719,0.8571428571428571,1.0,1.0,2/66,3.82%,CLDN4;BIK
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.3434596536192649,0.7265196427343487,0.8461538461538461,1.0,1.0,1/40,2.25%,NXF1
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.2970739056313551,0.7264855406575471,0.9565217391304348,1.0,1.0,34/106,22.25%,IRS1;RELA;MAPKAPK2;PLCG2;GAB1;ZNF274;FOXO3;PIK3CA;RPS6KA2;MAPK8;IRAK1;SOS1;MAGED1;SH2B2;RAP1A;RPS6KA1;MAP3K1;PIK3CD;MAPK10;RPS6KA5;IRAK3;TP53;AKT3;ABL1;PIK3R3;RIPK2;BAD;IKBKB;MAPK3;CAMK4;RPS6KA6;CRK;AKT2;GRB2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3791705830890285,0.726380336163073,0.8596491228070176,1.0,1.0,7/15,28.54%,ANK2;RYR2;HSPA5;BCAP31;UBAC2;VAPA;GBF1
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,-0.3875478279786505,-0.7262314506507879,0.8085106382978723,1.0,1.0,3/14,11.00%,RNASE1;PLXNA2;RND1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.43460932703698674,0.7261059299374676,0.8235294117647058,1.0,1.0,2/6,21.60%,FBP1;PFKP
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.31058089105265063,0.7261010040680211,0.8545454545454545,1.0,1.0,10/72,13.94%,PYHIN1;DNAJB2;RNF139;CBFA2T3;RNF217;KEAP1;ARIH1;BAG2;PTEN;PRICKLE1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.47306905380127395,-0.7260007204769988,0.8431372549019608,1.0,1.0,1/5,21.52%,GK5
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.41360710809321644,0.725978834135027,0.7796610169491526,1.0,1.0,5/11,30.72%,TBCCD1;ARHGAP21;STK25;RIPOR1;YWHAZ
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.33164739516878083,0.725968607956469,0.8461538461538461,1.0,1.0,3/52,6.52%,SYK;DOCK1;MYO1E
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.2880730220534191,0.7258663718138634,1.0,1.0,1.0,20/111,16.64%,ACSM2A;PPARG;LPIN3;ADIPOR2;MSMO1;CEL;ACADM;CPT1C;CYP4F12;ABCD3;ACSBG1;OXSM;ABCD2;FASN;SGPL1;ACACA;LIPG;PNPLA8;PEX2;ELOVL4
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.285126618912207,0.7258559493892961,0.925,1.0,1.0,23/117,16.15%,LSAMP;LRP4;NPY;PCLO;PCDH17;UNC5D;NRXN1;RAB3C;LIFR;PTPRD;FAM171B;SYNPR;ANK2;GUCY1A2;ADGRB3;TMEM196;CNTN1;SLC26A4;SEMA6D;CPE;DST;CNTN2;MAPK10
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.3845844334466222,0.725682229508251,0.7959183673469388,1.0,1.0,4/11,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.3845844334466222,0.725682229508251,0.7959183673469388,1.0,1.0,4/11,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.38873937741377573,0.7256499680776662,0.7254901960784313,1.0,1.0,5/19,9.21%,VCAN;BGN;SDC4;GPC5;GPC4
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.457474731346182,-0.7256353336305629,0.813953488372093,1.0,1.0,3/5,20.65%,SLC25A29;SLC6A20;PDZK1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.398354938730444,0.7253856474088219,0.8301886792452831,1.0,1.0,4/14,14.72%,TOP2A;HMGB1;TOP1MT;KAT6A
prerank,KEGG_2021_Human__Huntington disease,0.27207707196748193,0.7253378871097894,1.0,1.0,1.0,38/260,21.05%,TUBA1C;NDUFC2-KCTD14;SLC1A3;PPARG;SEM1;SP1;HDAC2;ATG101;GRM5;HIP1;PSMD13;HAP1;DCTN3;DNAH8;KLC2;MAPK8;CREB3L2;CREB1;IFT57;SLC25A31;PLCB1;COX6A1;PPIF;DNAH14;MAPK10;PSMA1;NDUFB11;TP53;CASP3;TUBB1;KCNJ10;ATG2B;POLR2H;ACTR10;HDAC1;TAF4;PSMD4;NRF1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32235706706260114,0.7252876512514667,0.9454545454545454,1.0,1.0,15/62,23.43%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2;BLK
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.35944123223410473,-0.725228500148933,0.813953488372093,1.0,1.0,4/38,8.18%,APOBEC3H;APOBEC3G;OAS3;OAS1
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,0.4308499821752628,0.7252048638323598,0.8596491228070176,1.0,1.0,5/10,21.36%,LNPEP;HLA-E;CTSV;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.40999036693151697,-0.7251910287301253,0.8222222222222222,1.0,1.0,1/8,8.57%,OAZ3
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.3644510290208842,-0.7249711933283599,0.9069767441860465,1.0,1.0,4/27,7.28%,CELA2A;DSG2;PCSK6;FLG
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3847005398504314,0.7247025700478389,0.7959183673469388,1.0,1.0,2/20,5.14%,NEDD4;ZFYVE16
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3277294639554274,0.7246697081947019,0.9245283018867925,1.0,1.0,12/40,26.48%,HDAC2;ACTL6A;ARID1A;ARID1B;SMARCAD1;SMARCD2;SMARCA2;HDAC1;ACTR5;RBBP4;HNRNPC;SRCAP
prerank,KEGG_2021_Human__Parkinson disease,0.2753767225873751,0.7246256714473553,1.0,1.0,1.0,32/199,21.90%,TUBA1C;NDUFC2-KCTD14;SEM1;UBE2J1;HTRA2;SNCA;GNAI3;MCU;PSMD13;SNCAIP;KLC2;MAPK8;UBE2J2;ATF6;SLC25A31;COX6A1;PPIF;GPR37;NFE2L2;MAPK10;PSMA1;NDUFB11;TP53;RYR3;CASP3;PRKACB;TUBB1;HSPA5;DDIT3;PSMD4;SLC18A2;GNAI1
prerank,KEGG_2021_Human__Alcoholism,-0.2901083562101953,-0.7245344786467288,0.9795918367346939,1.0,1.0,15/111,13.38%,SLC29A3;H4C5;DRD2;H4C3;SHC3;PPP1CA;CAMKK2;GNG13;CREB3L1;CAMKK1;HDAC7;GNGT1;GNB3;CRH;GNB5
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.3455388979997622,-0.724492968261499,0.7916666666666666,1.0,1.0,11/43,14.16%,GUCY2C;CLCA1;FAM3D;ANGPT4;DLL4;OLFM4;CEACAM1;SPINK4;SLC5A1;CDH17;GPX2
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.38097375278927126,0.7244071596397176,0.8163265306122449,1.0,1.0,3/23,5.54%,KAT2B;DLGAP5;RBPJ
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.31448762587081813,0.7243075724096488,0.9333333333333333,1.0,1.0,18/101,18.94%,VAPB;ST6GALNAC3;GAL3ST1;ELOVL5;ESYT3;TEX2;PPM1L;CERS3;ESYT2;SGPL1;CERS5;ELOVL4;TECR;ALDH3B1;ABCA2;HEXB;PLPP1;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.3400714146963498,-0.7242111224206549,0.8888888888888888,1.0,1.0,4/58,5.43%,NUPR1;TIMP4;GOLGA2;PTPN3
prerank,KEGG_2021_Human__Serotonergic synapse,0.2854091968350674,0.7239688713426994,0.9555555555555556,1.0,1.0,24/97,21.90%,RAPGEF3;HTR1F;GNB4;GNG12;KCNJ3;PTGS1;GNAI3;KCND2;HTR2C;GNG4;GABRB2;PLCB1;HTR7;HTR1E;CASP3;GABRB1;PRKACB;TRPC1;HTR2A;MAPK3;HTR5A;GNAQ;SLC18A2;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.43677725927242145,0.7238813815548837,0.82,1.0,1.0,1/11,3.09%,ANGPT1
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.3050559459329505,0.7232454233600718,0.8936170212765957,1.0,1.0,11/84,17.93%,HEMGN;CEP152;DCUN1D1;POLE2;TMEM161B;UBA6;PSME4;TRPM7;FRRS1;WDR36;ERI1
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.2787145548095487,-0.7232314092858154,0.9444444444444444,1.0,1.0,14/164,7.93%,ARAP3;DOCK8;NOXA1;RASGRF2;RNASE1;DHDDS;FMNL1;VAV3;MPZ;DOCK2;ARHGAP15;ARHGDIB;ARHGAP12;TAGAP
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.4284199831841949,0.722988677246253,0.7708333333333334,1.0,1.0,3/9,14.65%,MTTP;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.4595006074944327,-0.7229354515177133,0.717391304347826,1.0,1.0,2/7,17.32%,KDM2B;WNT5A
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.2932119475499246,0.7228550760992251,0.9259259259259259,1.0,1.0,15/96,14.47%,BOK;LRP4;GNG12;TENM3;ARHGEF17;TEAD2;GPR176;MAGI1;AMOTL1;BCAR1;HTRA1;FIGN;FJX1;NR2F2;PTPRU
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.3543222002117823,-0.722839988313078,0.8043478260869565,1.0,1.0,11/25,28.53%,TOMM20;VDAC1;PINK1;MAP1LC3A;TOMM7;MAP1LC3B;MFN2;SRC;TOMM22;PRKN;UBB
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.3690845691801762,-0.7227755245706686,0.7380952380952381,1.0,1.0,3/13,15.11%,FLOT1;CAV1;CGAS
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.3838479310830873,-0.722767031757479,0.8604651162790697,1.0,1.0,3/24,7.30%,DLL4;NIBAN2;TSPAN15
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.2858993870479285,0.7227615238407914,1.0,1.0,1.0,14/123,17.81%,CDC25A;REXO2;SEM1;RRAD;H2BC21;MCM7;PSMD13;CHEK2;PSME4;H2AX;ORC4;PSMA1;ARTN;TP53
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.45422526120996765,0.7225959968978197,0.8214285714285714,1.0,1.0,1/6,4.11%,FHIT
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.2993917052267684,0.7224400968487646,1.0,1.0,1.0,24/93,27.43%,MRPL28;MRPS12;MRPL54;MRPL44;EEF1D;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;LTN1;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33;EEF1A1;MRPL2
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.32636701773068366,0.7218038533113267,0.8909090909090909,1.0,1.0,12/51,22.25%,SYK;DOCK1;MYO1E;CD247;WASL;VAV2;ABL1;LYN;MAPK3;CRK;WIPF1;GRB2
prerank,Reactome_2022__FGFR3b Ligand Binding And Activation R-HSA-190371,0.44395595652976494,0.7217947008830615,0.7636363636363637,1.0,1.0,2/6,9.37%,FGFR3;FGF17
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,0.4157252970131061,0.7217669480326788,0.8679245283018868,1.0,1.0,3/11,4.70%,BTLA;IL2RA;IL7R
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.4193934811589808,-0.721730308628057,0.7857142857142857,1.0,1.0,2/9,6.96%,PAH;DBH
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.3219980083731454,-0.7215906695989608,0.9148936170212766,1.0,1.0,3/37,12.16%,CCT6B;GAPDHS;USP11
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.27017535334172577,-0.7215592602208488,1.0,1.0,1.0,29/171,17.13%,IFT27;HAUS7;CNGB1;DYNLT5;TTC8;PRKD2;CYS1;KIF17;PLK4;SMOX;NPHP4;EXOC3;HAUS1;PTGES2;TUBB;TUBG1;B9D1;RAB8A;DCTN2;DYNLRB1;DCTN1;AHI1;CSNK1D;TUBB4A;TRAF3IP1;CDK1;RAB11A;HAUS8;PAFAH1B1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3239621437699163,0.7213718288971153,0.9166666666666666,1.0,1.0,18/45,24.54%,INSIG1;CYP39A1;MSMO1;CYP27A1;CYP7B1;OSBPL6;CH25H;HSD17B10;SC5D;SQLE;AKR1C3;DHCR7;FAXDC2;HSD3B7;OSBPL3;OSBPL9;OSBPL7;BAAT
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,0.4263042128530721,0.7210964956623297,0.7704918032786885,1.0,1.0,3/9,7.44%,HIF1A;HDAC3;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.34313405266927444,0.7210833197847923,0.875,1.0,1.0,2/33,4.98%,BOK;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.45877473798219687,-0.720988524391012,0.7708333333333334,1.0,1.0,2/6,13.03%,RAB7B;DAB2IP
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.3886308423284861,0.7209475342231635,0.8666666666666667,1.0,1.0,5/16,22.70%,SLC1A3;SLC25A13;SLC1A6;SLC25A12;GJA1
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.39896093858828513,0.7208501428900793,0.8518518518518519,1.0,1.0,4/14,24.90%,PIK3CA;SOS1;GRB2;EGFR
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.34287892625622557,0.7208108960519881,0.85,1.0,1.0,3/36,10.80%,CWH43;PIGQ;PIGF
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.3975914860839116,0.7206750670483603,0.8870967741935484,1.0,1.0,4/16,13.08%,FGFR3;FGF17;SOS1;FGF5
prerank,KEGG_2021_Human__Dopaminergic synapse,0.2897353947927262,0.7206302342507163,0.9791666666666666,1.0,1.0,15/116,16.15%,DRD5;GNB4;GNG12;KCNJ3;PPP1CC;GNAI3;GNG4;MAPK8;PPP3CA;CREB3L2;PPP3CC;CREB1;PLCB1;PPP2R2B;MAPK10
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.4196369828209757,0.720357268958756,0.7586206896551724,1.0,1.0,3/9,7.89%,WNT4;CD244;SNCA
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.33306650799131204,0.7202715820945722,0.9347826086956522,1.0,1.0,13/48,22.23%,RNF152;PEX12;UBE2D3;SHPRH;UBE2J2;PEX2;UBE2D1;RNF144A;UBE2A;UBE2E1;HLA-B;HLTF;PEX13
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3190578460325493,0.7202016391970943,0.8867924528301887,1.0,1.0,10/72,16.17%,CDC20B;DNAJB2;CBFA2T3;RNF217;KEAP1;ARIH1;BAG2;PRICKLE1;NFE2L2;SIRT6
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.34777094345543513,0.720034474665121,0.9387755102040817,1.0,1.0,8/26,32.10%,EXOSC4;TENT4B;ERI1;NCBP1;LSM11;TUT4;LSM10;DCP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.4338173320613016,-0.7199735749520898,0.7727272727272727,1.0,1.0,3/8,12.64%,SAPCD2;MISP;GPSM2
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.37357152677546845,-0.7198961489656058,0.8846153846153846,1.0,1.0,6/41,16.60%,SFTPA2;ARSL;SUMF1;ARSI;ARSG;SMPD3
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.46564074034058467,0.7198787812248252,0.8363636363636363,1.0,1.0,3/7,20.31%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4146735866955351,0.7196482618309628,0.8545454545454545,1.0,1.0,3/11,20.31%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.45400064972619036,-0.7195249395662806,0.8292682926829268,1.0,1.0,3/9,23.69%,KDM2B;KDM4B;RIOX1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.3378184565102085,-0.7195104911928312,0.8780487804878049,1.0,1.0,5/49,7.09%,CLDN4;CTNNA1;CLDN1;CDH4;F11R
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.31332165723899474,0.7193313374106978,0.9473684210526315,1.0,1.0,21/79,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3555611508392581,-0.719160422700416,0.9583333333333334,1.0,1.0,4/25,10.00%,TERF2IP;ERCC1;RAD50;RTEL1
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.2974665796935811,0.7190278882144582,0.9807692307692307,1.0,1.0,34/132,17.08%,HSD17B2;STARD4;INSIG1;SCD;CYP39A1;MSMO1;FDFT1;FDX1;CYP27A1;HMGCS1;CYP7B1;SMARCD3;NCOA2;OSBPL6;TBL1X;DAND5;MVD;HSD11B2;SYCP2;FASN;SOAT2;SLC10A1;FDXR;IDI2;CH25H;ACACA;LRP2;CHD9;ACACB;SC5D;SLCO1A2;CYP2R1;AKR1C1;SQLE
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.3850044070849658,0.7188314987653003,0.8775510204081632,1.0,1.0,1/18,2.50%,URI1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.37278001270740074,-0.7187837588925475,0.8775510204081632,1.0,1.0,3/27,6.14%,CTNNA1;BOC;RBM4
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.3669120343201203,0.718639624749004,0.9137931034482759,1.0,1.0,4/20,24.90%,PIK3CA;SOS1;GRB2;EGFR
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.41413959088388574,0.7184418257707779,0.7796610169491526,1.0,1.0,2/10,12.03%,RAB39A;RAB34
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.40422251359458417,0.7182841783317495,0.8545454545454545,1.0,1.0,2/10,15.81%,NLRP7;GAS1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.2992219751907357,0.7180468600477526,0.9534883720930233,1.0,1.0,7/60,13.30%,EFNA5;UTRN;CDKN2A;EPHA3;CORO1C;GPM6B;SEMA3E
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.44972740864133326,0.7177927707451429,0.7708333333333334,1.0,1.0,2/7,17.81%,ESR1;TP53
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.361168710534196,0.7175170645237061,0.8245614035087719,1.0,1.0,12/35,24.02%,CPNE7;NUS1;CPNE1;MVD;CPNE3;ABCA8;IDI2;DOLK;SAMD8;HDHD5;IDI1;SGMS1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3297100744044277,-0.7172947660683916,0.8727272727272727,1.0,1.0,3/50,6.07%,TEK;LDB1;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3681075534076501,-0.7171907379007805,0.8717948717948718,1.0,1.0,2/15,12.59%,CEACAM1;GBP1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.3219401059503808,-0.716870914089711,0.9523809523809523,1.0,1.0,7/44,8.95%,F5;PSD4;TTC22;F11R;OLFM4;OAS1;CEACAM1
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.3219401059503808,-0.716870914089711,0.9523809523809523,1.0,1.0,7/44,8.95%,F5;PSD4;TTC22;F11R;OLFM4;OAS1;CEACAM1
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.38152694924683006,0.7167228031723465,0.8431372549019608,1.0,1.0,2/19,13.12%,GFAP;HSPA8
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.29715924879966243,-0.7165394937785364,0.9433962264150944,1.0,1.0,4/86,4.11%,CD24;ERN2;PRKCD;BCL2L2
prerank,Reactome_2022__LTC4-CYSLTR Mediated IL4 Production R-HSA-9664535,0.444076802301102,0.7164165836181655,0.82,1.0,1.0,3/5,28.62%,DPEP2;DPEP1;GGT5
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.48007269445860545,-0.7163772559057254,0.8035714285714286,1.0,1.0,1/6,4.34%,TST
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.289275239002386,-0.7160379665697761,0.9807692307692307,1.0,1.0,9/67,11.75%,PLK3;DCDC1;DRD2;SVIL;ENTR1;PLK4;ANKRD53;E2F7;KIF20B
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.3327988067371909,0.716016261253695,0.9137931034482759,1.0,1.0,3/45,9.35%,NDC80;CHMP6;RRS1
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,-0.3372426616591313,-0.7159656246939605,0.84,1.0,1.0,4/48,8.71%,CLDN4;CRABP2;F11R;CDH3
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2768137563898307,-0.7159419262649163,0.9818181818181818,1.0,1.0,20/202,13.95%,TEKT3;CFAP61;ABCC4;TEKT5;DNAAF1;CNGB1;TTC8;TMEM107;TXNDC15;CYS1;PLK4;ATP6V1D;UBXN10;CFAP221;EXOC3;RAB17;CFAP52;B9D1;DCDC2;RAB8A
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.45158164721261923,-0.7158427735191337,0.8,1.0,1.0,1/6,10.61%,CCN3
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.3521675695193322,-0.7154018504182872,0.8571428571428571,1.0,1.0,5/29,11.13%,SYT12;CBARP;CACNA1G;SYT10;DOC2A
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.35012567769011804,0.7153581731071511,0.8787878787878788,1.0,1.0,2/24,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4480123650974994,0.7151768983034396,0.7454545454545455,1.0,1.0,1/5,11.63%,SMAD4
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.35025501121745517,-0.7150089164949143,0.8181818181818182,1.0,1.0,4/16,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,-0.41983198336351535,-0.7148912829820558,0.803921568627451,1.0,1.0,3/12,15.27%,UPB1;NT5C;UPP1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.44793253191040727,-0.7147358475727786,0.8333333333333334,1.0,1.0,1/5,11.45%,APOA1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.4776148624993051,0.7147107378466429,0.7916666666666666,1.0,1.0,4/5,37.58%,VEGFA;EGFR;NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.41818894248541844,-0.7146217549298473,0.7954545454545454,1.0,1.0,2/9,16.97%,KCNJ11;CACNA1H
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.3201611456563284,0.7144882546383805,0.9423076923076923,1.0,1.0,19/71,29.15%,SEM1;RELA;PSMD13;PPP3CA;PSME4;NFATC3;PSMA1;IKBKB;PSMD4;NFKBIB;BCL10;REL;PSMB5;CHUK;PSMB1;NFKB1;NFKBIA;PSMC5;BTRC
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.33051963996848854,0.7143707555134039,0.9,1.0,1.0,7/50,13.45%,TYR;AANAT;PRIMPOL;RGR;REV1;MAPK8;PCLAF
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.4138966848408058,0.7142150500451095,0.7894736842105263,1.0,1.0,4/10,13.61%,MID2;GSN;TRIM26;PTX3
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.48360020945702586,0.7141183589675696,0.8125,1.0,1.0,1/5,4.40%,SIX4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.310186534372024,0.7138076624570903,0.9821428571428571,1.0,1.0,11/75,19.47%,KAT2B;BMI1;SF3B1;CTCFL;EZH2;TAF1A;EPC1;POLR1H;EED;H3-3A;POLR2H
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.3615216291030414,0.7137284273859227,0.86,1.0,1.0,2/31,6.55%,PAWR;EPS8
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,0.32129642623445503,0.7135714422813206,0.9574468085106383,1.0,1.0,8/70,6.36%,PBX3;LRP4;RRAD;BTLA;PRDM14;ST6GALNAC3;CXCL12;CCDC80
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.26383762624516366,0.7135443031343045,1.0,1.0,1.0,27/192,21.31%,LIN28A;PWP2;SMAD1;SMAD2;MRPL44;EXOSC4;FARS2;INTS6;RPL21;PRKRA;BOP1;BYSL;HNRNPA2B1;RPL18A;MPHOSPH6;RPL7;PUS10;WDR36;AGO3;ZCCHC8;INTS11;EXOSC1;WDR18;TEX10;C1D;RPL23A;RRP1B
prerank,KEGG_2021_Human__Pertussis,-0.3337987395274714,-0.7135247722780979,0.9148936170212766,1.0,1.0,8/54,8.91%,NLRP3;SFTPA2;C5;FOS;C2;SFTPA1;JUN;C1S
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.42975268033696923,0.7134663727253553,0.8245614035087719,1.0,1.0,3/8,23.16%,WNK1;ATP1B2;DLG1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.38490720586034205,0.7134318617430745,0.8367346938775511,1.0,1.0,5/21,17.29%,GAL3ST1;TEX2;ST3GAL6;TECR;AGMO
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,0.4832079865068708,0.7133164989821855,0.851063829787234,1.0,1.0,3/5,22.81%,KIT;ENPP3;ITGAM
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.3857151682990346,0.7132797316667774,0.76,1.0,1.0,5/19,9.21%,VCAN;BGN;SDC4;GPC5;GPC4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.42278977651105726,0.7132608996351228,0.8979591836734694,1.0,1.0,1/8,8.16%,MCM7
prerank,Reactome_2022__Choline Catabolism R-HSA-6798163,0.47208117760062296,0.71317848236186,0.9074074074074074,1.0,1.0,1/6,4.62%,ALDH7A1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.47208117760062296,0.71317848236186,0.9074074074074074,1.0,1.0,1/6,4.62%,ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.34326908731364564,0.7129571751628042,0.8823529411764706,1.0,1.0,8/26,22.38%,SASH3;PAXIP1;HLA-E;VAMP3;DNAJB9;KMT5B;TNFSF4;PTPRC
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.39119813367074174,-0.7129070717138912,0.76,1.0,1.0,2/10,16.15%,OARD1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4009245685283831,-0.7127161005295979,0.7380952380952381,1.0,1.0,2/11,9.83%,MBTPS2;CREB3L1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.39203818492048687,0.7126962764146402,0.88,1.0,1.0,3/16,11.63%,ST18;FER;SMAD4
prerank,Reactome_2022__Eicosanoids R-HSA-211979,-0.39949768661784085,-0.7126638584067388,0.7872340425531915,1.0,1.0,3/9,21.64%,CYP4F2;TBXAS1;CYP4B1
prerank,Reactome_2022__rRNA Modification In Mitochondrion R-HSA-6793080,-0.49025518194185097,-0.7123461373857407,0.76,1.0,1.0,2/5,17.81%,MRM1;NSUN4
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.4352490966751575,-0.7120211236716584,0.7906976744186046,1.0,1.0,1/9,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.4352490966751575,-0.7120211236716584,0.7906976744186046,1.0,1.0,1/9,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.34723168308601654,0.711965121461922,0.8688524590163934,1.0,1.0,7/39,17.85%,NLGN1;TENM1;RALA;GPM6A;TRPM2;WASL;FMR1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,-0.29819142843850677,-0.7118767110966981,1.0,1.0,1.0,7/95,11.33%,ARAP3;AGRN;SENP3;NFE2L1;LSM14B;ATXN7L3;B3GNT5
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,-0.29819142843850677,-0.7118767110966981,1.0,1.0,1.0,7/95,11.33%,ARAP3;AGRN;SENP3;NFE2L1;LSM14B;ATXN7L3;B3GNT5
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,-0.29819142843850677,-0.7118767110966981,1.0,1.0,1.0,7/95,11.33%,ARAP3;AGRN;SENP3;NFE2L1;LSM14B;ATXN7L3;B3GNT5
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.39140535672917287,0.7118573560007021,0.8679245283018868,1.0,1.0,4/14,14.34%,DSCAML1;BMPR1A;GREM1;FBXL15
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.32769570555398747,0.7116931099459372,0.9272727272727272,1.0,1.0,5/48,16.35%,SEM1;RNF146;PSMD13;PSME4;PSMA1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.36518576058641683,0.7116775008702524,0.88,1.0,1.0,4/21,17.93%,RPP40;RRS1;URB1;ERI1
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.3558817129759308,0.7114700846024642,0.8979591836734694,1.0,1.0,5/19,20.64%,PAPOLA;PCF11;CSTF3;WDR33;NCBP1
prerank,KEGG_2021_Human__Other glycan degradation,0.4020187777182436,0.7111191830856456,0.7924528301886793,1.0,1.0,3/15,18.26%,ENGASE;HEXD;HEXB
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.35082453537747676,-0.7110235526464692,0.875,1.0,1.0,9/48,11.12%,CD24;RAC2;ALOX5;JCHAIN;PLCB2;HCK;GNG13;SPI1;CDHR2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2988184936833591,0.7108359235260534,0.96,1.0,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2988184936833591,0.7108359235260534,0.96,1.0,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2988184936833591,0.7108359235260534,0.96,1.0,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.3772749179726281,-0.7108214676086493,0.8461538461538461,1.0,1.0,1/18,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.38678344421396577,0.7106046663020442,0.8301886792452831,1.0,1.0,4/22,17.54%,PLA2G10;NR1H3;PNPLA8;PLBD1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.28925152837898405,-0.7105433464702681,1.0,1.0,1.0,22/114,17.76%,SIGIRR;NUPR1;NLRP3;TRIB1;ADGRG3;TNFRSF4;PTCH1;SPI1;TMSB4X;WFS1;PYDC1;MTURN;DAB2IP;CYP1B1;UFL1;CMKLR1;ID2;NFKBIE;SFRP5;CHP1;HAVCR2;BHLHE40
prerank,Reactome_2022__Beta Oxidation Of lauroyl-CoA To decanoyl-CoA-CoA R-HSA-77310,0.5007887559317927,0.7102489575903482,0.9056603773584906,1.0,1.0,4/5,38.39%,HADHB;HADH;ACADL;ECHS1
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.3058051396913858,0.7098443716669144,0.9622641509433962,1.0,1.0,14/53,22.25%,ICOSLG;BTLA;PIK3CA;RICTOR;PKN2;CD247;MAP3K8;MLST8;AKT3;THEM4;LYN;PIK3R3;AKT2;GRB2
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.3939160246381296,0.7097435255061475,0.8888888888888888,1.0,1.0,4/15,11.63%,FOXO3;SMAD2;FOXO1;SMAD4
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.3096861432710647,0.7093002573804336,0.88,1.0,1.0,4/84,9.34%,RAB38;RALA;AK6;MTX2
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.38556753938470606,0.7092938695227384,0.8461538461538461,1.0,1.0,6/25,14.99%,ACD;H2BC21;H2AC6;TERF1;H2AZ2;H2AX
prerank,KEGG_2021_Human__Amoebiasis,-0.31230364885015666,-0.7092625378560777,0.9803921568627451,1.0,1.0,8/69,7.66%,COL4A2;COL4A1;ARG2;GNAL;RAB7B;LAMB3;PLCB2;LAMB1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4687357739976617,0.7090579760278732,0.8571428571428571,1.0,1.0,1/5,25.08%,TMEM33
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.36879744671461767,0.7088319031818577,0.8363636363636363,1.0,1.0,5/21,26.08%,TBC1D12;MTMR3;ANXA2;PIKFYVE;ELAPOR1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.35497951432238983,-0.7085001973533126,0.8653846153846154,1.0,1.0,6/26,11.26%,SYCE2;TERB1;STAG3;MEIOB;SYCE1;IHO1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.3429780367147541,-0.7083500517728037,0.8157894736842105,1.0,1.0,4/35,15.11%,FGF1;FGF20;FRS3;FGFR4
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.42545692389521267,0.7082063388390556,0.8448275862068966,1.0,1.0,7/12,41.27%,TRAPPC8;ACBD5;PIK3R4;PIK3C3;ATM;USP30;RB1CC1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4433786262797364,-0.7080151049205715,0.8913043478260869,1.0,1.0,2/10,5.62%,XYLT2;XYLT1
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.4174242647101656,0.7077757069356108,0.8620689655172413,1.0,1.0,2/10,12.78%,ERBIN;SOS1
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.28913512767587135,0.7077529075340067,0.9545454545454546,1.0,1.0,19/88,18.22%,NXPH1;SSTR3;KCNH8;DSCAML1;PAK5;BCL11B;RTN1;GRIK3;NOL4;JAKMIP2;ABCD2;SEZ6L;FRMPD3;PPP2R2B;NELL2;GLCCI1;PDZD4;CACNA1I;STMN4
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.40933830014906797,0.7076630798861996,0.8461538461538461,1.0,1.0,1/11,6.38%,PLPPR1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.34557225328081326,-0.7076018392671296,0.8297872340425532,1.0,1.0,7/30,17.93%,SLX4;RAD50;RAD51AP1;BRCA1;EXO1;MUS81;BLM
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.48509427960181634,0.7075484550495977,0.9038461538461539,1.0,1.0,1/5,6.66%,PDGFRA
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.29540595647682805,0.707414579194813,1.0,1.0,1.0,21/94,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.36841754745925615,0.7070777700948139,0.8163265306122449,1.0,1.0,4/20,11.26%,MYC;SMG1;LIG4;HNRNPD
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.3058676245990304,0.7065477204025468,0.9818181818181818,1.0,1.0,11/91,11.94%,TSHZ3;C8ORF88;CNRIP1;GYPC;COLGALT2;PCDH18;BCAT1;MAGEL2;TCF4;STK32B;CRISPLD1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.44240278573757863,0.7064195470785221,0.8301886792452831,1.0,1.0,3/9,15.21%,GLRA1;PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.39179880787782373,-0.7064146568491632,0.8333333333333334,1.0,1.0,3/17,14.35%,ANKRD53;GPSM2;DCTN1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.30835110841376784,0.7063930587370367,0.9464285714285714,1.0,1.0,28/85,31.06%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33;MRPL2;TRMT112;MRPL33;GFM2;GADD45GIP1;MRPL14;MRPL55
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.33929272164960445,0.7063704525442612,0.9148936170212766,1.0,1.0,4/28,10.55%,PPP1R15B;DLC1;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.2896499981113991,0.7063378817926055,1.0,1.0,1.0,4/148,5.04%,SGO1;NDC80;NDE1;DLGAP5
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.42144619716576104,-0.7059332715426537,0.8421052631578947,1.0,1.0,1/13,1.43%,GATD3
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.40513680418987513,0.7059084559985134,0.8571428571428571,1.0,1.0,1/9,1.85%,PRKG1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.38483056148518757,0.7058627601283807,0.8727272727272727,1.0,1.0,7/14,30.46%,DPP4;FAP;DDR1;DDR2;CLASP2;MELTF;CLASP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.30875513240517366,0.705769633144266,0.9574468085106383,1.0,1.0,13/68,19.95%,VAPB;TLCD3B;ELOVL5;PPM1L;CERS3;ABCA8;SGPL1;CERS5;ELOVL4;ALDH3B1;PLPP1;SAMD8;ST8SIA1
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,-0.4381772807212552,-0.7056863211173418,0.8863636363636364,1.0,1.0,3/9,10.34%,ETV5;UCHL1;DDX4
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.30169094462878454,-0.7056682131470944,0.9795918367346939,1.0,1.0,9/53,18.05%,ABRAXAS1;TICRR;RPS27L;CCND1;BRCA1;MUS81;CDK1;BLM;MRNIP
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.30474288525900267,0.7056430772918002,0.9814814814814815,1.0,1.0,9/63,20.95%,SEM1;ANAPC16;PSMD13;PSME4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.40295854418216215,0.705607994350307,0.8653846153846154,1.0,1.0,3/12,11.63%,CHD7;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.39804545496933946,0.7056065404801455,0.8297872340425532,1.0,1.0,2/10,13.72%,MTMR9;MTMR3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.3949590843436408,-0.7055957724497752,0.803921568627451,1.0,1.0,1/15,1.76%,TERF2IP
prerank,Reactome_2022__Defective GALNT12 Causes CRCS1 R-HSA-5083636,-0.37585155970928263,-0.7055804055115698,0.8157894736842105,1.0,1.0,3/13,10.15%,MUC5B;MUC19;MUC15
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.3580341773742577,-0.7055416340748406,0.8222222222222222,1.0,1.0,4/33,11.50%,DNAAF1;DNAH11;CCDC40;MMP21
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.4368051183246526,-0.7054896651477479,0.7948717948717948,1.0,1.0,3/9,19.80%,HLA-DRB1;HLA-DQA1;HLA-DPA1
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.330490324681155,0.704891869604197,0.9545454545454546,1.0,1.0,13/58,20.73%,SIRT1;H2BC21;HDAC2;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;POLR2H;HDAC1;DPEP2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.34518260962469954,-0.7048437930588721,0.8222222222222222,1.0,1.0,6/33,16.36%,PLK3;GOLGA2;DDRGK1;UFL1;TEX264;CDK1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.4295499639177024,0.7046556256572318,0.8333333333333334,1.0,1.0,2/5,21.70%,SLC25A30;SLC25A14
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,0.394487456366122,0.7046117374482938,0.8301886792452831,1.0,1.0,1/13,1.43%,CD99
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.4282732990141377,-0.704531698974926,0.8695652173913043,1.0,1.0,2/8,18.30%,CAV1;CAV3
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.35072957478411954,0.7044351795244997,0.9230769230769231,1.0,1.0,1/23,5.50%,SLC8A1
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,0.36759796169467984,0.7043760804346483,0.9024390243902439,1.0,1.0,2/17,4.78%,ITGAX;IRF8
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.34759467460898374,0.7043447062935341,0.8958333333333334,1.0,1.0,5/22,14.90%,FGF2;PTEN;CD34;KNG1;PHLDB2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3038703285944226,-0.7043296912168405,0.9183673469387755,1.0,1.0,2/83,1.32%,TBC1D10C;STX16
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.3811763177956947,0.704281671319391,0.8545454545454545,1.0,1.0,3/17,17.64%,PWP2;RPS5;ERAL1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.45929144018376805,0.7042811141011228,0.8181818181818182,1.0,1.0,2/6,23.76%,GFUS;GMDS
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.4504575484778777,0.7040615838942771,0.8813559322033898,1.0,1.0,5/7,42.97%,DPYSL5;DPYSL3;DPYS;DPYD;DPYSL2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.2992691262688364,0.7040295841050125,0.9310344827586207,1.0,1.0,20/79,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.42382496501636946,-0.7040093299202992,0.8163265306122449,1.0,1.0,2/5,15.92%,ZP3;CD27
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.3113499829620579,-0.7038693914739181,0.9629629629629629,1.0,1.0,5/72,7.78%,PM20D1;CD200R1;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.43940187688421883,-0.7038124023059078,0.8260869565217391,1.0,1.0,1/6,1.86%,CGA
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.38566818842634987,0.7035285207452211,0.8653846153846154,1.0,1.0,6/24,14.99%,ACD;H2BC21;H2AC6;TERF1;H2AZ2;H2AX
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.35856243286139144,0.7035001088862857,0.9285714285714286,1.0,1.0,3/25,10.31%,PDGFRA;ZSWIM5;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.356915483447243,-0.703404268178488,0.8846153846153846,1.0,1.0,4/35,7.78%,NUPR1;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4092930512613682,0.7033190015762157,0.8269230769230769,1.0,1.0,6/12,29.07%,BCL3;PIBF1;ADIPOR1;HGS;INPP5F;PARP14
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.36440953096549916,-0.70329572483922,0.8717948717948718,1.0,1.0,5/18,15.11%,RFTN1;FLOT1;CAV1;IFNK;CGAS
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4178760149856428,0.7031753955500831,0.8947368421052632,1.0,1.0,2/12,12.10%,ALG6;ALG9
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.3231711425373115,-0.702978290091409,0.8867924528301887,1.0,1.0,4/36,15.98%,IFT27;KIF17;DYNLRB1;TRAF3IP1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.29814704851770346,0.7025309981693351,0.9818181818181818,1.0,1.0,8/56,20.95%,SEM1;ANAPC16;PSMD13;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.46442273324396555,0.7022913887635466,0.8627450980392157,1.0,1.0,1/6,9.38%,AUTS2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.39765921510163094,-0.702222551652704,0.84,1.0,1.0,6/19,9.99%,IRF4;NLRP3;CD86;ZP3;HLA-DRB1;ZFPM1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.45238098628122664,-0.7021078952132546,0.7857142857142857,1.0,1.0,3/8,25.41%,SMUG1;MBD4;OGG1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.385560512972801,0.7019727450157447,0.851063829787234,1.0,1.0,3/13,17.05%,CAVIN1;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.41490296366119683,-0.7019716968650543,0.8461538461538461,1.0,1.0,2/8,8.48%,AK8;AK7
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,0.4282366680801511,0.7018567455994035,0.8620689655172413,1.0,1.0,3/9,13.08%,FGFR3;FGF17;FGF5
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,0.4274482949613227,0.7017775080264764,0.8363636363636363,1.0,1.0,3/10,13.08%,FGFR3;FGF17;FGF5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.31926188061551053,0.701500209376162,0.9302325581395349,1.0,1.0,15/56,21.36%,SIRT1;RELA;PDGFRA;FER;PTPRK;PXN;MAPK8;TRPM2;PPIF;NFE2L2;AKR1C3;RHOB;ABL1;MAPK3;ANXA1
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.27830049382242034,0.7013756666511809,1.0,1.0,1.0,24/112,21.67%,SYK;SEM1;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7;PPP3CA;PSME4;UBA3;NFATC3;TAB3;PSMA1;PKN2;RPS6KA5;PRKACB;LYN;UBE2D1;IKBKB;PSMD4;MUC17;CARD9
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.4198259916503994,0.7013708463571683,0.92,1.0,1.0,1/10,8.16%,MCM7
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.3156075073024527,0.7013443149369818,0.9090909090909091,1.0,1.0,2/31,3.42%,GNB4;GNG12
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.4036750852849291,0.7007791773590297,0.8363636363636363,1.0,1.0,2/10,16.60%,TSPAN6;RNF26
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.38458011118503266,-0.7007299823649046,0.8,1.0,1.0,4/13,27.38%,ITPR3;P2RX4;ORAI1;TRPC6
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3698030841131658,0.700560191146456,0.8085106382978723,1.0,1.0,2/20,13.34%,PPP1R14D;MGAT5
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.31882299132362385,0.7004801789084425,0.8780487804878049,1.0,1.0,7/41,15.67%,GNB4;GNG12;ADRA2C;GNAI3;GNG4;RGSL1;GNAZ
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.32481342086980725,-0.7004770401887044,0.9152542372881356,1.0,1.0,8/38,22.62%,MTFR2;UQCRC1;ETFRF1;ETFDH;NR4A3;NDUFA5;NDUFS1;UQCRH
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.3970790117714327,-0.7004616642239073,0.9166666666666666,1.0,1.0,1/8,4.64%,DHDDS
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.2953736472631762,-0.7003326710636625,1.0,1.0,1.0,8/113,8.34%,NTRK1;DOCK8;RGS8;AGRN;SFRP1;ADCYAP1;F11R;ZC3H15
prerank,KEGG_2021_Human__Hepatitis C,0.2889380316455215,0.6999764892542124,1.0,1.0,1.0,32/118,22.84%,MYC;LDLR;EIF3E;RELA;CLDN2;TICAM1;PIK3CA;NR1H3;CLDN6;SOS1;IKBKE;PPP2R2B;CLDN18;PIK3CD;CTNNB1;FADD;CDK4;TP53;CD81;CASP3;IRF3;AKT3;PIK3R3;BAD;IKBKB;MAPK3;AKT2;GRB2;MX2;EIF2AK3;CLDN9;CDK6
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.2880082979176053,0.6999100525535539,0.9803921568627451,1.0,1.0,6/97,9.92%,NXPH1;NGB;HRH3;B4GALNT4;GRM5;CAMK2N2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.34621816371086384,-0.6994255000505042,0.8409090909090909,1.0,1.0,6/28,12.17%,SOX30;RNF8;FAM9B;TTC21A;TOPAZ1;RSPH1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.44029911267499133,-0.6991521292450958,0.8103448275862069,1.0,1.0,1/7,6.36%,PAX2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.3727693651031265,-0.6988113446771467,0.85,1.0,1.0,1/14,5.24%,PPP1R17
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.4916006670390577,-0.6982586453816337,0.8571428571428571,1.0,1.0,1/5,6.07%,SFRP1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.34927604273841295,0.6981063788523736,0.9,1.0,1.0,2/21,8.45%,CIAO3;ISCA2
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.3290987048121804,-0.6981007477523482,0.9259259259259259,1.0,1.0,2/43,5.45%,SPTLC3;DEGS2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.42902085354105773,0.6979928239134555,0.8888888888888888,1.0,1.0,3/6,25.05%,ABCA1;ABCA7;APOE
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3745499621145275,-0.6977714105425898,0.8571428571428571,1.0,1.0,1/14,1.71%,RAC2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.4128268286431554,0.6976888910937392,0.8545454545454545,1.0,1.0,2/8,26.80%,OTUD7B;YOD1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.33828659973989994,0.697665827619296,0.9130434782608695,1.0,1.0,9/31,19.62%,DCXR;GALK1;PGM1;SLC37A4;GALK2;IRS2;BRAT1;CHST15;FBP1
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.3213439211435053,0.6975072434746505,0.8688524590163934,1.0,1.0,5/38,13.67%,POLE2;REV3L;REV1;PCLAF;SLC19A1
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.35294096774042205,0.6973839669017992,0.8421052631578947,1.0,1.0,6/26,14.44%,SYK;PLCG2;PPP3CA;SOS1;ITK;NFATC3
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.2925928253404367,0.6973445778674576,1.0,1.0,1.0,24/91,16.86%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;KCNH8;MAP2K6;TICAM1;PELI3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;MAP3K1;TAB3;MAPK10;MAP3K8;RPS6KA5
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.2925928253404367,0.6973445778674576,1.0,1.0,1.0,24/91,16.86%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;KCNH8;MAP2K6;TICAM1;PELI3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;MAP3K1;TAB3;MAPK10;MAP3K8;RPS6KA5
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.2925928253404367,0.6973445778674576,1.0,1.0,1.0,24/91,16.86%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;KCNH8;MAP2K6;TICAM1;PELI3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;MAP3K1;TAB3;MAPK10;MAP3K8;RPS6KA5
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.46228048081388307,0.6971724018590403,0.8837209302325582,1.0,1.0,2/5,20.09%,HSD17B10;PNPT1
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.30954901958358344,-0.6971245145689319,0.926829268292683,1.0,1.0,6/79,7.96%,CGA;PRKCD;CAMK2A;EGR1;PLCB2;JUN
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.3596624115091188,0.6969987505741038,0.8823529411764706,1.0,1.0,2/15,8.67%,SPR;GCH1
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.29044687593763246,0.696808952634878,1.0,1.0,1.0,24/95,16.86%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;KCNH8;MAP2K6;TICAM1;PELI3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;MAP3K1;TAB3;MAPK10;MAP3K8;RPS6KA5
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.46002818865465256,0.6965972564474583,0.9024390243902439,1.0,1.0,1/7,13.08%,XPO1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.3540078099621786,0.6964794444176527,0.9285714285714286,1.0,1.0,6/36,14.31%,EFNA5;CDKN2A;KANK1;CORO1C;SEMA3E;FZD4
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.36310205889246344,0.696382303581237,0.8823529411764706,1.0,1.0,5/15,27.49%,RUVBL2;NOP10;NAF1;SHQ1;CCT3
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.3628098395423764,-0.6962239185826433,0.8260869565217391,1.0,1.0,2/21,12.53%,RNASE1;FRS3
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,-0.41719055562700075,-0.696118243877346,0.8,1.0,1.0,1/8,1.99%,SERINC2
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.2921300891672283,-0.6959747240806541,0.94,1.0,1.0,8/82,10.53%,RAC2;PRKCD;ARPC5L;VAV3;INPP5D;HCK;LIMK1;PIP5K1B
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.2894018073573448,-0.6959695144940368,1.0,1.0,1.0,7/98,8.25%,SELP;WARS1;BIK;HCK;SVIP;CLU;TMC8
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.409150271365963,-0.6959556652828133,0.8260869565217391,1.0,1.0,3/12,24.36%,RAC1;AKAP13;FHOD1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.389055741108721,0.6959340722024957,0.8983050847457628,1.0,1.0,4/9,18.32%,GADL1;GLYATL2;CTH;MPST
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.33055341914104014,0.6958625128560674,0.92,1.0,1.0,6/47,12.35%,DCC;HDAC2;KANK1;EFNB2;SPRY3;PTEN
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.43307267388712056,-0.6953876714992453,0.7727272727272727,1.0,1.0,2/10,16.47%,FOXM1;NEK6
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.42769694928370855,0.6953178266926939,0.819672131147541,1.0,1.0,1/7,3.48%,WNT4
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3016741225384521,0.6951663528306374,0.9444444444444444,1.0,1.0,11/50,16.53%,SLC16A5;SLC10A3;SLC26A6;ABCC2;SLC10A5;NCOA2;SLC10A1;ABCC11;SLCO1A2;SLC16A13;AKR1C1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2601146398960253,-0.6950535817982043,1.0,1.0,1.0,44/283,16.67%,TEKT3;IFT27;ABCC4;HAUS7;TEKT5;DNAAF1;CNGB1;TTC8;TMEM107;TBC1D32;RSPH9;TXNDC15;CYS1;KIF17;PLK4;ATP6V1D;CCDC40;UBXN10;CFAP74;RSPH1;CFAP46;CFAP221;NPHP4;EXOC3;HAUS1;TUBB;RAB17;TUBG1;CFAP52;B9D1;DCDC2;RAB8A;DCTN2;DYNLRB1;DCTN1;AHI1;CSNK1D;TUBB4A;SPATA6;TRAF3IP1;RSPH4A;CDK1;RAB11A;HAUS8
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.31890917658234014,-0.6949600120500262,0.8653846153846154,1.0,1.0,7/31,16.85%,FGF1;DRD2;SVIL;KIF20B;CDC6;HTR2B;FGFR2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.41331480286056516,0.6946088574055536,0.9272727272727272,1.0,1.0,3/12,12.35%,SPEF2;CTNNA2;PTEN
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.37579029992292184,0.6944611434474747,0.9069767441860465,1.0,1.0,5/16,17.38%,KAT2B;RIOK2;METTL18;SIRT7;RIOK1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.33657078697085546,0.6944538887879875,0.9107142857142857,1.0,1.0,3/30,12.35%,PLCG2;EZH2;PTEN
prerank,Reactome_2022__PTK6 Expression R-HSA-8849473,0.49830280127427357,0.6941772382694281,0.8723404255319149,1.0,1.0,1/5,2.54%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3459318068383586,0.6940188958784057,0.9245283018867925,1.0,1.0,6/23,22.98%,ACD;TERF1;TENT4B;GNL3L;POT1;HNRNPU
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.39928198716891183,-0.6937518039329951,0.8235294117647058,1.0,1.0,2/13,13.87%,ABCB1;ABCB4
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,-0.3999618363322527,-0.6937118104494685,0.8695652173913043,1.0,1.0,7/16,20.72%,ENTPD2;CARTPT;MEIS2;ID2;EGR3;THSD7A;ETV1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.38559341223659804,-0.6934864707956264,0.75,1.0,1.0,2/7,11.69%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.3330907451121309,0.6934626220599235,0.9183673469387755,1.0,1.0,7/23,18.32%,AHCY;GADL1;CBS;CTH;SMS;CPS1;MPST
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.39683601902196164,-0.6931392278707602,0.9183673469387755,1.0,1.0,4/15,10.61%,FAM3D;SFRP1;KCNJ11;CCN3
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,0.4033255079698761,0.6927153250745822,0.819672131147541,1.0,1.0,3/10,13.08%,FGFR1;FGF17;FGF5
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4101944382076064,0.692585609317059,0.8909090909090909,1.0,1.0,1/13,1.72%,RSPO3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.32033649850981444,-0.692196068333528,0.875,1.0,1.0,5/52,8.18%,APOBEC3H;APOBEC3G;TRIM5;OAS3;OAS1
prerank,KEGG_2021_Human__Phototransduction,-0.37007409788531287,-0.6921104416358695,0.85,1.0,1.0,3/19,5.63%,GUCA1B;PDE6B;CNGB1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.3606615097614639,-0.6916276202217977,0.8888888888888888,1.0,1.0,4/25,16.21%,MEFV;TTBK1;APH1B;PSME3
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.3937766954810846,0.6912371180445606,0.84,1.0,1.0,5/14,18.81%,DMC1;TPRKB;SMC5;RAD54B;NSMCE2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.40297012412696476,-0.6911780883641507,0.8444444444444444,1.0,1.0,1/12,3.27%,ASS1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3071968729821316,-0.6909161794529542,0.9166666666666666,1.0,1.0,9/56,16.77%,COL5A1;TLCD2;TRIM72;FER1L5;OTOF;MYH9;PACSIN3;DMKN;RAB3A
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.4375401640710541,-0.6908952966697297,0.8478260869565217,1.0,1.0,2/5,16.97%,MED1;ZNF385A
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4022885987865207,0.6905190685460582,0.7959183673469388,1.0,1.0,1/9,4.40%,SIX4
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.32675587885011825,0.6902262364366683,0.9615384615384616,1.0,1.0,7/34,11.51%,VCAN;BGN;SDC4;GPC5;GPC4;EXT1;CHST6
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.4371478798042646,-0.690158932990433,0.8333333333333334,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.3911328386721977,0.689866762422509,0.819672131147541,1.0,1.0,1/6,16.70%,COX10
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.3682014345208553,0.6897079483429347,0.8823529411764706,1.0,1.0,2/17,17.08%,AUP1;SQLE
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.34301796868883705,0.6897063368859373,0.8771929824561403,1.0,1.0,6/27,22.70%,FGFR3;LRRC17;LRP6;TP53;PTPRC;GJA1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.40122796350640844,-0.6895956097616028,0.85,1.0,1.0,5/11,13.93%,PRKCD;CEACAM1;ZNF703;SERPINE2;CD9
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.2591520514989252,0.6895193382829491,1.0,1.0,1.0,38/229,24.14%,NXF1;U2AF1;HNRNPH1;SF3B1;THOC6;SNRPN;ELAVL2;PAPOLA;NXT1;SNRNP48;PCF11;HNRNPD;PUF60;CDC5L;HSPA8;LSM8;RBM5;SRSF11;HNRNPA2B1;PPIL6;RANBP2;FUS;CSTF3;RBM17;POLR2H;WDR33;NCBP1;XAB2;NUP153;SNRPA;CWC27;SRSF3;HNRNPU;LSM2;HNRNPF;DHX15;SF3B6;DHX9
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.3921827017459891,0.6894112936973176,0.8947368421052632,1.0,1.0,2/12,12.03%,RAB39A;RAB34
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.33137621530027556,0.6893746037735171,0.8627450980392157,1.0,1.0,12/44,24.65%,KAT2B;HDAC2;TAF1A;CCNH;POLR1H;MNAT1;POLR2H;HDAC1;ERCC3;RBBP4;POLR1D;TAF1B
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.43576928568653805,-0.689288685192907,0.8857142857142857,1.0,1.0,1/8,13.28%,ATP6V0A2
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.3136040589540824,0.6892532303393955,0.9791666666666666,1.0,1.0,17/60,29.15%,SEM1;RELA;PSMD13;PSME4;PSMA1;IKBKB;PSMD4;NFKBIB;BCL10;REL;PSMB5;CHUK;PSMB1;NFKB1;NFKBIA;PSMC5;BTRC
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.30267157371715625,0.6890992567595103,1.0,1.0,1.0,8/58,20.95%,SEM1;ANAPC16;PSMD13;PSME4;PSMA1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),-0.43902856414523656,-0.6889645157073148,0.7735849056603774,1.0,1.0,4/5,26.72%,LAPTM4B;TSKU;THBS1;ATP6AP2
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.3643703989663296,-0.6889009277726283,0.9361702127659575,1.0,1.0,1/20,2.67%,CD86
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3505231570461663,0.6888749483677925,0.8947368421052632,1.0,1.0,4/35,14.43%,FHIT;RYBP;PML;EIF3H
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.37607006462264303,0.6888422773529436,0.8666666666666667,1.0,1.0,4/15,21.36%,CYB5R4;RIMS2;GAL;ANXA1
prerank,KEGG_2021_Human__Basal transcription factors,-0.32260210054477806,-0.6886049107900497,0.9056603773584906,1.0,1.0,9/40,18.26%,TBPL2;GTF2E1;TAF11;TAF7;GTF2F1;GTF2H2;TBP;GTF2IRD1;TAF7L
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.34267041602301507,0.6880085194934482,0.9344262295081968,1.0,1.0,2/22,8.45%,CIAO3;ISCA2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.39096009349115457,-0.6879008786431954,0.86,1.0,1.0,3/11,13.26%,AQP7;AQP8;UPK3A
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.3160454587805565,0.6878570499333581,0.9285714285714286,1.0,1.0,16/45,30.35%,RALA;IL23R;LMNB1;HNRNPA2B1;PKN2;ANXA2;CANX;HNRNPF;IL12A;JAK2;AURKAIP1;IL27RA;PDCD4;GSTO1;IL12RB2;IL23A
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.28239272123444586,0.6878356547459713,0.9555555555555556,1.0,1.0,7/74,7.36%,RIN2;FGF2;ANGPT1;RRAS;GLUL;ANXA3;BMPER
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3036725132639156,-0.6875852380937676,0.9259259259259259,1.0,1.0,15/53,26.53%,NDUFC1;UQCRC1;NDUFS5;COX6C;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;UQCRH;NDUFA1;SDHC;NDUFB4;AFG1L;UQCR10
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3073477613058299,0.6873760099234334,0.9629629629629629,1.0,1.0,6/46,17.52%,MYC;TF;CYBRD1;SMAD4;HJV;FRRS1
prerank,Reactome_2022__Defective GALNT3 Causes HFTC R-HSA-5083625,-0.35985182875192256,-0.6873499932420024,0.8378378378378378,1.0,1.0,3/13,10.15%,MUC5B;MUC19;MUC15
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.33970165176668876,-0.6870402197525485,0.9069767441860465,1.0,1.0,4/17,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.3682441730710497,0.6869544956880832,0.9122807017543859,1.0,1.0,1/24,2.93%,NEDD4
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.4487656773951589,-0.686937090707264,0.8043478260869565,1.0,1.0,1/7,10.93%,GTF2H2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.42452839840946005,0.6869345353484201,0.8813559322033898,1.0,1.0,3/6,28.52%,CD74;CARD9;SLA2
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.2896118073485735,0.6868522285723121,1.0,1.0,1.0,18/98,20.95%,SEM1;RELA;PLCG2;PAG1;TAB2;PIK3CA;PSMD13;PTEN;ITK;PSME4;PSMA1;PKN2;CD247;ZAP70;UBE2D1;RIPK2;IKBKB;PSMD4
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.3072778578729019,-0.6868329060698232,0.9761904761904762,1.0,1.0,5/37,8.48%,GPR132;ARG2;TGFBI;CIITA;PTPN7
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.39420650087790143,-0.6865195911965779,0.875,1.0,1.0,2/10,15.54%,GOLGA2;SKP1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3401882763831618,0.6864793873431554,0.9038461538461539,1.0,1.0,5/25,18.53%,LLGL1;DNAJC1;HSPA8;STXBP5;NDFIP2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.3168975124650088,0.6861458701677452,0.8974358974358975,1.0,1.0,6/27,18.65%,LIN28A;NUDT16L1;EXOSC4;TENT4B;ZCCHC8;SLFN14
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.3795406934858296,-0.6855618682241628,0.8260869565217391,1.0,1.0,5/12,16.73%,CLDN1;CBLN2;MYADM;DCTN1;CHCHD10
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.33386831812304657,0.6855283013404371,0.8666666666666667,1.0,1.0,8/33,27.50%,HAP1;HSPB1;RAB27B;DLG2;AP3M2;TRAK2;RAB21;KIF3B
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.4636992873095531,0.6854870141779631,0.9245283018867925,1.0,1.0,2/5,13.74%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.3870544805753837,-0.6852831516523082,0.8235294117647058,1.0,1.0,3/15,8.41%,PIGG;PIGH;PIGL
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.39002740240184286,0.6852012073538792,0.8571428571428571,1.0,1.0,3/11,18.49%,SPEF2;DYNC1I2;DNAAF2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.4183448438413888,0.6849656686544103,0.8913043478260869,1.0,1.0,5/10,32.81%,DGKZ;DGKD;DGKE;DGKI;DGKH
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,0.2903487028289259,0.6848401965226899,0.9830508474576272,1.0,1.0,9/85,14.50%,MMP16;CCDC106;MEX3B;COLGALT2;GPSM1;PPM1E;CRISPLD1;DLL3;RIMS4
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.24314259279403524,0.6848360296120126,1.0,1.0,1.0,50/253,24.59%,NDE1;CEP70;SSTR3;PRKAB2;PCM1;ACSS2;HDAC3;RAB3IP;CEP152;MTX2;BBS9;SMARCD3;NCOA2;LZTFL1;DCTN3;TBL1X;CEP135;BBIP1;DYNC1I2;MEF2C;CNTRL;NEDD1;CREB1;CHD9;CCP110;IFT57;HCFC1;C2CD3;EXOC6;ARL3;GABPA;TTC21B;ATAT1;IFT140;POLG2;DYNC2I2;TFB1M;GLUD1;NRF1;CAMK4;TFB2M;TRIP11;IQCB1;CEP162;NINL;CEP290;AKAP9;ARL13B;WDR35;LIN9
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,0.4250049069162538,0.6847861502864481,0.8113207547169812,1.0,1.0,2/6,23.60%,MLXIPL;PPP2R1B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3014623856263844,0.6847014930653132,0.9814814814814815,1.0,1.0,19/68,25.06%,PRMT1;PAXIP1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;BCL3;CNOT2;TP53;CDC25C;RPS6KA6;GTSE1;MDM4;EP300;SESN2;RBL2
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.36822769451529175,0.6843620152248087,0.9454545454545454,1.0,1.0,4/18,24.90%,PIK3CA;SOS1;GRB2;EGFR
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.4437216950200633,0.6843586819629995,0.8461538461538461,1.0,1.0,1/5,8.70%,GPSM1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.3652376859448446,0.6842992954817635,0.9215686274509803,1.0,1.0,1/15,3.48%,WNT4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.33263043698688516,0.6838780965231944,0.9076923076923077,1.0,1.0,7/34,14.23%,RAPGEF3;HCLS1;ABI3;PDGFRA;ABL2;SEMA3E;TRPM2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.338490873622784,0.6838300213802956,0.8333333333333334,1.0,1.0,8/30,21.36%,SIRT1;RELA;TRPM2;PPIF;NFE2L2;RHOB;ABL1;ANXA1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.4185194453950771,0.6837986156360599,0.9166666666666666,1.0,1.0,5/8,27.68%,RBPJ;CTNNB1;RHOB;BMP4;STARD13
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.46210251656198054,-0.6837489179781229,0.7608695652173914,1.0,1.0,1/5,13.87%,ABCB4
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.40739556428655843,-0.6835906410037506,0.8545454545454545,1.0,1.0,4/12,14.13%,ALOX5;HAO2;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.4488439962424451,-0.6834553064894711,0.7884615384615384,1.0,1.0,1/6,3.43%,PRKCD
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,0.3425111992977214,0.6831253800098499,0.9361702127659575,1.0,1.0,6/27,19.62%,GOLT1A;SLC25A1;SLC25A13;SLC37A4;SLC25A12;FBP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.4344433359162415,0.6830949658722999,0.8771929824561403,1.0,1.0,1/7,20.59%,IKBKB
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),0.45441315229599377,0.6829638639552349,0.8367346938775511,1.0,1.0,2/5,15.22%,SPX;NENF
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.423706786844873,0.6828800237596367,0.8870967741935484,1.0,1.0,1/6,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.3312869518287567,-0.6828353006158897,0.9148936170212766,1.0,1.0,4/26,10.96%,FGF1;DNAAF1;CHI3L1;CCDC40
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.3175717222573273,0.6826947468155097,0.9622641509433962,1.0,1.0,13/48,22.07%,REXO2;CDKN2A;SEPTIN4;TP53BP2;MAPK8;PPP3CC;TP53;CASP3;AKT3;BAD;MAPK3;PPP1R13B;AKT2
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.3854247788914425,0.6825460526066212,0.896551724137931,1.0,1.0,9/18,30.63%,VRK2;LMNB1;BANF1;LEMD3;CCNB2;LMNA;LBR;PPP2R2A;CCNB1
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,0.3645464380512444,0.6823460465765285,0.9607843137254902,1.0,1.0,4/23,6.66%,MME;TLR2;ITGAV;PDGFRA
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.3069751941692528,-0.6822630824080489,0.9642857142857143,1.0,1.0,8/61,8.08%,RAC2;LILRB3;FOS;VAV3;INPP5D;BTK;JUN;CD72
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3473341741373056,-0.6821906719532895,0.875,1.0,1.0,5/20,20.63%,RNF8;ATXN7L3;PHC1;UHRF1;RNF20
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.3618598282696643,-0.6820801615052857,0.9523809523809523,1.0,1.0,1/24,3.74%,DNAJB13
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.2895705070989597,0.6819596663044925,0.9444444444444444,1.0,1.0,3/89,3.60%,SWSAP1;SEM1;RFWD3
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.2546454465664315,0.6818437099138938,1.0,1.0,1.0,44/190,29.80%,SEM1;DCC;ROBO2;CXCL12;ABL2;PSMD13;RPS5;NCK2;SOS1;RPL21;PSME4;NELL2;PSMA1;RPL18A;PKN2;FLRT3;RPL7;RPS3A;PRKACB;ABL1;NCBP1;RPL23A;PSMD4;ROBO3;ZSWIM8;VASP;COL4A5;ARHGAP39;PRKAR2A;SLIT2;RPL9;PSMB5;RPS29;RPS19;PSMB1;PABPC1;SRGAP2;PSMC5;NCK1;TMPRSS4;RSL24D1;RPS15A;CLASP2;RPS23
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.39155061593101115,-0.6818133035206925,0.8571428571428571,1.0,1.0,1/17,1.04%,CD24
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),-0.4378383032087649,-0.6815652772214821,0.8461538461538461,1.0,1.0,2/7,16.52%,MISP;PARD3B
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,-0.41398385893011813,-0.6815521007050112,0.8780487804878049,1.0,1.0,1/11,5.41%,XDH
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.42209914848408403,-0.6814770969972547,0.7307692307692307,1.0,1.0,1/5,14.29%,PDE3A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.42209914848408403,-0.6814770969972547,0.7307692307692307,1.0,1.0,1/5,14.29%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2987268280070739,0.6814403494849854,0.9787234042553191,1.0,1.0,6/63,12.35%,SIRT1;CDKN2A;ERBIN;ZNF675;TMIGD3;IRAK1
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,0.4057536542160761,0.681252325289885,0.88,1.0,1.0,2/6,30.72%,GP1BA;YWHAZ
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4413214553065186,0.6812187717372316,0.8947368421052632,1.0,1.0,3/7,22.19%,USH2A;CTNNB1;ERCC3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3283874152526278,-0.6811791767382139,0.9019607843137255,1.0,1.0,5/42,10.86%,INHA;IL11;ALAS2;ZFPM1;SPI1
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.44509660212494095,-0.6810589687244548,0.7727272727272727,1.0,1.0,2/6,11.71%,XDH;ACP3
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.28154591366146575,0.6810226874862823,0.9622641509433962,1.0,1.0,17/99,27.93%,RPP25;RPP40;HSD17B10;CTU1;RANBP2;TRDMT1;CDKAL1;TRMT13;TRMT5;NUP153;METTL1;TRMT9B;MTO1;TRMT11;TYW3;NLRP2B;TRMT112
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.27251218787887344,0.6808553017093435,0.9591836734693877,1.0,1.0,21/99,20.13%,RHOBTB3;EFNA5;EPHA5;EPHA3;BICD1;DLC1;PLXNB1;CDK2AP2;GPM6B;RHOBTB1;SORBS3;RICTOR;PHLDB2;PRKAA1;RHOG;RHOD;PHLDB1;RHOB;MLST8;ABL1;IQCJ-SCHIP1
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.27904410830872206,0.6807978137595428,0.9767441860465116,1.0,1.0,10/80,13.39%,SEM1;MAPKAPK2;PSMD13;HNRNPD;EXOSC4;ANP32A;HSPB1;XPO1;HSPA8;PSME4
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.35802535192755375,-0.6804935388120964,0.8372093023255814,1.0,1.0,4/17,19.66%,ADAMTS9;FUCA1;FBXO2;FBXO44
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.446788415593276,0.6801983960550889,0.9122807017543859,1.0,1.0,1/5,20.16%,ATP2C1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.29844278949623854,-0.6800205723258893,0.9272727272727272,1.0,1.0,15/54,26.53%,NDUFC1;UQCRC1;NDUFS5;COX6C;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;UQCRH;NDUFA1;SDHC;NDUFB4;AFG1L;UQCR10
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3813079427364049,-0.6800119869275743,0.851063829787234,1.0,1.0,1/9,1.88%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.4613335309101533,0.6799324891619645,0.8771929824561403,1.0,1.0,1/5,4.31%,PRMT1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.4075250195411981,0.6799289804936886,0.9166666666666666,1.0,1.0,2/10,6.90%,PTGS1;HPGDS
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.34602164309107347,0.6796856367506078,0.8958333333333334,1.0,1.0,12/32,31.99%,ANAPC16;CCND3;CDK4;FZR1;UBE2D1;UBE2E1;CDK6;ANAPC15;CDC27;ANAPC7;RB1;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.2941836842404776,0.6796041697886118,1.0,1.0,1.0,6/74,12.40%,NEDD4;SEC22B;ASB5;FOXO1;HECW2;TIPARP
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.40427884664039193,-0.6795198550954731,0.8809523809523809,1.0,1.0,2/7,17.97%,KIF1A;KIF1C
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.3414124827875985,-0.6794539176540274,0.9347826086956522,1.0,1.0,1/24,1.87%,MTFR2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.35862469284681164,-0.6794216526695472,0.8148148148148148,1.0,1.0,2/13,13.03%,KIF20B;DAB2IP
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.2996517799455734,0.6793114558661203,0.9333333333333333,1.0,1.0,5/47,13.67%,POLE2;REV3L;REV1;PCLAF;SLC19A1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.314987456958169,-0.679163296089618,0.8461538461538461,1.0,1.0,2/30,6.14%,WTIP;RBM4
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.2890713135890378,-0.6791180101896652,0.9591836734693877,1.0,1.0,15/65,19.75%,FGF1;PLK3;ORC6;ENTR1;PLK4;ESRRB;RFPL1;CALM1;HTR2B;RAB11A;FGFR2;BLM;KIF18B;PLK2;BECN1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.3915841581181705,0.6791094705996431,0.7857142857142857,1.0,1.0,2/12,15.19%,LMO2;THRB
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3802094945068146,0.6790597031814711,0.8245614035087719,1.0,1.0,2/9,19.44%,ABL2;ABL1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.3382595540923264,0.6790100657054595,0.9642857142857143,1.0,1.0,6/25,19.92%,LPIN3;CEL;LIPG;PLBD2;PLBD1;ACOX1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,-0.3871191993065741,-0.6788158634674205,0.9230769230769231,1.0,1.0,1/16,9.70%,PLXNA2
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.2829252304907048,0.6787449014336024,1.0,1.0,1.0,15/118,19.23%,GFAP;PRKAB2;CHMP6;ATG101;ATG4C;DYNC1I2;RRAGC;HSPA8;MTMR3;PRKAA1;UBAP1;MTERF3;RRAGD;MVB12A;MLST8
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.34914113623237053,-0.6787272571107069,0.9545454545454546,1.0,1.0,6/29,18.53%,HGSNAT;G6PC3;SGSH;IDUA;GYG2;ALDOB
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.35566131404631207,-0.6787101289288852,0.8928571428571429,1.0,1.0,3/22,6.14%,CTNNA1;BOC;RBM4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3189641390520462,0.678090015229644,0.9642857142857143,1.0,1.0,4/42,6.01%,BRINP3;ZFP36L2;WEE2;SCRIB
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3358655045877277,0.6780010828215007,0.8979591836734694,1.0,1.0,4/30,9.52%,ABI3;FER;AUTS2;PIK3CA
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.37354586932203154,-0.6779937785245789,0.8333333333333334,1.0,1.0,2/23,7.55%,CD101;HLA-DRB1
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.40413226969114724,-0.677699592096096,0.875,1.0,1.0,3/11,25.44%,IFNGR2;STAT1;PTPN11
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.3868920688831912,-0.6776888826562274,0.8431372549019608,1.0,1.0,6/15,23.29%,WBP4;SNRNP200;RBM22;WBP11;CWC15;CACTIN
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,0.4348580797030863,0.6776748462131263,0.9245283018867925,1.0,1.0,1/8,7.42%,DPP4
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.36528322622910564,0.6776540321982633,0.8771929824561403,1.0,1.0,4/14,20.21%,KPTN;RNF128;CD81;LMBRD1
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.36600469079743325,-0.6776274454897553,0.8947368421052632,1.0,1.0,10/20,28.53%,TOMM20;VDAC1;PINK1;MAP1LC3A;TOMM7;MAP1LC3B;MFN2;TOMM22;PRKN;UBB
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.33254112808791386,0.6775522850683104,0.86,1.0,1.0,1/22,1.33%,IL17RD
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.32187034533941744,-0.6775256848911256,0.8181818181818182,1.0,1.0,4/23,18.49%,RHBDF1;PTK2B;PSME3;UBE3A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.4312193940846146,0.6773247364259,0.819672131147541,1.0,1.0,2/5,11.92%,MEGF10;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.4408937554712341,0.6771527948998025,0.8958333333333334,1.0,1.0,2/6,9.13%,IL4;DENND1B
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.4408937554712341,0.6771527948998025,0.8958333333333334,1.0,1.0,2/6,9.13%,IL4;DENND1B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.30695353129639175,0.6769899339872176,0.96,1.0,1.0,16/52,17.69%,INSIG1;CYP39A1;MSMO1;FDFT1;CYP27A1;CYP7B1;OSBPL6;HSD11B2;FDXR;CH25H;HSD17B10;STAR;SC5D;PRLR;SQLE;AKR1C3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3258512596508379,-0.6768100134875057,0.9111111111111111,1.0,1.0,4/22,21.59%,RPF2;DHX30;BRIX1;RPL5
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.30521305867975035,0.676714956805733,0.9591836734693877,1.0,1.0,9/34,27.61%,RBBP6;DBN1;RHOBTB1;PHIP;MSI2;GPS1;HNRNPC;STK38;TWF1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.420882635479258,0.6766556176998297,0.8636363636363636,1.0,1.0,2/7,18.93%,CTH;KIT
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.318054176515122,0.6762959012243184,0.8888888888888888,1.0,1.0,6/49,17.23%,SEM1;PSMD13;PSME4;DVL2;PSMA1;KLHL12
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.28240712891117115,-0.6761849668458846,0.9787234042553191,1.0,1.0,6/110,5.36%,SELE;RAC2;ASS1;GSTT2B;FOS;GPC1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3305417885610671,-0.676154102909507,0.9574468085106383,1.0,1.0,13/42,15.60%,DRD4;DRD2;CYP24A1;PAQR7;SFRP1;GLDC;TRPV1;IL18;CYP1B1;ABCB4;TGFB1;FGFR4;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.4046810536351981,0.6758316787448724,0.8775510204081632,1.0,1.0,1/10,6.82%,VSIR
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.3885084582075443,-0.6757774628096236,0.8627450980392157,1.0,1.0,1/7,11.45%,APOA1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.4145771211842858,0.6755156137995734,0.8771929824561403,1.0,1.0,3/6,38.68%,TRMT112;APEH;ETF1
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,-0.40910154898219264,-0.6755070138990703,0.8478260869565217,1.0,1.0,1/8,18.29%,AP2A2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.4158179489802503,-0.6754534783013955,0.8909090909090909,1.0,1.0,1/7,7.13%,DHX8
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.33497563725899604,0.6754346434399285,0.9333333333333333,1.0,1.0,3/24,9.97%,RRAS;MYH11;PLXNB1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.39480096305549583,-0.6753582362211693,0.8222222222222222,1.0,1.0,1/8,9.44%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3588434126167029,-0.6753527745637632,0.86,1.0,1.0,4/23,15.18%,STAC;ABCB1;ATP1B1;CTSS
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.35564169826384917,0.6751567600839641,0.9591836734693877,1.0,1.0,2/20,11.76%,FBXO5;ZNF207
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.4584889727400233,-0.6751145782027154,0.88,1.0,1.0,3/5,30.67%,PRKCH;CHRM1;PRKCI
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.3757511369476809,0.6751060948178045,0.9090909090909091,1.0,1.0,2/14,8.32%,LOC400499;CRHBP
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.40016403618277596,0.6748754150344847,0.873015873015873,1.0,1.0,2/8,27.34%,POMK;IPPK
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.34068210313413594,0.6748488230090173,0.8846153846153846,1.0,1.0,6/17,17.69%,FDX1;FDXR;HSD17B10;STAR;AKR1C1;AKR1C3
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3887135041695022,0.6746709526530376,0.8793103448275862,1.0,1.0,1/11,2.91%,PYHIN1
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.3940098255338347,-0.6745625577286053,0.8780487804878049,1.0,1.0,2/10,10.43%,PCCB;MCCC2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.3637455394567084,0.6745027242472987,0.896551724137931,1.0,1.0,3/18,16.70%,CDH2;PIEZO1;CTNNB1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.34041599085371543,0.674462244162019,0.8301886792452831,1.0,1.0,6/27,25.70%,CHMP6;STAM2;MVB12A;VTA1;HGS;VPS37D
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.3046338632628401,-0.6744606371059664,0.94,1.0,1.0,11/35,22.45%,PER2;ENO2;GAPDHS;GOT2;G6PC3;PFKFB1;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.4167230232176079,-0.6743598712212507,0.782608695652174,1.0,1.0,1/5,1.88%,CXCL13
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.3492249529450293,-0.6741528072010466,0.8571428571428571,1.0,1.0,5/26,9.99%,ALOX5;CYP21A2;HSD3B2;HSD3B1;DHRS11
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.2952335517009969,-0.674138986143344,0.9019607843137255,1.0,1.0,12/38,22.45%,PER2;ENO2;GAPDHS;GOT2;G6PC3;PFKFB1;SORD;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.423248197474111,0.6740856048138788,0.8867924528301887,1.0,1.0,2/6,22.48%,CARD16;CARD18
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.2943851579326525,0.6739644992502871,0.9523809523809523,1.0,1.0,2/50,3.70%,SLC16A5;SLC38A3
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.45463898986429707,0.6738276750262484,0.859375,1.0,1.0,2/6,19.96%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.393371537362995,0.6737684600185085,0.9454545454545454,1.0,1.0,5/15,22.80%,PCSK5;NR1H3;ANGPTL4;HDAC9;FURIN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.38344668599378406,0.6735654402633217,0.8723404255319149,1.0,1.0,1/11,2.87%,PPARG
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,-0.4029852177039097,-0.6735387527158709,0.9230769230769231,1.0,1.0,1/11,4.09%,RNASE1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.36000932614718023,0.6733376308644273,0.9347826086956522,1.0,1.0,8/24,27.68%,FGF2;VEGFA;HDAC9;AKT3;ANXA1;MEOX2;CIB1;STARD13
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.38623871488335704,-0.6732976120268894,0.813953488372093,1.0,1.0,1/10,7.88%,HFE
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.3511871307862241,0.6731140651778471,0.8333333333333334,1.0,1.0,3/19,14.02%,MID2;TRIM26;PML
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3172636255617496,0.6729948769876487,0.9375,1.0,1.0,12/39,24.47%,ST6GALNAC3;FUT9;ST8SIA4;ST3GAL6;FUT8;ABO;B4GALNT2;ST8SIA1;NAGA;ST6GALNAC4;GAL3ST3;ST6GAL2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3560212371381826,0.672782104915255,0.8666666666666667,1.0,1.0,5/20,17.55%,SLC1A3;SLC7A2;SLC3A2;SLC1A6;SLC36A1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.3156229189764179,0.6725894174105027,0.896551724137931,1.0,1.0,19/38,33.06%,PLPPR1;PTEN;MTMR9;MTMR3;MTMR11;PLPP1;INPP5J;PLPP5;PIP4P1;PLPPR5;INPP5F;OCRL;MTMR8;PIP4P2;PLPP3;SGPP2;MTM1;MTMR10;PLPP2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.40076208502384214,0.6724545395927098,0.8461538461538461,1.0,1.0,4/10,26.67%,SPX;ACSL1;SLC27A1;CD36
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.2771005318550247,-0.6724179852972025,1.0,1.0,1.0,8/121,8.78%,DUSP4;SIGIRR;DUSP6;FOS;BTK;JUN;ECSIT;LY86
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.4872147050095984,-0.6723906720509687,0.8723404255319149,1.0,1.0,1/6,12.79%,FUCA1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.4872147050095984,-0.6723906720509687,0.8723404255319149,1.0,1.0,1/6,12.79%,FUCA1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.37901068821647055,0.6720914189679217,0.8367346938775511,1.0,1.0,4/12,17.69%,DHRS3;EZH2;CTBP2;AKR1C3
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.38266390434429975,0.6720794184062013,0.9,1.0,1.0,5/12,24.57%,TTC21B;IFT140;DYNC2I2;CILK1;WDR35
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.33160095891667385,0.6717770648053697,0.9,1.0,1.0,6/44,12.51%,MYRF;ADGRG6;GAL3ST1;MARVELD1;ACSBG1;ABCD2
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.3097762160649731,0.6717672856300818,0.975,1.0,1.0,10/42,16.64%,ACTG2;ENTHD1;MYL12A;MYH11;GUCY1A2;ITGA1;TPM2;SORBS3;GUCY1A1;PKN2
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.35148056701242336,0.67174061626373,0.8846153846153846,1.0,1.0,7/14,24.81%,SLC39A8;SLC30A6;SLC30A1;SLC30A2;SLC39A14;SLC30A7;SLC39A6
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.39902449854376476,0.6716171743132521,0.9166666666666666,1.0,1.0,3/8,10.69%,SAG;CNGA1;PDE6A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.4006214986846029,0.6715971599324112,0.8363636363636363,1.0,1.0,2/11,15.19%,LMO2;THRB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.3761195088767215,0.6714355668814961,0.9310344827586207,1.0,1.0,6/16,20.58%,NAIF1;SLC25A31;PPIF;THEM4;HEBP2;BAD
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.382973956628218,0.6712492611041176,0.8666666666666667,1.0,1.0,7/13,23.75%,NUS1;GALK1;PGM1;DOLK;GFPT1;DPM1;GALT
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.33436763300032585,0.6710920331764034,0.9,1.0,1.0,3/30,3.64%,GNB4;GNG12;KCNJ3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4060891433043769,0.6708851208906721,0.9047619047619048,1.0,1.0,1/10,3.01%,PADI2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.32265261547104496,-0.6706306609928022,0.94,1.0,1.0,3/30,10.93%,CMTR1;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.32265261547104496,-0.6706306609928022,0.94,1.0,1.0,3/30,10.93%,CMTR1;GTF2F1;GTF2H2
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.2650120706725321,0.6704876313335163,1.0,1.0,1.0,44/137,21.64%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;TLR2;KCNH8;MAP2K6;PLCG2;TICAM1;PELI3;UBE2D3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;IKBKE;MAP3K1;DNM3;TAB3;MAPK10;MAP3K8;BIRC3;FADD;RPS6KA5;IRAK3;TP53;CTSV;IRF3;LGMN;UBE2D1;ITGB2;RIPK2;IKBKB;TLR1;MAPK3;DUSP7;TMED7-TICAM2
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.35175597963366523,-0.6703415823634838,0.8979591836734694,1.0,1.0,5/18,13.16%,NLRP3;MEFV;IL18;ENTPD5;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.394572222360174,-0.6701360813349142,0.9074074074074074,1.0,1.0,1/9,4.39%,CBARP
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4158405270134702,0.6701218762530003,0.9047619047619048,1.0,1.0,2/9,18.20%,TSPAN6;RIOK3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.41708700795571446,0.6700378242452175,0.8775510204081632,1.0,1.0,1/7,2.84%,KAT2B
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.43781077296761944,0.6697017829448598,0.8679245283018868,1.0,1.0,3/5,32.83%,TP53;BMP4;ZC3H8
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.43322226266717767,0.6696934767868747,0.875,1.0,1.0,2/8,24.26%,DYRK1A;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.27566680798489646,0.6696465790220091,1.0,1.0,1.0,48/198,20.92%,LGALS9;PPARG;ROR1;FANK1;HCLS1;MID2;RELA;TLR2;ESR1;EPHA5;PLCG2;TICAM1;RPS6KA4;FER;ANXA3;CD40;NEUROD2;STING1;TAB2;NHLH2;TRIM26;IRAK1;PTEN;IL18R1;FZD1;DVL2;LRP6;FZD4;IKBKE;TRIM52;RNF25;TAB3;CTNNB1;RPS6KA5;EDA;IRAK3;VEGFA;WNT2;JMY;KIT;CX3CR1;ERC1;RIPK2;IKBKB;EDN1;DDIT3;CARD16;STK36
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2781758352358661,-0.6696363455542245,0.9622641509433962,1.0,1.0,2/110,1.32%,TBC1D10C;STX16
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.29091464839946013,0.6696357116545089,0.9795918367346939,1.0,1.0,13/77,20.95%,SEM1;RELA;TAB2;PIK3CA;PSMD13;PTEN;PSME4;PSMA1;CD247;UBE2D1;RIPK2;IKBKB;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.4202093106365037,-0.6693670681244834,0.8297872340425532,1.0,1.0,3/7,16.85%,VDR;MED1;FGFR2
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.46121956544612625,0.6693162249976814,0.9230769230769231,1.0,1.0,1/5,3.42%,SLC26A6
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4084377917387373,0.6692477399576517,0.8823529411764706,1.0,1.0,2/10,11.95%,NPPA;PDE4B
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.27791578708458176,-0.6691416676625302,0.9782608695652174,1.0,1.0,5/112,6.42%,NUPR1;ALOX5;CAMK2A;IER3;MBTPS2
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.3502665177677225,-0.6689867884176417,0.9344262295081968,1.0,1.0,2/19,4.64%,RNASE1;DHDDS
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.3880686303327927,-0.6689658555349951,0.8723404255319149,1.0,1.0,1/10,7.08%,LAMB3
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),-0.44126212907821744,-0.6686625366235656,0.8048780487804879,1.0,1.0,2/5,13.86%,SLC36A2;SLC6A20
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.44149150372426593,-0.6682495533676543,0.8125,1.0,1.0,3/5,9.36%,KCNN2;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.44149150372426593,-0.6682495533676543,0.8125,1.0,1.0,3/5,9.36%,KCNN2;KCNQ1;KCNA5
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,0.4035275129349214,0.6677399976043024,0.896551724137931,1.0,1.0,3/9,13.08%,FGFR1;FGF17;FGF5
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.37717471008446984,0.667731531316478,0.9,1.0,1.0,4/13,24.27%,SLC25A13;GPD2;SLC25A12;UQCRFS1
prerank,CellMarker_Augmented_2021__B cell:Bone Marrow,-0.42454309713270627,-0.667354247484209,0.8367346938775511,1.0,1.0,1/7,1.04%,CD24
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.31671674985614545,0.6673196200557615,0.9183673469387755,1.0,1.0,8/36,21.54%,ST6GALNAC3;FUT9;ST3GAL6;ABO;B4GALT3;HEXB;ST8SIA1;NAGA
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.4065803351094187,-0.6672973656797826,0.8125,1.0,1.0,2/5,12.91%,CARTPT;CRH
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.35451140547123244,-0.6671839208073932,0.875,1.0,1.0,4/17,15.09%,RAB7B;FLOT1;DAB2IP;IFI35
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4002652508865159,-0.6671247764940637,0.8,1.0,1.0,2/5,20.69%,APH1B;APH1A
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.446340243651634,0.6671107376462815,0.8703703703703703,1.0,1.0,1/6,20.06%,MINPP1
prerank,KEGG_2021_Human__Yersinia infection,-0.2710339681795079,-0.666934404727302,1.0,1.0,1.0,14/117,15.28%,RAC2;NLRP3;MEFV;ARPC5L;FOS;VAV3;JUN;LIMK1;PIP5K1B;IL18;PTK2B;RAC1;ARPC5;GIT2
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.3206945950211018,-0.66690409950284,0.9347826086956522,1.0,1.0,5/27,20.35%,POLR3H;POLR3E;TBP;POLR3A;POLR3F
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.37099011350842204,0.6668639182868434,0.8163265306122449,1.0,1.0,1/12,3.42%,SLC26A6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.29319709733458665,-0.6667723949474038,0.9615384615384616,1.0,1.0,17/82,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.29115883067887627,-0.6666357321472787,0.9565217391304348,1.0,1.0,15/51,22.45%,PER2;OAS1;ENO2;KCNJ11;GAPDHS;GOT2;G6PC3;PFKFB1;SORD;APOD;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3316653797209055,-0.6665740110251227,0.9111111111111111,1.0,1.0,4/18,14.25%,RIN3;LRPAP1;WDR54;RAC1
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,0.2726200286483621,0.6663618339756419,1.0,1.0,1.0,16/96,24.03%,CHCHD4;RPP40;GMNN;AK6;TPRKB;DCTPP1;PSMA1;OLA1;PRPS2;MRPL18;TIMM10;BANF1;HPRT1;DPM1;GGCT;SF3B6
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.3765645579698522,0.6659495287336805,0.8333333333333334,1.0,1.0,3/11,16.06%,VSIR;IL23R;TNFRSF21
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.28215242825311054,0.6658589720177477,1.0,1.0,1.0,23/88,16.86%,PELI2;RELA;PELI1;MAPKAPK2;TIFA;KCNH8;MAP2K6;PELI3;HMGB1;TAB2;MAPKAPK3;RPS6KA2;MEF2C;MAPK8;IRAK1;TANK;CREB1;RPS6KA1;MAP3K1;TAB3;MAPK10;MAP3K8;RPS6KA5
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.32332334777362354,-0.6657790795695465,0.8727272727272727,1.0,1.0,4/23,10.96%,FGF1;DNAAF1;CHI3L1;CCDC40
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3539079438111497,0.6655194139973614,0.9310344827586207,1.0,1.0,1/17,1.53%,TSPAN12
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.31088346148519275,0.6653212880716616,0.9411764705882353,1.0,1.0,5/27,20.64%,PAPOLA;PCF11;CSTF3;WDR33;NCBP1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.3622897402194164,-0.6648675921256435,0.8703703703703703,1.0,1.0,1/13,1.90%,ENTPD2
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",0.35447922774087726,0.6643674682842168,0.94,1.0,1.0,2/16,7.42%,PAX6;DPP4
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.3321577823609049,0.6642188329070875,0.8936170212765957,1.0,1.0,6/17,31.21%,CREB1;NBEA;PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.3375523949201604,0.6636612718037859,0.9375,1.0,1.0,2/19,11.92%,SIX4;MEF2C
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,-0.3802258579802138,-0.6630982404237363,0.8541666666666666,1.0,1.0,2/13,14.55%,RFC3;RFC2
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.3151802950070341,0.6628748782693752,0.9259259259259259,1.0,1.0,12/41,20.72%,ACD;H2BC21;SYCP2;H2AC6;TERF1;H2AZ2;LMNB1;H2AX;SUN2;SMC3;POT1;SYCP3
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.34821320034338354,-0.6628563144455875,0.9583333333333334,1.0,1.0,6/19,14.15%,PLCB2;GNG13;TAS2R5;ITPR3;GNB3;TAS2R8
prerank,Reactome_2022__Sodium/Proton Exchangers R-HSA-425986,-0.4516384992259651,-0.6627905822739756,0.82,1.0,1.0,1/6,4.69%,SLC9A8
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.3204088569709469,0.6626227078271989,0.94,1.0,1.0,9/39,23.88%,NAV3;SNCA;DYRK1A;TOGARAM1;ABL1;MAP2;CAMSAP2;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.3706555058891386,0.6626132000168277,0.8888888888888888,1.0,1.0,1/10,7.42%,DPP4
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.3169082892647575,0.6625053498823442,0.9444444444444444,1.0,1.0,11/31,30.12%,UBE2D3;IKBKE;IRF3;UBE2D1;NLRC5;TRIM4;CYLD;IFIH1;PCBP2;ATG12;HERC5
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.34507277915367074,0.6624983351717325,0.9433962264150944,1.0,1.0,7/20,26.08%,TCN2;ACACA;ABCD4;LMBRD1;MMAB;MCCC1;MTR
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.34079159988520896,0.6620519094939514,0.9137931034482759,1.0,1.0,9/24,31.58%,TCN2;SLC19A1;SLC52A1;SLC19A2;SLC2A14;SLC27A1;SLC46A1;SLC35F3;CD320
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.3577561819307742,0.6620038403408304,0.9795918367346939,1.0,1.0,4/17,22.38%,NAV3;CD34;ZFP36;PTPRC
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.3551129269075602,-0.6617357043185383,0.9166666666666666,1.0,1.0,6/22,18.94%,RAC2;PARVG;RAC1;PARVB;RHOQ;NCKAP1L
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.27047637067232355,0.6616336033313279,1.0,1.0,1.0,12/75,19.27%,SEM1;SPOP;SPOPL;PSMD13;GPR161;PSME4;GAS1;PSMA1;NUMB;ARRB2;SMURF1;DZIP1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.2823533633730741,-0.6614816612208995,1.0,1.0,1.0,6/69,9.55%,KDM4D;ABRAXAS1;TICRR;RNF8;EYA1;RAD51AP1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.36664880121974175,-0.6612555721838427,0.82,1.0,1.0,5/16,17.38%,TMIE;PAX2;USH1C;FGFR2;PAX8
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.2994474576887676,0.661038117653468,0.9122807017543859,1.0,1.0,13/60,19.92%,PPARG;ZBTB20;TLCD3B;SLC4A7;NR1D2;ABHD8;NR1H3;TENT4B;SLC4A1;PNPLA8;IRS2;WNK1;ACOX1
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.3649110749546313,-0.6606374011312378,0.8604651162790697,1.0,1.0,1/20,1.43%,GATD3
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,-0.3852863220734019,-0.6604853255491793,0.8888888888888888,1.0,1.0,3/12,15.03%,MPZ;RABGGTA;BCL2L14
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.35591364049993807,0.6602071311677442,0.8958333333333334,1.0,1.0,8/22,25.12%,TLR2;HMGB1;NR1H3;MFHAS1;TICAM2;TLR1;NINJ1;LBP
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.30745798741458863,-0.6601893631409022,0.9523809523809523,1.0,1.0,4/27,15.13%,PRKCD;STMN1;MYADM;TUBB4A
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.44403572719437107,-0.6595513021169537,0.8918918918918919,1.0,1.0,3/5,25.71%,SLIT3;MYO9B;RHOA
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,-0.423569362305928,-0.6593607020169974,0.8627450980392157,1.0,1.0,1/8,8.01%,DPH6
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.4331230204770864,0.6591204536847638,0.8679245283018868,1.0,1.0,1/6,4.31%,PRMT1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.4195334311266739,-0.6591087076401463,0.8695652173913043,1.0,1.0,6/6,58.06%,SRC;BDNF;FYN;STAP1;DOCK3;NTRK2
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.27266454015883357,-0.658561746979334,1.0,1.0,1.0,10/139,13.35%,ATP6V1E2;ATP6V1C2;ATP6V1E1;EIF2S2;EIF2S3;RPS27L;ATP6V1D;RPL38;SH3BP4;ATP6V1F
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.32069962274597885,-0.6584933159701131,0.9787234042553191,1.0,1.0,10/37,17.25%,FOS;VGF;TRIB1;EGR1;EGR4;CHD4;FOSL1;ID2;EGR3;TPH1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.3139621758552963,-0.6584679915371471,0.9534883720930233,1.0,1.0,5/42,13.85%,DNASE1L1;ADAMTS9;DAB2IP;DENND3;SUPV3L1
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.2693038309583737,0.6584201831682808,0.98,1.0,1.0,32/94,31.65%,TF;GPATCH8;RCBTB1;FCHSD2;MGAT5;CICP14;TMEM170B;STK35;SPEN;DOCK4;POGZ;DIP2B;UBAP1L;ATG2B;WNK1;ZSWIM8;FAM168A;LENG8;PIKFYVE;TRIM9;WDR7;SIK3;ZKSCAN8;KIDINS220;MYO5A;SIRPA;CDS2;CLASP2;NISCH;ZNF337;CLSTN1;SCAMP5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.30499218346562207,-0.6576940423108394,1.0,1.0,1.0,1/50,0.73%,AMACR
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.2826383185913992,0.6575823882788886,0.9811320754716981,1.0,1.0,9/53,23.71%,TSR3;PUS7L;CTU1;TRDMT1;CDKAL1;NOP10;TFB1M;METTL1;TRMT9B
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.3507641873054075,0.6575315786599321,0.88,1.0,1.0,6/16,20.65%,PTGS1;HPGDS;CD74;PNPLA8;AKR1C3;EDN1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.3506906950123293,0.6573485473591798,0.8888888888888888,1.0,1.0,4/22,15.11%,HSD17B2;FDX1;FDXR;STAR
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.3569411712577218,0.6570872079842808,0.9454545454545454,1.0,1.0,5/17,19.39%,FUT9;ST3GAL6;FUT8;ABO;B4GALNT2
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.280753695788492,0.6568768350050821,1.0,1.0,1.0,23/126,16.86%,ANTXR2;CCL5;TRPV2;RELA;TICAM1;NLRP7;CASR;ERBIN;STING1;TAB2;MCU;MAPK8;TANK;TRPM2;IKBKE;NEK7;PLCB1;TAB3;MAPK10;PKN2;TRPM7;BIRC3;FADD
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.3208036379004629,0.656753840520746,0.9347826086956522,1.0,1.0,14/30,33.21%,RACGAP1;PHLDB2;CRB2;PLCB1;PHLDB1;RPS6KA6;TDG;INSR;NIPBL;ZBED3;CLASP2;CLASP1;SEPTIN7;B4GALT5
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.28650098145431313,0.6567298388312506,0.9649122807017544,1.0,1.0,5/54,16.35%,SIRT1;ODC1;PSMD13;PSME4;PSMA1
prerank,Reactome_2022__Release Of Hh-Np From Secreting Cell R-HSA-5362798,0.39495166496667705,0.6566394315167176,0.8367346938775511,1.0,1.0,1/6,7.10%,GPC5
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,-0.38947517864748477,-0.6566278917592223,0.8571428571428571,1.0,1.0,8/8,61.07%,UBB;UBA52;UBC;GYG1;GYS1;PPP1R3C;NHLRC1;RPS27A
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.34135670085439357,0.6566011429892239,0.9387755102040817,1.0,1.0,10/27,23.16%,LLGL1;RPS6KA2;LRRC7;GRIN2D;CREB1;RPS6KA1;MPP3;MAPK3;RPS6KA6;DLG1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.3452517605744294,0.6561191828225434,0.9454545454545454,1.0,1.0,2/17,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.27742908213897843,-0.6559663861792016,1.0,1.0,1.0,20/125,19.64%,EIF2S3B;RPF2;EIF2S2;EIF2S3;RPS27L;SRPK3;PRPF19;CELF3;SNRNP200;WDR77;RPL38;PRMT7;SRSF10;PRPF6;CRNKL1;RPS27;BRIX1;EIF4H;COIL;SNRPD2
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.35502525887902686,-0.6557078993877427,0.9111111111111111,1.0,1.0,2/19,5.23%,RASGRF2;CAMK2A
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.3976118429113251,-0.6556422447986882,0.9111111111111111,1.0,1.0,3/11,17.77%,CAV1;CALM1;TACR1
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,-0.41236458168682977,-0.6551707260911243,0.88,1.0,1.0,1/7,4.55%,SLC39A4
prerank,KEGG_2021_Human__Spliceosome,-0.2757253476452364,-0.6551354218550046,0.9795918367346939,1.0,1.0,23/122,20.90%,SNRNP27;RNU4-2;PRPF4;DHX8;PRPF19;SNRNP200;SNRPA1;SF3A3;ISY1-RAB43;SRSF10;PRPF6;SYF2;MAGOHB;SNW1;DHX38;CRNKL1;SF3A1;RBM22;SNRPD2;WBP11;SRSF7;RBMX;SLU7
prerank,Reactome_2022__Signaling By RNF43 Mutants R-HSA-5340588,0.4194157493145468,0.6547950281088277,0.875,1.0,1.0,3/6,14.69%,LRP6;FZD4;FZD6
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.29308813153598823,-0.6545626295835936,0.9607843137254902,1.0,1.0,13/63,21.82%,ENO2;PGP;GAPDHS;TAC4;POM121C;PFKFB1;NUP133;LOC112694756;SEC13;ALDOB;PRKCA;ENO3;NUP93
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.3821686228237819,-0.6544694394609714,0.9148936170212766,1.0,1.0,4/12,21.58%,PTK2B;CAV1;CAV3;ACTN2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.25704509436800255,0.6537957774567561,1.0,1.0,1.0,20/104,31.70%,EIF3E;SMG1;RPS5;RPL21;RPL18A;RPL7;RPS3A;NCBP1;RPL23A;RPL9;RPS29;RPS19;PABPC1;PPP2R2A;RPS15A;SMG9;RPS23;RPS12;PYM1;RPLP0
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,0.3216555810478759,0.6537167748736126,0.9591836734693877,1.0,1.0,4/45,7.94%,IL10RA;ZNF462;PIP4K2A;PWWP2A
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,0.32993962563354073,0.6535445458778424,0.9622641509433962,1.0,1.0,2/22,6.30%,WNT4;WNT9A
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.2712161655647715,-0.6535273060231199,1.0,1.0,1.0,15/102,15.00%,ERN2;TTC23L;RASGRF2;ERLEC1;MBTPS2;FLOT1;JUN;CREB3L1;DDRGK1;WFS1;DAB2IP;ALOX15;UFL1;ANKS4B;SEC16A
prerank,KEGG_2021_Human__Folate biosynthesis,0.3444223117054256,0.6535100088659378,0.8936170212765957,1.0,1.0,5/21,18.91%,SPR;GCH1;GPHN;AKR1C3;MOCOS
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),-0.4692451311444942,-0.6534577661112966,0.8863636363636364,1.0,1.0,2/5,17.50%,TAMM41;CRLS1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.31838025872784065,0.6534278193606551,0.9056603773584906,1.0,1.0,6/25,24.10%,LRIG3;POLE2;SLC19A1;POLK;LRIG1;POLD4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.35244097691685017,0.6530013159413471,0.8703703703703703,1.0,1.0,6/14,20.30%,MCTP2;SNCAIP;MEF2C;FMR1;MCTP1;KCNMB4
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.34492826472051,-0.6529475739785937,0.8936170212765957,1.0,1.0,3/22,8.22%,SLC39A4;SLC11A1;HEPH
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.34827556678504257,-0.6527430045700326,0.9215686274509803,1.0,1.0,3/13,20.69%,ITGB3BP;APH1B;APH1A
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.33857558337484117,0.6524954836027492,0.8888888888888888,1.0,1.0,3/22,19.23%,RRAGC;RRAGD;MLST8
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.44297265529604657,-0.6519672754450322,0.8461538461538461,1.0,1.0,4/6,18.46%,SLC14A2;UPK3A;SLC14A1;AQP1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.3189984502792975,0.6518753941366029,0.9387755102040817,1.0,1.0,6/26,20.53%,UBE2E2;UBE2D3;UBE2E3;RNF26;FZR1;UBE2A
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,0.43536694154056965,0.6514364681913072,0.9130434782608695,1.0,1.0,2/8,9.97%,RRAS;PLXNB1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.4168643698871054,0.6513774445055809,0.9411764705882353,1.0,1.0,1/7,10.93%,LIG4
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.3704060079144349,-0.6513726032373697,0.8837209302325582,1.0,1.0,1/11,10.16%,VIT
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.416626273968926,-0.6513119447684456,0.875,1.0,1.0,1/5,19.97%,DAGLA
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.31106169808085427,0.651182414298804,0.8979591836734694,1.0,1.0,7/45,20.95%,SEM1;PSMD13;PSME4;PSMA1;TP53;CARD16;PSMD4
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.4084811021809212,-0.6511143673259687,0.8695652173913043,1.0,1.0,2/6,20.69%,APH1B;APH1A
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,-0.3674001567657989,-0.651041447664698,0.88,1.0,1.0,1/11,4.09%,RNASE1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.36518635049343035,0.6507688659797878,0.8653846153846154,1.0,1.0,1/12,5.96%,TET2
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.33817082507038676,0.6507643972858997,0.9423076923076923,1.0,1.0,6/18,23.00%,MYL12A;EFNB2;NCK2;PKN2;EPHB4;EFNB1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.3253304858820005,0.6502326848327995,0.9259259259259259,1.0,1.0,5/28,18.36%,GLRA1;RRAGC;CPEB1;VEGFA;RRAGD
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.31237645563310246,-0.6501864603255053,0.9787234042553191,1.0,1.0,2/38,3.18%,PLA2G2C;ENPP2
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.4021480017493121,-0.6499872533965607,0.9411764705882353,1.0,1.0,2/10,9.52%,CYP24A1;VDR
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.27350556640117374,-0.6499540406337554,0.9791666666666666,1.0,1.0,1/64,1.24%,RTF1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.42419747131192814,-0.6498023491261122,0.9166666666666666,1.0,1.0,1/5,16.06%,VDAC1
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,-0.43761361390035186,-0.6497348414835545,0.875,1.0,1.0,2/7,12.43%,HMGCL;BDH1
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.3225364645797397,-0.6493954169071923,0.9454545454545454,1.0,1.0,4/20,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,0.34419946122773615,0.6493139577964863,0.9285714285714286,1.0,1.0,6/30,10.07%,SELPLG;OLIG2;IL7R;F3;PDGFC;TNC
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.3252085105405283,-0.64922508746844,0.9795918367346939,1.0,1.0,4/34,11.53%,PARP2;XPC;PARP1;COPS7A
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.4055000487364704,-0.6492172504057354,0.9183673469387755,1.0,1.0,1/7,17.00%,STAT1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.28431108797310306,-0.6491643028453953,0.9807692307692307,1.0,1.0,3/94,4.71%,DUSP4;DUSP6;FOS
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.3492831525282707,-0.6491362490018842,0.9591836734693877,1.0,1.0,5/18,16.77%,SLC6A11;SLC6A12;ALDH5A1;CPLX1;RAB3A
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.3656863445949266,-0.6488092515019374,0.8604651162790697,1.0,1.0,4/16,25.57%,MLYCD;NR4A3;ABCB11;TYSND1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.37856552200377036,0.648734380856435,0.8846153846153846,1.0,1.0,1/10,4.40%,SIX4
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.2767351334523293,0.6486716625515587,1.0,1.0,1.0,3/62,4.68%,REXO2;RRAD;H2BC21
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.42357182967109297,0.6485832499078046,0.9107142857142857,1.0,1.0,2/5,20.65%,BCAR1;EDN1
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.33133991153252007,-0.6484886719093602,0.9722222222222222,1.0,1.0,2/32,5.87%,CAMK2A;CRYBA4
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.327761820162953,0.6484832269765437,0.9166666666666666,1.0,1.0,6/26,15.29%,NEO1;TF;CYBRD1;BDH2;PICALM;HJV
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.2900638780487853,0.6484412319788485,0.9444444444444444,1.0,1.0,3/43,5.58%,MLC1;GLRA1;PTGFR
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.3829930573608211,0.6483708142699296,0.9107142857142857,1.0,1.0,1/9,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.2995286653828439,-0.6483655009005656,1.0,1.0,1.0,12/61,14.25%,FBLN2;PLEKHA2;SFRP1;OLFM4;TRIOBP;VIT;MYADM;APOA1;RREB1;PTK2B;ALOX15;RAC1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.3750154758949332,-0.6480551011313137,0.8409090909090909,1.0,1.0,4/7,31.87%,MCTS1;EIF2D;MTIF3;MRRF
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2696186528620004,-0.6480135232368988,1.0,1.0,1.0,12/96,14.15%,CXCL13;WARS1;BIK;ERCC1;CLU;TTBK1;PARP1;GTF2H2;PSMC4;DAB2IP;TGFB1;RPA3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.3945870659242435,-0.6475923948671977,0.8775510204081632,1.0,1.0,1/11,4.63%,SLC19A3
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.27956666739496205,-0.6475680627320081,1.0,1.0,1.0,3/98,4.71%,DUSP4;DUSP6;FOS
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3601477055130562,-0.6474931242951,0.9245283018867925,1.0,1.0,3/16,17.93%,RECQL5;MCM2;BLM
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.3639785960603867,0.6473619661040949,0.9298245614035088,1.0,1.0,4/12,18.00%,SYK;MAPK8;DVL2;NOXO1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.34214525646005967,-0.6473412741995739,0.8695652173913043,1.0,1.0,2/11,12.61%,CAV2;NUCKS1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.37682303508791676,0.6470525508965469,0.8653846153846154,1.0,1.0,2/10,16.94%,GAL3ST1;DGKZ
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.29950754882676034,0.6466587513684466,0.98,1.0,1.0,10/50,19.07%,MOSMO;SPOP;SPOPL;GPR161;LRP2;CSNK1G3;GAS1;ARRB2;PRKACB;SMURF1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.41745882800351153,0.6465711748515985,0.8545454545454545,1.0,1.0,3/6,34.85%,RAB11FIP2;SELENOT;RAB11B
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.2551983019521772,-0.6464801096027778,1.0,1.0,1.0,22/161,16.28%,CLDN4;CYTH4;NLRP3;CLDN1;ARPC5L;FOS;TUBB2A;MYO5B;JUN;ARF1;TUBB8;CLDN15;IL18;MYH9;TUBB;RAC1;ARPC5;TUBB4A;MYO1H;CLDN16;CLDN5;NAIP
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.331706790401195,-0.6463418616551511,0.9166666666666666,1.0,1.0,8/33,16.57%,NLRP3;MYO5B;GNG13;GNGT1;GNB3;GNB5;RAB11A;ADCY1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2751164709622558,-0.6463263167676615,0.9791666666666666,1.0,1.0,1/62,1.24%,RTF1
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,-0.3521915236453961,-0.6462502168452173,0.92,1.0,1.0,1/14,5.12%,GOLGA2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3049478039827453,0.645818527483985,0.9814814814814815,1.0,1.0,7/52,18.20%,CCL5;HLA-E;POLR3G;PLSCR1;BIRC3;IRAK3;RIOK3
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.24989899350360148,0.645759530826774,1.0,1.0,1.0,12/104,16.35%,CCNA2;SEM1;GMNN;MCM7;ANAPC16;PSMD13;GINS1;POLE2;PSME4;SLC19A1;ORC4;PSMA1
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.3137584571782392,-0.6453859212385455,1.0,1.0,1.0,8/46,13.95%,CNGB1;TTC8;PRKD2;CYS1;SMOX;EXOC3;PTGES2;RAB8A
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.3622569762450194,-0.6453464710141283,0.8444444444444444,1.0,1.0,4/16,17.47%,IRF5;STAT1;PTPRS;HAVCR2
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.3170954146312526,0.645341909859283,0.9375,1.0,1.0,5/34,11.56%,TUBA1C;TTLL2;TPGS1;TTLL9;VASH2
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.2805305358896241,0.645208919678908,1.0,1.0,1.0,17/79,20.72%,MSH4;ACD;H2BC21;TEX15;SYCP2;H2AC6;TERF1;H2AZ2;LMNB1;H2AX;ARTN;CDK4;SUN2;SMC3;SPAM1;POT1;SYCP3
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2862031573135782,0.6450905173690239,0.9574468085106383,1.0,1.0,10/47,22.98%,NOVA1;KHDRBS2;NSRP1;PUF60;KHDRBS3;RBM5;FMR1;RBFOX1;MBNL2;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.30111462431660435,0.6449298856693187,0.9803921568627451,1.0,1.0,3/23,12.92%,BMP2;DLC1;MTMR9
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.3543609920933316,0.6449216569077547,0.90625,1.0,1.0,2/13,9.26%,NEDD4;PTPN14
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.31406700967592704,0.6449103163408394,0.9574468085106383,1.0,1.0,5/43,16.64%,SEM1;PSMD13;PSME4;PSMA1;PKN2
prerank,Reactome_2022__NADE Modulates Death Signaling R-HSA-205025,-0.41584865776533075,-0.6447142005270573,0.8666666666666667,1.0,1.0,1/5,11.03%,BEX3
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.39062680095885616,0.6446397700039506,0.8679245283018868,1.0,1.0,1/9,3.41%,ENPP1
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.2934983480362569,0.6446035349919013,1.0,1.0,1.0,10/33,24.58%,RYBP;YAF2;EZH2;RNF2;EPC1;EED;MGA;E2F6;RBBP4;PHC3
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.4215434549368233,0.6443368291961186,0.8727272727272727,1.0,1.0,1/7,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.4215434549368233,0.6443368291961186,0.8727272727272727,1.0,1.0,1/7,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.344243495269781,0.6440877229260406,0.9347826086956522,1.0,1.0,8/23,16.53%,SLC10A3;ABCC2;SLC10A5;NCOA2;SLC10A1;ABCC11;SLCO1A2;AKR1C1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.297585854098702,-0.6437295406491453,0.9607843137254902,1.0,1.0,8/37,17.02%,RSPH9;CCDC40;GAS2L2;CFAP74;RSPH1;CFAP46;RSPH4A;CHP1
prerank,KEGG_2021_Human__GnRH secretion,0.28678403178044315,0.6433647201967713,1.0,1.0,1.0,17/61,22.07%,GNRH1;KCNJ3;TRPC4;GNRH2;PIK3CA;HCN1;TRPC5;PLCB1;PIK3CD;CACNA1I;ARRB2;AKT3;PIK3R3;TRPC1;MAPK3;GNAQ;AKT2
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.45382793728672444,0.6433269561544355,0.8727272727272727,1.0,1.0,2/5,22.25%,SOS1;GRB2
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,-0.4092612278243034,-0.6431597517254867,0.8409090909090909,1.0,1.0,1/5,15.54%,SKP1
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.24334811211715746,0.6430319012446345,1.0,1.0,1.0,44/274,21.57%,TIMELESS;CCNA2;ACD;SEM1;RRAD;H2BC21;LRIG3;INO80E;ACTL6A;PAXIP1;INO80D;LIG4;POLE2;NFRKB;CHEK2;FANCL;REV3L;EYA2;REV1;MAPK8;H2AC6;TERF1;H2AZ2;PCLAF;SLC19A1;CCNH;H2AX;USP45;SIRT6;MNAT1;ARTN;TP53;RAD51B;FAAP20;POLK;ABL1;POLR2H;POLG2;POT1;GPS1;ACTR5;FAAP100;TDP2;XAB2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.3373842944517712,-0.642959709002666,0.975,1.0,1.0,5/25,16.37%,WNT7A;ARF1;SHANK1;EPHB1;SHANK3
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.366040965516455,0.6426398189530909,0.8524590163934426,1.0,1.0,2/10,14.44%,PPP3CA;NFATC3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.37806022581247545,-0.6422201369339678,0.9636363636363636,1.0,1.0,3/10,14.29%,ATP4A;SLC4A4;ATP1B1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.3138375641363666,-0.6420248942268518,0.9069767441860465,1.0,1.0,4/17,14.55%,RFC3;POLR1A;RPA3;RFC2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.37304945994926086,-0.641823732122904,0.9148936170212766,1.0,1.0,5/15,21.56%,WFS1;MAPK7;PAX8;PDGFB;MTPN
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.3949559950790196,-0.6412595614476904,0.875,1.0,1.0,5/5,60.52%,PRKN;UBE2D4;ITCH;UBE2T;UBE2S
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.30890989061887103,-0.6410287994767642,0.9545454545454546,1.0,1.0,6/37,10.55%,DRD4;DRD2;ERLEC1;IRF5;GPRC6A;TRPV1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.38224943088359065,0.6407468027108562,0.9245283018867925,1.0,1.0,4/11,19.74%,MID2;TRIM26;PML;TRIM28
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.2828156833714465,-0.6407338491075731,0.9795918367346939,1.0,1.0,9/53,19.22%,EIF2S2;EIF2S3;RPS27L;EIF3J;EIF4EBP1;RPS8;RPS27;EIF4H;EIF3L
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.33099094692080394,0.6406376906464811,0.9787234042553191,1.0,1.0,1/25,4.04%,SF3B1
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),-0.445548569119704,-0.6404727289210435,1.0,1.0,1.0,1/5,7.19%,SLC11A1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.37573348476244556,-0.6402306162818505,0.8181818181818182,1.0,1.0,7/7,62.44%,MAP1LC3B;NBR1;PJVK;SQSTM1;PEX5;USP30;ATM
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.354933266492961,0.6400173889470031,0.8928571428571429,1.0,1.0,7/16,40.48%,TP53;CRYAB;MAP3K20;ATM;WRN;TMEM109;XRCC5
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.37461086212737416,0.6396199838845328,0.9122807017543859,1.0,1.0,5/11,29.16%,CD74;AXL;GAS6;DHX9;IFIH1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3261380090388598,0.639559506584316,0.9180327868852459,1.0,1.0,2/19,14.02%,RAP1GDS1;PML
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),-0.41775844712942434,-0.639485901879996,0.8837209302325582,1.0,1.0,1/6,4.62%,CACNA1G
prerank,Reactome_2022__Synthesis Of Dolichyl-phosphate R-HSA-446199,-0.40146803503225803,-0.6392958958442728,0.9069767441860465,1.0,1.0,1/5,4.64%,DHDDS
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.3134425159183726,0.6392947084053426,0.9387755102040817,1.0,1.0,5/29,16.70%,CTBP2;LRP6;FZD4;FZD6;CTNNB1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.3569457024770993,-0.6391685073724286,0.8666666666666667,1.0,1.0,5/19,18.30%,CBARP;UBASH3B;PTK2B;CACNB1;CAV3
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.2907711008692086,-0.6388787684165004,0.9591836734693877,1.0,1.0,12/52,18.27%,TERF2IP;PARP2;RFC3;SMUG1;PARP1;POLR1A;XRCC1;RPA3;RFC2;H2BC15;MBD4;PNKP
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.41935806076128535,-0.6385274160768626,0.8846153846153846,1.0,1.0,2/6,23.30%,FFAR4;METRNL
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.35122888119982226,0.6383695592943958,0.8985507246376812,1.0,1.0,6/16,20.28%,FGF2;EFNB2;GREM1;VEGFA;PIK3R3;EPHB4
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,-0.3602858054406032,-0.638322317171937,0.8536585365853658,1.0,1.0,4/11,21.95%,MBTPS2;MBTPS1;NFYB;HSP90B1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.3684669848199166,0.6382301016617987,0.9019607843137255,1.0,1.0,2/13,7.29%,SIRT1;IL15
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.3331703969363988,-0.6379582825418262,0.9069767441860465,1.0,1.0,2/25,10.00%,TRIM5;DHX58
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3262149565693191,0.6377839987177226,0.9795918367346939,1.0,1.0,3/27,8.93%,TET2;WDR5B;PAXIP1
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.2653727818024403,0.6373720975429648,1.0,1.0,1.0,16/80,23.60%,GOLT1A;SLC25A1;MAP4K2;SLC25A13;SLC37A4;RANBP2;PFKFB4;PRKACB;BPGM;SLC25A12;GNPDA2;FBP1;PFKP;NUP153;PFKFB2;PPP2R1B
prerank,Reactome_2022__Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) R-HSA-3656244,-0.4036945716378684,-0.6373714936256182,0.8409090909090909,1.0,1.0,1/5,10.32%,ACAN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.41212756745975565,0.6373359058433699,0.9642857142857143,1.0,1.0,3/7,27.66%,NFATC3;KIT;PDCD4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.38395071948522413,0.6368186405399887,0.9285714285714286,1.0,1.0,1/11,3.64%,KCNJ3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.38696254693829146,0.6367543553389582,0.9411764705882353,1.0,1.0,1/12,3.52%,RNF152
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3871792147645307,0.6366212795743196,0.9074074074074074,1.0,1.0,3/11,18.80%,KDM3A;ARID1A;PLPP1
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.35624439701286764,-0.6364422462515132,0.926829268292683,1.0,1.0,3/20,7.72%,SFTPA2;SFTPA1;ADGRF5
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.3841675760668473,-0.6364199060672393,0.8333333333333334,1.0,1.0,1/6,4.64%,DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.3841675760668473,-0.6364199060672393,0.8333333333333334,1.0,1.0,1/6,4.64%,DHDDS
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.3409592958334915,-0.6362731010372015,0.9545454545454546,1.0,1.0,6/19,18.29%,GOLGA2;TUBGCP2;TUBG1;CSNK1D;NDEL1;TUBGCP5
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,-0.42018754761167687,-0.6362719055491369,0.9347826086956522,1.0,1.0,2/8,12.43%,HMGCL;BDH1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.3823414526795998,0.6358968401972049,0.8873239436619719,1.0,1.0,7/12,29.14%,TLR2;OASL;ANKRD17;PUM2;PUM1;TLR5;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.3584919767092356,-0.6358170640444694,0.88,1.0,1.0,1/9,6.42%,MBTPS2
prerank,Reactome_2022__Highly Calcium Permeable Nicotinic Acetylcholine Receptors R-HSA-629597,-0.36690291007264175,-0.6357060106102406,0.8913043478260869,1.0,1.0,1/9,12.20%,CHRNA2
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.37347272619091676,0.6353076108225933,0.9482758620689655,1.0,1.0,2/11,18.55%,ESCO1;SMC3
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.32391494829073075,-0.6352707130608564,0.9375,1.0,1.0,5/26,20.35%,POLR3H;POLR3E;TBP;POLR3A;POLR3F
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3661722215976465,-0.63526720944232,0.8444444444444444,1.0,1.0,3/16,15.89%,DNAAF1;CCDC40;SPA17
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.4157185988206009,0.6352385570959054,0.9,1.0,1.0,1/5,15.21%,ANO6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.28373170259043773,0.6351400880923979,1.0,1.0,1.0,5/55,11.67%,AUP1;STING1;UBA5;RETREG1;DYNC1I2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.4175638932394018,-0.6350168198108551,0.9347826086956522,1.0,1.0,2/11,14.16%,GOT2;GGACT
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.30160814095796884,0.6348560536638168,0.9636363636363636,1.0,1.0,5/31,18.93%,POLE2;REV1;PCLAF;SLC19A1;POLK
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.34112060803596034,0.6348069101469406,0.9038461538461539,1.0,1.0,3/21,13.81%,LLGL1;LRRC7;GRIN2D
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.29032607360141005,0.634501252767176,0.9629629629629629,1.0,1.0,10/40,27.93%,CTU1;TRDMT1;CDKAL1;TRMT13;TRMT5;METTL1;TRMT9B;TRMT11;TYW3;TRMT112
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.36959306139998677,-0.6340953883203713,0.8928571428571429,1.0,1.0,2/10,8.18%,OAS3;OAS1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.3149890888675166,-0.6336706317112174,0.9574468085106383,1.0,1.0,4/34,14.22%,CENPH;ITGB3BP;SMARCA5;CENPF
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.3220900175189231,0.633227006194397,0.9444444444444444,1.0,1.0,10/24,21.69%,ITGAV;MEGF10;HMGB1;XKR6;NR1H3;RHOBTB1;RHOG;XKR4;ANXA1;GAS6
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.3697668136873159,0.6329857999788746,0.8275862068965517,1.0,1.0,1/8,4.00%,CNTNAP2
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.42342834083732744,-0.6329842503125024,0.9024390243902439,1.0,1.0,1/5,9.97%,COL1A1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.3998187853964002,0.6329145328080488,0.9259259259259259,1.0,1.0,2/8,7.21%,CCNA2;RPS6KA4
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.3426251100412338,-0.6328641629811816,0.9642857142857143,1.0,1.0,2/23,4.09%,ZC3H12D;RNASE1
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.2796085340669836,0.6323491497744502,1.0,1.0,1.0,15/51,25.38%,STOM;SCRIB;ARHGAP5;SLC4A7;VAMP3;FMNL3;PKN2;ARHGAP21;WASL;ARHGAP32;CDC42BPA;GJA1;FNBP1L;ARL13B;FNBP1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.4009471950609731,0.6321867166407694,0.875,1.0,1.0,1/5,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.29362168742897343,-0.6321774121512925,0.98,1.0,1.0,9/53,18.29%,PLK3;TUBGCP2;CCDC88C;STMN3;DCTN1;TRPV4;RAB11A;CHP1;TUBGCP5
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3896710879490185,0.6319087904604057,0.9215686274509803,1.0,1.0,4/9,12.03%,MAPKAPK2;MAPKAPK3;CARMIL1;RAB34
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,-0.40252811733233584,-0.6313639483349999,0.8695652173913043,1.0,1.0,1/7,7.14%,PLCB2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.369662609036355,-0.6313220938640814,0.8913043478260869,1.0,1.0,3/16,13.11%,CBARP;MMP9;CAV1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.31916628575253425,-0.6311536550769377,0.9523809523809523,1.0,1.0,3/30,9.16%,PRKCD;RBM3;RBM4B
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,0.370826864508095,0.6307415632077966,0.9215686274509803,1.0,1.0,3/12,18.32%,GADL1;ETHE1;MPST
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.3420072089153458,-0.6304619223055029,0.8571428571428571,1.0,1.0,1/12,6.62%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.3420072089153458,-0.6304619223055029,0.8571428571428571,1.0,1.0,1/12,6.62%,PER2
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.2992134178260767,-0.6303389989885577,0.98,1.0,1.0,8/56,11.78%,NR4A1;CACNA1G;CYP21A2;PLCB2;HSD3B2;HSD3B1;CREB3L1;ITPR3
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4159647960632157,-0.6302319264969848,0.8723404255319149,1.0,1.0,5/5,58.42%,GPS2;PPIA;PARP10;PLAA;TRIM44
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.31997914833662894,0.629911425811199,0.9523809523809523,1.0,1.0,4/20,18.47%,MYH11;PLXNB1;LIMK2;RHOB
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.31568480178756003,-0.6295922960971486,0.9298245614035088,1.0,1.0,4/18,11.67%,ASS1;ASPG;GOT2;FOLH1B
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.27963139134008425,0.6295900592259125,0.9591836734693877,1.0,1.0,15/92,24.86%,SIRT1;MAPKAPK2;BAG2;HSPA8;TNFRSF21;RANBP2;MRPL18;DNAJB1;MLST8;HSPA5;MAPK3;NUP153;HSPA1A;CRYAB;EP300
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.28882785620060014,-0.6295654017271501,0.9583333333333334,1.0,1.0,8/35,27.17%,POM121C;TOMM20;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.341775462406826,0.6295046562030672,0.9310344827586207,1.0,1.0,7/17,33.26%,RNF128;CD81;ABCA2;APOE;DACT1;CTSC;FAF1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.3629541727600938,0.6292727127671618,0.8780487804878049,1.0,1.0,4/11,29.59%,PRICKLE1;BMP4;SOX8;NOTCH1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.3509741255467212,0.6291106365160979,0.8958333333333334,1.0,1.0,2/12,11.77%,PLXNB1;PLXNB2
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,-0.37087192998621454,-0.629071079365517,0.8367346938775511,1.0,1.0,2/12,6.21%,CAMK2A;NEUROD6
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3804430882918181,-0.6288909109671339,0.9069767441860465,1.0,1.0,3/11,13.84%,PLK3;RPS27L;CCND1
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.26890096350528897,0.6284146403204962,0.98,1.0,1.0,15/75,22.25%,SYK;DOCK1;MYO1E;PLCG2;PIK3CA;PRKCSH;CD247;WASL;VAV2;ABL1;LYN;MAPK3;CRK;WIPF1;GRB2
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.39304278567364,0.6282428557683593,0.9,1.0,1.0,2/9,12.14%,SLC26A6;SLC5A11
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.29246855789473103,0.6280221599536789,0.9777777777777777,1.0,1.0,1/26,4.48%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.387340831423723,0.6280010924119721,0.8846153846153846,1.0,1.0,8/11,29.62%,SPX;NPPA;SLC2A5;BMPR2;ACE;GSK3A;PRCP;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3162518666977317,0.6279725032659496,0.9215686274509803,1.0,1.0,9/22,26.20%,HTRA2;PML;WWOX;FADD;RET;PPP2R1B;PAK2;BCL10;BID
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.3134902947002371,0.6278377260202835,0.9833333333333333,1.0,1.0,7/20,21.22%,CNOT6L;PLAGL1;CNOT4;CNOT8;CNOT2;TP53;CDC25C
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.2753188538752121,0.6277347990382822,0.9787234042553191,1.0,1.0,7/37,18.47%,SIRT1;RGR;LIG4;TANK;EEF1D;TP53;RHOB
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.36219409118760615,-0.6276856749128074,0.9183673469387755,1.0,1.0,2/11,10.93%,PER2;TMSB4X
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.2755285388491544,-0.62741839693126,1.0,1.0,1.0,1/67,0.60%,HK2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.3638368058736261,-0.6273937844171139,0.8604651162790697,1.0,1.0,2/11,6.96%,PAH;DBH
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.37427286489488126,-0.6273775130584854,0.9361702127659575,1.0,1.0,2/13,14.15%,POLR1A;RPA3
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.3393219466651033,0.6273704095476295,0.9107142857142857,1.0,1.0,1/14,8.00%,PLA2G10
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.31908634912553513,0.6271449416809586,0.9642857142857143,1.0,1.0,1/24,3.21%,SEM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.2655630666558614,0.627129925531824,1.0,1.0,1.0,11/133,10.25%,LGALS9;F2;SSC5D;NAV3;VSIR;NLRP7;RPS6KA4;HMGB1;BTN2A2;C5AR2;IL23R
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.37605815501320194,-0.6270843839445905,0.8928571428571429,1.0,1.0,2/8,6.16%,SFRP1;MEOX1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.34306256222635,0.6268734183759075,0.9272727272727272,1.0,1.0,1/15,3.87%,CDH2
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,0.40586452872649026,0.6268510722122111,0.9130434782608695,1.0,1.0,3/8,11.93%,MOGAT2;FUT8;MAN2A1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3394561786950126,0.6267945698519134,0.9361702127659575,1.0,1.0,1/13,11.31%,CHEK2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2668891176909089,0.6266036695912911,1.0,1.0,1.0,12/94,14.43%,FHIT;DNAJB2;RYBP;CBFA2T3;RNF217;KEAP1;UBQLN4;ARIH1;BAG2;XPO1;PRICKLE1;EIF3H
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.3566871696275128,0.6259959315833362,0.8958333333333334,1.0,1.0,4/11,24.20%,TK1;SCO2;UCK2;DCK
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.40212892006286377,-0.6258485019939031,0.9137931034482759,1.0,1.0,1/7,10.86%,SPI1
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,0.3812849346000729,0.6256694097618277,0.8983050847457628,1.0,1.0,4/8,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.27301244936531605,-0.6254488514529423,0.9807692307692307,1.0,1.0,17/86,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,KEGG_2021_Human__Pyruvate metabolism,0.28642890334655136,0.6251132994472999,0.9821428571428571,1.0,1.0,8/40,15.96%,ALDH7A1;ALDH1B1;ALDH9A1;ACSS2;LDHD;ACACA;ACACB;ME3
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.3410524613765702,0.6249654575996888,0.9787234042553191,1.0,1.0,4/16,22.23%,HNRNPD;NEK7;MAPK3;MAPK15
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3258124377279315,0.6249277962739554,0.9074074074074074,1.0,1.0,5/18,32.79%,CPEB1;NCBP1;CPSF6;CPEB3;NUDT21
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.35632480871680633,-0.6246910966293598,0.8043478260869565,1.0,1.0,2/10,15.97%,HLA-DRB1;ZFP36L1
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.33204264365162434,0.6244544097355921,0.9298245614035088,1.0,1.0,6/14,38.49%,CTNNB1;PPP2R1B;PPP2R5A;PPP2R5B;PPP2R5E;GSK3B
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.39112834961996046,0.6241675759276224,0.9361702127659575,1.0,1.0,1/5,9.22%,FAM3A
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.2926015301819728,0.6240746826616806,0.9803921568627451,1.0,1.0,13/47,20.73%,SYT1;AGR2;RIMS2;DBN1;L1CAM;PLCB1;CDKL5;MACF1;SMURF1;SYT3;CPNE9;GOLGA4;SYT17
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.34026371605097216,0.6239725509072149,0.9166666666666666,1.0,1.0,5/15,21.69%,PELI3;ZNF675;CCDC3;CARD16;GAS6
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.33948121367279954,0.6233674136607724,0.9629629629629629,1.0,1.0,5/18,19.39%,FUT9;ST3GAL6;FUT8;ABO;B4GALNT2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3183496521307141,-0.6232255845453587,0.9,1.0,1.0,4/18,18.46%,RCSD1;ZFP36L1;TRPV4;AQP1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.3588819941491931,0.6230146425075017,0.9107142857142857,1.0,1.0,6/10,26.87%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.3588819941491931,0.6230146425075017,0.9107142857142857,1.0,1.0,6/10,26.87%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,Reactome_2022__Atorvastatin ADME R-HSA-9754706,0.4173542241551017,0.6221663570005224,0.8823529411764706,1.0,1.0,2/6,12.86%,ABCC2;CYP3A4
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.3877904224720201,-0.6220998572240511,0.9318181818181818,1.0,1.0,2/5,16.02%,TTN;HTR2B
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,0.3842213023059989,0.6216958849535424,0.9642857142857143,1.0,1.0,1/11,3.71%,HPD
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.33971665581635657,0.6210321453024567,0.9215686274509803,1.0,1.0,3/15,26.40%,MYH11;LYN;MYL12B
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.3270441709039907,0.6207494992030232,0.9482758620689655,1.0,1.0,5/17,31.21%,CREB1;PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.3180654054555381,-0.6205869748225761,0.8936170212765957,1.0,1.0,5/27,20.35%,POLR3H;POLR3E;TBP;POLR3A;POLR3F
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.2594084558413861,-0.6203217157017715,1.0,1.0,1.0,6/113,8.56%,TBC1D10C;ALS2CL;RIN3;MPZ;RAB7B;TRAPPC2L
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.2983445804357677,0.6202753093018024,0.9818181818181818,1.0,1.0,6/36,14.99%,H2BC21;CENPO;H2AC6;H2AZ2;CENPP;H2AX
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.3487700937988358,-0.6202347917542441,1.0,1.0,1.0,4/17,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,-0.26908499106358197,-0.6200408290199048,1.0,1.0,1.0,4/92,6.42%,CSPG4P10;CCDC85C;GPC1;NFE2L1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.4015052344846235,-0.6198292757832975,0.9148936170212766,1.0,1.0,1/6,6.91%,PRKD2
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.39281760156090073,0.6195092438686155,0.9433962264150944,1.0,1.0,2/6,21.01%,CA2;ATP8B1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2790698557803306,-0.6193006601652159,1.0,1.0,1.0,1/61,1.49%,CTSO
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,0.3813392535021326,0.6190218485943597,0.8958333333333334,1.0,1.0,1/7,19.33%,MCF2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.2984952024173657,0.6187283651619363,0.9682539682539683,1.0,1.0,4/34,15.01%,FHIT;RYBP;EIF3H;MARCHF7
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.41146966972650706,-0.6186221719141803,0.875,1.0,1.0,5/5,58.87%,PARN;TOE1;TRIR;PDE12;XRN1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.3525947194676502,-0.6184999811892407,0.925,1.0,1.0,2/12,9.17%,PTGES;PRXL2B
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.3061436360967237,-0.6183972708682874,0.975,1.0,1.0,3/16,15.11%,FLOT1;CAV1;CGAS
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.33624215928247353,-0.6183966804468001,0.9148936170212766,1.0,1.0,10/17,33.53%,TIMM44;TOMM20;PAM16;GRPEL1;TIMM23;TIMM17B;DNAJC19;ROMO1;TOMM40;TOMM70
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.2766218399361016,-0.6182932617315389,0.96,1.0,1.0,11/62,16.26%,SLX4;RFC3;RAD50;RAD51AP1;RTEL1;POLR1A;RPA3;RFC2;BRCA1;EXO1;MUS81
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.301789263889987,0.6181413063656708,0.9491525423728814,1.0,1.0,6/32,16.45%,KAT2B;SEC22B;TMEM39A;SMAD4;CCP110;LIMK2
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.29408757466523194,-0.6180126220696536,0.9777777777777777,1.0,1.0,4/46,9.12%,EIF2S2;EIF2S3;RPS27L;EIF3J
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.41833403907076094,0.6177246443181652,0.8913043478260869,1.0,1.0,1/6,13.61%,PTX3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.36566444701273615,0.6176878126540475,0.9591836734693877,1.0,1.0,2/14,7.00%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.32783952257963045,0.6176104211587047,0.9607843137254902,1.0,1.0,4/18,17.12%,PTPRD;DBN1;CAPRIN1;CDKL5
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),0.4100911472939968,0.6172267570068666,0.9032258064516129,1.0,1.0,1/5,12.47%,CD34
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.32731154818394487,0.6167592386021625,0.9821428571428571,1.0,1.0,3/19,17.54%,PLA2G10;PNPLA8;PLBD1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.3299078901959603,-0.6165702089667839,0.9,1.0,1.0,9/17,28.70%,CAV1;TGFB1;UBE3A;CATSPER4;YAP1;THBS1;TGFB2;SRC;TRERF1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.26542294341333605,0.6163688223860649,0.9375,1.0,1.0,8/45,19.87%,DOCK1;CASS4;PTPRD;CARMIL1;CAPRIN1;CDKL5;ABL1;DOCK5
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.26916665438806775,0.6163347414033908,0.9811320754716981,1.0,1.0,11/68,25.10%,NEDD4;ARIH1;KPNA4;RANBP2;IRF3;UBE2E1;MAPK3;NUP153;MX2;SGIP1;USP18
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.24624920680932172,0.616084627426274,1.0,1.0,1.0,23/150,21.22%,SIRT1;CDK11A;BRINP3;FBXO5;DLGAP5;SCRIB;ANAPC16;PSMD13;HECA;PSME4;NEK7;GAS1;PSMA1;PKN2;RCC1;BORA;LGMN;PIM2;FZR1;UBE2D1;UBE2E1;PSMD4;CDC25C
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.33684261329089643,-0.6160736687044204,0.9230769230769231,1.0,1.0,1/11,4.93%,DRD2
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.384416002976341,-0.615754566478476,0.9056603773584906,1.0,1.0,1/7,4.95%,KDELR1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.38093573393104463,0.6157009949566782,0.8813559322033898,1.0,1.0,1/9,7.04%,HDAC3
prerank,Reactome_2022__Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors R-HSA-629594,-0.3518773101907393,-0.6154995227054844,0.8913043478260869,1.0,1.0,1/10,12.20%,CHRNA2
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,0.34332232548234665,0.614952480200098,0.9565217391304348,1.0,1.0,2/14,6.90%,PTGS1;HPGDS
prerank,Reactome_2022__Disinhibition Of SNARE Formation R-HSA-114516,0.4162193598132753,0.6148335311731897,0.9285714285714286,1.0,1.0,1/5,17.95%,STXBP3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.43644818306546057,-0.6144212188408039,0.9148936170212766,1.0,1.0,1/6,8.01%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.43644818306546057,-0.6144212188408039,0.9148936170212766,1.0,1.0,1/6,8.01%,DPH6
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.2853301125305306,0.6143666451669904,0.9649122807017544,1.0,1.0,3/30,9.55%,SNCA;LEPR;EPB41
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.37645565392077945,0.6142106285849749,0.8846153846153846,1.0,1.0,4/8,27.67%,ANXA2;ANXA1;AKT2;C2CD5
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.2716267061283159,-0.6140858251893611,0.9821428571428571,1.0,1.0,6/57,11.95%,MUC5B;MAPK4;FOS;JUN;MMP9;FOSL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.379150433364605,0.6139914365750446,0.9056603773584906,1.0,1.0,2/7,20.67%,WNK1;ATP1B2
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.30493507887471427,-0.6129951159180461,0.9622641509433962,1.0,1.0,2/25,9.34%,NR4A1;FOXO4
prerank,KEGG_2021_Human__Sulfur metabolism,0.36922953824045646,0.6128578608671843,0.8333333333333334,1.0,1.0,4/10,22.19%,SELENBP1;ETHE1;MPST;PAPSS2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.3438535224638407,0.6124973070401422,0.9814814814814815,1.0,1.0,13/21,32.70%,TLR2;GPR108;BIRC3;IRAK3;OTUD4;CD36;APPL1;TLR5;NLRP2B;LRRC14;APPL2;LGR4;FLOT2
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.2969870607985034,0.6124782579697069,0.9565217391304348,1.0,1.0,5/45,16.64%,SEM1;PSMD13;PSME4;PSMA1;PKN2
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.25054436413496695,0.6123412134129682,1.0,1.0,1.0,11/121,16.94%,AP1M2;SEM1;PSMD13;XPO1;PSME4;PACS1;PSMA1;PKN2;CD247;RANBP2;RCC1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.33235837027199155,0.612283252259176,0.95,1.0,1.0,1/14,8.00%,PLA2G10
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.3405988008711058,0.6121726888157683,0.9811320754716981,1.0,1.0,2/15,7.00%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.29733329475017795,0.6121217307009402,0.9464285714285714,1.0,1.0,7/29,16.32%,LATS1;ANKRD13A;LZTFL1;GPM6B;PICALM;MFHAS1;LEPROTL1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.3643365658628618,-0.6119166289062269,0.9534883720930233,1.0,1.0,2/8,18.77%,HFE;IRF1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.40117154910517383,0.6118928537323691,0.9137931034482759,1.0,1.0,2/6,11.28%,SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.3669356230836021,0.6114472708735766,0.9166666666666666,1.0,1.0,2/9,26.08%,NREP;MTR
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.29396276414626193,-0.6114431909417499,0.9512195121951219,1.0,1.0,11/49,16.85%,CRABP2;RBP2;LAMB3;HLA-DRB1;FLG2;KRTDAP;WNT10A;BNC1;EDAR;ZNF750;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.3259172215188495,0.6113456480314841,0.9180327868852459,1.0,1.0,3/19,13.21%,EPHA3;NR1H3;PICALM
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.35103302139900217,-0.6112785182986074,1.0,1.0,1.0,1/9,6.56%,PEX7
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,-0.34082579456366,-0.6110300702772764,0.8867924528301887,1.0,1.0,3/10,13.84%,B3GALT5;B3GALT4;ST3GAL3
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.40402758066782585,0.6109859811607564,0.94,1.0,1.0,2/8,21.54%,ABHD10;NAGA
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3725740721387034,-0.6104351216530746,0.9591836734693877,1.0,1.0,1/7,12.82%,CTPS1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.3096605268064953,0.6103497372037867,0.9298245614035088,1.0,1.0,4/21,17.29%,LPIN3;MOGAT2;DGAT2;AGMO
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.27582581190729727,-0.6101194596145376,0.9795918367346939,1.0,1.0,4/52,9.12%,EIF2S2;EIF2S3;RPS27L;EIF3J
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.3899286286866366,-0.6100757239954345,0.9333333333333333,1.0,1.0,1/5,9.08%,WWC1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.3653713223257812,0.6098427682501161,0.9122807017543859,1.0,1.0,3/12,17.80%,GREM1;PLCB1;WASL
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,-0.4024864860166119,-0.6095351257804469,0.9056603773584906,1.0,1.0,1/5,10.53%,PIP5K1B
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.3181218274808029,0.6090893900157606,0.8939393939393939,1.0,1.0,6/20,20.28%,FGF2;EFNB2;GREM1;VEGFA;PIK3R3;EPHB4
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.36192873417049237,0.6089458901450517,0.9183673469387755,1.0,1.0,5/9,23.43%,FER;LYN;ENPP3;ADGRE2;BLK
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.2663217571891056,0.6083358614620974,1.0,1.0,1.0,14/69,28.73%,SP1;INTS6;POU2F1;TAF5;ELL2;GTF2B;INTS11;POLR2H;NCBP1;INTS14;SNAPC1;INTS8;ICE2;GTF2F2
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,-0.3316725599560374,-0.6079289663874153,0.9767441860465116,1.0,1.0,1/15,4.17%,ST8SIA2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.2663956784869082,0.607573713740383,0.9836065573770492,1.0,1.0,14/68,28.73%,SP1;INTS6;POU2F1;TAF5;ELL2;GTF2B;INTS11;POLR2H;NCBP1;INTS14;SNAPC1;INTS8;ICE2;GTF2F2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.314418563588684,0.6075217453678798,0.9122807017543859,1.0,1.0,2/17,12.07%,CTNNA2;FCHSD2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.285664916233528,0.6074103329833327,1.0,1.0,1.0,4/28,12.77%,NDE1;RANBP9;ZNF207;HDGFL3
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.29952241134771096,-0.6073598503348409,1.0,1.0,1.0,5/27,14.67%,TTC8;TMEM107;TBC1D32;DCTN1;CSNK1D
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.3450549745878673,-0.6072844214906168,0.9523809523809523,1.0,1.0,7/17,22.98%,MYO5B;MYO15A;MYO7B;MYO1H;MYO5C;ACTN4;MYO1F
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.3357788720088559,0.6071593682622861,0.9636363636363636,1.0,1.0,3/16,9.14%,MDFIC;LATS1;RAB23
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.320581570023502,0.606862858750309,1.0,1.0,1.0,2/21,7.91%,TGFBR1;CAVIN1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.32088260590371365,0.6068000334765007,0.98,1.0,1.0,5/16,26.04%,ACTL6A;EPC1;RUVBL2;ING3;MSL3
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.2954526286626055,0.6066577934303111,1.0,1.0,1.0,9/35,22.38%,CASS4;GRM5;NCK2;GPRC5B;EFNA1;DLG3;GAS6;ACE;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.35951001419895423,-0.606639951784199,0.9318181818181818,1.0,1.0,1/11,7.86%,BTBD18
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.3685862194308491,0.6064492505310861,0.9056603773584906,1.0,1.0,2/7,26.81%,HEBP2;PRELID1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.31827768045177285,0.6061865270912936,0.9230769230769231,1.0,1.0,2/11,14.53%,ABCA1;LIPG
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.2584473890891479,0.6060186469103749,1.0,1.0,1.0,8/99,11.33%,NXPH1;HRH3;SYT1;ZDHHC22;ELAVL2;FAM171B;CPT1C;GABRA5
prerank,KEGG_2021_Human__DNA replication,-0.29834994583051716,-0.6060084841873631,0.9444444444444444,1.0,1.0,7/31,19.99%,RFC3;LIG1;RPA3;RFC2;MCM2;RFC1;MCM3
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.28859306282099695,0.6060010540150974,0.9795918367346939,1.0,1.0,4/25,15.40%,GMNN;MCM7;POLE2;ORC4
prerank,Reactome_2022__Synthesis Of Wybutosine At G37 Of tRNA(Phe) R-HSA-6782861,0.40117709919240474,0.605683026106891,0.9655172413793104,1.0,1.0,2/5,26.21%,TRMT5;TYW3
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3644749009830558,0.6056543292677854,0.9411764705882353,1.0,1.0,3/11,19.24%,TNFRSF10B;IRAK1;TNFRSF10A
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.2888534886575326,-0.605304693217607,0.96,1.0,1.0,8/32,17.00%,NR4A1;CCN3;MYH9;CYP1B1;LPXN;SCG2;EGR3;STAT1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.342638012079171,0.6052803665614424,0.9245283018867925,1.0,1.0,3/11,21.92%,MFF;PNPT1;PID1
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.2756963094626574,0.6050818476279561,1.0,1.0,1.0,3/45,5.54%,KAT2B;DLGAP5;RBPJ
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,0.39522714042755,0.6049779893895596,0.8823529411764706,1.0,1.0,2/7,20.02%,CREB1;HDAC1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.27045946577204416,-0.6049120269817907,1.0,1.0,1.0,4/52,9.12%,EIF2S2;EIF2S3;RPS27L;EIF3J
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.38433815029453094,0.6049016371147121,0.8958333333333334,1.0,1.0,4/7,30.35%,IL23R;CARD9;CD80;IL23A
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.38433815029453094,0.6049016371147121,0.8958333333333334,1.0,1.0,4/7,30.35%,IL23R;CARD9;CD80;IL23A
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.27962845824184673,0.604103938596113,0.9555555555555556,1.0,1.0,3/32,11.86%,DOCK1;CASS4;CARMIL1
prerank,KEGG_2021_Human__Proteasome,0.3018971657553511,0.6040541031343709,0.9615384615384616,1.0,1.0,4/39,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.34445506210902366,-0.6039845992570054,0.9361702127659575,1.0,1.0,3/12,13.11%,DSG2;CTNNA3;CAV1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.2710446703261275,-0.6039379278592901,1.0,1.0,1.0,2/51,7.07%,PIAS3;EYA1
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.2404164741247534,0.6030819830531421,1.0,1.0,1.0,35/161,27.15%,REXO2;TLR2;STING1;TAB2;SIKE1;RPS5;HLA-E;IRAK1;IKBKE;TAB3;RANBP2;G3BP1;RPS3A;IRF3;AKT3;HLA-F;SEC24B;RIPK2;IKBKB;TLR1;HLA-B;NUP153;AKT2;GJA1;GEMIN6;VPS18;TAB1;PALS1;TRAF6;RPS29;CHUK;GEMIN2;RPS19;TJP1;TRIM4
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.2902134605074217,-0.602870416934249,1.0,1.0,1.0,3/39,9.13%,ABRAXAS1;RNF8;RAD50
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.4177735867286051,0.6028253707986219,0.9629629629629629,1.0,1.0,2/5,21.90%,EPB41;GNAI1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3647228813450878,-0.6028029943935364,0.8627450980392157,1.0,1.0,1/12,3.22%,TICRR
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.27249728470141044,-0.602712992245722,0.9807692307692307,1.0,1.0,5/56,8.93%,PRKCD;CAMK2A;PRKD2;TTBK1;DYRK4
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.2552318976144626,0.6025408689331497,1.0,1.0,1.0,12/104,19.23%,PRKAB2;CHMP6;ATG101;ATG4C;DYNC1I2;RRAGC;HSPA8;MTMR3;PRKAA1;MTERF3;RRAGD;MLST8
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.4066002870772562,-0.6024992306019955,0.9433962264150944,1.0,1.0,3/7,13.11%,TPCN2;CAV2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3452483353824173,0.6024790598086825,0.9111111111111111,1.0,1.0,3/8,24.26%,WNK1;NEXMIF;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.3947079558744613,0.6023932816129564,0.9636363636363636,1.0,1.0,2/5,26.77%,FADD;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.32386273231657464,0.6020321942697262,0.9615384615384616,1.0,1.0,4/18,16.58%,ENPP1;GREM1;BCOR;HEY2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.39472495310594,-0.6016042737648407,0.8809523809523809,1.0,1.0,1/5,8.62%,P2RY12
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.3876400885006825,0.6014968740774479,0.8620689655172413,1.0,1.0,3/7,20.42%,LEPR;GREM1;SUCO
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.3906156191580677,0.6014536306715276,0.9523809523809523,1.0,1.0,1/6,15.21%,ANO6
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.39262396945472267,0.60117274856942,0.9183673469387755,1.0,1.0,1/5,5.43%,SLC7A2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.30302282216520565,-0.6010410174572871,0.9782608695652174,1.0,1.0,3/29,7.77%,RAC2;GULP1;ARHGAP12
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.38606776614513805,-0.6006655607068316,0.9318181818181818,1.0,1.0,2/7,17.50%,TAMM41;CRLS1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3406023590045939,-0.6006398097793209,0.86,1.0,1.0,4/11,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3406023590045939,-0.6006398097793209,0.86,1.0,1.0,4/11,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.2792202295925964,0.6002393056201808,1.0,1.0,1.0,3/24,17.47%,PHKA1;PGM1;GBE1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.34603278384214625,0.6002249842756822,0.9433962264150944,1.0,1.0,5/11,29.79%,CANX;IL12A;JAK2;IL27RA;IL12RB2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.38608996065215473,-0.6002150494431882,0.8536585365853658,1.0,1.0,2/6,17.27%,SMOX;SAT2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.3834708950825239,-0.6000132073143546,0.8571428571428571,1.0,1.0,1/5,15.04%,PHF19
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.3354333172880996,0.5998563507702102,0.9591836734693877,1.0,1.0,8/16,35.56%,MAP3K8;IKBKB;CHUK;NFKB1;MAP2K4;BTRC;CUL1;FBXW11
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.3370893936854368,-0.5995028821476716,0.9361702127659575,1.0,1.0,4/17,16.47%,LAS1L;FTSJ3;NSA2;RRP15
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.23392097511346258,0.5992626076848401,1.0,1.0,1.0,32/174,24.14%,U2AF1;HNRNPH1;SF3B1;SNRPN;ELAVL2;PAPOLA;PCF11;HNRNPD;PUF60;CDC5L;HSPA8;LSM8;RBM5;SRSF11;HNRNPA2B1;PPIL6;FUS;CSTF3;RBM17;POLR2H;WDR33;NCBP1;XAB2;SNRPA;CWC27;SRSF3;HNRNPU;LSM2;HNRNPF;DHX15;SF3B6;DHX9
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.35657663089733366,0.5992020100180212,0.9473684210526315,1.0,1.0,1/7,20.16%,ATP2C1
prerank,KEGG_2021_Human__Renin secretion,0.2631635055692555,0.5989186826666179,1.0,1.0,1.0,17/55,22.26%,PDE1A;GNAI3;GUCY1A2;NPPA;PPP3CA;PPP3CC;CREB1;ADORA1;ADRB1;PLCB1;GUCY1A1;PRKACB;EDN1;GNAQ;GNAI1;PDE1B;ACE
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.23513454050976162,0.5986484724370953,1.0,1.0,1.0,32/210,22.83%,AP1M2;SEM1;CHMP6;TAF3;PSMD13;LIG4;XPO1;PSME4;PACS1;CCNH;TAF5;TAF2;PSMA1;PKN2;CD247;UBAP1;RANBP2;NELFB;RCC1;MNAT1;GTF2B;MVB12A;BANF1;POLR2H;TAF4;NCBP1;PSMD4;VTA1;NUP153;ERCC3;FURIN;LRIG1
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.254667758184799,0.5983186287974949,1.0,1.0,1.0,17/83,21.61%,MYC;EIF3E;LRRN3;FKBP5;FAM117B;ARHGAP45;IGF1R;SNED1;SGSM3;NELL2;C1ORF162;TMEM204;CD55;THEM4;PDK1;PASK;CAMK4
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.27184099388914834,-0.5980065118179102,1.0,1.0,1.0,7/39,21.82%,CPSF4;POM121C;NUP133;GNL3;SEC13;KPNA7;NUP93
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.27011576763298784,0.5977207824708968,1.0,1.0,1.0,7/51,20.95%,SEM1;PSMD13;PSME4;PSMA1;NUMB;PRKACB;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3594788800378479,0.5976798294746944,0.9333333333333333,1.0,1.0,1/7,16.51%,UBR5
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.2612339422314895,0.597623903875899,0.9795918367346939,1.0,1.0,14/67,29.11%,TUBA1C;CHMP6;VRK2;LMNB1;RCC1;BANF1;LEMD3;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;TUBB2B;PPP2R2A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2676709841204338,-0.5976116234313148,1.0,1.0,1.0,17/84,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.2359391715728711,0.5975711882146141,1.0,1.0,1.0,24/137,23.80%,CHMP6;TAF3;LIG4;XPO1;CCNH;TAF5;TAF2;UBAP1;RANBP2;NELFB;RCC1;MNAT1;GTF2B;MVB12A;BANF1;POLR2H;TAF4;NCBP1;VTA1;NUP153;ERCC3;FURIN;LRIG1;SGIP1
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.30308443529810425,0.5975305808578868,1.0,1.0,1.0,12/34,31.99%,ANAPC16;CCND3;CDK4;FZR1;UBE2D1;UBE2E1;CDK6;ANAPC15;CDC27;ANAPC7;RB1;CDKN1B
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,0.3691799782711336,0.5973931005017069,0.8833333333333333,1.0,1.0,4/8,40.97%,ARAP1;CBL;RPS27A;PTK6
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3164759442676985,0.596953737817308,0.9791666666666666,1.0,1.0,9/28,23.10%,TAP1;HLA-E;TAPBPL;HLA-F;SEC24B;CANX;HLA-B;ACE;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3751238019798046,-0.5964467712095697,0.9130434782608695,1.0,1.0,1/9,5.07%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3751238019798046,-0.5964467712095697,0.9130434782608695,1.0,1.0,1/9,5.07%,ACTN3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3060896661002556,-0.596406202775241,0.9259259259259259,1.0,1.0,5/24,16.69%,SPI1;DAB2IP;DEDD2;DELE1;DAXX
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.3683153196644457,0.5962825432288544,0.8863636363636364,1.0,1.0,1/8,9.95%,GSN
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.35869039791373364,-0.5957761181749821,0.9347826086956522,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.35869039791373364,-0.5957761181749821,0.9347826086956522,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.35139688887276516,-0.5957601516852189,0.9038461538461539,1.0,1.0,2/8,17.10%,RAB7B;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.3368205173737371,-0.5952379053908343,0.9361702127659575,1.0,1.0,2/7,23.29%,PTPRS;CACTIN
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.31849309170275963,0.5951058510504951,0.95,1.0,1.0,5/21,16.11%,PDGFRA;DSCAML1;RYR2;FBN1;MESP1
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.2861631986505454,0.5947862781917344,0.9333333333333333,1.0,1.0,6/22,27.61%,DBN1;PHIP;MSI2;HNRNPC;STK38;TWF1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.2851606770306114,0.5946600467493514,1.0,1.0,1.0,7/44,17.39%,PLA2G10;FOXO3;GRM5;METTL18;NR1H3;PM20D2;CSF1
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.2849973485987411,-0.5946105448410242,0.9615384615384616,1.0,1.0,5/26,19.75%,ATG14;HLA-C;SEC24C;SEC13;BECN1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.38803003003918907,0.5943903912405669,0.9130434782608695,1.0,1.0,1/6,7.36%,SLC4A7
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,0.36264979772262734,0.594152617591069,0.9636363636363636,1.0,1.0,2/8,15.66%,PRKAB2;PRKAA1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.3214737152954795,0.5940281946417478,1.0,1.0,1.0,11/28,29.39%,SIRT1;NCOA2;H3-3A;HDAC1;TRIM68;FOXH1;EP300;PIAS2;KDM4C;FOXP1;PRMT2
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.35336654574220405,0.5940024254276159,0.9166666666666666,1.0,1.0,5/11,36.24%,MTMR9;PIKFYVE;MTM1;PIK3R4;PIK3C3
prerank,KEGG_2021_Human__Non-homologous end-joining,-0.3259278732584404,-0.593985250894498,0.9148936170212766,1.0,1.0,4/11,25.60%,RAD50;POLL;XRCC4;PRKDC
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.29270984032463143,-0.5933134420599485,1.0,1.0,1.0,6/38,17.00%,ARHGDIB;CREB3L1;DCTN2;DCTN1;RAB11A;DYNC1LI2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.3819207264264315,0.5930573158832197,0.9811320754716981,1.0,1.0,3/6,16.69%,CTNNA2;PTEN;GRID2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.25923530165633774,-0.5930424118959999,1.0,1.0,1.0,16/46,27.64%,PSMB4;OAZ3;PSMC4;BHMT;AZIN1;PSMD8;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NQO1;PSMB9
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.27823898054140994,-0.5928129164501805,1.0,1.0,1.0,1/29,4.09%,RNASE1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.3576964302900002,0.5927330438175732,0.9523809523809523,1.0,1.0,3/8,27.26%,PIK3CD;KIT;MILR1
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.30728683534753426,-0.5927115174552446,0.9148936170212766,1.0,1.0,2/23,4.81%,ST8SIA2;CHST10
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3689391367453555,-0.5924838274119526,0.9148936170212766,1.0,1.0,1/8,5.36%,GPC1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.37929020428093285,0.5920528382684629,0.9423076923076923,1.0,1.0,3/5,24.15%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.37929020428093285,0.5920528382684629,0.9423076923076923,1.0,1.0,3/5,24.15%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.297348407317215,0.591971054481619,0.9795918367346939,1.0,1.0,9/18,37.49%,RUVBL2;NOP10;NAF1;SHQ1;CCT3;DCP2;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.2644234051839821,-0.5918745299586032,1.0,1.0,1.0,13/44,23.78%,AFG3L2;APOO;SPG7;DNAJC11;LETM1;DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;SAMM50;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.3923054295268684,-0.5917180482574049,0.8979591836734694,1.0,1.0,1/5,8.50%,ENTR1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3509763894557255,-0.5916124301593187,0.8913043478260869,1.0,1.0,3/6,27.89%,ATP9A;EIPR1;PRKN
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.2294337108767296,0.5914082002073775,1.0,1.0,1.0,22/184,21.31%,GLUL;RIOK2;DDX31;PWP2;RRS1;EXOSC4;XPO1;NOC2L;RPL21;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;EXOSC1;WDR18;TEX10;C1D;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.2928347485080274,0.5903308214235473,0.9833333333333333,1.0,1.0,8/23,33.76%,PLA2G10;PLSCR1;PLA2G15;SLC27A1;LPCAT3;MBOAT2;SERINC5;MBOAT1
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.2895547491742801,0.5902055243737102,1.0,1.0,1.0,10/32,28.95%,TANK;BIRC3;FADD;IKBKB;OTUD7B;USP2;CHUK;TRADD;CYLD;OTULIN
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.3332137572537659,-0.5901501557480718,0.9361702127659575,1.0,1.0,4/14,17.73%,SLC2A8;SLC5A1;SLC2A1;HNF1A
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,-0.3464464952177404,-0.5899864655555918,0.9361702127659575,1.0,1.0,3/9,26.73%,MAP1LC3A;MAP1LC3B;SRC
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.26240492538585386,0.5898813861705181,1.0,1.0,1.0,6/45,18.47%,SIRT1;LIG4;TANK;EEF1D;TP53;RHOB
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.2532776925431876,0.5898399388743276,1.0,1.0,1.0,11/81,18.94%,VAPB;ESYT3;PPM1L;CERS3;EGFL7;ESYT2;SGPL1;ALDH3B1;HEXB;PLPP1;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.3384772584731746,-0.5897352275348607,0.926829268292683,1.0,1.0,4/18,14.78%,F11R;DAB2IP;SH3BP4;USP17L2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.2912240306047815,0.5894973594053742,0.9803921568627451,1.0,1.0,2/24,7.04%,HCLS1;HDAC3
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.3735554414137635,0.5892024261375982,0.9787234042553191,1.0,1.0,2/6,11.23%,ANK2;DAND5
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.2887254330594572,0.5882339146647628,1.0,1.0,1.0,4/40,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.26676121073683556,-0.5879018728954628,0.9814814814814815,1.0,1.0,3/42,9.16%,ATG14;RBM3;RBM4B
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,0.32273156625369165,0.5878363566102504,0.9333333333333333,1.0,1.0,3/13,24.69%,SLC37A4;GBE1;GAA
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.36020329745970764,0.5877873266687926,0.9464285714285714,1.0,1.0,2/8,22.18%,VEGFA;RYK
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.30845750871716243,-0.5875790068709504,0.9302325581395349,1.0,1.0,1/16,3.40%,NMUR2
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.2507980058874797,-0.5872945207808886,1.0,1.0,1.0,16/91,25.45%,EIF2S2;EIF2S3;RPS27L;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;RPL5;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.26235173854269445,0.5872313147904251,1.0,1.0,1.0,11/71,16.56%,LRRC46;TTC29;TEX26;CYP2S1;C6ORF118;SPAG6;CDHR3;MORN5;CCDC181;FAM81B;PPIL6
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.328785014596815,-0.5868779940574074,0.92,1.0,1.0,1/14,5.94%,PCSK6
prerank,KEGG_2021_Human__Ribosome,0.22245218513933598,0.5867231670879705,1.0,1.0,1.0,24/122,30.81%,MRPL28;MRPS12;RPS5;RPL21;RPL18A;RPL7;RPS3A;MRPL18;MRPS9;RPL23A;MRPL11;MRPS15;MRPL10;RPL9;RPS29;RPS19;MRPL2;RPS10-NUDT3;RSL24D1;RPS15A;MRPL33;RPS23;MRPL14;RPS12
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.26007396791459586,0.5864143007437237,0.9629629629629629,1.0,1.0,10/50,26.34%,HDAC2;RNF2;RANBP2;SATB2;HDAC1;SCMH1;NUP153;PHC3;PIAS2;PHC2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.2988838804813866,0.5862734390701682,0.94,1.0,1.0,6/23,20.82%,RYBP;RNF2;BCOR;PCGF1;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3334433455070337,-0.5861454158971011,0.9777777777777777,1.0,1.0,3/13,18.22%,SMUG1;NT5C;MBD4
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.2575025101768695,0.5860287546444656,1.0,1.0,1.0,13/72,19.76%,SPTBN5;CD59;ANK2;BET1;TMEM115;DCTN3;DYNC1I2;ANK1;COG5;CD55;TMED3;STX5;ACTR10
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.2745440826494947,-0.58583345419176,1.0,1.0,1.0,4/31,11.63%,RIN3;PAX2;LRPAP1;WDR54
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,0.3424645173028861,0.5858188187022899,0.9807692307692307,1.0,1.0,5/12,29.79%,CANX;IL12A;JAK2;IL27RA;IL12RB2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.353260047729413,0.5856230762002138,0.9322033898305084,1.0,1.0,1/8,12.54%,SMC5
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.3865335478376076,-0.5856116529872031,0.875,1.0,1.0,5/5,61.36%,ALKBH1;ALKBH5;ALKBH3;JMJD6;FTO
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.35877565983743337,-0.5854898814101337,0.86,1.0,1.0,2/7,20.69%,APH1B;APH1A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.2825743679360327,0.58511604271735,0.9827586206896551,1.0,1.0,7/29,19.82%,GRIK2;ZDHHC2;NETO1;DBN1;PPFIA3;SHISA8;MCTP1
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,-0.3226708419057483,-0.5850735122850752,0.9038461538461539,1.0,1.0,1/12,5.48%,GNAL
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Kidney,0.3217429234484843,0.5846833482299969,0.9615384615384616,1.0,1.0,5/21,16.51%,LY6D;BPIFC;KLK5;SERPINB7;KRT17
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Colon,0.3217429234484843,0.5846833482299969,0.9615384615384616,1.0,1.0,5/21,16.51%,LY6D;BPIFC;KLK5;SERPINB7;KRT17
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.22351898461705502,-0.5846578068942829,1.0,1.0,1.0,50/257,21.02%,SNRNP27;DDX41;PRPF4;ZCRB1;RBM4;DHX8;WBP4;RNF113A;RBM4B;SRPK3;PRPF19;RNPC3;GTF2F1;SNRNP200;SNRPA1;CPSF4;RBMX2;CPSF3;SNIP1;WDR77;CWC25;PRMT7;SF3A3;SUGP1;ESS2;CWF19L1;FIP1L1;DNAJC8;CSTF2;HNRNPL;SRSF10;PRPF6;SYF2;MAGOHB;SNW1;DHX38;CRNKL1;MFAP1;DHX35;SF3A1;RBM22;COIL;SNRPD2;PRCC;PDCD7;WBP11;SRSF7;RBMX;SLU7;NONO
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.32192456166994343,0.5845991579683374,0.9375,1.0,1.0,2/18,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.32192456166994343,0.5845991579683374,0.9375,1.0,1.0,2/18,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3666431104282737,-0.5842686402701308,0.9333333333333333,1.0,1.0,1/12,3.84%,ARPC5L
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.37943928865006654,0.583739987468999,0.9464285714285714,1.0,1.0,2/7,10.18%,GLUL;PYCR1
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.33673668741907364,-0.5834429352332221,0.9583333333333334,1.0,1.0,5/15,20.56%,CLTA;CLTB;WNT5A;AP2A2;PRKCA
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.2807232068180487,-0.5831401748745005,0.98,1.0,1.0,3/35,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.3371360324636511,-0.5831391306478356,0.9375,1.0,1.0,3/13,19.27%,PEX7;PAFAH1B1;TMEM86B
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.2702433705578671,0.5829334447393636,1.0,1.0,1.0,12/53,28.49%,SEM1;PSMD13;PSME4;PSMA1;TP53;PSMD4;GTSE1;CCNB2;FKBPL;PSMB5;PSMB1;PSMC5
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.35620108583490484,-0.5828850604797445,0.8571428571428571,1.0,1.0,2/7,22.63%,SUPV3L1;TRMT10B
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.23766770714688817,-0.5824948904299792,1.0,1.0,1.0,28/154,25.45%,ERN2;SENP3;LAS1L;PDCD11;UTP11;RPL38;EMG1;DEDD2;EBNA1BP2;RPL12;UTP15;RPL37A;MRTO4;RPS27;RPL4;RPL5;MAPT;EXOSC10;SBDS;WDR55;RRP12;RPL22;UTP14A;FCF1;RPL34;RPL31;DDX49;RPL37
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.3674815905015518,-0.5823970577443145,0.9302325581395349,1.0,1.0,3/6,27.89%,D2HGDH;ADAM9;PRKN
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2881322793024678,-0.5819521717175425,0.975609756097561,1.0,1.0,4/28,10.45%,SVIP;HFE;CAMLG;DDRGK1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.30961452116153376,0.581670058762769,0.8867924528301887,1.0,1.0,2/11,16.05%,GSN;WASHC5
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.35638577626285994,-0.5813829440946084,0.9375,1.0,1.0,1/7,10.22%,SAPCD2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.3317609415221977,-0.5812485459112218,0.9090909090909091,1.0,1.0,2/10,14.10%,PTCH1;CYP26B1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.3391893719445455,-0.5812437224972544,0.8863636363636364,1.0,1.0,1/8,7.15%,HCK
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.32694758922994105,-0.5810420504919325,0.9285714285714286,1.0,1.0,1/13,3.41%,ALOX5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.30422362547333964,0.580773091007797,0.9807692307692307,1.0,1.0,5/24,18.14%,WNT4;PRKCSH;PROX1;COBL;CITED2
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.2540200487684978,-0.580588599212486,1.0,1.0,1.0,16/77,22.79%,NDUFC1;TMEM126B;ECSIT;UQCRC1;NDUFAF3;NDUFS5;TMEM186;COX6C;ETFDH;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;UQCRH;NDUFA1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.269543707566069,0.5803615849463274,1.0,1.0,1.0,6/29,23.10%,CHCHD4;HSPA8;SDF2L1;DNAJB1;HSPA5;HSPA1A
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.27729762615244924,-0.5801169326932104,1.0,1.0,1.0,2/27,7.45%,EIF2S2;EIF2S3
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,0.35542145848822837,0.5799607008702633,0.9473684210526315,1.0,1.0,3/9,37.93%,VPS18;VPS41;VPS45
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.33967964471898765,0.5797794363557607,0.9622641509433962,1.0,1.0,5/13,28.17%,LIG4;ANXA1;BRCC3;IKBIP;NIPBL
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.30922131224554295,0.5796677152848854,0.8939393939393939,1.0,1.0,7/15,21.72%,CCL5;CYP7B1;CH25H;PIK3CD;CCL25;GAS6;HSD3B7
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.3445005363427511,0.5795185138890847,0.9285714285714286,1.0,1.0,1/10,5.20%,IMMP2L
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.37800948435922466,-0.5794936147298818,0.9230769230769231,1.0,1.0,1/5,20.63%,RNF20
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.28619497922255566,0.5793361031119134,1.0,1.0,1.0,11/27,28.41%,CTNNA2;PLXNB2;NTNG2;RAPGEF2;NEXMIF;ARHGEF2;TNN;PHACTR1;SEMA6A;NIPBL;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.3330769195188688,0.5792840521437865,0.9615384615384616,1.0,1.0,1/13,2.45%,CDK11A
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.36976614210339,0.5789938078193013,0.9444444444444444,1.0,1.0,1/8,5.13%,ODC1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.3103365184483623,0.5786842283697555,0.92,1.0,1.0,2/20,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.2793128050281038,0.5786812422945022,0.9642857142857143,1.0,1.0,16/43,28.65%,SNCA;GSN;NPPA;SNCAIP;GGA1;CALB1;H3-3A;ADAM10;IAPP;ITM2B;FURIN;USP9X;BACE1;CD36;B2M;APP
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.32442302386168254,0.5786688018427122,0.9344262295081968,1.0,1.0,4/14,23.64%,SMAP1;WASL;DGKD;SNAP91
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.3405365124200346,0.578648018324599,0.9411764705882353,1.0,1.0,4/10,28.77%,SPEF2;DNAAF2;ROPN1L;SPAG17
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,-0.3643214224440157,-0.5784916738676728,0.9259259259259259,1.0,1.0,2/8,12.43%,HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.27550472396997056,0.5784764249785858,1.0,1.0,1.0,11/35,25.05%,DBN1;KIAA0319;L1CAM;DIP2B;CDKL5;MACF1;ABL1;MAP2;GOLGA4;NRCAM;APOE
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.3417414002449046,-0.5783723561309324,0.8717948717948718,1.0,1.0,1/9,6.42%,MBTPS2
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,-0.33863067675659114,-0.5772121698176167,1.0,1.0,1.0,2/10,13.16%,PIAS3;NFKB2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.35761841335242994,-0.5771448538740902,0.9622641509433962,1.0,1.0,1/9,9.00%,ERI2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.2763907232486791,0.5764913666471501,1.0,1.0,1.0,2/33,6.65%,HES6;ELAPOR2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.36701728029277797,0.5763532290317973,0.9555555555555556,1.0,1.0,3/8,28.65%,ABCD2;INSR;APP
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.273521947575615,-0.5763386633430649,0.9814814814814815,1.0,1.0,17/42,25.99%,SRPK3;PRPF19;CELF3;SNRNP200;SF3A3;SRSF10;PRPF6;CRNKL1;SF3A1;SNRPD2;LUC7L2;KHDC4;CELF5;SF3A2;DDX1;USP39;SMN1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-0.3588958549615673,-0.576287724739052,0.9333333333333333,1.0,1.0,1/5,9.98%,MMP9
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.36733109800275743,0.5761919291721666,0.9215686274509803,1.0,1.0,2/5,24.20%,ENPP3;DCK
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.33439038243089736,-0.5758486927995742,0.9555555555555556,1.0,1.0,11/11,66.58%,GAK;EHD3;LAMP1;CLN3;RBSN;AP1G1;ANKFY1;AP4M1;SORT1;LAPTM5;CCDC91
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.23668496185314675,-0.5757023824199946,1.0,1.0,1.0,5/105,9.29%,RAC2;SPTLC3;DEGS2;PLCB2;S1PR3
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.35860080933193383,0.5754094626266089,0.9607843137254902,1.0,1.0,2/6,16.59%,HIGD1C;HIGD1B
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.2621723017120773,0.5753989717275187,0.9795918367346939,1.0,1.0,5/52,16.35%,SEM1;PSMD13;PSME4;UBA3;PSMA1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2820206302259087,-0.5752719367415255,0.98,1.0,1.0,4/25,14.29%,KCNE2;KCNE1;KCNS1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2586394296151902,-0.5746067118630841,0.975,1.0,1.0,9/46,19.37%,PIAS3;PER2;CAMLG;CAV1;USP4;UFL1;CHP1;SH3RF2;GTPBP4
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.23853687347677202,0.574399309705887,1.0,1.0,1.0,18/94,21.77%,TLR2;STING1;TAB2;SIKE1;HLA-E;IRAK1;IKBKE;TAB3;RANBP2;G3BP1;IRF3;HLA-F;SEC24B;RIPK2;IKBKB;TLR1;HLA-B;NUP153
prerank,Reactome_2022__Condensation Of Prometaphase Chromosomes R-HSA-2514853,0.3308396883709063,0.5743943295947634,0.8846153846153846,1.0,1.0,4/9,30.63%,RAB33B;CCNB2;NCAPG;CCNB1
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.26743038937875824,-0.5742308663427164,0.94,1.0,1.0,13/32,34.49%,POM121C;NUP133;SEC13;NUP93;SUMO2;NUP43;NUP214;PIAS4;NDC1;NUP88;NUP37;NUP35;NUP50
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,-0.33284630011415567,-0.5739921900283154,0.9777777777777777,1.0,1.0,2/13,6.42%,PCSK6;MBTPS2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3643448257285278,0.5730608959941729,0.9423076923076923,1.0,1.0,2/8,16.58%,NFATC3;HEY2
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.2219411855018561,0.5729181336490907,1.0,1.0,1.0,33/182,24.14%,U2AF1;HNRNPH1;SF3B1;SNRPN;ELAVL2;PAPOLA;SNRNP48;PCF11;HNRNPD;PUF60;CDC5L;HSPA8;LSM8;RBM5;SRSF11;HNRNPA2B1;PPIL6;FUS;CSTF3;RBM17;POLR2H;WDR33;NCBP1;XAB2;SNRPA;CWC27;SRSF3;HNRNPU;LSM2;HNRNPF;DHX15;SF3B6;DHX9
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.2783662400444202,0.5729020399250266,1.0,1.0,1.0,5/45,17.67%,SEM1;PSMD13;PSME4;PSMA1;CDK4
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.297661057548792,0.5728812721966297,1.0,1.0,1.0,9/28,27.67%,TCAF2;MFF;ITGB2;MYO1C;AKT2;ITGAM;MIEF2;CIB1;C2CD5
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.3340263146309232,0.5728522630327028,0.9767441860465116,1.0,1.0,2/11,19.73%,FADD;LYN
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.3071022993806772,0.5727919311156224,0.9830508474576272,1.0,1.0,1/17,4.85%,GLUL
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.26864708178989766,0.5721941119701288,1.0,1.0,1.0,15/55,24.65%,H2BC21;HDAC2;H2AC6;H2AZ2;TAF1A;CCNH;H2AX;POLR1H;MNAT1;POLR2H;HDAC1;DPEP2;ERCC3;POLR1D;TAF1B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.3403835057934234,0.5721869991497114,0.9583333333333334,1.0,1.0,1/10,9.99%,BIN1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.3300681281397546,0.5721213977178646,0.9772727272727273,1.0,1.0,2/17,7.00%,ST6GALNAC3;ST8SIA4
prerank,CellMarker_Augmented_2021__M2 macrophage:Peripheral Blood,0.36636736961528704,0.5720160746441822,0.9491525423728814,1.0,1.0,2/5,26.67%,FCER2;CD36
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.37419960633653676,-0.5718850770531535,0.9318181818181818,1.0,1.0,2/9,13.28%,CAV1;ATP6V0A2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2808566910585447,0.5718626984974006,0.9811320754716981,1.0,1.0,4/33,18.36%,GLRA1;RRAGC;CPEB1;RRAGD
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.376201132958878,-0.5715153000526039,0.9433962264150944,1.0,1.0,1/5,14.31%,MFSD2A
prerank,Reactome_2022__Activated NTRK3 Signals Thru RAS R-HSA-9034864,-0.3623723288954368,-0.5715050071560229,0.8461538461538461,1.0,1.0,1/6,8.97%,NTRK3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.3297227509279469,-0.5714893055419582,0.9215686274509803,1.0,1.0,4/8,28.53%,EIF5A;MSX1;PRKN;UBB
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,0.3639112209687977,0.5713417220713674,0.8909090909090909,1.0,1.0,1/8,11.90%,NR1H3
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.3284086960008008,-0.5712528328007835,0.875,1.0,1.0,2/9,14.78%,DHX58;USP17L2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,-0.3105589882430485,-0.5710720402677577,0.9811320754716981,1.0,1.0,1/15,5.96%,DLL4
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.23043657342607995,-0.5710338070493138,1.0,1.0,1.0,23/108,25.45%,EIF2S2;EIF2S3;RPS27L;EIF3J;RPL38;RPL12;EIF4EBP1;RPL37A;RPS8;EIF2B1;RPS27;RPL4;EIF4H;EIF3L;RPL5;RPL26L1;EIF2B2;RPS20;EIF2B4;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.33881245829909906,0.5708477354099368,0.9333333333333333,1.0,1.0,6/9,32.04%,EFNA1;ANXA2;FURIN;EPHA4;NELL1;ATRAID
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.34041824977854007,0.5707504203353617,0.9019607843137255,1.0,1.0,3/8,24.45%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.34041824977854007,0.5707504203353617,0.9019607843137255,1.0,1.0,3/8,24.45%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.38950776032917217,0.5705399475401924,0.9090909090909091,1.0,1.0,4/6,28.30%,SLC3A2;SLC7A8;SLC38A5;SLC16A10
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.2688872645486814,0.5692119918868099,0.9807692307692307,1.0,1.0,7/47,17.80%,CORO7;GSN;MSRB1;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.35908453308861316,-0.5691221479078774,0.9215686274509803,1.0,1.0,1/7,4.55%,SLC39A4
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.21098239140928612,0.5690610843532551,1.0,1.0,1.0,27/186,21.31%,RPP25;RIOK2;TSR3;RPP40;PWP2;RPS5;EXOSC4;RPL21;HSD17B10;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;ERI1;RPS3A;RIOK3;EXOSC1;WDR18;TEX10;NOP10;C1D;TFB1M;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.31315819762925123,-0.5686964480219838,0.9767441860465116,1.0,1.0,7/19,22.98%,MYO5B;MYO15A;MYO7B;MYO1H;MYO5C;ACTN4;MYO1F
prerank,Reactome_2022__Estrogen-stimulated Signaling Thru PRKCZ R-HSA-9634635,-0.37744866092552287,-0.5685795428983054,0.9574468085106383,1.0,1.0,5/5,62.27%,HRAS;PRKCZ;NRAS;MAPK1;PDPK1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.3609449888725931,-0.5684046528004502,0.9591836734693877,1.0,1.0,1/8,9.00%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.3609449888725931,-0.5684046528004502,0.9591836734693877,1.0,1.0,1/8,9.00%,ERI2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.3086709656278103,-0.568195188206523,0.9411764705882353,1.0,1.0,3/15,14.64%,CLTA;NSG2;CLTB
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.3504026617436614,0.5680527283488126,0.9574468085106383,1.0,1.0,1/7,7.66%,SLC24A2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.3133375454994251,0.5674491987397569,0.9629629629629629,1.0,1.0,5/13,32.47%,MFF;PNPT1;PID1;CSPG5;MTM1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.3574673480976718,-0.5672127893037592,0.9574468085106383,1.0,1.0,7/7,64.27%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.3574673480976718,-0.5672127893037592,0.9574468085106383,1.0,1.0,7/7,64.27%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.2864320451349534,0.5669266848267943,1.0,1.0,1.0,6/26,21.62%,SLC38A3;SLC7A9;SLC3A2;SLC36A1;SLC6A15;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2950427341389119,-0.5663684818046113,0.9512195121951219,1.0,1.0,2/25,8.82%,HFE;LAMP3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.2406305466974363,-0.5663431982592588,1.0,1.0,1.0,17/117,18.27%,GINS3;RECQL5;ORC6;PSMB4;RPAIN;RFC3;PSMC4;RPA3;RFC2;PSMD8;CDC6;MCM2;PSME3;RFC1;CDC7;BLM;PNKP
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.36099058481571616,-0.5656551570569829,0.9714285714285714,1.0,1.0,2/9,16.06%,CAMKK2;VDAC1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.32867175378907687,0.5655969223755835,0.9,1.0,1.0,2/10,10.99%,MUC13;CRACD
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.3491431303397462,0.5651216228158373,0.9322033898305084,1.0,1.0,2/7,21.95%,TAC1;TACR3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.3965393133897135,0.5649558058880665,0.9591836734693877,1.0,1.0,2/5,20.77%,HTR2C;HTR2A
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.263200175051861,-0.5647395070213088,0.9767441860465116,1.0,1.0,6/43,14.42%,GTF2E1;TAF11;TAF7;GTF2F1;GTF2H2;TBP
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.37708016656747645,-0.5643006902927772,0.8947368421052632,1.0,1.0,2/6,19.09%,DHX30;MPV17L2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2746335430788851,0.5638479976274,0.9607843137254902,1.0,1.0,6/26,20.35%,TICAM1;GPR108;MFHAS1;IRAK3;LYN;TICAM2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.30067348937747623,0.5637756074038488,0.96,1.0,1.0,4/14,26.61%,NLRP7;GAS1;SERPINE1;CHAC1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.2907533800590346,-0.5636970168732219,1.0,1.0,1.0,5/27,16.78%,CALB2;SHISA7;SHANK3;ADCY1;AKAP5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.2795152690995508,-0.5632861247380928,1.0,1.0,1.0,2/31,7.08%,ACTN3;LAMB3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.2757464825635042,-0.5632108427316226,0.9772727272727273,1.0,1.0,4/35,13.63%,TIMP4;PTPN3;DAB2IP;AZIN1
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.3049189022024874,-0.5625402067677335,1.0,1.0,1.0,3/18,17.09%,CAMLG;OTOF;EMD
prerank,KEGG_2021_Human__Homologous recombination,-0.27960682472203546,-0.5624884762347845,0.9787234042553191,1.0,1.0,6/37,17.93%,ABRAXAS1;RAD50;RPA3;BRCA1;MUS81;BLM
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.24020848383079624,0.5624428051088655,1.0,1.0,1.0,17/145,13.41%,COX19;IDH1;PEX12;GDAP1;CHCHD4;TIMM22;PECR;UBE2D3;MTX2;LDHD;ZFAND6;SLC25A13;ABCD3;BCS1L;SYCP2;ABCD2;UBE2J2
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.34176428005981296,0.5623337281834287,0.9696969696969697,1.0,1.0,1/8,6.50%,MEGF10
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,0.31603314454844206,0.5620689728339676,0.9454545454545454,1.0,1.0,4/14,19.39%,FUT9;ST3GAL6;ABO;B4GALNT2
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.20606630045298,0.5620520452201982,1.0,1.0,1.0,25/178,21.31%,RPP25;RIOK2;TSR3;RPP40;PWP2;RPS5;EXOSC4;RPL21;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;ERI1;RPS3A;RIOK3;EXOSC1;WDR18;TEX10;NOP10;C1D;RPL23A;RRP1B
prerank,Reactome_2022__Signaling By MST1 R-HSA-8852405,-0.34693235287204516,-0.5618399968363854,0.8723404255319149,1.0,1.0,1/5,17.90%,SPINT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2984243731222076,-0.5616475288911823,0.9245283018867925,1.0,1.0,4/14,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3047887464921505,0.5612045314625623,0.9649122807017544,1.0,1.0,2/18,12.08%,LLGL1;FMNL3
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3098225599526523,0.5611891026993358,0.9818181818181818,1.0,1.0,3/13,17.39%,PLA2G10;MSR1;CSF1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.3620911858281409,0.5611091211308072,0.94,1.0,1.0,4/8,35.18%,LIMK2;DLG1;CLASP1;TPPP
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,-0.3346262774949378,-0.5609383067915558,0.9772727272727273,1.0,1.0,1/7,13.89%,SLC2A1
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,0.3308845081367612,0.560736666600951,0.9649122807017544,1.0,1.0,1/11,6.41%,ITGAV
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.31418899197243827,-0.56055508839901,0.9761904761904762,1.0,1.0,3/11,13.00%,TBPL2;TCF7;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.3666225297157666,-0.55936917817401,0.9534883720930233,1.0,1.0,4/8,22.06%,ADAMTS1;PDGFB;NR4A3;FGF9
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.30814776147275963,-0.5592292607515389,0.9583333333333334,1.0,1.0,4/13,25.00%,KCNB1;MEAK7;MTOR;SCTR
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.3275913392186415,0.5592006028940136,0.9791666666666666,1.0,1.0,5/11,26.90%,RAPGEF6;AFDN;RAPGEF2;TJP2;TJP1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.3654815466548344,-0.5590205005854467,0.9803921568627451,1.0,1.0,2/5,25.88%,DCN;RACK1
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,-0.3191248549112264,-0.5586715808862863,0.9622641509433962,1.0,1.0,1/10,7.14%,PLCB2
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.3400059170241744,-0.5580830815861965,0.8269230769230769,1.0,1.0,2/9,17.01%,ADCY1;AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.3400059170241744,-0.5580830815861965,0.8269230769230769,1.0,1.0,2/9,17.01%,ADCY1;AHR
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.2731077276407797,0.5575929399940258,1.0,1.0,1.0,2/24,11.92%,NLGN1;MEF2C
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.316256403775207,-0.5575729313435029,0.9298245614035088,1.0,1.0,4/13,25.38%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.34821618678138755,-0.5575103258897838,0.9375,1.0,1.0,1/5,10.36%,BEX4
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3229806917809959,-0.5571273499311903,0.9795918367346939,1.0,1.0,4/16,14.90%,RHBDF1;CEACAM1;WDR54;RHBDF2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.216085052997279,-0.5570103193792308,1.0,1.0,1.0,46/234,21.02%,SNRNP27;DDX41;PRPF4;ZCRB1;RBM4;DHX8;WBP4;RNF113A;RBM4B;PRPF19;RNPC3;GTF2F1;SNRNP200;SNRPA1;CPSF4;RBMX2;CPSF3;SNIP1;CWC25;SF3A3;SUGP1;ESS2;CWF19L1;FIP1L1;DNAJC8;CSTF2;HNRNPL;SRSF10;PRPF6;SYF2;MAGOHB;SNW1;DHX38;CRNKL1;MFAP1;DHX35;SF3A1;RBM22;SNRPD2;PRCC;PDCD7;WBP11;SRSF7;RBMX;SLU7;NONO
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.31669613179927414,0.556924810549878,1.0,1.0,1.0,4/12,27.31%,ADGRB3;CD81;JAM2;ADAMTS5
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.262587759977561,0.5567711170222328,0.9811320754716981,1.0,1.0,4/32,13.69%,GLRA1;GLRB;RRAGC;CPEB1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.316325919265318,0.5562901385225866,0.9464285714285714,1.0,1.0,6/12,27.24%,H6PD;ABCA2;SEC14L2;SREBF2;CLCN2;LPCAT3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.3755790571528431,0.5562654244818491,0.896551724137931,1.0,1.0,1/5,14.02%,PML
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.2637635675070573,0.5561891407066419,0.9807692307692307,1.0,1.0,8/34,22.92%,ALDH1A1;DHRS3;LDHD;RARB;AKR1C3;RDH16;PDHA1;PDK4
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.27081423979010977,0.5556417769906468,0.9807692307692307,1.0,1.0,2/25,7.04%,HCLS1;HDAC3
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.30520932036233234,-0.5553903447083394,0.972972972972973,1.0,1.0,5/15,28.53%,CLTA;AP2A2;NR1H2;VLDLR;UBB
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.3463635551985981,0.55512148090163,0.9393939393939394,1.0,1.0,4/7,18.20%,TICAM1;SLC3A2;IRAK3;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.32467685414694736,-0.5548717070724429,0.9090909090909091,1.0,1.0,4/13,16.78%,SHISA7;SHANK3;ADCY1;AKAP5
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.35414301120603076,-0.5547933856255326,1.0,1.0,1.0,1/7,6.36%,PAX2
prerank,Reactome_2022__Neurotransmitter Clearance R-HSA-112311,0.3489514327829238,0.554244071511013,0.9636363636363636,1.0,1.0,2/9,15.26%,ACHE;BCHE
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.28563856825909256,-0.554130555442432,0.9787234042553191,1.0,1.0,2/21,7.71%,POLR3H;POLR3E
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.33059105734521743,0.5538498496732736,0.9795918367346939,1.0,1.0,5/11,25.05%,CD34;KNG1;EDN1;SERPINE1;APOE
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.326033029928306,0.5536699002257428,0.9074074074074074,1.0,1.0,3/7,26.64%,DYRK1A;ABCA7;BACE1
prerank,KEGG_2021_Human__Phenylalanine metabolism,0.33821272512035333,0.5531765209252527,0.9354838709677419,1.0,1.0,1/11,3.71%,HPD
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.3082086461278884,0.5531207329293066,0.9761904761904762,1.0,1.0,4/14,26.34%,RNF2;SCMH1;PHC3;PHC2
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.24706755329031735,-0.5531171152400836,1.0,1.0,1.0,13/57,21.67%,PSMB4;SPRED3;SPRED2;SPRED1;PSMC4;DAB2IP;PSMD8;PSME3;RASA3;RASAL1;PSMD12;PSMC3;PSMC2
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.25430865702033845,0.5527831980187619,1.0,1.0,1.0,4/46,16.35%,SEM1;PSMD13;NFE2L2;PSMA1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.2131302630435356,0.5526289448697347,1.0,1.0,1.0,27/151,29.80%,SEM1;ROBO2;PSMD13;RPS5;RPL21;PSME4;PSMA1;RPL18A;RPL7;RPS3A;NCBP1;RPL23A;PSMD4;ROBO3;ZSWIM8;COL4A5;SLIT2;RPL9;PSMB5;RPS29;RPS19;PSMB1;PABPC1;PSMC5;RSL24D1;RPS15A;RPS23
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,0.3390149365786297,0.5523155180963848,0.8863636363636364,1.0,1.0,2/8,20.74%,HSD17B10;TFB1M
prerank,Reactome_2022__Defective CHST6 Causes MCDC1 R-HSA-3656225,0.3661856181917482,0.5523067129145167,0.9565217391304348,1.0,1.0,2/5,19.06%,CHST6;PRELP
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,0.34787110595031184,0.5520115647808153,0.9375,1.0,1.0,1/8,19.33%,MCF2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.31544640562014126,-0.5518635617312241,0.9512195121951219,1.0,1.0,1/8,11.20%,SEMA3F
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.35226115220047244,0.5517085574326558,0.9230769230769231,1.0,1.0,2/5,17.69%,AKR1C1;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),0.3692293950433651,0.5516145425689509,0.9491525423728814,1.0,1.0,3/5,30.35%,IL23R;IL12A;IL23A
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.32374357762081796,0.5512233925078592,0.9821428571428571,1.0,1.0,2/8,26.81%,HEBP2;PRELID1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.32010662469646634,0.5510202528464133,0.9814814814814815,1.0,1.0,3/12,19.84%,TAP1;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.2333802772363527,-0.5507197160052982,1.0,1.0,1.0,11/67,16.24%,POLR1G;SSU72;GTF2H2;CPSF4;CPSF3;POLR1A;TBP;TTF2;FIP1L1;POLR1C;CSTF2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.2100832414017294,0.5501678552866442,1.0,1.0,1.0,45/277,23.18%,U2AF1;HNRNPH1;SF3B1;THOC6;SYNCRIP;SNRPN;ELAVL2;TRA2A;NOVA1;PAPOLA;CMTR2;SNRNP48;PCF11;HNRNPD;PUF60;PRPF40B;CDC5L;HSPA8;LSM8;RBM5;CCNH;RBM41;SPEN;SRSF11;HNRNPA2B1;MNAT1;ZCCHC8;PSPC1;FUS;RBM10;RAVER2;CSTF3;RBM17;POLR2H;WDR33;NCBP1;XAB2;SNRPA;CWC27;SRSF3;ERCC3;HNRNPU;LSM2;HNRNPF;GEMIN6
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.34275660680468956,0.5494214013666744,0.9818181818181818,1.0,1.0,2/9,10.99%,MUC13;CRACD
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.30317109135370685,-0.5493296480864963,0.9347826086956522,1.0,1.0,3/11,26.73%,CHMP3;ATP9A;SRC
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.32441984167965354,-0.549094520825896,0.9,1.0,1.0,1/9,16.57%,ADCY1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.2577324798379989,0.5490131903985804,1.0,1.0,1.0,7/28,23.79%,CARMIL1;SNX2;ARHGEF6;RHOD;KIT;ARHGEF4;SNX1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.3392641828214517,0.5488928755492819,0.9344262295081968,1.0,1.0,2/7,23.10%,NFE2L2;BCAP31
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.24762952006356342,0.5487879875436046,1.0,1.0,1.0,6/52,20.95%,SEM1;PSMD13;PSME4;PSMA1;PRKACB;PSMD4
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.3014709791940426,0.5486175756391038,1.0,1.0,1.0,5/13,22.70%,APELA;ACVR1B;VEGFA;TIMP1;GJA1
prerank,KEGG_2021_Human__Allograft rejection,0.3063847955432282,0.5481561955759543,0.9629629629629629,1.0,1.0,3/19,11.11%,IL4;CD40;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.2656495869382945,0.5480864320949818,0.9814814814814815,1.0,1.0,1/35,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.25377003409007165,0.5478735002006698,1.0,1.0,1.0,13/54,23.87%,KIAA0586;MAPK8;SLC26A4;RAB9A;PICALM;DZIP1L;AFDN;BORA;MAP2;RABGAP1L;DLG1;TRIM68;CEP290
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.35635703634003146,0.5474955611823326,0.9629629629629629,1.0,1.0,2/8,14.86%,CTCFL;PCGF5
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.2815424931498811,0.5472782799958572,1.0,1.0,1.0,1/26,3.21%,SEM1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.31443353120771067,-0.547245495299258,0.9607843137254902,1.0,1.0,2/8,24.94%,TGFB1;THBS1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2917581070462678,0.5470288281347099,0.9811320754716981,1.0,1.0,5/12,37.49%,GNL3L;CCT3;CCT7;DKC1;CCT4
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.27997015262369923,0.5466108549851657,0.9803921568627451,1.0,1.0,6/24,15.92%,SCNN1B;SCN3A;SCN2B;GRM4;SCN9A;GRM1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3290329513525032,-0.546060420678701,0.9629629629629629,1.0,1.0,3/10,12.79%,WNT7A;AKNA;WNT3A
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.2821310175681775,-0.5459310614343248,0.9814814814814815,1.0,1.0,2/24,7.96%,PER2;JUN
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.33611742300818603,-0.5458902305027726,0.9607843137254902,1.0,1.0,2/9,13.36%,TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.29782903495203245,-0.5458458947378663,1.0,1.0,1.0,4/20,17.78%,TTBK1;CCND1;RGCC;PDGFB
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.2940278144486104,0.5457385690587021,0.9827586206896551,1.0,1.0,6/15,38.94%,MAPK3;GRB2;BRAF;CBL;MKNK1;RPS27A
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.2687401660422626,0.5457217972592223,1.0,1.0,1.0,4/45,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.21362758307961843,-0.5452964893074684,1.0,1.0,1.0,21/169,18.82%,BUD23;SENP3;LAS1L;RPS27L;ISG20L2;NOL12;PDCD11;FTSJ3;UTP11;RPP38;RPL38;EMG1;EBNA1BP2;CSNK1D;RPL12;UTP15;GNL3;RPL37A;RPS8;RPS27;RPL4
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.31762385190383113,0.545191283373022,0.9787234042553191,1.0,1.0,3/9,21.42%,PTGFR;AKR1C3;TNFSF4
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.2805365639265752,-0.5445624367593215,0.9772727272727273,1.0,1.0,4/20,21.42%,MBTPS2;GNB3;MBTPS1;EPHX2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.28821283795569824,-0.5444987929146545,1.0,1.0,1.0,1/22,7.86%,BTBD18
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.3033043297500029,0.5439448045773445,0.9433962264150944,1.0,1.0,6/14,30.12%,RNF26;ZMPSTE24;DHX9;ELMOD2;PCBP2;HERC5
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.25217087552088946,-0.5439415185891109,1.0,1.0,1.0,14/37,34.49%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214;NPM1;NDC1;NUP88;TSC1;NUP37;NUP35;NUP50
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.347817734915303,0.5436340135922227,0.9464285714285714,1.0,1.0,4/7,26.89%,H6PD;AKR1C3;CLCN2;SIRT5
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.3558454855278754,-0.5433195861879957,0.96,1.0,1.0,1/6,14.35%,DCTN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.3474646050467418,0.5430660107132976,0.9649122807017544,1.0,1.0,2/6,11.92%,MTSS1;MEF2C
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.34042256929572645,-0.5430213096437773,0.9302325581395349,1.0,1.0,2/5,18.30%,MYLK3;CAV3
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.2877722582742294,-0.5428645729701667,0.9824561403508771,1.0,1.0,2/21,6.36%,CRYBA4;PAX2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.30086057005226613,-0.5424804738521947,0.8979591836734694,1.0,1.0,4/12,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.30046624324413684,-0.5421980565085319,0.9555555555555556,1.0,1.0,3/12,21.55%,PARP1;TYMP;MPV17
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.32020063136506177,-0.5420836085811611,0.8958333333333334,1.0,1.0,3/9,17.76%,SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.2766439239024582,-0.5418052670280071,1.0,1.0,1.0,4/31,14.14%,RCC1L;APOO;SPG7;DNAJC11
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.27449698768188385,0.5415788870240771,1.0,1.0,1.0,5/19,19.45%,CNTN1;MIB1;NOTCH2;ADAM10;JAG1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.3211821600186685,0.5410262953278133,0.9782608695652174,1.0,1.0,5/12,30.68%,THEM5;PNPLA8;SLC27A1;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.3205413334595183,-0.5406554994019819,0.9473684210526315,1.0,1.0,6/6,67.96%,TRIM62;PRKN;UBE2D4;UBE2T;UBE2S;RNF6
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,0.330278197146577,0.5404508922265998,0.94,1.0,1.0,2/6,30.23%,CASP3;CASP7
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,0.330278197146577,0.5404508922265998,0.94,1.0,1.0,2/6,30.23%,CASP3;CASP7
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.2993184399848542,-0.539368238535902,0.9056603773584906,1.0,1.0,11/11,70.09%,ADCY1;ADCY8;ADCY7;PTHLH;ADCY6;ADCY9;ADCY3;ADCY10;ADCY5;ADCY2;PDE4D
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.31681833225608996,0.5392262279250997,0.9795918367346939,1.0,1.0,8/12,40.92%,PTEN;SPTBN4;B4GALT5;ARHGAP35;MYCBP2;EPHB6;B4GALT6;CHRNB2
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.26806351337825424,0.5390631401289305,0.9811320754716981,1.0,1.0,9/29,24.65%,CAVIN1;TAF1A;CCNH;POLR1H;MNAT1;POLR2H;ERCC3;POLR1D;TAF1B
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Nasal Concha,0.34876765835577705,0.538901253427,0.9821428571428571,1.0,1.0,1/5,12.47%,CD34
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.24501740137697656,-0.5387521508715418,0.9767441860465116,1.0,1.0,16/44,34.49%,GTF2F1;POM121C;NUP133;GNL3;SEC13;NUP93;NUP43;NUP214;POLR2C;POLR2B;NDC1;POLR2I;NUP88;NUP37;NUP35;NUP50
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.2542942049534001,0.538578710235554,1.0,1.0,1.0,3/36,10.28%,NDE1;MYO1E;HAP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.3425480513793231,0.5384527440159008,0.9473684210526315,1.0,1.0,2/7,20.77%,HTR2C;HTR2A
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.2052598204301846,-0.5381871540238636,1.0,1.0,1.0,28/146,26.07%,RPS27L;CLTA;PARP1;GTF2F1;CPSF4;RPL38;TGFB1;POM121C;RPL12;NUP133;GNL3;RPL37A;RPS8;SEC13;RPS27;RPL4;KPNA7;RPL5;NUP93;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37;IPO5;NUP43;RAN
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.3692052226307373,0.5381408008159559,0.9836065573770492,1.0,1.0,1/5,7.63%,TF
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2635027042712448,-0.5377517264408322,0.9761904761904762,1.0,1.0,6/25,18.30%,ANKRD53;RAC1;DCTN1;TRPV4;KATNB1;CAV3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.3477395411314468,0.5375437151819497,0.9607843137254902,1.0,1.0,3/7,29.59%,SMAD4;RGS2;NOTCH1
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.23336198131807945,-0.5374958029460383,1.0,1.0,1.0,10/74,17.42%,GATD3;DLL4;PSMB4;PSMC4;SMAD3;PSMD8;APH1B;SKP1;PSME3;SNW1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.35401501990071055,-0.5369197107741688,0.94,1.0,1.0,1/5,16.77%,RAB3A
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.24470940726124812,0.5366215143825311,1.0,1.0,1.0,6/52,20.95%,SEM1;PSMD13;PSME4;PSMA1;PRKACB;PSMD4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.2273226177112987,0.536553611786843,1.0,1.0,1.0,21/84,30.92%,FBXO5;ANAPC16;PSMD13;PSME4;PSMA1;TP53;FZR1;UBE2D1;UBE2E1;PSMD4;ERCC3;GTSE1;PSMB5;ANAPC15;PSMB1;PSMC5;BTRC;TRIM39;CDC27;CCNB1;ANAPC7
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.31907605423337265,0.5361711952417461,1.0,1.0,1.0,4/13,23.57%,ESR1;PLPP1;NR3C1;BMP4
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.30872810080306223,-0.5361672837461572,0.8771929824561403,1.0,1.0,2/11,12.99%,UBASH3B;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.29292700293177365,0.5358214580133772,1.0,1.0,1.0,4/11,25.03%,CD81;SAR1A;BCAP31;EDEM1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.31934168415660524,-0.5357644701469306,1.0,1.0,1.0,1/8,8.85%,PGP
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.2943914781430012,0.5357037795410475,1.0,1.0,1.0,8/17,39.29%,CNTN4;HES5;B2M;DLX1;CALR;SOX9;GSK3B;HES1
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.24715438209880264,-0.5353968225646832,1.0,1.0,1.0,8/46,20.56%,ZCRB1;RNPC3;GTF2F1;SNRNP200;PRPF6;SNRPD2;PDCD7;SRSF7
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.2580093395157212,-0.5349197690868065,1.0,1.0,1.0,7/32,27.17%,POM121C;NUP133;GNL3;SEC13;NUP93;NUP43;NUP214
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.32293334246558636,0.5348157955098902,0.9508196721311475,1.0,1.0,1/8,17.28%,MTRF1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.3551437343355939,0.534810349069364,0.9375,1.0,1.0,3/5,28.45%,IL4I1;FAH;QDPR
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.3551437343355939,0.534810349069364,0.9375,1.0,1.0,3/5,28.45%,IL4I1;FAH;QDPR
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.28758223532611393,0.5346502183095438,1.0,1.0,1.0,8/17,39.48%,SEC61A1;RYR2;EDEM1;RAB10;SRPRB;SEC61G;ZFAND2A;RAB3GAP1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.3483541864386953,-0.5341420355507275,0.9361702127659575,1.0,1.0,1/8,8.01%,DPH6
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.33104857884476746,-0.5340257496342254,0.9814814814814815,1.0,1.0,1/8,9.08%,PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.33104857884476746,-0.5340257496342254,0.9814814814814815,1.0,1.0,1/8,9.08%,PDPR
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.26076835237012597,-0.5339688456791967,1.0,1.0,1.0,2/22,10.00%,RAD50;RTEL1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.3421824720802574,-0.5339030739156368,0.9555555555555556,1.0,1.0,7/7,65.80%,SRC;BDNF;FYN;STAP1;DOCK3;NTRK2;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.3346555527632506,-0.5335263089305867,0.9215686274509803,1.0,1.0,2/6,15.41%,CARTPT;ID2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.2965067486990837,-0.5332140759146147,0.9736842105263158,1.0,1.0,3/13,23.88%,EPHB1;PAFAH1B1;TSKU
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.32849098566223445,-0.532994518587423,0.9285714285714286,1.0,1.0,6/6,67.16%,PRDM5;SETDB1;SUV39H1;SUV39H2;BEND3;SETDB2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.32915345667912743,-0.5327649919378156,0.9607843137254902,1.0,1.0,6/6,67.10%,MSH3;TCF7L2;MSH2;MSH6;AXIN2;RMI2
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.29645298072737436,-0.5326964145281605,1.0,1.0,1.0,2/16,8.26%,HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.32948235824378336,0.532597817072986,0.9444444444444444,1.0,1.0,2/8,25.74%,PTPN23;RAB21
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.24043841400722402,-0.5325132170890291,1.0,1.0,1.0,15/43,27.64%,PSMB4;OAZ3;PSMC4;AZIN1;PSMD8;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NQO1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.31891737518924346,0.5320743364108499,0.9583333333333334,1.0,1.0,2/8,12.69%,PLXNB1;GREM1
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.23219426134213414,-0.5315723667198052,1.0,1.0,1.0,16/84,25.45%,RPS27L;SARS1;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;SECISBP2;RPL5;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.2749891413487536,0.5309404788268769,1.0,1.0,1.0,7/26,34.98%,DYNC1I2;ARL13B;WDR81;ACBD5;DYNC1I1;IFT88;DYNC1H1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.2708144217293167,0.5309266711572863,0.9782608695652174,1.0,1.0,3/20,18.25%,DLC1;PTPRK;RHOD
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.24411456303458948,-0.530907242277325,0.9791666666666666,1.0,1.0,7/33,27.17%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.24411456303458948,-0.530907242277325,0.9791666666666666,1.0,1.0,7/33,27.17%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.22604526627535576,-0.5307601446623591,1.0,1.0,1.0,16/87,25.45%,TMA7;ZC3H15;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;RPL5;RPL26L1;DRG1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.3093000655704607,-0.5307199638274126,0.9743589743589743,1.0,1.0,1/9,9.72%,ZNF703
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.341762219511223,-0.5292793345093793,0.9565217391304348,1.0,1.0,1/6,15.76%,VPS35
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2378349105975397,0.5285429072959722,1.0,1.0,1.0,17/63,29.15%,RELA;PSMD13;TNFRSF10B;IRAK1;PSME4;PSMA1;BIRC3;TNFRSF10A;PSMD4;REL;TRAF6;PSMB5;CHUK;PSMB1;PSMC5;DICER1;BTRC
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.3003054123164845,0.5283653558478479,0.9649122807017544,1.0,1.0,1/10,15.66%,PRKAA1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.30243245446445877,0.5279428802841021,0.9423076923076923,1.0,1.0,5/8,33.16%,CX3CR1;JAK2;SIRPA;CD47;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.3399326155132762,0.5279288844317832,0.9846153846153847,1.0,1.0,3/6,32.83%,TNFSF4;BMP4;ZC3H8
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.2985025581371191,0.5276350393139673,0.9795918367346939,1.0,1.0,4/12,32.21%,PCGF5;HNRNPU;RBM15B;YTHDC1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.3572784929839862,0.5276138709760315,0.9591836734693877,1.0,1.0,3/5,25.42%,NOTCH2;DOCK10;DOCK11
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.206939588755528,0.5275080225853277,1.0,1.0,1.0,21/165,21.31%,RIOK2;TSR3;PWP2;EXOSC4;RPL21;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;ERI1;RIOK3;EXOSC1;WDR18;TEX10;C1D;TFB1M;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.3327377451889363,-0.5273546780616228,0.9111111111111111,1.0,1.0,3/6,32.18%,SKP1;CAND2;RBX1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.2548977256857054,0.527102539179271,0.98,1.0,1.0,6/32,20.64%,PAPOLA;PCF11;MAZ;CSTF3;WDR33;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.34855290466855066,-0.5266446702104243,0.9787234042553191,1.0,1.0,4/5,25.94%,CAV1;PROM2;STX1B;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.30769840588268615,-0.5266008449954057,0.9555555555555556,1.0,1.0,2/8,17.78%,FOXO4;PDGFB
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.31560056042194284,-0.52619898914127,0.9583333333333334,1.0,1.0,2/9,13.86%,SLC36A2;SLC6A20
prerank,Reactome_2022__Sperm Motility And Taxes R-HSA-1300642,-0.3185955580074934,-0.5260398513094915,0.9523809523809523,1.0,1.0,3/7,21.65%,KCNU1;CATSPER4;HVCN1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.33563164911420973,0.5258720601293492,0.9148936170212766,1.0,1.0,1/8,12.47%,CD34
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.33563164911420973,0.5258720601293492,0.9148936170212766,1.0,1.0,1/8,12.47%,CD34
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.26255334179939704,0.525737369274527,1.0,1.0,1.0,5/27,19.07%,RANBP17;XPO1;STRADA;STYX;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.31147238404832095,0.5249941630277482,0.9444444444444444,1.0,1.0,5/8,36.98%,HEY2;GAS6;NOTCH1;ROCK1;SOX9
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.2857866535671446,0.5249134118653379,0.9818181818181818,1.0,1.0,4/15,31.21%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.3048370104556577,-0.524690855002553,0.9387755102040817,1.0,1.0,2/9,25.44%,STAT1;PTPN11
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.34416997917849723,0.5244528477406326,0.9591836734693877,1.0,1.0,7/7,65.59%,SASH1;DDX3X;BIRC2;PTPN22;PLAA;PARP10;GPS2
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,-0.33382227689978233,-0.5244073226301523,0.9347826086956522,1.0,1.0,5/5,66.63%,GABBR2;GAD2;GAD1;SLC6A1;GABBR1
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.225172049739166,0.5243472612936824,1.0,1.0,1.0,10/71,20.64%,PCF11;DAND5;INTS6;POU2F1;TAF5;ELL2;GTF2B;INTS11;POLR2H;NCBP1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.3540386249615972,0.5241846269363197,0.9555555555555556,1.0,1.0,3/5,39.74%,ATP8A1;ATP11B;SCARB2
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3099593403791798,-0.5240540355864437,0.98,1.0,1.0,1/9,14.35%,DCTN1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.27694224219182134,-0.5239777807849548,0.975,1.0,1.0,6/25,16.81%,PCSK6;ZNF703;SMAD3;TGFB1;LATS2;TGFBR3
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.26610613881078704,-0.5236041129796787,1.0,1.0,1.0,6/29,18.28%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.3158279915551077,-0.5232479894854679,1.0,1.0,1.0,1/6,10.61%,CCN3
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3418387343250397,0.5227040419860752,0.9807692307692307,1.0,1.0,1/6,7.72%,MTTP
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.23392028687938327,0.5226766721078262,1.0,1.0,1.0,14/70,26.34%,CDKN2A;SMC5;RNF2;PML;RANBP2;SMC3;NSMCE2;SCMH1;NUP153;PHC3;HERC2;TDG;PIAS2;PHC2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.29953649664821597,-0.5223365991620194,0.9583333333333334,1.0,1.0,4/16,15.54%,RNF8;KDM2B;RING1;SKP1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.29635041779417903,0.5218470348417842,0.9803921568627451,1.0,1.0,1/11,8.16%,MCM7
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.32587905767041436,-0.5214722506769359,0.92,1.0,1.0,2/5,20.77%,GRN;CYBA
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.33576787281128906,0.5212127854126878,0.967741935483871,1.0,1.0,1/6,15.16%,IL21R
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.33576787281128906,0.5212127854126878,0.967741935483871,1.0,1.0,1/6,15.16%,IL21R
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,0.32395852456254903,0.5204015132578811,0.9615384615384616,1.0,1.0,2/6,17.81%,SMAD4;TP53
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.33802957752072416,0.5202319019998698,0.98,1.0,1.0,2/5,33.84%,SAE1;UBA2
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.27662870082327956,0.5201190273610339,1.0,1.0,1.0,3/11,24.88%,CREB1;PRKACB;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.238220612929069,0.5200711941013353,1.0,1.0,1.0,12/47,25.05%,HDAC2;BAG2;TANK;ASPH;FADD;PERP;ASTL;BAD;FURIN;OGT;AURKAIP1;APOE
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.33226168801085876,-0.5192132477303807,0.9090909090909091,1.0,1.0,2/5,20.65%,SLC25A29;PDZK1
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.2568938667303384,0.5191761983331475,0.9803921568627451,1.0,1.0,5/15,31.21%,NBEA;PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.24417643885317392,-0.5189842887292517,0.9795918367346939,1.0,1.0,7/35,23.59%,POLR3H;POLR3E;TBP;POLR3A;POLR3F;GTF3C6;ZNF143
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.3283860858991799,0.5181571860706227,0.9814814814814815,1.0,1.0,3/8,25.25%,ALCAM;SLIT1;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.3283860858991799,0.5181571860706227,0.9814814814814815,1.0,1.0,3/8,25.25%,ALCAM;SLIT1;SLIT2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.3359077638754698,-0.5173109831154218,0.9591836734693877,1.0,1.0,1/6,15.40%,CALM1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.31478958914038535,0.5170529202552995,1.0,1.0,1.0,4/7,30.72%,ARHGAP21;STK25;RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.3058100345955648,-0.5163282682649063,0.9318181818181818,1.0,1.0,3/9,20.56%,TGFB1;ID2;PRKCA
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.33541773953226206,0.5163022869989241,0.9807692307692307,1.0,1.0,1/5,22.70%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.27265789376699484,0.5159939978849142,0.9807692307692307,1.0,1.0,5/21,22.26%,PDGFC;GREM1;VEGFA;RAP2A;ACE
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.2584754236444922,0.5155003823905194,1.0,1.0,1.0,9/31,24.65%,CAVIN1;TAF1A;CCNH;POLR1H;MNAT1;POLR2H;MAPK3;ERCC3;TAF1B
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.2897782227553256,-0.5154610782664804,0.9534883720930233,1.0,1.0,1/7,10.36%,BEX4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.3288560993728602,-0.5150569785728872,0.9512195121951219,1.0,1.0,1/8,10.52%,PARP1
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.2542370066550281,0.5144063813884555,1.0,1.0,1.0,6/31,22.19%,CCNH;NELFB;MNAT1;POLR2H;NCBP1;ERCC3
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.26361737480186165,0.5143300692360107,0.9818181818181818,1.0,1.0,8/19,37.03%,SLC2A5;IRS2;ZBED3;SELENOT;LPL;EIF2B5;KHK;GPLD1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.2984855655466162,-0.514251675024454,0.9583333333333334,1.0,1.0,9/9,70.17%,UBB;DIS3L2;UBA52;UBC;CHFR;TUT7;RPS27A;ISG15;TUT4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.26512575679967376,-0.514242063652823,1.0,1.0,1.0,4/25,15.06%,P2RY12;ABLIM2;RAC1;PARVB
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.26787309241224205,0.5142412629644392,1.0,1.0,1.0,5/27,20.75%,SKA3;STMN4;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.28012514296129765,0.5138161951805433,1.0,1.0,1.0,3/15,21.49%,HORMAD1;FMN2;NANOS1
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.254086122136732,0.5134194841020914,1.0,1.0,1.0,6/28,19.45%,CNTN1;MIB1;NUMB;ARRB2;ADAM10;JAG1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.33943089195635556,0.5132501458765121,0.9444444444444444,1.0,1.0,3/6,21.36%,HLA-E;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.33943089195635556,0.5132501458765121,0.9444444444444444,1.0,1.0,3/6,21.36%,HLA-E;HLA-F;HLA-B
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,-0.3012667046080032,-0.5129355546746712,1.0,1.0,1.0,1/10,7.14%,PLCB2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.2652296370831426,-0.5123556505093898,1.0,1.0,1.0,8/35,20.59%,SFRP1;AR;AKR1C2;ADCY1;AHR;AQP1;NDOR1;PCK2
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.20622189951961853,0.5122644260653231,1.0,1.0,1.0,21/127,23.80%,CHMP6;TAF3;XPO1;CCNH;TAF5;TAF2;UBAP1;RANBP2;NELFB;RCC1;MNAT1;GTF2B;MVB12A;POLR2H;TAF4;NCBP1;VTA1;NUP153;ERCC3;FURIN;SGIP1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.31014873160696776,-0.5116909161496163,0.9583333333333334,1.0,1.0,2/8,23.69%,KDM1B;RIOX1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2787780509318586,-0.5112839730039859,1.0,1.0,1.0,4/17,17.76%,FLOT1;ADAM19;BMP6;RGCC
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.20905742604510122,-0.5110269415342147,1.0,1.0,1.0,12/101,19.22%,EIF2S2;EIF2S3;RPS27L;EIF3J;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;EIF4H;EIF3L
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.3344863300438388,-0.5108739357265077,0.9534883720930233,1.0,1.0,1/5,17.38%,PAX8
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.3184429424645782,0.5103383133540761,0.9615384615384616,1.0,1.0,3/9,23.21%,GRID2;FMR1;CBLN1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.2815518064081527,0.5101801800636908,0.9811320754716981,1.0,1.0,4/11,27.11%,ATP1A2;ATP1B2;ATP12A;KCNJ2
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.23875243327844575,0.5099483451476168,1.0,1.0,1.0,2/48,9.76%,SEM1;PSMD13
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.3170727150523716,-0.509158038004403,1.0,1.0,1.0,1/8,14.31%,MFSD2A
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.20725443670797936,-0.5091090679794074,1.0,1.0,1.0,12/100,19.22%,EIF2S2;EIF2S3;RPS27L;EIF3J;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;EIF4H;EIF3L
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.26656910627035546,0.5087454793910525,0.9636363636363636,1.0,1.0,1/22,5.88%,TLR2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.2494077591133715,-0.5087143753430479,1.0,1.0,1.0,3/29,12.23%,COPG2;RAB6C;COPG1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.32176272382191906,-0.5085928599633752,1.0,1.0,1.0,1/6,15.04%,PHF19
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.227869185640285,-0.5085108408023185,1.0,1.0,1.0,15/48,25.87%,PSMB4;OAZ3;SMOX;PSMC4;AZIN1;PSMD8;PSME3;PSMD12;PSMC3;PSMC2;AZIN2;PSMD2;PSMA5;PSMC1;PSMD3
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.3476978404101028,0.5075768585665282,0.9836065573770492,1.0,1.0,4/5,34.81%,NPNT;PLPP3;ITGA4;ITGB1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.28674869853289164,-0.5067163438017199,0.9767441860465116,1.0,1.0,9/9,71.34%,SLC2A1;CYB5R3;SLC2A3;SLC23A1;SLC23A2;CYB5A;RGN;GSTO1;GSTO2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.2966576988760477,-0.505863066703201,1.0,1.0,1.0,1/9,9.04%,MLYCD
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.29109992551591496,-0.5051106537690359,1.0,1.0,1.0,2/12,17.26%,NRDE2;AKAP8L
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.22425181711858302,-0.5050364237709626,1.0,1.0,1.0,19/56,28.62%,ORC6;PSMB4;PSMC4;PSMD8;CDC6;MCM2;PSME3;MCM3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;MCM6;PSMB9;UBB;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.27991381623620837,0.5049107584614434,0.9803921568627451,1.0,1.0,4/13,25.01%,PPP1R15B;DNAJB9;HSPA5;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.3287593451310684,-0.5044762012932645,0.9523809523809523,1.0,1.0,5/5,67.14%,YAP1;PAK1;WBP2;KMT2D;LMO3
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,0.2874404451422531,0.5042334705767184,1.0,1.0,1.0,1/11,7.41%,ABCA1
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.2065653772027584,0.5042130692867494,1.0,1.0,1.0,18/91,31.70%,EIF3E;RPS5;RPL21;EIF3H;RPL18A;RPL7;RPS3A;RPL23A;EIF3G;RPL9;RPS29;RPS19;RSL24D1;RPS15A;RPS23;RPS12;EIF3A;RPLP0
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.23642471728027573,0.5041578556504609,1.0,1.0,1.0,4/48,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.20014976184047045,-0.5039642138839623,1.0,1.0,1.0,25/127,27.25%,RPS27L;PARP1;GTF2F1;RPL38;POM121C;RPL12;NUP133;GNL3;RPL37A;RPS8;SEC13;RPS27;RPL4;RPL5;NUP93;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37;IPO5;NUP43;NUP214;RPL35A
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.3394506451215764,0.5034952679147835,1.0,1.0,1.0,3/5,26.93%,PYCR1;DAO;ALDH18A1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.2851569513465639,0.5031412171692746,0.9795918367346939,1.0,1.0,1/11,10.14%,UQCC3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.31678096676045747,0.5013058231215826,0.9814814814814815,1.0,1.0,1/6,9.65%,NECTIN2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.29124512832737154,-0.5011445480377176,1.0,1.0,1.0,2/14,14.35%,ARF1;DCTN1
prerank,Reactome_2022__PTK6 Regulates Cell Cycle R-HSA-8849470,-0.31596950626150805,-0.5011152708655696,0.9433962264150944,1.0,1.0,1/5,13.84%,CCND1
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.3441894258403496,0.5009914740165353,0.9433962264150944,1.0,1.0,3/5,38.49%,GSK3A;EPM2AIP1;GSK3B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.24179842099771787,-0.5007978006521069,0.9433962264150944,1.0,1.0,5/24,18.30%,DSG2;CTNNA3;CAV1;CALM1;CAV3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.27901030088580675,0.5007540249577317,1.0,1.0,1.0,3/13,17.59%,DYNC1I2;APBA1;ARHGAP21
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.32093579577356385,0.5004300035737135,1.0,1.0,1.0,4/8,23.43%,NOC2L;IRS2;LYN;BLK
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.31745193048560594,-0.5004242608710306,0.9591836734693877,1.0,1.0,2/10,16.31%,JUN;HIF1AN
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.27179720457545015,0.49982481001568574,1.0,1.0,1.0,2/17,13.78%,PROX1;CCND3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.2748796133824937,0.4978154948823915,0.9615384615384616,1.0,1.0,1/14,9.52%,PIK3CA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.24061500043959033,-0.49752147803316465,1.0,1.0,1.0,6/33,18.28%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.23793197324713278,0.49685286817110247,1.0,1.0,1.0,4/43,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.32798363265082814,0.4968207551195739,0.9811320754716981,1.0,1.0,1/6,7.75%,HMGB1
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.25132396746446994,-0.4967264238912166,1.0,1.0,1.0,2/23,13.23%,CRYBA4;DEDD2
prerank,KEGG_2021_Human__Selenocompound metabolism,-0.28251178675391375,-0.4964832148761741,0.9803921568627451,1.0,1.0,2/15,14.40%,TXNRD2;INMT
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.2803099566850508,0.4964351163846891,1.0,1.0,1.0,2/12,16.70%,COX6A1;COX10
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.3273919166642667,-0.4960669009184261,0.9821428571428571,1.0,1.0,2/6,18.53%,SORD;ALDOB
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.26059766679627794,0.49569380587139966,0.9836065573770492,1.0,1.0,5/14,32.74%,PANK1;PPCS;ACLY;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.31659678103812816,0.4955582455182904,0.9545454545454546,1.0,1.0,2/9,25.74%,NUP153;AHCTF1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.3258205422986973,0.49520194671331996,1.0,1.0,1.0,2/5,26.96%,KIT;SHH
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.3269580326591417,-0.49506500832074246,0.9803921568627451,1.0,1.0,1/5,18.53%,ALDOB
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.30921550040949375,-0.49422556176140325,0.9433962264150944,1.0,1.0,2/8,21.58%,CAV3;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.30222863681411,0.49398667438563965,0.9666666666666667,1.0,1.0,2/6,20.22%,GPR62;RAPGEF2
prerank,Reactome_2022__Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,0.3173021404447742,0.4923811431006341,1.0,1.0,1.0,2/6,28.65%,ANXA1;APP
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,0.304651627355312,0.4922301858653915,0.9833333333333333,1.0,1.0,3/8,38.94%,HGS;RAB7A;RPS27A
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.268859550790517,0.49218544476830217,0.9811320754716981,1.0,1.0,3/16,19.41%,TLR2;KIT;ANXA2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.259413697485236,-0.4921355001593064,0.9807692307692307,1.0,1.0,2/20,9.26%,FLOT1;CDC37
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,-0.2830048173005764,-0.49191503156594046,1.0,1.0,1.0,6/12,26.23%,RTEL1;CIAO1;CIAO2B;NDOR1;MMS19;ERCC2
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.2011070374677619,-0.4918674345034465,1.0,1.0,1.0,8/64,18.26%,GTF2E1;TAF11;TAF7;GTF2F1;GTF2H2;TBP;CTDP1;TAF7L
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,0.26696113480782796,0.4905991769525619,0.9791666666666666,1.0,1.0,4/11,33.13%,PPP2R1B;POLA1;RB1;PRIM1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.3080490228552501,-0.49055194163508986,0.9444444444444444,1.0,1.0,6/6,69.21%,ATPAF1;TMEM70;ATPAF2;OXA1L;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21276157903940177,-0.49006550647765673,1.0,1.0,1.0,17/82,21.67%,PSMB4;FBXO39;FBXL18;PSMC4;CCNF;PSMD8;SKP1;PSME3;FBXL16;CUL2;FBXO2;FBXO44;PSMD12;FBXL13;FBXL12;PSMC3;PSMC2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.23340408144876074,-0.4878792361884563,1.0,1.0,1.0,9/26,24.56%,CELF3;SF3A3;SRSF10;SF3A1;SLU7;LUC7L2;KHDC4;CELF5;SF3A2
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.2853085952290799,0.4873563673586297,1.0,1.0,1.0,11/11,71.48%,HGS;RAB7A;RPS27A;KPNB1;ATP6V1H;RAB5A;UBC;UBA52;KPNA1;CORO1A;UBB
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.25976395213178083,0.4873271270219629,0.9824561403508771,1.0,1.0,4/14,25.08%,AGR2;DNAJB9;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.306336097957386,-0.48685767614940667,0.975,1.0,1.0,4/10,27.40%,DAB2IP;PACSIN1;ALK;VLDLR
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.22883948897551243,-0.4862210110468889,1.0,1.0,1.0,9/34,27.17%,POM121C;CDK1;NEK6;NUP133;SEC13;NUP93;NEK9;NUP43;NUP214
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.2801285870206277,-0.4853045506100764,1.0,1.0,1.0,3/12,20.69%,ADAM19;APH1B;APH1A
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.3005654475194784,0.48367853726497,1.0,1.0,1.0,2/9,20.60%,NR1H3;AXL
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,0.2053515951147191,0.48331973897895436,1.0,1.0,1.0,18/73,26.13%,MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.2506943974970074,0.4815249473888684,1.0,1.0,1.0,5/26,23.88%,NAV3;TOGARAM1;CLIP1;HSPA1A;AKAP9
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.3132985290440793,0.48113051894116626,0.9795918367346939,1.0,1.0,1/5,17.29%,AGMO
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.2759117826545917,-0.48105493637244556,0.9803921568627451,1.0,1.0,1/13,6.32%,SPACA3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2573565296812786,-0.48079335724143535,0.9761904761904762,1.0,1.0,4/12,26.10%,PACSIN3;ADAM8;ADAM9;SNX33
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.22901010728999946,0.4806476584272959,1.0,1.0,1.0,7/43,18.12%,NPC2;BTN2A2;FASN;ACACA;ACACB;PM20D2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3099891165475796,-0.4806344506426149,0.94,1.0,1.0,6/6,69.01%,ADAM17;FBXW7;BTC;EGF;TGFA;ADRA2A
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.2802941941235016,0.4793584420581521,1.0,1.0,1.0,4/11,24.93%,CCP110;LIMK2;EVI5L;CDK10
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.3103661820265799,0.4792943376890535,0.96,1.0,1.0,3/6,31.78%,CARD9;ACE;KMT2E
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.2333873912347601,0.4792010291302479,1.0,1.0,1.0,4/39,14.77%,NFIA;GTF3C4;POLR3G;POU2F1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.23320694986961088,-0.47866093147957595,1.0,1.0,1.0,4/28,15.15%,WNT7A;PTCH1;CYP26B1;OSR1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.2589576092238751,0.47840770436180424,1.0,1.0,1.0,3/18,25.74%,PTPN23;MAPK3;RAB21
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.31839623760911406,0.47787762012416013,0.9444444444444444,1.0,1.0,2/6,25.30%,TMEM120A;SCN1A
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,0.20364233825099956,0.47696030861205946,1.0,1.0,1.0,18/73,26.13%,MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.25986401032852235,-0.4765972276356245,0.9591836734693877,1.0,1.0,1/9,8.95%,PCCB
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.28527969788259394,-0.4760911555920987,0.9787234042553191,1.0,1.0,2/15,15.04%,CAMLG;EMC1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.26037164508735877,-0.47585650168764887,1.0,1.0,1.0,3/18,12.59%,AR;MISP;GBP1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.2723459456013844,0.4754711910042938,0.9574468085106383,1.0,1.0,2/11,18.93%,DSP;KIT
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.30366191740809556,-0.4749343478684939,0.9019607843137255,1.0,1.0,1/6,15.00%,SEC16A
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.31260803002767457,0.4737284095285697,1.0,1.0,1.0,2/5,22.25%,DNM3;MX2
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.31260803002767457,0.4737284095285697,1.0,1.0,1.0,2/5,22.25%,DNM3;MX2
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.2198215196505545,0.473315045311234,1.0,1.0,1.0,4/47,16.35%,SEM1;PSMD13;PSME4;PSMA1
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.33304556521600504,0.4730815417806164,1.0,1.0,1.0,1/5,16.45%,LIMK2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.262813292231732,-0.472536058072215,1.0,1.0,1.0,2/21,11.50%,DNAH11;MMP21
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.26497238311596355,-0.472508895579889,0.972972972972973,1.0,1.0,3/12,19.80%,HLA-DRB1;HLA-DQA1;HLA-DPA1
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,0.20316541952251466,0.47085628930519374,1.0,1.0,1.0,18/73,26.13%,MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.21991946325083042,-0.4699571760211426,1.0,1.0,1.0,10/29,32.56%,GTF2F1;CTDP1;ELOB;NELFE;SUPT5H;POLR2C;POLR2B;TCEA1;SSRP1;POLR2I
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.2907048128416954,0.4675019734814846,0.9696969696969697,1.0,1.0,3/6,39.76%,DHX9;YBX1;DDX3X
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.2728823093672647,0.4665768246689212,0.984375,1.0,1.0,5/7,43.59%,MVB12A;VCP;CHMP2B;LYST;UBXN6
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.26637327276168843,-0.46633478354331764,0.9772727272727273,1.0,1.0,7/7,73.38%,PTPRS;RTN4RL1;CERS2;RTN4R;THY1;EPHA4;INPP5F
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.2564585410276781,0.46545620254635667,1.0,1.0,1.0,6/22,34.98%,DYNC1I2;ARL13B;DYNC1I1;VCP;IFT88;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.2749176339782202,-0.4649950928309668,1.0,1.0,1.0,2/13,17.00%,IRF5;STAT1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.3176855347084516,0.4632541557154871,1.0,1.0,1.0,2/6,22.26%,DMD;ACE
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.2676168700526371,-0.4630453472772171,1.0,1.0,1.0,2/11,20.41%,CAV2;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.2307971524862067,-0.4627363068391612,1.0,1.0,1.0,5/33,19.59%,DHX58;TRAF3IP1;PTPRS;HAVCR2;NLRX1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.28788347750413235,-0.46257148869548825,0.926829268292683,1.0,1.0,1/5,13.89%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.30906413491107,0.46198880002365583,0.9827586206896551,1.0,1.0,1/5,11.90%,NR1H3
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.30906413491107,0.46198880002365583,0.9827586206896551,1.0,1.0,1/5,11.90%,NR1H3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.25938712757492133,-0.4608018565810696,1.0,1.0,1.0,3/9,26.95%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.2759456758677059,-0.46070964196003605,0.9743589743589743,1.0,1.0,3/12,15.69%,TMSB4X;CCDC22;NFKBIE
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.308034446862875,-0.46020174605739445,0.9807692307692307,1.0,1.0,5/5,69.21%,ATPAF1;TMEM70;OXA1L;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.29538141207647167,-0.459726605887299,1.0,1.0,1.0,7/7,70.48%,CD63;EMP2;DMTN;LIMS2;FLNA;LIMS1;LOXL3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.2958073064546659,-0.45939970834495253,0.9591836734693877,1.0,1.0,7/7,70.43%,HAAO;NMNAT2;NMNAT1;NADSYN1;NMNAT3;QPRT;KYNU
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.22300094999566294,0.4591194181332563,1.0,1.0,1.0,5/28,22.19%,CCNH;MNAT1;POLR2H;NCBP1;ERCC3
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.23968393075037192,0.4583588333091358,1.0,1.0,1.0,3/14,28.99%,SEC24B;SAR1A;SEC31A
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.19149556071935225,-0.45803802098942303,1.0,1.0,1.0,19/102,25.71%,RPS27L;RPN1;RPL38;SRP68;RPL12;RPL37A;RPS8;RPS27;RPL4;SRPRA;RPL5;SRP14;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37;SSR3
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.1930409942013563,-0.4566691206468016,1.0,1.0,1.0,19/104,25.45%,RPS27L;SARS1;VSIG2;RPL38;INMT;RPL12;RPL37A;RPS8;RPS27;RPL4;SECISBP2;RPL5;RPL26L1;RARS1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.22305050100542573,0.4562040898424305,1.0,1.0,1.0,6/22,29.96%,TAP1;SLC19A1;DISP1;SLC27A1;SLC38A5;SLC46A1
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,0.2874115159109042,0.4558887487231046,0.9821428571428571,1.0,1.0,2/8,22.25%,SOS1;GRB2
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,0.1917652822212217,0.45511919564132725,1.0,1.0,1.0,18/79,26.13%,MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.28987221959299575,-0.4547390233382559,0.9534883720930233,1.0,1.0,9/9,71.03%,KIF11;KIF25;CHEK1;RANBP1;NSFL1C;NEK2;UBXN2B;MAP9;CEP85
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.2699158893282926,-0.4547250121589734,0.925,1.0,1.0,2/6,19.19%,TCF7;MICB
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,0.26405717531238176,0.4540238042567076,0.9811320754716981,1.0,1.0,11/11,73.61%,JOSD2;VCP;RPS27A;RAD23B;ATXN3;UBC;UBA52;JOSD1;UBB;PRKN;RAD23A
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.2856380447238736,0.45356681729362275,0.9803921568627451,1.0,1.0,2/8,26.08%,NREP;MTR
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,0.1863271460675366,0.45276067558512345,1.0,1.0,1.0,9/73,20.70%,CMC1;TPRKB;LSM8;DERL2;PSMA1;VPS29;EXOSC1;NOP10;C1D
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.1898624610924661,-0.45240546314737873,1.0,1.0,1.0,12/76,21.94%,PDZD2;OAS3;OAS1;OAS2;POM121C;NUP133;STAT1;GNL3;SEC13;KPNA7;NUP93;RNASEL
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.2707988396100805,0.4518786057347491,1.0,1.0,1.0,4/16,21.31%,SP1;ZNF639;CHD1;RRP1B
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.2749470091057006,-0.45185848051909,1.0,1.0,1.0,4/11,22.42%,SERPINE2;PLAU;S100A10;PLG
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.3016609094780675,-0.4517588888143505,1.0,1.0,1.0,6/6,69.85%,RHOT2;UBB;MAP1S;UXT;LRPPRC;RHOT1
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.20934005526075727,-0.45105185910108564,1.0,1.0,1.0,10/31,32.56%,GTF2F1;CTDP1;ELOB;NELFE;SUPT5H;POLR2C;POLR2B;TCEA1;SSRP1;POLR2I
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.2337102950653157,0.4501275786510621,1.0,1.0,1.0,1/18,9.52%,PIK3CA
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.28215484240974986,0.44879962884970837,1.0,1.0,1.0,3/6,34.68%,TNFRSF21;EPHA4;NF1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.2615819026861349,-0.4485203891126292,1.0,1.0,1.0,1/7,14.18%,PRKCH
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.2765407484894389,-0.4483943981457753,0.9387755102040817,1.0,1.0,1/8,10.32%,ACAN
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.26988874355379644,0.4464461091393967,1.0,1.0,1.0,4/8,25.42%,MEF2C;LYN;DOCK10;DOCK11
prerank,Reactome_2022__RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,-0.268623875782909,-0.4462920241198087,0.9545454545454546,1.0,1.0,3/7,25.71%,RHPN2;RHPN1;RHOA
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.18291171464945166,0.4459409818141606,1.0,1.0,1.0,8/85,20.91%,RPS5;RPL21;SEC61A1;RPL18A;RPL7;SEC61A2;RPS3A;RPL23A
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.26975429710653903,-0.44540101719805236,0.9782608695652174,1.0,1.0,2/8,16.02%,TTN;HTR2B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.26409119519321966,-0.4448342623598767,1.0,1.0,1.0,3/9,25.88%,BAK1;COPS5;RACK1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.273179697636451,-0.4443627263896729,1.0,1.0,1.0,1/8,14.93%,BRCA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.19299001344020328,-0.44380029512280256,1.0,1.0,1.0,5/61,18.17%,C2ORF49;SARS1;CPSF4;CSTF2;DTWD2
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.24357018237644015,-0.4429972896488534,1.0,1.0,1.0,4/15,22.20%,CCND1;CDKN1C;E2F1;E2F3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.24371209664293977,0.4425895580727165,1.0,1.0,1.0,6/17,29.14%,BIRC3;OASL;ANKRD17;PUM2;PUM1;ZCCHC3
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.2608895671530925,-0.44244994574452756,0.9824561403508771,1.0,1.0,1/15,11.52%,APOB
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.2466603951476188,-0.44125338395329416,1.0,1.0,1.0,2/15,13.89%,PTCH1;TGFB1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.2534257750781471,-0.44076111973968995,1.0,1.0,1.0,4/15,23.90%,P2RY12;APOD;P2RX4;RTN4RL2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.2965122099484965,0.44034739264168754,1.0,1.0,1.0,1/5,10.93%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.24151479289940828,-0.43959646920191914,0.9795918367346939,1.0,1.0,14/14,75.87%,ATAD5;BRPF3;GLI2;STN1;KAT7;NPM2;PCNA;CTC1;EGF;BCAR3;FAF1;DNA2;EGFR;DHX9
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.27484383872799545,-0.43934096384643,1.0,1.0,1.0,7/7,72.53%,ADAM8;OSMR;PARK7;PTGS2;IL6ST;CREB3L3;PTGER3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.28107698859603464,-0.43816510905221695,0.9818181818181818,1.0,1.0,6/6,71.91%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.28107698859603464,-0.43816510905221695,0.9818181818181818,1.0,1.0,6/6,71.91%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.2064211011312761,0.4380246086482583,1.0,1.0,1.0,6/42,22.19%,CCNH;NELFB;MNAT1;POLR2H;NCBP1;ERCC3
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.20210910900659373,-0.437685342878255,1.0,1.0,1.0,15/54,28.53%,EPAS1;TOMM20;VDAC1;DYNC1LI2;PLIN2;PINK1;MAP1LC3A;TOMM7;MAP1LC3B;MFN2;SRC;TOMM22;DYNLL1;PRKN;UBB
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.2635812985046375,-0.43740240587234186,1.0,1.0,1.0,7/7,73.66%,PLIN2;PLIN3;FITM2;CIDEA;PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.2663606681493399,-0.43438947527200084,1.0,1.0,1.0,6/6,73.38%,PTPRS;RTN4RL1;CERS2;RTN4R;EPHA4;INPP5F
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.2717750578315252,-0.4342059927317948,0.9818181818181818,1.0,1.0,2/8,19.84%,KIF26A;RHOXF1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.2257262280701724,0.4334599123647518,1.0,1.0,1.0,1/14,11.86%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.1999257818432042,0.4330561264494587,1.0,1.0,1.0,8/51,28.71%,RANBP2;FMR1;H3-3A;POLR2H;NUP153;PUM2;PUM1;IPO8
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.1999257818432042,0.4330561264494587,1.0,1.0,1.0,8/51,28.71%,RANBP2;FMR1;H3-3A;POLR2H;NUP153;PUM2;PUM1;IPO8
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.268288000025969,0.4323375192439134,1.0,1.0,1.0,2/7,27.34%,IMPA1;IPPK
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.21100369679218378,0.4317594119136724,1.0,1.0,1.0,6/40,22.19%,CCNH;NELFB;MNAT1;POLR2H;NCBP1;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.2505561077192484,-0.431291780924205,1.0,1.0,1.0,10/10,74.96%,ABCB4;ABCA12;ABCA3;LRP1;DBI;TRIAP1;SPP1;CYP19A1;PRELID1;APOE
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.21435890958361464,-0.4310083684956137,1.0,1.0,1.0,2/26,10.93%,GTF2F1;GTF2H2
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,-0.2687706607976003,-0.43091096697369435,0.9787234042553191,1.0,1.0,1/8,10.32%,ACAN
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.2761756620318252,0.43008214282092494,1.0,1.0,1.0,1/6,20.59%,IKBKB
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.24945115183396716,-0.42954855428068767,0.9565217391304348,1.0,1.0,2/8,17.93%,WFS1;ATG10
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.25033288961472056,-0.42930954703312124,0.9767441860465116,1.0,1.0,3/14,20.15%,WNT7A;OSR1;TWIST1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.2610609000141958,-0.4287748542621897,1.0,1.0,1.0,6/6,73.91%,NRP1;TAOK2;SEMA3A;CHRNA7;PTN;PHACTR1
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.21882730900173686,0.42868980815340907,1.0,1.0,1.0,4/14,31.21%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.25454782692823713,-0.4286169084812454,0.9714285714285714,1.0,1.0,3/8,29.57%,NOD1;LDOC1;VIM
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,-0.25255865926105436,-0.42808227437375507,1.0,1.0,1.0,4/9,25.36%,CTSS;CTSB;HSP90B1;CTSL
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.20729363998327352,-0.42773674601349104,1.0,1.0,1.0,6/29,24.69%,DAB2IP;DAXX;BAK1;STUB1;HSPB8;BAG3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.21665301431808034,0.42716388401475686,1.0,1.0,1.0,3/17,22.43%,SIRT7;MAF1;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2293456141252691,-0.42706161022688305,1.0,1.0,1.0,2/18,14.93%,PAX2;BRCA1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.28603198637266963,-0.42701449069926584,1.0,1.0,1.0,5/5,71.41%,CRY2;PER1;CRY1;LMO3;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.2384330175883214,-0.4256054722873378,1.0,1.0,1.0,4/14,25.38%,SRSF10;SRSF7;RBMX;RNPS1
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.20807318072643602,0.42291281973936873,1.0,1.0,1.0,4/33,21.77%,XPO1;RANBP2;RCC1;NUP153
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.2197328664950105,0.4221349638664223,1.0,1.0,1.0,3/18,25.97%,PTBP2;SFSWAP;SRSF9
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.25942434960501964,0.42186304681602727,0.9591836734693877,1.0,1.0,2/7,29.12%,TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.25942434960501964,0.42186304681602727,0.9591836734693877,1.0,1.0,2/7,29.12%,TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.2814763405569485,0.4207566129311482,0.9824561403508771,1.0,1.0,2/5,37.05%,LTN1;ZNF598
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.16774539329517563,0.4206397512967547,1.0,1.0,1.0,16/83,31.70%,RPS5;RPL21;EEF1D;RPL18A;RPL7;RPS3A;RPL23A;RPL9;RPS29;RPS19;EEF1A1;RSL24D1;RPS15A;RPS23;RPS12;RPLP0
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.21306159650680476,0.41873875076978473,1.0,1.0,1.0,4/30,24.90%,MAP4K2;RANBP2;NUP153;MAP4K5
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.2728291766697548,-0.4181281516098085,0.9791666666666666,1.0,1.0,2/6,21.69%,PRPS1;G6PD
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.22747335320380566,0.41774489140256704,1.0,1.0,1.0,4/16,26.64%,ACHE;ADAM10;APOE;BACE1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.24171058029883502,-0.41670859944131533,1.0,1.0,1.0,1/10,14.93%,BRCA1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.15851390134149312,0.4158789548675263,1.0,1.0,1.0,17/104,29.80%,SMG1;RPS5;RPL21;RPL18A;RPL7;RPS3A;NCBP1;RPL23A;RPL9;RPS29;RPS19;PABPC1;RSL24D1;PPP2R2A;RPS15A;SMG9;RPS23
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.2498328765010356,0.41523753891103626,1.0,1.0,1.0,5/7,41.66%,FZD3;PAK2;BCL2L1;DFFA;CIDEA
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.2151687079035598,-0.4151778939219736,1.0,1.0,1.0,3/22,15.11%,FFAR4;PDE3A;CGAS
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.290950964865777,-0.41398006067699356,0.9696969696969697,1.0,1.0,1/5,14.28%,LETM1
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.16518621695472577,0.41391632168409814,1.0,1.0,1.0,16/82,31.70%,RPS5;DNAJC3;RPL21;RPL18A;RPL7;RPS3A;RPL23A;RPL9;RPS29;RPS19;RSL24D1;RPS15A;RPS23;PBRM1;RPS12;RPLP0
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.24735731557678065,0.41345085395091463,0.9811320754716981,1.0,1.0,2/10,18.27%,SYNE3;SUN2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.2326644397026702,0.41293494199431896,0.9791666666666666,1.0,1.0,2/14,21.54%,HEXB;NAGA
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.19349387772004945,-0.4128027286924839,1.0,1.0,1.0,8/32,27.17%,POM121C;NUP133;GNL3;SEC13;NUP93;NUP43;RAN;NUP214
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.226308534449589,-0.412487411297038,1.0,1.0,1.0,4/23,22.65%,DLL4;APH1B;APH1A;NEURL1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.25893273626286456,0.4117676248228945,1.0,1.0,1.0,1/6,18.92%,SAT1
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,0.24212866719857523,0.41171769118243035,1.0,1.0,1.0,3/8,34.18%,PDSS2;COQ7;COQ3
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.21961006419048001,0.4116000704076793,1.0,1.0,1.0,6/13,30.99%,PRKAA1;CCDC3;ASXL3;PPP2R5A;SLC22A13;ADRA2A
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.20730703797930206,-0.41017324790209503,1.0,1.0,1.0,4/32,17.09%,CAMLG;OTOF;EMC1;EMD
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,0.238654110075245,0.40821602253673495,1.0,1.0,1.0,8/8,76.14%,SAE1;UBA2;SENP1;SUMO1;SENP5;UBE2I;SENP2;SUMO2
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,-0.23610716652466157,-0.408122077144341,1.0,1.0,1.0,13/13,76.41%,AMER1;PPP2R5D;PROC;CSNK1A1;PPP2R1A;PPP2CB;PPP2R5C;AXIN1;GSK3B;PPP2R5E;PPP2R5B;PPP2R5A;PPP2R1B
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.26007207668492205,-0.40800597048822357,1.0,1.0,1.0,1/6,15.85%,NHP2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.24000669464701116,0.4064426465180361,1.0,1.0,1.0,2/11,25.74%,PTPN23;RAB21
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.1970575213994804,0.40637217288748084,1.0,1.0,1.0,4/35,21.77%,XPO1;RANBP2;RCC1;NUP153
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.21880939015517176,0.40518682783440896,1.0,1.0,1.0,3/12,29.85%,ALDH6A1;DPYSL5;DPYSL3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.23823899626117082,0.40413106889882655,1.0,1.0,1.0,1/7,15.96%,ME3
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.1587083798388686,0.40168666737271996,1.0,1.0,1.0,16/86,31.70%,RPS5;RPL21;RPL18A;RPL7;RPS3A;NCBP1;RPL23A;RPL9;RPS29;RPS19;PABPC1;RSL24D1;RPS15A;RPS23;RPS12;RPLP0
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.27060660546985893,0.40115330957514256,1.0,1.0,1.0,5/5,72.95%,TJP1;FERMT2;CAMSAP3;KIFC3;PLEKHA7
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.23837185595345256,0.39974706927052067,1.0,1.0,1.0,5/10,36.08%,EMC2;EMC9;EMC6;EMC10;MMGT1
prerank,CellMarker_Augmented_2021__Macrophage:Spleen,0.23959178873245482,0.3992957518486971,1.0,1.0,1.0,1/5,22.81%,ITGAM
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.24340190578190907,-0.39847924231653237,1.0,1.0,1.0,3/8,26.12%,MTHFD1L;HAAO;MTHFD1
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.19576025526613197,-0.3982565914955605,1.0,1.0,1.0,8/32,27.67%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214;NPM1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.2170619753665924,0.3973738633411598,1.0,1.0,1.0,4/15,31.21%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.18563028620508484,-0.3955967357982176,1.0,1.0,1.0,5/26,26.07%,NUP133;SEC13;NUP93;NUP43;RAN
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.2709851424245292,-0.39492237359143073,1.0,1.0,1.0,5/5,72.91%,CAPG;ASAP1;FSCN1;LCP1;IL5
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.21783584209031526,-0.39391744435943854,1.0,1.0,1.0,13/13,78.23%,NUP133;NUP93;NDC1;RTN4;NUP35;NUP98;NUP107;SEH1L;TPR;NUP205;NUP54;AHCTF1;NUP153
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.17012952867762368,-0.3936270287413517,1.0,1.0,1.0,9/48,27.17%,WDR77;POM121C;NUP133;SEC13;SNRPD2;NUP93;NUP43;SMN1;NUP214
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.1684424574638854,-0.39014677918289514,1.0,1.0,1.0,14/80,25.45%,RPS27L;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;RPL5;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.16192460278049192,-0.3898980232826927,1.0,1.0,1.0,14/83,25.45%,RPS27L;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;RPL5;RPL26L1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.1979506426814041,0.38943562420609634,1.0,1.0,1.0,7/22,30.63%,PKN2;LGMN;PPP1R10;USP2;EIF4E;APP;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.28238702179541975,0.3889761463698043,1.0,1.0,1.0,3/5,35.03%,HNRNPU;CCNB1;SIRT2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.1752359277897949,0.3873435181699518,1.0,1.0,1.0,11/48,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.1752359277897949,0.3873435181699518,1.0,1.0,1.0,11/48,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.18596264426468972,0.38675672488113744,1.0,1.0,1.0,9/27,32.49%,MAPK8;MAP3K8;IKBKB;MAPK3;CHUK;NFKB1;BTRC;MAP3K7;CUL1
prerank,"Reactome_2022__Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",-0.23336121393218365,-0.3819030398285088,1.0,1.0,1.0,3/7,22.92%,CDK1;NEK6;NEK9
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.21883667171041052,0.3814593617826679,1.0,1.0,1.0,4/10,29.59%,VEGFA;NEXMIF;EPCAM;NOTCH1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.23901253030255104,0.37999648592990865,0.9803921568627451,1.0,1.0,2/7,26.93%,PHF14;BRPF1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.2328472179866228,0.37846318456774175,1.0,1.0,1.0,1/10,12.35%,IRAK1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.16913718142868883,0.37789392436193053,1.0,1.0,1.0,11/51,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.2245394696340866,-0.3760920042467981,1.0,1.0,1.0,2/8,16.97%,MED1;ZNF385A
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.1658491165238075,0.37367184474583215,1.0,1.0,1.0,10/42,32.17%,RPS5;RPS3A;GEMIN6;RPS29;GEMIN2;RPS19;RPS15A;RPS23;RPS12;DDX20
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.1885499247100852,0.3688020547366525,1.0,1.0,1.0,3/22,20.64%,NELFB;POLR2H;NCBP1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.15343440297378252,-0.36843034376151346,1.0,1.0,1.0,16/88,25.45%,RPL38;SRP68;SEC62;RPL12;RPL37A;RPS8;RPS27;RPL4;SRPRA;RPL5;SRP14;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.1799112122250832,-0.3657163247478394,1.0,1.0,1.0,5/25,24.69%,DAB2IP;DAXX;BAK1;HSPB8;BAG3
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.16810385672320668,-0.3645195265161087,1.0,1.0,1.0,33/33,83.22%,POM121C;NUP133;SEC13;NUP93;NUP43;NUP214;NDC1;NUP88;NUP37;NUP35;NUP50;KPNA1;NUP98;NUP210;NUP85;NUP107;PSIP1;POM121;NUP155;SEH1L;HMGA1;TPR;AAAS;NUP205;NUP54;NUP58;NUP160;NUP188;NUP42;SGIP1;NUP153;BANF1;RANBP2
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.1681277543477231,-0.3552732335587001,1.0,1.0,1.0,36/36,83.22%,POM121C;NUP133;SEC13;NUP93;NUP43;NUP214;NDC1;NUP88;NUP37;NUP35;NUP50;KPNA1;SLC25A4;NUP98;NUP210;NUP85;NUP107;PSIP1;POM121;NUP155;SEH1L;HMGA1;SLC25A5;TPR;AAAS;NUP205;NUP54;NUP58;NUP160;NUP188;NUP42;SLC25A6;SGIP1;NUP153;BANF1;RANBP2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.1658991459364574,-0.352849127871968,1.0,1.0,1.0,8/33,27.17%,POM121C;NUP133;GNL3;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.20020301465855572,0.35154090025395796,1.0,1.0,1.0,3/10,31.45%,PRKAA1;ADRA2A;PLIN5
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.14677313339541537,-0.34807154049677486,1.0,1.0,1.0,19/97,27.25%,RPL38;SRP68;SEC62;RPL12;RPL37A;RPS8;RPS27;RPL4;SRPRA;RPL5;SRP14;RPS20;ZFAND2B;RPL22;RPL34;RPL31;RPL37;SGTB;RPL35A
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.16012551348322074,0.34492254794682126,1.0,1.0,1.0,7/43,26.34%,RNF2;RANBP2;SCMH1;NUP153;PHC3;HNRNPC;PHC2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.21128093503052098,-0.34144404936543443,1.0,0.9998035066867633,1.0,6/6,78.88%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.21128093503052098,-0.34144404936543443,1.0,0.9998035066867633,1.0,6/6,78.88%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.18958438278566808,0.33291118010744486,1.0,1.0,1.0,5/11,35.83%,MICALL1;FNBP1L;BIN3;EHD2;SNX9
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.20794624293355674,0.32673949135248154,1.0,1.0,1.0,3/9,26.96%,PROX1;BMP4;SHH
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.14714245095251652,0.29783603208002796,1.0,0.9999978069357849,1.0,37/37,85.31%,PML;RANBP2;NUP153;PIAS2;NUP42;NUP188;NUP160;NUP58;PIAS1;NUP54;NUP205;AAAS;TPR;MDM2;TRIM27;SUMO1;SEH1L;NUP155;POM121;NUP107;UBE2I;NUP85;NUP210;NUP98;NUP50;NUP35;NUP37;VHL;NUP88;NDC1;PIAS4;NUP214;NUP43;NUP93;SEC13;NUP133;POM121C
